Citrus Sinensis ID: 002746

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-----
Protein Sequence
MLVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPGMPICPPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKSETRSKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGEKHMPSKMNALHLEDIIAICNPQA
Secondary Structure (PSIPRED)
ccccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccccccccHHHcccccccEEEccccccccccccccccccccccEEcccccccccccHHHHHHccccEEEcccccEEEcccccccccccccEEEcccccccccccccccccccccHHccccccEEEccccccccccccccccccccEEEccccccEEcccccccccccccEEEccccEEEEcccccccccccccEEEccccEEEEcccccccccccccEEEcccccccccccHHHHcccccccEEccccEEcccccccccccccccEEEcccccccccccHHHHccccccccEEcccccccccccHHHHcccccccEEcccccccccccHHHHHcccccEEEcccccccccccHHHHccccccccccccccccccccHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEEccccEEEEEEEccccccccHHHHHHHHHHccccccccccEEEEEEcccccEEEEccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHccccccccEEccccccccccccccEEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHcccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHHcccccccccccccHHHHHHccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccHHHcccccccEEEcccccccccccHHHcccccccEEEEccccccccccHHHHHccccccEEEEccccccccccHHHccccccEEEEEccccccccccHHHcccccEEEEcccccccccccHHHHHccccccEEEEccccccccccccccccccHHHcccccEEEEEcccccccccccHHHccccEEEEEcccccccccccHHHccccccEEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEcccccccccccHHHcccccHHHHEEcccccccccccHHHcccccccEEEcccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEcccccccccccHHHccccccEEEEEcccccccccccccccccccHHHEccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccHHHHHHHHHcccHccEEEcccccEEEEEEcccccEEEEEEEcccccccccHHHHHHHHHHHccHHHHHHHHEEEccccccEEEEEccccccHHHHHccccccccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEccccccEEcccccHHHHHHHHHHHHHcccccccccccccccccEEEEcccccccccHHcEEEEEcccccHEHHHHHHHHHHcccccccccccccccHHHHHHHHHcccHHHHccHHHHccccccccccccHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mlvdnhlfgaippefSKLRRLRHLQldgnnlhgqipESLALLSNLTlvtlhdnnltgmlpisffhnctslrnvdlsqnfftgkipeeigncpnlwtlslynnqltgqlpaslinTSMYNLDVEYnhlsgelpsdimsklpsltyLHLSynnmvshddntnlvpffnslgnctdleELELAGmdlggtlpdsigrLNLTQLLLQenkitgsipphignlSNLISLNLSSNLLSGTISAEISWLSQLEQLFLShnlfsgeipaalgklhhlglldlsfnklsgeipvsLGNLVQIYSLFLnnnqlsrsipptlgrctdlykldlsynrltgsipaeiSGIREIRIFLNLshnqlegplpielsklenvqeidlssnkftgnIFIQISNCIAVRLINIShnalqgnlpdslgdlknleaidvsgnhlsgiipislnkihtlTFINLsfnefkgmipsggifnsatkmsfvgnqhlcgtvpgmpicppkqhwlhtrMYFIIFVLVISISAFLSTICLVTGIHRIKLIIssgksetrskpitpelmhnfprITYRELLEATAEFdeqrllgtgsygRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLpymangsldshlyphsetefgsgssdltLLQRVNICSDIAEGMaylhhhspvrvihcdlkpsnvllnddmTALVSDFGIAKLVMTVGvgndgaenmgnsTANMLCgsigymapeygfgsntstkgdvySFGILVLEMvtrrrptddmfaggLSLHKWVKNHYHGRLEKVIDSsllrasrdqspevKRMWDVAIGELIELGIlctqespstrptmldAADDLDRLKRYlgekhmpskmnALHLEDIIAICNPQA
Flexible Loop (DISEMBL)
MLVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPGMPICPPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLiissgksetrskpitpelmhnfpRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLqsgnftksfnRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRlekvidssllrasrdqspevkRMWDVAIGELIELGILctqespstrptmldAADDLDRLKRYLGEKHMPSKMNALHLEDIIAICNPQA
Low Complexity Region (SEG)
MLVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPEslallsnltlvtlHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGnlsnlislnlssnllsGTISAEISWLSQLEQLFLSHNLFSGEIPAAlgklhhlglldlSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPGMPICPPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKSETRSKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMldaaddldRLKRYLGEKHMPSKMNALHLEDIIAICNPQA
Disordered region (IsUnstruct)
*****HLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPGMPICPPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIIS*************ELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPH*********SDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLL*********VKRMWDVAIGELIELGILCT*********************************NALHLEDIIAIC****
Disordered Region (DISOPRED)
MLVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTV*********************FVLVISISAFLSTICLVTGIHRI**********************NFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSE*****GSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVG*************ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRA*********RMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL*****************************
Disordered Region (DISEMBL)
MLVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPGMPICPPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKSETRSKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGEKHMPSKMNALHLEDIIAICNPQA
Disordered Region (DISPRO)
*LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPGMPICPPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSG********ITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSET*****SSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVG**********NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLK****************************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPGMPICPPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKSETRSKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGEKHMPSKMNALHLEDIIAICNPQA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	885	2.2.26 [Sep-21-2011]
Q9ZUI0	980	Putative leucine-rich rep	yes	no	0.961	0.868	0.486	0.0
C0LGP4	1010	Probable LRR receptor-lik	no	no	0.915	0.801	0.362	1e-138
C0LGT6	1031	LRR receptor-like serine/	no	no	0.928	0.797	0.341	1e-128
Q9FL28	1173	LRR receptor-like serine/	no	no	0.901	0.680	0.346	1e-123
Q9SD62	1025	Putative receptor-like pr	no	no	0.920	0.795	0.341	1e-119
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.926	0.656	0.332	1e-113
C0LGX3	993	LRR receptor-like serine/	no	no	0.916	0.816	0.315	1e-112
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.920	0.683	0.324	1e-111
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.920	0.650	0.326	1e-111
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.911	0.732	0.321	1e-108

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  739 bits (1908), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 424/872 (48%), Positives = 574/872 (65%), Gaps = 21/872 (2%)

Query: 2   LVDNHLFGAIPPEFSKLRR-LRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLP 60
           L  N   G IPPE   L   L+ L L  N LHG IP+ L LL+ L  + L  N L G +P
Sbjct: 97  LSRNFFVGKIPPEIGSLHETLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIP 156

Query: 61  ISFFHN--CTSLRNVDLSQNFFTGKIPEEIGNC--PNLWTLSLYNNQLTGQLPASLIN-T 115
           +  F N   +SL+ +DLS N  TG+IP    +C    L  L L++N+LTG +P+SL N T
Sbjct: 157 VQLFCNGSSSSLQYIDLSNNSLTGEIPLNY-HCHLKELRFLLLWSNKLTGTVPSSLSNST 215

Query: 116 SMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLE 175
           ++  +D+E N LSGELPS ++SK+P L +L+LSYN+ VSH++NTNL PFF SL N +DL+
Sbjct: 216 NLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQ 275

Query: 176 ELELAGMDLGGTLPDSIGRL--NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSG 233
           ELELAG  LGG +  S+  L  NL Q+ L +N+I GSIPP I NL NL  LNLSSNLLSG
Sbjct: 276 ELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSG 335

Query: 234 TISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQI 293
            I  E+  LS+LE+++LS+N  +GEIP  LG +  LGLLD+S N LSG IP S GNL Q+
Sbjct: 336 PIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQL 395

Query: 294 YSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAE-ISGIREIRIFLNLSHNQL 352
             L L  N LS ++P +LG+C +L  LDLS+N LTG+IP E +S +R ++++LNLS N L
Sbjct: 396 RRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHL 455

Query: 353 EGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLK 412
            GP+P+ELSK++ V  +DLSSN+ +G I  Q+ +CIA+  +N+S N     LP SLG L 
Sbjct: 456 SGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLP 515

Query: 413 NLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHL 472
            L+ +DVS N L+G IP S  +  TL  +N SFN   G +   G F+  T  SF+G+  L
Sbjct: 516 YLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLL 575

Query: 473 CGTVPGMPICPPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKSETR 532
           CG++ GM  C  K  +    +  ++ ++   +        LV      K +    K E  
Sbjct: 576 CGSIKGMQACKKKHKYPSVLLPVLLSLIATPVLCVFG-YPLVQRSRFGKNLTVYAKEEVE 634

Query: 533 SKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQ 592
            +    +    +PRI+Y++L+ AT  F+   L+G+G +G VYKG+L++ T +AVKVL  +
Sbjct: 635 DEEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPK 694

Query: 593 SG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETE 651
           +   F+ SF RECQ+LKR RHRNL+RIIT CS P F ALVLP M NGSL+ HLYP   + 
Sbjct: 695 TALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPGEYS- 753

Query: 652 FGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI 711
               S +L L+Q VNICSD+AEG+AYLHH+SPV+V+HCDLKPSN+LL+D+MTALV+DFGI
Sbjct: 754 ----SKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGI 809

Query: 712 AKLVMTV--GVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEM 769
           ++LV  V   V  D + + G ST  +LCGS+GY+APEYG G   ST GDVYSFG+L+LE+
Sbjct: 810 SRLVQGVEETVSTDDSVSFG-STDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEI 868

Query: 770 VTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPE-VKRMWDVAIGEL 828
           V+ RRPTD +   G SLH+++K+HY   LE +I+ +L R      PE  +++W   I E+
Sbjct: 869 VSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWREVILEM 928

Query: 829 IELGILCTQESPSTRPTMLDAADDLDRLKRYL 860
           IELG++CTQ +PSTRP MLD A ++ RLK YL
Sbjct: 929 IELGLVCTQYNPSTRPDMLDVAHEMGRLKEYL 960

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  491 bits (1264), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 323/890 (36%), Positives = 485/890 (54%), Gaps = 80/890 (8%)

Query: 5   NHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFF 64
           N+L G IP       RL +L+LD N L G +P  L  L+NL  + L+ NN+ G LP S  
Sbjct: 124 NYLRGPIPLGLYNCSRLLNLRLDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSL- 182

Query: 65  HNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNLDVE 123
            N T L  + LS N   G+IP ++     +W+L L  N  +G  P +L N +S+  L + 
Sbjct: 183 GNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIG 242

Query: 124 YNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMD 183
           YNH SG L  D+   LP+L   ++  N        T  +P   +L N + LE L +   +
Sbjct: 243 YNHFSGRLRPDLGILLPNLLSFNMGGNYF------TGSIP--TTLSNISTLERLGMNENN 294

Query: 184 LGGTLP---------------DSIGR------------LNLTQLL---LQENKITGSIPP 213
           L G++P               +S+G              N TQL    +  N++ G +P 
Sbjct: 295 LTGSIPTFGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPI 354

Query: 214 HIGNLS-NLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLL 272
            I NLS  L++L+L   L+SG+I  +I  L  L++L L  N+ SG +P +LGKL +L  L
Sbjct: 355 SIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYL 414

Query: 273 DLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIP 332
            L  N+LSG IP  +GN+  + +L L+NN     +P +LG C+ L +L +  N+L G+IP
Sbjct: 415 SLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIP 474

Query: 333 AEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRL 392
            EI  I+++ + L++S N L G LP ++  L+N+  + L  NK +G +   + NC+ +  
Sbjct: 475 LEIMKIQQL-LRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMES 533

Query: 393 INISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMI 452
           + +  N   G++PD L  L  ++ +D+S N LSG IP        L ++NLSFN  +G +
Sbjct: 534 LFLEGNLFYGDIPD-LKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKV 592

Query: 453 PSGGIFNSATKMSFVGNQHLCGTVPGMPICP--------PKQHWLHTRMYFIIFVLVISI 504
           P  GIF +AT +S VGN  LCG + G  + P         K+H   +R+  ++  + + I
Sbjct: 593 PVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKH--SSRLKKVVIGVSVGI 650

Query: 505 SA----FLSTICLVTGIHRIKLIISSGKSETRSKPITPELMHNFPRITYRELLEATAEFD 560
           +     F++++ L+    R K      K      P T E++H   +I+Y +L  AT  F 
Sbjct: 651 TLLLLLFMASVTLIWLRKRKK-----NKETNNPTPSTLEVLHE--KISYGDLRNATNGFS 703

Query: 561 EQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRII 619
              ++G+GS+G VYK +L  +   +AVKVL +Q     KSF  EC+ LK IRHRNL++++
Sbjct: 704 SSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLL 763

Query: 620 TACSLPDF-----KALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           TACS  DF     +AL+  +M NGSLD  L+P    E    S  LTLL+R+NI  D+A  
Sbjct: 764 TACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASV 823

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           + YLH H    + HCDLKPSNVLL+DD+TA VSDFG+A+L++      D        ++ 
Sbjct: 824 LDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKF----DEESFFNQLSSA 879

Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
            + G+IGY APEYG G   S  GDVYSFGIL+LEM T +RPT+++F G  +L+ + K+  
Sbjct: 880 GVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSAL 939

Query: 795 HGRLEKVIDSSLLRAS-RDQSPEVKRMWDVAIGELIELGILCTQESPSTR 843
             R+  ++D S+L    R   P V+      +  + E+G+ C +ESP  R
Sbjct: 940 PERILDIVDESILHIGLRVGFPVVE-----CLTMVFEVGLRCCEESPMNR 984

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  458 bits (1178), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 319/934 (34%), Positives = 478/934 (51%), Gaps = 112/934 (11%)

Query: 7   LFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHN 66
           L G I P    L  LR L L  N+    IP+ +  L  L  + +  N L G +P S   N
Sbjct: 85  LTGVISPSIGNLSFLRLLNLADNSFGSTIPQKVGRLFRLQYLNMSYNLLEGRIPSSL-SN 143

Query: 67  CTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNLDVEYN 125
           C+ L  VDLS N     +P E+G+   L  L L  N LTG  PASL N TS+  LD  YN
Sbjct: 144 CSRLSTVDLSSNHLGHGVPSELGSLSKLAILDLSKNNLTGNFPASLGNLTSLQKLDFAYN 203

Query: 126 HLSGELPSDIMSKLPSLTYLHLSYNNM----------------VSHDDNT---NLVPFF- 165
            + GE+P ++ ++L  + +  ++ N+                 +S  DN+   NL   F 
Sbjct: 204 QMRGEIPDEV-ARLTQMVFFQIALNSFSGGFPPALYNISSLESLSLADNSFSGNLRADFG 262

Query: 166 ---------------------NSLGNCTDLEELELAGMDLGGTLPDSIGRL--------- 195
                                 +L N + LE  +++   L G++P S G+L         
Sbjct: 263 YLLPNLRRLLLGTNQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIR 322

Query: 196 -------------------NLTQLLLQE---NKITGSIPPHIGNLSN-LISLNLSSNLLS 232
                              N TQL   +   N++ G +P  I NLS  L SL L  NL+S
Sbjct: 323 NNSLGNNSSSGLEFIGAVANCTQLEYLDVGYNRLGGELPASIANLSTTLTSLFLGQNLIS 382

Query: 233 GTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQ 292
           GTI  +I  L  L++L L  N+ SGE+P + GKL +L ++DL  N +SGEIP   GN+ +
Sbjct: 383 GTIPHDIGNLVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTR 442

Query: 293 IYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQL 352
           +  L LN+N     IP +LGRC  L  L +  NRL G+IP EI  I  +  +++LS+N L
Sbjct: 443 LQKLHLNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSL-AYIDLSNNFL 501

Query: 353 EGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLK 412
            G  P E+ KLE +  +  S NK +G +   I  C+++  + +  N+  G +PD +  L 
Sbjct: 502 TGHFPEEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLV 560

Query: 413 NLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHL 472
           +L+ +D S N+LSG IP  L  + +L  +NLS N+F+G +P+ G+F +AT +S  GN ++
Sbjct: 561 SLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNI 620

Query: 473 CGTVPGMPICP------PKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISS 526
           CG V  M + P      P++    +    ++  + I I++ L  I + +    +K    +
Sbjct: 621 CGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKN 680

Query: 527 GKSETR-SKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGIL-QDGTAI 584
             S+   S   T  + H   +++Y EL  AT+ F    L+G+G++G V+KG+L  +   +
Sbjct: 681 NASDGNPSDSTTLGMFHE--KVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLV 738

Query: 585 AVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL-----PDFKALVLPYMANGS 639
           AVKVL L     TKSF  EC+  K IRHRNL+++IT CS       DF+ALV  +M  GS
Sbjct: 739 AVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGS 798

Query: 640 LDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN 699
           LD  L           S  LT  +++NI  D+A  + YLH H    V HCD+KPSN+LL+
Sbjct: 799 LDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLD 858

Query: 700 DDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDV 759
           DD+TA VSDFG+A+L+       D    +   ++  + G+IGY APEYG G   S +GDV
Sbjct: 859 DDLTAHVSDFGLAQLLYKY----DRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDV 914

Query: 760 YSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKR 819
           YSFGIL+LEM + ++PTD+ FAG  +LH + K+   G       +++             
Sbjct: 915 YSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSILSGCTSSGGSNAI------------- 961

Query: 820 MWDVAIGELIELGILCTQESPSTRPTMLDAADDL 853
             D  +  ++++GI C++E P  R    +A  +L
Sbjct: 962 --DEGLRLVLQVGIKCSEEYPRDRMRTDEAVREL 993

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  443 bits (1140), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 311/897 (34%), Positives = 473/897 (52%), Gaps = 99/897 (11%)

Query: 2    LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
            L +NHL G I  E   L  L  L L  NN  G+ P+S+  L NLT++T+  NN++G LP 
Sbjct: 319  LSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPA 378

Query: 62   SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLD 121
                  T+LRN+    N  TG IP  I NC  L  L L +NQ+TG++P      ++  + 
Sbjct: 379  DL-GLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRMNLTFIS 437

Query: 122  VEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAG 181
            +  NH +GE+P DI                                  NC++LE L +A 
Sbjct: 438  IGRNHFTGEIPDDIF---------------------------------NCSNLETLSVAD 464

Query: 182  MDLGGTLPDSIGRLNLTQLL-LQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEIS 240
             +L GTL   IG+L   ++L +  N +TG IP  IGNL +L  L L SN  +G I  E+S
Sbjct: 465  NNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPREIGNLKDLNILYLHSNGFTGRIPREMS 524

Query: 241  WLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNN 300
             L+ L+ L +  N   G IP  +  +  L +LDLS NK SG+IP     L  +  L L  
Sbjct: 525  NLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQG 584

Query: 301  NQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEI-SGIREIRIFLNLSHNQLEGPLPIE 359
            N+ + SIP +L   + L   D+S N LTG+IP E+ + ++ ++++LN S+N L G +P E
Sbjct: 585  NKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKE 644

Query: 360  LSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPD------------- 406
            L KLE VQEIDLS+N F+G+I   +  C  V  ++ S N L G++PD             
Sbjct: 645  LGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLN 704

Query: 407  ------------SLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPS 454
                        S G++ +L ++D+S N+L+G IP SL  + TL  + L+ N  KG +P 
Sbjct: 705  LSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPE 764

Query: 455  GGIFNSATKMSFVGNQHLCGTVPGMPICPPKQHWLH----TRMYFIIFVLVISISAFLST 510
             G+F +      +GN  LCG+   +  C  KQ   H    TR+  II     ++   L  
Sbjct: 765  SGVFKNINASDLMGNTDLCGSKKPLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLL 824

Query: 511  ICLVTGIHRIKLIISSGKSETRSKPITPEL--MHNFPRITYRELLEATAEFDEQRLLGTG 568
            + ++T   + +  I     E  S+   P+L       R   +EL +AT  F+   ++G+ 
Sbjct: 825  VLILTCCKKKEKKI-----ENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSS 879

Query: 569  SYGRVYKGILQDGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIIT-ACSLP 625
            S   VYKG L+DGT IAVKVL L+  S    K F  E + L +++HRNL++I+  A    
Sbjct: 880  SLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESG 939

Query: 626  DFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVR 685
              KALVLP+M NG+L+  ++       GS +   +LL+++++C  IA G+ YLH      
Sbjct: 940  KTKALVLPFMENGNLEDTIH-------GSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFP 992

Query: 686  VIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAP 745
            ++HCDLKP+N+LL+ D  A VSDFG A++   +G   DG+     S      G+IGY+AP
Sbjct: 993  IVHCDLKPANILLDSDRVAHVSDFGTARI---LGFREDGSTTASTSAFE---GTIGYLAP 1046

Query: 746  EYGFGSNTSTKGDVYSFGILVLEMVTRRRPT--DDMFAGGLSLHKWV-KNHYHGR--LEK 800
            E+ +    +TK DV+SFGI+++E++T++RPT  +D  +  ++L + V K+  +GR  + +
Sbjct: 1047 EFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVR 1106

Query: 801  VIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLK 857
            V+D  L     D    +K+  + AI + ++L + CT   P  RP M +    L +L+
Sbjct: 1107 VLDMEL----GDSIVSLKQ--EEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  431 bits (1108), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 297/870 (34%), Positives = 469/870 (53%), Gaps = 55/870 (6%)

Query: 5    NHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFF 64
            N+L G  P     L  L+ L    N + G+IP  +A L  +    +  N   G+ P   +
Sbjct: 187  NNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIY 246

Query: 65   HNCTSLRNVDLSQNFFTGKIPEEIGNC-PNLWTLSLYNNQLTGQLPASLIN-TSMYNLDV 122
             N +SL  + ++ N F+G +  + G+  PNL  L +  N  TG +P +L N +S+  LD+
Sbjct: 247  -NLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDI 305

Query: 123  EYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGM 182
              NHL+G++P   +S       L L  NN    + ++  + F  +L NC+ L+ L +   
Sbjct: 306  PSNHLTGKIP---LSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFN 362

Query: 183  DLGGTLPDSIGRLN--LTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEIS 240
             LGG LP  I  L+  LT+L L  N I+GSIP  IGNL +L +L+L  NLL+G +   + 
Sbjct: 363  KLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLG 422

Query: 241  WLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNN 300
             LS+L ++ L  N  SGEIP++                        LGN+  +  L+L N
Sbjct: 423  ELSELRKVLLYSNGLSGEIPSS------------------------LGNISGLTYLYLLN 458

Query: 301  NQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIEL 360
            N    SIP +LG C+ L  L+L  N+L GSIP E+  +  + + LN+S N L GPL  ++
Sbjct: 459  NSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSL-VVLNVSFNLLVGPLRQDI 517

Query: 361  SKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVS 420
             KL+ +  +D+S NK +G I   ++NC+++  + +  N+  G +PD  G L  L  +D+S
Sbjct: 518  GKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLS 576

Query: 421  GNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPGMP 480
             N+LSG IP  +     L  +NLS N F G +P+ G+F + + MS  GN +LCG +P + 
Sbjct: 577  KNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQ 636

Query: 481  ICP-----PKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKSETRSKP 535
            + P     P++H    ++  I    V++    L    +    +++++      +    + 
Sbjct: 637  LQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRS 696

Query: 536  ITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQSG 594
             +P +   + +I+Y EL + T  F    L+G+G++G V+KG L     A+A+KVL L   
Sbjct: 697  FSP-VKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKR 755

Query: 595  NFTKSFNRECQVLKRIRHRNLMRIITACSLP-----DFKALVLPYMANGSLDSHLYPHSE 649
               KSF  EC+ L  IRHRNL++++T CS       DF+ALV  +M NG+LD  L+P   
Sbjct: 756  GAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEI 815

Query: 650  TEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDF 709
             E G+ S  L L  R+NI  D+A  + YLH +    + HCD+KPSN+LL+ D+TA VSDF
Sbjct: 816  EETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDF 875

Query: 710  GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEM 769
            G+A+L++     +    ++  S+A +  G+IGY APEYG G + S  GDVYSFGI++LE+
Sbjct: 876  GLAQLLLKF---DRDTFHIQFSSAGVR-GTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEI 931

Query: 770  VTRRRPTDDMFAGGLSLHKWVKNHYHGRLE-KVIDSSLLRASRDQSPEVKRMWDVAIGEL 828
             T +RPT+ +F  GL+LH + K+    R    + D ++LR +  Q   +     +    +
Sbjct: 932  FTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVECLTL----V 987

Query: 829  IELGILCTQESPSTRPTMLDAADDLDRLKR 858
              +G+ C++ESP  R +M +A   L  ++ 
Sbjct: 988  FRVGVSCSEESPVNRISMAEAISKLVSIRE 1017

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  410 bits (1053), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 308/927 (33%), Positives = 465/927 (50%), Gaps = 107/927 (11%)

Query: 1    MLVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLP 60
            +L    L G IP E SK + L+ L L  N+L G IPE+L  L  LT + LH+N L G L 
Sbjct: 342  VLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLS 401

Query: 61   ISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYN 119
             S   N T+L+ + L  N   GK+P+EI     L  L LY N+ +G++P  + N TS+  
Sbjct: 402  PSI-SNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKM 460

Query: 120  LDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELEL 179
            +D+  NH  GE+P  I  +L  L  LHL  N +V        +P   SLGNC  L  L+L
Sbjct: 461  IDMFGNHFEGEIPPSI-GRLKELNLLHLRQNELVGG------LPA--SLGNCHQLNILDL 511

Query: 180  AGMDLGGTLPDSIGRLN-LTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTI--- 235
            A   L G++P S G L  L QL+L  N + G++P  + +L NL  +NLS N L+GTI   
Sbjct: 512  ADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPL 571

Query: 236  SAEISWLS--------------------QLEQLFLSHNLFSGEIPAALGKLHHLGLLDLS 275
                S+LS                     L++L L  N  +G+IP  LGK+  L LLD+S
Sbjct: 572  CGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMS 631

Query: 276  FNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGR---------------------- 313
             N L+G IP+ L    ++  + LNNN LS  IPP LG+                      
Sbjct: 632  SNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTEL 691

Query: 314  --CTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDL 371
              CT L  L L  N L GSIP EI  +  + + LNL  NQ  G LP  + KL  + E+ L
Sbjct: 692  FNCTKLLVLSLDGNSLNGSIPQEIGNLGALNV-LNLDKNQFSGSLPQAMGKLSKLYELRL 750

Query: 372  SSNKFTGNIFIQISNCIAVR-LINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPI 430
            S N  TG I ++I     ++  +++S+N   G++P ++G L  LE +D+S N L+G +P 
Sbjct: 751  SRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPG 810

Query: 431  SLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPGMPICPP-----K 485
            S+  + +L ++N+SFN   G +     F+     SF+GN  LCG+   +  C       K
Sbjct: 811  SVGDMKSLGYLNVSFNNLGGKLKKQ--FSRWPADSFLGNTGLCGSP--LSRCNRVRSNNK 866

Query: 486  QHWLHTRMYFIIFVLVISISAFLSTICLVTGI-----HRIKLIISSGKSETRSKPITPEL 540
            Q  L  R   ++ +  IS    +  + LV  +     H     +  G +   S   + + 
Sbjct: 867  QQGLSARS--VVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQA 924

Query: 541  MH--------NFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQ 592
             H        +   I + +++EAT    E+ ++G+G  G+VYK  L++G  +AVK +  +
Sbjct: 925  THKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWK 984

Query: 593  SGNFT-KSFNRECQVLKRIRHRNLMRIITACSLPD--FKALVLPYMANGSLDSHLYPHSE 649
                + KSF+RE + L RIRHR+L++++  CS        L+  YM NGS+   L+   +
Sbjct: 985  DDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLH-EDK 1043

Query: 650  TEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDF 709
                     L    R+ I   +A+G+ YLHH     ++H D+K SNVLL+ +M A + DF
Sbjct: 1044 PVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDF 1103

Query: 710  GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEM 769
            G+AK++       +  +   +S     C S GY+APEY +    + K DVYS GI+++E+
Sbjct: 1104 GLAKVL------TENCDTNTDSNTWFAC-SYGYIAPEYAYSLKATEKSDVYSMGIVLMEI 1156

Query: 770  VTRRRPTDDMFAGGLSLHKWVKNHYH---GRLEKVIDSSLLRASRDQSPEVKRMWDVAIG 826
            VT + PTD +F   + + +WV+ H        +K+ID  L        P +    D A  
Sbjct: 1157 VTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKL-------KPLLPFEEDAAC- 1208

Query: 827  ELIELGILCTQESPSTRPTMLDAADDL 853
            +++E+ + CT+ SP  RP+   A D L
Sbjct: 1209 QVLEIALQCTKTSPQERPSSRQACDSL 1235

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1

 Score =  406 bits (1044), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 287/909 (31%), Positives = 471/909 (51%), Gaps = 98/909 (10%)

Query: 1   MLVDNHLFGAIPPEFS-KLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGML 59
           ++++ + F    PEFS + R+LR L+L+ N   G+IP+S   L+ L ++ L+ N L+G++
Sbjct: 128 LILNQNNFSGKLPEFSPEFRKLRVLELESNLFTGEIPQSYGRLTALQVLNLNGNPLSGIV 187

Query: 60  PISFFHNCTSLRNVDLSQ-NFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSM 117
           P +F    T L  +DL+  +F    IP  +GN  NL  L L ++ L G++P S++N   +
Sbjct: 188 P-AFLGYLTELTRLDLAYISFDPSPIPSTLGNLSNLTDLRLTHSNLVGEIPDSIMNLVLL 246

Query: 118 YNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEEL 177
            NLD+  N L+GE+P  I  +L S+  + L Y+N +S       +P   S+GN T+L   
Sbjct: 247 ENLDLAMNSLTGEIPESI-GRLESVYQIEL-YDNRLSGK-----LP--ESIGNLTELRNF 297

Query: 178 ELAGMDLGGTLPDSIGRL------------------------NLTQLLLQENKITGSIPP 213
           +++  +L G LP+ I  L                        NL +  +  N  TG++P 
Sbjct: 298 DVSQNNLTGELPEKIAALQLISFNLNDNFFTGGLPDVVALNPNLVEFKIFNNSFTGTLPR 357

Query: 214 HIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLD 273
           ++G  S +   ++S+N  SG +   + +  +L+++    N  SGEIP + G  H L  + 
Sbjct: 358 NLGKFSEISEFDVSTNRFSGELPPYLCYRRKLQKIITFSNQLSGEIPESYGDCHSLNYIR 417

Query: 274 LSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPA 333
           ++ NKLSGE+P     L        NNNQL  SIPP++ +   L +L++S N  +G IP 
Sbjct: 418 MADNKLSGEVPARFWELPLTRLELANNNQLQGSIPPSISKARHLSQLEISANNFSGVIPV 477

Query: 334 EISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLI 393
           ++  +R++R+ ++LS N   G +P  ++KL+N++ +++  N   G I   +S+C  +  +
Sbjct: 478 KLCDLRDLRV-IDLSRNSFLGSIPSCINKLKNLERVEMQENMLDGEIPSSVSSCTELTEL 536

Query: 394 NISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIP 453
           N+S+N L+G +P  LGDL  L  +D+S N L+G IP  L ++    F N+S N+  G IP
Sbjct: 537 NLSNNRLRGGIPPELGDLPVLNYLDLSNNQLTGEIPAELLRLKLNQF-NVSDNKLYGKIP 595

Query: 454 SGGIFNSATKMSFVGNQHLCGTVPGMPICPPKQHWLHTRMYFIIFVLVISISAFLSTICL 513
           S G      + SF+GN +LC   P +    P +    TR     ++L ISI      +C+
Sbjct: 596 S-GFQQDIFRPSFLGNPNLCA--PNLDPIRPCRSKRETR-----YILPISI------LCI 641

Query: 514 VTGIHRIKLIISSGKSETRSKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRV 573
           V     +  +    K   + KP     +  F R+ + E  +   +  E  ++G+G  G V
Sbjct: 642 VALTGALVWLFIKTKPLFKRKPKRTNKITIFQRVGFTE-EDIYPQLTEDNIIGSGGSGLV 700

Query: 574 YKGILQDGTAIAVKVLQLQSGNFTKS---FNRECQVLKRIRHRNLMRIITACSLPDFKAL 630
           Y+  L+ G  +AVK L  ++G  T+S   F  E + L R+RH N+++++  C+  +F+ L
Sbjct: 701 YRVKLKSGQTLAVKKLWGETGQKTESESVFRSEVETLGRVRHGNIVKLLMCCNGEEFRFL 760

Query: 631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCD 690
           V  +M NGSL   L  HSE E     S L    R +I    A+G++YLHH S   ++H D
Sbjct: 761 VYEFMENGSLGDVL--HSEKEH-RAVSPLDWTTRFSIAVGAAQGLSYLHHDSVPPIVHRD 817

Query: 691 LKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC--GSIGYMAPEYG 748
           +K +N+LL+ +M   V+DFG+AK +          +N G S  +M C  GS GY+APEYG
Sbjct: 818 VKSNNILLDHEMKPRVADFGLAKPLKR-------EDNDGVSDVSMSCVAGSYGYIAPEYG 870

Query: 749 FGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY-------------- 794
           + S  + K DVYSFG+++LE++T +RP D  F     + K+                   
Sbjct: 871 YTSKVNEKSDVYSFGVVLLELITGKRPNDSSFGENKDIVKFAMEAALCYPSPSAEDGAMN 930

Query: 795 ------HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLD 848
                 +  L K++D  +  ++R+   E++++ DVA        +LCT   P  RPTM  
Sbjct: 931 QDSLGNYRDLSKLVDPKMKLSTREYE-EIEKVLDVA--------LLCTSSFPINRPTMRK 981

Query: 849 AADDLDRLK 857
             + L   K
Sbjct: 982 VVELLKEKK 990

Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  404 bits (1039), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 297/915 (32%), Positives = 450/915 (49%), Gaps = 100/915 (10%)

Query: 5    NHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFF 64
            N L G++P    K + L  L L  N   G+IP  +     L  ++L  N L+G +P    
Sbjct: 315  NQLSGSLPSWMGKWKVLDSLLLANNRFSGEIPHEIEDCPMLKHLSLASNLLSGSIPRELC 374

Query: 65   HNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEY 124
             +  SL  +DLS N  +G I E    C +L  L L NNQ+ G +P  L    +  LD++ 
Sbjct: 375  GS-GSLEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKLPLMALDLDS 433

Query: 125  NHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDL 184
            N+ +GE+P  +  K  +L     SYN +  +      +P    +GN   L+ L L+   L
Sbjct: 434  NNFTGEIPKSLW-KSTNLMEFTASYNRLEGY------LP--AEIGNAASLKRLVLSDNQL 484

Query: 185  GGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLS 243
             G +P  IG+L +L+ L L  N   G IP  +G+ ++L +L+L SN L G I  +I+ L+
Sbjct: 485  TGEIPREIGKLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALA 544

Query: 244  QLEQLFLSHNLFSGEIPAA------------LGKLHHLGLLDLSFNKLSGEIPVSLGNLV 291
            QL+ L LS+N  SG IP+             L  L H G+ DLS+N+LSG IP  LG  +
Sbjct: 545  QLQCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECL 604

Query: 292  QIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEIS--------------- 336
             +  + L+NN LS  IP +L R T+L  LDLS N LTGSIP E+                
Sbjct: 605  VLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQL 664

Query: 337  --------GIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCI 388
                    G+    + LNL+ N+L+GP+P  L  L+ +  +DLS N  +G +  ++S   
Sbjct: 665  NGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTME 724

Query: 389  AVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEF 448
             +  + I  N   G +P  LG+L  LE +DVS N LSG IP  +  +  L F+NL+ N  
Sbjct: 725  KLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNL 784

Query: 449  KGMIPSGGIFNSATKMSFVGNQHLCGTVPG----MPICPPKQHW----LHTRMYFIIFVL 500
            +G +PS G+    +K    GN+ LCG V G    +     +  W    L      I+FV 
Sbjct: 785  RGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKIEGTKLRSAWGIAGLMLGFTIIVFVF 844

Query: 501  VISISAFLSTICL-------------VTGIHRIKLIISSGKSETRSKPITPEL-MHNFPR 546
            V S+  +  T  +             + G     L   SG S +R +P++  + M   P 
Sbjct: 845  VFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSG-SRSR-EPLSINIAMFEQPL 902

Query: 547  ITYR--ELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNREC 604
            +  R  +++EAT  F ++ ++G G +G VYK  L     +AVK L        + F  E 
Sbjct: 903  LKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEM 962

Query: 605  QVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
            + L +++H NL+ ++  CS  + K LV  YM NGSLD  L   +          L   +R
Sbjct: 963  ETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGM-----LEVLDWSKR 1017

Query: 665  VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
            + I    A G+A+LHH     +IH D+K SN+LL+ D    V+DFG+A+L+         
Sbjct: 1018 LKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISAC------ 1071

Query: 725  AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMF--AG 782
                 +  + ++ G+ GY+ PEYG  +  +TKGDVYSFG+++LE+VT + PT   F  + 
Sbjct: 1072 ----ESHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESE 1127

Query: 783  GLSLHKW-VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPS 841
            G +L  W ++    G+   VID  L+  +   S             L+++ +LC  E+P+
Sbjct: 1128 GGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQL----------RLLQIAMLCLAETPA 1177

Query: 842  TRPTMLDAADDLDRL 856
             RP MLD    L  +
Sbjct: 1178 KRPNMLDVLKALKEI 1192

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  404 bits (1038), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 303/928 (32%), Positives = 469/928 (50%), Gaps = 113/928 (12%)

Query: 1    MLVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLP 60
             L +  L G IP E S  + L+ L L  N L GQIP+SL  L  LT + L++N+L G L 
Sbjct: 343  FLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLS 402

Query: 61   ISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYN 119
             S   N T+L+   L  N   GK+P+EIG    L  + LY N+ +G++P  + N T +  
Sbjct: 403  -SSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQE 461

Query: 120  LDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELEL 179
            +D   N LSGE+PS I  +L  LT LHL  N +V +      +P   SLGNC  +  ++L
Sbjct: 462  IDWYGNRLSGEIPSSI-GRLKDLTRLHLRENELVGN------IPA--SLGNCHQMTVIDL 512

Query: 180  AGMDLGGTLPDSIGRLNLTQL-LLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISA- 237
            A   L G++P S G L   +L ++  N + G++P  + NL NL  +N SSN  +G+IS  
Sbjct: 513  ADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPL 572

Query: 238  ----------------------EISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLS 275
                                  E+   + L++L L  N F+G IP   GK+  L LLD+S
Sbjct: 573  CGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDIS 632

Query: 276  FNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEI 335
             N LSG IPV LG   ++  + LNNN LS  IP  LG+   L +L LS N+  GS+P EI
Sbjct: 633  RNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEI 692

Query: 336  SGIREIRIF-----------------------LNLSHNQLEGPLPIELSKLENVQEIDLS 372
              +  I                          LNL  NQL GPLP  + KL  + E+ LS
Sbjct: 693  FSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLS 752

Query: 373  SNKFTGNIFIQISNCIAVR-LINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPIS 431
             N  TG I ++I     ++  +++S+N   G +P ++  L  LE++D+S N L G +P  
Sbjct: 753  RNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQ 812

Query: 432  LNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPGMPICPPKQHW--- 488
            +  + +L ++NLS+N  +G +     F+     +FVGN  LCG+        P  H    
Sbjct: 813  IGDMKSLGYLNLSYNNLEGKLKKQ--FSRWQADAFVGNAGLCGS--------PLSHCNRA 862

Query: 489  --LHTRMYFIIFVLVISISAFLSTICLVTGI--------HRIKLIISSGKSETRSKPITP 538
               + R      V++IS  + L+ I L+  +        H +   +  G S   S   + 
Sbjct: 863  GSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSS 922

Query: 539  E--LMHN---FPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQS 593
            +  L  N      I + +++EAT   +E+ ++G+G  G+VYK  L++G  IAVK +  + 
Sbjct: 923  QAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKD 982

Query: 594  GNFT-KSFNRECQVLKRIRHRNLMRIITACS--LPDFKALVLPYMANGSLDSHLYPHSET 650
               + KSFNRE + L  IRHR+L++++  CS        L+  YMANGS+   L+ +  T
Sbjct: 983  DLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENT 1042

Query: 651  EFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG 710
            +       L    R+ I   +A+G+ YLH+     ++H D+K SNVLL+ ++ A + DFG
Sbjct: 1043 K---KKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFG 1099

Query: 711  IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
            +AK++        G  +    +  M  GS GY+APEY +    + K DVYS GI+++E+V
Sbjct: 1100 LAKILT-------GNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIV 1152

Query: 771  TRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQ--SPEVKRMW---DVAI 825
            T + PT+ MF     + +WV        E V+D+     +R++    E+K +    + A 
Sbjct: 1153 TGKMPTEAMFDEETDMVRWV--------ETVLDTPPGSEAREKLIDSELKSLLPCEEEAA 1204

Query: 826  GELIELGILCTQESPSTRPTMLDAADDL 853
             +++E+ + CT+  P  RP+   A++ L
Sbjct: 1205 YQVLEIALQCTKSYPQERPSSRQASEYL 1232

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  393 bits (1010), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 293/912 (32%), Positives = 452/912 (49%), Gaps = 105/912 (11%)

Query: 5    NHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFF 64
            N   G IP E S    L+ L L  N L G +P+ L  L NLT + L  N L+G +P S  
Sbjct: 197  NGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSV- 255

Query: 65   HNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNLDVE 123
             N + L  + L +N+FTG IP EIG    +  L LY NQLTG++P  + N      +D  
Sbjct: 256  GNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFS 315

Query: 124  YNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMD 183
             N L+G +P +    + +L  LHL         +N  L P    LG  T LE+L+L+   
Sbjct: 316  ENQLTGFIPKE-FGHILNLKLLHLF--------ENILLGPIPRELGELTLLEKLDLSINR 366

Query: 184  LGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISA----- 237
            L GT+P  +  L  L  L L +N++ G IPP IG  SN   L++S+N LSG I A     
Sbjct: 367  LNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRF 426

Query: 238  -------------------------------------------EISWLSQLEQLFLSHNL 254
                                                       E+  L  L  L L  N 
Sbjct: 427  QTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNW 486

Query: 255  FSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRC 314
             SG I A LGKL +L  L L+ N  +GEIP  +GNL +I    +++NQL+  IP  LG C
Sbjct: 487  LSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSC 546

Query: 315  TDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSN 374
              + +LDLS N+ +G I  E+  +  + I L LS N+L G +P     L  + E+ L  N
Sbjct: 547  VTIQRLDLSGNKFSGYIAQELGQLVYLEI-LRLSDNRLTGEIPHSFGDLTRLMELQLGGN 605

Query: 375  KFTGNIFIQISNCIAVRL-INISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLN 433
              + NI +++    ++++ +NISHN L G +PDSLG+L+ LE + ++ N LSG IP S+ 
Sbjct: 606  LLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIG 665

Query: 434  KIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGT-----VPGMPICPPKQHW 488
             + +L   N+S N   G +P   +F      +F GN  LC +      P +P    K +W
Sbjct: 666  NLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNW 725

Query: 489  L---HTRMYFIIFVLVISISAFLST-ICLVTGIHRIKLIISSGKSETRSKPITPELM--H 542
            L     R   +    ++  S FL T + L   I R +    + + +T+     P++M  +
Sbjct: 726  LINGSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTK-----PDVMDSY 780

Query: 543  NFPR--ITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVL--QLQSGNFTK 598
             FP+   TY+ L++AT  F E  +LG G+ G VYK  +  G  IAVK L  + +  +   
Sbjct: 781  YFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDN 840

Query: 599  SFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSD 658
            SF  E   L +IRHRN++++   C   +   L+  YM+ GSL   L      + G  +  
Sbjct: 841  SFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQL------QRGEKNCL 894

Query: 659  LTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV 718
            L    R  I    AEG+ YLHH    +++H D+K +N+LL++   A V DFG+AKL+   
Sbjct: 895  LDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLI--- 951

Query: 719  GVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
                   +   + + + + GS GY+APEY +    + K D+YSFG+++LE++T + P   
Sbjct: 952  -------DLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQP 1004

Query: 779  MFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQE 838
            +  GG  L  WV+      +  +I +  +  +R  + + + + ++++  ++++ + CT  
Sbjct: 1005 LEQGG-DLVNWVRRS----IRNMIPTIEMFDARLDTNDKRTVHEMSL--VLKIALFCTSN 1057

Query: 839  SPSTRPTMLDAA 850
            SP++RPTM +  
Sbjct: 1058 SPASRPTMREVV 1069

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	885
224075720	978	predicted protein [Populus trichocarpa]	0.969	0.877	0.756	0.0
224115750	911	predicted protein [Populus trichocarpa]	0.971	0.944	0.746	0.0
255543361	969	serine-threonine protein kinase, plant-t	0.936	0.855	0.717	0.0
359483193	992	PREDICTED: putative leucine-rich repeat	0.968	0.863	0.726	0.0
449440217	1009	PREDICTED: putative leucine-rich repeat	0.934	0.819	0.657	0.0
449501625	1009	PREDICTED: LOW QUALITY PROTEIN: putative	0.934	0.819	0.656	0.0
356547478	955	PREDICTED: putative leucine-rich repeat	0.926	0.858	0.656	0.0
242044720	1223	hypothetical protein SORBIDRAFT_02g02504	0.957	0.692	0.554	0.0
414885517	1119	TPA: putative leucine-rich repeat recept	0.954	0.755	0.553	0.0
326501888	1001	predicted protein [Hordeum vulgare subsp	0.951	0.841	0.550	0.0

>gi|224075720|ref|XP_002304735.1| predicted protein [Populus trichocarpa] gi|222842167|gb|EEE79714.1| predicted protein [Populus trichocarpa]

 Score = 1314 bits (3401), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 655/866 (75%), Positives = 746/866 (86%), Gaps = 8/866 (0%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           L +N  +G IPPEFS L+ L  L LD NNLHG  PE L++L NLT+++L+ N+LTG LP 
Sbjct: 92  LSENSFYGIIPPEFSSLQHLHSLLLDSNNLHGPFPEFLSILPNLTVLSLNGNHLTGALPP 151

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTS-MYNL 120
           SFF NCTSL N+DLSQN  TG+IPEEIGNCP +W L+LYNNQ TG+LPASL N S +YN+
Sbjct: 152 SFFSNCTSLANIDLSQNLLTGRIPEEIGNCPGIWNLNLYNNQFTGELPASLANISELYNI 211

Query: 121 DVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELA 180
           DVEYN+L+GELP++I+ KL S+  LHLSYNNMVSHD NTNL PFF +L NCT+LEELE+A
Sbjct: 212 DVEYNNLTGELPANIIGKLYSVVSLHLSYNNMVSHDRNTNLEPFFTALANCTELEELEMA 271

Query: 181 GMDLGGTLPDSIGRL--NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAE 238
           GM+LGG LP SIGRL  NL  +L+QEN+I+G IP  I +LSNL  LNL+SN L+GTI AE
Sbjct: 272 GMNLGGRLPSSIGRLSVNLDTMLMQENRISGMIPSEIAHLSNLTVLNLTSNSLNGTIPAE 331

Query: 239 ISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFL 298
           I+ +S LEQLFLSHNL +G IPAAL +L  LGLLDLS N+LSGEIP +LGNLV++  LFL
Sbjct: 332 INQMSSLEQLFLSHNLLTGAIPAALCQLPRLGLLDLSNNQLSGEIPATLGNLVRLSFLFL 391

Query: 299 NNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPI 358
           NNN LS +IPPTLG+CTDL KLDLSYN+LTGSIP EISGIREIR FLNLSHN L+GPLPI
Sbjct: 392 NNNLLSGTIPPTLGQCTDLSKLDLSYNKLTGSIPTEISGIREIRRFLNLSHNHLDGPLPI 451

Query: 359 ELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAID 418
           ELSKLENV+EID+SSN  +G++F QIS+CIAV+LIN SHN+++G+LPDS+GDLKNLE+ D
Sbjct: 452 ELSKLENVEEIDVSSNNLSGSVFFQISSCIAVKLINFSHNSIEGHLPDSIGDLKNLESFD 511

Query: 419 VSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPG 478
           VSGNHLSG IP SLNKI +L+F+NLSFN F G+IPSGG+FNS T  SF+GN+HLCGTV G
Sbjct: 512 VSGNHLSGGIPTSLNKIQSLSFLNLSFNNFAGVIPSGGVFNSVTDKSFLGNRHLCGTVYG 571

Query: 479 MPICPPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKS---ETRSKP 535
           MP C  K++W H+RM  IIFVLV   SA L+TIC V GI RIK  +SSG S   E   K 
Sbjct: 572 MPKCSRKRNWFHSRM-LIIFVLVTFASAILTTICCVIGIRRIKATVSSGNSVDEELARKQ 630

Query: 536 ITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGN 595
            TPEL+HNFPRITYRELLEAT  F+EQRLLGTG YGRVYKG+LQDGTAIAVKVLQLQSGN
Sbjct: 631 KTPELIHNFPRITYRELLEATEGFEEQRLLGTGGYGRVYKGLLQDGTAIAVKVLQLQSGN 690

Query: 596 FTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSG 655
            TKSFNRECQVLKRIRHRNL+RIITACSLPDFKALVLPYMANGSLDS LYPHSET  GSG
Sbjct: 691 STKSFNRECQVLKRIRHRNLIRIITACSLPDFKALVLPYMANGSLDSRLYPHSETGLGSG 750

Query: 656 SSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
           SSDLTLLQRV ICSDIAEGMAYLHHHSPV+VIHCDLKPSNVLLNDDMTALVSDFGIA+LV
Sbjct: 751 SSDLTLLQRVRICSDIAEGMAYLHHHSPVKVIHCDLKPSNVLLNDDMTALVSDFGIARLV 810

Query: 716 MTVGVGNDGA-ENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           MTV  GN GA ENMGNSTAN+LCGS+GY+APEYGFGSNTSTKGDVYSFG+LVLE++TR+R
Sbjct: 811 MTVAGGNGGAVENMGNSTANLLCGSVGYIAPEYGFGSNTSTKGDVYSFGVLVLEILTRKR 870

Query: 775 PTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGIL 834
           PTDDMF  GL+LHKWVK HYHGR+E+V+DSSL+RASRDQSPEVKRMW+VAIGEL ELGIL
Sbjct: 871 PTDDMFVDGLNLHKWVKTHYHGRVERVVDSSLMRASRDQSPEVKRMWEVAIGELAELGIL 930

Query: 835 CTQESPSTRPTMLDAADDLDRLKRYL 860
           CTQESP+TRPTMLDAADDLDRLKRYL
Sbjct: 931 CTQESPTTRPTMLDAADDLDRLKRYL 956

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224115750|ref|XP_002332048.1| predicted protein [Populus trichocarpa] gi|222831934|gb|EEE70411.1| predicted protein [Populus trichocarpa]

 Score = 1296 bits (3355), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 647/867 (74%), Positives = 733/867 (84%), Gaps = 7/867 (0%)

Query: 1   MLVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLP 60
           +L +NH +G IPPEFS LR L  L+LD NNL G  P  LA L NLT++TL +N+L G LP
Sbjct: 45  ILDENHFYGIIPPEFSSLRHLHSLRLDSNNLRGSFPGFLAALPNLTVLTLTENHLMGTLP 104

Query: 61  ISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTS-MYN 119
            S F NCTSL N++LSQN  TGKIP+EIGNCP+LW L+LYNNQ TG+LPASL N S +YN
Sbjct: 105 PSLFSNCTSLANIELSQNLLTGKIPQEIGNCPSLWNLNLYNNQFTGELPASLANISELYN 164

Query: 120 LDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELEL 179
           +DVE N L+GELP++I+ KL S+  LH SYN MVSHD NTNL PFF +L NCT+L+ELEL
Sbjct: 165 IDVESNSLTGELPANIIGKLYSVVSLHFSYNKMVSHDHNTNLEPFFTALANCTELQELEL 224

Query: 180 AGMDLGGTLPDSIGRL--NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISA 237
           AGM LGG LP SIGRL  +L+ LLLQEN I G+IPP I  LS+L  LNL+SN L+GTISA
Sbjct: 225 AGMRLGGRLPSSIGRLSGDLSTLLLQENSIFGTIPPGIARLSSLTWLNLTSNSLNGTISA 284

Query: 238 EISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLF 297
           EIS LS LEQLFLSHNL +G IPAALG+L HLGLLDLS N+LSGEIP SLGNLV++  +F
Sbjct: 285 EISRLSYLEQLFLSHNLLTGAIPAALGQLPHLGLLDLSNNQLSGEIPASLGNLVRLSFMF 344

Query: 298 LNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLP 357
           LNNN L+ +IPPTLG+CTDL  LDLSYNRLTGSIP EISGIREIR +LNLSHN L+GPLP
Sbjct: 345 LNNNLLTGTIPPTLGKCTDLSMLDLSYNRLTGSIPPEISGIREIRRYLNLSHNLLDGPLP 404

Query: 358 IELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAI 417
           IELSKLENV+EID+SSN  +G+IF QIS+CIAV  +N SHN+++G+LPDS+GDLKNLE+ 
Sbjct: 405 IELSKLENVEEIDVSSNNLSGSIFFQISSCIAVTRLNFSHNSIEGHLPDSIGDLKNLESF 464

Query: 418 DVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVP 477
           DVSGNHLSG IP SLNK  +L+F+NLSFN+F G+IPSGG+FNS T  SF+GNQ LCG V 
Sbjct: 465 DVSGNHLSGGIPTSLNKSRSLSFLNLSFNDFAGVIPSGGVFNSVTDKSFIGNQDLCGAVS 524

Query: 478 GMPICPPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKS---ETRSK 534
           GMP C  K+HW   R++ I+FVL+   SAFL+TI  V GI RIK ++SSG S   E   K
Sbjct: 525 GMPKCSHKRHWFRLRLFLIVFVLLTFASAFLTTIFCVIGIRRIKAMVSSGNSVDTEQARK 584

Query: 535 PITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSG 594
           P TPEL+HNFPR+TYREL EAT  FDEQRL+GTGSYGRVYKG+L DGTAIAVKVLQ QSG
Sbjct: 585 PETPELIHNFPRVTYRELSEATGGFDEQRLVGTGSYGRVYKGLLPDGTAIAVKVLQFQSG 644

Query: 595 NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGS 654
           N TKSFNRECQVLKRIRHRNL+RIITACSLPDFKALVLPYMANGSLDS LYPHSET  GS
Sbjct: 645 NSTKSFNRECQVLKRIRHRNLIRIITACSLPDFKALVLPYMANGSLDSRLYPHSETGLGS 704

Query: 655 GSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL 714
           GSSDLTLLQRV+ICSDIAEGMAYLHHHSPV+VIHCDLKPSNVLLNDDMTALVSDFGIA+L
Sbjct: 705 GSSDLTLLQRVSICSDIAEGMAYLHHHSPVKVIHCDLKPSNVLLNDDMTALVSDFGIARL 764

Query: 715 VMT-VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRR 773
           VMT  G      ENMGNSTAN+LCGSIGY+APEYGFGSNTSTKGDVYSFG+LVLEMVTR+
Sbjct: 765 VMTVGGGNGGVVENMGNSTANLLCGSIGYIAPEYGFGSNTSTKGDVYSFGVLVLEMVTRK 824

Query: 774 RPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGI 833
           RPTDDMF GGL+LHKWVK HYHGRLE+V+D SL+RASRDQ  EVKRMW+VAIGEL+ELGI
Sbjct: 825 RPTDDMFVGGLNLHKWVKTHYHGRLERVVDPSLMRASRDQFHEVKRMWEVAIGELVELGI 884

Query: 834 LCTQESPSTRPTMLDAADDLDRLKRYL 860
           LCTQESPSTRPTMLDAADDLDRLKRYL
Sbjct: 885 LCTQESPSTRPTMLDAADDLDRLKRYL 911

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255543361|ref|XP_002512743.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223547754|gb|EEF49246.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score = 1217 bits (3149), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 621/866 (71%), Positives = 712/866 (82%), Gaps = 37/866 (4%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           LV+N+ +G IP E   LR LR LQLD NNLHG  PESLALLSNLTL+TL DNNLTG LP 
Sbjct: 114 LVENNFYGTIPCELFHLRHLRDLQLDNNNLHGSFPESLALLSNLTLITLGDNNLTGELPP 173

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLD 121
           SFF NC++L NVD S NFFTG+IP+EIG+CPNLWTL LYNNQ TG+LP SL N S+YNLD
Sbjct: 174 SFFSNCSALGNVDFSYNFFTGRIPKEIGDCPNLWTLGLYNNQFTGELPVSLTNISLYNLD 233

Query: 122 VEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAG 181
           VEYNHLSGELP +I+ KL  +  L+LS+NNMVSH+ NTNL PFF +L NCT+LEELELAG
Sbjct: 234 VEYNHLSGELPVNIVGKLHKIGNLYLSFNNMVSHNQNTNLKPFFTALENCTELEELELAG 293

Query: 182 MDLGGTLPDSIGRLN--LTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEI 239
           M LGG+LP SIG L+  L  L+L EN+I GSIPP I NLSNL  LNL+SN L+GTI AEI
Sbjct: 294 MALGGSLPSSIGNLSKLLYSLMLNENRIHGSIPPDIANLSNLTVLNLTSNYLNGTIPAEI 353

Query: 240 SWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLN 299
           S L  L+Q+FLS N+F+G IP ALG+  HLGLLDLS+N+ SGEIP SLG L  + S+FLN
Sbjct: 354 SQLVFLQQIFLSRNMFTGAIPEALGQFPHLGLLDLSYNQFSGEIPRSLGYLTHMNSMFLN 413

Query: 300 NNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIE 359
           NN LS +IPPTLG+C DLYKLDLS+N+LTG+IP EISG+REIRIFLNLSHNQL+GPLPIE
Sbjct: 414 NNLLSGTIPPTLGKCIDLYKLDLSFNKLTGNIPPEISGMREIRIFLNLSHNQLDGPLPIE 473

Query: 360 LSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDV 419
           LSKLENVQEID+SSN  TGNIF+QIS+CIA+R IN+SHN+LQG+LPDSLGDLKNLE++DV
Sbjct: 474 LSKLENVQEIDVSSNNLTGNIFLQISSCIALRTINLSHNSLQGHLPDSLGDLKNLESLDV 533

Query: 420 SGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPGM 479
           SGN LSG+IP+SL+KIH+LT++NLSFN F+G+IPSGGIFNS T  SF+GN+ LCG   G+
Sbjct: 534 SGNQLSGMIPLSLSKIHSLTYLNLSFNNFEGLIPSGGIFNSLTSWSFLGNRRLCGAFSGI 593

Query: 480 PICPPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKS---ETRSKPI 536
             C P +HW H+  + IIF++VIS+SAFLSTIC VTGI  IKL+ISS  S   E   K  
Sbjct: 594 LACSPTRHWFHSNKFLIIFIIVISVSAFLSTICCVTGIRWIKLLISSQDSLRIERTRKST 653

Query: 537 TPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNF 596
           TPEL+ + PRITYREL EAT  FDE RL+GTGS G VYKGIL DGT IAVKVLQ QS N 
Sbjct: 654 TPELIPHVPRITYRELSEATEGFDEHRLVGTGSIGHVYKGILPDGTPIAVKVLQFQSRNS 713

Query: 597 TKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGS 656
           TK+FNRECQVLKRIRHRNL+RIITACSLPDFKALVLPYMANGSLD+HLYPHSET   SGS
Sbjct: 714 TKTFNRECQVLKRIRHRNLIRIITACSLPDFKALVLPYMANGSLDNHLYPHSETGLDSGS 773

Query: 657 SDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM 716
           SDLTL+QRVNICSDIAEGMAYLHHHSPV+VIHCDLKPSNVLLNDDMTALVSDFGIA+L+ 
Sbjct: 774 SDLTLMQRVNICSDIAEGMAYLHHHSPVKVIHCDLKPSNVLLNDDMTALVSDFGIARLIS 833

Query: 717 TVGVGNDGA-ENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           TVG GN G  EN+GNSTAN+LCGSIGY+AP                              
Sbjct: 834 TVGGGNAGLFENIGNSTANLLCGSIGYIAP------------------------------ 863

Query: 776 TDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILC 835
            DDMF GGL LHKWV++HYHGR+E+V+DSSL+RASRDQSPEVK+ W+VA+GELIELG+LC
Sbjct: 864 -DDMFVGGLDLHKWVRSHYHGRVEQVLDSSLVRASRDQSPEVKKTWEVAVGELIELGLLC 922

Query: 836 TQESPSTRPTMLDAADDLDRLKRYLG 861
           TQESPSTRPTMLDAADDLDRLKRYLG
Sbjct: 923 TQESPSTRPTMLDAADDLDRLKRYLG 948

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483193|ref|XP_003632918.1| PREDICTED: putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130-like [Vitis vinifera]

 Score = 1178 bits (3048), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 626/862 (72%), Positives = 710/862 (82%), Gaps = 5/862 (0%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           L +N+    IP E S LRRLR L+L  NN+ G IPESL+LL +L L+ L  NNLTG +P 
Sbjct: 104 LAENNFSSTIPLEISSLRRLRFLKLHNNNMQGSIPESLSLLHDLELLHLFGNNLTGPIPA 163

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTS-MYNL 120
           S F NC+ L+NVDLS N  TGKIP EIGNCP LWTL+LYNNQ TGQ+P SL N S M+NL
Sbjct: 164 SLFSNCSMLQNVDLSGNRLTGKIPPEIGNCPYLWTLNLYNNQFTGQIPFSLTNASYMFNL 223

Query: 121 DVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELA 180
           D EYNH+SGELPSDI+ KL  L YLH+SYN+MVSHD NTNL PFF SL NC+ LEELE+ 
Sbjct: 224 DFEYNHISGELPSDIVVKLYRLVYLHISYNDMVSHDANTNLDPFFASLVNCSSLEELEME 283

Query: 181 GMDLGGTLPDSIGRL--NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAE 238
           GM LGG LP+ +G+L  NLT L+L  N+I+GSIPP +GN S L SLNLSSNLLSGTI  E
Sbjct: 284 GMSLGGKLPNFMGQLGVNLTNLVLNGNQISGSIPPSLGNFSILTSLNLSSNLLSGTIPLE 343

Query: 239 ISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFL 298
            S LS L+QL LSHN  +G IP  LG +  LG LDLS N LSG IP S+GNL Q+  LFL
Sbjct: 344 FSGLSNLQQLILSHNSLNGSIPKELGNIGGLGHLDLSHNNLSGNIPESIGNLFQLNYLFL 403

Query: 299 NNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPI 358
           NNN LS ++P +LG C DL KLD SYNRLTG IP EIS + EIRIFLNLSHN LEGPLPI
Sbjct: 404 NNNNLSGAVPRSLGHCIDLNKLDFSYNRLTGGIPPEISSLLEIRIFLNLSHNLLEGPLPI 463

Query: 359 ELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAID 418
           ELSKL+NVQEIDLSSN F G+IF  I NCIA+RL+N SHNAL+G LPDSLGD KNLE  D
Sbjct: 464 ELSKLQNVQEIDLSSNNFNGSIFDPILNCIALRLLNFSHNALEGPLPDSLGDFKNLEVFD 523

Query: 419 VSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPG 478
           VS N LSG IP +LN+  TLTF+NLS+N F G IPSGGIF S T +SF+GN +LCG+V G
Sbjct: 524 VSKNQLSGKIPTTLNRTRTLTFLNLSYNNFDGQIPSGGIFASVTNLSFLGNPNLCGSVVG 583

Query: 479 MPICPPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKSETRSKPITP 538
           +P C  K++WLH+  + IIF +VISISAFLSTI  V G   IK I+SSG+SET  K  TP
Sbjct: 584 IPTCRKKRNWLHSHRFVIIFSVVISISAFLSTIGCVIGCRYIKRIMSSGRSETVRKS-TP 642

Query: 539 ELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTK 598
           +LMHNFPR+TYREL EAT  FD+QRL+G+GSYGRV+KG+L DGTAIAVKVLQLQ+GN TK
Sbjct: 643 DLMHNFPRMTYRELSEATGGFDDQRLIGSGSYGRVFKGVLSDGTAIAVKVLQLQTGNSTK 702

Query: 599 SFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSD 658
           SFNRECQVLKRIRHRNL+RIITACSLPDFKALVLP+MANGSLDS LYPHSET  GSGSSD
Sbjct: 703 SFNRECQVLKRIRHRNLIRIITACSLPDFKALVLPFMANGSLDSRLYPHSETGLGSGSSD 762

Query: 659 LTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV 718
           L+L+QRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND+MTALVSDFGI++LV TV
Sbjct: 763 LSLIQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDEMTALVSDFGISRLVSTV 822

Query: 719 GVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
           G    G E+MGNSTANMLCGSIGY+APEYG+G+NT+TKGDVYSFGILVLEMVTR+RPTDD
Sbjct: 823 GNAG-GVEHMGNSTANMLCGSIGYIAPEYGYGANTTTKGDVYSFGILVLEMVTRKRPTDD 881

Query: 779 MFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQE 838
           MF GGL+LH+WVK+HYHGR+E+V+DSSLLRAS  Q PEVK+MW VAIGELIELGILCTQE
Sbjct: 882 MFVGGLNLHRWVKSHYHGRMERVVDSSLLRASTAQPPEVKKMWQVAIGELIELGILCTQE 941

Query: 839 SPSTRPTMLDAADDLDRLKRYL 860
           S STRPTMLDAADDLDRLKRYL
Sbjct: 942 SSSTRPTMLDAADDLDRLKRYL 963

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449440217|ref|XP_004137881.1| PREDICTED: putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130-like [Cucumis sativus]

 Score = 1109 bits (2869), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 567/862 (65%), Positives = 674/862 (78%), Gaps = 35/862 (4%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           +V+N+ FG IPPE   LR L  L+LD N+L G IP SLA LS LT+++L +N L G +P 
Sbjct: 144 IVNNNFFGEIPPELFSLRNLHRLRLDSNSLEGPIPTSLASLSKLTVISLMENKLNGTVPP 203

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLD 121
           S F NCTSL NVDLS NF  G+IPEEIGNCP LW L+LYNNQ +G+LP SL NTS+YNLD
Sbjct: 204 SLFSNCTSLLNVDLSNNFLIGRIPEEIGNCPKLWNLNLYNNQFSGELPLSLTNTSLYNLD 263

Query: 122 VEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAG 181
           VEYNHLSGELP+ ++  LP+L++LHLS N+MVSHD NTNL PF  SL NC+ LEELELAG
Sbjct: 264 VEYNHLSGELPAVLVENLPALSFLHLSNNDMVSHDGNTNLEPFITSLRNCSSLEELELAG 323

Query: 182 MDLGGTLPDSIGRL--NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEI 239
           M LGG LPDSIG L  N + L LQEN+I GSIPP +  LS L  LNL+SNLL+GTI AEI
Sbjct: 324 MGLGGWLPDSIGHLGVNFSVLSLQENQIFGSIPPSLAKLSKLAGLNLTSNLLNGTIPAEI 383

Query: 240 SWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLN 299
           S LS+LEQLFLSHNLF+  IP ALG+L H+GLLDLS N+LSGEIP S+G L Q+  LFLN
Sbjct: 384 SRLSKLEQLFLSHNLFTSNIPEALGELPHIGLLDLSHNQLSGEIPESIGCLTQMIYLFLN 443

Query: 300 NNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIE 359
           NN L+ +IP  L +CT L KLDLS+N L+GSIP EI G++EIRIF+NLSHN  +G LPIE
Sbjct: 444 NNLLTGTIPLALVKCTGLQKLDLSFNMLSGSIPREILGLQEIRIFINLSHNNFQGNLPIE 503

Query: 360 LSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDV 419
           LSKL+NVQE+DLSSN  TG IF QIS+CIA+RLIN S+N+LQG+LPDSLG+L+NLE+ D+
Sbjct: 504 LSKLKNVQEMDLSSNNLTGTIFPQISSCIALRLINFSNNSLQGHLPDSLGELENLESFDI 563

Query: 420 SGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPGM 479
           S N LSG IP+SL K+ +LT++NLS N F+GMIP  G F S+T +SF+ N  LCGT+PG+
Sbjct: 564 SENQLSGPIPVSLGKLQSLTYLNLSSNNFQGMIPREGFFKSSTPLSFLNNPLLCGTIPGI 623

Query: 480 PICPPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKSETRSKPITPE 539
             CP K++   + ++  IF+L+I +S+FL+TIC      R+K IIS+  SE+  +   P+
Sbjct: 624 QACPGKRNRFQSPVFLTIFILIICLSSFLTTICCGIACRRLKAIISARNSESSRRSKMPD 683

Query: 540 LMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKS 599
            MHNFPRIT R+L EAT  FD QRL+G+GSYG+VYKGIL DGT +A+KVL  QSGN TKS
Sbjct: 684 FMHNFPRITSRQLSEATGGFDVQRLIGSGSYGQVYKGILPDGTTVAIKVLHTQSGNSTKS 743

Query: 600 FNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDL 659
           FNREC+VLKRIRHRNL+RIITACSLPDFKA+VLPYMANGSLD+HLYPHS T   SGSSDL
Sbjct: 744 FNRECEVLKRIRHRNLIRIITACSLPDFKAIVLPYMANGSLDNHLYPHSPTSSTSGSSDL 803

Query: 660 TLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVG 719
            L++RVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL DDMTALVSDFGI++L MT G
Sbjct: 804 NLIERVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLKDDMTALVSDFGISRL-MTPG 862

Query: 720 VGNDG-AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
           +G+    ENMG STANML GSIGY+AP                               DD
Sbjct: 863 IGSSATVENMGKSTANMLSGSIGYIAP-------------------------------DD 891

Query: 779 MFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQE 838
           MF  GLSLHKWVK+HY+GR+EKV+D SL RA RD+SPE+K+MW+VAI ELIELG+LCTQE
Sbjct: 892 MFVEGLSLHKWVKSHYYGRVEKVVDYSLQRALRDESPEMKKMWEVAIRELIELGLLCTQE 951

Query: 839 SPSTRPTMLDAADDLDRLKRYL 860
           SP TRPTMLDAADDLDRLKRYL
Sbjct: 952 SPFTRPTMLDAADDLDRLKRYL 973

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449501625|ref|XP_004161420.1| PREDICTED: LOW QUALITY PROTEIN: putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130-like [Cucumis sativus]

 Score = 1106 bits (2860), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 566/862 (65%), Positives = 673/862 (78%), Gaps = 35/862 (4%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           +V+N+  G IPPE   LR L  L+LD N+L G IP SLA LS LT+++L +N L G +P 
Sbjct: 144 IVNNNFXGEIPPELFSLRNLHRLRLDSNSLEGPIPTSLASLSKLTVISLMENKLNGTVPP 203

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLD 121
           S F NCTSL NVDLS NF  G+IPEEIGNCP LW L+LYNNQ +G+LP SL NTS+YNLD
Sbjct: 204 SLFSNCTSLLNVDLSNNFLIGRIPEEIGNCPKLWNLNLYNNQFSGELPLSLTNTSLYNLD 263

Query: 122 VEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAG 181
           VEYNHLSGELP+ ++  LP+L++LHLS N+MVSHD NTNL PF  SL NC+ LEELELAG
Sbjct: 264 VEYNHLSGELPAVLVENLPALSFLHLSNNDMVSHDGNTNLEPFITSLRNCSSLEELELAG 323

Query: 182 MDLGGTLPDSIGRL--NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEI 239
           M LGG LPDSIG L  N + L LQEN+I GSIPP +  LS L  LNL+SNLL+GTI AEI
Sbjct: 324 MGLGGWLPDSIGHLGVNFSVLSLQENQIFGSIPPSLAKLSKLAGLNLTSNLLNGTIPAEI 383

Query: 240 SWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLN 299
           S LS+LEQLFLSHNLF+  IP ALG+L H+GLLDLS N+LSGEIP S+G L Q+  LFLN
Sbjct: 384 SRLSKLEQLFLSHNLFTSNIPEALGELPHIGLLDLSHNQLSGEIPESIGCLTQMIYLFLN 443

Query: 300 NNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIE 359
           NN L+ +IP  L +CT L KLDLS+N L+GSIP EI G++EIRIF+NLSHN  +G LPIE
Sbjct: 444 NNLLTGTIPLALVKCTGLQKLDLSFNMLSGSIPREILGLQEIRIFINLSHNNFQGNLPIE 503

Query: 360 LSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDV 419
           LSKL+NVQE+DLSSN  TG IF QIS+CIA+RLIN S+N+LQG+LPDSLG+L+NLE+ D+
Sbjct: 504 LSKLKNVQEMDLSSNNLTGTIFPQISSCIALRLINFSNNSLQGHLPDSLGELENLESFDI 563

Query: 420 SGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPGM 479
           S N LSG IP+SL K+ +LT++NLS N F+GMIP  G F S+T +SF+ N  LCGT+PG+
Sbjct: 564 SENQLSGPIPVSLGKLQSLTYLNLSSNNFQGMIPREGFFKSSTPLSFLNNPLLCGTIPGI 623

Query: 480 PICPPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKSETRSKPITPE 539
             CP K++   + ++  IF+L+I +S+FL+TIC      R+K IIS+  SE+  +   P+
Sbjct: 624 QACPGKRNRFQSPVFLTIFILIICLSSFLTTICCGIACRRLKAIISARNSESSRRSKMPD 683

Query: 540 LMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKS 599
            MHNFPRIT R+L EAT  FD QRL+G+GSYG+VYKGIL DGT +A+KVL  QSGN TKS
Sbjct: 684 FMHNFPRITSRQLSEATGGFDVQRLIGSGSYGQVYKGILPDGTTVAIKVLHTQSGNSTKS 743

Query: 600 FNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDL 659
           FNREC+VLKRIRHRNL+RIITACSLPDFKA+VLPYMANGSLD+HLYPHS T   SGSSDL
Sbjct: 744 FNRECEVLKRIRHRNLIRIITACSLPDFKAIVLPYMANGSLDNHLYPHSPTSSTSGSSDL 803

Query: 660 TLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVG 719
            L++RVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL DDMTALVSDFGI++L MT G
Sbjct: 804 NLIERVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLKDDMTALVSDFGISRL-MTPG 862

Query: 720 VGNDG-AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
           +G+    ENMG STANML GSIGY+AP                               DD
Sbjct: 863 IGSSATVENMGKSTANMLSGSIGYIAP-------------------------------DD 891

Query: 779 MFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQE 838
           MF  GLSLHKWVK+HY+GR+EKV+D SL RA RD+SPE+K+MW+VAI ELIELG+LCTQE
Sbjct: 892 MFVEGLSLHKWVKSHYYGRVEKVVDYSLQRALRDESPEMKKMWEVAIRELIELGLLCTQE 951

Query: 839 SPSTRPTMLDAADDLDRLKRYL 860
           SP TRPTMLDAADDLDRLKRYL
Sbjct: 952 SPFTRPTMLDAADDLDRLKRYL 973

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356547478|ref|XP_003542139.1| PREDICTED: putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130-like [Glycine max]

 Score = 1080 bits (2792), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 566/862 (65%), Positives = 672/862 (77%), Gaps = 42/862 (4%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           +V +HLFG IPPEFS LRRL  + L+GNNLHG IPES ++LS L    + +NN++G LP 
Sbjct: 110 IVRSHLFGIIPPEFSNLRRLHSITLEGNNLHGSIPESFSMLSKLYFFIIKENNISGSLPP 169

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLD 121
           S F NCT L  VD S N  TG+IPEEIGNC +LW++SLY+NQ TGQLP SL N ++ NLD
Sbjct: 170 SLFSNCTLLDVVDFSSNSLTGQIPEEIGNCKSLWSISLYDNQFTGQLPLSLTNLTLQNLD 229

Query: 122 VEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAG 181
           VEYN+L GELP+  +S  P+L YLHLSYNNM+SHD+NTNL PFF +L N ++LEELELAG
Sbjct: 230 VEYNYLFGELPTKFVSSWPNLLYLHLSYNNMISHDNNTNLDPFFTALRNNSNLEELELAG 289

Query: 182 MDLGGTLPDSI-GRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEI 239
           M LGG    ++ G+L +L  LLLQEN+I GSIP  + NLS L  LNL+SNLL+GTIS++I
Sbjct: 290 MGLGGRFTYTVAGQLTSLRTLLLQENQIFGSIPRSLANLSRLFILNLTSNLLNGTISSDI 349

Query: 240 SW-LSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFL 298
            + L +LEQL LSHNLF   IP A+GK   LGLLDLS+N+ SG IP SLGNLV + SLFL
Sbjct: 350 FFSLPKLEQLSLSHNLFKTPIPEAIGKCLDLGLLDLSYNQFSGRIPDSLGNLVGLNSLFL 409

Query: 299 NNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPI 358
           NNN LS +IPPTLGRCT+LY+LDLS+NRLTGSIP E++G+ EIRIF+N+SHN LEGPLPI
Sbjct: 410 NNNLLSGTIPPTLGRCTNLYRLDLSHNRLTGSIPLELAGLHEIRIFINVSHNHLEGPLPI 469

Query: 359 ELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAID 418
           ELSKL  VQEIDLSSN  TG+IF Q++ CIAV +IN S+N LQG LP SLGDLKNLE+ D
Sbjct: 470 ELSKLAKVQEIDLSSNYLTGSIFPQMAGCIAVSMINFSNNFLQGELPQSLGDLKNLESFD 529

Query: 419 VSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPG 478
           VS N LSG+IP +L KI TLTF+NLSFN  +G IPSGGIFNS + +SF+GN  LCGT+ G
Sbjct: 530 VSRNQLSGLIPATLGKIDTLTFLNLSFNNLEGKIPSGGIFNSVSTLSFLGNPQLCGTIAG 589

Query: 479 MPICPPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKSETRSKPITP 538
           + +C  ++ W HTR   IIF+LVI IS  LS IC V G  R+K+IISS ++E       P
Sbjct: 590 ISLCSQRRKWFHTRSLLIIFILVIFISTLLSIICCVIGCKRLKVIISSQRTEASKNATRP 649

Query: 539 ELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTK 598
           EL+ NFPRITY+EL +AT  FD QRL+G+GSYG VY+G+L DGT IAVKVL LQSGN TK
Sbjct: 650 ELISNFPRITYKELSDATGGFDNQRLVGSGSYGHVYRGVLTDGTPIAVKVLHLQSGNSTK 709

Query: 599 SFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSD 658
           SFNRECQVLKRIRHRNL+RIITACSLPDFKALVLPYMANGSL+S LYP        GSSD
Sbjct: 710 SFNRECQVLKRIRHRNLIRIITACSLPDFKALVLPYMANGSLESRLYP------SCGSSD 763

Query: 659 LTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV 718
           L+++QRVNICSD+AEGMAYLHHHSPVRVIHCDLKPSN+LLNDDMTALVSDFG+A+L+M+V
Sbjct: 764 LSIVQRVNICSDVAEGMAYLHHHSPVRVIHCDLKPSNILLNDDMTALVSDFGVARLIMSV 823

Query: 719 GVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
           G G    +NMGNS+AN+ CGSIGY+AP                               DD
Sbjct: 824 GGG--AIDNMGNSSANLFCGSIGYIAP-------------------------------DD 850

Query: 779 MFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQE 838
           MF GGLSLH+WVK H+HGR+EKVIDS+L+ AS DQS EV++MW+ AI ELIELG+LCTQE
Sbjct: 851 MFVGGLSLHQWVKIHFHGRVEKVIDSALVTASIDQSREVRKMWEAAIVELIELGLLCTQE 910

Query: 839 SPSTRPTMLDAADDLDRLKRYL 860
           SPSTRPTMLDAADDL+RLKRYL
Sbjct: 911 SPSTRPTMLDAADDLNRLKRYL 932

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|242044720|ref|XP_002460231.1| hypothetical protein SORBIDRAFT_02g025040 [Sorghum bicolor] gi|241923608|gb|EER96752.1| hypothetical protein SORBIDRAFT_02g025040 [Sorghum bicolor]

 Score =  931 bits (2405), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 482/869 (55%), Positives = 620/869 (71%), Gaps = 22/869 (2%)

Query: 5    NHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFF 64
            N L G IP E SKLR +  + L  N LHG IP SL+ L+++  + L  NNL+G +P + F
Sbjct: 341  NQLTGQIPAELSKLRNIGAIDLGSNQLHGGIPPSLSELTDMFYLGLRQNNLSGNIPPAIF 400

Query: 65   HNCTSLRNVDLSQNFFTGKIPEEIGNCP--NLWTLSLYNNQLTGQLPASLIN-TSMYNLD 121
             NCT L  +D+  N  +G+IP  I +    +   ++LY+N+L G LP  + N T +  LD
Sbjct: 401  LNCTGLGLIDVGNNSLSGEIPRAISSTQGCSFVVINLYSNKLEGTLPRWIANCTDLMTLD 460

Query: 122  VEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAG 181
            VE N L  ELP+ I+S    L YLHLS N+  SHDDN+NL PFF +L NCT L+E+E + 
Sbjct: 461  VECNLLDDELPTSIISSKKKLLYLHLSNNSFRSHDDNSNLEPFFVALSNCTSLQEVEASA 520

Query: 182  MDLGGTLPDSIGRL---NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAE 238
            + +GG LP  +G L   N+  L L+ N I G IP  +G++ N+  +NLSSNLL+GTI   
Sbjct: 521  VGMGGQLPSQLGSLLPINIWHLNLELNAIEGPIPESVGDVINMTWMNLSSNLLNGTIPTS 580

Query: 239  ISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFL 298
            +  L  LE+L LS+N  +GEIPA +G    LG LDLS N LSG IP S+G+L ++  LFL
Sbjct: 581  LCRLKNLERLALSNNSLTGEIPACIGSATSLGELDLSGNMLSGAIPSSIGSLAELRYLFL 640

Query: 299  NNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIF-LNLSHNQLEGPLP 357
              N+LS +IPP+LGR   L  +DLS N LTG IP E  GI +  ++ LNLS NQL G LP
Sbjct: 641  QGNKLSGAIPPSLGRYATLLVIDLSNNSLTGVIPDEFPGIAKTTLWTLNLSRNQLGGKLP 700

Query: 358  IELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAI 417
              LS ++ VQ+IDLS N F G IF  + +CIA+ ++++SHN+L G+LP +L  LK+LE++
Sbjct: 701  TGLSNMQQVQKIDLSRNNFNGEIF-SLGDCIALTVLDLSHNSLAGDLPSTLDKLKSLESL 759

Query: 418  DVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVP 477
            DVS NHLSG IP+SL     L ++NLS+N+F G++PS G F +   +S++GN+ L G  P
Sbjct: 760  DVSNNHLSGEIPMSLTDCQMLKYLNLSYNDFWGVVPSTGPFVNFGCLSYLGNRRLSG--P 817

Query: 478  GMPICPPK-QHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKSET----R 532
             +  C  + + W  +R + +I  +  +  AF  TI     + +I+  +++ + +     R
Sbjct: 818  VLRRCRGRHRSWYQSRKFLVIMCVCSAALAFALTILCAVSVRKIRERVTAMREDMFRGRR 877

Query: 533  SKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQ 592
                +P + + FPRITYREL+EAT +F E RL+GTGSYGRVY+G L+DGT +AVKVLQLQ
Sbjct: 878  GGGSSPVMKYKFPRITYRELVEATEDFSEDRLVGTGSYGRVYRGTLRDGTMVAVKVLQLQ 937

Query: 593  SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEF 652
            +GN TKSFNRECQVLKRIRHRNLMRI+TACSLPDFKALVLP+MANGSL+  LY     E 
Sbjct: 938  TGNSTKSFNRECQVLKRIRHRNLMRIVTACSLPDFKALVLPFMANGSLERCLYAGPPAE- 996

Query: 653  GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA 712
                  L+L+QRVNICSDIAEGMAYLHHHSPV+VIHCDLKPSNVL+NDDMTALVSDFGI+
Sbjct: 997  ------LSLVQRVNICSDIAEGMAYLHHHSPVKVIHCDLKPSNVLINDDMTALVSDFGIS 1050

Query: 713  KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR 772
            +LVM++G   + A ++G STANMLCGSIGY+ PEYG+GSN +TKGDVYSFG+LVLEMVTR
Sbjct: 1051 RLVMSIGGVANTAADVGASTANMLCGSIGYIPPEYGYGSNPTTKGDVYSFGVLVLEMVTR 1110

Query: 773  RRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELG 832
            R+PTDDMF  GLSLHKWVK HYHGR + V+D +L+R  RDQ+PEV+RM DVAIGEL+ELG
Sbjct: 1111 RKPTDDMFDAGLSLHKWVKTHYHGRADAVVDQALVRMVRDQTPEVRRMSDVAIGELLELG 1170

Query: 833  ILCTQESPSTRPTMLDAADDLDRLKRYLG 861
            ILCTQE  S RPTM+DAADDLDRLKRYLG
Sbjct: 1171 ILCTQEQASARPTMMDAADDLDRLKRYLG 1199

Source: Sorghum bicolor

Species: Sorghum bicolor

Genus: Sorghum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|414885517|tpg|DAA61531.1| TPA: putative leucine-rich repeat receptor-like protein kinase family protein [Zea mays]

 Score =  924 bits (2389), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 480/867 (55%), Positives = 618/867 (71%), Gaps = 22/867 (2%)

Query: 5    NHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFF 64
            N L G IP E S +R L  + L GN LHG IP SL+ L+ +  + L  N+L+G +P +  
Sbjct: 241  NQLTGQIPAELSNIRDLGAIHLRGNQLHGGIPPSLSELTAMFYLGLEQNDLSGTIPPAIL 300

Query: 65   HNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWT-LSLYNNQLTGQLPASLIN-TSMYNLDV 122
             NCT L  +D+  N  +G+IP  I +   L+  ++LY+N L G LP  L N T +  LDV
Sbjct: 301  LNCTQLALLDVGDNNLSGEIPRAISSARCLFVVINLYSNNLNGTLPRWLANCTQLMTLDV 360

Query: 123  EYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGM 182
            E N L  ELP+ I+S    LTYLHLS N  +SHD+N+NL PFF +L NCT L+E+E   +
Sbjct: 361  ENNLLDDELPTSIISGNQELTYLHLSNNRFLSHDNNSNLEPFFVALSNCTLLQEVEAGAV 420

Query: 183  DLGGTLPDSIGRL---NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEI 239
             + G LP  +G L   N   L L+ N I G IP  IG++ N++ LNLSSNLL+GTI   +
Sbjct: 421  GMRGQLPWRLGSLLPMNTGHLNLELNAIEGPIPASIGDIINMMWLNLSSNLLNGTIPTSL 480

Query: 240  SWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLN 299
              L +LE+L LS+N  +GEIPA +G    LG +DLS N LSG IP S+ +L ++ +L L 
Sbjct: 481  CRLKRLERLVLSNNALTGEIPACIGDATGLGEIDLSGNVLSGAIPSSIRSLSELQTLTLQ 540

Query: 300  NNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIE 359
             N+LS +IP +LGRCT L  +DLS N LTG IP EI+GI      LNLS NQL G LP  
Sbjct: 541  RNELSGAIPSSLGRCTALLVIDLSCNSLTGVIPEEITGI--AMKTLNLSRNQLGGKLPAG 598

Query: 360  LSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDV 419
            L  ++ V++IDLS N F G I  ++  CIA+ ++++SHN+L G+LP  LG LKNLE+++V
Sbjct: 599  LGSMQQVEKIDLSWNNFNGEILPRLGECIALTVLDLSHNSLAGDLPPELGGLKNLESLNV 658

Query: 420  SGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPGM 479
            S NHLSG IP SL   + L ++NLS+N+F G++P+ G F + + +S++GN+ L G  P +
Sbjct: 659  SNNHLSGEIPTSLTDCYMLKYLNLSYNDFSGVVPTTGPFVNFSCLSYLGNRRLSG--PVL 716

Query: 480  PICPPK-QHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKSET----RSK 534
              C  + + W  +R + ++  +  ++ AF  TI     + +I+  ++S + +     R  
Sbjct: 717  RRCRERHRSWYQSRKFLVVLCVCSAVLAFALTILCAVSVRKIRERVASMREDMFRGRRGG 776

Query: 535  PITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSG 594
              +P + + FPRITYREL+EAT EF E RL+GTGSYGRVY+G L+DGT +AVKVLQLQ+G
Sbjct: 777  GSSPVMKYKFPRITYRELVEATDEFSEDRLVGTGSYGRVYRGALRDGTMVAVKVLQLQTG 836

Query: 595  NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGS 654
            N TKSFNRECQVLKRIRHRNLMRI+TACSLPDFKALVLP+MANGSL+  LY     E   
Sbjct: 837  NSTKSFNRECQVLKRIRHRNLMRIVTACSLPDFKALVLPFMANGSLERCLYAGPPAE--- 893

Query: 655  GSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL 714
                L+L+QRVNICSDIAEGMAYLHHHSPV+VIHCDLKPSNVL+NDDMTALVSDFGI++L
Sbjct: 894  ----LSLVQRVNICSDIAEGMAYLHHHSPVKVIHCDLKPSNVLINDDMTALVSDFGISRL 949

Query: 715  VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
            VM++G G   A ++G STANMLCGSIGY+ PEYG+GSNT+TKGDVYSFG+LVLEMVTRR+
Sbjct: 950  VMSIG-GVANAADVGASTANMLCGSIGYIPPEYGYGSNTTTKGDVYSFGVLVLEMVTRRK 1008

Query: 775  PTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGIL 834
            PTDDMF  GLSLHKWVK HYHGR + V+D +L+R  RDQ+PEV+RM DVAIGEL+ELGIL
Sbjct: 1009 PTDDMFEAGLSLHKWVKAHYHGRADAVVDQALVRMVRDQTPEVRRMSDVAIGELLELGIL 1068

Query: 835  CTQESPSTRPTMLDAADDLDRLKRYLG 861
            C+Q+  S RPTM+DAADDLDRLKRYLG
Sbjct: 1069 CSQDQASARPTMMDAADDLDRLKRYLG 1095

Source: Zea mays

Species: Zea mays

Genus: Zea

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|326501888|dbj|BAK06436.1| predicted protein [Hordeum vulgare subsp. vulgare]

 Score =  891 bits (2303), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 477/867 (55%), Positives = 611/867 (70%), Gaps = 25/867 (2%)

Query: 5   NHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFF 64
           N L G IP E S LR L  L L  N L G IP SL+ L++L  ++L DN+L+G +P   F
Sbjct: 127 NFLAGQIPAELSNLRGLEVLDLGHNQLSGGIPPSLSELASLAYLSLKDNHLSGPIPAVLF 186

Query: 65  HNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNLDVE 123
            NCTSL  VD   N  +G+IP E      +  L+LY+N+LTG+LP  L N T +Y LDVE
Sbjct: 187 KNCTSLGLVDFGNNDLSGEIPLEASE--TILVLNLYSNRLTGRLPRWLANCTYLYLLDVE 244

Query: 124 YNHLSGELPSDIMSKLPSLTYLHLSYN-NMVSHDDNTNLVPFFNSLGNCTDLEELELAGM 182
            N L+ ELP+DI++    L YLHLS N    SHD NTNL PFF ++ NC+ + E+E   +
Sbjct: 245 DNSLADELPADIIAGKQQLRYLHLSNNYRFSSHDGNTNLEPFFAAVSNCSQILEIEAGAV 304

Query: 183 DLGGTLPDSIGRL---NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEI 239
            +GG LP  +G L   N++ L L+ N+I G+IP +IG++ N+  +NLSSN L+GT+ A I
Sbjct: 305 RMGGWLPSRLGSLLPPNMSHLNLELNEIKGTIPANIGDVINITLMNLSSNQLNGTVPASI 364

Query: 240 SWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLN 299
             L +LE+L LS+N  +G IPA +G    LG LDLS N LSG IP  +G   ++ +L+L 
Sbjct: 365 CALPKLERLSLSNNGLTGMIPACIGNATSLGELDLSGNALSGSIPSGIG--TRLVNLYLQ 422

Query: 300 NNQLSRSIPPT-LGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPI 358
           NNQLS  IP   L  C  L  LDLS N LTG +P  +SG  +I I+LNLSHNQ+ G LP 
Sbjct: 423 NNQLSGEIPANRLAECIRLLHLDLSNNSLTGEVPDMVSGT-DI-IYLNLSHNQIRGELPR 480

Query: 359 ELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAID 418
            LS ++  Q IDLS N F+G I  Q+  C  + ++++SHN L G LP SL  LK+L+ +D
Sbjct: 481 GLSDMQQAQAIDLSWNNFSGTISPQLGLCRELEVLDLSHNLLTGVLPSSLELLKDLKNLD 540

Query: 419 VSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPG 478
           VS N L+G IP +L K  +L   NLS+N+F G +P+ G+F   T +S++GN  LCG+V  
Sbjct: 541 VSNNSLTGEIPANLTKCTSLKHFNLSYNDFVGHVPTTGVFADFTFLSYIGNPRLCGSVVR 600

Query: 479 MPICPPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKSET----RSK 534
              C   + W  +R Y ++  +  ++ AF+ TI  V    +I+  +++ + +     RS 
Sbjct: 601 RN-CQRHRSWYQSRKYLVVMCVCAAVLAFVLTIFCVVSAWKIRDWLAAVRDDMFRGRRSG 659

Query: 535 PITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSG 594
             +P + + FPRIT++ELLEAT EF E RL+GTGSYGRVY+G L+DGT +AVKVLQLQSG
Sbjct: 660 GSSPVMKYKFPRITHQELLEATEEFSEDRLVGTGSYGRVYRGTLRDGTMVAVKVLQLQSG 719

Query: 595 NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGS 654
           N TKSF+RECQVLKRIRHRNLMRIITACSL DFKALVLP+MA GSL+  LY    +E   
Sbjct: 720 NSTKSFSRECQVLKRIRHRNLMRIITACSLADFKALVLPFMAKGSLERCLYAGPPSE--- 776

Query: 655 GSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL 714
               L+L+QRVNICSDIAEG+AYLHHHSPV+VIHCDLKPSNVL+NDDMTALVSDFGI++L
Sbjct: 777 ----LSLVQRVNICSDIAEGVAYLHHHSPVKVIHCDLKPSNVLINDDMTALVSDFGISRL 832

Query: 715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           VM++G G   A ++G STANMLCGSIGY+ PEYG+GSN +TKGDVYSFG+LV+EMVTR++
Sbjct: 833 VMSIG-GVANAADVGASTANMLCGSIGYIPPEYGYGSNPTTKGDVYSFGVLVMEMVTRKK 891

Query: 775 PTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGIL 834
           PTD+MF  GLSLHKWVK+HYHGR + V+D +L R   DQ+PEV+RM D AIG L+ELGIL
Sbjct: 892 PTDEMFEAGLSLHKWVKSHYHGRADAVVDQALARMVLDQTPEVRRMSDAAIGGLLELGIL 951

Query: 835 CTQESPSTRPTMLDAADDLDRLKRYLG 861
           CTQES STRP+MLDAADDLDRLKRYLG
Sbjct: 952 CTQESASTRPSMLDAADDLDRLKRYLG 978

Source: Hordeum vulgare subsp. vulgare

Species: Hordeum vulgare

Genus: Hordeum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	885
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.958	0.865	0.457	8.6e-191
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.923	0.797	0.362	6.8e-127
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.923	0.808	0.341	6.9e-118
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.922	0.808	0.335	8.8e-118
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.896	0.769	0.351	1e-116
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.906	0.782	0.342	1.9e-113
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.933	0.817	0.320	2.2e-112
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.929	0.701	0.327	1.6e-109
TAIR|locus:2011339	1120	AT1G35710 [Arabidopsis thalian	0.837	0.661	0.310	3.5e-105
TAIR|locus:2160791	1102	AT5G63930 [Arabidopsis thalian	0.853	0.685	0.295	1.8e-101

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 1849 (655.9 bits), Expect = 8.6e-191, P = 8.6e-191
 Identities = 398/869 (45%), Positives = 543/869 (62%)

Query:     5 NHLFGAIPPEFSKLRR-LRHLQLDGNNLHGQIPEXXXXXXXXXXXXXHDNNLTGMLPISF 63
             N   G IPPE   L   L+ L L  N LHG IP+               N L G +P+  
Sbjct:   100 NFFVGKIPPEIGSLHETLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQL 159

Query:    64 FHN--CTSLRNVDLSQNFFTGKIPEEIGNC--PNLWTLSLYNNQLTGQLPASLIN-TSMY 118
             F N   +SL+ +DLS N  TG+IP    +C    L  L L++N+LTG +P+SL N T++ 
Sbjct:   160 FCNGSSSSLQYIDLSNNSLTGEIPLNY-HCHLKELRFLLLWSNKLTGTVPSSLSNSTNLK 218

Query:   119 NLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELE 178
              +D+E N LSGELPS ++SK+P L +L+LSYN+ VSH++NTNL PFF SL N +DL+ELE
Sbjct:   219 WMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELE 278

Query:   179 LAGMDLGGTLPDSIGRL--NLTQLLLQENKITGSIPPHIGXXXXXXXXXXXXXXXXGTIS 236
             LAG  LGG +  S+  L  NL Q+ L +N+I GSIPP I                 G I 
Sbjct:   279 LAGNSLGGEITSSVRHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGPIP 338

Query:   237 AEISWLSQLEQLFLSHNLFSGEIPAAXXXXXXXXXXXXSFNKLSGEIPVSLGNLVQIYSL 296
              E+  LS+LE+++LS+N  +GEIP              S N LSG IP S GNL Q+  L
Sbjct:   339 RELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRL 398

Query:   297 FLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEI-SGIREIRIFLNLSHNQLEGP 355
              L  N LS ++P +LG+C +L  LDLS+N LTG+IP E+ S +R ++++LNLS N L GP
Sbjct:   399 LLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGP 458

Query:   356 LPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLE 415
             +P+ELSK++ V  +DLSSN+ +G I  Q+ +CIA+  +N+S N     LP SLG L  L+
Sbjct:   459 IPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLK 518

Query:   416 AIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGT 475
              +DVS N L+G IP S  +  TL  +N SFN   G +   G F+  T  SF+G+  LCG+
Sbjct:   519 ELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGS 578

Query:   476 VPGMPICPPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKSETRSKP 535
             + GM  C  K+H   + +  ++  L+ +    +    LV      K +    K E   + 
Sbjct:   579 IKGMQACK-KKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEE 637

Query:   536 ITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSG- 594
                +    +PRI+Y++L+ AT  F+   L+G+G +G VYKG+L++ T +AVKVL  ++  
Sbjct:   638 KQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTAL 697

Query:   595 NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGS 654
              F+ SF RECQ+LKR RHRNL+RIIT CS P F ALVLP M NGSL+ HLYP    E+ S
Sbjct:   698 EFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNALVLPLMPNGSLERHLYPG---EYSS 754

Query:   655 GSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL 714
                +L L+Q VNICSD+AEG+AYLHH+SPV+V+HCDLKPSN+LL+D+MTALV+DFGI++L
Sbjct:   755 --KNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRL 812

Query:   715 VMTVG--VGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR 772
             V  V   V  D + + G ST  +LCGS+GY+APEYG G   ST GDVYSFG+L+LE+V+ 
Sbjct:   813 VQGVEETVSTDDSVSFG-STDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSG 871

Query:   773 RRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPE-VKRMWDVAIGELIEL 831
             RRPTD +   G SLH+++K+HY   LE +I+ +L R      PE  +++W   I E+IEL
Sbjct:   872 RRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCEKLWREVILEMIEL 931

Query:   832 GILCTQESPSTRPTMXXXXXXXXRLKRYL 860
             G++CTQ +PSTRP M        RLK YL
Sbjct:   932 GLVCTQYNPSTRPDMLDVAHEMGRLKEYL 960

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1246 (443.7 bits), Expect = 6.8e-127, P = 6.8e-127
 Identities = 314/867 (36%), Positives = 467/867 (53%)

Query:     2 LVDNHLFGAIPPEF-SKLRRLRHLQLDGNNLHGQIPEXXXXXXXXXXXXXHDNNLTGMLP 60
             L  N L G IP E  + L+ L +L L  N L G+IP                N L+G +P
Sbjct:   158 LSHNQLRGMIPREIGASLKHLSNLYLYKNGLSGEIPSALGNLTSLQEFDLSFNRLSGAIP 217

Query:    61 ISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTS--MY 118
              S     +SL  ++L QN  +G IP  I N  +L   S+  N+L G +P +   T   + 
Sbjct:   218 SSL-GQLSSLLTMNLGQNNLSGMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFKTLHLLE 276

Query:   119 NLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDL---E 175
              +D+  N   G++P+ + +    LT + + Y N+ S    +     F  L N T+L    
Sbjct:   277 VIDMGTNRFHGKIPASV-ANASHLTVIQI-YGNLFSGIITSG----FGRLRNLTELYLWR 330

Query:   176 EL-ELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGXXXXXXXXXXXXXXX-XG 233
              L +    D  G + D      L  L L EN + G +P                     G
Sbjct:   331 NLFQTREQDDWGFISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTSLSFLALELNKITG 390

Query:   234 TISAEISWLSQLEQLFLSHNLFSGEIPAAXXXXXXXXXXXXSFNKLSGEIPVSLGNLVQI 293
             +I  +I  L  L+ L+L +N F G +P++              N LSG IP+++GNL ++
Sbjct:   391 SIPKDIGNLIGLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYENNLSGSIPLAIGNLTEL 450

Query:   294 YSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLE 353
               L L  N+ S  IP TL   T+L  L LS N L+G IP+E+  I+ + I +N+S N LE
Sbjct:   451 NILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLE 510

Query:   354 GPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKN 413
             G +P E+  L+N+ E    SN+ +G I   + +C  +R + + +N L G++P +LG LK 
Sbjct:   511 GSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKG 570

Query:   414 LEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLC 473
             LE +D+S N+LSG IP SL  I  L  +NLSFN F G +P+ G F +A+ +S  GN  LC
Sbjct:   571 LETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLC 630

Query:   474 GTVPGM--PICPPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKSET 531
             G +P +  P C P    L  R +F +  + +S++A L+   +++ ++   L+I+  K   
Sbjct:   631 GGIPDLHLPRCCPL---LENRKHFPVLPISVSLAAALA---ILSSLY---LLITWHKRTK 681

Query:   532 RSKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQL 591
             +  P     M   P ++Y +L++AT  F    LLG+GS+G VYKG L     +AVKVL+L
Sbjct:   682 KGAPSRTS-MKGHPLVSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKL 740

Query:   592 QSGNFTKSFNRECQVLKRIRHRNLMRIITACSL-----PDFKALVLPYMANGSLDSHLYP 646
             ++    KSF  EC+ L+ +RHRNL++I+T CS       DFKA+V  +M NGSL+  ++P
Sbjct:   741 ENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHP 800

Query:   647 HSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALV 706
               ET   +    L L +RV I  D+A  + YLH H P  V+HCD+K SNVLL+ DM A V
Sbjct:   801 --ETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHV 858

Query:   707 SDFGIAKLVMTVGVGNDGAENMGNSTANM-LCGSIGYMAPEYGFGSNTSTKGDVYSFGIL 765
              DFG+A++++      DG   +  ST++M   G+IGY APEYG G   ST GD+YS+GIL
Sbjct:   859 GDFGLARILV------DGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGIL 912

Query:   766 VLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRD------QSPEVKR 819
             VLE+VT +RPTD  F   L L ++V+   HGR+  V+D+ L+  S +       SP  +R
Sbjct:   913 VLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDTKLILDSENWLNSTNNSP-CRR 971

Query:   820 MWDVAIGELIELGILCTQESPSTR-PT 845
             + +  +  L+ LG+ C+QE PS+R PT
Sbjct:   972 ITECIVW-LLRLGLSCSQELPSSRTPT 997

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 1161 (413.8 bits), Expect = 6.9e-118, P = 6.9e-118
 Identities = 295/865 (34%), Positives = 451/865 (52%)

Query:     2 LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPEXXXXXXXXXXXXXHDNNLTGMLPI 61
             L  N L G++P E   L  L  L L GNN+ G++P                NNL G +P 
Sbjct:   145 LDSNRLGGSVPSELGSLTNLVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIP- 203

Query:    62 SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASL--INTSMYN 119
             S     T + ++ L  N F+G  P  + N  +L  L +  N  +G+L   L  +  ++ +
Sbjct:   204 SDVAQLTQIWSLQLVANNFSGVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLS 263

Query:   120 LDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELEL 179
              ++  N+ +G +P+ + S + +L  L ++ NN+      T  +P F   GN  +L+ L L
Sbjct:   264 FNMGGNYFTGSIPTTL-SNISTLERLGMNENNL------TGSIPTF---GNVPNLKLLFL 313

Query:   180 AGMDLGGTLPDSIGRL----NLTQLL---LQENKITGSIPPHIGXXXXXXXXXXXXXXX- 231
                 LG      +  L    N TQL    +  N++ G +P  I                 
Sbjct:   314 HTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRNRLGGDLPISIANLSAKLVTLDLGGTLI 373

Query:   232 XGTISAEISWLSQLEQLFLSHNLFSGEIPAAXXXXXXXXXXXXSFNKLSGEIPVSLGNLV 291
              G+I  +I  L  L++L L  N+ SG +P +              N+LSG IP  +GN+ 
Sbjct:   374 SGSIPYDIGNLINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMT 433

Query:   292 QIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQ 351
              + +L L+NN     +P +LG C+ L +L +  N+L G+IP EI  I+++ + L++S N 
Sbjct:   434 MLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQL-LRLDMSGNS 492

Query:   352 LEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDL 411
             L G LP ++  L+N+  + L  NK +G +   + NC+ +  + +  N   G++PD  G L
Sbjct:   493 LIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKG-L 551

Query:   412 KNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQH 471
               ++ +D+S N LSG IP        L ++NLSFN  +G +P  GIF +AT +S VGN  
Sbjct:   552 VGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNND 611

Query:   472 LCGTVPGMPICP-----PKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISS 526
             LCG + G  + P     P     H+     + V+ +S+   L  +  +  +  I L    
Sbjct:   612 LCGGIMGFQLKPCLSQAPSVVKKHSSRLKKV-VIGVSVGITLLLLLFMASVTLIWLRKRK 670

Query:   527 GKSETRSK-PITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGIL-QDGTAI 584
                ET +  P T E++H   +I+Y +L  AT  F    ++G+GS+G VYK +L  +   +
Sbjct:   671 KNKETNNPTPSTLEVLHE--KISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVV 728

Query:   585 AVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDF-----KALVLPYMANGS 639
             AVKVL +Q     KSF  EC+ LK IRHRNL++++TACS  DF     +AL+  +M NGS
Sbjct:   729 AVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGS 788

Query:   640 LDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN 699
             LD  L+P    E    S  LTLL+R+NI  D+A  + YLH H    + HCDLKPSNVLL+
Sbjct:   789 LDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLD 848

Query:   700 DDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDV 759
             DD+TA VSDFG+A+L++      +   N  +S    + G+IGY APEYG G   S  GDV
Sbjct:   849 DDLTAHVSDFGLARLLLKFD--EESFFNQLSSAG--VRGTIGYAAPEYGVGGQPSINGDV 904

Query:   760 YSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRAS-RDQSPEVK 818
             YSFGIL+LEM T +RPT+++F G  +L+ + K+    R+  ++D S+L    R   P V+
Sbjct:   905 YSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVVE 964

Query:   819 RMWDVAIGELIELGILCTQESPSTR 843
                   +  + E+G+ C +ESP  R
Sbjct:   965 -----CLTMVFEVGLRCCEESPMNR 984

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 1160 (413.4 bits), Expect = 8.8e-118, P = 8.8e-118
 Identities = 290/865 (33%), Positives = 456/865 (52%)

Query:     2 LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPEXXXXXXXXXXXXXHDNNLTGMLP- 60
             L  N+L   +P E   LR+L +L L  N+L G+ P                N+L G +P 
Sbjct:   145 LFSNNLGDGVPSELGSLRKLLYLYLGLNDLKGKFPVFIRNLTSLIVLNLGYNHLEGEIPD 204

Query:    61 -ISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINT--SM 117
              I+      SL    L+ N F+G  P    N  +L  L L  N  +G L     N   ++
Sbjct:   205 DIAMLSQMVSLT---LTMNNFSGVFPPAFYNLSSLENLYLLGNGFSGNLKPDFGNLLPNI 261

Query:   118 YNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEEL 177
             + L +  N L+G +P+ + + + +L    +  N M       ++ P F  L N   L  L
Sbjct:   262 HELSLHGNFLTGAIPTTL-ANISTLEMFGIGKNRMTG-----SISPNFGKLEN---LHYL 312

Query:   178 ELAGMDLG----GTLP--DSIGRLN-LTQLLLQENKITGSIPPHI-GXXXXXXXXXXXXX 229
             ELA   LG    G L   D++   + L  L +  N++ G++P  I               
Sbjct:   313 ELANNSLGSYSFGDLAFLDALTNCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGN 372

Query:   230 XXXGTISAEISWLSQLEQLFLSHNLFSGEIPAAXXXXXXXXXXXXSFNKLSGEIPVSLGN 289
                G+I  +I  L  L+ L L+ NL +G +P +              N+ SGEIP  +GN
Sbjct:   373 LIYGSIPHDIGNLIGLQSLLLADNLLTGPLPTSLGNLVGLGELILFSNRFSGEIPSFIGN 432

Query:   290 LVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSH 349
             L Q+  L+L+NN     +PP+LG C+ +  L + YN+L G+IP EI  I  + + LN+  
Sbjct:   433 LTQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTL-VHLNMES 491

Query:   350 NQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLG 409
             N L G LP ++ +L+N+ E+ L +N  +G++   +  C+++ +I +  N   G +PD  G
Sbjct:   492 NSLSGSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPDIKG 551

Query:   410 DLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGN 469
              L  ++ +D+S N+LSG I         L ++NLS N F+G +P+ GIF +AT +S  GN
Sbjct:   552 -LMGVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGIFQNATLVSVFGN 610

Query:   470 QHLCGTVPGMPI--CPPKQHWLHTRMYFIIFVLVISISAFLSTICL--VTGIHRIKLIIS 525
             ++LCG++  + +  C  +   + TR   ++  + I +S  ++ + L  +  +   K   +
Sbjct:   611 KNLCGSIKELKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIALLLLLFIVSLSWFKKRKN 670

Query:   526 SGKSETRSKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQ-DGTAI 584
             + K    S P T E+ H   +++Y +L  AT  F    ++G+GS+G V+K +LQ +   +
Sbjct:   671 NQKINN-SAPFTLEIFHE--KLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIV 727

Query:   585 AVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDF-----KALVLPYMANGS 639
             AVKVL +Q     KSF  EC+ LK IRHRNL++++TAC+  DF     +AL+  +M NGS
Sbjct:   728 AVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGS 787

Query:   640 LDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN 699
             LD  L+P    E    S  LTLL+R+NI  D+A  + YLH H    + HCDLKPSN+LL+
Sbjct:   788 LDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLD 847

Query:   700 DDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDV 759
             DD+TA VSDFG+A+L++      +   N  +S    + G+IGY APEYG G   S  GDV
Sbjct:   848 DDLTAHVSDFGLARLLLKFD--QESFFNQLSSAG--VRGTIGYAAPEYGMGGQPSIHGDV 903

Query:   760 YSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRAS-RDQSPEVK 818
             YSFG+LVLEM T +RPT+++F G  +L+ + K     R+  + D S+L +  R   P ++
Sbjct:   904 YSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAALPERVLDIADKSILHSGLRVGFPVLE 963

Query:   819 RMWDVAIGELIELGILCTQESPSTR 843
                   +  ++++G+ C +ESP  R
Sbjct:   964 -----CLKGILDVGLRCCEESPLNR 983

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 1150 (409.9 bits), Expect = 1.0e-116, P = 1.0e-116
 Identities = 302/858 (35%), Positives = 450/858 (52%)

Query:     2 LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPEXXXXXXXXXXXXXHDNNLTGMLPI 61
             L  N+L G  P     L  L+ L    N + G+IP+               N+ +G  P 
Sbjct:   176 LSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPP 235

Query:    62 SFFHNCTSLRNVDLSQNFFTGKIPEEIGNC-PNLWTLSLYNNQLTGQLPASLIN-TSMYN 119
             + + N +SL ++ L+ N F+G +  + G   PNL  L L  NQ TG +P +L N +S+  
Sbjct:   236 ALY-NISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANISSLER 294

Query:   120 LDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELEL 179
              D+  N+LSG +P     KL +L +L +  NN + ++ ++ L  F  ++ NCT LE L++
Sbjct:   295 FDISSNYLSGSIPLSF-GKLRNLWWLGIR-NNSLGNNSSSGL-EFIGAVANCTQLEYLDV 351

Query:   180 AGMDLGGTLPDSIGRLN--LTQLLLQENKITGSIPPHIGXXXXXXXXXXXXXXXXGTISA 237
                 LGG LP SI  L+  LT L L +N I+G+IP  IG                     
Sbjct:   352 GYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGN-------------------- 391

Query:   238 EISWLSQLEQLFLSHNLFSGEIPAAXXXXXXXXXXXXSFNKLSGEIPVSLGNLVQIYSLF 297
                 L  L++L L  N+ SGE+P +              N +SGEIP   GN+ ++  L 
Sbjct:   392 ----LVSLQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLH 447

Query:   298 LNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLP 357
             LN+N     IP +LGRC  L  L +  NRL G+IP EI  I  +  +++LS+N L G  P
Sbjct:   448 LNSNSFHGRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLA-YIDLSNNFLTGHFP 506

Query:   358 IELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAI 417
              E+ KLE +  +  S NK +G +   I  C+++  + +  N+  G +PD +  L +L+ +
Sbjct:   507 EEVGKLELLVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNV 565

Query:   418 DVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVP 477
             D S N+LSG IP  L  + +L  +NLS N+F+G +P+ G+F +AT +S  GN ++CG V 
Sbjct:   566 DFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVR 625

Query:   478 GMPI--C-----PPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKSE 530
              M +  C     P K+  L  R   ++  + I I++ L  I + +    +K    +  S+
Sbjct:   626 EMQLKPCIVQASPRKRKPLSVRKK-VVSGICIGIASLLLIIIVASLCWFMKRKKKNNASD 684

Query:   531 TR-SKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGIL-QDGTAIAVKV 588
                S   T  + H   +++Y EL  AT+ F    L+G+G++G V+KG+L  +   +AVKV
Sbjct:   685 GNPSDSTTLGMFHE--KVSYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKV 742

Query:   589 LQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL-----PDFKALVLPYMANGSLDSH 643
             L L     TKSF  EC+  K IRHRNL+++IT CS       DF+ALV  +M  GSLD  
Sbjct:   743 LNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMW 802

Query:   644 LYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMT 703
             L           S  LT  +++NI  D+A  + YLH H    V HCD+KPSN+LL+DD+T
Sbjct:   803 LQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLT 862

Query:   704 ALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFG 763
             A VSDFG+A+L+       +   N  +S    + G+IGY APEYG G   S +GDVYSFG
Sbjct:   863 AHVSDFGLAQLLYKYD--RESFLNQFSSAG--VRGTIGYAAPEYGMGGQPSIQGDVYSFG 918

Query:   764 ILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEK----VIDSSL---LRAS---RDQ 813
             IL+LEM + ++PTD+ FAG  +LH + K+   G         ID  L   L+      ++
Sbjct:   919 ILLLEMFSGKKPTDESFAGDYNLHSYTKSILSGCTSSGGSNAIDEGLRLVLQVGIKCSEE 978

Query:   814 SPEVKRMWDVAIGELIEL 831
              P  +   D A+ ELI +
Sbjct:   979 YPRDRMRTDEAVRELISI 996

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1119 (399.0 bits), Expect = 1.9e-113, P = 1.9e-113
 Identities = 294/859 (34%), Positives = 449/859 (52%)

Query:     5 NHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPEXXXXXXXXXXXXXHDNNLTGMLPISFF 64
             N+L G  P     L  L+ L    N + G+IP                N   G+ P   +
Sbjct:   187 NNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIY 246

Query:    65 HNCTSLRNVDLSQNFFTGKIPEEIGNC-PNLWTLSLYNNQLTGQLPASLINTSMYNLDVE 123
              N +SL  + ++ N F+G +  + G+  PNL  L +  N  TG +P +L N S      +
Sbjct:   247 -NLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLR---Q 302

Query:   124 YNHLSGELPSDI---MSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELA 180
              +  S  L   I     +L +L  L L+ N++ ++      + F  +L NC+ L+ L + 
Sbjct:   303 LDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGD--LDFLGALTNCSQLQYLNVG 360

Query:   181 GMDLGGTLPDSIGRLN--LTQLLLQENKITGSIPPHIGXXXXXXXXXXXXXXXXGTISAE 238
                LGG LP  I  L+  LT+L L  N I+GSIP  IG                      
Sbjct:   361 FNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGN--------------------- 399

Query:   239 ISWLSQLEQLFLSHNLFSGEIPAAXXXXXXXXXXXXSFNKLSGEIPVSLGNLVQIYSLFL 298
                L  L+ L L  NL +G++P +              N LSGEIP SLGN+  +  L+L
Sbjct:   400 ---LVSLQTLDLGENLLTGKLPPSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYL 456

Query:   299 NNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPI 358
              NN    SIP +LG C+ L  L+L  N+L GSIP E+  +  + + LN+S N L GPL  
Sbjct:   457 LNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSL-VVLNVSFNLLVGPLRQ 515

Query:   359 ELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAID 418
             ++ KL+ +  +D+S NK +G I   ++NC+++  + +  N+  G +PD  G L  L  +D
Sbjct:   516 DIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLD 574

Query:   419 VSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPG 478
             +S N+LSG IP  +     L  +NLS N F G +P+ G+F + + MS  GN +LCG +P 
Sbjct:   575 LSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPS 634

Query:   479 MPI--CPPKQHWLHTRMYFIIFVLVISISAFLSTICL-VTGIHRIKLIISSGKSETRSKP 535
             + +  C  +    H+ +  II + V ++ A L  +CL V  +   KL + S ++      
Sbjct:   635 LQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNEND 694

Query:   536 ITPELMHNF-PRITYRELLEATAEFDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQS 593
              +   + +F  +I+Y EL + T  F    L+G+G++G V+KG L     A+A+KVL L  
Sbjct:   695 RSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCK 754

Query:   594 GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDF-----KALVLPYMANGSLDSHLYPHS 648
                 KSF  EC+ L  IRHRNL++++T CS  DF     +ALV  +M NG+LD  L+P  
Sbjct:   755 RGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDE 814

Query:   649 ETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSD 708
               E G+ S  L L  R+NI  D+A  + YLH +    + HCD+KPSN+LL+ D+TA VSD
Sbjct:   815 IEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSD 874

Query:   709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLE 768
             FG+A+L++      D   ++  S+A +  G+IGY APEYG G + S  GDVYSFGI++LE
Sbjct:   875 FGLAQLLLKFD--RD-TFHIQFSSAGVR-GTIGYAAPEYGMGGHPSIMGDVYSFGIVLLE 930

Query:   769 MVTRRRPTDDMFAGGLSLHKWVKNHYHGRLE-KVIDSSLLRASRDQSPEVKRMWDVAIGE 827
             + T +RPT+ +F  GL+LH + K+    R    + D ++LR +  Q   +     +    
Sbjct:   931 IFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRGAYAQHFNMVECLTL---- 986

Query:   828 LIELGILCTQESPSTRPTM 846
             +  +G+ C++ESP  R +M
Sbjct:   987 VFRVGVSCSEESPVNRISM 1005

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1109 (395.4 bits), Expect = 2.2e-112, P = 2.2e-112
 Identities = 275/857 (32%), Positives = 437/857 (50%)

Query:     2 LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPEXXXXXXXXXXXXXHDNNLTGMLPI 61
             L  N L   +P E   L +L  L L  NNL G++P               DNN+ G +P 
Sbjct:   145 LYSNPLRQGVPSELGSLTKLVILDLGRNNLKGKLPRSLGNLTSLKSLGFTDNNIEGEVPD 204

Query:    62 SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINT--SMYN 119
                   + +  + LS N F G  P  I N   L  L L+ +  +G L     N   ++  
Sbjct:   205 ELAR-LSQMVGLGLSMNKFFGVFPPAIYNLSALEDLFLFGSGFSGSLKPDFGNLLPNIRE 263

Query:   120 LDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHD-DNTNLVPFFNSLGNCTDLEELE 178
             L++  N L G +P+ + S + +L    ++ N M      N   VP    L    DL E  
Sbjct:   264 LNLGENDLVGAIPTTL-SNISTLQKFGINKNMMTGGIYPNFGKVPSLQYL----DLSENP 318

Query:   179 LAGMDLGGT-LPDSIGRLNLTQLL-LQENKITGSIPPHIGXXXXXXXXXXXXXXXX-GTI 235
             L     G     DS+      QLL +   ++ G++P  I                  G+I
Sbjct:   319 LGSYTFGDLEFIDSLTNCTHLQLLSVGYTRLGGALPTSIANMSTELISLNLIGNHFFGSI 378

Query:   236 SAEISWLSQLEQLFLSHNLFSGEIPAAXXXXXXXXXXXXSFNKLSGEIPVSLGNLVQIYS 295
               +I  L  L++L L  N+ +G +P +              N++SGEIP  +GNL Q+  
Sbjct:   379 PQDIGNLIGLQRLQLGKNMLTGPLPTSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEI 438

Query:   296 LFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGP 355
             L+L+NN     +PP+LG+C+ +  L + YN+L G+IP EI  I  + + L++  N L G 
Sbjct:   439 LYLSNNSFEGIVPPSLGKCSHMLDLRIGYNKLNGTIPKEIMQIPTL-VNLSMEGNSLSGS 497

Query:   356 LPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLE 415
             LP ++  L+N+ ++ L +NKF+G++   + NC+A+  + +  N+  G +P+  G L  + 
Sbjct:   498 LPNDIGSLQNLVKLSLENNKFSGHLPQTLGNCLAMEQLFLQGNSFDGAIPNIRG-LMGVR 556

Query:   416 AIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGT 475
              +D+S N LSG IP        L ++NLS N F G +PS G F ++T +   GN++LCG 
Sbjct:   557 RVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGG 616

Query:   476 VPGMPI--CPPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKSETRS 533
             +  + +  C  ++  + T+    +  + I +S  ++ + L+     +       +   ++
Sbjct:   617 IKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLLLLVIASMVLCWFRKRRKNQQT 676

Query:   534 KPITPELMHNF-PRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL 591
               + P  +  F  +I+Y +L  AT  F    ++G+GS+G V+K +L  +   +AVKVL +
Sbjct:   677 NNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNM 736

Query:   592 QSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDF-----KALVLPYMANGSLDSHLYP 646
             Q     KSF  EC+ LK  RHRNL++++TAC+  DF     +AL+  Y+ NGS+D  L+P
Sbjct:   737 QRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHP 796

Query:   647 HSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALV 706
                 E       LTLL+R+NI  D+A  + YLH H    + HCDLKPSNVLL DD+TA V
Sbjct:   797 EEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHV 856

Query:   707 SDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
             SDFG+A+L++      D    +   ++  + G+IGY APEYG G   S  GDVYSFG+L+
Sbjct:   857 SDFGLARLLLKF----DKESFLNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLL 912

Query:   767 LEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIG 826
             LEM T +RPTD++F G L+LH + K     ++ ++ D ++L         V       + 
Sbjct:   913 LEMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAILHIGL----RVGFRTAECLT 968

Query:   827 ELIELGILCTQESPSTR 843
              ++E+G+ C +E P+ R
Sbjct:   969 LVLEVGLRCCEEYPTNR 985

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1082 (385.9 bits), Expect = 1.6e-109, P = 1.6e-109
 Identities = 286/872 (32%), Positives = 448/872 (51%)

Query:     2 LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPEXXXXXXXXXXXXXHDNNLTGMLPI 61
             L +NHL G I  E   L  L  L L  NN  G+ P+               NN++G LP 
Sbjct:   319 LSENHLVGPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPA 378

Query:    62 SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLD 121
                   T+LRN+    N  TG IP  I NC  L  L L +NQ+TG++P      ++  + 
Sbjct:   379 DL-GLLTNLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRMNLTFIS 437

Query:   122 VEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAG 181
             +  NH +GE+P DI +   +L  L ++ NN+        L P    +G    L  L+++ 
Sbjct:   438 IGRNHFTGEIPDDIFN-CSNLETLSVADNNLTG-----TLKPL---IGKLQKLRILQVSY 488

Query:   182 MDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGXXXXXXXXXXXXXXXXGTISAEIS 240
               L G +P  IG L +L  L L  N  TG IP  +                 G I  E+ 
Sbjct:   489 NSLTGPIPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMF 548

Query:   241 WLSQLEQLFLSHNLFSGEIPAAXXXXXXXXXXXXSFNKLSGEIPVSLGNLVQIYSLFLNN 300
              +  L  L LS+N FSG+IPA               NK +G IP SL +L  + +  +++
Sbjct:   549 DMKLLSVLDLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISD 608

Query:   301 NQLSRSIPPTLG---RCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLP 357
             N L+ +IP  L    +   LY L+ S N LTG+IP E+  +  ++  ++LS+N   G +P
Sbjct:   609 NLLTGTIPGELLASLKNMQLY-LNFSNNLLTGTIPKELGKLEMVQE-IDLSNNLFSGSIP 666

Query:   358 IELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRL-INISHNALQGNLPDSLGDLKNLEA 416
               L   +NV  +D S N  +G+I  ++   + + + +N+S N+  G +P S G++ +L +
Sbjct:   667 RSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVS 726

Query:   417 IDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTV 476
             +D+S N+L+G IP SL  + TL  + L+ N  KG +P  G+F +      +GN  LCG+ 
Sbjct:   727 LDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSK 786

Query:   477 PGMPICPPKQHWLH-TRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKSETRSKP 535
               +  C  KQ   H ++   +I +++ S +A L  + LV  +   K      K E  S+ 
Sbjct:   787 KPLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKK--KEKKIENSSES 844

Query:   536 ITPELMH--NFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQ- 592
               P+L       R   +EL +AT  F+   ++G+ S   VYKG L+DGT IAVKVL L+ 
Sbjct:   845 SLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKE 904

Query:   593 -SGNFTKSFNRECQVLKRIRHRNLMRIIT-ACSLPDFKALVLPYMANGSLDSHLYPHSET 650
              S    K F  E + L +++HRNL++I+  A      KALVLP+M NG+L+       +T
Sbjct:   905 FSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLE-------DT 957

Query:   651 EFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG 710
               GS +   +LL+++++C  IA G+ YLH      ++HCDLKP+N+LL+ D  A VSDFG
Sbjct:   958 IHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFG 1017

Query:   711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
              A+++   G   DG+     S      G+IGY+APE+ +    +TK DV+SFGI+++E++
Sbjct:  1018 TARIL---GFREDGSTTASTSAFE---GTIGYLAPEFAYMRKVTTKADVFSFGIIMMELM 1071

Query:   771 TRRRPT--DDMFAGGLSLHKWV-KNHYHGR--LEKVIDSSLLRASRDQSPEVKRMWDVAI 825
             T++RPT  +D  +  ++L + V K+  +GR  + +V+D  L     D    +K+  + AI
Sbjct:  1072 TKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMEL----GDSIVSLKQ--EEAI 1125

Query:   826 GELIELGILCTQESPSTRPTMXXXXXXXXRLK 857
              + ++L + CT   P  RP M        +L+
Sbjct:  1126 EDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)]

 Score = 924 (330.3 bits), Expect = 3.5e-105, Sum P(2) = 3.5e-105
 Identities = 246/792 (31%), Positives = 388/792 (48%)

Query:     2 LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPEXXXXXXXXXXXXXHDNNLTGMLPI 61
             L  N+L G IPP+   +  +  L+L  N L G IP              ++N LTG++P 
Sbjct:   301 LFQNYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYENYLTGVIPP 360

Query:    62 SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINT-SMYNL 120
                 N  S+ ++ L+ N  TG IP   GN  NL  L LY N LTG +P  L N  SM NL
Sbjct:   361 EL-GNMESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGNMESMINL 419

Query:   121 DVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELA 180
             D+  N L+G +P D       L  L+L  N++      +  +P    + N + L  L L 
Sbjct:   420 DLSQNKLTGSVP-DSFGNFTKLESLYLRVNHL------SGAIP--PGVANSSHLTTLILD 470

Query:   181 GMDLGGTLPDSI--GRLNLTQLLLQENKITGSIPPHIGXXXXXXXXXXXXXXXXGTISAE 238
               +  G  P+++  GR  L  + L  N + G IP  +                 G I   
Sbjct:   471 TNNFTGFFPETVCKGR-KLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEA 529

Query:   239 ISWLSQLEQLFLSHNLFSGEIPAAXXXXXXXXXXXXSFNKLSGEIPVSLGNLVQIYSLFL 298
                   L  +  SHN F GEI +             S N ++G IP  + N+ Q+  L L
Sbjct:   530 FGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDL 589

Query:   299 NNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPI 358
             + N L   +P  +G  T+L +L L+ N+L+G +PA +S +  +   L+LS N     +P 
Sbjct:   590 STNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLES-LDLSSNNFSSEIPQ 648

Query:   359 ELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAID 418
                    + +++LS NKF G+I  ++S    +  +++SHN L G +P  L  L++L+ +D
Sbjct:   649 TFDSFLKLHDMNLSRNKFDGSI-PRLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLD 707

Query:   419 VSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPG 478
             +S N+LSG+IP +   +  LT +++S N+ +G +P    F  AT  +   N  LC  +P 
Sbjct:   708 LSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPK 767

Query:   479 MPICPP---KQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRI-KLIISSGKSETRSK 534
               + P    K+   +  +   I V ++ +   LS IC  T  + I K  + +G++   + 
Sbjct:   768 QRLKPCRELKKPKKNGNLVVWILVPILGVLVILS-ICANTFTYCIRKRKLQNGRN---TD 823

Query:   535 PITPELMHNFP---RITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVL-- 589
             P T E M  F    +  Y++++E+T EFD   L+GTG Y +VY+  LQD T IAVK L  
Sbjct:   824 PETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHD 882

Query:   590 ----QLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLY 645
                 ++      + F  E + L  IRHRN++++   CS      L+  YM  GSL+  L 
Sbjct:   883 TIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLA 942

Query:   646 PHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL 705
                E +       LT  +R+N+   +A  ++Y+HH     ++H D+   N+LL++D TA 
Sbjct:   943 NDEEAK------RLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAK 996

Query:   706 VSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGIL 765
             +SDFG AKL+ T            +S  + + G+ GY+APE+ +    + K DVYSFG+L
Sbjct:   997 ISDFGTAKLLKT-----------DSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVL 1045

Query:   766 VLEMVTRRRPTD 777
             +LE++  + P D
Sbjct:  1046 ILELIIGKHPGD 1057

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)]

 Score = 865 (309.6 bits), Expect = 1.8e-101, Sum P(2) = 1.8e-101
 Identities = 241/816 (29%), Positives = 390/816 (47%)

Query:     1 MLVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPEXXXXXXXXXXXXXHDNNLTGMLP 60
             +L +N   G IP E S    L  L L  N L G IP+             + N L G +P
Sbjct:   247 ILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIP 306

Query:    61 ISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINT-SMYN 119
                  N +    +D S+N  TG+IP E+GN   L  L L+ NQLTG +P  L    ++  
Sbjct:   307 REI-GNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSK 365

Query:   120 LDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELEL 179
             LD+  N L+G +P      L  L  L L  N++      +  +P    LG  +DL  L++
Sbjct:   366 LDLSINALTGPIPLGFQY-LRGLFMLQLFQNSL------SGTIP--PKLGWYSDLWVLDM 416

Query:   180 AGMDLGGTLPDSIG-RLNLTQLLLQENKITGSIPPHIGXXXXXXXXXXXXXXXXGTISAE 238
             +   L G +P  +    N+  L L  N ++G+IP  I                 G   + 
Sbjct:   417 SDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSN 476

Query:   239 ISWLSQLEQLFLSHNLFSGEIPAAXXXXXXXXXXXXSFNKLSGEIPVSLGNLVQIYSLFL 298
             +     +  + L  N F G IP              + N  +GE+P  +G L Q+ +L +
Sbjct:   477 LCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNI 536

Query:   299 NNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPI 358
             ++N+L+  +P  +  C  L +LD+  N  +G++P+E+  + ++ + L LS+N L G +P+
Sbjct:   537 SSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLEL-LKLSNNNLSGTIPV 595

Query:   359 ELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRL-INISHNALQGNLPDSLGDLKNLEAI 417
              L  L  + E+ +  N F G+I  ++ +   +++ +N+S+N L G +P  L +L  LE +
Sbjct:   596 ALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFL 655

Query:   418 DVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGT-- 475
              ++ N+LSG IP S   + +L   N S+N   G IP   +  + +  SF+GN+ LCG   
Sbjct:   656 LLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFIGNEGLCGPPL 712

Query:   476 ---VPGMPICPP----KQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHR--IKLIISS 526
                +   P  P     K   + +     I   VI     L  I L+  + R  ++ + SS
Sbjct:   713 NQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIG-GVSLMLIALIVYLMRRPVRTVASS 771

Query:   527 GKSETRSKPITPELMHNFPR---ITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTA 583
              +     +P    L   FP     T+++L+ AT  FDE  ++G G+ G VYK +L  G  
Sbjct:   772 AQD---GQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYT 828

Query:   584 IAVKVLQLQ-----SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANG 638
             +AVK L        + N   SF  E   L  IRHRN++++   C+      L+  YM  G
Sbjct:   829 LAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKG 888

Query:   639 SLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL 698
             SL   L+          S +L   +R  I    A+G+AYLHH    R+ H D+K +N+LL
Sbjct:   889 SLGEILH--------DPSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILL 940

Query:   699 NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA-NMLCGSIGYMAPEYGFGSNTSTKG 757
             +D   A V DFG+AK++           +M +S + + + GS GY+APEY +    + K 
Sbjct:   941 DDKFEAHVGDFGLAKVI-----------DMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKS 989

Query:   758 DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH 793
             D+YS+G+++LE++T + P   +  GG  +  WV+++
Sbjct:   990 DIYSYGVVLLELLTGKAPVQPIDQGG-DVVNWVRSY 1024

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9ZUI0	Y2241_ARATH	2, ., 7, ., 1, 1, ., 1	0.4862	0.9615	0.8683	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	885
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-82
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-76
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-52
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-42
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-42
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-41
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-40
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-39
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-38
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-38
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-35
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-31
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-30
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-29
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-29
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-26
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-25
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-24
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-24
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-24
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-24
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-23
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-23
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-23
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-22
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-22
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-21
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-21
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-21
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-21
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-20
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-20
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-20
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-20
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-20
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-19
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-19
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-19
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-19
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-19
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-18
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-18
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-18
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-18
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-17
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-17
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-17
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-17
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-17
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	6e-17
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	9e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-17
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-16
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-16
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-16
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-16
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-16
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-16
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-15
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-15
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-15
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-15
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	9e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	9e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-14
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-14
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-14
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-13
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-13
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-13
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-13
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-12
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-12
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-12
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-12
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-12
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-12
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-12
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-12
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	9e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-11
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-11
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-10
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-10
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	7e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-09
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-09
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-09
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	8e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-08
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-08
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	8e-08
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-07
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	2e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-07
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-07
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	6e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-07
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-07
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-06
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-06
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-06
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-06
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-06
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-06
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-05
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-05
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-05
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-05
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-05
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-05
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-05
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	1e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-04
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-04
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-04
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	7e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.002
PLN03210	1153	PLN03210, PLN03210, Resistant to P	0.002
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.003
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	0.003
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	0.003

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  284 bits (728), Expect = 4e-82
 Identities = 241/875 (27%), Positives = 388/875 (44%), Gaps = 116/875 (13%)

Query: 5   NHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFF 64
           N L G IP   + L  L  L L  N L GQIP  L  + +L  + L  NNL+G +P    
Sbjct: 174 NVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEI- 232

Query: 65  HNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNLDVE 123
              TSL ++DL  N  TG IP  +GN  NL  L LY N+L+G +P S+ +   + +LD+ 
Sbjct: 233 GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLS 292

Query: 124 YNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMD 183
            N LSGE+P +++ +L +L  LHL  NN                                
Sbjct: 293 DNSLSGEIP-ELVIQLQNLEILHLFSNN-------------------------------- 319

Query: 184 LGGTLPDSIGRLNLTQLL-LQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWL 242
             G +P ++  L   Q+L L  NK +G IP ++G  +NL  L+LS+N L+G I   +   
Sbjct: 320 FTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS 379

Query: 243 SQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQ 302
             L +L L  N   GEIP +LG    L  + L  N  SGE+P     L  +Y L ++NN 
Sbjct: 380 GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNN 439

Query: 303 LSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSK 362
           L   I         L  L L+ N+  G +P +  G + +   L+LS NQ  G +P +L  
Sbjct: 440 LQGRINSRKWDMPSLQMLSLARNKFFGGLP-DSFGSKRLEN-LDLSRNQFSGAVPRKLGS 497

Query: 363 LENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGN 422
           L  + ++ LS NK +G I  ++S+C  +  +++SHN L G +P S  ++  L  +D+S N
Sbjct: 498 LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQN 557

Query: 423 HLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCG--TVPGMP 480
            LSG IP +L  + +L  +N+S N   G +PS G F +    +  GN  LCG  T  G+P
Sbjct: 558 QLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLP 617

Query: 481 IC----PPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKSETRSKPI 536
            C         W +       F+++ ++ AF               +   G++    K +
Sbjct: 618 PCKRVRKTPSWWFYITCTLGAFLVL-ALVAF-------------GFVFIRGRNNLELKRV 663

Query: 537 TPE--------LMHNFPR-ITYRELLEATAEFDEQRLLGTGSYGRVYKG-ILQDGTAIAV 586
             E              + IT  ++L +     E+ ++  G  G  YKG  +++G    V
Sbjct: 664 ENEDGTWELQFFDSKVSKSITINDILSSL---KEENVISRGKKGASYKGKSIKNGMQFVV 720

Query: 587 KVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYP 646
           K +     +   S   +   + +++H N++++I  C       L+  Y+   +L   L  
Sbjct: 721 KEIN-DVNSIPSSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-- 774

Query: 647 HSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN-DDMTAL 705
                      +L+  +R  I   IA+ + +LH      V+  +L P  ++++  D   L
Sbjct: 775 ----------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824

Query: 706 VSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGIL 765
                +  L+                T      S  Y+APE     + + K D+Y FG++
Sbjct: 825 R--LSLPGLL---------------CTDTKCFISSAYVAPETRETKDITEKSDIYGFGLI 867

Query: 766 VLEMVTRRRPTDDMFAGGLSLHKWVKNHYHG-RLEKVIDSSLLR-ASRDQSPEVKRMWDV 823
           ++E++T + P D  F    S+ +W +  Y    L+  ID S+    S +Q+  V      
Sbjct: 868 LIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIV------ 921

Query: 824 AIGELIELGILCTQESPSTRPTMLDAADDLDRLKR 858
              E++ L + CT   P+ RP   D    L+   R
Sbjct: 922 ---EVMNLALHCTATDPTARPCANDVLKTLESASR 953

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  266 bits (682), Expect = 7e-76
 Identities = 167/449 (37%), Positives = 242/449 (53%), Gaps = 17/449 (3%)

Query: 9   GAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLS-NLTLVTLHDNNLTGMLPISFFHNC 67
           G I     +L  ++ + L  N L G IP+ +   S +L  + L +NN TG +P     N 
Sbjct: 83  GKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPN- 141

Query: 68  TSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNLDVEYNH 126
             L  +DLS N  +G+IP +IG+  +L  L L  N L G++P SL N TS+  L +  N 
Sbjct: 142 --LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ 199

Query: 127 LSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGG 186
           L G++P + + ++ SL +++L YNN+      +  +P    +G  T L  L+L   +L G
Sbjct: 200 LVGQIPRE-LGQMKSLKWIYLGYNNL------SGEIP--YEIGGLTSLNHLDLVYNNLTG 250

Query: 187 TLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQL 245
            +P S+G L NL  L L +NK++G IPP I +L  LISL+LS N LSG I   +  L  L
Sbjct: 251 PIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNL 310

Query: 246 EQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSR 305
           E L L  N F+G+IP AL  L  L +L L  NK SGEIP +LG    +  L L+ N L+ 
Sbjct: 311 EILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTG 370

Query: 306 SIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLEN 365
            IP  L    +L+KL L  N L G IP  +   R +R  + L  N   G LP E +KL  
Sbjct: 371 EIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLR-RVRLQDNSFSGELPSEFTKLPL 429

Query: 366 VQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLS 425
           V  +D+S+N   G I  +  +  ++++++++ N   G LPDS G  K LE +D+S N  S
Sbjct: 430 VYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFS 488

Query: 426 GIIPISLNKIHTLTFINLSFNEFKGMIPS 454
           G +P  L  +  L  + LS N+  G IP 
Sbjct: 489 GAVPRKLGSLSELMQLKLSENKLSGEIPD 517

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  197 bits (503), Expect = 2e-52
 Identities = 121/311 (38%), Positives = 175/311 (56%), Gaps = 13/311 (4%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           L DN L G IP    +L+ L  L L  NN  G+IP +L  L  L ++ L  N  +G +P 
Sbjct: 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350

Query: 62  SF-FHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASL-INTSMYN 119
           +   HN  +L  +DLS N  TG+IPE + +  NL+ L L++N L G++P SL    S+  
Sbjct: 351 NLGKHN--NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRR 408

Query: 120 LDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELEL 179
           + ++ N  SGELPS+   KLP + +L +S NN+    ++           +   L+ L L
Sbjct: 409 VRLQDNSFSGELPSEFT-KLPLVYFLDISNNNLQGRINSRKW--------DMPSLQMLSL 459

Query: 180 AGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEI 239
           A     G LPDS G   L  L L  N+ +G++P  +G+LS L+ L LS N LSG I  E+
Sbjct: 460 ARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDEL 519

Query: 240 SWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLN 299
           S   +L  L LSHN  SG+IPA+  ++  L  LDLS N+LSGEIP +LGN+  +  + ++
Sbjct: 520 SSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNIS 579

Query: 300 NNQLSRSIPPT 310
           +N L  S+P T
Sbjct: 580 HNHLHGSLPST 590

Length = 968

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  154 bits (393), Expect = 2e-42
 Identities = 70/293 (23%), Positives = 118/293 (40%), Gaps = 47/293 (16%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLM 616
           ++    LG GS+G+VY     + G  +A+KV++ +      +   RE ++LK+++H N++
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           R+       D   LV+ Y   G L   L              L+  +       I   + 
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR---------LSEDEARFYLRQILSALE 111

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YLH      ++H DLKP N+LL++D    ++DFG+A+ +                     
Sbjct: 112 YLHSK---GIVHRDLKPENILLDEDGHVKLADFGLARQLDP------------GEKLTTF 156

Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHG 796
            G+  YMAPE   G       D++S G+++ E++T + P    F G   L +  K     
Sbjct: 157 VGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKP 212

Query: 797 RLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDA 849
           +         +      SPE K        +LI        + P  R T  +A
Sbjct: 213 KPPFPPPEWDI------SPEAK--------DLIR---KLLVKDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  154 bits (392), Expect = 3e-42
 Identities = 69/217 (31%), Positives = 111/217 (51%), Gaps = 27/217 (12%)

Query: 563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRII 619
           R LG+GS+G VYK   +  G  +AVK+L+ +S      ++  RE ++L+R+ H N++R+I
Sbjct: 5   RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 620 TACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLH 679
            A    D   LV+ Y   G L  +L          G   L+  +   I   I  G+ YLH
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYLSRG-------GP--LSEDEAKKIALQILRGLEYLH 115

Query: 680 HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS 739
            +    +IH DLKP N+LL+++    ++DFG+AK +              +S+     G+
Sbjct: 116 SN---GIIHRDLKPENILLDENGVVKIADFGLAKKL-----------LKSSSSLTTFVGT 161

Query: 740 IGYMAPE-YGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
             YMAPE    G+    K DV+S G+++ E++T + P
Sbjct: 162 PWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  151 bits (384), Expect = 1e-41
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 26/209 (12%)

Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNLMRIITAC 622
           LG G +G VY     + G  +A+K+++ + S +  +   RE ++LK++ H N++++    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
              +   LV+ Y   GSL   L  +           L+  + + I   I EG+ YLH + 
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGK--------LSEDEILRILLQILEGLEYLHSN- 111

Query: 683 PVRVIHCDLKPSNVLL-NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIG 741
              +IH DLKP N+LL +D+    ++DFG++KL+               S    + G+  
Sbjct: 112 --GIIHRDLKPENILLDSDNGKVKLADFGLSKLL-----------TSDKSLLKTIVGTPA 158

Query: 742 YMAPEYGFGSNT-STKGDVYSFGILVLEM 769
           YMAPE   G    S K D++S G+++ E+
Sbjct: 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  149 bits (379), Expect = 2e-40
 Identities = 83/298 (27%), Positives = 135/298 (45%), Gaps = 42/298 (14%)

Query: 563 RLLGTGSYGRVYKGILQDG----TAIAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNLMR 617
           + LG G++G VYKG L+      T +AVK L+  +    +  F +E +V+K++ H N++R
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           ++  C+  +   LVL YM  G L  +L            S L+L   ++    IA+GM Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L      + +H DL   N L+ +D+   +SDFG+++ V       D       +   +  
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV------YDDDYYRKKTGGKL-- 169

Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLSLHKWVKNHYHG 796
             I +MAPE       ++K DV+SFG+L+ E+ T    P   +      + ++++  Y  
Sbjct: 170 -PIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--VLEYLRKGY-- 224

Query: 797 RLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD 854
           RL K              PE          EL EL + C Q  P  RPT  +  + L+
Sbjct: 225 RLPK--------------PE------YCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  146 bits (370), Expect = 3e-39
 Identities = 81/298 (27%), Positives = 129/298 (43%), Gaps = 51/298 (17%)

Query: 563 RLLGTGSYGRVYKGIL-----QDGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLM 616
           + LG G++G VYKG L        T +AVK L+  +     + F  E  ++K++ H N++
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           R++  C+  +   +V  YM  G L   L  H E         LTL   + +   IA+GM 
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK--------LTLKDLLQMALQIAKGME 116

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL        +H DL   N L+ +++   +SDFG+++ +       D             
Sbjct: 117 YLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIY-----EDDYYRKRGGGK--- 165

Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLSLHKWVKNHYH 795
              I +MAPE       ++K DV+SFG+L+ E+ T   +P   M      + + +++ Y 
Sbjct: 166 -LPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM--SNEEVLELLEDGY- 221

Query: 796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDL 853
            RL +              PE     D    EL EL + C    P  RPT  +  +DL
Sbjct: 222 -RLPR--------------PEN--CPD----ELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  144 bits (365), Expect = 1e-38
 Identities = 79/302 (26%), Positives = 134/302 (44%), Gaps = 60/302 (19%)

Query: 563 RLLGTGSYGRVYKGILQD-----GTAIAVKVLQL-QSGNFTKSFNRECQVLKRIRHRNLM 616
           + LG G++G VYKG L+         +AVK L+   S    + F RE ++++++ H N++
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           +++  C+  +   +V+ YM  G L S+L  +           L+L   ++    IA GM 
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--------LSLSDLLSFALQIARGME 116

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL        IH DL   N L+ +++   +SDFG+++ +          +        + 
Sbjct: 117 YLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL-------YDDDYYRKRGGKL- 165

Query: 737 CGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLSLHKWVK 791
              I +MAPE    G F    ++K DV+SFG+L+ E+ T   +P   M      + +++K
Sbjct: 166 --PIRWMAPESLKEGKF----TSKSDVWSFGVLLWEIFTLGEQPYPGM--SNEEVLEYLK 217

Query: 792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAAD 851
           N Y  RL +              P           EL +L + C  E P  RPT  +  +
Sbjct: 218 NGY--RLPQ----------PPNCPP----------ELYDLMLQCWAEDPEDRPTFSELVE 255

Query: 852 DL 853
            L
Sbjct: 256 IL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  143 bits (364), Expect = 2e-38
 Identities = 78/302 (25%), Positives = 132/302 (43%), Gaps = 59/302 (19%)

Query: 563 RLLGTGSYGRVYKGILQDG-----TAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLM 616
           + LG G++G VYKG L+         +AVK L+  +     + F RE ++++++ H N++
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           +++  C+  +   +V+ YM  G L  +L  +   E       L+L   ++    IA GM 
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-------LSLSDLLSFALQIARGME 117

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL        IH DL   N L+ +++   +SDFG+++ +          +        + 
Sbjct: 118 YLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL-------YDDDYYKVKGGKL- 166

Query: 737 CGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLSLHKWVK 791
              I +MAPE    G F    ++K DV+SFG+L+ E+ T    P   M      + +++K
Sbjct: 167 --PIRWMAPESLKEGKF----TSKSDVWSFGVLLWEIFTLGEEPYPGM--SNAEVLEYLK 218

Query: 792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAAD 851
             Y  RL K              P           EL +L + C  E P  RPT  +  +
Sbjct: 219 KGY--RLPK----------PPNCPP----------ELYKLMLQCWAEDPEDRPTFSELVE 256

Query: 852 DL 853
            L
Sbjct: 257 IL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  135 bits (343), Expect = 1e-35
 Identities = 66/221 (29%), Positives = 106/221 (47%), Gaps = 32/221 (14%)

Query: 563 RLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFT--KSFNRECQVLKRIRHRNLMRII 619
            LLG GS+G VY  + +D G  +AVK ++L   +    ++  RE ++L  ++H N++R  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 620 TACSLPDFKAL--VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIAEG 674
            +    +   L   L Y++ GSL S L      +FG        L    I      I EG
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLK-----KFGK-------LPEPVIRKYTRQILEG 113

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           +AYLH +    ++H D+K +N+L++ D    ++DFG AK +       D     G  +  
Sbjct: 114 LAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRL------GDIETGEGTGS-- 162

Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            + G+  +MAPE   G       D++S G  V+EM T + P
Sbjct: 163 -VRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  122 bits (307), Expect = 7e-31
 Identities = 69/216 (31%), Positives = 112/216 (51%), Gaps = 27/216 (12%)

Query: 562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
            R LG G +G V++G+  + T +AVK L+  + +  K F  E Q++K++RH  L+++   
Sbjct: 11  LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
           C+L +   +V   M  GSL  +L        G     L L Q +++ + +A GMAYL   
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQ-------GGAGRALKLPQLIDMAAQVASGMAYLEAQ 122

Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS-- 739
           +    IH DL   NVL+ ++    V+DFG+A+++          E++  +      G+  
Sbjct: 123 N---YIHRDLAARNVLVGENNICKVADFGLARVIK---------EDIYEARE----GAKF 166

Query: 740 -IGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
            I + APE    +  S K DV+SFGIL+ E+VT  R
Sbjct: 167 PIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  118 bits (299), Expect = 7e-30
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 24/219 (10%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLM 616
            F+    +G G +G VYK    + G  +A+KV++L+S    +    E Q+LK+ +H N++
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           +   +    D   +V+ + + GSL   L   ++T        LT  Q   +C ++ +G+ 
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT--------LTESQIAYVCKELLKGLE 112

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YLH +    +IH D+K +N+LL  D    + DFG++            ++    +T   +
Sbjct: 113 YLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSA---------QLSDTKARNT---M 157

Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            G+  +MAPE   G     K D++S GI  +E+   + P
Sbjct: 158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  118 bits (297), Expect = 2e-29
 Identities = 73/214 (34%), Positives = 112/214 (52%), Gaps = 23/214 (10%)

Query: 562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLMRIIT 620
           +R LG G +G V+ G     T +AVK L+   G  + ++F +E Q++K++RH  L+++  
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTTKVAVKTLK--PGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68

Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
            CS  +   +V  YM+ GSL   L      + G G   L L Q V++ + IAEGMAYL  
Sbjct: 69  VCSEEEPIYIVTEYMSKGSLLDFL------KSGEG-KKLRLPQLVDMAAQIAEGMAYLES 121

Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
                 IH DL   N+L+ +++   ++DFG+A+L+      +D  E      A      I
Sbjct: 122 R---NYIHRDLAARNILVGENLVCKIADFGLARLIE-----DD--EYTAREGAKF---PI 168

Query: 741 GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
            + APE       + K DV+SFGIL+ E+VT  R
Sbjct: 169 KWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  116 bits (292), Expect = 7e-29
 Identities = 68/218 (31%), Positives = 113/218 (51%), Gaps = 27/218 (12%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           EF  +R LG+G +G V++G+ ++   +A+K+L+       + F +E Q LKR+RH++L+ 
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSD---LTLLQRVNICSDIAEG 674
           +   CS+ +   ++   M  GSL + L           S +   L +   +++   +AEG
Sbjct: 67  LFAVCSVGEPVYIITELMEKGSLLAFL----------RSPEGQVLPVASLIDMACQVAEG 116

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           MAYL        IH DL   N+L+ +D+   V+DFG+A+L+          E++  S+  
Sbjct: 117 MAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLI---------KEDVYLSSDK 164

Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR 772
            +     + APE       STK DV+SFGIL+ EM T 
Sbjct: 165 KI--PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTY 200

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 5e-26
 Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 26/213 (12%)

Query: 557 AEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLM 616
            E      +G G +G V  G  + G  +AVK L+       ++F  E  V+  +RH NL+
Sbjct: 6   KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLV 63

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           +++      +   +V  YMA GSL  +L          G + +TL Q++    D+ EGM 
Sbjct: 64  QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR-------GRAVITLAQQLGFALDVCEGME 116

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL        +H DL   NVL+++D+ A VSDFG+AK             + G  +  + 
Sbjct: 117 YLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK-----------EASQGQDSGKL- 161

Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEM 769
              + + APE       STK DV+SFGIL+ E+
Sbjct: 162 --PVKWTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  108 bits (270), Expect = 3e-25
 Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 24/229 (10%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRH-R 613
            +   R LG GS+G VY    +D   +A+KVL  +        + F RE Q+L  + H  
Sbjct: 1   SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           N++++           LV+ Y+  GSL+  L              L+  + + I + I  
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGP------LSESEALFILAQILS 112

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALV-SDFGIAKLVMTVGVGNDGAENMGNST 732
            + YLH      +IH D+KP N+LL+ D   +   DFG+AKL+      + G+ +   + 
Sbjct: 113 ALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP-----DPGSTSSIPAL 164

Query: 733 ANMLCGSIGYMAPEYGFGSNT---STKGDVYSFGILVLEMVTRRRPTDD 778
            +   G+ GYMAPE   G +    S+  D++S GI + E++T   P + 
Sbjct: 165 PSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213

Length = 384

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  103 bits (258), Expect = 2e-24
 Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 40/227 (17%)

Query: 560 DEQRL--LGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNL 615
           D +R+  LG GS G VYK   +  G   A+K + +     F K   RE + L+      +
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYV 61

Query: 616 MR----IITACSLPDFKALVLPYMANGSLDSHLYPH---SETEFGSGSSDLTLLQRVNIC 668
           ++          +    ++VL YM  GSL   L       E                 I 
Sbjct: 62  VKCYGAFYKEGEI----SIVLEYMDGGSLADLLKKVGKIPEPVLAY------------IA 105

Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
             I +G+ YLH      +IH D+KPSN+L+N      ++DFGI+K++             
Sbjct: 106 RQILKGLDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ------- 156

Query: 729 GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                N   G++ YM+PE   G + S   D++S G+ +LE    + P
Sbjct: 157 ----CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  102 bits (256), Expect = 6e-24
 Identities = 81/302 (26%), Positives = 129/302 (42%), Gaps = 36/302 (11%)

Query: 563 RLLGTGSYGRVYKG---ILQDGTA--IAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNLM 616
           + LG G +G+V       L D T   +AVK L        +S F RE ++L+ + H N++
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 617 RIITACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +    C  P  ++  L++ Y+ +GSL  +L  H +         + L + +   S I +G
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD--------QINLKRLLLFSSQICKG 121

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           M YL      R IH DL   N+L+  +    +SDFG+AK V+         +  G S   
Sbjct: 122 MDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK-VLPEDKDYYYVKEPGES--- 174

Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
                I + APE    S  S+  DV+SFG+ + E+ T   P+    A    L        
Sbjct: 175 ----PIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPA--EFLRMIGIAQG 228

Query: 795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD 854
              + ++++  L    R   P           E+ +L  LC +  P  RP+  D    +D
Sbjct: 229 QMIVTRLLE-LLKEGERLPRP------PSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281

Query: 855 RL 856
           RL
Sbjct: 282 RL 283

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  102 bits (255), Expect = 7e-24
 Identities = 86/306 (28%), Positives = 132/306 (43%), Gaps = 50/306 (16%)

Query: 563 RLLGTGSYGRVYKGIL--QDGTAIAVKVLQLQSGNFTKS----FNRECQVLKRIRHRNLM 616
           ++LG G +G V +G L   DG+ + V V  ++    T S    F  E   +K   H N+M
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 617 RIITAC----SLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           ++I  C    SL       ++LP+M +G L S L     +  G     L L   +    D
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL---YSRLGGLPEKLPLQTLLKFMVD 121

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           IA GM YL   S    IH DL   N +L +DMT  V+DFG++K + +      G      
Sbjct: 122 IALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYS------GDYYRQG 172

Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV 790
             A M    + ++A E       ++K DV++FG+ + E+ TR          G + +  V
Sbjct: 173 RIAKM---PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR----------GQTPYPGV 219

Query: 791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAA 850
           +NH        I   L   +R + PE        + EL +L   C +  P  RPT     
Sbjct: 220 ENHE-------IYDYLRHGNRLKQPE------DCLDELYDLMYSCWRADPKDRPTFTKLR 266

Query: 851 DDLDRL 856
           + L+ +
Sbjct: 267 EVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 7e-24
 Identities = 63/215 (29%), Positives = 94/215 (43%), Gaps = 27/215 (12%)

Query: 565 LGTGSYGRVYK-GILQDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRHRNLMRIIT 620
           LG GS+G+V        G   A+KVL+   +      +    E  +L RI H  ++++  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
           A    +   LVL Y   G L SHL        G  S +          ++I   + YLH 
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKE-----GRFSEERARF----YAAEIVLALEYLHS 111

Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
                +I+ DLKP N+LL+ D    ++DFG+AK +               S  N  CG+ 
Sbjct: 112 L---GIIYRDLKPENILLDADGHIKLTDFGLAKELS-----------SEGSRTNTFCGTP 157

Query: 741 GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            Y+APE   G       D +S G+L+ EM+T + P
Sbjct: 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  101 bits (253), Expect = 8e-24
 Identities = 85/285 (29%), Positives = 135/285 (47%), Gaps = 53/285 (18%)

Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNLMRIITACS 623
           LG G +G V+ G     T +A+K   L+ G+ +   F  E  ++K+++H  L+R+    +
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 624 L-PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
             P +  ++  YM NGSL   L    +T  G     LT+ + +++ + IAEGMA++   +
Sbjct: 72  QEPIY--IITEYMENGSLVDFL----KTPEGI---KLTINKLIDMAAQIAEGMAFIERKN 122

Query: 683 PVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGY 742
               IH DL+ +N+L+++ +   ++DFG+A+L+       +  E      A      I +
Sbjct: 123 ---YIHRDLRAANILVSETLCCKIADFGLARLI-------EDNEYTAREGAKF---PIKW 169

Query: 743 MAPE-YGFGSNTSTKGDVYSFGILVLEMVTRRR-PTDDMFAGGLSLHKWVKNHYHGRLEK 800
            APE   +G+ T  K DV+SFGIL+ E+VT  R P                  Y G    
Sbjct: 170 TAPEAINYGTFT-IKSDVWSFGILLTEIVTYGRIP------------------YPGMTNP 210

Query: 801 VIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
            +  +L R  R   P      D    EL EL  LC +E P  RPT
Sbjct: 211 EVIQNLERGYRMPRP------DNCPEELYELMRLCWKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  101 bits (252), Expect = 1e-23
 Identities = 67/212 (31%), Positives = 109/212 (51%), Gaps = 26/212 (12%)

Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLMRIITACS 623
           LG G +G V+ G     T +A+K L+   G  + ++F +E QV+K++RH  L+++    S
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 624 L-PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
             P +  +V  YM+ GSL   L        G     L L Q V++ + IA GMAY+    
Sbjct: 72  EEPIY--IVTEYMSKGSLLDFLK-------GEMGKYLRLPQLVDMAAQIASGMAYVER-- 120

Query: 683 PVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGY 742
            +  +H DL+ +N+L+ +++   V+DFG+A+L+       +  E      A      I +
Sbjct: 121 -MNYVHRDLRAANILVGENLVCKVADFGLARLI-------EDNEYTARQGAKF---PIKW 169

Query: 743 MAPEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
            APE       + K DV+SFGIL+ E+ T+ R
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 1e-23
 Identities = 66/231 (28%), Positives = 114/231 (49%), Gaps = 32/231 (13%)

Query: 557 AEFDEQRLLGTGSYGRVYKGI-LQDG----TAIAVKVLQLQSGNFTKSFN---RECQVLK 608
            E ++ ++LG+G++G VYKG+ + +G      +A+KVL+ ++    K+      E  V+ 
Sbjct: 7   TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMA 64

Query: 609 RIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNIC 668
            + H +++R++  C L     L+   M  G L  ++  H +   GS      LL   N C
Sbjct: 65  SVDHPHVVRLLGIC-LSSQVQLITQLMPLGCLLDYVRNH-KDNIGS----QYLL---NWC 115

Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
             IA+GM+YL      R++H DL   NVL+       ++DFG+AKL+       D  E  
Sbjct: 116 VQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL-------DVDEKE 165

Query: 729 GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDD 778
            ++    +   I +MA E       + K DV+S+G+ V E++T   +P + 
Sbjct: 166 YHAEGGKV--PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  100 bits (250), Expect = 2e-23
 Identities = 80/284 (28%), Positives = 133/284 (46%), Gaps = 46/284 (16%)

Query: 563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITAC 622
           + LG G +G V+ G   + T +AVK L+  + +  ++F  E  ++K ++H  L+R+    
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
           +  +   ++  YMA GSL   L    +++ G     + L + ++  + IAEGMAY+   +
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFL----KSDEGG---KVLLPKLIDFSAQIAEGMAYIERKN 123

Query: 683 PVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGY 742
               IH DL+ +NVL+++ +   ++DFG+A+++       +  E      A      I +
Sbjct: 124 ---YIHRDLRAANVLVSESLMCKIADFGLARVI-------EDNEYTAREGAKF---PIKW 170

Query: 743 MAPE-YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKV 801
            APE   FGS T  K DV+SFGIL+ E+VT                 + K  Y G     
Sbjct: 171 TAPEAINFGSFT-IKSDVWSFGILLYEIVT-----------------YGKIPYPGMSNSD 212

Query: 802 IDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
           + S+L R  R    E          EL ++   C +E    RPT
Sbjct: 213 VMSALQRGYRMPRME------NCPDELYDIMKTCWKEKAEERPT 250

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  100 bits (249), Expect = 2e-23
 Identities = 84/283 (29%), Positives = 132/283 (46%), Gaps = 49/283 (17%)

Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLMRIITACS 623
           LG G +G V+ G     T +AVK L+   G  + +SF  E Q++K++RH  L+++    S
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLK--PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 624 L-PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
             P +  +V  YM+ GSL   L      + G G + L L   V++ + +A GMAY+    
Sbjct: 72  EEPIY--IVTEYMSKGSLLDFL------KDGEGRA-LKLPNLVDMAAQVAAGMAYIER-- 120

Query: 683 PVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGY 742
            +  IH DL+ +N+L+ D +   ++DFG+A+L+       +  E      A      I +
Sbjct: 121 -MNYIHRDLRSANILVGDGLVCKIADFGLARLI-------EDNEYTARQGAKF---PIKW 169

Query: 743 MAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVI 802
            APE       + K DV+SFGIL+ E+VT+ R                   Y G   + +
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP-----------------YPGMNNREV 212

Query: 803 DSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
              + R  R   P+     D  I  L EL + C ++ P  RPT
Sbjct: 213 LEQVERGYRMPCPQ-----DCPI-SLHELMLQCWKKDPEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 99.3 bits (248), Expect = 6e-23
 Identities = 82/299 (27%), Positives = 136/299 (45%), Gaps = 53/299 (17%)

Query: 563 RLLGTGSYGRVYKGILQD------GTAIAVKVLQLQSGNFTK--SFNRECQVLKRIRHRN 614
           R LG GS+G VY+G+ +        T +A+K +  ++ +  +   F  E  V+K     +
Sbjct: 12  RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN-ENASMRERIEFLNEASVMKEFNCHH 70

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPH-SETEFGSGSSDLTLLQRVNICSDIAE 673
           ++R++   S      +V+  MA G L S+L     E E   G    TL + + + ++IA+
Sbjct: 71  VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           GMAYL      + +H DL   N ++ +D+T  + DFG+ + +          +       
Sbjct: 131 GMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE-------TDYYRKGGK 180

Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAG----GLSLHKW 789
            +L   + +MAPE       +TK DV+SFG+++ EM T         A     GLS ++ 
Sbjct: 181 GLL--PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT--------LAEQPYQGLS-NEE 229

Query: 790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLD 848
           V       L+ VID   L     ++   K         L+EL  +C Q +P  RPT L+
Sbjct: 230 V-------LKFVIDGGHLD--LPENCPDK---------LLELMRMCWQYNPKMRPTFLE 270

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 98.0 bits (245), Expect = 1e-22
 Identities = 52/233 (22%), Positives = 100/233 (42%), Gaps = 48/233 (20%)

Query: 559 FDEQRLLGTGSYGRVYKG-ILQDGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           ++  + +G GS+G+VY      DG    +K + L   S    +    E ++LK++ H N+
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 616 MR----IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           ++          L     +V+ Y   G L   +    + + G    +  +L   +    +
Sbjct: 62  IKYYESFEEKGKL----CIVMEYADGGDLSQKI--KKQKKEGKPFPEEQIL---DWFVQL 112

Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
              + YLH     +++H D+KP N+ L  +    + DFGI+K++              +S
Sbjct: 113 CLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVL--------------SS 155

Query: 732 T---ANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           T   A  + G+  Y++PE      Y      + K D++S G ++ E+ T + P
Sbjct: 156 TVDLAKTVVGTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 97.6 bits (243), Expect = 2e-22
 Identities = 68/231 (29%), Positives = 110/231 (47%), Gaps = 38/231 (16%)

Query: 564 LLGTGSYGRVYKGI-LQDGTAIAVKVLQL---QSGN-------FTKSFNRECQVLKRIRH 612
           L+G G+YGRVY  + +  G  +AVK ++L    +G          K+   E + LK + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 613 RNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLT--LLQRVNICSD 670
            N+++ +   +  ++ ++ L Y+  GS+ S L  +   E       L     ++V     
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFE-----EQLVRFFTEQV----- 117

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
             EG+AYLH      ++H DLK  N+L++ D    +SDFGI+K            +   N
Sbjct: 118 -LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK---------KSDDIYDN 164

Query: 731 STANMLCGSIGYMAPE--YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
                + GS+ +MAPE  + +    S K D++S G +VLEM   RRP  D 
Sbjct: 165 DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 96.9 bits (242), Expect = 3e-22
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 26/215 (12%)

Query: 564 LLGTGSYGRVYKGI-LQDGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIIT 620
           L+G G++G VYKG+ L+ G  +A+K + L+       KS  +E  +LK ++H N+++ I 
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
           +    D   ++L Y  NGSL   +       FG     L           + +G+AYLH 
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIKK-----FGPFPESLV----AVYVYQVLQGLAYLHE 117

Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
                VIH D+K +N+L   D    ++DFG+A  +       +       S      G+ 
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATKL-------NDVSKDDASVV----GTP 163

Query: 741 GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            +MAPE    S  ST  D++S G  V+E++T   P
Sbjct: 164 YWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 96.7 bits (240), Expect = 4e-22
 Identities = 82/283 (28%), Positives = 131/283 (46%), Gaps = 49/283 (17%)

Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLMRIITACS 623
           LG G +G V+ G     T +A+K L+   G    ++F +E Q++K++RH  L+ +    S
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLK--PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 624 L-PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
             P +  +V  +M  GSL   L      + G G   L L Q V++ + IA+GMAY+    
Sbjct: 72  EEPIY--IVTEFMGKGSLLDFL------KEGDGKY-LKLPQLVDMAAQIADGMAYIER-- 120

Query: 683 PVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGY 742
            +  IH DL+ +N+L+ D++   ++DFG+A+L+       +  E      A      I +
Sbjct: 121 -MNYIHRDLRAANILVGDNLVCKIADFGLARLI-------EDNEYTARQGAKF---PIKW 169

Query: 743 MAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVI 802
            APE       + K DV+SFGIL+ E+VT+ R                   Y G + + +
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP-----------------YPGMVNREV 212

Query: 803 DSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
              + R  R   P+           L EL  LC ++ P  RPT
Sbjct: 213 LEQVERGYRMPCPQ------GCPESLHELMKLCWKKDPDERPT 249

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 95.3 bits (237), Expect = 1e-21
 Identities = 79/302 (26%), Positives = 133/302 (44%), Gaps = 63/302 (20%)

Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G YG VY+G+ +     +AVK L+ +     + F +E  V+K I+H NL++++  C+
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 624 L-PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
             P F  ++  +M  G+L  +L   +  E  +    + LL    + + I+  M YL   +
Sbjct: 73  REPPF-YIITEFMTYGNLLDYLRECNRQEVNA----VVLLY---MATQISSAMEYLEKKN 124

Query: 683 PVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS--- 739
               IH DL   N L+ ++    V+DFG+++L             M   T     G+   
Sbjct: 125 ---FIHRDLAARNCLVGENHLVKVADFGLSRL-------------MTGDTYTAHAGAKFP 168

Query: 740 IGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK-NHYHGR 797
           I + APE     N  S K DV++FG+L+ E+ T           G+S +  +  +  +  
Sbjct: 169 IKWTAPE-SLAYNKFSIKSDVWAFGVLLWEIATY----------GMSPYPGIDLSQVYEL 217

Query: 798 LEKVIDSSLLRASRDQSPEVKRMWDVAIG---ELIELGILCTQESPSTRPTMLDAADDLD 854
           LEK          R + PE         G   ++ EL   C Q +PS RP+  +     +
Sbjct: 218 LEK--------GYRMERPE---------GCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260

Query: 855 RL 856
            +
Sbjct: 261 TM 262

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 29/221 (13%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSG--NFTKSFNRECQVLKRIRHRNLMRII 619
             +G G++G+VY  + L  G  +AVK +++Q       K    E +VL+ ++H NL++  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 620 TACSLPDFKALV-LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
               +   K  + + Y + G+L+  L      E G    D  +++   +   + EG+AYL
Sbjct: 66  -GVEVHREKVYIFMEYCSGGTLEELL------EHG-RILDEHVIRVYTL--QLLEGLAYL 115

Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           H H    ++H D+KP+N+ L D    + + DFG A  +       +    MG    ++  
Sbjct: 116 HSH---GIVHRDIKPANIFL-DHNGVIKLGDFGCAVKL------KNNTTTMGEEVQSLA- 164

Query: 738 GSIGYMAPEYGFGSNTSTKG---DVYSFGILVLEMVTRRRP 775
           G+  YMAPE   G      G   D++S G +VLEM T +RP
Sbjct: 165 GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 85/304 (27%), Positives = 129/304 (42%), Gaps = 49/304 (16%)

Query: 563 RLLGTGSYGRVYKGIL------QDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNL 615
           R LG G++G+V+ G         D   +AVK L+  + N   K F RE ++L   +H N+
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSE-----TEFGSGSSDLTLLQRVNICSD 670
           ++    C+  D   +V  YM +G L+  L  H           S   +LTL Q + I   
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           IA GM YL   +    +H DL   N L+  D+   + DFG+++ V T     D    +G 
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT----TD-YYRVGG 182

Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLSLHKW 789
            T  ML   I +M PE       +T+ DV+SFG+++ E+ T  ++P             W
Sbjct: 183 HT--ML--PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP-------------W 225

Query: 790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDA 849
                   +E +    LL+  R    EV           I LG  C +  P  R  + D 
Sbjct: 226 YGLSNEEVIECITQGRLLQRPRTCPSEVYD---------IMLG--CWKRDPQQRINIKDI 274

Query: 850 ADDL 853
            + L
Sbjct: 275 HERL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 93.9 bits (233), Expect = 3e-21
 Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 23/215 (10%)

Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           +G+G +G V+ G   +   +A+K ++ +     + F  E QV+ ++ H  L+++   C+ 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
                LV  +M +G L  +L      + G  S + TLL    +C D+ EGMAYL   +  
Sbjct: 71  RSPICLVFEFMEHGCLSDYL----RAQRGKFSQE-TLLG---MCLDVCEGMAYLESSN-- 120

Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
            VIH DL   N L+ ++    VSDFG+ + V+         +   +ST       + + +
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD--------DQYTSSTGTKF--PVKWSS 169

Query: 745 PEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDD 778
           PE    S  S+K DV+SFG+L+ E+ +  + P ++
Sbjct: 170 PEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 93.6 bits (233), Expect = 4e-21
 Identities = 80/297 (26%), Positives = 120/297 (40%), Gaps = 68/297 (22%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFT-----KSFNRECQVLKRIRHRNLM 616
            LLG+GS+G VY+G+ L DG   AVK + L     T     K   +E  +L +++H N++
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           + +      D   + L  +  GSL   L      ++GS                I  G+ 
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLL-----KKYGS----FPEPVIRLYTRQILLGLE 116

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YLH       +H D+K +N+L++ +    ++DFG+AK V+              S A   
Sbjct: 117 YLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE------------FSFAKSF 161

Query: 737 CGSIGYMAPE-------YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKW 789
            GS  +MAPE       YG  +      D++S G  VLEM T + P             W
Sbjct: 162 KGSPYWMAPEVIAQQGGYGLAA------DIWSLGCTVLEMATGKPP-------------W 202

Query: 790 VKNHYHGRLEKVIDSSLLRASRDQ-SPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
            +      + K+  S  L    D  S E K           +  + C Q  PS RPT
Sbjct: 203 SQLEGVAAVFKIGRSKELPPIPDHLSDEAK-----------DFILKCLQRDPSLRPT 248

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 93.2 bits (232), Expect = 5e-21
 Identities = 67/223 (30%), Positives = 98/223 (43%), Gaps = 31/223 (13%)

Query: 565 LGTGSYGRVYKGILQ--DGT--AIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMRII 619
           LG G++G V KG+     G    +AVK L Q       K F RE  V+ ++ H  ++R+I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 620 TACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLH 679
             C       LV+     G L  +L    E       SDL  L        +A GMAYL 
Sbjct: 63  GVCKGEPL-MLVMELAPLGPLLKYLKKRREIP----VSDLKEL-----AHQVAMGMAYLE 112

Query: 680 HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND--GAENMGNSTANMLC 737
                  +H DL   NVLL +   A +SDFG+++    +G G+D   A   G        
Sbjct: 113 S---KHFVHRDLAARNVLLVNRHQAKISDFGMSR---ALGAGSDYYRATTAGR------- 159

Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
             + + APE       S+K DV+S+G+ + E  +   +P  +M
Sbjct: 160 WPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 93.1 bits (232), Expect = 6e-21
 Identities = 58/233 (24%), Positives = 101/233 (43%), Gaps = 47/233 (20%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           FD    LG GSYG VYK I  + G  +A+KV+ ++     +   +E  +LK+        
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL--QEIIKEISILKQCDSPY--- 59

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN----------I 667
                        ++ Y  +   ++ L+     E+    S   +++  N          I
Sbjct: 60  -------------IVKYYGSYFKNTDLW--IVMEYCGAGSVSDIMKITNKTLTEEEIAAI 104

Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA-KLVMTVGVGNDGAE 726
                +G+ YLH +   + IH D+K  N+LLN++  A ++DFG++ +L  T         
Sbjct: 105 LYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT--------- 152

Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
               +  N + G+  +MAPE       + K D++S GI  +EM   + P  D+
Sbjct: 153 ---MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 97.6 bits (243), Expect = 1e-20
 Identities = 68/237 (28%), Positives = 113/237 (47%), Gaps = 37/237 (15%)

Query: 1   MLVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLP 60
           +L  N L G IP      R LR ++L  N+  G++P     L  +  + + +NNL G + 
Sbjct: 386 ILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRIN 445

Query: 61  ISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTS-MYN 119
            S   +  SL+ + L++N F G +P+  G+   L  L L  NQ +G +P  L + S +  
Sbjct: 446 -SRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQ 503

Query: 120 LDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELEL 179
           L +  N LSGE+P ++ S                                 C  L  L+L
Sbjct: 504 LKLSENKLSGEIPDELSS---------------------------------CKKLVSLDL 530

Query: 180 AGMDLGGTLPDSIGRLN-LTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTI 235
           +   L G +P S   +  L+QL L +N+++G IP ++GN+ +L+ +N+S N L G++
Sbjct: 531 SHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSL 587

Length = 968

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 92.9 bits (231), Expect = 1e-20
 Identities = 61/233 (26%), Positives = 110/233 (47%), Gaps = 28/233 (12%)

Query: 551 ELLEATAEFDEQRLLGTGSYGRVYKGIL------QDGTAIAVKVLQLQ-SGNFTKSFNRE 603
           E+  +   F E+  LG G++G+VYKG L         T++A+K L+        + F +E
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58

Query: 604 CQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLY---PHSETEFGSGSSD-- 658
            +++  ++H N++ ++  C+      ++  Y+A+G L   L    PHS+    SG     
Sbjct: 59  AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118

Query: 659 --LTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM 716
             L     ++I   IA GM YL  H     +H DL   N L+ + +T  +SDFG+++ + 
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175

Query: 717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEM 769
           +     D       S        + +M PE       +T+ D++SFG+++ E+
Sbjct: 176 S----ADYYRVQSKSLL-----PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 92.3 bits (230), Expect = 2e-20
 Identities = 59/238 (24%), Positives = 101/238 (42%), Gaps = 30/238 (12%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVL---QLQSGNFTKSFNRECQVLKRI-RH 612
           +F   +++G GS+  V     +      A+K+L   QL      K    E +VL R+  H
Sbjct: 2   DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61

Query: 613 RNLMRIITACSLPDFKAL--VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
             ++++    +  D + L  VL Y  NG L  ++  +       GS D    +     ++
Sbjct: 62  PGIIKLY--YTFQDEENLYFVLEYAPNGELLQYIRKY-------GSLDEKCTR--FYAAE 110

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGV--GNDGAENM 728
           I   + YLH      +IH DLKP N+LL+ DM   ++DFG AK++        N G    
Sbjct: 111 ILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167

Query: 729 GNST-------ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
            +S             G+  Y++PE           D+++ G ++ +M+T + P    
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 92.0 bits (228), Expect = 2e-20
 Identities = 78/302 (25%), Positives = 138/302 (45%), Gaps = 49/302 (16%)

Query: 561 EQRLLGTGSYGRVYKGILQ--DGTAIAVKVLQLQSGNFTKS---FNRECQVLKRIRHRNL 615
           +Q+++G G +G V++GIL+      +AV +  L+ G   K    F  E  ++ +  H N+
Sbjct: 9   KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI 68

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +R+    +      ++  YM NG+LD +L  H          + +  Q V +   IA GM
Sbjct: 69  IRLEGVVTKFKPAMIITEYMENGALDKYLRDHD--------GEFSSYQLVGMLRGIAAGM 120

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL   S +  +H DL   N+L+N ++   VSDFG+++++       D  E    ++   
Sbjct: 121 KYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL------EDDPEGTYTTSGGK 171

Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLSLHKWVKNHY 794
           +   I + APE       ++  DV+SFGI++ E+++   RP  DM            NH 
Sbjct: 172 I--PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM-----------SNH- 217

Query: 795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD 854
              + K I+      +    P        A+ +L+   + C Q+  + RP  +D  + LD
Sbjct: 218 --EVMKAINDGFRLPAPMDCPS-------AVYQLM---LQCWQQDRARRPRFVDIVNLLD 265

Query: 855 RL 856
           +L
Sbjct: 266 KL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 92.0 bits (228), Expect = 2e-20
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 24/219 (10%)

Query: 565 LGTGSYGRVY----KGIL--QDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRI 618
           LG G++G+V+      +L  QD   +AVK L+  S +  + F RE ++L  ++H++++R 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 619 ITACSLPDFKALVLPYMANGSLDSHLYPHS------ETEFGSGSSDLTLLQRVNICSDIA 672
              C+      +V  YM +G L+  L  H                 LTL Q + I S IA
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
            GM YL   + +  +H DL   N L+   +   + DFG+++ + +      G   M    
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM---- 185

Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                  I +M PE       +T+ D++SFG+++ E+ T
Sbjct: 186 -----LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 90.7 bits (225), Expect = 4e-20
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 24/208 (11%)

Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTK-SFNRECQVLKRIRHRNLMRIITACS 623
           LGTG +G V  G  +    +A+K+++   G+ ++  F  E +V+ ++ H  L+++   C+
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +V  YM+NG L ++L                  Q + +C D+ EGMAYL     
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLR--------EHGKRFQPSQLLEMCKDVCEGMAYLESK-- 119

Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
            + IH DL   N L++D     VSDFG+++ V+     ++   ++G+         + + 
Sbjct: 120 -QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD----DEYTSSVGSKF------PVRWS 168

Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
            PE    S  S+K DV++FG+L+ E+ +
Sbjct: 169 PPEVLLYSKFSSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 90.7 bits (226), Expect = 6e-20
 Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 24/207 (11%)

Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           +G G+ G VYK      G  +A+K ++L+  N     N E  ++K  +H N++    +  
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVDYYDSYL 85

Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
           + D   +V+ YM  GSL   +  +           +   Q   +C ++ +G+ YLH    
Sbjct: 86  VGDELWVVMEYMDGGSLTDIITQNF--------VRMNEPQIAYVCREVLQGLEYLHSQ-- 135

Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
             VIH D+K  N+LL+ D +  ++DFG A  +               S  N + G+  +M
Sbjct: 136 -NVIHRDIKSDNILLSKDGSVKLADFGFAAQL-----------TKEKSKRNSVVGTPYWM 183

Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMV 770
           APE     +   K D++S GI+ +EM 
Sbjct: 184 APEVIKRKDYGPKVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 90.7 bits (226), Expect = 7e-20
 Identities = 55/225 (24%), Positives = 109/225 (48%), Gaps = 36/225 (16%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNL 615
           +++   +G G+YG+VYK    + G  +A+K +++++    F  +  RE ++L+++RH N+
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 616 MR---IITACSLPDFKALVLPYMA---NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS 669
           +R   I+T+        +V  YM     G LDS     +E++                  
Sbjct: 61  VRLKEIVTSKGKGSI-YMVFEYMDHDLTGLLDSPEVKFTESQIKC------------YMK 107

Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
            + EG+ YLH +    ++H D+K SN+L+N+D    ++DFG+A+             N  
Sbjct: 108 QLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPY--------TKRNSA 156

Query: 730 NSTANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRR 773
           + T  ++  ++ Y  PE   G+     + D++S G ++ E+   +
Sbjct: 157 DYTNRVI--TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 89.7 bits (222), Expect = 1e-19
 Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 22/220 (10%)

Query: 562 QRLLGTGSYGRVYKGIL------QDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNL 615
           +R LG G++G+V+          QD   +AVK L+  S N  K F+RE ++L  ++H ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEF----GSGSSDLTLLQRVNICSDI 671
           ++    C   D   +V  YM +G L+  L  H         G+  ++LT  Q ++I   I
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A GM YL   +    +H DL   N L+ +++   + DFG+++ V +      G   M   
Sbjct: 130 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM--- 183

Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                   I +M PE       +T+ DV+S G+++ E+ T
Sbjct: 184 ------LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 89.5 bits (222), Expect = 2e-19
 Identities = 80/321 (24%), Positives = 144/321 (44%), Gaps = 71/321 (22%)

Query: 563 RLLGTGSYGRVYK----GIL--QDGTAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNL 615
           R +G G++GRV++    G+L  +  T +AVK+L+ + S +    F RE  ++    H N+
Sbjct: 11  RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNI 70

Query: 616 MRIITACSLPDFKALVLPYMANGSLDS---HLYPHSETEFGSGSS----------DLTLL 662
           ++++  C++     L+  YMA G L+    H  P ++      +S           L+  
Sbjct: 71  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 663 QRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV---- 718
           +++ I   +A GMAYL   S  + +H DL   N L+ ++M   ++DFG+++ + +     
Sbjct: 131 EQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187

Query: 719 GVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
              ND                I +M PE  F +  +T+ DV+++G+++ E          
Sbjct: 188 ASENDAI-------------PIRWMPPESIFYNRYTTESDVWAYGVVLWE---------- 224

Query: 779 MFAGGLSLHKWVKNHYHGRLEKVI----DSSLLRASRDQSPEVKRMWDVAIGELIELGIL 834
           +F+ G+      + +Y    E+VI    D ++L +  D  P           EL  L  L
Sbjct: 225 IFSYGM------QPYYGMAHEEVIYYVRDGNVL-SCPDNCPL----------ELYNLMRL 267

Query: 835 CTQESPSTRPTMLDAADDLDR 855
           C  + PS RP+       L R
Sbjct: 268 CWSKLPSDRPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 88.8 bits (220), Expect = 2e-19
 Identities = 64/222 (28%), Positives = 110/222 (49%), Gaps = 27/222 (12%)

Query: 563 RLLGTGSYGRVYKG----ILQDGTA---IAVKVLQLQSGNFTKS-FNRECQVLKRIRHRN 614
             LG+G++G VY+G    IL  G+    +AVK L+  + +  K  F +E  ++    H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +++++  C L + + +++  M  G L S+L       F  G   LTL + ++IC D+A+G
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERF--GPPLLTLKELLDICLDVAKG 118

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLND-----DMTALVSDFGIAKLVMTVGVGNDGAENMG 729
             YL     +  IH DL   N L+++     D    + DFG+A+ +      +D     G
Sbjct: 119 CVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK----SDYYRKEG 171

Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                     + +MAPE       +T+ DV+SFG+L+ E++T
Sbjct: 172 EGLLP-----VRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 88.6 bits (219), Expect = 3e-19
 Identities = 69/222 (31%), Positives = 102/222 (45%), Gaps = 28/222 (12%)

Query: 563 RLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQSGNFTKS----FNRECQVLKRIRHRNLMR 617
           + LG G +G V +G L QD + + V V  ++    T+S    F  E   +K   H N+MR
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 618 IITAC-------SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           +I  C         P    ++LP+M +G L S L     +  G     L     V   +D
Sbjct: 65  LIGVCLQTVESEGYPS-PVVILPFMKHGDLHSFLL---YSRLGDCPQYLPTQMLVKFMTD 120

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           IA GM YL   S    IH DL   N +LN++M   V+DFG++K +       +G      
Sbjct: 121 IASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIY------NGDYYRQG 171

Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR 772
             A M    + ++A E       +TK DV+SFG+ + E+ TR
Sbjct: 172 RIAKM---PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 88.3 bits (219), Expect = 3e-19
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 30/211 (14%)

Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           LG+G +G V+ G  +    +A+K+++  + +    F  E +V+ ++ H NL+++   C+ 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
                +V  YMANG L ++L      + G+      LL    +CSD+ E M YL  +   
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKG-KLGTE----WLLD---MCSDVCEAMEYLESNG-- 120

Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM----TVGVGNDGAENMGNSTANMLCGSI 740
             IH DL   N L+ +D    VSDFG+A+ V+    T   G                  +
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF--------------PV 165

Query: 741 GYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            +  PE    S  S+K DV+SFG+L+ E+ +
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 88.2 bits (219), Expect = 5e-19
 Identities = 82/327 (25%), Positives = 133/327 (40%), Gaps = 71/327 (21%)

Query: 558 EFDEQRL-----LGTGSYGRVYKGILQD------GTAIAVKVLQLQSGNFT----KSFNR 602
           E    RL     LG G++G+V K            + +AVK+L+    + T         
Sbjct: 8   ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK---DDATEKDLSDLVS 64

Query: 603 ECQVLKRI-RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSD--- 658
           E +++K I +H+N++ ++  C+      +V+ Y A+G+L   L         +   D   
Sbjct: 65  EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124

Query: 659 ----LTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL 714
               LT    V+    +A GM +L   +  + IH DL   NVL+ +D    ++DFG+A+ 
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARD 181

Query: 715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           +       D      N         + +MAPE  F    + + DV+SFG+L+ E+ T   
Sbjct: 182 IHH----IDYYRKTTNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT--- 229

Query: 775 PTDDMFAG----GLSLHKWVKNHYHG-RLEKVIDSSLLRASRDQSPEVKRMWDVAIGELI 829
                  G    G+ + +  K    G R+EK  + +                     EL 
Sbjct: 230 -----LGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQ--------------------ELY 264

Query: 830 ELGILCTQESPSTRPTMLDAADDLDRL 856
            L   C  E PS RPT     +DLDR+
Sbjct: 265 HLMRDCWHEVPSQRPTFKQLVEDLDRM 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 87.6 bits (217), Expect = 5e-19
 Identities = 65/227 (28%), Positives = 114/227 (50%), Gaps = 29/227 (12%)

Query: 564 LLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGN---------FTKSFNRECQVLKRIRHR 613
           L+G+GS+G VY G+    G  +AVK ++L S +            +  RE  +LK ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           N+++ + +    D   + L Y+  GS+ + L       +G+    L      N    I +
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALL-----NNYGAFEETLVR----NFVRQILK 117

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           G+ YLH+     +IH D+K +N+L+++     +SDFGI+K +         + +   + A
Sbjct: 118 GLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKL------EANSLSTKTNGA 168

Query: 734 N-MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
              L GS+ +MAPE    ++ + K D++S G LV+EM+T + P  D 
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 87.1 bits (216), Expect = 6e-19
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 23/211 (10%)

Query: 563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTK-SFNRECQVLKRIRHRNLMRIITA 621
             +G G++G VYKG+L+  T +AVK  +       K  F +E ++LK+  H N++++I  
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
           C       +V+  +  GSL + L            + LT+ + + +  D A GM YL   
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLR--------KKKNRLTVKKLLQMSLDAAAGMEYLESK 112

Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIG 741
           +    IH DL   N L+ ++    +SDFG+++         +    +   +  +    I 
Sbjct: 113 N---CIHRDLAARNCLVGENNVLKISDFGMSR---------EEEGGIYTVSDGLKQIPIK 160

Query: 742 YMAPE-YGFGSNTSTKGDVYSFGILVLEMVT 771
           + APE   +G  TS + DV+S+GIL+ E  +
Sbjct: 161 WTAPEALNYGRYTS-ESDVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 63/225 (28%), Positives = 103/225 (45%), Gaps = 28/225 (12%)

Query: 562 QRLLGTGSYGRVYKGILQ--DGTAIAVKVLQLQSGNFTKS---FNRECQVLKRIRHRNLM 616
           ++++G G +G V +G L+      I V +  L++G+  K    F  E  ++ +  H N++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           R+    +      ++  YM NGSLD  L  +            T+ Q V +   IA GM 
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDG--------KFTVGQLVGMLRGIASGMK 120

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL   + V   H DL   N+L+N ++   VSDFG+++ +             G       
Sbjct: 121 YLSEMNYV---HRDLAARNILVNSNLVCKVSDFGLSRRLEDS---EATYTTKGGKI---- 170

Query: 737 CGSIGYMAPE-YGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
              I + APE   +   TS   DV+SFGI++ E+++   RP  DM
Sbjct: 171 --PIRWTAPEAIAYRKFTSAS-DVWSFGIVMWEVMSYGERPYWDM 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 85.1 bits (210), Expect = 4e-18
 Identities = 74/295 (25%), Positives = 133/295 (45%), Gaps = 45/295 (15%)

Query: 563 RLLGTGSYGRVY----KGILQDG--TAIAVKVLQLQSGNFTK-SFNRECQVLKRIRHRNL 615
           R LG GS+G VY    KG+++D   T +A+K +   +    +  F  E  V+K     ++
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYP-HSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +R++   S      +++  M  G L S+L     E E     +  +L + + +  +IA+G
Sbjct: 72  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           MAYL+ +   + +H DL   N ++ +D T  + DFG+ + +        G + +      
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL------ 182

Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNH 793
                + +M+PE       +T  DV+SFG+++ E+ T   +P       G+S  +     
Sbjct: 183 ---LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ-----GMSNEQ----- 229

Query: 794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLD 848
               L  V++  LL    D  P++          L EL  +C Q +P  RP+ L+
Sbjct: 230 ---VLRFVMEGGLLDKP-DNCPDM----------LFELMRMCWQYNPKMRPSFLE 270

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 84.7 bits (210), Expect = 5e-18
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 25/213 (11%)

Query: 565 LGTGSYGRVYKG-ILQDGTAIAVKVLQLQSGN-FTKSFNRECQVLKRIRHRNLMRIITAC 622
           LG G+ G V K      G  +AVK ++L+      K   RE  +L +     ++    A 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
                 ++ + YM  GSLD  +    +           +L ++ +   + +G+ YLH   
Sbjct: 69  YNNGDISICMEYMDGGSLDK-ILKEVQGRI-----PERILGKIAVA--VLKGLTYLHEK- 119

Query: 683 PVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGY 742
             ++IH D+KPSN+L+N      + DFG++               + NS A    G+  Y
Sbjct: 120 -HKIIHRDVKPSNILVNSRGQIKLCDFGVSG-------------QLVNSLAKTFVGTSSY 165

Query: 743 MAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           MAPE   G++ S K D++S G+ ++E+ T R P
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 83.9 bits (207), Expect = 6e-18
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 22/206 (10%)

Query: 564 LLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTK-SFNRECQVLKRIRHRNLMRIITAC 622
           LLG G++G V+KG L+D T +AVK  +       K  F  E ++LK+  H N++++I  C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
           +      +V+  +  G   S L    +        +L   Q V    D A GMAYL   +
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKD--------ELKTKQLVKFALDAAAGMAYLESKN 113

Query: 683 PVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGY 742
               IH DL   N L+ ++    +SDFG+++        +DG      S++ +    I +
Sbjct: 114 ---CIHRDLAARNCLVGENNVLKISDFGMSRQ------EDDGIY----SSSGLKQIPIKW 160

Query: 743 MAPEYGFGSNTSTKGDVYSFGILVLE 768
            APE       S++ DV+S+GIL+ E
Sbjct: 161 TAPEALNYGRYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 84.4 bits (209), Expect = 7e-18
 Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 30/222 (13%)

Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G++G+VYK    + G   A K++Q++S    + F  E  +L   +H N++ +  A  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
             +   +++ +   G+LDS +    E E G     LT  Q   +C  + E + +LH H  
Sbjct: 73  YENKLWILIEFCDGGALDSIM---LELERG-----LTEPQIRYVCRQMLEALNFLHSH-- 122

Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGI-AKLVMTVGVGNDGAENMGNSTANMLCGSIGY 742
            +VIH DLK  N+LL  D    ++DFG+ AK   T+               +   G+  +
Sbjct: 123 -KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL------------QKRDTFIGTPYW 169

Query: 743 MAPEY----GFGSNT-STKGDVYSFGILVLEMVTRRRPTDDM 779
           MAPE      F  N    K D++S GI ++E+     P  ++
Sbjct: 170 MAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 84.6 bits (209), Expect = 8e-18
 Identities = 77/316 (24%), Positives = 136/316 (43%), Gaps = 57/316 (18%)

Query: 563 RLLGTGSYGRVYKGI------LQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNL 615
           + LG G +G+V K            T +AVK+L+  + +   +    E  +LK++ H ++
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHL---------------YPHSETEFGSGSSDLT 660
           +++  ACS      L++ Y   GSL S L                 +S          LT
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 661 LLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGV 720
           +   ++    I+ GM YL   + ++++H DL   NVL+ +     +SDFG+++ V     
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY---- 178

Query: 721 GNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMF 780
             +    +  S   +    + +MA E  F    +T+ DV+SFG+L+ E+VT         
Sbjct: 179 --EEDSYVKRSKGRI---PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--------- 224

Query: 781 AGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESP 840
            GG        N Y G   + + + L    R + PE          E+  L + C ++ P
Sbjct: 225 LGG--------NPYPGIAPERLFNLLKTGYRMERPE------NCSEEMYNLMLTCWKQEP 270

Query: 841 STRPTMLDAADDLDRL 856
             RPT  D + +L+++
Sbjct: 271 DKRPTFADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 83.0 bits (205), Expect = 2e-17
 Identities = 76/286 (26%), Positives = 127/286 (44%), Gaps = 45/286 (15%)

Query: 563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITAC 622
           + LG+G +G V+ G  +    +A+K +  +     + F  E +V+ ++ H  L+++   C
Sbjct: 10  KELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
           +      +V  +M NG L ++L        G  S D+ L    ++C D+ EGM YL  +S
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYL----RQRQGKLSKDMLL----SMCQDVCEGMEYLERNS 120

Query: 683 PVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGY 742
               IH DL   N L++      VSDFG+ + V+     +D  E   +S A      + +
Sbjct: 121 ---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL-----DD--EYTSSSGAKF---PVKW 167

Query: 743 MAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVI 802
             PE    S  S+K DV+SFG+L+ E+ T          G +   K  K++Y       +
Sbjct: 168 SPPEVFNFSKYSSKSDVWSFGVLMWEVFTE---------GKMPFEK--KSNYE------V 210

Query: 803 DSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLD 848
              + R  R   P++  M       + E+   C  E P  RPT  +
Sbjct: 211 VEMISRGFRLYRPKLASM------TVYEVMYSCWHEKPEGRPTFAE 250

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 83.7 bits (207), Expect = 2e-17
 Identities = 78/299 (26%), Positives = 123/299 (41%), Gaps = 67/299 (22%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFN---RECQVLKRIRHRN 614
           F + R +G GS+G VY    ++    +A+K +        + +    +E + L+++RH N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 615 LMRIITACSLPDFKA-LVLPYM---ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
            +     C L +  A LV+ Y    A+  L+ H  P  E E  +            IC  
Sbjct: 77  TIEY-KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAA------------ICHG 123

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
             +G+AYLH H     IH D+K  N+LL +  T  ++DFG A LV               
Sbjct: 124 ALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLV--------------- 165

Query: 731 STANMLCGSIGYMAPEYGFGSNTST---KGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH 787
           S AN   G+  +MAPE     +      K DV+S GI  +E+  R+ P  +M A      
Sbjct: 166 SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----- 220

Query: 788 KWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRM-WDVAIGELIELGILCTQESPSTRPT 845
                           S+L   +++ SP +    W       ++    C Q+ P  RP+
Sbjct: 221 ----------------SALYHIAQNDSPTLSSNDWSDYFRNFVD---SCLQKIPQDRPS 260

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 82.7 bits (204), Expect = 3e-17
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 25/223 (11%)

Query: 562 QRLLGTGSYGRVYKG------ILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNL 615
           +R LG G++G+V+          +D   +AVK L+  +    K F RE ++L  ++H ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHS-------ETEFGSGSSDLTLLQRVNIC 668
           ++    C   D   +V  YM +G L+  L  H        + +      +L L Q ++I 
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
           S IA GM YL   +    +H DL   N L+  ++   + DFG+++ V +      G   M
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 729 GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                      I +M PE       +T+ DV+SFG+++ E+ T
Sbjct: 187 ---------LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 74/299 (24%), Positives = 125/299 (41%), Gaps = 56/299 (18%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQL-QSGNFTKSFNRECQVLKRIRHRNL 615
           E  E   +G G+   VY  I L +   +A+K + L +         +E Q + +  H N+
Sbjct: 4   ELIEV--IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNV 61

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++  T+  + D   LV+PY++ GSL   +   S   +  G  D  ++    +  ++ +G+
Sbjct: 62  VKYYTSFVVGDELWLVMPYLSGGSL-LDIMKSS---YPRGGLDEAII--ATVLKEVLKGL 115

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS--TA 733
            YLH +     IH D+K  N+LL +D +  ++DFG++  +         A+    +    
Sbjct: 116 EYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASL---------ADGGDRTRKVR 163

Query: 734 NMLCGSIGYMAPE-------YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSL 786
               G+  +MAPE       Y F      K D++SFGI  +E+ T   P          L
Sbjct: 164 KTFVGTPCWMAPEVMEQVHGYDF------KADIWSFGITAIELATGAAPYSKYPPMK-VL 216

Query: 787 HKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
              ++N          D   L    D     K     +  ++I    LC Q+ PS RPT
Sbjct: 217 MLTLQN----------DPPSLETGADYKKYSK-----SFRKMIS---LCLQKDPSKRPT 257

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 82.7 bits (204), Expect = 3e-17
 Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 27/222 (12%)

Query: 556 TAEFDEQRLLGTGSYGRVYKGI-LQDGTAI----AVKVLQLQSGNFT-KSFNRECQVLKR 609
             E  + +LLG+G +G V+KGI + +G +I    A+K +Q +SG  T +        +  
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65

Query: 610 IRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS 669
           + H  ++R++  C     + LV      GSL  H+  H        S D   L  +N C 
Sbjct: 66  LDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHR------DSLDPQRL--LNWCV 116

Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
            IA+GM YL  H   R++H +L   N+LL  D    ++DFG+A L+       D  +   
Sbjct: 117 QIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP-----DDKKYFY 168

Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           +         I +MA E       + + DV+S+G+ V EM++
Sbjct: 169 SEHKT----PIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.2 bits (203), Expect = 3e-17
 Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 26/219 (11%)

Query: 563 RLLGTGSYGRVYKGILQD-GTAIAVKVLQL-----QSGNFTKSFNRECQVLKRIRHRNLM 616
           +LLG G++GRVY     D G  +AVK +       ++     +   E Q+LK ++H  ++
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           +        +  ++ + YM  GS+   L  +     G+ +  +T          I EG+ 
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQLKAY-----GALTETVTR----KYTRQILEGVE 118

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YLH +    ++H D+K +N+L +      + DFG +K + T+            +    +
Sbjct: 119 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI--------CSSGTGMKSV 167

Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            G+  +M+PE   G     K DV+S G  V+EM+T + P
Sbjct: 168 TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 82.2 bits (203), Expect = 3e-17
 Identities = 61/234 (26%), Positives = 108/234 (46%), Gaps = 35/234 (14%)

Query: 553 LEATAEFDEQR---LLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLK 608
           LE   E+DE     +LG G+YG VY    L     IA+K +  +   + +  + E  +  
Sbjct: 1   LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS 60

Query: 609 RIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNIC 668
            ++HRN+++ + + S   F  + +  +  GSL + L     +++G    +   +      
Sbjct: 61  YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIIFYT-- 114

Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAEN 727
             I EG+ YLH +   +++H D+K  NVL+N     + +SDFG +K +  +         
Sbjct: 115 KQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--------- 162

Query: 728 MGNSTANMLCGSIGYMAPEY------GFGSNTSTKGDVYSFGILVLEMVTRRRP 775
             N       G++ YMAPE       G+G+      D++S G  ++EM T + P
Sbjct: 163 --NPCTETFTGTLQYMAPEVIDKGPRGYGA----PADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 66/235 (28%), Positives = 108/235 (45%), Gaps = 30/235 (12%)

Query: 544 FPRITYRELLEATAEFDEQRLLGTGSYGRVY----KGILQDG--TAIAVKVLQLQSGNFT 597
           FPR   +E+            LG G +G V+    KGI ++G  T + VK LQ       
Sbjct: 2   FPRSNLQEIT----------TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENL 51

Query: 598 KS-FNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGS 656
           +S F RE  + +++ H+N++R++  C   +   ++L Y   G L   L      +     
Sbjct: 52  QSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKP 111

Query: 657 SDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM 716
             L+  Q+V +C+ IA GM +L +    R +H DL   N L++      VS   ++K V 
Sbjct: 112 PPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVY 168

Query: 717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                N     + N+        + ++APE     + STK DV+SFG+L+ E+ T
Sbjct: 169 -----NSEYYKLRNALI-----PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 81.2 bits (200), Expect = 6e-17
 Identities = 77/286 (26%), Positives = 135/286 (47%), Gaps = 49/286 (17%)

Query: 562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           ++ LG G +G V+       T +AVK ++  S +  ++F  E  V+K ++H  L+++  A
Sbjct: 11  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKL-HA 68

Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
               +   ++  +MA GSL   L    +++ GS      L + ++  + IAEGMA++   
Sbjct: 69  VVTKEPIYIITEFMAKGSLLDFL----KSDEGS---KQPLPKLIDFSAQIAEGMAFIEQR 121

Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIG 741
           +    IH DL+ +N+L++  +   ++DFG+A+++       +  E      A      I 
Sbjct: 122 N---YIHRDLRAANILVSASLVCKIADFGLARVI-------EDNEYTAREGAKF---PIK 168

Query: 742 YMAPE-YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHG-RLE 799
           + APE   FGS T  K DV+SFGIL++E+VT  R        G+S  + ++    G R+ 
Sbjct: 169 WTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIP----YPGMSNPEVIRALERGYRMP 223

Query: 800 KVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
           +           +  PE          EL  + + C +  P  RPT
Sbjct: 224 RP----------ENCPE----------ELYNIMMRCWKNRPEERPT 249

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 81.5 bits (201), Expect = 6e-17
 Identities = 68/231 (29%), Positives = 111/231 (48%), Gaps = 29/231 (12%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT------KSFNRECQVLKRIR 611
           E+ +  +LG G+YG VY G+   G  IAVK ++L + N        +    E  +LK ++
Sbjct: 1   EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNIC--- 668
           H N+++ +  C   +  ++ + ++  GS+ S L       FG        L     C   
Sbjct: 61  HVNIVQYLGTCLDDNTISIFMEFVPGGSISSIL-----NRFGP-------LPEPVFCKYT 108

Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
             I +G+AYLH++    V+H D+K +NV+L  +    + DFG A+ +  VG+ +    NM
Sbjct: 109 KQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL-HGTHSNM 164

Query: 729 GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
             S    + G+  +MAPE    S    K D++S G  V EM T + P   M
Sbjct: 165 LKS----MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 81.9 bits (202), Expect = 7e-17
 Identities = 68/222 (30%), Positives = 98/222 (44%), Gaps = 35/222 (15%)

Query: 562 QRLLGTGSYGRVYKGIL------QDGTAIAVKVLQLQSGN---FTKSFNRECQVLKRIRH 612
            R+LG G +G+V    L       DGT   V V  L+       T  + +E  +LK + H
Sbjct: 9   IRVLGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYH 65

Query: 613 RNLMRIITACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
            N+++    CS    K   L++ Y+  GSL  +L  H           L L Q +     
Sbjct: 66  ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----------LNLAQLLLFAQQ 115

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I EGMAYLH       IH DL   NVLL++D    + DFG+AK V          E+ G+
Sbjct: 116 ICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED-GD 171

Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR 772
           S        + + A E    +  S   DV+SFG+ + E++T 
Sbjct: 172 S-------PVFWYAVECLKENKFSYASDVWSFGVTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 81.6 bits (201), Expect = 8e-17
 Identities = 66/223 (29%), Positives = 115/223 (51%), Gaps = 29/223 (13%)

Query: 562 QRLLGTGSYGRVYKGILQ-DGTAI--AVKVL-QLQSGNFTKSFNRECQVLKRI-RHRNLM 616
           + ++G G++G+V + +++ DG  +  A+K+L +  S N  + F  E +VL ++  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLY--------PHSETEFGSGSSDLTLLQRVNIC 668
            ++ AC    +  + + Y   G+L   L         P    E G+ S+ LT  Q +   
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST-LTSQQLLQFA 125

Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
           SD+A GM YL   S  + IH DL   NVL+ +++ + ++DFG+++          G E  
Sbjct: 126 SDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR----------GEEVY 172

Query: 729 GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              T   L   + +MA E    S  +TK DV+SFG+L+ E+V+
Sbjct: 173 VKKTMGRL--PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 81.1 bits (200), Expect = 9e-17
 Identities = 61/224 (27%), Positives = 105/224 (46%), Gaps = 25/224 (11%)

Query: 562 QRLLGTGSYGRVYKGIL--QDGTAIAVKVLQLQSGNFTKS---FNRECQVLKRIRHRNLM 616
           ++++G G +G V  G L       I V +  L++G   K    F  E  ++ +  H N++
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
            +    +      +V  YM NGSLD+ L  H            T++Q V +   IA GM 
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD--------GQFTVIQLVGMLRGIASGMK 120

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL   S +  +H DL   N+L+N ++   VSDFG+++++       D  E    +    +
Sbjct: 121 YL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL------EDDPEAAYTTRGGKI 171

Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
              I + APE       ++  DV+S+GI++ E+++   RP  +M
Sbjct: 172 --PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 80.8 bits (199), Expect = 9e-17
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 30/215 (13%)

Query: 562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
            + +G G +G V  G  + G  +AVK ++  +    ++F  E  V+ ++RH NL++++  
Sbjct: 11  LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGV 67

Query: 622 CSLPDFKAL--VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLH 679
             + +   L  V  YMA GSL  +L     +  G           +    D+ E M YL 
Sbjct: 68  I-VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC-------LLKFSLDVCEAMEYLE 119

Query: 680 HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS 739
            ++    +H DL   NVL+++D  A VSDFG+ K   +              T  +    
Sbjct: 120 ANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----------QDTGKL---P 162

Query: 740 IGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           + + APE       STK DV+SFGIL+ E+ +  R
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 60/221 (27%), Positives = 107/221 (48%), Gaps = 36/221 (16%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLM 616
           +++  + +G+G+YG VYK   +  G  +A+KV++L+ G+  +   +E  +LK  RH N++
Sbjct: 4   DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV 63

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
               +    D   +V+ Y   GSL   +Y  +          L+ LQ   +C +  +G+A
Sbjct: 64  AYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGP-------LSELQIAYVCRETLKGLA 115

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI-AKLVMTVGVGNDGAENMGNSTANM 735
           YLH       IH D+K +N+LL +D    ++DFG+ A+L  T+            +    
Sbjct: 116 YLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI------------AKRKS 160

Query: 736 LCGSIGYMAPE-------YGFGSNTSTKGDVYSFGILVLEM 769
             G+  +MAPE        G+      K D+++ GI  +E+
Sbjct: 161 FIGTPYWMAPEVAAVERKGGYDG----KCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 80.9 bits (199), Expect = 2e-16
 Identities = 64/220 (29%), Positives = 110/220 (50%), Gaps = 27/220 (12%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAI----AVKVLQLQSG-NFTKSFNRECQVLKRIR 611
           E    ++LG+G++G VYKGI + +G  +    A+K+L   +G      F  E  ++  + 
Sbjct: 8   ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67

Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           H +L+R++  C  P  + LV   M +G L  +++ H +     GS  L     +N C  I
Sbjct: 68  HPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDN---IGSQLL-----LNWCVQI 118

Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+A+L+       +G E   N+
Sbjct: 119 AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL-------EGDEKEYNA 168

Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               +   I +MA E       + + DV+S+G+ + E++T
Sbjct: 169 DGGKM--PIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 59/223 (26%), Positives = 109/223 (48%), Gaps = 31/223 (13%)

Query: 563 RLLGTGSYGRVYKGILQD---GTAIAVKVLQLQSGNFT------KSFNRECQVLKRIRHR 613
           + LGTG++   Y+   +D   GT +AVK +       +      ++  +E +++ R+ H 
Sbjct: 6   QQLGTGAFSSCYQA--RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63

Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           +++R++ A        L + +MA GS+   L     +++G+    +     +N    +  
Sbjct: 64  HIIRMLGATCEDSHFNLFVEWMAGGSVSHLL-----SKYGAFKEAVI----INYTEQLLR 114

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGNST 732
           G++YLH +   ++IH D+K +N+L++     L ++DFG A  +   G G    E  G   
Sbjct: 115 GLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAG--EFQGQ-- 167

Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              L G+I +MAPE   G       DV+S G +++EM T + P
Sbjct: 168 ---LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 80/301 (26%), Positives = 135/301 (44%), Gaps = 47/301 (15%)

Query: 563 RLLGTGSYGRVYKGILQD------GTAIAVKVLQLQSGNFTK--SFNRECQVLKRIRHRN 614
           R LG GS+G VY+G  +D       T +AVK +  +S +  +   F  E  V+K     +
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFLNEASVMKGFTCHH 70

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYP-HSETEFGSGSSDLTLLQRVNICSDIAE 673
           ++R++   S      +V+  MA+G L S+L     E E   G    TL + + + ++IA+
Sbjct: 71  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           GMAYL+     + +H DL   N ++  D T  + DFG+ + +        G + +     
Sbjct: 131 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL----- 182

Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKN 792
                 + +MAPE       +T  D++SFG+++ E+ +   +P       GLS  + +K 
Sbjct: 183 ----LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ-----GLSNEQVLKF 233

Query: 793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD 852
                   V+D   L    D  PE           + +L  +C Q +P  RPT L+  + 
Sbjct: 234 --------VMDGGYLDQP-DNCPE----------RVTDLMRMCWQFNPKMRPTFLEIVNL 274

Query: 853 L 853
           L
Sbjct: 275 L 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 30/218 (13%)

Query: 564 LLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNLMRIIT- 620
           L+G G+YG VY+G  +  G  +A+K++ L + +   S   RE  +L ++R      I   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 621 -ACSLPDFKA-LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
               L   +  +++ Y   GS+ + +      E               I  ++   + Y+
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV----------IIREVLVALKYI 117

Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCG 738
           H    V VIH D+K +N+L+ +     + DFG+A L+           N  +S  +   G
Sbjct: 118 HK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALL-----------NQNSSKRSTFVG 163

Query: 739 SIGYMAPEYGF-GSNTSTKGDVYSFGILVLEMVTRRRP 775
           +  +MAPE    G    TK D++S GI + EM T   P
Sbjct: 164 TPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 79.6 bits (196), Expect = 3e-16
 Identities = 83/311 (26%), Positives = 133/311 (42%), Gaps = 60/311 (19%)

Query: 563 RLLGTGSYGRVYKGIL--QDGTAIAVKVLQLQSGNFTKS----FNRECQVLKRIRHRNLM 616
           R+LG G +G V +  L  +DG+   V V  L++  F+ S    F RE   +K   H N++
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 617 RII-------TACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS 669
           ++I           LP    ++LP+M +G L + L     +  G     L L   V    
Sbjct: 65  KLIGVSLRSRAKGRLP-IPMVILPFMKHGDLHTFLL---MSRIGEEPFTLPLQTLVRFMI 120

Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           DIA GM YL   S    IH DL   N +LN++MT  V+DFG++K + +      G     
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG----- 172

Query: 730 NSTANMLCGS---IGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSL 786
                  C S   + ++A E    +  +T  DV++FG+ + E++TR              
Sbjct: 173 -------CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRG------------- 212

Query: 787 HKWVKNHYHGRLEKVIDSSLLRASR-DQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
               +  Y G     I + L++ +R  Q P+        + ++ EL   C    P  RP+
Sbjct: 213 ----QTPYAGVENSEIYNYLIKGNRLKQPPD-------CLEDVYELMCQCWSPEPKCRPS 261

Query: 846 MLDAADDLDRL 856
                D L+ +
Sbjct: 262 FQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 4e-16
 Identities = 57/228 (25%), Positives = 92/228 (40%), Gaps = 34/228 (14%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNF-TKSFNRECQVLKRIRHRNL 615
            F     +G GS+G VYK I  +    +A+KV+ L+      +   +E Q L + R   +
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYI 61

Query: 616 MRIITACSLPDFK-ALVLPYMANGSLDSHL---YPHSETEFGSGSSDLTLLQRVNICSDI 671
            +      L   K  +++ Y   GS    L       ET                I  ++
Sbjct: 62  TKYY-GSFLKGSKLWIIMEYCGGGSC-LDLLKPGKLDETYIAF------------ILREV 107

Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ YLH       IH D+K +N+LL+++    ++DFG++           G      S
Sbjct: 108 LLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS-----------GQLTSTMS 153

Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
             N   G+  +MAPE    S    K D++S GI  +E+     P  D+
Sbjct: 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 78.5 bits (193), Expect = 5e-16
 Identities = 58/210 (27%), Positives = 107/210 (50%), Gaps = 28/210 (13%)

Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           +G G +G V +G    G  +AVK ++       ++F  E  V+ ++ H+NL+R++    L
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLL-GVIL 69

Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
            +   +V+  M+ G+L + L          G + ++++Q +    D+AEGM YL      
Sbjct: 70  HNGLYIVMELMSKGNLVNFLRTR-------GRALVSVIQLLQFSLDVAEGMEYLESK--- 119

Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
           +++H DL   N+L+++D  A VSDFG+A+             +MG   + +    + + A
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLAR-----------VGSMGVDNSKL---PVKWTA 165

Query: 745 PEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           PE       S+K DV+S+G+L+ E+ +  R
Sbjct: 166 PEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 78.9 bits (194), Expect = 6e-16
 Identities = 67/237 (28%), Positives = 115/237 (48%), Gaps = 32/237 (13%)

Query: 551 ELLEATAEFDEQRLLGTGSYGRVYKGIL------QDGTAIAVKVLQLQS-GNFTKSFNRE 603
           E+  +T  F E+  LG   +G+VYKG L      +   A+A+K L+ ++ G   + F  E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 604 CQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLY---PHSETEFGSGSSDLT 660
             +  R++H N++ ++   +     +++  Y ++  L   L    PHS+   GS   D T
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDV--GSTDDDKT 116

Query: 661 LLQR------VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL 714
           +         V+I + IA GM +L  H    V+H DL   NVL+ D +   +SD G+ + 
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFRE 173

Query: 715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           V       D  + MGNS   +L   I +M+PE       S   D++S+G+++ E+ +
Sbjct: 174 VYAA----DYYKLMGNS---LL--PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 81.4 bits (201), Expect = 8e-16
 Identities = 43/140 (30%), Positives = 73/140 (52%), Gaps = 23/140 (16%)

Query: 345 LNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNL 404
           L L +  L G +P ++SKL ++Q I+LS N   GNI   + +  ++ ++++S+N+  G++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 405 PDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKM 464
           P+SLG L +L  ++++GN LSG +P +L                      GG        
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL----------------------GGRLLHRASF 520

Query: 465 SFVGNQHLCGTVPGMPICPP 484
           +F  N  LCG +PG+  C P
Sbjct: 521 NFTDNAGLCG-IPGLRACGP 539

Length = 623

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 34/224 (15%)

Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRN 614
           F+  R++G G++G+V     +D     A+K +  Q        ++   E ++L+ + H  
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHL---YPHSETEFGSGSSDLTLLQRVNICSDI 671
           L+ +  +    +   LV+  +  G L  HL      SE +            +  IC +I
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQV-----------KFWIC-EI 109

Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
              + YLH      +IH D+KP N+LL++     ++DF IA  V          + +  S
Sbjct: 110 VLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP--------DTLTTS 158

Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           T     G+ GYMAPE       S   D +S G+   E +  +RP
Sbjct: 159 T----SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 67/292 (22%), Positives = 117/292 (40%), Gaps = 52/292 (17%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFN---RECQVLKRIRHR 613
           +F+    +G GS+G V+K + + D    A+K + L   N  +       E +VL ++   
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSS 59

Query: 614 NLMRIITACSLPDFK-ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIA 672
            ++R      L   K  +V+ Y  NG L  H     +         L   Q       I 
Sbjct: 60  YIIRYYE-SFLDKGKLNIVMEYAENGDL--HKLLKMQR-----GRPLPEDQVWRFFIQIL 111

Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
            G+A+LH     +++H D+K  N+ L+      + D G+AKL+           +   + 
Sbjct: 112 LGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-----------SDNTNF 157

Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN 792
           AN + G+  Y++PE       + K DV++ G+++ E  T + P D    G L        
Sbjct: 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL-------- 209

Query: 793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP 844
                        +L+  R   P V +M+   + +LI+    C  +    RP
Sbjct: 210 -------------ILKIIRGVFPPVSQMYSQQLAQLID---QCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 80/290 (27%), Positives = 129/290 (44%), Gaps = 59/290 (20%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLM 616
           F+   L+G G+YG+VYKG  ++ G   A+KV+ + +G+  +   +E  +LK+   HRN+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIA 66

Query: 617 RIITAC------SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR--VNIC 668
               A        + D   LV+ +   GS+         T+    +   TL +     IC
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSV---------TDLIKNTKGNTLKEEWIAYIC 117

Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI-AKLVMTVGVGNDGAEN 727
            +I  G+++LH H   +VIH D+K  NVLL ++    + DFG+ A+L  TVG        
Sbjct: 118 REILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-------- 166

Query: 728 MGNSTANMLCGSIGYMAPEY-----GFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMF-- 780
                 N   G+  +MAPE         +    K D++S GI  +EM     P  DM   
Sbjct: 167 ----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 222

Query: 781 ----------AGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRM 820
                     A  L   KW K     + +  I+S L++ +  Q P  +++
Sbjct: 223 RALFLIPRNPAPRLKSKKWSK-----KFQSFIESCLVK-NHSQRPTTEQL 266

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 67/249 (26%), Positives = 115/249 (46%), Gaps = 39/249 (15%)

Query: 558 EFDEQRL-----LGTGSYGRVY------------KGILQDGTA-----IAVKVLQL-QSG 594
           EF  Q L     LG G +G V+            K   ++  A     +AVKVL+   S 
Sbjct: 1   EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60

Query: 595 NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGS 654
           N  + F +E ++L R+   N+ R++  C++     +++ YM NG L+  L  H     G 
Sbjct: 61  NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120

Query: 655 GSSDLTLLQR--VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA 712
             +  +L     + + + IA GM YL   + V   H DL   N L+  + T  ++DFG++
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFV---HRDLATRNCLVGKNYTIKIADFGMS 177

Query: 713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT- 771
           + + +    +D     G +    L   I +MA E       +TK DV++FG+ + E++T 
Sbjct: 178 RNLYS----SDYYRVQGRA---PL--PIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTL 228

Query: 772 -RRRPTDDM 779
            R +P + +
Sbjct: 229 CREQPYEHL 237

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 77.5 bits (192), Expect = 2e-15
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 33/216 (15%)

Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNLMRIITA 621
           LG G+YG VYK    + G  +A+K ++L +       +  RE  +LK ++H N+++++  
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66

Query: 622 CSLPDFKALVLPYMAN---GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
                   LV  Y        LD    P S     S      + Q       +  G+AY 
Sbjct: 67  IHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKS-----IMYQ-------LLRGLAYC 114

Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCG 738
           H H   R++H DLKP N+L+N D    ++DFG+A+              +   T  ++  
Sbjct: 115 HSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGI---------PLRTYTHEVV-- 160

Query: 739 SIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRR 773
           ++ Y APE   GS   ST  D++S G +  EM+T +
Sbjct: 161 TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 77.2 bits (191), Expect = 2e-15
 Identities = 54/222 (24%), Positives = 98/222 (44%), Gaps = 38/222 (17%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFN-------RECQVLKRIRHRN 614
           + LG G+Y  VYK    + G  +A+K  +++ G   ++ +       RE ++L+ ++H N
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIK--KIKLGERKEAKDGINFTALREIKLLQELKHPN 63

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           ++ ++          LV  +M     ++ L    E      S  LT     +       G
Sbjct: 64  IIGLLDVFGHKSNINLVFEFM-----ETDL----EKVIKDKSIVLTPADIKSYMLMTLRG 114

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           + YLH +    ++H DLKP+N+L+  D    ++DFG+A+             + G+    
Sbjct: 115 LEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR-------------SFGSPNRK 158

Query: 735 MLCGSIG--YMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           M    +   Y APE  FG+     G D++S G +  E++ R 
Sbjct: 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 68/231 (29%), Positives = 101/231 (43%), Gaps = 43/231 (18%)

Query: 559 FDEQRL-----LGTGSYGRVYK---GILQDGTA--IAVKVLQLQSGNFTKSFNRECQVLK 608
           F+E+ L     LG G++G V       LQD T   +AVK LQ  +    + F RE ++LK
Sbjct: 1   FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILK 60

Query: 609 RIRHRNLMRIITACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN 666
            ++H N+++    C     +   LV+ Y+  GSL  +L  H E           LL    
Sbjct: 61  SLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHR-----KLLL--- 112

Query: 667 ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV------MTVGV 720
             S I +GM YL      R +H DL   N+L+  +    + DFG+ K++        V  
Sbjct: 113 YASQICKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKV-- 167

Query: 721 GNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                   G S        I + APE    S  S   DV+SFG+++ E+ T
Sbjct: 168 -----REPGES-------PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 76.6 bits (188), Expect = 4e-15
 Identities = 64/222 (28%), Positives = 98/222 (44%), Gaps = 28/222 (12%)

Query: 559 FDEQRLLGTGSYGRVYK-GILQDGTAIAVKVLQLQSGNFTK----SFNRECQVLKRIRHR 613
           F + R+LG G +G V    +   G   A K L+ +     K    + N E Q+L+++  R
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-EKQILEKVNSR 60

Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
            ++ +  A    D   LVL  M  G L  H+Y   E  F  G +       V   ++I  
Sbjct: 61  FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRA-------VFYAAEICC 113

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           G+  LH     R+++ DLKP N+LL+D     +SD G+A     V V           T 
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA-----VHVPEG-------QTI 158

Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
               G++GYMAPE       +   D ++ G L+ EM+  + P
Sbjct: 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 76.3 bits (188), Expect = 5e-15
 Identities = 76/310 (24%), Positives = 121/310 (39%), Gaps = 65/310 (20%)

Query: 558 EFDEQRLLGTGSYGRVYKGIL-QDGTAIAVK-VLQLQSGNFTKSFNRECQVLKRIRHRNL 615
           +  E   LG G+ G V K  L   G   A+K +    + +  K   RE ++ K  +   +
Sbjct: 2   KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61

Query: 616 MRIITACSLPDFK--ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD--- 670
           ++   A          + + Y   GSLDS +Y               + +R     +   
Sbjct: 62  VKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKK-------------VKKRGGRIGEKVL 107

Query: 671 --IAE----GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
             IAE    G++YLH     ++IH D+KPSN+LL       + DFG++            
Sbjct: 108 GKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG----------- 153

Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP---TDDMFA 781
              + NS A    G+  YMAPE   G   S   DV+S G+ +LE+   R P     +   
Sbjct: 154 --ELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL 211

Query: 782 GGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPS 841
           G + L  ++ N  +  L+               P     W     + I+    C ++ P+
Sbjct: 212 GPIELLSYIVNMPNPELK-------------DEPGNGIKWSEEFKDFIK---QCLEKDPT 255

Query: 842 TRPT---MLD 848
            RPT   ML+
Sbjct: 256 RRPTPWDMLE 265

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 76.4 bits (188), Expect = 5e-15
 Identities = 64/212 (30%), Positives = 108/212 (50%), Gaps = 24/212 (11%)

Query: 565 LGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFN-RECQVLKRIRHRNLMRIITAC 622
           LG G+Y  VYKG  +  G  +A+K + L +   T S   RE  ++K ++H N++R+    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
              +   LV  YM     D  L  + +T    G+ D   ++  +    + +G+A+ H + 
Sbjct: 68  HTENKLMLVFEYM-----DKDLKKYMDTHGVRGALDPNTVK--SFTYQLLKGIAFCHEN- 119

Query: 683 PVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGY 742
             RV+H DLKP N+L+N      ++DFG+A+     G+         N+ +N +  ++ Y
Sbjct: 120 --RVLHRDLKPQNLLINKRGELKLADFGLAR---AFGIPV-------NTFSNEVV-TLWY 166

Query: 743 MAPEYGFGSNT-STKGDVYSFGILVLEMVTRR 773
            AP+   GS T ST  D++S G ++ EM+T R
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 75.7 bits (186), Expect = 5e-15
 Identities = 62/232 (26%), Positives = 110/232 (47%), Gaps = 39/232 (16%)

Query: 562 QRLLGTGSYGRVYKGILQ----DGTAIAVKVLQLQSGNFT----KSFNRECQVLKRIRHR 613
           + ++G G +G V +G L+        +A+K L+     +T    + F  E  ++ +  H 
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLK---SGYTEKQRRDFLSEASIMGQFDHP 65

Query: 614 NLMRI--ITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           N++ +  +   S P    ++  +M NG+LDS L   ++ +F       T++Q V +   I
Sbjct: 66  NIIHLEGVVTKSRPVM--IITEFMENGALDSFLR-QNDGQF-------TVIQLVGMLRGI 115

Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A GM YL   S +  +H DL   N+L+N ++   VSDFG+++ +          ++  + 
Sbjct: 116 AAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL---------EDDTSDP 163

Query: 732 TANMLCGS---IGYMAPEYGFGSNTSTKGDVYSFGILVLE-MVTRRRPTDDM 779
           T     G    I + APE       ++  DV+S+GI++ E M    RP  DM
Sbjct: 164 TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 75.9 bits (186), Expect = 5e-15
 Identities = 60/221 (27%), Positives = 110/221 (49%), Gaps = 29/221 (13%)

Query: 564 LLGTGSYGRVYKGILQ-DGTAI--AVKVL-QLQSGNFTKSFNRECQVLKRI-RHRNLMRI 618
           ++G G++G+V K  ++ DG  +  A+K + +  S +  + F  E +VL ++  H N++ +
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 619 ITACSLPDFKALVLPYMANGSLDSHLY--------PHSETEFGSGSSDLTLLQRVNICSD 670
           + AC    +  L + Y  +G+L   L         P       + S+ L+  Q ++  +D
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST-LSSQQLLHFAAD 120

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A GM YL   S  + IH DL   N+L+ ++  A ++DFG+++          G E    
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----------GQEVYVK 167

Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            T   L   + +MA E    S  +T  DV+S+G+L+ E+V+
Sbjct: 168 KTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 75.6 bits (186), Expect = 9e-15
 Identities = 64/227 (28%), Positives = 100/227 (44%), Gaps = 39/227 (17%)

Query: 563 RLLGTGSYGRVY----KGILQDGTAIAVKVLQ----LQSGNFTKSFNRECQVLKRIRHRN 614
           R+LGTG+YG+V+     G    G   A+KVL+    +Q     +    E QVL+ +R   
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65

Query: 615 LMRIITACSLPDFKA-LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
            +  +      D K  L+L Y+  G L +HLY                   V +   IAE
Sbjct: 66  FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT----------ESEVRVY--IAE 113

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            +  L H   + +I+ D+K  N+LL+ +   +++DFG++K  +         E    S  
Sbjct: 114 IVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA------EEEERAYS-- 165

Query: 734 NMLCGSIGYMAPEYGFGSNTSTKG-----DVYSFGILVLEMVTRRRP 775
              CG+I YMAPE        + G     D +S G+L  E++T   P
Sbjct: 166 --FCGTIEYMAPEV---IRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 75.4 bits (185), Expect = 9e-15
 Identities = 78/307 (25%), Positives = 131/307 (42%), Gaps = 50/307 (16%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDG----TAIAVKVLQLQ-SGNFTKSFNRECQVLKRIR 611
           E  + ++LG+G++G VYKGI + DG      +A+KVL+   S    K    E  V+  + 
Sbjct: 8   ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 67

Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
              + R++  C L     LV   M  G L  ++  + +     GS DL     +N C  I
Sbjct: 68  SPYVCRLLGIC-LTSTVQLVTQLMPYGCLLDYVRENKDR---IGSQDL-----LNWCVQI 118

Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM+YL     VR++H DL   NVL+       ++DFG+A+L+       D  E   ++
Sbjct: 119 AKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLL-------DIDETEYHA 168

Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
               +   I +MA E       + + DV+S+G+ V E++T                 +  
Sbjct: 169 DGGKV--PIKWMALESILHRRFTHQSDVWSYGVTVWELMT-----------------FGA 209

Query: 792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAAD 851
             Y G   + I   L +  R   P +  +      ++  + + C       RP   +  D
Sbjct: 210 KPYDGIPAREIPDLLEKGERLPQPPICTI------DVYMIMVKCWMIDSECRPRFRELVD 263

Query: 852 DLDRLKR 858
           +  R+ R
Sbjct: 264 EFSRMAR 270

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 28/221 (12%)

Query: 563 RLLGTGSYGRVYKGILQD-GTAIAVKVLQL-----QSGNFTKSFNRECQVLKRIRHRNLM 616
           +LLG G++GRVY     D G  +A K +Q      ++     +   E Q+LK ++H  ++
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 617 RIITACSLPDFKALV--LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +          K L   + YM  GS+   L       +G+ +  +T          I EG
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-----KAYGALTESVTR----KYTRQILEG 118

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           M+YLH +    ++H D+K +N+L +      + DFG +K + T+ +   G  +       
Sbjct: 119 MSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS------- 168

Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            + G+  +M+PE   G     K DV+S G  V+EM+T + P
Sbjct: 169 -VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 65/222 (29%), Positives = 98/222 (44%), Gaps = 34/222 (15%)

Query: 563 RLLGTGSYGRVYKGILQ----DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNL 615
           R LG G++G VY+G+ +    D   + V V  L    S      F  E  ++ +  H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 616 MRIITAC--SLPDFKALVLPYMANGSLDSHL---YPHSETEFGSGSSDLTLLQRVNICSD 670
           +R+I      LP F  ++L  MA G L S L    P  E       S LT+   +    D
Sbjct: 72  VRLIGVSFERLPRF--ILLELMAGGDLKSFLRENRPRPER-----PSSLTMKDLLFCARD 124

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLND---DMTALVSDFGIAKLVMTVGVGNDGAEN 727
           +A+G  YL  +     IH D+   N LL        A ++DFG+A+ +         A  
Sbjct: 125 VAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY-------RASY 174

Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEM 769
                  ML   I +M PE       ++K DV+SFG+L+ E+
Sbjct: 175 YRKGGRAML--PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 76.8 bits (189), Expect = 2e-14
 Identities = 39/99 (39%), Positives = 58/99 (58%)

Query: 190 DSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLF 249
            + G+  +  L L    + G IP  I  L +L S+NLS N + G I   +  ++ LE L 
Sbjct: 413 STKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLD 472

Query: 250 LSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLG 288
           LS+N F+G IP +LG+L  L +L+L+ N LSG +P +LG
Sbjct: 473 LSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 79/312 (25%), Positives = 132/312 (42%), Gaps = 51/312 (16%)

Query: 551 ELLEATAEFDEQRLLGTGSYGRVYKGIL-----QDGTAIAVKVLQ-LQSGNFTKSFNREC 604
           EL  +   F E+  LG  ++G++YKG L          +A+K L+ + +      F +E 
Sbjct: 1   ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58

Query: 605 QVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLY---PHSET-----EFGSGS 656
            ++  + H N++ ++   +      ++  Y+  G L   L    PHS+      E G+  
Sbjct: 59  SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118

Query: 657 SDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM 716
           S L     ++I   IA GM YL  H     +H DL   N+L+ + +   +SD G+++ + 
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY 175

Query: 717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPT 776
           +       A+       ++L   I +M PE       S+  D++SFG+++ E        
Sbjct: 176 S-------ADYYRVQPKSLL--PIRWMPPEAIMYGKFSSDSDIWSFGVVLWE-------- 218

Query: 777 DDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCT 836
             +F+ GL  +    N     +E V    LL  S D  P   RM+         L   C 
Sbjct: 219 --IFSFGLQPYYGFSNQE--VIEMVRKRQLLPCSEDCPP---RMY--------SLMTECW 263

Query: 837 QESPSTRPTMLD 848
           QE PS RP   D
Sbjct: 264 QEGPSRRPRFKD 275

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 74.5 bits (184), Expect = 2e-14
 Identities = 63/236 (26%), Positives = 97/236 (41%), Gaps = 68/236 (28%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---------QLQSGNFTKSFNRECQVL 607
           +F+  + LGTGS+GRV     +      A+K+L         Q++          E ++L
Sbjct: 2   DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH------VLNEKRIL 55

Query: 608 KRIRHRNLMRIITACSLPDFKAL--VLPYMANGSLDSHL-----YPHSETEFGSGSSDLT 660
           + IRH  L+ +    S  D   L  V+ Y+  G L SHL     +P     F +      
Sbjct: 56  QSIRHPFLVNLY--GSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYA------ 107

Query: 661 LLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGV 720
                   + +   + YLH      +++ DLKP N+LL+ D    ++DFG AK V     
Sbjct: 108 --------AQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154

Query: 721 GNDGAENMGNSTANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGILVLEMV 770
                          LCG+  Y+APE      YG         D ++ GIL+ EM+
Sbjct: 155 ------------TYTLCGTPEYLAPEIILSKGYGKAV------DWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 62/221 (28%), Positives = 108/221 (48%), Gaps = 28/221 (12%)

Query: 563 RLLGTGSYGRVYKGILQD-GTAIAVKVLQL--QSGNFTKSFNR-EC--QVLKRIRHRNLM 616
           +LLG G++GRVY     D G  +AVK +Q   +S   +K  N  EC  Q+LK + H  ++
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 617 RIITACSLPDFKAL--VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +       P  + L   + +M  GS+   L       +G+ + ++T          I EG
Sbjct: 68  QYYGCLRDPMERTLSIFMEHMPGGSIKDQL-----KSYGALTENVTR----KYTRQILEG 118

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           ++YLH +    ++H D+K +N+L +      + DFG +K + T+ +   G ++       
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS------- 168

Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            + G+  +M+PE   G     K D++S G  V+EM+T + P
Sbjct: 169 -VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 70/273 (25%), Positives = 118/273 (43%), Gaps = 49/273 (17%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQL---QSGNFTKSFNRECQVLKRIRHRN 614
           F + R +G GS+G VY    +++   +A+K +     QS    +   +E + L+++RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 615 LMRIITACSLPDFKA-LVLPYM---ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
            ++    C L +  A LV+ Y    A+  L+ H  P  E E  +            +   
Sbjct: 77  TIQY-RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA------------VTHG 123

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
             +G+AYLH H+   +IH D+K  N+LL++     + DFG A ++               
Sbjct: 124 ALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM--------------- 165

Query: 731 STANMLCGSIGYMAPEYGFGSNTST---KGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH 787
           + AN   G+  +MAPE     +      K DV+S GI  +E+  R+ P  +M A     H
Sbjct: 166 APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225

Query: 788 -------KWVKNHYHGRLEKVIDSSLLRASRDQ 813
                       H+       +DS L +  +D+
Sbjct: 226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 258

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 73.6 bits (181), Expect = 3e-14
 Identities = 56/219 (25%), Positives = 103/219 (47%), Gaps = 24/219 (10%)

Query: 562 QRLLGTGSYGRVYKGILQDGT-----AIAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNL 615
             LL  G++GR++ GIL D        + VK ++  +     +   +E  +L  + H+N+
Sbjct: 11  SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70

Query: 616 MRIITACS-LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           + I+  C    +   ++ PYM  G+L   L      E  +  + L+  Q V++   IA G
Sbjct: 71  LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQA-LSTQQLVHMAIQIACG 129

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV--MTVGVGNDGAENMGNST 732
           M+YLH      VIH D+   N ++++++   ++D  +++ +  M      D  EN     
Sbjct: 130 MSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDN-ENR---- 181

Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                  + +MA E       S+  DV+SFG+L+ E++T
Sbjct: 182 ------PVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 74.3 bits (182), Expect = 3e-14
 Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 27/220 (12%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAI----AVKVL-QLQSGNFTKSFNRECQVLKRIR 611
           EF + ++LG+G++G VYKG+ + +G  +    A+K L +  S    K    E  V+  + 
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67

Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L+   M  G L  ++  H +     GS  L     +N C  I
Sbjct: 68  NPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 118

Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+AKL     +G D  E     
Sbjct: 119 AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL-----LGADEKEYHAEG 170

Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                   I +MA E       + + DV+S+G+ V E++T
Sbjct: 171 GKV----PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 76.0 bits (187), Expect = 4e-14
 Identities = 37/94 (39%), Positives = 54/94 (57%)

Query: 257 GEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTD 316
           G IP  + KL HL  ++LS N + G IP SLG++  +  L L+ N  + SIP +LG+ T 
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 317 LYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHN 350
           L  L+L+ N L+G +PA + G    R   N + N
Sbjct: 492 LRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525

Length = 623

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 73.3 bits (180), Expect = 4e-14
 Identities = 58/216 (26%), Positives = 89/216 (41%), Gaps = 28/216 (12%)

Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQ----SGNFTKSFNRECQVLKRIRHRNLMRII 619
           LG G +G V    ++  G   A K L  +          + N E ++L+++  R ++ + 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALN-EKKILEKVSSRFIVSLA 59

Query: 620 TACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLH 679
            A    D   LV+  M  G L  H+Y   E  F    +       +   + I  G+ +LH
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARA-------IFYAAQIICGLEHLH 112

Query: 680 HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS 739
                R+++ DLKP NVLL+D     +SD G+A             E  G        G+
Sbjct: 113 QR---RIVYRDLKPENVLLDDHGNVRISDLGLA------------VELKGGKKIKGRAGT 157

Query: 740 IGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            GYMAPE   G       D ++ G  + EM+  R P
Sbjct: 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 73.5 bits (180), Expect = 4e-14
 Identities = 61/222 (27%), Positives = 112/222 (50%), Gaps = 27/222 (12%)

Query: 562 QRLLGTGSYGRVYKG-ILQDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRI-RHRNLM 616
           Q ++G G++G+V K  I +DG  +   + +++   S +  + F  E +VL ++  H N++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYP----HSETEFG---SGSSDLTLLQRVNICS 669
            ++ AC    +  L + Y  +G+L   L       ++  F    S +S L+  Q ++  +
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           D+A GM YL   S  + IH DL   N+L+ ++  A ++DFG+++          G E   
Sbjct: 132 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----------GQEVYV 178

Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
             T   L   + +MA E    S  +T  DV+S+G+L+ E+V+
Sbjct: 179 KKTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 74.0 bits (181), Expect = 5e-14
 Identities = 76/299 (25%), Positives = 124/299 (41%), Gaps = 67/299 (22%)

Query: 559 FDEQRLLGTGSYGRVY-KGILQDGTAIAVKVLQLQSGNFTKSFN---RECQVLKRIRHRN 614
           F + R +G GS+G VY    ++    +A+K +        + +    +E + L+RI+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 615 LMRIITACSLPDFKA-LVLPYM---ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
            +     C L +  A LV+ Y    A+  L+ H  P  E E  +            I   
Sbjct: 87  SIEY-KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA------------ITHG 133

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
             +G+AYLH H+   +IH D+K  N+LL +     ++DFG A +                
Sbjct: 134 ALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIA--------------- 175

Query: 731 STANMLCGSIGYMAPEYGFGSNTST---KGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH 787
           S AN   G+  +MAPE     +      K DV+S GI  +E+  R+ P  +M A      
Sbjct: 176 SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----- 230

Query: 788 KWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRM-WDVAIGELIELGILCTQESPSTRPT 845
                           S+L   ++++SP ++   W       ++    C Q+ P  RPT
Sbjct: 231 ----------------SALYHIAQNESPTLQSNEWSDYFRNFVD---SCLQKIPQDRPT 270

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 75.2 bits (185), Expect = 7e-14
 Identities = 39/89 (43%), Positives = 50/89 (56%)

Query: 224 LNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEI 283
           L L +  L G I  +IS L  L+ + LS N   G IP +LG +  L +LDLS+N  +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 284 PVSLGNLVQIYSLFLNNNQLSRSIPPTLG 312
           P SLG L  +  L LN N LS  +P  LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 73.3 bits (181), Expect = 7e-14
 Identities = 64/226 (28%), Positives = 98/226 (43%), Gaps = 40/226 (17%)

Query: 562 QRLLGTGSYGRVYKGI-LQDGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRN---L 615
            + +G+G+YG V   +  + G  +A+K +          K   RE ++L+ +RH N   L
Sbjct: 5   LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGL 64

Query: 616 MRIITACSLPDFKAL--VLPYMANGSLDSHLYP--HSETEFGSGSSDLTLLQRVNICSDI 671
           + I+   S  DF  +  V   M     ++ L+    S          LT          I
Sbjct: 65  LDILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSP-------QPLTDDHIQYFLYQI 112

Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ YLH      VIH DLKPSN+L+N +    + DFG+A+     GV  D  E     
Sbjct: 113 LRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLAR-----GVDPDEDE----- 159

Query: 732 TANMLCGSIG---YMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
               L   +    Y APE    S+  TK  D++S G +  E++TR+
Sbjct: 160 -KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 72.6 bits (178), Expect = 7e-14
 Identities = 72/290 (24%), Positives = 120/290 (41%), Gaps = 55/290 (18%)

Query: 562 QRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNLMRII 619
           Q +LG G+ G VYK   L     +AVKV+ L  +    K    E ++L +     ++   
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 620 TACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLH 679
            A  + +  ++   +M  GSLD +                 +L R+ +   + +G+ YL 
Sbjct: 66  GAFFVENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVA--VVKGLTYLW 112

Query: 680 HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS 739
               ++++H D+KPSN+L+N      + DFG++  ++             NS A    G+
Sbjct: 113 ---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV-------------NSIAKTYVGT 156

Query: 740 IGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLE 799
             YMAPE   G       DV+S GI  +E+   R P   +           KN   G L 
Sbjct: 157 NAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQ----------KN--QGSLM 204

Query: 800 KVIDSSLLRASRDQSPEVKRMWDVAIGELIELGI----LCTQESPSTRPT 845
            +    LL+   D+ P V     + +G+  E  +     C ++ P  RP 
Sbjct: 205 PL---QLLQCIVDEDPPV-----LPVGQFSEKFVHFITQCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 28/221 (12%)

Query: 563 RLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGN--FTKSFNR-EC--QVLKRIRHRNLM 616
           +LLG G++G VY     D G  +AVK +     +   +K  N  EC  Q+LK +RH  ++
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 617 RIITACSLPDFKALVL--PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +       P+ K L +   YM  GS+   L       +G+ + ++T          I +G
Sbjct: 68  QYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-----KAYGALTENVTR----RYTRQILQG 118

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           ++YLH +    ++H D+K +N+L +      + DFG +K + T+ +   G ++       
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS------- 168

Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            + G+  +M+PE   G     K DV+S    V+EM+T + P
Sbjct: 169 -VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 26/219 (11%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK      G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++++      +   LV  ++ +  L   +         S  S + L    +    + +G+
Sbjct: 62  VKLLDVIHTENKLYLVFEFL-HQDLKKFMD-------ASPLSGIPLPLIKSYLFQLLQGL 113

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
           A+ H H   RV+H DLKP N+L+N +    ++DFG+A+     GV       +   T  +
Sbjct: 114 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGV------PVRTYTHEV 161

Query: 736 LCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRR 773
           +  ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 162 V--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 72.3 bits (177), Expect = 3e-13
 Identities = 81/269 (30%), Positives = 130/269 (48%), Gaps = 35/269 (13%)

Query: 166 NSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLN 225
           +SL     L+ L  +G+       + +  L L  L L  N++  +I   +  L+NL SL+
Sbjct: 64  SSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLD 122

Query: 226 LSSNLLSGTISAEISWL-SQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIP 284
           L +N ++  I   I  L S L++L LS N     +P+ L  L +L  LDLSFN LS ++P
Sbjct: 123 LDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLP 179

Query: 285 VSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIF 344
             L NL  + +L L+ N++   +PP +   + L +LDLS N +                 
Sbjct: 180 KLLSNLSNLNNLDLSGNKI-SDLPPEIELLSALEELDLSNNSII---------------- 222

Query: 345 LNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNL 404
                      L   LS L+N+  ++LS+NK   ++   I N   +  +++S+N  Q + 
Sbjct: 223 ----------ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNN--QISS 269

Query: 405 PDSLGDLKNLEAIDVSGNHLSGIIPISLN 433
             SLG L NL  +D+SGN LS  +P+   
Sbjct: 270 ISSLGSLTNLRELDLSGNSLSNALPLIAL 298

Length = 394

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 34/220 (15%)

Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITAC 622
           LG G+ G V K   +  GT +A KV+ + +  +  K   RE Q++   R   ++    A 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIA----EGMAYL 678
              +   + + +M  GSLD         + G           V I   IA    EG+ YL
Sbjct: 73  LNENNICMCMEFMDCGSLDRIY-----KKGGP--------IPVEILGKIAVAVVEGLTYL 119

Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCG 738
           ++    R++H D+KPSN+L+N      + DFG++  ++             NS A+   G
Sbjct: 120 YNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELI-------------NSIADTFVG 164

Query: 739 SIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
           +  YM+PE   G   + K DV+S GI ++E+   + P   
Sbjct: 165 TSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 70.7 bits (174), Expect = 3e-13
 Identities = 62/232 (26%), Positives = 105/232 (45%), Gaps = 43/232 (18%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVK--VLQLQSGNFTKSFNRECQVLKRIR---H 612
           ++E   +G G+YG VYK   L  G  +A+K   + L       S  RE  +LK++    H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 613 RNLMRIITACSLPDFK-----ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI 667
            N++R++  C  P         LV  ++ +  L ++L    +     G    T+    ++
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPK----PGLPPETIK---DL 112

Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
              +  G+ +LH H   R++H DLKP N+L+  D    ++DFG+A++             
Sbjct: 113 MRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY------------ 157

Query: 728 MGNSTANMLCGSI----GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
               +  M   S+     Y APE    S+ +T  D++S G +  E+  RRRP
Sbjct: 158 ----SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRP 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 71.2 bits (174), Expect = 4e-13
 Identities = 83/327 (25%), Positives = 142/327 (43%), Gaps = 69/327 (21%)

Query: 558 EFDEQRL-----LGTGSYGRVYK----GILQDGTA----IAVKVLQLQSGNFTKS-FNRE 603
           E    RL     LG G +G+V      GI +D       +AVK+L+  + +   S    E
Sbjct: 8   ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67

Query: 604 CQVLKRI-RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLY----PHSETEFGS---G 655
            +++K I +H+N++ ++ AC+      +++ Y + G+L  +L     P  +  F +    
Sbjct: 68  MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127

Query: 656 SSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
              LT    V+    +A GM YL   +  + IH DL   NVL+ +D    ++DFG+A+ V
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184

Query: 716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRR- 774
             +       +    +T   L   + +MAPE  F    + + DV+SFG+L+ E+ T    
Sbjct: 185 HNI-------DYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS 235

Query: 775 -----PTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELI 829
                P +++F       K +K  +  R++K  + +                     EL 
Sbjct: 236 PYPGIPVEELF-------KLLKEGH--RMDKPANCT--------------------HELY 266

Query: 830 ELGILCTQESPSTRPTMLDAADDLDRL 856
            +   C    PS RPT     +DLDR+
Sbjct: 267 MIMRECWHAVPSQRPTFKQLVEDLDRV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 69.7 bits (170), Expect = 5e-13
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 22/206 (10%)

Query: 565 LGTGSYGRVYKGILQ-DGTAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMRIITAC 622
           +G G++G V+ G L+ D T +AVK   +    +    F +E ++LK+  H N++R+I  C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
           +      +V+  +  G   + L     TE       L + + + +  + A GM YL    
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFL----RTE----GPRLKVKELIQMVENAAAGMEYLESKH 114

Query: 683 PVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGY 742
               IH DL   N L+ +     +SDFG+++         +  + +  ST  M    + +
Sbjct: 115 ---CIHRDLAARNCLVTEKNVLKISDFGMSR---------EEEDGVYASTGGMKQIPVKW 162

Query: 743 MAPEYGFGSNTSTKGDVYSFGILVLE 768
            APE       S++ DV+SFGIL+ E
Sbjct: 163 TAPEALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 69.6 bits (171), Expect = 5e-13
 Identities = 53/224 (23%), Positives = 89/224 (39%), Gaps = 46/224 (20%)

Query: 565 LGTGSYGRVYKGILQ-DGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNLMRIIT 620
           LG G +GRV    ++      A+K +    +      +    E ++L+   H  ++++  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59

Query: 621 ACSLPDFKAL--VLPYMANGSL-----DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
             +  D K +  ++ Y   G L     D  L+      F                + +  
Sbjct: 60  -RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARF--------------YIACVVL 104

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
              YLH+     +I+ DLKP N+LL+ +    + DFG AK    +  G            
Sbjct: 105 AFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAK---KLKSGQ---------KT 149

Query: 734 NMLCGSIGYMAPE--YGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              CG+  Y+APE     G + S   D +S GIL+ E++T R P
Sbjct: 150 WTFCGTPEYVAPEIILNKGYDFSV--DYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 69.4 bits (170), Expect = 6e-13
 Identities = 66/220 (30%), Positives = 111/220 (50%), Gaps = 26/220 (11%)

Query: 563 RLLGTGSYGRVYKGIL--QDGTAI--AVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           R++G G +G VY G L   DG  I  AVK L ++      + F +E  ++K   H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 618 IITACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++  C LP   +  +VLPYM +G L + +         S + + T+   +     +A+GM
Sbjct: 61  LLGIC-LPSEGSPLVVLPYMKHGDLRNFIR--------SETHNPTVKDLIGFGLQVAKGM 111

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL   +  + +H DL   N +L++  T  V+DFG+A+ +      +    ++ N T   
Sbjct: 112 EYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIY-----DKEYYSVHNHTGAK 163

Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           L   + +MA E       +TK DV+SFG+L+ E++TR  P
Sbjct: 164 L--PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 70.0 bits (171), Expect = 6e-13
 Identities = 69/235 (29%), Positives = 108/235 (45%), Gaps = 37/235 (15%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLM 616
           F+   ++G G+YG+VYKG  ++ G   A+KV+ + + +  +    E  +LK+   HRN+ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TEDEEEEIKLEINMLKKYSHHRNIA 76

Query: 617 RIITAC---SLP---DFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
               A    S P   D   LV+ +   GS+   +     T+  +   D        IC +
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV---KNTKGNALKEDWI----AYICRE 129

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI-AKLVMTVGVGNDGAENMG 729
           I  G+A+LH H   +VIH D+K  NVLL ++    + DFG+ A+L  TVG          
Sbjct: 130 ILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG---------- 176

Query: 730 NSTANMLCGSIGYMAPEY-----GFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
               N   G+  +MAPE         +    + D++S GI  +EM     P  DM
Sbjct: 177 --RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 70.6 bits (173), Expect = 7e-13
 Identities = 59/229 (25%), Positives = 102/229 (44%), Gaps = 40/229 (17%)

Query: 557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFN----RECQVLKRIR 611
           +E +    +G+G+ G VYK I +  G   A+KV+    GN   +      RE ++L+ + 
Sbjct: 74  SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIY---GNHEDTVRRQICREIEILRDVN 130

Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           H N+++            ++L +M  GSL+                        ++   I
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADE-------------QFLADVARQI 177

Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+AYLH      ++H D+KPSN+L+N      ++DFG+++++         A+ M   
Sbjct: 178 LSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRIL---------AQTM--D 223

Query: 732 TANMLCGSIGYMAPE-----YGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
             N   G+I YM+PE        G+     GD++S G+ +LE    R P
Sbjct: 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 71.8 bits (176), Expect = 9e-13
 Identities = 36/89 (40%), Positives = 52/89 (58%), Gaps = 1/89 (1%)

Query: 24  LQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGK 83
           L LD   L G IP  ++ L +L  + L  N++ G +P S   + TSL  +DLS N F G 
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPS-LGSITSLEVLDLSYNSFNGS 481

Query: 84  IPEEIGNCPNLWTLSLYNNQLTGQLPASL 112
           IPE +G   +L  L+L  N L+G++PA+L
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 70.4 bits (172), Expect = 1e-12
 Identities = 76/275 (27%), Positives = 130/275 (47%), Gaps = 23/275 (8%)

Query: 182 MDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISW 241
           ++       ++   + T LLL  +         + + S + SL+ S NLL+         
Sbjct: 42  LESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLL-SPSGISSLDGSENLLN--------- 91

Query: 242 LSQLEQLFLSHNLFSGEIP--AALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLN 299
           L  L  L L+ N     I     L  L  L L + +   +   I +   NL     L L+
Sbjct: 92  LLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNL---KELDLS 148

Query: 300 NNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIE 359
           +N++  S+P  L    +L  LDLS+N L+  +P  +S +  +   L+LS N++   LP E
Sbjct: 149 DNKI-ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNN-LDLSGNKIS-DLPPE 204

Query: 360 LSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDV 419
           +  L  ++E+DLS+N     +   +SN   +  + +S+N L+ +LP+S+G+L NLE +D+
Sbjct: 205 IELLSALEELDLSNNSIIELL-SSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDL 262

Query: 420 SGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPS 454
           S N +S     SL  +  L  ++LS N     +P 
Sbjct: 263 SNNQIS--SISSLGSLTNLRELDLSGNSLSNALPL 295

Length = 394

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 81/327 (24%), Positives = 139/327 (42%), Gaps = 69/327 (21%)

Query: 558 EFDEQRL-----LGTGSYGRVYK----GILQD--GTAIAVKVLQLQSGNFTKSFN---RE 603
           EF   +L     LG G +G+V      GI +D    A+ V V  L+     K  +    E
Sbjct: 11  EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70

Query: 604 CQVLKRI-RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLY----PHSETEFGSG--- 655
            +++K I +H+N++ ++ AC+      +++ Y + G+L  +L     P  E  +      
Sbjct: 71  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130

Query: 656 SSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
              +T    V+    +A GM YL   +  + IH DL   NVL+ ++    ++DFG+A+ V
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDV 187

Query: 716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRR- 774
             +    D  +   N         + +MAPE  F    + + DV+SFG+L+ E+ T    
Sbjct: 188 NNI----DYYKKTTNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 238

Query: 775 -----PTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELI 829
                P +++F       K +K  +  R++K  + +                     EL 
Sbjct: 239 PYPGIPVEELF-------KLLKEGH--RMDKPANCT--------------------NELY 269

Query: 830 ELGILCTQESPSTRPTMLDAADDLDRL 856
            +   C    PS RPT     +DLDR+
Sbjct: 270 MMMRDCWHAIPSHRPTFKQLVEDLDRI 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 58/214 (27%), Positives = 105/214 (49%), Gaps = 27/214 (12%)

Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNLMRIITA 621
           +G G+YG VYKG   + G  +A+K ++L+S       +  RE  +LK ++H N++ +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
                   L+  ++   S+D  L  + ++       D  L++  +    I +G+ + H  
Sbjct: 68  LMQESRLYLIFEFL---SMD--LKKYLDSLPKGQYMDAELVK--SYLYQILQGILFCHSR 120

Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV-MTVGVGNDGAENMGNSTANMLCGSI 740
              RV+H DLKP N+L+++     ++DFG+A+   + V V           T  ++  ++
Sbjct: 121 ---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV----------YTHEVV--TL 165

Query: 741 GYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRR 773
            Y APE   GS   ST  D++S G +  EM T++
Sbjct: 166 WYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 35/217 (16%)

Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G G+YG VYK      G  +A+K ++L  +S    K+  RE ++LK + H N+++++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRV-NICSDIAEGMAYLHH 680
                   LV  +M     D+ LY     +             + +    + +G+A+ H 
Sbjct: 67  FRHKGDLYLVFEFM-----DTDLY-----KLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116

Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
           H    ++H DLKP N+L+N +    ++DFG+A+                 S        +
Sbjct: 117 H---GILHRDLKPENLLINTEGVLKLADFGLARSF--------------GSPVRPYTHYV 159

Query: 741 G---YMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
               Y APE   G    +   D++S G +  E+++RR
Sbjct: 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 72/296 (24%), Positives = 118/296 (39%), Gaps = 67/296 (22%)

Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFN---RECQVLKRIRHRNLMRIIT 620
           +G GS+G VY          +AVK +        + +    +E + L++++H N +    
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY-K 87

Query: 621 ACSLPDFKA-LVLPYM---ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
            C L +  A LV+ Y    A+  L+ H  P  E E  +            I     +G+A
Sbjct: 88  GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA------------ITHGALQGLA 135

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YLH H+   +IH D+K  N+LL +     ++DFG A                  S AN  
Sbjct: 136 YLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS---------------SPANSF 177

Query: 737 CGSIGYMAPEYGFGSNTST---KGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH 793
            G+  +MAPE     +      K DV+S GI  +E+  R+ P  +M A            
Sbjct: 178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----------- 226

Query: 794 YHGRLEKVIDSSLLRASRDQSPEVK-RMWDVAIGELIELGILCTQESPSTRPTMLD 848
                     S+L   +++ SP ++   W  +    ++    C Q+ P  RP   +
Sbjct: 227 ----------SALYHIAQNDSPTLQSNEWTDSFRGFVD---YCLQKIPQERPASAE 269

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 68.4 bits (168), Expect = 2e-12
 Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 27/212 (12%)

Query: 568 GSYGRVY---KGILQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           G+YGRV+   K    D    A+KV+    +   N       E  +L + +   ++++   
Sbjct: 4   GAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-- 59

Query: 622 CSLPDFKAL--VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLH 679
            S    K L  V+ Y+  G L S L   +    GS   D+         ++I   + YLH
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLL--EN---VGSLDEDVA----RIYIAEIVLALEYLH 110

Query: 680 HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS 739
            +    +IH DLKP N+L++ +    ++DFG++K+ +   V      N        + G+
Sbjct: 111 SNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGL---VRRQINLNDDEKEDKRIVGT 164

Query: 740 IGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
             Y+APE   G   S   D +S G ++ E + 
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 31/216 (14%)

Query: 565 LGTGSYGRVYKGILQD---GTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNLMRII 619
           +G G+YG VYK   +D      IA+K ++L+  +     +  RE  +LK ++H N++R+ 
Sbjct: 10  IGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67

Query: 620 TACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLH 679
                     LV  Y+    LD   +  S  +F   + +  L++       I  G+AY H
Sbjct: 68  DVVHSEKRLYLVFEYL---DLDLKKHMDSSPDF---AKNPRLIK--TYLYQILRGIAYCH 119

Query: 680 HHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGNSTANMLCG 738
            H   RV+H DLKP N+L++    AL ++DFG+A+           A  +   T      
Sbjct: 120 SH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR-----------AFGIPVRTFTHEVV 165

Query: 739 SIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRR 773
           ++ Y APE   GS   ST  D++S G +  EMV ++
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 64/233 (27%), Positives = 105/233 (45%), Gaps = 43/233 (18%)

Query: 559 FDEQRLLGTGSYGRVY---KGILQD-GTAIAVKVLQ----LQSGNFTKSFNRECQVLKRI 610
           F+  ++LGTG+YG+V+   K    D G   A+KVL+    +Q    T+    E QVL+ I
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 611 RHRNLMRIITACSLPDFKA-LVLPYMANGSLDSHL-----YPHSETEFGSGSSDLTLLQR 664
           R    +  +      D K  L+L Y+  G L +HL     +   E +  SG         
Sbjct: 62  RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG--------- 112

Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
                +I   + +LH    + +I+ D+K  N+LL+ +   +++DFG++K           
Sbjct: 113 -----EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE------- 157

Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG--DVYSFGILVLEMVTRRRP 775
                   A   CG+I YMAP+   G +       D +S G+L+ E++T   P
Sbjct: 158 ---DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 50/222 (22%), Positives = 97/222 (43%), Gaps = 30/222 (13%)

Query: 565 LGTGSYGRVYK-GILQDGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G G++G V+K    + G  +A+K + L+   G       RE + L+  +H  +++++  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
                   LV+ YM    L S +    E           +         + +G+AY+H +
Sbjct: 68  FPHGSGFVLVMEYMP-SDL-SEVLRDEERPLPEAQVKSYMRM-------LLKGVAYMHAN 118

Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIG 741
               ++H DLKP+N+L++ D    ++DFG+A+L        +      +        +  
Sbjct: 119 ---GIMHRDLKPANLLISADGVLKIADFGLARL-----FSEEEPRLYSHQ-----VATRW 165

Query: 742 YMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAG 782
           Y APE  +G+     G D+++ G +  E++    P   +F G
Sbjct: 166 YRAPELLYGARKYDPGVDLWAVGCIFAELL-NGSP---LFPG 203

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 55/195 (28%), Positives = 85/195 (43%), Gaps = 40/195 (20%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQ---LQSGNFTKSFNRECQVL-KRIRHRNLMR 617
           +++G GS+G+V       DG   AVKVLQ   +      K    E  VL K ++H  L+ 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 618 IITACSLPDFKALVLPYMANGSLDSHL-----YPHSETEFGSGSSDLTLLQRVNICSDIA 672
           +  +    D    VL Y+  G L  HL     +P     F                ++IA
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF--------------YAAEIA 106

Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM-GNS 731
             + YLH    + +I+ DLKP N+LL+     +++DFG+ K            E +  + 
Sbjct: 107 SALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK------------EGIEHSK 151

Query: 732 TANMLCGSIGYMAPE 746
           T +  CG+  Y+APE
Sbjct: 152 TTSTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 59/227 (25%), Positives = 93/227 (40%), Gaps = 38/227 (16%)

Query: 559 FDEQRLLGTGSYGRVYK-GILQDGTAIAVKVLQLQSGNFTKSFN--RECQVLKRIRHRNL 615
           F   + LG GSYG VYK   L D    A+K + L S +  +  +   E ++L  + H N+
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61

Query: 616 MR----IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS-- 669
           +      +    L     +V+ Y   G L   +    +           L+    I    
Sbjct: 62  ISYKEAFLDGNKL----CIVMEYAPFGDLSKAISKRKKKR--------KLIPEQEIWRIF 109

Query: 670 -DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
             +  G+  LH     +++H DLK +N+LL  +    + D GI+K+             +
Sbjct: 110 IQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKV-------------L 153

Query: 729 GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
             + A    G+  YMAPE   G   S K D++S G L+ EM T   P
Sbjct: 154 KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 69.1 bits (169), Expect = 2e-12
 Identities = 83/326 (25%), Positives = 140/326 (42%), Gaps = 59/326 (18%)

Query: 563 RLLGTGSYGRVYKGILQDGTA----IAVKVLQ----LQSGNFTKSFNRECQVLKRIRHRN 614
           ++LG G YG+V++     G       A+KVL+    +++   T     E  +L+ ++H  
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           ++ +I A        L+L Y++ G L  HL    E  F   ++   L       S+I+  
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHL--EREGIFMEDTACFYL-------SEISLA 112

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           + +LH      +I+ DLKP N+LL+      ++DFG+ K                 +  +
Sbjct: 113 LEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK-----------ESIHEGTVTH 158

Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT---------RRRPTDDMFAGGLS 785
             CG+I YMAPE    S      D +S G L+ +M+T         R++  D +  G L+
Sbjct: 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN 218

Query: 786 LHKWVKNHYHGRLEKVID---SSLLRASRDQSPEVKRM-------WDVAIGELIELGI-- 833
           L  ++       L+K++    SS L A    + EV+         WD  +   +E     
Sbjct: 219 LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKP 278

Query: 834 -LCTQESPS------TRPTMLDAADD 852
            L ++E  S      TR T +D+ DD
Sbjct: 279 LLQSEEDVSQFDSKFTRQTPVDSPDD 304

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 69.2 bits (169), Expect = 2e-12
 Identities = 64/233 (27%), Positives = 106/233 (45%), Gaps = 42/233 (18%)

Query: 558 EFDEQRLLGTGSYGRVY---KGILQD-GTAIAVKVLQ----LQSGNFTKSFNRECQVLKR 609
            F+  ++LGTG+YG+V+   K    D G   A+KVLQ    +Q     +    E  VL+ 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 610 IRHRNLMRIITACSLPDFKA-LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNIC 668
           +R    +  +      + K  L+L Y++ G + +HLY                 QR N  
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-----------------QRDNFS 103

Query: 669 SD-----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
            D       E +  L H   + +++ D+K  N+LL+ +   +++DFG++K  ++      
Sbjct: 104 EDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS------ 157

Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRP 775
             E    + +   CG+I YMAPE   G     K  D +S GIL+ E++T   P
Sbjct: 158 --EEKERTYS--FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 69.2 bits (170), Expect = 2e-12
 Identities = 63/240 (26%), Positives = 97/240 (40%), Gaps = 58/240 (24%)

Query: 554 EATAEFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQ--LQSGNFTKSFNRECQVLKRI 610
           E    +     +G+G+YG+V        G  +A+K L    QS    K   RE ++LK +
Sbjct: 12  EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM 71

Query: 611 RHRN---LMRIIT-ACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
            H N   L+ + T A SL DF+   LV   M                     +DL  + +
Sbjct: 72  DHENVIGLLDVFTPASSLEDFQDVYLVTHLMG--------------------ADLNNIVK 111

Query: 665 VNICSD---------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
               SD         I  G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+  
Sbjct: 112 CQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168

Query: 716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPE--YGFGSNTSTKGDVYSFGILVLEMVTRR 773
                     + M    A        Y APE    +     T  D++S G ++ E++T +
Sbjct: 169 ---------DDEMTGYVATRW-----YRAPEIMLNWMHYNQTV-DIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 55/230 (23%), Positives = 96/230 (41%), Gaps = 33/230 (14%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQ-------VLKR 609
           +++    +G GS+G V K     DG  +  K  ++  GN T    +E Q       +L+ 
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWK--EIDYGNMT---EKEKQQLVSEVNILRE 55

Query: 610 IRHRNLMRIITACSLPDFKAL--VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI 667
           ++H N++R          + L  V+ Y   G L + L    + E      +        I
Sbjct: 56  LKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDL-AQLIQKCKKERKYIEEEFIW----RI 110

Query: 668 CSDIAEGMAYLHHHSPV--RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGA 725
            + +   +   H+ S     V+H DLKP+N+ L+ +    + DFG+AK++          
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL---------- 160

Query: 726 ENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
               +S A    G+  YM+PE     +   K D++S G L+ E+     P
Sbjct: 161 -GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 69.2 bits (169), Expect = 3e-12
 Identities = 85/305 (27%), Positives = 130/305 (42%), Gaps = 26/305 (8%)

Query: 29  NNLHGQIPESLALLSNLTLVTLHDNN-LTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEE 87
           +N    +P SL+ L +L L++    + L G        N   L ++DL+ N     I E 
Sbjct: 56  SNTLLLLPSSLSRLLSLDLLSPSGISSLDG---SENLLNLLPLPSLDLNLNRLRSNISE- 111

Query: 88  IGNCPNLWTLSLYNNQLTGQLPASLINTSM--YNLDVEYNHLSGELPSDIMSKLPSLTYL 145
           +    NL +L L NN +T  +P  +         LD+  N +   LPS +   LP+L  L
Sbjct: 112 LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPL-RNLPNLKNL 168

Query: 146 HLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQEN 205
            LS+N++               L N ++L  L+L+G  +   LP  I  L+  + L   N
Sbjct: 169 DLSFNDLSD---------LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSN 218

Query: 206 KITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGK 265
                +   + NL NL  L LS+N L     +  +  + LE L LS+N       ++LG 
Sbjct: 219 NSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSN-LETLDLSNNQ--ISSISSLGS 275

Query: 266 LHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYN 325
           L +L  LDLS N LS  +P+       +  L L  N L       L   + L   ++  N
Sbjct: 276 LTNLRELDLSGNSLSNALPLIAL---LLLLLELLLNLLLTLKALELKLNSILLNNNILSN 332

Query: 326 RLTGS 330
             T S
Sbjct: 333 GETSS 337

Length = 394

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 39/226 (17%)

Query: 557 AEFDEQRLLGTGSYGRVYKG-ILQDGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHR 613
            EF++   +G G+YG VY+      G  +A+K +++  +      S  RE  +L  +RH 
Sbjct: 7   TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66

Query: 614 N---LMRIITACSLPDFKALVLPY----MANGSLDSHLYPHSETEFGSGSSDLTLLQRVN 666
           N   L  ++    L D   LV+ Y    +A+  LD+   P SE++               
Sbjct: 67  NIVELKEVVVGKHL-DSIFLVMEYCEQDLAS-LLDNMPTPFSESQVKC------------ 112

Query: 667 ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
           +   +  G+ YLH +    +IH DLK SN+LL D     ++DFG+A+           A+
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP------AK 163

Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVT 771
            M   T  ++  ++ Y APE   G  T T   D+++ G ++ E++ 
Sbjct: 164 PM---TPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLA 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 61/241 (25%), Positives = 109/241 (45%), Gaps = 42/241 (17%)

Query: 558 EFDEQRL-----LGTGSYGRVY----KGIL---------QDGTAIAVKVLQLQS---GNF 596
           EF  Q+L     LG G +G V+    +G+           DG  + V V  L++      
Sbjct: 1   EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA 60

Query: 597 TKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSG- 655
              F +E +++ R+++ N++R++  C   D   ++  YM NG L+  L   S+ E  S  
Sbjct: 61  RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL---SQREIESTF 117

Query: 656 --SSDLTLLQRVNI---CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG 710
             ++++  +   N+      IA GM YL   + +  +H DL   N L+ +  T  ++DFG
Sbjct: 118 THANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFG 174

Query: 711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
           +++ + +     D     G +        I +MA E       +T  DV++FG+ + EM 
Sbjct: 175 MSRNLYS----GDYYRIQGRAVL-----PIRWMAWESILLGKFTTASDVWAFGVTLWEMF 225

Query: 771 T 771
           T
Sbjct: 226 T 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 36/221 (16%)

Query: 557 AEFDEQRLLGTGSYGRVYKGILQD---GTAIAVKVLQLQ---SGNFTKSFNRECQVLKRI 610
            + +  + +GTG++GRV+   ++D       A+KV+ +         +  + E +VLK +
Sbjct: 1   DDLERIKTVGTGTFGRVHL--VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV 58

Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
            H  ++R+        F  +++ Y+  G L S+L   +   F + +            S+
Sbjct: 59  SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLF-------YASE 109

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I   + YLH      +++ DLKP N+LL+ +    ++DFG AK +               
Sbjct: 110 IVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLR-------------- 152

Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
                LCG+  Y+APE    S    K  D ++ GIL+ EM+
Sbjct: 153 DRTWTLCGTPEYLAPEV-IQSKGHNKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 26/221 (11%)

Query: 559 FDEQRLLGTGSYGRVYK-GILQDGTAIAVKVLQLQSGNFTKSFN---RECQVLKRIRHRN 614
           F + R+LG G +G V    +   G   A K L+ +     K  +    E Q+L+++  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           ++ +  A    D   LVL  M  G L  H+Y      F     +  L     I      G
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF---EEERALFYAAEILC----G 114

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           +  LH  +    ++ DLKP N+LL+D     +SD G+A  +       +G    G     
Sbjct: 115 LEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKI------PEGESIRGR---- 161

Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              G++GYMAPE       +   D +  G L+ EM+  + P
Sbjct: 162 --VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 66.6 bits (163), Expect = 5e-12
 Identities = 59/216 (27%), Positives = 84/216 (38%), Gaps = 30/216 (13%)

Query: 564 LLGTGSYGRVYKGILQD--GTAIAVKVLQLQSGNFTK---SFNRECQVLKRIRHRNLMR- 617
            LG GS+G V +G      G  I V V  L+S   +     F +E  ++  + H NL+R 
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 618 --IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
             ++    L     +V      GSL   L   +   F      ++ L   +    IA GM
Sbjct: 62  YGVVLTHPL----MMVTELAPLGSLLDRLRKDALGHF-----LISTL--CDYAVQIANGM 110

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL      R IH DL   N+LL  D    + DFG   L+  +    D          + 
Sbjct: 111 RYLESK---RFIHRDLAARNILLASDDKVKIGDFG---LMRALPQNED----HYVMEEH- 159

Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           L     + APE       S   DV+ FG+ + EM T
Sbjct: 160 LKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 71/290 (24%), Positives = 121/290 (41%), Gaps = 52/290 (17%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLM 616
           F +   +G GS+G V+KGI  +    +A+K++ L+   +  +   +E  VL +     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 617 RIITACSLPDFKA-LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +   +  L D K  +++ Y+  GS    L P        G  D T  Q   I  +I +G+
Sbjct: 66  KYYGS-YLKDTKLWIIMEYLGGGSALDLLEP--------GPLDET--QIATILREILKGL 114

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH     + IH D+K +NVLL++     ++DFG+A  +    +             N 
Sbjct: 115 DYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-----------NT 160

Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH 795
             G+  +MAPE    S   +K D++S GI  +E+     P                   H
Sbjct: 161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP-------------------H 201

Query: 796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
             L  +    L    ++  P ++  +   + E +E    C  + PS RPT
Sbjct: 202 SELHPM--KVLFLIPKNNPPTLEGNYSKPLKEFVE---ACLNKEPSFRPT 246

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 67.7 bits (165), Expect = 5e-12
 Identities = 66/241 (27%), Positives = 110/241 (45%), Gaps = 34/241 (14%)

Query: 553 LEATAEFDEQRL-----LGTGSYGRVYK----GILQD----GTAIAVKVLQLQSGNFTKS 599
           L+   EF   RL     LG G +G+V +    GI +        +AVK+L+  + +   +
Sbjct: 3   LDPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLA 62

Query: 600 -FNRECQVLKRI-RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLY----PHSETEFG 653
               E +++K I +H+N++ ++  C+      +++ Y A G+L   L     P  +  F 
Sbjct: 63  DLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFD 122

Query: 654 ---SGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG 710
                   L+    V+    +A GM YL      R IH DL   NVL+ +D    ++DFG
Sbjct: 123 ITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFG 179

Query: 711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
           +A+ V  +    D  +   N         + +MAPE  F    + + DV+SFGIL+ E+ 
Sbjct: 180 LARGVHDI----DYYKKTSNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGILMWEIF 230

Query: 771 T 771
           T
Sbjct: 231 T 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 67.3 bits (165), Expect = 5e-12
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 30/224 (13%)

Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNLMRII-T 620
           LG G++G VYK   ++ G  +A+K + + +    F  +  RE ++LK+++H N++ +I  
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 621 ACSLPDFKA-------LVLPYMA---NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           A   PD          +V PYM    +G L++             S  LT  Q       
Sbjct: 76  AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP------------SVKLTESQIKCYMLQ 123

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           + EG+ YLH +    ++H D+K +N+L+++     ++DFG+A+          G    G 
Sbjct: 124 LLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGT 180

Query: 731 STANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRR 773
                L  +  Y  PE   G    +T  D++  G +  EM TRR
Sbjct: 181 RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 67.0 bits (164), Expect = 6e-12
 Identities = 64/222 (28%), Positives = 110/222 (49%), Gaps = 36/222 (16%)

Query: 562 QRL--LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNLM 616
           Q++  +G G+YG VYK      G  +A+K ++L++ +     +  RE  +LK + H N++
Sbjct: 2   QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIV 61

Query: 617 R---IITACSLPDFKA-LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIA 672
           R   ++ +    + K  LV  +     LD  L  + ++       D  L++       + 
Sbjct: 62  RLLDVVHS----ENKLYLVFEF-----LDLDLKKYMDS-SPLTGLDPPLIKS--YLYQLL 109

Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+AY H H   RV+H DLKP N+L++ +    ++DFG+A+     GV       +   T
Sbjct: 110 QGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR---AFGV------PVRTYT 157

Query: 733 ANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRR 773
             ++  ++ Y APE   GS   ST  D++S G +  EMV RR
Sbjct: 158 HEVV--TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 66.9 bits (163), Expect = 6e-12
 Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 31/226 (13%)

Query: 562 QRLLGTGSYGRVYKGILQ----DGTAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNLM 616
           +R+LGTG +G + +G L+        +A+  L+   S    + F  E   L +  H N++
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           R+    +  +   +V  YM+NG+LDS L  H           L   Q + +   +A GM 
Sbjct: 70  RLEGVITRGNTMMIVTEYMSNGALDSFLRKH--------EGQLVAGQLMGMLPGLASGMK 121

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL   S +  +H  L    VL+N D+   +S F                E+   +    +
Sbjct: 122 YL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR------------RLQEDKSEAIYTTM 166

Query: 737 CGS--IGYMAPEYGFGSNTSTKGDVYSFGILVLE-MVTRRRPTDDM 779
            G   + + APE     + S+  DV+SFGI++ E M    RP  DM
Sbjct: 167 SGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 67.1 bits (164), Expect = 8e-12
 Identities = 55/229 (24%), Positives = 92/229 (40%), Gaps = 38/229 (16%)

Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQ--SGNFTKSFN------------RECQVLKR 609
           LG G+YG+V K      G  +A+K +++   S + TK               RE +++  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 610 IRHRNLMRIITACSLPDFKALVLPYMANG---SLDSHLYPHSETEFGSGSSDLTLLQRVN 666
           I+H N+M ++      DF  LV+  MA+     +D  +              LT  Q   
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIR-------------LTESQVKC 123

Query: 667 ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA-KLVMTVGVGNDGA 725
           I   I  G+  LH       +H DL P+N+ +N      ++DFG+A +            
Sbjct: 124 ILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180

Query: 726 ENMGNSTANMLCG--SIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVT 771
           +        M     ++ Y APE   G+       D++S G +  E++T
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229

Length = 335

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 66.6 bits (162), Expect = 8e-12
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 26/223 (11%)

Query: 559 FDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLM 616
           F +   +G GS+G VYKGI  +    +A+K++ L+   +  +   +E  VL +     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           R   +        +++ Y+  GS    L P        G  + T +    I  +I +G+ 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKP--------GPLEETYI--ATILREILKGLD 115

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YLH     R IH D+K +NVLL++     ++DFG+A  +    +             N  
Sbjct: 116 YLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR-----------NTF 161

Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
            G+  +MAPE    S    K D++S GI  +E+     P  D+
Sbjct: 162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 66.2 bits (161), Expect = 9e-12
 Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 34/225 (15%)

Query: 562 QRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIIT 620
           QR+ G+G+YG VYK   L  G   AVK+++L+ G+      +E  ++K  +H N++    
Sbjct: 15  QRV-GSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73

Query: 621 ACSLPDFKALVLPYMANGSLDS--HLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
           +    +   + + Y   GSL    H+           +  L+ LQ   +C +  +G+AYL
Sbjct: 74  SYLSREKLWICMEYCGGGSLQDIYHV-----------TGPLSELQIAYVCRETLQGLAYL 122

Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI-AKLVMTVGVGNDGAENMGNSTANMLC 737
           H       +H D+K +N+LL D+    ++DFG+ AK+  T+            +      
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATI------------AKRKSFI 167

Query: 738 GSIGYMAPEYGFGSNTSTKG---DVYSFGILVLEMVTRRRPTDDM 779
           G+  +MAPE              D+++ GI  +E+   + P  D+
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 68.0 bits (166), Expect = 1e-11
 Identities = 75/301 (24%), Positives = 128/301 (42%), Gaps = 59/301 (19%)

Query: 563 RLLGTGSYGRV-YKGILQDGTAIAVKVLQLQSGNFTKSFNR---ECQVLKRIRHRNLMRI 618
           R+LG+G+ G V     + DG   AVKV+ ++ G      NR   E   L      ++++ 
Sbjct: 38  RVLGSGATGTVLCAKRVSDGEPFAVKVVDME-GMSEADKNRAQAEVCCLLNCDFFSIVK- 95

Query: 619 ITACSLPDFK-------------ALVLPYMANGSLDSHLYPHSETE--FGSGSSDLTLLQ 663
              C   DF              ALVL Y   G L   +   ++T   F    + L  +Q
Sbjct: 96  ---CH-EDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151

Query: 664 RVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
            +         +A  H HS   +IH D+K +N+LL  +    + DFG +K+         
Sbjct: 152 VL---------LAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKMY-------- 193

Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGG 783
            A  + +      CG+  Y+APE       S K D++S G+L+ E++T +RP D     G
Sbjct: 194 -AATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD-----G 247

Query: 784 LSLHKWVKNHYHGRLEKV----------IDSSLLRASRDQSPEVKRMWDVAIGELIELGI 833
            ++ + +     GR + +          I ++LL +   + P   ++ ++ I +L   G+
Sbjct: 248 ENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGL 307

Query: 834 L 834
           L
Sbjct: 308 L 308

Length = 496

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 66.5 bits (162), Expect = 1e-11
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 25/212 (11%)

Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           +G G+ G VY  I +  G  +A+K + LQ     +    E  V++  +H N++  + +  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
           + D   +V+ Y+A GSL   +   +ET    G       Q   +C +  + + +LH +  
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV---TETCMDEG-------QIAAVCRECLQALEFLHSN-- 134

Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
            +VIH D+K  N+LL  D +  ++DFG    +          E    ST   + G+  +M
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--------PEQSKRST---MVGTPYWM 182

Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           APE         K D++S GI+ +EMV    P
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 66.8 bits (163), Expect = 1e-11
 Identities = 66/262 (25%), Positives = 107/262 (40%), Gaps = 69/262 (26%)

Query: 557 AEFDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQLQSGNFTKS---FNRECQVLKR 609
           ++F+    LGTGS+GRV    +KG    G   A+K L+ +     K      +E  +L  
Sbjct: 18  SDFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILME 74

Query: 610 IRHRNLMRIITACSLPDFKAL--VLPYMANGSLDSHL-----YPHSETEFGSGSSDLTLL 662
           + H  ++ ++  CS  D   +  +L ++  G L +HL     +P+   +F          
Sbjct: 75  LSHPFIVNMM--CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF---------- 122

Query: 663 QRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGN 722
                 +++     YLH      +I+ DLKP N+LL++     V+DFG AK V       
Sbjct: 123 ----YHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV------- 168

Query: 723 DGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-----DVYSFGILVLEMVTRRRPTD 777
                        LCG+  Y+APE        +KG     D ++ G+L+ E +    P  
Sbjct: 169 -------PDRTFTLCGTPEYLAPEV-----IQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216

Query: 778 D---------MFAGGLSLHKWV 790
           D         + AG L    W 
Sbjct: 217 DDTPFRIYEKILAGRLKFPNWF 238

Length = 329

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 78/309 (25%), Positives = 133/309 (43%), Gaps = 52/309 (16%)

Query: 565 LGTGSYGRVYK----GILQDG----TAIAVKVLQLQSGNFTKS-FNRECQVLKRI-RHRN 614
           LG G +G+V      G+ ++     T +AVK+L+  +     S    E +++K I +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY----PHSETEFGSGSSDLTLLQRVNICS- 669
           ++ ++ AC+      +++ Y + G+L  +L     P  E  +         L   ++ S 
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 670 --DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
              +A GM YL   +  + IH DL   NVL+ +D    ++DFG+A+ +  +       + 
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI-------DY 195

Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH 787
              +T   L   + +MAPE  F    + + DV+SFG+L+ E+ T          GG    
Sbjct: 196 YKKTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT---------LGG---- 240

Query: 788 KWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTML 847
               + Y G   + +   L    R   P           EL  +   C    PS RPT  
Sbjct: 241 ----SPYPGVPVEELFKLLKEGHRMDKPS------NCTNELYMMMRDCWHAVPSQRPTFK 290

Query: 848 DAADDLDRL 856
              +DLDR+
Sbjct: 291 QLVEDLDRI 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 55/221 (24%), Positives = 103/221 (46%), Gaps = 35/221 (15%)

Query: 563 RLLGTGSYGRVYK----GILQDGTAIAVKVLQLQS---GNFTKSFNRECQVLKRI-RHRN 614
           + LG G++G+V +    G+ +    + V V  L+     +  ++   E +++  +  H N
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           ++ ++ AC++     ++  Y   G L + L    E       S LTL   ++    +A+G
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE-------SFLTLEDLLSFSYQVAKG 153

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           MA+L   +    IH DL   NVLL       + DFG+A+ +M             N +  
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIM-------------NDSNY 197

Query: 735 MLCGS----IGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           ++ G+    + +MAPE  F    + + DV+S+GIL+ E+ +
Sbjct: 198 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 66.3 bits (161), Expect = 1e-11
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 25/212 (11%)

Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           +G G+ G VY  I +  G  +A+K + LQ     +    E  V++  ++ N++  + +  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
           + D   +V+ Y+A GSL   +   +ET    G       Q   +C +  + + +LH +  
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV---TETCMDEG-------QIAAVCRECLQALDFLHSN-- 134

Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
            +VIH D+K  N+LL  D +  ++DFG    +          E    ST   + G+  +M
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--------PEQSKRST---MVGTPYWM 182

Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           APE         K D++S GI+ +EMV    P
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 65/284 (22%), Positives = 121/284 (42%), Gaps = 39/284 (13%)

Query: 557 AEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRH 612
           A F  ++ +G G +  VY+   L DG  +A+K +Q   L          +E  +LK++ H
Sbjct: 2   ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61

Query: 613 RNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIA 672
            N+++   +    +   +VL     G L S +  H + +             V +CS   
Sbjct: 62  PNVIKYYASFIEDNELNIVLELADAGDL-SRMIKHFKKQKRLIPEKTVWKYFVQLCS--- 117

Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
              A  H HS  RV+H D+KP+NV +       + D G+ +   +             + 
Sbjct: 118 ---ALEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-----------KTTA 162

Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK- 791
           A+ L G+  YM+PE    +  + K D++S G L+ EM   + P    +   ++L+   K 
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKK 219

Query: 792 -----------NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVA 824
                      +HY   L ++++   +    ++ P++  ++DVA
Sbjct: 220 IEQCDYPPLPSDHYSEELRQLVNMC-INPDPEKRPDITYVYDVA 262

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 35/222 (15%)

Query: 563 RLLGTGSYGRVY---KGILQD-GTAIAVKVLQLQSGNFTKSFNR-----ECQVLKRIRHR 613
           ++LG GS+G+V+   K    D G   A+KVL+  +    K  +R     E  +L  + H 
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHP 58

Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
            ++++  A        L+L ++  G L + L    E  F        L       +++A 
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYL-------AELAL 109

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + +LH    + +I+ DLKP N+LL+++    ++DFG++K  +                A
Sbjct: 110 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID-----------HEKKA 155

Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              CG++ YMAPE       +   D +SFG+L+ EM+T   P
Sbjct: 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 42/229 (18%)

Query: 559 FDEQRLLGTGSYGRVYK-GILQDGTAIAVKVLQLQSGNFTK----SFNRECQVLKRIRHR 613
           F   R+LG G +G V    +   G   A K L+ +     K    + N E Q+L+++  R
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-EKQILEKVNSR 60

Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI-CSDIA 672
            ++ +  A    D   LVL  M  G L  H+Y      F          +R     ++I 
Sbjct: 61  FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE--------ERAVFYAAEIT 112

Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
            G+  LH     R+++ DLKP N+LL+D     +SD G+A     V +           T
Sbjct: 113 CGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLA-----VEIPE-------GET 157

Query: 733 ANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                G++GYMAPE      Y F        D +  G L+ EM+  + P
Sbjct: 158 IRGRVGTVGYMAPEVVKNERYTFSP------DWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 67.5 bits (165), Expect = 2e-11
 Identities = 64/232 (27%), Positives = 101/232 (43%), Gaps = 28/232 (12%)

Query: 563 RLLGTGSYGRVYKGILQD---GTAIAVKVLQLQ-SGN--FTKSFNRECQVLKRIRHRNLM 616
           RL+G G  G VY     D      +A+K ++   S N    K F RE ++   + H  ++
Sbjct: 8   RLIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRV----NICSDIA 672
            + + CS  D     +PY+   +L S L    + E  S S +L     V    +I   I 
Sbjct: 66  PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKE--SLSKELAEKTSVGAFLSIFHKIC 123

Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK---------LVMTVGVGND 723
             + Y+H      V+H DLKP N+LL      ++ D+G A          L + V   N 
Sbjct: 124 ATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              +M  +    + G+  YMAPE   G   S   D+Y+ G+++ +M+T   P
Sbjct: 181 CYSSM--TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 31/220 (14%)

Query: 565 LGTGSYGRVYKGILQDGTAIA-VKVLQLQSGNFTK---SFNRECQVLKRIRHRNLMRIIT 620
           +G G +G+V  G    G + A V V +L++         F +E Q  + + H N+++ + 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 621 AC--SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
            C  S+P    LVL +   G L ++L   S     +  +   +LQR  +  ++A G+ +L
Sbjct: 63  QCIESIPYL--LVLEFCPLGDLKNYL--RSNRGMVAQMAQKDVLQR--MACEVASGLLWL 116

Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCG 738
           H       IH DL   N  L  D++  + D+G+A          D        T +    
Sbjct: 117 HQAD---FIHSDLALRNCQLTADLSVKIGDYGLA----LEQYPEDYYI-----TKDCHAV 164

Query: 739 SIGYMAPEY--GFGSNTST-----KGDVYSFGILVLEMVT 771
            + ++APE     G +        K +++S G+ + E+ T
Sbjct: 165 PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 67.2 bits (164), Expect = 3e-11
 Identities = 59/261 (22%), Positives = 111/261 (42%), Gaps = 36/261 (13%)

Query: 579 QDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRHRNLMRII-TACSLPDFKALVLPY 634
             G  +A+K+L+    +  +    F RE  +  R+ H N++ ++ +  + P     V  Y
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPS 694
           +   +L   L   ++    +G +   +LQ       + + +A  H+     ++H DLKP 
Sbjct: 61  VPGRTLREVL--AADGALPAGETGRLMLQ-------VLDALACAHNQG---IVHRDLKPQ 108

Query: 695 NVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS 751
           N+++        A V DFGI  L+  V    D        T  +L G+  Y APE   G 
Sbjct: 109 NIMVSQTGVRPHAKVLDFGIGTLLPGVR---DADVATLTRTTEVL-GTPTYCAPEQLRGE 164

Query: 752 NTSTKGDVYSFGILVLEMVTRRR-----PTDDMFAGGLS-----LHKWVKNHYHGRLEKV 801
             +   D+Y++G++ LE +T +R        ++    LS     L  W+  H    L +V
Sbjct: 165 PVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGH---PLGQV 221

Query: 802 IDSSLLRASRDQSPEVKRMWD 822
           +  +L +  R ++     + +
Sbjct: 222 LRKALNKDPRQRAASAPALAE 242

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 59/240 (24%), Positives = 110/240 (45%), Gaps = 39/240 (16%)

Query: 558 EFDEQRL-----LGTGSYGRVY----KGILQ-------------DGTAIAVKVLQLQSG- 594
           EF  +RL     LG G +G V+    +G+ +                 +AVK+L+  +  
Sbjct: 1   EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60

Query: 595 NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGS 654
           N    F +E +++ R++  N++R++  C   D   ++  YM NG L+  L  H E +  +
Sbjct: 61  NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRH-EPQEAA 119

Query: 655 GSSDLTLLQRVNIC---SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI 711
             +D+  +    +    + IA GM YL   S +  +H DL   N L+  + T  ++DFG+
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGM 176

Query: 712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           ++ + +     D     G +        I +M+ E       +T  DV++FG+ + E++T
Sbjct: 177 SRNLYS----GDYYRIQGRAVL-----PIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 65.3 bits (159), Expect = 4e-11
 Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 39/232 (16%)

Query: 550 RELLEATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQV 606
           + + E    +   + +G+G+YG V   I  + G  +A+K L    QS  F K   RE  +
Sbjct: 8   KTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTL 67

Query: 607 LKRIRHRNLMRII----TACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLT 660
           LK ++H N++ ++    +A S  +F+   LV+PYM         +P SE +       + 
Sbjct: 68  LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK-------VQ 120

Query: 661 LLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGV 720
            L    +C     G+ Y+H      +IH DLKP N+ +N+D    + DFG+A+       
Sbjct: 121 YLVYQMLC-----GLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR------- 165

Query: 721 GNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVT 771
            +  AE  G            Y APE         +  D++S G ++ EM+T
Sbjct: 166 -HADAEMTGYVVTRW------YRAPEVILNWMHYNQTVDIWSVGCIMAEMLT 210

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 64.7 bits (157), Expect = 4e-11
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 30/218 (13%)

Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G++G+VYK   ++ G   A KV++ +S    + +  E ++L    H  +++++ A  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +++ +   G++D+ +      E   G   LT  Q   IC  + E + YLH    
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIML-----ELDRG---LTEPQIQVICRQMLEALQYLH---S 128

Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGI-AKLVMTVGVGNDGAENMGNSTANMLCGSIGY 742
           +++IH DLK  NVLL  D    ++DFG+ AK V T+               +   G+  +
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL------------QRRDSFIGTPYW 176

Query: 743 MAPEYGF-----GSNTSTKGDVYSFGILVLEMVTRRRP 775
           MAPE         +    K D++S GI ++EM     P
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 4e-11
 Identities = 61/253 (24%), Positives = 104/253 (41%), Gaps = 57/253 (22%)

Query: 552 LLEATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI 610
           L + T  F+   ++G G+YG+VYK    + G  +A+K++ +      +    E  +L++ 
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKY 59

Query: 611 -RHRNLMRIITACSLPDFKA------LVLPYMANGSLDSHLYPHSETEFGSGSSDL--TL 661
             H N+     A    +         LV+     GS+                +DL   L
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV----------------TDLVKGL 103

Query: 662 LQRVN---------ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI- 711
            ++           I  +   G+AYLH +   +VIH D+K  N+LL  +    + DFG+ 
Sbjct: 104 RKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVS 160

Query: 712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPE-----YGFGSNTSTKGDVYSFGILV 766
           A+L  T+G  N               G+  +MAPE         ++   + DV+S GI  
Sbjct: 161 AQLDSTLGRRNTFI------------GTPYWMAPEVIACDEQPDASYDARSDVWSLGITA 208

Query: 767 LEMVTRRRPTDDM 779
           +E+   + P  DM
Sbjct: 209 IELADGKPPLCDM 221

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 26/223 (11%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLM 616
           F +   +G GS+G V+KGI  +    +A+K++ L+   +  +   +E  VL +     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           +   +        +++ Y+  GS    L      EF          Q   +  +I +G+ 
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEF----------QIATMLKEILKGLD 115

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YLH     + IH D+K +NVLL++     ++DFG+A  +    +             N  
Sbjct: 116 YLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR-----------NTF 161

Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
            G+  +MAPE    S   +K D++S GI  +E+     P  DM
Sbjct: 162 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (158), Expect = 4e-11
 Identities = 64/213 (30%), Positives = 95/213 (44%), Gaps = 31/213 (14%)

Query: 565 LGTGSYGRVYKGILQDGTAI-AVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           +G G++G+VY+   +D   I A+KVL        K    + +V   I  RN    I   +
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLS------KKEIVAKKEVAHTIGERN----ILVRT 50

Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD------IAEGMAY 677
           L D    ++    +   DS LY    T++ SG      LQ+    S+      IAE +  
Sbjct: 51  LLDESPFIVGLKFSFQTDSDLY--LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLA 108

Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L H     +++ DLKP N+LL+      + DFG++K  +T            N T N  C
Sbjct: 109 LEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT-----------DNKTTNTFC 157

Query: 738 GSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEM 769
           G+  Y+APE        TK  D +S G+LV EM
Sbjct: 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 64.6 bits (157), Expect = 4e-11
 Identities = 55/218 (25%), Positives = 100/218 (45%), Gaps = 26/218 (11%)

Query: 565 LGTGSYGRVYKG--ILQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIR---HRNLMR 617
           +G G+YG+V+K   +   G  +A+K +++Q+G      S  RE  VL+ +    H N++R
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +   C++          +    +D  L  + +     G    T+    ++   +  G+ +
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI---KDMMFQLLRGLDF 125

Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH H   RV+H DLKP N+L+       ++DFG+A++                     + 
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF------------QMALTSVV 170

Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            ++ Y APE    S+ +T  D++S G +  EM  RR+P
Sbjct: 171 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 63.8 bits (155), Expect = 4e-11
 Identities = 76/291 (26%), Positives = 121/291 (41%), Gaps = 55/291 (18%)

Query: 563 RLLGTGSYGRV----YKGILQDGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLM 616
           R++G GSYG V    ++    DG    +K L L+  S    K+  +E Q+L +++H N++
Sbjct: 6   RVVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV 62

Query: 617 RIITACSLPD-FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
               +    D    +V+ +   G L  H     + +       L   Q V     IA  +
Sbjct: 63  AYRESWEGEDGLLYIVMGFCEGGDL-YHKLKEQKGKL------LPENQVVEWFVQIAMAL 115

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH      ++H DLK  NV L       V D GIA+++          EN     A+ 
Sbjct: 116 QYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL----------ENQ-CDMAST 161

Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH 795
           L G+  YM+PE       + K DV++ G  V EM T +             H +     +
Sbjct: 162 LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK-------------HAFNAKDMN 208

Query: 796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTM 846
             + ++I+  L    +D SPE        +GELI   +L  +  P  RP++
Sbjct: 209 SLVYRIIEGKLPPMPKDYSPE--------LGELIA-TMLSKR--PEKRPSV 248

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 64.9 bits (159), Expect = 5e-11
 Identities = 78/267 (29%), Positives = 120/267 (44%), Gaps = 68/267 (25%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFT---KSFNRECQVLKRIR-HR 613
           ++  + LG G+YG V+K I  +    +A+K +     N T   ++F RE   L+ +  H 
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHP 67

Query: 614 N---LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           N   L+ +I A +  D   LV  YM             ET       DL  + R NI  D
Sbjct: 68  NIVKLLNVIKAENDKDI-YLVFEYM-------------ET-------DLHAVIRANILED 106

Query: 671 I---------AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
           +          + + Y+H      VIH DLKPSN+LLN D    ++DFG+A+ +      
Sbjct: 107 VHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL------ 157

Query: 722 NDGAENMGNSTANMLCGSIG---YMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTD 777
              +E   N    +L   +    Y APE   GS   TKG D++S G ++ EM+   +P  
Sbjct: 158 ---SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEML-LGKP-- 211

Query: 778 DMFAGGLSLHKWVKNHYHGRLEKVIDS 804
            +F G  +L++         LEK+I+ 
Sbjct: 212 -LFPGTSTLNQ---------LEKIIEV 228

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 64.0 bits (156), Expect = 5e-11
 Identities = 52/227 (22%), Positives = 97/227 (42%), Gaps = 29/227 (12%)

Query: 556 TAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNR---ECQVLKRIR 611
              F  ++ +G G +  VYK I L DG  +A+K +Q+      K+      E  +LK++ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS-- 669
           H N+++ + +    +   +VL     G L S +  H +           L+    I    
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDL-SRMIKHFK-------KQKRLIPERTIWKYF 112

Query: 670 -DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
             +   + ++H     R++H D+KP+NV +       + D G+ +   +           
Sbjct: 113 VQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS----------- 158

Query: 729 GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
             + A+ L G+  YM+PE    +  + K D++S G L+ EM   + P
Sbjct: 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 64.7 bits (158), Expect = 6e-11
 Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 32/234 (13%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFT--KSFNRECQVLKRIRHRNLMRI- 618
             +G+G+YG V   I  + G  +A+K +       T  K   RE ++L+  +H N++ I 
Sbjct: 11  ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70

Query: 619 -ITACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
            I      DFK   +V+  M +   D H   HS          LT          +  G+
Sbjct: 71  DILRPPGADFKDVYVVMDLMES---DLHHIIHS-------DQPLTEEHIRYFLYQLLRGL 120

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            Y+H      VIH DLKPSN+L+N+D    + DFG+A+ + +     +    M    A  
Sbjct: 121 KYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT--EHKYFMTEYVATR 175

Query: 736 LCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK 788
                 Y APE        +T  D++S G +  EM+ RR+    +F G   +H+
Sbjct: 176 W-----YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ----LFPGKNYVHQ 220

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 64.3 bits (157), Expect = 6e-11
 Identities = 58/235 (24%), Positives = 95/235 (40%), Gaps = 58/235 (24%)

Query: 563 RLLGTGSYGRV----YKGILQDGTAIAVKVLQ----LQSGNFTKSFNREC-QVLKRI--- 610
           ++LG GS+G+V     KG        AVKVL+    LQ  +       EC    KR+   
Sbjct: 1   KVLGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDV------ECTMTEKRVLAL 51

Query: 611 --RHRNLMRIITACSLPDFKALVLPYMANGSLDSHL-----YPHSETEFGSGSSDLTLLQ 663
             +H  L ++ +     D    V+ Y+  G L  H+     +      F +         
Sbjct: 52  AGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAA-------- 103

Query: 664 RVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
                 +I  G+ +LH      +I+ DLK  NVLL+ +    ++DFG+ K          
Sbjct: 104 ------EIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK---------- 144

Query: 724 GAENMGN-STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
             E +    T +  CG+  Y+APE           D ++ G+L+ EM+  + P +
Sbjct: 145 --EGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 63.9 bits (155), Expect = 6e-11
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 30/222 (13%)

Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G++G+VYK   ++ G   A KV+  +S    + +  E  +L    H N+++++ A  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
             +   +++ + A G++D+ +    E E       LT  Q   +C    E + YLH +  
Sbjct: 73  YENNLWILIEFCAGGAVDAVML---ELE-----RPLTEPQIRVVCKQTLEALNYLHEN-- 122

Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGI-AKLVMTVGVGNDGAENMGNSTANMLCGSIGY 742
            ++IH DLK  N+L   D    ++DFG+ AK   T+               +   G+  +
Sbjct: 123 -KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI------------QRRDSFIGTPYW 169

Query: 743 MAPEYGFGSNTST-----KGDVYSFGILVLEMVTRRRPTDDM 779
           MAPE      +       K DV+S GI ++EM     P  ++
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 64.6 bits (157), Expect = 6e-11
 Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 42/232 (18%)

Query: 554 EATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRI 610
           E    + + + +G+G+YG V   +  + G  +A+K L    QS  F K   RE ++LK +
Sbjct: 12  EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 71

Query: 611 RHRN---LMRIITA-CSLPDFKA--LVLPYMAN--GSLDSHLYPHSETEFGSGSSDLTLL 662
           +H N   L+ + T   SL  F    LV+P+M    G L  H       +         + 
Sbjct: 72  KHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH------EKLSEDRIQFLVY 125

Query: 663 QRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGN 722
           Q       + +G+ Y+H      +IH DLKP N+ +N+D    + DFG+A+         
Sbjct: 126 Q-------MLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR--------Q 167

Query: 723 DGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
             +E  G            Y APE        T+  D++S G ++ EM+T +
Sbjct: 168 TDSEMTGYVVTRW------YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 64.0 bits (155), Expect = 6e-11
 Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 25/212 (11%)

Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           +G G+ G VY  + +  G  +A++ + LQ     +    E  V++  ++ N++  + +  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
           + D   +V+ Y+A GSL   +   +ET    G       Q   +C +  + + +LH +  
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV---TETCMDEG-------QIAAVCRECLQALEFLHSN-- 135

Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
            +VIH D+K  N+LL  D +  ++DFG    +               S  + + G+  +M
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-----------EQSKRSTMVGTPYWM 183

Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           APE         K D++S GI+ +EM+    P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 63.7 bits (155), Expect = 6e-11
 Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 23/215 (10%)

Query: 565 LGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNR---ECQVLKRIRHRNLMRIIT 620
           LG G +G V    ++  G   A K L  +     K +     E ++L ++  R ++ +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
           A        LV+  M  G L  H+Y   E   G         +     + I  G+ +LH 
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG-----FPEPRACFYTAQIISGLEHLHQ 115

Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
               R+I+ DLKP NVLL++D    +SD G+A  +             G S      G+ 
Sbjct: 116 R---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKD-----------GQSKTKGYAGTP 161

Query: 741 GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           G+MAPE   G       D ++ G+ + EM+  R P
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 63.5 bits (154), Expect = 7e-11
 Identities = 53/230 (23%), Positives = 103/230 (44%), Gaps = 35/230 (15%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLM 616
           +F+  + +G+G+YG VYK   +  G   A+KV++L+ G       +E  ++K  +H N++
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
               +    D   + + +   GSL    +          +  L+  Q   +  +  +G+ 
Sbjct: 70  AYFGSYLRRDKLWICMEFCGGGSLQDIYHV---------TGPLSESQIAYVSRETLQGLY 120

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI-AKLVMTVGVGNDGAENMGNSTANM 735
           YLH       +H D+K +N+LL D+    ++DFG+ A++  T+            +    
Sbjct: 121 YLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATI------------AKRKS 165

Query: 736 LCGSIGYMAPEYGFGSNTSTKG------DVYSFGILVLEMVTRRRPTDDM 779
             G+  +MAPE    +    KG      D+++ GI  +E+   + P  D+
Sbjct: 166 FIGTPYWMAPEV---AAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 64.0 bits (156), Expect = 7e-11
 Identities = 67/233 (28%), Positives = 108/233 (46%), Gaps = 42/233 (18%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRN 614
           +FD    +G G+YG+VYK   +D G  +A+K ++L +    F  +  RE ++L+++ HRN
Sbjct: 8   KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRN 67

Query: 615 ---LMRIITACSLP-DFKA------LVLPYMAN---GSLDSHLYPHSETEFGSGSSDLTL 661
              L  I+T      DFK       LV  YM +   G L+S L   SE    S       
Sbjct: 68  IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS------- 120

Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
                    + EG+ Y H  +    +H D+K SN+LLN+     ++DFG+A+L       
Sbjct: 121 -----FMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLY------ 166

Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
              +E     T  ++  ++ Y  PE   G        DV+S G ++ E+ T++
Sbjct: 167 --NSEESRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 56/226 (24%), Positives = 100/226 (44%), Gaps = 34/226 (15%)

Query: 564 LLGTGSYGRVYKGILQDGTA--IAVKVLQLQSGNFTKSFNR----------ECQVLK-RI 610
            LG+G++G VYK   ++     +A+K + + +  F K              E  ++K ++
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRV-NICS 669
           RH N++R        D   +V+  +    L  H   +S  E     ++    +R+ NI  
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHF--NSLKEKKQRFTE----ERIWNIFV 120

Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
            +   + YLH     R++H DL P+N++L +D    ++DFG+AK            +   
Sbjct: 121 QMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAK------------QKQP 166

Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            S    + G+I Y  PE         K DV++FG ++ +M T + P
Sbjct: 167 ESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 26/220 (11%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNL 615
           +F++   LG G+ G V+K   +  G  +A K++ L+          RE QVL       +
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +    A       ++ + +M  GSLD  L         +G     +L +V+I   + +G+
Sbjct: 66  VGFYGAFYSDGEISICMEHMDGGSLDQVLKK-------AGRIPEQILGKVSIA--VIKGL 116

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL      +++H D+KPSN+L+N      + DFG++  ++             +S AN 
Sbjct: 117 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------------DSMANS 161

Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
             G+  YM+PE   G++ S + D++S G+ ++EM   R P
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 28/222 (12%)

Query: 559 FDEQRLLGTGSYGRVYK-GILQDGTAIAVKVLQLQSGNFTK----SFNRECQVLKRIRHR 613
           F   R+LG G +G V    +   G   A K L+ +     K    + N E ++L+++  R
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-EKRILEKVNSR 60

Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
            ++ +  A    D   LVL  M  G L  H+Y         G+      + +   +++  
Sbjct: 61  FVVSLAYAYETKDALCLVLTIMNGGDLKFHIY-------NMGNPGFDEQRAIFYAAELCC 113

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           G+  L      R+++ DLKP N+LL+D     +SD G+A  +       +G    G    
Sbjct: 114 GLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQI------PEGETVRGR--- 161

Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
               G++GYMAPE       +   D +  G L+ EM+  + P
Sbjct: 162 ---VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 63.7 bits (155), Expect = 1e-10
 Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 33/226 (14%)

Query: 548 TYRELLEATAEFDEQRL--LGTGSYGRVYKGILQDGTAIAVKVLQL-QSGNFTKSFNREC 604
           T ++  E  A      +  L  GS GRV+    + G    V VL++ Q G    +   E 
Sbjct: 55  TKQKAREVVASLGYTVIKTLTPGSEGRVFVAT-KPGQPDPV-VLKIGQKG----TTLIEA 108

Query: 605 QVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
            +L+ + H +++R+           +VLP+       S LY    T     S  L + Q 
Sbjct: 109 MLLQNVNHPSVIRMKDTLVSGAITCMVLPH-----YSSDLY----TYLTKRSRPLPIDQA 159

Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
           + I   I EG+ YLH     R+IH D+K  N+ +ND     + D G A+    V      
Sbjct: 160 LIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAF- 213

Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
              +G      L G++   APE       ++K D++S GI++ EM+
Sbjct: 214 ---LG------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 63.1 bits (153), Expect = 2e-10
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 34/221 (15%)

Query: 563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNREC-QVLKRI-----RHRNL 615
           ++LG GS+G+V+   L+      A+K L+          + EC  V KR+      H  L
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALK--KDVVLMDDDVECTMVEKRVLSLAWEHPFL 58

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
             +       +    V+ Y+  G L  H+                L +     ++I  G+
Sbjct: 59  THLYCTFQTKENLFFVMEYLNGGDLMFHI---------QSCHKFDLPRATFYAAEIICGL 109

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM-GNSTAN 734
            +LH      +++ DLK  N+LL+ D    ++DFG+ K            ENM G++   
Sbjct: 110 QFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK------------ENMLGDAKTC 154

Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
             CG+  Y+APE   G   +T  D +SFG+L+ EM+  + P
Sbjct: 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 24/208 (11%)

Query: 565 LGTGSYGRVYKGILQ---DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIIT 620
           LG+G++G V KG+ +       +A+KVL+ ++  +      RE +++ ++ +  ++R+I 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
            C       LV+   + G L+  L             ++T+   V +   ++ GM YL  
Sbjct: 63  VCEAEAL-MLVMEMASGGPLNKFL--------SGKKDEITVSNVVELMHQVSMGMKYLEG 113

Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
            +    +H DL   NVLL +   A +SDFG++K      +G D +     S        +
Sbjct: 114 KN---FVHRDLAARNVLLVNQHYAKISDFGLSK-----ALGADDSYYKARSAGKW---PL 162

Query: 741 GYMAPEYGFGSNTSTKGDVYSFGILVLE 768
            + APE       S++ DV+S+GI + E
Sbjct: 163 KWYAPECINFRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 62.2 bits (152), Expect = 2e-10
 Identities = 55/225 (24%), Positives = 107/225 (47%), Gaps = 41/225 (18%)

Query: 568 GSYGRVYKGI-LQDGTAIAVKVLQL---QSGNFTKSFNRECQVLKRIRHRNLMRI--ITA 621
           G+YG VY+    + G  +A+K L++   + G F  +  RE  +L +++H N++ +  +  
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEG-FPITSLREINILLKLQHPNIVTVKEVVV 74

Query: 622 CSLPDFKALVLPYMAN---GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
            S  D   +V+ Y+ +     +++   P  ++E         L+ +      +  G+A+L
Sbjct: 75  GSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVK------CLMLQ------LLSGVAHL 122

Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCG 738
           H +    ++H DLK SN+LLN+     + DFG+A+              +   T  ++  
Sbjct: 123 HDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY---------GSPLKPYTQLVV-- 168

Query: 739 SIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRRRPTDDMFAG 782
           ++ Y APE   G+   ST  D++S G +  E++T+      +F G
Sbjct: 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK----KPLFPG 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 26/143 (18%)

Query: 634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH-HSPVRVIHCDLK 692
           +M  GSLD  L         +G     +L +++I   +  G+ YL   H    ++H D+K
Sbjct: 80  HMDGGSLDQVLKK-------AGRIPENILGKISIA--VLRGLTYLREKHK---IMHRDVK 127

Query: 693 PSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN 752
           PSN+L+N      + DFG++  ++             +S AN   G+  YM+PE   G++
Sbjct: 128 PSNILVNSRGEIKLCDFGVSGQLI-------------DSMANSFVGTRSYMSPERLQGTH 174

Query: 753 TSTKGDVYSFGILVLEMVTRRRP 775
            + + D++S G+ ++EM   R P
Sbjct: 175 YTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 62.4 bits (151), Expect = 2e-10
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 25/212 (11%)

Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           +G G+ G V+  I +  G  +A+K + LQ     +    E  V+K +++ N++  + +  
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
           + D   +V+ Y+A GSL   +   +ET            Q   +C +  + + +LH +  
Sbjct: 87  VGDELFVVMEYLAGGSLTDVV---TETCMDEA-------QIAAVCRECLQALEFLHAN-- 134

Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
            +VIH D+K  NVLL  D +  ++DFG    +          E    ST   + G+  +M
Sbjct: 135 -QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT--------PEQSKRST---MVGTPYWM 182

Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           APE         K D++S GI+ +EMV    P
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 32/226 (14%)

Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIR---HRNLMRI 618
           +G G+YG VYK      G  +A+K +++Q+       S  RE  +LKR+    H N++R+
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 619 ITAC--SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           +  C  S  D +  V     +   D   Y       G  +  +  L R  +      G+ 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR-----GLD 122

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           +LH +    ++H DLKP N+L+       ++DFG+A++                     +
Sbjct: 123 FLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSC------------QMALTPV 167

Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAG 782
             ++ Y APE    S  +T  D++S G +  EM  RR+P   +F G
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP---LFCG 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 43/149 (28%), Positives = 64/149 (42%), Gaps = 22/149 (14%)

Query: 630 LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHC 689
           LV+  M  G L  H+Y         G   L + + ++  + I  G+ +LH    + +++ 
Sbjct: 70  LVMSLMNGGDLKYHIY-------NVGERGLEMERVIHYSAQITCGILHLHS---MDIVYR 119

Query: 690 DLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF 749
           D+KP NVLL+D     +SD G+A             E     T     G+ GYMAPE   
Sbjct: 120 DMKPENVLLDDQGNCRLSDLGLA------------VELKDGKTITQRAGTNGYMAPEILK 167

Query: 750 GSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
               S   D ++ G  + EMV  R P  D
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 62.3 bits (151), Expect = 3e-10
 Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 25/205 (12%)

Query: 584 IAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDS 642
           +AVK+L+   + N    F +E ++L R++  N++R++  C   D   ++  YM NG L+ 
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 643 HLYPHSETEFGSGSSD----------LTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLK 692
            L  H   +     +D          ++    +++   IA GM YL   S +  +H DL 
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165

Query: 693 PSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN 752
             N L+ +++T  ++DFG+++ +       D     G +        I +MA E      
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLY----AGDYYRIQGRAVL-----PIRWMAWECILMGK 216

Query: 753 TSTKGDVYSFGILVLE--MVTRRRP 775
            +T  DV++FG+ + E  M+ + +P
Sbjct: 217 FTTASDVWAFGVTLWEILMLCKEQP 241

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 51/225 (22%), Positives = 100/225 (44%), Gaps = 28/225 (12%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTK----SFNRECQVLKRIRHR 613
           ++++ R++G G++G V+    +    + V + Q+     TK    +   ECQVLK + H 
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKL-VIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59

Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           N++             +V+ Y   G+L  ++     +          LL    I     +
Sbjct: 60  NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNS----------LLDEDTILHFFVQ 109

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGNST 732
            +  LHH     ++H DLK  N+LL+     + + DFGI+K++ +             S 
Sbjct: 110 ILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS------------KSK 157

Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           A  + G+  Y++PE   G   + K D+++ G ++ E+ + +R  +
Sbjct: 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 42/117 (35%), Positives = 56/117 (47%), Gaps = 22/117 (18%)

Query: 667 ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA-KLVMTVGVGNDGA 725
           I   I + + YLH  S + VIH D+KPSNVL+N +    + DFGI+  LV          
Sbjct: 108 IAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV---------- 155

Query: 726 ENMGNSTA-NMLCGSIGYMAPEY----GFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
               +S A  +  G   YMAPE             K DV+S GI ++E+ T R P D
Sbjct: 156 ----DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 61.1 bits (148), Expect = 5e-10
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 31/219 (14%)

Query: 563 RLLGTGSYGRVY------KGILQDGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNL 615
           R LG G +G+V       +G    G  +AVK L+ +S GN      +E ++L+ + H N+
Sbjct: 10  RDLGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68

Query: 616 MRIITACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           ++    C+        L++ ++ +GSL  +L P ++ +       + L Q++     I +
Sbjct: 69  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNK-------INLKQQLKYAVQICK 120

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           GM YL      + +H DL   NVL+  +    + DFG+ K + T         +    T 
Sbjct: 121 GMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET---------DKEYYTV 168

Query: 734 -NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            + L   + + APE    S      DV+SFG+ + E++T
Sbjct: 169 KDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 61.6 bits (149), Expect = 5e-10
 Identities = 69/265 (26%), Positives = 111/265 (41%), Gaps = 47/265 (17%)

Query: 563 RLLGTGSYGRVYKGIL----QDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNL 615
           +LLG G++G+V   IL      G   A+K+L+ +   + +       E +VL+  RH  L
Sbjct: 1   KLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
             +  A    D    V+ Y   G L  HL    E  F    +           ++I   +
Sbjct: 58  TALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARF-------YGAEIVSAL 108

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH      V++ D+K  N++L+ D    ++DFG+ K  ++     DGA      T   
Sbjct: 109 EYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-----DGA------TMKT 154

Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH 795
            CG+  Y+APE    ++     D +  G+++ EM+  R P                N  H
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--------------FYNQDH 200

Query: 796 GRLEKVIDSSLLRASRDQSPEVKRM 820
            RL ++I    +R  R  SPE K +
Sbjct: 201 ERLFELILMEEIRFPRTLSPEAKSL 225

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 61.2 bits (148), Expect = 6e-10
 Identities = 59/221 (26%), Positives = 106/221 (47%), Gaps = 38/221 (17%)

Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTK-SFNRECQVLKRIRHRNLM 616
           +++   LG GSY  VYKG  + +G  +A+KV++LQ    T  +  RE  +LK ++H N++
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV 66

Query: 617 RIITACSLPDFKALVLPYMANG---SLDSH---LYPHSETEFGSGSSDLTLLQRVNICSD 670
            +       +   LV  Y+       +D H   L+P +   F        L Q       
Sbjct: 67  LLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLF--------LFQ------- 111

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +  G++Y+H      ++H DLKP N+L++D     ++DFG+A+           A+++ +
Sbjct: 112 LLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR-----------AKSVPS 157

Query: 731 STANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMV 770
            T +    ++ Y  P+   GS   ST  D++  G + +EM+
Sbjct: 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 60.8 bits (147), Expect = 7e-10
 Identities = 54/211 (25%), Positives = 102/211 (48%), Gaps = 30/211 (14%)

Query: 565 LGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGN---FTKSFNRECQVLKRIRHRNLMRIIT 620
           LG GSY  VYKGI + +G  +A+KV+ +++     FT    RE  +LK ++H N++ +  
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI--REASLLKGLKHANIVLLHD 70

Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
                +    V  YM +  L  ++  H     G    ++ L         +  G+AY+H 
Sbjct: 71  IIHTKETLTFVFEYM-HTDLAQYMIQHPG---GLHPYNVRLFM-----FQLLRGLAYIHG 121

Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
                ++H DLKP N+L++      ++DFG+A+           A+++ + T +    ++
Sbjct: 122 Q---HILHRDLKPQNLLISYLGELKLADFGLAR-----------AKSIPSQTYSSEVVTL 167

Query: 741 GYMAPEYGFGS-NTSTKGDVYSFGILVLEMV 770
            Y  P+   G+ + S+  D++  G + +EM+
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 60.5 bits (147), Expect = 8e-10
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 47/225 (20%)

Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNLMRIITA 621
           +G G+YG V+K   ++    +A+K ++L   +     S  RE  +LK ++H+N++R+   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 622 CSLPDFKALVLPYM----------ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
                   LV  Y            NG +D  +           S    LL+        
Sbjct: 68  LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK---------SFMFQLLK-------- 110

Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+A+ H H    V+H DLKP N+L+N +    ++DFG+A+    + V    AE +   
Sbjct: 111 --GLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIPVRCYSAEVV--- 161

Query: 732 TANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRRRP 775
                  ++ Y  P+  FG+   ST  D++S G +  E+    RP
Sbjct: 162 -------TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 61.0 bits (148), Expect = 8e-10
 Identities = 41/144 (28%), Positives = 67/144 (46%), Gaps = 23/144 (15%)

Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
           ++I  G+ +LH      +I+ DLK  NVLL+ D    ++DFG+ K  M            
Sbjct: 103 AEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMN----------- 148

Query: 729 GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP-----TDDMFAGG 783
           G   A+  CG+  Y+APE   G   +   D +SFG+L+ EM+  + P      D++F   
Sbjct: 149 GEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208

Query: 784 LS----LHKWVKNHYHGRLEKVID 803
           L+      +W+       L K+ +
Sbjct: 209 LNDRPHFPRWISKEAKDCLSKLFE 232

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 60.7 bits (147), Expect = 1e-09
 Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 34/221 (15%)

Query: 563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNREC-QVLKRI-----RHRNL 615
           ++LG GS+G+V    L+  G   AVK L+          + EC  V KR+      +  L
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALK--KDVVLIDDDVECTMVEKRVLALAWENPFL 58

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
             +       +    V+ ++  G L  H+      +         L +     ++I  G+
Sbjct: 59  THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFD---------LYRATFYAAEIVCGL 109

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM-GNSTAN 734
            +LH      +I+ DLK  NV+L+ D    ++DFG+ K            EN+ G++ A+
Sbjct: 110 QFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK------------ENVFGDNRAS 154

Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
             CG+  Y+APE   G   +   D +SFG+L+ EM+  + P
Sbjct: 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 31/214 (14%)

Query: 564 LLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGN---FTKSFNRECQVLKRIRHRNLMRII 619
           L+G GSYG V K   ++ G  +A+K   L+S +     K   RE ++LK++RH NL+ +I
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66

Query: 620 TACSLPDFKALVLPYMANGSLDS-HLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
                     LV  ++ +  LD    YP+             L Q       I  G+ + 
Sbjct: 67  EVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQ-------ILRGIEFC 116

Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCG 738
           H H+   +IH D+KP N+L++      + DFG A+ +   G      E   +  A     
Sbjct: 117 HSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG------EVYTDYVATRW-- 165

Query: 739 SIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVT 771
              Y APE   G     +  D+++ G LV EM+T
Sbjct: 166 ---YRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 20/214 (9%)

Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRN-LMRIIT 620
           +G G+YG+VYK      G  +A+K  +L+        +  RE  +L+ +     ++R++ 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
              + +       Y+    LDS L    ++        L      +    + +G+A+ H 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128

Query: 681 HSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS 739
           H    V+H DLKP N+L++     L ++D G+ +   ++ V +   E +          +
Sbjct: 129 HG---VMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIPVKSYTHEIV----------T 174

Query: 740 IGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTR 772
           + Y APE   GS   ST  D++S G +  EM  +
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 60.8 bits (147), Expect = 1e-09
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 28/213 (13%)

Query: 563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNR---ECQVL-KRIRHRNLMR 617
           +++G GS+G+V     + DG+  AVKVLQ ++    K  N    E  VL K ++H  L+ 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +  +    +    VL Y+  G L  HL    E  F    +           +++A  + Y
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARF-------YAAEVASAIGY 111

Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH    + +I+ DLKP N+LL+     +++DFG+ K         +G E     T +  C
Sbjct: 112 LH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK---------EGVEPEE--TTSTFC 157

Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
           G+  Y+APE           D +  G ++ EM+
Sbjct: 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 34/213 (15%)

Query: 565 LGTGSYGRVYKGILQ---DGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNLMRII 619
           LG+G++G V KG+ +       +AVK+L+  + +        RE  V++++ +  ++R+I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 620 TACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLH 679
             C    +  LV+     G L+  L           +  +T      +   ++ GM YL 
Sbjct: 63  GICEAESW-MLVMELAELGPLNKFL---------QKNKHVTEKNITELVHQVSMGMKYLE 112

Query: 680 HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS 739
             +    +H DL   NVLL     A +SDFG++K      +G D       +        
Sbjct: 113 ETN---FVHRDLAARNVLLVTQHYAKISDFGLSK-----ALGADENYYKAKTHGKW---P 161

Query: 740 IGYMAPE----YGFGSNTSTKGDVYSFGILVLE 768
           + + APE    Y F    S+K DV+SFG+L+ E
Sbjct: 162 VKWYAPECMNYYKF----SSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 48/196 (24%), Positives = 90/196 (45%), Gaps = 26/196 (13%)

Query: 581 GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSL 640
           G  +AVK++ L+     +    E  +++  +H+N++ +  +  + +   +++ ++  G+L
Sbjct: 46  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105

Query: 641 DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND 700
              +   S+T        L   Q   +C  + + + YLH      VIH D+K  ++LL  
Sbjct: 106 TDIV---SQTR-------LNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTL 152

Query: 701 DMTALVSDFGI-AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDV 759
           D    +SDFG  A++   V                 L G+  +MAPE    +   T+ D+
Sbjct: 153 DGRVKLSDFGFCAQISKDV------------PKRKSLVGTPYWMAPEVISRTPYGTEVDI 200

Query: 760 YSFGILVLEMVTRRRP 775
           +S GI+V+EMV    P
Sbjct: 201 WSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 54/221 (24%), Positives = 88/221 (39%), Gaps = 37/221 (16%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           +F+  R LGTGS+GRV     ++     V + + +         ++ QV      R ++ 
Sbjct: 31  DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII----KQKQVDHVFSERKILN 86

Query: 618 IITACSLPDFKALVLPYMAN--GSLDSHLYPHSETEFGSGSSDLTLLQRVNI------CS 669
            I             P+  N  GS     Y +   EF  G    T L+R         C 
Sbjct: 87  YINH-----------PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF 135

Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
             A+ +    +   + +++ DLKP N+LL+ D    ++DFG AK+V T            
Sbjct: 136 YAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT------------ 183

Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
                 LCG+  Y+APE           D ++ GI + E++
Sbjct: 184 --RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 60.6 bits (147), Expect = 1e-09
 Identities = 56/215 (26%), Positives = 87/215 (40%), Gaps = 32/215 (14%)

Query: 565 LGTGSYGRVY---KGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           L  GS G V+   K   +    + VK          K+  RE  +LK I HR ++ +I A
Sbjct: 100 LTPGSEGEVFVCTKHGDEQRKKVIVKA-----VTGGKTPGREIDILKTISHRAIINLIHA 154

Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
                   +V+P           Y      +   S  L L Q + I   + E +AYLH  
Sbjct: 155 YRWKSTVCMVMPK----------YKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR 204

Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIA-KLVMTVGVGNDGAENMGNSTANMLCGSI 740
               +IH D+K  N+ L++   A++ DFG A KL        D  +  G S      G++
Sbjct: 205 G---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP----DTPQCYGWS------GTL 251

Query: 741 GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              +PE         K D++S G+++ EM  +   
Sbjct: 252 ETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 59/245 (24%), Positives = 107/245 (43%), Gaps = 47/245 (19%)

Query: 557 AEFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNL 615
           + + + R LG GS G V+  +  D    +AVK + L      K   RE ++++R+ H N+
Sbjct: 5   SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNI 64

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSG-------SSDL-TLLQRVNI 667
           +++                +     D      S TE  S         +DL  +L++  +
Sbjct: 65  VKVYEV-------------LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPL 111

Query: 668 CSDIAE--------GMAYLHHHSPVRVIHCDLKPSNVLLN-DDMTALVSDFGIAKLVMTV 718
             + A         G+ Y+H      V+H DLKP+NV +N +D+   + DFG+A++V   
Sbjct: 112 SEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV--- 165

Query: 719 GVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTD 777
              +    + G  +  ++  +  Y +P      N  TK  D+++ G +  EM+T +    
Sbjct: 166 ---DPHYSHKGYLSEGLV--TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP--- 217

Query: 778 DMFAG 782
            +FAG
Sbjct: 218 -LFAG 221

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 63/245 (25%), Positives = 98/245 (40%), Gaps = 82/245 (33%)

Query: 564 LLGTGSYGRVYKG-ILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLM--RIIT 620
            +G+G+ G+VYK    + G  +AVK ++       ++ N+E    KRI    LM   ++ 
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQMR-------RTGNKE--ENKRI----LMDLDVV- 67

Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLT--------------LLQRVN 666
                              L SH  P+    +G   +D                LL+R+ 
Sbjct: 68  -------------------LKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQ 108

Query: 667 --ICSDIAEGMAY-----LHH----HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA-KL 714
             I  DI   M       LH+    H    VIH D+KPSN+LL+      + DFGI+ +L
Sbjct: 109 GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRL 165

Query: 715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEY----GFGSNTSTKGDVYSFGILVLEMV 770
           V          ++   + +    G   YMAPE             + DV+S GI ++E+ 
Sbjct: 166 V----------DSKAKTRS---AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELA 212

Query: 771 TRRRP 775
           T + P
Sbjct: 213 TGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 55/244 (22%), Positives = 106/244 (43%), Gaps = 38/244 (15%)

Query: 563 RLLGTGSYGRVYKGILQD----GTAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNLMR 617
           R +G G +G VY+G+         A+AVK  +   S +  + F +E  ++++  H ++++
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +I   +      +V+     G L S+L  +  +        L L   +     ++  +AY
Sbjct: 72  LIGVITENPV-WIVMELAPLGELRSYLQVNKYS--------LDLASLILYSYQLSTALAY 122

Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L      R +H D+   NVL++      + DFG+++ +          E+     A+   
Sbjct: 123 LE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL----------EDESYYKASKGK 169

Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH-YHG 796
             I +MAPE       ++  DV+ FG+ + E++        M   G+   + VKN+   G
Sbjct: 170 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL--------ML--GVKPFQGVKNNDVIG 219

Query: 797 RLEK 800
           R+E 
Sbjct: 220 RIEN 223

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 43/154 (27%), Positives = 75/154 (48%), Gaps = 11/154 (7%)

Query: 565 LGTGSYGRVYKGILQDG---TAIAVKVLQLQSGNFTK-SFNRECQVLKRIRHRNLMRIIT 620
           +G G +G+V  G +  G     + VK L++ +    +  F  E Q  + ++H NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
            C+      LV+ +   G L  +L    + E    + D T LQR  +  +IA G+ +LH 
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAE--LMTPDPTTLQR--MACEIALGLLHLHK 118

Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL 714
           ++    IH DL   N LL  D+T  + D+G++  
Sbjct: 119 NN---FIHSDLALRNCLLTADLTVKIGDYGLSHN 149

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 33/220 (15%)

Query: 563 RLLGTGSYGRVYKGIL----QDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNL 615
           +LLG G++G+V   IL      G   A+K+L+ +   + +       E +VLK  RH  L
Sbjct: 1   KLLGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFL 57

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
             +  +    D    V+ Y+  G L  HL    E  F   S D T      I S     +
Sbjct: 58  TSLKYSFQTKDRLCFVMEYVNGGELFFHL--SRERVF---SEDRTRFYGAEIVS----AL 108

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH     ++++ DLK  N++L+ D    ++DFG+ K  +T     D A      T   
Sbjct: 109 DYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT-----DAA------TMKT 154

Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            CG+  Y+APE    ++     D +  G+++ EM+  R P
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 58.3 bits (141), Expect = 4e-09
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 33/221 (14%)

Query: 565 LGTGSYGRVYKGILQ-DGTAIAVKV--LQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           LG G+YG VYK + +  G  +A+K   L+L    F +    E  +L +     ++    A
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQII-MELDILHKAVSPYIVDFYGA 67

Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
             +     + + YM  GSLD  LY       G       +L+R  I   + +G+ +L   
Sbjct: 68  FFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGI---PEDVLRR--ITYAVVKGLKFLKEE 121

Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIA-KLVMTVGVGNDGAENMGNSTANMLCGSI 740
               +IH D+KP+NVL+N +    + DFG++  LV ++            +  N+ C S 
Sbjct: 122 H--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL------------AKTNIGCQS- 166

Query: 741 GYMAPEYGFGSNTSTKG------DVYSFGILVLEMVTRRRP 775
            YMAPE       +         DV+S G+ +LEM   R P
Sbjct: 167 -YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 4e-09
 Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 50/224 (22%)

Query: 565 LGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGN---FTKSFNRECQVLKRIRHRN---LMR 617
           LG GSY  VYKG  +  G  +A+K ++L+      FT    RE  +LK ++H N   L  
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI--REASLLKDLKHANIVTLHD 70

Query: 618 II-TACSLPDFKALVLPYMANG---SLDSH---LYPHSETEFGSGSSDLTLLQRVNICSD 670
           II T  +L     LV  Y+       +D     L  H+   F        L Q       
Sbjct: 71  IIHTKKTL----TLVFEYLDTDLKQYMDDCGGGLSMHNVRLF--------LFQ------- 111

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +  G+AY H     RV+H DLKP N+L+++     ++DFG+A+           A+++ +
Sbjct: 112 LLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR-----------AKSVPS 157

Query: 731 STANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
            T +    ++ Y  P+   GS   ST  D++  G +  EM T R
Sbjct: 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 58.9 bits (142), Expect = 4e-09
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 26/220 (11%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNL 615
           +F+    LG G+ G V K   +  G  +A K++ L+          RE QVL       +
Sbjct: 6   DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +    A       ++ + +M  GSLD  L                +L +V+I   +  G+
Sbjct: 66  VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIP-------EEILGKVSIA--VLRGL 116

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
           AYL      +++H D+KPSN+L+N      + DFG++  ++             +S AN 
Sbjct: 117 AYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------------DSMANS 161

Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
             G+  YM+PE   G++ S + D++S G+ ++E+   R P
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 57.6 bits (139), Expect = 6e-09
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 34/218 (15%)

Query: 562 QRLLGTGSYGRVYKGILQDGTAIA---VKVL-QLQSG----NFTKSFNRECQVLKRIRHR 613
           Q+ LG GS+G VY  +++D  A+A   +KVL ++  G    N T   N+E Q+L ++ H 
Sbjct: 5   QQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62

Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHL--YPHSETEFGSGSSDLTLLQRVNICSDI 671
            +++   +    D   ++  Y     LD  L    H+              Q       +
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSEN-------QVCEWFIQL 115

Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H     R++H DLK  N+ L +++   + DFG+++L+M       G+ ++   
Sbjct: 116 LLGVHYMHQR---RILHRDLKAKNIFLKNNLLK-IGDFGVSRLLM-------GSCDL--- 161

Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEM 769
            A    G+  YM+PE        +K D++S G ++ EM
Sbjct: 162 -ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 57.8 bits (140), Expect = 6e-09
 Identities = 48/199 (24%), Positives = 90/199 (45%), Gaps = 42/199 (21%)

Query: 581 GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSL 640
           G  +AVK + L+     +    E  +++  +H N++ + ++  + D   +V+ ++  G+L
Sbjct: 44  GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103

Query: 641 D---SHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVL 697
               +H   + E             Q   +C  + + +++LH      VIH D+K  ++L
Sbjct: 104 TDIVTHTRMNEE-------------QIATVCLAVLKALSFLHAQ---GVIHRDIKSDSIL 147

Query: 698 LNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPE------YGFGS 751
           L  D    +SDFG    V         ++ +    +  L G+  +MAPE      YG   
Sbjct: 148 LTSDGRVKLSDFGFCAQV---------SKEVPRRKS--LVGTPYWMAPEVISRLPYG--- 193

Query: 752 NTSTKGDVYSFGILVLEMV 770
              T+ D++S GI+V+EMV
Sbjct: 194 ---TEVDIWSLGIMVIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 58.0 bits (140), Expect = 7e-09
 Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 29/219 (13%)

Query: 565 LGTGSYGRVYKGILQDGTAI----AVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIIT 620
           +G GS+G+V +   +D   I     ++   + S +       E  VL ++    ++ +  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
           +   P+   LVL ++  G L  HL    E  F    +              AE +  L +
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHL--QREGRFDLSRARFY----------TAELLCALEN 108

Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS-TANMLCGS 739
                VI+ DLKP N+LL+      + DFG+ KL            NM +    N  CG+
Sbjct: 109 LHKFNVIYRDLKPENILLDYQGHIALCDFGLCKL------------NMKDDDKTNTFCGT 156

Query: 740 IGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
             Y+APE   G   +   D ++ G+L+ EM+T   P  D
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 58.1 bits (140), Expect = 8e-09
 Identities = 82/368 (22%), Positives = 141/368 (38%), Gaps = 105/368 (28%)

Query: 558 EFDEQRL-----LGTGSYGRVYK----GILQDGTAIAVKVLQLQSGNFT---KSFNRECQ 605
           EF   RL     LG G++G+V +    GI +  +   V V  L+ G      K+   E +
Sbjct: 3   EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELK 62

Query: 606 VLKRI-RHRNLMRIITACSLPDFKALV---------------------LPY--------- 634
           +L  I  H N++ ++ AC+ P+   +V                      PY         
Sbjct: 63  ILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRG 122

Query: 635 -------------MANGSLDSHLYP-HSETEFGSGSSD----------LTLLQRVNICSD 670
                               S L+     +  GS +            LT+   +     
Sbjct: 123 RFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQ 182

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A GM +L   +  + IH DL   N+LL+++    + DFG+A+ +          + +  
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK------DPDYVRK 233

Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV 790
            +A +    + +MAPE  F    +T+ DV+SFG+L+ E          +F+ G S +  V
Sbjct: 234 GSARL---PLKWMAPESIFDKVYTTQSDVWSFGVLLWE----------IFSLGASPYPGV 280

Query: 791 K--NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLD 848
           +    +  RL+   D + +RA  + +PE+ R+            + C Q  P  RPT   
Sbjct: 281 QINEEFCQRLK---DGTRMRAPENATPEIYRIM-----------LACWQGDPKERPTFSA 326

Query: 849 AADDLDRL 856
             + L  L
Sbjct: 327 LVEILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 32/222 (14%)

Query: 565 LGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTK-SFNRECQVLKRIRHRNLMRIITAC 622
           LG G+Y  V+KG  +     +A+K ++L+       +  RE  +LK ++H N++ +    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI-CSDIAEGMAYLHHH 681
                  LV  Y     LDS L      ++     +L  +  V I    +  G++Y H  
Sbjct: 73  HTERCLTLVFEY-----LDSDL-----KQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR 122

Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIG 741
              +++H DLKP N+L+N+     ++DFG+A+           A+++   T +    ++ 
Sbjct: 123 ---KILHRDLKPQNLLINEKGELKLADFGLAR-----------AKSVPTKTYSNEVVTLW 168

Query: 742 YMAPEYGFGSNT-STKGDVYSFGILVLEMVTRRRPTDDMFAG 782
           Y  P+   GS   ST  D++  G ++ EM T R     MF G
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR----PMFPG 206

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 32/215 (14%)

Query: 563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQ----LQSGNFTKSFNRECQVLKRIRHRNLMR 617
           +++G GS+G+V     + +    AVKVLQ    L+        +    +LK ++H  L+ 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI-CSDIAEGMA 676
           +  +    D    VL Y+  G L  HL    E  F        L  R     ++IA  + 
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHL--QRERCF--------LEPRARFYAAEIASALG 110

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM-GNSTANM 735
           YLH    + +++ DLKP N+LL+     +++DFG+ K            EN+  N T + 
Sbjct: 111 YLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK------------ENIEHNGTTST 155

Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
            CG+  Y+APE           D +  G ++ EM+
Sbjct: 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 48/223 (21%)

Query: 563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQ---------VLKRIRH 612
           +++G GS+G+V     + DG   AVKVLQ +        NR+ Q         +LK ++H
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKI-----VLNRKEQKHIMAERNVLLKNVKH 55

Query: 613 RNLMRIITACSLPDFKALVLPYMANGSLDSHL-----YPHSETEFGSGSSDLTLLQRVNI 667
             L+ +  +    +    VL ++  G L  HL     +P     F               
Sbjct: 56  PFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARF--------------Y 101

Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
            ++IA  + YLH    + +++ DLKP N+LL+     +++DFG+ K  +           
Sbjct: 102 AAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-------- 150

Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
               T    CG+  Y+APE           D +  G ++ EM+
Sbjct: 151 ---DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 2e-08
 Identities = 66/258 (25%), Positives = 105/258 (40%), Gaps = 61/258 (23%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQ-LQSGNFTKSFNRECQVLKRIRHRNL 615
            +     +G G+YG V        G  +A+K +   +   F +   RE ++L+R +H N+
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65

Query: 616 MRI---ITACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           + I   I   S   F    +V   M             ET       DL  L +    S+
Sbjct: 66  IGILDIIRPPSFESFNDVYIVQELM-------------ET-------DLYKLIKTQHLSN 105

Query: 671 ---------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
                    I  G+ Y+H      V+H DLKPSN+LLN +    + DFG+A+      + 
Sbjct: 106 DHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR------IA 156

Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMF 780
           +   ++ G  T  +   +  Y APE    S   TK  D++S G ++ EM++  RP   +F
Sbjct: 157 DPEHDHTGFLTEYV--ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS-NRP---LF 210

Query: 781 AGGLSLHKWVKNHYHGRL 798
            G           Y  +L
Sbjct: 211 PG---------KDYLHQL 219

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 64/283 (22%), Positives = 120/283 (42%), Gaps = 37/283 (13%)

Query: 557 AEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVK---VLQLQSGNFTKSFNRECQVLKRIRH 612
           A F  ++ +G G +  VY+   L D   +A+K   + ++      +   +E  +LK++ H
Sbjct: 2   ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61

Query: 613 RNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIA 672
            N+++ + +    +   +VL     G L S +  + + +             V +CS   
Sbjct: 62  PNVIKYLDSFIEDNELNIVLELADAGDL-SQMIKYFKKQKRLIPERTVWKYFVQLCS--- 117

Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
              A  H HS  RV+H D+KP+NV +       + D G+ +   +             + 
Sbjct: 118 ---AVEHMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-----------KTTA 162

Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP--TDDMFAGGLSLHKWV 790
           A+ L G+  YM+PE    +  + K D++S G L+ EM   + P   D M     SL + +
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLFSLCQKI 220

Query: 791 ---------KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVA 824
                      HY  +L +++ S  +    DQ P++  +  +A
Sbjct: 221 EQCDYPPLPTEHYSEKLRELV-SMCIYPDPDQRPDIGYVHQIA 262

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 57.0 bits (138), Expect = 2e-08
 Identities = 66/252 (26%), Positives = 105/252 (41%), Gaps = 68/252 (26%)

Query: 563 RLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFT--KSFNRECQVLKRIRHRNLMR 617
           + +G+G+ G V   Y  +   G  +A+K L     N T  K   RE  ++K + H+N++ 
Sbjct: 22  KPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIG 79

Query: 618 IITAC----SLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           ++       SL +F+   LV+  M                      D  L Q + +  D 
Sbjct: 80  LLNVFTPQKSLEEFQDVYLVMELM----------------------DANLCQVIQMDLD- 116

Query: 672 AEGMAYL---------HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGN 722
            E M+YL         H HS   +IH DLKPSN+++  D T  + DFG+A+   T G   
Sbjct: 117 HERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG--- 169

Query: 723 DGAENMGNSTANMLCGSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
                    T+ M+   +    Y APE   G       D++S G ++ EM+        +
Sbjct: 170 ---------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTV----L 216

Query: 780 FAGGLSLHKWVK 791
           F G   + +W K
Sbjct: 217 FPGTDHIDQWNK 228

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 70/265 (26%), Positives = 112/265 (42%), Gaps = 46/265 (17%)

Query: 563 RLLGTGSYGRVYKGIL----QDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNL 615
           +LLG G++G+V   IL      G   A+K+L+ +   + +       E +VL+  RH  L
Sbjct: 1   KLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 57

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
             +  +    D    V+ Y   G L  HL    E  F    +           ++I   +
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARF-------YGAEIVSAL 108

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH  S   V++ DLK  N++L+ D    ++DFG+ K     G+  DGA      T   
Sbjct: 109 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGI-KDGA------TMKT 155

Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH 795
            CG+  Y+APE    ++     D +  G+++ EM+  R P                N  H
Sbjct: 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--------------FYNQDH 201

Query: 796 GRLEKVIDSSLLRASRDQSPEVKRM 820
            +L ++I    +R  R  SPE K +
Sbjct: 202 EKLFELILMEEIRFPRTLSPEAKSL 226

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 16/153 (10%)

Query: 565 LGTGSYGRVYKGILQDGTAIA-VKVLQLQSGNFTK---SFNRECQVLKRIRHRNLMRIIT 620
           +G G +G+V    +   T +A V V +L++   +K    F ++    + ++H N+++ + 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 621 AC--SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
            C  ++P    LV  Y   G L S+L           +S L LLQR  +  +IA G+ ++
Sbjct: 63  QCVEAIPYL--LVFEYCELGDLKSYLSQEQWHR---RNSQLLLLQR--MACEIAAGVTHM 115

Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI 711
           H H+    +H DL   N  L  D+T  V D+GI
Sbjct: 116 HKHN---FLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 36/221 (16%)

Query: 559 FDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHR 613
           + + + +G+G+ G V   +  +L  G  +AVK L    Q+    K   RE  +LK + H+
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 80

Query: 614 NLMRIITAC----SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS 669
           N++ ++       SL +F+ +   Y+    +D++L      E         L Q   +C 
Sbjct: 81  NIISLLNVFTPQKSLEEFQDV---YLVMELMDANLCQVIHMELDHERMSYLLYQM--LC- 134

Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
               G+ +LH      +IH DLKPSN+++  D T  + DFG+A+   T            
Sbjct: 135 ----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACT------------ 175

Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
           N        +  Y APE   G       D++S G ++ E+V
Sbjct: 176 NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 56.0 bits (135), Expect = 3e-08
 Identities = 69/266 (25%), Positives = 109/266 (40%), Gaps = 49/266 (18%)

Query: 563 RLLGTGSYGRVYKGIL----QDGTAIAVKVLQ----LQSGNFTKSFNRECQVLKRIRHRN 614
           +LLG G++G+V   IL      G   A+K+L+    +       +   E +VL+  RH  
Sbjct: 1   KLLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLT-ESRVLQNTRHPF 56

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           L  +  +    D    V+ Y   G L  HL    E  F   S D        I S     
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVF---SEDRARFYGAEIVS----A 107

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           + YLH      V++ DLK  N++L+ D    ++DFG+ K  ++ G           +T  
Sbjct: 108 LGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-----------ATMK 153

Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
             CG+  Y+APE    ++     D +  G+++ EM+  R P                N  
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--------------FYNQD 199

Query: 795 HGRLEKVIDSSLLRASRDQSPEVKRM 820
           H +L ++I    +R  R  SPE K +
Sbjct: 200 HEKLFELILMEEIRFPRTLSPEAKSL 225

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 55.9 bits (135), Expect = 4e-08
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 16/110 (14%)

Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
           ++IA G+ +LH      +I+ DLK  NV+L+ +    ++DFG+ K            EN+
Sbjct: 108 AEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK------------ENI 152

Query: 729 -GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
            G  T    CG+  Y+APE           D ++FG+L+ EM+  + P D
Sbjct: 153 FGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 55.7 bits (134), Expect = 4e-08
 Identities = 78/301 (25%), Positives = 129/301 (42%), Gaps = 60/301 (19%)

Query: 581 GTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANG 638
           GT + V++  L++      K+   E  +    RH N+M   T  +   +  ++ P+MA G
Sbjct: 25  GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84

Query: 639 SLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL 698
           S +S L    +T F  G S+  L+   NI      G+ YLH +     IH ++K S++L+
Sbjct: 85  SANSLL----KTYFPEGMSE-ALIG--NILFGALRGLNYLHQNG---YIHRNIKASHILI 134

Query: 699 NDDMTALVSDFGIAKLVMTVGVGNDG--AENMGNSTANMLCGSIGYMAPE------YGFG 750
           + D   LVS  G++ L   V  G       +    + ++L     +++PE      YG+ 
Sbjct: 135 SGD--GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVL----PWLSPELLRQDLYGY- 187

Query: 751 SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKW-------------------VK 791
              + K D+YS GI   E+ T R P  DM    + L K                    +K
Sbjct: 188 ---NVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMK 244

Query: 792 NHYHGRLEKVIDSSLLRASRDQSPEVKRM-------WDVAIGELIELGILCTQESPSTRP 844
           N   G ++  I  S++ A   Q+   +R+       +  A   L+E   LC Q+ P  RP
Sbjct: 245 NSQSG-VDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVE---LCLQQDPEKRP 300

Query: 845 T 845
           +
Sbjct: 301 S 301

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 51/212 (24%), Positives = 92/212 (43%), Gaps = 25/212 (11%)

Query: 565 LGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           +G GS G V     +  G  +AVK + L+     +    E  +++   H N++ +  +  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
           + D   +V+ ++  G+L + +  H+          +   Q   +C  +   ++YLH+   
Sbjct: 90  VGDELWVVMEFLEGGAL-TDIVTHTR---------MNEEQIATVCLSVLRALSYLHNQG- 138

Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
             VIH D+K  ++LL  D    +SDFG    V           +        L G+  +M
Sbjct: 139 --VIHRDIKSDSILLTSDGRIKLSDFGFCAQV-----------SKEVPKRKSLVGTPYWM 185

Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           APE        T+ D++S GI+V+EM+    P
Sbjct: 186 APEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 55.8 bits (134), Expect = 5e-08
 Identities = 59/241 (24%), Positives = 104/241 (43%), Gaps = 52/241 (21%)

Query: 550 RELLEATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQV 606
           + + E    +     +G+G+YG V      + G  +AVK L    QS    K   RE ++
Sbjct: 10  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 69

Query: 607 LKRIRHRNLMRIIT----ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLL 662
           LK ++H N++ ++     A SL +F             D +L  H     G+  +++   
Sbjct: 70  LKHMKHENVIGLLDVFTPARSLEEFN------------DVYLVTHL---MGADLNNIVKC 114

Query: 663 QRVN------ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM 716
           Q++       +   I  G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+   
Sbjct: 115 QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--- 168

Query: 717 TVGVGNDGAENMGNSTANMLCGSIG---YMAPEYGFG-SNTSTKGDVYSFGILVLEMVTR 772
                          T + + G +    Y APE      + +   D++S G ++ E++T 
Sbjct: 169 --------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214

Query: 773 R 773
           R
Sbjct: 215 R 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 55.0 bits (132), Expect = 5e-08
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 33/226 (14%)

Query: 553 LEATAEFDEQRLLGTGSYGRVYKG--ILQDGTAIAVKVLQLQSGNFTK-SFNRECQVLKR 609
           LE   + D+   LG G+Y  VYKG   L D   +A+K ++L+       +  RE  +LK 
Sbjct: 5   LETYIKLDK---LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKD 60

Query: 610 IRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI-C 668
           ++H N++ +           LV  Y     LD  L      ++     +   +  V +  
Sbjct: 61  LKHANIVTLHDIIHTEKSLTLVFEY-----LDKDL-----KQYLDDCGNSINMHNVKLFL 110

Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
             +  G+ Y H     +V+H DLKP N+L+N+     ++DFG+A+           A+++
Sbjct: 111 FQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR-----------AKSI 156

Query: 729 GNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
              T +    ++ Y  P+   GS + ST+ D++  G +  EM T R
Sbjct: 157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 55.5 bits (133), Expect = 6e-08
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 38/225 (16%)

Query: 563 RLLGTGSYGRVYKGILQDGTAI-AVKVLQLQSGNFTKSFN---RECQVLKRIRHRNLMRI 618
           R++G GSY +V    L+    I A+KV++ +  N  +  +    E  V ++  +   +  
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 619 ITACSLPDFKAL-VLPYMANGSLDSHL-----YPHSETEFGSGSSDLTLLQRVNICSDIA 672
           + +C   + +   V+ Y+  G L  H+      P     F S              ++I+
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS--------------AEIS 106

Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
             + YLH      +I+ DLK  NVLL+ +    ++D+G+ K  +  G            T
Sbjct: 107 LALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-----------DT 152

Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
            +  CG+  Y+APE   G +     D ++ G+L+ EM+  R P D
Sbjct: 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 55.4 bits (133), Expect = 6e-08
 Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 42/237 (17%)

Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  IL+   AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91

Query: 622 C----SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
                SL +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 92  FTPQKSLEEFQDV---YIVMELMDANLCQVIQMELDHERMSYLLYQM--LC-----GIKH 141

Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG------------TSFMMT 183

Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EM+        +F G   + +W K
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV----LFPGTDHIDQWNK 236

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 55.1 bits (132), Expect = 7e-08
 Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 42/237 (17%)

Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  +L    AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84

Query: 622 CS----LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
            +    L +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 85  FTPQKSLEEFQDV---YLVMELMDANLCQVIQMELDHERMSYLLYQM--LC-----GIKH 134

Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG------------TSFMMT 176

Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EMV  +     +F G   + +W K
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 229

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 54.6 bits (131), Expect = 8e-08
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 30/214 (14%)

Query: 565 LGTGSYGRVYKG---ILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           LG G+Y  V+KG   + ++  A+    L+ + G    +  RE  +LK ++H N++ +   
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTLHDI 72

Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI-CSDIAEGMAYLHH 680
                   LV  Y     LD  L      ++     ++  +  V I    I  G+AY H 
Sbjct: 73  VHTDKSLTLVFEY-----LDKDL-----KQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR 122

Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
               +V+H DLKP N+L+N+     ++DFG+A+           A+++   T +    ++
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLAR-----------AKSVPTKTYSNEVVTL 168

Query: 741 GYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRR 773
            Y  P+   GS+  ST+ D++  G +  EM + R
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 50/212 (23%), Positives = 91/212 (42%), Gaps = 25/212 (11%)

Query: 565 LGTGSYGRV-YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           +G GS G V    +   G  +AVK + L+     +    E  +++  +H N++ +  +  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
           + D   +V+ ++  G+L + +  H+          +   Q   +C  + + ++ LH    
Sbjct: 88  VGDELWVVMEFLEGGAL-TDIVTHTR---------MNEEQIAAVCLAVLKALSVLHAQG- 136

Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
             VIH D+K  ++LL  D    +SDFG    V           +        L G+  +M
Sbjct: 137 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-----------SKEVPRRKSLVGTPYWM 183

Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           APE         + D++S GI+V+EMV    P
Sbjct: 184 APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 59/241 (24%), Positives = 98/241 (40%), Gaps = 59/241 (24%)

Query: 563 RLLGTGSYGRVYKGILQDGTAI-AVKVLQLQSGNFTKSFNRECQVL-KRI-----RHRNL 615
           ++LG GS+G+V    L+    + A+KVL+       +  + +C +  KRI     +H  L
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDV--ILQDDDVDCTMTEKRILALAAKHPFL 58

Query: 616 MRIITACSLPDFKALVLPYMANGSL-----DSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
             +       D    V+ Y+  G L      S  +    + F +    L L+        
Sbjct: 59  TALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALM-------- 110

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
                 +LH H    VI+ DLK  N+LL+ +    ++DFG+ K  +           +  
Sbjct: 111 ------FLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGI-----------LNG 150

Query: 731 STANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGILVLEMVTRRRP-----TDDM 779
            T    CG+  Y+APE      YG         D ++ G+L+ EM+  + P      DD+
Sbjct: 151 VTTTTFCGTPDYIAPEILQELEYGPSV------DWWALGVLMYEMMAGQPPFEADNEDDL 204

Query: 780 F 780
           F
Sbjct: 205 F 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 60/222 (27%), Positives = 91/222 (40%), Gaps = 35/222 (15%)

Query: 565 LGTGSYGRV----YKGILQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIR-HRNL-- 615
           LG G+YG V          +   +A+K +          K   RE ++L+  R H+N+  
Sbjct: 8   LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66

Query: 616 ---MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIA 672
              M I+   +   F  L L Y      D H    S            + Q       I 
Sbjct: 67  LYDMDIVFPGN---FNELYL-YEELMEADLHQIIRSGQPLTDAHFQSFIYQ-------IL 115

Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
            G+ Y+H      V+H DLKP N+L+N D    + DFG+A+     G   +  EN G  T
Sbjct: 116 CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR-----GFSENPGENAGFMT 167

Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
             +   +  Y APE      + TK  DV+S G ++ E++ R+
Sbjct: 168 EYV--ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 85/374 (22%), Positives = 142/374 (37%), Gaps = 112/374 (29%)

Query: 558 EFDEQRL-----LGTGSYGRVYK----GILQDGTAIAVKVLQLQSG---NFTKSFNRECQ 605
           EF   RL     LG G++G+V +    GI +  T   V V  L+ G   +  ++   E +
Sbjct: 3   EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 62

Query: 606 VLKRI-RHRNLMRIITACSLPDFKALVL---------------------PYMANGS---- 639
           +L  I  H N++ ++ AC+ P    +V+                     PY    +    
Sbjct: 63  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQ 122

Query: 640 ---------------LDSHLYPHSETEFG--------------SGSSDL-----TLLQRV 665
                          LDS     S    G              +   DL     TL   +
Sbjct: 123 GKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLI 182

Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGA 725
                +A+GM +L   +  + IH DL   N+LL+++    + DFG+A+ +          
Sbjct: 183 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK------DP 233

Query: 726 ENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLS 785
           + +    A +    + +MAPE  F    + + DV+SFG+L+ E          +F+ G S
Sbjct: 234 DYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWE----------IFSLGAS 280

Query: 786 LHKWVK--NHYHGRLEKVIDSSLLRASRDQSPEV-KRMWDVAIGELIELGILCTQESPST 842
            +  VK    +  RL+   + + +RA    +PE+ + M D            C    PS 
Sbjct: 281 PYPGVKIDEEFCRRLK---EGTRMRAPDYTTPEMYQTMLD------------CWHGEPSQ 325

Query: 843 RPTMLDAADDLDRL 856
           RPT  +  + L  L
Sbjct: 326 RPTFSELVEHLGNL 339

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 53.1 bits (128), Expect = 2e-07
 Identities = 67/264 (25%), Positives = 103/264 (39%), Gaps = 58/264 (21%)

Query: 218 LSNLISLNLSSNLLSGTISAEISWLS-------QLEQLFLSHNLFSGEIPA-------AL 263
           L  L  L L  N L          L+        L++L LS N  +G IP         L
Sbjct: 22  LLCLQVLRLEGNTLGE---EAAKALASALRPQPSLKELCLSLN-ETGRIPRGLQSLLQGL 77

Query: 264 GKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSL---FLNNNQLSRSIPPTLGR-----CT 315
            K   L  LDLS N L  +    L +L++  SL    LNNN L       L +       
Sbjct: 78  TKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPP 137

Query: 316 DLYKLDLSYNRLTGSIPAEISG-IREIRIF--LNLSHNQLEGP----LPIELSKLENVQE 368
            L KL L  NRL G+    ++  +R  R    LNL++N +       L   L    N++ 
Sbjct: 138 ALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEV 197

Query: 369 IDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSG-- 426
           +DL++N  T      ++  +A                     LK+LE +++  N+L+   
Sbjct: 198 LDLNNNGLTDEGASALAETLA--------------------SLKSLEVLNLGDNNLTDAG 237

Query: 427 ---IIPISLNKIHTLTFINLSFNE 447
              +    L+   +L  ++LS N+
Sbjct: 238 AAALASALLSPNISLLTLSLSCND 261

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 62/263 (23%), Positives = 119/263 (45%), Gaps = 23/263 (8%)

Query: 565 LGTGSYGRVYKGILQDGTAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMRIITA-C 622
           +G G+YG VYK   +DG       L Q++    + S  RE  +L+ ++H N++ +     
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
           S  D K  +L   A   L   +  H  ++       L      ++   I +G+ YLH + 
Sbjct: 69  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN- 127

Query: 683 PVRVIHCDLKPSNVLLNDDMT----ALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCG 738
              V+H DLKP+N+L+  +        ++D G A+L       N   + + +    ++  
Sbjct: 128 --WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF------NSPLKPLADLDPVVV-- 177

Query: 739 SIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR 797
           +  Y APE   G+   TK  D+++ G +  E++T    ++ +F       K    ++H +
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT----SEPIFHCRQEDIKTSNPYHHDQ 233

Query: 798 LEKVIDSSLLRASRDQSPEVKRM 820
           L+++ +     A +D   ++K+M
Sbjct: 234 LDRIFNVMGFPADKDWE-DIKKM 255

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 34/115 (29%), Positives = 56/115 (48%), Gaps = 14/115 (12%)

Query: 663 QRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGN 722
           Q V   ++I+ G+ +LH      +I+ DLK  NV+L+ +    ++DFG+ K  M  GV  
Sbjct: 102 QAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-- 156

Query: 723 DGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
                    T    CG+  Y+APE           D +++G+L+ EM+  + P D
Sbjct: 157 ---------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 52.8 bits (127), Expect = 3e-07
 Identities = 53/225 (23%), Positives = 93/225 (41%), Gaps = 45/225 (20%)

Query: 565 LGTGSYGRV----YKGILQDGTAIAVKVL---------QLQSGNFTKSFNRECQVLKRIR 611
           LG G +G+V    YK     G   A+K L         +++S        R  +     R
Sbjct: 7   LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVES---LMCEKRIFETANSER 60

Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           H  L+ +       D    V+ Y A G L  H+  H++          +  + V   + +
Sbjct: 61  HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI--HTDV--------FSEPRAVFYAACV 110

Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG-N 730
             G+ YLH +   ++++ DLK  N+LL+ +    ++DFG+ K            E MG  
Sbjct: 111 VLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK------------EGMGFG 155

Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              +  CG+  ++APE    ++ +   D +  G+L+ EM+    P
Sbjct: 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 52.9 bits (127), Expect = 4e-07
 Identities = 83/365 (22%), Positives = 145/365 (39%), Gaps = 100/365 (27%)

Query: 558 EFDEQRL-----LGTGSYGRVYK----GILQDGTAIAVKVLQLQSG---NFTKSFNRECQ 605
           EF   RL     LG G++G+V +    GI +  +   V V  L+ G   +  K+   E +
Sbjct: 3   EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELK 62

Query: 606 VLKRI-RHRNLMRIITACSLPDFKALVL-PYMANGSLDSHL---------YPHSETEFG- 653
           +L  I  H N++ ++ AC+ P    +V+  Y   G+L ++L         Y +  T    
Sbjct: 63  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKRE 122

Query: 654 ----------------SGSSD--------------------------LTLLQRVNICSDI 671
                           S SS                           LTL   ++    +
Sbjct: 123 MKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQV 182

Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A GM +L   +  + IH DL   N+LL+++    + DFG+A+ +          + +   
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK------DPDYVRKG 233

Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
            A +    + +MAPE  F    +T+ DV+SFG+L+ E          +F+ G S +  V+
Sbjct: 234 DARL---PLKWMAPESIFDKVYTTQSDVWSFGVLLWE----------IFSLGASPYPGVQ 280

Query: 792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAAD 851
                 +++     L   +R ++PE       A  E+  + + C   +P  RPT  +  +
Sbjct: 281 ------IDEEFCRRLKEGTRMRAPE------YATPEIYSIMLDCWHNNPEDRPTFSELVE 328

Query: 852 DLDRL 856
            L  L
Sbjct: 329 ILGDL 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 51.3 bits (123), Expect = 6e-07
 Identities = 27/104 (25%), Positives = 50/104 (48%), Gaps = 14/104 (13%)

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I   ++Y+H      ++H D+K  N+ L       + DFGI+K++               
Sbjct: 110 IVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKIL-----------GSEY 155

Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           S A  + G+  YM+PE   G   + K D+++ G ++ E++T +R
Sbjct: 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 6e-07
 Identities = 60/257 (23%), Positives = 98/257 (38%), Gaps = 58/257 (22%)

Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNR---ECQVLKRIRHRN 614
           F + +LLG G  GRV+   L+  G   A+KVL  +         R   E ++L  + H  
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN---ICSDI 671
           L  +  +     +  LV+ Y   G L                    LLQR     +  ++
Sbjct: 63  LPTLYASFQTETYLCLVMDYCPGGELFR------------------LLQRQPGKCLSEEV 104

Query: 672 AE--------GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGV--- 720
           A          + YLH      +++ DLKP N+LL++    ++SDF ++K          
Sbjct: 105 ARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161

Query: 721 --GNDGAENMGNST-------------ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGIL 765
                G+     ++             +N   G+  Y+APE   G    +  D ++ GIL
Sbjct: 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGIL 221

Query: 766 VLEMVTRRRPTDDMFAG 782
           + EM+    P    F G
Sbjct: 222 LYEMLYGTTP----FKG 234

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 51.4 bits (124), Expect = 7e-07
 Identities = 39/158 (24%), Positives = 75/158 (47%), Gaps = 14/158 (8%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFN-RECQVLKRI-RHRNL 615
           +   + LG G++G VY     + G  +A+K ++ +  ++ +  N RE + L+++  H N+
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +++       D    V  YM  G+L   L    +          +     +I   I +G+
Sbjct: 61  VKLKEVFRENDELYFVFEYM-EGNL-YQLMKDRK------GKPFSESVIRSIIYQILQGL 112

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK 713
           A++H H      H DLKP N+L++      ++DFG+A+
Sbjct: 113 AHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 51.9 bits (124), Expect = 8e-07
 Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 34/202 (16%)

Query: 655 GSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL 714
           GS  LT L  ++    +A GM +L   +    +H DL   NVLL       + DFG+A+ 
Sbjct: 230 GSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARD 286

Query: 715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           +M          N  +  +  L   + +MAPE  F +  +T  DV+S+GIL+ E+ +   
Sbjct: 287 IMH-------DSNYVSKGSTFL--PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS--- 334

Query: 775 PTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGIL 834
                  GG          Y G    ++DS+     +      K   D A  E+ ++ + 
Sbjct: 335 ------LGGTP--------YPG---MIVDSTFYNKIKSGYRMAKP--DHATQEVYDIMVK 375

Query: 835 CTQESPSTRPTMLDAADDLDRL 856
           C    P  RP+ L  +D ++ L
Sbjct: 376 CWNSEPEKRPSFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 51.2 bits (123), Expect = 1e-06
 Identities = 41/167 (24%), Positives = 70/167 (41%), Gaps = 41/167 (24%)

Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFN---------RECQVLKRIRHRN 614
           +G GSYG V+K   ++ G  +A+K        F +S +         RE ++LK+++H N
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIK-------KFVESEDDPVIKKIALREIRMLKQLKHPN 61

Query: 615 LMRIITACSLPDFKA-----LVLPYMANGSLDS-HLYPHSETEFGSGSSDLTLLQRVNIC 668
           L+ +I       F+      LV  Y  +  L+     P    E               I 
Sbjct: 62  LVNLIEV-----FRRKRKLHLVFEYCDHTVLNELEKNPRGVPE----------HLIKKII 106

Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
               + + + H H+    IH D+KP N+L+       + DFG A+++
Sbjct: 107 WQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARIL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.4 bits (123), Expect = 1e-06
 Identities = 35/102 (34%), Positives = 54/102 (52%), Gaps = 14/102 (13%)

Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
           S +A+GM +L   +    IH D+   NVLL D   A + DFG+A+ +M     ND    +
Sbjct: 219 SQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIM-----NDSNYVV 270

Query: 729 -GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEM 769
            GN+        + +MAPE  F    + + DV+S+GIL+ E+
Sbjct: 271 KGNARL-----PVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 18/214 (8%)

Query: 565 LGTGSYGRVYKGILQDGTAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMRIITA-C 622
           +G G+YG VYK   +DG       L Q++    + S  RE  +L+ ++H N++ +     
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
           S  D K  +L   A   L   +  H  ++       L      ++   I +G+ YLH + 
Sbjct: 69  SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN- 127

Query: 683 PVRVIHCDLKPSNVLLNDDMT----ALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCG 738
              V+H DLKP+N+L+  +        ++D G A+L       N   + + +    ++  
Sbjct: 128 --WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF------NSPLKPLADLDPVVV-- 177

Query: 739 SIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVT 771
           +  Y APE   G+   TK  D+++ G +  E++T
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 40/226 (17%)

Query: 563 RLLGTGSYGRVYKGILQDGTAI-AVKVLQLQSGNFTKSFN---RECQVLKRIRHRNLMRI 618
           R++G GSY +V    L+    I A+KV++ +  +  +  +    E  V ++      +  
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 619 ITACSLPDFKA-LVLPYMANGSLDSHL-----YPHSETEFGSGSSDLTLLQRVNICSDIA 672
           + +C     +  LV+ Y+  G L  H+      P     F                ++I 
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF--------------YAAEIC 106

Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG-NS 731
             + +LH      +I+ DLK  NVLL+ D    ++D+G+ K            E +G   
Sbjct: 107 IALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK------------EGLGPGD 151

Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           T +  CG+  Y+APE   G       D ++ G+L+ EM+  R P D
Sbjct: 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 51.6 bits (123), Expect = 1e-06
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 52/226 (23%)

Query: 564 LLGTGSYGRVYKGILQDGT-AIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRI---- 618
           ++G GS+G VY+ I  D +  +A+K + LQ   +    NRE  ++K + H N++ +    
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKKV-LQDPQYK---NRELLIMKNLNHINIIFLKDYY 128

Query: 619 ITACSLPDFKALVL------------PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN 666
            T C   + K + L             YM + + ++H  P            L  L    
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF----------LVKLYSYQ 178

Query: 667 ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGA 725
           +C      +AY+H      + H DLKP N+L++ +   L + DFG AK ++         
Sbjct: 179 LC----RALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA-------- 223

Query: 726 ENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMV 770
              G  + + +C    Y APE   G+ N +T  D++S G ++ EM+
Sbjct: 224 ---GQRSVSYICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMI 265

Length = 440

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 50.8 bits (122), Expect = 1e-06
 Identities = 42/156 (26%), Positives = 70/156 (44%), Gaps = 17/156 (10%)

Query: 564 LLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNLMRIIT 620
           ++G G+YG V K   +  G  +A+K  +    +    K+  RE +VL+++RH N++ +  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 621 ACSLPDFKALVLPYMANGSLDS-HLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLH 679
           A        LV  Y+    L+     P         S    LLQ           +AY H
Sbjct: 68  AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQ----------AIAYCH 117

Query: 680 HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
            H    +IH D+KP N+L+++     + DFG A+ +
Sbjct: 118 SH---NIIHRDIKPENILVSESGVLKLCDFGFARAL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 51.1 bits (122), Expect = 1e-06
 Identities = 62/239 (25%), Positives = 99/239 (41%), Gaps = 55/239 (23%)

Query: 563 RLLGTGSYGRVYKGIL-QDGTAIAVKVLQ----LQSGNFTKSFNRECQVL-KRI-----R 611
           R+LG GS+G+V    L + G   AVKVL+    LQ  +       EC +  KRI      
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDV------ECTMTEKRILSLARN 54

Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHL-----YPHSETEFGSGSSDLTLLQRVN 666
           H  L ++      PD    V+ ++  G L  H+     +  +   F +            
Sbjct: 55  HPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA------------ 102

Query: 667 ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
             ++I   + +LH      +I+ DLK  NVLL+ +    ++DFG+ K  +  G       
Sbjct: 103 --AEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK------ 151

Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP-----TDDMF 780
                T +  CG+  Y+APE           D ++ G+L+ EM+    P      DD+F
Sbjct: 152 -----TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 30/211 (14%)

Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRHRNLMRIIT 620
           +G G YG+V+    +D G  +A+K ++   L   N  +    E  +L   +   L++++ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
           A    ++  L + Y+  G   + L        G  S D     R  + +++ E +  LH 
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLL-----NNLGVLSEDHA---RFYM-AEMFEAVDALHE 119

Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
              +  IH DLKP N L++      ++DFG++K ++T               AN + GS 
Sbjct: 120 ---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY--------------ANSVVGSP 162

Query: 741 GYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            YMAPE   G       D +S G ++ E + 
Sbjct: 163 DYMAPEVLRGKGYDFTVDYWSLGCMLYEFLC 193

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 51.4 bits (123), Expect = 2e-06
 Identities = 23/59 (38%), Positives = 35/59 (59%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLP 60
           L  N + G IPP    +  L  L L  N+ +G IPESL  L++L ++ L+ N+L+G +P
Sbjct: 449 LSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 65/292 (22%), Positives = 121/292 (41%), Gaps = 49/292 (16%)

Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNF--TKSFNRECQVLKRIRHRNL 615
           ++  + +G GS+G++Y    + D     +K + L        ++  +E  +L +++H N+
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +    +        +V+ Y   G L   +       F   S D  L   V I    + G+
Sbjct: 62  VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF---SEDQILSWFVQI----SLGL 114

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDD-MTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
            ++H     +++H D+K  N+ L+ + M A + DFGIA+ +      ND  E      A 
Sbjct: 115 KHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL------NDSME-----LAY 160

Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
              G+  Y++PE       + K D++S G ++ E+ T + P +     G +LH+ V    
Sbjct: 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE-----GNNLHQLVLKIC 215

Query: 795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTM 846
            G    +            SP   R     I +L ++       SP  RP++
Sbjct: 216 QGYFAPI------------SPNFSRDLRSLISQLFKV-------SPRDRPSI 248

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 33/109 (30%), Positives = 54/109 (49%), Gaps = 14/109 (12%)

Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
           ++IA G+ +LH      +I+ DLK  NV+L+ +    ++DFG+ K  M  GV        
Sbjct: 108 AEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-------- 156

Query: 729 GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
              T    CG+  Y+APE           D ++FG+L+ EM+  + P +
Sbjct: 157 ---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 48.8 bits (116), Expect = 5e-06
 Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 25/216 (11%)

Query: 563 RLLGTGSYGR--VYKGILQDGTAIAVKVLQL-QSGNFTKSFNRECQVLKRIRHRNLMRII 619
           R++G GS+GR  + + +  D    A+K ++L +S +  +   +E  +L +++H N++   
Sbjct: 6   RVVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFK 64

Query: 620 TACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLH 679
            +        +V+ Y   G L   +       F     D  L   V +C      +   H
Sbjct: 65  ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLF---PEDTILQWFVQMC------LGVQH 115

Query: 680 HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS 739
            H   RV+H D+K  N+ L  +    + DFG A+L+ + G           + A    G+
Sbjct: 116 IHEK-RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-----------AYACTYVGT 163

Query: 740 IGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
             Y+ PE       + K D++S G ++ E+ T + P
Sbjct: 164 PYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 49.3 bits (117), Expect = 5e-06
 Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 36/183 (19%)

Query: 549 YRELLEATAEFDEQRL-----LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSF 600
           YR+ L  T     +R      +G+G+YG V   Y   L+   A+       QS    +  
Sbjct: 2   YRQELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRT 61

Query: 601 NRECQVLKRIRHRN---LMRIIT-ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGS 656
            RE ++LK ++H N   L+ + T A S+ +F  + L                    G+  
Sbjct: 62  YRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYL---------------VTNLMGADL 106

Query: 657 SDLTLLQRVN------ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG 710
           +++   Q+++      +   +  G+ Y+H      +IH DLKPSNV +N+D    + DFG
Sbjct: 107 NNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163

Query: 711 IAK 713
           +A+
Sbjct: 164 LAR 166

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 49.8 bits (119), Expect = 6e-06
 Identities = 34/98 (34%), Positives = 56/98 (57%), Gaps = 10/98 (10%)

Query: 120 LDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELEL 179
           L ++   L G +P+DI SKL  L  ++LS N++         +P   SLG+ T LE L+L
Sbjct: 423 LGLDNQGLRGFIPNDI-SKLRHLQSINLSGNSI------RGNIPP--SLGSITSLEVLDL 473

Query: 180 AGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIG 216
           +     G++P+S+G+L +L  L L  N ++G +P  +G
Sbjct: 474 SYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 49.0 bits (117), Expect = 6e-06
 Identities = 31/110 (28%), Positives = 54/110 (49%), Gaps = 16/110 (14%)

Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
           ++I+  + +LH      +I+ DLK  NVLL+ +    ++D+G+ K            E +
Sbjct: 103 AEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK------------EGI 147

Query: 729 G-NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
               T +  CG+  Y+APE   G +     D ++ G+L+ EM+  R P D
Sbjct: 148 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 48.3 bits (115), Expect = 7e-06
 Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 38/217 (17%)

Query: 565 LGTGSYGRVYKGIL----QDGTAIAVK---VLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           +G GS+G   K IL    +DG    +K   + ++      +S  +E  VL  ++H N+++
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREES-RKEVAVLSNMKHPNIVQ 63

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
              +        +V+ Y   G L   +       F     D  L   V IC      +A 
Sbjct: 64  YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLF---PEDQILDWFVQIC------LAL 114

Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
            H H   +++H D+K  N+ L  D T  + DFGIA+++              NST  +  
Sbjct: 115 KHVHDR-KILHRDIKSQNIFLTKDGTIKLGDFGIARVL--------------NSTVELAR 159

Query: 738 GSIG---YMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
             IG   Y++PE       + K D+++ G ++ EM T
Sbjct: 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 47.9 bits (114), Expect = 1e-05
 Identities = 47/169 (27%), Positives = 76/169 (44%), Gaps = 26/169 (15%)

Query: 554 EATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRI 610
           E T  + + + +G G++G V     Q  G  +A+K +     +    K   RE ++LK +
Sbjct: 7   EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL 66

Query: 611 RHRNLMRI--ITACSLPDFKALVLPYMANGSLDSHLYPHS---ETEFGSGSSDLTLLQRV 665
           RH N++ +  I    L D    V   +     D H    S   E +F        L Q  
Sbjct: 67  RHENIISLSDIFISPLEDI-YFVTELLGT---DLHRLLTSRPLEKQF----IQYFLYQ-- 116

Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL 714
                I  G+ Y+H      V+H DLKPSN+L+N++    + DFG+A++
Sbjct: 117 -----ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 47.3 bits (113), Expect = 2e-05
 Identities = 55/234 (23%), Positives = 105/234 (44%), Gaps = 41/234 (17%)

Query: 559 FDEQRLLGTGSYGRVYKGILQ---DGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRH 612
           ++ +  +G G+YGRVYK   +   DG   A+K  +    Q    ++S  RE  +L+ ++H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 613 RNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGS-----GSSDLTLLQRVNI 667
            N++ ++        K++   Y+        L+ ++E +          +    +    +
Sbjct: 62  ENVVSLVEVFLEHADKSV---YL--------LFDYAEHDLWQIIKFHRQAKRVSIPPSMV 110

Query: 668 CS---DIAEGMAYLHHHSPVRVIHCDLKPSNVLL--NDDMTALV--SDFGIAKLVMTVGV 720
            S    I  G+ YLH +    V+H DLKP+N+L+        +V   D G+A+L      
Sbjct: 111 KSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF----- 162

Query: 721 GNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
            N   + +  +  + +  +I Y APE   G+   TK  D+++ G +  E++T  
Sbjct: 163 -NAPLKPL--ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 47.4 bits (113), Expect = 2e-05
 Identities = 31/97 (31%), Positives = 47/97 (48%), Gaps = 21/97 (21%)

Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIA-KLVMTVGVGNDGAENMGNSTA-NMLCGSIGY 742
           ++IH D+KPSN+LL+ +    + DFGI+ +LV              +S A     G   Y
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV--------------DSIAKTRDAGCRPY 173

Query: 743 MAPEYGFGSNTS----TKGDVYSFGILVLEMVTRRRP 775
           MAPE     +       + DV+S GI + E+ T + P
Sbjct: 174 MAPER-IDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 18/71 (25%), Positives = 33/71 (46%), Gaps = 3/71 (4%)

Query: 644 LYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMT 703
           L    E   G    +++  ++ +I   +AE +A LH    + + H DL P N+L++D   
Sbjct: 71  LMEWIE---GETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI 127

Query: 704 ALVSDFGIAKL 714
             + D+  A  
Sbjct: 128 LGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 39/155 (25%), Positives = 67/155 (43%), Gaps = 32/155 (20%)

Query: 625 PDFKALVLPYMANGSLDSHLYPH---SETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
           PD    +L  M  G L  HL  H   SE E    ++++ L            G+ ++H+ 
Sbjct: 69  PDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL------------GLEHMHNR 116

Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIG 741
               V++ DLKP+N+LL++     +SD G+A              +      +   G+ G
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLAC-------------DFSKKKPHASVGTHG 160

Query: 742 YMAPE-YGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           YMAPE    G+   +  D +S G ++ +++    P
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 51/221 (23%), Positives = 84/221 (38%), Gaps = 48/221 (21%)

Query: 568 GSYGRVY--KGILQDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRHR-----NLMR 617
           G++G VY  K     G   A+KVL+   + + N   +   E    + I         + +
Sbjct: 7   GAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKNQVTNVKAE----RAIMMIQGESPYVAK 61

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE---G 674
           +  +    D+  LV+ Y+  G   S +              L  L        IAE   G
Sbjct: 62  LYYSFQSKDYLYLVMEYLNGGDCASLI------------KTLGGLPEDWAKQYIAEVVLG 109

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           +  LH      +IH D+KP N+L++      ++DFG+++          G EN       
Sbjct: 110 VEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN---------GLEN------K 151

Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              G+  Y+APE   G       D +S G ++ E +    P
Sbjct: 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 49/222 (22%), Positives = 93/222 (41%), Gaps = 43/222 (19%)

Query: 565 LGTGSYGRVYKGILQD--------GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLM 616
           LG G++ +++KGI ++         T + +KVL     N+++SF     ++ ++ H++L+
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
                C   D   +V  Y+  GSLD++L  +           + +  ++ +   +A  + 
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNL--------INISWKLEVAKQLAWALH 114

Query: 677 YLHHHSPVRVIHCDLKPSNVLL---NDDMTA-----LVSDFGIAKLVMTVGVGNDGAENM 728
           +L       + H ++   NVLL    D  T       +SD GI+  V+            
Sbjct: 115 FLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL------------ 159

Query: 729 GNSTANMLCGSIGYMAPE-YGFGSNTSTKGDVYSFGILVLEM 769
                 +L   I ++ PE      N S   D +SFG  + E+
Sbjct: 160 ---PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEI 198

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 35/118 (29%), Positives = 57/118 (48%), Gaps = 12/118 (10%)

Query: 654 SGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK 713
           + S  L+ +  V     +A GM +L   +    +H DL   NVL+ +     + DFG+A+
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR 287

Query: 714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            +M          N  +  +  L   + +MAPE  F +  +T  DV+SFGIL+ E+ T
Sbjct: 288 DIMR-------DSNYISKGSTFL--PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 47.5 bits (113), Expect = 3e-05
 Identities = 35/114 (30%), Positives = 55/114 (48%), Gaps = 3/114 (2%)

Query: 366 VQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDL-KNLEAIDVSGNHL 424
           V  IDLS    +G I   I     ++ IN+S+N L G +PD +     +L  +++S N+ 
Sbjct: 71  VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNF 130

Query: 425 SGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPG 478
           +G   I    I  L  ++LS N   G IP+     S+ K+  +G   L G +P 
Sbjct: 131 TG--SIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182

Length = 968

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 46.6 bits (111), Expect = 3e-05
 Identities = 50/233 (21%), Positives = 95/233 (40%), Gaps = 57/233 (24%)

Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFN----RECQVLKRIRHRNLMRII 619
           +G G++G V+K    +    +A+K + +   N  + F     RE ++L+ ++H N++ +I
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLM--ENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 620 TACSLP-----DFKA---LVLPYMANGSLDSHLYPHSETEFGSGSSDLT-LLQRVNICSD 670
             C         +K    LV  +  +                    DL  LL   N+   
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCEH--------------------DLAGLLSNKNVKFT 117

Query: 671 IAE----------GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGV 720
           ++E          G+ Y+H +   +++H D+K +N+L+  D    ++DFG+A+       
Sbjct: 118 LSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR--AFSLS 172

Query: 721 GNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTR 772
            N       N        ++ Y  PE   G  +     D++  G ++ EM TR
Sbjct: 173 KNSKPNRYTNRVV-----TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 46.7 bits (111), Expect = 3e-05
 Identities = 30/104 (28%), Positives = 52/104 (50%), Gaps = 14/104 (13%)

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I  G+ YLH      ++H D+KP N+L+N +    + DFG+A++        D +++M  
Sbjct: 112 ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP-----DESKHMTQ 163

Query: 731 STANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
                      Y APE   GS + ++  D++S G +  E++ RR
Sbjct: 164 EVVTQY-----YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.1 bits (100), Expect = 3e-05
 Identities = 22/59 (37%), Positives = 30/59 (50%), Gaps = 1/59 (1%)

Query: 20 RLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQN 78
           L+ L L  N L      +   L NL ++ L  NNLT + P + F    SLR++DLS N
Sbjct: 1  NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEA-FSGLPSLRSLDLSGN 58

Length = 60

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 47.0 bits (111), Expect = 3e-05
 Identities = 49/203 (24%), Positives = 76/203 (37%), Gaps = 30/203 (14%)

Query: 603 ECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLL 662
           E   L R+ H N+++I               YM     D  LY     E         L 
Sbjct: 213 EILALGRLNHENILKIEEILRSEANT-----YMITQKYDFDLYSFMYDEAFDWKDRPLLK 267

Query: 663 QRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGN 722
           Q   I   +   + Y+H     ++IH D+K  N+ LN D   ++ DFG     M      
Sbjct: 268 QTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGT---AMPF---- 317

Query: 723 DGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRR-PTDDMFA 781
              E    +      G++   +PE   G       D++S G+++L+M++    P  D   
Sbjct: 318 ---EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD--- 371

Query: 782 GGLSLHKWVKNHYHGRLEKVIDS 804
           GG    K        +L K+IDS
Sbjct: 372 GGGKPGK--------QLLKIIDS 386

Length = 501

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 46.5 bits (111), Expect = 4e-05
 Identities = 56/253 (22%), Positives = 97/253 (38%), Gaps = 72/253 (28%)

Query: 558 EFDEQRLLGTGSYGRVYKGIL----QDGTAIAVKVLQLQSGNFTKSFNRECQVLKR--IR 611
           +F+  +++G G++G V+   L      G   A+KVL            R+  ++KR  I 
Sbjct: 2   DFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVL------------RKSDMIKRNQIA 46

Query: 612 H----RNLMRIITA-------CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLT 660
           H    R+++    +        S  D + L   Y+               E+  G   + 
Sbjct: 47  HVRAERDILADADSPWIVKLYYSFQDEEHL---YLV-------------MEYMPGGDLMN 90

Query: 661 LLQRVNICSD------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK- 713
           LL R ++  +      IAE +  L     +  IH D+KP N+L++ D    ++DFG+ K 
Sbjct: 91  LLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKK 150

Query: 714 -------LVMTVGVGNDGAENMGNST----------ANMLCGSIGYMAPEYGFGSNTSTK 756
                          N    +               AN   G+  Y+APE   G+    +
Sbjct: 151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE 210

Query: 757 GDVYSFGILVLEM 769
            D +S G+++ EM
Sbjct: 211 CDWWSLGVILYEM 223

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 46.9 bits (111), Expect = 4e-05
 Identities = 26/91 (28%), Positives = 47/91 (51%), Gaps = 9/91 (9%)

Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
           +++H DLK +N+ L       + DFG +K           ++++    A+  CG+  Y+A
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQY---------SDSVSLDVASSFCGTPYYLA 239

Query: 745 PEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           PE       S K D++S G+++ E++T  RP
Sbjct: 240 PELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 45.9 bits (109), Expect = 6e-05
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 33/223 (14%)

Query: 562 QRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFN--RECQVLKRIRHRNLM-- 616
           Q ++G GSYG V   I    G  +A+K +     + + +    RE ++L+ +RH +++  
Sbjct: 5   QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 64

Query: 617 -RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
             I+   S  +FK +   Y+    ++S L+     +    + DLT          +   +
Sbjct: 65  KHIMLPPSRREFKDI---YVVFELMESDLH-----QVIKANDDLTPEHHQFFLYQLLRAL 116

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            Y+H  +   V H DLKP N+L N D    + DFG+A++       ND        TA  
Sbjct: 117 KYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF-----NDTP------TAIF 162

Query: 736 LCGSIG---YMAPEY--GFGSNTSTKGDVYSFGILVLEMVTRR 773
               +    Y APE    F S  +   D++S G +  E++T +
Sbjct: 163 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 45.3 bits (107), Expect = 6e-05
 Identities = 39/155 (25%), Positives = 67/155 (43%), Gaps = 32/155 (20%)

Query: 625 PDFKALVLPYMANGSLDSHLYPH---SETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
           PD  + +L  M  G L  HL  H   SE E    ++++ L            G+ ++H+ 
Sbjct: 69  PDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIIL------------GLEHMHNR 116

Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIG 741
               V++ DLKP+N+LL++     +SD G+A              +      +   G+ G
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLAC-------------DFSKKKPHASVGTHG 160

Query: 742 YMAPE-YGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           YMAPE    G    +  D +S G ++ +++    P
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 55/238 (23%), Positives = 83/238 (34%), Gaps = 31/238 (13%)

Query: 120 LDVEYNHLSGELPSDIMSKL---PSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEE 176
           L +E N L  E    + S L   PSL  L LS N           +     L     L+E
Sbjct: 28  LRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQG--LTKGCGLQE 85

Query: 177 LELA----GMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIG-----NLSNLISLNLS 227
           L+L+    G D  G L   +   +L +L L  N +       +          L  L L 
Sbjct: 86  LDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLG 145

Query: 228 SNLLSGT----ISAEISWLSQLEQLFLSHNLFSG-------EIPAALGKLHHLGLLDLSF 276
            N L G     ++  +     L++L L++N           E   A   L  L L +   
Sbjct: 146 RNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGL 205

Query: 277 NKL-SGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTL-----GRCTDLYKLDLSYNRLT 328
               +  +  +L +L  +  L L +N L+ +    L          L  L LS N +T
Sbjct: 206 TDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 44.5 bits (105), Expect = 2e-04
 Identities = 30/92 (32%), Positives = 45/92 (48%), Gaps = 1/92 (1%)

Query: 372 SSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPIS 431
           SS        I  +N   V  I++S   + G +  ++  L  ++ I++S N LSG IP  
Sbjct: 53  SSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDD 112

Query: 432 LNKI-HTLTFINLSFNEFKGMIPSGGIFNSAT 462
           +     +L ++NLS N F G IP G I N  T
Sbjct: 113 IFTTSSSLRYLNLSNNNFTGSIPRGSIPNLET 144

Length = 968

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 62/246 (25%), Positives = 105/246 (42%), Gaps = 44/246 (17%)

Query: 552 LLEATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI 610
           L + T  ++    +G G+YG+VYK    +DG+  AVK+L   S +  +    E  +L+ +
Sbjct: 17  LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSL 75

Query: 611 -RHRNLMRIITACSLPDFKA-----LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
             H N+++        D        LVL     GS+         TE   G   L   QR
Sbjct: 76  PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSV---------TELVKGL--LICGQR 124

Query: 665 VN------ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV 718
           ++      I      G+ +LH++   R+IH D+K +N+LL  +    + DFG++  + + 
Sbjct: 125 LDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181

Query: 719 GVGNDGAENMGNSTANMLCGSIGYMAPEY-----GFGSNTSTKGDVYSFGILVLEMVTRR 773
            +             N   G+  +MAPE       +  +   + DV+S GI  +E+    
Sbjct: 182 RL-----------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGD 230

Query: 774 RPTDDM 779
            P  DM
Sbjct: 231 PPLFDM 236

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 44.3 bits (105), Expect = 2e-04
 Identities = 30/101 (29%), Positives = 47/101 (46%), Gaps = 15/101 (14%)

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           G+ Y+H      V+H DLKPSN+LLN +    + DFG+A+        ++  + M     
Sbjct: 120 GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR------TTSEKGDFMTEYVV 170

Query: 734 NMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
                   Y APE     +  T   DV+S G +  E++ R+
Sbjct: 171 TRW-----YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 44.5 bits (105), Expect = 2e-04
 Identities = 27/89 (30%), Positives = 48/89 (53%), Gaps = 16/89 (17%)

Query: 630 LVLPYMANGSLDS--HLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVI 687
           LV+ Y+  G + S  H+Y + + E             V   S++A  + YLH H    +I
Sbjct: 81  LVMEYLIGGDVKSLLHIYGYFDEEMA-----------VKYISEVALALDYLHRHG---II 126

Query: 688 HCDLKPSNVLLNDDMTALVSDFGIAKLVM 716
           H DLKP N+L++++    ++DFG++K+ +
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSKVTL 155

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 44.0 bits (104), Expect = 3e-04
 Identities = 26/81 (32%), Positives = 46/81 (56%), Gaps = 2/81 (2%)

Query: 73  VDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNLDVEYNHLSGEL 131
           + L      G IP +I    +L +++L  N + G +P SL + TS+  LD+ YN  +G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 132 PSDIMSKLPSLTYLHLSYNNM 152
           P + + +L SL  L+L+ N++
Sbjct: 483 P-ESLGQLTSLRILNLNGNSL 502

Length = 623

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.1 bits (92), Expect = 3e-04
 Identities = 17/59 (28%), Positives = 35/59 (59%)

Query: 390 VRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEF 448
           ++ +++S+N L      +   L NL+ +D+SGN+L+ I P + + + +L  ++LS N  
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 43.7 bits (103), Expect = 3e-04
 Identities = 48/182 (26%), Positives = 74/182 (40%), Gaps = 48/182 (26%)

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM-G 729
           +A+GM++L   +    IH DL   N+LL       + DFG+A+      + ND    + G
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKG 274

Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT------RRRPTDDMFAGG 783
           N+        + +MAPE  F    + + DV+S+GIL+ E+ +         P D  F   
Sbjct: 275 NARL-----PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF--- 326

Query: 784 LSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTR 843
              +K +K  Y                R  SPE       A  E+ ++   C    P  R
Sbjct: 327 ---YKMIKEGY----------------RMLSPE------CAPSEMYDIMKSCWDADPLKR 361

Query: 844 PT 845
           PT
Sbjct: 362 PT 363

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.1 bits (92), Expect = 4e-04
 Identities = 21/60 (35%), Positives = 30/60 (50%)

Query: 244 QLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQL 303
            L+ L LS+N  +     A   L +L +LDLS N L+   P +   L  + SL L+ N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 43.4 bits (102), Expect = 4e-04
 Identities = 40/172 (23%), Positives = 70/172 (40%), Gaps = 29/172 (16%)

Query: 603 ECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLL 662
           E  +L+ I H +++++    +   F  L+LP        + LY +   +      D+  +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILP-----RYKTDLYCYLAAKRNIAICDILAI 187

Query: 663 QRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGN 722
           +R      +   + YLH +   R+IH D+K  N+ +N      + DFG A   + +    
Sbjct: 188 ER-----SVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI---- 235

Query: 723 DGAENMGNSTANML---CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                     AN      G+I   APE           D++S GI++ EM T
Sbjct: 236 ---------NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.7 bits (91), Expect = 5e-04
 Identities = 25/62 (40%), Positives = 30/62 (48%), Gaps = 4/62 (6%)

Query: 196 NLTQLLLQENKITGSIPPHI-GNLSNLISLNLSSNLLSGTISAEISW-LSQLEQLFLSHN 253
           NL  L L  N++T  IP      L NL  L+LS N L+ +IS E    L  L  L LS N
Sbjct: 1   NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGN 58

Query: 254 LF 255
             
Sbjct: 59  NL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.3 bits (90), Expect = 7e-04
 Identities = 22/61 (36%), Positives = 30/61 (49%), Gaps = 1/61 (1%)

Query: 44  NLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQ 103
           NL  + L +N LT  +P   F    +L+ +DLS N  T   PE     P+L +L L  N 
Sbjct: 1   NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 104 L 104
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 42.1 bits (99), Expect = 8e-04
 Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 37/231 (16%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQD---GTAIAVKVL---QLQSGNFTKSFNRECQVLKRIR 611
           +FD + L+G G +G V   ++++   G   A+KV+    L +      F  E  +L    
Sbjct: 2   DFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59

Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
              + ++  A    D   LV+ Y   G L S L  + E +F     D  + Q       +
Sbjct: 60  SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRY-EDQF-----DEDMAQFY-----L 108

Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG-IAKLVMTVGVGNDGAENMGN 730
           AE +  +H    +  +H D+KP NVL++      ++DFG  A+L          A  M N
Sbjct: 109 AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL---------TANKMVN 159

Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKG------DVYSFGILVLEMVTRRRP 775
           S   +  G+  Y+APE     N   KG      D +S G++  EM+  R P
Sbjct: 160 SK--LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 42.2 bits (100), Expect = 0.001
 Identities = 19/69 (27%), Positives = 30/69 (43%), Gaps = 11/69 (15%)

Query: 661 LLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGV 720
           L     +   + E +A LH      ++H DL  SN ++ DD   L+ DFG+ K       
Sbjct: 427 LEGNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIVRDDRLYLI-DFGLGKY------ 476

Query: 721 GNDGAENMG 729
            +D  E+  
Sbjct: 477 -SDLIEDKA 484

Length = 535

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.1 bits (87), Expect = 0.002
 Identities = 24/60 (40%), Positives = 29/60 (48%)

Query: 220 NLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKL 279
           NL SL+LS+N L+         L  L+ L LS N  +   P A   L  L  LDLS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 41.4 bits (97), Expect = 0.002
 Identities = 41/173 (23%), Positives = 70/173 (40%), Gaps = 27/173 (15%)

Query: 599 SFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSD 658
           S   E ++L+R+ H  ++ ++    +     LVLP        S LY    T  G+    
Sbjct: 206 SSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP-----KYRSDLY----TYLGARLRP 256

Query: 659 LTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV 718
           L L Q   +   +   + Y+H      +IH D+K  NVL+N      + DFG A      
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFA--- 310

Query: 719 GVGNDGAENMGNSTANM---LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLE 768
                     G+ +      + G++   APE   G   +   D++S G+++ E
Sbjct: 311 ---------RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|215633 PLN03210, PLN03210, Resistant to P

 Score = 41.8 bits (98), Expect = 0.002
 Identities = 77/323 (23%), Positives = 130/323 (40%), Gaps = 64/323 (19%)

Query: 130 ELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLP 189
           E+P   +S   +L  L LS        D ++LV   +S+     LE+L+++  +    LP
Sbjct: 649 EIPD--LSMATNLETLKLS--------DCSSLVELPSSIQYLNKLEDLDMSRCENLEILP 698

Query: 190 -----DSIGRLNL----------------TQLLLQENKITGSIPP--HIGNLSNLISLNL 226
                 S+ RLNL                + L L E  I    P    + NL  LI   +
Sbjct: 699 TGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIE-EFPSNLRLENLDELILCEM 757

Query: 227 SSNLLSGTISAEISWLS----QLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGE 282
            S  L   +      ++     L +LFLS      E+P+++  LH L  L++        
Sbjct: 758 KSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLET 817

Query: 283 IPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIRE-- 340
           +P  + NL  + SL L+     R+ P      T++  L+LS            +GI E  
Sbjct: 818 LPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSR-----------TGIEEVP 862

Query: 341 --IRIFLNLSHNQLEG-----PLPIELSKLENVQEIDLSS-NKFTGNIFIQISNCIAVRL 392
             I  F NLS   + G      + + +SKL++++ +D S     T   +    + +A+  
Sbjct: 863 WWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCGALTEASWNGSPSEVAMAT 922

Query: 393 INISHNALQGNLPDSLGDLKNLE 415
            NI H+ L   +  +  +  NL+
Sbjct: 923 DNI-HSKLPSTVCINFINCFNLD 944

syringae 6; Provisional. Length = 1153

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.4 bits (85), Expect = 0.003
 Identities = 22/56 (39%), Positives = 28/56 (50%), Gaps = 2/56 (3%)

Query: 1  MLVDNHLFGAIPPE-FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNL 55
           L +N L   IP   F  L  L+ L L GNNL    PE+ + L +L  + L  NNL
Sbjct: 6  DLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 40.4 bits (94), Expect = 0.003
 Identities = 59/231 (25%), Positives = 96/231 (41%), Gaps = 40/231 (17%)

Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIR-HRNLMRIITAC 622
           +G G+YG+V+K +  ++G+  AVK+L     +  +    E  +LK +  H N+++     
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 623 SLPDFKA-----LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN---ICSDIAEG 674
              D K      LVL     GS+         T+   G   L   +R+    I   + E 
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSV---------TDLVKGF--LKRGERMEEPIIAYILHEA 133

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI-AKLVMTVGVGNDGAENMGNSTA 733
           +  L H    + IH D+K +N+LL  +    + DFG+ A+L  T                
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST------------RLRR 181

Query: 734 NMLCGSIGYMAPEY-----GFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
           N   G+  +MAPE         S    + DV+S GI  +E+     P  D+
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 40.1 bits (94), Expect = 0.003
 Identities = 48/228 (21%), Positives = 94/228 (41%), Gaps = 48/228 (21%)

Query: 565 LGTGSYGRVYKGILQDG-----------TAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR 613
           LG G++  +YKG+L+              ++ +KVL       + +F     ++ ++ H+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-SDHRDSLAFFETASLMSQLSHK 61

Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           +L+++   C + D   +V  Y+  G LD  L  H E    S    L + ++      +A 
Sbjct: 62  HLVKLYGVC-VRDENIMVEEYVKFGPLDVFL--HREKNNVSLHWKLDVAKQ------LAS 112

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-------VSDFGIAKLVMTVGVGNDGAE 726
            + YL      +++H ++   N+L+              +SD GI    +TV    +  E
Sbjct: 113 ALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP---ITVLSREERVE 166

Query: 727 NMGNSTANMLCGSIGYMAPEY--GFGSNTSTKGDVYSFGILVLEMVTR 772
                        I ++APE      ++ +   D +SFG  +LE+ + 
Sbjct: 167 R------------IPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	885
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.98
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.98
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.98
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.98
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.95
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.88
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.85
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.84
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.83
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.8
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.77
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.77
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.76
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.76
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.76
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.75
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.74
PRK10345	210	hypothetical protein; Provisional	99.74
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.74
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.72
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.71
smart00090	237	RIO RIO-like kinase.	99.7
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.66
PRK14879	211	serine/threonine protein kinase; Provisional	99.66
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.63
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.63
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.62
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.61
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.56
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.56
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.54
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.52
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.49
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.44
PLN03150	623	hypothetical protein; Provisional	99.41
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.38
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.38
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.36
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.28
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.25
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.25
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.23
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.23
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.21
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.2
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.2
PLN03150	623	hypothetical protein; Provisional	99.19
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.18
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.13
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.13
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.12
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.11
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.1
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.08
KOG1243	690	consensus Protein kinase [General function predict	99.08
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.08
COG4248	637	Uncharacterized protein with protein kinase and he	99.08
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.06
KOG3087	229	consensus Serine/threonine protein kinase [General	99.04
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.01
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.0
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.99
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.92
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.9
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.87
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.84
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.82
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.79
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.78
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.72
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.69
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.51
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.48
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.44
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.4
KOG1644	233	consensus U2-associated snRNP A' protein [RNA proc	98.39
PRK09902	216	hypothetical protein; Provisional	98.39

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.7e-95  Score=909.28  Aligned_cols=801  Identities=29%  Similarity=0.463  Sum_probs=584.7

Q ss_pred             CCCCcccccCCccccCCCCCcEEeCCCCcccccCchhhhCCCCCcEEEccCcccccCCchhhhcCCCCCCEEEcCCCccc
Q 002746            2 LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFT   81 (885)
Q Consensus         2 l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~f~~l~~L~~L~Ls~N~l~   81 (885)
                      |++|++.+.+|..|+++++|++|+|++|.+.+.+|.+|..+++|++|+|++|++++.+|. .|.++++|++|+|++|++.
T Consensus       147 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~L~~n~l~  225 (968)
T PLN00113        147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPR-ELGQMKSLKWIYLGYNNLS  225 (968)
T ss_pred             CcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCCh-HHcCcCCccEEECcCCccC
Confidence            445555556666666666666666666666656666666666666666666666555553 3556666666666666666


Q ss_pred             ccCCccCCCCCCCcEEEcccccCcccCCccccc-CccceEecccccccCCCChhhhcCCCCCcEEECCCCcccCCCCCCC
Q 002746           82 GKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTN  160 (885)
Q Consensus        82 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  160 (885)
                      +..|..|+++++|++|+|++|++++..|..+.. .+|++|++++|.+.+.+|.. +.++++|++|+|++|.+....    
T Consensus       226 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~Ls~n~l~~~~----  300 (968)
T PLN00113        226 GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPS-IFSLQKLISLDLSDNSLSGEI----  300 (968)
T ss_pred             CcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchh-HhhccCcCEEECcCCeeccCC----
Confidence            666666666666666666666666555555544 45666666666666555543 355666666666666654321    


Q ss_pred             cccccccCCCCCCCcEEEecCcccCccCCCccccc-cccEEEccCCcccccCCccccCCCCCCeeeccccccccccchhh
Q 002746          161 LVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEI  239 (885)
Q Consensus       161 ~~~~~~~l~~l~~L~~L~l~~~~l~~~~p~~~~~~-~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  239 (885)
                          +..+.++++|+.|++++|.+.+..|..+..+ +|+.|++++|++++.+|..+..+++|+.|++++|++++..|..+
T Consensus       301 ----p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~  376 (968)
T PLN00113        301 ----PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGL  376 (968)
T ss_pred             ----ChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhH
Confidence                2235667777777777777777777666555 67777777777777777777777777777777777777777777


Q ss_pred             cCCCCCCeEecccccccccCcccccCCCCCCeeecccccccccCCccccCCCcccEEEccCCccCCCCCcccCCCCCCCE
Q 002746          240 SWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYK  319 (885)
Q Consensus       240 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~  319 (885)
                      ..+++|+.|++++|.+.+..|..+..+++|+.|++++|++++..|..|.+++.|+.|++++|++++..|..+..+++|+.
T Consensus       377 ~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  456 (968)
T PLN00113        377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQM  456 (968)
T ss_pred             hCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcE
Confidence            77777788888888777777778888888888888888888888888888888888888888888888887888888888


Q ss_pred             EECcCCcCcccCCccccCccceeeeeeccCCcCCCCchhhhcCCCCcceeecCCCccccccccccccCccccEEEecCCc
Q 002746          320 LDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNA  399 (885)
Q Consensus       320 L~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~  399 (885)
                      |++++|++.+.+|..+ +..++ +.|++++|++++..|..+..+++|+.|+|++|++++.+|..+..+++|+.|+|++|.
T Consensus       457 L~L~~n~~~~~~p~~~-~~~~L-~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  534 (968)
T PLN00113        457 LSLARNKFFGGLPDSF-GSKRL-ENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQ  534 (968)
T ss_pred             EECcCceeeeecCccc-ccccc-eEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCc
Confidence            8888888887777655 34666 469999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCccccccccccccccCcccccccCcccCCCceecEEEcccccccccCCCCCccCCCCccccccCcccccCCC--
Q 002746          400 LQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVP--  477 (885)
Q Consensus       400 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~--  477 (885)
                      +++.+|..|..+++|+.|+|++|++++.+|..+.++++|+.|++++|++++.+|..+.+.++...++.||+.+|+..+  
T Consensus       535 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~  614 (968)
T PLN00113        535 LSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTS  614 (968)
T ss_pred             ccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCcccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999998664  


Q ss_pred             CCCCCCCCCCcCccceeeeehhHHHHHHHHHHH-HHHHHHhhheeeeeccCCCCCCCCCCCcccc--cCCCCcCHHHHHH
Q 002746          478 GMPICPPKQHWLHTRMYFIIFVLVISISAFLST-ICLVTGIHRIKLIISSGKSETRSKPITPELM--HNFPRITYRELLE  554 (885)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  554 (885)
                      +.+.|.....  ... .+.+++++++++.++++ ++++..+++++. ...++.+...........  .....++++++  
T Consensus       615 ~~~~c~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  688 (968)
T PLN00113        615 GLPPCKRVRK--TPS-WWFYITCTLGAFLVLALVAFGFVFIRGRNN-LELKRVENEDGTWELQFFDSKVSKSITINDI--  688 (968)
T ss_pred             CCCCCccccc--cce-eeeehhHHHHHHHHHHHHHHHHHHHHhhhc-ccccccccccccccccccccccchhhhHHHH--
Confidence            2345643211  111 11222111111111111 122222222111 000111110000000000  00112333333  


Q ss_pred             HhhCCcccceecccCcceEEEEEe-CCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEe
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                       ...|...++||+|+||.||+|+. .++..||||+++....    ....|++++++++|||||+++++|.+++..++|||
T Consensus       689 -~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        689 -LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             -HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence             35677888999999999999996 4789999998863322    22456889999999999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      |+++|+|.++++.            ++|..+.+|+.|+|+|++|||..+.++|+||||||+||+++.++.+++. ||.+.
T Consensus       764 y~~~g~L~~~l~~------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~  830 (968)
T PLN00113        764 YIEGKNLSEVLRN------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG  830 (968)
T ss_pred             CCCCCcHHHHHhc------------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence            9999999998851            7899999999999999999996655569999999999999999888875 66543


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      ....               .....||+.|+|||++.+..++.++|||||||++|||+||+.||+..........+|++..
T Consensus       831 ~~~~---------------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~  895 (968)
T PLN00113        831 LLCT---------------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYC  895 (968)
T ss_pred             cccc---------------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHh
Confidence            3210               1123578999999999999999999999999999999999999976555566777887665


Q ss_pred             hcch-hhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHhc
Q 002746          794 YHGR-LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLG  861 (885)
Q Consensus       794 ~~~~-~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~  861 (885)
                      +... ...++|+.+.......        .....++.+++.+||+.||++||+|+||++.|+++.+...
T Consensus       896 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~  956 (968)
T PLN00113        896 YSDCHLDMWIDPSIRGDVSVN--------QNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS  956 (968)
T ss_pred             cCccchhheeCccccCCCCcc--------HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence            5432 3344454443221111        1234578899999999999999999999999998866443

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.5e-51  Score=512.14  Aligned_cols=466  Identities=34%  Similarity=0.502  Sum_probs=305.2

Q ss_pred             CCCCcccccCCcccc-CCCCCcEEeCCCCcccccCchhhhCCCCCcEEEccCcccccCCchhhhcCCCCCCEEEcCCCcc
Q 002746            2 LVDNHLFGAIPPEFS-KLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFF   80 (885)
Q Consensus         2 l~~n~~~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~f~~l~~L~~L~Ls~N~l   80 (885)
                      |++|++.+.+|..+. .+++|++|+|++|++++.+|.  +.+++|++|+|++|.+++.+|.. |+++++|++|+|++|.+
T Consensus       100 Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~-~~~l~~L~~L~L~~n~l  176 (968)
T PLN00113        100 LSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPND-IGSFSSLKVLDLGGNVL  176 (968)
T ss_pred             CCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChH-HhcCCCCCEEECccCcc
Confidence            566777777776543 667777777777766655543  34555666666666655444432 45566666666666665


Q ss_pred             cccCCccCCCCCCCcEEEcccccCcccCCccccc-CccceEecccccccCCCChhhhcCCCCCcEEECCCCcccCCCCCC
Q 002746           81 TGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNT  159 (885)
Q Consensus        81 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  159 (885)
                      .+..|..|+++++|++|+|++|++.+..|..+.. .+|+.|+|++|++.+.+|.. |+++++|++|+|++|.+.......
T Consensus       177 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~L~~n~l~~~~p~~  255 (968)
T PLN00113        177 VGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYE-IGGLTSLNHLDLVYNNLTGPIPSS  255 (968)
T ss_pred             cccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChh-HhcCCCCCEEECcCceeccccChh
Confidence            5555555556666666666666555555554443 45555555555555444443 355555555555555544211100


Q ss_pred             -----C-----------cccccccCCCCCCCcEEEecCcccCccCCCccccc-cccEEEccCCcccccCCccccCCCCCC
Q 002746          160 -----N-----------LVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLI  222 (885)
Q Consensus       160 -----~-----------~~~~~~~l~~l~~L~~L~l~~~~l~~~~p~~~~~~-~L~~L~l~~n~i~~~~~~~~~~l~~L~  222 (885)
                           +           ....+.++.++++|+.|++++|.+.+.+|..+..+ +|+.|++++|.+++..|..+..+++|+
T Consensus       256 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~  335 (968)
T PLN00113        256 LGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQ  335 (968)
T ss_pred             HhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCC
Confidence                 0           00011234455555555555555555555544433 455555555555555555555555555


Q ss_pred             eeeccccccccccchhhcCCCCCCeEecccccccccCcccccCCCCCCeeecccccccccCCccccCCCcccEEEccCCc
Q 002746          223 SLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQ  302 (885)
Q Consensus       223 ~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~  302 (885)
                      +|++++|.+++..|..+..+++|+.|+|++|.+++..|..+..+++|+.|++++|++.+..|..+.++++|+.|++++|+
T Consensus       336 ~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~  415 (968)
T PLN00113        336 VLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNS  415 (968)
T ss_pred             EEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCE
Confidence            55555555555555555555555555555555555555555555556666666666655566666666666677777777


Q ss_pred             cCCCCCcccCCCCCCCEEECcCCcCcccCCccccCccceeeeeeccCCcCCCCchhhhcCCCCcceeecCCCcccccccc
Q 002746          303 LSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFI  382 (885)
Q Consensus       303 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~  382 (885)
                      +++..|..|..+++|+.|++++|++++.+|..+..+++| +.|+|++|++.+.+|..+ ..++|+.|++++|++++..|.
T Consensus       416 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~  493 (968)
T PLN00113        416 FSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSL-QMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPR  493 (968)
T ss_pred             eeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCC-cEEECcCceeeeecCccc-ccccceEEECcCCccCCccCh
Confidence            666666666677777777777777776666666666666 347777777776666554 357788888888888888888


Q ss_pred             ccccCccccEEEecCCccCCCCCCccccccccccccccCcccccccCcccCCCceecEEEcccccccccCCCC-CccCCC
Q 002746          383 QISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSG-GIFNSA  461 (885)
Q Consensus       383 ~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~  461 (885)
                      .+.++++|+.|+|++|++++.+|..+..+++|++|+|++|.+++.+|..+..+++|+.|+|++|++++.+|.. ..+.++
T Consensus       494 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L  573 (968)
T PLN00113        494 KLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESL  573 (968)
T ss_pred             hhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCccc
Confidence            8999999999999999999999999999999999999999999999999999999999999999999988763 557778


Q ss_pred             CccccccCcccc
Q 002746          462 TKMSFVGNQHLC  473 (885)
Q Consensus       462 ~~~~~~~n~~~c  473 (885)
                      ..+.+.+|+..+
T Consensus       574 ~~l~ls~N~l~~  585 (968)
T PLN00113        574 VQVNISHNHLHG  585 (968)
T ss_pred             CEEeccCCccee
Confidence            888899998665

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-50  Score=432.73  Aligned_cols=290  Identities=38%  Similarity=0.664  Sum_probs=245.2

Q ss_pred             CCCCcCHHHHHHHhhCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeee
Q 002746          543 NFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITAC  622 (885)
Q Consensus       543 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  622 (885)
                      ....|++.++..+|++|...+.||+|+||.||+|...+|+.||||++........++|..|++++++++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45568999999999999999999999999999999999999999988754432145699999999999999999999999


Q ss_pred             ecCC-cceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCC
Q 002746          623 SLPD-FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDD  701 (885)
Q Consensus       623 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~  701 (885)
                      .+.+ +.+||||||++|+|.++++.....       +++|.+|.+||.++|+||+|||+..+++||||||||+|||+|++
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~  213 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED  213 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence            9998 499999999999999999875421       58999999999999999999999998899999999999999999


Q ss_pred             CCEEEcccccceeeecccCCCCCCCCCCCCccccc-cccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccc
Q 002746          702 MTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML-CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMF  780 (885)
Q Consensus       702 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~  780 (885)
                      +++||+|||+|+..+..           ....... .||.+|+|||+...+..++|+|||||||+++|++||+.|.+...
T Consensus       214 ~~aKlsDFGLa~~~~~~-----------~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~  282 (361)
T KOG1187|consen  214 FNAKLSDFGLAKLGPEG-----------DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR  282 (361)
T ss_pred             CCEEccCccCcccCCcc-----------ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC
Confidence            99999999999654210           0111111 79999999999999999999999999999999999999987643


Q ss_pred             -cCCccHHHHHHHhhcc-hhhhhhhhhhhh-ccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 002746          781 -AGGLSLHKWVKNHYHG-RLEKVIDSSLLR-ASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLK  857 (885)
Q Consensus       781 -~~~~~~~~~~~~~~~~-~~~~~~d~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~  857 (885)
                       .+...+..|+...... .+.+++|+.+.. .+.. .        .....+..++.+|++.+|.+||+|.||++.|+.+.
T Consensus       283 ~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~-~--------~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  283 PRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPD-E--------KEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             CcccccHHHHHHHHHHCcchhheeCCCccCCCCCh-H--------HHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence             3345588998666655 588899988763 2210 0        24556899999999999999999999999986654


Q ss_pred             HH
Q 002746          858 RY  859 (885)
Q Consensus       858 ~~  859 (885)
                      ..
T Consensus       354 ~~  355 (361)
T KOG1187|consen  354 SL  355 (361)
T ss_pred             cc
Confidence            43

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-47  Score=381.76  Aligned_cols=252  Identities=27%  Similarity=0.428  Sum_probs=208.0

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeec-CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCc-ceEEEec
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDF-KALVLPY  634 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lV~e~  634 (885)
                      +.+..+.||+|..|+||+++++ +++.+|+|.+... .....+++.+|++++++.+||+||++||+|..+.. ..++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            3455678999999999999976 6888999999654 34457889999999999999999999999999884 9999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH-HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      |++|+|+..+....         .+++....+|+.+|++||.|||+ ++   ||||||||+|||++..|++||||||.+.
T Consensus       160 MDgGSLd~~~k~~g---------~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~  227 (364)
T KOG0581|consen  160 MDGGSLDDILKRVG---------RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSG  227 (364)
T ss_pred             cCCCCHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccH
Confidence            99999999987553         38999999999999999999996 65   9999999999999999999999999998


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      .+.             .+.+....||..|||||.+.+..|+.++||||||++++|+++|+.||......-....      
T Consensus       228 ~lv-------------nS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~------  288 (364)
T KOG0581|consen  228 ILV-------------NSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIF------  288 (364)
T ss_pred             Hhh-------------hhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHH------
Confidence            763             2355678999999999999999999999999999999999999999965311111111      


Q ss_pred             hcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       794 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                            +.++..+..... ..|.     +.+++++..++..|+++||.+||+++|+++|
T Consensus       289 ------~Ll~~Iv~~ppP-~lP~-----~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  289 ------ELLCAIVDEPPP-RLPE-----GEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             ------HHHHHHhcCCCC-CCCc-----ccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                  111211111111 1111     1267889999999999999999999999987

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-45  Score=393.44  Aligned_cols=265  Identities=32%  Similarity=0.510  Sum_probs=212.9

Q ss_pred             CcccceecccCcceEEEEEeCCCCEEEEEEeeecCCc--chhhHHHHHHHHhhcCCcccceeeeeeecCC-cceEEEecc
Q 002746          559 FDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNLMRIITACSLPD-FKALVLPYM  635 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lV~e~~  635 (885)
                      +...+.+|+|+||+||+|.|+....||||++......  ..+.|.+|+.++++++|||||+++|+|..+. ..++|||||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            3444569999999999999984444999999854322  2568999999999999999999999999887 789999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCC-CEEEccccccee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDM-TALVSDFGIAKL  714 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfg~a~~  714 (885)
                      ++|+|.++++....       ..+++..+++|+.+||+|++|||++++  ||||||||+|||++.++ ++||+|||+++.
T Consensus       123 ~~GsL~~~l~~~~~-------~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  123 PGGSLSVLLHKKRK-------RKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             CCCcHHHHHhhccc-------CCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCcccee
Confidence            99999999987411       249999999999999999999999984  99999999999999997 999999999987


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccC--CCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF--GSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      .....           .......||+.|||||++.  ...|+.|+||||||+++|||+||+.||.....     .+.+..
T Consensus       194 ~~~~~-----------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~~~~~~  257 (362)
T KOG0192|consen  194 KVISK-----------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----VQVASA  257 (362)
T ss_pred             ecccc-----------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHH
Confidence            63210           1222367999999999999  56999999999999999999999999987432     111111


Q ss_pred             hhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHhcCCCCC
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGEKHMP  866 (885)
Q Consensus       793 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~~~~~  866 (885)
                                  -.....+...+.      .++..+..++.+||..||++||++.|++..|+.+..........
T Consensus       258 ------------v~~~~~Rp~~p~------~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~~  313 (362)
T KOG0192|consen  258 ------------VVVGGLRPPIPK------ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGPE  313 (362)
T ss_pred             ------------HHhcCCCCCCCc------cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCcc
Confidence                        111111111111      14567889999999999999999999999999998866654443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-46  Score=377.90  Aligned_cols=253  Identities=26%  Similarity=0.423  Sum_probs=206.8

Q ss_pred             hhCCcccceecccCcceEEEEEe-CCCCEEEEEEeeecCCc-------chhhHHHHHHHHhhcCCcccceeeeeeecCCc
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQSGN-------FTKSFNRECQVLKRIRHRNLMRIITACSLPDF  627 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  627 (885)
                      .+.|.+.+.+|+|+||.|-+|.. ++|+.||||+++.+...       ......+|+++|++++||+||++.++|+.++.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            35688899999999999999994 48999999999754211       12235699999999999999999999999999


Q ss_pred             ceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCC---CCE
Q 002746          628 KALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDD---MTA  704 (885)
Q Consensus       628 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~---~~~  704 (885)
                      .|||||||+||+|.+.+..+..         +.+..-..++.|++.|+.|||++|   |+||||||+|||+..+   ..+
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk~---------l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~ll  318 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANKY---------LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLL  318 (475)
T ss_pred             eEEEEEEecCccHHHHHHhccc---------cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEE
Confidence            9999999999999998876553         566667889999999999999999   9999999999999765   889


Q ss_pred             EEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCC---CccccchhhHHHHHHHHcCCCCCCcccc
Q 002746          705 LVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNT---STKGDVYSFGILVLEMVTRRRPTDDMFA  781 (885)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~slG~vl~elltg~~P~~~~~~  781 (885)
                      ||+|||+|+..+.            .......+|||.|.|||++.+..+   ..+.|+||+||+||-+++|.+||.+...
T Consensus       319 KItDFGlAK~~g~------------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~  386 (475)
T KOG0615|consen  319 KITDFGLAKVSGE------------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT  386 (475)
T ss_pred             Eecccchhhcccc------------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC
Confidence            9999999998642            355667899999999999887653   3478999999999999999999976322


Q ss_pred             CCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          782 GGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      . .++.               +....+.+.    ..+..|...+++..++|.+|+..||++|||+.|++.+
T Consensus       387 ~-~sl~---------------eQI~~G~y~----f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  387 D-PSLK---------------EQILKGRYA----FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             C-ccHH---------------HHHhcCccc----ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            1 1111               111111111    1123477788999999999999999999999999986

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-44  Score=386.10  Aligned_cols=262  Identities=25%  Similarity=0.409  Sum_probs=219.8

Q ss_pred             hCCcccceecccCcceEEEEEe-CCCCEEEEEEeeec---CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      .+|...++||+|||+.||.++. ..|+.||+|++...   +....+...+|+++.+.++|||||+++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5789999999999999999997 78999999999753   4455778999999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      |+|+.|+|..++++..         .++++.+..+..||+.|+.|||+.+   |+|||||..|++++++.++||+|||+|
T Consensus        98 ELC~~~sL~el~Krrk---------~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLA  165 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRK---------PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLA  165 (592)
T ss_pred             EecCCccHHHHHHhcC---------CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEeccccee
Confidence            9999999999988544         3899999999999999999999998   999999999999999999999999999


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      +.+..           +.......+|||.|.|||++.....+..+||||+|||+|.|++|++||+..     .+      
T Consensus       166 t~le~-----------~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-----~v------  223 (592)
T KOG0575|consen  166 TQLEY-----------DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-----TV------  223 (592)
T ss_pred             eeecC-----------cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-----hH------
Confidence            98843           234455689999999999999999999999999999999999999999752     11      


Q ss_pred             hhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHhcCCCCCCcccc
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGEKHMPSKMNA  871 (885)
Q Consensus       793 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~~~~~~~~~~  871 (885)
                            .+..+..-...+..  |.      ..+.+..++|..+++++|.+|||+.+|+.+     .++....+|+..+.
T Consensus       224 ------kety~~Ik~~~Y~~--P~------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h-----~Ff~~g~~p~~lp~  283 (592)
T KOG0575|consen  224 ------KETYNKIKLNEYSM--PS------HLSAEAKDLIRKLLRPNPSERPSLDEVLDH-----PFFKSGFTPARLPS  283 (592)
T ss_pred             ------HHHHHHHHhcCccc--cc------ccCHHHHHHHHHHhcCCcccCCCHHHHhcC-----HhhhCCCcCCCCCc
Confidence                  11111111111111  10      245678999999999999999999999986     55555556655553

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-44  Score=366.26  Aligned_cols=199  Identities=30%  Similarity=0.564  Sum_probs=180.5

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec--CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ..+|...+.||+|+||+||+|+++ ++.+||||.+...  ..+..+.+..|+++|+.++|||||++++++..++..++||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            357888888999999999999965 6899999999755  3445677899999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCC------CCEEE
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDD------MTALV  706 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~------~~~kl  706 (885)
                      |||.||+|..+++.+..         +++.....++.|+|.|+++||+++   ||||||||.|||++..      -.+||
T Consensus        89 EyC~gGDLs~yi~~~~~---------l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKI  156 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGR---------LPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKI  156 (429)
T ss_pred             EeCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEe
Confidence            99999999999997753         899999999999999999999999   9999999999999864      46899


Q ss_pred             cccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCc
Q 002746          707 SDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD  778 (885)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~  778 (885)
                      +|||+|+.+.+            .......+|++-|||||++...+|+.|+|+||+|+++|++++|+.||+.
T Consensus       157 ADFGfAR~L~~------------~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  157 ADFGFARFLQP------------GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             cccchhhhCCc------------hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            99999998843            3455678999999999999999999999999999999999999999975

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-45  Score=352.17  Aligned_cols=259  Identities=24%  Similarity=0.386  Sum_probs=206.7

Q ss_pred             hCCcccceecccCcceEEEEE-eCCCCEEEEEEeeec--CCcchhhHHHHHHHHhhcCCcccceeee-eeecCCc-ceEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIIT-ACSLPDF-KALV  631 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~-~~lV  631 (885)
                      .+|.+.++||+|.||+||++. ..+|..||.|.++..  ......+...|+.+|++++|||||++++ .+.++.. .++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            457888999999999999998 558999999998844  3345667889999999999999999998 4555554 7899


Q ss_pred             EecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCC-ceEecCCCCCceEecCCCCEEEcccc
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV-RVIHCDLKPSNVLLNDDMTALVSDFG  710 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-~ivH~Dlkp~NILl~~~~~~kl~Dfg  710 (885)
                      ||||..|+|...++..+.     ....+++..+|+++.|++.||.++|.+-+. .|+||||||.||+++.+|.+|++|||
T Consensus        99 mE~c~~GDLsqmIk~~K~-----qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKK-----QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             HHhhcccCHHHHHHHHHh-----ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence            999999999998865432     234599999999999999999999994321 28999999999999999999999999


Q ss_pred             cceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHH
Q 002746          711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~  790 (885)
                      +++.+..           +...+...+|||.||+||.+.+..|+.||||||+||++|||..-++||...     .+.+.-
T Consensus       174 L~r~l~s-----------~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~  237 (375)
T KOG0591|consen  174 LGRFLSS-----------KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLC  237 (375)
T ss_pred             hHhHhcc-----------hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHH
Confidence            9998843           234556789999999999999999999999999999999999999999641     222221


Q ss_pred             HHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       791 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                      +.+....            .. +.|.     +..+.++.++|..|+.+||+.||+.-..+..+.
T Consensus       238 ~KI~qgd------------~~-~~p~-----~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  238 KKIEQGD------------YP-PLPD-----EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             HHHHcCC------------CC-CCcH-----HHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            1111111            11 1111     236778999999999999999999655544443

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=374.96  Aligned_cols=256  Identities=33%  Similarity=0.468  Sum_probs=212.1

Q ss_pred             CcccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCC
Q 002746          559 FDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANG  638 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g  638 (885)
                      +...+.||+|-||.||.|.|+....||+|.++.. ....+.|.+|+++|++++|++||+++|+|..++..+||||||+.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            4556789999999999999998889999999854 334588999999999999999999999999988999999999999


Q ss_pred             ccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecc
Q 002746          639 SLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV  718 (885)
Q Consensus       639 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~  718 (885)
                      +|.++++...       +..+...+.+.++.|||+|++||++++   +|||||.+.||||+++..+||+|||+|+.....
T Consensus       287 sLl~yLr~~~-------~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  287 SLLDYLRTRE-------GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD  356 (468)
T ss_pred             cHHHHhhhcC-------CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC
Confidence            9999998632       224888999999999999999999998   999999999999999999999999999954321


Q ss_pred             cCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhhcch
Q 002746          719 GVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHYHGR  797 (885)
Q Consensus       719 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~  797 (885)
                      .+.          ......-...|+|||.+..+.++.|||||||||+||||+| |+.|+..+     +..+.+       
T Consensus       357 ~Y~----------~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m-----sn~ev~-------  414 (468)
T KOG0197|consen  357 EYT----------ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM-----SNEEVL-------  414 (468)
T ss_pred             cee----------ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC-----CHHHHH-------
Confidence            111          1111122467999999999999999999999999999999 88887653     222222       


Q ss_pred             hhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 002746          798 LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRY  859 (885)
Q Consensus       798 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~  859 (885)
                            +.+.++++-+.|.      .|+.++.++|..||+.+|++|||++.+...++++...
T Consensus       415 ------~~le~GyRlp~P~------~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  415 ------ELLERGYRLPRPE------GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             ------HHHhccCcCCCCC------CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence                  2333444444443      3888999999999999999999999999998887643

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=357.87  Aligned_cols=242  Identities=26%  Similarity=0.422  Sum_probs=202.1

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEE
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV  631 (885)
                      .++|++.++||+|+||.||.++.+ +++.+|+|+++...   ....+....|..+|.+++||+||+++..|++.+..|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            467999999999999999999955 68899999997552   33467788999999999999999999999999999999


Q ss_pred             EecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccc
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~  711 (885)
                      +||+.||.|..++.+...         +++..+.-++.+|+.||.|||++|   |||||+||+|||+|++|+++|+|||+
T Consensus       104 ld~~~GGeLf~hL~~eg~---------F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL  171 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGR---------FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGL  171 (357)
T ss_pred             EeccCCccHHHHHHhcCC---------cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEecccc
Confidence            999999999999986653         888888889999999999999999   99999999999999999999999999


Q ss_pred             ceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      ++.....           +......+||+.|||||++.+..|+.++|+||+|+++|||++|.+||..     .+..++.+
T Consensus       172 ~k~~~~~-----------~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-----~~~~~~~~  235 (357)
T KOG0598|consen  172 CKEDLKD-----------GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-----EDVKKMYD  235 (357)
T ss_pred             chhcccC-----------CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-----ccHHHHHH
Confidence            9854221           2333457999999999999999999999999999999999999999965     22333333


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCC
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP  844 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  844 (885)
                      .....+            .. ..+.      ..+.+..+++.+.+..||++|.
T Consensus       236 ~I~~~k------------~~-~~p~------~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  236 KILKGK------------LP-LPPG------YLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             HHhcCc------------CC-CCCc------cCCHHHHHHHHHHhccCHHHhc
Confidence            322221            01 1110      1345688999999999999995

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-43  Score=370.00  Aligned_cols=366  Identities=26%  Similarity=0.272  Sum_probs=305.2

Q ss_pred             CEEEcCCCcccccCCccCCCCCCCcEEEcccccCcccCCccccc-CccceEecccccccCCCChhhhcCCCCCcEEECCC
Q 002746           71 RNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSY  149 (885)
Q Consensus        71 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~  149 (885)
                      +.||+|+|+|..+.+..|.++++|++++|.+|.++ .+|..... ..++.|+|.+|.|+ ++..+.++.++.|+.||||.
T Consensus        81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~-sv~se~L~~l~alrslDLSr  158 (873)
T KOG4194|consen   81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLIS-SVTSEELSALPALRSLDLSR  158 (873)
T ss_pred             eeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccc-cccHHHHHhHhhhhhhhhhh
Confidence            44666666666665566666666666666666665 44444433 33666666666666 77777778888888888888


Q ss_pred             CcccCCCCCCCcccccccCCCCCCCcEEEecCcccCccCCCccccc-cccEEEccCCcccccCCccccCCCCCCeeeccc
Q 002746          150 NNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSS  228 (885)
Q Consensus       150 N~l~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~p~~~~~~-~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~  228 (885)
                      |.|+.++..        +|..-.++++|++++|+++..-.+.|..+ +|..|.|+.|+|+...+..|.+|++|+.|+|..
T Consensus       159 N~is~i~~~--------sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnr  230 (873)
T KOG4194|consen  159 NLISEIPKP--------SFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNR  230 (873)
T ss_pred             chhhcccCC--------CCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccc
Confidence            888877653        46677778888888888877777777666 689999999999987778889999999999999


Q ss_pred             cccccccchhhcCCCCCCeEecccccccccCcccccCCCCCCeeecccccccccCCccccCCCcccEEEccCCccCCCCC
Q 002746          229 NLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIP  308 (885)
Q Consensus       229 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  308 (885)
                      |+|.-...-.|.++++|+.|.|..|.|+....++|..+.+++.|+|+.|++.....+++-+++.|+.|+|++|.|.++-+
T Consensus       231 N~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~  310 (873)
T KOG4194|consen  231 NRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHI  310 (873)
T ss_pred             cceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeec
Confidence            99995557789999999999999999998888899999999999999999998888999999999999999999999999


Q ss_pred             cccCCCCCCCEEECcCCcCcccCCccccCccceeeeeeccCCcCCCCchhhhcCCCCcceeecCCCcccccccc---ccc
Q 002746          309 PTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFI---QIS  385 (885)
Q Consensus       309 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~---~~~  385 (885)
                      +++.-+++|++|||++|+|+...+..|..+..| +.|+|++|.++..-...|..+++|++|||++|.|+..+.+   .|.
T Consensus       311 d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~L-e~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~  389 (873)
T KOG4194|consen  311 DSWSFTQKLKELDLSSNRITRLDEGSFRVLSQL-EELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFN  389 (873)
T ss_pred             chhhhcccceeEeccccccccCChhHHHHHHHh-hhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhc
Confidence            999999999999999999997777888888888 5699999999988888999999999999999999865543   478


Q ss_pred             cCccccEEEecCCccCCCCCCccccccccccccccCcccccccCcccCCCceecEEEcccccc
Q 002746          386 NCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEF  448 (885)
Q Consensus       386 ~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  448 (885)
                      ++++|+.|.|.+|+|+.+.-.+|..+++|++|||.+|.|..+-|.+|..+ .|+.|-+..-.|
T Consensus       390 gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssf  451 (873)
T KOG4194|consen  390 GLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSF  451 (873)
T ss_pred             cchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccce
Confidence            89999999999999997777899999999999999999999999999999 888876644333

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-42  Score=360.78  Aligned_cols=262  Identities=23%  Similarity=0.334  Sum_probs=211.8

Q ss_pred             HHhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec---CCcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcc
Q 002746          554 EATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFK  628 (885)
Q Consensus       554 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  628 (885)
                      ....+|.+.+.||+|+|++|++|+.. .+++||||++...   +....+....|-++|.++ .||.|++++..|+++...
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            34568999999999999999999954 7999999998643   233345677899999999 899999999999999999


Q ss_pred             eEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcc
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSD  708 (885)
Q Consensus       629 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D  708 (885)
                      |+|+||+++|+|.+++++...         +++.-...++.+|+.||+|||.+|   ||||||||+|||+|.|++++|+|
T Consensus       150 YFvLe~A~nGdll~~i~K~Gs---------fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITD  217 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYGS---------FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITD  217 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhCc---------chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEee
Confidence            999999999999999987653         888888999999999999999999   99999999999999999999999


Q ss_pred             cccceeeecccCCCCCC--CCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccH
Q 002746          709 FGIAKLVMTVGVGNDGA--ENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSL  786 (885)
Q Consensus       709 fg~a~~~~~~~~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~  786 (885)
                      ||.|+.+.+........  ...........+||..|.+||++.....+..+|+|+|||++|+|+.|.+||....+- .. 
T Consensus       218 FGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-li-  295 (604)
T KOG0592|consen  218 FGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-LI-  295 (604)
T ss_pred             ccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-HH-
Confidence            99999987643222211  111222235689999999999999999999999999999999999999999763110 00 


Q ss_pred             HHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          787 HKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       787 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                                 +.++++     ..-...+       ..++.+.+|+.+.+..||.+|+|.+|+.+|
T Consensus       296 -----------FqkI~~-----l~y~fp~-------~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  296 -----------FQKIQA-----LDYEFPE-------GFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             -----------HHHHHH-----hcccCCC-------CCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                       111111     1001111       134568899999999999999999998886

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=360.44  Aligned_cols=270  Identities=27%  Similarity=0.426  Sum_probs=215.2

Q ss_pred             HHHHhhCCcccceecccCcceEEEEEeCCCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcce
Q 002746          552 LLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKA  629 (885)
Q Consensus       552 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  629 (885)
                      ..+..+++.+...||+|.||+||+|+|.  ..||||+++...  ....+.|+.|+.++++-+|.||+-++|||..+.. .
T Consensus       387 WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A  463 (678)
T KOG0193|consen  387 WEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A  463 (678)
T ss_pred             cccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence            3344456677889999999999999996  579999998653  3457889999999999999999999999998887 9


Q ss_pred             EEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccc
Q 002746          630 LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDF  709 (885)
Q Consensus       630 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df  709 (885)
                      +|+.||+|.+|..+++....        .++..+.+.||.|||+|+.|||.++   |||||+|..||++.+++.|||+||
T Consensus       464 IiTqwCeGsSLY~hlHv~et--------kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDF  532 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQET--------KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDF  532 (678)
T ss_pred             eeehhccCchhhhhccchhh--------hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecc
Confidence            99999999999999987653        3888999999999999999999998   999999999999999999999999


Q ss_pred             ccceeeecccCCCCCCCCCCCCccccccccccccCCcccCC---CCCCccccchhhHHHHHHHHcCCCCCCccccCCccH
Q 002746          710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG---SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSL  786 (885)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~  786 (885)
                      |+|+.-....         +........|..-|||||++..   .+|++.+||||||+|+|||++|..||.. ...+   
T Consensus       533 GLatvk~~w~---------g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~d---  599 (678)
T KOG0193|consen  533 GLATVKTRWS---------GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRD---  599 (678)
T ss_pred             cceeeeeeec---------cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChh---
Confidence            9997653321         1223334457889999998764   4689999999999999999999999973 1111   


Q ss_pred             HHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHhcCCC
Q 002746          787 HKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGEKH  864 (885)
Q Consensus       787 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~~~  864 (885)
                       +.+..+.             +++-  .+..-.....+++++.+|+..||..++++||.+.+++..|+.+.+...+-+
T Consensus       600 -qIifmVG-------------rG~l--~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~  661 (678)
T KOG0193|consen  600 -QIIFMVG-------------RGYL--MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKIN  661 (678)
T ss_pred             -heEEEec-------------cccc--CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccc
Confidence             1111111             1100  111122234577889999999999999999999999999998877644333

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=364.99  Aligned_cols=396  Identities=22%  Similarity=0.221  Sum_probs=349.8

Q ss_pred             CCEEEcCCCcccccCCccCCCC--CCCcEEEcccccCcccCCccccc-CccceEecccccccCCCChhhhcCCC-CCcEE
Q 002746           70 LRNVDLSQNFFTGKIPEEIGNC--PNLWTLSLYNNQLTGQLPASLIN-TSMYNLDVEYNHLSGELPSDIMSKLP-SLTYL  145 (885)
Q Consensus        70 L~~L~Ls~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~~~l~-~L~~L  145 (885)
                      -..||.+++.|..+....+.+.  +.-++|++++|+|....+..|.. ++|+++.+.+|.+. .||.  |+... +|+.|
T Consensus        54 ~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~--f~~~sghl~~L  130 (873)
T KOG4194|consen   54 TRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPR--FGHESGHLEKL  130 (873)
T ss_pred             ceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hccc--ccccccceeEE
Confidence            4568899998886554455543  24567999999999777776666 89999999999998 8997  44444 59999


Q ss_pred             ECCCCcccCCCCCCCcccccccCCCCCCCcEEEecCcccCccCCCcccc-ccccEEEccCCcccccCCccccCCCCCCee
Q 002746          146 HLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGR-LNLTQLLLQENKITGSIPPHIGNLSNLISL  224 (885)
Q Consensus       146 ~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~p~~~~~-~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L  224 (885)
                      +|.+|.|.++...        +++.+..|+.||++.|.+....-.++.. .++++|+|++|+|+......|.++.+|..|
T Consensus       131 ~L~~N~I~sv~se--------~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tl  202 (873)
T KOG4194|consen  131 DLRHNLISSVTSE--------ELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTL  202 (873)
T ss_pred             eeeccccccccHH--------HHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheee
Confidence            9999999998865        4888999999999999998766666655 699999999999999999999999999999


Q ss_pred             eccccccccccchhhcCCCCCCeEecccccccccCcccccCCCCCCeeecccccccccCCccccCCCcccEEEccCCccC
Q 002746          225 NLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLS  304 (885)
Q Consensus       225 ~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  304 (885)
                      .|+.|+|+...+..|..+++|+.|+|..|+|.-..--.|.+|++|+.|.|..|.|+....+.|.++.++++|+|+.|+++
T Consensus       203 kLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~  282 (873)
T KOG4194|consen  203 KLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQ  282 (873)
T ss_pred             ecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhh
Confidence            99999999899999999999999999999999444678999999999999999999999999999999999999999999


Q ss_pred             CCCCcccCCCCCCCEEECcCCcCcccCCccccCccceeeeeeccCCcCCCCchhhhcCCCCcceeecCCCcccccccccc
Q 002746          305 RSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQI  384 (885)
Q Consensus       305 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~  384 (885)
                      ..-...+.+++.|+.|+||+|.|...-++.+.-.++| ++|+|++|+|+...+..|..|..|++|+|++|.++...-..|
T Consensus       283 ~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL-~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af  361 (873)
T KOG4194|consen  283 AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKL-KELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAF  361 (873)
T ss_pred             hhhcccccccchhhhhccchhhhheeecchhhhcccc-eeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHH
Confidence            8888999999999999999999998888888888888 579999999999999999999999999999999998888889


Q ss_pred             ccCccccEEEecCCccCCCCCC---ccccccccccccccCcccccccCcccCCCceecEEEcccccccccCCCCCccCCC
Q 002746          385 SNCIAVRLINISHNALQGNLPD---SLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSA  461 (885)
Q Consensus       385 ~~l~~L~~L~ls~N~l~~~~~~---~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~  461 (885)
                      .++.+|+.|||++|.|+..+-+   .|..|+.|+.|+|.+|+|..+...+|.++++|+.|||.+|.|.++-|....-..+
T Consensus       362 ~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~L  441 (873)
T KOG4194|consen  362 VGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMEL  441 (873)
T ss_pred             HHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchh
Confidence            9999999999999999876544   6888999999999999999888899999999999999999999998886554567


Q ss_pred             CccccccCcccccCCC
Q 002746          462 TKMSFVGNQHLCGTVP  477 (885)
Q Consensus       462 ~~~~~~~n~~~c~~~~  477 (885)
                      ..+.+..-..+|++..
T Consensus       442 k~Lv~nSssflCDCql  457 (873)
T KOG4194|consen  442 KELVMNSSSFLCDCQL  457 (873)
T ss_pred             hhhhhcccceEEeccH
Confidence            7666666666676543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.3e-41  Score=329.77  Aligned_cols=271  Identities=19%  Similarity=0.288  Sum_probs=208.1

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEe
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      +.|+...++|+|+||+||+|+.+ +|+.||||+|..+.  ....+-..+|+++|++++|+|+|.++++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45777889999999999999966 69999999997442  3345678899999999999999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      ||+..-|++ +.....        .++.....+++.|++.|+.|+|+++   ||||||||+|||++.+|.+||||||+|+
T Consensus        82 ~~dhTvL~e-Le~~p~--------G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR  149 (396)
T KOG0593|consen   82 YCDHTVLHE-LERYPN--------GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFAR  149 (396)
T ss_pred             ecchHHHHH-HHhccC--------CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhH
Confidence            997755544 333322        2788889999999999999999998   9999999999999999999999999999


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      .+..           ++...+..+.|..|.|||.+-| .+|+...||||+||++.||++|.+-|..  ..+.+..-.+..
T Consensus       150 ~L~~-----------pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG--~SDiDQLy~I~k  216 (396)
T KOG0593|consen  150 TLSA-----------PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPG--RSDIDQLYLIRK  216 (396)
T ss_pred             hhcC-----------CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCC--cchHHHHHHHHH
Confidence            8742           2334455788999999999887 6899999999999999999999987743  112222112222


Q ss_pred             hhcch---hhhhhhh--hhhhcc---CCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          793 HYHGR---LEKVIDS--SLLRAS---RDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       793 ~~~~~---~~~~~d~--~~~~~~---~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ...+-   -..++..  .+.+..   ..-.+.+++-+...+.-+.+++..|++.||++|++.+|++.+
T Consensus       217 tLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  217 TLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             HHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            22221   1122211  111111   111233445555666779999999999999999999999765

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.1e-41  Score=373.35  Aligned_cols=268  Identities=26%  Similarity=0.447  Sum_probs=218.8

Q ss_pred             hhCCcccceecccCcceEEEEEeC------CCCEEEEEEeeecCCc-chhhHHHHHHHHhhcCCcccceeeeeeecCCcc
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ------DGTAIAVKVLQLQSGN-FTKSFNRECQVLKRIRHRNLMRIITACSLPDFK  628 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  628 (885)
                      ..+....+.||+|+||.||+|+..      +...||||.++..... ...+|++|+++++.++|||||+++|.|.+++..
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            345566788999999999999843      3567999999976555 688999999999999999999999999999999


Q ss_pred             eEEEecccCCccccccccCCccccCC-CCCC----CCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCC
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGS-GSSD----LTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMT  703 (885)
Q Consensus       629 ~lV~e~~~~gsL~~~l~~~~~~~~~~-~~~~----l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~  703 (885)
                      +||+|||..|+|.++|+.+.+..... ++.+    ++..+.+.||.|||.|++||-++.   +|||||..+|+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence            99999999999999998776553222 3333    899999999999999999999998   999999999999999999


Q ss_pred             EEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccC
Q 002746          704 ALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAG  782 (885)
Q Consensus       704 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~  782 (885)
                      |||+|||+++.+...++.+-.         ....-..+|||||.+..+++|.+||||||||+|||+++ |+.||....  
T Consensus       642 VKIsDfGLsRdiYssDYYk~~---------~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS--  710 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVR---------GNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS--  710 (774)
T ss_pred             EEecccccchhhhhhhhhccc---------CCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc--
Confidence            999999999988665443221         12234679999999999999999999999999999999 899986531  


Q ss_pred             CccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 002746          783 GLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRY  859 (885)
Q Consensus       783 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~  859 (885)
                         -.+.+.....+        .+.     ..|      +.|+.++..||.+||+..|++||+++||-..|+.....
T Consensus       711 ---n~EVIe~i~~g--------~lL-----~~P------e~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  711 ---NQEVIECIRAG--------QLL-----SCP------ENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             ---hHHHHHHHHcC--------Ccc-----cCC------CCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence               12222222111        111     111      24788999999999999999999999999999887543

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=341.01  Aligned_cols=265  Identities=23%  Similarity=0.359  Sum_probs=211.5

Q ss_pred             hhCCcccceecccCcceEEEEE-eCCCCEEEEEEeeecCCcc-hhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEe
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNF-TKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      .+.|+..++||.|..++||+|+ ...++.||||++....... .+.+.+|+..++.++||||++++..|..+...++||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            3678999999999999999999 4578999999998775443 5889999999999999999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      ||.+|++.+.++.....       .+++..+..|.+++++||.|||++|   .||||||+.|||++.+|.+||+|||.+.
T Consensus       105 fMa~GS~ldIik~~~~~-------Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa  174 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPD-------GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSA  174 (516)
T ss_pred             hhcCCcHHHHHHHHccc-------cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeee
Confidence            99999999999866543       2889999999999999999999999   9999999999999999999999999987


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCC--CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG--SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      .+...| .+.      ........||+.|||||++..  ..|+.|+||||||++..|+.+|+.||..+....     ...
T Consensus       175 ~l~~~G-~R~------~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk-----vLl  242 (516)
T KOG0582|consen  175 SLFDSG-DRQ------VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK-----VLL  242 (516)
T ss_pred             eecccC-cee------eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH-----HHH
Confidence            775533 111      112256789999999999543  468999999999999999999999998753321     111


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ....+..+... ..     ....++    .......+.+++..|+..||.+|||+++++.+
T Consensus       243 ~tLqn~pp~~~-t~-----~~~~d~----~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  243 LTLQNDPPTLL-TS-----GLDKDE----DKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             HHhcCCCCCcc-cc-----cCChHH----hhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            11111111110 00     000011    11244579999999999999999999999875

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=353.38  Aligned_cols=250  Identities=23%  Similarity=0.358  Sum_probs=209.1

Q ss_pred             hCCcccceecccCcceEEEEE-eCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      ..|.....||+|+.|.||.|. ..+++.||||++........+-+.+|+.+|+..+|+|||++++.|...+..++|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            456667889999999999998 4578999999999887777788999999999999999999999999899999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++|+|.+.+....          +++.++..|+.++++||+|||.+|   |+|||||.+|||++.+|.+||+|||++..+
T Consensus       353 ~ggsLTDvVt~~~----------~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi  419 (550)
T KOG0578|consen  353 EGGSLTDVVTKTR----------MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQI  419 (550)
T ss_pred             CCCchhhhhhccc----------ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecc
Confidence            9999999886443          889999999999999999999999   999999999999999999999999998776


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhc
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~  795 (885)
                      ...           .......+|||.|||||+.....|++|.||||||++++||+-|.+||-.    +..+         
T Consensus       420 ~~~-----------~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~Pl---------  475 (550)
T KOG0578|consen  420 SEE-----------QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPL---------  475 (550)
T ss_pred             ccc-----------cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChH---------
Confidence            432           2244567899999999999999999999999999999999999999842    1111         


Q ss_pred             chhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       796 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                         ..+.--...+...-      +..+.++.++.+++.+|++.||++||+++|+++|
T Consensus       476 ---rAlyLIa~ng~P~l------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  476 ---RALYLIATNGTPKL------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             ---HHHHHHhhcCCCCc------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence               11000000011110      1123467789999999999999999999999986

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=344.79  Aligned_cols=259  Identities=27%  Similarity=0.435  Sum_probs=203.5

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCC--cceEEEe
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPD--FKALVLP  633 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lV~e  633 (885)
                      .+|...+.||+|+||+||++... +|...|||..........+.+.+|+.+|++++|||||+++|......  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            45677899999999999999965 48999999987653333567899999999999999999999855444  5889999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecC-CCCEEEcccccc
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND-DMTALVSDFGIA  712 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfg~a  712 (885)
                      |+++|+|.+++.....        .+++..+..+..||++||+|||++|   ||||||||+|||++. ++.+||+|||.|
T Consensus        97 y~~~GsL~~~~~~~g~--------~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a  165 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG--------KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLA  165 (313)
T ss_pred             ccCCCcHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccc
Confidence            9999999999986542        3899999999999999999999998   999999999999999 799999999999


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      +......        ..........||+.|||||++..+ ....++||||+||++.||+||++||...    .....++.
T Consensus       166 ~~~~~~~--------~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~  233 (313)
T KOG0198|consen  166 KKLESKG--------TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALL  233 (313)
T ss_pred             ccccccc--------ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHH
Confidence            8764210        011223346899999999999853 3446999999999999999999999752    11111111


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                      .....            .   ..|.   +.+..+.+..+++.+|+..+|++||||++++++....
T Consensus       234 ~ig~~------------~---~~P~---ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~  280 (313)
T KOG0198|consen  234 LIGRE------------D---SLPE---IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK  280 (313)
T ss_pred             HHhcc------------C---CCCC---CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence            11100            0   0111   1112566789999999999999999999999985443

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.5e-40  Score=316.49  Aligned_cols=285  Identities=22%  Similarity=0.336  Sum_probs=215.9

Q ss_pred             hCCcccceecccCcceEEEEEe-CCCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEe
Q 002746          557 AEFDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      .+|...+++|+|.||.||+|+. .+|+.||||+++...  ........+|++.|+.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4678889999999999999994 579999999998553  3345678899999999999999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      ||+ .+|...++....        .+....+..++.++.+|++|||.+.   |+||||||.|+|++++|.+||+|||+|+
T Consensus        82 fm~-tdLe~vIkd~~i--------~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr  149 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKNI--------ILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLAR  149 (318)
T ss_pred             ecc-ccHHHHhccccc--------ccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchh
Confidence            995 488888765443        4888999999999999999999999   9999999999999999999999999999


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHH--HH
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK--WV  790 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~--~~  790 (885)
                      .+.+.           .......+-|..|.|||.+.|. .|+...||||.|||+.||+-|.+-|..    ..++.+  .+
T Consensus       150 ~f~~p-----------~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG----~sDidQL~~I  214 (318)
T KOG0659|consen  150 FFGSP-----------NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG----DSDIDQLSKI  214 (318)
T ss_pred             ccCCC-----------CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC----CchHHHHHHH
Confidence            88542           1222223678999999988775 689999999999999999998876543    222222  22


Q ss_pred             HHhhcch----hhhhhh-hhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHhcCCCC
Q 002746          791 KNHYHGR----LEKVID-SSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGEKHM  865 (885)
Q Consensus       791 ~~~~~~~----~~~~~d-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~~~~  865 (885)
                      -......    ++++.. +.......-+.+.....+..++.+..+++..++..+|.+|++++|++++  ...+.......
T Consensus       215 f~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~--~yf~~~P~pt~  292 (318)
T KOG0659|consen  215 FRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH--PYFKSLPLPTP  292 (318)
T ss_pred             HHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc--hhhhcCCCCCC
Confidence            2222111    111111 1111111112223333556678889999999999999999999999997  44444444444


Q ss_pred             CCccc
Q 002746          866 PSKMN  870 (885)
Q Consensus       866 ~~~~~  870 (885)
                      +.+++
T Consensus       293 ~~~lp  297 (318)
T KOG0659|consen  293 PSKLP  297 (318)
T ss_pred             hhhCc
Confidence            44443

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=322.92  Aligned_cols=236  Identities=27%  Similarity=0.338  Sum_probs=199.4

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ++|+..+.||.|+||.|.+++.+ +|..+|+|++....   -+..+....|..+|+.+.||+++++++.|.+.+..+|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            56888999999999999999966 68899999997553   223456778999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||++||.|..++++..+         ++.+.+.-+|.||+.|++|||+.+   |++||+||+|||+|.+|.+||+|||+|
T Consensus       124 eyv~GGElFS~Lrk~~r---------F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFA  191 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGR---------FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFA  191 (355)
T ss_pred             eccCCccHHHHHHhcCC---------CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccce
Confidence            99999999999987653         899999999999999999999998   999999999999999999999999999


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      +.+..              ...+.+|||.|+|||.+....++.++|.|||||++|||+.|.+||.+..            
T Consensus       192 K~v~~--------------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~------------  245 (355)
T KOG0616|consen  192 KRVSG--------------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN------------  245 (355)
T ss_pred             EEecC--------------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC------------
Confidence            98732              2456799999999999999999999999999999999999999996521            


Q ss_pred             hhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCC
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTR  843 (885)
Q Consensus       793 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  843 (885)
                           ..++.++.+.+... ..+       ..+.++.+++...+++|-.+|
T Consensus       246 -----~~~iY~KI~~~~v~-fP~-------~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  246 -----PIQIYEKILEGKVK-FPS-------YFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             -----hHHHHHHHHhCccc-CCc-------ccCHHHHHHHHHHHhhhhHhh
Confidence                 11222222222211 111       145568899999999999998

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=8.8e-44  Score=358.56  Aligned_cols=437  Identities=28%  Similarity=0.413  Sum_probs=309.5

Q ss_pred             CCccccCCCCCcEEeCCCCcccccCchhhhCCCCCcEEEccCcccccCCchhhhcCCCCCCEEEcCCCcccccCCccCCC
Q 002746           11 IPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGN   90 (885)
Q Consensus        11 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~f~~l~~L~~L~Ls~N~l~~~~~~~~~~   90 (885)
                      +.+++.++..|+.|++.+|++. ..|.+++.+.+++.|+.++|+++ .+|.. ...+.+|..|+.++|.+. ..|..++.
T Consensus        60 l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~-i~s~~~l~~l~~s~n~~~-el~~~i~~  135 (565)
T KOG0472|consen   60 LREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQ-IGSLISLVKLDCSSNELK-ELPDSIGR  135 (565)
T ss_pred             ccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHH-Hhhhhhhhhhhcccccee-ecCchHHH
Confidence            3345566666666666666665 56666666666666666666666 56654 345666666666666666 55556666


Q ss_pred             CCCCcEEEcccccCcccCCcccccCccceEecccccccCCCChhhhcCCCCCcEEECCCCcccCCCCCCCcccccccCCC
Q 002746           91 CPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGN  170 (885)
Q Consensus        91 l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~  170 (885)
                      +..|..|+..+|++++.+++.+...++..|++.+|++. .+|++... ++.|++||...|.+++++.+         ++.
T Consensus       136 ~~~l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~-m~~L~~ld~~~N~L~tlP~~---------lg~  204 (565)
T KOG0472|consen  136 LLDLEDLDATNNQISSLPEDMVNLSKLSKLDLEGNKLK-ALPENHIA-MKRLKHLDCNSNLLETLPPE---------LGG  204 (565)
T ss_pred             HhhhhhhhccccccccCchHHHHHHHHHHhhccccchh-hCCHHHHH-HHHHHhcccchhhhhcCChh---------hcc
Confidence            66666666666666655555555566666666666666 55555544 66666666666666665543         566


Q ss_pred             CCCCcEEEecCcccCccCCCccccccccEEEccCCcccccCCcc-ccCCCCCCeeeccccccccccchhhcCCCCCCeEe
Q 002746          171 CTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPH-IGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLF  249 (885)
Q Consensus       171 l~~L~~L~l~~~~l~~~~p~~~~~~~L~~L~l~~n~i~~~~~~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  249 (885)
                      +.+|+.|++..|++. .+|.+-+...|.+|++..|.|. .+|.+ ..++.+|.+||+.+|+++ ..|+.++-+.+|.+||
T Consensus       205 l~~L~~LyL~~Nki~-~lPef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLD  281 (565)
T KOG0472|consen  205 LESLELLYLRRNKIR-FLPEFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLD  281 (565)
T ss_pred             hhhhHHHHhhhcccc-cCCCCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhc
Confidence            666666666666664 4443223335666666666666 34443 336666666666666666 5566666666666666


Q ss_pred             cccccccccCcccccCCCCCCeeeccccccccc--------------------------------------CCccc---c
Q 002746          250 LSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGE--------------------------------------IPVSL---G  288 (885)
Q Consensus       250 L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~--------------------------------------~~~~~---~  288 (885)
                      +|+|.|+ .+|..++++ +|+.|.+.+|.+..+                                      .+..|   .
T Consensus       282 lSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~  359 (565)
T KOG0472|consen  282 LSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIY  359 (565)
T ss_pred             ccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchh
Confidence            6666666 456666666 666666666665410                                      00011   1


Q ss_pred             CCCcccEEEccCCccCCCCCcccCCCCC---CCEEECcCCcCcccCCccccCccceeeeeeccCCcCCCCchhhhcCCCC
Q 002746          289 NLVQIYSLFLNNNQLSRSIPPTLGRCTD---LYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLEN  365 (885)
Q Consensus       289 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~---L~~L~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~p~~~~~l~~  365 (885)
                      .+.+.+.|+++.-+++ .+|.....-.+   ...++++.|++. .+|..+..+..+.+.+.+++|.++ .+|..++.+++
T Consensus       360 ~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~k  436 (565)
T KOG0472|consen  360 AIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQK  436 (565)
T ss_pred             hhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhc
Confidence            1234555666666665 34433332233   677899999998 889888888888777888888887 89999999999


Q ss_pred             cceeecCCCccccccccccccCccccEEEecCCccCCCCCCccccccccccccccCcccccccCcccCCCceecEEEccc
Q 002746          366 VQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSF  445 (885)
Q Consensus       366 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~  445 (885)
                      |..|+|++|-+. .+|..++.+..|+.||+|+|++. .+|..+-.+..|+.+-.++|++..+.|..+.+|.+|++|||.+
T Consensus       437 Lt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~n  514 (565)
T KOG0472|consen  437 LTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQN  514 (565)
T ss_pred             ceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCC
Confidence            999999999998 58888999999999999999998 8999999999999999999999988777799999999999999


Q ss_pred             ccccccCCCCCccCCCCccccccCccc
Q 002746          446 NEFKGMIPSGGIFNSATKMSFVGNQHL  472 (885)
Q Consensus       446 N~l~~~~p~~~~~~~~~~~~~~~n~~~  472 (885)
                      |.+...||..|...++..+.+.|||..
T Consensus       515 Ndlq~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  515 NDLQQIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             CchhhCChhhccccceeEEEecCCccC
Confidence            999999999999999999999999875

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.8e-40  Score=340.13  Aligned_cols=285  Identities=22%  Similarity=0.360  Sum_probs=215.3

Q ss_pred             hhCCcccceecccCcceEEEEE-eCCCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecC--CcceE
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLP--DFKAL  630 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l  630 (885)
                      .+.|+..+.||+|.||.||+|+ ..+|+.||+|+++...  .+...-..+|+.+|++++||||+++.+.+.+.  ...||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            3567888899999999999999 4579999999998664  44566678999999999999999999998776  67899


Q ss_pred             EEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccc
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG  710 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg  710 (885)
                      |+|||+. +|.-++....        ..++..++.-+++|++.||+|+|.+|   |+|||||.+|||+|.+|.+||+|||
T Consensus       196 VFeYMdh-DL~GLl~~p~--------vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFG  263 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPG--------VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFG  263 (560)
T ss_pred             EEecccc-hhhhhhcCCC--------cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEecccc
Confidence            9999965 6665554322        24899999999999999999999999   9999999999999999999999999


Q ss_pred             cceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHH
Q 002746          711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKW  789 (885)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~  789 (885)
                      +|+++....          ....+..+-|..|.|||++.|. .|+.+.|+||.|||+.||++|++.|..-.+ -.++...
T Consensus       264 LAr~y~~~~----------~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE-veQl~kI  332 (560)
T KOG0600|consen  264 LARFYTPSG----------SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE-VEQLHKI  332 (560)
T ss_pred             ceeeccCCC----------CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH-HHHHHHH
Confidence            999885421          2235667889999999998775 699999999999999999999999864211 1222222


Q ss_pred             HHHhhcch--hhhhhh-h--hhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHhcCCC
Q 002746          790 VKNHYHGR--LEKVID-S--SLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGEKH  864 (885)
Q Consensus       790 ~~~~~~~~--~~~~~d-~--~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~~~  864 (885)
                      .+-.....  .+...+ +  ............+...+...+....+|+..+|+.||.+|.|+.++++.     .++.+..
T Consensus       333 fklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s-----eyF~t~p  407 (560)
T KOG0600|consen  333 FKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS-----EYFTTEP  407 (560)
T ss_pred             HHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC-----cccccCC
Confidence            22222111  111111 0  111111122233444455567789999999999999999999999885     4554444


Q ss_pred             CCCc
Q 002746          865 MPSK  868 (885)
Q Consensus       865 ~~~~  868 (885)
                      .+..
T Consensus       408 ~~~~  411 (560)
T KOG0600|consen  408 LPCD  411 (560)
T ss_pred             CCCC
Confidence            4443

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.9e-40  Score=345.86  Aligned_cols=264  Identities=19%  Similarity=0.255  Sum_probs=204.2

Q ss_pred             HhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec---CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceE
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKAL  630 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  630 (885)
                      ..++|+...+||+|+||.||+|+-+ +|..+|+|+++..   .....+....|-.+|...++|.||++|..|++.+..||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4578999999999999999999955 6999999999855   23456778899999999999999999999999999999


Q ss_pred             EEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccc
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG  710 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg  710 (885)
                      ||||++||++..+|.....         +++..+..++.+++-|++.+|+.|   ||||||||+|+|+|..|++||+|||
T Consensus       219 iMEylPGGD~mTLL~~~~~---------L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFG  286 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKDT---------LTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFG  286 (550)
T ss_pred             EEEecCCccHHHHHHhcCc---------CchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeecccc
Confidence            9999999999999976553         888999999999999999999999   9999999999999999999999999


Q ss_pred             cceeeecccC------------------CCCCCC----CC--------------CCCccccccccccccCCcccCCCCCC
Q 002746          711 IAKLVMTVGV------------------GNDGAE----NM--------------GNSTANMLCGSIGYMAPEYGFGSNTS  754 (885)
Q Consensus       711 ~a~~~~~~~~------------------~~~~~~----~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~  754 (885)
                      +++-+.....                  ..+...    ..              ....+...+|||.|+|||++.+..|+
T Consensus       287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~  366 (550)
T KOG0605|consen  287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG  366 (550)
T ss_pred             ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence            9965532100                  000000    00              00112236899999999999999999


Q ss_pred             ccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhh
Q 002746          755 TKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGIL  834 (885)
Q Consensus       755 ~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  834 (885)
                      ..+|+||+|||+|||+.|.+||...    .....|-.-...       ...+.     ..+.     ...+.+..++|.+
T Consensus       367 ~~cDwWSLG~ImyEmLvGyPPF~s~----tp~~T~rkI~nw-------r~~l~-----fP~~-----~~~s~eA~DLI~r  425 (550)
T KOG0605|consen  367 KECDWWSLGCIMYEMLVGYPPFCSE----TPQETYRKIVNW-------RETLK-----FPEE-----VDLSDEAKDLITR  425 (550)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHHH-------hhhcc-----CCCc-----CcccHHHHHHHHH
Confidence            9999999999999999999999652    111112110000       00000     0000     0134678999999


Q ss_pred             hcCCCCCCCCC---HHHHHHH
Q 002746          835 CTQESPSTRPT---MLDAADD  852 (885)
Q Consensus       835 cl~~dP~~RPt---~~ev~~~  852 (885)
                      |++ ||++|-.   ++||.+|
T Consensus       426 ll~-d~~~RLG~~G~~EIK~H  445 (550)
T KOG0605|consen  426 LLC-DPENRLGSKGAEEIKKH  445 (550)
T ss_pred             Hhc-CHHHhcCcccHHHHhcC
Confidence            999 9999965   5666553

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-40  Score=351.17  Aligned_cols=248  Identities=26%  Similarity=0.358  Sum_probs=209.6

Q ss_pred             hCCcccceecccCcceEEEEEe-CCCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      +-|..++.||.|+.|.|..|+. .+|+.+|||++....   ......+.+|+-+|+.+.|||++++|+.++...+.|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4578889999999999999995 489999999997552   223456788999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++|.|.+++..+..         +++..+.+++.||+.|+.|+|..+   |+|||+||+|+|+|..+++||+|||+|
T Consensus        92 Eyv~gGELFdylv~kG~---------l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMA  159 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGP---------LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMA  159 (786)
T ss_pred             EecCCchhHHHHHhhCC---------CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeecccee
Confidence            99999999999987653         889999999999999999999998   999999999999999999999999999


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCC-CccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      ..-.            ++......||+|.|.|||++.|.+| +.++||||.|||||.|+||+.||++     +.+.....
T Consensus       160 sLe~------------~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir~LLl  222 (786)
T KOG0588|consen  160 SLEV------------PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIRVLLL  222 (786)
T ss_pred             eccc------------CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHHHHHH
Confidence            7632            3456677899999999999999998 6899999999999999999999985     12222221


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDL  853 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  853 (885)
                      .+.            .+.+..+        ...+.++.+|+++|+..||++|.|++||.+|-
T Consensus       223 KV~------------~G~f~MP--------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  223 KVQ------------RGVFEMP--------SNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             HHH------------cCcccCC--------CcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence            111            1111111        12466799999999999999999999999984

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.9e-40  Score=346.22  Aligned_cols=247  Identities=24%  Similarity=0.385  Sum_probs=207.7

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEe
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      ++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+..  .+..+.+.+|+++++.++|||||.++++|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46888899999999999999965 68899999986443  2345668899999999999999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      |+.| +|..++....         .+++..+..|+.+++.||.|||+.+   |.|||+||.|||++..+.+|+||||+|+
T Consensus        82 ~a~g-~L~~il~~d~---------~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar  148 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG---------KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLAR  148 (808)
T ss_pred             hhhh-hHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhh
Confidence            9977 9999987554         3899999999999999999999998   9999999999999999999999999999


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      .+..           .........|||-|||||+..+..|+..+|.||+||++||+++|++||-.     ..+.+.++.+
T Consensus       149 ~m~~-----------~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-----~si~~Lv~~I  212 (808)
T KOG0597|consen  149 AMST-----------NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-----RSITQLVKSI  212 (808)
T ss_pred             hccc-----------CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-----HHHHHHHHHH
Confidence            7743           23445567899999999999999999999999999999999999999943     1222222222


Q ss_pred             hcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       794 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..+.            .. ..       ...+.++..++...+.+||.+|.+..+++.|
T Consensus       213 ~~d~------------v~-~p-------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  213 LKDP------------VK-PP-------STASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             hcCC------------CC-Cc-------ccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            2211            11 11       1356679999999999999999999999886

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=343.85  Aligned_cols=272  Identities=22%  Similarity=0.275  Sum_probs=210.7

Q ss_pred             HhhCCcccceecccCcceEEEEEe-CCCCEEEEEEeeecCCcch-hhHHHHHHHHhhcC-CcccceeeeeeecCC-cceE
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIR-HRNLMRIITACSLPD-FKAL  630 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~l  630 (885)
                      ..++|.+.+.||.|.||.||+|+. .+|..||||+++..-..+. ..-.+|+..|++++ |||||++.+.+.+.+ ..++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            457899999999999999999994 4799999999985543332 23468999999998 999999999998888 8899


Q ss_pred             EEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccc
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG  710 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg  710 (885)
                      ||||| ..+|.+.++.+..        .+++..+..|+.||.+||+|+|++|   +.|||+||+|||+.....+||+|||
T Consensus        88 VfE~M-d~NLYqLmK~R~r--------~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFG  155 (538)
T KOG0661|consen   88 VFEFM-DCNLYQLMKDRNR--------LFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFG  155 (538)
T ss_pred             eHHhh-hhhHHHHHhhcCC--------cCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccc
Confidence            99999 5689988876632        4899999999999999999999999   9999999999999988899999999


Q ss_pred             cceeeecccCCCCCCCCCCCCccccccccccccCCccc-CCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHH
Q 002746          711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYG-FGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKW  789 (885)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~  789 (885)
                      +|+.+..            ..+.+..+.|..|+|||++ +.+.|+.+.||||+|||++|+++-++-|-...+- +.+-+ 
T Consensus       156 LARev~S------------kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~-Dqi~K-  221 (538)
T KOG0661|consen  156 LAREVRS------------KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI-DQIYK-  221 (538)
T ss_pred             ccccccc------------CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH-HHHHH-
Confidence            9997643            3455667899999999975 5567899999999999999999998877542111 11111 


Q ss_pred             HHHhhcchhhhhhhh--hhhhc-----cCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          790 VKNHYHGRLEKVIDS--SLLRA-----SRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       790 ~~~~~~~~~~~~~d~--~~~~~-----~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      +-.+......+.+.+  .+...     ..-....+..+...++.++.+++.+|+++||.+|||++|++++
T Consensus       222 Ic~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  222 ICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            111111111111111  11111     1111123455556688899999999999999999999999986

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-39  Score=349.95  Aligned_cols=250  Identities=26%  Similarity=0.446  Sum_probs=205.4

Q ss_pred             HhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec----CC-cchhhHHHHHHHHhhcC-CcccceeeeeeecCCc
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ----SG-NFTKSFNRECQVLKRIR-HRNLMRIITACSLPDF  627 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  627 (885)
                      ..+.|.+.+.||+|+||.|+.|+.. +++.||+|++...    .. ...+...+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            4578999999999999999999854 7899999977643    12 33566778999999998 9999999999999999


Q ss_pred             ceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCC-CCEEE
Q 002746          628 KALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDD-MTALV  706 (885)
Q Consensus       628 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-~~~kl  706 (885)
                      .++||||+.+|+|.+++....         .+.+..+..++.|++.|++|+|++|   |+||||||+|||+|.+ +++||
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g---------~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl  162 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKG---------RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKL  162 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcC---------CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEE
Confidence            999999999999999998743         3788999999999999999999999   9999999999999999 99999


Q ss_pred             cccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCC-CC-ccccchhhHHHHHHHHcCCCCCCccccCCc
Q 002746          707 SDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN-TS-TKGDVYSFGILVLEMVTRRRPTDDMFAGGL  784 (885)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~slG~vl~elltg~~P~~~~~~~~~  784 (885)
                      +|||++.....           ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++.     
T Consensus       163 ~DFG~s~~~~~-----------~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-----  226 (370)
T KOG0583|consen  163 SDFGLSAISPG-----------EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-----  226 (370)
T ss_pred             eccccccccCC-----------CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-----
Confidence            99999987621           134455679999999999999987 74 8899999999999999999999862     


Q ss_pred             cHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHH-HHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          785 SLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVA-IGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ........             +........    .   .+ +.++..++.+|+..+|.+|+++.|+.++
T Consensus       227 ~~~~l~~k-------------i~~~~~~~p----~---~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  227 NVPNLYRK-------------IRKGEFKIP----S---YLLSPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             cHHHHHHH-------------HhcCCccCC----C---CcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence            11111111             111110000    0   12 5678999999999999999999999953

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=9.3e-39  Score=340.80  Aligned_cols=247  Identities=18%  Similarity=0.246  Sum_probs=197.9

Q ss_pred             cceecccCcceEEEEEeCCCCEEEEEEeeecCCcc---hhhHHHHHHHHhhcCCcccceeeeeeec----CCcceEEEec
Q 002746          562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNF---TKSFNRECQVLKRIRHRNLMRIITACSL----PDFKALVLPY  634 (885)
Q Consensus       562 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lV~e~  634 (885)
                      ...||+|++|.||+|.+ +|+.||||.++......   .+.+.+|+.++++++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999998 48999999987543322   4678899999999999999999999876    3467899999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH-SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      +++|+|.+++....         .+++.....++.+++.|+.|||+. +   ++||||||+||++++++.+||+|||+++
T Consensus       104 ~~~g~L~~~l~~~~---------~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~  171 (283)
T PHA02988        104 CTRGYLREVLDKEK---------DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEK  171 (283)
T ss_pred             CCCCcHHHHHhhCC---------CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHh
Confidence            99999999987543         378899999999999999999985 6   8899999999999999999999999997


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCC--CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG--SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      .+...              .....|+..|+|||++.+  ..++.++|||||||++|||++|+.||....     ..++..
T Consensus       172 ~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-----~~~~~~  232 (283)
T PHA02988        172 ILSSP--------------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-----TKEIYD  232 (283)
T ss_pred             hhccc--------------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC-----HHHHHH
Confidence            65211              112357889999999876  678999999999999999999999997521     111111


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR  858 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~  858 (885)
                      ...            ....+...+      ..++.++.+++.+||+.||++|||++|+++.|+.++.
T Consensus       233 ~i~------------~~~~~~~~~------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        233 LII------------NKNNSLKLP------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             HHH------------hcCCCCCCC------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            110            000000001      0145679999999999999999999999999998864

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.3e-39  Score=352.85  Aligned_cols=268  Identities=25%  Similarity=0.406  Sum_probs=203.2

Q ss_pred             hhCCcccceecccCcceEEEEEe------CCCCEEEEEEeeecCC-cchhhHHHHHHHHhhc-CCcccceeeeeeecCC-
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGIL------QDGTAIAVKVLQLQSG-NFTKSFNRECQVLKRI-RHRNLMRIITACSLPD-  626 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-  626 (885)
                      .++|++.+.||+|+||.||+|.+      .+++.||||+++.... ...+.+.+|+.++.++ +||||++++++|..++ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46799999999999999999974      2356899999874332 3346789999999999 8999999999887654 


Q ss_pred             cceEEEecccCCccccccccCCcccc-----------------------------------------------------C
Q 002746          627 FKALVLPYMANGSLDSHLYPHSETEF-----------------------------------------------------G  653 (885)
Q Consensus       627 ~~~lV~e~~~~gsL~~~l~~~~~~~~-----------------------------------------------------~  653 (885)
                      ..++||||+++|+|.+++........                                                     .
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            57899999999999988864321000                                                     0


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecccCCCCCCCCCCCCcc
Q 002746          654 SGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA  733 (885)
Q Consensus       654 ~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~  733 (885)
                      .....+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.+....         .....
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~---------~~~~~  233 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDP---------DYVRK  233 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCc---------chhcc
Confidence            00124788899999999999999999998   9999999999999999999999999998653210         00111


Q ss_pred             ccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCC
Q 002746          734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRD  812 (885)
Q Consensus       734 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  812 (885)
                      ....+++.|+|||++.+..++.++|||||||++|||++ |..||......    ..+.....        +     ....
T Consensus       234 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~----~~~~~~~~--------~-----~~~~  296 (338)
T cd05102         234 GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN----EEFCQRLK--------D-----GTRM  296 (338)
T ss_pred             cCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc----HHHHHHHh--------c-----CCCC
Confidence            12346788999999999999999999999999999997 99999652111    01111100        0     0000


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 002746          813 QSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR  858 (885)
Q Consensus       813 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~  858 (885)
                      ..+      ..+++++.+++.+||+.||++|||+.|+++.|+.+..
T Consensus       297 ~~~------~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         297 RAP------ENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             CCC------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            000      1134568999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-40  Score=356.54  Aligned_cols=255  Identities=27%  Similarity=0.450  Sum_probs=213.0

Q ss_pred             cccceecccCcceEEEEEeC----CCCEEEEEEeeec-CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          560 DEQRLLGTGSYGRVYKGILQ----DGTAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       560 ~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      .+.++||.|.||.||+|+++    ....||||.++.. ..+...+|..|+.||.+++||||+++.|++......++|.||
T Consensus       632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy  711 (996)
T KOG0196|consen  632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY  711 (996)
T ss_pred             EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence            46789999999999999976    2456999999854 344577899999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      |++|+|+.+|+.+..        ++.+.+..-+.++||.|+.||-+++   +|||||.+.|||++.+..+|++|||+++.
T Consensus       712 MENGsLDsFLR~~DG--------qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRv  780 (996)
T KOG0196|consen  712 MENGSLDSFLRQNDG--------QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV  780 (996)
T ss_pred             hhCCcHHHHHhhcCC--------ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceee
Confidence            999999999987652        4899999999999999999999998   99999999999999999999999999997


Q ss_pred             eecccCCCCCCCCCCCCccccc--cccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHH
Q 002746          715 VMTVGVGNDGAENMGNSTANML--CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~  791 (885)
                      +....          ....+..  --..+|.|||.+.-+++|.+|||||||+||||.++ |..||.++...     +   
T Consensus       781 ledd~----------~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ-----d---  842 (996)
T KOG0196|consen  781 LEDDP----------EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-----D---  842 (996)
T ss_pred             cccCC----------CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH-----H---
Confidence            74321          0011111  12468999999999999999999999999999887 99999765221     1   


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRY  859 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~  859 (885)
                                +-+.+..+++-+.|.      .|+..+.+||..||++|-.+||.+.|++..|.++.+.
T Consensus       843 ----------VIkaIe~gyRLPpPm------DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  843 ----------VIKAIEQGYRLPPPM------DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             ----------HHHHHHhccCCCCCC------CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence                      122333444444333      3788899999999999999999999999999998763

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-40  Score=342.97  Aligned_cols=253  Identities=28%  Similarity=0.411  Sum_probs=206.2

Q ss_pred             CCCcCHHHHHHHhhCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeee
Q 002746          544 FPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS  623 (885)
Q Consensus       544 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  623 (885)
                      ...++++++.+       .+-||+|+.|.||+|+++ ++.||||+++       +.-..+++-|++++||||+.|.|+|.
T Consensus       118 ~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl~-netVAVKKV~-------elkETdIKHLRkLkH~NII~FkGVCt  182 (904)
T KOG4721|consen  118 LWEIPFEEISE-------LEWLGSGAQGAVFLGRLH-NETVAVKKVR-------ELKETDIKHLRKLKHPNIITFKGVCT  182 (904)
T ss_pred             hccCCHHHhhh-------hhhhccCcccceeeeecc-CceehhHHHh-------hhhhhhHHHHHhccCcceeeEeeeec
Confidence            34556666543       356999999999999987 8899999875       22345788899999999999999999


Q ss_pred             cCCcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCC
Q 002746          624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMT  703 (885)
Q Consensus       624 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~  703 (885)
                      ....+++|||||..|-|...|+....         +.....+.|.++||.|+.|||.+.   |||||||.-|||++.+..
T Consensus       183 qsPcyCIiMEfCa~GqL~~VLka~~~---------itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~  250 (904)
T KOG4721|consen  183 QSPCYCIIMEFCAQGQLYEVLKAGRP---------ITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDV  250 (904)
T ss_pred             CCceeEEeeeccccccHHHHHhccCc---------cCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccce
Confidence            99999999999999999999986553         778888999999999999999997   999999999999999999


Q ss_pred             EEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCC
Q 002746          704 ALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGG  783 (885)
Q Consensus       704 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~  783 (885)
                      +||+|||.++....            .+....++||..|||||++.+.+.++|.||||||||||||+||..||.+.... 
T Consensus       251 VKIsDFGTS~e~~~------------~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-  317 (904)
T KOG4721|consen  251 VKISDFGTSKELSD------------KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-  317 (904)
T ss_pred             EEeccccchHhhhh------------hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-
Confidence            99999999986532            23344578999999999999999999999999999999999999999763111 


Q ss_pred             ccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 002746          784 LSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR  858 (885)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~  858 (885)
                          ..+..+..+.+.            -..      -..|++.|.-|++.||+..|..||++.+++.||+-...
T Consensus       318 ----AIIwGVGsNsL~------------Lpv------PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p  370 (904)
T KOG4721|consen  318 ----AIIWGVGSNSLH------------LPV------PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP  370 (904)
T ss_pred             ----eeEEeccCCccc------------ccC------cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence                111111111000            011      12477889999999999999999999999999964433

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=2.6e-43  Score=355.12  Aligned_cols=439  Identities=27%  Similarity=0.377  Sum_probs=374.6

Q ss_pred             CCCcccccCCccccCCCCCcEEeCCCCcccccCchhhhCCCCCcEEEccCcccccCCchhhhcCCCCCCEEEcCCCcccc
Q 002746            3 VDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTG   82 (885)
Q Consensus         3 ~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~f~~l~~L~~L~Ls~N~l~~   82 (885)
                      ++|++ ..+|.+++.+..++.|+.++|++. .+|+.+..+.+|+.|+.+.|++. .+|.+ ++.+-.|+.|+..+|+|. 
T Consensus        76 ~~n~l-~~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~-i~~~~~l~dl~~~~N~i~-  150 (565)
T KOG0472|consen   76 HDNKL-SQLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDS-IGRLLDLEDLDATNNQIS-  150 (565)
T ss_pred             ccchh-hhCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCch-HHHHhhhhhhhccccccc-
Confidence            34444 567889999999999999999998 89999999999999999999999 78866 567999999999999999 


Q ss_pred             cCCccCCCCCCCcEEEcccccCcccCCcccccCccceEecccccccCCCChhhhcCCCCCcEEECCCCcccCCCCCCCcc
Q 002746           83 KIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLV  162 (885)
Q Consensus        83 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  162 (885)
                      ..|+++..+.+|..|++.+|+++..+|+......|.+||+..|.+. .+|+++ +.+.+|..|+|.+|+|..++      
T Consensus       151 slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~l-g~l~~L~~LyL~~Nki~~lP------  222 (565)
T KOG0472|consen  151 SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-TLPPEL-GGLESLELLYLRRNKIRFLP------  222 (565)
T ss_pred             cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-cCChhh-cchhhhHHHHhhhcccccCC------
Confidence            7788899999999999999999988888887789999999999998 899886 99999999999999998866      


Q ss_pred             cccccCCCCCCCcEEEecCcccCccCCCccc-cc-cccEEEccCCcccccCCccccCCCCCCeeeccccccccccchhhc
Q 002746          163 PFFNSLGNCTDLEELELAGMDLGGTLPDSIG-RL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEIS  240 (885)
Q Consensus       163 ~~~~~l~~l~~L~~L~l~~~~l~~~~p~~~~-~~-~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  240 (885)
                          .|..+..|++++++.|++. .+|.... ++ ++..|++++|+++ ..|+.+.-+++|++||+|+|.|+ ..|..++
T Consensus       223 ----ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLg  295 (565)
T KOG0472|consen  223 ----EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLG  295 (565)
T ss_pred             ----CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccc
Confidence                4899999999999999997 5555543 55 7999999999999 78999999999999999999999 6678899


Q ss_pred             CCCCCCeEeccccccccc--------------------------------------Ccc---cccCCCCCCeeecccccc
Q 002746          241 WLSQLEQLFLSHNLFSGE--------------------------------------IPA---ALGKLHHLGLLDLSFNKL  279 (885)
Q Consensus       241 ~l~~L~~L~L~~N~i~~~--------------------------------------~~~---~~~~l~~L~~L~Ls~N~l  279 (885)
                      ++ .|+.|.+.+|.+..+                                      .+.   ....+.+.+.|++++-++
T Consensus       296 nl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~ql  374 (565)
T KOG0472|consen  296 NL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQL  374 (565)
T ss_pred             cc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhccccccc
Confidence            99 999999999997621                                      001   112345789999999999


Q ss_pred             cccCCccccCCC--cccEEEccCCccCCCCCcccCCCCCCC-EEECcCCcCcccCCccccCccceeeeeeccCCcCCCCc
Q 002746          280 SGEIPVSLGNLV--QIYSLFLNNNQLSRSIPPTLGRCTDLY-KLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPL  356 (885)
Q Consensus       280 ~~~~~~~~~~l~--~L~~L~l~~N~l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~  356 (885)
                      +.++...|....  -++..+++.|++. .+|..+..+..+. .+++++|.+. .+|..++.++++ .+|+|++|-+. .+
T Consensus       375 t~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kL-t~L~L~NN~Ln-~L  450 (565)
T KOG0472|consen  375 TLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKL-TFLDLSNNLLN-DL  450 (565)
T ss_pred             ccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcc-eeeecccchhh-hc
Confidence            955444444332  2889999999998 7888887777665 4666777766 899999999999 78999999999 79


Q ss_pred             hhhhcCCCCcceeecCCCccccccccccccCccccEEEecCCccCCCCCCccccccccccccccCcccccccCcccCCCc
Q 002746          357 PIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIH  436 (885)
Q Consensus       357 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  436 (885)
                      |..++.+..|+.||+|+|+|. ..|..+..+..++.+-.++|++..+.|+.+..|.+|..|||.+|.|. .+|..+++|.
T Consensus       451 P~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~Lgnmt  528 (565)
T KOG0472|consen  451 PEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMT  528 (565)
T ss_pred             chhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhcccc
Confidence            999999999999999999998 68888888889999999999999887888999999999999999999 8899999999


Q ss_pred             eecEEEcccccccccCCC-CCccCCCCccccccC
Q 002746          437 TLTFINLSFNEFKGMIPS-GGIFNSATKMSFVGN  469 (885)
Q Consensus       437 ~L~~L~l~~N~l~~~~p~-~~~~~~~~~~~~~~n  469 (885)
                      +|++|++++|+|. .|+. +-.-.+...+++.++
T Consensus       529 nL~hLeL~gNpfr-~Pr~~iLmkgT~aiL~ylrd  561 (565)
T KOG0472|consen  529 NLRHLELDGNPFR-QPRHQILMKGTAAILSYLRD  561 (565)
T ss_pred             ceeEEEecCCccC-CCHHHHhccChHHHHHHhcc
Confidence            9999999999999 4443 323333444445544

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=334.71  Aligned_cols=249  Identities=23%  Similarity=0.383  Sum_probs=205.6

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      ..|...+.||+|+||.||+|... .++.||+|++..... ...++..+|+.++..++++||.++|+.+..+...+++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45677789999999999999965 688999999987643 3467889999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      |.+|++.+.+.....         +++..+.-|.+++..|+.|||.++   .+|||||+.||++..+|.+|++|||.|-.
T Consensus        93 ~~gGsv~~lL~~~~~---------~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~q  160 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGNI---------LDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQ  160 (467)
T ss_pred             hcCcchhhhhccCCC---------CccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeee
Confidence            999999999986543         366667778999999999999998   99999999999999999999999999976


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      +...           .......+||+.|||||++.+..|+.|+||||||++.+||.+|.+|+.+.....           
T Consensus       161 l~~~-----------~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr-----------  218 (467)
T KOG0201|consen  161 LTNT-----------VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR-----------  218 (467)
T ss_pred             eech-----------hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce-----------
Confidence            6432           222356799999999999999999999999999999999999999998753321           


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                         +.-.+       .....|.+.   +.+++.+.+++..|+..+|+.||++.+++++
T Consensus       219 ---vlflI-------pk~~PP~L~---~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  219 ---VLFLI-------PKSAPPRLD---GDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ---EEEec-------cCCCCCccc---cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence               00000       001111111   1345668999999999999999999988765

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-38  Score=321.00  Aligned_cols=269  Identities=26%  Similarity=0.380  Sum_probs=210.1

Q ss_pred             hhCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhc--CCcccceeeeeeecCC----cce
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI--RHRNLMRIITACSLPD----FKA  629 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~----~~~  629 (885)
                      .++....+.||+|.||.||+|.|+ |+.||||+|.   ..+++.+.+|.++++.+  +|+||+.++++-..+.    +.+
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~---srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFS---SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             hheeEEEEEecCccccceeecccc-CCceEEEEec---ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            456778899999999999999998 9999999997   44467888999998875  9999999998875543    568


Q ss_pred             EEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-----cCCCceEecCCCCCceEecCCCCE
Q 002746          630 LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH-----HSPVRVIHCDLKPSNVLLNDDMTA  704 (885)
Q Consensus       630 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-----~~~~~ivH~Dlkp~NILl~~~~~~  704 (885)
                      ||++|.+.|||.++|....          ++....++++..+|.||+|||.     +|.|.|.|||||+.|||+..++.+
T Consensus       286 LvTdYHe~GSL~DyL~r~t----------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C  355 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNRNT----------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  355 (513)
T ss_pred             EeeecccCCcHHHHHhhcc----------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence            9999999999999998653          7889999999999999999996     567889999999999999999999


Q ss_pred             EEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCC------CCccccchhhHHHHHHHHcC------
Q 002746          705 LVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN------TSTKGDVYSFGILVLEMVTR------  772 (885)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~vl~elltg------  772 (885)
                      .|+|+|+|-........       -....+..+||.+|||||++...-      ....+||||||.|+||+...      
T Consensus       356 ~IADLGLAv~h~~~t~~-------idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi  428 (513)
T KOG2052|consen  356 CIADLGLAVRHDSDTDT-------IDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGI  428 (513)
T ss_pred             EEeeceeeEEecccCCc-------ccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCE
Confidence            99999999876443111       123445679999999999987642      23568999999999999863      


Q ss_pred             ----CCCCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 002746          773 ----RRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLD  848 (885)
Q Consensus       773 ----~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e  848 (885)
                          +.||.+....+.++.+.-+-+.-.+....+...+.             ...+...+.++|+.||..+|..|-|+-.
T Consensus       429 ~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~-------------s~~~l~~m~klMkeCW~~Np~aRltALr  495 (513)
T KOG2052|consen  429 VEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWK-------------SDPALRVMAKLMKECWYANPAARLTALR  495 (513)
T ss_pred             ehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccc-------------cCHHHHHHHHHHHHhhcCCchhhhHHHH
Confidence                35776665555554443222222211111111110             1235677899999999999999999999


Q ss_pred             HHHHHHHHHH
Q 002746          849 AADDLDRLKR  858 (885)
Q Consensus       849 v~~~L~~l~~  858 (885)
                      +.+.|.++..
T Consensus       496 iKKtl~~l~~  505 (513)
T KOG2052|consen  496 IKKTLAKLSN  505 (513)
T ss_pred             HHHHHHHHhc
Confidence            9888888754

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=367.88  Aligned_cols=273  Identities=25%  Similarity=0.399  Sum_probs=221.0

Q ss_pred             hCCcccceecccCcceEEEEEeC--CCC----EEEEEEeeec-CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcce
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ--DGT----AIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKA  629 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~--~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  629 (885)
                      ...+..+.||+|+||.||.|...  +|.    .||||.++.. +.+...+|.+|+.++++++|||||+++|.|.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            34566789999999999999954  343    3888888754 3456788999999999999999999999999999999


Q ss_pred             EEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccc
Q 002746          630 LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDF  709 (885)
Q Consensus       630 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df  709 (885)
                      +++|||++|+|..+++..+...+.  ...+.....+.++.+||+|+.||++++   +|||||.++|+|+++...+||+||
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~--~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQ--PSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCC--CCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEccc
Confidence            999999999999999988776654  456999999999999999999999998   999999999999999999999999


Q ss_pred             ccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHH
Q 002746          710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~  788 (885)
                      |+|+.+...++.+.+.+         ..-...|||||.+..+.++.|+|||||||++||++| |..||......      
T Consensus       847 GlArDiy~~~yyr~~~~---------a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~------  911 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGE---------AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF------  911 (1025)
T ss_pred             chhHhhhhchheeccCc---------cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH------
Confidence            99996655433332211         123468999999999999999999999999999999 88998652110      


Q ss_pred             HHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHhcCCCCCC
Q 002746          789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGEKHMPS  867 (885)
Q Consensus       789 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~~~~~~  867 (885)
                                 ++...-+.++ +-..|.      .|++.+.++|..||+.+|++||++.++++.+..+........+..
T Consensus       912 -----------~v~~~~~~gg-RL~~P~------~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~  972 (1025)
T KOG1095|consen  912 -----------EVLLDVLEGG-RLDPPS------YCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGP  972 (1025)
T ss_pred             -----------HHHHHHHhCC-ccCCCC------CCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcccc
Confidence                       1111111122 212221      388899999999999999999999999999998887666555443

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.5e-39  Score=304.56  Aligned_cols=249  Identities=23%  Similarity=0.354  Sum_probs=207.7

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec---CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEE
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV  631 (885)
                      .++|++.+.||+|.||.||.|+.+ ++..||+|++...   ..+...++.+|+++-+.++||||+++|++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            368999999999999999999954 6888999998644   345567899999999999999999999999999999999


Q ss_pred             EecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccc
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~  711 (885)
                      +||.++|++...++.....       .++....+.+..|+|.|+.|+|.++   |+||||||+|+|++.++..||+|||-
T Consensus       101 lEya~~gel~k~L~~~~~~-------~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGw  170 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMK-------RFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGW  170 (281)
T ss_pred             EEecCCchHHHHHHhcccc-------cccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCc
Confidence            9999999999999854433       2677778889999999999999998   99999999999999999999999998


Q ss_pred             ceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      +..-             +.......+||..|.+||...+...+...|+|++|++.||++.|.+||.... .+..+.+..+
T Consensus       171 sV~~-------------p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k  236 (281)
T KOG0580|consen  171 SVHA-------------PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRK  236 (281)
T ss_pred             eeec-------------CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHH
Confidence            7643             1334456799999999999999999999999999999999999999997632 1111111111


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .       ++.++                 ...+.++.++|.+|+..+|.+|.+..|++++
T Consensus       237 ~-------~~~~p-----------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  237 V-------DLKFP-----------------STISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             c-------cccCC-----------------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            0       00111                 1245678999999999999999999999986

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=308.54  Aligned_cols=273  Identities=25%  Similarity=0.295  Sum_probs=213.9

Q ss_pred             HhhCCcccceecccCcceEEEEE-eCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCC-----cc
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPD-----FK  628 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~  628 (885)
                      ..++|.+.+.+|+|||+-||.++ ..+++.||+|++.....+..+..++|++..++++|||+++++++...+.     ..
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            45789999999999999999998 5678999999998777777889999999999999999999999875443     47


Q ss_pred             eEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcc
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSD  708 (885)
Q Consensus       629 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D  708 (885)
                      |++++|+..|+|.+.+.....     ++..+++.+.+.|+.++.+||++||+..+ +++||||||.||++.+++.+++.|
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~-----kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D  172 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKI-----KGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMD  172 (302)
T ss_pred             EEEeehhccccHHHHHHHHhh-----cCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEe
Confidence            999999999999999876543     23358999999999999999999999874 699999999999999999999999


Q ss_pred             cccceeeecccCCCCCCCCCCCCccccccccccccCCcccC---CCCCCccccchhhHHHHHHHHcCCCCCCccccCCcc
Q 002746          709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF---GSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLS  785 (885)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~  785 (885)
                      ||.++...-.-.++..  ...-.....-..|..|+|||.+.   +...++++|||||||++|+|+.|..||+..+..+.+
T Consensus       173 ~GS~~~a~i~i~~~~~--a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS  250 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQ--ALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS  250 (302)
T ss_pred             ccCccccceEeechHH--HHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence            9999866421111000  00001111234688999999864   446799999999999999999999999876554443


Q ss_pred             HHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 002746          786 LHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       786 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                      ++-.+.           ...+.      .|...    ..++.+.+++..|+++||.+||++.+++..++.+
T Consensus       251 laLAv~-----------n~q~s------~P~~~----~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  251 LALAVQ-----------NAQIS------IPNSS----RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             EEEeee-----------ccccc------cCCCC----CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            322111           00000      00000    1456789999999999999999999999998775

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-40  Score=312.38  Aligned_cols=252  Identities=23%  Similarity=0.363  Sum_probs=208.0

Q ss_pred             hhCCcccceecccCcceEEEEEe-CCCCEEEEEEeeec--CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      +++|++.+.||+|+|+.||++.. .+|+.+|+|++...  +....+.+.+|+.+-+.++||||+++...+......++|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            46788889999999999999985 47999999988633  3446788999999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecC---CCCEEEccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND---DMTALVSDF  709 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Df  709 (885)
                      |+|.||+|..-+-...         ..++..+-..+.||+++|.|+|.++   |||||+||+|+++-.   .--+|++||
T Consensus        90 e~m~G~dl~~eIV~R~---------~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~F  157 (355)
T KOG0033|consen   90 DLVTGGELFEDIVARE---------FYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADF  157 (355)
T ss_pred             ecccchHHHHHHHHHH---------HHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeeccc
Confidence            9999999976554331         3677788889999999999999999   999999999999953   356899999


Q ss_pred             ccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHH
Q 002746          710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKW  789 (885)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~  789 (885)
                      |+|..+.            +......+.|||+|||||++...+|+..+|||+.||+||-++.|+.||.+.     +    
T Consensus       158 GvAi~l~------------~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~-----~----  216 (355)
T KOG0033|consen  158 GLAIEVN------------DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-----D----  216 (355)
T ss_pred             ceEEEeC------------CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc-----c----
Confidence            9999873            134455678999999999999999999999999999999999999999751     1    


Q ss_pred             HHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       790 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                              -..+.+..+.+.+.-..+    .|+...++..+++++|+..||++|.|+.|++.+
T Consensus       217 --------~~rlye~I~~g~yd~~~~----~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  217 --------QHRLYEQIKAGAYDYPSP----EWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             --------HHHHHHHHhccccCCCCc----ccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence                    111122222233332222    366678889999999999999999999999876

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4e-38  Score=336.90  Aligned_cols=251  Identities=22%  Similarity=0.324  Sum_probs=198.6

Q ss_pred             CcccceecccCcceEEEEEe-CCCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          559 FDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      |+..+.||+|+||.||+|.. .+|+.||+|.+....   ......+.+|++++++++|++++++++++.+++..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            67789999999999999996 478999999986432   22234678899999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +++|+|..++.....       ..+++..+..++.|++.||+|||+++   |+||||||+||++++++.++|+|||+++.
T Consensus        82 ~~~g~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~  151 (285)
T cd05631          82 MNGGDLKFHIYNMGN-------PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQ  151 (285)
T ss_pred             cCCCcHHHHHHhhCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEE
Confidence            999999877754321       13788999999999999999999998   99999999999999999999999999976


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      ....            .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....      
T Consensus       152 ~~~~------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~------  212 (285)
T cd05631         152 IPEG------------ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-KREE------  212 (285)
T ss_pred             cCCC------------CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-hHHH------
Confidence            5211            11123468999999999999999999999999999999999999997532110 0000      


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT-----MLDAADD  852 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~  852 (885)
                             ++..+.......       ....+.++.+++.+||+.||.+||+     ++|++++
T Consensus       213 -------~~~~~~~~~~~~-------~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         213 -------VDRRVKEDQEEY-------SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             -------HHHHhhcccccC-------CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence                   111111000000       0123557889999999999999997     7888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9e-39  Score=338.55  Aligned_cols=257  Identities=23%  Similarity=0.326  Sum_probs=213.0

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCCc-ceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDF-KALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lV~  632 (885)
                      ++|...+.+|+|+||.++.++.+ ++..||+|.+....  ....+...+|+.++++++|||||.+.+.|++++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57889999999999999999865 68899999987553  3345578899999999999999999999999988 89999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      +|++||++.+.+...+..       -+++..+..++.|+..|+.|||+..   |+|||||+.||+++.++.++|+|||+|
T Consensus        84 ~Y~eGg~l~~~i~~~k~~-------~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGla  153 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGV-------LFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLA  153 (426)
T ss_pred             eecCCCCHHHHHHHHhhc-------cccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhh
Confidence            999999999999766522       3889999999999999999999887   999999999999999999999999999


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      +.+.+.           ........||+.||.||.+.+.+|+.|+||||+||++|||.+-+++|...     +....   
T Consensus       154 K~l~~~-----------~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-----~m~~L---  214 (426)
T KOG0589|consen  154 KILNPE-----------DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-----NMSEL---  214 (426)
T ss_pred             hhcCCc-----------hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-----chHHH---
Confidence            987442           23455678999999999999999999999999999999999999999752     22222   


Q ss_pred             hhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRY  859 (885)
Q Consensus       793 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~  859 (885)
                               +.+....... +.+      ...+.++..++..|++.+|+.||++.+++.+ -.+.+.
T Consensus       215 ---------i~ki~~~~~~-Plp------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~-P~l~~~  264 (426)
T KOG0589|consen  215 ---------ILKINRGLYS-PLP------SMYSSELRSLVKSMLRKNPEHRPSALELLRR-PHLLRY  264 (426)
T ss_pred             ---------HHHHhhccCC-CCC------ccccHHHHHHHHHHhhcCCccCCCHHHHhhC-hhhhhH
Confidence                     2222222211 111      1246679999999999999999999999987 444433

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-38  Score=339.43  Aligned_cols=243  Identities=25%  Similarity=0.375  Sum_probs=201.6

Q ss_pred             HhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec---CCcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcce
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFKA  629 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  629 (885)
                      ...+|...++||+|+||.|++|..+ +++.+|||++++.   .....+..+.|.+|+... +||.++.++.+|+..++.+
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            3468999999999999999999966 6889999999865   345567788899998877 5999999999999999999


Q ss_pred             EEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccc
Q 002746          630 LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDF  709 (885)
Q Consensus       630 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df  709 (885)
                      .||||+.||++..+.+..          .+++..+.-+|..|+.||+|||++|   |||||||.+|||+|.+|++||+||
T Consensus       446 fvmey~~Ggdm~~~~~~~----------~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADF  512 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHTD----------VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADF  512 (694)
T ss_pred             EEEEecCCCcEEEEEecc----------cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccc
Confidence            999999999965555432          3889999999999999999999999   999999999999999999999999


Q ss_pred             ccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHH
Q 002746          710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKW  789 (885)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~  789 (885)
                      |+++.-..           ......+.+|||.|||||++.+..|+.+.|.|||||++|||+.|..||....+        
T Consensus       513 GlcKe~m~-----------~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE--------  573 (694)
T KOG0694|consen  513 GLCKEGMG-----------QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE--------  573 (694)
T ss_pred             ccccccCC-----------CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH--------
Confidence            99985421           23345678999999999999999999999999999999999999999974211        


Q ss_pred             HHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCH
Q 002746          790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTM  846 (885)
Q Consensus       790 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  846 (885)
                               .++.|..+.+...-  |   .   .++.+...++.+++.++|++|-.+
T Consensus       574 ---------ee~FdsI~~d~~~y--P---~---~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  574 ---------EEVFDSIVNDEVRY--P---R---FLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ---------HHHHHHHhcCCCCC--C---C---cccHHHHHHHHHHhccCcccccCC
Confidence                     12222222222110  0   0   156789999999999999999876

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-38  Score=339.28  Aligned_cols=245  Identities=23%  Similarity=0.293  Sum_probs=199.2

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999976 68999999987432   223456889999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++|+|.+++....         .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++
T Consensus        81 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~  148 (291)
T cd05612          81 EYVPGGELFSYLRNSG---------RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFA  148 (291)
T ss_pred             eCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcc
Confidence            9999999999886543         2788899999999999999999998   999999999999999999999999999


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      +....              ......||+.|+|||++.+..++.++|||||||++|||++|+.||....     .......
T Consensus       149 ~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-----~~~~~~~  209 (291)
T cd05612         149 KKLRD--------------RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN-----PFGIYEK  209 (291)
T ss_pred             hhccC--------------CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHH
Confidence            76521              1123468999999999999999999999999999999999999996421     1111111


Q ss_pred             hhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT-----MLDAADD  852 (885)
Q Consensus       793 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~  852 (885)
                      ....             ......       ..+..+.+++.+|++.||.+||+     ++|++++
T Consensus       210 i~~~-------------~~~~~~-------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         210 ILAG-------------KLEFPR-------HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             HHhC-------------CcCCCc-------cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            1100             000000       12446889999999999999995     8888876

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.7e-38  Score=338.77  Aligned_cols=269  Identities=22%  Similarity=0.348  Sum_probs=200.7

Q ss_pred             hCCcccceecccCcceEEEEEeCC-----------------CCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCccccee
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQD-----------------GTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRI  618 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~  618 (885)
                      ++|.+.+.||+|+||.||+|.+++                 +..||+|.++.... .....+.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578889999999999999998542                 33699999875432 234678999999999999999999


Q ss_pred             eeeeecCCcceEEEecccCCccccccccCCcccc----------CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEe
Q 002746          619 ITACSLPDFKALVLPYMANGSLDSHLYPHSETEF----------GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIH  688 (885)
Q Consensus       619 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~----------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH  688 (885)
                      ++++...+..++||||+++|+|.+++........          ......+++..++.++.|++.||+|||+.+   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            9999999999999999999999988754321110          011134788999999999999999999998   999


Q ss_pred             cCCCCCceEecCCCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHH
Q 002746          689 CDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLE  768 (885)
Q Consensus       689 ~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~e  768 (885)
                      |||||+||+++.++.+||+|||+++.+.....         ........++..|+|||++.+..++.++||||||+++||
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e  232 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDY---------YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWE  232 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCce---------eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHH
Confidence            99999999999999999999999986532110         011112345788999999988899999999999999999


Q ss_pred             HHc--CCCCCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCH
Q 002746          769 MVT--RRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTM  846 (885)
Q Consensus       769 llt--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  846 (885)
                      |++  |..||.....  ......+......        ..........       ..++..+.+++.+||+.||++|||+
T Consensus       233 l~~~~~~~p~~~~~~--~~~~~~~~~~~~~--------~~~~~~~~~~-------~~~~~~~~~li~~cl~~~p~~RPs~  295 (304)
T cd05096         233 ILMLCKEQPYGELTD--EQVIENAGEFFRD--------QGRQVYLFRP-------PPCPQGLYELMLQCWSRDCRERPSF  295 (304)
T ss_pred             HHHccCCCCCCcCCH--HHHHHHHHHHhhh--------ccccccccCC-------CCCCHHHHHHHHHHccCCchhCcCH
Confidence            987  5567754211  1111111111100        0000000000       0135678999999999999999999


Q ss_pred             HHHHHHHH
Q 002746          847 LDAADDLD  854 (885)
Q Consensus       847 ~ev~~~L~  854 (885)
                      +||.+.|+
T Consensus       296 ~~i~~~l~  303 (304)
T cd05096         296 SDIHAFLT  303 (304)
T ss_pred             HHHHHHHh
Confidence            99998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.4e-38  Score=343.41  Aligned_cols=245  Identities=24%  Similarity=0.341  Sum_probs=199.4

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      .+|++.+.||+|+||.||+|+.. +++.||+|+++...   ....+.+.+|++++++++||||+++++++..++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57899999999999999999976 68999999987432   233467889999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++|+|.+++....         .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        98 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~  165 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG---------RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFA  165 (329)
T ss_pred             cCCCCChHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCc
Confidence            9999999999886543         2788888999999999999999998   999999999999999999999999999


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      +....              ......||+.|+|||++.+..++.++|||||||++|||++|+.||....     ..+....
T Consensus       166 ~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-----~~~~~~~  226 (329)
T PTZ00263        166 KKVPD--------------RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT-----PFRIYEK  226 (329)
T ss_pred             eEcCC--------------CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC-----HHHHHHH
Confidence            86521              1123468999999999999999999999999999999999999996421     1111111


Q ss_pred             hhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT-----MLDAADD  852 (885)
Q Consensus       793 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~  852 (885)
                      .....             .. .+.      ..+.++.+++.+||+.||.+||+     ++|++.+
T Consensus       227 i~~~~-------------~~-~p~------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        227 ILAGR-------------LK-FPN------WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             HhcCC-------------cC-CCC------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            11100             00 000      02345889999999999999997     6888766

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-38  Score=305.08  Aligned_cols=256  Identities=25%  Similarity=0.393  Sum_probs=208.3

Q ss_pred             HHHhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC--------cchhhHHHHHHHHhhc-CCcccceeeeee
Q 002746          553 LEATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG--------NFTKSFNRECQVLKRI-RHRNLMRIITAC  622 (885)
Q Consensus       553 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~~~~~~  622 (885)
                      ...-..|+..+++|+|..++|.++..+ +|..+|+|++.....        ...+.-.+|+.+|+++ .||+|+++.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            344567788889999999999999855 788999999864321        1233456799999998 699999999999


Q ss_pred             ecCCcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCC
Q 002746          623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDM  702 (885)
Q Consensus       623 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~  702 (885)
                      +.+...++|+|.|+.|.|.+++...-         .+++....+|++|+.+|++|||.+.   |||||+||+|||+|++.
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~V---------tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~  160 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSKV---------TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNM  160 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhhe---------eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeecccc
Confidence            99999999999999999999997554         3889999999999999999999998   99999999999999999


Q ss_pred             CEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC------CCCccccchhhHHHHHHHHcCCCCC
Q 002746          703 TALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS------NTSTKGDVYSFGILVLEMVTRRRPT  776 (885)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~vl~elltg~~P~  776 (885)
                      ++||+|||+|+.+.+            +......+|||+|.|||.+.+.      .|+...|+|++||++|.++.|.+||
T Consensus       161 ~i~isDFGFa~~l~~------------GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF  228 (411)
T KOG0599|consen  161 NIKISDFGFACQLEP------------GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF  228 (411)
T ss_pred             ceEEeccceeeccCC------------chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch
Confidence            999999999997743            3455668999999999987653      5778899999999999999999999


Q ss_pred             CccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 002746          777 DDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDL  853 (885)
Q Consensus       777 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  853 (885)
                      .--       .+          .-.+.-.+.+.+.-..|+    |...+....++|.+|++.||.+|.|++|+++|-
T Consensus       229 wHR-------kQ----------mlMLR~ImeGkyqF~spe----Wadis~~~KdLIsrlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  229 WHR-------KQ----------MLMLRMIMEGKYQFRSPE----WADISATVKDLISRLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             hHH-------HH----------HHHHHHHHhcccccCCcc----hhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence            530       00          001111122222222333    666778899999999999999999999999874

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.7e-37  Score=339.28  Aligned_cols=199  Identities=27%  Similarity=0.412  Sum_probs=173.9

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEe
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      .++|++.+.||+|+||.||+|+.. ++..||+|.++.... .....+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            368999999999999999999976 688899999875432 335678999999999999999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      |+++|+|.+++....         .+++..+..++.|++.|+.|||+++  +|+||||||+||+++.++.+||+|||++.
T Consensus        84 ~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  152 (331)
T cd06649          84 HMDGGSLDQVLKEAK---------RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSG  152 (331)
T ss_pred             cCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccc
Confidence            999999999886543         2788899999999999999999863  39999999999999999999999999987


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCc
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD  778 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~  778 (885)
                      ....             .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       153 ~~~~-------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         153 QLID-------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             cccc-------------cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            5521             112234689999999999999999999999999999999999999964

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.8e-38  Score=341.70  Aligned_cols=242  Identities=23%  Similarity=0.300  Sum_probs=194.8

Q ss_pred             ceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCC
Q 002746          563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANG  638 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g  638 (885)
                      ++||+|+||.||+|+.. +|+.||+|+++...   ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999965 78999999997542   223456788999999999999999999999999999999999999


Q ss_pred             ccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecc
Q 002746          639 SLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV  718 (885)
Q Consensus       639 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~  718 (885)
                      +|.+++....         .+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+|+.....
T Consensus        81 ~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~  148 (323)
T cd05571          81 ELFFHLSRER---------VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD  148 (323)
T ss_pred             cHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC
Confidence            9988886543         3789999999999999999999998   999999999999999999999999998753211


Q ss_pred             cCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchh
Q 002746          719 GVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRL  798 (885)
Q Consensus       719 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  798 (885)
                                 ........||+.|+|||++.+..++.++||||+||++|||++|+.||...     +...........  
T Consensus       149 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~-----~~~~~~~~~~~~--  210 (323)
T cd05571         149 -----------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHEKLFELILME--  210 (323)
T ss_pred             -----------CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC-----CHHHHHHHHHcC--
Confidence                       11223456999999999999999999999999999999999999999642     111111110000  


Q ss_pred             hhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 002746          799 EKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP-----TMLDAADD  852 (885)
Q Consensus       799 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  852 (885)
                                 .....       ...+.++.+++.+||+.||++||     ++.+++++
T Consensus       211 -----------~~~~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         211 -----------EIRFP-------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             -----------CCCCC-------CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence                       00000       01345688999999999999999     79998865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-38  Score=322.34  Aligned_cols=260  Identities=26%  Similarity=0.384  Sum_probs=199.9

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC--------------cchhhHHHHHHHHhhcCCcccceeee
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG--------------NFTKSFNRECQVLKRIRHRNLMRIIT  620 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~~~~  620 (885)
                      .++|++.+.||+|.||.|-+|+.. +++.||||++.....              ...+...+|+.++++++|||||+++.
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            478999999999999999999954 799999999863210              11247889999999999999999999


Q ss_pred             eeecC--CcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEe
Q 002746          621 ACSLP--DFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL  698 (885)
Q Consensus       621 ~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl  698 (885)
                      +..++  +..|||+|||..|.+...-.         ....+...++++++.+++.||+|||.+|   ||||||||+|+|+
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w~p~---------d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl  243 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKWCPP---------DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLL  243 (576)
T ss_pred             eecCcccCceEEEEEeccCCccccCCC---------CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEE
Confidence            98765  57799999999888753221         1122889999999999999999999999   9999999999999


Q ss_pred             cCCCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCC----CCccccchhhHHHHHHHHcCCC
Q 002746          699 NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN----TSTKGDVYSFGILVLEMVTRRR  774 (885)
Q Consensus       699 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~vl~elltg~~  774 (885)
                      +++|++||+|||.+.......      ............|||.|+|||...++.    .+.+.||||+||+||.|+.|+.
T Consensus       244 ~~~g~VKIsDFGVs~~~~~~~------~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~  317 (576)
T KOG0585|consen  244 SSDGTVKISDFGVSNEFPQGS------DEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQL  317 (576)
T ss_pred             cCCCcEEeeccceeeecccCC------ccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccC
Confidence            999999999999998663321      111122334478999999999877632    3678999999999999999999


Q ss_pred             CCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          775 PTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       775 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                      ||-+.+.  ..           -..+++...+.      .|.    .++..+++.++|.+++++||+.|.+..+|..|..
T Consensus       318 PF~~~~~--~~-----------l~~KIvn~pL~------fP~----~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw  374 (576)
T KOG0585|consen  318 PFFDDFE--LE-----------LFDKIVNDPLE------FPE----NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW  374 (576)
T ss_pred             CcccchH--HH-----------HHHHHhcCccc------CCC----cccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence            9964211  00           11122222211      111    0123567899999999999999999999998865


Q ss_pred             HH
Q 002746          855 RL  856 (885)
Q Consensus       855 ~l  856 (885)
                      ..
T Consensus       375 vt  376 (576)
T KOG0585|consen  375 VT  376 (576)
T ss_pred             ec
Confidence            44

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-38  Score=319.37  Aligned_cols=248  Identities=23%  Similarity=0.374  Sum_probs=209.9

Q ss_pred             hhCCcccceecccCcceEEEEEe-CCCCEEEEEEeeecCC---cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEE
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQSG---NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV  631 (885)
                      ..+|++.+.||+|.||.|-+|.. ..|+.||||.++...-   ++.-.+.+|+++++.++||||+.+|.+|+..+..++|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            35788999999999999999995 6899999999986543   3345678999999999999999999999999999999


Q ss_pred             EecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccc
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~  711 (885)
                      |||..+|.|.+++....         .+++..+..+++||.+|+.|+|+++   +||||+|.+|||+|.++++||+|||+
T Consensus       132 MEYaS~GeLYDYiSer~---------~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGL  199 (668)
T KOG0611|consen  132 MEYASGGELYDYISERG---------SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGL  199 (668)
T ss_pred             EEecCCccHHHHHHHhc---------cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccch
Confidence            99999999999997665         3899999999999999999999998   99999999999999999999999999


Q ss_pred             ceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCC-CccccchhhHHHHHHHHcCCCCCCccccCCccHHHHH
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~  790 (885)
                      +-.+..            ....+.++|++-|.+||.+.|.+| ++..|-||+||+||.++.|..||+.     .+....+
T Consensus       200 SNly~~------------~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-----~Dhk~lv  262 (668)
T KOG0611|consen  200 SNLYAD------------KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-----RDHKRLV  262 (668)
T ss_pred             hhhhcc------------ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-----chHHHHH
Confidence            987632            456778899999999999999998 6889999999999999999999975     2222333


Q ss_pred             HHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 002746          791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDL  853 (885)
Q Consensus       791 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  853 (885)
                      +++..            +.++.+.         -+.+..-+|++|+..+|++|.|+.+|..+-
T Consensus       263 rQIs~------------GaYrEP~---------~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  263 RQISR------------GAYREPE---------TPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             HHhhc------------ccccCCC---------CCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            32222            2222111         123466789999999999999999998873

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.4e-37  Score=345.00  Aligned_cols=265  Identities=24%  Similarity=0.380  Sum_probs=203.2

Q ss_pred             hhCCcccceecccCcceEEEEEe------CCCCEEEEEEeeecC-CcchhhHHHHHHHHhhc-CCcccceeeeeeecCCc
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGIL------QDGTAIAVKVLQLQS-GNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDF  627 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  627 (885)
                      .++|++.+.||+|+||.||+|++      .++..||||+++... ....+.+.+|++++..+ +||||++++++|...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            35788899999999999999974      235689999987443 23456788999999999 89999999999999999


Q ss_pred             ceEEEecccCCccccccccCCccc--------------------------------------------------------
Q 002746          628 KALVLPYMANGSLDSHLYPHSETE--------------------------------------------------------  651 (885)
Q Consensus       628 ~~lV~e~~~~gsL~~~l~~~~~~~--------------------------------------------------------  651 (885)
                      .++||||+++|+|.++++......                                                        
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999998886432100                                                        


Q ss_pred             ----------cCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecccCC
Q 002746          652 ----------FGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG  721 (885)
Q Consensus       652 ----------~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~  721 (885)
                                .......+++..+.+++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+..... 
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-  269 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN-  269 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc-
Confidence                      0001224789999999999999999999998   99999999999999999999999999986532110 


Q ss_pred             CCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhhcchhhh
Q 002746          722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHYHGRLEK  800 (885)
Q Consensus       722 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~  800 (885)
                              ........++..|+|||++.+..++.++|||||||++|||++ |..||...... ....+++.         
T Consensus       270 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~---------  331 (375)
T cd05104         270 --------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIK---------  331 (375)
T ss_pred             --------ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHH---------
Confidence                    011112235678999999999999999999999999999998 88898653111 11111111         


Q ss_pred             hhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 002746          801 VIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDR  855 (885)
Q Consensus       801 ~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  855 (885)
                         ...    ....+.      ..+.++.+++.+||+.||++||++.|+++.|++
T Consensus       332 ---~~~----~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         332 ---EGY----RMLSPE------CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ---hCc----cCCCCC------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence               110    000000      124568999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-38  Score=344.32  Aligned_cols=253  Identities=22%  Similarity=0.289  Sum_probs=202.1

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ++|++.+.||+|+||.||+|+.. +++.||||+++...   ......+..|++++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36889999999999999999976 58999999997542   233466889999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++|+|.+++....         .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+|
T Consensus        81 e~~~g~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a  148 (333)
T cd05600          81 EYVPGGDFRTLLNNLG---------VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLS  148 (333)
T ss_pred             eCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCC
Confidence            9999999999986443         3788899999999999999999998   999999999999999999999999999


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      +....              ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ......
T Consensus       149 ~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~  209 (333)
T cd05600         149 KGIVT--------------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP-----NETWEN  209 (333)
T ss_pred             ccccc--------------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH-----HHHHHH
Confidence            75421              22345689999999999999999999999999999999999999964211     111000


Q ss_pred             hhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       793 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ...  ..    ..+. ......+.     ...+.++.+++.+|+..+|.+||+++|++++
T Consensus       210 i~~--~~----~~~~-~~~~~~~~-----~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         210 LKY--WK----ETLQ-RPVYDDPR-----FNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             HHh--cc----cccc-CCCCCccc-----cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            000  00    0000 00000000     1235678999999999999999999999986

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.6e-37  Score=332.98  Aligned_cols=272  Identities=17%  Similarity=0.242  Sum_probs=203.0

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEe
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      ++|++.+.||+|+||.||+|+.. +++.||||+++...  ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36899999999999999999976 68899999987542  2335678899999999999999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      |++++.+..+....         ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~~~~l~~~~~~~---------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~  148 (287)
T cd07848          81 YVEKNMLELLEEMP---------NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFAR  148 (287)
T ss_pred             cCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcc
Confidence            99988776543221         13788899999999999999999998   9999999999999999999999999998


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      .+....          ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... +...
T Consensus       149 ~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~-~~~~~-~~~~  216 (287)
T cd07848         149 NLSEGS----------NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI-DQLFT-IQKV  216 (287)
T ss_pred             cccccc----------cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHH-HHHh
Confidence            653210          11122346899999999999989999999999999999999999999753111 11111 1111


Q ss_pred             hcc---hhhhhh--hhhhhh----ccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          794 YHG---RLEKVI--DSSLLR----ASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       794 ~~~---~~~~~~--d~~~~~----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ...   ......  ++....    ..........+.....+.++.+++.+|++.||++|||++|++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         217 LGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             hCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000   000000  000000    00001111122233456789999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.5e-37  Score=344.33  Aligned_cols=267  Identities=25%  Similarity=0.401  Sum_probs=203.9

Q ss_pred             hhCCcccceecccCcceEEEEEeC------CCCEEEEEEeeecC-CcchhhHHHHHHHHhhc-CCcccceeeeeeecCCc
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ------DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDF  627 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  627 (885)
                      .++|++.+.||+|+||.||+|++.      ++..||||+++... ......+.+|+++++.+ +|+||++++++|...+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            357899999999999999999842      24579999997543 23345688999999999 89999999999999999


Q ss_pred             ceEEEecccCCccccccccCCccc--------------------------------------------------------
Q 002746          628 KALVLPYMANGSLDSHLYPHSETE--------------------------------------------------------  651 (885)
Q Consensus       628 ~~lV~e~~~~gsL~~~l~~~~~~~--------------------------------------------------------  651 (885)
                      .++||||+++|+|.++++......                                                        
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999998875432100                                                        


Q ss_pred             -----cCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecccCCCCCCC
Q 002746          652 -----FGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE  726 (885)
Q Consensus       652 -----~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  726 (885)
                           .......+++..+++++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.+....       
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~-------  266 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS-------  266 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCc-------
Confidence                 0011224788999999999999999999998   9999999999999999999999999997653210       


Q ss_pred             CCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhhcchhhhhhhhh
Q 002746          727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSS  805 (885)
Q Consensus       727 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  805 (885)
                        .........++..|+|||++.+..++.++|||||||++|||++ |+.||....... ...            ......
T Consensus       267 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~------------~~~~~~  331 (374)
T cd05106         267 --NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFY------------KMVKRG  331 (374)
T ss_pred             --ceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHH------------HHHHcc
Confidence              0011112235678999999998899999999999999999997 999997532111 011            111100


Q ss_pred             hhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 002746          806 LLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLK  857 (885)
Q Consensus       806 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~  857 (885)
                      .......          ..+.++.+++.+||+.||++||++.++++.|+++.
T Consensus       332 ~~~~~~~----------~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         332 YQMSRPD----------FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             cCccCCC----------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            0000000          12456899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=7.1e-38  Score=342.26  Aligned_cols=245  Identities=22%  Similarity=0.278  Sum_probs=198.5

Q ss_pred             hCCcccceecccCcceEEEEEeCC--CCEEEEEEeeec---CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQD--GTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV  631 (885)
                      ++|.+.+.||+|+||.||+|....  +..||+|++...   .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            568999999999999999998543  368999998643   223356688999999999999999999999999999999


Q ss_pred             EecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccc
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~  711 (885)
                      |||+++|+|.+++....         .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       110 ~Ey~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~  177 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNK---------RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGF  177 (340)
T ss_pred             EeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCC
Confidence            99999999999886543         2788999999999999999999998   99999999999999999999999999


Q ss_pred             ceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      ++.+..              ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .....
T Consensus       178 a~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~  238 (340)
T PTZ00426        178 AKVVDT--------------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-----LLIYQ  238 (340)
T ss_pred             CeecCC--------------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-----HHHHH
Confidence            986521              11234689999999999998899999999999999999999999964211     01011


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP-----TMLDAADD  852 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  852 (885)
                      ..        .     .......+       ..+.++.+++.+|++.||++|+     +++|+.++
T Consensus       239 ~i--------~-----~~~~~~p~-------~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        239 KI--------L-----EGIIYFPK-------FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             HH--------h-----cCCCCCCC-------CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            10        0     00000000       1244578999999999999995     89998876

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-38  Score=339.70  Aligned_cols=260  Identities=28%  Similarity=0.428  Sum_probs=207.4

Q ss_pred             CCcccceecccCcceEEEEEeCC--C--CE-EEEEEeeec---CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcce
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQD--G--TA-IAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKA  629 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~~--~--~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  629 (885)
                      +....++||+|+||.||+|++..  +  .. ||||..+..   ......+|.+|+++++.++|||||++||++......+
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            34455899999999999999652  2  23 899998853   2445678999999999999999999999999999999


Q ss_pred             EEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccc
Q 002746          630 LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDF  709 (885)
Q Consensus       630 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df  709 (885)
                      +|||+|.||+|.++++....        .++..++..++.++|.||+|||+++   ++||||.++|+|++.++.+||+||
T Consensus       238 ivmEl~~gGsL~~~L~k~~~--------~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDF  306 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKK--------SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDF  306 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcc
Confidence            99999999999999987653        3899999999999999999999998   999999999999999999999999


Q ss_pred             ccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHH
Q 002746          710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~  788 (885)
                      |+++.-...        ..   ......-...|+|||.+....+++++|||||||++||+++ |..||......  ....
T Consensus       307 GLs~~~~~~--------~~---~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~  373 (474)
T KOG0194|consen  307 GLSRAGSQY--------VM---KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKA  373 (474)
T ss_pred             ccccCCcce--------ee---ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHH
Confidence            998743100        00   0001124578999999999999999999999999999999 88898753111  1111


Q ss_pred             HHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHhcC
Q 002746          789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGE  862 (885)
Q Consensus       789 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~  862 (885)
                      ++.               ...++...+.      ..+.++..++.+||..+|++||+|.++.+.++.+......
T Consensus       374 kI~---------------~~~~r~~~~~------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  374 KIV---------------KNGYRMPIPS------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             HHH---------------hcCccCCCCC------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            110               1111111111      2456788999999999999999999999999999877654

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-37  Score=318.47  Aligned_cols=278  Identities=26%  Similarity=0.369  Sum_probs=204.3

Q ss_pred             hCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhh--cCCcccceeeeeeecCC----cceE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKR--IRHRNLMRIITACSLPD----FKAL  630 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~~~l  630 (885)
                      ......++||+|.||.||+|.+. ++.||||+|.   ....+.|..|-++++.  ++|+||++++++-...+    +++|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            34455678999999999999987 6999999997   3446789999999886  48999999999876555    7899


Q ss_pred             EEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccC------CCceEecCCCCCceEecCCCCE
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS------PVRVIHCDLKPSNVLLNDDMTA  704 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~ivH~Dlkp~NILl~~~~~~  704 (885)
                      |++|.+.|+|.++|..+.          ++|....+|+..+++||+|||+.-      .++|+|||||++|||+..|+++
T Consensus       286 Vt~fh~kGsL~dyL~~nt----------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc  355 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKANT----------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC  355 (534)
T ss_pred             EeeeccCCcHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence            999999999999998764          899999999999999999999843      4679999999999999999999


Q ss_pred             EEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCC------CCccccchhhHHHHHHHHcCCCCCCc
Q 002746          705 LVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN------TSTKGDVYSFGILVLEMVTRRRPTDD  778 (885)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~vl~elltg~~P~~~  778 (885)
                      .|+|||+|..+.+...         ....-.-+||.+|||||++.+..      .-.+.||||+|.|+|||+++..-++.
T Consensus       356 cIaDFGLAl~~~p~~~---------~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~  426 (534)
T KOG3653|consen  356 CIADFGLALRLEPGKP---------QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP  426 (534)
T ss_pred             EeeccceeEEecCCCC---------CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC
Confidence            9999999998864221         11222368999999999987653      22468999999999999997654321


Q ss_pred             cccCC--ccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHH--HHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          779 MFAGG--LSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWD--VAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       779 ~~~~~--~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~--~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                      .....  ..+..-+..  +..+.+..+--.....+   |..+..|.  ..+.-+.+.+..||..||+.|.|+.=|.+.+.
T Consensus       427 ~~vp~Yqlpfe~evG~--hPt~e~mq~~VV~kK~R---P~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~  501 (534)
T KOG3653|consen  427 GPVPEYQLPFEAEVGN--HPTLEEMQELVVRKKQR---PKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMA  501 (534)
T ss_pred             CCCCcccCchhHHhcC--CCCHHHHHHHHHhhccC---CCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHH
Confidence            00000  001000000  00011111111111111   11111221  23456889999999999999999999999999


Q ss_pred             HHHHHhcC
Q 002746          855 RLKRYLGE  862 (885)
Q Consensus       855 ~l~~~~~~  862 (885)
                      ++.+..+.
T Consensus       502 ~l~~~~~~  509 (534)
T KOG3653|consen  502 ELMMLWED  509 (534)
T ss_pred             HHhccCCc
Confidence            99876654

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.6e-37  Score=324.36  Aligned_cols=251  Identities=27%  Similarity=0.401  Sum_probs=200.6

Q ss_pred             hCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEeccc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMA  636 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~  636 (885)
                      ++|++.+.||+|+||.||+|.++++..+|+|.++... ...+.+.+|++++++++||||+++++++..++..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4688899999999999999999888899999886332 234678999999999999999999999999999999999999


Q ss_pred             CCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeee
Q 002746          637 NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM  716 (885)
Q Consensus       637 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~  716 (885)
                      +|+|.++++....        .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||.++...
T Consensus        83 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~  151 (256)
T cd05114          83 NGCLLNYLRQRQG--------KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL  151 (256)
T ss_pred             CCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence            9999998864321        3789999999999999999999998   9999999999999999999999999987652


Q ss_pred             cccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhhc
Q 002746          717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~  795 (885)
                      ...          ........++..|+|||+..+..++.++||||||+++|||++ |+.||....     ..+.+.....
T Consensus       152 ~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~-----~~~~~~~i~~  216 (256)
T cd05114         152 DDE----------YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-----NYEVVEMISR  216 (256)
T ss_pred             CCc----------eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHHC
Confidence            211          011112235678999999998899999999999999999999 899986421     1111111111


Q ss_pred             chhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDL  853 (885)
Q Consensus       796 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  853 (885)
                      .             .....+.      ..+.++.+++.+||+++|++||+++|+++.|
T Consensus       217 ~-------------~~~~~~~------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         217 G-------------FRLYRPK------LASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             C-------------CCCCCCC------CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            0             0000000      0234689999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2e-37  Score=332.11  Aligned_cols=269  Identities=22%  Similarity=0.285  Sum_probs=199.5

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            57899999999999999999965 68999999987543 23345678999999999999999999999999899999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      ++ |+|.+++.....        .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        85 ~~-~~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~  152 (288)
T cd07871          85 LD-SDLKQYLDNCGN--------LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARA  152 (288)
T ss_pred             CC-cCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceee
Confidence            97 488887754321        3688899999999999999999998   99999999999999999999999999975


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      ....           ........|++.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+. .+...
T Consensus       153 ~~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-~~~~-~~~~~  219 (288)
T cd07871         153 KSVP-----------TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK-EELH-LIFRL  219 (288)
T ss_pred             ccCC-----------CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHH-HHHHH
Confidence            4211           111223467899999998765 56899999999999999999999999642111 1111 11111


Q ss_pred             hcchhhhhh----hh-h----hhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          794 YHGRLEKVI----DS-S----LLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       794 ~~~~~~~~~----d~-~----~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ......+.+    +. .    ....... .+ ........+.++.+++.+|++.||.+|||++|++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         220 LGTPTEETWPGITSNEEFRSYLFPQYRA-QP-LINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hCCCChHHhhccccchhhhccccCccCC-Cc-hHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            111111110    00 0    0000000 00 001111245678899999999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.7e-38  Score=309.34  Aligned_cols=283  Identities=22%  Similarity=0.286  Sum_probs=210.2

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC--cchhhHHHHHHHHhhcCCcccceeeeeeecC--CcceEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG--NFTKSFNRECQVLKRIRHRNLMRIITACSLP--DFKALV  631 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lV  631 (885)
                      ++|+..+.|++|.||.||+|+++ +++.||+|+++....  ...-...+|+.+|.+.+|||||.+-.++...  +..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            56888899999999999999965 789999999986542  3345578999999999999999998877543  568999


Q ss_pred             EecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccc
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~  711 (885)
                      ||||+. +|...+.....        ++...+..-+..|+++|++|||...   |+|||+||+|+|+...|.+||+|||+
T Consensus       156 Me~~Eh-DLksl~d~m~q--------~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGL  223 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQ--------PFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGL  223 (419)
T ss_pred             HHHHHh-hHHHHHHhccC--------CCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccch
Confidence            999965 77777765442        3788888999999999999999999   99999999999999999999999999


Q ss_pred             ceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHH
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~  790 (885)
                      |+.++.           +....+..+-|..|.|||.+.|. .|+.+.|+||+|||+.||+++++-|....+ -.++...+
T Consensus       224 AR~ygs-----------p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE-~dQl~~If  291 (419)
T KOG0663|consen  224 AREYGS-----------PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE-IDQLDKIF  291 (419)
T ss_pred             hhhhcC-----------CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch-HHHHHHHH
Confidence            998743           13345566789999999988775 589999999999999999999998864211 11222222


Q ss_pred             HHhh-cch--hhhhhhhhhhh---ccCCChHHHHHHHHH--HHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHhcC
Q 002746          791 KNHY-HGR--LEKVIDSSLLR---ASRDQSPEVKRMWDV--AIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGE  862 (885)
Q Consensus       791 ~~~~-~~~--~~~~~d~~~~~---~~~~~~~~~~~~~~~--~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~  862 (885)
                      +... +.+  ++.+.+.....   -...+...++.-+..  .++.-++++...+..||++|.|++|.+++     .|+.+
T Consensus       292 ~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h-----~~F~e  366 (419)
T KOG0663|consen  292 KLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH-----EYFRE  366 (419)
T ss_pred             HHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc-----ccccc
Confidence            2111 111  12221111111   011111222222222  34678899999999999999999999985     67776


Q ss_pred             CCCCCc
Q 002746          863 KHMPSK  868 (885)
Q Consensus       863 ~~~~~~  868 (885)
                      ...|..
T Consensus       367 ~P~p~~  372 (419)
T KOG0663|consen  367 TPLPID  372 (419)
T ss_pred             CCCCCC
Confidence            555443

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.3e-37  Score=326.48  Aligned_cols=256  Identities=26%  Similarity=0.364  Sum_probs=201.4

Q ss_pred             hhCCcccceecccCcceEEEEEeC----CCCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceE
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ----DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKAL  630 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  630 (885)
                      ..+|++.+.||+|+||.||+|++.    .+..||+|.++.... .....+.+|+.++++++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            357889999999999999999853    356899999875432 334578899999999999999999999999999999


Q ss_pred             EEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccc
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG  710 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg  710 (885)
                      ||||+++|+|.+++.....        .+++..++.++.|++.|++|||+++   ++||||||+||+++.++.++++|||
T Consensus        84 v~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg  152 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEG--------QLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFR  152 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCc
Confidence            9999999999998865421        3789999999999999999999998   9999999999999999999999999


Q ss_pred             cceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHH
Q 002746          711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKW  789 (885)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~  789 (885)
                      .+.......          ........++..|+|||.+.+..++.++|||||||++||+++ |+.||.....     ...
T Consensus       153 ~~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-----~~~  217 (266)
T cd05064         153 RLQEDKSEA----------IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-----QDV  217 (266)
T ss_pred             ccccccccc----------hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----HHH
Confidence            876431100          001112235678999999999999999999999999999775 9999965311     111


Q ss_pred             HHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 002746          790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       790 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                      +....             .......+      ..++..+.+++.+||+.+|.+||+++|+.+.|..+
T Consensus       218 ~~~~~-------------~~~~~~~~------~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         218 IKAVE-------------DGFRLPAP------RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHHH-------------CCCCCCCC------CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            11100             00000000      12455689999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.8e-37  Score=339.68  Aligned_cols=257  Identities=23%  Similarity=0.380  Sum_probs=197.2

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      .+|+..+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++++.++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45667789999999999999965 689999999864432 3356788999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +++|+|.....             ..+..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.
T Consensus       154 ~~~~~L~~~~~-------------~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~  217 (353)
T PLN00034        154 MDGGSLEGTHI-------------ADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRI  217 (353)
T ss_pred             CCCCccccccc-------------CCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccccccee
Confidence            99999865321             456677889999999999999998   99999999999999999999999999986


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCC-----CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHH
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-----SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKW  789 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~  789 (885)
                      +...           ........||..|+|||++..     ...+.++|||||||++|||++|+.||.....  ......
T Consensus       218 ~~~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--~~~~~~  284 (353)
T PLN00034        218 LAQT-----------MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--GDWASL  284 (353)
T ss_pred             cccc-----------cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccHHHH
Confidence            6321           111223468999999998743     2345689999999999999999999973211  111111


Q ss_pred             HHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHhcCCCCC
Q 002746          790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGEKHMP  866 (885)
Q Consensus       790 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~~~~~  866 (885)
                      ....            .........       ..++.++.+++.+||+.||++||++.|++++     .|+......
T Consensus       285 ~~~~------------~~~~~~~~~-------~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h-----p~~~~~~~~  337 (353)
T PLN00034        285 MCAI------------CMSQPPEAP-------ATASREFRHFISCCLQREPAKRWSAMQLLQH-----PFILRAQPG  337 (353)
T ss_pred             HHHH------------hccCCCCCC-------CccCHHHHHHHHHHccCChhhCcCHHHHhcC-----cccccCCcc
Confidence            1000            000000000       1135578999999999999999999999985     555555444

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.5e-37  Score=336.49  Aligned_cols=242  Identities=23%  Similarity=0.301  Sum_probs=193.8

Q ss_pred             ceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCC
Q 002746          563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANG  638 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g  638 (885)
                      +.||+|+||.||+|... +|..||+|+++...   ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999965 68999999997542   223456778999999999999999999999999999999999999


Q ss_pred             ccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecc
Q 002746          639 SLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV  718 (885)
Q Consensus       639 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~  718 (885)
                      +|..++....         .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  148 (323)
T cd05595          81 ELFFHLSRER---------VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  148 (323)
T ss_pred             cHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC
Confidence            9988776433         3789999999999999999999998   999999999999999999999999998743211


Q ss_pred             cCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchh
Q 002746          719 GVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRL  798 (885)
Q Consensus       719 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  798 (885)
                                 ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ........    
T Consensus       149 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~~~~----  208 (323)
T cd05595         149 -----------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELIL----  208 (323)
T ss_pred             -----------CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHh----
Confidence                       1112235689999999999999999999999999999999999999964211     11111000    


Q ss_pred             hhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 002746          799 EKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP-----TMLDAADD  852 (885)
Q Consensus       799 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  852 (885)
                          ...    . ...       ...++++.+++.+||+.||++||     ++.+++++
T Consensus       209 ----~~~----~-~~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         209 ----MEE----I-RFP-------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             ----cCC----C-CCC-------CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence                000    0 000       01345688999999999999998     88888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.7e-37  Score=331.91  Aligned_cols=273  Identities=22%  Similarity=0.317  Sum_probs=199.0

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEe
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      .++|++.+.||+|+||.||+|+.. +++.||||+++.... .....+.+|+++++.++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            367999999999999999999976 689999999874432 234567889999999999999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      |++ +++.+++....        ..+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++
T Consensus        84 ~~~-~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~  151 (303)
T cd07869          84 YVH-TDLCQYMDKHP--------GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR  151 (303)
T ss_pred             CCC-cCHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcce
Confidence            995 56766665432        13788889999999999999999998   9999999999999999999999999987


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      .....           ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||....+....+..... 
T Consensus       152 ~~~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-  219 (303)
T cd07869         152 AKSVP-----------SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFL-  219 (303)
T ss_pred             eccCC-----------CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHH-
Confidence            54211           112233468899999998765 45789999999999999999999999753221111111111 


Q ss_pred             hhcch----hhhhhh-hhhhh-c-cCCChHHHHHHHHH--HHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          793 HYHGR----LEKVID-SSLLR-A-SRDQSPEVKRMWDV--AIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       793 ~~~~~----~~~~~d-~~~~~-~-~~~~~~~~~~~~~~--~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .....    +..... +.... . ...........+..  .+.++.+++.+|++.||++|||++|++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         220 VLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             HhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            00000    000000 00000 0 00001111111211  23568899999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.2e-37  Score=331.23  Aligned_cols=270  Identities=22%  Similarity=0.330  Sum_probs=196.4

Q ss_pred             hCCcccceecccCcceEEEEEeC--CCCEEEEEEeeecCC--cchhhHHHHHHHHhhc---CCcccceeeeeeec-----
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ--DGTAIAVKVLQLQSG--NFTKSFNRECQVLKRI---RHRNLMRIITACSL-----  624 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----  624 (885)
                      .+|++.+.||+|+||.||+|+..  +++.||+|+++....  .....+.+|+.+++.+   +||||++++++|..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36889999999999999999863  467899999875432  2234566787777665   69999999998852     


Q ss_pred             CCcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCE
Q 002746          625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA  704 (885)
Q Consensus       625 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~  704 (885)
                      ....++||||++ ++|.+++.....       ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~  149 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPE-------PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQI  149 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCE
Confidence            445789999996 688888764332       23788999999999999999999998   9999999999999999999


Q ss_pred             EEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCc
Q 002746          705 LVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGL  784 (885)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~  784 (885)
                      ||+|||.++.....            .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .
T Consensus       150 kl~Dfg~~~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~  216 (290)
T cd07862         150 KLADFGLARIYSFQ------------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-D  216 (290)
T ss_pred             EEccccceEeccCC------------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-H
Confidence            99999999765321            1123356899999999998889999999999999999999999999753111 1


Q ss_pred             cHHHHHHHhh---cchhhhhh--hhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          785 SLHKWVKNHY---HGRLEKVI--DSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       785 ~~~~~~~~~~---~~~~~~~~--d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .+...+....   +..+....  ......  ..............+..+.+++.+|++.||++|||+.|++++
T Consensus       217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         217 QLGKILDVIGLPGEEDWPRDVALPRQAFH--SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             HHHHHHHHhCCCChhhchhhhcccchhcc--CCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            1111111110   00010000  000000  000111222223355678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.9e-37  Score=323.81  Aligned_cols=255  Identities=27%  Similarity=0.420  Sum_probs=204.3

Q ss_pred             hhCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      .++|++.+.||+|++|.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            36789999999999999999998888899999876432 23578899999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++|+|.+++.....       ..+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.++|+|||.++..
T Consensus        84 ~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~  153 (261)
T cd05072          84 AKGSLLDFLKSDEG-------GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVI  153 (261)
T ss_pred             CCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceec
Confidence            99999998865432       23788899999999999999999998   999999999999999999999999999865


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhh
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      ....          ........++..|+|||+..+..++.++|||||||++|||++ |+.||.....  .....++..  
T Consensus       154 ~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~--  219 (261)
T cd05072         154 EDNE----------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--SDVMSALQR--  219 (261)
T ss_pred             CCCc----------eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--HHHHHHHHc--
Confidence            3210          011112345678999999988889999999999999999998 9999864211  111111110  


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDR  855 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  855 (885)
                                    ......      ...++.++.+++.+|+..+|++||+++++.+.|+.
T Consensus       220 --------------~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         220 --------------GYRMPR------MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             --------------CCCCCC------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                          000000      01134568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.9e-37  Score=327.44  Aligned_cols=263  Identities=25%  Similarity=0.429  Sum_probs=204.4

Q ss_pred             hCCcccceecccCcceEEEEEeCC------CCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcce
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQD------GTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKA  629 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  629 (885)
                      .+|++.+.||+|+||.||+|....      ...||+|.++.... .....+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468888999999999999998642      25799998874432 33467899999999999999999999999988999


Q ss_pred             EEEecccCCccccccccCCcccc-------CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCC
Q 002746          630 LVLPYMANGSLDSHLYPHSETEF-------GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDM  702 (885)
Q Consensus       630 lV~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~  702 (885)
                      ++|||+++|+|.+++........       ......+++..+..++.|++.||+|||+.+   |+||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999998865432111       011135889999999999999999999998   99999999999999999


Q ss_pred             CEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCcccc
Q 002746          703 TALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFA  781 (885)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~  781 (885)
                      .++|+|||+++.......         ........+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus       162 ~~~L~dfg~~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~  232 (283)
T cd05048         162 TVKISDFGLSRDIYSADY---------YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN  232 (283)
T ss_pred             cEEECCCcceeecccccc---------ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999986532110         011122356788999999988899999999999999999998 9999864211


Q ss_pred             CCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 002746          782 GGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDR  855 (885)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  855 (885)
                           .+...         .+...    .....      ...++.++.+++.+||+.+|++||+++||+++|+.
T Consensus       233 -----~~~~~---------~i~~~----~~~~~------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         233 -----QEVIE---------MIRSR----QLLPC------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -----HHHHH---------HHHcC----CcCCC------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                 11111         11100    00000      01256779999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.8e-37  Score=335.69  Aligned_cols=242  Identities=23%  Similarity=0.301  Sum_probs=194.8

Q ss_pred             ceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCC
Q 002746          563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANG  638 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g  638 (885)
                      +.||+|+||.||+|... +++.||+|+++...   ......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999965 68999999997442   233467788999999999999999999999999999999999999


Q ss_pred             ccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecc
Q 002746          639 SLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV  718 (885)
Q Consensus       639 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~  718 (885)
                      +|..++....         .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~  148 (328)
T cd05593          81 ELFFHLSRER---------VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD  148 (328)
T ss_pred             CHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc
Confidence            9988876443         3789999999999999999999998   999999999999999999999999998753110


Q ss_pred             cCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchh
Q 002746          719 GVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRL  798 (885)
Q Consensus       719 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  798 (885)
                                 ........||+.|+|||++.+..++.++|||||||++|||++|+.||...     +..+........  
T Consensus       149 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~-----~~~~~~~~~~~~--  210 (328)
T cd05593         149 -----------AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHEKLFELILME--  210 (328)
T ss_pred             -----------ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC-----CHHHHHHHhccC--
Confidence                       11123356899999999999999999999999999999999999999642     111111111100  


Q ss_pred             hhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 002746          799 EKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP-----TMLDAADD  852 (885)
Q Consensus       799 ~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  852 (885)
                                 .....       ...+.++.+++.+|++.||++||     ++.|++++
T Consensus       211 -----------~~~~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         211 -----------DIKFP-------RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             -----------CccCC-------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence                       00000       01345688999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-37  Score=334.71  Aligned_cols=240  Identities=24%  Similarity=0.342  Sum_probs=192.0

Q ss_pred             ecccCcceEEEEEeC-CCCEEEEEEeeec---CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCCcc
Q 002746          565 LGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSL  640 (885)
Q Consensus       565 lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL  640 (885)
                      ||+|+||.||+|+.. +++.||+|+++..   .......+..|++++++++||||+++++++..++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999965 5889999998743   223346678899999999999999999999999999999999999999


Q ss_pred             ccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecccC
Q 002746          641 DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGV  720 (885)
Q Consensus       641 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~  720 (885)
                      .+++....         .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++.....  
T Consensus        81 ~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--  146 (312)
T cd05585          81 FHHLQREG---------RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--  146 (312)
T ss_pred             HHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC--
Confidence            99886543         2788999999999999999999998   999999999999999999999999998753211  


Q ss_pred             CCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhhh
Q 002746          721 GNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEK  800 (885)
Q Consensus       721 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  800 (885)
                               ........||+.|+|||++.+..++.++||||+||++|||++|+.||...     ...+........    
T Consensus       147 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~-----~~~~~~~~~~~~----  208 (312)
T cd05585         147 ---------DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE-----NVNEMYRKILQE----  208 (312)
T ss_pred             ---------CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC-----CHHHHHHHHHcC----
Confidence                     11223456899999999999999999999999999999999999999642     111211111110    


Q ss_pred             hhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC---HHHHHHH
Q 002746          801 VIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT---MLDAADD  852 (885)
Q Consensus       801 ~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~ev~~~  852 (885)
                               .....       ...+.++.+++.+||+.||++||+   +.|++.+
T Consensus       209 ---------~~~~~-------~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         209 ---------PLRFP-------DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             ---------CCCCC-------CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence                     00000       113456889999999999999985   5666554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.8e-37  Score=338.46  Aligned_cols=272  Identities=22%  Similarity=0.281  Sum_probs=197.5

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeec--CCcchhhHHHHHHHHhhcCCcccceeeeeeecCC-----cce
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPD-----FKA  629 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~  629 (885)
                      +|++.+.||+|+||.||+|+.. ++..||||+++..  .......+.+|++++++++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5888999999999999999965 6899999998743  2223456889999999999999999999875432     468


Q ss_pred             EEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccc
Q 002746          630 LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDF  709 (885)
Q Consensus       630 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df  709 (885)
                      +||||+. ++|.+++....         .+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        81 lv~e~~~-~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Df  147 (338)
T cd07859          81 VVFELME-SDLHQVIKAND---------DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDF  147 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc---------cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccC
Confidence            9999995 68887775432         3789999999999999999999998   999999999999999999999999


Q ss_pred             ccceeeecccCCCCCCCCCCCCccccccccccccCCcccCC--CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHH
Q 002746          710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG--SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH  787 (885)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~  787 (885)
                      |+++.......        .........||+.|+|||++.+  ..++.++|||||||++|||++|+.||.....  ....
T Consensus       148 g~~~~~~~~~~--------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~  217 (338)
T cd07859         148 GLARVAFNDTP--------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQL  217 (338)
T ss_pred             ccccccccccC--------ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHH
Confidence            99976432110        0111233568999999999866  6789999999999999999999999964211  1111


Q ss_pred             HHHHHhhcchhhhhhh----hh---hhhc-cCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          788 KWVKNHYHGRLEKVID----SS---LLRA-SRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       788 ~~~~~~~~~~~~~~~d----~~---~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..+.............    ..   .... ...........+...+.++.+++.+||+.||++|||++|++++
T Consensus       218 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         218 DLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            1111111111110000    00   0000 0000001111112245678899999999999999999999986

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.2e-37  Score=325.85  Aligned_cols=256  Identities=30%  Similarity=0.493  Sum_probs=207.8

Q ss_pred             HhhCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      ...+|.+.+.||+|+||.||+|...+++.+|+|+++.........+..|+.+++.++|+|++++++++...+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34678899999999999999999888999999999866554567899999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +++|+|.+++.....       ..+++..+..++.|++.|++|||+++   |+||||||+||+++.++.+||+|||.+..
T Consensus        84 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~  153 (261)
T cd05148          84 MEKGSLLAFLRSPEG-------QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARL  153 (261)
T ss_pred             cccCCHHHHHhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhh
Confidence            999999999875432       23789999999999999999999998   99999999999999999999999999976


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      +...           ........++..|+|||+..+..++.++||||||+++|+|++ |+.||.....  ......+.  
T Consensus       154 ~~~~-----------~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--~~~~~~~~--  218 (261)
T cd05148         154 IKED-----------VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--HEVYDQIT--  218 (261)
T ss_pred             cCCc-----------cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHHH--
Confidence            5321           011112345678999999988899999999999999999998 8999864211  00111110  


Q ss_pred             hcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 002746          794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDR  855 (885)
Q Consensus       794 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  855 (885)
                                .    ..+...+      ..++.++.+++.+||+.+|.+|||++++++.|+.
T Consensus       219 ----------~----~~~~~~~------~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         219 ----------A----GYRMPCP------AKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             ----------h----CCcCCCC------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence                      0    0000000      1235668899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1e-36  Score=322.31  Aligned_cols=255  Identities=25%  Similarity=0.401  Sum_probs=203.0

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      .+|.+.+.||+|++|.||+|.+. .++.||+|+++.. ......+.+|++++++++|+|++++++++..++..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45788899999999999999965 5888999998743 233567889999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++++|.+++.....       ..+++..+..++.|+++||+|||+++   |+||||||+||++++++.+||+|||.+...
T Consensus        85 ~~~~L~~~~~~~~~-------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~  154 (263)
T cd05052          85 TYGNLLDYLRECNR-------QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM  154 (263)
T ss_pred             CCCcHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccc
Confidence            99999998865432       23789999999999999999999998   999999999999999999999999999765


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhh
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      .....          .......++..|+|||+..+..++.++|||||||++|||++ |..||...     ...++.... 
T Consensus       155 ~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-----~~~~~~~~~-  218 (263)
T cd05052         155 TGDTY----------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVYELL-  218 (263)
T ss_pred             cccee----------eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHH-
Confidence            32110          01111234678999999999999999999999999999998 89998542     111111111 


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                              .......   ..       ..++.++.+++.+||+.+|++||++.|+.+.|+.+
T Consensus       219 --------~~~~~~~---~~-------~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         219 --------EKGYRME---RP-------EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             --------HCCCCCC---CC-------CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                    0000000   00       11356799999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1e-36  Score=326.86  Aligned_cols=267  Identities=26%  Similarity=0.429  Sum_probs=208.2

Q ss_pred             hCCcccceecccCcceEEEEEeC------CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ------DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKAL  630 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  630 (885)
                      .+|.+.+.||+|+||.||++...      ++..+|+|.+........+.+.+|++++++++|||++++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            57888999999999999999842      345689998875554556779999999999999999999999999999999


Q ss_pred             EEecccCCccccccccCCcccc----CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEE
Q 002746          631 VLPYMANGSLDSHLYPHSETEF----GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALV  706 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl  706 (885)
                      ||||+++++|.+++........    ......+++..++.++.|++.||+|||+++   |+||||||+||++++++.++|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            9999999999998864432100    112234899999999999999999999998   999999999999999999999


Q ss_pred             cccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCcc
Q 002746          707 SDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS  785 (885)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~  785 (885)
                      +|||.++.+.....         ........++..|+|||++.+..++.++|||||||++|||++ |..||.....    
T Consensus       162 ~dfg~~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~----  228 (288)
T cd05093         162 GDFGMSRDVYSTDY---------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN----  228 (288)
T ss_pred             ccCCccccccCCce---------eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----
Confidence            99999986532110         011122345788999999998899999999999999999998 8999864211    


Q ss_pred             HHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 002746          786 LHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRY  859 (885)
Q Consensus       786 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~  859 (885)
                       .........+            ......       ...+.++.+++.+||+.+|.+|||++||.+.|+.+.+.
T Consensus       229 -~~~~~~i~~~------------~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         229 -NEVIECITQG------------RVLQRP-------RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             -HHHHHHHHcC------------CcCCCC-------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence             1111111000            000000       01345689999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.2e-38  Score=317.10  Aligned_cols=269  Identities=26%  Similarity=0.376  Sum_probs=196.5

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCC-----cceE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPD-----FKAL  630 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~l  630 (885)
                      -.|...+++|.|+||.||+|... +++.||||+.....    +.-.+|.++|++++|||||++..+|....     ...+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            35667799999999999999965 57999999876332    23356999999999999999998885432     2348


Q ss_pred             EEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCC-CCEEEccc
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDD-MTALVSDF  709 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Df  709 (885)
                      |||||+. +|.+.++....     ....++...+.-+..||.+||+|||+.+   |+||||||.|+|+|.+ |.+|||||
T Consensus       100 VleymP~-tL~~~~r~~~~-----~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDF  170 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTR-----ANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDF  170 (364)
T ss_pred             HHHhchH-HHHHHHHHHhh-----cCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccC
Confidence            9999965 77777764211     1123677777889999999999999988   9999999999999966 99999999


Q ss_pred             ccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHH
Q 002746          710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~  788 (885)
                      |.|+.+..            +.+-.....|..|+|||.+.|. .|+.+.||||.|||+.||+-|++-|.. ..+..++..
T Consensus       171 GSAK~L~~------------~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG-~s~~dQL~e  237 (364)
T KOG0658|consen  171 GSAKVLVK------------GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG-DSSVDQLVE  237 (364)
T ss_pred             Ccceeecc------------CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC-CCHHHHHHH
Confidence            99998854            2223456789999999998775 689999999999999999999998865 222334444


Q ss_pred             HHHHhhcchhhhhhhhhhhhccCCChHHH-----HH-HHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          789 WVKNHYHGRLEKVIDSSLLRASRDQSPEV-----KR-MWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       789 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~-----~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .++-.......++..-..... ....+.+     .+ +....+++..+++.+++..+|.+|.++.|++.+
T Consensus       238 Iik~lG~Pt~e~I~~mn~~y~-~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  238 IIKVLGTPTREDIKSMNPNYT-EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             HHHHhCCCCHHHHhhcCcccc-cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            443333222221111000000 0000110     01 223456789999999999999999999999875

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=7.8e-37  Score=333.94  Aligned_cols=199  Identities=27%  Similarity=0.431  Sum_probs=173.0

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEe
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      .++|++.+.||+|+||.||+|.+. ++..+|+|+++.... .....+.+|++++++++||||++++++|..++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            368999999999999999999976 688899998875432 334678999999999999999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      |+++|+|.+++....         .+++.....++.+++.|+.|||+.+  +|+||||||+|||++.++.+||+|||++.
T Consensus        84 ~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~  152 (333)
T cd06650          84 HMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG  152 (333)
T ss_pred             cCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcch
Confidence            999999999886433         2778888999999999999999753  29999999999999999999999999987


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCc
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD  778 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~  778 (885)
                      .+..             .......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       153 ~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         153 QLID-------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             hhhh-------------hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            5522             111234689999999999998999999999999999999999999964

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.5e-36  Score=325.99  Aligned_cols=267  Identities=26%  Similarity=0.422  Sum_probs=208.7

Q ss_pred             hCCcccceecccCcceEEEEEeC------CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ------DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKAL  630 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  630 (885)
                      ++|.+.+.||+|+||.||+|...      ++..+++|.++.......+.+.+|++++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            46888899999999999999843      345689998875554455779999999999999999999999999999999


Q ss_pred             EEecccCCccccccccCCcccc-------CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCC
Q 002746          631 VLPYMANGSLDSHLYPHSETEF-------GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMT  703 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~  703 (885)
                      ||||+++++|.+++..+.....       ......+++..++.++.|++.|++|||+++   |+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            9999999999999875432100       011224889999999999999999999998   999999999999999999


Q ss_pred             EEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccC
Q 002746          704 ALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAG  782 (885)
Q Consensus       704 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~  782 (885)
                      ++|+|||+++.......         ........++..|+|||++.+..++.++|||||||++|||+| |+.||..... 
T Consensus       162 ~~l~dfg~a~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-  231 (291)
T cd05094         162 VKIGDFGMSRDVYSTDY---------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-  231 (291)
T ss_pred             EEECCCCcccccCCCce---------eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence            99999999976532110         011123456788999999999999999999999999999999 9999865211 


Q ss_pred             CccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 002746          783 GLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRY  859 (885)
Q Consensus       783 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~  859 (885)
                          ...+......        .     ....+      ..++.++.+++.+||+.+|++||++++|++.|+++.+.
T Consensus       232 ----~~~~~~~~~~--------~-----~~~~~------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         232 ----TEVIECITQG--------R-----VLERP------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             ----HHHHHHHhCC--------C-----CCCCC------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence                1111110000        0     00000      11345689999999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5e-37  Score=350.83  Aligned_cols=254  Identities=19%  Similarity=0.249  Sum_probs=201.2

Q ss_pred             CCcccceecccCcceEEEEEeC-C-CCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-D-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      .|.+.+.||+|++|.||+|... + ++.||+|.+..........+..|+.+++.++||||+++++++..++..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4889999999999999999854 3 6788888776554444567788999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++|+|.+++.....     ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+.+
T Consensus       148 ~gg~L~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~  219 (478)
T PTZ00267        148 SGGDLNKQIKQRLK-----EHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQY  219 (478)
T ss_pred             CCCCHHHHHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence            99999987754321     1124788899999999999999999998   999999999999999999999999999865


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhc
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~  795 (885)
                      ....         .........||++|+|||++.+..++.++|||||||++|||++|+.||...     .........  
T Consensus       220 ~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~-----~~~~~~~~~--  283 (478)
T PTZ00267        220 SDSV---------SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP-----SQREIMQQV--  283 (478)
T ss_pred             CCcc---------ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHH--
Confidence            3210         011223456999999999999999999999999999999999999999642     111111111  


Q ss_pred             chhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       796 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                                +.+..... +      ..++.++.+++.+||..||++||++++++.+
T Consensus       284 ----------~~~~~~~~-~------~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        284 ----------LYGKYDPF-P------CPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             ----------HhCCCCCC-C------ccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence                      11111000 0      0134568999999999999999999999754

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.9e-37  Score=312.85  Aligned_cols=263  Identities=23%  Similarity=0.313  Sum_probs=207.5

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec---CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      +.|++.+.||.|.-|+||+|+.+ .+..+|+|++...   ......+...|.+||+.++||.++.+|+.|+.++..++||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            45677889999999999999977 4588999999754   2334566788999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      |||+||+|...++++...       .+++..+.-++.+++-||+|||-.|   ||+|||||+|||+.++|++.|+||.++
T Consensus       157 eyCpGGdL~~LrqkQp~~-------~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS  226 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGK-------RFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLS  226 (459)
T ss_pred             ecCCCccHHHHHhhCCCC-------ccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeecccc
Confidence            999999999999877654       4888999999999999999999999   999999999999999999999999998


Q ss_pred             eeeeccc--CC-----------------------C--CCCC------------------CCCCCccccccccccccCCcc
Q 002746          713 KLVMTVG--VG-----------------------N--DGAE------------------NMGNSTANMLCGSIGYMAPEY  747 (885)
Q Consensus       713 ~~~~~~~--~~-----------------------~--~~~~------------------~~~~~~~~~~~gt~~y~aPE~  747 (885)
                      ..+....  ..                       +  ....                  +.........+||-+|.|||+
T Consensus       227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv  306 (459)
T KOG0610|consen  227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV  306 (459)
T ss_pred             ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence            6653110  00                       0  0000                  111123345789999999999


Q ss_pred             cCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHH
Q 002746          748 GFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGE  827 (885)
Q Consensus       748 ~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~  827 (885)
                      +.|...+.+.|+|+|||++|||+.|+.||.... ....+...+..            .+      ..+..    ...+..
T Consensus       307 I~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~-~~~Tl~NIv~~------------~l------~Fp~~----~~vs~~  363 (459)
T KOG0610|consen  307 IRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSN-NKETLRNIVGQ------------PL------KFPEE----PEVSSA  363 (459)
T ss_pred             eecCCCCchhhHHHHHHHHHHHHhCCCCcCCCC-chhhHHHHhcC------------CC------cCCCC----CcchhH
Confidence            999999999999999999999999999997532 22233322211            10      00110    024567


Q ss_pred             HHHHHhhhcCCCCCCCCC----HHHHHHH
Q 002746          828 LIELGILCTQESPSTRPT----MLDAADD  852 (885)
Q Consensus       828 l~~l~~~cl~~dP~~RPt----~~ev~~~  852 (885)
                      +.+||++.+.+||.+|..    ++||.+|
T Consensus       364 akDLIr~LLvKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  364 AKDLIRKLLVKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             HHHHHHHHhccChhhhhccccchHHhhcC
Confidence            999999999999999988    7777765

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=8.3e-37  Score=339.34  Aligned_cols=268  Identities=25%  Similarity=0.420  Sum_probs=205.4

Q ss_pred             hhCCcccceecccCcceEEEEEeC------CCCEEEEEEeeecCC-cchhhHHHHHHHHhhcC-CcccceeeeeeecCCc
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ------DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIR-HRNLMRIITACSLPDF  627 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  627 (885)
                      .++|.+.+.||+|+||.||+|+..      .+..||||+++.... ...+.+.+|+++++++. ||||++++++|...+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            467889999999999999999853      134699999974432 33467899999999996 9999999999999999


Q ss_pred             ceEEEecccCCccccccccCCcccc-------------------------------------------------------
Q 002746          628 KALVLPYMANGSLDSHLYPHSETEF-------------------------------------------------------  652 (885)
Q Consensus       628 ~~lV~e~~~~gsL~~~l~~~~~~~~-------------------------------------------------------  652 (885)
                      .++||||+++|+|.+++........                                                       
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999988754321000                                                       


Q ss_pred             --------------------------------CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecC
Q 002746          653 --------------------------------GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND  700 (885)
Q Consensus       653 --------------------------------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~  700 (885)
                                                      ......+++..+..++.|++.||+|||+.+   |+||||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence                                            001124788889999999999999999998   999999999999999


Q ss_pred             CCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCcc
Q 002746          701 DMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDM  779 (885)
Q Consensus       701 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~  779 (885)
                      ++.+||+|||+++.+....         .........++..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus       273 ~~~~kL~DfGla~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~  343 (400)
T cd05105         273 GKIVKICDFGLARDIMHDS---------NYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM  343 (400)
T ss_pred             CCEEEEEeCCcceeccccc---------cccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence            9999999999998653211         0111123356788999999999899999999999999999997 99998653


Q ss_pred             ccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 002746          780 FAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR  858 (885)
Q Consensus       780 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~  858 (885)
                      .... .....                +........+      ..++.++.+++.+||+.||++||++.+|.+.|+++.+
T Consensus       344 ~~~~-~~~~~----------------~~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         344 IVDS-TFYNK----------------IKSGYRMAKP------DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             chhH-HHHHH----------------HhcCCCCCCC------ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            1110 00000                0000000000      1245678999999999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-36  Score=320.18  Aligned_cols=255  Identities=31%  Similarity=0.470  Sum_probs=204.1

Q ss_pred             hhCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      .++|++.+.||+|++|.||+|...+++.||+|.++... ...+.+.+|++++++++|||++++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45688999999999999999998888899999987443 23567899999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++++|.+++....       ...+++..+..++.|++.|+.|||+.+   |+||||||+||++++++.++|+|||+++.+
T Consensus        84 ~~~~L~~~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  153 (261)
T cd05068          84 KYGSLLEYLQGGA-------GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVI  153 (261)
T ss_pred             cCCcHHHHHhccC-------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence            9999999986543       123789999999999999999999998   999999999999999999999999999876


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhh
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      ....          ........++..|+|||+..+..++.++||||||+++|||++ |+.||.....     .....   
T Consensus       154 ~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~---  215 (261)
T cd05068         154 KEDI----------YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-----AEVLQ---  215 (261)
T ss_pred             cCCc----------ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH---
Confidence            4211          001111223468999999999999999999999999999999 9999864211     00000   


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDR  855 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  855 (885)
                            .++.    ......+      ..++.++.+++.+|++.+|.+||++.++.+.|+.
T Consensus       216 ------~~~~----~~~~~~~------~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         216 ------QVDQ----GYRMPCP------PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ------HHHc----CCCCCCC------CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence                  0000    0000000      0134568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.3e-36  Score=330.34  Aligned_cols=257  Identities=25%  Similarity=0.426  Sum_probs=201.3

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCC----EEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGT----AIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKAL  630 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  630 (885)
                      .+|+..+.||+|+||.||+|++. ++.    .||+|+++... ....+.+.+|+.+++.++||||++++++|..+ ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            56899999999999999999864 333    48999987443 33456788999999999999999999999764 5679


Q ss_pred             EEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccc
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG  710 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg  710 (885)
                      |+||+++|+|.+++.....        .+++..++.++.||+.||+|||+++   |+||||||+||+++.++.+||+|||
T Consensus        86 v~e~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG  154 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFG  154 (316)
T ss_pred             eeecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccc
Confidence            9999999999998875432        3788899999999999999999998   9999999999999999999999999


Q ss_pred             cceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHH
Q 002746          711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKW  789 (885)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~  789 (885)
                      +++.+.....         ........++..|+|||++.+..++.++|||||||++|||++ |+.||....     ..++
T Consensus       155 ~a~~~~~~~~---------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~-----~~~~  220 (316)
T cd05108         155 LAKLLGADEK---------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEI  220 (316)
T ss_pred             ccccccCCCc---------ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-----HHHH
Confidence            9987632110         011112234678999999999999999999999999999998 999986421     1111


Q ss_pred             HHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 002746          790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR  858 (885)
Q Consensus       790 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~  858 (885)
                      .         ......    .....+      ..++.++.+++.+||..+|++||++.+++..+..+.+
T Consensus       221 ~---------~~~~~~----~~~~~~------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         221 S---------SILEKG----ERLPQP------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             H---------HHHhCC----CCCCCC------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence            0         111000    000000      0134568899999999999999999999999988865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.1e-36  Score=325.46  Aligned_cols=262  Identities=27%  Similarity=0.444  Sum_probs=205.0

Q ss_pred             hCCcccceecccCcceEEEEEeCC------CCEEEEEEeeecCCc-chhhHHHHHHHHhhcCCcccceeeeeeecCCcce
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQD------GTAIAVKVLQLQSGN-FTKSFNRECQVLKRIRHRNLMRIITACSLPDFKA  629 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  629 (885)
                      ++|.+.+.||+|+||.||+|...+      ++.||||.++..... ..+.+.+|++++++++|+|++++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            568888999999999999998643      478999998755433 4578999999999999999999999999999999


Q ss_pred             EEEecccCCccccccccCCcccc-----CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCE
Q 002746          630 LVLPYMANGSLDSHLYPHSETEF-----GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA  704 (885)
Q Consensus       630 lV~e~~~~gsL~~~l~~~~~~~~-----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~  704 (885)
                      +||||+++|+|.+++........     ......+++..+..++.|++.|++|||+++   |+||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            99999999999999875432100     112335889999999999999999999998   9999999999999999999


Q ss_pred             EEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCC
Q 002746          705 LVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGG  783 (885)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~  783 (885)
                      +|+|||.++.+.....         ........+++.|+|||++.+..++.++|||||||++|||++ |..||.....  
T Consensus       162 kl~d~g~~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~--  230 (280)
T cd05049         162 KIGDFGMSRDVYTTDY---------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--  230 (280)
T ss_pred             EECCcccceecccCcc---------eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence            9999999976532110         011122345788999999999999999999999999999998 9999864211  


Q ss_pred             ccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          784 LSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                         ...+.....             ......+      ...+.++.+++.+||+.+|++||+++||++.|+
T Consensus       231 ---~~~~~~~~~-------------~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         231 ---EEVIECITQ-------------GRLLQRP------RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ---HHHHHHHHc-------------CCcCCCC------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence               111111100             0000000      113456899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.4e-36  Score=319.81  Aligned_cols=252  Identities=27%  Similarity=0.419  Sum_probs=200.3

Q ss_pred             hCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEeccc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMA  636 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~  636 (885)
                      ++|.+.+.||+|+||.||+|.+.++..+|+|.++... ...+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4678889999999999999998877789999887432 234678999999999999999999999998889999999999


Q ss_pred             CCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeee
Q 002746          637 NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM  716 (885)
Q Consensus       637 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~  716 (885)
                      +|+|.+++.....        .+++..++.++.|++.|++|||+.+   |+|+||||+||+++.++.+||+|||.++.+.
T Consensus        83 ~~~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~  151 (256)
T cd05113          83 NGCLLNYLREHGK--------RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVL  151 (256)
T ss_pred             CCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecC
Confidence            9999998864321        3789999999999999999999998   9999999999999999999999999987652


Q ss_pred             cccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhhc
Q 002746          717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~  795 (885)
                      ...          ........++..|+|||+..+..++.++|||||||++|||++ |+.||.....     .......  
T Consensus       152 ~~~----------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~~~~~~~--  214 (256)
T cd05113         152 DDE----------YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-----SETVEKV--  214 (256)
T ss_pred             CCc----------eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----HHHHHHH--
Confidence            210          011112345678999999988889999999999999999999 9999864211     0110000  


Q ss_pred             chhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       796 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                                .. ......+.      ..+.++.+++.+||+.+|.+||++.++++.++
T Consensus       215 ----------~~-~~~~~~~~------~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         215 ----------SQ-GLRLYRPH------LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ----------hc-CCCCCCCC------CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                      00 00000000      12456899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1e-36  Score=331.95  Aligned_cols=242  Identities=26%  Similarity=0.386  Sum_probs=193.1

Q ss_pred             ceecccCcceEEEEEe----CCCCEEEEEEeeecC----CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          563 RLLGTGSYGRVYKGIL----QDGTAIAVKVLQLQS----GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      +.||+|+||.||+|+.    ..++.||||+++...    ......+..|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999985    357899999987431    22345678899999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +++|+|.+++....         .+.+..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  149 (323)
T cd05584          82 LSGGELFMHLEREG---------IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKE  149 (323)
T ss_pred             CCCchHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence            99999998886443         2677888889999999999999998   99999999999999999999999999875


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      ....           ........||+.|+|||++.+..++.++|||||||++|||++|+.||....     ....+....
T Consensus       150 ~~~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~-----~~~~~~~~~  213 (323)
T cd05584         150 SIHE-----------GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN-----RKKTIDKIL  213 (323)
T ss_pred             cccC-----------CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC-----HHHHHHHHH
Confidence            4211           111223468999999999999889999999999999999999999996421     111111111


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP-----TMLDAADD  852 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  852 (885)
                      ..             .....+       ..+.++.+++.+|++.+|++||     ++++++++
T Consensus       214 ~~-------------~~~~~~-------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         214 KG-------------KLNLPP-------YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             cC-------------CCCCCC-------CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            10             000000       1345688999999999999999     88888775

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.2e-36  Score=320.68  Aligned_cols=261  Identities=20%  Similarity=0.318  Sum_probs=206.5

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ++|++.+.||+|+||.||+|+.. +++.||||.++...   ......+.+|+++++.++|||++++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            47899999999999999999965 78999999876432   233456889999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++|+|.+++.....     ....+++..+..++.|++.|++|||+++   |+||||||+||+++.++.++|+|||.+
T Consensus        82 e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~  153 (267)
T cd08228          82 ELADAGDLSQMIKYFKK-----QKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             EecCCCcHHHHHHHhhh-----ccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccc
Confidence            99999999887753221     1123788899999999999999999998   999999999999999999999999999


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      ..+...           ........|++.|+|||.+.+..++.++||||||+++|||++|+.||....   .....+...
T Consensus       154 ~~~~~~-----------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~---~~~~~~~~~  219 (267)
T cd08228         154 RFFSSK-----------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLFSLCQK  219 (267)
T ss_pred             eeccch-----------hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc---ccHHHHHHH
Confidence            876321           111123457889999999988889999999999999999999999985421   111122111


Q ss_pred             hhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLK  857 (885)
Q Consensus       793 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~  857 (885)
                      ....            ......      ....+.++.+++.+||+.+|++||++.||++.+++++
T Consensus       220 ~~~~------------~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         220 IEQC------------DYPPLP------TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             HhcC------------CCCCCC------hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            1100            000000      1123466899999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.5e-36  Score=317.88  Aligned_cols=255  Identities=29%  Similarity=0.430  Sum_probs=202.0

Q ss_pred             hhCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      ..+|.+.+.||+|+||.||+|++.++..||+|+++.... ..+.+.+|++++++++|+||+++++++. .+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            357899999999999999999987777899999874332 3467899999999999999999999875 45678999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++|+|.+++.....       ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||.++.+
T Consensus        83 ~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~  152 (262)
T cd05071          83 SKGSLLDFLKGEMG-------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI  152 (262)
T ss_pred             CCCcHHHHHhhccc-------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeec
Confidence            99999999875322       13789999999999999999999998   999999999999999999999999999766


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhh
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      ....          ........++..|+|||+..+..++.++||||||+++|||++ |+.||......     .....  
T Consensus       153 ~~~~----------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-----~~~~~--  215 (262)
T cd05071         153 EDNE----------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQ--  215 (262)
T ss_pred             cccc----------cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-----HHHHH--
Confidence            3211          011112346778999999988899999999999999999999 88888642110     10000  


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                             +    ........      ...++.++.+++.+|++++|++||+++++.+.|+.+
T Consensus       216 -------~----~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         216 -------V----ERGYRMPC------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             -------H----hcCCCCCC------ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                   0    00000000      012456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.1e-36  Score=331.96  Aligned_cols=245  Identities=22%  Similarity=0.329  Sum_probs=192.5

Q ss_pred             CcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHH---hhcCCcccceeeeeeecCCcceEE
Q 002746          559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVL---KRIRHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lV  631 (885)
                      |++.+.||+|+||.||+|... +++.||||+++...   ....+.+.+|++++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677889999999999999965 68999999997442   22345566776655   566899999999999999999999


Q ss_pred             EecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccc
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~  711 (885)
                      |||+++|+|..++...          .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        81 ~E~~~~~~L~~~~~~~----------~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~  147 (324)
T cd05589          81 MEYAAGGDLMMHIHTD----------VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGL  147 (324)
T ss_pred             EcCCCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccC
Confidence            9999999998877532          3889999999999999999999998   99999999999999999999999999


Q ss_pred             ceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      ++.....           ........|++.|+|||++.+..++.++|||||||++|||++|+.||....     ......
T Consensus       148 ~~~~~~~-----------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~-----~~~~~~  211 (324)
T cd05589         148 CKEGMGF-----------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD-----EEEVFD  211 (324)
T ss_pred             CccCCCC-----------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC-----HHHHHH
Confidence            8643211           111234578999999999999999999999999999999999999996421     111111


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP-----TMLDAADD  852 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  852 (885)
                      ....             .......       ..+.++.+++.+|++.||.+||     ++++++++
T Consensus       212 ~i~~-------------~~~~~p~-------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         212 SIVN-------------DEVRYPR-------FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             HHHh-------------CCCCCCC-------CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            1110             0000000       1345688999999999999999     56666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-36  Score=319.09  Aligned_cols=256  Identities=28%  Similarity=0.411  Sum_probs=203.4

Q ss_pred             hCCcccceecccCcceEEEEEeCC----CCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQD----GTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV  631 (885)
                      ++|++.+.||+|+||.||+|.+..    ...||||.++... ......+..|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            578899999999999999999752    4579999887543 23356788999999999999999999999999999999


Q ss_pred             EecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccc
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~  711 (885)
                      |||+++|+|.+++.....        .+++..+..++.|++.|++|||+++   |+||||||+||++++++.++|+|||+
T Consensus        84 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~  152 (266)
T cd05033          84 TEYMENGSLDKFLRENDG--------KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGL  152 (266)
T ss_pred             EEcCCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccch
Confidence            999999999999865432        3889999999999999999999998   99999999999999999999999999


Q ss_pred             ceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHH
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~  790 (885)
                      ++.+....         .........++..|+|||...+..++.++||||||+++|||++ |..||......  .....+
T Consensus       153 ~~~~~~~~---------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~  221 (266)
T cd05033         153 SRRLEDSE---------ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAV  221 (266)
T ss_pred             hhcccccc---------cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHH
Confidence            98764110         0011112235678999999999999999999999999999998 99998642110  111111


Q ss_pred             HHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 002746          791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       791 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                      .                .......+      ..++.++.+++.+||+.+|++||+++|++++|+++
T Consensus       222 ~----------------~~~~~~~~------~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         222 E----------------DGYRLPPP------MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             H----------------cCCCCCCC------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0                00000000      01345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-36  Score=337.16  Aligned_cols=267  Identities=20%  Similarity=0.251  Sum_probs=198.3

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      ..+|++.+.||+|+||.||+|... +++.||+|...      ...+.+|++++++++||||+++++++......++|+||
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            357999999999999999999965 68899999653      24568899999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +. ++|..++....         .+++..++.++.|++.||+|||+++   ||||||||+|||++.++.+||+|||+|+.
T Consensus       165 ~~-~~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~  231 (391)
T PHA03212        165 YK-TDLYCYLAAKR---------NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACF  231 (391)
T ss_pred             CC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence            85 67777765432         2788999999999999999999998   99999999999999999999999999975


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCcccc--CC----ccHHH
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFA--GG----LSLHK  788 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~--~~----~~~~~  788 (885)
                      ....          .........||+.|+|||++.+..++.++|||||||++|||++|+.||-....  +.    ..+..
T Consensus       232 ~~~~----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~  301 (391)
T PHA03212        232 PVDI----------NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL  301 (391)
T ss_pred             cccc----------cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHH
Confidence            3211          01122345799999999999999999999999999999999999988643211  11    11111


Q ss_pred             HHHHhhcc--h----hhhhhhhhh---hh-ccCC--ChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          789 WVKNHYHG--R----LEKVIDSSL---LR-ASRD--QSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       789 ~~~~~~~~--~----~~~~~d~~~---~~-~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .+......  .    .....+...   .. ....  ..+... .....+.++.+++.+|++.||++|||++|++++
T Consensus       302 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        302 IIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWT-NLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             HHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHH-HHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            11111100  0    000001000   00 0000  001101 112356689999999999999999999999985

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=9e-37  Score=334.13  Aligned_cols=252  Identities=24%  Similarity=0.355  Sum_probs=196.4

Q ss_pred             CCcccceecccCcceEEEEEeC----CCCEEEEEEeeecC----CcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcc
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ----DGTAIAVKVLQLQS----GNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFK  628 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  628 (885)
                      +|++.+.||+|+||.||+|+..    +++.||+|+++...    ....+.+..|+.++.++ +|++|+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788999999999999999853    58899999987431    22345678899999999 589999999999999999


Q ss_pred             eEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcc
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSD  708 (885)
Q Consensus       629 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D  708 (885)
                      ++||||+++|+|.+++....         .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~D  148 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD---------NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTD  148 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEee
Confidence            99999999999999886443         2788999999999999999999998   99999999999999999999999


Q ss_pred             cccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHH
Q 002746          709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH  787 (885)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~  787 (885)
                      ||+++.+....          ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ....
T Consensus       149 fG~~~~~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~  217 (332)
T cd05614         149 FGLSKEFLSEE----------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER-NTQS  217 (332)
T ss_pred             CcCCccccccC----------CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC-CCHH
Confidence            99997652211          1112235689999999998775 4789999999999999999999999642111 1111


Q ss_pred             HHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 002746          788 KWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP-----TMLDAADD  852 (885)
Q Consensus       788 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  852 (885)
                      .....             +........       ...+.++.+++.+|++.||++||     ++++++++
T Consensus       218 ~~~~~-------------~~~~~~~~~-------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         218 EVSRR-------------ILKCDPPFP-------SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             HHHHH-------------HhcCCCCCC-------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            11110             110000000       01345688999999999999999     77788765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.3e-37  Score=324.71  Aligned_cols=250  Identities=29%  Similarity=0.491  Sum_probs=191.4

Q ss_pred             ccceecccCcceEEEEEeC-----CCCEEEEEEeeecCCc-chhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          561 EQRLLGTGSYGRVYKGILQ-----DGTAIAVKVLQLQSGN-FTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       561 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      +.+.||.|+||.||+|.+.     .+..|+||.++..... ..+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999976     3677999999654332 367899999999999999999999999988889999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +++|+|.+++.....       ..+++..++.|+.||++||+|||+++   |+||||+++||+++.++.+||+|||++..
T Consensus        83 ~~~g~L~~~L~~~~~-------~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~  152 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNK-------EPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRP  152 (259)
T ss_dssp             -TTEBHHHHHHHTCT-------TTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEE
T ss_pred             ccccccccccccccc-------cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence            999999999987621       24899999999999999999999998   99999999999999999999999999986


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      .....         .........+...|+|||.+.+..++.++||||||+++||+++ |+.||.+.     ...++....
T Consensus       153 ~~~~~---------~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-----~~~~~~~~~  218 (259)
T PF07714_consen  153 ISEKS---------KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-----DNEEIIEKL  218 (259)
T ss_dssp             TTTSS---------SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-----CHHHHHHHH
T ss_pred             ccccc---------cccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccccccc
Confidence            52110         0111223346788999999988889999999999999999999 78998653     111111111


Q ss_pred             hcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 002746          794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDL  853 (885)
Q Consensus       794 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  853 (885)
                      .....            ....+       .++..+.+++.+||+.+|++||+++|+++.|
T Consensus       219 ~~~~~------------~~~~~-------~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  219 KQGQR------------LPIPD-------NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HTTEE------------TTSBT-------TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ccccc------------ceecc-------chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            11000            00000       1345688999999999999999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.9e-36  Score=322.60  Aligned_cols=268  Identities=27%  Similarity=0.341  Sum_probs=200.6

Q ss_pred             CcccceecccCcceEEEEEe-----CCCCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecC--CcceE
Q 002746          559 FDEQRLLGTGSYGRVYKGIL-----QDGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLP--DFKAL  630 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l  630 (885)
                      |.+.+.||+|+||+||++..     .++..||+|.++.... .....+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            48889999999999988653     3578899999875432 3456788999999999999999999988654  35689


Q ss_pred             EEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccc
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG  710 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg  710 (885)
                      ||||+++|+|.+++...          .+++..+..++.|++.|++|||+++   |+||||||+||++++++.++|+|||
T Consensus        86 v~e~~~~~~l~~~~~~~----------~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg  152 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH----------KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFG  152 (283)
T ss_pred             EecCCCCCCHHHHHHHc----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecc
Confidence            99999999999988643          2889999999999999999999998   9999999999999999999999999


Q ss_pred             cceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHH
Q 002746          711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~  790 (885)
                      +++.+......        ........++..|+|||...+..++.++||||||+++|||++|+.||............+.
T Consensus       153 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~  224 (283)
T cd05080         153 LAKAVPEGHEY--------YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPK  224 (283)
T ss_pred             cccccCCcchh--------hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccc
Confidence            99866321100        0001122356679999999888999999999999999999999999865321111111000


Q ss_pred             HH-hhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 002746          791 KN-HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLK  857 (885)
Q Consensus       791 ~~-~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~  857 (885)
                      .. .......+..+....    ...+      ..++.++.+++.+||+.+|++|||++++++.|++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~----~~~~------~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         225 QGQMTVVRLIELLERGMR----LPCP------KNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             ccccchhhhhhhhhcCCC----CCCC------CCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            00 000011111111110    0000      113567999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.6e-37  Score=333.84  Aligned_cols=242  Identities=23%  Similarity=0.292  Sum_probs=193.2

Q ss_pred             ceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCC
Q 002746          563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANG  638 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g  638 (885)
                      +.||+|+||.||+|... +|+.||+|+++...   ......+..|++++..++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999964 78999999997542   223456778999999999999999999999999999999999999


Q ss_pred             ccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          639 SLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH-HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       639 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      +|..++....         .+++..+..++.|++.||+|||+ .+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~  148 (325)
T cd05594          81 ELFFHLSRER---------VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  148 (325)
T ss_pred             cHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCC
Confidence            9988776433         37899999999999999999997 67   99999999999999999999999999875321


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcch
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR  797 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  797 (885)
                      .           ........||+.|+|||++.+..++.++|||||||++|||++|+.||...     ............ 
T Consensus       149 ~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~-----~~~~~~~~i~~~-  211 (325)
T cd05594         149 D-----------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-----DHEKLFELILME-  211 (325)
T ss_pred             C-----------CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC-----CHHHHHHHHhcC-
Confidence            1           11122356999999999999999999999999999999999999999642     111111111000 


Q ss_pred             hhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 002746          798 LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP-----TMLDAADD  852 (885)
Q Consensus       798 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  852 (885)
                                 . ....       ...+.++.+++.+|++.||++|+     ++++++++
T Consensus       212 -----------~-~~~p-------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         212 -----------E-IRFP-------RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             -----------C-CCCC-------CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence                       0 0000       01345688999999999999996     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=325.18  Aligned_cols=265  Identities=24%  Similarity=0.379  Sum_probs=209.2

Q ss_pred             hhCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCCcc-hhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNF-TKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      .....+.++||+|-||.|..|....+..||||.++...... ..+|.+|+++|.+++|||||.++|+|..++..++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            34556778999999999999999888999999999775544 58899999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      |++|+|.+++..+....       +.-....+||.|||.|++||.+..   +||||+.+.|+|+|.++++||+|||+++.
T Consensus       617 mEnGDLnqFl~aheapt-------~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~  686 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPT-------AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRN  686 (807)
T ss_pred             HhcCcHHHHHHhccCcc-------cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccc
Confidence            99999999998775321       334455779999999999999987   99999999999999999999999999997


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc--CCCCCCccccCCccHHHHHHH
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT--RRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt--g~~P~~~~~~~~~~~~~~~~~  792 (885)
                      +...++.+-         ....+-..+|||||.+.-+++|.++|||+||+++||+++  ...||.++.+.     +.+  
T Consensus       687 lysg~yy~v---------qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e-----~vv--  750 (807)
T KOG1094|consen  687 LYSGDYYRV---------QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE-----QVV--  750 (807)
T ss_pred             cccCCceee---------ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-----HHH--
Confidence            644322111         111234679999999999999999999999999999877  67788764221     111  


Q ss_pred             hhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       793 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                         ++.-++.+..-....... |      ..|+.++.+++.+||.+|-++||+++++..+|++.
T Consensus       751 ---en~~~~~~~~~~~~~l~~-P------~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  751 ---ENAGEFFRDQGRQVVLSR-P------PACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ---HhhhhhcCCCCcceeccC-C------CcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence               111111111111111001 1      13777899999999999999999999999998765

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.3e-36  Score=331.54  Aligned_cols=248  Identities=22%  Similarity=0.318  Sum_probs=193.0

Q ss_pred             ceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcceEEEecccC
Q 002746          563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~  637 (885)
                      +.||+|+||.||+|+.. +++.||+|+++...   ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 68899999997542   23345677888888776 899999999999999999999999999


Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      |+|..++....         .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~L~~~~~~~~---------~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~  148 (329)
T cd05618          81 GDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  148 (329)
T ss_pred             CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccC
Confidence            99988775432         3889999999999999999999998   99999999999999999999999999875321


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCC---ccHHHHHHHhh
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGG---LSLHKWVKNHY  794 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~---~~~~~~~~~~~  794 (885)
                      .           ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .....++... 
T Consensus       149 ~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-  216 (329)
T cd05618         149 P-----------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV-  216 (329)
T ss_pred             C-----------CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH-
Confidence            1           112233578999999999999999999999999999999999999996422111   1111111111 


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC------HHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT------MLDAADD  852 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt------~~ev~~~  852 (885)
                                 +........       ...+.++.+++.+||+.||++||+      +++++++
T Consensus       217 -----------i~~~~~~~p-------~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         217 -----------ILEKQIRIP-------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             -----------HhcCCCCCC-------CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence                       010000000       013456889999999999999998      4677665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.2e-36  Score=347.34  Aligned_cols=258  Identities=22%  Similarity=0.324  Sum_probs=202.5

Q ss_pred             HHhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCC----
Q 002746          554 EATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPD----  626 (885)
Q Consensus       554 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----  626 (885)
                      ...++|.+.+.||+|+||+||+|+.. +|+.||||++....  ......+.+|+.++..++|+|++++.+.+...+    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            34578999999999999999999854 79999999987542  233456888999999999999999987765432    


Q ss_pred             ----cceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCC
Q 002746          627 ----FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDM  702 (885)
Q Consensus       627 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~  702 (885)
                          ..++||||+++|+|.+++.....     ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~-----~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~  180 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAK-----TNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNG  180 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhc-----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCC
Confidence                25799999999999998864322     1224888999999999999999999998   99999999999999999


Q ss_pred             CEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccC
Q 002746          703 TALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAG  782 (885)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~  782 (885)
                      .+||+|||+++.+....         .........||+.|+|||++.+..++.++|||||||++|||++|+.||...   
T Consensus       181 ~vkL~DFGls~~~~~~~---------~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~---  248 (496)
T PTZ00283        181 LVKLGDFGFSKMYAATV---------SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE---  248 (496)
T ss_pred             CEEEEecccCeeccccc---------cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC---
Confidence            99999999998763211         011223457999999999999999999999999999999999999999642   


Q ss_pred             CccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          783 GLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       783 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                        ....++.....            .......       ...++++.+++.+||+.||.+||++.+++.+
T Consensus       249 --~~~~~~~~~~~------------~~~~~~~-------~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        249 --NMEEVMHKTLA------------GRYDPLP-------PSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             --CHHHHHHHHhc------------CCCCCCC-------CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence              22222221111            1110000       1135678999999999999999999999875

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-37  Score=308.78  Aligned_cols=274  Identities=23%  Similarity=0.273  Sum_probs=209.5

Q ss_pred             HhhCCcccceecccCcceEEEEEeC-CCCEEEEEEee--ecCCcchhhHHHHHHHHhhcCCcccceeeeeeec-----CC
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL-----PD  626 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~  626 (885)
                      ....|...+.||+|+||.|+.|... +|+.||||++.  .......++..+|+++++.++|+||+.+.+.+..     -.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3456666789999999999999955 79999999987  4455667888999999999999999999998855     34


Q ss_pred             cceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEE
Q 002746          627 FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALV  706 (885)
Q Consensus       627 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl  706 (885)
                      ..|+|+|+| +.+|...++...         .+.......+..|+++||.|+|+.+   |+|||+||+|++++.+..+||
T Consensus       100 DvYiV~elM-etDL~~iik~~~---------~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI  166 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQQ---------DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKI  166 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcCc---------cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEe
Confidence            678999999 678888887554         2888999999999999999999998   999999999999999999999


Q ss_pred             cccccceeeecccCCCCCCCCCCCCccccccccccccCCccc-CCCCCCccccchhhHHHHHHHHcCCCCCCccccCCcc
Q 002746          707 SDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYG-FGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLS  785 (885)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~  785 (885)
                      +|||+|+.....         ......+..+.|..|.|||++ ....||.+.||||.||++.||++|++-|...  ...+
T Consensus       167 ~DFGLAR~~~~~---------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~--d~v~  235 (359)
T KOG0660|consen  167 CDFGLARYLDKF---------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK--DYVH  235 (359)
T ss_pred             ccccceeecccc---------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC--chHH
Confidence            999999977432         012334556789999999975 4568999999999999999999999987531  1111


Q ss_pred             HHHHHHHhhcch----hhhhh----hhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          786 LHKWVKNHYHGR----LEKVI----DSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       786 ~~~~~~~~~~~~----~~~~~----d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..+.+....+..    +..+-    .+.+..............+..+.+...+++.+|+..||.+|+|++|++++
T Consensus       236 Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  236 QLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            111122222111    11111    11111111122223344555677889999999999999999999999997

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-36  Score=317.56  Aligned_cols=251  Identities=28%  Similarity=0.431  Sum_probs=199.4

Q ss_pred             hCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEeccc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMA  636 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~  636 (885)
                      .+|++.+.||+|+||.||+|.++++..+|+|++.... .....+.+|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            4578889999999999999998877889999986332 234578899999999999999999999999999999999999


Q ss_pred             CCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeee
Q 002746          637 NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM  716 (885)
Q Consensus       637 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~  716 (885)
                      +++|.+++.....        .+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||.++...
T Consensus        83 ~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~  151 (256)
T cd05059          83 NGCLLNYLRERKG--------KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVL  151 (256)
T ss_pred             CCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecc
Confidence            9999998864321        3789999999999999999999998   9999999999999999999999999987653


Q ss_pred             cccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhhc
Q 002746          717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~  795 (885)
                      ...          ........++..|+|||+..+..++.++||||||+++||+++ |+.||......     .....   
T Consensus       152 ~~~----------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~---  213 (256)
T cd05059         152 DDQ----------YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-----EVVES---  213 (256)
T ss_pred             ccc----------ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-----HHHHH---
Confidence            210          001111234567999999999999999999999999999999 89998642111     10000   


Q ss_pred             chhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDL  853 (885)
Q Consensus       796 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  853 (885)
                            +..    ......+      ..++.++.+++.+||+.+|++|||+.|+++.|
T Consensus       214 ------~~~----~~~~~~~------~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         214 ------VSA----GYRLYRP------KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ------HHc----CCcCCCC------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                  000    0000000      01356799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-36  Score=324.05  Aligned_cols=252  Identities=23%  Similarity=0.314  Sum_probs=198.6

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEe
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      .|++.+.||+|+||.||++... +++.||||++....   ......+.+|++++++++||||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3788899999999999999965 68999999987432   1223457789999999999999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      |+++|+|..++.....       ..+++..+..++.|++.|++|||+.+   |+||||||+||++++++.++|+|||+++
T Consensus        81 ~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~  150 (285)
T cd05605          81 LMNGGDLKFHIYNMGN-------PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAV  150 (285)
T ss_pred             ccCCCcHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCce
Confidence            9999999887754321       23789999999999999999999998   9999999999999999999999999997


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      .+...            .......|++.|+|||++.+..++.++||||+||++|||++|+.||...... .....+    
T Consensus       151 ~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~----  213 (285)
T cd05605         151 EIPEG------------ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEV----  213 (285)
T ss_pred             ecCCC------------CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHH----
Confidence            65211            1112346899999999999889999999999999999999999999752110 000000    


Q ss_pred             hcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 002746          794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP-----TMLDAADD  852 (885)
Q Consensus       794 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  852 (885)
                               ...+.......       ....+..+.+++.+||..||++||     ++++++++
T Consensus       214 ---------~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         214 ---------ERRVKEDQEEY-------SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ---------HHHhhhccccc-------CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence                     01111100000       012455688999999999999999     78888775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.9e-36  Score=330.97  Aligned_cols=268  Identities=25%  Similarity=0.385  Sum_probs=202.1

Q ss_pred             hhCCcccceecccCcceEEEEEeC------CCCEEEEEEeeecCC-cchhhHHHHHHHHhhc-CCcccceeeeeeecC-C
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ------DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRI-RHRNLMRIITACSLP-D  626 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~  626 (885)
                      .++|++.+.||+|+||.||+|...      +++.||+|+++.... ...+.+..|++++.++ +|+||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357899999999999999999742      357899999874422 2345678899999999 899999999988654 4


Q ss_pred             cceEEEecccCCccccccccCCcccc----------------------------------------------------CC
Q 002746          627 FKALVLPYMANGSLDSHLYPHSETEF----------------------------------------------------GS  654 (885)
Q Consensus       627 ~~~lV~e~~~~gsL~~~l~~~~~~~~----------------------------------------------------~~  654 (885)
                      ..++||||+++|+|.+++........                                                    ..
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            56799999999999988754321000                                                    00


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecccCCCCCCCCCCCCccc
Q 002746          655 GSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN  734 (885)
Q Consensus       655 ~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~  734 (885)
                      ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.++|+|||+++.+.....         .....
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~---------~~~~~  233 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD---------YVRKG  233 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcc---------hhhcc
Confidence            0125889999999999999999999998   99999999999999999999999999987632110         01111


Q ss_pred             cccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCC
Q 002746          735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQ  813 (885)
Q Consensus       735 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  813 (885)
                      ...++..|+|||++.+..++.++|||||||++|||++ |..||...... ..+...+            ...    ....
T Consensus       234 ~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-~~~~~~~------------~~~----~~~~  296 (337)
T cd05054         234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-EEFCRRL------------KEG----TRMR  296 (337)
T ss_pred             CCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-HHHHHHH------------hcc----CCCC
Confidence            2345678999999999999999999999999999998 99998642111 1111110            000    0000


Q ss_pred             hHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 002746          814 SPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR  858 (885)
Q Consensus       814 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~  858 (885)
                      .+      .....++.+++.+||+.+|++||++.|++++|+++..
T Consensus       297 ~~------~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         297 AP------EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             CC------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            00      0134568999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.7e-36  Score=330.84  Aligned_cols=248  Identities=21%  Similarity=0.301  Sum_probs=193.9

Q ss_pred             ceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcceEEEecccC
Q 002746          563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~  637 (885)
                      ++||+|+||.||+|+.. +++.||+|+++...   ....+.+..|..++.++ +||||+++++++..+...++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999965 68899999997542   22345678899999888 799999999999999999999999999


Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      |+|..++....         .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++....
T Consensus        81 g~L~~~~~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  148 (329)
T cd05588          81 GDLMFHMQRQR---------KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR  148 (329)
T ss_pred             CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccccc
Confidence            99988775432         3889999999999999999999998   99999999999999999999999999864211


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccC---CccHHHHHHHhh
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAG---GLSLHKWVKNHY  794 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~---~~~~~~~~~~~~  794 (885)
                      .           ........||+.|+|||++.+..++.++|||||||++|||++|+.||+.....   ......+.... 
T Consensus       149 ~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-  216 (329)
T cd05588         149 P-----------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV-  216 (329)
T ss_pred             C-----------CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH-
Confidence            0           11223457899999999999999999999999999999999999999642111   11111111111 


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC------HHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT------MLDAADD  852 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt------~~ev~~~  852 (885)
                                 +.........       ..+.++.+++.+|++.||.+||+      ++|++++
T Consensus       217 -----------~~~~~~~~p~-------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         217 -----------ILEKQIRIPR-------SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             -----------HHcCCCCCCC-------CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence                       1111100000       13456889999999999999997      6777654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.8e-36  Score=321.55  Aligned_cols=264  Identities=26%  Similarity=0.412  Sum_probs=202.4

Q ss_pred             HhhCCcccceecccCcceEEEEEeC------CCCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCc
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ------DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDF  627 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  627 (885)
                      ..++|++.+.||+|+||.||+|.+.      .+..||+|+++... .....++.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999999753      35679999886432 2234568899999999999999999999999999


Q ss_pred             ceEEEecccCCccccccccCCcc-ccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEE
Q 002746          628 KALVLPYMANGSLDSHLYPHSET-EFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALV  706 (885)
Q Consensus       628 ~~lV~e~~~~gsL~~~l~~~~~~-~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl  706 (885)
                      .++||||+++|+|.+++...... ........+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            99999999999999988653221 11112234678899999999999999999998   999999999999999999999


Q ss_pred             cccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCcc
Q 002746          707 SDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS  785 (885)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~  785 (885)
                      +|||+++.+......         .......+++.|+|||++.+..++.++|||||||++|||++ |..||....     
T Consensus       161 ~dfg~~~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-----  226 (277)
T cd05062         161 GDFGMTRDIYETDYY---------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-----  226 (277)
T ss_pred             CCCCCccccCCccee---------ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-----
Confidence            999998765321100         01112245788999999998899999999999999999999 688886421     


Q ss_pred             HHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          786 LHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       786 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                      ..+........        ..    ....       ..++..+.+++.+|++.+|++||++.|+++.|+
T Consensus       227 ~~~~~~~~~~~--------~~----~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         227 NEQVLRFVMEG--------GL----LDKP-------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHHHHHHHcC--------Cc----CCCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            11111111100        00    0000       013456899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-37  Score=338.85  Aligned_cols=262  Identities=17%  Similarity=0.209  Sum_probs=199.9

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ++|++.+.||+|+||.||+|+.. +++.||||+++...   ......+.+|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36889999999999999999965 68999999997432   233456788999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++|+|.+++....         .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.++|+|||++
T Consensus        81 E~~~~g~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~  148 (364)
T cd05599          81 EYLPGGDMMTLLMKKD---------TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLC  148 (364)
T ss_pred             CCCCCcHHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccc
Confidence            9999999999886543         2788999999999999999999998   999999999999999999999999999


Q ss_pred             eeeecccCCCCCCCC---------------------------CCCCccccccccccccCCcccCCCCCCccccchhhHHH
Q 002746          713 KLVMTVGVGNDGAEN---------------------------MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGIL  765 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~v  765 (885)
                      +.+............                           ..........||+.|+|||++.+..++.++|||||||+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i  228 (364)
T cd05599         149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI  228 (364)
T ss_pred             eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhH
Confidence            765321100000000                           00001123469999999999999999999999999999


Q ss_pred             HHHHHcCCCCCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC
Q 002746          766 VLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT  845 (885)
Q Consensus       766 l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt  845 (885)
                      +|||++|+.||.....     .+.........      ..+.  .. ..       ...++++.+++.+|+. +|.+|++
T Consensus       229 l~el~~G~~Pf~~~~~-----~~~~~~i~~~~------~~~~--~~-~~-------~~~s~~~~~li~~ll~-~p~~R~~  286 (364)
T cd05599         229 MYEMLVGYPPFCSDNP-----QETYRKIINWK------ETLQ--FP-DE-------VPLSPEAKDLIKRLCC-EAERRLG  286 (364)
T ss_pred             HHHhhcCCCCCCCCCH-----HHHHHHHHcCC------CccC--CC-CC-------CCCCHHHHHHHHHHcc-CHhhcCC
Confidence            9999999999964211     11111110000      0000  00 00       0134568889999997 8999997


Q ss_pred             ---HHHHHHH
Q 002746          846 ---MLDAADD  852 (885)
Q Consensus       846 ---~~ev~~~  852 (885)
                         ++|++++
T Consensus       287 ~~~~~~ll~h  296 (364)
T cd05599         287 NNGVNEIKSH  296 (364)
T ss_pred             CCCHHHHhcC
Confidence               9998875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.7e-36  Score=330.45  Aligned_cols=247  Identities=23%  Similarity=0.310  Sum_probs=194.5

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCc-ccceeeeeeecCCcceEEE
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHR-NLMRIITACSLPDFKALVL  632 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lV~  632 (885)
                      +|++.+.||+|+||.||+|+.. +++.||||+++...   ....+.+..|.+++..++|+ +|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788999999999999999966 57889999987432   23345678899999999765 5888999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++|+|..++....         .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        81 E~~~~g~L~~~~~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~  148 (324)
T cd05587          81 EYVNGGDLMYHIQQVG---------KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMC  148 (324)
T ss_pred             cCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcc
Confidence            9999999998886443         2788999999999999999999998   999999999999999999999999998


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      +.....           ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ......
T Consensus       149 ~~~~~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~~~  212 (324)
T cd05587         149 KENIFG-----------GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-----DELFQS  212 (324)
T ss_pred             eecCCC-----------CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHH
Confidence            643110           1122345689999999999999999999999999999999999999964211     111111


Q ss_pred             hhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCH-----HHHHHH
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTM-----LDAADD  852 (885)
Q Consensus       793 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~ev~~~  852 (885)
                      ..        .     ......       ...+.++.+++.+|+..||.+||+.     +++.++
T Consensus       213 i~--------~-----~~~~~~-------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         213 IM--------E-----HNVSYP-------KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             HH--------c-----CCCCCC-------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            10        0     000000       0134568899999999999999986     566554

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.4e-36  Score=330.17  Aligned_cols=242  Identities=22%  Similarity=0.319  Sum_probs=191.7

Q ss_pred             ceecccCcceEEEEEeC-CCCEEEEEEeeec---CCcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcceEEEecccC
Q 002746          563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~  637 (885)
                      +.||+|+||.||+|+.. +++.||||+++..   .....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 6889999998743   223345677888888876 799999999999999999999999999


Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      |+|..++....         .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 g~L~~~i~~~~---------~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~  148 (320)
T cd05590          81 GDLMFHIQKSR---------RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF  148 (320)
T ss_pred             chHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCc
Confidence            99998876543         2788999999999999999999998   99999999999999999999999999875321


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcch
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR  797 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  797 (885)
                      .           ........||+.|+|||++.+..++.++|||||||++|||++|+.||....     ............
T Consensus       149 ~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-----~~~~~~~i~~~~  212 (320)
T cd05590         149 N-----------GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN-----EDDLFEAILNDE  212 (320)
T ss_pred             C-----------CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-----HHHHHHHHhcCC
Confidence            1           112233568999999999999999999999999999999999999996421     111111111100


Q ss_pred             hhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCH------HHHHHH
Q 002746          798 LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTM------LDAADD  852 (885)
Q Consensus       798 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~ev~~~  852 (885)
                                   ....+       ..+.++.+++.+|++.||++||++      ++++.+
T Consensus       213 -------------~~~~~-------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         213 -------------VVYPT-------WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             -------------CCCCC-------CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence                         00000       134568899999999999999998      555543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.6e-36  Score=316.76  Aligned_cols=253  Identities=30%  Similarity=0.451  Sum_probs=200.6

Q ss_pred             hCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEeccc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMA  636 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~  636 (885)
                      ++|++.+.||+|+||.||+|...++..||+|.++.... ..+.+.+|+.++++++|++++++++++. ....++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            56888999999999999999988888999999875432 3467899999999999999999999885 456789999999


Q ss_pred             CCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeee
Q 002746          637 NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM  716 (885)
Q Consensus       637 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~  716 (885)
                      +++|.+++.....       ..+++..+..++.+++.|++|||+.+   |+||||||+||++++++.++|+|||.+..+.
T Consensus        84 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          84 KGSLLDFLKDGEG-------RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIE  153 (260)
T ss_pred             CCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeecc
Confidence            9999998865321       23789999999999999999999998   9999999999999999999999999998653


Q ss_pred             cccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhhc
Q 002746          717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~  795 (885)
                      ...          ........++..|+|||+..+..++.++||||||+++|||++ |..||.....     ........ 
T Consensus       154 ~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~~~~~~~~-  217 (260)
T cd05070         154 DNE----------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-----REVLEQVE-  217 (260)
T ss_pred             Ccc----------cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHH-
Confidence            211          011112235668999999988899999999999999999999 8899864211     11111100 


Q ss_pred             chhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDR  855 (885)
Q Consensus       796 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  855 (885)
                              .    ......+      ...+.++.+++.+|++++|++|||++++.+.|++
T Consensus       218 --------~----~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         218 --------R----GYRMPCP------QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             --------c----CCCCCCC------CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                    0    0000000      1134568999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.5e-36  Score=321.10  Aligned_cols=263  Identities=23%  Similarity=0.367  Sum_probs=201.4

Q ss_pred             hCCcccceecccCcceEEEEEe-----CCCCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGIL-----QDGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKAL  630 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  630 (885)
                      .+|++.+.||+|+||.||+|++     .++..||+|.++.... .....+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4678889999999999999984     2467899999874332 234678899999999999999999999999999999


Q ss_pred             EEecccCCccccccccCCcc--------ccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCC
Q 002746          631 VLPYMANGSLDSHLYPHSET--------EFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDM  702 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~--------~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~  702 (885)
                      ||||+++|+|.+++......        ..+.....+++.....++.|++.||+|||+++   |+||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            99999999999988533211        00111234788999999999999999999998   99999999999999999


Q ss_pred             CEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCcccc
Q 002746          703 TALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFA  781 (885)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~  781 (885)
                      .+||+|||+++.+.....         ........++..|+|||+..+..++.++|||||||++|||++ |..||.... 
T Consensus       162 ~~kl~dfg~~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~-  231 (283)
T cd05090         162 HVKISDLGLSREIYSADY---------YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-  231 (283)
T ss_pred             cEEeccccccccccCCcc---------eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-
Confidence            999999999986532110         111122345678999999988889999999999999999999 888985421 


Q ss_pred             CCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 002746          782 GGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDR  855 (885)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  855 (885)
                          .......         +....   .. ..      ...++.++.+++.+||+.+|++||++.++.++|..
T Consensus       232 ----~~~~~~~---------~~~~~---~~-~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         232 ----NQEVIEM---------VRKRQ---LL-PC------SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ----HHHHHHH---------HHcCC---cC-CC------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                0111111         11000   00 00      01134568899999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.6e-36  Score=330.20  Aligned_cols=242  Identities=22%  Similarity=0.309  Sum_probs=192.5

Q ss_pred             ceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcceEEEecccC
Q 002746          563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~  637 (885)
                      ++||+|+||.||+|+.. +++.||+|+++...   ....+.+..|.+++..+ +||+|+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999965 57899999987542   23345677888888866 899999999999999999999999999


Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      |+|..++....         .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~  148 (321)
T cd05591          81 GDLMFQIQRSR---------KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGIL  148 (321)
T ss_pred             CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceeccc
Confidence            99988876443         2788899999999999999999998   99999999999999999999999999875321


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcch
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR  797 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  797 (885)
                      .           ........||+.|+|||++.+..++.++|||||||++|||++|+.||....     ............
T Consensus       149 ~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~-----~~~~~~~i~~~~  212 (321)
T cd05591         149 N-----------GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN-----EDDLFESILHDD  212 (321)
T ss_pred             C-----------CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC-----HHHHHHHHHcCC
Confidence            1           111233568999999999999999999999999999999999999996421     111111111100


Q ss_pred             hhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCC-------CHHHHHHH
Q 002746          798 LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP-------TMLDAADD  852 (885)
Q Consensus       798 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-------t~~ev~~~  852 (885)
                                  .. . +.      ..+.++.+++.+|++.||++||       ++++++++
T Consensus       213 ------------~~-~-p~------~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         213 ------------VL-Y-PV------WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             ------------CC-C-CC------CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence                        00 0 00      1245688999999999999999       78888765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.6e-36  Score=338.12  Aligned_cols=262  Identities=20%  Similarity=0.243  Sum_probs=196.1

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEe
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      .|++.+.||+|+||+||+|+.. +++.||+|+++...   ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999865 68899999997432   2334678899999999999999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      |+++|+|.+++....         .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        82 ~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~  149 (381)
T cd05626          82 YIPGGDMMSLLIRME---------VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCT  149 (381)
T ss_pred             cCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCc
Confidence            999999999886543         2788888999999999999999998   9999999999999999999999999986


Q ss_pred             eeecccCCCCC------------------------------------CCCCCCCccccccccccccCCcccCCCCCCccc
Q 002746          714 LVMTVGVGNDG------------------------------------AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG  757 (885)
Q Consensus       714 ~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  757 (885)
                      .+.........                                    .............||+.|+|||++.+..++.++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~  229 (381)
T cd05626         150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC  229 (381)
T ss_pred             ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcc
Confidence            44211000000                                    000000011235799999999999998999999


Q ss_pred             cchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhh--h
Q 002746          758 DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGIL--C  835 (885)
Q Consensus       758 Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--c  835 (885)
                      |||||||++|||++|+.||......     ....        .+....  ...  ..+.    ....+.++.+++.+  |
T Consensus       230 DiwSlG~il~elltG~~Pf~~~~~~-----~~~~--------~i~~~~--~~~--~~~~----~~~~s~~~~dli~~ll~  288 (381)
T cd05626         230 DWWSVGVILFEMLVGQPPFLAPTPT-----ETQL--------KVINWE--NTL--HIPP----QVKLSPEAVDLITKLCC  288 (381)
T ss_pred             ceeehhhHHHHHHhCCCCCcCCCHH-----HHHH--------HHHccc--ccc--CCCC----CCCCCHHHHHHHHHHcc
Confidence            9999999999999999999652110     0000        000000  000  0000    00124457778877  5


Q ss_pred             cCCCCCCCCCHHHHHHH
Q 002746          836 TQESPSTRPTMLDAADD  852 (885)
Q Consensus       836 l~~dP~~RPt~~ev~~~  852 (885)
                      +..+|..||+++|++.+
T Consensus       289 ~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         289 SAEERLGRNGADDIKAH  305 (381)
T ss_pred             CcccccCCCCHHHHhcC
Confidence            56666779999999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.4e-36  Score=336.47  Aligned_cols=253  Identities=18%  Similarity=0.234  Sum_probs=198.5

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec---CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEE
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV  631 (885)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++..   .......+.+|+.+++.++||||+++++++.++...++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            468999999999999999999965 6889999998643   222345578899999999999999999999999999999


Q ss_pred             EecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccc
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~  711 (885)
                      |||+++|+|.+++...          .++...+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.
T Consensus       122 ~Ey~~gg~L~~~l~~~----------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~  188 (370)
T cd05596         122 MEYMPGGDLVNLMSNY----------DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  188 (370)
T ss_pred             EcCCCCCcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccc
Confidence            9999999999988543          2677788889999999999999998   99999999999999999999999999


Q ss_pred             ceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC----CCCccccchhhHHHHHHHHcCCCCCCccccCCccHH
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS----NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH  787 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~  787 (885)
                      ++.....+          ........||+.|+|||++.+.    .++.++|||||||++|||++|+.||....     ..
T Consensus       189 ~~~~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~  253 (370)
T cd05596         189 CMKMDANG----------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-----LV  253 (370)
T ss_pred             eeeccCCC----------cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC-----HH
Confidence            98653211          1112345799999999987653    47899999999999999999999996421     11


Q ss_pred             HHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 002746          788 KWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPST--RPTMLDAADD  852 (885)
Q Consensus       788 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~  852 (885)
                      .....        +.+..    .....+.    ....+.++.+++.+|++.+|.+  ||++.|++++
T Consensus       254 ~~~~~--------i~~~~----~~~~~~~----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         254 GTYSK--------IMDHK----NSLTFPD----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             HHHHH--------HHcCC----CcCCCCC----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            11111        11100    0000000    0013557889999999999998  9999999886

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=339.11  Aligned_cols=262  Identities=18%  Similarity=0.215  Sum_probs=196.5

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec---CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ++|.+.+.||+|+||.||+|... +++.||||++...   .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36889999999999999999865 7899999998643   1233456888999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++|+|.+++....         .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+|
T Consensus        81 E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla  148 (377)
T cd05629          81 EFLPGGDLMTMLIKYD---------TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLS  148 (377)
T ss_pred             eCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccc
Confidence            9999999999886443         2788888899999999999999998   999999999999999999999999999


Q ss_pred             eeeecccCCC------CCCCCC------------------------------CCCccccccccccccCCcccCCCCCCcc
Q 002746          713 KLVMTVGVGN------DGAENM------------------------------GNSTANMLCGSIGYMAPEYGFGSNTSTK  756 (885)
Q Consensus       713 ~~~~~~~~~~------~~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~  756 (885)
                      +.+.......      ......                              .........||+.|+|||++.+..++.+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  228 (377)
T cd05629         149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE  228 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc
Confidence            7442211000      000000                              0000112469999999999999999999


Q ss_pred             ccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhc
Q 002746          757 GDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCT  836 (885)
Q Consensus       757 ~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  836 (885)
                      +|||||||++|||++|+.||.....     ..........      ...+      ..+.    ....+.++.+++.+|+
T Consensus       229 ~DiwSlGvil~elltG~~Pf~~~~~-----~~~~~~i~~~------~~~~------~~p~----~~~~s~~~~dli~~lL  287 (377)
T cd05629         229 CDWWSLGAIMFECLIGWPPFCSENS-----HETYRKIINW------RETL------YFPD----DIHLSVEAEDLIRRLI  287 (377)
T ss_pred             eeeEecchhhhhhhcCCCCCCCCCH-----HHHHHHHHcc------CCcc------CCCC----CCCCCHHHHHHHHHHh
Confidence            9999999999999999999964211     1111100000      0000      0000    0013456889999999


Q ss_pred             CCCCCCC---CCHHHHHHH
Q 002746          837 QESPSTR---PTMLDAADD  852 (885)
Q Consensus       837 ~~dP~~R---Pt~~ev~~~  852 (885)
                      + +|.+|   |++.|++.+
T Consensus       288 ~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         288 T-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             c-CHhhcCCCCCHHHHhcC
Confidence            8 66664   699999886

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.5e-36  Score=321.87  Aligned_cols=255  Identities=23%  Similarity=0.368  Sum_probs=200.5

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      ..+|++.+.||+|+||.||+|+.. +++.||+|+++.........+.+|+.++++++||||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            357899999999999999999964 6889999999765545556788999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +++++|.+++....         .+++..+..++.|++.|+.|||+.+   |+|||+||+||+++.++.++|+|||.+..
T Consensus        88 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~  155 (267)
T cd06646          88 CGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAK  155 (267)
T ss_pred             CCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCcccee
Confidence            99999999886432         2788999999999999999999998   99999999999999999999999999986


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccC---CCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF---GSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      +...           ........|++.|+|||.+.   ...++.++|||||||++|||++|+.||....... ....+  
T Consensus       156 ~~~~-----------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~-~~~~~--  221 (267)
T cd06646         156 ITAT-----------IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFLM--  221 (267)
T ss_pred             eccc-----------ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh-hheee--
Confidence            6321           11112345888999999874   3457889999999999999999999985421110 00000  


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDL  853 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  853 (885)
                                ..........   ..    ....+.++.+++.+||+.+|++||+++++++++
T Consensus       222 ----------~~~~~~~~~~---~~----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         222 ----------SKSNFQPPKL---KD----KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ----------ecCCCCCCCC---cc----ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence                      0000000000   00    011345789999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-37  Score=343.38  Aligned_cols=265  Identities=22%  Similarity=0.267  Sum_probs=206.7

Q ss_pred             hCCcccceecccCcceEEEEEeCCC-CEEEEEEeeecCCcchhhHHHHHHHHhhcC-Ccccceeeeee-ec------CCc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQDG-TAIAVKVLQLQSGNFTKSFNRECQVLKRIR-HRNLMRIITAC-SL------PDF  627 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~-~~------~~~  627 (885)
                      .++++.++|.+|||+.||.|....+ ..||+|++-.......+...+|++++++++ |+|||.+++.. ..      ..+
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            4567889999999999999997765 999999987666667788999999999996 99999999932 11      235


Q ss_pred             ceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEc
Q 002746          628 KALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVS  707 (885)
Q Consensus       628 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~  707 (885)
                      .+|.||||.+|.|-+++..+-..       .+.+..+++|+.++++|+++||... ++|||||||-+|||++.+++.|||
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~-------~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLC  188 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQT-------RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLC  188 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhc-------cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeC
Confidence            67999999999999999755432       3899999999999999999999986 679999999999999999999999


Q ss_pred             ccccceeeecccCCCCCCCCCCCCccccccccccccCCcc---cCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCc
Q 002746          708 DFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEY---GFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGL  784 (885)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~---~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~  784 (885)
                      |||.|+-........++..  --...-....|+.|+|||.   +.+..+++|+|||+|||+||-|+....||+....-  
T Consensus       189 DFGSatt~~~~~~~~~e~~--~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--  264 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQEVN--YVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--  264 (738)
T ss_pred             cccccccccCCCccHHHHH--HHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--
Confidence            9999874422110000000  0001113467999999996   56788999999999999999999999999763111  


Q ss_pred             cHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 002746          785 SLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR  858 (885)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~  858 (885)
                                     .+    +.+.+.-+.      .+..+..+.+||+.||+++|.+||++.+|++.+.++..
T Consensus       265 ---------------aI----lng~Y~~P~------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  265 ---------------AI----LNGNYSFPP------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             ---------------eE----EeccccCCC------CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                           00    111111000      01256679999999999999999999999999888864

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-37  Score=337.55  Aligned_cols=262  Identities=21%  Similarity=0.267  Sum_probs=203.4

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ++|.+.+.||+|+||+||+|+.. +++.||||+++...   ......+..|++++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36889999999999999999976 78999999997432   234567889999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++|+|.+++....         .+++..+..++.|++.||+|||++|   |+||||||+||+++.++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~  148 (350)
T cd05573          81 EYMPGGDLMNLLIRKD---------VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLC  148 (350)
T ss_pred             cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCC
Confidence            9999999999887542         3788999999999999999999998   999999999999999999999999999


Q ss_pred             eeeecccCCCC------------------CCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCC
Q 002746          713 KLVMTVGVGND------------------GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRR  774 (885)
Q Consensus       713 ~~~~~~~~~~~------------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~  774 (885)
                      +.+........                  ..............||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~  228 (350)
T cd05573         149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP  228 (350)
T ss_pred             ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCC
Confidence            86643210000                  000000112234579999999999999999999999999999999999999


Q ss_pred             CCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-HHHHHHH
Q 002746          775 PTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT-MLDAADD  852 (885)
Q Consensus       775 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~ev~~~  852 (885)
                      ||.....     .........     .. ..+.   .....       ..++++.+++.+|++ ||.+||+ ++|++++
T Consensus       229 Pf~~~~~-----~~~~~~i~~-----~~-~~~~---~p~~~-------~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         229 PFYSDTL-----QETYNKIIN-----WK-ESLR---FPPDP-------PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCCCH-----HHHHHHHhc-----cC-Cccc---CCCCC-------CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            9965211     111000000     00 0000   00000       035568899999998 9999999 9999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.3e-36  Score=327.89  Aligned_cols=241  Identities=24%  Similarity=0.347  Sum_probs=188.5

Q ss_pred             ceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcceEEEecccC
Q 002746          563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~  637 (885)
                      +.||+|+||.||+|+.. +++.||+|+++...   ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 58889999997542   22334556677777654 899999999999999999999999999


Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      |+|..++....         .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+|+....
T Consensus        81 g~L~~~~~~~~---------~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~  148 (316)
T cd05592          81 GDLMFHIQSSG---------RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMN  148 (316)
T ss_pred             CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence            99988886443         2788889999999999999999998   99999999999999999999999999975421


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcch
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR  797 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  797 (885)
                      .           ........||+.|+|||++.+..++.++|||||||++|||++|+.||....     ..+.......  
T Consensus       149 ~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~-----~~~~~~~i~~--  210 (316)
T cd05592         149 G-----------EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED-----EDELFDSILN--  210 (316)
T ss_pred             C-----------CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHc--
Confidence            1           112234568999999999999999999999999999999999999996421     1111111100  


Q ss_pred             hhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHH-HHHH
Q 002746          798 LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTML-DAAD  851 (885)
Q Consensus       798 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-ev~~  851 (885)
                                 ..... +      ...+.++.+++.+||+.+|++||++. ++.+
T Consensus       211 -----------~~~~~-~------~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         211 -----------DRPHF-P------RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             -----------CCCCC-C------CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence                       00000 0      01345688999999999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.3e-36  Score=336.00  Aligned_cols=254  Identities=19%  Similarity=0.236  Sum_probs=197.2

Q ss_pred             HhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec---CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceE
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKAL  630 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  630 (885)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++...   .....+.+.+|+.+++.++||||+++++++..++..++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            4578999999999999999999976 6889999998642   22234568899999999999999999999999999999


Q ss_pred             EEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccc
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG  710 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg  710 (885)
                      ||||+++|+|.+++...          .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       121 v~Ey~~gg~L~~~l~~~----------~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG  187 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY----------DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFG  187 (370)
T ss_pred             EEcCCCCCcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecc
Confidence            99999999999988543          2678888999999999999999998   9999999999999999999999999


Q ss_pred             cceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCC----CCccccchhhHHHHHHHHcCCCCCCccccCCccH
Q 002746          711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN----TSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSL  786 (885)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~  786 (885)
                      +|+.+...+          ........||+.|+|||++.+..    ++.++||||+||++|||++|+.||....     .
T Consensus       188 ~a~~~~~~~----------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~-----~  252 (370)
T cd05621         188 TCMKMDETG----------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS-----L  252 (370)
T ss_pred             cceecccCC----------ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC-----H
Confidence            998653211          11123457999999999986543    7889999999999999999999996421     1


Q ss_pred             HHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 002746          787 HKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPST--RPTMLDAADD  852 (885)
Q Consensus       787 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~  852 (885)
                      .....        .+.+...    ....+.    ....+..+.+++.+|+..++.+  ||+++|++++
T Consensus       253 ~~~~~--------~i~~~~~----~~~~p~----~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         253 VGTYS--------KIMDHKN----SLNFPE----DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HHHHH--------HHHhCCc----ccCCCC----cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            11111        1111000    000000    0013456788899999865544  8999999986

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-36  Score=317.65  Aligned_cols=259  Identities=28%  Similarity=0.463  Sum_probs=199.4

Q ss_pred             CcccceecccCcceEEEEEeCC----CCEEEEEEeeecCC--cchhhHHHHHHHHhhcCCcccceeeeeeecCCc-----
Q 002746          559 FDEQRLLGTGSYGRVYKGILQD----GTAIAVKVLQLQSG--NFTKSFNRECQVLKRIRHRNLMRIITACSLPDF-----  627 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----  627 (885)
                      |.+.+.||+|+||.||+|....    +..||+|+++....  .....+.+|++.++.++|||++++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5677899999999999998642    36799999875422  234578999999999999999999998866554     


Q ss_pred             -ceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEE
Q 002746          628 -KALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALV  706 (885)
Q Consensus       628 -~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl  706 (885)
                       .++|+||+++|+|..++.....   +.....+++.....++.|++.||+|||+++   |+||||||+||++++++.+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl  154 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRL---GGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCV  154 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhc---cCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEE
Confidence             6899999999999988754321   112235889999999999999999999998   999999999999999999999


Q ss_pred             cccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCcc
Q 002746          707 SDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS  785 (885)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~  785 (885)
                      +|||.++.+......         .......++..|+|||++.+..++.++|||||||++|||++ |..||.....    
T Consensus       155 ~dfg~~~~~~~~~~~---------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~----  221 (273)
T cd05035         155 ADFGLSKKIYSGDYY---------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN----  221 (273)
T ss_pred             CCccceeeccccccc---------cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH----
Confidence            999999876432110         01112235678999999988899999999999999999999 8888864211    


Q ss_pred             HHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 002746          786 LHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       786 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                       .++.......            ... ..+      ..++.++.+++.+||+.||.+||++.|+++.|+++
T Consensus       222 -~~~~~~~~~~------------~~~-~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         222 -HEIYDYLRHG------------NRL-KQP------EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             -HHHHHHHHcC------------CCC-CCC------cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             1111111100            000 000      12456799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.3e-36  Score=318.49  Aligned_cols=257  Identities=27%  Similarity=0.447  Sum_probs=198.2

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCC----EEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGT----AIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKAL  630 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  630 (885)
                      .+|++.+.||+|+||+||+|.+. ++.    .+++|.+..... ....++..|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46788899999999999999964 344    477777753322 234567788889999999999999998864 45678


Q ss_pred             EEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccc
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG  710 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg  710 (885)
                      |+||+++|+|.+++.....        .+++..+..++.|++.|++|||+++   ++||||||+||++++++.+||+|||
T Consensus        86 i~e~~~~gsL~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg  154 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRD--------SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFG  154 (279)
T ss_pred             EEEeCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCc
Confidence            9999999999999865432        3789999999999999999999998   9999999999999999999999999


Q ss_pred             cceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHH
Q 002746          711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKW  789 (885)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~  789 (885)
                      .++.+....         .........++..|+|||+..+..++.++|||||||++||+++ |+.||.....  ....++
T Consensus       155 ~~~~~~~~~---------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~  223 (279)
T cd05111         155 VADLLYPDD---------KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPDL  223 (279)
T ss_pred             cceeccCCC---------cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHH
Confidence            998653211         0111223456788999999998899999999999999999998 9999865211  011111


Q ss_pred             HHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 002746          790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR  858 (885)
Q Consensus       790 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~  858 (885)
                                  +..    ......+.      .+..++.+++.+||..+|++|||+.|+.+.|..+.+
T Consensus       224 ------------~~~----~~~~~~~~------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         224 ------------LEK----GERLAQPQ------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             ------------HHC----CCcCCCCC------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                        110    00000000      123457889999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3e-36  Score=326.81  Aligned_cols=241  Identities=24%  Similarity=0.364  Sum_probs=190.1

Q ss_pred             ceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhh-cCCcccceeeeeeecCCcceEEEecccC
Q 002746          563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKR-IRHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lV~e~~~~  637 (885)
                      +.||+|+||.||+|+.. +++.||||+++...   ......+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999976 57899999997542   2334556678888876 4999999999999999999999999999


Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      |+|..++....         .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++....
T Consensus        81 g~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  148 (316)
T cd05619          81 GDLMFHIQSCH---------KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENML  148 (316)
T ss_pred             CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCC
Confidence            99998886432         2788899999999999999999998   99999999999999999999999999875321


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcch
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR  797 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  797 (885)
                      .           ........||+.|+|||++.+..++.++|||||||++|||++|+.||....     ..+......   
T Consensus       149 ~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~~~~i~---  209 (316)
T cd05619         149 G-----------DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD-----EEELFQSIR---  209 (316)
T ss_pred             C-----------CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-----HHHHHHHHH---
Confidence            0           112234568999999999999999999999999999999999999996421     111111100   


Q ss_pred             hhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHH-HHHH
Q 002746          798 LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTML-DAAD  851 (885)
Q Consensus       798 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-ev~~  851 (885)
                                .... ..+.      ..+.++.+++.+|++.||++||++. ++.+
T Consensus       210 ----------~~~~-~~~~------~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         210 ----------MDNP-CYPR------WLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ----------hCCC-CCCc------cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence                      0000 0000      1345688999999999999999997 5654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.4e-36  Score=327.66  Aligned_cols=241  Identities=24%  Similarity=0.364  Sum_probs=189.6

Q ss_pred             ceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcceEEEecccC
Q 002746          563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~  637 (885)
                      +.||+|+||.||+|+.. +|+.||+|+++...   .........|..++... +||+|+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999976 68899999997542   22345567788887754 899999999999999999999999999


Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      |+|..++....         .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.++|+|||+++....
T Consensus        81 g~L~~~i~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~  148 (316)
T cd05620          81 GDLMFHIQDKG---------RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVF  148 (316)
T ss_pred             CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeeccc
Confidence            99988876432         2788899999999999999999998   99999999999999999999999999874311


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcch
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR  797 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  797 (885)
                                 .........||+.|+|||++.+..++.++||||+||++|||++|+.||....     ..+.......  
T Consensus       149 -----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~-----~~~~~~~~~~--  210 (316)
T cd05620         149 -----------GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD-----EDELFESIRV--  210 (316)
T ss_pred             -----------CCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----HHHHHHHHHh--
Confidence                       0112234568999999999999999999999999999999999999996421     1111111100  


Q ss_pred             hhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHH-HHHH
Q 002746          798 LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTML-DAAD  851 (885)
Q Consensus       798 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-ev~~  851 (885)
                                 ..... +.      ..+.++.+++.+|++.||++||++. ++.+
T Consensus       211 -----------~~~~~-~~------~~~~~~~~li~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         211 -----------DTPHY-PR------WITKESKDILEKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             -----------CCCCC-CC------CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence                       00000 00      1345688999999999999999985 5553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1e-35  Score=315.59  Aligned_cols=261  Identities=21%  Similarity=0.341  Sum_probs=208.0

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ++|++.+.||+|++|.||+|... +|+.||+|.++...   ....+.+.+|++++++++|++++++++++..++..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999976 79999999886432   233567889999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++|+|..++.....     ....+++..++.++.+++.|++|||+.+   |+||||||+||+++.++.++|+|||.+
T Consensus        82 e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~  153 (267)
T cd08224          82 ELADAGDLSRMIKHFKK-----QKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             ecCCCCCHHHHHHHhcc-----cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEecccee
Confidence            99999999988754321     1224789999999999999999999998   999999999999999999999999998


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      ......           ........|+..|+|||...+..++.++|||||||++|+|++|+.||....   .....+...
T Consensus       154 ~~~~~~-----------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~  219 (267)
T cd08224         154 RFFSSK-----------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLYSLCKK  219 (267)
T ss_pred             eeccCC-----------CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---ccHHHHHhh
Confidence            765321           111123457889999999998889999999999999999999999985421   122221111


Q ss_pred             hhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLK  857 (885)
Q Consensus       793 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~  857 (885)
                      ....            ... ..+     ....+.++.+++.+||..+|++||++.++++.+++++
T Consensus       220 ~~~~------------~~~-~~~-----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         220 IEKC------------DYP-PLP-----ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             hhcC------------CCC-CCC-----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            1100            000 000     0124557899999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3e-36  Score=319.61  Aligned_cols=261  Identities=22%  Similarity=0.336  Sum_probs=206.6

Q ss_pred             hCCcccceecccCcceEEEEEe-CCCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ++|.+.+.||+|++|.||+|.. .+++.+|||.+....   .....++.+|+.+++.++|+||+++++++..++..++||
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688889999999999999995 478999999886432   223457889999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++++|.+++.....     ....+++..++.++.|++.|++|||+++   |+|+||||+||+++.++.++++|||.+
T Consensus        82 e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~  153 (267)
T cd08229          82 ELADAGDLSRMIKHFKK-----QKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             EecCCCCHHHHHHHhhc-----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhh
Confidence            99999999988763221     1224889999999999999999999998   999999999999999999999999998


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      ..+...           ........|+..|+|||+..+..++.++||||||+++|||++|..||.....   ....+.+.
T Consensus       154 ~~~~~~-----------~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~  219 (267)
T cd08229         154 RFFSSK-----------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKK  219 (267)
T ss_pred             hccccC-----------CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc---hHHHHhhh
Confidence            765321           1111234588899999999988899999999999999999999999864211   11111111


Q ss_pred             hhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLK  857 (885)
Q Consensus       793 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~  857 (885)
                      ....            ......      ....+.++.+++.+||+.+|.+||||.+|++.++++.
T Consensus       220 ~~~~------------~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         220 IEQC------------DYPPLP------SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             hhcC------------CCCCCC------cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            1000            000000      0124567999999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6.4e-36  Score=314.93  Aligned_cols=250  Identities=23%  Similarity=0.321  Sum_probs=202.2

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeec--CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      +|.+.+.||+|++|.||+|+.. +++.|++|.+...  .......+.+|++++++++|||++++++++..++..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999975 6899999998743  234467788999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +++++|.+++.....       ..+++..++.++.|++.|+.|||+.+   |+||||||+||+++.++.++|+|||.++.
T Consensus        81 ~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~  150 (256)
T cd08529          81 AENGDLHKLLKMQRG-------RPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKL  150 (256)
T ss_pred             CCCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEccccccee
Confidence            999999998875421       23889999999999999999999998   99999999999999999999999999886


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      +...           ........|++.|+|||+..+..++.++||||||+++|||++|+.||.....     ........
T Consensus       151 ~~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~  214 (256)
T cd08529         151 LSDN-----------TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----GALILKII  214 (256)
T ss_pred             ccCc-----------cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHH
Confidence            6321           1112234578899999999999999999999999999999999999965211     11111100


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                                  ..... ..+      ...+.++.+++.+||+.+|++||++.+++++
T Consensus       215 ------------~~~~~-~~~------~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         215 ------------RGVFP-PVS------QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ------------cCCCC-CCc------cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                        00000 000      0245678999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.9e-36  Score=333.82  Aligned_cols=210  Identities=20%  Similarity=0.283  Sum_probs=174.6

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ++|++.+.||+|+||+||+|... +++.||+|+++...   ......+..|+.++.+++|++|+++++++.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            36889999999999999999865 68999999997432   223456788999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++|+|.+++....         .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus        81 E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla  148 (363)
T cd05628          81 EFLPGGDMMTLLMKKD---------TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLC  148 (363)
T ss_pred             cCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCc
Confidence            9999999999886543         3789999999999999999999998   999999999999999999999999999


Q ss_pred             eeeecccCCCC-------CC-----------------CCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHH
Q 002746          713 KLVMTVGVGND-------GA-----------------ENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLE  768 (885)
Q Consensus       713 ~~~~~~~~~~~-------~~-----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~e  768 (885)
                      +.+........       ..                 ...........+||+.|+|||++.+..++.++|||||||++||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e  228 (363)
T cd05628         149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE  228 (363)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHH
Confidence            86532110000       00                 0000011124579999999999999999999999999999999


Q ss_pred             HHcCCCCCCc
Q 002746          769 MVTRRRPTDD  778 (885)
Q Consensus       769 lltg~~P~~~  778 (885)
                      |++|+.||..
T Consensus       229 ll~G~~Pf~~  238 (363)
T cd05628         229 MLIGYPPFCS  238 (363)
T ss_pred             HHhCCCCCCC
Confidence            9999999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.1e-36  Score=328.21  Aligned_cols=247  Identities=22%  Similarity=0.308  Sum_probs=194.2

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcceEEE
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      +|.+.+.||+|+||.||+|... +++.||+|+++...   ....+.+..|..++... +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788899999999999999966 57899999987542   22234566788888777 5899999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++|+|..++....         .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        81 E~~~~g~L~~~~~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~  148 (323)
T cd05616          81 EYVNGGDLMYQIQQVG---------RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC  148 (323)
T ss_pred             cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCc
Confidence            9999999988876443         2788999999999999999999998   999999999999999999999999998


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      +.....           ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ......
T Consensus       149 ~~~~~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-----~~~~~~  212 (323)
T cd05616         149 KENMWD-----------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQS  212 (323)
T ss_pred             eecCCC-----------CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-----HHHHHH
Confidence            753211           1122345689999999999999999999999999999999999999965211     111111


Q ss_pred             hhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCH-----HHHHHH
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTM-----LDAADD  852 (885)
Q Consensus       793 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~ev~~~  852 (885)
                      .        ....     .....       ..+.++.+++.+|++.||++|++.     .++.++
T Consensus       213 i--------~~~~-----~~~p~-------~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         213 I--------MEHN-----VAYPK-------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             H--------HhCC-----CCCCC-------cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence            1        1000     00000       134568899999999999999985     566543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.9e-36  Score=320.62  Aligned_cols=248  Identities=23%  Similarity=0.287  Sum_probs=192.7

Q ss_pred             ecccCcceEEEEEeC-CCCEEEEEEeeecCC---cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCCcc
Q 002746          565 LGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG---NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSL  640 (885)
Q Consensus       565 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL  640 (885)
                      ||+|+||+||+|... +++.||+|.+.....   ...+.+..|+++++.++|++|+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999965 688999999864321   2235677899999999999999999999999999999999999999


Q ss_pred             ccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecccC
Q 002746          641 DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGV  720 (885)
Q Consensus       641 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~  720 (885)
                      ..++.....     ....+++..+..++.|++.||+|||+++   |+||||||+||+++.++.++|+|||.+..+...  
T Consensus        81 ~~~~~~~~~-----~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~--  150 (280)
T cd05608          81 RYHIYNVDE-----ENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--  150 (280)
T ss_pred             HHHHHhccc-----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCC--
Confidence            877643221     1224889999999999999999999998   999999999999999999999999999765321  


Q ss_pred             CCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhhh
Q 002746          721 GNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEK  800 (885)
Q Consensus       721 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  800 (885)
                               ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........        
T Consensus       151 ---------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~--------  212 (280)
T cd05608         151 ---------QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQR--------  212 (280)
T ss_pred             ---------CccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHh--------
Confidence                     111223468999999999999999999999999999999999999996521110 00010000        


Q ss_pred             hhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 002746          801 VIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP-----TMLDAADD  852 (885)
Q Consensus       801 ~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  852 (885)
                           +.......       ....+.++.+++.+|++.||++||     ++++++++
T Consensus       213 -----~~~~~~~~-------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         213 -----ILNDSVTY-------PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             -----hcccCCCC-------cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence                 00000000       012456789999999999999999     67777764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.2e-36  Score=349.17  Aligned_cols=278  Identities=21%  Similarity=0.299  Sum_probs=206.8

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|+++...   ....+++.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999965 68999999987432   223567899999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccc-cC-CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccc
Q 002746          633 PYMANGSLDSHLYPHSETE-FG-SGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG  710 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~-~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg  710 (885)
                      ||+++|+|.+++....... +. ......++..+++++.||++||+|||+++   |+||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999886432111 00 11224677888999999999999999998   9999999999999999999999999


Q ss_pred             cceeeecccCCCCC-C-C-----CCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCC
Q 002746          711 IAKLVMTVGVGNDG-A-E-----NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGG  783 (885)
Q Consensus       711 ~a~~~~~~~~~~~~-~-~-----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~  783 (885)
                      +|+........... . .     ...........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            99876221100000 0 0     000111223569999999999999999999999999999999999999996521110


Q ss_pred             ccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHHHHHHH
Q 002746          784 LSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP-TMLDAADDLDRLKRY  859 (885)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~ev~~~L~~l~~~  859 (885)
                           ....   .   ...++.-.           ..+...+..+.+++.+|++.||++|| +++++.+.|+.+...
T Consensus       239 -----i~~~---~---~i~~P~~~-----------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        239 -----ISYR---D---VILSPIEV-----------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             -----hhhh---h---hccChhhc-----------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence                 0000   0   00000000           00112456688999999999999995 677777777776543

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.6e-36  Score=317.68  Aligned_cols=248  Identities=25%  Similarity=0.391  Sum_probs=196.9

Q ss_pred             CCcccceecccCcceEEEEEe-CCCCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          558 EFDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      +|++.++||+|+||.||+|.. .+++.||+|++.... ......+.+|++++++++|||++++++++..++..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            578889999999999999985 478999999987542 233467889999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++|++..+.             .+++..+..++.|++.|++|||+.+   |+|+||||+||+++.++.++|+|||++..+
T Consensus        82 ~~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~  145 (279)
T cd06619          82 DGGSLDVYR-------------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL  145 (279)
T ss_pred             CCCChHHhh-------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceec
Confidence            999986542             2677888899999999999999998   999999999999999999999999999765


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccH--HHHHHHh
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSL--HKWVKNH  793 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~--~~~~~~~  793 (885)
                      ..             .......||..|+|||++.+..++.++|||||||++|+|++|+.||..........  ..+... 
T Consensus       146 ~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-  211 (279)
T cd06619         146 VN-------------SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC-  211 (279)
T ss_pred             cc-------------ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH-
Confidence            22             11223468999999999999999999999999999999999999996532211100  011000 


Q ss_pred             hcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       794 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                             ..+..     ....+     ....+.++.+++.+|++.+|++||+++|++++
T Consensus       212 -------~~~~~-----~~~~~-----~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         212 -------IVDED-----PPVLP-----VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             -------HhccC-----CCCCC-----CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence                   00000     00000     01124568899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1e-35  Score=320.46  Aligned_cols=265  Identities=27%  Similarity=0.413  Sum_probs=202.9

Q ss_pred             hCCcccceecccCcceEEEEEeCC-CC--EEEEEEeeec-CCcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcceEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQD-GT--AIAVKVLQLQ-SGNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV  631 (885)
                      ++|++.+.||+|+||.||+|...+ +.  .+++|.++.. .....+.+.+|+++++++ +||||+++++++......++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            468889999999999999998753 33  4788887732 233456789999999999 799999999999999999999


Q ss_pred             EecccCCccccccccCCccccC-------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCE
Q 002746          632 LPYMANGSLDSHLYPHSETEFG-------SGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA  704 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~-------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~  704 (885)
                      +||+++|+|.+++.........       .....+++..+..++.|++.|++|||+++   |+||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            9999999999998654321100       11234889999999999999999999998   9999999999999999999


Q ss_pred             EEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCC
Q 002746          705 LVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGG  783 (885)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~  783 (885)
                      ||+|||++......            ........+..|+|||+..+..++.++|||||||++|||++ |..||....   
T Consensus       159 kl~dfg~~~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~---  223 (297)
T cd05089         159 KIADFGLSRGEEVY------------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT---  223 (297)
T ss_pred             EECCcCCCccccce------------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---
Confidence            99999998632110            00111123457999999998899999999999999999997 999996421   


Q ss_pred             ccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 002746          784 LSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYL  860 (885)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~  860 (885)
                        ...+....         ....    ....+      ..++.++.+++.+||+.+|.+||+++++++.|+.+....
T Consensus       224 --~~~~~~~~---------~~~~----~~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         224 --CAELYEKL---------PQGY----RMEKP------RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             --HHHHHHHH---------hcCC----CCCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence              11111110         0000    00000      113456899999999999999999999999998887544

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.2e-35  Score=313.56  Aligned_cols=253  Identities=30%  Similarity=0.468  Sum_probs=200.1

Q ss_pred             hCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEeccc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMA  636 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~  636 (885)
                      ++|.+.+.||+|++|.||+|.+..+..+|+|.+.... ...+.+.+|++++++++|++++++++++. .+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            5688899999999999999998877789999876432 33567899999999999999999999875 456789999999


Q ss_pred             CCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeee
Q 002746          637 NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM  716 (885)
Q Consensus       637 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~  716 (885)
                      +|+|.++++....       ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.++|+|||.+....
T Consensus        84 ~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~  153 (260)
T cd05069          84 KGSLLDFLKEGDG-------KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIE  153 (260)
T ss_pred             CCCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEcc
Confidence            9999998865432       23789999999999999999999998   9999999999999999999999999997653


Q ss_pred             cccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhhc
Q 002746          717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~  795 (885)
                      ...          ........++..|+|||+..+..++.++||||||+++|||++ |+.||......  ....++..   
T Consensus       154 ~~~----------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~---  218 (260)
T cd05069         154 DNE----------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQVER---  218 (260)
T ss_pred             CCc----------ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHc---
Confidence            211          011112345678999999998899999999999999999999 89998652111  11111100   


Q ss_pred             chhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDR  855 (885)
Q Consensus       796 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  855 (885)
                                   ......+      ...+..+.+++.+||..+|++||++++|.+.|+.
T Consensus       219 -------------~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         219 -------------GYRMPCP------QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -------------CCCCCCC------cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                         0000000      1134568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8.2e-36  Score=322.82  Aligned_cols=269  Identities=26%  Similarity=0.398  Sum_probs=206.6

Q ss_pred             hhCCcccceecccCcceEEEEEeC--------CCCEEEEEEeeecC-CcchhhHHHHHHHHhhc-CCcccceeeeeeecC
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ--------DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRI-RHRNLMRIITACSLP  625 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  625 (885)
                      .++|.+.+.||+|+||.||+|...        ++..+|+|.++... ......+..|+++++++ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            357899999999999999999853        23569999987542 23345688899999999 799999999999999


Q ss_pred             CcceEEEecccCCccccccccCCcccc-------CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEe
Q 002746          626 DFKALVLPYMANGSLDSHLYPHSETEF-------GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL  698 (885)
Q Consensus       626 ~~~~lV~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl  698 (885)
                      +..++||||+++|+|.+++........       ......+++..+..++.|++.||+|||+++   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            999999999999999999876432110       011234889999999999999999999998   9999999999999


Q ss_pred             cCCCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCC
Q 002746          699 NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTD  777 (885)
Q Consensus       699 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~  777 (885)
                      +.++.+||+|||.++.......         ........++..|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~  244 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDY---------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP  244 (307)
T ss_pred             cCCCcEEECCCcccccccccch---------hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999876532110         000111234568999999998889999999999999999998 888885


Q ss_pred             ccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 002746          778 DMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLK  857 (885)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~  857 (885)
                      ..     ...+.....         ...    .....+      ..++.++.+++.+||..+|++||++.||++.|+++.
T Consensus       245 ~~-----~~~~~~~~~---------~~~----~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         245 GV-----PVEELFKLL---------KEG----HRMDKP------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             cC-----CHHHHHHHH---------HcC----CCCCCC------CcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence            31     111111111         000    000000      113457889999999999999999999999999988


Q ss_pred             HHh
Q 002746          858 RYL  860 (885)
Q Consensus       858 ~~~  860 (885)
                      ...
T Consensus       301 ~~~  303 (307)
T cd05098         301 ALT  303 (307)
T ss_pred             HHh
Confidence            764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.5e-36  Score=321.60  Aligned_cols=267  Identities=27%  Similarity=0.428  Sum_probs=204.8

Q ss_pred             HhhCCcccceecccCcceEEEEEeC------CCCEEEEEEeeecC-CcchhhHHHHHHHHhhc-CCcccceeeeeeecCC
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ------DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRI-RHRNLMRIITACSLPD  626 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  626 (885)
                      ..++|++.+.||+|+||.||+|...      ....+|+|.++... ......+.+|++++.++ +|+||+++++++..++
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            3467889999999999999999864      23679999987542 23345688999999999 8999999999999999


Q ss_pred             cceEEEecccCCccccccccCCcccc-------CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEec
Q 002746          627 FKALVLPYMANGSLDSHLYPHSETEF-------GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN  699 (885)
Q Consensus       627 ~~~lV~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~  699 (885)
                      ..++||||+++|+|..++........       ......+++..++.++.|++.||+|||+.+   |+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence            99999999999999998865321100       012345899999999999999999999998   99999999999999


Q ss_pred             CCCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCc
Q 002746          700 DDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDD  778 (885)
Q Consensus       700 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~  778 (885)
                      .++.+||+|||.++.+.....         ........++..|+|||+..+..++.++|||||||++||+++ |..||..
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  237 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDY---------YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG  237 (293)
T ss_pred             CCCeEEeCccccccccccccc---------eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence            999999999999987643110         001111234678999999988899999999999999999998 9999864


Q ss_pred             cccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 002746          779 MFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLK  857 (885)
Q Consensus       779 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~  857 (885)
                      ..     ..+...         .....    .....+      ..++.++.+++.+||+.+|++|||++|+++.|+.+.
T Consensus       238 ~~-----~~~~~~---------~~~~~----~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         238 IP-----VEELFK---------LLKEG----YRMEKP------QNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             CC-----HHHHHH---------HHHcC----CcCCCC------CCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            21     111100         00000    000000      013456889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.1e-35  Score=319.24  Aligned_cols=265  Identities=26%  Similarity=0.407  Sum_probs=203.2

Q ss_pred             CCcccceecccCcceEEEEEeC------CCCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceE
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ------DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKAL  630 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  630 (885)
                      +|++.+.||+|+||.||+|+..      ....+|+|.+..... .....+.+|+.+++.++||||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999853      235688888864432 234678899999999999999999999999999999


Q ss_pred             EEecccCCccccccccCCccc---------------cCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCc
Q 002746          631 VLPYMANGSLDSHLYPHSETE---------------FGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSN  695 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~---------------~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N  695 (885)
                      |+||+++|+|.+++.......               .......+++..++.++.|++.||+|||+.+   |+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999998876432110               0011235889999999999999999999998   9999999999


Q ss_pred             eEecCCCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCC
Q 002746          696 VLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRR  774 (885)
Q Consensus       696 ILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~  774 (885)
                      |++++++.+||+|||+++.......         ........++..|+|||+..+..++.++||||||+++|||++ |..
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~---------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~  228 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDS---------YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN  228 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccc---------hhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCC
Confidence            9999999999999999976532110         001112245678999999988899999999999999999998 999


Q ss_pred             CCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          775 PTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       775 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                      ||....     ..++.         ..+........    +      ..++.++.+++.+||+.+|++||+++|+++.|+
T Consensus       229 p~~~~~-----~~~~~---------~~~~~~~~~~~----~------~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~  284 (290)
T cd05045         229 PYPGIA-----PERLF---------NLLKTGYRMER----P------ENCSEEMYNLMLTCWKQEPDKRPTFADISKELE  284 (290)
T ss_pred             CCCCCC-----HHHHH---------HHHhCCCCCCC----C------CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence            986421     11111         11111110000    0      113456889999999999999999999999999


Q ss_pred             HHHH
Q 002746          855 RLKR  858 (885)
Q Consensus       855 ~l~~  858 (885)
                      ++.+
T Consensus       285 ~~~~  288 (290)
T cd05045         285 KMMV  288 (290)
T ss_pred             HHHh
Confidence            8864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.5e-36  Score=326.89  Aligned_cols=242  Identities=23%  Similarity=0.306  Sum_probs=193.0

Q ss_pred             ceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcceEEEecccC
Q 002746          563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~  637 (885)
                      +.||+|+||.||+|+.. +++.||||+++...   ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999976 58899999997542   23345677888888887 799999999999999999999999999


Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      |+|..++....         .+++..+..++.|++.||+|||+++   |+||||||+||++++++.+||+|||+++....
T Consensus        81 ~~L~~~~~~~~---------~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  148 (318)
T cd05570          81 GDLMFHIQRSG---------RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL  148 (318)
T ss_pred             CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCc
Confidence            99988876443         3889999999999999999999998   99999999999999999999999999864311


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcch
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR  797 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  797 (885)
                      .           ........||+.|+|||++.+..++.++|||||||++|||++|+.||....     ..........  
T Consensus       149 ~-----------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-----~~~~~~~i~~--  210 (318)
T cd05570         149 G-----------GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-----EDELFQSILE--  210 (318)
T ss_pred             C-----------CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-----HHHHHHHHHc--
Confidence            1           111223468999999999999999999999999999999999999996421     1111111110  


Q ss_pred             hhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCH-----HHHHHH
Q 002746          798 LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTM-----LDAADD  852 (885)
Q Consensus       798 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~ev~~~  852 (885)
                                 ......       ...+.++.+++.+||+.||++||++     .+++++
T Consensus       211 -----------~~~~~~-------~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         211 -----------DEVRYP-------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             -----------CCCCCC-------CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence                       000000       0134568999999999999999999     888765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-35  Score=320.92  Aligned_cols=268  Identities=26%  Similarity=0.413  Sum_probs=207.1

Q ss_pred             hhCCcccceecccCcceEEEEEeC--------CCCEEEEEEeeecC-CcchhhHHHHHHHHhhc-CCcccceeeeeeecC
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ--------DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRI-RHRNLMRIITACSLP  625 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  625 (885)
                      ..+|.+.+.||+|+||.||+|+..        ++..||+|.++... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            467889999999999999999742        24579999887432 23356788999999999 899999999999999


Q ss_pred             CcceEEEecccCCccccccccCCccccC-------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEe
Q 002746          626 DFKALVLPYMANGSLDSHLYPHSETEFG-------SGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL  698 (885)
Q Consensus       626 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~-------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl  698 (885)
                      ...++||||+++|+|.+++.........       .....+++..+..++.||+.||+|||+++   |+||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence            9999999999999999998754321100       11235889999999999999999999998   9999999999999


Q ss_pred             cCCCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCC
Q 002746          699 NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTD  777 (885)
Q Consensus       699 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~  777 (885)
                      +.++.+||+|||.++.+.....         ........+++.|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~  241 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDY---------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP  241 (304)
T ss_pred             cCCCcEEECCCccceecccccc---------cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999987633211         011112345678999999998889999999999999999998 788875


Q ss_pred             ccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 002746          778 DMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLK  857 (885)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~  857 (885)
                      ..     ...++.......             .....+      ..++.++.+++.+||+.+|++||++.|+++.|+++.
T Consensus       242 ~~-----~~~~~~~~~~~~-------------~~~~~~------~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         242 GI-----PVEELFKLLKEG-------------HRMDKP------ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             cC-----CHHHHHHHHHcC-------------CcCCCC------CCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence            32     122221111100             000000      013567899999999999999999999999999887


Q ss_pred             HH
Q 002746          858 RY  859 (885)
Q Consensus       858 ~~  859 (885)
                      ..
T Consensus       298 ~~  299 (304)
T cd05101         298 TL  299 (304)
T ss_pred             Hh
Confidence            64

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.1e-36  Score=318.60  Aligned_cols=255  Identities=24%  Similarity=0.342  Sum_probs=195.3

Q ss_pred             ecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCCcc
Q 002746          565 LGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSL  640 (885)
Q Consensus       565 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL  640 (885)
                      ||+|+||.||+++.. +|+.||+|.+....   ......+..|++++++++||||+++++++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999965 68999999986432   12234566799999999999999999999999999999999999999


Q ss_pred             ccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecccC
Q 002746          641 DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGV  720 (885)
Q Consensus       641 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~  720 (885)
                      ..++.....       ..+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.++|+|||++......  
T Consensus        81 ~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--  148 (277)
T cd05607          81 KYHIYNVGE-------RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--  148 (277)
T ss_pred             HHHHHhccc-------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC--
Confidence            887754332       23788999999999999999999998   999999999999999999999999998765221  


Q ss_pred             CCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhhh
Q 002746          721 GNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEK  800 (885)
Q Consensus       721 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  800 (885)
                                .......|+..|+|||++.+..++.++||||+||++|||++|+.||...... .....+...        
T Consensus       149 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~--------  209 (277)
T cd05607         149 ----------KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRR--------  209 (277)
T ss_pred             ----------ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHH--------
Confidence                      1112346889999999999989999999999999999999999999642111 011111110        


Q ss_pred             hhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHhcC
Q 002746          801 VIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGE  862 (885)
Q Consensus       801 ~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~  862 (885)
                      .....+    . ..      ....+.++.+++.+||+.||++||+++|+++.+.. +.|+..
T Consensus       210 ~~~~~~----~-~~------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~-h~~f~~  259 (277)
T cd05607         210 TLEDEV----K-FE------HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRK-HEFFKT  259 (277)
T ss_pred             hhcccc----c-cc------cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhc-ChhhcC
Confidence            000000    0 00      01135568999999999999999999877654432 345544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.1e-35  Score=312.28  Aligned_cols=248  Identities=25%  Similarity=0.418  Sum_probs=194.5

Q ss_pred             ceecccCcceEEEEEeC-CCCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCCcc
Q 002746          563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSL  640 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL  640 (885)
                      +.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36899999999999965 78999999876432 23456789999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecccC
Q 002746          641 DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGV  720 (885)
Q Consensus       641 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~  720 (885)
                      .+++....        ..+++..++.++.|++.||+|||+++   |+||||||+||+++.++.+||+|||.+....... 
T Consensus        81 ~~~~~~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-  148 (252)
T cd05084          81 LTFLRTEG--------PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV-  148 (252)
T ss_pred             HHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccc-
Confidence            99886432        13789999999999999999999998   9999999999999999999999999987542110 


Q ss_pred             CCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhhcchhh
Q 002746          721 GNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHYHGRLE  799 (885)
Q Consensus       721 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~  799 (885)
                              .........++..|+|||.+.+..++.++||||||+++|||++ |..||......              ...
T Consensus       149 --------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------------~~~  206 (252)
T cd05084         149 --------YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------------QTR  206 (252)
T ss_pred             --------ccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------------HHH
Confidence                    0001111223567999999999899999999999999999998 88888642110              011


Q ss_pred             hhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          800 KVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       800 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                      ..+......    ..+      ..++.++.+++.+|++.+|++|||+.|+.+.|+
T Consensus       207 ~~~~~~~~~----~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         207 EAIEQGVRL----PCP------ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHHHcCCCC----CCc------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            111110000    000      113456899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.7e-36  Score=327.69  Aligned_cols=237  Identities=26%  Similarity=0.333  Sum_probs=186.2

Q ss_pred             ceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHH-HHhhcCCcccceeeeeeecCCcceEEEecccC
Q 002746          563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQ-VLKRIRHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~  637 (885)
                      +.||+|+||+||+|+.. +|+.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999975 68999999987432   222334455544 56788999999999999999999999999999


Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      |+|..++....         .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~  148 (323)
T cd05575          81 GELFFHLQRER---------SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE  148 (323)
T ss_pred             CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccccc
Confidence            99988886433         3788889999999999999999998   99999999999999999999999999874311


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcch
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR  797 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  797 (885)
                      .           ........||+.|+|||++.+..++.++|||||||++|||++|+.||...     +..+.......  
T Consensus       149 ~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~-----~~~~~~~~i~~--  210 (323)
T cd05575         149 H-----------SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----DTAEMYDNILN--  210 (323)
T ss_pred             C-----------CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC-----CHHHHHHHHHc--
Confidence            0           11223356899999999999999999999999999999999999999642     11111111110  


Q ss_pred             hhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 002746          798 LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTML  847 (885)
Q Consensus       798 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  847 (885)
                                 ......+       ..+.++.+++.+|++.||++||++.
T Consensus       211 -----------~~~~~~~-------~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         211 -----------KPLRLKP-------NISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             -----------CCCCCCC-------CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence                       0000001       1245688999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.2e-35  Score=313.55  Aligned_cols=254  Identities=30%  Similarity=0.466  Sum_probs=202.0

Q ss_pred             hhCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      .++|++.++||+|+||.||+|...+++.||+|.+.... .....+.+|+.++++++|+|++++++++. .+..++||||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            46789999999999999999998889999999987443 23567899999999999999999999874 56789999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++|+|.+++.....       ..+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||.+...
T Consensus        83 ~~~~L~~~~~~~~~-------~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  152 (260)
T cd05067          83 ENGSLVDFLKTPEG-------IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLI  152 (260)
T ss_pred             CCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeec
Confidence            99999998864332       24788999999999999999999998   999999999999999999999999999765


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhh
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      ....          ........++..|+|||+..+..++.++||||||+++||+++ |+.||.....     .+..... 
T Consensus       153 ~~~~----------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~-  216 (260)
T cd05067         153 EDNE----------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-----PEVIQNL-  216 (260)
T ss_pred             CCCC----------cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-----HHHHHHH-
Confidence            3210          011112345678999999998889999999999999999999 9999964211     1111110 


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDR  855 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  855 (885)
                              ..    ......+      ...+.++.+++.+|++.+|++||+++++...|+.
T Consensus       217 --------~~----~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         217 --------ER----GYRMPRP------DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             --------Hc----CCCCCCC------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                    00    0000000      1134569999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.4e-35  Score=315.48  Aligned_cols=259  Identities=28%  Similarity=0.429  Sum_probs=195.6

Q ss_pred             CcccceecccCcceEEEEEeCCC-C--EEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecC------Cc
Q 002746          559 FDEQRLLGTGSYGRVYKGILQDG-T--AIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLP------DF  627 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~~~-~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~  627 (885)
                      |.+.+.||+|+||.||+|++.+. .  .||+|.++...  ....+.+..|+++++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            35678899999999999997643 2  58999887542  23356788999999999999999999987432      24


Q ss_pred             ceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEc
Q 002746          628 KALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVS  707 (885)
Q Consensus       628 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~  707 (885)
                      .++||||+++|+|.+++.....   ......+++.....++.|++.||+|||+++   |+||||||+||++++++.+||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~  154 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRL---GDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVA  154 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcc---cCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEEC
Confidence            5899999999999887743221   111224789999999999999999999998   9999999999999999999999


Q ss_pred             ccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccH
Q 002746          708 DFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSL  786 (885)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~  786 (885)
                      |||+++.+.....         ........+++.|+|||+..+..++.++|||||||++|||++ |+.||.....     
T Consensus       155 Dfg~~~~~~~~~~---------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----  220 (272)
T cd05075         155 DFGLSKKIYNGDY---------YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-----  220 (272)
T ss_pred             CCCcccccCcccc---------eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence            9999986632110         001122346778999999999999999999999999999999 7889864211     


Q ss_pred             HHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 002746          787 HKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       787 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                      .+.........            .....+       .++..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus       221 ~~~~~~~~~~~------------~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         221 SEIYDYLRQGN------------RLKQPP-------DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HHHHHHHHcCC------------CCCCCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11111100000            000000       1345689999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.1e-35  Score=312.95  Aligned_cols=248  Identities=29%  Similarity=0.392  Sum_probs=197.9

Q ss_pred             hCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeee-cCCcceEEEecc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS-LPDFKALVLPYM  635 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lV~e~~  635 (885)
                      .+|.+.+.||+|+||.||+|... |..||+|.++..  ...+.+..|+.++++++|++++++++++. .+...++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            57888999999999999999875 788999988633  23467899999999999999999999764 456789999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++|+|.+++.....       ..+++..++.++.|++.||+|||+++   |+||||||+||++++++.+|++|||++...
T Consensus        83 ~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~  152 (256)
T cd05082          83 AKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA  152 (256)
T ss_pred             CCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceec
Confidence            99999998865432       23788999999999999999999998   999999999999999999999999998754


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhh
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      ...              .....++..|+|||+..+..++.++|||||||++|||++ |+.||...     ...+......
T Consensus       153 ~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~~  213 (256)
T cd05082         153 SST--------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRVE  213 (256)
T ss_pred             ccc--------------CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHh
Confidence            221              112234568999999998899999999999999999997 99998642     1222211110


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDR  855 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  855 (885)
                      .             ......      .+.++..+.+++.+|++.+|++|||++++++.|++
T Consensus       214 ~-------------~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         214 K-------------GYKMDA------PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             c-------------CCCCCC------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            0             000000      01235568899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.4e-36  Score=335.94  Aligned_cols=209  Identities=22%  Similarity=0.298  Sum_probs=172.2

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEe
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      .|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999965 68899999987432   2334578899999999999999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      |+++|+|.+++....         .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+
T Consensus        82 ~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~  149 (382)
T cd05625          82 YIPGGDMMSLLIRMG---------IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT  149 (382)
T ss_pred             CCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCc
Confidence            999999999886543         2778888899999999999999998   9999999999999999999999999986


Q ss_pred             eeecccCCCC---C---------------------------------CCCCCCCccccccccccccCCcccCCCCCCccc
Q 002746          714 LVMTVGVGND---G---------------------------------AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG  757 (885)
Q Consensus       714 ~~~~~~~~~~---~---------------------------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  757 (885)
                      .+........   +                                 .............||+.|+|||++.+..++.++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~  229 (382)
T cd05625         150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC  229 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCee
Confidence            4321100000   0                                 000000011234799999999999999999999


Q ss_pred             cchhhHHHHHHHHcCCCCCCc
Q 002746          758 DVYSFGILVLEMVTRRRPTDD  778 (885)
Q Consensus       758 Dv~slG~vl~elltg~~P~~~  778 (885)
                      ||||+||++|||++|+.||..
T Consensus       230 DiwSlGvil~elltG~~Pf~~  250 (382)
T cd05625         230 DWWSVGVILYEMLVGQPPFLA  250 (382)
T ss_pred             eEEechHHHHHHHhCCCCCCC
Confidence            999999999999999999964

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=8.4e-36  Score=323.08  Aligned_cols=271  Identities=22%  Similarity=0.261  Sum_probs=198.7

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56889999999999999999965 68889999987543 23345678899999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +++ ++.+++.....        .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||.++.
T Consensus        86 ~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  153 (309)
T cd07872          86 LDK-DLKQYMDDCGN--------IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARA  153 (309)
T ss_pred             CCC-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcccccee
Confidence            975 77776653321        3788889999999999999999998   99999999999999999999999999875


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      ....           ........+|+.|+|||++.+ ..++.++||||+||++|||+||+.||...... ..... +...
T Consensus       154 ~~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~-~~~~  220 (309)
T cd07872         154 KSVP-----------TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-DELHL-IFRL  220 (309)
T ss_pred             cCCC-----------ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHH-HHHH
Confidence            4211           111223457899999998765 46789999999999999999999999653111 11111 1111


Q ss_pred             hcch----hhhhhhhhh-h-hccCCC-hHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          794 YHGR----LEKVIDSSL-L-RASRDQ-SPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       794 ~~~~----~~~~~d~~~-~-~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ....    +..+....- . ...... ...........+.++.+++.+|++.||.+|||++|++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         221 LGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            1111    111000000 0 000000 000001112345678999999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1e-35  Score=317.91  Aligned_cols=268  Identities=24%  Similarity=0.383  Sum_probs=208.1

Q ss_pred             HhhCCcccceecccCcceEEEEEeCC-----CCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeec-CCc
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQD-----GTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSL-PDF  627 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~  627 (885)
                      ..++|.+.+.||+|+||.||+|.+.+     +..||+|.++... ....+.+.+|+.++++++|+|++++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            34688999999999999999999765     6889999887432 2335668899999999999999999998766 567


Q ss_pred             ceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEc
Q 002746          628 KALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVS  707 (885)
Q Consensus       628 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~  707 (885)
                      .++++||+++|+|.+++........ .....+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEA-NNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhcccccc-ccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence            7899999999999998865432211 12245899999999999999999999998   9999999999999999999999


Q ss_pred             ccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccH
Q 002746          708 DFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSL  786 (885)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~  786 (885)
                      |||+++.+.....         ........++..|+|||++.+..++.++|||||||++||+++ |+.||.....  ...
T Consensus       160 d~g~~~~~~~~~~---------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~  228 (280)
T cd05043         160 DNALSRDLFPMDY---------HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEM  228 (280)
T ss_pred             CCCCcccccCCce---------EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHH
Confidence            9999986532110         001112345678999999998899999999999999999999 9999965211  111


Q ss_pred             HHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 002746          787 HKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRY  859 (885)
Q Consensus       787 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~  859 (885)
                      ..++...                .....+      ..++.++.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       229 ~~~~~~~----------------~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         229 AAYLKDG----------------YRLAQP------INCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             HHHHHcC----------------CCCCCC------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            1111110                000000      01345689999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.5e-36  Score=322.17  Aligned_cols=250  Identities=22%  Similarity=0.333  Sum_probs=201.6

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      .+|++.+.||+|++|.||+|... +++.||+|.+........+.+.+|+.+++.++|+|++++++++......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            57888999999999999999964 68999999988665555678899999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++++|.+++...          .+++.++..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||.+...
T Consensus       100 ~~~~L~~~~~~~----------~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~  166 (296)
T cd06654         100 AGGSLTDVVTET----------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (296)
T ss_pred             CCCCHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhc
Confidence            999999987532          2678899999999999999999998   999999999999999999999999998765


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhc
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~  795 (885)
                      ...           ........|++.|+|||...+..++.++|||||||++|+|++|+.||.....    ...+.. ...
T Consensus       167 ~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~----~~~~~~-~~~  230 (296)
T cd06654         167 TPE-----------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----LRALYL-IAT  230 (296)
T ss_pred             ccc-----------ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH----HHhHHH-Hhc
Confidence            321           1111234688999999999888899999999999999999999999965211    111100 000


Q ss_pred             chhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       796 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ...           .....+      ...+..+.+++.+||.++|++||++.|++++
T Consensus       231 ~~~-----------~~~~~~------~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         231 NGT-----------PELQNP------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCC-----------CCCCCc------cccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            000           000000      1134568899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.1e-35  Score=317.04  Aligned_cols=261  Identities=25%  Similarity=0.380  Sum_probs=200.8

Q ss_pred             hhCCcccceecccCcceEEEEEeCC------CCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcc
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQD------GTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFK  628 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  628 (885)
                      .++|.+.+.||+|++|.||+|.+.+      +..||+|.+..... .....+.+|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678999999999999999999753      56789998764432 2345689999999999999999999999999999


Q ss_pred             eEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCC---CEE
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDM---TAL  705 (885)
Q Consensus       629 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~---~~k  705 (885)
                      ++||||+++|+|.+++.......  .....+++..+.+++.||+.|++|||+++   ++||||||+||+++.++   .+|
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRP--ERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceE
Confidence            99999999999999886554211  12235899999999999999999999998   99999999999998654   699


Q ss_pred             EcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCc
Q 002746          706 VSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGL  784 (885)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~  784 (885)
                      |+|||+++.+.....         ........++..|+|||++.+..++.++|||||||++|||++ |+.||.....   
T Consensus       160 l~dfg~~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~---  227 (277)
T cd05036         160 IADFGMARDIYRASY---------YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---  227 (277)
T ss_pred             eccCccccccCCccc---------eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---
Confidence            999999986622110         000111233568999999999999999999999999999997 9999864211   


Q ss_pred             cHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          785 SLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                        .+....         +...   ......       ..++.++.+++.+|++.+|++||++.+|+++|+
T Consensus       228 --~~~~~~---------~~~~---~~~~~~-------~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         228 --QEVMEF---------VTGG---GRLDPP-------KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             --HHHHHH---------HHcC---CcCCCC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence              111111         1000   000000       013456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.3e-36  Score=332.65  Aligned_cols=253  Identities=21%  Similarity=0.238  Sum_probs=199.0

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ++|.+.+.||+|+||.||+|... +++.||+|+++...   ....+.+.+|+.+++.++|++|+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36889999999999999999965 68999999997542   234566889999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++|+|.+++.....        .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+|
T Consensus        81 e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a  149 (330)
T cd05601          81 EYQPGGDLLSLLNRYED--------QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSA  149 (330)
T ss_pred             CCCCCCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCC
Confidence            99999999998875421        3788999999999999999999998   999999999999999999999999999


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccC------CCCCCccccchhhHHHHHHHHcCCCCCCccccCCccH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF------GSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSL  786 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~  786 (885)
                      ..+....          ........||+.|+|||++.      +..++.++|||||||++|||++|+.||....     .
T Consensus       150 ~~~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-----~  214 (330)
T cd05601         150 ARLTANK----------MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT-----S  214 (330)
T ss_pred             eECCCCC----------ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC-----H
Confidence            8653211          11122346899999999876      4567899999999999999999999996421     1


Q ss_pred             HHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          787 HKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       787 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..........       .... ... ..       ...+.++.+++.+|++ +|++||++++++.+
T Consensus       215 ~~~~~~i~~~-------~~~~-~~~-~~-------~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         215 AKTYNNIMNF-------QRFL-KFP-ED-------PKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             HHHHHHHHcC-------CCcc-CCC-CC-------CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            1111111100       0000 000 00       0134568899999998 99999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7.7e-36  Score=318.56  Aligned_cols=262  Identities=24%  Similarity=0.402  Sum_probs=203.2

Q ss_pred             hCCcccceecccCcceEEEEEeC------CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ------DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKAL  630 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  630 (885)
                      .+|...+.||+|+||.||+|...      ++..+|+|.++.........+.+|+++++.++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            56788899999999999999742      356799998875555556789999999999999999999999999999999


Q ss_pred             EEecccCCccccccccCCccc------cCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCE
Q 002746          631 VLPYMANGSLDSHLYPHSETE------FGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA  704 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~  704 (885)
                      ||||+++|+|.+++.......      .......+++..+..++.|++.|++|||+.+   |+||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            999999999999886543210      0011134889999999999999999999998   9999999999999999999


Q ss_pred             EEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCC
Q 002746          705 LVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGG  783 (885)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~  783 (885)
                      ||+|||+++.+.....         ........+++.|+|||+..+..++.++|||||||++|||++ |+.||...... 
T Consensus       162 kL~dfg~~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-  231 (280)
T cd05092         162 KIGDFGMSRDIYSTDY---------YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-  231 (280)
T ss_pred             EECCCCceeEcCCCce---------eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-
Confidence            9999999976532100         011122345788999999999999999999999999999998 89998642111 


Q ss_pred             ccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          784 LSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                          ..+..        . ..   .......       ..++..+.+++.+||+.||.+||+++||++.|+
T Consensus       232 ----~~~~~--------~-~~---~~~~~~~-------~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         232 ----EAIEC--------I-TQ---GRELERP-------RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             ----HHHHH--------H-Hc---CccCCCC-------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                11100        0 00   0000000       013456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.8e-36  Score=332.76  Aligned_cols=260  Identities=18%  Similarity=0.244  Sum_probs=199.3

Q ss_pred             HHHHHHhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec---CCcchhhHHHHHHHHhhcCCcccceeeeeeecC
Q 002746          550 RELLEATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLP  625 (885)
Q Consensus       550 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  625 (885)
                      +++....++|++.+.||+|+||.||+|... +++.||+|++...   .......+.+|+.+++.++||||+++++++..+
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344455689999999999999999999976 6889999998642   222345678899999999999999999999999


Q ss_pred             CcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEE
Q 002746          626 DFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL  705 (885)
Q Consensus       626 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~k  705 (885)
                      +..++||||+++|+|.+++...          .++...+..++.||+.||+|||+++   |+||||||+|||++.++.+|
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ik  182 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNY----------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLK  182 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEE
Confidence            9999999999999999888543          2677888899999999999999998   99999999999999999999


Q ss_pred             EcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCC----CCccccchhhHHHHHHHHcCCCCCCcccc
Q 002746          706 VSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN----TSTKGDVYSFGILVLEMVTRRRPTDDMFA  781 (885)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~vl~elltg~~P~~~~~~  781 (885)
                      |+|||+|+.+...+          ........||+.|+|||++.+..    ++.++|||||||++|||++|+.||...  
T Consensus       183 L~DfG~a~~~~~~~----------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--  250 (371)
T cd05622         183 LADFGTCMKMNKEG----------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--  250 (371)
T ss_pred             EEeCCceeEcCcCC----------cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC--
Confidence            99999998653211          11123457999999999986543    789999999999999999999999642  


Q ss_pred             CCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHHH
Q 002746          782 GGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPST--RPTMLDAADDL  853 (885)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~L  853 (885)
                         ........        +..    .......+.    ....+.++.+++.+|+..++.+  ||+++|+.++.
T Consensus       251 ---~~~~~~~~--------i~~----~~~~~~~~~----~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         251 ---SLVGTYSK--------IMN----HKNSLTFPD----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ---CHHHHHHH--------HHc----CCCcccCCC----cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence               11111111        100    000000000    0113556889999999844443  78999998864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.2e-35  Score=313.04  Aligned_cols=248  Identities=25%  Similarity=0.378  Sum_probs=193.4

Q ss_pred             eecccCcceEEEEEeC---CCCEEEEEEeeecCC--cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCC
Q 002746          564 LLGTGSYGRVYKGILQ---DGTAIAVKVLQLQSG--NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANG  638 (885)
Q Consensus       564 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g  638 (885)
                      .||+|+||.||+|.++   ++..+|+|+++....  ...+.+..|+.+++.++||||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            5899999999999753   578899999874432  23567889999999999999999999886 45678999999999


Q ss_pred             ccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecc
Q 002746          639 SLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV  718 (885)
Q Consensus       639 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~  718 (885)
                      +|.+++....         .+++..+..++.|++.|++|||+++   |+||||||+||+++.++.+||+|||.++.+...
T Consensus        81 ~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~  148 (257)
T cd05116          81 PLNKFLQKNK---------HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             cHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence            9999886432         3788999999999999999999998   999999999999999999999999999865321


Q ss_pred             cCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhhcch
Q 002746          719 GVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHYHGR  797 (885)
Q Consensus       719 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~  797 (885)
                      ..        .........++..|+|||...+..++.++|||||||++|||++ |+.||.....     ..+....    
T Consensus       149 ~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~i----  211 (257)
T cd05116         149 EN--------YYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-----NEVTQMI----  211 (257)
T ss_pred             CC--------eeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHH----
Confidence            10        0001112234678999999988889999999999999999998 9999975311     1111111    


Q ss_pred             hhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 002746          798 LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       798 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                           ....   ... .+      ..++.++.+++.+||+.||++||++.+|++.|+.+
T Consensus       212 -----~~~~---~~~-~~------~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         212 -----ESGE---RME-CP------QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             -----HCCC---CCC-CC------CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence                 1100   000 00      01456789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.9e-36  Score=329.34  Aligned_cols=238  Identities=24%  Similarity=0.319  Sum_probs=189.9

Q ss_pred             ceecccCcceEEEEEe----CCCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEeccc
Q 002746          563 RLLGTGSYGRVYKGIL----QDGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMA  636 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~  636 (885)
                      +.||+|+||.||+++.    .+|+.||+|+++...  ......+..|++++++++||||+++++++..++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999875    358899999997542  2234567789999999999999999999999999999999999


Q ss_pred             CCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeee
Q 002746          637 NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM  716 (885)
Q Consensus       637 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~  716 (885)
                      +|+|.+++....         .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++...
T Consensus        82 ~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  149 (318)
T cd05582          82 GGDLFTRLSKEV---------MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  149 (318)
T ss_pred             CCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence            999998885432         3789999999999999999999998   9999999999999999999999999987542


Q ss_pred             cccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcc
Q 002746          717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHG  796 (885)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  796 (885)
                      ..           ........||+.|+|||++.+..++.++|||||||++|||++|+.||....     ...........
T Consensus       150 ~~-----------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~-----~~~~~~~i~~~  213 (318)
T cd05582         150 DH-----------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD-----RKETMTMILKA  213 (318)
T ss_pred             CC-----------CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC-----HHHHHHHHHcC
Confidence            11           111223568999999999998889999999999999999999999996421     11111111100


Q ss_pred             hhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 002746          797 RLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLD  848 (885)
Q Consensus       797 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e  848 (885)
                                   .....       ...+.++.+++.+||+.||++||++.+
T Consensus       214 -------------~~~~p-------~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         214 -------------KLGMP-------QFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -------------CCCCC-------CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence                         00000       013456889999999999999999555

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-35  Score=312.46  Aligned_cols=250  Identities=31%  Similarity=0.437  Sum_probs=202.8

Q ss_pred             hhCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      .++|++.+.||+|+||.||+|... |+.||+|.++.... ..+++..|+.++++++|+|++++++++...+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            357888999999999999999976 88999999975543 4678899999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++++|.+++.....       ..+++..+..++.|++.|+.|||+.+   |+||||||+||+++.++.++|+|||.++..
T Consensus        83 ~~~~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~  152 (256)
T cd05039          83 AKGSLVDYLRSRGR-------AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEA  152 (256)
T ss_pred             CCCcHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccc
Confidence            99999998865432       13899999999999999999999998   999999999999999999999999999765


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhh
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      ...              .....++..|+|||++.+..++.++||||||+++||+++ |+.||.....  ......+.   
T Consensus       153 ~~~--------------~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~---  213 (256)
T cd05039         153 SQG--------------QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPHVE---  213 (256)
T ss_pred             ccc--------------cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHh---
Confidence            211              011234568999999988899999999999999999997 9999864211  01111000   


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDR  855 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  855 (885)
                               .    ......+      ...++++.+++.+||..+|++||++.|+++.|+.
T Consensus       214 ---------~----~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         214 ---------K----GYRMEAP------EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ---------c----CCCCCCc------cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence                     0    0000000      1134678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=6.2e-36  Score=332.57  Aligned_cols=270  Identities=22%  Similarity=0.288  Sum_probs=197.0

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeec--CCcchhhHHHHHHHHhhcCCcccceeeeeeecCC-----cce
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPD-----FKA  629 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~  629 (885)
                      +|++.+.||+|+||.||+|... +++.||||++...  .....+.+.+|+++++.++|+||+++++++..++     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788899999999999999964 7899999998643  2223467889999999999999999999998776     779


Q ss_pred             EEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccc
Q 002746          630 LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDF  709 (885)
Q Consensus       630 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df  709 (885)
                      +|+||+. ++|...+....         .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        81 lv~e~~~-~~l~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Df  147 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ---------PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDF  147 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccc
Confidence            9999996 56766664332         3889999999999999999999998   999999999999999999999999


Q ss_pred             ccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHH
Q 002746          710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~  788 (885)
                      |+|+......          ........+|+.|+|||++.+. .++.++||||+||++|||++|+.||......  ....
T Consensus       148 g~a~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~  215 (372)
T cd07853         148 GLARVEEPDE----------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI--QQLD  215 (372)
T ss_pred             cceeecccCc----------cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH--HHHH
Confidence            9998653210          1112234578999999998774 4789999999999999999999999653111  1111


Q ss_pred             HHHHhhcch-hhhh------hhhhhhhccCC--ChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          789 WVKNHYHGR-LEKV------IDSSLLRASRD--QSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       789 ~~~~~~~~~-~~~~------~d~~~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .+....... ....      ....+......  ............++++.+++.+|++.||++|||+.|++++
T Consensus       216 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         216 LITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            111111100 0000      00001110000  0000001112235678999999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.6e-36  Score=319.54  Aligned_cols=269  Identities=25%  Similarity=0.348  Sum_probs=201.1

Q ss_pred             hCCcccceecccCcceEEEEEeC-----CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeec--CCcce
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-----DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL--PDFKA  629 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~  629 (885)
                      .+|.+.+.||+|+||.||+|...     ++..||+|.++.......+.+.+|++++++++|||++++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            46888899999999999999742     578999999876555556788999999999999999999998754  34678


Q ss_pred             EEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccc
Q 002746          630 LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDF  709 (885)
Q Consensus       630 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df  709 (885)
                      +||||+++|+|.+++.....        .+++..+..++.|++.||+|||+++   |+||||||+||++++++.+||+||
T Consensus        84 lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~df  152 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRE--------RLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDF  152 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCC
Confidence            99999999999998864321        3789999999999999999999998   999999999999999999999999


Q ss_pred             ccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHH
Q 002746          710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKW  789 (885)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~  789 (885)
                      |+++.+......        ........++..|+|||+..+..++.++|||||||++|||++|..|+....      ..+
T Consensus       153 g~~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~------~~~  218 (284)
T cd05081         153 GLTKVLPQDKEY--------YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPP------AEF  218 (284)
T ss_pred             cccccccCCCcc--------eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcc------hhh
Confidence            999876321100        000111223456999999998899999999999999999999987764321      111


Q ss_pred             HHHhhcchhhhhhh----hhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 002746          790 VKNHYHGRLEKVID----SSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       790 ~~~~~~~~~~~~~d----~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                      ..............    ..+........      ...++.++.+++.+||+.+|++||||+|+++.|+.+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         219 MRMMGNDKQGQMIVYHLIELLKNNGRLPA------PPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             hhhcccccccccchHHHHHHHhcCCcCCC------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            11111110000000    00101100000      012356799999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=8.4e-36  Score=319.04  Aligned_cols=263  Identities=24%  Similarity=0.357  Sum_probs=201.3

Q ss_pred             hCCcccceecccCcceEEEEEeC------CCCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcce
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ------DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKA  629 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  629 (885)
                      .+|.+.+.||+|+||.||+|+..      ++..||+|+++.... ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            34677889999999999999864      257899999875432 23466889999999999999999999999999999


Q ss_pred             EEEecccCCccccccccCCccc-------cCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCC
Q 002746          630 LVLPYMANGSLDSHLYPHSETE-------FGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDM  702 (885)
Q Consensus       630 lV~e~~~~gsL~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~  702 (885)
                      +++||+++++|.+++.......       .......+++..+..++.|++.||+|||+++   |+||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            9999999999998875322110       0011234788899999999999999999998   99999999999999999


Q ss_pred             CEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCcccc
Q 002746          703 TALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFA  781 (885)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~  781 (885)
                      .+||+|||+++.+.....         ........+++.|+|||+..+..++.++|||||||++|||++ |..||...  
T Consensus       162 ~~kl~Dfg~~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--  230 (283)
T cd05091         162 NVKISDLGLFREVYAADY---------YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--  230 (283)
T ss_pred             ceEecccccccccccchh---------eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--
Confidence            999999999876532110         011122345788999999988889999999999999999998 88888642  


Q ss_pred             CCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 002746          782 GGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDR  855 (885)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  855 (885)
                         ...++..........         ...          ..++..+.+++.+||+.+|++||+++|+++.|+.
T Consensus       231 ---~~~~~~~~i~~~~~~---------~~~----------~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         231 ---SNQDVIEMIRNRQVL---------PCP----------DDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             ---CHHHHHHHHHcCCcC---------CCC----------CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence               111222111111100         000          1245568899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.7e-35  Score=315.86  Aligned_cols=259  Identities=26%  Similarity=0.429  Sum_probs=201.4

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCC----EEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcce
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGT----AIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKA  629 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  629 (885)
                      ..+|++.+.||+|+||+||+|.+. +++    .||+|+++... ....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            467889999999999999999854 444    48999987443 2335678899999999999999999999875 4567


Q ss_pred             EEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccc
Q 002746          630 LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDF  709 (885)
Q Consensus       630 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df  709 (885)
                      +++||+++|+|.++++....        .+++..++.++.|++.||+|||+++   |+||||||+||+++.++.+||+||
T Consensus        85 l~~~~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~df  153 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKD--------RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDF  153 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCC
Confidence            99999999999998865421        3789999999999999999999998   999999999999999999999999


Q ss_pred             ccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHH
Q 002746          710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~  788 (885)
                      |+++.+.....         ........+++.|+|||...+..++.++|||||||++|||++ |..||+....  .....
T Consensus       154 G~~~~~~~~~~---------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~  222 (279)
T cd05109         154 GLARLLDIDET---------EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPD  222 (279)
T ss_pred             Cceeecccccc---------eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHH
Confidence            99987632110         001112235678999999998899999999999999999998 8999864211  11111


Q ss_pred             HHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 002746          789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRY  859 (885)
Q Consensus       789 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~  859 (885)
                      ++..                ......+      ..++.++.+++.+||+.||++||++.|+++.+..+.+.
T Consensus       223 ~~~~----------------~~~~~~~------~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         223 LLEK----------------GERLPQP------PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             HHHC----------------CCcCCCC------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence            1111                0000000      11345688999999999999999999999998877544

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=324.70  Aligned_cols=247  Identities=26%  Similarity=0.410  Sum_probs=201.5

Q ss_pred             eecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCCcccc
Q 002746          564 LLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDS  642 (885)
Q Consensus       564 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL~~  642 (885)
                      +||+|.||+||.|++. +...+|||.+.....+..+.+.+|+..-++++|.|||+++|.|.++++.-+.||-++||+|..
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            7999999999999966 466789999987777778889999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEec-CCCCEEEcccccceeeecccCC
Q 002746          643 HLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN-DDMTALVSDFGIAKLVMTVGVG  721 (885)
Q Consensus       643 ~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfg~a~~~~~~~~~  721 (885)
                      .++.....      -.=.+.+.-.+.+||++||.|||+..   |||||||-+|||++ -.|.+||+|||.++.+...   
T Consensus       662 LLrskWGP------lKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi---  729 (1226)
T KOG4279|consen  662 LLRSKWGP------LKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI---  729 (1226)
T ss_pred             HHHhccCC------CccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC---
Confidence            99866532      11256677788999999999999998   99999999999997 5799999999999877432   


Q ss_pred             CCCCCCCCCCccccccccccccCCcccCCC--CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhh
Q 002746          722 NDGAENMGNSTANMLCGSIGYMAPEYGFGS--NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLE  799 (885)
Q Consensus       722 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  799 (885)
                              ........||..|||||++..+  .|+.++|||||||++.||.||++||..+....-.+.+           
T Consensus       730 --------nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk-----------  790 (1226)
T KOG4279|consen  730 --------NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK-----------  790 (1226)
T ss_pred             --------CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh-----------
Confidence                    2233456799999999998765  5899999999999999999999999765333111111           


Q ss_pred             hhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          800 KVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       800 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                          -.+..... +.|      ...+.+...+|.+|+.+||.+||+++++++.
T Consensus       791 ----VGmyKvHP-~iP------eelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  791 ----VGMYKVHP-PIP------EELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             ----hcceecCC-CCc------HHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence                11111111 111      2356789999999999999999999999875

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.8e-36  Score=325.82  Aligned_cols=248  Identities=23%  Similarity=0.327  Sum_probs=192.7

Q ss_pred             ceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcceEEEecccC
Q 002746          563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~  637 (885)
                      +.||+|+||.||+|... +++.||+|+++...   ....+.+..|+.++.++ +||+|+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 67899999998542   23345678899998888 699999999999999999999999999


Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      |+|..++....         .+++..+..++.|++.|++|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~~L~~~~~~~~---------~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~  148 (327)
T cd05617          81 GDLMFHMQRQR---------KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG  148 (327)
T ss_pred             CcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccC
Confidence            99988775432         3889999999999999999999998   99999999999999999999999999874311


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccC-CccHHHHHHHhhcc
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAG-GLSLHKWVKNHYHG  796 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~-~~~~~~~~~~~~~~  796 (885)
                      .           ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......++...   
T Consensus       149 ~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~---  214 (327)
T cd05617         149 P-----------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV---  214 (327)
T ss_pred             C-----------CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH---
Confidence            1           11123457899999999999999999999999999999999999999643221 11111111111   


Q ss_pred             hhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCH------HHHHHH
Q 002746          797 RLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTM------LDAADD  852 (885)
Q Consensus       797 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~ev~~~  852 (885)
                               +....... +.      ..+.++.+++.+|+..||++||++      +++.++
T Consensus       215 ---------~~~~~~~~-p~------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         215 ---------ILEKPIRI-PR------FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             ---------HHhCCCCC-CC------CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence                     11110000 00      124567899999999999999985      466554

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.1e-36  Score=304.60  Aligned_cols=274  Identities=24%  Similarity=0.310  Sum_probs=204.4

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC--cchhhHHHHHHHHhhcCCcc-cceeeeeeecCC------
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG--NFTKSFNRECQVLKRIRHRN-LMRIITACSLPD------  626 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~------  626 (885)
                      ..|+..++||+|+||+||+|+.. +|+.||+|+++....  .......+|+.+++.++|+| ||.+++++....      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            45677788999999999999954 789999999986644  24566789999999999999 999999998877      


Q ss_pred             cceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEE
Q 002746          627 FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALV  706 (885)
Q Consensus       627 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl  706 (885)
                      ..++|+||+ .-+|..++.......     ..++...+..++.||+.|++|||+++   |+||||||.|||++++|.+||
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~-----~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKl  161 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKP-----QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKL  161 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEee
Confidence            678999998 458888887654321     23566888999999999999999998   999999999999999999999


Q ss_pred             cccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCcc
Q 002746          707 SDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLS  785 (885)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~  785 (885)
                      +|||+|+...-           +....+..++|..|+|||++.|. .|+...||||+||+++||++++.-|....+  .+
T Consensus       162 aDFGlAra~~i-----------p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~  228 (323)
T KOG0594|consen  162 ADFGLARAFSI-----------PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--ID  228 (323)
T ss_pred             eccchHHHhcC-----------CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HH
Confidence            99999985421           22335566889999999998887 689999999999999999999988865322  11


Q ss_pred             HHHHHHHhhcc----hhhhhhh-hhhhhccCC-C-hHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          786 LHKWVKNHYHG----RLEKVID-SSLLRASRD-Q-SPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       786 ~~~~~~~~~~~----~~~~~~d-~~~~~~~~~-~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ....+-.....    .++.... +.....+.. . ...+....+....+..+++.+|++.+|..|.|++.+++|
T Consensus       229 ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  229 QLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             HHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            11111111111    1111110 000000100 0 111222222233578999999999999999999999987

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.3e-36  Score=336.75  Aligned_cols=261  Identities=18%  Similarity=0.192  Sum_probs=196.6

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEe
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      +|++.+.||+|+||.||+|+.. +++.||||++....   ......+.+|++++++++|+||+++++.+.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6899999999999999999965 68999999986432   2234668899999999999999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      |+++|+|.+++....         .++...+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+
T Consensus        82 ~~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~  149 (376)
T cd05598          82 YIPGGDMMSLLIRLG---------IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT  149 (376)
T ss_pred             CCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence            999999999986543         2778888899999999999999998   9999999999999999999999999986


Q ss_pred             eeecccCCC---------C-------CCC----------------CCCCCccccccccccccCCcccCCCCCCccccchh
Q 002746          714 LVMTVGVGN---------D-------GAE----------------NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYS  761 (885)
Q Consensus       714 ~~~~~~~~~---------~-------~~~----------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s  761 (885)
                      .+.......         .       ...                ...........||+.|+|||++.+..++.++||||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  229 (376)
T cd05598         150 GFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS  229 (376)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeee
Confidence            432100000         0       000                00000112357999999999999999999999999


Q ss_pred             hHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCC
Q 002746          762 FGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPS  841 (885)
Q Consensus       762 lG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~  841 (885)
                      |||++|||++|+.||.....     ..+.......      ....   ....       ....+.++.+++.+|+ .+|.
T Consensus       230 lGvilyell~G~~Pf~~~~~-----~~~~~~i~~~------~~~~---~~~~-------~~~~s~~~~~li~~l~-~~p~  287 (376)
T cd05598         230 VGVILYEMLVGQPPFLADTP-----AETQLKVINW------ETTL---HIPS-------QAKLSREASDLILRLC-CGAE  287 (376)
T ss_pred             ccceeeehhhCCCCCCCCCH-----HHHHHHHhcc------Cccc---cCCC-------CCCCCHHHHHHHHHHh-cCHh
Confidence            99999999999999965211     1111110000      0000   0000       0013445777888876 4999


Q ss_pred             CCC---CHHHHHHH
Q 002746          842 TRP---TMLDAADD  852 (885)
Q Consensus       842 ~RP---t~~ev~~~  852 (885)
                      +|+   ++.|++++
T Consensus       288 ~R~~~~t~~ell~h  301 (376)
T cd05598         288 DRLGKNGADEIKAH  301 (376)
T ss_pred             hcCCCCCHHHHhCC
Confidence            999   88999876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.3e-35  Score=312.40  Aligned_cols=250  Identities=21%  Similarity=0.321  Sum_probs=200.2

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      +|++.+.||+|+||.||++... +++.||+|.++... ....+.+..|+.+++.++|+|++++++++..++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788899999999999999965 68999999986432 334567889999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++|++.+++.....       ..++....+.++.|++.|+.|||+++   |+|+||||+||++++++.++++|||.+...
T Consensus        81 ~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~  150 (255)
T cd08219          81 DGGDLMQKIKLQRG-------KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLL  150 (255)
T ss_pred             CCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceee
Confidence            99999888754321       13788889999999999999999998   999999999999999999999999999766


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhc
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~  795 (885)
                      ...+           .......|++.|+|||+..+..++.++||||||+++|+|++|+.||...     +..........
T Consensus       151 ~~~~-----------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-----~~~~~~~~~~~  214 (255)
T cd08219         151 TSPG-----------AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN-----SWKNLILKVCQ  214 (255)
T ss_pred             cccc-----------cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC-----CHHHHHHHHhc
Confidence            3211           1112346888999999999989999999999999999999999999642     11111111100


Q ss_pred             chhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       796 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                                   ......+      ...+.++.+++.+||+.||++||++.|++..
T Consensus       215 -------------~~~~~~~------~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         215 -------------GSYKPLP------SHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -------------CCCCCCC------cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                         0000000      1134568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.8e-36  Score=320.66  Aligned_cols=270  Identities=23%  Similarity=0.303  Sum_probs=194.9

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC--cchhhHHHHHHHHhhc---CCcccceeeeeeecC-----C
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG--NFTKSFNRECQVLKRI---RHRNLMRIITACSLP-----D  626 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~-----~  626 (885)
                      +|++.+.||+|+||+||+|... +++.||+|.++....  .....+.+|+++++.+   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4888999999999999999965 688999999875422  2234566788777665   799999999988642     3


Q ss_pred             cceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEE
Q 002746          627 FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALV  706 (885)
Q Consensus       627 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl  706 (885)
                      ..++||||++ ++|..++.....       ..+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl  149 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPP-------PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKL  149 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence            4689999997 478777754322       13789999999999999999999998   999999999999999999999


Q ss_pred             cccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccH
Q 002746          707 SDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSL  786 (885)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~  786 (885)
                      +|||+++.....            .......||..|+|||++.+..++.++||||+||++|||++|++||..... ...+
T Consensus       150 ~dfg~~~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~-~~~~  216 (288)
T cd07863         150 ADFGLARIYSCQ------------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-ADQL  216 (288)
T ss_pred             CccCccccccCc------------ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH-HHHH
Confidence            999999765321            111234678999999999998999999999999999999999999864211 1111


Q ss_pred             HHHHHHhhcchhhhhhhhhhh--h-cc-CCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          787 HKWVKNHYHGRLEKVIDSSLL--R-AS-RDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       787 ~~~~~~~~~~~~~~~~d~~~~--~-~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .+......... ...+.....  . .. ..............+.++.+++.+|++.||++|||+.|++.+
T Consensus       217 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         217 GKIFDLIGLPP-EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             HHHHHHhCCCC-hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            11111110000 000000000  0 00 000111122223356678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-35  Score=316.42  Aligned_cols=263  Identities=28%  Similarity=0.433  Sum_probs=203.4

Q ss_pred             hhCCcccceecccCcceEEEEEeCC------CCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcc
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQD------GTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFK  628 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  628 (885)
                      .++|.+.+.||+|+||.||+|....      +..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            3578899999999999999998642      4689999986442 23345788999999999999999999999999999


Q ss_pred             eEEEecccCCccccccccCCccccC-CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEc
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFG-SGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVS  707 (885)
Q Consensus       629 ~lV~e~~~~gsL~~~l~~~~~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~  707 (885)
                      ++||||+++|+|.+++......... .....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            9999999999999998654322110 12234788999999999999999999998   9999999999999999999999


Q ss_pred             ccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccH
Q 002746          708 DFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSL  786 (885)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~  786 (885)
                      |||+++.+.....         ........++..|+|||...+..++.++|||||||++||+++ |..||.....  ...
T Consensus       162 dfg~~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~  230 (277)
T cd05032         162 DFGMTRDIYETDY---------YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEV  230 (277)
T ss_pred             CcccchhhccCcc---------cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--HHH
Confidence            9999976532110         011122346789999999988889999999999999999998 8999854211  111


Q ss_pred             HHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          787 HKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       787 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                      .+++.           +..    ......       .++.++.+++.+||+.+|++|||+.|+++.|+
T Consensus       231 ~~~~~-----------~~~----~~~~~~-------~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         231 LKFVI-----------DGG----HLDLPE-------NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHHHh-----------cCC----CCCCCC-------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            11110           000    000000       12456899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-36  Score=322.06  Aligned_cols=251  Identities=24%  Similarity=0.345  Sum_probs=209.1

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCc---chhhHHHHHHHHhhcC-CcccceeeeeeecCCcceE
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGN---FTKSFNRECQVLKRIR-HRNLMRIITACSLPDFKAL  630 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l  630 (885)
                      ...|++.+.||+|.||.||+|+.+ +|+.+|+|.+......   ..+...+|+++|+++. |||||.++++|++....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            457888999999999999999976 4999999999755432   3468999999999998 9999999999999999999


Q ss_pred             EEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCC----CCEEE
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDD----MTALV  706 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~----~~~kl  706 (885)
                      |||++.||.|.+.+...          .+++..+..++.|++.|+.|||+.|   |||||+||+|+|+...    +.+|+
T Consensus       114 vmEL~~GGeLfd~i~~~----------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~  180 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK----------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKL  180 (382)
T ss_pred             EEEecCCchHHHHHHHc----------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEE
Confidence            99999999999988755          1788999999999999999999998   9999999999999733    57999


Q ss_pred             cccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccH
Q 002746          707 SDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSL  786 (885)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~  786 (885)
                      +|||+|.....            .......+||++|+|||++....|+..+||||+||++|.|++|.+||....... ..
T Consensus       181 ~DFGla~~~~~------------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~-~~  247 (382)
T KOG0032|consen  181 IDFGLAKFIKP------------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE-IF  247 (382)
T ss_pred             eeCCCceEccC------------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH-HH
Confidence            99999998733            234556789999999999999999999999999999999999999997632111 00


Q ss_pred             HHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          787 HKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       787 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .            .+..    ... ..   ....|+..+..+.+++..|+..||.+|+|+.++++|
T Consensus       248 ~------------~i~~----~~~-~f---~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  248 L------------AILR----GDF-DF---TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             H------------HHHc----CCC-CC---CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            0            1110    111 01   112355667889999999999999999999999996

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.7e-35  Score=317.32  Aligned_cols=266  Identities=26%  Similarity=0.386  Sum_probs=203.2

Q ss_pred             HhhCCcccceecccCcceEEEEEeC------CCCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCc
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ------DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDF  627 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  627 (885)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.++... ......+.+|+.++++++||||+++++++..++.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999999753      24579999876432 2234567889999999999999999999999999


Q ss_pred             ceEEEecccCCccccccccCCccc-cCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEE
Q 002746          628 KALVLPYMANGSLDSHLYPHSETE-FGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALV  706 (885)
Q Consensus       628 ~~lV~e~~~~gsL~~~l~~~~~~~-~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl  706 (885)
                      .++||||+++|+|.+++....... ...+....++..+..++.|++.||+|||+++   |+||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            999999999999999986533211 1112234677888999999999999999998   999999999999999999999


Q ss_pred             cccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCcc
Q 002746          707 SDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS  785 (885)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~  785 (885)
                      +|||+++.+......         .......++..|+|||...+..++.++|||||||++|||++ |..||....     
T Consensus       161 ~Dfg~~~~~~~~~~~---------~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-----  226 (288)
T cd05061         161 GDFGMTRDIYETDYY---------RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-----  226 (288)
T ss_pred             CcCCccccccccccc---------cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-----
Confidence            999999865321110         01112235678999999998899999999999999999998 788886421     


Q ss_pred             HHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 002746          786 LHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       786 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                      ..++.......        .    .....       ..++.++.+++.+|++.+|++|||+.|+++.++..
T Consensus       227 ~~~~~~~~~~~--------~----~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         227 NEQVLKFVMDG--------G----YLDQP-------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HHHHHHHHHcC--------C----CCCCC-------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            11111111100        0    00000       01245699999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.9e-35  Score=311.18  Aligned_cols=248  Identities=24%  Similarity=0.393  Sum_probs=192.3

Q ss_pred             ecccCcceEEEEEeC---CCCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCCcc
Q 002746          565 LGTGSYGRVYKGILQ---DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSL  640 (885)
Q Consensus       565 lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL  640 (885)
                      ||+|+||.||+|.+.   .+..||+|++..... ...+.+.+|+.++++++||||+++++++. .+..++||||+++|+|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence            899999999999864   355799999875432 33467899999999999999999999886 4567899999999999


Q ss_pred             ccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecccC
Q 002746          641 DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGV  720 (885)
Q Consensus       641 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~  720 (885)
                      .+++.....        .+++..+++++.|++.|++|||+++   ++||||||+||+++.++.+||+|||.+........
T Consensus        82 ~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  150 (257)
T cd05115          82 NKFLSGKKD--------EITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS  150 (257)
T ss_pred             HHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCcc
Confidence            998864321        3889999999999999999999998   99999999999999999999999999975532110


Q ss_pred             CCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhhcchhh
Q 002746          721 GNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHYHGRLE  799 (885)
Q Consensus       721 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~  799 (885)
                      .        ........++..|+|||+..+..++.++|||||||++||+++ |+.||.....     ..+...       
T Consensus       151 ~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~-------  210 (257)
T cd05115         151 Y--------YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-----PEVMSF-------  210 (257)
T ss_pred             c--------eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-----HHHHHH-------
Confidence            0        001111234578999999988889999999999999999996 9999975311     111111       


Q ss_pred             hhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 002746          800 KVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       800 ~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                        +...    .....+      ..+++++.+++.+||..+|++||++.+|.+.|+.+
T Consensus       211 --~~~~----~~~~~~------~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         211 --IEQG----KRLDCP------AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             --HHCC----CCCCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence              1000    000000      11356788999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.2e-35  Score=313.07  Aligned_cols=258  Identities=29%  Similarity=0.472  Sum_probs=201.8

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CC---CEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceE
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DG---TAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKAL  630 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  630 (885)
                      ..+|+..+.||+|+||.||+|+.. ++   ..+|+|.++... ....+.+..|++++++++|+|++++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            357888999999999999999965 33   378999886442 3345678899999999999999999999999999999


Q ss_pred             EEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccc
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG  710 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg  710 (885)
                      ||||+++++|.+++.....        .+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+|++|||
T Consensus        84 v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg  152 (268)
T cd05063          84 ITEYMENGALDKYLRDHDG--------EFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFG  152 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCc
Confidence            9999999999998864321        3789999999999999999999998   9999999999999999999999999


Q ss_pred             cceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHH
Q 002746          711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKW  789 (885)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~  789 (885)
                      ++........        ..........+..|+|||++.+..++.++|||||||++|||++ |+.||.....     .++
T Consensus       153 ~~~~~~~~~~--------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~  219 (268)
T cd05063         153 LSRVLEDDPE--------GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEV  219 (268)
T ss_pred             cceecccccc--------cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHH
Confidence            9976532110        0001111223567999999988889999999999999999997 9999864211     111


Q ss_pred             HHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 002746          790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       790 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                      .....         ..    .....+      ..++.++.+++.+||+.+|++||++++|++.|+++
T Consensus       220 ~~~i~---------~~----~~~~~~------~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         220 MKAIN---------DG----FRLPAP------MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             HHHHh---------cC----CCCCCC------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11111         00    000000      01345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.8e-35  Score=319.28  Aligned_cols=263  Identities=27%  Similarity=0.412  Sum_probs=200.7

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCC--EEEEEEeeecC-CcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcceEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGT--AIAVKVLQLQS-GNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV  631 (885)
                      ++|++.+.||+|+||.||+|.+. ++.  .+|+|.++... ......+.+|++++.++ +|+||+++++++...+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            57889999999999999999965 454  45777765332 23346788999999999 899999999999999999999


Q ss_pred             EecccCCccccccccCCcccc-------CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCE
Q 002746          632 LPYMANGSLDSHLYPHSETEF-------GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA  704 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~  704 (885)
                      |||+++|+|.++++.......       ......+++..++.++.|++.|++|||+++   |+||||||+|||++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            999999999998865432110       012235889999999999999999999998   9999999999999999999


Q ss_pred             EEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCC
Q 002746          705 LVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGG  783 (885)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~  783 (885)
                      ||+|||++......            .......++..|+|||+..+..++.++|||||||++|||+| |..||.....  
T Consensus       164 kl~dfg~~~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--  229 (303)
T cd05088         164 KIADFGLSRGQEVY------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--  229 (303)
T ss_pred             EeCccccCcccchh------------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh--
Confidence            99999998632110            00111234668999999988889999999999999999998 9999864211  


Q ss_pred             ccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 002746          784 LSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR  858 (885)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~  858 (885)
                         .+.....         .    .......+      ...+.++.+++.+||+.+|++||+++++++.+.++..
T Consensus       230 ---~~~~~~~---------~----~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         230 ---AELYEKL---------P----QGYRLEKP------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             ---HHHHHHH---------h----cCCcCCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence               1111100         0    00000000      0134568899999999999999999999999887754

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.6e-35  Score=328.89  Aligned_cols=268  Identities=25%  Similarity=0.365  Sum_probs=204.7

Q ss_pred             HhhCCcccceecccCcceEEEEEeC------CCCEEEEEEeeecCC-cchhhHHHHHHHHhhcC-CcccceeeeeeecCC
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ------DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIR-HRNLMRIITACSLPD  626 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  626 (885)
                      ..++|.+.+.||+|+||.||+|++.      .+..||+|+++.... ...+.+.+|++++.++. ||||++++++|...+
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3456888899999999999999864      246799999975432 22457889999999997 999999999999999


Q ss_pred             cceEEEecccCCccccccccCCccc-------------------------------------------------------
Q 002746          627 FKALVLPYMANGSLDSHLYPHSETE-------------------------------------------------------  651 (885)
Q Consensus       627 ~~~lV~e~~~~gsL~~~l~~~~~~~-------------------------------------------------------  651 (885)
                      ..++||||+++|+|.++++......                                                       
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            9999999999999999886543110                                                       


Q ss_pred             ----------------------------------cCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceE
Q 002746          652 ----------------------------------FGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVL  697 (885)
Q Consensus       652 ----------------------------------~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIL  697 (885)
                                                        .......+++...+.++.|++.||+|||+.+   |+||||||+||+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence                                              0001124678888999999999999999998   999999999999


Q ss_pred             ecCCCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCC
Q 002746          698 LNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPT  776 (885)
Q Consensus       698 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~  776 (885)
                      +++++.+||+|||+++.+.....         ........++..|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~  342 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSN---------YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY  342 (401)
T ss_pred             EeCCCEEEEEecCcceecccccc---------cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence            99999999999999986532110         011122356789999999998889999999999999999998 89998


Q ss_pred             CccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 002746          777 DDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       777 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                      ......     +.        ....+..    ..+...+      ..++.++.+++.+||..+|.+||+++|+++.|+.+
T Consensus       343 ~~~~~~-----~~--------~~~~~~~----~~~~~~p------~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         343 PELPMN-----EQ--------FYNAIKR----GYRMAKP------AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             CCCCch-----HH--------HHHHHHc----CCCCCCC------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            642111     00        0010110    0000000      01345789999999999999999999999999876


Q ss_pred             H
Q 002746          857 K  857 (885)
Q Consensus       857 ~  857 (885)
                      .
T Consensus       400 ~  400 (401)
T cd05107         400 L  400 (401)
T ss_pred             h
Confidence            3

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=8.6e-36  Score=324.45  Aligned_cols=241  Identities=23%  Similarity=0.321  Sum_probs=190.5

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcC-CcccceeeeeeecCCcceEEE
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIR-HRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lV~  632 (885)
                      +|+..+.||+|+||.||+|... +|+.||+|+++...   ....+.+..|..++..+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4778899999999999999965 68899999987432   233456778888988885 577888999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++|+|..++....         .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        81 Ey~~~g~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~  148 (323)
T cd05615          81 EYVNGGDLMYHIQQVG---------KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMC  148 (323)
T ss_pred             cCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccc
Confidence            9999999998886443         3889999999999999999999998   999999999999999999999999998


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      +.....           ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ......
T Consensus       149 ~~~~~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----~~~~~~  212 (323)
T cd05615         149 KEHMVD-----------GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-----DELFQS  212 (323)
T ss_pred             cccCCC-----------CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHH
Confidence            753211           1112234689999999999999999999999999999999999999965211     111111


Q ss_pred             hhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCH
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTM  846 (885)
Q Consensus       793 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  846 (885)
                      ..        .     ......       ...+.++.+++.+|++.+|.+|++.
T Consensus       213 i~--------~-----~~~~~p-------~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         213 IM--------E-----HNVSYP-------KSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             HH--------h-----CCCCCC-------ccCCHHHHHHHHHHcccCHhhCCCC
Confidence            11        0     000000       0134568899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.9e-35  Score=325.68  Aligned_cols=268  Identities=21%  Similarity=0.261  Sum_probs=195.7

Q ss_pred             HhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec--CCcchhhHHHHHHHHhhcCCcccceeeeeeecCC-----
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPD-----  626 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----  626 (885)
                      ..++|++.+.||+|+||.||+|... +|..||||++...  .......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3478999999999999999999965 6899999998643  2234567889999999999999999999886543     


Q ss_pred             -cceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEE
Q 002746          627 -FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL  705 (885)
Q Consensus       627 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~k  705 (885)
                       ..++||||+++ ++...+..           .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+|
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~-----------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~k  163 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM-----------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK  163 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc-----------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEE
Confidence             46899999975 45444421           2677888899999999999999998   99999999999999999999


Q ss_pred             EcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCcc
Q 002746          706 VSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLS  785 (885)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~  785 (885)
                      |+|||+++....            ........||+.|+|||++.+..++.++|||||||++|||++|+.||....    .
T Consensus       164 l~Dfg~a~~~~~------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~----~  227 (359)
T cd07876         164 ILDFGLARTACT------------NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD----H  227 (359)
T ss_pred             EecCCCcccccc------------CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----H
Confidence            999999975421            111233468999999999999999999999999999999999999997531    1


Q ss_pred             HHHHHH--Hhhcchhhhhhhh-------hhhhccCCChHHHHH------------HHHHHHHHHHHHHhhhcCCCCCCCC
Q 002746          786 LHKWVK--NHYHGRLEKVIDS-------SLLRASRDQSPEVKR------------MWDVAIGELIELGILCTQESPSTRP  844 (885)
Q Consensus       786 ~~~~~~--~~~~~~~~~~~d~-------~~~~~~~~~~~~~~~------------~~~~~~~~l~~l~~~cl~~dP~~RP  844 (885)
                      ...|..  ........+..+.       ...............            .....+.++.+++.+|++.||++||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~  307 (359)
T cd07876         228 IDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRI  307 (359)
T ss_pred             HHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCC
Confidence            111111  0010000000000       000000000000000            0011245689999999999999999


Q ss_pred             CHHHHHHHH
Q 002746          845 TMLDAADDL  853 (885)
Q Consensus       845 t~~ev~~~L  853 (885)
                      |+.|++++-
T Consensus       308 t~~e~l~hp  316 (359)
T cd07876         308 SVDEALRHP  316 (359)
T ss_pred             CHHHHhcCc
Confidence            999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=319.99  Aligned_cols=253  Identities=27%  Similarity=0.446  Sum_probs=210.6

Q ss_pred             hCCcccceecccCcceEEEEEeCC-CCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      .+....++||-|-||.||.|.|+. .-.||||.++.. ....++|..|+.+++.++|||+|+++|+|..+...|+|+|||
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM  345 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM  345 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence            345667899999999999999984 567999999843 445789999999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ..|+|.++++++.+.+       ++....+++|.||+.|++||..++   +|||||...|+|+.++..+|++|||+++++
T Consensus       346 ~yGNLLdYLRecnr~e-------v~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  346 CYGNLLDYLRECNRSE-------VPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             cCccHHHHHHHhchhh-------cchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhh
Confidence            9999999999877654       677778999999999999999998   999999999999999999999999999998


Q ss_pred             ecccCCCCCCCCCCCCccccccc---cccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHH
Q 002746          716 MTVGVGNDGAENMGNSTANMLCG---SIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~  791 (885)
                      ....+             +...|   ...|.|||-+....++.|+|||+|||+|||+.| |-.||..     .++.+.  
T Consensus       416 tgDTY-------------TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-----idlSqV--  475 (1157)
T KOG4278|consen  416 TGDTY-------------TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-----IDLSQV--  475 (1157)
T ss_pred             cCCce-------------ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-----ccHHHH--
Confidence            54321             12222   457999999999999999999999999999999 7788753     233221  


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLK  857 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~  857 (885)
                             .    ..+..+++...|+      +|++.+.++|+.||+..|.+||+++|+-+.++.+.
T Consensus       476 -------Y----~LLEkgyRM~~Pe------GCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  476 -------Y----GLLEKGYRMDGPE------GCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             -------H----HHHhccccccCCC------CCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence                   1    2222333333332      48889999999999999999999999999988764

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.4e-35  Score=318.00  Aligned_cols=259  Identities=25%  Similarity=0.405  Sum_probs=202.9

Q ss_pred             hhCCcccceecccCcceEEEEEeC------CCCEEEEEEeeecC-CcchhhHHHHHHHHhhc-CCcccceeeeeeecCCc
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ------DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDF  627 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  627 (885)
                      .++|.+.+.||+|+||.||+|...      .+..||||+++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            357899999999999999999742      35579999887543 23346789999999999 79999999999999999


Q ss_pred             ceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEc
Q 002746          628 KALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVS  707 (885)
Q Consensus       628 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~  707 (885)
                      .++||||+++|+|.++++....       ..+++.++..++.|++.|++|||+++   |+|+||||+||+++.++.++++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~-------~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~  183 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRE-------SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKIC  183 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEEC
Confidence            9999999999999998864332       12789999999999999999999998   9999999999999999999999


Q ss_pred             ccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccH
Q 002746          708 DFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSL  786 (885)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~  786 (885)
                      |||.++.+....         .........++..|+|||++.+..++.++||||+||++|||++ |+.||...... ..+
T Consensus       184 dfg~~~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-~~~  253 (302)
T cd05055         184 DFGLARDIMNDS---------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-SKF  253 (302)
T ss_pred             CCcccccccCCC---------ceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-HHH
Confidence            999997653211         0011112345788999999999999999999999999999998 99998653111 001


Q ss_pred             HHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 002746          787 HKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       787 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                                  ...++.......    +      ...+.++.+++.+|+.++|++|||+.|+++.|+++
T Consensus       254 ------------~~~~~~~~~~~~----~------~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         254 ------------YKLIKEGYRMAQ----P------EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ------------HHHHHcCCcCCC----C------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                        111111100000    0      01245689999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-35  Score=311.99  Aligned_cols=255  Identities=32%  Similarity=0.481  Sum_probs=204.0

Q ss_pred             hhCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      .++|.+.+.||+|++|.||+|..+++..||||.++... ...+.+.+|++++++++|+|++++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            46789999999999999999998888899999987443 23567899999999999999999999999888999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++++|.+++.....       ..+++..+..++.+++.|++|||+.+   |+|+||||+||++++++.++++|||.++.+
T Consensus        84 ~~~~L~~~i~~~~~-------~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~  153 (261)
T cd05034          84 SKGSLLDFLKSGEG-------KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLI  153 (261)
T ss_pred             CCCCHHHHHhcccc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceec
Confidence            99999999875432       23789999999999999999999998   999999999999999999999999999866


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhh
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      ....          ........++..|+|||...+..++.++||||+|+++||+++ |+.||.....     ........
T Consensus       154 ~~~~----------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~~~~~~~~  218 (261)
T cd05034         154 EDDE----------YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-----REVLEQVE  218 (261)
T ss_pred             cchh----------hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHH
Confidence            3210          011112234568999999998899999999999999999999 9999854211     11111000


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDR  855 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  855 (885)
                                   .......+      ...+.++.+++.+|++.+|++||+++++.+.|+.
T Consensus       219 -------------~~~~~~~~------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         219 -------------RGYRMPRP------PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -------------cCCCCCCC------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                         00000000      0124568999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.5e-35  Score=311.13  Aligned_cols=239  Identities=23%  Similarity=0.368  Sum_probs=186.8

Q ss_pred             ceecccCcceEEEEEeCC-------------CCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcce
Q 002746          563 RLLGTGSYGRVYKGILQD-------------GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKA  629 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  629 (885)
                      +.||+|+||.||+|++..             ...||+|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998532             2358889877555555667889999999999999999999999999999


Q ss_pred             EEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCC------
Q 002746          630 LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMT------  703 (885)
Q Consensus       630 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~------  703 (885)
                      +||||+++|+|..++.....        .+++..+++++.||++|++|||+++   |+||||||+|||++.++.      
T Consensus        81 lv~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~  149 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSD--------VLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGP  149 (262)
T ss_pred             EEEecccCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCc
Confidence            99999999999887754321        3788899999999999999999998   999999999999987654      


Q ss_pred             -EEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccC-CCCCCccccchhhHHHHHHHH-cCCCCCCccc
Q 002746          704 -ALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF-GSNTSTKGDVYSFGILVLEMV-TRRRPTDDMF  780 (885)
Q Consensus       704 -~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~vl~ell-tg~~P~~~~~  780 (885)
                       ++++|||.+..+..               .....++..|+|||++. +..++.++|||||||++|||+ +|+.||....
T Consensus       150 ~~~l~d~g~~~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~  214 (262)
T cd05077         150 FIKLSDPGIPITVLS---------------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT  214 (262)
T ss_pred             eeEeCCCCCCccccC---------------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence             89999999875421               11235778899999876 567899999999999999998 5888875421


Q ss_pred             cCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 002746          781 AGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDL  853 (885)
Q Consensus       781 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  853 (885)
                      .     ...         .......    .....        ..+.++.+++.+||+.||.+||++.++++.+
T Consensus       215 ~-----~~~---------~~~~~~~----~~~~~--------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         215 L-----AEK---------ERFYEGQ----CMLVT--------PSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             h-----hHH---------HHHHhcC----ccCCC--------CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            0     000         0000000    00000        1234688999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=7.4e-36  Score=316.57  Aligned_cols=253  Identities=22%  Similarity=0.353  Sum_probs=198.7

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46788889999999999999864 68899999988665444566889999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++++|.+++....         .+++.....++.|++.|+.|||+.+   |+|+||||+||+++.++.++|+|||.+...
T Consensus        89 ~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd06645          89 GGGSLQDIYHVTG---------PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQI  156 (267)
T ss_pred             CCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence            9999999876432         3788999999999999999999998   999999999999999999999999998765


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccC---CCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF---GSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      ...           ........|+..|+|||++.   ...++.++|||||||++|||++|+.||....... .....   
T Consensus       157 ~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~~~~~---  221 (267)
T cd06645         157 TAT-----------IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFLM---  221 (267)
T ss_pred             cCc-----------ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-hHHhh---
Confidence            321           11112346889999999874   4568899999999999999999999985432110 00000   


Q ss_pred             hhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       793 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                       ......   .+.. ...           ..++..+.+++.+|++.+|++||++++++++
T Consensus       222 -~~~~~~---~~~~-~~~-----------~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         222 -TKSNFQ---PPKL-KDK-----------MKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             -hccCCC---CCcc-ccc-----------CCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence             000000   0000 000           0124468899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.7e-35  Score=313.86  Aligned_cols=258  Identities=23%  Similarity=0.351  Sum_probs=199.3

Q ss_pred             HHHhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEE
Q 002746          553 LEATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       553 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV  631 (885)
                      +.+++.+.....||+|+||.||+|... ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            345566667789999999999999955 6788999998765555567899999999999999999999999999999999


Q ss_pred             EecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecC-CCCEEEcccc
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND-DMTALVSDFG  710 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfg  710 (885)
                      +||+++++|.+++......      ...++..+..++.|++.|++|||+++   |+||||||+||+++. ++.++|+|||
T Consensus        84 ~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg  154 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGP------LKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFG  154 (268)
T ss_pred             EecCCCCCHHHHHHHhccc------CCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecch
Confidence            9999999999988753211      01277888899999999999999998   999999999999986 6799999999


Q ss_pred             cceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCC--CCccccchhhHHHHHHHHcCCCCCCccccCCccHHH
Q 002746          711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN--TSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~  788 (885)
                      .+.......           .......|++.|+|||+..+..  ++.++||||||+++|+|++|+.||.......  ...
T Consensus       155 ~~~~~~~~~-----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~--~~~  221 (268)
T cd06624         155 TSKRLAGIN-----------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ--AAM  221 (268)
T ss_pred             hheecccCC-----------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh--hhH
Confidence            987653211           1112235789999999986643  7899999999999999999999986421110  000


Q ss_pred             HHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       789 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      +..             .........       .....+++.+++.+||+.+|++|||++|++++
T Consensus       222 ~~~-------------~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         222 FKV-------------GMFKIHPEI-------PESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             hhh-------------hhhccCCCC-------CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            100             000000000       01134568899999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-35  Score=325.54  Aligned_cols=269  Identities=21%  Similarity=0.255  Sum_probs=197.1

Q ss_pred             HHhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecC-----
Q 002746          554 EATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLP-----  625 (885)
Q Consensus       554 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----  625 (885)
                      +..++|.+.+.||+|+||.||+|... +++.||||++....  ....+.+.+|++++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            45678999999999999999999964 68899999986432  22345677899999999999999999887543     


Q ss_pred             -CcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCE
Q 002746          626 -DFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA  704 (885)
Q Consensus       626 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~  704 (885)
                       ...+++++++ +++|..++...          .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~  157 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQ----------KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCEL  157 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCE
Confidence             3458999987 77887776432          2788999999999999999999998   9999999999999999999


Q ss_pred             EEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccccCC
Q 002746          705 LVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGG  783 (885)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~  783 (885)
                      ||+|||+++....              ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .
T Consensus       158 kl~Dfg~~~~~~~--------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~  222 (343)
T cd07878         158 RILDFGLARQADD--------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-I  222 (343)
T ss_pred             EEcCCccceecCC--------------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH-H
Confidence            9999999986421              1123468999999999877 5688999999999999999999999964211 0


Q ss_pred             ccHHHHHHHhhcchhhhhhh---hh-----hhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          784 LSLHKWVKNHYHGRLEKVID---SS-----LLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~d---~~-----~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..+..+.. .......+...   ..     +..............+....+.+.+++.+|++.||.+|||++|++++
T Consensus       223 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         223 DQLKRIME-VVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHHHHH-HhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            11111111 11000001000   00     00000001111111222234568899999999999999999999986

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.6e-35  Score=312.23  Aligned_cols=257  Identities=27%  Similarity=0.412  Sum_probs=201.2

Q ss_pred             hCCcccceecccCcceEEEEEeC----CCCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ----DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV  631 (885)
                      .+|++.+.||+|+||.||+|.+.    .+..+|+|.++... ....+.+..|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            57888999999999999999864    23479999886432 23356789999999999999999999999999999999


Q ss_pred             EecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccc
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~  711 (885)
                      |||+++|+|.+++.....        .+++..+..++.|++.|++|||+++   ++||||||+||+++.++.++++|||.
T Consensus        84 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~  152 (267)
T cd05066          84 TEYMENGSLDAFLRKHDG--------QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGL  152 (267)
T ss_pred             EEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCc
Confidence            999999999999865421        3788999999999999999999998   99999999999999999999999999


Q ss_pred             ceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHH
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~  790 (885)
                      +..+......        ........++..|+|||++.+..++.++||||||+++||+++ |+.||.....  .....++
T Consensus       153 ~~~~~~~~~~--------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--~~~~~~~  222 (267)
T cd05066         153 SRVLEDDPEA--------AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--QDVIKAI  222 (267)
T ss_pred             ccccccccce--------eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--HHHHHHH
Confidence            9866321100        001111223568999999998899999999999999999887 9999865211  1111111


Q ss_pred             HHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 002746          791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       791 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                      ..                ......+      ..++.++.+++.+|++.+|.+||+|.++++.|+++
T Consensus       223 ~~----------------~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         223 EE----------------GYRLPAP------MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             hC----------------CCcCCCC------CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            10                0000000      11345688999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.3e-35  Score=335.22  Aligned_cols=271  Identities=20%  Similarity=0.298  Sum_probs=191.4

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecC--------C
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLP--------D  626 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~  626 (885)
                      ..+|.+.+.||+|+||.||+|... +++.||||++...    .....+|+.+++.++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            467999999999999999999965 6889999988532    23345799999999999999998876432        2


Q ss_pred             cceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCC-CEE
Q 002746          627 FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDM-TAL  705 (885)
Q Consensus       627 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~~k  705 (885)
                      ..++||||+++ ++.+++.....     ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++ .+|
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~-----~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vk  211 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYAR-----NNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLK  211 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCcee
Confidence            35689999975 56555542211     1224889999999999999999999998   99999999999999664 799


Q ss_pred             EcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCc
Q 002746          706 VSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGL  784 (885)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~  784 (885)
                      |+|||+|+.+...            .......||+.|+|||++.+. .++.++|||||||++|||++|++||..... ..
T Consensus       212 L~DFGla~~~~~~------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~-~~  278 (440)
T PTZ00036        212 LCDFGSAKNLLAG------------QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS-VD  278 (440)
T ss_pred             eeccccchhccCC------------CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HH
Confidence            9999999865321            111234689999999987664 689999999999999999999999964211 11


Q ss_pred             cHHHHHHHhhcchhhh--hhhhhhhhcc-C-CChHHHHHHH-HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          785 SLHKWVKNHYHGRLEK--VIDSSLLRAS-R-DQSPEVKRMW-DVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       785 ~~~~~~~~~~~~~~~~--~~d~~~~~~~-~-~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .+...+..........  ...+...... . .....+...+ ...+.++.+++.+||+.||.+|||+.|++++
T Consensus       279 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        279 QLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            1122111111100000  0001000000 0 0001111111 1245679999999999999999999999976

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=8e-36  Score=325.32  Aligned_cols=240  Identities=25%  Similarity=0.324  Sum_probs=186.1

Q ss_pred             ceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHH-HHHhhcCCcccceeeeeeecCCcceEEEecccC
Q 002746          563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNREC-QVLKRIRHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~  637 (885)
                      +.||+|+||+||+|+.. +++.||+|++....   ......+..|. .+++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999976 57889999987432   12223344444 456788999999999999999999999999999


Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      |+|..++....         .+....+..++.||+.||+|||+.|   |+||||||+|||++.++.+||+|||+|+....
T Consensus        81 ~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~  148 (325)
T cd05602          81 GELFYHLQRER---------CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE  148 (325)
T ss_pred             CcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccccc
Confidence            99998886433         2677888889999999999999998   99999999999999999999999999875321


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcch
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR  797 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  797 (885)
                      .           ........||+.|+|||++.+..++.++||||+||++|||++|+.||....     ..+......   
T Consensus       149 ~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~---  209 (325)
T cd05602         149 H-----------NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-----TAEMYDNIL---  209 (325)
T ss_pred             C-----------CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC-----HHHHHHHHH---
Confidence            1           111234569999999999999999999999999999999999999996421     111111111   


Q ss_pred             hhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 002746          798 LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAA  850 (885)
Q Consensus       798 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~  850 (885)
                           ..     .....+       ..+.++.+++.+|++.||.+||++.+.+
T Consensus       210 -----~~-----~~~~~~-------~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         210 -----NK-----PLQLKP-------NITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             -----hC-----CcCCCC-------CCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence                 00     000001       1345688999999999999999987433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-35  Score=311.14  Aligned_cols=253  Identities=24%  Similarity=0.366  Sum_probs=200.0

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC-----cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-----NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKAL  630 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  630 (885)
                      ++|++.+.||+|++|.||+|... +++.||+|.++....     ...+.+.+|++++++++||||+++++++..++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46889999999999999999864 689999999874421     123568889999999999999999999999999999


Q ss_pred             EEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccc
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG  710 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg  710 (885)
                      |+||+++++|.+++....         .+++..+..++.|++.|+.|||+.+   |+||||+|+||++++++.++|+|||
T Consensus        82 v~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg  149 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG---------ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG  149 (263)
T ss_pred             EEEECCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence            999999999998886432         2778888999999999999999998   9999999999999999999999999


Q ss_pred             cceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHH
Q 002746          711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~  790 (885)
                      .++.......        .........|+..|+|||+..+..++.++||||+|+++|||++|+.||.....    .... 
T Consensus       150 ~~~~~~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~-  216 (263)
T cd06625         150 ASKRLQTICS--------SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAI-  216 (263)
T ss_pred             cceecccccc--------ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch----HHHH-
Confidence            9976532110        01111234578899999999999999999999999999999999999865211    1100 


Q ss_pred             HHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       791 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ...        ....    .....+      ..++.++.+++.+||..+|.+|||+.|++++
T Consensus       217 ~~~--------~~~~----~~~~~~------~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         217 FKI--------ATQP----TNPQLP------SHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             HHH--------hccC----CCCCCC------ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            000        0000    000000      1134568899999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9e-37  Score=327.07  Aligned_cols=246  Identities=26%  Similarity=0.391  Sum_probs=198.5

Q ss_pred             cccceecccCcceEEEEEeC-CCCEEEEEEeee----cCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCc--ceEEE
Q 002746          560 DEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL----QSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDF--KALVL  632 (885)
Q Consensus       560 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lV~  632 (885)
                      ....+||+|+|-+||+|.+. +|..||--.++.    +.....++|..|+.+|+.++|||||++|.++.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            34467999999999999965 577777544332    233446889999999999999999999999987765  56899


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecC-CCCEEEccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND-DMTALVSDFGI  711 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfg~  711 (885)
                      |.|..|+|..|+++++.         .+......|++||++||.|||++. |||+|||||-+||+++. -|.|||+|.|+
T Consensus       123 EL~TSGtLr~Y~kk~~~---------vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGL  192 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRR---------VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGL  192 (632)
T ss_pred             ecccCCcHHHHHHHhcc---------CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhH
Confidence            99999999999998875         778899999999999999999997 57999999999999985 59999999999


Q ss_pred             ceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      |+.+.             ...+....|||.|||||.+. ..|++..||||||+.++||+|+..||..    ...-++..+
T Consensus       193 Atl~r-------------~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE----C~n~AQIYK  254 (632)
T KOG0584|consen  193 ATLLR-------------KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE----CTNPAQIYK  254 (632)
T ss_pred             HHHhh-------------ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh----hCCHHHHHH
Confidence            99873             23444579999999999877 6899999999999999999999999864    333344333


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .+..+.-+..+.+                  .-.+++.++|.+|+.. .++|||+.|++++
T Consensus       255 KV~SGiKP~sl~k------------------V~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  255 KVTSGIKPAALSK------------------VKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             HHHcCCCHHHhhc------------------cCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            3332221111110                  0134589999999999 8999999999986

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.8e-35  Score=320.16  Aligned_cols=263  Identities=23%  Similarity=0.344  Sum_probs=200.9

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      ++|++.+.||+|+||.||+|... ++..+|+|.++.... ....++.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36889999999999999999965 678899998875422 2345688999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH-SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      +++++|.+++....         .+++..+..++.|+++||.|||+. +   ++||||||+||+++.++.++|+|||.+.
T Consensus        81 ~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~  148 (308)
T cd06615          81 MDGGSLDQVLKKAG---------RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG  148 (308)
T ss_pred             cCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcc
Confidence            99999999986543         278888999999999999999974 5   9999999999999999999999999986


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      ....             .......|+..|+|||+..+..++.++|||||||++|||++|+.||....  ......+....
T Consensus       149 ~~~~-------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~  213 (308)
T cd06615         149 QLID-------------SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRP  213 (308)
T ss_pred             cccc-------------cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCc
Confidence            5421             11123468899999999988889999999999999999999999986421  11111111100


Q ss_pred             hcch---------------------hhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          794 YHGR---------------------LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       794 ~~~~---------------------~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ....                     ..+..+.... ......+     ....+.++.+++.+||..+|++||+++|++++
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         214 VSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVN-EPPPKLP-----SGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             cccccccCCcccccCCCCCccchhhHHHHHHHHhc-CCCccCc-----CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000                     0000000000 0000000     01145679999999999999999999999987

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3e-35  Score=312.26  Aligned_cols=259  Identities=25%  Similarity=0.400  Sum_probs=200.6

Q ss_pred             hCCcccceecccCcceEEEEEeC-CC---CEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DG---TAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV  631 (885)
                      ..|++.+.||+|+||.||+|.+. ++   ..||||.++... ......|..|+.++++++||||+++++++..+...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            45788899999999999999965 33   369999987542 23456799999999999999999999999999999999


Q ss_pred             EecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccc
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~  711 (885)
                      |||+++|+|.+++.....        .+++..++.++.|++.|++|||+++   ++||||||+||+++.++.++++|||.
T Consensus        84 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~  152 (269)
T cd05065          84 TEFMENGALDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGL  152 (269)
T ss_pred             EecCCCCcHHHHHhhCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcc
Confidence            999999999998864321        3789999999999999999999998   99999999999999999999999999


Q ss_pred             ceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHH
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~  790 (885)
                      +..+........      .........+..|+|||+..+..++.++|||||||++||+++ |..||.....  ....+++
T Consensus       153 ~~~~~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i  224 (269)
T cd05065         153 SRFLEDDTSDPT------YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAI  224 (269)
T ss_pred             ccccccCccccc------cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHH
Confidence            876633111000      000001112457999999999999999999999999999886 9999865211  1111111


Q ss_pred             HHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 002746          791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       791 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                      ...                .....+      ..++.++.+++.+||+.+|.+||++++++..|+.+
T Consensus       225 ~~~----------------~~~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         225 EQD----------------YRLPPP------MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HcC----------------CcCCCc------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            100                000000      12355688999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-35  Score=324.53  Aligned_cols=269  Identities=21%  Similarity=0.244  Sum_probs=193.3

Q ss_pred             HHhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          554 EATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       554 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ....+|.+.+.||+|+||.||+|+.. +++.||+|+...      .....|+.++++++||||+++++++......++|+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            34567999999999999999999976 577899997532      23356999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+. |+|.+++....        ..+++..+..|+.||+.||.|||+++   ||||||||+|||++.++.+||+|||.+
T Consensus       137 e~~~-~~l~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a  204 (357)
T PHA03209        137 PHYS-SDLYTYLTKRS--------RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAA  204 (357)
T ss_pred             EccC-CcHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccc
Confidence            9994 67777775432        23889999999999999999999998   999999999999999999999999998


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCC-CccccCCccH-----
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPT-DDMFAGGLSL-----  786 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~-~~~~~~~~~~-----  786 (885)
                      +....            ........||+.|+|||++.+..++.++|||||||++|||+++..|+ ..........     
T Consensus       205 ~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~  272 (357)
T PHA03209        205 QFPVV------------APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCH  272 (357)
T ss_pred             ccccc------------CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHH
Confidence            74311            11122356899999999999999999999999999999999865554 3321111111     


Q ss_pred             ---HHHHHHhh--cchhh-----hhhhhhhhh--ccCCChHHHHHH-HHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          787 ---HKWVKNHY--HGRLE-----KVIDSSLLR--ASRDQSPEVKRM-WDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       787 ---~~~~~~~~--~~~~~-----~~~d~~~~~--~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                         ...+....  +..+.     ......+..  ..+......... ....+.++.+++.+||+.||++|||+.|++++
T Consensus       273 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        273 SHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             HHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence               11111000  00000     000000000  000000000000 01234567789999999999999999999986

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.2e-35  Score=317.75  Aligned_cols=269  Identities=22%  Similarity=0.372  Sum_probs=201.9

Q ss_pred             hCCcccceecccCcceEEEEEeC-----------------CCCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCccccee
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-----------------DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRI  618 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~  618 (885)
                      ++|++.+.||+|+||.||+|...                 ++..||+|+++... ......+.+|++++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56899999999999999998633                 23468999987543 2335678999999999999999999


Q ss_pred             eeeeecCCcceEEEecccCCccccccccCCcccc--CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCce
Q 002746          619 ITACSLPDFKALVLPYMANGSLDSHLYPHSETEF--GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNV  696 (885)
Q Consensus       619 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI  696 (885)
                      ++++..++..++||||+++|+|.+++........  ......+++..+..++.|++.|++|||+.+   |+||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            9999999999999999999999998875432211  112234788999999999999999999998   99999999999


Q ss_pred             EecCCCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc--CCC
Q 002746          697 LLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT--RRR  774 (885)
Q Consensus       697 Ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt--g~~  774 (885)
                      +++.++.++|+|||+++.+.....         ........++..|+|||...+..++.++|||||||++|||++  |..
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~---------~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~  232 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDY---------YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQ  232 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcc---------eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCC
Confidence            999999999999999986532110         001112234678999999888889999999999999999998  778


Q ss_pred             CCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          775 PTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       775 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                      ||.....     .+++...     ................       ..++..+.+++.+||+.||.+||++.||++.|+
T Consensus       233 p~~~~~~-----~~~~~~~-----~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         233 PYSQLSD-----EQVIENT-----GEFFRDQGRQVYLPKP-------ALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             CccccCh-----HHHHHHH-----HHHHhhccccccCCCC-------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            8864211     1111110     0000000000000000       013456889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.1e-35  Score=315.88  Aligned_cols=251  Identities=23%  Similarity=0.325  Sum_probs=196.3

Q ss_pred             CcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      |+..+.||+|+||+||+|.+. +++.||+|.+....   ......+.+|++++++++|++++++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999999965 68899999986432   22234578899999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +++|+|..++.....       ..+++..+..++.|++.||.|||+++   |+||||||+||++++++.++|+|||++..
T Consensus        82 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~  151 (285)
T cd05632          82 MNGGDLKFHIYNMGN-------PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVK  151 (285)
T ss_pred             ccCccHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCccee
Confidence            999999887754321       23899999999999999999999998   99999999999999999999999999875


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      ....            .......|+..|+|||++.+..++.++|||||||++|||++|+.||...... .....      
T Consensus       152 ~~~~------------~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~-~~~~~------  212 (285)
T cd05632         152 IPEG------------ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK-VKREE------  212 (285)
T ss_pred             cCCC------------CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHH------
Confidence            4211            1112346899999999999989999999999999999999999999642110 00011      


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT-----MLDAADD  852 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~  852 (885)
                             +...........       ....+.++.+++.+|++.||++||+     +.+++.+
T Consensus       213 -------~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         213 -------VDRRVLETEEVY-------SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             -------HHHhhhcccccc-------CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence                   111111000000       0113456889999999999999999     5566654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-35  Score=318.17  Aligned_cols=269  Identities=22%  Similarity=0.348  Sum_probs=199.6

Q ss_pred             hCCcccceecccCcceEEEEEeCC---------------CCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeee
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQD---------------GTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIIT  620 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~  620 (885)
                      ++|++.+.||+|+||.||+|+...               ...||+|.++.... .....+.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578999999999999999987542               23489999875422 23457899999999999999999999


Q ss_pred             eeecCCcceEEEecccCCccccccccCCccc---cCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceE
Q 002746          621 ACSLPDFKALVLPYMANGSLDSHLYPHSETE---FGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVL  697 (885)
Q Consensus       621 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIL  697 (885)
                      ++......++||||+++++|.+++.......   .......+++..++.++.|++.|++|||+.+   ++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            9999999999999999999999885432110   0111224788999999999999999999998   999999999999


Q ss_pred             ecCCCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc--CCCC
Q 002746          698 LNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT--RRRP  775 (885)
Q Consensus       698 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt--g~~P  775 (885)
                      +++++.+||+|||++..+.....         ........++..|+|||+..+..++.++|||||||++|||++  |..|
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p  232 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDY---------YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQP  232 (295)
T ss_pred             EcCCCcEEecccccccccccCcc---------eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCC
Confidence            99999999999999976532110         011112345678999999988899999999999999999998  5667


Q ss_pred             CCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          776 TDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       776 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                      |.....  ......+....        ............+       ..+..+.+++.+||+.+|++||++.+|++.|+
T Consensus       233 ~~~~~~--~~~~~~~~~~~--------~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         233 YSLLSD--EQVIENTGEFF--------RNQGRQIYLSQTP-------LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             CcccCh--HHHHHHHHHhh--------hhccccccCCCCC-------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            754211  01111000000        0000000000000       12456999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=7.7e-36  Score=325.45  Aligned_cols=238  Identities=24%  Similarity=0.331  Sum_probs=186.3

Q ss_pred             ceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHH-HHhhcCCcccceeeeeeecCCcceEEEecccC
Q 002746          563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQ-VLKRIRHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~  637 (885)
                      +.||+|+||.||+|+.. +|+.||+|++....   ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999965 68999999987442   223344555554 46778999999999999999999999999999


Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      |+|..++....         .+++..+..++.||+.||+|||++|   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~  148 (325)
T cd05604          81 GELFFHLQRER---------SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA  148 (325)
T ss_pred             CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCC
Confidence            99988776432         3789999999999999999999998   99999999999999999999999999874311


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcch
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR  797 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  797 (885)
                      .           ........||+.|+|||++.+..++.++|||||||++|||++|+.||...     +..+......   
T Consensus       149 ~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~-----~~~~~~~~~~---  209 (325)
T cd05604         149 Q-----------SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR-----DVAEMYDNIL---  209 (325)
T ss_pred             C-----------CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC-----CHHHHHHHHH---
Confidence            0           11123456899999999999999999999999999999999999999642     1111111111   


Q ss_pred             hhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 002746          798 LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLD  848 (885)
Q Consensus       798 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e  848 (885)
                           ...+     ...+       ..+.++.+++.+|++.+|.+||++++
T Consensus       210 -----~~~~-----~~~~-------~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         210 -----HKPL-----VLRP-------GASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             -----cCCc-----cCCC-------CCCHHHHHHHHHHhccCHHhcCCCCC
Confidence                 0000     0000       12446789999999999999998864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=9.3e-36  Score=324.35  Aligned_cols=237  Identities=24%  Similarity=0.331  Sum_probs=184.4

Q ss_pred             ceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHH-HHhhcCCcccceeeeeeecCCcceEEEecccC
Q 002746          563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQ-VLKRIRHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~  637 (885)
                      ++||+|+||.||+|+.. +++.||+|++....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 68899999987432   222334555544 67889999999999999999999999999999


Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      |+|..++....         .+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~  148 (321)
T cd05603          81 GELFFHLQRER---------CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVE  148 (321)
T ss_pred             CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCC
Confidence            99988775432         2778888899999999999999998   99999999999999999999999999874311


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcch
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR  797 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  797 (885)
                      .           ........||+.|+|||++.+..++.++|||||||++|||++|+.||...     +..........  
T Consensus       149 ~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-----~~~~~~~~i~~--  210 (321)
T cd05603         149 P-----------EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR-----DVSQMYDNILH--  210 (321)
T ss_pred             C-----------CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC-----CHHHHHHHHhc--
Confidence            0           11122356899999999999999999999999999999999999999642     11111111110  


Q ss_pred             hhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 002746          798 LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTML  847 (885)
Q Consensus       798 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  847 (885)
                                 ......+       ..+.++.+++.+|++.||.+||++.
T Consensus       211 -----------~~~~~~~-------~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         211 -----------KPLQLPG-------GKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             -----------CCCCCCC-------CCCHHHHHHHHHHccCCHhhcCCCC
Confidence                       0000000       1234688999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.1e-35  Score=307.59  Aligned_cols=247  Identities=28%  Similarity=0.421  Sum_probs=195.0

Q ss_pred             ceecccCcceEEEEEeCCCCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCCccc
Q 002746          563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLD  641 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL~  641 (885)
                      ++||+|+||.||+|...++..||+|.++.... .....+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988889999999875432 23456889999999999999999999999999999999999999999


Q ss_pred             cccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecccCC
Q 002746          642 SHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG  721 (885)
Q Consensus       642 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~  721 (885)
                      +++.....        .+++..+..++.+++.||.|+|+++   ++||||||+||+++.++.+|++|||++........ 
T Consensus        81 ~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-  148 (250)
T cd05085          81 SFLRKKKD--------ELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-  148 (250)
T ss_pred             HHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-
Confidence            98764321        3789999999999999999999998   99999999999999999999999999875422100 


Q ss_pred             CCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhhcchhhh
Q 002746          722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHYHGRLEK  800 (885)
Q Consensus       722 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~  800 (885)
                               .......++..|+|||+..+..++.++||||||+++||+++ |..||.....     .......       
T Consensus       149 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-----~~~~~~~-------  207 (250)
T cd05085         149 ---------SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-----QQAREQV-------  207 (250)
T ss_pred             ---------ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHHH-------
Confidence                     01111234578999999998899999999999999999998 9999864211     1110000       


Q ss_pred             hhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          801 VIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       801 ~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                        ..    ..+...+      ..++.++.+++.+|++.+|++||++.|+++.|.
T Consensus       208 --~~----~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         208 --EK----GYRMSCP------QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             --Hc----CCCCCCC------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence              00    0000000      013457899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.8e-35  Score=314.58  Aligned_cols=252  Identities=24%  Similarity=0.367  Sum_probs=199.1

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      +.|++.+.||+|+||.||+|+.. ++..||+|++........+.+.+|+++++.++|+|++++++++..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56889999999999999999976 58899999987665555678899999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      +++++..++.....        .+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.++|+|||.+...
T Consensus        92 ~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  160 (292)
T cd06644          92 PGGAVDAIMLELDR--------GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKN  160 (292)
T ss_pred             CCCcHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceec
Confidence            99999887654321        3789999999999999999999998   999999999999999999999999998754


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccC-----CCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHH
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF-----GSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~  790 (885)
                      ...           ........+++.|+|||++.     ...++.++|||||||++|||++|+.||.....     ...+
T Consensus       161 ~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~  224 (292)
T cd06644         161 VKT-----------LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVL  224 (292)
T ss_pred             ccc-----------ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----HHHH
Confidence            221           11122345788999999874     34568899999999999999999999864211     1111


Q ss_pred             HHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       791 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .........     ..     ...       ..++.++.+++.+||..+|++||+++|++++
T Consensus       225 ~~~~~~~~~-----~~-----~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         225 LKIAKSEPP-----TL-----SQP-------SKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             HHHhcCCCc-----cC-----CCC-------cccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            110000000     00     000       0134568899999999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.6e-35  Score=315.31  Aligned_cols=271  Identities=24%  Similarity=0.362  Sum_probs=201.4

Q ss_pred             hCCcccceecccCcceEEEEEe-----CCCCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecC--Ccc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGIL-----QDGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLP--DFK  628 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  628 (885)
                      .-|.+.+.||+|+||.||+|..     .++..||+|.++... ....+.+.+|++++++++|||++++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4568889999999999999974     257889999987543 33456789999999999999999999998775  567


Q ss_pred             eEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcc
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSD  708 (885)
Q Consensus       629 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D  708 (885)
                      ++||||+++++|.+++.....        .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.++|+|
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~d  152 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKN--------KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGD  152 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECC
Confidence            899999999999998864321        3789999999999999999999998   99999999999999999999999


Q ss_pred             cccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHH
Q 002746          709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~  788 (885)
                      ||+++.+.....        .........++..|+|||+..+..++.++|||||||++|||++++.|+......   ...
T Consensus       153 fg~~~~~~~~~~--------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~---~~~  221 (284)
T cd05079         153 FGLTKAIETDKE--------YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL---FLK  221 (284)
T ss_pred             CccccccccCcc--------ceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch---hhh
Confidence            999986632110        001112244677899999998888999999999999999999988775431110   000


Q ss_pred             HHHHhh-cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 002746          789 WVKNHY-HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       789 ~~~~~~-~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                      ...... .......+. .+........      ...++.++.+++.+|++.+|++||+++++++.++.+
T Consensus       222 ~~~~~~~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         222 MIGPTHGQMTVTRLVR-VLEEGKRLPR------PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             hcccccccccHHHHHH-HHHcCccCCC------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            000000 000000000 0000000000      012456799999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.2e-35  Score=318.28  Aligned_cols=273  Identities=25%  Similarity=0.386  Sum_probs=207.4

Q ss_pred             hhCCcccceecccCcceEEEEEeC--------CCCEEEEEEeeecC-CcchhhHHHHHHHHhhc-CCcccceeeeeeecC
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ--------DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRI-RHRNLMRIITACSLP  625 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  625 (885)
                      ..+|.+.+.||+|+||.||+|...        ....||+|.++... ......+..|+++++++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            367889999999999999999742        24578999887442 23345688999999999 699999999999998


Q ss_pred             CcceEEEecccCCccccccccCCcccc-------CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEe
Q 002746          626 DFKALVLPYMANGSLDSHLYPHSETEF-------GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL  698 (885)
Q Consensus       626 ~~~~lV~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl  698 (885)
                      +..++||||+++|+|.+++........       ......+++..+..++.|++.||+|||++|   |+||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            899999999999999999865432100       011235889999999999999999999998   9999999999999


Q ss_pred             cCCCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCC
Q 002746          699 NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTD  777 (885)
Q Consensus       699 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~  777 (885)
                      +.++.+||+|||.++.+......         .......++..|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~  238 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYY---------KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP  238 (314)
T ss_pred             cCCCcEEEccccccccccccccc---------cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCC
Confidence            99999999999999865321100         00111234567999999988899999999999999999999 888985


Q ss_pred             ccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 002746          778 DMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLK  857 (885)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~  857 (885)
                      ..     ..........             .......+      ..++.++.+++.+||..+|++||++.|+++.|+++.
T Consensus       239 ~~-----~~~~~~~~~~-------------~~~~~~~~------~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         239 GI-----PVEELFKLLR-------------EGHRMDKP------SNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             CC-----CHHHHHHHHH-------------cCCCCCCC------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            42     1111111000             00000000      013456889999999999999999999999999998


Q ss_pred             HHhcCCC
Q 002746          858 RYLGEKH  864 (885)
Q Consensus       858 ~~~~~~~  864 (885)
                      ....+..
T Consensus       295 ~~~~~~~  301 (314)
T cd05099         295 AAVSEEY  301 (314)
T ss_pred             HHhcCCc
Confidence            7665543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.5e-35  Score=319.40  Aligned_cols=269  Identities=23%  Similarity=0.378  Sum_probs=202.3

Q ss_pred             hCCcccceecccCcceEEEEEeCC-----------------CCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCccccee
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQD-----------------GTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRI  618 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~  618 (885)
                      .+|++.+.||+|+||.||+|...+                 +..||+|.+..... ...+.+.+|++++++++|||++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            578999999999999999998542                 24589999875432 345678899999999999999999


Q ss_pred             eeeeecCCcceEEEecccCCccccccccCCcccc--CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCce
Q 002746          619 ITACSLPDFKALVLPYMANGSLDSHLYPHSETEF--GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNV  696 (885)
Q Consensus       619 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI  696 (885)
                      ++++..++..++||||+++++|.+++........  ......+++..++.++.|++.||+|||+.+   |+||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhce
Confidence            9999999999999999999999998865432110  012235899999999999999999999998   99999999999


Q ss_pred             EecCCCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc--CCC
Q 002746          697 LLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT--RRR  774 (885)
Q Consensus       697 Ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt--g~~  774 (885)
                      +++.++.++|+|||.++.......         ........++..|+|||+..+..++.++|||||||++|||++  |..
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  232 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDY---------YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ  232 (296)
T ss_pred             eecCCCceEEccccceeecccCcc---------eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCC
Confidence            999999999999999876532110         011123346788999999988889999999999999999998  677


Q ss_pred             CCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          775 PTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       775 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                      ||.....  ......+...+...     .   ........       ..++.++.+++.+|++.||.+|||+.|+++.|+
T Consensus       233 p~~~~~~--~~~~~~~~~~~~~~-----~---~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         233 PYEHLTD--QQVIENAGHFFRDD-----G---RQIYLPRP-------PNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             CCCCcCh--HHHHHHHHhccccc-----c---ccccCCCc-------cCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            8754211  11111111000000     0   00000000       113457999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.1e-35  Score=337.60  Aligned_cols=271  Identities=18%  Similarity=0.246  Sum_probs=191.9

Q ss_pred             HHHHhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCc------ccceeeeeeec
Q 002746          552 LLEATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR------NLMRIITACSL  624 (885)
Q Consensus       552 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~  624 (885)
                      +...+++|.+.+.||+|+||+||+|... .++.||||+++... .....+..|++++++++|.      +++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3345688999999999999999999965 57889999987432 2344567788887777554      58888888876


Q ss_pred             C-CcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCceEecCCCCCceEecCCC
Q 002746          625 P-DFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH-HSPVRVIHCDLKPSNVLLNDDM  702 (885)
Q Consensus       625 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NILl~~~~  702 (885)
                      + ...++|||++ +++|.+++....         .+++..+..|+.||+.||+|||+ .+   ||||||||+|||++.++
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~---------~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~  269 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHG---------PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSD  269 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCC
Confidence            4 4678999988 778887776442         38889999999999999999997 47   99999999999998765


Q ss_pred             ----------------CEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHH
Q 002746          703 ----------------TALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILV  766 (885)
Q Consensus       703 ----------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl  766 (885)
                                      .+||+|||.+....              .......||+.|+|||++.+..++.++|||||||++
T Consensus       270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~--------------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil  335 (467)
T PTZ00284        270 TVVDPVTNRALPPDPCRVRICDLGGCCDER--------------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCII  335 (467)
T ss_pred             cccccccccccCCCCceEEECCCCccccCc--------------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHH
Confidence                            49999999875321              112345789999999999999999999999999999


Q ss_pred             HHHHcCCCCCCccccCCccHHHHHHHhh---cchh---------hhhhhhhhhhccCCChHHHHHH------HH-HHHHH
Q 002746          767 LEMVTRRRPTDDMFAGGLSLHKWVKNHY---HGRL---------EKVIDSSLLRASRDQSPEVKRM------WD-VAIGE  827 (885)
Q Consensus       767 ~elltg~~P~~~~~~~~~~~~~~~~~~~---~~~~---------~~~~d~~~~~~~~~~~~~~~~~------~~-~~~~~  827 (885)
                      |||++|+.||.....  ......+....   +..+         ..+++....-..........+.      .. .....
T Consensus       336 ~elltG~~pf~~~~~--~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (467)
T PTZ00284        336 YELYTGKLLYDTHDN--LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDL  413 (467)
T ss_pred             HHHHhCCCCCCCCCh--HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHH
Confidence            999999999965211  11111111111   0000         0011000000000000000000      00 01345


Q ss_pred             HHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          828 LIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       828 l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      +.+++.+||+.||++|||++|+++|
T Consensus       414 ~~dli~~mL~~dP~~R~ta~e~L~H  438 (467)
T PTZ00284        414 LCDLIYGLLHYDRQKRLNARQMTTH  438 (467)
T ss_pred             HHHHHHHhCCcChhhCCCHHHHhcC
Confidence            7899999999999999999999985

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4e-35  Score=308.87  Aligned_cols=251  Identities=27%  Similarity=0.432  Sum_probs=200.0

Q ss_pred             hCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEeccc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMA  636 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~  636 (885)
                      .+|++.+.||+|+||.||+|.+.+++.+|+|.++... .....+.+|++++++++||+++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            4678889999999999999998778899999886432 234678999999999999999999999999999999999999


Q ss_pred             CCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeee
Q 002746          637 NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM  716 (885)
Q Consensus       637 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~  716 (885)
                      +|+|.+++.....        .+++..++.++.+++.|++|||+.+   ++||||||+||+++.++.++|+|||.++...
T Consensus        83 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  151 (256)
T cd05112          83 HGCLSDYLRAQRG--------KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVL  151 (256)
T ss_pred             CCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecc
Confidence            9999988864321        3788999999999999999999998   9999999999999999999999999987653


Q ss_pred             cccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhhc
Q 002746          717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~  795 (885)
                      ...          ........++.+|+|||+..+..++.++||||||+++|||++ |+.||....     ....+.... 
T Consensus       152 ~~~----------~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~-  215 (256)
T cd05112         152 DDQ----------YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-----NSEVVETIN-  215 (256)
T ss_pred             cCc----------ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-----HHHHHHHHh-
Confidence            210          011112235678999999998899999999999999999998 999986421     111111110 


Q ss_pred             chhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDL  853 (885)
Q Consensus       796 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  853 (885)
                                  .......+.      ..+.++.+++.+||+.+|++||++.|+++.|
T Consensus       216 ------------~~~~~~~~~------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         216 ------------AGFRLYKPR------LASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             ------------CCCCCCCCC------CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                        000000000      0245689999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.2e-35  Score=315.67  Aligned_cols=251  Identities=25%  Similarity=0.339  Sum_probs=197.7

Q ss_pred             CcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC---cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG---NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      |+..+.||+|+||.||+|... +++.||||.+.....   .....+.+|+.++++++|++++++++.+...+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677789999999999999965 688999999864321   2234577899999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +++|+|.+++.....       ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++..
T Consensus        82 ~~g~~L~~~l~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~  151 (285)
T cd05630          82 MNGGDLKFHIYHMGE-------AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVH  151 (285)
T ss_pred             cCCCcHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceee
Confidence            999999988754322       23788999999999999999999998   99999999999999999999999999875


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      ....            .......|+..|+|||++.+..++.++|||||||++|||++|+.||....... ....      
T Consensus       152 ~~~~------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~~------  212 (285)
T cd05630         152 VPEG------------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREE------  212 (285)
T ss_pred             cCCC------------ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHHH------
Confidence            4211            11123468999999999999999999999999999999999999997532110 0000      


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT-----MLDAADD  852 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~  852 (885)
                         .....+.. ....          ....+.++.+++.+||+.||++|||     ++|++++
T Consensus       213 ---~~~~~~~~-~~~~----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         213 ---VERLVKEV-QEEY----------SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             ---HHhhhhhh-hhhc----------CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence               00000000 0000          0113456889999999999999999     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.4e-35  Score=315.85  Aligned_cols=250  Identities=23%  Similarity=0.338  Sum_probs=201.9

Q ss_pred             hCCcccceecccCcceEEEEEe-CCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      .+|++.+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+++++.++|||++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4689999999999999999985 478999999997665555678899999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++++|..++...          .+++.++..++.|++.|++|||+.+   ++||||||+||+++.++.++|+|||++...
T Consensus        99 ~~~~L~~~~~~~----------~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~  165 (296)
T cd06655          99 AGGSLTDVVTET----------CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQI  165 (296)
T ss_pred             CCCcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhc
Confidence            999999887532          2789999999999999999999998   999999999999999999999999998765


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhc
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~  795 (885)
                      ....           .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.....    . ........
T Consensus       166 ~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~----~-~~~~~~~~  229 (296)
T cd06655         166 TPEQ-----------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP----L-RALYLIAT  229 (296)
T ss_pred             cccc-----------ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----H-HHHHHHHh
Confidence            3211           111234588899999999988899999999999999999999999965211    0 00000000


Q ss_pred             chhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       796 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ....     .+      ..      ....+..+.+++.+||..||.+||++.+++.+
T Consensus       230 ~~~~-----~~------~~------~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         230 NGTP-----EL------QN------PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             cCCc-----cc------CC------cccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            0000     00      00      01134568899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.1e-35  Score=320.43  Aligned_cols=272  Identities=26%  Similarity=0.395  Sum_probs=207.5

Q ss_pred             hhCCcccceecccCcceEEEEEeC--------CCCEEEEEEeeecC-CcchhhHHHHHHHHhhc-CCcccceeeeeeecC
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ--------DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRI-RHRNLMRIITACSLP  625 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  625 (885)
                      ..+|.+.+.||+|+||.||+|...        .+..||+|.++... ....+.+.+|+++++++ +||||++++++|..+
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            357899999999999999999742        12368999887432 23356789999999999 899999999999999


Q ss_pred             CcceEEEecccCCccccccccCCcccc-------CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEe
Q 002746          626 DFKALVLPYMANGSLDSHLYPHSETEF-------GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL  698 (885)
Q Consensus       626 ~~~~lV~e~~~~gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl  698 (885)
                      +..++||||+++|+|.+++........       ......+++..+..++.|++.||+|||+++   |+||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence            999999999999999998865432100       012235889999999999999999999998   9999999999999


Q ss_pred             cCCCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCC
Q 002746          699 NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTD  777 (885)
Q Consensus       699 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~  777 (885)
                      +.++.+||+|||+++.......         ........++..|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  238 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDY---------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP  238 (334)
T ss_pred             cCCCcEEECCcccceecccccc---------cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence            9999999999999986532110         001112234567999999999999999999999999999998 888885


Q ss_pred             ccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 002746          778 DMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLK  857 (885)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~  857 (885)
                      ..     ....+.......            ......       ..++.++.+++.+||+.+|++||++.|+++.|+.+.
T Consensus       239 ~~-----~~~~~~~~~~~~------------~~~~~~-------~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         239 GI-----PVEELFKLLKEG------------HRMDKP-------ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             CC-----CHHHHHHHHHcC------------CCCCCC-------CCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence            42     112221111100            000000       013456889999999999999999999999999998


Q ss_pred             HHhcCC
Q 002746          858 RYLGEK  863 (885)
Q Consensus       858 ~~~~~~  863 (885)
                      ....+.
T Consensus       295 ~~~~~~  300 (334)
T cd05100         295 TVTSTD  300 (334)
T ss_pred             hhcCCC
Confidence            655443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.1e-35  Score=320.04  Aligned_cols=203  Identities=23%  Similarity=0.326  Sum_probs=160.0

Q ss_pred             cceecccCcceEEEEEeC---CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeec--CCcceEEEeccc
Q 002746          562 QRLLGTGSYGRVYKGILQ---DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL--PDFKALVLPYMA  636 (885)
Q Consensus       562 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lV~e~~~  636 (885)
                      .++||+|+||+||+|+..   +++.||+|.++..  .....+.+|++++++++||||+++++++..  +...++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999864   4678999988643  224567899999999999999999998854  455689999985


Q ss_pred             CCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEe----cCCCCEEEcccccc
Q 002746          637 NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL----NDDMTALVSDFGIA  712 (885)
Q Consensus       637 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~Dfg~a  712 (885)
                       +++..++..............+++..+..++.|++.||+|||+++   |+||||||+|||+    +.++.+||+|||+|
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             477666543322111112235889999999999999999999998   9999999999999    45689999999999


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCc
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDD  778 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~  778 (885)
                      +.+.....        .........||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus       160 ~~~~~~~~--------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         160 RLFNSPLK--------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eccCCCCc--------cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            86632110        11122345789999999998764 589999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.6e-35  Score=318.62  Aligned_cols=250  Identities=22%  Similarity=0.323  Sum_probs=201.8

Q ss_pred             hCCcccceecccCcceEEEEEe-CCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      .+|.+.+.||+|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+|++++++++..++..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            6789999999999999999996 479999999997655555677889999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++++|.+++...          .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||.+...
T Consensus        99 ~~~~L~~~~~~~----------~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~  165 (297)
T cd06656          99 AGGSLTDVVTET----------CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (297)
T ss_pred             CCCCHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEc
Confidence            999999987532          2688899999999999999999998   999999999999999999999999998765


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhc
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~  795 (885)
                      ...           ........+++.|+|||...+..++.++|||||||++|++++|+.||.......... ..    ..
T Consensus       166 ~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-~~----~~  229 (297)
T cd06656         166 TPE-----------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LI----AT  229 (297)
T ss_pred             cCC-----------ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-ee----cc
Confidence            321           111123457889999999999889999999999999999999999996421110000 00    00


Q ss_pred             chhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       796 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                                 ........+      ...+..+.+++.+||..+|++||++++++++
T Consensus       230 -----------~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         230 -----------NGTPELQNP------ERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             -----------CCCCCCCCc------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                       000000000      1134557899999999999999999999995

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.1e-35  Score=315.48  Aligned_cols=263  Identities=26%  Similarity=0.468  Sum_probs=203.5

Q ss_pred             hhCCcccceecccCcceEEEEEeC------CCCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcc
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ------DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFK  628 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  628 (885)
                      .++|++.+.||+|+||.||+|...      ++..||+|+++.... .....+.+|+.++++++|||++++++++..++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467899999999999999999863      467899999874432 3356788999999999999999999999999999


Q ss_pred             eEEEecccCCccccccccCCccc-------------cCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCc
Q 002746          629 ALVLPYMANGSLDSHLYPHSETE-------------FGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSN  695 (885)
Q Consensus       629 ~lV~e~~~~gsL~~~l~~~~~~~-------------~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N  695 (885)
                      ++||||+++|+|.+++.......             .......+++..++.++.|++.||+|||+++   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999986443210             1112235789999999999999999999998   9999999999


Q ss_pred             eEecCCCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCC
Q 002746          696 VLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRR  774 (885)
Q Consensus       696 ILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~  774 (885)
                      |+++.++.++|+|||.+..+.....         ........++..|+|||...+..++.++|||||||++|||++ |..
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~  231 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADY---------YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ  231 (288)
T ss_pred             eEecCCCceEECccccceecccCcc---------ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999876532110         001112234567999999998899999999999999999998 888


Q ss_pred             CCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          775 PTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       775 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                      ||...     ...++.......        .....     +      +.++.++.+++.+|++.+|++|||+.|+++.|+
T Consensus       232 p~~~~-----~~~~~~~~~~~~--------~~~~~-----~------~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         232 PYYGM-----AHEEVIYYVRDG--------NVLSC-----P------DNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             CCCCC-----CHHHHHHHHhcC--------CCCCC-----C------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            88542     111221111111        10000     0      013456899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.9e-35  Score=322.12  Aligned_cols=267  Identities=23%  Similarity=0.382  Sum_probs=200.3

Q ss_pred             hCCcccceecccCcceEEEEEe------CCCCEEEEEEeeecCC-cchhhHHHHHHHHhhc-CCcccceeeeeeecC-Cc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGIL------QDGTAIAVKVLQLQSG-NFTKSFNRECQVLKRI-RHRNLMRIITACSLP-DF  627 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~  627 (885)
                      ++|++.+.||+|+||.||+|.+      .+++.||||+++.... .....+.+|+.++.++ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            5799999999999999999974      2478899999975432 2345688999999999 689999999988654 45


Q ss_pred             ceEEEecccCCccccccccCCcccc-------------------------------------------------------
Q 002746          628 KALVLPYMANGSLDSHLYPHSETEF-------------------------------------------------------  652 (885)
Q Consensus       628 ~~lV~e~~~~gsL~~~l~~~~~~~~-------------------------------------------------------  652 (885)
                      .++||||+++|+|.++++.......                                                       
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            6899999999999988764321000                                                       


Q ss_pred             ---CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecccCCCCCCCCCC
Q 002746          653 ---GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG  729 (885)
Q Consensus       653 ---~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  729 (885)
                         ......+++..+..++.|+++||+|||+++   |+||||||+||+++.++.+||+|||+++.+.....         
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~---------  234 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD---------  234 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcc---------
Confidence               000123688889999999999999999998   99999999999999999999999999976532110         


Q ss_pred             CCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhhcchhhhhhhhhhhh
Q 002746          730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLR  808 (885)
Q Consensus       730 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  808 (885)
                      ........++..|+|||+..+..++.++||||||+++|||++ |..||......    .....         .+..    
T Consensus       235 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~---------~~~~----  297 (343)
T cd05103         235 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----EEFCR---------RLKE----  297 (343)
T ss_pred             hhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc----HHHHH---------HHhc----
Confidence            001112235678999999988899999999999999999997 89998642111    00000         0000    


Q ss_pred             ccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 002746          809 ASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR  858 (885)
Q Consensus       809 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~  858 (885)
                      ......+.      ..+.++.+++.+||+.+|++||++.|++++|+.+..
T Consensus       298 ~~~~~~~~------~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         298 GTRMRAPD------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             cCCCCCCC------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            00000000      123468899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.5e-35  Score=308.50  Aligned_cols=254  Identities=27%  Similarity=0.428  Sum_probs=201.8

Q ss_pred             hhCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      .++|.+.+.||+|+||.||+|...++..+|+|.++... ...+.+.+|++++++++|+|++++++++.. ...++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            46789999999999999999998888889999887432 234678899999999999999999999887 7789999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++|+|.+++.....       ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||.++..
T Consensus        83 ~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  152 (260)
T cd05073          83 AKGSLLDFLKSDEG-------SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI  152 (260)
T ss_pred             CCCcHHHHHHhCCc-------cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeec
Confidence            99999999865432       23788899999999999999999998   999999999999999999999999999765


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhh
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      ....          ........++..|+|||++.+..++.++|||||||++|++++ |+.||.....  .....++..  
T Consensus       153 ~~~~----------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~--  218 (260)
T cd05073         153 EDNE----------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALER--  218 (260)
T ss_pred             cCCC----------cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhC--
Confidence            3210          011112345678999999998889999999999999999999 8999864211  111111110  


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDR  855 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  855 (885)
                                    ......+      ...+.++.+++.+|++++|++||++.++.+.|+.
T Consensus       219 --------------~~~~~~~------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         219 --------------GYRMPRP------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             --------------CCCCCCc------ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                          0000000      1134568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.9e-35  Score=317.66  Aligned_cols=271  Identities=21%  Similarity=0.260  Sum_probs=199.6

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57899999999999999999965 68899999987443 23345678899999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      ++ ++|..++.....        .+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.++|+|||++..
T Consensus        86 ~~-~~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  153 (301)
T cd07873          86 LD-KDLKQYLDDCGN--------SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARA  153 (301)
T ss_pred             cc-cCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhc
Confidence            97 588777754321        3788899999999999999999998   99999999999999999999999999875


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      ....           ........+++.|+|||++.+. .++.++|||||||++|||++|+.||.....  ......+...
T Consensus       154 ~~~~-----------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~--~~~~~~~~~~  220 (301)
T cd07873         154 KSIP-----------TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV--EEQLHFIFRI  220 (301)
T ss_pred             cCCC-----------CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHH
Confidence            4211           1112233568899999987654 578899999999999999999999964211  1111111111


Q ss_pred             hcch----hhhhhhhhhhhcc--C-CChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          794 YHGR----LEKVIDSSLLRAS--R-DQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       794 ~~~~----~~~~~d~~~~~~~--~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ....    +....+.......  . ...+........++.++.+++.+|++.||.+|||++|++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         221 LGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             cCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            1111    1111110000000  0 00000111112345678999999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.7e-35  Score=310.06  Aligned_cols=256  Identities=27%  Similarity=0.419  Sum_probs=200.4

Q ss_pred             CCcccceecccCcceEEEEEeCCCCEEEEEEeeecCC------cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEE
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSG------NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV  631 (885)
                      +|.+.+.||+|+||.||+|...+++.+|+|.++....      .....+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4788899999999999999988899999999874421      1235688899999999999999999999999999999


Q ss_pred             EecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccc
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~  711 (885)
                      +||+++++|.+++....         .+++..+..++.|++.|++|||+.+   |+|+||+|+||++++++.++|+|||.
T Consensus        81 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~  148 (265)
T cd06631          81 MEFVPGGSISSILNRFG---------PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGC  148 (265)
T ss_pred             EecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchh
Confidence            99999999999986542         2788889999999999999999998   99999999999999999999999999


Q ss_pred             ceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      +......+....     .........|+..|+|||+..+..++.++|||||||++|+|++|+.||.....    ......
T Consensus       149 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~~~~~~  219 (265)
T cd06631         149 ARRLAWVGLHGT-----HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR----LAAMFY  219 (265)
T ss_pred             hHhhhhcccccc-----ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh----HHHHHH
Confidence            876532111110     01112234689999999999998899999999999999999999999964211    100000


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ......    ..+.+              ....+.++.+++.+||+.+|.+||++.|++.+
T Consensus       220 ~~~~~~----~~~~~--------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         220 IGAHRG----LMPRL--------------PDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             hhhccC----CCCCC--------------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            000000    00000              01134568899999999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-35  Score=307.26  Aligned_cols=249  Identities=25%  Similarity=0.373  Sum_probs=195.1

Q ss_pred             ceecccCcceEEEEEeC-C---CCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccC
Q 002746          563 RLLGTGSYGRVYKGILQ-D---GTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~  637 (885)
                      +.||+|+||.||+|.+. .   +..||+|.++.... ...+.+.+|++++++++|+|++++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999854 2   26899999875433 24567899999999999999999999876 4467999999999


Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      |+|.+++....         .+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.+||+|||.++.+..
T Consensus        80 ~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~  147 (257)
T cd05060          80 GPLLKYLKKRR---------EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGA  147 (257)
T ss_pred             CcHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeec
Confidence            99999987543         3789999999999999999999998   99999999999999999999999999987643


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhhcc
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHYHG  796 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  796 (885)
                      ....        ........++..|+|||...+..++.++||||||+++|||++ |+.||.....  .....++..... 
T Consensus       148 ~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~-  216 (257)
T cd05060         148 GSDY--------YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGER-  216 (257)
T ss_pred             CCcc--------cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCc-
Confidence            2100        001111234568999999999999999999999999999998 9999865311  112222111000 


Q ss_pred             hhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 002746          797 RLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       797 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                                    ....       ..++.++.+++.+||+.+|++||++.++++.|+.+
T Consensus       217 --------------~~~~-------~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         217 --------------LPRP-------EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             --------------CCCC-------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence                          0000       11345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.7e-35  Score=313.78  Aligned_cols=251  Identities=24%  Similarity=0.362  Sum_probs=196.6

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEeccc
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMA  636 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~  636 (885)
                      .|++.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++|||++++++++..+...++|+||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            3677889999999999999976 577889998865544456678899999999999999999999999999999999999


Q ss_pred             CCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeee
Q 002746          637 NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM  716 (885)
Q Consensus       637 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~  716 (885)
                      +|+|..++....        ..+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.++++|||++....
T Consensus        86 ~~~l~~~~~~~~--------~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  154 (282)
T cd06643          86 GGAVDAVMLELE--------RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT  154 (282)
T ss_pred             CCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence            999988765322        13889999999999999999999998   9999999999999999999999999987542


Q ss_pred             cccCCCCCCCCCCCCccccccccccccCCcccC-----CCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF-----GSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      ..           ........|+..|+|||++.     +..++.++|||||||++|||++|+.||.....     ...+.
T Consensus       155 ~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~~~~~  218 (282)
T cd06643         155 RT-----------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-----MRVLL  218 (282)
T ss_pred             cc-----------ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-----HHHHH
Confidence            21           11122346889999999874     44578899999999999999999999865211     01010


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .......     +.+      ..+      ..++.++.+++.+||+.+|.+||++.+++++
T Consensus       219 ~~~~~~~-----~~~------~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         219 KIAKSEP-----PTL------AQP------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             HHhhcCC-----CCC------CCc------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000000     000      000      0134568999999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.3e-35  Score=309.52  Aligned_cols=250  Identities=25%  Similarity=0.378  Sum_probs=201.7

Q ss_pred             hCCcccceecccCcceEEEEEeCC-CCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      ++|+..+.||+|++|.||+|.+.+ ++.||+|.++....  .+.+.+|++++++++|+|++++++++..+...++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578899999999999999999774 78999999875433  678999999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++++|.+++.....        .+++..+..++.|++.|+.|||+.+   |+||||+|+||+++.++.++|+|||.+...
T Consensus        81 ~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~  149 (256)
T cd06612          81 GAGSVSDIMKITNK--------TLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQL  149 (256)
T ss_pred             CCCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhc
Confidence            99999998864322        3889999999999999999999998   999999999999999999999999999865


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhc
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~  795 (885)
                      ...           ........|+..|+|||++.+..++.++||||||+++|+|++|+.||.......    .. ..   
T Consensus       150 ~~~-----------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~----~~-~~---  210 (256)
T cd06612         150 TDT-----------MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR----AI-FM---  210 (256)
T ss_pred             ccC-----------ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh----hh-hh---
Confidence            321           111223457889999999999899999999999999999999999986521110    00 00   


Q ss_pred             chhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       796 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                            +..... .....       ....+.++.+++.+||+.+|++|||+.|++++
T Consensus       211 ------~~~~~~-~~~~~-------~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         211 ------IPNKPP-PTLSD-------PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             ------hccCCC-CCCCc-------hhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence                  000000 00000       01134568999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7.6e-35  Score=309.32  Aligned_cols=256  Identities=21%  Similarity=0.335  Sum_probs=200.6

Q ss_pred             hCCcccceecccCcceEEEEEeCC----CCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQD----GTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV  631 (885)
                      .+|.+.+.||+|+||.||+|.+.+    ...||+|...... ....+.+.+|+.++++++|||++++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457888999999999999998643    3468999887554 3345678999999999999999999998875 557899


Q ss_pred             EecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccc
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~  711 (885)
                      |||+++|+|.+++.....        .+++..+..++.+++.||+|||+.+   ++||||||+||+++.++.++++|||+
T Consensus        85 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~  153 (270)
T cd05056          85 MELAPLGELRSYLQVNKY--------SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGL  153 (270)
T ss_pred             EEcCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCce
Confidence            999999999999865321        3789999999999999999999998   99999999999999999999999999


Q ss_pred             ceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHH
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~  790 (885)
                      ++......          ........++..|+|||.+.+..++.++||||||+++||+++ |+.||......  ....++
T Consensus       154 ~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~  221 (270)
T cd05056         154 SRYLEDES----------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DVIGRI  221 (270)
T ss_pred             eeeccccc----------ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHH
Confidence            98653211          011112234568999999988889999999999999999986 99999653111  111111


Q ss_pred             HHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 002746          791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR  858 (885)
Q Consensus       791 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~  858 (885)
                      .                .......+      ..++.++.+++.+|+..+|++|||+.++++.|+.+..
T Consensus       222 ~----------------~~~~~~~~------~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         222 E----------------NGERLPMP------PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             H----------------cCCcCCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            0                00000000      1235578999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.2e-35  Score=309.01  Aligned_cols=254  Identities=28%  Similarity=0.439  Sum_probs=199.1

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCc---------chhhHHHHHHHHhhcCCcccceeeeeeecCCc
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGN---------FTKSFNRECQVLKRIRHRNLMRIITACSLPDF  627 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  627 (885)
                      +|.+...||+|++|.||+|... +++.||+|.+......         ..+.+.+|++++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4677889999999999999864 6889999988644221         12567889999999999999999999999999


Q ss_pred             ceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEc
Q 002746          628 KALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVS  707 (885)
Q Consensus       628 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~  707 (885)
                      .++||||+++++|.+++....         .+++..+..++.|++.|++|||+.+   ++||||+|+||++++++.++|+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~  148 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG---------AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKIS  148 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc---------CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEec
Confidence            999999999999999886543         2788889999999999999999998   9999999999999999999999


Q ss_pred             ccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHH
Q 002746          708 DFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH  787 (885)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~  787 (885)
                      |||.++.+........     .........|+..|+|||++.+..++.++||||+||++|+|++|+.||.....    ..
T Consensus       149 dfg~~~~~~~~~~~~~-----~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~  219 (267)
T cd06628         149 DFGISKKLEANSLSTK-----TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----LQ  219 (267)
T ss_pred             ccCCCcccccccccCC-----ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH----HH
Confidence            9999987642111000     01111234588999999999988899999999999999999999999975211    00


Q ss_pred             HHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          788 KWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       788 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      . +..        ...     ......+      ...+.++.+++.+||+.||.+||++.|++++
T Consensus       220 ~-~~~--------~~~-----~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         220 A-IFK--------IGE-----NASPEIP------SNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             H-HHH--------Hhc-----cCCCcCC------cccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            0 000        000     0000000      1134568899999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.4e-35  Score=324.75  Aligned_cols=270  Identities=20%  Similarity=0.220  Sum_probs=194.8

Q ss_pred             HhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCC-----
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPD-----  626 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----  626 (885)
                      ..++|.+.+.||+|+||.||+|... .++.||||++....  ......+.+|+.+++.++||||+++++++....     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999865 68899999987432  233467788999999999999999999886433     


Q ss_pred             -cceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEE
Q 002746          627 -FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL  705 (885)
Q Consensus       627 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~k  705 (885)
                       ..++||||+++ ++...+..           .+++..+..++.|++.||+|||++|   |+||||||+||+++.++.+|
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~-----------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~k  159 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK  159 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh-----------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEE
Confidence             46899999965 55554431           2678888999999999999999998   99999999999999999999


Q ss_pred             EcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCcc
Q 002746          706 VSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLS  785 (885)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~  785 (885)
                      |+|||+++....            ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus       160 l~Dfg~~~~~~~------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~  226 (355)
T cd07874         160 ILDFGLARTAGT------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQ  226 (355)
T ss_pred             EeeCcccccCCC------------ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HH
Confidence            999999975421            11123346899999999999999999999999999999999999999642110 01


Q ss_pred             HHHHHHHhhcc----------hhhhhhhhhhhhc-------cCCC-hHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 002746          786 LHKWVKNHYHG----------RLEKVIDSSLLRA-------SRDQ-SPEVKRMWDVAIGELIELGILCTQESPSTRPTML  847 (885)
Q Consensus       786 ~~~~~~~~~~~----------~~~~~~d~~~~~~-------~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  847 (885)
                      ....+......          ......+......       ..+. .+...........++.+++.+|++.||++|||+.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~  306 (355)
T cd07874         227 WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD  306 (355)
T ss_pred             HHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHH
Confidence            11111110000          0000000000000       0000 0000000011245688999999999999999999


Q ss_pred             HHHHH
Q 002746          848 DAADD  852 (885)
Q Consensus       848 ev~~~  852 (885)
                      |++++
T Consensus       307 ell~h  311 (355)
T cd07874         307 EALQH  311 (355)
T ss_pred             HHhcC
Confidence            99987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-35  Score=321.91  Aligned_cols=255  Identities=21%  Similarity=0.261  Sum_probs=194.7

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec---CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++...   .....+.+.+|..++..++|++|+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            36889999999999999999965 6899999998742   2233456889999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++|+|.+++.....        .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        81 e~~~g~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~  149 (331)
T cd05597          81 DYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSC  149 (331)
T ss_pred             ecCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCce
Confidence            99999999998864321        3788899999999999999999998   999999999999999999999999998


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCC-----CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-----SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH  787 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~  787 (885)
                      ..+....          ........||+.|+|||++.+     ..++.++|||||||++|||++|+.||...     ...
T Consensus       150 ~~~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~-----~~~  214 (331)
T cd05597         150 LRLLADG----------TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE-----SLV  214 (331)
T ss_pred             eecCCCC----------CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC-----CHH
Confidence            7653211          111123468999999999863     45788999999999999999999999642     111


Q ss_pred             HHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 002746          788 KWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPST--RPTMLDAADD  852 (885)
Q Consensus       788 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~  852 (885)
                      +.........       .... ....       ....+.++.+++.+|++.++++  ||++++++++
T Consensus       215 ~~~~~i~~~~-------~~~~-~~~~-------~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         215 ETYGKIMNHK-------EHFQ-FPPD-------VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             HHHHHHHcCC-------Cccc-CCCc-------cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            1111110000       0000 0000       0113456788888877654443  8899999987

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-35  Score=309.58  Aligned_cols=254  Identities=25%  Similarity=0.381  Sum_probs=202.9

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      ++|++.+.||+|++|.||+|... +++.+|+|.+........+.+.+|++++++++|||++++++++...+..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57889999999999999999965 57889999998665556678999999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++++|.+++.....        .+++..+..++.|++.|++|||+.+   |+||||+|+||+++.++.++|+|||.+...
T Consensus        83 ~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  151 (262)
T cd06613          83 GGGSLQDIYQVTRG--------PLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQL  151 (262)
T ss_pred             CCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhh
Confidence            99999998765421        3788999999999999999999998   999999999999999999999999998765


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCC---CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS---NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      ....           .......++..|+|||...+.   .++.++||||||+++|||++|+.||......     +-+..
T Consensus       152 ~~~~-----------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~-----~~~~~  215 (262)
T cd06613         152 TATI-----------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM-----RALFL  215 (262)
T ss_pred             hhhh-----------hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH
Confidence            3211           111234678899999998877   8899999999999999999999999652110     00000


Q ss_pred             hhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       793 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..        ..........       .....+.++.+++.+||+.+|.+|||+++++.+
T Consensus       216 ~~--------~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         216 IS--------KSNFPPPKLK-------DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             HH--------hccCCCcccc-------chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00        0000000000       011245678999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-36  Score=306.55  Aligned_cols=254  Identities=25%  Similarity=0.333  Sum_probs=205.9

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec---CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEE
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV  631 (885)
                      .+.|..-++||+||||.||-++.+ +|+.+|.|.+...   ......-...|-.+|.+++.+.||.+-.+|+..+..++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            356788899999999999999855 7999999987533   233445678899999999999999999999999999999


Q ss_pred             EecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccc
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~  711 (885)
                      +..|.||+|.-++.....       ..+++..+.-++.+|+-||++||++.   ||+||+||+|||+|+.|+++|+|.|+
T Consensus       264 LtlMNGGDLkfHiyn~g~-------~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGL  333 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGN-------PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGL  333 (591)
T ss_pred             EEeecCCceeEEeeccCC-------CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccce
Confidence            999999999999986653       24889999999999999999999998   99999999999999999999999999


Q ss_pred             ceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      |..+..            ......++||.+|||||++.+..|+...|.||+||++|||+.|+.||....+.       + 
T Consensus       334 Avei~~------------g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK-------v-  393 (591)
T KOG0986|consen  334 AVEIPE------------GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK-------V-  393 (591)
T ss_pred             EEecCC------------CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh-------h-
Confidence            998743            23344568999999999999999999999999999999999999999752111       0 


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP-----TMLDAADD  852 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  852 (885)
                        .    .+-+|..+.....       .+.+..+++..++....++.||++|-     ++++|.+|
T Consensus       394 --k----~eEvdrr~~~~~~-------ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H  446 (591)
T KOG0986|consen  394 --K----REEVDRRTLEDPE-------EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH  446 (591)
T ss_pred             --h----HHHHHHHHhcchh-------hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence              0    1112222222111       11234677899999999999999986     45566554

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-35  Score=307.44  Aligned_cols=256  Identities=31%  Similarity=0.466  Sum_probs=201.2

Q ss_pred             ceecccCcceEEEEEeCC----CCEEEEEEeeecCCc-chhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccC
Q 002746          563 RLLGTGSYGRVYKGILQD----GTAIAVKVLQLQSGN-FTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~  637 (885)
                      +.||+|+||.||+|....    +..||+|.++..... ..+.+.+|+++++.++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999763    888999999855433 267889999999999999999999999999999999999999


Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      ++|.+++..............+++..++.++.|++.|++|||+++   |+||||||+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999876521100001234899999999999999999999998   99999999999999999999999999987643


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhhcc
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHYHG  796 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  796 (885)
                      ...         ........++..|+|||...+..++.++||||+|+++|||++ |..||...     ...+......  
T Consensus       158 ~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~~~~~~~~--  221 (262)
T cd00192         158 DDY---------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-----SNEEVLEYLR--  221 (262)
T ss_pred             ccc---------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHHH--
Confidence            211         011223457889999999988889999999999999999999 69998753     1111111110  


Q ss_pred             hhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          797 RLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       797 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                            +     ......+      ..++.++.+++.+||+.+|++||++.|++++|+
T Consensus       222 ------~-----~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         222 ------K-----GYRLPKP------EYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ------c-----CCCCCCC------ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  0     0000000      113567999999999999999999999998863

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.5e-35  Score=306.77  Aligned_cols=250  Identities=22%  Similarity=0.312  Sum_probs=202.2

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      +|+..+.||+|+||.||.++.. +++.+++|.+....  ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4888999999999999999854 68899999987542  34456788999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +++|+|.+++.....       ..+++..+..++.|++.|++|||+.+   ++||||+|+||+++.++.+||+|||.+..
T Consensus        81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~  150 (256)
T cd08221          81 ANGGTLYDKIVRQKG-------QLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKI  150 (256)
T ss_pred             cCCCcHHHHHHhccc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEE
Confidence            999999998865421       23788999999999999999999998   99999999999999999999999999986


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      .....           .......|++.|+|||+..+..++.++||||||+++|||++|+.||...     ...+......
T Consensus       151 ~~~~~-----------~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~~~~~~~~  214 (256)
T cd08221         151 LGSEY-----------SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT-----NPLNLVVKIV  214 (256)
T ss_pred             ccccc-----------ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC-----CHHHHHHHHH
Confidence            63311           1122346889999999998888999999999999999999999998642     1111111111


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..            ......       ...+.++.+++.+||+.+|++||+++|++++
T Consensus       215 ~~------------~~~~~~-------~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         215 QG------------NYTPVV-------SVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             cC------------CCCCCc-------cccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            11            111000       1245678899999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=8.6e-38  Score=330.15  Aligned_cols=372  Identities=26%  Similarity=0.383  Sum_probs=268.3

Q ss_pred             CCCCCcEEeCCCCccc-ccCchhhhCCCCCcEEEccCcccccCCchhhhcCCCCCCEEEcCCCcccccCCccCCCCCCCc
Q 002746           17 KLRRLRHLQLDGNNLH-GQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLW   95 (885)
Q Consensus        17 ~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~f~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   95 (885)
                      -|+-++-.|+++|.++ +-.|.....+++++.|-|.+.++. .+|.. ++.|.+|++|.+++|++. .+-+.++.|+.|+
T Consensus         5 VLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeE-L~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LR   81 (1255)
T KOG0444|consen    5 VLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEE-LSRLQKLEHLSMAHNQLI-SVHGELSDLPRLR   81 (1255)
T ss_pred             ccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHH-HHHHhhhhhhhhhhhhhH-hhhhhhccchhhH
Confidence            3556788999999998 678999999999999999999998 88866 789999999999999999 5667889999999


Q ss_pred             EEEcccccCcccCCcccccCccceEecccccccCCCChhhhcCCCCCcEEECCCCcccCCCCCCCcccccccCCCCCCCc
Q 002746           96 TLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLE  175 (885)
Q Consensus        96 ~L~L~~N~l~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~  175 (885)
                      .+.+.+|++..                      .-||.++| .|..|+.||||+|++...+.+                 
T Consensus        82 sv~~R~N~LKn----------------------sGiP~diF-~l~dLt~lDLShNqL~EvP~~-----------------  121 (1255)
T KOG0444|consen   82 SVIVRDNNLKN----------------------SGIPTDIF-RLKDLTILDLSHNQLREVPTN-----------------  121 (1255)
T ss_pred             HHhhhcccccc----------------------CCCCchhc-ccccceeeecchhhhhhcchh-----------------
Confidence            99999999972                      13555554 356666666666665543321                 


Q ss_pred             EEEecCcccCccCCCccccc-cccEEEccCCcccccCCccccCCCCCCeeeccccccccccchhhcCCCCCCeEeccccc
Q 002746          176 ELELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNL  254 (885)
Q Consensus       176 ~L~l~~~~l~~~~p~~~~~~-~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~  254 (885)
                                      +... ++..|+|++|+|..++-..|.+++.|-.||||+|++. ..|..+..+..|++|+|++|.
T Consensus       122 ----------------LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NP  184 (1255)
T KOG0444|consen  122 ----------------LEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNP  184 (1255)
T ss_pred             ----------------hhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCCh
Confidence                            1111 3444555555555444444556666666666666666 445556666666666666666


Q ss_pred             ccccCcccccCCCCCCeeeccccccc-ccCCccccCCCcccEEEccCCccCCCCCcccCCCCCCCEEECcCCcCcccCCc
Q 002746          255 FSGEIPAALGKLHHLGLLDLSFNKLS-GEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPA  333 (885)
Q Consensus       255 i~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  333 (885)
                      +...--..+-.+++|+.|.+++.+-+ ..+|.++..+.+|..++|+.|.+. .+|+.+.++++|+.|+||+|+|+ .+..
T Consensus       185 L~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~  262 (1255)
T KOG0444|consen  185 LNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNM  262 (1255)
T ss_pred             hhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeec
Confidence            55322234445566666666665432 245666777777777777777775 66777777777777777777777 5555


Q ss_pred             cccCccceeeeeeccCCcCCCCchhhhcCCCCcceeecCCCccc-cccccccccCccccEEEecCCccCCCCCCcccccc
Q 002746          334 EISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFT-GNIFIQISNCIAVRLINISHNALQGNLPDSLGDLK  412 (885)
Q Consensus       334 ~~~~l~~l~~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~  412 (885)
                      ......++ +.|+||+|+++ .+|.++.+|++|+.|.+.+|+++ .-+|..++.+.+|+.+..++|.|. ..|+.++.+.
T Consensus       263 ~~~~W~~l-EtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~  339 (1255)
T KOG0444|consen  263 TEGEWENL-ETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCV  339 (1255)
T ss_pred             cHHHHhhh-hhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhH
Confidence            55555566 45777788777 67888888888888888888876 236777888888888888888887 7888888888


Q ss_pred             ccccccccCcccccccCcccCCCceecEEEcccccccccCCC
Q 002746          413 NLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPS  454 (885)
Q Consensus       413 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~  454 (885)
                      .|+.|.|+.|++- ++|+++.-++.|+.|||..|+=--.||.
T Consensus       340 kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPK  380 (1255)
T KOG0444|consen  340 KLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPK  380 (1255)
T ss_pred             HHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCC
Confidence            8888888888888 7888888888888888888877666664

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-35  Score=314.61  Aligned_cols=253  Identities=25%  Similarity=0.407  Sum_probs=201.1

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      .++|++.+.||+|++|.||+|.+. ++..||+|.++.......+.+..|++++++++|||++++++++..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            356889999999999999999975 6899999999866555567789999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +++++|.+++.....        .+++..+..++.|++.|+.|||+++   |+|+||||+||+++.++.++|+|||.+..
T Consensus        84 ~~~~~L~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~  152 (280)
T cd06611          84 CDGGALDSIMLELER--------GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAK  152 (280)
T ss_pred             cCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchh
Confidence            999999998865321        3889999999999999999999998   99999999999999999999999998875


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccC-----CCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHH
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF-----GSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKW  789 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~  789 (885)
                      ....           ........|++.|+|||++.     +..++.++||||||+++|||++|+.||.....     .+.
T Consensus       153 ~~~~-----------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~-----~~~  216 (280)
T cd06611         153 NKST-----------LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP-----MRV  216 (280)
T ss_pred             hccc-----------ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH-----HHH
Confidence            4221           11122346889999999864     34567899999999999999999999965311     111


Q ss_pred             HHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       790 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      +.........     .+     .. +      ..++.++.+++.+||+.+|.+||++.+++++
T Consensus       217 ~~~~~~~~~~-----~~-----~~-~------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         217 LLKILKSEPP-----TL-----DQ-P------SKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             HHHHhcCCCC-----Cc-----CC-c------ccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            1111000000     00     00 0      1134568899999999999999999999886

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.6e-35  Score=312.19  Aligned_cols=253  Identities=26%  Similarity=0.381  Sum_probs=197.0

Q ss_pred             HhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhc-CCcccceeeeeeecC------C
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLMRIITACSLP------D  626 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~------~  626 (885)
                      +++.|++.+.||+|+||.||+|... +++.||+|++.... .....+..|+.++.++ +|+|++++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            5677899999999999999999965 68899999987543 3356788999999998 799999999998653      3


Q ss_pred             cceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEE
Q 002746          627 FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALV  706 (885)
Q Consensus       627 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl  706 (885)
                      ..++||||+++|+|.+++.....       ..+++..+..++.|++.|++|||+++   |+||||||+||++++++.++|
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l  152 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKG-------NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKL  152 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEE
Confidence            57899999999999998875322       23789999999999999999999998   999999999999999999999


Q ss_pred             cccccceeeecccCCCCCCCCCCCCccccccccccccCCcccC-----CCCCCccccchhhHHHHHHHHcCCCCCCcccc
Q 002746          707 SDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF-----GSNTSTKGDVYSFGILVLEMVTRRRPTDDMFA  781 (885)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~  781 (885)
                      +|||++......           ........|+..|+|||++.     +..++.++|||||||++|||++|+.||.....
T Consensus       153 ~Dfg~~~~~~~~-----------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~  221 (272)
T cd06637         153 VDFGVSAQLDRT-----------VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP  221 (272)
T ss_pred             ccCCCceecccc-----------cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            999999765221           11122346889999999876     34578899999999999999999999964211


Q ss_pred             CCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          782 GGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                          ...+...         ...    ......      ...++.++.+++.+||..+|.+|||+.|++++
T Consensus       222 ----~~~~~~~---------~~~----~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         222 ----MRALFLI---------PRN----PAPRLK------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             ----HHHHHHH---------hcC----CCCCCC------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                1111000         000    000000      00134568899999999999999999999874

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.3e-35  Score=328.47  Aligned_cols=210  Identities=19%  Similarity=0.280  Sum_probs=174.4

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec---CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ++|+..+.||+|+||.||+|... +++.||+|+++..   .......+..|+.++..++||+|+++++++.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888999999999999999965 6899999999743   2233566788999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++|+|.+++....         .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.++|+|||++
T Consensus        81 E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~  148 (360)
T cd05627          81 EFLPGGDMMTLLMKKD---------TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLC  148 (360)
T ss_pred             eCCCCccHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCC
Confidence            9999999999886543         2788999999999999999999998   999999999999999999999999998


Q ss_pred             eeeecccCCCCC------------------------CCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHH
Q 002746          713 KLVMTVGVGNDG------------------------AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLE  768 (885)
Q Consensus       713 ~~~~~~~~~~~~------------------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~e  768 (885)
                      +.+.........                        .............||+.|+|||++.+..++.++|||||||++||
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilye  228 (360)
T cd05627         149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE  228 (360)
T ss_pred             cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeee
Confidence            755321100000                        00000011123579999999999999999999999999999999


Q ss_pred             HHcCCCCCCc
Q 002746          769 MVTRRRPTDD  778 (885)
Q Consensus       769 lltg~~P~~~  778 (885)
                      |++|+.||..
T Consensus       229 l~tG~~Pf~~  238 (360)
T cd05627         229 MLIGYPPFCS  238 (360)
T ss_pred             cccCCCCCCC
Confidence            9999999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.7e-35  Score=306.50  Aligned_cols=250  Identities=27%  Similarity=0.352  Sum_probs=198.4

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecC-CcceEEEe
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLP-DFKALVLP  633 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lV~e  633 (885)
                      +|++.+.||+|++|.||++... +++.||+|.+....  ....+.+.+|++++++++|+|++++++.+... ...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4888999999999999999965 57889999987442  23356788999999999999999999887644 45689999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      |+++++|.+++.....       ..+++.+++.++.+++.|++|||+.+   |+||||||+||+++.++.++|+|||++.
T Consensus        81 ~~~~~~l~~~l~~~~~-------~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~  150 (257)
T cd08223          81 FCEGGDLYHKLKEQKG-------KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIAR  150 (257)
T ss_pred             ccCCCcHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceE
Confidence            9999999988865321       23789999999999999999999998   9999999999999999999999999998


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      .+...           ........|++.|+|||+..+..++.++||||||+++|||++|+.||...     +...+....
T Consensus       151 ~~~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-----~~~~~~~~~  214 (257)
T cd08223         151 VLENQ-----------CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-----DMNSLVYRI  214 (257)
T ss_pred             Eeccc-----------CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHH
Confidence            66321           11122345789999999999999999999999999999999999998642     111111111


Q ss_pred             hcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       794 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .....            ....       ...+.++.+++.+|++.+|++||++.|++++
T Consensus       215 ~~~~~------------~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         215 IEGKL------------PPMP-------KDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             HhcCC------------CCCc-------cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            11000            0000       1134568999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.7e-35  Score=312.15  Aligned_cols=271  Identities=20%  Similarity=0.288  Sum_probs=202.1

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEe
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      ++|++.+.||+|++|.||+|... +|+.||+|++....  ....+.+.+|++++++++|+|++++++++..+...++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            36888999999999999999976 68999999986442  2234668899999999999999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      |++++.+..+.....         .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||.+.
T Consensus        81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~  148 (286)
T cd07847          81 YCDHTVLNELEKNPR---------GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFAR  148 (286)
T ss_pred             ccCccHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccce
Confidence            999998887764322         3789999999999999999999998   9999999999999999999999999998


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      ......           .......++..|+|||++.+ ..++.++||||||+++|||++|+.||...... .... .+..
T Consensus       149 ~~~~~~-----------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~-~~~~-~~~~  215 (286)
T cd07847         149 ILTGPG-----------DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV-DQLY-LIRK  215 (286)
T ss_pred             ecCCCc-----------ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH-HHHH-HHHH
Confidence            663211           01122357789999998876 45789999999999999999999999653211 1111 1111


Q ss_pred             hhcchhh---hhhhhh-----hhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          793 HYHGRLE---KVIDSS-----LLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       793 ~~~~~~~---~~~d~~-----~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .......   ...+..     ...............+...+..+.+++.+||+.+|++||++.|++.+
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         216 TLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             HhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            1111000   000000     00000001111222233456779999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.9e-35  Score=313.96  Aligned_cols=262  Identities=23%  Similarity=0.320  Sum_probs=203.1

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      ++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++..+...++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56788899999999999999965 68899999887543 33457889999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH-SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      +++|+|..++....         .+++.....++.+++.|+.|||+. +   |+||||||+||+++.++.++|+|||++.
T Consensus        85 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~  152 (284)
T cd06620          85 MDCGSLDRIYKKGG---------PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSG  152 (284)
T ss_pred             CCCCCHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCccc
Confidence            99999998876432         378999999999999999999974 5   9999999999999999999999999986


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      ....             .......|+..|+|||++.+..++.++|||||||++|++++|+.||..........      .
T Consensus       153 ~~~~-------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~------~  213 (284)
T cd06620         153 ELIN-------------SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ------D  213 (284)
T ss_pred             chhh-------------hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh------h
Confidence            5421             11123468899999999988899999999999999999999999997532211000      0


Q ss_pred             hcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 002746          794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDR  855 (885)
Q Consensus       794 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  855 (885)
                      ......+.+...+..... ..+     ....+.++.+++.+|++.||++||++.|++++..-
T Consensus       214 ~~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~  269 (284)
T cd06620         214 DPMGILDLLQQIVQEPPP-RLP-----SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF  269 (284)
T ss_pred             hhhHHHHHHHHHhhccCC-CCC-----chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence            000011111111111000 000     01145678999999999999999999999987433

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=8e-35  Score=307.71  Aligned_cols=253  Identities=26%  Similarity=0.426  Sum_probs=190.9

Q ss_pred             ceecccCcceEEEEEeC----CCCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeee-cCCcceEEEeccc
Q 002746          563 RLLGTGSYGRVYKGILQ----DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACS-LPDFKALVLPYMA  636 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lV~e~~~  636 (885)
                      +.||+|+||.||+|.+.    .+..||+|.+.... ....+.+.+|+.+++.++|||++++++++. .++..++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    24579999885332 234567889999999999999999999775 4556789999999


Q ss_pred             CCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeee
Q 002746          637 NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM  716 (885)
Q Consensus       637 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~  716 (885)
                      +|+|.+++.....        ..++..+..++.|+++|++|||+.+   |+||||||+||+++.++.+||+|||+++.+.
T Consensus        81 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~  149 (262)
T cd05058          81 HGDLRNFIRSETH--------NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY  149 (262)
T ss_pred             CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence            9999999864332        2567778899999999999999998   9999999999999999999999999997653


Q ss_pred             cccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcC-CCCCCccccCCccHHHHHHHhhc
Q 002746          717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg-~~P~~~~~~~~~~~~~~~~~~~~  795 (885)
                      .....       .........++..|+|||+..+..++.++|||||||++|||++| ..||...     ...........
T Consensus       150 ~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-----~~~~~~~~~~~  217 (262)
T cd05058         150 DKEYY-------SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----DSFDITVYLLQ  217 (262)
T ss_pred             CCcce-------eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHhc
Confidence            21100       00111223457789999999888999999999999999999995 5556432     11111111100


Q ss_pred             chhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLK  857 (885)
Q Consensus       796 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~  857 (885)
                                   ......+      ...+..+.+++.+||+.+|++||++.|+++.++++.
T Consensus       218 -------------~~~~~~~------~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         218 -------------GRRLLQP------EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             -------------CCCCCCC------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence                         0000000      012456889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5e-35  Score=308.15  Aligned_cols=250  Identities=20%  Similarity=0.301  Sum_probs=200.7

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      +|++.+.||+|+||.||++... +|+.||+|.+....  ....+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788999999999999999954 68999999987432  23356789999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +++++|.+++.....       ..+++..+..++.|++.|++|||+++   ++|+||+|+||+++.++.++++|||.+..
T Consensus        81 ~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~  150 (256)
T cd08218          81 CEGGDLYKKINAQRG-------VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARV  150 (256)
T ss_pred             CCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceee
Confidence            999999988864321       13788899999999999999999998   99999999999999999999999999976


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      ....           ........|++.|+|||+..+..++.++|||||||++|+|++|+.||...     .....+    
T Consensus       151 ~~~~-----------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~~~~~~----  210 (256)
T cd08218         151 LNST-----------VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-----NMKNLV----  210 (256)
T ss_pred             cCcc-----------hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-----CHHHHH----
Confidence            5321           11112235788999999999989999999999999999999999998641     111111    


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                              +..+.+......       ...+.++.+++.+||+.+|++||++.||+++
T Consensus       211 --------~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         211 --------LKIIRGSYPPVS-------SHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             --------HHHhcCCCCCCc-------ccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                    111111111000       1134568999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=9.5e-35  Score=308.44  Aligned_cols=256  Identities=27%  Similarity=0.412  Sum_probs=195.0

Q ss_pred             ceecccCcceEEEEEeCC-CC--EEEEEEeeecC-CcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcceEEEecccC
Q 002746          563 RLLGTGSYGRVYKGILQD-GT--AIAVKVLQLQS-GNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~  637 (885)
                      ++||+|+||.||+|++.+ +.  .+|+|.++... ....+.+..|++++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999753 43  46888876432 33456788999999999 899999999999999999999999999


Q ss_pred             CccccccccCCcccc-------CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccc
Q 002746          638 GSLDSHLYPHSETEF-------GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG  710 (885)
Q Consensus       638 gsL~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg  710 (885)
                      |+|.+++........       ......+++..+..++.|++.|++|||+.+   ++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            999998865432110       011234789999999999999999999998   9999999999999999999999999


Q ss_pred             cceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHH
Q 002746          711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKW  789 (885)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~  789 (885)
                      ++......            ........+..|+|||+..+..++.++|||||||++|||++ |..||....     ....
T Consensus       158 l~~~~~~~------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----~~~~  220 (270)
T cd05047         158 LSRGQEVY------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAEL  220 (270)
T ss_pred             Cccccchh------------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-----HHHH
Confidence            98532110            00111234567999999988889999999999999999997 999986421     1111


Q ss_pred             HHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 002746          790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLK  857 (885)
Q Consensus       790 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~  857 (885)
                      ....         ....    ....+      ..++.++.+++.+||+.+|.+||++.|+++.|.++.
T Consensus       221 ~~~~---------~~~~----~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         221 YEKL---------PQGY----RLEKP------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HHHH---------hCCC----CCCCC------CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            1111         0000    00000      013456889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.8e-35  Score=311.87  Aligned_cols=238  Identities=22%  Similarity=0.362  Sum_probs=184.7

Q ss_pred             eecccCcceEEEEEeCC-------------------------CCEEEEEEeeecCCcchhhHHHHHHHHhhcCCccccee
Q 002746          564 LLGTGSYGRVYKGILQD-------------------------GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRI  618 (885)
Q Consensus       564 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~  618 (885)
                      .||+|+||.||+|.+..                         ...||+|++..........+.+|+++++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997421                         23588898875544445678899999999999999999


Q ss_pred             eeeeecCCcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEe
Q 002746          619 ITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL  698 (885)
Q Consensus       619 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl  698 (885)
                      ++++..+...++||||+++|+|..++.....        .+++..+..++.|+++||+|||+++   |+||||||+||++
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill  150 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--------RVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILL  150 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEE
Confidence            9999999999999999999999988864321        3788999999999999999999998   9999999999999


Q ss_pred             cCCC-------CEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHH
Q 002746          699 NDDM-------TALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMV  770 (885)
Q Consensus       699 ~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~ell  770 (885)
                      +.++       .++++|||.+.....               .....++..|+|||.+.+ ..++.++|||||||++||++
T Consensus       151 ~~~~~~~~~~~~~kl~d~g~~~~~~~---------------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~  215 (274)
T cd05076         151 ARLGLAEGTSPFIKLSDPGVSFTALS---------------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEIC  215 (274)
T ss_pred             eccCcccCccceeeecCCcccccccc---------------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHH
Confidence            8643       379999998764311               112346788999998865 56899999999999999984


Q ss_pred             -cCCCCCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 002746          771 -TRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDA  849 (885)
Q Consensus       771 -tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev  849 (885)
                       +|+.||......  ....+            ....    .....        ....++.+++.+||+.+|++||+++++
T Consensus       216 ~~g~~p~~~~~~~--~~~~~------------~~~~----~~~~~--------~~~~~~~~li~~cl~~~p~~Rps~~~i  269 (274)
T cd05076         216 FDGEVPLKERTPS--EKERF------------YEKK----HRLPE--------PSCKELATLISQCLTYEPTQRPSFRTI  269 (274)
T ss_pred             hCCCCCccccChH--HHHHH------------HHhc----cCCCC--------CCChHHHHHHHHHcccChhhCcCHHHH
Confidence             799998642111  00111            0000    00000        012358899999999999999999999


Q ss_pred             HHHH
Q 002746          850 ADDL  853 (885)
Q Consensus       850 ~~~L  853 (885)
                      ++.|
T Consensus       270 l~~L  273 (274)
T cd05076         270 LRDL  273 (274)
T ss_pred             HHhh
Confidence            9876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=301.22  Aligned_cols=250  Identities=25%  Similarity=0.382  Sum_probs=206.9

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      +-|++..+||+|+||.||+|.++ +|..+|+|.+....  +.+++.+|+.++++.+.|++|++||.+......++|||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            45788899999999999999865 79999999887443  4578899999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ..|++.+.++.++.        ++.+..+..+.+.-+.||+|||...   -+|||||+-|||++.+|++|++|||.|-.+
T Consensus       111 GAGSiSDI~R~R~K--------~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQL  179 (502)
T KOG0574|consen  111 GAGSISDIMRARRK--------PLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQL  179 (502)
T ss_pred             CCCcHHHHHHHhcC--------CccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchh
Confidence            99999999876553        3889999999999999999999986   899999999999999999999999998655


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhc
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~  795 (885)
                      ...           ......+.|||.|||||++..-.|+.++||||+|++..||..|++||.+......        .+ 
T Consensus       180 TDT-----------MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA--------IF-  239 (502)
T KOG0574|consen  180 TDT-----------MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA--------IF-  239 (502)
T ss_pred             hhh-----------HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce--------eE-
Confidence            321           2234567899999999999999999999999999999999999999987533210        00 


Q ss_pred             chhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       796 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                                +  ....+.|.. +.-+..+.++.++++.|+-..|++|.|+.+++++
T Consensus       240 ----------M--IPT~PPPTF-~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  240 ----------M--IPTKPPPTF-KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             ----------e--ccCCCCCCC-CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence                      0  000001100 0112356789999999999999999999998876

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.5e-35  Score=319.66  Aligned_cols=195  Identities=26%  Similarity=0.414  Sum_probs=170.3

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcC-C-----cccceeeeeeecCCcceE
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIR-H-----RNLMRIITACSLPDFKAL  630 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~l  630 (885)
                      +|++.++||+|+||.|-+|++. +++.||||+++.. .....+...|+.+|..++ |     -|+|+++++|.-.++.+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            8999999999999999999965 6999999999855 344677788999999996 3     379999999999999999


Q ss_pred             EEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecC--CCCEEEcc
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND--DMTALVSD  708 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~--~~~~kl~D  708 (885)
                      |+|.+ .-+|.++++.+.-.       .++...+..|+.||+.||.+||+.+   |||+||||+|||+.+  ...+||+|
T Consensus       266 VfELL-~~NLYellK~n~f~-------Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVID  334 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNKFR-------GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVID  334 (586)
T ss_pred             eehhh-hhhHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEe
Confidence            99998 66999999876543       3889999999999999999999998   999999999999974  35899999


Q ss_pred             cccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCc
Q 002746          709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD  778 (885)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~  778 (885)
                      ||.|+...              .......-+..|+|||++.|.+|+.+.||||||||++||++|.+-|..
T Consensus       335 FGSSc~~~--------------q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG  390 (586)
T KOG0667|consen  335 FGSSCFES--------------QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG  390 (586)
T ss_pred             cccccccC--------------CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence            99998752              222356778999999999999999999999999999999999776643

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7e-35  Score=327.20  Aligned_cols=269  Identities=20%  Similarity=0.252  Sum_probs=196.6

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      ...|.+.+.||+|+||.||+|... .++.||||...      ...+.+|++++++++|+|||++++++...+..++||||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            346999999999999999999976 57889999643      23467899999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +. ++|..++.....        .+++..++.|+.|++.||.|||+++   ||||||||+|||++.++.+||+|||+++.
T Consensus       242 ~~-~~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~  309 (461)
T PHA03211        242 YR-SDLYTYLGARLR--------PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACF  309 (461)
T ss_pred             cC-CCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCcee
Confidence            95 688777754321        3899999999999999999999998   99999999999999999999999999986


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccC---C---ccHHH
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAG---G---LSLHK  788 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~---~---~~~~~  788 (885)
                      +....         .........||+.|+|||++.+..++.++|||||||++|||++|..|+-.....   .   ..+.+
T Consensus       310 ~~~~~---------~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~  380 (461)
T PHA03211        310 ARGSW---------STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILR  380 (461)
T ss_pred             ccccc---------ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHH
Confidence            53210         011122356999999999999999999999999999999999988765322111   0   11112


Q ss_pred             HHHHhhc--chhhhhhhhhhhh--------ccCC--ChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          789 WVKNHYH--GRLEKVIDSSLLR--------ASRD--QSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       789 ~~~~~~~--~~~~~~~d~~~~~--------~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .+.....  ..+.......+..        ....  ..+...+ +.....++.+++.+||+.||.+|||+.|++++
T Consensus       381 ~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        381 IIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTR-YYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhh-hccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            2211100  0000000000000        0000  0000000 01234578899999999999999999999986

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-35  Score=327.49  Aligned_cols=270  Identities=20%  Similarity=0.222  Sum_probs=197.9

Q ss_pred             hhCCcccceecccCcceEEEEEeC---CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ---DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ..+|.+.+.||+|+||.||+|...   .+..||+|.+...     ....+|++++++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            357999999999999999999753   3578999987532     34568999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+. ++|.+++....         .+++..++.++.|++.||+|||+++   ||||||||+|||++.++.++|+|||+|
T Consensus       166 e~~~-~~l~~~l~~~~---------~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a  232 (392)
T PHA03207        166 PKYK-CDLFTYVDRSG---------PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA  232 (392)
T ss_pred             hhcC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccc
Confidence            9985 67777773222         3899999999999999999999998   999999999999999999999999999


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCC--ccHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGG--LSLHKWV  790 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~--~~~~~~~  790 (885)
                      +.+....         .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..+...+
T Consensus       233 ~~~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~  303 (392)
T PHA03207        233 CKLDAHP---------DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSII  303 (392)
T ss_pred             cccCccc---------ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHH
Confidence            7653211         0111224579999999999999999999999999999999999999996532211  1111111


Q ss_pred             HHhhcch--hhh----hhhhhhhhc--cCCChHHHHHHH--HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          791 KNHYHGR--LEK----VIDSSLLRA--SRDQSPEVKRMW--DVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       791 ~~~~~~~--~~~----~~d~~~~~~--~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .......  ...    .+.+.+...  ........+...  ...+.++.+++.+|+..||++||++.|++.+
T Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        304 RCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            1111000  000    000000000  000000000000  1134568899999999999999999999987

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-34  Score=309.31  Aligned_cols=258  Identities=25%  Similarity=0.426  Sum_probs=201.6

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCC----EEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcce
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGT----AIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKA  629 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  629 (885)
                      ..+|.+.+.||+|+||.||+|.+. +|+    .||+|.++.... .....+.+|+.++++++|||++++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            357888999999999999999965 333    589998765433 335678899999999999999999999987 7889


Q ss_pred             EEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccc
Q 002746          630 LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDF  709 (885)
Q Consensus       630 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df  709 (885)
                      +||||+++|+|.+++.....        .+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+||
T Consensus        85 ~v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~df  153 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHKD--------NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDF  153 (279)
T ss_pred             EEEecCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCC
Confidence            99999999999998865432        3889999999999999999999988   999999999999999999999999


Q ss_pred             ccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHH
Q 002746          710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~  788 (885)
                      |.++.+.....         ........++..|+|||......++.++||||||+++||+++ |+.||...     ...+
T Consensus       154 g~~~~~~~~~~---------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-----~~~~  219 (279)
T cd05057         154 GLAKLLDVDEK---------EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-----PAVE  219 (279)
T ss_pred             cccccccCccc---------ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC-----CHHH
Confidence            99987632110         011111224568999999988889999999999999999999 99998652     1111


Q ss_pred             HHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 002746          789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR  858 (885)
Q Consensus       789 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~  858 (885)
                      +......            .... ..+.      .++.++.+++.+||..+|.+||++.++++.|.++.+
T Consensus       220 ~~~~~~~------------~~~~-~~~~------~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         220 IPDLLEK------------GERL-PQPP------ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             HHHHHhC------------CCCC-CCCC------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1111100            0000 0000      123458899999999999999999999999998855

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=6.5e-35  Score=307.45  Aligned_cols=250  Identities=25%  Similarity=0.363  Sum_probs=197.0

Q ss_pred             ceecccCcceEEEEEeCC--C--CEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccC
Q 002746          563 RLLGTGSYGRVYKGILQD--G--TAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~  637 (885)
                      +.||+|++|.||+|.+.+  +  ..||+|.++.... ...+.+.+|++++++++||||+++++++.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999753  3  3689999986654 556789999999999999999999999988 888999999999


Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      |+|.+++.....       ..+++..++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++.+..
T Consensus        80 ~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~  149 (257)
T cd05040          80 GSLLDRLRKDAL-------GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ  149 (257)
T ss_pred             CcHHHHHHhccc-------ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence            999998875431       24899999999999999999999998   99999999999999999999999999987643


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhhcc
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHYHG  796 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  796 (885)
                      ....        ........++..|+|||+..+..++.++|||||||++|||++ |+.||....     ..+......  
T Consensus       150 ~~~~--------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~~~--  214 (257)
T cd05040         150 NEDH--------YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS-----GSQILKKID--  214 (257)
T ss_pred             cccc--------eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHH--
Confidence            1100        011113456789999999998899999999999999999999 999986421     111111110  


Q ss_pred             hhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          797 RLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       797 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                             ..   ......+      ...+.++.+++.+|++.+|++||++.|+++.|.
T Consensus       215 -------~~---~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         215 -------KE---GERLERP------EACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -------hc---CCcCCCC------ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                   00   0000000      113456899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=8.3e-35  Score=306.02  Aligned_cols=246  Identities=26%  Similarity=0.451  Sum_probs=195.5

Q ss_pred             hCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEeccc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMA  636 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~  636 (885)
                      .+|.+.+.||+|+||.||+|.. .++.||+|..+...  ....+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            5688999999999999999975 57889999986432  346789999999999999999999998654 4789999999


Q ss_pred             CCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeee
Q 002746          637 NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM  716 (885)
Q Consensus       637 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~  716 (885)
                      +|+|.+++.....       ..+++..+..++.|++.|+.|||+.+   ++||||||+||+++.++.++|+|||.+....
T Consensus        82 ~~~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~  151 (254)
T cd05083          82 KGNLVNFLRTRGR-------ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS  151 (254)
T ss_pred             CCCHHHHHHhcCc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence            9999999865432       23788999999999999999999998   9999999999999999999999999987542


Q ss_pred             cccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhhc
Q 002746          717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~  795 (885)
                      ..              ......+..|+|||++.+..++.++|||||||++|||++ |+.||....     ...+...   
T Consensus       152 ~~--------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~---  209 (254)
T cd05083         152 MG--------------VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-----LKEVKEC---  209 (254)
T ss_pred             cc--------------CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-----HHHHHHH---
Confidence            10              011233567999999998899999999999999999998 999986421     1111111   


Q ss_pred             chhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       796 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                            +...    .....+      ..++.++.+++.+||+.+|++||+++++++.|+
T Consensus       210 ------~~~~----~~~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         210 ------VEKG----YRMEPP------EGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             ------HhCC----CCCCCC------CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence                  1100    000000      113567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=306.85  Aligned_cols=248  Identities=23%  Similarity=0.332  Sum_probs=207.2

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEe
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      +-|+..+.||+|.|++|-+|++- .|++||||++...+  ......+.+|++.++.++|||||++|.+...+...|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            45888899999999999999844 79999999997553  3345678899999999999999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEec-CCCCEEEcccccc
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN-DDMTALVSDFGIA  712 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~-~~~~~kl~Dfg~a  712 (885)
                      .=++|+|.+++-++..        .+.+..+.+++.||..|+.|+|+.+   +||||+||+||.+- .-|.+|++|||++
T Consensus        98 LGD~GDl~DyImKHe~--------Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFS  166 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEE--------GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFS  166 (864)
T ss_pred             ecCCchHHHHHHhhhc--------cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeecccc
Confidence            9999999999987754        2888899999999999999999998   99999999998775 6699999999999


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCC-ccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTS-TKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      -.+.+            .......+|+..|.|||++.|..|+ ++.||||+|||||-+++|+.||+...+.         
T Consensus       167 Nkf~P------------G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS---------  225 (864)
T KOG4717|consen  167 NKFQP------------GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS---------  225 (864)
T ss_pred             ccCCC------------cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch---------
Confidence            76632            4556678999999999999999986 6789999999999999999999864222         


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                          +.+..+.|=    .+  .      +-..++.++.++|..|+..||.+|.+.+|++..
T Consensus       226 ----ETLTmImDC----KY--t------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  226 ----ETLTMIMDC----KY--T------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             ----hhhhhhhcc----cc--c------CchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence                111111110    00  0      012367889999999999999999999998764

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=9.3e-35  Score=322.28  Aligned_cols=269  Identities=19%  Similarity=0.208  Sum_probs=195.2

Q ss_pred             HhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec--CCcchhhHHHHHHHHhhcCCcccceeeeeeecC------
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIITACSLP------  625 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------  625 (885)
                      ..++|.+.+.||+|+||.||+|... .++.||||++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3478999999999999999999965 6889999998743  223346778899999999999999999987543      


Q ss_pred             CcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEE
Q 002746          626 DFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL  705 (885)
Q Consensus       626 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~k  705 (885)
                      ...++||||+++ ++...+..           .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+|
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~k  166 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM-----------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK  166 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh-----------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEE
Confidence            346899999965 55555532           2678888999999999999999998   99999999999999999999


Q ss_pred             EcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCcc
Q 002746          706 VSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLS  785 (885)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~  785 (885)
                      |+|||+|+....            ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus       167 L~DfG~a~~~~~------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~  233 (364)
T cd07875         167 ILDFGLARTAGT------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQ  233 (364)
T ss_pred             EEeCCCccccCC------------CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HH
Confidence            999999975421            11122346899999999999999999999999999999999999999652110 11


Q ss_pred             HHHHHHHhhcchhhh---hhhhhhhh----c--cCCC----------hHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCH
Q 002746          786 LHKWVKNHYHGRLEK---VIDSSLLR----A--SRDQ----------SPEVKRMWDVAIGELIELGILCTQESPSTRPTM  846 (885)
Q Consensus       786 ~~~~~~~~~~~~~~~---~~d~~~~~----~--~~~~----------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  846 (885)
                      ....+.. ......+   .+.+.+..    .  ....          .+...........++.+++.+|++.||.+|||+
T Consensus       234 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~  312 (364)
T cd07875         234 WNKVIEQ-LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV  312 (364)
T ss_pred             HHHHHHh-cCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCH
Confidence            1111111 0000000   00000000    0  0000          000000001123568899999999999999999


Q ss_pred             HHHHHH
Q 002746          847 LDAADD  852 (885)
Q Consensus       847 ~ev~~~  852 (885)
                      .|++++
T Consensus       313 ~e~L~h  318 (364)
T cd07875         313 DEALQH  318 (364)
T ss_pred             HHHhcC
Confidence            999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-35  Score=309.97  Aligned_cols=248  Identities=24%  Similarity=0.363  Sum_probs=201.1

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      +|++.+.||.|++|.||+|... +++.||+|++.... ......+.+|+++++.++|+|++++++++.++...++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            6788899999999999999965 68899999987543 334567889999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++++|.+++...          .+++..+..++.|++.|+.|||+++   ++||||+|+||++++++.++|+|||.++.+
T Consensus        82 ~~~~L~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  148 (274)
T cd06609          82 GGGSCLDLLKPG----------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQL  148 (274)
T ss_pred             CCCcHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceee
Confidence            999999988643          3789999999999999999999998   999999999999999999999999999876


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhc
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~  795 (885)
                      ....           .......|+..|+|||+..+..++.++||||||+++|||++|+.||.....     .........
T Consensus       149 ~~~~-----------~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~  212 (274)
T cd06609         149 TSTM-----------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-----MRVLFLIPK  212 (274)
T ss_pred             cccc-----------cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-----HHHHHHhhh
Confidence            4311           112234678899999999998899999999999999999999999964211     111100000


Q ss_pred             chhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       796 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .             .....+.     ...+.++.+++.+||..+|++|||+++++.+
T Consensus       213 ~-------------~~~~~~~-----~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         213 N-------------NPPSLEG-----NKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             c-------------CCCCCcc-----cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            0             0000000     0034568899999999999999999999885

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.3e-34  Score=307.17  Aligned_cols=256  Identities=21%  Similarity=0.323  Sum_probs=189.2

Q ss_pred             ceecccCcceEEEEEeCC---CCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCC
Q 002746          563 RLLGTGSYGRVYKGILQD---GTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANG  638 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g  638 (885)
                      +.||+|+||.||+|.+.+   +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999998653   45789998875432 23457889999999999999999999999999999999999999


Q ss_pred             ccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecc
Q 002746          639 SLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV  718 (885)
Q Consensus       639 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~  718 (885)
                      +|.+++......    .....++..+..++.|++.|++|||+.+   ++||||||+||+++.++.+|++|||.++.....
T Consensus        81 ~L~~~l~~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~  153 (269)
T cd05087          81 DLKGYLRSCRKA----ELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE  153 (269)
T ss_pred             cHHHHHHHhhhc----ccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCc
Confidence            999998654321    1123667788899999999999999998   999999999999999999999999998754211


Q ss_pred             cCCCCCCCCCCCCccccccccccccCCcccCCC-------CCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHH
Q 002746          719 GVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-------NTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       719 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~  790 (885)
                      ..         ........|+..|+|||++.+.       .++.++||||||+++|||++ |+.||.......  ...+.
T Consensus       154 ~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~~  222 (269)
T cd05087         154 DY---------YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTYT  222 (269)
T ss_pred             ce---------eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHHH
Confidence            00         0111234577889999987642       35789999999999999996 999996532110  00000


Q ss_pred             HHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       791 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                         .........++.+.              ...++.+.+++.+|| .+|++|||++||++.|+
T Consensus       223 ---~~~~~~~~~~~~~~--------------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         223 ---VREQQLKLPKPRLK--------------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             ---hhcccCCCCCCccC--------------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence               00000000000000              012345788999999 58999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.2e-35  Score=343.72  Aligned_cols=257  Identities=20%  Similarity=0.303  Sum_probs=196.8

Q ss_pred             HhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeec--CCcce
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSL--PDFKA  629 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~  629 (885)
                      ...+|.+.+.||+|+||+||+|+.. .+..||+|++....  ......+..|+.++++++|||||+++++|..  ....+
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            3468999999999999999999965 57789999987442  2345678899999999999999999998854  35678


Q ss_pred             EEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCC----CceEecCCCCCceEecCC----
Q 002746          630 LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP----VRVIHCDLKPSNVLLNDD----  701 (885)
Q Consensus       630 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~----~~ivH~Dlkp~NILl~~~----  701 (885)
                      +||||+++|+|.+++......     ...+++..++.|+.||+.||+|||+.++    .+||||||||+|||++.+    
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~-----~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKM-----FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            999999999999988653211     1248999999999999999999998542    249999999999999642    


Q ss_pred             -------------CCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCC--CCCCccccchhhHHHH
Q 002746          702 -------------MTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG--SNTSTKGDVYSFGILV  766 (885)
Q Consensus       702 -------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~vl  766 (885)
                                   +.+||+|||++..+...            .......||+.|+|||++.+  ..++.++|||||||++
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~------------s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~IL  233 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIE------------SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCII  233 (1021)
T ss_pred             ccccccccccCCCCceEEccCCcccccccc------------ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHH
Confidence                         35899999999765221            11223468999999998854  4588999999999999


Q ss_pred             HHHHcCCCCCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCH
Q 002746          767 LEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTM  846 (885)
Q Consensus       767 ~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  846 (885)
                      |||++|+.||...    .....++.....             ......       ...+.++.+++..||..+|.+||++
T Consensus       234 YELLTGk~PF~~~----~~~~qli~~lk~-------------~p~lpi-------~~~S~eL~dLI~~~L~~dPeeRPSa  289 (1021)
T PTZ00266        234 YELCSGKTPFHKA----NNFSQLISELKR-------------GPDLPI-------KGKSKELNILIKNLLNLSAKERPSA  289 (1021)
T ss_pred             HHHHHCCCCCCcC----CcHHHHHHHHhc-------------CCCCCc-------CCCCHHHHHHHHHHhcCChhHCcCH
Confidence            9999999999642    112222111100             000000       0124568899999999999999999


Q ss_pred             HHHHHH
Q 002746          847 LDAADD  852 (885)
Q Consensus       847 ~ev~~~  852 (885)
                      .|++.+
T Consensus       290 ~QlL~h  295 (1021)
T PTZ00266        290 LQCLGY  295 (1021)
T ss_pred             HHHhcc
Confidence            999864

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=5e-35  Score=319.51  Aligned_cols=273  Identities=19%  Similarity=0.270  Sum_probs=196.6

Q ss_pred             ccceeccc--CcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          561 EQRLLGTG--SYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       561 ~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      +.++||+|  +|++||+++.+ +|+.||+|+++...  ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  67899999865 78999999987542  233456788999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++|+|.+++..+...       .+++..++.++.|++.||+|||+++   |+||||||+||+++.++.++++|||.+...
T Consensus        82 ~~~~l~~~~~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~  151 (327)
T cd08227          82 AYGSAKDLICTHFMD-------GMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM  151 (327)
T ss_pred             CCCcHHHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence            999999988654321       3788999999999999999999998   999999999999999999999999876544


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCC--CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG--SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      ...+....    ..........++..|+|||++.+  ..++.++|||||||++|||++|+.||.......     .....
T Consensus       152 ~~~~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~~  222 (327)
T cd08227         152 INHGQRLR----VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ-----MLLEK  222 (327)
T ss_pred             cccccccc----ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH-----HHHHH
Confidence            22111000    00111122356788999999876  458899999999999999999999997532211     11111


Q ss_pred             hcchhhhhhh-------------------hhhhhcc-----C--CChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 002746          794 YHGRLEKVID-------------------SSLLRAS-----R--DQSPEVKRMWDVAIGELIELGILCTQESPSTRPTML  847 (885)
Q Consensus       794 ~~~~~~~~~d-------------------~~~~~~~-----~--~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  847 (885)
                      .........+                   .......     .  ............+++++.+++.+||+.||++|||++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~  302 (327)
T cd08227         223 LNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSAS  302 (327)
T ss_pred             hcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHH
Confidence            1111100000                   0000000     0  000000011123456799999999999999999999


Q ss_pred             HHHHH
Q 002746          848 DAADD  852 (885)
Q Consensus       848 ev~~~  852 (885)
                      |++++
T Consensus       303 ell~~  307 (327)
T cd08227         303 TLLNH  307 (327)
T ss_pred             HHhcC
Confidence            99985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=323.86  Aligned_cols=241  Identities=24%  Similarity=0.323  Sum_probs=184.3

Q ss_pred             ecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhc---CCcccceeeeeeecCCcceEEEecccC
Q 002746          565 LGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRI---RHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       565 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lV~e~~~~  637 (885)
                      ||+|+||+||+|+.. +++.||||++....   ......+..|..++.+.   +||+|+++++++..++..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999965 68999999986432   12223445566666655   699999999999999999999999999


Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      |+|..++....         .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.++|+|||+++....
T Consensus        81 g~L~~~l~~~~---------~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~  148 (330)
T cd05586          81 GELFWHLQKEG---------RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLT  148 (330)
T ss_pred             ChHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCC
Confidence            99988876433         3788999999999999999999998   99999999999999999999999999875321


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcc
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHG  796 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  796 (885)
                      .           ........||+.|+|||++.+. .++.++||||+||++|||++|+.||...     ...+........
T Consensus       149 ~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~-----~~~~~~~~i~~~  212 (330)
T cd05586         149 D-----------NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE-----DTQQMYRNIAFG  212 (330)
T ss_pred             C-----------CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC-----CHHHHHHHHHcC
Confidence            1           1122345699999999998764 4799999999999999999999999642     111111111100


Q ss_pred             hhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCC----CHHHHHHH
Q 002746          797 RLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP----TMLDAADD  852 (885)
Q Consensus       797 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP----t~~ev~~~  852 (885)
                                  ......       ...+.++.+++.+|++.||.+||    ++.|++++
T Consensus       213 ------------~~~~~~-------~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         213 ------------KVRFPK-------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             ------------CCCCCC-------ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence                        000000       01345688999999999999998    56666553

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.3e-35  Score=310.22  Aligned_cols=253  Identities=27%  Similarity=0.450  Sum_probs=198.2

Q ss_pred             CcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcch--hhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFT--KSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      |++.+.||+|+||+||+|... +++.||+|++........  ....+|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            577899999999999999976 566899999986543322  23355999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++++|.+++....         .+++..+..++.|+++||++||+.+   |+|+||||+||++++++.++|+|||.+..+
T Consensus        81 ~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~  148 (260)
T PF00069_consen   81 PGGSLQDYLQKNK---------PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL  148 (260)
T ss_dssp             TTEBHHHHHHHHS---------SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred             ccccccccccccc---------ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence            9999999887222         3889999999999999999999998   999999999999999999999999999764


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccC-CCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhh
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF-GSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      ..           .........++..|+|||+.. +..++.++||||+|+++|+|++|..||...  ...+.........
T Consensus       149 ~~-----------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~--~~~~~~~~~~~~~  215 (260)
T PF00069_consen  149 SE-----------NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES--NSDDQLEIIEKIL  215 (260)
T ss_dssp             TS-----------TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS--SHHHHHHHHHHHH
T ss_pred             cc-----------cccccccccccccccccccccccccccccccccccccccccccccccccccc--cchhhhhhhhhcc
Confidence            11           122333457899999999998 888999999999999999999999999753  0001111111111


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..        ....... .       ......++.+++.+||+.||++||++.+++++
T Consensus       216 ~~--------~~~~~~~-~-------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  216 KR--------PLPSSSQ-Q-------SREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HT--------HHHHHTT-S-------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             cc--------ccccccc-c-------cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00        0000000 0       00012579999999999999999999999874

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7e-35  Score=312.12  Aligned_cols=272  Identities=27%  Similarity=0.373  Sum_probs=204.3

Q ss_pred             hCCcccceecccCcceEEEEEeC-----CCCEEEEEEeeecCCc-chhhHHHHHHHHhhcCCcccceeeeeeec--CCcc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-----DGTAIAVKVLQLQSGN-FTKSFNRECQVLKRIRHRNLMRIITACSL--PDFK  628 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~  628 (885)
                      +.|.+.+.||+|+||.||+|++.     ++..||||+++..... ..+.+.+|++++++++|+|++++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45777899999999999999854     3688999999755443 46789999999999999999999999877  5578


Q ss_pred             eEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcc
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSD  708 (885)
Q Consensus       629 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D  708 (885)
                      ++||||+++++|.+++.....        .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~d  152 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRD--------QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISD  152 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCcc--------ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcc
Confidence            999999999999999875432        3889999999999999999999998   99999999999999999999999


Q ss_pred             cccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHH
Q 002746          709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~  788 (885)
                      ||.+........        .........++..|+|||...+..++.++||||||+++|||++|+.|+.........   
T Consensus       153 fg~~~~~~~~~~--------~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---  221 (284)
T cd05038         153 FGLAKVLPEDKD--------YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---  221 (284)
T ss_pred             cccccccccCCc--------ceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---
Confidence            999987632100        000111223456799999998889999999999999999999999998653211100   


Q ss_pred             HHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 002746          789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       789 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                      ++...........+...+....+...+      ..++.++.+++.+||+.+|++||+|.||+++|+.+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         222 MIGIAQGQMIVTRLLELLKEGERLPRP------PSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             ccccccccccHHHHHHHHHcCCcCCCC------ccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            000000000000001111111110000      12446799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.1e-35  Score=320.57  Aligned_cols=255  Identities=20%  Similarity=0.234  Sum_probs=195.5

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec---CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ++|++.+.||+|+||.||+++.. .++.||+|++...   .......+.+|+.++..++|++|+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36889999999999999999966 5788999998632   2223445888999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++|+|.+++.....        .+++..+..++.|++.|++|||+++   |+||||||+||+++.++.+||+|||++
T Consensus        81 ey~~~g~L~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a  149 (332)
T cd05623          81 DYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSC  149 (332)
T ss_pred             eccCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchh
Confidence            99999999999865321        3788889999999999999999998   999999999999999999999999998


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccC-----CCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF-----GSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH  787 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~  787 (885)
                      ..+...+          ........||+.|+|||++.     ...++.++|||||||++|||++|+.||...     +..
T Consensus       150 ~~~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~-----~~~  214 (332)
T cd05623         150 LKLMEDG----------TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE-----SLV  214 (332)
T ss_pred             eecccCC----------cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC-----CHH
Confidence            7553211          11122346999999999876     346789999999999999999999999642     111


Q ss_pred             HHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 002746          788 KWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPST--RPTMLDAADD  852 (885)
Q Consensus       788 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~  852 (885)
                      +........        .    .....+.   ....++.++.+++.+|++.++.+  ||+++|++++
T Consensus       215 ~~~~~i~~~--------~----~~~~~p~---~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         215 ETYGKIMNH--------K----ERFQFPA---QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             HHHHHHhCC--------C----ccccCCC---ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            111111100        0    0000000   01124566888999988665544  7899999887

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.1e-35  Score=321.18  Aligned_cols=255  Identities=20%  Similarity=0.235  Sum_probs=195.8

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec---CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|++...   .......+.+|..++..++|++|+++++++..++..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999965 6888999998642   2223455788999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++|+|.+++.....        .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++
T Consensus        81 Ey~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a  149 (331)
T cd05624          81 DYYVGGDLLTLLSKFED--------RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSC  149 (331)
T ss_pred             eCCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccce
Confidence            99999999999865321        3788889999999999999999998   999999999999999999999999999


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCC-----CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-----SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH  787 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~  787 (885)
                      +.+....          ........||++|+|||++.+     ..++.++|||||||++|||++|+.||...     ...
T Consensus       150 ~~~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~-----~~~  214 (331)
T cd05624         150 LKMNQDG----------TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE-----SLV  214 (331)
T ss_pred             eeccCCC----------ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC-----CHH
Confidence            7653211          111123468999999998875     46788999999999999999999999642     111


Q ss_pred             HHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 002746          788 KWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPST--RPTMLDAADD  852 (885)
Q Consensus       788 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~  852 (885)
                      +......        ..    ..+...+   ......++++.+++.+|++.++++  |++++++.++
T Consensus       215 ~~~~~i~--------~~----~~~~~~p---~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         215 ETYGKIM--------NH----EERFQFP---SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             HHHHHHH--------cC----CCcccCC---CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            1111110        00    0000000   001123566889999999876654  5688888876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.7e-34  Score=311.42  Aligned_cols=283  Identities=22%  Similarity=0.305  Sum_probs=207.9

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCc-----chhhHHHHHHHHhhcCCcccceeeeeeecCCcceEE
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGN-----FTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV  631 (885)
                      +|+..+.||+|++|.||+|... +++.||||.++.....     ....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778899999999999999965 6899999999754322     345577899999999999999999999999999999


Q ss_pred             EecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccc
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~  711 (885)
                      |||+ +|+|.+++....        ..+++..+..++.|+++||+|||+++   |+||||||+||+++.++.++|+|||+
T Consensus        81 ~e~~-~~~L~~~i~~~~--------~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~  148 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--------IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGL  148 (298)
T ss_pred             Eccc-CCCHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEcccee
Confidence            9999 999999886543        13889999999999999999999998   99999999999999999999999999


Q ss_pred             ceeeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHH
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~  790 (885)
                      ++......           .......+++.|+|||.+.+ ..++.++|||||||++|||++|..||...... ..+....
T Consensus       149 ~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~  216 (298)
T cd07841         149 ARSFGSPN-----------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIF  216 (298)
T ss_pred             eeeccCCC-----------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHH
Confidence            98763211           11122346788999998755 45789999999999999999998887642111 1111111


Q ss_pred             HHhhcchhhhhh-h-h---hhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHhcCCCC
Q 002746          791 KNHYHGRLEKVI-D-S---SLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGEKHM  865 (885)
Q Consensus       791 ~~~~~~~~~~~~-d-~---~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~~~~  865 (885)
                      . .......... + .   ....................+.++.+++.+||+.+|++|||++|++++     .|+.+...
T Consensus       217 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~-----~~~~~~~~  290 (298)
T cd07841         217 E-ALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH-----PYFSNDPA  290 (298)
T ss_pred             H-HcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC-----ccccCCCC
Confidence            1 0100000000 0 0   000000000111122223346779999999999999999999999994     67776666


Q ss_pred             CCccc
Q 002746          866 PSKMN  870 (885)
Q Consensus       866 ~~~~~  870 (885)
                      +-.++
T Consensus       291 ~~~~~  295 (298)
T cd07841         291 PTPPS  295 (298)
T ss_pred             CCCCC
Confidence            65544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.9e-34  Score=307.44  Aligned_cols=248  Identities=25%  Similarity=0.376  Sum_probs=200.8

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      ..|+..+.||+|+||.||+|.+. ++..||+|++.... ......+.+|++++++++|||++++++++.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45777889999999999999975 58899999987543 33456788999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +++|+|.+++...          .+++.....++.|++.|++|||+.+   ++|+||+|+||+++.++.++++|||.+..
T Consensus        84 ~~~~~L~~~i~~~----------~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~  150 (277)
T cd06640          84 LGGGSALDLLRAG----------PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQ  150 (277)
T ss_pred             CCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEccccccee
Confidence            9999999988642          2678888999999999999999998   99999999999999999999999999976


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      +....           .......++..|+|||++.+..++.++|||||||++|||++|..||......     .....  
T Consensus       151 ~~~~~-----------~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~~~--  212 (277)
T cd06640         151 LTDTQ-----------IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-----RVLFL--  212 (277)
T ss_pred             ccCCc-----------cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-----hHhhh--
Confidence            53211           1112345788999999998888999999999999999999999998653111     00000  


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                             ..    ......      ....++.++.+++.+||+.+|++||+++|++.+
T Consensus       213 -------~~----~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         213 -------IP----KNNPPT------LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             -------hh----cCCCCC------CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence                   00    000000      112356678999999999999999999999887

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.5e-35  Score=311.62  Aligned_cols=247  Identities=26%  Similarity=0.375  Sum_probs=198.3

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      .|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4666788999999999999865 57889999987443 334567889999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++++|.+++...          .+++..+..++.|++.|+.|||+++   ++|+||+|+||++++++.++++|||++..+
T Consensus        85 ~~~~L~~~~~~~----------~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06642          85 GGGSALDLLKPG----------PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQL  151 (277)
T ss_pred             CCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccc
Confidence            999999887532          2788899999999999999999998   999999999999999999999999998765


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhc
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~  795 (885)
                      ...           ........|+..|+|||++.+..++.++|||||||++|||++|+.||......     .+...   
T Consensus       152 ~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~~~---  212 (277)
T cd06642         152 TDT-----------QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-----RVLFL---  212 (277)
T ss_pred             cCc-----------chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-----hHHhh---
Confidence            321           11112245788999999999989999999999999999999999998653211     00000   


Q ss_pred             chhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       796 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                            +...    .....      ...++.++.+++.+||+.+|++||+|.|++++
T Consensus       213 ------~~~~----~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         213 ------IPKN----SPPTL------EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ------hhcC----CCCCC------CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                  0000    00000      01134568899999999999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=9e-35  Score=311.48  Aligned_cols=273  Identities=21%  Similarity=0.262  Sum_probs=197.8

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      +|++.+.||+|++|.||+|+.. ++..||+|+++...  ....+.+.+|+.++++++|||++++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999965 68999999987442  22346788999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      ++ ++|.+++.....      ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||++..
T Consensus        81 ~~-~~l~~~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  150 (285)
T cd07861          81 LS-MDLKKYLDSLPK------GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARA  150 (285)
T ss_pred             CC-CCHHHHHhcCCC------CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceee
Confidence            97 678777754321      124889999999999999999999998   99999999999999999999999999875


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      ....           ........+++.|+|||++.+. .++.++|||||||++|||+||+.||...... ..........
T Consensus       151 ~~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~-~~~~~~~~~~  218 (285)
T cd07861         151 FGIP-----------VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI-DQLFRIFRIL  218 (285)
T ss_pred             cCCC-----------cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHh
Confidence            4221           1111223568899999987654 4689999999999999999999999642111 0000000000


Q ss_pred             hc---chhhhhhh-hhhhhcc-CCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          794 YH---GRLEKVID-SSLLRAS-RDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       794 ~~---~~~~~~~d-~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..   ..+....+ ....... ..............+.++.+++.+|++.||++|||+.+++.+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         219 GTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             CCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            00   00000000 0000000 000001111122245678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.3e-35  Score=309.73  Aligned_cols=239  Identities=24%  Similarity=0.404  Sum_probs=186.7

Q ss_pred             ceecccCcceEEEEEeCC--------CCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          563 RLLGTGSYGRVYKGILQD--------GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      +.||+|+||.||+|....        ..+||+|.+........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            368999999999998642        234888887655445567788999999999999999999999998999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCC--------EEE
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMT--------ALV  706 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~--------~kl  706 (885)
                      +++|+|..+++....        .+++..+..++.||+.|++|||+++   |+||||||+||+++.++.        +++
T Consensus        81 ~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l  149 (258)
T cd05078          81 VKFGSLDTYLKKNKN--------LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKL  149 (258)
T ss_pred             CCCCcHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEe
Confidence            999999999875432        3788999999999999999999998   999999999999987765        589


Q ss_pred             cccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCC-CCCCccccCCc
Q 002746          707 SDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR-RPTDDMFAGGL  784 (885)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~-~P~~~~~~~~~  784 (885)
                      +|||.+.....               .....++..|+|||++.+. .++.++||||||+++|||++|. .||.....   
T Consensus       150 ~d~g~~~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~---  211 (258)
T cd05078         150 SDPGISITVLP---------------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS---  211 (258)
T ss_pred             cccccccccCC---------------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH---
Confidence            99998865421               1224578899999998774 5789999999999999999995 55543100   


Q ss_pred             cHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 002746          785 SLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDL  853 (885)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  853 (885)
                        ....         .....     .....+       ..+.++.+++.+||+.+|++|||++++++.|
T Consensus       212 --~~~~---------~~~~~-----~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         212 --QKKL---------QFYED-----RHQLPA-------PKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             --HHHH---------HHHHc-----cccCCC-------CCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence              0000         00000     000000       1234688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.6e-34  Score=307.82  Aligned_cols=262  Identities=25%  Similarity=0.394  Sum_probs=202.8

Q ss_pred             hCCcccceecccCcceEEEEEeC------CCCEEEEEEeeecCCc-chhhHHHHHHHHhhcCCcccceeeeeeecCCcce
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ------DGTAIAVKVLQLQSGN-FTKSFNRECQVLKRIRHRNLMRIITACSLPDFKA  629 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  629 (885)
                      ++|++.+.||+|+||.||+|+.+      +...||+|.+...... ..+.+.+|++++++++|+|++++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57888999999999999999964      3467999988654433 4567999999999999999999999999989999


Q ss_pred             EEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccc
Q 002746          630 LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDF  709 (885)
Q Consensus       630 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df  709 (885)
                      +||||+++|+|.+++.......-......+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            99999999999999875542111111224899999999999999999999998   999999999999999999999999


Q ss_pred             ccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHH
Q 002746          710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~  788 (885)
                      |++.......          ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.....     ..
T Consensus       162 ~~~~~~~~~~----------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-----~~  226 (275)
T cd05046         162 SLSKDVYNSE----------YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-----EE  226 (275)
T ss_pred             ccccccCccc----------ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-----HH
Confidence            9986442110          111223356778999999988889999999999999999999 7888854211     11


Q ss_pred             HHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       789 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                      .+..........        ...          ..++..+.+++.+||+.+|.+||++.|+++.|.
T Consensus       227 ~~~~~~~~~~~~--------~~~----------~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         227 VLNRLQAGKLEL--------PVP----------EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHHHHHcCCcCC--------CCC----------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            111111000000        000          013456899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-35  Score=311.29  Aligned_cols=256  Identities=21%  Similarity=0.328  Sum_probs=199.0

Q ss_pred             HHhhCCcccceecccCcceEEEEEeCCCCEEEEEEeeec--CCcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcceE
Q 002746          554 EATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFKAL  630 (885)
Q Consensus       554 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  630 (885)
                      .....|++.+.||+||.+.||++...+.+.||+|++...  +.....-|..|++.|.++ .|.+||++|+|-..++..||
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            345678999999999999999999888888888876533  334567799999999999 58999999999999999999


Q ss_pred             EEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccc
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG  710 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg  710 (885)
                      ||||= .-+|..+++.....       ...| .+..+..||+.|+.++|+.|   |||.||||.|+|+-. |.+||+|||
T Consensus       438 vmE~G-d~DL~kiL~k~~~~-------~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFG  504 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKKSI-------DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFG  504 (677)
T ss_pred             Eeecc-cccHHHHHHhccCC-------CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeec
Confidence            99984 66899999876542       1334 67889999999999999999   999999999999964 689999999


Q ss_pred             cceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCC-----------CCccccchhhHHHHHHHHcCCCCCCcc
Q 002746          711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN-----------TSTKGDVYSFGILVLEMVTRRRPTDDM  779 (885)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~Dv~slG~vl~elltg~~P~~~~  779 (885)
                      +|..+...         ..+.....-+||+.||+||.+....           ++.++||||+|||+|+|+.|+.||...
T Consensus       505 IA~aI~~D---------TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~  575 (677)
T KOG0596|consen  505 IANAIQPD---------TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI  575 (677)
T ss_pred             hhcccCcc---------ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence            99877432         1233344568999999999865432           467899999999999999999999752


Q ss_pred             ccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          780 FAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       780 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..      .|      .++..+.|+.-.-.+..-.+         ..++.++++.|+++||++||++.|++++
T Consensus       576 ~n------~~------aKl~aI~~P~~~Iefp~~~~---------~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  576 IN------QI------AKLHAITDPNHEIEFPDIPE---------NDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             HH------HH------HHHHhhcCCCccccccCCCC---------chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            11      11      12333333322111111111         1238899999999999999999999875

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-34  Score=310.69  Aligned_cols=252  Identities=24%  Similarity=0.361  Sum_probs=197.3

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      +|++.+.||+|+||.||+|... +++.||+|.++... ......+.+|++++++++|+||+++++++..++..++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            6788899999999999999976 78999999887542 223467889999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH-SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      ++++|..++.....      ...+++..+..++.+++.|+.|||+. +   |+||||||+||+++.++.++|+|||.+..
T Consensus        82 ~~~~l~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  152 (286)
T cd06622          82 DAGSLDKLYAGGVA------TEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGN  152 (286)
T ss_pred             CCCCHHHHHHhccc------cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCccc
Confidence            99999888764321      12489999999999999999999974 6   99999999999999999999999999876


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCCC------CCccccchhhHHHHHHHHcCCCCCCccccCCccHHH
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN------TSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~  788 (885)
                      +..             .......|++.|+|||++.+..      ++.++|||||||++|||++|+.||.....     ..
T Consensus       153 ~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~  214 (286)
T cd06622         153 LVA-------------SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-----AN  214 (286)
T ss_pred             ccC-------------CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-----hh
Confidence            521             1112235788999999875543      48899999999999999999999964211     01


Q ss_pred             HHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       789 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      +...     .....+     ......      ...++.++.+++.+||+.+|++||++++++.+
T Consensus       215 ~~~~-----~~~~~~-----~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         215 IFAQ-----LSAIVD-----GDPPTL------PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             HHHH-----HHHHhh-----cCCCCC------CcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            0000     000000     000000      01245678899999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.9e-35  Score=313.93  Aligned_cols=258  Identities=24%  Similarity=0.327  Sum_probs=201.3

Q ss_pred             CcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccC
Q 002746          559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~  637 (885)
                      |.....||+|+||.||++... ++..||||.+........+.+.+|+.++++++|+|++++++.+...+..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            444567999999999999864 6889999998755545567788999999999999999999999999999999999999


Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      ++|.+++...          .+++..+..++.||+.|++|||+++   |+||||||+||+++.++.++|+|||++.....
T Consensus       104 ~~L~~~~~~~----------~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (292)
T cd06658         104 GALTDIVTHT----------RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK  170 (292)
T ss_pred             CcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence            9999887432          2788899999999999999999998   99999999999999999999999999875422


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcch
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR  797 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  797 (885)
                      .           ........|+..|+|||+..+..++.++||||||+++|||++|+.||.....    . ..+...    
T Consensus       171 ~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~-~~~~~~----  230 (292)
T cd06658         171 E-----------VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP----L-QAMRRI----  230 (292)
T ss_pred             c-----------cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----H-HHHHHH----
Confidence            1           1111234688999999999888899999999999999999999999864211    0 000000    


Q ss_pred             hhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHhcCCCCCC
Q 002746          798 LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGEKHMPS  867 (885)
Q Consensus       798 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~~~~~~  867 (885)
                       ..........            ....+..+.+++.+|+..||.+|||++|++++     .++....-+.
T Consensus       231 -~~~~~~~~~~------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~-----~~~~~~~~~~  282 (292)
T cd06658         231 -RDNLPPRVKD------------SHKVSSVLRGFLDLMLVREPSQRATAQELLQH-----PFLKLAGPPS  282 (292)
T ss_pred             -HhcCCCcccc------------ccccCHHHHHHHHHHccCChhHCcCHHHHhhC-----hhhhccCCcc
Confidence             0000000000            00134568889999999999999999999985     4444444443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.8e-35  Score=313.39  Aligned_cols=270  Identities=21%  Similarity=0.262  Sum_probs=196.6

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      +|++.+.||+|++|.||+|+.. +|+.||+|.++...  ......+.+|++++++++|||++++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999975 68999999987442  22345678899999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      ++ ++|.+++....        ..+++..++.++.||++||.|||+++   |+||||||+||+++.++.++|+|||.++.
T Consensus        81 ~~-~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~  148 (284)
T cd07839          81 CD-QDLKKYFDSCN--------GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARA  148 (284)
T ss_pred             CC-CCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhc
Confidence            96 57776665322        13789999999999999999999998   99999999999999999999999999975


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      ....           ........++..|+|||++.+. .++.++|||||||++|||+||+.|+.........+ +.+...
T Consensus       149 ~~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~-~~~~~~  216 (284)
T cd07839         149 FGIP-----------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KRIFRL  216 (284)
T ss_pred             cCCC-----------CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHH-HHHHHH
Confidence            5221           1112234578899999987765 46899999999999999999999964321111111 111111


Q ss_pred             hcch----hhh---hhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          794 YHGR----LEK---VIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       794 ~~~~----~~~---~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ....    ...   ..+........ ............+.++.+++.+|++.||.+|||++|++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         217 LGTPTEESWPGVSKLPDYKPYPMYP-ATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             hCCCChHHhHHhhhcccccccCCCC-CcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            1000    000   00000000000 0001111122346778999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.5e-34  Score=312.32  Aligned_cols=258  Identities=26%  Similarity=0.471  Sum_probs=199.0

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCC----EEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcce
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGT----AIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKA  629 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  629 (885)
                      ..+|+..+.||+|+||.||+|.+. +|.    .||+|.+..... .....+.+|+.++++++||||++++++|..+ ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            356788899999999999999864 344    478888764432 2234688999999999999999999998754 467


Q ss_pred             EEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccc
Q 002746          630 LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDF  709 (885)
Q Consensus       630 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df  709 (885)
                      +|+||+++|+|.+++..+..        .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+||
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Df  153 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKD--------NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDF  153 (303)
T ss_pred             eeehhcCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccc
Confidence            99999999999998865432        3788899999999999999999998   999999999999999999999999


Q ss_pred             ccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHH
Q 002746          710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~  788 (885)
                      |+++.+....         .........++..|+|||++.+..++.++|||||||++|||++ |+.||.....  ....+
T Consensus       154 g~~~~~~~~~---------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~  222 (303)
T cd05110         154 GLARLLEGDE---------KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPD  222 (303)
T ss_pred             cccccccCcc---------cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHH
Confidence            9998663211         0011122345778999999999999999999999999999997 8999864211  11111


Q ss_pred             HHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 002746          789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR  858 (885)
Q Consensus       789 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~  858 (885)
                      ++..                ......+      ..++.++.+++.+||..+|++||+++|+++.+..+.+
T Consensus       223 ~~~~----------------~~~~~~~------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         223 LLEK----------------GERLPQP------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             HHHC----------------CCCCCCC------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            1110                0000000      0124468899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.4e-34  Score=315.03  Aligned_cols=202  Identities=23%  Similarity=0.336  Sum_probs=159.2

Q ss_pred             ceecccCcceEEEEEeC---CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeec--CCcceEEEecccC
Q 002746          563 RLLGTGSYGRVYKGILQ---DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL--PDFKALVLPYMAN  637 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lV~e~~~~  637 (885)
                      ..||+|+||.||+|+..   ++..||+|.++...  ....+.+|++++++++||||+++++++..  +...++||||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            57999999999999965   45789999886432  33567899999999999999999998853  4567899999864


Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEe----cCCCCEEEcccccce
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL----NDDMTALVSDFGIAK  713 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl----~~~~~~kl~Dfg~a~  713 (885)
                       ++.+++..............+++..+..++.|++.||+|||+++   |+||||||+||++    +.++.+||+|||+|+
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             66665543221111112235889999999999999999999998   9999999999999    566899999999998


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCc
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDD  778 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~  778 (885)
                      .+.....        .........||+.|+|||++.+. .++.++|||||||++|||+||+.||..
T Consensus       161 ~~~~~~~--------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         161 LFNSPLK--------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             ccCCCcc--------cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            6632110        01122345689999999988764 579999999999999999999999964

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-34  Score=301.28  Aligned_cols=248  Identities=27%  Similarity=0.442  Sum_probs=196.3

Q ss_pred             ceecccCcceEEEEEeCCCCEEEEEEeeecCCc-chhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCCccc
Q 002746          563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGN-FTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLD  641 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL~  641 (885)
                      ++||+|++|.||+|...+++.||+|.++..... ..+.+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            469999999999999877999999998755433 4567899999999999999999999999999999999999999999


Q ss_pred             cccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecccCC
Q 002746          642 SHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG  721 (885)
Q Consensus       642 ~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~  721 (885)
                      +++.....        .+++..+..++.+++.|++|||+++   ++||||||+||+++.++.++|+|||.+........ 
T Consensus        81 ~~l~~~~~--------~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-  148 (251)
T cd05041          81 TFLRKKKN--------RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY-  148 (251)
T ss_pred             HHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcc-
Confidence            98864321        3788899999999999999999998   99999999999999999999999999976531100 


Q ss_pred             CCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHHhhcchhhh
Q 002746          722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHYHGRLEK  800 (885)
Q Consensus       722 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~  800 (885)
                              ........++..|+|||+..+..++.++|||||||++|||+| |..||......  .....           
T Consensus       149 --------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~-----------  207 (251)
T cd05041         149 --------TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRER-----------  207 (251)
T ss_pred             --------eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHH-----------
Confidence                    000011234567999999988899999999999999999999 88888642110  01111           


Q ss_pred             hhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          801 VIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       801 ~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                       +....    ....+      ...+.++.+++.+|++.+|.+||++.|+++.|+
T Consensus       208 -~~~~~----~~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         208 -IESGY----RMPAP------QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             -HhcCC----CCCCC------ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence             11000    00000      113457999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-35  Score=311.19  Aligned_cols=258  Identities=24%  Similarity=0.379  Sum_probs=208.2

Q ss_pred             HhhCCcccceecccCcceEEEEEeC---CCC--EEEEEEeeec-CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcc
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ---DGT--AIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFK  628 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~---~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  628 (885)
                      ..+.....++||.|-||.||+|...   .|+  .||||..+.. .....+.|.+|+.+++.++|||||+++|.|.+ ...
T Consensus       387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~  465 (974)
T KOG4257|consen  387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM  465 (974)
T ss_pred             ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence            3344456678999999999999853   233  4888988864 44557889999999999999999999999975 457


Q ss_pred             eEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcc
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSD  708 (885)
Q Consensus       629 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D  708 (885)
                      ++|||.++-|.|..+++..+.        .++......++.||..||+|||+..   +|||||...|||+.....+|++|
T Consensus       466 WivmEL~~~GELr~yLq~nk~--------sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaD  534 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQNKD--------SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLAD  534 (974)
T ss_pred             eEEEecccchhHHHHHHhccc--------cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecc
Confidence            999999999999999987654        3888899999999999999999987   99999999999999999999999


Q ss_pred             cccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHH
Q 002746          709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLH  787 (885)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~  787 (885)
                      ||+++.+....+          ..++...-...|||||.+.-++++.++|||.|||.+||++. |..||......+.   
T Consensus       535 FGLSR~~ed~~y----------YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV---  601 (974)
T KOG4257|consen  535 FGLSRYLEDDAY----------YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV---  601 (974)
T ss_pred             cchhhhccccch----------hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce---
Confidence            999998854221          11112233567999999999999999999999999999887 9999976432211   


Q ss_pred             HHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 002746          788 KWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR  858 (885)
Q Consensus       788 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~  858 (885)
                                     -..+..+.+.+.|.      .|++.+..++.+||++||.+||++.|+.+.|.++..
T Consensus       602 ---------------I~~iEnGeRlP~P~------nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  602 ---------------IGHIENGERLPCPP------NCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             ---------------EEEecCCCCCCCCC------CCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence                           01122223323322      378889999999999999999999999999987765

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8.9e-35  Score=311.66  Aligned_cols=262  Identities=23%  Similarity=0.334  Sum_probs=198.7

Q ss_pred             HHHHHHhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhc-CCcccceeeeeee----
Q 002746          550 RELLEATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLMRIITACS----  623 (885)
Q Consensus       550 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~----  623 (885)
                      +.+..+.++|++.+.||+|+||.||+|... +++.+|+|+++... .....+..|+.+++++ +|||++++++++.    
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   89 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV   89 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence            344456789999999999999999999865 68899999876432 2346688899999999 6999999999874    


Q ss_pred             -cCCcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCC
Q 002746          624 -LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDM  702 (885)
Q Consensus       624 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~  702 (885)
                       .++..++||||+++|+|.+++.....     ....+++..+..++.|+++|+.|||+.+   |+||||||+||+++.++
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~  161 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFLK-----RGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEG  161 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhhc-----cCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCC
Confidence             34567999999999999987653211     1124788899999999999999999998   99999999999999999


Q ss_pred             CEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCC-----CCCCccccchhhHHHHHHHHcCCCCCC
Q 002746          703 TALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-----SNTSTKGDVYSFGILVLEMVTRRRPTD  777 (885)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~elltg~~P~~  777 (885)
                      .++|+|||.++.+...           ........|++.|+|||++..     ..++.++||||+||++|||++|+.||.
T Consensus       162 ~~kl~dfg~~~~~~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~  230 (286)
T cd06638         162 GVKLVDFGVSAQLTST-----------RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA  230 (286)
T ss_pred             CEEEccCCceeecccC-----------CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCC
Confidence            9999999999865321           111223458899999998753     457889999999999999999999986


Q ss_pred             ccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 002746          778 DMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDL  853 (885)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  853 (885)
                      ....    ...+.. ..........           .+      ..++.++.+++.+||+.+|++||++.|++++.
T Consensus       231 ~~~~----~~~~~~-~~~~~~~~~~-----------~~------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         231 DLHP----MRALFK-IPRNPPPTLH-----------QP------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             CCch----hHHHhh-ccccCCCccc-----------CC------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            5311    111100 0000000000           00      01234688999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.1e-34  Score=303.32  Aligned_cols=249  Identities=24%  Similarity=0.375  Sum_probs=198.9

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      +|+..+.||+|++|.||+|... +++.+|+|.+....  ......+.+|++++++++|||++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4788899999999999999964 68899999987442  23456788999999999999999999999989999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCC-CCEEEcccccce
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDD-MTALVSDFGIAK  713 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~Dfg~a~  713 (885)
                      +++++|.+++.....       ..+++..+..++.+++.|++|||+++   |+||||||+||+++.+ +.++++|||.+.
T Consensus        81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~  150 (256)
T cd08220          81 APGGTLAEYIQKRCN-------SLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISK  150 (256)
T ss_pred             CCCCCHHHHHHHhcc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCce
Confidence            999999999865431       23788999999999999999999998   9999999999999854 568999999998


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      .....            .......|+..|+|||...+..++.++||||||+++|+|++|+.||...     .....+...
T Consensus       151 ~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~-----~~~~~~~~~  213 (256)
T cd08220         151 ILSSK------------SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA-----NLPALVLKI  213 (256)
T ss_pred             ecCCC------------ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC-----chHHHHHHH
Confidence            65321            1112345788999999999888999999999999999999999998642     111111111


Q ss_pred             hcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       794 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ...            ......       +.++.++.+++.+||+.+|++|||+.|++++
T Consensus       214 ~~~------------~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         214 MSG------------TFAPIS-------DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             Hhc------------CCCCCC-------CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            100            000000       1135568999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.5e-34  Score=304.60  Aligned_cols=252  Identities=25%  Similarity=0.373  Sum_probs=193.0

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC-----cchhhHHHHHHHHhhcCCcccceeeeeeecC--Ccc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-----NFTKSFNRECQVLKRIRHRNLMRIITACSLP--DFK  628 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  628 (885)
                      .+|...+.||+|+||.||+|... ++..||+|+++....     ...+.+.+|+.++++++||||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36888999999999999999865 689999998864321     2345688899999999999999999988653  566


Q ss_pred             eEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcc
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSD  708 (885)
Q Consensus       629 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D  708 (885)
                      ++++||+++++|.+++....         .+++...+.++.|++.|++|||+.+   |+||||||+||+++.++.++|+|
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~d  149 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG---------ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGD  149 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEcc
Confidence            89999999999998886432         2788888999999999999999998   99999999999999999999999


Q ss_pred             cccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHH
Q 002746          709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~  788 (885)
                      ||++..+.....        .........++..|+|||++.+..++.++|||||||++|||++|+.||.....    . .
T Consensus       150 fg~~~~~~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----~-~  216 (266)
T cd06651         150 FGASKRLQTICM--------SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----M-A  216 (266)
T ss_pred             CCCccccccccc--------cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----H-H
Confidence            999876532110        01111224578899999999998899999999999999999999999975211    1 1


Q ss_pred             HHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       789 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .+....            ........+      ....+.+.+++ +||..+|++||+|+|++.+
T Consensus       217 ~~~~~~------------~~~~~~~~~------~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         217 AIFKIA------------TQPTNPQLP------SHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             HHHHHh------------cCCCCCCCc------hhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            110000            000000001      11234466666 6888999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.5e-34  Score=306.99  Aligned_cols=262  Identities=24%  Similarity=0.320  Sum_probs=199.0

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecC--CcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLP--DFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lV~  632 (885)
                      ++|+..+.||.|++|.||+|... +++.+|+|.+..... .....+.+|++++++++||||++++++|...  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999975 688999999874432 3456789999999999999999999988653  4678999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++++|.+++.....     ....+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~-----~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~  152 (287)
T cd06621          81 EYCEGGSLDSIYKKVKK-----RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVS  152 (287)
T ss_pred             EecCCCCHHHHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccc
Confidence            99999999887653221     1224788899999999999999999998   999999999999999999999999998


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      ......             ......++..|+|||...+..++.++||||+||++|+|++|+.||...........+....
T Consensus       153 ~~~~~~-------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  219 (287)
T cd06621         153 GELVNS-------------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY  219 (287)
T ss_pred             cccccc-------------ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH
Confidence            754211             1112356788999999999899999999999999999999999997542211111111111


Q ss_pred             hhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       793 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .........     . ......       ...++++.+++.+||+.+|++|||+.|++++
T Consensus       220 ~~~~~~~~~-----~-~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         220 IVNMPNPEL-----K-DEPGNG-------IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             HhcCCchhh-----c-cCCCCC-------CchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            110000000     0 000000       0134568999999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.3e-34  Score=303.41  Aligned_cols=248  Identities=27%  Similarity=0.386  Sum_probs=198.6

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC-----CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEE
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-----GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV  631 (885)
                      +|...+.||+|++|.||+|... +++.||+|.+....     ....+.+..|++++++++|+|++++++++..+...++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4777899999999999999976 78999999987543     22456788999999999999999999999999999999


Q ss_pred             EecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccc
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~  711 (885)
                      +||+++++|.+++....         .+++..+..++.|++.|++|||+.+   |+|+||+|+||+++.++.+||+|||.
T Consensus        81 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~  148 (258)
T cd06632          81 LELVPGGSLAKLLKKYG---------SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGM  148 (258)
T ss_pred             EEecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCcc
Confidence            99999999999886442         2788899999999999999999998   99999999999999999999999999


Q ss_pred             ceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCC-CCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHH
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~  790 (885)
                      +.......            ......|+..|+|||...... ++.++|+||||+++|+|++|+.||.....    . ...
T Consensus       149 ~~~~~~~~------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----~-~~~  211 (258)
T cd06632         149 AKQVVEFS------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----V-AAV  211 (258)
T ss_pred             ceeccccc------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH----H-HHH
Confidence            87653211            122345788999999987766 89999999999999999999999965311    1 111


Q ss_pred             HHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       791 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ......            ......      ....++++.+++.+||+.+|++||++.+++.+
T Consensus       212 ~~~~~~------------~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         212 FKIGRS------------KELPPI------PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             HHHHhc------------ccCCCc------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            000000            000000      01134568899999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1e-34  Score=312.36  Aligned_cols=261  Identities=22%  Similarity=0.322  Sum_probs=203.4

Q ss_pred             CcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccC
Q 002746          559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~  637 (885)
                      |+....||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++|||++++++++..++..++|+||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            334457999999999999965 6899999998765555567788999999999999999999999999999999999999


Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      ++|..++...          .+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||++..+..
T Consensus       103 ~~L~~~~~~~----------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~  169 (297)
T cd06659         103 GALTDIVSQT----------RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK  169 (297)
T ss_pred             CCHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccc
Confidence            9998876432          2788999999999999999999998   99999999999999999999999999875432


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcch
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR  797 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  797 (885)
                      .           ........|+..|+|||++.+..++.++|||||||++|||++|+.||.....     ...+.......
T Consensus       170 ~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~  233 (297)
T cd06659         170 D-----------VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP-----VQAMKRLRDSP  233 (297)
T ss_pred             c-----------cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhccC
Confidence            1           1111234688999999999988999999999999999999999999864211     01011000000


Q ss_pred             hhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHhcCCCCCCccc
Q 002746          798 LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGEKHMPSKMN  870 (885)
Q Consensus       798 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~~~~~~~~~  870 (885)
                           .... .           .....+.++.+++.+|++.+|++||+++|++++     .++.+...+....
T Consensus       234 -----~~~~-~-----------~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~-----~~~~~~~~~~~~~  284 (297)
T cd06659         234 -----PPKL-K-----------NAHKISPVLRDFLERMLTREPQERATAQELLDH-----PFLLQTGLPECLV  284 (297)
T ss_pred             -----CCCc-c-----------ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC-----hhhccCCCccccc
Confidence                 0000 0           001134568899999999999999999999996     4444554444433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=8.7e-35  Score=311.74  Aligned_cols=271  Identities=23%  Similarity=0.327  Sum_probs=200.3

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC--cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEe
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG--NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++.....  ...+.+.+|++++++++||||+++++++..++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36888999999999999999976 589999998764322  235678899999999999999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      |++++++..+.....         .+++..+..++.|++.|++|||+.+   |+||||+|+||++++++.++|+|||++.
T Consensus        81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~  148 (286)
T cd07846          81 FVDHTVLDDLEKYPN---------GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR  148 (286)
T ss_pred             cCCccHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeee
Confidence            999998887654321         2789999999999999999999998   9999999999999999999999999987


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      .+...           ........++..|+|||+..+ ..++.++||||||+++|||++|+.||..... ...... +..
T Consensus       149 ~~~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-~~~~~~-~~~  215 (286)
T cd07846         149 TLAAP-----------GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-IDQLYH-IIK  215 (286)
T ss_pred             eccCC-----------ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-HHHHHH-HHH
Confidence            65321           111223457889999998765 3468899999999999999999999864211 000000 000


Q ss_pred             hh---cchhhhhhhhh-----hhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          793 HY---HGRLEKVIDSS-----LLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       793 ~~---~~~~~~~~d~~-----~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..   ........+..     ...................+..+.+++.+||..+|++||++++++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         216 CLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             HhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            00   00000110100     00000001111112223456779999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5e-34  Score=302.52  Aligned_cols=253  Identities=21%  Similarity=0.323  Sum_probs=184.3

Q ss_pred             eecccCcceEEEEEeCCC---CEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCCc
Q 002746          564 LLGTGSYGRVYKGILQDG---TAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGS  639 (885)
Q Consensus       564 ~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gs  639 (885)
                      .||+|+||.||+|...++   ..+++|.++... ....+.+.+|+.+++.++||||++++++|......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999985433   345666655332 2345789999999999999999999999999999999999999999


Q ss_pred             cccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeeccc
Q 002746          640 LDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVG  719 (885)
Q Consensus       640 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  719 (885)
                      |.+++......     ....++..+..++.||++||+|||+.+   |+||||||+|||++.++.++|+|||++.......
T Consensus        82 L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~  153 (268)
T cd05086          82 LKSYLSQEQWH-----RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED  153 (268)
T ss_pred             HHHHHHhhhcc-----cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcch
Confidence            99998754211     123567778899999999999999998   9999999999999999999999999986431110


Q ss_pred             CCCCCCCCCCCCccccccccccccCCcccCC-------CCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHH
Q 002746          720 VGNDGAENMGNSTANMLCGSIGYMAPEYGFG-------SNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       720 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~  791 (885)
                               .........|+..|+|||+..+       ..++.++|||||||++|||++ |..||.....     .+.+.
T Consensus       154 ---------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~  219 (268)
T cd05086         154 ---------YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----REVLN  219 (268)
T ss_pred             ---------hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHH
Confidence                     0011123467889999998743       245789999999999999997 4667754211     11111


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDL  853 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  853 (885)
                      ....+......++.+..              .....+.+++..|| .+|++||+++||++.|
T Consensus       220 ~~~~~~~~~~~~~~~~~--------------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         220 HVIKDQQVKLFKPQLEL--------------PYSERWYEVLQFCW-LSPEKRATAEEVHRLL  266 (268)
T ss_pred             HHHhhcccccCCCccCC--------------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence            11111111111111100              12345788899999 6799999999998876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-34  Score=309.04  Aligned_cols=272  Identities=23%  Similarity=0.275  Sum_probs=196.8

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      ++|++.+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57899999999999999999976 689999999875432 2235577899999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      ++ ++|.+++.....        .+++.....++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||.++.
T Consensus        85 ~~-~~L~~~~~~~~~--------~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  152 (291)
T cd07844          85 LD-TDLKQYMDDCGG--------GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARA  152 (291)
T ss_pred             CC-CCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccc
Confidence            97 488887754321        3788999999999999999999998   99999999999999999999999999864


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      ....           ........++..|+|||+..+ ..++.++||||+|+++|||++|+.||............. ...
T Consensus       153 ~~~~-----------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~  220 (291)
T cd07844         153 KSVP-----------SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI-FRV  220 (291)
T ss_pred             cCCC-----------CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHH-HHh
Confidence            3210           111122346789999998865 457899999999999999999999996532111111111 010


Q ss_pred             hcchhhhhhhhh-----hh--hccCCChHHHHHHHHHHH--HHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          794 YHGRLEKVIDSS-----LL--RASRDQSPEVKRMWDVAI--GELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       794 ~~~~~~~~~d~~-----~~--~~~~~~~~~~~~~~~~~~--~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ............     ..  .........+........  .++.+++.+|++.+|++||++.|++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         221 LGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             cCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            000000000000     00  000000011111111122  568899999999999999999998864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.2e-34  Score=305.58  Aligned_cols=254  Identities=28%  Similarity=0.468  Sum_probs=195.7

Q ss_pred             ceecccCcceEEEEEeCC-------CCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          563 RLLGTGSYGRVYKGILQD-------GTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      +.||+|+||.||+|+..+       +..+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            468999999999998642       2578999876432 23456788999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCC-----CEEEccc
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDM-----TALVSDF  709 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-----~~kl~Df  709 (885)
                      +++|+|.+++........  ....+++..+..++.|++.|++|||+.+   ++|+||||+||+++.++     .++++||
T Consensus        81 ~~~~~L~~~l~~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~df  155 (269)
T cd05044          81 MEGGDLLSYLRDARVERF--GPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDF  155 (269)
T ss_pred             cCCCcHHHHHHHhhhccc--CCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCc
Confidence            999999999875432211  1223788999999999999999999998   99999999999999877     8999999


Q ss_pred             ccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHH
Q 002746          710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~  788 (885)
                      |++..+.....         ........++..|+|||++.+..++.++|||||||++|||++ |+.||.....     .+
T Consensus       156 g~~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-----~~  221 (269)
T cd05044         156 GLARDIYKSDY---------YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-----QE  221 (269)
T ss_pred             ccccccccccc---------cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-----HH
Confidence            99976532110         011112345678999999999999999999999999999998 9999864211     11


Q ss_pred             HHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       789 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                      .....         ..    ......      ....+.++.+++.+||+.+|.+||++.++++.|+
T Consensus       222 ~~~~~---------~~----~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         222 VLQHV---------TA----GGRLQK------PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             HHHHH---------hc----CCccCC------cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            11100         00    000000      0124567899999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.3e-34  Score=309.16  Aligned_cols=272  Identities=22%  Similarity=0.310  Sum_probs=196.3

Q ss_pred             HhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ++.+|.+.+.||+|+||.||+|... +++.||+|+++.... .....+.+|+++++.++|+||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3578999999999999999999864 689999999875432 22346788999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+. +++..++.....        .+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++
T Consensus        83 e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~  150 (291)
T cd07870          83 EYMH-TDLAQYMIQHPG--------GLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLA  150 (291)
T ss_pred             eccc-CCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccc
Confidence            9996 666665543221        2677888899999999999999998   999999999999999999999999998


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      +.....           ........+++.|+|||+..+. .++.++|||||||++|||++|+.||+........+.+...
T Consensus       151 ~~~~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~  219 (291)
T cd07870         151 RAKSIP-----------SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWT  219 (291)
T ss_pred             cccCCC-----------CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHH
Confidence            754221           1111223568899999998764 5788999999999999999999999753221111111100


Q ss_pred             Hhh-cc-h-------hhhhhhhhhhhccCCChHHHHHHHHH--HHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          792 NHY-HG-R-------LEKVIDSSLLRASRDQSPEVKRMWDV--AIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       792 ~~~-~~-~-------~~~~~d~~~~~~~~~~~~~~~~~~~~--~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ... +. .       ...... ......  ........+..  .+.++.+++.+|+..||++|||++|++.+
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         220 VLGVPTEDTWPGVSKLPNYKP-EWFLPC--KPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             HcCCCChhhhhhhhhcccccc-hhcccc--CCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            000 00 0       000000 000000  00001111110  14568899999999999999999999764

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.7e-34  Score=303.85  Aligned_cols=255  Identities=22%  Similarity=0.311  Sum_probs=186.1

Q ss_pred             ceecccCcceEEEEEeCC---CCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCC
Q 002746          563 RLLGTGSYGRVYKGILQD---GTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANG  638 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g  638 (885)
                      +.||+|+||.||+|...+   ...+|+|.+..... .....+.+|+++++.++|+||+++++++......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            358999999999997543   35688887764332 23456889999999999999999999999999999999999999


Q ss_pred             ccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecc
Q 002746          639 SLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV  718 (885)
Q Consensus       639 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~  718 (885)
                      +|.+++.......    ....++.....++.||+.|++|||+++   |+||||||+||+++.++.+||+|||++......
T Consensus        81 ~L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  153 (269)
T cd05042          81 DLKNYLRSNRGMV----AQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPE  153 (269)
T ss_pred             cHHHHHHhccccc----cccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccc
Confidence            9999987544211    112567788899999999999999998   999999999999999999999999998653221


Q ss_pred             cCCCCCCCCCCCCccccccccccccCCcccC-------CCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHH
Q 002746          719 GVGNDGAENMGNSTANMLCGSIGYMAPEYGF-------GSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       719 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~  790 (885)
                      +.         ........++..|+|||+..       ...++.++|||||||++|||++ |..||...... ..+...+
T Consensus       154 ~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~  223 (269)
T cd05042         154 DY---------YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-QVLKQVV  223 (269)
T ss_pred             hh---------eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-HHHHHHh
Confidence            00         00112234567899999864       3456889999999999999999 78888642111 0011100


Q ss_pred             HHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 002746          791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDL  853 (885)
Q Consensus       791 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  853 (885)
                      .    ........+.+              ....+..+.+++..|| .||++||+++||++.|
T Consensus       224 ~----~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         224 R----EQDIKLPKPQL--------------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             h----ccCccCCCCcc--------------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            0    00000000000              0113455778888899 5999999999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.5e-34  Score=306.18  Aligned_cols=253  Identities=25%  Similarity=0.390  Sum_probs=202.1

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      +|+..+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++|+||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5778889999999999999976 68999999987553 234567889999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH-HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      ++++|.+++....        ..++.....+++.|++.|++|||+ .+   ++||||||+||+++.++.++|+|||.+..
T Consensus        82 ~~~~L~~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~  150 (265)
T cd06605          82 DGGSLDKILKEVQ--------GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQ  150 (265)
T ss_pred             CCCcHHHHHHHcc--------CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchh
Confidence            9999999886542        137888999999999999999999 87   99999999999999999999999999875


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      ....             ......++..|+|||+..+..++.++||||||+++|+|++|+.||.............++...
T Consensus       151 ~~~~-------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  217 (265)
T cd06605         151 LVNS-------------LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV  217 (265)
T ss_pred             hHHH-------------HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh
Confidence            5321             001156788999999999999999999999999999999999999653221111222111111


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                                  ..... ..+.     ...+.++.+++.+||..+|++|||+.|++.+
T Consensus       218 ------------~~~~~-~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         218 ------------NEPPP-RLPS-----GKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             ------------cCCCC-CCCh-----hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence                        00000 0000     0145668999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=310.88  Aligned_cols=245  Identities=28%  Similarity=0.391  Sum_probs=195.7

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCc---chhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEe
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGN---FTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      .|.-.+.||.|+||.||-|+.. +.+.||||++......   ...++.+|+..|.+++|||.|.+-|+|-.+...+||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            3555678999999999999954 6888999999755433   24567899999999999999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      || -|+-.+.+.-++.        ++-+..+..|+.+.+.||+|||+.+   .||||||+-|||+++.|.||++|||.|.
T Consensus       107 YC-lGSAsDlleVhkK--------plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAs  174 (948)
T KOG0577|consen  107 YC-LGSASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSAS  174 (948)
T ss_pred             HH-hccHHHHHHHHhc--------cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchh
Confidence            99 4566666644432        3778888999999999999999998   9999999999999999999999999998


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccC---CCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHH
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF---GSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~  790 (885)
                      .+.               ++..++|||.|||||++.   .+.|+-++||||+|+++.|+...++|+-.+... ..+...+
T Consensus       175 i~~---------------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-SALYHIA  238 (948)
T KOG0577|consen  175 IMA---------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIA  238 (948)
T ss_pred             hcC---------------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-HHHHHHH
Confidence            763               345678999999999864   568999999999999999999999997543111 0000110


Q ss_pred             HHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       791 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .                ..    .|.+.  .+.++..|..++-.|++.-|.+|||.++++.+
T Consensus       239 Q----------------Ne----sPtLq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  239 Q----------------NE----SPTLQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             h----------------cC----CCCCC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            0                00    01000  12356679999999999999999999998876

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.6e-34  Score=306.13  Aligned_cols=271  Identities=20%  Similarity=0.279  Sum_probs=202.1

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      +|++.+.||+|++|.||+|.+. +|+.||+|++....  ....+.+.+|+.++++++|||++++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788899999999999999965 68999999987553  33456789999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      + +++|.+++....        ..+++..++.++.|+++||+|||+.+   |+|+||||+||+++.++.++|+|||.+..
T Consensus        81 ~-~~~L~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~  148 (286)
T cd07832          81 M-PSDLSEVLRDEE--------RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARL  148 (286)
T ss_pred             c-CCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeeccc
Confidence            9 999998876433        13889999999999999999999998   99999999999999999999999999976


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      .....          ........|+..|+|||++.+. .++.++||||+|+++|||++|.+||.....  .....++...
T Consensus       149 ~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~  216 (286)
T cd07832         149 FSEEE----------PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRT  216 (286)
T ss_pred             ccCCC----------CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHH
Confidence            53211          0112234688999999988654 468999999999999999999888754211  1111111111


Q ss_pred             hcch----hhhhhhh-hhhhc--cCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          794 YHGR----LEKVIDS-SLLRA--SRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       794 ~~~~----~~~~~d~-~~~~~--~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ....    .++..+. .....  ...............+.++.+++.+|++.+|++||++++++.+
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         217 LGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            1110    0000000 00000  0000011112222345779999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.1e-34  Score=308.03  Aligned_cols=250  Identities=22%  Similarity=0.325  Sum_probs=201.2

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      .+|.+.+.||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            67899999999999999999854 68899999987554455677899999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++++|.+++....          +++..+..++.|++.|+.|||+++   ++||||||+||+++.++.++|+|||++...
T Consensus        99 ~~~~L~~~~~~~~----------l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~  165 (293)
T cd06647          99 AGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (293)
T ss_pred             CCCcHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecc
Confidence            9999999886432          678889999999999999999998   999999999999999999999999998765


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhc
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~  795 (885)
                      ...           ........|++.|+|||...+..++.++||||||+++|++++|+.||....... ....+    ..
T Consensus       166 ~~~-----------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~-~~~~~----~~  229 (293)
T cd06647         166 TPE-----------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYLI----AT  229 (293)
T ss_pred             ccc-----------ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh-heeeh----hc
Confidence            321           111223468889999999988889999999999999999999999996421110 00000    00


Q ss_pred             chhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       796 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                                  .... ..+    .....+..+.+++.+||..+|++||++.+++.+
T Consensus       230 ------------~~~~-~~~----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         230 ------------NGTP-ELQ----NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ------------CCCC-CCC----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                        0000 000    011134568899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.3e-34  Score=307.69  Aligned_cols=260  Identities=25%  Similarity=0.363  Sum_probs=200.1

Q ss_pred             CHHHHHHHhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhc-CCcccceeeeeeec-
Q 002746          548 TYRELLEATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLMRIITACSL-  624 (885)
Q Consensus       548 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-  624 (885)
                      +..++..+.+.|++.+.||+|+||.||+|... +++.||+|++.... .....+..|+.++.++ +|+|++++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            44555566789999999999999999999964 68899999986443 2345688899999998 79999999999853 


Q ss_pred             -----CCcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEec
Q 002746          625 -----PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN  699 (885)
Q Consensus       625 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~  699 (885)
                           ....++||||+++|+|.+++.....       ..+++..+..++.|++.|++|||+.+   |+||||||+||+++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~  155 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-------NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLT  155 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEC
Confidence                 4567899999999999988864332       23778888999999999999999998   99999999999999


Q ss_pred             CCCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccC-----CCCCCccccchhhHHHHHHHHcCCC
Q 002746          700 DDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF-----GSNTSTKGDVYSFGILVLEMVTRRR  774 (885)
Q Consensus       700 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~  774 (885)
                      +++.++|+|||++......           ........|++.|+|||.+.     +..++.++|||||||++|||++|+.
T Consensus       156 ~~~~~~l~dfg~~~~~~~~-----------~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~  224 (282)
T cd06636         156 ENAEVKLVDFGVSAQLDRT-----------VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP  224 (282)
T ss_pred             CCCCEEEeeCcchhhhhcc-----------ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCC
Confidence            9999999999998755221           01122346889999999875     3467889999999999999999999


Q ss_pred             CCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          775 PTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       775 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ||......    ... .        .. ...   ......      ...++.++.+++.+||+.||.+||++.|++++
T Consensus       225 p~~~~~~~----~~~-~--------~~-~~~---~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         225 PLCDMHPM----RAL-F--------LI-PRN---PPPKLK------SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             CccccCHH----hhh-h--------hH-hhC---CCCCCc------ccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            99642110    000 0        00 000   000000      01245679999999999999999999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.6e-34  Score=307.65  Aligned_cols=272  Identities=23%  Similarity=0.300  Sum_probs=198.0

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      +|+..+.||+|++|.||+|+.. +++.||||+++...  ......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999965 68999999887442  22345788999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +. ++|..++.....       ..+++..+..++.|++.|++|||+.+   ++||||+|+||+++.++.+||+|||.+..
T Consensus        81 ~~-~~l~~~~~~~~~-------~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~  149 (284)
T cd07860          81 LH-QDLKKFMDASPL-------SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA  149 (284)
T ss_pred             cc-cCHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhh
Confidence            95 678877754321       23789999999999999999999998   99999999999999999999999999875


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCCC-CCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      +...           ........++..|+|||+..+.. ++.++||||||+++|||+||+.||..... .....+.+...
T Consensus       150 ~~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~  217 (284)
T cd07860         150 FGVP-----------VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTL  217 (284)
T ss_pred             cccC-----------ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHh
Confidence            5221           11112234678999999876654 58899999999999999999999964211 01111111111


Q ss_pred             hcch--hhhhhh--hhhhhcc-CCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          794 YHGR--LEKVID--SSLLRAS-RDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       794 ~~~~--~~~~~d--~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ....  ....+.  +...... ..............+.++.+++.+|++.||++|||++|++.+
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         218 GTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             CCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            0000  000000  0000000 000011111222345678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5.5e-34  Score=300.51  Aligned_cols=251  Identities=29%  Similarity=0.485  Sum_probs=198.8

Q ss_pred             CcccceecccCcceEEEEEeCC-----CCEEEEEEeeecCCc-chhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          559 FDEQRLLGTGSYGRVYKGILQD-----GTAIAVKVLQLQSGN-FTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      |++.+.||+|+||.||+|++.+     +..||+|+++..... ..+.+..|++++..++|+|++++++++...+..++||
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4567899999999999999763     388999999755433 4678999999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++++|.+++......       .+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.++|+|||.+
T Consensus        81 e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~  150 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPK-------ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLS  150 (258)
T ss_pred             eccCCCCHHHHHHhhhhc-------cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCc
Confidence            999999999998754321       1789999999999999999999998   999999999999999999999999999


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~  791 (885)
                      +.......          .......+++.|+|||...+..++.++||||+|+++|+|++ |+.||...     .......
T Consensus       151 ~~~~~~~~----------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-----~~~~~~~  215 (258)
T smart00219      151 RDLYDDDY----------YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-----SNEEVLE  215 (258)
T ss_pred             eecccccc----------cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHH
Confidence            87643210          00001236789999999988889999999999999999998 78888641     1111111


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDL  853 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  853 (885)
                      .....             .....+.      ..+.++.+++.+|++.+|++|||+.|+++.|
T Consensus       216 ~~~~~-------------~~~~~~~------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      216 YLKKG-------------YRLPKPE------NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HHhcC-------------CCCCCCC------cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            11100             0000000      1355789999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.8e-34  Score=303.54  Aligned_cols=255  Identities=28%  Similarity=0.413  Sum_probs=196.9

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC----------cchhhHHHHHHHHhhcCCcccceeeeeeecCC
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG----------NFTKSFNRECQVLKRIRHRNLMRIITACSLPD  626 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  626 (885)
                      +|.+.+.||+|++|.||+|... +|+.||+|.++....          ...+.+..|++++++++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4677889999999999999854 689999998863211          11246788999999999999999999999999


Q ss_pred             cceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEE
Q 002746          627 FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALV  706 (885)
Q Consensus       627 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl  706 (885)
                      ..++||||+++|+|.++++...         .+++..+..++.|++.|+.|||+.+   ++||||+|+||+++.++.+++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l  149 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG---------RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKI  149 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEE
Confidence            9999999999999999886542         3788889999999999999999998   999999999999999999999


Q ss_pred             cccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCC--CCccccchhhHHHHHHHHcCCCCCCccccCCc
Q 002746          707 SDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN--TSTKGDVYSFGILVLEMVTRRRPTDDMFAGGL  784 (885)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~  784 (885)
                      +|||.++......         .........|+..|+|||...+..  ++.++||||||+++||+++|..||....    
T Consensus       150 ~d~~~~~~~~~~~---------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~----  216 (272)
T cd06629         150 SDFGISKKSDDIY---------DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE----  216 (272)
T ss_pred             eeccccccccccc---------cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc----
Confidence            9999987542110         011122345889999999887654  7899999999999999999999986421    


Q ss_pred             cHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          785 SLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ....+ ...........+.+              ......+.++.+++.+||.++|++||++.||+++
T Consensus       217 ~~~~~-~~~~~~~~~~~~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         217 AIAAM-FKLGNKRSAPPIPP--------------DVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             hHHHH-HHhhccccCCcCCc--------------cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            11111 11000000000000              0111245679999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.4e-34  Score=301.90  Aligned_cols=252  Identities=23%  Similarity=0.342  Sum_probs=194.2

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC-----CcchhhHHHHHHHHhhcCCcccceeeeeeecC--Ccc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-----GNFTKSFNRECQVLKRIRHRNLMRIITACSLP--DFK  628 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  628 (885)
                      .+|.+.+.||+|+||.||+|... ++..||+|.+....     ....+.+.+|++++++++||||+++++++.++  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46889999999999999999965 58999999886432     12245788899999999999999999988764  456


Q ss_pred             eEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcc
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSD  708 (885)
Q Consensus       629 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D  708 (885)
                      ++||||+++++|.+++....         .+++....+++.|++.||+|||+++   |+|+||||+||+++.++.++|+|
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~D  149 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG---------ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGD  149 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECc
Confidence            79999999999998886443         2678888999999999999999998   99999999999999999999999


Q ss_pred             cccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHH
Q 002746          709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~  788 (885)
                      ||.++.......        .........|+..|+|||+..+..++.++|||||||++|||++|+.||.....    ...
T Consensus       150 fg~~~~~~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~  217 (265)
T cd06652         150 FGASKRLQTICL--------SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----MAA  217 (265)
T ss_pred             Cccccccccccc--------cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch----HHH
Confidence            999986532110        01112234588999999999888899999999999999999999999964211    000


Q ss_pred             HHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       789 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      . ...            .........+      ......+.+++.+|+. +|++||+++|++++
T Consensus       218 ~-~~~------------~~~~~~~~~~------~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         218 I-FKI------------ATQPTNPVLP------PHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             H-HHH------------hcCCCCCCCc------hhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            0 000            0000000011      1234567888999985 89999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.8e-34  Score=308.58  Aligned_cols=263  Identities=24%  Similarity=0.304  Sum_probs=200.0

Q ss_pred             CHHHHHHHhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhc-CCcccceeeeeeecC
Q 002746          548 TYRELLEATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLMRIITACSLP  625 (885)
Q Consensus       548 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  625 (885)
                      +..++..+.++|.+.+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            34455556789999999999999999999964 68899999986432 2346778899999998 899999999998654


Q ss_pred             C-----cceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecC
Q 002746          626 D-----FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND  700 (885)
Q Consensus       626 ~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~  700 (885)
                      +     ..++||||+++|+|.++++....     ....+++..++.++.|++.||+|||+.+   |+||||||+||+++.
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~  163 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLI-----CGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTT  163 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcC
Confidence            3     57899999999999988753221     1124789999999999999999999998   999999999999999


Q ss_pred             CCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC-----CCCccccchhhHHHHHHHHcCCCC
Q 002746          701 DMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-----NTSTKGDVYSFGILVLEMVTRRRP  775 (885)
Q Consensus       701 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~vl~elltg~~P  775 (885)
                      ++.+||+|||.+.......           .......|+..|+|||++...     .++.++|||||||++|||++|+.|
T Consensus       164 ~~~~kl~dfg~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p  232 (291)
T cd06639         164 EGGVKLVDFGVSAQLTSTR-----------LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP  232 (291)
T ss_pred             CCCEEEeecccchhccccc-----------ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCC
Confidence            9999999999987653211           111224578899999987543     368999999999999999999999


Q ss_pred             CCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          776 TDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       776 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      |...... .....+    ........         .  .+      +....++.+++.+||+.+|++||++.|++++
T Consensus       233 ~~~~~~~-~~~~~~----~~~~~~~~---------~--~~------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         233 LFDMHPV-KTLFKI----PRNPPPTL---------L--HP------EKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             CCCCcHH-HHHHHH----hcCCCCCC---------C--cc------cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            8653110 000000    00000000         0  00      1133468899999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.9e-34  Score=302.54  Aligned_cols=259  Identities=27%  Similarity=0.441  Sum_probs=195.9

Q ss_pred             CcccceecccCcceEEEEEeC----CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCC------
Q 002746          559 FDEQRLLGTGSYGRVYKGILQ----DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPD------  626 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  626 (885)
                      |.+.+.||+|+||.||+|.+.    .+..||||+++...  ....+++.+|++++++++|||++++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999854    36889999987542  233567889999999999999999999886532      


Q ss_pred             cceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEE
Q 002746          627 FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALV  706 (885)
Q Consensus       627 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl  706 (885)
                      ..++++||+++|+|..++......   .....+++.....++.|++.|++|||+.+   |+||||||+||+++.++.+|+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl  154 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIG---EEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCV  154 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhccc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEE
Confidence            236889999999998876432211   11234788999999999999999999998   999999999999999999999


Q ss_pred             cccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCcc
Q 002746          707 SDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS  785 (885)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~  785 (885)
                      +|||.++......         .........+++.|++||...+..++.++|||||||++|||++ |+.||.....  ..
T Consensus       155 ~dfg~~~~~~~~~---------~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~  223 (273)
T cd05074         155 ADFGLSKKIYSGD---------YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SE  223 (273)
T ss_pred             CcccccccccCCc---------ceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HH
Confidence            9999998653210         0001112345678999999988889999999999999999999 8888864211  11


Q ss_pred             HHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 002746          786 LHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       786 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                      ...++..   ..       ..     ...+       ..+.++.+++.+||+.+|++||++.|+++.|+.+
T Consensus       224 ~~~~~~~---~~-------~~-----~~~~-------~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         224 IYNYLIK---GN-------RL-----KQPP-------DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HHHHHHc---CC-------cC-----CCCC-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1111110   00       00     0000       1345689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.8e-34  Score=306.25  Aligned_cols=253  Identities=25%  Similarity=0.313  Sum_probs=191.9

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC-cchhhHHHHHHH-HhhcCCcccceeeeeeecCCcceEEEe
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQV-LKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      ++|++.+.||+|+||.||+|... +|+.||+|+++.... .....+..|+.. ++..+|||++++++++..++..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36888999999999999999976 699999999875432 233455566665 566789999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH-SPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      |++ |+|.+++.....     ....+++..++.++.|++.|++|||++ +   ++||||||+||+++.++.+||+|||.+
T Consensus        81 ~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~  151 (283)
T cd06617          81 VMD-TSLDKFYKKVYD-----KGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGIS  151 (283)
T ss_pred             hhc-ccHHHHHHHhcc-----CCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence            996 677766643221     113489999999999999999999987 6   999999999999999999999999998


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCC----CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG----SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~  788 (885)
                      ..+...            .......|+..|+|||++.+    ..++.++|||||||++|||++|+.||.........+..
T Consensus       152 ~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  219 (283)
T cd06617         152 GYLVDS------------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ  219 (283)
T ss_pred             cccccc------------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH
Confidence            765211            11122457889999998765    45688999999999999999999999642111111111


Q ss_pred             HHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       789 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .            ...     .....+.     ...+.++.+++.+||..+|++||+++|++++
T Consensus       220 ~------------~~~-----~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         220 V------------VEE-----PSPQLPA-----EKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             H------------Hhc-----CCCCCCc-----cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0            000     0000000     1135678999999999999999999999885

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4e-34  Score=301.78  Aligned_cols=237  Identities=24%  Similarity=0.414  Sum_probs=186.8

Q ss_pred             ceecccCcceEEEEEeCCCC-----------EEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEE
Q 002746          563 RLLGTGSYGRVYKGILQDGT-----------AIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV  631 (885)
                      +.||+|+||.||+|.+.+..           .|++|.++..... ...+.+|+.++++++|||++++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999976432           5788877644332 6788999999999999999999999988 778999


Q ss_pred             EecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCC-------CE
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDM-------TA  704 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-------~~  704 (885)
                      |||+++|+|.+++.....        .+++..+..++.|++.||+|||+++   |+||||||+||+++.++       .+
T Consensus        79 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~  147 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN--------NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFI  147 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeE
Confidence            999999999998875432        3788999999999999999999998   99999999999999887       79


Q ss_pred             EEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC--CCCccccchhhHHHHHHHHc-CCCCCCcccc
Q 002746          705 LVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS--NTSTKGDVYSFGILVLEMVT-RRRPTDDMFA  781 (885)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~  781 (885)
                      |++|||+++....               .....++..|+|||++.+.  .++.++||||||+++|||++ |..||.....
T Consensus       148 kl~Dfg~a~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~  212 (259)
T cd05037         148 KLSDPGIPITVLS---------------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS  212 (259)
T ss_pred             EeCCCCccccccc---------------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence            9999999986522               1123466789999998876  78999999999999999999 5777754311


Q ss_pred             CCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 002746          782 GGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDL  853 (885)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  853 (885)
                           ..+.....        .     ......+.        ..++.+++.+||..+|.+||++.|+++.|
T Consensus       213 -----~~~~~~~~--------~-----~~~~~~~~--------~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         213 -----SEKERFYQ--------D-----QHRLPMPD--------CAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             -----hhHHHHHh--------c-----CCCCCCCC--------chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                 11110000        0     00000000        14688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6.9e-34  Score=303.06  Aligned_cols=247  Identities=26%  Similarity=0.368  Sum_probs=198.7

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      -|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++|||++++++++..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4677889999999999999865 68899999886432 233467889999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++++|..++...          .+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++++|||++..+
T Consensus        85 ~~~~l~~~i~~~----------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06641          85 GGGSALDLLEPG----------PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQL  151 (277)
T ss_pred             CCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceec
Confidence            999999888532          2788999999999999999999998   999999999999999999999999998765


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhc
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~  795 (885)
                      ....           .......|+..|+|||+..+..++.++|||||||++|+|++|..||.....     ..+......
T Consensus       152 ~~~~-----------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~  215 (277)
T cd06641         152 TDTQ-----------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-----MKVLFLIPK  215 (277)
T ss_pred             ccch-----------hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----HHHHHHHhc
Confidence            3211           111224578899999999888899999999999999999999999864211     111111100


Q ss_pred             chhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       796 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .             .....      ....+.++.+++.+||+.+|.+||++.+++++
T Consensus       216 ~-------------~~~~~------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         216 N-------------NPPTL------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             C-------------CCCCC------CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            0             00000      01134568899999999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=7.7e-34  Score=300.55  Aligned_cols=255  Identities=25%  Similarity=0.391  Sum_probs=200.7

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCc--chhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      +|.+.+.||+|+||.||+|... +++.||+|.++.....  ..+.+..|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5788899999999999999965 6899999998855442  567889999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +++++|.+++....         .+++..+..++.+++.|++|||+.+   |+|+||+|+||++++++.+||+|||.+..
T Consensus        81 ~~~~~L~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~  148 (264)
T cd06626          81 CSGGTLEELLEHGR---------ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVK  148 (264)
T ss_pred             CCCCcHHHHHhhcC---------CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccc
Confidence            99999999886542         2678888999999999999999998   99999999999999999999999999987


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCCC---CCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN---TSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      .......       .........++..|+|||++.+..   ++.++||||||+++||+++|+.||......    .....
T Consensus       149 ~~~~~~~-------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~----~~~~~  217 (264)
T cd06626         149 LKNNTTT-------MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE----FQIMF  217 (264)
T ss_pred             cCCCCCc-------ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch----HHHHH
Confidence            6432110       001022346788999999988766   889999999999999999999999642111    00000


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ....             ......+.    +..++.++.+++.+||+.+|.+||++.|++.+
T Consensus       218 ~~~~-------------~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         218 HVGA-------------GHKPPIPD----SLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             HHhc-------------CCCCCCCc----ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0000             00000000    01135568899999999999999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.6e-34  Score=302.48  Aligned_cols=254  Identities=22%  Similarity=0.376  Sum_probs=197.4

Q ss_pred             CCcccceecccCcceEEEEEeCC--CCEEEEEEeeecC----------CcchhhHHHHHHHHhh-cCCcccceeeeeeec
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQD--GTAIAVKVLQLQS----------GNFTKSFNRECQVLKR-IRHRNLMRIITACSL  624 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~  624 (885)
                      +|++.+.||+|+||.||+|.+..  ++.+|+|.+....          .....++..|+.++.+ ++|||++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999999764  6889999886331          1123456778888765 799999999999999


Q ss_pred             CCcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCceEecCCCCCceEecCCCC
Q 002746          625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH-HSPVRVIHCDLKPSNVLLNDDMT  703 (885)
Q Consensus       625 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NILl~~~~~  703 (885)
                      ++..++||||+++++|.+++.....     ....+++..++.++.|++.|+.|||+ .+   ++||||+|+||+++.++.
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~  152 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKE-----KKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDK  152 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHh-----ccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCc
Confidence            9999999999999999888743221     12248889999999999999999996 55   999999999999999999


Q ss_pred             EEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCC
Q 002746          704 ALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGG  783 (885)
Q Consensus       704 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~  783 (885)
                      ++|+|||.+......            .......|+..|+|||...+..++.++||||||+++|||++|+.||...    
T Consensus       153 ~~l~dfg~~~~~~~~------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~----  216 (269)
T cd08528         153 VTITDFGLAKQKQPE------------SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST----  216 (269)
T ss_pred             EEEecccceeecccc------------cccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc----
Confidence            999999999765321            0223346888999999999888999999999999999999999998642    


Q ss_pred             ccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          784 LSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                       ..............            .....      ...+.++.+++.+||+.||++||++.|+.++++
T Consensus       217 -~~~~~~~~~~~~~~------------~~~~~------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         217 -NMLSLATKIVEAVY------------EPLPE------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             -CHHHHHHHHhhccC------------CcCCc------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence             11111111110000            00000      013456889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.7e-34  Score=306.45  Aligned_cols=245  Identities=26%  Similarity=0.327  Sum_probs=198.3

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ++|.+.+.||+|++|.||+|... +++.||+|+++...   ....+.+.+|++++++++||||+++++++......++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36888999999999999999965 68999999987432   233567889999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++++|.+++....         .+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||++
T Consensus        81 e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~  148 (290)
T cd05580          81 EYVPGGELFSHLRKSG---------RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFA  148 (290)
T ss_pred             ecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCc
Confidence            9999999999886543         3788999999999999999999998   999999999999999999999999998


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      ......              .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....     .......
T Consensus       149 ~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~  209 (290)
T cd05580         149 KRVKGR--------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-----PIQIYEK  209 (290)
T ss_pred             cccCCC--------------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHH
Confidence            765221              123468899999999988889999999999999999999999986421     0000000


Q ss_pred             hhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP-----TMLDAADD  852 (885)
Q Consensus       793 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  852 (885)
                              ...     .......       ..+..+.+++.+||..+|.+||     +++|++++
T Consensus       210 --------~~~-----~~~~~~~-------~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         210 --------ILE-----GKVRFPS-------FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             --------Hhc-----CCccCCc-------cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence                    000     0000000       1245688999999999999999     77777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.3e-34  Score=301.90  Aligned_cols=252  Identities=21%  Similarity=0.282  Sum_probs=198.0

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeec--CCcceEEE
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSL--PDFKALVL  632 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lV~  632 (885)
                      +|++.+.||.|+||.||+|... +++.||+|+++...  ....+.+..|++++++++|+|++++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999854 68899999987432  2335568889999999999999999998754  34568999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhh-----ccCCCceEecCCCCCceEecCCCCEEEc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLH-----HHSPVRVIHCDLKPSNVLLNDDMTALVS  707 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-----~~~~~~ivH~Dlkp~NILl~~~~~~kl~  707 (885)
                      ||+++++|.+++.....     ....+++..++.++.|++.||+|||     +.+   |+||||||+||+++.++.+|++
T Consensus        81 e~~~~~~L~~~l~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~  152 (265)
T cd08217          81 EYCEGGDLAQLIQKCKK-----ERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLG  152 (265)
T ss_pred             hhccCCCHHHHHHHHhh-----cccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEe
Confidence            99999999998865421     1234889999999999999999999     665   9999999999999999999999


Q ss_pred             ccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHH
Q 002746          708 DFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH  787 (885)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~  787 (885)
                      |||.+......           ........|++.|+|||+..+..++.++||||||+++|+|++|+.||....     ..
T Consensus       153 d~g~~~~~~~~-----------~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~  216 (265)
T cd08217         153 DFGLAKILGHD-----------SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QL  216 (265)
T ss_pred             cccccccccCC-----------cccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HH
Confidence            99999866321           111223468899999999999889999999999999999999999997521     11


Q ss_pred             HHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          788 KWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       788 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .+......         ..   .....       ...+.++.+++.+|++.+|++||++++|+++
T Consensus       217 ~~~~~~~~---------~~---~~~~~-------~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         217 QLASKIKE---------GK---FRRIP-------YRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             HHHHHHhc---------CC---CCCCc-------cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            11111110         00   00000       1134578999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.7e-34  Score=302.28  Aligned_cols=256  Identities=24%  Similarity=0.400  Sum_probs=199.4

Q ss_pred             CCcccceecccCcceEEEEEe-CCCCEEEEEEeeecCC------cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceE
Q 002746          558 EFDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQSG------NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKAL  630 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  630 (885)
                      +|+..+.||+|++|.||+|.. .+++.||+|+++....      ...+.+.+|++++++++|+|++++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999985 4789999999874331      134678899999999999999999999999999999


Q ss_pred             EEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCC-CEEEccc
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDM-TALVSDF  709 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Df  709 (885)
                      |+||+++++|.+++....         .+++..+..++.|++.|++|||+++   ++|+||+|+||+++.++ .++|+||
T Consensus        81 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~df  148 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG---------AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADF  148 (268)
T ss_pred             EEeccCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccc
Confidence            999999999999886432         3788999999999999999999998   99999999999998775 5999999


Q ss_pred             ccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHH
Q 002746          710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKW  789 (885)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~  789 (885)
                      |.+..+......       .........|+..|+|||+..+..++.++||||+|+++|+|++|+.||.....  ......
T Consensus       149 g~~~~~~~~~~~-------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~  219 (268)
T cd06630         149 GAAARLAAKGTG-------AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH--SNHLAL  219 (268)
T ss_pred             cccccccccccc-------CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--cchHHH
Confidence            999876432110       01112234688999999999888899999999999999999999999964211  111111


Q ss_pred             HHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       790 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      +....            ........+      +..+.++.+++.+|+..+|++||++.|++.+
T Consensus       220 ~~~~~------------~~~~~~~~~------~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         220 IFKIA------------SATTAPSIP------EHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             HHHHh------------ccCCCCCCc------hhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            10000            000000000      1245678899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.1e-34  Score=304.05  Aligned_cols=249  Identities=23%  Similarity=0.313  Sum_probs=198.5

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEeccc
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMA  636 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~  636 (885)
                      .|...+.||+|++|.||+|... +++.+|+|+++.......+.+.+|+.+++.++|||++++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3555679999999999999964 788999999875544455678899999999999999999999999999999999999


Q ss_pred             CCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeee
Q 002746          637 NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM  716 (885)
Q Consensus       637 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~  716 (885)
                      +++|.+++...          .+++..+..++.|++.|++|||+.+   |+||||+|+||+++.++.++++|||.+....
T Consensus       100 ~~~L~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~  166 (285)
T cd06648         100 GGALTDIVTHT----------RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVS  166 (285)
T ss_pred             CCCHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhc
Confidence            99999887642          2788899999999999999999998   9999999999999999999999999886542


Q ss_pred             cccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcc
Q 002746          717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHG  796 (885)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  796 (885)
                      ..           ........|++.|+|||...+..++.++||||||+++|||++|+.||...     ............
T Consensus       167 ~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~-----~~~~~~~~~~~~  230 (285)
T cd06648         167 KE-----------VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE-----PPLQAMKRIRDN  230 (285)
T ss_pred             cC-----------CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC-----CHHHHHHHHHhc
Confidence            21           11112345889999999999888999999999999999999999998541     111111111100


Q ss_pred             hhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          797 RLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       797 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..     +..    . ..       ..++.++.+++.+||+.+|++||++.+++++
T Consensus       231 ~~-----~~~----~-~~-------~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         231 LP-----PKL----K-NL-------HKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             CC-----CCC----c-cc-------ccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            00     000    0 00       0134568999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=6.9e-34  Score=307.46  Aligned_cols=263  Identities=19%  Similarity=0.259  Sum_probs=198.2

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEe
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      +|++.+.||+|+||.||+|... .++.||+|.+....   ......+.+|+++++.++||||+++++.+..++..++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            6888999999999999999965 57899999987542   2234567899999999999999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      |+++++|.+++....         .+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.++++|||.++
T Consensus        82 ~~~g~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~  149 (305)
T cd05609          82 YVEGGDCATLLKNIG---------ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSK  149 (305)
T ss_pred             cCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCcc
Confidence            999999999986442         3788899999999999999999998   9999999999999999999999999986


Q ss_pred             eeecccCCCC----CCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHH
Q 002746          714 LVMTVGVGND----GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKW  789 (885)
Q Consensus       714 ~~~~~~~~~~----~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~  789 (885)
                      ..........    ..............|+..|+|||++.+..++.++|||||||++|||++|+.||...     ...++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~-----~~~~~  224 (305)
T cd05609         150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-----TPEEL  224 (305)
T ss_pred             ccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHH
Confidence            4211000000    00000001112245788999999998888999999999999999999999998631     11122


Q ss_pred             HHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       790 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                      ..........          .....       ...+.++.+++.+||+.+|++||++.++.+.++
T Consensus       225 ~~~~~~~~~~----------~~~~~-------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         225 FGQVISDDIE----------WPEGD-------EALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             HHHHHhcccC----------CCCcc-------ccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            1111110000          00000       013556899999999999999999655555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-34  Score=303.12  Aligned_cols=256  Identities=23%  Similarity=0.348  Sum_probs=198.3

Q ss_pred             HhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhc-CCcccceeeeeeecCC------
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLMRIITACSLPD------  626 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~------  626 (885)
                      ++++|++.+.||+|++|.||+|... +++.+|+|++..... ..+.+.+|+++++++ +|+||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4678999999999999999999975 678999999875433 346789999999999 7999999999997644      


Q ss_pred             cceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEE
Q 002746          627 FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALV  706 (885)
Q Consensus       627 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl  706 (885)
                      ..++||||+++++|.+++.....     ....+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l  154 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRK-----KGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKL  154 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEE
Confidence            47899999999999988764321     1124889999999999999999999998   999999999999999999999


Q ss_pred             cccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCC-----CCCCccccchhhHHHHHHHHcCCCCCCcccc
Q 002746          707 SDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-----SNTSTKGDVYSFGILVLEMVTRRRPTDDMFA  781 (885)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~elltg~~P~~~~~~  781 (885)
                      +|||.+......           ........|+..|+|||++.+     ..++.++|||||||++|+|++|+.||.....
T Consensus       155 ~d~~~~~~~~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  223 (275)
T cd06608         155 VDFGVSAQLDST-----------LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP  223 (275)
T ss_pred             CCCccceecccc-----------hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch
Confidence            999998765321           111223458899999998754     3467899999999999999999999964211


Q ss_pred             CCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          782 GGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       782 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      . ....+.            ...    ... ....    ....+.++.+++.+||..||++|||++|++++
T Consensus       224 ~-~~~~~~------------~~~----~~~-~~~~----~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         224 M-RALFKI------------PRN----PPP-TLKS----PENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             H-HHHHHh------------hcc----CCC-CCCc----hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            1 001000            000    000 0000    01245578899999999999999999999874

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=9.4e-37  Score=322.31  Aligned_cols=377  Identities=25%  Similarity=0.394  Sum_probs=264.8

Q ss_pred             CCCCccc-ccCCccccCCCCCcEEeCCCCcccccCchhhhCCCCCcEEEccCcccccCCchhhhcCCCCCCEEEcCCCcc
Q 002746            2 LVDNHLF-GAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFF   80 (885)
Q Consensus         2 l~~n~~~-~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~f~~l~~L~~L~Ls~N~l   80 (885)
                      ++.|-.. +-.|.+...|+.++.|.|...++. .+|+.++.+.+|+.|.+++|+++ .+- +-++.|+.|+.+++..|++
T Consensus        14 fsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vh-GELs~Lp~LRsv~~R~N~L   90 (1255)
T KOG0444|consen   14 FSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVH-GELSDLPRLRSVIVRDNNL   90 (1255)
T ss_pred             ccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhh-hhhccchhhHHHhhhcccc
Confidence            4566666 678889999999999999999998 89999999999999999999998 444 3368899999999999999


Q ss_pred             cc-cCCccCCCCCCCcEEEcccccCcccCCccccc-CccceEecccccccCCCChhhhcCCCCCcEEECCCCcccCCCCC
Q 002746           81 TG-KIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDN  158 (885)
Q Consensus        81 ~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  158 (885)
                      .. -+|..+..|..|+.|+|++|+++ +.|..+.. .++..|+||+|+|. +||..+|-+|..|-+||||+|++..++..
T Consensus        91 KnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~LPPQ  168 (1255)
T KOG0444|consen   91 KNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEMLPPQ  168 (1255)
T ss_pred             ccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhhcCHH
Confidence            83 35667788999999999999999 45555443 56777788888877 77777777777777777777776654432


Q ss_pred             CCcccccccCCCCCCCcEEEecCcccCccCCCccccccccEEEccCCcccccCCccccCCCCCCeeeccccccc-cccch
Q 002746          159 TNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLS-GTISA  237 (885)
Q Consensus       159 ~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~p~~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~  237 (885)
                               ...+..                       |++|.|++|.+....-..+..+++|++|.+++.+-+ .-+|.
T Consensus       169 ---------~RRL~~-----------------------LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Pt  216 (1255)
T KOG0444|consen  169 ---------IRRLSM-----------------------LQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPT  216 (1255)
T ss_pred             ---------HHHHhh-----------------------hhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCC
Confidence                     222223                       333333333333222223344566666666665433 23455


Q ss_pred             hhcCCCCCCeEecccccccccCcccccCCCCCCeeecccccccccCCccccCCCcccEEEccCCccCCCCCcccCCCCCC
Q 002746          238 EISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDL  317 (885)
Q Consensus       238 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L  317 (885)
                      .+..+.+|..+|||+|.+. ..|+.+-++++|+.|+||+|+|+ ..........+|++|+|++|+++ .+|.+++++++|
T Consensus       217 sld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL  293 (1255)
T KOG0444|consen  217 SLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKL  293 (1255)
T ss_pred             chhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHH
Confidence            5666666666666666666 56666666666666666666665 33333444455555556666555 555555555555


Q ss_pred             CEEECcCCcCcccCCccccCccceeeeeeccCCcCCCCchhhhcCCCCcceeecCCCccccccccccccCccccEEEecC
Q 002746          318 YKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISH  397 (885)
Q Consensus       318 ~~L~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~  397 (885)
                      +.|++.+|+++                       + .-+|..+++|.+|+.+.+++|++. ..|..++.|..|+.|.|++
T Consensus       294 ~kLy~n~NkL~-----------------------F-eGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~  348 (1255)
T KOG0444|consen  294 TKLYANNNKLT-----------------------F-EGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDH  348 (1255)
T ss_pred             HHHHhccCccc-----------------------c-cCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccc
Confidence            55555555554                       1 146778888999999999999987 7889999999999999999


Q ss_pred             CccCCCCCCccccccccccccccCcccccccCcccCCCceecEEEcc
Q 002746          398 NALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLS  444 (885)
Q Consensus       398 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  444 (885)
                      |+|- .+|+++.-|+.|+.|||..|.--.-.|..-..-++|.+-++.
T Consensus       349 NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP~da~~~lefYNID  394 (1255)
T KOG0444|consen  349 NRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKPNDARKKLEFYNID  394 (1255)
T ss_pred             ccee-echhhhhhcCCcceeeccCCcCccCCCCcchhhhcceeeecc
Confidence            9987 789999999999999999996553444433333555554443

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.4e-34  Score=301.15  Aligned_cols=250  Identities=22%  Similarity=0.360  Sum_probs=199.7

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      +|.+.+.||+|+||.||+|... +|..||+|.+....  ....+.+.+|++++++++|+|++++++.+..+...++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788899999999999999976 58899999987542  23456788999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCC-CEEEcccccce
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDM-TALVSDFGIAK  713 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfg~a~  713 (885)
                      +++++|.+++.....       ..+++..+..++.|+++|++|||+.+   |+|+||||+||++++++ .++++|||.+.
T Consensus        81 ~~~~~L~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~  150 (257)
T cd08225          81 CDGGDLMKRINRQRG-------VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIAR  150 (257)
T ss_pred             CCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccch
Confidence            999999998865332       23789999999999999999999998   99999999999999875 46999999987


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      .....           ........|++.|+|||+..+..++.++||||||+++|||++|+.||...     ...+++...
T Consensus       151 ~~~~~-----------~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-----~~~~~~~~~  214 (257)
T cd08225         151 QLNDS-----------MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-----NLHQLVLKI  214 (257)
T ss_pred             hccCC-----------cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHHHH
Confidence            65321           11112245889999999998888999999999999999999999998642     122222221


Q ss_pred             hcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       794 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .......            ..+       ..+.++.+++.+|+..+|++|||+.|++++
T Consensus       215 ~~~~~~~------------~~~-------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         215 CQGYFAP------------ISP-------NFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             hcccCCC------------CCC-------CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            1111100            000       134568899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=6e-34  Score=312.22  Aligned_cols=273  Identities=22%  Similarity=0.286  Sum_probs=198.0

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec-CCcchhhHHHHHHHHhhcCCcccceeeeeeecCC-----cc
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPD-----FK  628 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~  628 (885)
                      +++|++.+.||+|+||.||+|+.. +|+.||+|+++.. .......+.+|+.++++++|+||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999865 6899999998643 2334566888999999999999999998875443     46


Q ss_pred             eEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcc
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSD  708 (885)
Q Consensus       629 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D  708 (885)
                      ++|+||+++ ++...+...          .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|
T Consensus        84 ~lv~e~~~~-~l~~~~~~~----------~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~d  149 (336)
T cd07849          84 YIVQELMET-DLYKLIKTQ----------HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICD  149 (336)
T ss_pred             EEEehhccc-CHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECc
Confidence            899999964 666665432          3788999999999999999999998   99999999999999999999999


Q ss_pred             cccceeeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHH
Q 002746          709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH  787 (885)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~  787 (885)
                      ||++........        .........||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.....  ....
T Consensus       150 fg~~~~~~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~  219 (336)
T cd07849         150 FGLARIADPEHD--------HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQL  219 (336)
T ss_pred             ccceeecccccc--------ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHH
Confidence            999986532110        0112233568899999998654 5688999999999999999999999964211  1111


Q ss_pred             HHHHHhhcch----hhhhhhhhh----hhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          788 KWVKNHYHGR----LEKVIDSSL----LRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       788 ~~~~~~~~~~----~~~~~d~~~----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..+.......    ...+.+...    ..................+.++.+++.+||+.+|++|||+.|++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         220 NLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1111111111    111111100    0000001111111222345679999999999999999999999997

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-34  Score=308.83  Aligned_cols=263  Identities=23%  Similarity=0.294  Sum_probs=201.9

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCc---chhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGN---FTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ++|++.+.||+|++|.||+|... +++.||+|.+......   ..+.+..|+++++.++|+||+++++.+...+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888999999999999999976 5899999998754322   3456889999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+.+++|.+++.....       ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++
T Consensus        81 e~~~~~~L~~~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~  150 (316)
T cd05574          81 DYCPGGELFRLLQRQPG-------KCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLS  150 (316)
T ss_pred             EecCCCCHHHHHHhCCC-------CccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchh
Confidence            99999999998864321       23788999999999999999999998   999999999999999999999999998


Q ss_pred             eeeecccCCCCCC------------------CCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCC
Q 002746          713 KLVMTVGVGNDGA------------------ENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRR  774 (885)
Q Consensus       713 ~~~~~~~~~~~~~------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~  774 (885)
                      .............                  ............||..|+|||+..+..++.++||||||+++|+|++|+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~  230 (316)
T cd05574         151 KQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT  230 (316)
T ss_pred             hcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCC
Confidence            7653321100000                  0000111223468999999999999999999999999999999999999


Q ss_pred             CCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC----HHHHH
Q 002746          775 PTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT----MLDAA  850 (885)
Q Consensus       775 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt----~~ev~  850 (885)
                      ||......    ..         .....+....  . ...       ...+.++.+++.+||+.+|++||+    ++|++
T Consensus       231 pf~~~~~~----~~---------~~~~~~~~~~--~-~~~-------~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll  287 (316)
T cd05574         231 PFKGSNRD----ET---------FSNILKKEVT--F-PGS-------PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK  287 (316)
T ss_pred             CCCCCchH----HH---------HHHHhcCCcc--C-CCc-------cccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence            99642111    01         1111111100  0 000       013567999999999999999999    67776


Q ss_pred             HH
Q 002746          851 DD  852 (885)
Q Consensus       851 ~~  852 (885)
                      .+
T Consensus       288 ~~  289 (316)
T cd05574         288 QH  289 (316)
T ss_pred             cC
Confidence            64

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-34  Score=302.66  Aligned_cols=248  Identities=24%  Similarity=0.364  Sum_probs=196.8

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC-CcchhhHHHHHHHHhhcC---CcccceeeeeeecCCcceEEE
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIR---HRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lV~  632 (885)
                      .|+..+.||+|+||.||+|.+. +++.||+|.++... ....+.+.+|++++++++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4777889999999999999964 78999999987542 334567889999999986   999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++++|.+++...          .+++...+.++.|++.|+.|||+.+   |+||||+|+||+++.++.++|+|||.+
T Consensus        82 e~~~~~~L~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~  148 (277)
T cd06917          82 EYAEGGSVRTLMKAG----------PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVA  148 (277)
T ss_pred             ecCCCCcHHHHHHcc----------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCce
Confidence            999999999887543          2789999999999999999999998   999999999999999999999999999


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      ..+....           .......|+..|+|||...+ ..++.++|||||||++|+|++|+.||.....     ..++.
T Consensus       149 ~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-----~~~~~  212 (277)
T cd06917         149 ALLNQNS-----------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-----FRAMM  212 (277)
T ss_pred             eecCCCc-----------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-----hhhhh
Confidence            8763311           11223468889999998765 4568999999999999999999999964211     11111


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ........     .+.             ....+.++.+++.+||+.||++||++.|++.+
T Consensus       213 ~~~~~~~~-----~~~-------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         213 LIPKSKPP-----RLE-------------DNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             ccccCCCC-----CCC-------------cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            00000000     000             00134568899999999999999999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-34  Score=304.91  Aligned_cols=272  Identities=20%  Similarity=0.293  Sum_probs=201.1

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEe
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      ++|++.+.||+|++|.||+|... +++.||+|+++...  ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36889999999999999999976 58899999987432  3345778999999999999999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      |++++.+..+.....         .+++..+..++.|++.|++|||+.+   |+|||++|+||++++++.+||+|||.+.
T Consensus        81 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~  148 (288)
T cd07833          81 YVERTLLELLEASPG---------GLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFAR  148 (288)
T ss_pred             cCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeeccc
Confidence            999877766554321         2788999999999999999999998   9999999999999999999999999998


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      ......          ........++..|+|||+..+. .++.++||||||+++|+|++|+.||.....  .........
T Consensus       149 ~~~~~~----------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~--~~~~~~~~~  216 (288)
T cd07833         149 ALRARP----------ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD--IDQLYLIQK  216 (288)
T ss_pred             ccCCCc----------cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHH
Confidence            763321          0122234678899999999888 789999999999999999999999864211  111111111


Q ss_pred             hhcc---hhhhhh--hhhhhhc---cCCChHHHHH-HHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          793 HYHG---RLEKVI--DSSLLRA---SRDQSPEVKR-MWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       793 ~~~~---~~~~~~--d~~~~~~---~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ....   ......  +......   .......... ....++.++.+++.+||..+|++||++++++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         217 CLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             HhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            1000   000000  0000000   0000000111 111236789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.5e-34  Score=300.77  Aligned_cols=261  Identities=25%  Similarity=0.386  Sum_probs=203.6

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      ++|++.+.||.|++|+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+|++++++.+..++..++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            36889999999999999999965 68899999986442 23457789999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +++++|.+++.....      ...+++.....++.|++.|++|||+.+   |+||||||+||++++++.++|+|||++..
T Consensus        81 ~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~  151 (267)
T cd06610          81 LSGGSLLDIMKSSYP------RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSAS  151 (267)
T ss_pred             cCCCcHHHHHHHhcc------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHH
Confidence            999999999865432      123788999999999999999999998   99999999999999999999999999977


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      +......       .........|+..|+|||++... .++.++|||||||++|||++|+.||...... ..+.++... 
T Consensus       152 ~~~~~~~-------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~-  222 (267)
T cd06610         152 LADGGDR-------TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQN-  222 (267)
T ss_pred             hccCccc-------cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcC-
Confidence            6432110       00112334688999999998776 7899999999999999999999999653111 111111110 


Q ss_pred             hcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       794 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                         ..     +... ..   .     .+...+.++.+++.+||+.||++||+++|++++
T Consensus       223 ---~~-----~~~~-~~---~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         223 ---DP-----PSLE-TG---A-----DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             ---CC-----CCcC-Cc---c-----ccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence               00     0000 00   0     012245678999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.4e-33  Score=298.57  Aligned_cols=252  Identities=27%  Similarity=0.420  Sum_probs=203.7

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      +|++.+.||+|++|.||+|+.. +++.||||++..... ...+.+..|++++.+++|+|++++++++..+...++||||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            6888999999999999999976 599999999875543 44678999999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH-HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      ++++|.+++....         .+++..++.++.|+++|++|||+ .+   ++||||+|+||+++.++.++|+|||.+..
T Consensus        82 ~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~  149 (264)
T cd06623          82 DGGSLADLLKKVG---------KIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKV  149 (264)
T ss_pred             CCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCcccee
Confidence            9999999986542         38899999999999999999999 88   99999999999999999999999999986


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      .....           .......++..|+|||...+..++.++||||||+++|+|++|+.||......  ...+....  
T Consensus       150 ~~~~~-----------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~--  214 (264)
T cd06623         150 LENTL-----------DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELMQA--  214 (264)
T ss_pred             cccCC-----------CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHHHH--
Confidence            63211           1112345788999999999989999999999999999999999999764220  11111111  


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                            +......     ..+.     ...+..+.+++.+|+..+|++||++.|++++
T Consensus       215 ------~~~~~~~-----~~~~-----~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         215 ------ICDGPPP-----SLPA-----EEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ------HhcCCCC-----CCCc-----ccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                  0100000     0000     0034569999999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=337.59  Aligned_cols=255  Identities=28%  Similarity=0.414  Sum_probs=202.0

Q ss_pred             hhCCcccceecccCcceEEEEE-eCCCCEEEEEEeeecCC--cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSG--NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      +-+|.....||.|.||.||.|. ..+|+-.|||-++....  .......+|+.++..++|||+|++||+-...+..++.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            4467777899999999999999 55788899998875533  33566889999999999999999999998888999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      |||++|+|.+.+...+.         .++.....+..|++.|++|||++|   ||||||||+||+++.+|.+|++|||.|
T Consensus      1314 EyC~~GsLa~ll~~gri---------~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRI---------EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred             HHhccCcHHHHHHhcch---------hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccce
Confidence            99999999998864432         556666778899999999999999   999999999999999999999999999


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCC---CCccccchhhHHHHHHHHcCCCCCCccccCCccHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN---TSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKW  789 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~  789 (885)
                      ..+...-      ..+ ........||+.|||||++.+..   -..+.||||+|||+.||+||+.||..+...      |
T Consensus      1382 ~ki~~~~------~~~-~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne------~ 1448 (1509)
T KOG4645|consen 1382 VKIKNNA------QTM-PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE------W 1448 (1509)
T ss_pred             eEecCch------hcC-CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch------h
Confidence            9885431      111 13344678999999999987654   457899999999999999999999764222      2


Q ss_pred             HHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       790 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .-.          ..--++.. .+.|+      ..+.+-.+++.+|+..||++|+++.|++++
T Consensus      1449 aIM----------y~V~~gh~-Pq~P~------~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1449 AIM----------YHVAAGHK-PQIPE------RLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             HHH----------hHHhccCC-CCCch------hhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            111          00111111 11121      145667889999999999999999988876

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.6e-34  Score=301.11  Aligned_cols=248  Identities=23%  Similarity=0.304  Sum_probs=199.4

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEe
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      +|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|++++++++||||+++++++..+...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788999999999999999976 68999999987442   2345788999999999999999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      |+.+++|.+++....         .+++..+..++.|+++||.|||+.+   |+|+||+|+||++++++.++|+|||.+.
T Consensus        81 ~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~  148 (258)
T cd05578          81 LLLGGDLRYHLSQKV---------KFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIAT  148 (258)
T ss_pred             CCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeeccccc
Confidence            999999998886542         3788999999999999999999998   9999999999999999999999999987


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      .....            .......|+..|+|||+..+..++.++||||||+++|+|++|+.||......   ...+....
T Consensus       149 ~~~~~------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~  213 (258)
T cd05578         149 KVTPD------------TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAK  213 (258)
T ss_pred             ccCCC------------ccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHH
Confidence            65321            1122345788999999998888999999999999999999999999753111   11111110


Q ss_pred             hcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCH--HHHHH
Q 002746          794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTM--LDAAD  851 (885)
Q Consensus       794 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~--~ev~~  851 (885)
                      .            ........       ...+.++.+++.+||+.||.+||++  +|+.+
T Consensus       214 ~------------~~~~~~~~-------~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         214 Q------------ETADVLYP-------ATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             h------------ccccccCc-------ccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            0            00000000       1134678899999999999999999  66654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.6e-33  Score=304.92  Aligned_cols=246  Identities=28%  Similarity=0.388  Sum_probs=192.9

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC---cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG---NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ..|+..+.||+|+||.||+|... +++.||+|++.....   ...+.+.+|+++++.++|||+++++++|..++..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999965 689999999864322   23356889999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||++ |++.+.+....        ..+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||.+
T Consensus        95 e~~~-g~l~~~~~~~~--------~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~  162 (307)
T cd06607          95 EYCL-GSASDILEVHK--------KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSA  162 (307)
T ss_pred             HhhC-CCHHHHHHHcc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcc
Confidence            9997 56655554322        13789999999999999999999998   999999999999999999999999998


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccC---CCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF---GSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKW  789 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~  789 (885)
                      .....               .....|++.|+|||++.   ...++.++||||||+++|||++|+.||.....     ...
T Consensus       163 ~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~-----~~~  222 (307)
T cd06607         163 SLVSP---------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSA  222 (307)
T ss_pred             eecCC---------------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH-----HHH
Confidence            75421               11235788999999874   45688999999999999999999999864211     110


Q ss_pred             HHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       790 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .......            ......+      ..++.++.+++.+||+.+|++||++.+++.+
T Consensus       223 ~~~~~~~------------~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         223 LYHIAQN------------DSPTLSS------NDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             HHHHhcC------------CCCCCCc------hhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0000000            0000000      1145678999999999999999999999886

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.1e-33  Score=301.49  Aligned_cols=242  Identities=23%  Similarity=0.274  Sum_probs=185.1

Q ss_pred             eecccCcceEEEEEeC-CCCEEEEEEeeecCC---cchhhHHHHHHHHhh---cCCcccceeeeeeecCCcceEEEeccc
Q 002746          564 LLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG---NFTKSFNRECQVLKR---IRHRNLMRIITACSLPDFKALVLPYMA  636 (885)
Q Consensus       564 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~h~niv~~~~~~~~~~~~~lV~e~~~  636 (885)
                      +||+|+||.||+|... +++.||+|.+.....   .....+.+|..+++.   .+||+++.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999965 688999999864421   112334455444433   479999999999999999999999999


Q ss_pred             CCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeee
Q 002746          637 NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM  716 (885)
Q Consensus       637 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~  716 (885)
                      +|+|.+++....         .+++..+..++.|++.||+|||+.+   |+||||||+||++++++.++++|||++....
T Consensus        81 ~~~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~  148 (279)
T cd05633          81 GGDLHYHLSQHG---------VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (279)
T ss_pred             CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence            999998876443         3899999999999999999999998   9999999999999999999999999987542


Q ss_pred             cccCCCCCCCCCCCCccccccccccccCCcccC-CCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhc
Q 002746          717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF-GSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~  795 (885)
                      ..             ......|+..|+|||... +..++.++||||+||++|||++|+.||.......  . ..+.... 
T Consensus       149 ~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~-~~~~~~~-  211 (279)
T cd05633         149 KK-------------KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--K-HEIDRMT-  211 (279)
T ss_pred             cc-------------CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC--H-HHHHHHh-
Confidence            11             112235899999999876 4567899999999999999999999996532211  0 0000000 


Q ss_pred             chhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP-----TMLDAADD  852 (885)
Q Consensus       796 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  852 (885)
                                 .......       .+..+.++.+++.+|++.||++||     +++|++++
T Consensus       212 -----------~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         212 -----------LTVNVEL-------PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             -----------hcCCcCC-------ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence                       0000000       012456789999999999999999     69999886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-35  Score=310.33  Aligned_cols=251  Identities=21%  Similarity=0.371  Sum_probs=201.9

Q ss_pred             CCcccceecccCcceEEEEEeCC-CCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEeccc
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMA  636 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~  636 (885)
                      -|+++..||.|+||.||+|..++ +-..|.|++........++|.-|++||+..+||+||++++.|..++..++..|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            45666789999999999999764 34457788887777778899999999999999999999999999999999999999


Q ss_pred             CCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeee
Q 002746          637 NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM  716 (885)
Q Consensus       637 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~  716 (885)
                      ||-++..+-.-..        .+...++..+++|++.||.|||++.   |||||+|+-|||++-+|.++|+|||.+....
T Consensus       113 GGAVDaimlEL~r--------~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~  181 (1187)
T KOG0579|consen  113 GGAVDAIMLELGR--------VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK  181 (1187)
T ss_pred             CchHhHHHHHhcc--------ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch
Confidence            9999888765432        4899999999999999999999998   9999999999999999999999999876542


Q ss_pred             cccCCCCCCCCCCCCccccccccccccCCcccCC-----CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-----SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      ..           ......+.|||.|||||+..+     .+|+.++||||||++|.||..+.+|.+.....     ..+-
T Consensus       182 ~t-----------~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-----RVll  245 (1187)
T KOG0579|consen  182 ST-----------RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLL  245 (1187)
T ss_pred             hH-----------HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-----HHHH
Confidence            21           233456789999999998654     57899999999999999999999998653111     1110


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .+...+.+.++.           |      ..++..|.+++.+|+..+|..||+++++++|
T Consensus       246 KiaKSePPTLlq-----------P------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  246 KIAKSEPPTLLQ-----------P------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             HHhhcCCCcccC-----------c------chhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            001011111110           0      1245679999999999999999999999875

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-34  Score=307.44  Aligned_cols=250  Identities=22%  Similarity=0.330  Sum_probs=208.6

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC--cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG--NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ...|.+...||+|.|+.|..|+.. ++..||+|.+....-  .....+.+|++++..++|||||+++.+.+.+...++||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            467899999999999999999955 799999999975532  22345889999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+.+|.+.+++..+.+         .....+..++.|+.+|++|||+++   |||||||++|||++.+.++||+|||++
T Consensus       135 eya~~ge~~~yl~~~gr---------~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS  202 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGR---------MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFS  202 (596)
T ss_pred             EeccCchhHHHHHhccc---------chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccc
Confidence            99999999999988765         445778889999999999999999   999999999999999999999999999


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCC-CccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      ..+..            .......+|++.|.|||+..+..| ++++|+||+|+++|.|+.|..||+...           
T Consensus       203 ~~~~~------------~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~-----------  259 (596)
T KOG0586|consen  203 TFFDY------------GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN-----------  259 (596)
T ss_pred             eeecc------------cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc-----------
Confidence            98843            345566799999999999999887 689999999999999999999997521           


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                            +.+.-+..+.+.++-..        ..+.++.+++++++-.+|.+|++++++.++-+
T Consensus       260 ------lk~Lr~rvl~gk~rIp~--------~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W  308 (596)
T KOG0586|consen  260 ------LKELRPRVLRGKYRIPF--------YMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW  308 (596)
T ss_pred             ------cccccchheeeeecccc--------eeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence                  11111122222222111        13456889999999999999999999988643

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=310.73  Aligned_cols=255  Identities=27%  Similarity=0.361  Sum_probs=200.9

Q ss_pred             CcccceecccCcceEEEEEeC--CCC--EEEEEEeeecCCc-chhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEe
Q 002746          559 FDEQRLLGTGSYGRVYKGILQ--DGT--AIAVKVLQLQSGN-FTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      ....+.||+|.||+|++|.|.  +|+  .||||+++..... ...+|.+|+.+|.+++|+|++++||.+-+ ....||+|
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            345578999999999999987  344  4799999866443 67899999999999999999999999876 66789999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      .++.|+|.+.|+....       ..+.......++.|||.|+.||..++   .||||+...|+++-..-.+||+|||+.+
T Consensus       191 LaplGSLldrLrka~~-------~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmR  260 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRKAKK-------AILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMR  260 (1039)
T ss_pred             hcccchHHHHHhhccc-------cceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeeccccee
Confidence            9999999999987322       23778888899999999999999998   9999999999999988899999999998


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHHH
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~~  792 (885)
                      -++...   +..     .......-...|||||.+....++.++|||+|||++|||+| |..||..-  .+   .+    
T Consensus       261 aLg~ne---d~Y-----vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~--~g---~q----  323 (1039)
T KOG0199|consen  261 ALGENE---DMY-----VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC--RG---IQ----  323 (1039)
T ss_pred             ccCCCC---cce-----EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC--CH---HH----
Confidence            775422   111     11112233567999999999999999999999999999999 67888531  11   11    


Q ss_pred             hhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       793 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                           +-+.+|+.    .+-..+      ..|++++++++..||...|++|||+..+.+.+-..
T Consensus       324 -----IL~~iD~~----erLpRP------k~csedIY~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  324 -----ILKNIDAG----ERLPRP------KYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             -----HHHhcccc----ccCCCC------CCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence                 12222311    111111      13788999999999999999999999998655433

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.6e-33  Score=301.92  Aligned_cols=253  Identities=24%  Similarity=0.370  Sum_probs=203.0

Q ss_pred             HhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEe
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      .++.|++.+.||+|++|.||+|... ++..||+|++..... ..+.+..|++++++++|+|++++++++..++..++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            3567888899999999999999976 689999999975543 45778899999999999999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      |+++++|.+++....        ..+++..+..++.|++.||+|||+.|   |+|+||+|+||+++.++.++|+|||.+.
T Consensus        96 ~~~~~~L~~~l~~~~--------~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~  164 (286)
T cd06614          96 YMDGGSLTDIITQNF--------VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAA  164 (286)
T ss_pred             ccCCCcHHHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhh
Confidence            999999999987653        13899999999999999999999988   9999999999999999999999999986


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      .....           ........++..|+|||++.+..++.++||||||+++|+|++|+.||.....    . ..... 
T Consensus       165 ~~~~~-----------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~----~-~~~~~-  227 (286)
T cd06614         165 QLTKE-----------KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP----L-RALFL-  227 (286)
T ss_pred             hhccc-----------hhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH----H-HHHHH-
Confidence            54221           0111233578899999999888899999999999999999999999864211    0 00000 


Q ss_pred             hcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       794 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                             .....    .. ..+.    ...++.++.+++.+|++.+|.+||++.+++++
T Consensus       228 -------~~~~~----~~-~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         228 -------ITTKG----IP-PLKN----PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             -------HHhcC----CC-CCcc----hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                   00000    00 0000    01135578999999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-34  Score=303.12  Aligned_cols=270  Identities=23%  Similarity=0.289  Sum_probs=197.4

Q ss_pred             CcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      |++.+.||.|++|.||+|... +|..||+|++....  ....+.+.+|++++++++|||++++++++.+++..++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            667889999999999999965 79999999987543  223456889999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      + ++|.+++.....       ..+++..+..++.|+++||+|||+++   ++||||+|+||+++.++.++|+|||.+..+
T Consensus        81 ~-~~l~~~~~~~~~-------~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~  149 (283)
T cd07835          81 D-LDLKKYMDSSPL-------TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAF  149 (283)
T ss_pred             C-cCHHHHHhhCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence            5 688888765432       23889999999999999999999998   999999999999999999999999999754


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhh
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      ...           ........++..|+|||++.+. .++.++||||||+++|||++|+.||...... ..+.+......
T Consensus       150 ~~~-----------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~  217 (283)
T cd07835         150 GVP-----------VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLG  217 (283)
T ss_pred             CCC-----------ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhC
Confidence            221           1111223468899999987654 5688999999999999999999999642110 11111111100


Q ss_pred             cchhhhhh-----hhhhhhccC-CChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          795 HGRLEKVI-----DSSLLRASR-DQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       795 ~~~~~~~~-----d~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                       ......+     .+....... ...+.........+.++.+++.+|++.+|++|||++|++++
T Consensus       218 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         218 -TPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             -CCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence             0000000     000000000 00001111112234678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.8e-33  Score=304.96  Aligned_cols=282  Identities=23%  Similarity=0.326  Sum_probs=202.6

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC--cchhhHHHHHHHHhhcCCcccceeeeeeecC--CcceE
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG--NFTKSFNRECQVLKRIRHRNLMRIITACSLP--DFKAL  630 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l  630 (885)
                      .++|++.+.||+|+||.||+|... +|+.||+|+++....  .....+.+|++++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            367999999999999999999965 689999999875432  2234567899999999999999999998765  45789


Q ss_pred             EEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccc
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG  710 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg  710 (885)
                      ||||+. ++|.+++....        ..+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.+||+|||
T Consensus        86 v~e~~~-~~l~~~l~~~~--------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg  153 (309)
T cd07845          86 VMEYCE-QDLASLLDNMP--------TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFG  153 (309)
T ss_pred             EEecCC-CCHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccc
Confidence            999996 47777765432        13889999999999999999999998   9999999999999999999999999


Q ss_pred             cceeeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHH
Q 002746          711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKW  789 (885)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~  789 (885)
                      .+.......           .......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.....  ......
T Consensus       154 ~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~--~~~~~~  220 (309)
T cd07845         154 LARTYGLPA-----------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE--IEQLDL  220 (309)
T ss_pred             eeeecCCcc-----------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH
Confidence            998663211           11122345788999998865 4578999999999999999999999964211  111111


Q ss_pred             HHHhhcchhhhhh----hhhhhhc---cCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHhcC
Q 002746          790 VKNHYHGRLEKVI----DSSLLRA---SRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGE  862 (885)
Q Consensus       790 ~~~~~~~~~~~~~----d~~~~~~---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~  862 (885)
                      +............    +......   ...............++++.+++.+|++.||++|||++|++.+     .|+.+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h-----~~f~~  295 (309)
T cd07845         221 IIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES-----SYFKE  295 (309)
T ss_pred             HHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC-----hhhcc
Confidence            1111111100000    0000000   0000011111122246678899999999999999999999985     56665


Q ss_pred             CCCCC
Q 002746          863 KHMPS  867 (885)
Q Consensus       863 ~~~~~  867 (885)
                      ...+.
T Consensus       296 ~~~~~  300 (309)
T cd07845         296 KPLPC  300 (309)
T ss_pred             CCCCC
Confidence            55543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-33  Score=305.18  Aligned_cols=277  Identities=21%  Similarity=0.282  Sum_probs=198.5

Q ss_pred             CCcccceecccCcceEEEEEeC---CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecC--Ccce
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ---DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLP--DFKA  629 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~  629 (885)
                      +|++.+.||+|++|.||+|...   +++.||+|.+....   ....+.+.+|++++++++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999965   47899999998632   33456788999999999999999999999888  7889


Q ss_pred             EEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecC----CCCEE
Q 002746          630 LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND----DMTAL  705 (885)
Q Consensus       630 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~----~~~~k  705 (885)
                      +||||+++ ++.+++......    ....++...++.++.|++.|++|||+.+   |+||||||+||+++.    ++.+|
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~k  152 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQA----KRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVK  152 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccC----CCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEE
Confidence            99999975 555555432211    1124788999999999999999999998   999999999999999    89999


Q ss_pred             EcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCc
Q 002746          706 VSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGL  784 (885)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~  784 (885)
                      |+|||+++.+.....        .........++..|+|||++.+. .++.++|||||||++|||++|+.||........
T Consensus       153 l~Dfg~~~~~~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~  224 (316)
T cd07842         153 IGDLGLARLFNAPLK--------PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIK  224 (316)
T ss_pred             ECCCccccccCCCcc--------cccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccccc
Confidence            999999986633110        01122334678999999987664 578999999999999999999999975432210


Q ss_pred             --------cHHHHHHHhhcc------------hhhhhhhhhhhhccCCChHHHHHHHH---HHHHHHHHHHhhhcCCCCC
Q 002746          785 --------SLHKWVKNHYHG------------RLEKVIDSSLLRASRDQSPEVKRMWD---VAIGELIELGILCTQESPS  841 (885)
Q Consensus       785 --------~~~~~~~~~~~~------------~~~~~~d~~~~~~~~~~~~~~~~~~~---~~~~~l~~l~~~cl~~dP~  841 (885)
                              .+..++......            ......+........  ........+   ..+.++.+++.+|++.||+
T Consensus       225 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~  302 (316)
T cd07842         225 KSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYP--SNSLAKWMEKHKKPDSQGFDLLRKLLEYDPT  302 (316)
T ss_pred             ccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCC--CccHHHHHHhccCCCHHHHHHHHHHhcCCcc
Confidence                    011111100000            000000000000000  011111111   2456799999999999999


Q ss_pred             CCCCHHHHHHH
Q 002746          842 TRPTMLDAADD  852 (885)
Q Consensus       842 ~RPt~~ev~~~  852 (885)
                      +|||+.|++++
T Consensus       303 ~Rps~~eil~~  313 (316)
T cd07842         303 KRITAEEALEH  313 (316)
T ss_pred             cCcCHHHHhcC
Confidence            99999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.8e-33  Score=302.49  Aligned_cols=271  Identities=23%  Similarity=0.302  Sum_probs=197.2

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC--cchhhHHHHHHHHhhcCCcccceeeeeeecC--CcceEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG--NFTKSFNRECQVLKRIRHRNLMRIITACSLP--DFKALV  631 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lV  631 (885)
                      ++|++.+.||+|+||.||+|... +++.+|+|.++....  .....+.+|++++++++||||+++++++..+  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57888899999999999999976 688999999875432  2234577899999999999999999998877  888999


Q ss_pred             EecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccc
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~  711 (885)
                      |||++ ++|.+++.....        .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||.
T Consensus        85 ~e~~~-~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~  152 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQ--------PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGL  152 (293)
T ss_pred             ehhcC-cCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCc
Confidence            99997 488877754332        3889999999999999999999998   99999999999999999999999999


Q ss_pred             ceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHH
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~  790 (885)
                      +..+...           ........+++.|+|||...+. .++.++||||+|+++|||++|+.||...... ....+..
T Consensus       153 ~~~~~~~-----------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~  220 (293)
T cd07843         153 AREYGSP-----------LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIF  220 (293)
T ss_pred             eeeccCC-----------ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Confidence            8865321           0111234578899999988664 4689999999999999999999999642110 0111111


Q ss_pred             HHhhcchhhhhhhh--hhh--h-cc--CCChHHHHHHHHH--HHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          791 KNHYHGRLEKVIDS--SLL--R-AS--RDQSPEVKRMWDV--AIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       791 ~~~~~~~~~~~~d~--~~~--~-~~--~~~~~~~~~~~~~--~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                       .............  .+.  . ..  .............  .++.+.+++.+|++.+|++|||+.|++++
T Consensus       221 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         221 -KLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             -HHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence             1010000000000  000  0 00  0000011111111  25678899999999999999999999874

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.9e-33  Score=307.93  Aligned_cols=275  Identities=24%  Similarity=0.307  Sum_probs=201.3

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeec----CCcc
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSL----PDFK  628 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~  628 (885)
                      ..+|++.+.||+|++|.||+|... +|+.||+|++....  ....+.+..|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            368999999999999999999965 69999999987542  2335667889999999999999999988753    3457


Q ss_pred             eEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcc
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSD  708 (885)
Q Consensus       629 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D  708 (885)
                      ++||||+. |+|.+++....         .+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~d  150 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ---------PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGD  150 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecc
Confidence            89999995 68888775432         2789999999999999999999998   99999999999999999999999


Q ss_pred             cccceeeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHH
Q 002746          709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH  787 (885)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~  787 (885)
                      ||.+..+......       .........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.....  ....
T Consensus       151 fg~~~~~~~~~~~-------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~--~~~~  221 (334)
T cd07855         151 FGMARGLSSSPTE-------HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY--VHQL  221 (334)
T ss_pred             cccceeecccCcC-------CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh--HHHH
Confidence            9999766332110       1112223468899999998765 4688999999999999999999999965211  1111


Q ss_pred             HHHHHhhcchhhhhhh----hhhhh----ccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          788 KWVKNHYHGRLEKVID----SSLLR----ASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       788 ~~~~~~~~~~~~~~~d----~~~~~----~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..+............+    ..+..    ................+.++.+++.+|++.+|++||++++++.+
T Consensus       222 ~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         222 KLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             HHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            1111111111111111    11000    00001111122223356789999999999999999999999985

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.2e-33  Score=299.00  Aligned_cols=266  Identities=19%  Similarity=0.224  Sum_probs=194.0

Q ss_pred             CcccceecccCcceEEEEEeC-CCCEEEEEEeeecC-CcchhhHHHHHHHHhhcC-CcccceeeeeeecC--CcceEEEe
Q 002746          559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIR-HRNLMRIITACSLP--DFKALVLP  633 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lV~e  633 (885)
                      |.+.+.||+|+||.||+|... +++.||+|+++... ........+|+.++.++. |+|++++++++.++  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567889999999999999965 68999999987542 222334457888888885 99999999999887  88899999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      |++ |++.+.+....        ..+++..+..++.|++.||+|||+.+   |+||||||+||+++. +.+||+|||.++
T Consensus        81 ~~~-~~l~~~l~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~  147 (282)
T cd07831          81 LMD-MNLYELIKGRK--------RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCR  147 (282)
T ss_pred             cCC-ccHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccc
Confidence            997 57777665432        13889999999999999999999998   999999999999999 999999999997


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccC-CCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF-GSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      .+...            .......++..|+|||+.. +..++.++||||+||++|||++|+.||.....  .....+...
T Consensus       148 ~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~  213 (282)
T cd07831         148 GIYSK------------PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHD  213 (282)
T ss_pred             ccccC------------CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHH
Confidence            65321            1112235788999999764 45578999999999999999999999965211  112222222


Q ss_pred             hhcchhhhhhhhhhhhcc-------CCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          793 HYHGRLEKVIDSSLLRAS-------RDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       793 ~~~~~~~~~~d~~~~~~~-------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ........+ ........       ..............+.++.+++.+||+++|++||+++|++++
T Consensus       214 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         214 VLGTPDAEV-LKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             HcCCCCHHH-HHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            221111111 00000000       000001111222356789999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.3e-33  Score=295.75  Aligned_cols=251  Identities=20%  Similarity=0.283  Sum_probs=194.0

Q ss_pred             HHHHHHHhhCCccccee--cccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhc-CCcccceeeeeeec
Q 002746          549 YRELLEATAEFDEQRLL--GTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLMRIITACSL  624 (885)
Q Consensus       549 ~~~~~~~~~~~~~~~~l--g~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  624 (885)
                      ..+.....++|++.+.+  |+|+||.||+++.. ++..+|+|.++......     .|+.....+ +|||++++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence            34455556778887776  99999999999964 68889999987432111     122222222 79999999999999


Q ss_pred             CCcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCC-C
Q 002746          625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDM-T  703 (885)
Q Consensus       625 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~  703 (885)
                      ++..++||||+++|+|.+++....         .+++..+..++.|+++|+.|||+.+   ++||||||+||+++.++ .
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~  148 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKEG---------KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDR  148 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCe
Confidence            999999999999999999886543         3899999999999999999999998   99999999999999988 9


Q ss_pred             EEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCC
Q 002746          704 ALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGG  783 (885)
Q Consensus       704 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~  783 (885)
                      ++|+|||.++....               .....|+..|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus       149 ~~l~dfg~~~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~  213 (267)
T PHA03390        149 IYLCDYGLCKIIGT---------------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE  213 (267)
T ss_pred             EEEecCccceecCC---------------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch
Confidence            99999999876521               112357899999999999899999999999999999999999997543322


Q ss_pred             ccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-HHHHHHH
Q 002746          784 LSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT-MLDAADD  852 (885)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~ev~~~  852 (885)
                      .....+.... ..        ..     .       .....+..+.+++.+|++.+|.+||+ ++|++++
T Consensus       214 ~~~~~~~~~~-~~--------~~-----~-------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        214 LDLESLLKRQ-QK--------KL-----P-------FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             hhHHHHHHhh-cc--------cC-----C-------cccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence            2222222111 00        00     0       00124567899999999999999996 6888864

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.1e-33  Score=293.54  Aligned_cols=250  Identities=27%  Similarity=0.440  Sum_probs=202.2

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEeccc
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMA  636 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~  636 (885)
                      +|+..+.||+|++|.||+|... ++..+++|+++.......+.+.+|++++++++|++++++++++..+...++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4778899999999999999976 688999999986554456789999999999999999999999999999999999999


Q ss_pred             CCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeee
Q 002746          637 NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM  716 (885)
Q Consensus       637 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~  716 (885)
                      +++|.+++....        ..+++..+..++.|+++|+.|||+.+   ++||||+|+||++++++.++|+|||.+....
T Consensus        81 ~~~L~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  149 (253)
T cd05122          81 GGSLKDLLKSTN--------QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLS  149 (253)
T ss_pred             CCcHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccc
Confidence            999999886542        13889999999999999999999988   9999999999999999999999999987653


Q ss_pred             cccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcc
Q 002746          717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHG  796 (885)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  796 (885)
                      ...            ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....     ...........
T Consensus       150 ~~~------------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~  212 (253)
T cd05122         150 DTK------------ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP-----PMKALFKIATN  212 (253)
T ss_pred             ccc------------cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc-----hHHHHHHHHhc
Confidence            210            0233468889999999988889999999999999999999999986421     11111100000


Q ss_pred             hhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          797 RLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       797 ~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ....         ..  .+      ..++.++.+++.+||+.||++|||+.|++++
T Consensus       213 ~~~~---------~~--~~------~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         213 GPPG---------LR--NP------EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             CCCC---------cC--cc------cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0000         00  00      0024568999999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=313.70  Aligned_cols=255  Identities=28%  Similarity=0.470  Sum_probs=205.8

Q ss_pred             CcccceecccCcceEEEEEeC-CC----CEEEEEEeeec-CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          559 FDEQRLLGTGSYGRVYKGILQ-DG----TAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~-~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ....++||+|+||+||+|.|- +|    .+||+|++... ..+...++..|+-++.+++|||+++++|+|..+. ..||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            445678999999999999863 44    45899988644 3445788999999999999999999999998766 78999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      +||+.|+|.++++.++.        .+.....+.|+.|||+|+.|||++.   +|||||.++|||+.+-.++||+|||+|
T Consensus       777 q~mP~G~LlDyvr~hr~--------~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla  845 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRD--------NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLA  845 (1177)
T ss_pred             HhcccchHHHHHHHhhc--------cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchh
Confidence            99999999999998764        3777888999999999999999987   999999999999999999999999999


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccccCCccHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~~~~~~~~~~  791 (885)
                      +.+.+.+.         ........-.+.|||-|.+....++.++|||||||++||++| |..|++.+..          
T Consensus       846 ~ll~~d~~---------ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~----------  906 (1177)
T KOG1025|consen  846 KLLAPDEK---------EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA----------  906 (1177)
T ss_pred             hccCcccc---------cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH----------
Confidence            98865321         111122223567999999999999999999999999999999 9999875311          


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR  858 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~  858 (885)
                          +++.+.+.    .+.+-..|.      .+..++..++.+||..|+..||+++++.+.+.++.+
T Consensus       907 ----~eI~dlle----~geRLsqPp------iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  907 ----EEIPDLLE----KGERLSQPP------ICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             ----HHhhHHHh----ccccCCCCC------CccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence                12222222    222222222      277889999999999999999999999999888765

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.7e-33  Score=300.73  Aligned_cols=264  Identities=17%  Similarity=0.271  Sum_probs=182.3

Q ss_pred             hhCCcccceecccCcceEEEEEeCC----CCEEEEEEeeecCCcch-----------hhHHHHHHHHhhcCCcccceeee
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQD----GTAIAVKVLQLQSGNFT-----------KSFNRECQVLKRIRHRNLMRIIT  620 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~  620 (885)
                      .++|.+.+.||+|+||.||+|.+.+    +..+|+|+.........           .....+...+..++|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3689999999999999999999764    34566665443221110           11122334456678999999998


Q ss_pred             eeecCC----cceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCce
Q 002746          621 ACSLPD----FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNV  696 (885)
Q Consensus       621 ~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI  696 (885)
                      ++....    ..++++|++.. ++.+.+....         ..++..+..|+.|++.|++|||+++   |+||||||+||
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Ni  157 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---------CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENI  157 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhhc---------cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence            765543    33567777633 3433333211         2467778899999999999999998   99999999999


Q ss_pred             EecCCCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCC
Q 002746          697 LLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPT  776 (885)
Q Consensus       697 Ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~  776 (885)
                      |++.++.++|+|||+|+.+...+....    ..........||+.|+|||+..+..++.++|||||||++|||++|+.||
T Consensus       158 ll~~~~~~~l~DFGla~~~~~~~~~~~----~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~  233 (294)
T PHA02882        158 MVDGNNRGYIIDYGIASHFIIHGKHIE----YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPW  233 (294)
T ss_pred             EEcCCCcEEEEEcCCceeeccCCcccc----cccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999987743211111    0111222346999999999999999999999999999999999999999


Q ss_pred             CccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 002746          777 DDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDL  853 (885)
Q Consensus       777 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  853 (885)
                      ....... .........+   ...+.....             ....+++++.+++..|++.+|++||+++++++.+
T Consensus       234 ~~~~~~~-~~~~~~~~~~---~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        234 KGFGHNG-NLIHAAKCDF---IKRLHEGKI-------------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             Cccccch-HHHHHhHHHH---HHHhhhhhh-------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            7642211 1111000000   000000000             0112456789999999999999999999999865

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.7e-33  Score=302.54  Aligned_cols=248  Identities=28%  Similarity=0.386  Sum_probs=193.6

Q ss_pred             CcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      |...+.||+|+||.||+|+.. ++..||+|++....   ......+..|++++++++|||++++++++..++..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            667789999999999999965 68899999986432   22345688899999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +. |++.+.+....        ..+++..+..++.+++.|+.|||+.+   |+||||+|+||+++.++.++|+|||++..
T Consensus       107 ~~-g~l~~~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~  174 (317)
T cd06635         107 CL-GSASDLLEVHK--------KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASI  174 (317)
T ss_pred             CC-CCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccc
Confidence            96 46766654322        13789999999999999999999998   99999999999999999999999998865


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccC---CCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF---GSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      ...               .....|++.|+|||++.   +..++.++|||||||++|||++|+.||..... ......+..
T Consensus       175 ~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-~~~~~~~~~  238 (317)
T cd06635         175 ASP---------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-MSALYHIAQ  238 (317)
T ss_pred             cCC---------------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHh
Confidence            421               12235788999999873   45688999999999999999999999864210 000111110


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                      .                .......      ...+..+.+++.+||+.+|.+||++.|++++...+
T Consensus       239 ~----------------~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  281 (317)
T cd06635         239 N----------------ESPTLQS------NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL  281 (317)
T ss_pred             c----------------cCCCCCC------ccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence            0                0000000      11345688999999999999999999999876543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-33  Score=297.86  Aligned_cols=270  Identities=23%  Similarity=0.314  Sum_probs=196.5

Q ss_pred             CcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC--cchhhHHHHHHHHhhc---CCcccceeeeeeecCCc-----
Q 002746          559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG--NFTKSFNRECQVLKRI---RHRNLMRIITACSLPDF-----  627 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~-----  627 (885)
                      |++.+.||+|+||.||+|+.+ +++.||+|+++....  .....+.+|+.+++++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            677889999999999999976 489999999974422  2234566788877666   69999999999988776     


Q ss_pred             ceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEc
Q 002746          628 KALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVS  707 (885)
Q Consensus       628 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~  707 (885)
                      .+++|||+. ++|.+++.....       ..+++..++.++.|+++||+|||+.+   ++|+||+|+||+++.++.++|+
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~-------~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~  149 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK-------PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIA  149 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEe
Confidence            899999997 478777754322       13889999999999999999999998   9999999999999999999999


Q ss_pred             ccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHH
Q 002746          708 DFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH  787 (885)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~  787 (885)
                      |||.+..+...            .......++..|+|||++.+..++.++|||||||++|||++|+.||..... .....
T Consensus       150 dfg~~~~~~~~------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~  216 (287)
T cd07838         150 DFGLARIYSFE------------MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLD  216 (287)
T ss_pred             ccCcceeccCC------------cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHH
Confidence            99999765321            111223478899999999999999999999999999999999999865211 11122


Q ss_pred             HHHHHhhcchhhhhhhhh--hhhc-cCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          788 KWVKNHYHGRLEKVIDSS--LLRA-SRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       788 ~~~~~~~~~~~~~~~d~~--~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .+................  .... ...............+.++.+++.+||+.||++||+++|++.+
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         217 KIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             HHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            221111100000000000  0000 0000111122223456778999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.3e-33  Score=297.59  Aligned_cols=273  Identities=25%  Similarity=0.329  Sum_probs=200.5

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      +|++.+.||+|++|.||+|+.. +|+.||||+++.... .....+.+|++++++++|+|++++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788999999999999999975 688999999875532 23466778999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++ +|.+++.....      ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.++++|||.+...
T Consensus        81 ~~-~l~~~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~  150 (284)
T cd07836          81 DK-DLKKYMDTHGV------RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAF  150 (284)
T ss_pred             Cc-cHHHHHHhcCC------CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhh
Confidence            84 77777654331      124899999999999999999999998   999999999999999999999999999754


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh-
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH-  793 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~-  793 (885)
                      ...           ........++..|+|||++.+. .++.++|||||||++|+|++|+.||...... .......... 
T Consensus       151 ~~~-----------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~  218 (284)
T cd07836         151 GIP-----------VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRIMG  218 (284)
T ss_pred             cCC-----------ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhC
Confidence            221           1111223568899999987664 5689999999999999999999999653111 1111111000 


Q ss_pred             --hcchhhhhhh-hhhhhcc-CCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          794 --YHGRLEKVID-SSLLRAS-RDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       794 --~~~~~~~~~d-~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                        .........+ +...... .........+.+..+.++.+++.+|++.||.+||+++|++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         219 TPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             CCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              0000110100 0000000 111112222333456789999999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2e-33  Score=301.33  Aligned_cols=254  Identities=23%  Similarity=0.327  Sum_probs=199.2

Q ss_pred             cceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCCcc
Q 002746          562 QRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSL  640 (885)
Q Consensus       562 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL  640 (885)
                      ..+||+|+||.||+|... ++..||||++..........+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            357999999999999864 7899999998655445567789999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecccC
Q 002746          641 DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGV  720 (885)
Q Consensus       641 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~  720 (885)
                      .+++...          .+++.....++.|++.|++|||+.+   ++||||+|+||++++++.++|+|||.+......  
T Consensus       105 ~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~--  169 (292)
T cd06657         105 TDIVTHT----------RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--  169 (292)
T ss_pred             HHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccc--
Confidence            8876432          2688889999999999999999998   999999999999999999999999988755221  


Q ss_pred             CCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhhh
Q 002746          721 GNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEK  800 (885)
Q Consensus       721 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  800 (885)
                               ........|++.|+|||+..+..++.++||||+|+++|||++|..||.....  ......+....      
T Consensus       170 ---------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~------  232 (292)
T cd06657         170 ---------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNL------  232 (292)
T ss_pred             ---------cccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhC------
Confidence                     1111234578999999999888899999999999999999999999864100  00001110000      


Q ss_pred             hhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHhcCCCCC
Q 002746          801 VIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGEKHMP  866 (885)
Q Consensus       801 ~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~~~~~  866 (885)
                        ...+.        .    ....+.++.+++.+||+.+|.+||++.+++++     .++.....+
T Consensus       233 --~~~~~--------~----~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~-----~~~~~~~~~  279 (292)
T cd06657         233 --PPKLK--------N----LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH-----PFLAKAGPP  279 (292)
T ss_pred             --CcccC--------C----cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC-----hHHhccCCC
Confidence              00000        0    01134567889999999999999999999985     555554443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-36  Score=332.21  Aligned_cols=421  Identities=27%  Similarity=0.370  Sum_probs=315.2

Q ss_pred             CCCcEEeCCCCcccccCchhhhCCCCCcEEEccCcccccCCchhhhcCCCCCCEEEcCCCcccccCCccCCCCCCCcEEE
Q 002746           19 RRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLS   98 (885)
Q Consensus        19 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~f~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~   98 (885)
                      -+|+.|+|++|++. ..|..+..+.+|+.|++++|.|. .+|.+ ..++.+|++|.|.+|++. ..|..+..+++|+.|+
T Consensus        45 v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s-~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~Ld  120 (1081)
T KOG0618|consen   45 VKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSS-CSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLD  120 (1081)
T ss_pred             eeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchh-hhhhhcchhheeccchhh-cCchhHHhhhcccccc
Confidence            34888888888886 67778888888888888888887 67744 567788888888888887 7777788888888888


Q ss_pred             cccccCcccCCccc--------------------ccCccceEecccccccCCCChhhhcCCCCCcEEECCCCcccCCCCC
Q 002746           99 LYNNQLTGQLPASL--------------------INTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDN  158 (885)
Q Consensus        99 L~~N~l~~~~~~~~--------------------~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  158 (885)
                      ++.|++.. .|..+                    ....++.+++..|.+.+.++.++ ..+..  .|+|++|.+..+   
T Consensus       121 lS~N~f~~-~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i-~~l~~--~ldLr~N~~~~~---  193 (1081)
T KOG0618|consen  121 LSFNHFGP-IPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDI-YNLTH--QLDLRYNEMEVL---  193 (1081)
T ss_pred             cchhccCC-CchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcch-hhhhe--eeecccchhhhh---
Confidence            88887763 33222                    12235566677777766666554 33444  599999988732   


Q ss_pred             CCcccccccCCCCCCCcEEEecCcccCccCCCccccccccEEEccCCcccccCCccccCCCCCCeeeccccccccccchh
Q 002746          159 TNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAE  238 (885)
Q Consensus       159 ~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~p~~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  238 (885)
                              .+.++..|+.+....|++...   .+...+++.|+.++|.++...+.  ..-.+|+++++++|+++ ..|++
T Consensus       194 --------dls~~~~l~~l~c~rn~ls~l---~~~g~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~-~lp~w  259 (1081)
T KOG0618|consen  194 --------DLSNLANLEVLHCERNQLSEL---EISGPSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLS-NLPEW  259 (1081)
T ss_pred             --------hhhhccchhhhhhhhcccceE---EecCcchheeeeccCcceeeccc--cccccceeeecchhhhh-cchHH
Confidence                    267788888888888887522   23345799999999999844332  23478999999999999 45699


Q ss_pred             hcCCCCCCeEecccccccccCcccccCCCCCCeeecccccccccCCccccCCCcccEEEccCCccCCCCCcccC-CCCC-
Q 002746          239 ISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLG-RCTD-  316 (885)
Q Consensus       239 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~-  316 (885)
                      ++.+.+|+.|+..+|+++ .+|..+..+++|+.|.+.+|.+. .+|....+++.|++|+|..|+|. .+|+.+. .+.. 
T Consensus       260 i~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~  336 (1081)
T KOG0618|consen  260 IGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNAS  336 (1081)
T ss_pred             HHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHH
Confidence            999999999999999997 78888999999999999999998 56777888999999999999997 5555433 3333 


Q ss_pred             CCEEECcCCcCcccCCcccc-CccceeeeeeccCCcCCCCchhhhcCCCCcceeecCCCccccccccccccCccccEEEe
Q 002746          317 LYKLDLSYNRLTGSIPAEIS-GIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINI  395 (885)
Q Consensus       317 L~~L~l~~N~l~~~~~~~~~-~l~~l~~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l  395 (885)
                      |..|..+.|++. ..|..-. ....| ..|.+.+|.++...-..+.++.+|+.|+|++|+|.......+.++..|+.|+|
T Consensus       337 l~~ln~s~n~l~-~lp~~~e~~~~~L-q~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~L  414 (1081)
T KOG0618|consen  337 LNTLNVSSNKLS-TLPSYEENNHAAL-QELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNL  414 (1081)
T ss_pred             HHHHhhhhcccc-ccccccchhhHHH-HHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhc
Confidence            677777888877 4442222 23334 45788888888776667888888888888888888666666788888888888


Q ss_pred             cCCccCCCCCCccccccccccccccCcccccccCcccCCCceecEEEccccccccc-CCCCCccCCCCccccccCccc
Q 002746          396 SHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGM-IPSGGIFNSATKMSFVGNQHL  472 (885)
Q Consensus       396 s~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~~~~~~~~~~~n~~~  472 (885)
                      |+|+|+ .+|+.+..++.|++|...+|+|. ..| .+.+++.|+.+|||.|+|+.. +|....++++..+.+.||.|.
T Consensus       415 SGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  415 SGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             ccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence            888888 67788888888888888888888 666 788888888888888888753 344344477777788888763

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-33  Score=297.52  Aligned_cols=270  Identities=21%  Similarity=0.321  Sum_probs=198.7

Q ss_pred             CcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecC--CcceEEEe
Q 002746          559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLP--DFKALVLP  633 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lV~e  633 (885)
                      |++.+.||+|++|.||+|+.. +++.+|+|+++...  ......+.+|++++++++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999976 58899999998653  33456788999999999999999999999888  78999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      |+++ +|..++....        ..+++..++.++.|+++|++|||+.+   ++|+||||+||++++++.++|+|||.+.
T Consensus        81 ~~~~-~l~~~~~~~~--------~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~  148 (287)
T cd07840          81 YMDH-DLTGLLDSPE--------VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLAR  148 (287)
T ss_pred             cccc-cHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEcccccee
Confidence            9974 7877775432        13889999999999999999999998   9999999999999999999999999998


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      ......          ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||.....  ......+..
T Consensus       149 ~~~~~~----------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~--~~~~~~~~~  216 (287)
T cd07840         149 PYTKRN----------SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE--LEQLEKIFE  216 (287)
T ss_pred             eccCCC----------cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHH
Confidence            663321          011223456788999997665 4578999999999999999999999965321  111111111


Q ss_pred             hhcch----hhhhhh---hhhhhccCCChHHHHHHHHH-HHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          793 HYHGR----LEKVID---SSLLRASRDQSPEVKRMWDV-AIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       793 ~~~~~----~~~~~d---~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .....    .....+   .................... ++.++.+++.+||+.+|.+||++++++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         217 LCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             HhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            11000    000000   00000001111111222222 26789999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5.4e-33  Score=292.82  Aligned_cols=252  Identities=22%  Similarity=0.389  Sum_probs=203.3

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC--cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG--NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      +|.+.+.||+|++|.||+|... ++..||+|++.....  .....+.+|+++++.++|+|++++.+.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5788899999999999999975 689999999875533  4566788999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +++++|.+++.....     ....+++..+..++.+++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||.+..
T Consensus        81 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~  152 (258)
T cd08215          81 ADGGDLSQKIKKQKK-----EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV  152 (258)
T ss_pred             cCCCcHHHHHHHhhc-----cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceee
Confidence            999999998875431     1234899999999999999999999998   99999999999999999999999999986


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      .....           .......|++.|+|||...+..++.++||||+|+++|+|++|+.||....     ..+......
T Consensus       153 ~~~~~-----------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~  216 (258)
T cd08215         153 LSSTV-----------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKIL  216 (258)
T ss_pred             cccCc-----------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHh
Confidence            53311           12223468889999999988889999999999999999999999986421     111111111


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ...            .. ..+.      ..+.++.+++.+||..+|++||++.|++++
T Consensus       217 ~~~------------~~-~~~~------~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         217 KGQ------------YP-PIPS------QYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             cCC------------CC-CCCC------CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000            00 0000      134568999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4e-33  Score=300.28  Aligned_cols=272  Identities=20%  Similarity=0.275  Sum_probs=196.8

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC--cchhhHHHHHHHHhhcC-CcccceeeeeeecCCc-----
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG--NFTKSFNRECQVLKRIR-HRNLMRIITACSLPDF-----  627 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~-----  627 (885)
                      ++|++.+.||+|+||.||+|... +++.||+|+.+....  .....+.+|++++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36888999999999999999965 689999998864422  23467888999999995 6999999999877665     


Q ss_pred             ceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecC-CCCEEE
Q 002746          628 KALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND-DMTALV  706 (885)
Q Consensus       628 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~~kl  706 (885)
                      .++||||+++ ++.+++......    ....+++..++.++.||+.||+|||+++   |+||||||+||+++. ++.+||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl  152 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRG----PGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKI  152 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhccc----CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEE
Confidence            7999999985 787777543211    1234799999999999999999999998   999999999999998 899999


Q ss_pred             cccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccccCCcc
Q 002746          707 SDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLS  785 (885)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~  785 (885)
                      +|||.++.+...           ........+++.|+|||++.+ ..++.++||||||+++|||++|..||....    .
T Consensus       153 ~dfg~~~~~~~~-----------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~----~  217 (295)
T cd07837         153 ADLGLGRAFSIP-----------VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS----E  217 (295)
T ss_pred             eecccceecCCC-----------ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC----H
Confidence            999998765221           111122356788999998765 457899999999999999999999986421    1


Q ss_pred             HHHHHHHhhc---ch----hhhhhhhhhhhccCC-ChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          786 LHKWVKNHYH---GR----LEKVIDSSLLRASRD-QSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       786 ~~~~~~~~~~---~~----~~~~~d~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .... ...+.   ..    .....+......... ............+.++.+++.+|+.++|++||++.|++.+
T Consensus       218 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         218 LQQL-LHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             HHHH-HHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            1111 11100   00    000000000000000 1111122223356779999999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.5e-33  Score=307.44  Aligned_cols=267  Identities=20%  Similarity=0.259  Sum_probs=195.6

Q ss_pred             HhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec--CCcchhhHHHHHHHHhhcCCcccceeeeeeecC------
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIITACSLP------  625 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------  625 (885)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++...  .......+.+|+.++++++|+||+++++++..+      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            3478999999999999999999965 7899999998633  223345677899999999999999999988644      


Q ss_pred             CcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEE
Q 002746          626 DFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL  705 (885)
Q Consensus       626 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~k  705 (885)
                      ...++||||+. ++|.+.+...           ++...+..++.|++.||+|||++|   |+||||||+||+++.++.+|
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~-----------l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~k  158 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD-----------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK  158 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEE
Confidence            24689999995 4776665321           677888999999999999999998   99999999999999999999


Q ss_pred             EcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCcc
Q 002746          706 VSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLS  785 (885)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~  785 (885)
                      |+|||.++.....            .......++..|+|||++.+..++.++|||||||++|+|++|+.||.....    
T Consensus       159 L~Dfg~~~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~----  222 (353)
T cd07850         159 ILDFGLARTAGTS------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH----  222 (353)
T ss_pred             EccCccceeCCCC------------CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH----
Confidence            9999999765221            112234578899999999999999999999999999999999999964211    


Q ss_pred             HHHHH--HHhhcch---hhhhhhhhhh----hccCCChHHHHHH-------------HHHHHHHHHHHHhhhcCCCCCCC
Q 002746          786 LHKWV--KNHYHGR---LEKVIDSSLL----RASRDQSPEVKRM-------------WDVAIGELIELGILCTQESPSTR  843 (885)
Q Consensus       786 ~~~~~--~~~~~~~---~~~~~d~~~~----~~~~~~~~~~~~~-------------~~~~~~~l~~l~~~cl~~dP~~R  843 (885)
                      ...|.  .......   +...++....    .............             ....+.++.+++.+|++.||++|
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  302 (353)
T cd07850         223 IDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKR  302 (353)
T ss_pred             HHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhC
Confidence            11111  0101000   0011110000    0000000000000             11235568899999999999999


Q ss_pred             CCHHHHHHH
Q 002746          844 PTMLDAADD  852 (885)
Q Consensus       844 Pt~~ev~~~  852 (885)
                      ||+.|++++
T Consensus       303 ~t~~eiL~~  311 (353)
T cd07850         303 ISVDDALQH  311 (353)
T ss_pred             cCHHHHhcC
Confidence            999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-34  Score=279.96  Aligned_cols=241  Identities=24%  Similarity=0.328  Sum_probs=194.5

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC---cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEE
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG---NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV  631 (885)
                      .++|+..++||+|.||.|.+++-+ +|+.+|+|+++...-   .....-..|-++|+..+||.+..+-..|+..++.+.|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            467888999999999999999955 799999999986532   2234456788999999999999999999999999999


Q ss_pred             EecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccc
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~  711 (885)
                      |||..||.|.-++.+.+.         +++....-+-..|+.||.|||+++   ||+||+|.+|.|+|.||++||+|||+
T Consensus       247 MeyanGGeLf~HLsrer~---------FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGL  314 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRERV---------FSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGL  314 (516)
T ss_pred             EEEccCceEeeehhhhhc---------ccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeeccc
Confidence            999999999999876543         677777778899999999999998   99999999999999999999999999


Q ss_pred             ceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      ++.-..           ........+|||.|.|||++....|+.+.|.|.+|||+|||++|+.||....           
T Consensus       315 CKE~I~-----------~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d-----------  372 (516)
T KOG0690|consen  315 CKEEIK-----------YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD-----------  372 (516)
T ss_pred             chhccc-----------ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc-----------
Confidence            974321           1234456799999999999999999999999999999999999999996421           


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCC
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP  844 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  844 (885)
                         ++.+-+++-   .... ...       ...+++...++...+..||.+|-
T Consensus       373 ---h~kLFeLIl---~ed~-kFP-------r~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  373 ---HEKLFELIL---MEDL-KFP-------RTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             ---hhHHHHHHH---hhhc-cCC-------ccCCHHHHHHHHHHhhcChHhhc
Confidence               111111111   1110 011       11345678888999999999995

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-34  Score=324.81  Aligned_cols=267  Identities=21%  Similarity=0.262  Sum_probs=210.0

Q ss_pred             HHHHHHhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec---CCcchhhHHHHHHHHhhcCCcccceeeeeeecC
Q 002746          550 RELLEATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLP  625 (885)
Q Consensus       550 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  625 (885)
                      +++.-..++|++.++||+|+||.|..++.+ +++.||+|++...   +.....-|..|-.+|...+.+=|+++..+|.++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            444455678999999999999999999965 6888999998753   344567799999999999999999999999999


Q ss_pred             CcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEE
Q 002746          626 DFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL  705 (885)
Q Consensus       626 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~k  705 (885)
                      .+.|+|||||+||+|-.++....         .+++..+.-++..|+-||.-+|+.|   +|||||||+|||+|..|++|
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~---------~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHik  215 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD---------RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIK  215 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC---------CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEe
Confidence            99999999999999999987654         2788888889999999999999999   99999999999999999999


Q ss_pred             EcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccC----C-CCCCccccchhhHHHHHHHHcCCCCCCccc
Q 002746          706 VSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF----G-SNTSTKGDVYSFGILVLEMVTRRRPTDDMF  780 (885)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~  780 (885)
                      |+|||.+..+...|          .......+|||.|.+||++.    + +.|+..+|+||+||++|||+.|..||... 
T Consensus       216 LADFGsClkm~~dG----------~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-  284 (1317)
T KOG0612|consen  216 LADFGSCLKMDADG----------TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-  284 (1317)
T ss_pred             eccchhHHhcCCCC----------cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-
Confidence            99999998775432          33445678999999999864    3 57899999999999999999999999541 


Q ss_pred             cCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC---HHHHHHHHHHHH
Q 002746          781 AGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT---MLDAADDLDRLK  857 (885)
Q Consensus       781 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~ev~~~L~~l~  857 (885)
                          .++..        ..++.+    ....-..|..    -.++++..++|++.++ +|+.|-.   ++|+..|     
T Consensus       285 ----slveT--------Y~KIm~----hk~~l~FP~~----~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H-----  338 (1317)
T KOG0612|consen  285 ----SLVET--------YGKIMN----HKESLSFPDE----TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH-----  338 (1317)
T ss_pred             ----HHHHH--------HHHHhc----hhhhcCCCcc----cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC-----
Confidence                11111        111111    1111111110    1156778999999888 6777776   8887764     


Q ss_pred             HHhcCCCC
Q 002746          858 RYLGEKHM  865 (885)
Q Consensus       858 ~~~~~~~~  865 (885)
                      .++....|
T Consensus       339 pFF~g~~W  346 (1317)
T KOG0612|consen  339 PFFEGIDW  346 (1317)
T ss_pred             ccccCCCh
Confidence            55555554

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-33  Score=297.08  Aligned_cols=269  Identities=22%  Similarity=0.307  Sum_probs=201.1

Q ss_pred             CcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC--cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG--NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      |++.+.||+|++|.||+|... +++.+|+|.++....  .....+.+|++++++++|++++++++++..++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999965 688999999874432  24567889999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++ ++.+++....        ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||.+...
T Consensus        81 ~~-~l~~~l~~~~--------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~  148 (283)
T cd05118          81 DT-DLYKLIKDRQ--------RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSF  148 (283)
T ss_pred             CC-CHHHHHHhhc--------ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence            75 7777765432        13889999999999999999999998   999999999999999999999999999766


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhh
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      ....           .......++..|+|||...+. .++.++||||+|+++|+|++|+.||.....  ......+....
T Consensus       149 ~~~~-----------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~  215 (283)
T cd05118         149 GSPV-----------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE--IDQLFKIFRTL  215 (283)
T ss_pred             CCCc-----------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHc
Confidence            3311           111223577889999998776 789999999999999999999999864211  11101111110


Q ss_pred             cch----hhhhh---hhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          795 HGR----LEKVI---DSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       795 ~~~----~~~~~---d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ...    .....   ...................+.++.++.+++.+||++||.+||++.+++.+
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         216 GTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             CCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            000    00000   00000001111112233345567889999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.5e-33  Score=305.11  Aligned_cols=272  Identities=21%  Similarity=0.307  Sum_probs=196.2

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCC------
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPD------  626 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  626 (885)
                      ..+|.+.+.||+|+||.||+|+.. +|+.||||+++...  ......+.+|++++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999965 68999999986432  223456889999999999999999999986543      


Q ss_pred             cceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEE
Q 002746          627 FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALV  706 (885)
Q Consensus       627 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl  706 (885)
                      ..++|+||+.. ++..+..           ..+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.++|
T Consensus        94 ~~~lv~e~~~~-~l~~~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL  158 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG-----------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKI  158 (342)
T ss_pred             eEEEEeccccc-CHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence            35899999863 5544331           12788899999999999999999998   999999999999999999999


Q ss_pred             cccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccccCCcc
Q 002746          707 SDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLS  785 (885)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~  785 (885)
                      +|||+++....              ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..
T Consensus       159 ~dfg~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-~~  223 (342)
T cd07879         159 LDFGLARHADA--------------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQ  223 (342)
T ss_pred             eeCCCCcCCCC--------------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HH
Confidence            99999875421              1122357889999998876 46889999999999999999999999642110 01


Q ss_pred             HHHHHHHhhcchhhhh---hhhhh----hhc-cCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHH
Q 002746          786 LHKWVKNHYHGRLEKV---IDSSL----LRA-SRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD--LDR  855 (885)
Q Consensus       786 ~~~~~~~~~~~~~~~~---~d~~~----~~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~  855 (885)
                      +.. +...........   .....    ... ...........+...+.++.+++.+||+.||++||+++|++.+  ++.
T Consensus       224 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~  302 (342)
T cd07879         224 LTQ-ILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS  302 (342)
T ss_pred             HHH-HHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhh
Confidence            111 111111111111   00000    000 0000111111222345678899999999999999999999976  666


Q ss_pred             HHH
Q 002746          856 LKR  858 (885)
Q Consensus       856 l~~  858 (885)
                      ++.
T Consensus       303 ~~~  305 (342)
T cd07879         303 FRD  305 (342)
T ss_pred             ccc
Confidence            654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.5e-33  Score=301.00  Aligned_cols=276  Identities=20%  Similarity=0.296  Sum_probs=194.4

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCCc-----
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDF-----  627 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----  627 (885)
                      .++|++.+.||+|+||.||+|... +++.||||.+....  ......+.+|++++++++||||+++++++...+.     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357999999999999999999965 68999999986442  2223456789999999999999999999876543     


Q ss_pred             ---ceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCE
Q 002746          628 ---KALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA  704 (885)
Q Consensus       628 ---~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~  704 (885)
                         .++||||+.+ ++...+....        ..+++..++.++.|++.||+|||+++   |+|+||||+||+++.++.+
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~  158 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKN--------VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGIL  158 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcE
Confidence               4899999964 6766664322        13789999999999999999999998   9999999999999999999


Q ss_pred             EEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCC
Q 002746          705 LVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGG  783 (885)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~  783 (885)
                      ||+|||.+..+......       .........++..|+|||++.+. .++.++||||||+++|||++|+.||.....  
T Consensus       159 kl~dfg~~~~~~~~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~--  229 (310)
T cd07865         159 KLADFGLARAFSLSKNS-------KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE--  229 (310)
T ss_pred             EECcCCCcccccCCccc-------CCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH--
Confidence            99999999866332110       01122334678899999987665 468899999999999999999999864211  


Q ss_pred             ccHHHHHHHhhc---ch-hhhhhhhhhhhccC---CChHHHH-HHH-HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          784 LSLHKWVKNHYH---GR-LEKVIDSSLLRASR---DQSPEVK-RMW-DVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       784 ~~~~~~~~~~~~---~~-~~~~~d~~~~~~~~---~~~~~~~-~~~-~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ......+.....   .. .+...+........   ....... +.. ......+.+++.+||..||++|||++|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         230 QHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             HHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            111111111110   00 00000000000000   0000000 000 0023457899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5.4e-33  Score=304.94  Aligned_cols=275  Identities=23%  Similarity=0.322  Sum_probs=198.0

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec--CCcchhhHHHHHHHHhhc-CCcccceeeeeeecCC--cce
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRI-RHRNLMRIITACSLPD--FKA  629 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~--~~~  629 (885)
                      .++|++.+.||+|+||.||+|... +++.+|+|++...  .......+.+|+.+++++ +||||++++++|...+  ..+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            467889999999999999999976 6889999988532  223345677899999999 9999999999986543  578


Q ss_pred             EEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccc
Q 002746          630 LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDF  709 (885)
Q Consensus       630 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df  709 (885)
                      +||||++ ++|..++...          .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        86 lv~e~~~-~~L~~~~~~~----------~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~  151 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN----------ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADF  151 (337)
T ss_pred             EEecccc-cCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeec
Confidence            9999997 5888777543          2788889999999999999999998   999999999999999999999999


Q ss_pred             ccceeeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHH
Q 002746          710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~  788 (885)
                      |.++.+.......      .........|+..|+|||++.+ ..++.++||||||+++|+|++|+.||...... .....
T Consensus       152 g~~~~~~~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~-~~~~~  224 (337)
T cd07852         152 GLARSLSELEENP------ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL-NQLEK  224 (337)
T ss_pred             cchhccccccccc------cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH-HHHHH
Confidence            9998764321100      0112233468999999998755 45789999999999999999999999642111 01111


Q ss_pred             HHHHhhcch----hhhh---hhhhhhhc-cCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          789 WVKNHYHGR----LEKV---IDSSLLRA-SRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       789 ~~~~~~~~~----~~~~---~d~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .. ......    ....   ....+... ...............+.++.+++.+||+.+|++|||+.+++++
T Consensus       225 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         225 II-EVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HH-HHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            10 000000    0000   00000000 0001111112222346779999999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4.5e-33  Score=302.35  Aligned_cols=284  Identities=24%  Similarity=0.293  Sum_probs=197.1

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC--cchhhHHHHHHHHhhcCCcccceeeeeeecCC------
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG--NFTKSFNRECQVLKRIRHRNLMRIITACSLPD------  626 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  626 (885)
                      .++|.+.+.||+|++|.||+|... +++.||+|++.....  .....+.+|++++++++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999965 689999999865432  22356788999999999999999998875443      


Q ss_pred             --cceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCE
Q 002746          627 --FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA  704 (885)
Q Consensus       627 --~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~  704 (885)
                        ..++|+||+.+ ++...+....        ..+++..+..++.|+++||+|||+++   |+||||||+||++++++.+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~--------~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~  154 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPS--------VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGIL  154 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence              35899999865 5555554322        13889999999999999999999998   9999999999999999999


Q ss_pred             EEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCC
Q 002746          705 LVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGG  783 (885)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~  783 (885)
                      +|+|||++.........................|++.|+|||+..+. .++.++|||||||++|||++|+.||...... 
T Consensus       155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-  233 (311)
T cd07866         155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-  233 (311)
T ss_pred             EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-
Confidence            99999999866432211110000011122344678899999987654 5789999999999999999999999642111 


Q ss_pred             ccHHHHHHHhhc---chhhhhhh-hhhh--hccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          784 LSLHKWVKNHYH---GRLEKVID-SSLL--RASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       784 ~~~~~~~~~~~~---~~~~~~~d-~~~~--~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ............   .......+ +...  .......+.....+.....++.+++.+|+..+|++|||+.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         234 DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            011111110000   00000000 0000  000011111222223344678999999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-34  Score=273.87  Aligned_cols=249  Identities=20%  Similarity=0.261  Sum_probs=188.0

Q ss_pred             cccceecccCcceEEEEEeC-CCCEEEEEEeeecC-CcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcceEEEeccc
Q 002746          560 DEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFKALVLPYMA  636 (885)
Q Consensus       560 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~  636 (885)
                      +....||.|..|.||+++.+ .|..+|||.+.... .+..+++...++++.+- ..|.||+.+|||..+...++.||.|.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs  174 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS  174 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence            44566999999999999966 58899999997553 33456677777776655 48999999999999999999999883


Q ss_pred             CCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeee
Q 002746          637 NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM  716 (885)
Q Consensus       637 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~  716 (885)
                       .....+++....        ++++..+-++...+++||.||-+++  +|+|||+||+|||+|+.|++|+||||++-.+.
T Consensus       175 -~C~ekLlkrik~--------piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlv  243 (391)
T KOG0983|consen  175 -TCAEKLLKRIKG--------PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLV  243 (391)
T ss_pred             -HHHHHHHHHhcC--------CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceee
Confidence             344444443322        3777777889999999999999876  59999999999999999999999999987663


Q ss_pred             cccCCCCCCCCCCCCccccccccccccCCcccCC---CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG---SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      .            +...+..+|.+.|||||.+.-   ..|+.++||||||+.++|+.||+.||..-. .+......+.+.
T Consensus       244 d------------SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~-tdFe~ltkvln~  310 (391)
T KOG0983|consen  244 D------------SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK-TDFEVLTKVLNE  310 (391)
T ss_pred             c------------ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC-ccHHHHHHHHhc
Confidence            2            233344579999999998764   368899999999999999999999996421 111111111111


Q ss_pred             hcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       794 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .+    ..++     ..           ...++++.+++..|+.+|+.+||...+++++
T Consensus       311 eP----P~L~-----~~-----------~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  311 EP----PLLP-----GH-----------MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CC----CCCC-----cc-----------cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            00    0011     00           1145679999999999999999999998875

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.1e-33  Score=297.11  Aligned_cols=244  Identities=25%  Similarity=0.330  Sum_probs=189.9

Q ss_pred             ecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCCcc
Q 002746          565 LGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSL  640 (885)
Q Consensus       565 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL  640 (885)
                      ||+|+||+||+|... +|+.||+|.+....   ......+..|++++++++|||++++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999865 68999999986432   22345567899999999999999999999999999999999999999


Q ss_pred             ccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecccC
Q 002746          641 DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGV  720 (885)
Q Consensus       641 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~  720 (885)
                      .+++.....       ..+++..+..++.|++.|+.|||+.+   |+||||+|+||+++.++.++|+|||.+.....   
T Consensus        81 ~~~l~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---  147 (277)
T cd05577          81 KYHIYNVGE-------PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG---  147 (277)
T ss_pred             HHHHHHcCc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc---
Confidence            988865432       13789999999999999999999998   99999999999999999999999999875522   


Q ss_pred             CCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhhh
Q 002746          721 GNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEK  800 (885)
Q Consensus       721 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  800 (885)
                               ........++..|+|||+..+..++.++||||||+++|+|++|+.||...... ........         
T Consensus       148 ---------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~---------  208 (277)
T cd05577         148 ---------GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK-VEKEELKR---------  208 (277)
T ss_pred             ---------CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc-ccHHHHHh---------
Confidence                     11112345788999999998888999999999999999999999999653211 00011000         


Q ss_pred             hhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 002746          801 VIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP-----TMLDAAD  851 (885)
Q Consensus       801 ~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~  851 (885)
                          .........       ....+.++.+++.+||+.+|++||     ++.+++.
T Consensus       209 ----~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         209 ----RTLEMAVEY-------PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             ----ccccccccC-------CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence                000000000       011345688999999999999999     5555654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.8e-33  Score=305.87  Aligned_cols=276  Identities=23%  Similarity=0.270  Sum_probs=201.0

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec--CCcchhhHHHHHHHHhhcCCcccceeeeeeecC-----Cc
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIITACSLP-----DF  627 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~  627 (885)
                      .++|.+.+.||+|+||+||+|+.. +++.||||.++..  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457899999999999999999964 6899999998743  223345677899999999999999999988654     24


Q ss_pred             ceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEc
Q 002746          628 KALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVS  707 (885)
Q Consensus       628 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~  707 (885)
                      .++|+||+. ++|.+++....         .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~  150 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ---------TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKIC  150 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEC
Confidence            689999995 67877775432         3889999999999999999999998   9999999999999999999999


Q ss_pred             ccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccccCCccH
Q 002746          708 DFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSL  786 (885)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~  786 (885)
                      |||+++.....+           .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.....  ...
T Consensus       151 Dfg~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~  217 (337)
T cd07858         151 DFGLARTTSEKG-----------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY--VHQ  217 (337)
T ss_pred             cCccccccCCCc-----------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh--HHH
Confidence            999997653210           11223457889999998765 4688999999999999999999999964211  000


Q ss_pred             HHHHHHhhcch----hhhhhhhhhh----hccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHH
Q 002746          787 HKWVKNHYHGR----LEKVIDSSLL----RASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD--LDRL  856 (885)
Q Consensus       787 ~~~~~~~~~~~----~~~~~d~~~~----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~l  856 (885)
                      ...+.......    .....+....    .......+........++.++.+++.+||+.+|++|||++|++++  +..+
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         218 LKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             HHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            11111111000    0000000000    000001111122233467789999999999999999999999998  5554


Q ss_pred             H
Q 002746          857 K  857 (885)
Q Consensus       857 ~  857 (885)
                      .
T Consensus       298 ~  298 (337)
T cd07858         298 H  298 (337)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=277.02  Aligned_cols=268  Identities=21%  Similarity=0.307  Sum_probs=206.7

Q ss_pred             ceecccCcceEEEEE-eCCCCEEEEEEeeecCCcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcceEEEecccCCcc
Q 002746          563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFKALVLPYMANGSL  640 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~gsL  640 (885)
                      +.||+|++|.|-.|. ..+|.+||||++.........+..+|++++.+. .|+||++++++|++++..|||||.|.||.|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            579999999999998 678999999999888777788899999999988 599999999999999999999999999999


Q ss_pred             ccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCC---CCEEEcccccceeeec
Q 002746          641 DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDD---MTALVSDFGIAKLVMT  717 (885)
Q Consensus       641 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~Dfg~a~~~~~  717 (885)
                      ..+++++..         +.+..+.++.+.||.||.|||.+|   |.|||+||+|||-..-   .-+|||||.++.-+..
T Consensus       164 LshI~~~~~---------F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~  231 (463)
T KOG0607|consen  164 LSHIQKRKH---------FNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL  231 (463)
T ss_pred             HHHHHHhhh---------ccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccccccccc
Confidence            999987664         888999999999999999999999   9999999999999744   3489999999865433


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccC-----CCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGF-----GSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      ...    ............+|+..|||||+..     ...|+.++|.||+|||+|-|++|.+||....+.+.   .|-+.
T Consensus       232 ~~~----~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC---GWdrG  304 (463)
T KOG0607|consen  232 NND----CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC---GWDRG  304 (463)
T ss_pred             CCC----CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC---CccCC
Confidence            211    1111222334568999999999742     23578999999999999999999999976533211   12111


Q ss_pred             hhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       793 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..=..-...+-+.+..+.-...   ..-|...+.+..+++...+..|+.+|-++.+++.+
T Consensus       305 e~Cr~CQ~~LFesIQEGkYeFP---dkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  305 EVCRVCQNKLFESIQEGKYEFP---DKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             CccHHHHHHHHHHHhccCCcCC---hhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence            1100111122223332221111   12366788889999999999999999999999874

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.7e-33  Score=293.86  Aligned_cols=250  Identities=25%  Similarity=0.308  Sum_probs=200.5

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      +|++.+.||+|++|.||++... +++.+|+|.+....  ......+.+|++++++++|+||+++++++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999999865 68899999987542  23355678899999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +++++|.+++.....     ....+++..++.++.|++.|++|||+.+   ++||||+|+||+++.++.+|++|||.++.
T Consensus        81 ~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~  152 (256)
T cd08530          81 APFGDLSKAISKRKK-----KRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKV  152 (256)
T ss_pred             cCCCCHHHHHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhh
Confidence            999999998865321     1234889999999999999999999998   99999999999999999999999999976


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      ....             ......+++.|+|||...+..++.++|+||+|+++|||++|+.||....     ........ 
T Consensus       153 ~~~~-------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~-  213 (256)
T cd08530         153 LKKN-------------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS-----MQDLRYKV-  213 (256)
T ss_pred             hccC-------------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHH-
Confidence            5321             1122357889999999999999999999999999999999999996421     11110000 


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                              .   ........       ...+.++.+++.+|++.+|++||++.|++++
T Consensus       214 --------~---~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         214 --------Q---RGKYPPIP-------PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             --------h---cCCCCCCc-------hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                    0   00000000       1245679999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-33  Score=290.74  Aligned_cols=248  Identities=28%  Similarity=0.427  Sum_probs=200.5

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC--cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG--NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      +|++.+.||+|++|.||+|+.. +++.||+|.+.....  ...+.+.+|++++++++|+|++++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999865 678999999975543  3456789999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +++++|.+++....         .+++..+..++.|++.|+.|||+.+   |+||||||+||+++.++.++|+|||.+..
T Consensus        81 ~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~  148 (254)
T cd06627          81 AENGSLRQIIKKFG---------PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATK  148 (254)
T ss_pred             CCCCcHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEecccccee
Confidence            99999998886442         3889999999999999999999998   99999999999999999999999999987


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      .....           .......++..|+|||...+..++.++||||+|+++|+|++|+.||....    ......... 
T Consensus       149 ~~~~~-----------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----~~~~~~~~~-  212 (254)
T cd06627         149 LNDVS-----------KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN----PMAALFRIV-  212 (254)
T ss_pred             cCCCc-----------ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHh-
Confidence            63311           11223467889999999888888999999999999999999999986421    111110000 


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .            .......       ...+.++.+++.+|+..+|++||++.|++.+
T Consensus       213 ~------------~~~~~~~-------~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         213 Q------------DDHPPLP-------EGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             c------------cCCCCCC-------CCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence            0            0000000       1134568899999999999999999999853

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-33  Score=319.44  Aligned_cols=280  Identities=19%  Similarity=0.183  Sum_probs=189.2

Q ss_pred             HhhCCcccceecccCcceEEEEEeCC--CCEEEEEEe--------------e---ecCCcchhhHHHHHHHHhhcCCccc
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQD--GTAIAVKVL--------------Q---LQSGNFTKSFNRECQVLKRIRHRNL  615 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~h~ni  615 (885)
                      ...+|++.+.||+|+||.||+|..+.  +..+++|.+              .   .........+.+|++++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            35789999999999999999987542  222222211              0   0111234567899999999999999


Q ss_pred             ceeeeeeecCCcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCc
Q 002746          616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSN  695 (885)
Q Consensus       616 v~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~N  695 (885)
                      +++++++...+..++|++++. +++..++......    ............|+.|++.||+|||+++   ||||||||+|
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~----~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~N  297 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFD----WKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLEN  297 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhcccc----ccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence            999999999999999999985 5666655432211    0111345667789999999999999998   9999999999


Q ss_pred             eEecCCCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCC
Q 002746          696 VLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP  775 (885)
Q Consensus       696 ILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P  775 (885)
                      ||++.++.+||+|||+++.+....          ........||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus       298 ILl~~~~~vkL~DFGla~~~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~  367 (501)
T PHA03210        298 IFLNCDGKIVLGDFGTAMPFEKER----------EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC  367 (501)
T ss_pred             EEECCCCCEEEEeCCCceecCccc----------ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            999999999999999998763210          1112235789999999999999999999999999999999998764


Q ss_pred             -CCcccc-CCccHHHHHHHh------hcchhhhhhhhhhhhccCCChHHHHHHHH--HHHHHHHHHHhhhcCCCCCCCCC
Q 002746          776 -TDDMFA-GGLSLHKWVKNH------YHGRLEKVIDSSLLRASRDQSPEVKRMWD--VAIGELIELGILCTQESPSTRPT  845 (885)
Q Consensus       776 -~~~~~~-~~~~~~~~~~~~------~~~~~~~~~d~~~~~~~~~~~~~~~~~~~--~~~~~l~~l~~~cl~~dP~~RPt  845 (885)
                       +..... ....+.+.+...      ++....+..+.............+.....  ..+.++.+++.+|++.||.+|||
T Consensus       368 p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rps  447 (501)
T PHA03210        368 PIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPG  447 (501)
T ss_pred             CccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcC
Confidence             432111 111122221111      11100011110000000000001111111  13456888899999999999999


Q ss_pred             HHHHHHH
Q 002746          846 MLDAADD  852 (885)
Q Consensus       846 ~~ev~~~  852 (885)
                      +.|++++
T Consensus       448 a~elL~h  454 (501)
T PHA03210        448 AAELLAL  454 (501)
T ss_pred             HHHHhhC
Confidence            9999875

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6e-33  Score=298.65  Aligned_cols=272  Identities=24%  Similarity=0.286  Sum_probs=195.1

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC--cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEe
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG--NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      ++|++.+.||+|++|.||+|... +++.||+|.++....  ...+.+.+|++++++++|||++++++++..+...++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46889999999999999999976 688999999864422  234678899999999999999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecC-CCCEEEcccccc
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND-DMTALVSDFGIA  712 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfg~a  712 (885)
                      |++ +++.+++.....       ...++..+..++.||+.||+|||+++   |+||||+|+||+++. ++.+||+|||++
T Consensus        82 ~~~-~~l~~~~~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~  150 (294)
T PLN00009         82 YLD-LDLKKHMDSSPD-------FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLA  150 (294)
T ss_pred             ccc-ccHHHHHHhCCC-------CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccc
Confidence            995 577766643321       12577888899999999999999998   999999999999985 567999999999


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      ......           ........+++.|+|||++.+ ..++.++||||+||++|+|+||+.||...... ....+.. 
T Consensus       151 ~~~~~~-----------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-~~~~~~~-  217 (294)
T PLN00009        151 RAFGIP-----------VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-DELFKIF-  217 (294)
T ss_pred             cccCCC-----------ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH-
Confidence            754221           111122356889999998766 45789999999999999999999999652111 0111100 


Q ss_pred             Hhhcchhhhhhh-----hhhhhcc-CCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          792 NHYHGRLEKVID-----SSLLRAS-RDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       792 ~~~~~~~~~~~d-----~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..........++     +...... ..............+.++.+++.+|++.+|++||++.+++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        218 RILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             HHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000000000000     0000000 000000011112245668899999999999999999999985

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=8e-33  Score=300.73  Aligned_cols=276  Identities=21%  Similarity=0.266  Sum_probs=193.7

Q ss_pred             ccceecccCcceEEEEEeCCCCEEEEEEeeec--CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCC
Q 002746          561 EQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANG  638 (885)
Q Consensus       561 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g  638 (885)
                      +.+.+|.|+++.||++.. +++.||||+++..  .....+.+.+|++++++++|+||+++++++..++..+++|||+++|
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            334445555555555544 6999999998754  2344568999999999999999999999999999999999999999


Q ss_pred             ccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecc
Q 002746          639 SLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV  718 (885)
Q Consensus       639 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~  718 (885)
                      ++.+++......       .+++.....++.|++.||+|||+++   |+||||||+||+++.++.++++|||.+..+...
T Consensus        85 ~l~~~l~~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~  154 (314)
T cd08216          85 SCEDLLKTHFPE-------GLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKH  154 (314)
T ss_pred             CHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccc
Confidence            999988754321       3788889999999999999999998   999999999999999999999999998766432


Q ss_pred             cCCCCCCCCCCCCccccccccccccCCcccCCC--CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcc
Q 002746          719 GVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS--NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHG  796 (885)
Q Consensus       719 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  796 (885)
                      +...    ...........++..|+|||++.+.  .++.++|||||||++|||++|+.||....... ...+........
T Consensus       155 ~~~~----~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~  229 (314)
T cd08216         155 GKRQ----RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKVRGTVPC  229 (314)
T ss_pred             cccc----cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCcc
Confidence            1110    0011122334578899999998663  57899999999999999999999997532111 111111100000


Q ss_pred             hhh----hhhhhhhhh------ccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          797 RLE----KVIDSSLLR------ASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       797 ~~~----~~~d~~~~~------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ...    .........      ................+.++.+++.+||+.+|++|||++|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         230 LLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             ccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            000    000000000      00000000011112345679999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=6.9e-33  Score=292.88  Aligned_cols=243  Identities=21%  Similarity=0.297  Sum_probs=193.5

Q ss_pred             ecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCCcc
Q 002746          565 LGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSL  640 (885)
Q Consensus       565 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL  640 (885)
                      ||.|++|.||+|+.. +++.||+|++....   ....+.+.+|+++++.++||||+++++++.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999976 58999999987442   23456789999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecccC
Q 002746          641 DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGV  720 (885)
Q Consensus       641 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~  720 (885)
                      .+++....         .+++..+..++.|+++||+|||+.+   ++|+||+|+||+++.++.++|+|||.++.....  
T Consensus        81 ~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~--  146 (262)
T cd05572          81 WTILRDRG---------LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG--  146 (262)
T ss_pred             HHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcc--
Confidence            99987543         2788899999999999999999998   999999999999999999999999999865321  


Q ss_pred             CCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhhh
Q 002746          721 GNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEK  800 (885)
Q Consensus       721 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  800 (885)
                                .......|+..|+|||...+..++.++|+||+|+++|+|++|..||.....   +..+......      
T Consensus       147 ----------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~------  207 (262)
T cd05572         147 ----------QKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE---DPMEIYNDIL------  207 (262)
T ss_pred             ----------cccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC---CHHHHHHHHh------
Confidence                      011234678899999999888899999999999999999999999975321   1111111111      


Q ss_pred             hhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 002746          801 VIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT-----MLDAADD  852 (885)
Q Consensus       801 ~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~  852 (885)
                        +    .......+.      ..+.++.+++.+||+.+|++||+     ++|++++
T Consensus       208 --~----~~~~~~~~~------~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         208 --K----GNGKLEFPN------YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             --c----cCCCCCCCc------ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence              0    000000010      12456899999999999999999     7777763

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.1e-32  Score=290.54  Aligned_cols=252  Identities=27%  Similarity=0.420  Sum_probs=202.3

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC--cchhhHHHHHHHHhhcCCcccceeeeeeecC--CcceEEE
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG--NFTKSFNRECQVLKRIRHRNLMRIITACSLP--DFKALVL  632 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lV~  632 (885)
                      +|...+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|++++++++|+|++++++.+...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4777899999999999999976 789999999875542  3467889999999999999999999999888  8889999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++++|.+++....         .+++..++.++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||.+
T Consensus        81 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~  148 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---------KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCA  148 (260)
T ss_pred             EecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccE
Confidence            9999999999886543         3889999999999999999999998   999999999999999999999999999


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      ........         ........++..|+|||...+...+.++||||||+++|+|++|+.||....    .....+. 
T Consensus       149 ~~~~~~~~---------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~-  214 (260)
T cd06606         149 KRLGDIET---------GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG----NPMAALY-  214 (260)
T ss_pred             Eecccccc---------cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----chHHHHH-
Confidence            87643210         011233568889999999988889999999999999999999999997532    0111000 


Q ss_pred             hhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       793 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                             .....   .... ..+      ...+.++.+++.+|+..+|++||++.|++.+
T Consensus       215 -------~~~~~---~~~~-~~~------~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         215 -------KIGSS---GEPP-EIP------EHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             -------hcccc---CCCc-CCC------cccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence                   00000   0000 000      1135678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.5e-33  Score=300.67  Aligned_cols=256  Identities=23%  Similarity=0.271  Sum_probs=190.5

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC-CcchhhHHHHHHHHhhcC-CcccceeeeeeecCCcceEEEec
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIR-HRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      +|...+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4556678999999999999965 68999999987442 234567889999999996 99999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH-SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      +.. ++.++......    .....+++.....++.+++.|++|||+. +   |+||||||+||+++.++.++|+|||+++
T Consensus        85 ~~~-~l~~l~~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~  156 (288)
T cd06616          85 MDI-SLDKFYKYVYE----VLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISG  156 (288)
T ss_pred             ccC-CHHHHHHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhH
Confidence            864 44332211000    0112488999999999999999999975 6   9999999999999999999999999997


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCCC---CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHH
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS---NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~  790 (885)
                      .+...            .......|+..|+|||++.+.   .++.++|||||||++|||++|+.||....    .....+
T Consensus       157 ~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~  220 (288)
T cd06616         157 QLVDS------------IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQL  220 (288)
T ss_pred             HhccC------------CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHH
Confidence            55221            111223578899999998776   68999999999999999999999996421    111111


Q ss_pred             HHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       791 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ........     +.+....          ...++.++.+++.+||+.+|++|||++||+++
T Consensus       221 ~~~~~~~~-----~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         221 TQVVKGDP-----PILSNSE----------EREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             hhhcCCCC-----CcCCCcC----------CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11100000     0000000          01145678999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=9.4e-33  Score=298.49  Aligned_cols=274  Identities=23%  Similarity=0.320  Sum_probs=197.8

Q ss_pred             HhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCC-----
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPD-----  626 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----  626 (885)
                      ..++|++.+.||+|+||.||+|... +++.||+|+++...  ......+.+|++++++++|||++++++++.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4578999999999999999999976 58899999987543  223456788999999999999999999987654     


Q ss_pred             -----cceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCC
Q 002746          627 -----FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDD  701 (885)
Q Consensus       627 -----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~  701 (885)
                           ..++|+||+++ ++...+....        ..+++..+..++.|++.||+|||+.+   |+||||||+||+++++
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~  152 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESGL--------VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNK  152 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence                 78899999976 5555554321        13889999999999999999999998   9999999999999999


Q ss_pred             CCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccc
Q 002746          702 MTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMF  780 (885)
Q Consensus       702 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~  780 (885)
                      +.+||+|||.+..+....          ........++..|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus       153 ~~~kl~dfg~~~~~~~~~----------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~  222 (302)
T cd07864         153 GQIKLADFGLARLYNSEE----------SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ  222 (302)
T ss_pred             CcEEeCcccccccccCCc----------ccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999998663211          011122346778999998765 457899999999999999999999996421


Q ss_pred             cCCccHHHHHHHhhcchhh----hhhhhhhhh---ccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          781 AGGLSLHKWVKNHYHGRLE----KVIDSSLLR---ASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       781 ~~~~~~~~~~~~~~~~~~~----~~~d~~~~~---~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                        .......+.........    .+.......   ............+...+..+.+++.+||+.+|.+||++.+++.+
T Consensus       223 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         223 --ELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             --hHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              11111111111111111    110000000   00000011111222346679999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-34  Score=307.57  Aligned_cols=278  Identities=22%  Similarity=0.305  Sum_probs=203.7

Q ss_pred             CcccceecccCcceEEEEE-eCCCCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCC------cceE
Q 002746          559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPD------FKAL  630 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~l  630 (885)
                      |...+.||+||||.||+|+ ..+|+.||||.++... ....+...+|++++++++|+|||+.++.-++..      ..++
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            3455789999999999999 5589999999998543 344678899999999999999999998765543      5689


Q ss_pred             EEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEec--CCC--CEEE
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN--DDM--TALV  706 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~--~~~--~~kl  706 (885)
                      |||||.+|+|...+..-..      ...+++.+.+.+...++.|+.|||++|   ||||||||.||++-  ++|  .-||
T Consensus        95 vmEyC~gGsL~~~L~~PEN------~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKL  165 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPEN------AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKL  165 (732)
T ss_pred             EEeecCCCcHHHHhcCccc------ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEee
Confidence            9999999999999975443      234999999999999999999999998   99999999999995  333  4799


Q ss_pred             cccccceeeecccCCCCCCCCCCCCccccccccccccCCcccC-CCCCCccccchhhHHHHHHHHcCCCCCCccccCCcc
Q 002746          707 SDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF-GSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLS  785 (885)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~  785 (885)
                      +|||.|+.+..            .+.....+||..|.+||++. .+.|+..+|.|||||++||.+||..||.........
T Consensus       166 tDfG~Arel~d------------~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~  233 (732)
T KOG4250|consen  166 TDFGAARELDD------------NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNN  233 (732)
T ss_pred             ecccccccCCC------------CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcccc
Confidence            99999997632            34566789999999999988 488999999999999999999999999764332211


Q ss_pred             HHHHHHHhhcc---hhhhhhhhhhhhcc--CCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCC--CHHHHHHHHHHHHH
Q 002746          786 LHKWVKNHYHG---RLEKVIDSSLLRAS--RDQSPEVKRMWDVAIGELIELGILCTQESPSTRP--TMLDAADDLDRLKR  858 (885)
Q Consensus       786 ~~~~~~~~~~~---~~~~~~d~~~~~~~--~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP--t~~ev~~~L~~l~~  858 (885)
                       .+.+......   .+.-...+...+..  ....|............+..++..++..+|++|.  ...+..+.+..+.+
T Consensus       234 -~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  234 -KEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             -chhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence             1111111111   11111111111110  0111111222233445577788888888999998  77676666666543

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=7.1e-33  Score=302.02  Aligned_cols=270  Identities=21%  Similarity=0.279  Sum_probs=197.1

Q ss_pred             HHHhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec--CCcchhhHHHHHHHHhhcCCcccceeeeeeec-CCcc
Q 002746          553 LEATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIITACSL-PDFK  628 (885)
Q Consensus       553 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~  628 (885)
                      ...+++|++.+.||+|+||.||+|... +++.||+|++...  .....+.+..|++++++++|||++++++++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            346788999999999999999999855 7899999987532  22335678899999999999999999998865 4567


Q ss_pred             eEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcc
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSD  708 (885)
Q Consensus       629 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D  708 (885)
                      ++|+||+ +++|..++...          .+++.....++.|+++||+|||+.+   |+||||+|+||++++++.++|+|
T Consensus        86 ~lv~e~~-~~~L~~~~~~~----------~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~d  151 (328)
T cd07856          86 YFVTELL-GTDLHRLLTSR----------PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICD  151 (328)
T ss_pred             EEEeehh-ccCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCc
Confidence            8999998 56887776532          2677888899999999999999998   99999999999999999999999


Q ss_pred             cccceeeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccccCCccHH
Q 002746          709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH  787 (885)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~  787 (885)
                      ||.+.....              ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.....  ....
T Consensus       152 fg~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~--~~~~  215 (328)
T cd07856         152 FGLARIQDP--------------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH--VNQF  215 (328)
T ss_pred             cccccccCC--------------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHH
Confidence            999875321              1122356889999998765 5689999999999999999999999964211  0000


Q ss_pred             HHHHHhhcchhhhhhhhh--------hhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          788 KWVKNHYHGRLEKVIDSS--------LLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       788 ~~~~~~~~~~~~~~~d~~--------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..+.........++.+..        +.................++.++.+++.+|++.+|++||++++++.+
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         216 SIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            111111110011111000        00000000001111112245679999999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-32  Score=301.79  Aligned_cols=278  Identities=23%  Similarity=0.281  Sum_probs=204.5

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCC-----cce
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPD-----FKA  629 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~  629 (885)
                      +|.+.+.||+|++|.||+|+.. +++.||+|++....  ....+.+.+|+++++.++|+||+++++++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888999999999999999975 58999999987543  344577899999999999999999999987775     779


Q ss_pred             EEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccc
Q 002746          630 LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDF  709 (885)
Q Consensus       630 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Df  709 (885)
                      +||||++ ++|.+++....         .+++..+..++.|++.||+|||+.|   |+||||||+||+++.++.++|+||
T Consensus        81 lv~e~~~-~~l~~~l~~~~---------~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~df  147 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ---------PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDF  147 (330)
T ss_pred             EEecchh-hhHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccc
Confidence            9999997 57877775432         3889999999999999999999998   999999999999999999999999


Q ss_pred             ccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHH
Q 002746          710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~  788 (885)
                      |.+.........        ........++..|+|||++.+. .++.++||||+|+++|+|++|+.||.....  .....
T Consensus       148 g~~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~--~~~~~  217 (330)
T cd07834         148 GLARGVDPDEDE--------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY--IDQLN  217 (330)
T ss_pred             CceEeecccccc--------cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH--HHHHH
Confidence            999876432100        0112234578899999999887 789999999999999999999999965321  00011


Q ss_pred             HHHHhhcchhhhhh---h-h----hhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH--HHHHHH
Q 002746          789 WVKNHYHGRLEKVI---D-S----SLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD--LDRLKR  858 (885)
Q Consensus       789 ~~~~~~~~~~~~~~---d-~----~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~l~~  858 (885)
                      .+............   . .    .+..................+.++.+++.+||+.+|++||++++++.+  +++++.
T Consensus       218 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         218 LIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             HHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence            11111100000000   0 0    000000000111111222356779999999999999999999999986  555443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-32  Score=290.39  Aligned_cols=252  Identities=24%  Similarity=0.351  Sum_probs=194.7

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC-----CcchhhHHHHHHHHhhcCCcccceeeeeeecC--Ccc
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-----GNFTKSFNRECQVLKRIRHRNLMRIITACSLP--DFK  628 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  628 (885)
                      .+|.+.+.||+|+||.||+|... ++..||+|.+....     ......+.+|++++++++|+||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46889999999999999999965 68999999875321     22345788999999999999999999998664  356


Q ss_pred             eEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcc
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSD  708 (885)
Q Consensus       629 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D  708 (885)
                      ++|+||+++++|.+++....         .+++.....++.|++.|+.|||+.+   |+|+||||+||+++.++.++|+|
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~d  149 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG---------ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGD  149 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECc
Confidence            79999999999998886432         2678889999999999999999998   99999999999999999999999


Q ss_pred             cccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHH
Q 002746          709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~  788 (885)
                      ||.++.......        .........|+..|+|||+..+..++.++|||||||++||+++|+.||.....    ...
T Consensus       150 fg~~~~~~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~  217 (264)
T cd06653         150 FGASKRIQTICM--------SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MAA  217 (264)
T ss_pred             cccccccccccc--------cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HHH
Confidence            999986532100        01111234588999999999988899999999999999999999999965211    110


Q ss_pred             HHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       789 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                       +....            ........+      ....+++.+++.+|+. +|.+||++.+++.+
T Consensus       218 -~~~~~------------~~~~~~~~p------~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         218 -IFKIA------------TQPTKPMLP------DGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             -HHHHH------------cCCCCCCCC------cccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence             00000            000000000      1234568999999999 47999999988764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.9e-33  Score=302.76  Aligned_cols=275  Identities=22%  Similarity=0.281  Sum_probs=192.9

Q ss_pred             ceeccc--CcceEEEEEeC-CCCEEEEEEeeecCC--cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccC
Q 002746          563 RLLGTG--SYGRVYKGILQ-DGTAIAVKVLQLQSG--NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       563 ~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~  637 (885)
                      ..||+|  +||+||+|... +|+.||+|++.....  ...+.+.+|+.+++.++||||++++++|..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  99999999965 799999999875432  2346788999999999999999999999999999999999999


Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      |++.+++......       .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++++||+.+.....
T Consensus        84 ~~l~~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~  153 (328)
T cd08226          84 GSANSLLKTYFPE-------GMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVR  153 (328)
T ss_pred             CCHHHHHHhhccc-------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhc
Confidence            9999988754321       3788899999999999999999998   99999999999999999999999987644322


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCC--CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhh-
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS--NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY-  794 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~-  794 (885)
                      .+.....    .........++..|+|||++.+.  .++.++|||||||++|||++|+.||...... ........... 
T Consensus       154 ~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~  228 (328)
T cd08226         154 NGQKAKV----VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT-QMLLQKLKGPPY  228 (328)
T ss_pred             cCccccc----cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH-HHHHHHhcCCCC
Confidence            1111000    00111122356779999998764  4789999999999999999999999653211 00111000000 


Q ss_pred             --------cchhhhh------hh-----hhhhhc---cCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          795 --------HGRLEKV------ID-----SSLLRA---SRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       795 --------~~~~~~~------~d-----~~~~~~---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                              +......      .+     ..+...   ......-.......++.++.+++.+||+.||++|||+.|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         229 SPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             CCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                    0000000      00     000000   0000000000122356789999999999999999999999875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.2e-32  Score=301.92  Aligned_cols=281  Identities=21%  Similarity=0.265  Sum_probs=197.8

Q ss_pred             hCCc-ccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcc--------------hhhHHHHHHHHhhcCCcccceeee
Q 002746          557 AEFD-EQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNF--------------TKSFNRECQVLKRIRHRNLMRIIT  620 (885)
Q Consensus       557 ~~~~-~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~~  620 (885)
                      ++|. +.+.||+|+||+||+|... +++.||||+++......              ...+.+|++++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3454 4578999999999999965 68999999986432211              124778999999999999999999


Q ss_pred             eeecCCcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecC
Q 002746          621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND  700 (885)
Q Consensus       621 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~  700 (885)
                      ++...+..++||||+. |+|.+++....         .+++.....++.|++.||+|||+.+   |+||||+|+||+++.
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~  154 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKI---------RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINS  154 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECC
Confidence            9999999999999996 68888775432         3788999999999999999999998   999999999999999


Q ss_pred             CCCEEEcccccceeeecccCCCCCCCC---CCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCC
Q 002746          701 DMTALVSDFGIAKLVMTVGVGNDGAEN---MGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPT  776 (885)
Q Consensus       701 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~  776 (885)
                      ++.++|+|||.++..............   ..........++..|+|||++.+. .++.++||||+||++|||++|+.||
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~  234 (335)
T PTZ00024        155 KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF  234 (335)
T ss_pred             CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            999999999999876421111000000   001122233568899999998764 4689999999999999999999999


Q ss_pred             CccccCCccHHHHHHHhhcchhhhhhhhhh----hhc-cCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 002746          777 DDMFAGGLSLHKWVKNHYHGRLEKVIDSSL----LRA-SRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAAD  851 (885)
Q Consensus       777 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~----~~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~  851 (885)
                      .....  ......+...........+....    ... .....+.........+.++.+++.+|++.+|++||+++|++.
T Consensus       235 ~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        235 PGENE--IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCCCH--HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            65321  11111111111111000000000    000 000111111122234567899999999999999999999998


Q ss_pred             H
Q 002746          852 D  852 (885)
Q Consensus       852 ~  852 (885)
                      +
T Consensus       313 ~  313 (335)
T PTZ00024        313 H  313 (335)
T ss_pred             C
Confidence            4

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.5e-32  Score=292.70  Aligned_cols=242  Identities=23%  Similarity=0.288  Sum_probs=184.5

Q ss_pred             eecccCcceEEEEEeC-CCCEEEEEEeeecCC---cchhhHHHHHHH---HhhcCCcccceeeeeeecCCcceEEEeccc
Q 002746          564 LLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG---NFTKSFNRECQV---LKRIRHRNLMRIITACSLPDFKALVLPYMA  636 (885)
Q Consensus       564 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~---l~~l~h~niv~~~~~~~~~~~~~lV~e~~~  636 (885)
                      +||+|+||.||+|... +++.||+|.+.....   .....+..|..+   ++...||+++++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 688999999864321   112234444443   444579999999999999999999999999


Q ss_pred             CCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeee
Q 002746          637 NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM  716 (885)
Q Consensus       637 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~  716 (885)
                      +|+|..++....         .+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.++|+|||++..+.
T Consensus        81 g~~L~~~l~~~~---------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~  148 (278)
T cd05606          81 GGDLHYHLSQHG---------VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (278)
T ss_pred             CCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence            999988875432         3899999999999999999999998   9999999999999999999999999987542


Q ss_pred             cccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhc
Q 002746          717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~  795 (885)
                      ..             ......|+..|+|||++.+. .++.++||||+||++|||++|+.||........  ...      
T Consensus       149 ~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~------  207 (278)
T cd05606         149 KK-------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEI------  207 (278)
T ss_pred             cc-------------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHH------
Confidence            11             11234689999999998754 689999999999999999999999975311110  000      


Q ss_pred             chhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP-----TMLDAADD  852 (885)
Q Consensus       796 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  852 (885)
                             +........ ..+      ...+.++.+++.+|+..+|.+||     ++.|++++
T Consensus       208 -------~~~~~~~~~-~~~------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         208 -------DRMTLTMAV-ELP------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             -------HHHhhccCC-CCC------CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence                   000000000 000      11345789999999999999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.8e-33  Score=319.00  Aligned_cols=263  Identities=25%  Similarity=0.379  Sum_probs=183.6

Q ss_pred             HhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeeeecCCc-----
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDF-----  627 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----  627 (885)
                      -..+|+..++||+||||.||+++-+ ||+.||||++.... ........+|+.++++++|||||+++.++.+...     
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            3467888999999999999999966 89999999997553 3334567899999999999999999876432210     


Q ss_pred             --------------------------------------------------------------------------------
Q 002746          628 --------------------------------------------------------------------------------  627 (885)
Q Consensus       628 --------------------------------------------------------------------------------  627 (885)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------------ceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHH
Q 002746          628 ----------------------------------KALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE  673 (885)
Q Consensus       628 ----------------------------------~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~  673 (885)
                                                        .|+=||||+..++.+++..+...        -.....|+++.+|++
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--------~~~d~~wrLFreIlE  708 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--------SQRDEAWRLFREILE  708 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--------hhhHHHHHHHHHHHH
Confidence                                              12223333333333333222110        024456899999999


Q ss_pred             HHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec------ccCCCCCCCCCC-CCccccccccccccCCc
Q 002746          674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT------VGVGNDGAENMG-NSTANMLCGSIGYMAPE  746 (885)
Q Consensus       674 ~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE  746 (885)
                      ||.|+|++|   ||||||||.||++|++..+||+|||+|+....      ...........+ ....+..+||.-|+|||
T Consensus       709 GLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE  785 (1351)
T KOG1035|consen  709 GLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE  785 (1351)
T ss_pred             HHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence            999999999   99999999999999999999999999998431      111111111111 22455678999999999


Q ss_pred             ccCCCC---CCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHH
Q 002746          747 YGFGSN---TSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDV  823 (885)
Q Consensus       747 ~~~~~~---~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~  823 (885)
                      ++.+..   |+.|+|+||+|+|++||+.   ||...    ...+..+.......++..                ...+..
T Consensus       786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts----MERa~iL~~LR~g~iP~~----------------~~f~~~  842 (1351)
T KOG1035|consen  786 LLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS----MERASILTNLRKGSIPEP----------------ADFFDP  842 (1351)
T ss_pred             HhcccccccccchhhhHHHHHHHHHHhc---cCCch----HHHHHHHHhcccCCCCCC----------------cccccc
Confidence            987654   9999999999999999984   56431    222222222221111111                111222


Q ss_pred             HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 002746          824 AIGELIELGILCTQESPSTRPTMLDAAD  851 (885)
Q Consensus       824 ~~~~l~~l~~~cl~~dP~~RPt~~ev~~  851 (885)
                      ..+.-..+|.+++++||.+|||+.|++.
T Consensus       843 ~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  843 EHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             cchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            3345678999999999999999999975

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-33  Score=273.52  Aligned_cols=253  Identities=21%  Similarity=0.283  Sum_probs=200.3

Q ss_pred             HhhCCccc-ceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhc-CCcccceeeeeeec----CCc
Q 002746          555 ATAEFDEQ-RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLMRIITACSL----PDF  627 (885)
Q Consensus       555 ~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~  627 (885)
                      .+++|.+. ++||-|-.|.|-.|..+ +|+++|+|++...     ....+|++.--.. .|||||.++++|+.    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45666654 57999999999999855 7999999998622     4456788874444 79999999998854    345


Q ss_pred             ceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEec---CCCCE
Q 002746          628 KALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN---DDMTA  704 (885)
Q Consensus       628 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~---~~~~~  704 (885)
                      ..+|||.|+||.|...+..+..       ..+++.++..|++||+.|+.|||..+   |.||||||+|+|..   .+..+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~-------~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~l  203 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGD-------QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPL  203 (400)
T ss_pred             eEeeeecccchHHHHHHHHccc-------ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcce
Confidence            5789999999999999876643       34889999999999999999999998   99999999999997   45679


Q ss_pred             EEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCc
Q 002746          705 LVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGL  784 (885)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~  784 (885)
                      ||+|||+|+.-..            .......+-||.|.|||++....|+..+|+||+||++|-|+.|.+||-.....  
T Consensus       204 KLtDfGFAK~t~~------------~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~--  269 (400)
T KOG0604|consen  204 KLTDFGFAKETQE------------PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--  269 (400)
T ss_pred             EecccccccccCC------------CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc--
Confidence            9999999985421            23344567899999999999999999999999999999999999999664221  


Q ss_pred             cHHHHHHHhhcchhhhhhhhhhh-hccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          785 SLHKWVKNHYHGRLEKVIDSSLL-RASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .+            ..-...++. +.+.-+.    ..|+.++++..++|+.+++.+|.+|-|+.|+.++
T Consensus       270 ai------------spgMk~rI~~gqy~FP~----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  270 AI------------SPGMKRRIRTGQYEFPE----PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             cC------------ChhHHhHhhccCccCCC----hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            10            011111222 1222222    2488899999999999999999999999999986

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.7e-32  Score=296.77  Aligned_cols=248  Identities=26%  Similarity=0.342  Sum_probs=192.4

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec---CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ..|+..+.||+|++|.||+|+.. ++..+|+|.+...   ......++.+|+++++.++|+|++++++++..+...++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34677788999999999999965 6788999988643   2223456788999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+. |++.+.+....        ..+++..+..++.|++.|+.|||+.+   ++||||||+||+++.++.++|+|||++
T Consensus        95 e~~~-~~l~~~~~~~~--------~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~  162 (308)
T cd06634          95 EYCL-GSASDLLEVHK--------KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA  162 (308)
T ss_pred             EccC-CCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccc
Confidence            9996 57766654322        13788999999999999999999998   999999999999999999999999998


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccC---CCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF---GSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKW  789 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~  789 (885)
                      .....               .....|++.|+|||++.   ...++.++|||||||++|||++|+.||.....     ...
T Consensus       163 ~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~  222 (308)
T cd06634         163 SIMAP---------------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSA  222 (308)
T ss_pred             eeecC---------------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-----HHH
Confidence            76522               11235788999999864   35678899999999999999999999864211     011


Q ss_pred             HHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       790 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                      .........            ....      ....+..+.+++.+||+.+|++||++++++.+-.
T Consensus       223 ~~~~~~~~~------------~~~~------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         223 LYHIAQNES------------PALQ------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             HHHHhhcCC------------CCcC------cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence            100000000            0000      0123456889999999999999999999998743

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.7e-32  Score=294.76  Aligned_cols=244  Identities=27%  Similarity=0.367  Sum_probs=190.0

Q ss_pred             CcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC---cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG---NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      |...+.||+|+||.||+|+.. +++.||+|++.....   .....+.+|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            666778999999999999965 688999999874422   2335678899999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +. |++.+++....        ..+++..+..++.|++.|+.|||+.|   |+||||+|+||+++.++.++|+|||.+..
T Consensus       103 ~~-~~l~~~l~~~~--------~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~  170 (313)
T cd06633         103 CL-GSASDLLEVHK--------KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK  170 (313)
T ss_pred             CC-CCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcc
Confidence            96 56666654322        13789999999999999999999998   99999999999999999999999998864


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccC---CCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF---GSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      ..               ......|+..|+|||++.   +..++.++|||||||++|||++|..||.....     ...+.
T Consensus       171 ~~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-----~~~~~  230 (313)
T cd06633         171 SS---------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALY  230 (313)
T ss_pred             cC---------------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHH
Confidence            21               112346788999999874   45688999999999999999999999865211     11111


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..........           ..       ...+..+.+++.+||+++|.+||++.+++.+
T Consensus       231 ~~~~~~~~~~-----------~~-------~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         231 HIAQNDSPTL-----------QS-------NEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             HHHhcCCCCC-----------Cc-------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1110000000           00       0123458899999999999999999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-32  Score=292.77  Aligned_cols=269  Identities=22%  Similarity=0.254  Sum_probs=195.7

Q ss_pred             CcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC-cchhhHHHHHHHHhhcC-CcccceeeeeeecCCcceEEEecc
Q 002746          559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIR-HRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      |.+.+.||+|++|+||+|+.. +++.||+|++..... .......+|+..+++++ |+|++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567889999999999999976 578899999864432 22334567899999998 999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                       +|++.+++.....       ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||.++..
T Consensus        81 -~~~l~~~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~  149 (283)
T cd07830          81 -EGNLYQLMKDRKG-------KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREI  149 (283)
T ss_pred             -CCCHHHHHHhccc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceec
Confidence             8899887765431       23799999999999999999999998   999999999999999999999999999765


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccC-CCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhh
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF-GSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      ...            .......++..|+|||+.. +..++.++||||||+++|||++|+.||......  ..........
T Consensus       150 ~~~------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~--~~~~~~~~~~  215 (283)
T cd07830         150 RSR------------PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEI--DQLYKICSVL  215 (283)
T ss_pred             cCC------------CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChH--HHHHHHHHhc
Confidence            321            1112345788999999774 455789999999999999999999998643110  1111111111


Q ss_pred             cchhhh----h--hhhhhhhccC-CChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          795 HGRLEK----V--IDSSLLRASR-DQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       795 ~~~~~~----~--~d~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .....+    .  .+..+..... .............+.++.+++.+||+.+|++||+++|++.+
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         216 GTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             CCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            000000    0  0000000000 00001111112234679999999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=8.3e-33  Score=303.69  Aligned_cols=273  Identities=21%  Similarity=0.258  Sum_probs=195.5

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecC----------
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLP----------  625 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----------  625 (885)
                      .+|.+.+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            68999999999999999999965 6899999998766555567789999999999999999999776544          


Q ss_pred             ----CcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEec-C
Q 002746          626 ----DFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN-D  700 (885)
Q Consensus       626 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~-~  700 (885)
                          ...++||||++ ++|.+++...          .+++..+..++.||++|+.|||+.|   |+||||||+||+++ +
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~  150 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQG----------PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTE  150 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCC
Confidence                34689999997 5787766422          2788999999999999999999998   99999999999998 5


Q ss_pred             CCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCcc
Q 002746          701 DMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDM  779 (885)
Q Consensus       701 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~  779 (885)
                      ++.++++|||.++.+.....        .........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       151 ~~~~kl~dfg~~~~~~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~  222 (342)
T cd07854         151 DLVLKIGDFGLARIVDPHYS--------HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA  222 (342)
T ss_pred             CceEEECCcccceecCCccc--------cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            56789999999976532110        0111122357889999997654 56788999999999999999999999653


Q ss_pred             ccCCccHHHHHHHhhcc---hhhhh---hhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          780 FAGGLSLHKWVKNHYHG---RLEKV---IDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       780 ~~~~~~~~~~~~~~~~~---~~~~~---~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ... .............   .....   ....+..................+.++.+++.+|++.||++|||+.|++.+
T Consensus       223 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         223 HEL-EQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             CHH-HHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            211 0011111100000   00000   000010000000011111122345678899999999999999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.2e-32  Score=295.44  Aligned_cols=255  Identities=26%  Similarity=0.359  Sum_probs=196.6

Q ss_pred             CCcccceecccCcceEEEEEeC----CCCEEEEEEeeecC----CcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcc
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ----DGTAIAVKVLQLQS----GNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFK  628 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  628 (885)
                      +|.+.+.||+|++|.||+|+..    +++.||||.++...    ....+.+..|++++.++ +||+++++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778899999999999999843    57889999987432    22345688999999999 599999999999999999


Q ss_pred             eEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcc
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSD  708 (885)
Q Consensus       629 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D  708 (885)
                      ++||||+++|+|.+++....         .+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.++++|
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~d  148 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE---------HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTD  148 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC---------CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEE
Confidence            99999999999998886432         2788889999999999999999998   99999999999999999999999


Q ss_pred             cccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCC--CCccccchhhHHHHHHHHcCCCCCCccccCCccH
Q 002746          709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN--TSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSL  786 (885)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~  786 (885)
                      ||+++......          ........|+..|+|||...+..  .+.++||||||+++|||++|..||...... ...
T Consensus       149 fg~~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~  217 (288)
T cd05583         149 FGLSKEFLAEE----------EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQ  217 (288)
T ss_pred             Ccccccccccc----------ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chH
Confidence            99987653211          01112345788999999987765  788999999999999999999998532110 111


Q ss_pred             HHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHH
Q 002746          787 HKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDR  855 (885)
Q Consensus       787 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  855 (885)
                      ..+.+.             +........       ...+.++.+++.+||+.+|++|||++++.+.|..
T Consensus       218 ~~~~~~-------------~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         218 SEISRR-------------ILKSKPPFP-------KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             HHHHHH-------------HHccCCCCC-------cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            111111             111110000       0134568899999999999999999888776654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-32  Score=302.12  Aligned_cols=274  Identities=22%  Similarity=0.267  Sum_probs=197.7

Q ss_pred             HHHHHHhhCCcccceecccCcceEEEEEe-CCCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecC-
Q 002746          550 RELLEATAEFDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLP-  625 (885)
Q Consensus       550 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-  625 (885)
                      .++...+++|.+.+.||+|+||.||+|.. .+++.||+|+++...  ....+.+.+|++++++++||||+++++++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            55666789999999999999999999985 478999999986432  22346678899999999999999999987543 


Q ss_pred             -----CcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecC
Q 002746          626 -----DFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND  700 (885)
Q Consensus       626 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~  700 (885)
                           ...+++++++ +++|.+++...          .+++..+..++.|+++|++|||+.+   |+||||||+||+++.
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~  155 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNE  155 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcC
Confidence                 3357788876 78887776532          2788999999999999999999998   999999999999999


Q ss_pred             CCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCcc
Q 002746          701 DMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDM  779 (885)
Q Consensus       701 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~  779 (885)
                      ++.+||+|||+++....              ......|+..|+|||...+ ..++.++|||||||++|||++|+.||...
T Consensus       156 ~~~~kl~dfg~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  221 (345)
T cd07877         156 DCELKILDFGLARHTDD--------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  221 (345)
T ss_pred             CCCEEEecccccccccc--------------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999875421              1123457889999998766 46789999999999999999999999542


Q ss_pred             ccCCccHHHHHHHhh--cchh-hhhhhhh---hhhc-cCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          780 FAGGLSLHKWVKNHY--HGRL-EKVIDSS---LLRA-SRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       780 ~~~~~~~~~~~~~~~--~~~~-~~~~d~~---~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ... ..+...+....  .... ..+.+..   .... ...............+.++.+++.+|++.||.+||++.+++.+
T Consensus       222 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         222 DHI-DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CHH-HHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            110 11111111000  0000 0000000   0000 0000000001111235678999999999999999999999987

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-32  Score=301.20  Aligned_cols=269  Identities=21%  Similarity=0.287  Sum_probs=196.8

Q ss_pred             HhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCC-----
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPD-----  626 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----  626 (885)
                      ..++|++.+.||+|+||.||+|... ++..||||++....  ....+.+.+|++++++++||||+++++++..+.     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4678999999999999999999854 78999999986432  223456889999999999999999999887554     


Q ss_pred             -cceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEE
Q 002746          627 -FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL  705 (885)
Q Consensus       627 -~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~k  705 (885)
                       ..++||||+ +++|..++...          .+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.++
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~~----------~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~k  158 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKHE----------KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELK  158 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEE
Confidence             348999998 77888776532          2788999999999999999999998   99999999999999999999


Q ss_pred             EcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccccCCc
Q 002746          706 VSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGL  784 (885)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~  784 (885)
                      ++|||.+.....              ......+++.|+|||.+.+ ..++.++||||+|+++|++++|+.||...... .
T Consensus       159 l~dfg~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~  223 (343)
T cd07880         159 ILDFGLARQTDS--------------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-D  223 (343)
T ss_pred             Eeeccccccccc--------------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-H
Confidence            999999875421              1122356889999998776 45789999999999999999999999642110 0


Q ss_pred             cHHHHHHHhhc--chhhhhhhh----h-hhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          785 SLHKWVKNHYH--GRLEKVIDS----S-LLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       785 ~~~~~~~~~~~--~~~~~~~d~----~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ...+.......  ..+...+..    . ...............+..++.++.+++.+|++.||++|||+.+++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         224 QLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            11111100000  000000000    0 00000001111222233456678999999999999999999999964

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=9.8e-33  Score=292.16  Aligned_cols=251  Identities=23%  Similarity=0.308  Sum_probs=193.1

Q ss_pred             ecccCcceEEEEEeC-CCCEEEEEEeeecCC---cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCCcc
Q 002746          565 LGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG---NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSL  640 (885)
Q Consensus       565 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL  640 (885)
                      ||+|+||.||+|+.. +|+.||+|++.....   ...+.+.+|++++++++|||++++++.+......++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999977 499999999875432   3456788999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecccC
Q 002746          641 DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGV  720 (885)
Q Consensus       641 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~  720 (885)
                      .+++....         .+++..++.++.|+++||+|||+.+   ++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~  148 (265)
T cd05579          81 ASLLENVG---------SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQ  148 (265)
T ss_pred             HHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcc
Confidence            99886533         3789999999999999999999998   99999999999999999999999999875432110


Q ss_pred             CCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhhh
Q 002746          721 GNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEK  800 (885)
Q Consensus       721 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  800 (885)
                      ..   ............++..|+|||...+..++.++||||||+++||+++|+.||....     ..........     
T Consensus       149 ~~---~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~-----  215 (265)
T cd05579         149 IN---LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-----PEEIFQNILN-----  215 (265)
T ss_pred             cc---cccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhc-----
Confidence            00   0000112233467889999999988889999999999999999999999996421     1111111100     


Q ss_pred             hhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 002746          801 VIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDL  853 (885)
Q Consensus       801 ~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  853 (885)
                              ..... +..    ...+.++.+++.+||+.+|++|||+.++.+.+
T Consensus       216 --------~~~~~-~~~----~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         216 --------GKIEW-PED----VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             --------CCcCC-Ccc----ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence                    00000 000    00245689999999999999999995555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.4e-33  Score=303.80  Aligned_cols=268  Identities=23%  Similarity=0.301  Sum_probs=197.8

Q ss_pred             HhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec--CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCc----
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDF----  627 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----  627 (885)
                      ..++|++.+.||+|++|.||+|+.. ++..||||++...  .....+.+.+|+.++++++|+|++++.+++..++.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4578999999999999999999975 6889999998643  22234567789999999999999999988866654    


Q ss_pred             --ceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEE
Q 002746          628 --KALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL  705 (885)
Q Consensus       628 --~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~k  705 (885)
                        .++|+||+ +++|.+++...          .+++..+..++.|+++|++|||+.+   |+||||||+||+++.++.++
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~----------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~k  158 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ----------KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELK  158 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEE
Confidence              78999998 66888877542          3789999999999999999999998   99999999999999999999


Q ss_pred             EcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccccCCc
Q 002746          706 VSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGL  784 (885)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~  784 (885)
                      |+|||.+.....              ......++..|+|||...+ ..++.++|||||||++||+++|+.||.....  .
T Consensus       159 L~dfg~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--~  222 (343)
T cd07851         159 ILDFGLARHTDD--------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH--I  222 (343)
T ss_pred             Eccccccccccc--------------cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--H
Confidence            999999975421              1122357888999998765 3678999999999999999999999964211  1


Q ss_pred             cHHHHHHHhhcchhhhhhh----hh----hhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          785 SLHKWVKNHYHGRLEKVID----SS----LLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~d----~~----~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .....+..........+..    ..    +........+.....+...+.++.+++.+|++.+|++|||+.|++.+
T Consensus       223 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         223 DQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            1111111111111111100    00    00000111111122222346789999999999999999999999885

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2e-32  Score=294.76  Aligned_cols=251  Identities=21%  Similarity=0.300  Sum_probs=189.8

Q ss_pred             hCCcccceecccCcceEEEEEeCC-CCEEEEEEeeecCC-cchhhHHHHHHHHhhc-CCcccceeeeeeecCCcceEEEe
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSG-NFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      ++|++.+.||+|++|.||+|.+.+ ++.||||.++.... .....+..|+.++.+. .|+||+++++++.++...++|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            568889999999999999999874 89999999975432 2344566777776666 49999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH-HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      |+. +++...+....        ..+++..+..++.|++.|++|||+ .+   |+||||+|+||++++++.+||+|||.+
T Consensus        95 ~~~-~~l~~l~~~~~--------~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~  162 (296)
T cd06618          95 LMS-TCLDKLLKRIQ--------GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGIS  162 (296)
T ss_pred             ccC-cCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccc
Confidence            985 45655543321        148889999999999999999997 46   999999999999999999999999998


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCC----CCccccchhhHHHHHHHHcCCCCCCccccCCccHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN----TSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~  788 (885)
                      ..+...            .......++..|+|||++.+..    ++.++||||||+++|||++|+.||......    .+
T Consensus       163 ~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~  226 (296)
T cd06618         163 GRLVDS------------KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE----FE  226 (296)
T ss_pred             hhccCC------------CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH----HH
Confidence            765221            1112234778999999987654    789999999999999999999999642111    11


Q ss_pred             HHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       789 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .....        .......... .        ..++.++.+++.+||..||.+||++++++++
T Consensus       227 ~~~~~--------~~~~~~~~~~-~--------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         227 VLTKI--------LQEEPPSLPP-N--------EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             HHHHH--------hcCCCCCCCC-C--------CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11111        1100000000 0        0134568999999999999999999999886

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-32  Score=289.51  Aligned_cols=242  Identities=20%  Similarity=0.304  Sum_probs=184.9

Q ss_pred             ceecccCcceEEEEEeC-CCCEEEEEEeeecCC---cchhhHHHHHHHH-hhcCCcccceeeeeeecCCcceEEEecccC
Q 002746          563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG---NFTKSFNRECQVL-KRIRHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~lV~e~~~~  637 (885)
                      +.||+|+||.||+|... +++.||+|.++....   .....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999965 688999999864321   1123344454443 455899999999999999999999999999


Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      ++|.+++....         .+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||+++....
T Consensus        82 ~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  149 (260)
T cd05611          82 GDCASLIKTLG---------GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE  149 (260)
T ss_pred             CCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc
Confidence            99999886432         3788899999999999999999998   99999999999999999999999999875321


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcch
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR  797 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  797 (885)
                                     .....|+..|+|||...+..++.++||||||+++|||++|..||....     ............
T Consensus       150 ---------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~  209 (260)
T cd05611         150 ---------------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET-----PDAVFDNILSRR  209 (260)
T ss_pred             ---------------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHhcc
Confidence                           122357889999999988889999999999999999999999996421     111111110000


Q ss_pred             hhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          798 LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       798 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .             ...+.   ....++.++.+++.+||+.+|++||++.++.+.
T Consensus       210 ~-------------~~~~~---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~  248 (260)
T cd05611         210 I-------------NWPEE---VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI  248 (260)
T ss_pred             c-------------CCCCc---ccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence            0             00000   001245678999999999999999977655443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.7e-32  Score=289.63  Aligned_cols=251  Identities=24%  Similarity=0.335  Sum_probs=193.6

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeec-----CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEE
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ-----SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV  631 (885)
                      +|.+.+.||+|+||.||++.+. .+..+++|+++..     ......++..|+.++++++|||++++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            5788899999999999999865 3455666665532     122344577899999999999999999999999999999


Q ss_pred             EecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccc
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~  711 (885)
                      |||+++++|..++.....     ....+++..++.++.|++.|+.|||+.+   ++|+||||+||+++. +.++|+|||.
T Consensus        81 ~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~  151 (260)
T cd08222          81 TEYCEGRDLDCKLEELKH-----TGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGV  151 (260)
T ss_pred             EEeCCCCCHHHHHHHHhh-----cccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCc
Confidence            999999999988764321     1234899999999999999999999998   999999999999975 5699999999


Q ss_pred             ceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      +..+...           ........|++.|+|||...+..++.++||||||+++|+|++|..||...     .......
T Consensus       152 ~~~~~~~-----------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~-----~~~~~~~  215 (260)
T cd08222         152 SRLLMGS-----------CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ-----NFLSVVL  215 (260)
T ss_pred             eeecCCC-----------cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----cHHHHHH
Confidence            8765321           11112345788999999998888899999999999999999999998641     1111111


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ......            .. ..+      ..++.++.+++.+||+.+|++||++.|++++
T Consensus       216 ~~~~~~------------~~-~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         216 RIVEGP------------TP-SLP------ETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             HHHcCC------------CC-CCc------chhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            111000            00 000      1245678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.6e-33  Score=274.21  Aligned_cols=290  Identities=22%  Similarity=0.308  Sum_probs=210.1

Q ss_pred             HHhhCCcccceecccCcceEEEEEeC---C--CCEEEEEEeeecCC--cchhhHHHHHHHHhhcCCcccceeeeeeec-C
Q 002746          554 EATAEFDEQRLLGTGSYGRVYKGILQ---D--GTAIAVKVLQLQSG--NFTKSFNRECQVLKRIRHRNLMRIITACSL-P  625 (885)
Q Consensus       554 ~~~~~~~~~~~lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~  625 (885)
                      +....|+....||+|.||.||+|...   +  ...+|+|+|+..+.  .......+|+..++.++|||++.+..++.. +
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            44567999999999999999999643   2  33789999986532  345678899999999999999999998877 7


Q ss_pred             CcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCC----
Q 002746          626 DFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDD----  701 (885)
Q Consensus       626 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~----  701 (885)
                      ...++++||.+. +|...++-++..+    ...++......|..||+.|+.|||+..   |+|||+||.|||+..+    
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~----~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgper  172 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASK----AKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPER  172 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccch----hccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCcc
Confidence            778899999965 7777776665432    236899999999999999999999998   9999999999999877    


Q ss_pred             CCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccc
Q 002746          702 MTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMF  780 (885)
Q Consensus       702 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~  780 (885)
                      |.+||+|||+|+.+...-        .+-.....++-|..|.|||.+.|. .||.+.|||+.||++.||+|-.+-|....
T Consensus       173 G~VKIaDlGlaR~~~~pl--------kpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E  244 (438)
T KOG0666|consen  173 GRVKIADLGLARLFNNPL--------KPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE  244 (438)
T ss_pred             CeeEeecccHHHHhhccc--------cccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence            999999999999884310        011234456779999999998876 58999999999999999999888775432


Q ss_pred             cCC--------ccHHHHHHHhhcc----hhhhhhh--------hhhhhccCCChHHHHHHHHH---HHHHHHHHHhhhcC
Q 002746          781 AGG--------LSLHKWVKNHYHG----RLEKVID--------SSLLRASRDQSPEVKRMWDV---AIGELIELGILCTQ  837 (885)
Q Consensus       781 ~~~--------~~~~~~~~~~~~~----~~~~~~d--------~~~~~~~~~~~~~~~~~~~~---~~~~l~~l~~~cl~  837 (885)
                      ..-        ..+.. +.....-    .++.+..        ..+.....+ .-.+++++..   -++...+++.+++.
T Consensus       245 ~k~~~~~Pfq~dQl~r-If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~-n~sL~~~~~~~k~k~~~a~~LL~klL~  322 (438)
T KOG0666|consen  245 EKIKTKNPFQHDQLDR-IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYD-NVSLHKYYHKHKVKDPSALDLLQKLLT  322 (438)
T ss_pred             hhcccCCCchHHHHHH-HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcC-cchHHHHHHHhcCCCchHHHHHHHHhc
Confidence            110        01111 1111100    0111100        000001111 1123333332   23458899999999


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHhcCCCCC
Q 002746          838 ESPSTRPTMLDAADDLDRLKRYLGEKHMP  866 (885)
Q Consensus       838 ~dP~~RPt~~ev~~~L~~l~~~~~~~~~~  866 (885)
                      .||.+|.|+++++++     .++.++..|
T Consensus       323 yDP~kRIta~qAleh-----~yF~~d~lp  346 (438)
T KOG0666|consen  323 YDPIKRITAEQALEH-----PYFTEDPLP  346 (438)
T ss_pred             cCchhhccHHHHhcc-----cccccCCCC
Confidence            999999999999996     566666655

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.6e-32  Score=292.02  Aligned_cols=252  Identities=24%  Similarity=0.313  Sum_probs=193.7

Q ss_pred             CCcccceecccCcceEEEEEe----CCCCEEEEEEeeecC----CcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcc
Q 002746          558 EFDEQRLLGTGSYGRVYKGIL----QDGTAIAVKVLQLQS----GNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFK  628 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  628 (885)
                      +|++.+.||+|+||.||+|..    .+|+.||+|+++...    ....+.+..|+++++++ +|++|+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478889999999999999986    368999999987432    22346788899999999 589999999999988889


Q ss_pred             eEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcc
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSD  708 (885)
Q Consensus       629 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D  708 (885)
                      ++||||+++++|.+++....         .+++..+..++.|+++||.|||+.+   ++||||+|+||+++.++.++|+|
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d  148 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE---------RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD  148 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEee
Confidence            99999999999999886543         2778888999999999999999998   99999999999999999999999


Q ss_pred             cccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC--CCCccccchhhHHHHHHHHcCCCCCCccccCCccH
Q 002746          709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS--NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSL  786 (885)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~  786 (885)
                      ||++.......          ........|+..|+|||...+.  .++.++||||||+++|+|++|+.||..... ....
T Consensus       149 fg~~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~  217 (290)
T cd05613         149 FGLSKEFHEDE----------VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQ  217 (290)
T ss_pred             Cccceeccccc----------ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccH
Confidence            99987653211          0111234588899999998753  467899999999999999999999863211 1111


Q ss_pred             HHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 002746          787 HKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP-----TMLDAADD  852 (885)
Q Consensus       787 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  852 (885)
                      ..+......             ......       ......+.+++.+||+.+|++||     +++++..+
T Consensus       218 ~~~~~~~~~-------------~~~~~~-------~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         218 AEISRRILK-------------SEPPYP-------QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             HHHHHHhhc-------------cCCCCC-------ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            111111110             000000       01234588999999999999997     66777664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.7e-32  Score=297.58  Aligned_cols=273  Identities=19%  Similarity=0.219  Sum_probs=193.7

Q ss_pred             CCcccceecccCcceEEEEEeC-C--CCEEEEEEeeec--CCcchhhHHHHHHHHhhc-CCcccceeeeeeecC----Cc
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-D--GTAIAVKVLQLQ--SGNFTKSFNRECQVLKRI-RHRNLMRIITACSLP----DF  627 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~~  627 (885)
                      +|.+.+.||+|+||.||+|+.. .  +..||+|++...  .....+.+.+|+++++++ +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788899999999999999965 4  778999998643  222346788899999999 599999999875432    45


Q ss_pred             ceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEc
Q 002746          628 KALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVS  707 (885)
Q Consensus       628 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~  707 (885)
                      .++++||+. ++|.+++....         .+++..+..++.|++.||+|||+.|   |+||||||+||+++.++.+||+
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~  147 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ---------PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKIC  147 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeC
Confidence            678888885 68888775432         3789999999999999999999998   9999999999999999999999


Q ss_pred             ccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccccCCccH
Q 002746          708 DFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSL  786 (885)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~  786 (885)
                      |||.++.+......       .........||..|+|||+..+ ..++.++||||+||++|+|++|+.||.....  ...
T Consensus       148 Dfg~a~~~~~~~~~-------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~--~~~  218 (332)
T cd07857         148 DFGLARGFSENPGE-------NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY--VDQ  218 (332)
T ss_pred             cCCCceeccccccc-------ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH--HHH
Confidence            99999876432110       0111223468999999998765 4689999999999999999999999864211  111


Q ss_pred             HHHHHHhhcch----hhhhhhhhhh----hccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          787 HKWVKNHYHGR----LEKVIDSSLL----RASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       787 ~~~~~~~~~~~----~~~~~d~~~~----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ...+.......    ...+.++...    .............+...+.++.+++.+|++.+|++|||+.|++.+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         219 LNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            11111110000    0111110000    000000011111122235679999999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.98  E-value=2.4e-32  Score=291.78  Aligned_cols=259  Identities=21%  Similarity=0.308  Sum_probs=201.7

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcC-CcccceeeeeeecCCcceEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIR-HRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lV  631 (885)
                      ++|.+.+.||+|++|.||+|... ++..||+|++....   ....+.+..|++++++++ |+||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36888999999999999999965 79999999987432   233467888999999998 99999999999999999999


Q ss_pred             EecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccc
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~  711 (885)
                      |||+++++|.+++....         .+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++++|||.
T Consensus        81 ~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~  148 (280)
T cd05581          81 LEYAPNGELLQYIRKYG---------SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGT  148 (280)
T ss_pred             EcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCcc
Confidence            99999999999886543         3899999999999999999999998   99999999999999999999999999


Q ss_pred             ceeeecccCCCCC---------CCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccC
Q 002746          712 AKLVMTVGVGNDG---------AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAG  782 (885)
Q Consensus       712 a~~~~~~~~~~~~---------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~  782 (885)
                      +............         .............|+..|+|||...+..++.++||||||++++++++|+.||..... 
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-  227 (280)
T cd05581         149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-  227 (280)
T ss_pred             ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-
Confidence            9876432211000         000011222344678999999999888899999999999999999999999975310 


Q ss_pred             CccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCH----HHHHHH
Q 002746          783 GLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTM----LDAADD  852 (885)
Q Consensus       783 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~----~ev~~~  852 (885)
                          ....        ....     .......+       ..++.+.+++.+||+.+|.+||++    +|++.+
T Consensus       228 ----~~~~--------~~~~-----~~~~~~~~-------~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         228 ----YLTF--------QKIL-----KLEYSFPP-------NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             ----HHHH--------HHHH-----hcCCCCCC-------ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence                0000        0000     00000001       124568999999999999999999    777654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=5.5e-32  Score=289.37  Aligned_cols=269  Identities=25%  Similarity=0.313  Sum_probs=199.1

Q ss_pred             CcccceecccCcceEEEEEeC-CCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      |+..+.||+|++|.||+|+.. +++.||+|+++...  ....+.+..|++++++++|++++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999966 59999999988553  334567888999999999999999999999999999999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      + ++|.+++....        ..+++..+..++.+++.||+|||+.+   |+||||+|+||++++++.++|+|||.++..
T Consensus        81 ~-~~l~~~i~~~~--------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~  148 (282)
T cd07829          81 D-MDLKKYLDKRP--------GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAF  148 (282)
T ss_pred             C-cCHHHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCccccc
Confidence            7 58988887542        13889999999999999999999998   999999999999999999999999998765


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhh
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                      ...           ........++..|+|||.+.+. .++.++|||||||++||+++|+.||.....  ......+....
T Consensus       149 ~~~-----------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--~~~~~~~~~~~  215 (282)
T cd07829         149 GIP-----------LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE--IDQLFKIFQIL  215 (282)
T ss_pred             CCC-----------ccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHHHh
Confidence            321           1112223457789999998776 789999999999999999999999865211  11111111111


Q ss_pred             cchhh----hhhhhh-hhhccCCC-hHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          795 HGRLE----KVIDSS-LLRASRDQ-SPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       795 ~~~~~----~~~d~~-~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .....    ...+-. ........ ...........+.++.+++.+||..+|++||++++++.+
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         216 GTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             CCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            11100    000000 00000000 000111122235679999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.98  E-value=8.2e-33  Score=279.52  Aligned_cols=269  Identities=20%  Similarity=0.253  Sum_probs=202.4

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcC--Ccc----cceeeeeeecCCcc
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIR--HRN----LMRIITACSLPDFK  628 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~n----iv~~~~~~~~~~~~  628 (885)
                      +.+|.+...+|+|.||.|-.+.+. .+..||||+++. .....+..+-|+++++++.  .|+    +|++.+||...++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            689999999999999999999965 478999999983 3455678889999999993  232    78888999999999


Q ss_pred             eEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecC--------
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND--------  700 (885)
Q Consensus       629 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~--------  700 (885)
                      ++|+|.+ |-|+.+++..+...       +++..++..|+.|++++++|||+.+   ++|.|+||+|||+.+        
T Consensus       167 Civfell-G~S~~dFlk~N~y~-------~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~  235 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYI-------PFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYN  235 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCcc-------ccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEec
Confidence            9999998 66899999875432       4888999999999999999999998   999999999999942        


Q ss_pred             ------------CCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHH
Q 002746          701 ------------DMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLE  768 (885)
Q Consensus       701 ------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~e  768 (885)
                                  +..++++|||.|+...              ......+.|..|.|||++.+-.++.++||||+||||+|
T Consensus       236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~--------------e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~E  301 (415)
T KOG0671|consen  236 PKKKVCFIRPLKSTAIKVIDFGSATFDH--------------EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVE  301 (415)
T ss_pred             cCCccceeccCCCcceEEEecCCcceec--------------cCcceeeeccccCCchheeccCcCCccCceeeeeEEEE
Confidence                        2358999999998752              22245678999999999999999999999999999999


Q ss_pred             HHcCCCCCCccccCCccHHHHHHHhhcchhhhhhhhh-----------------hhh---ccCCChHHHHH---HHHHHH
Q 002746          769 MVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSS-----------------LLR---ASRDQSPEVKR---MWDVAI  825 (885)
Q Consensus       769 lltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~-----------------~~~---~~~~~~~~~~~---~~~~~~  825 (885)
                      ++||..-|..-. ..+.+ ..++.+........+...                 ..+   ...+....+..   .-+...
T Consensus       302 lytG~~LFqtHe-n~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~  379 (415)
T KOG0671|consen  302 LYTGETLFQTHE-NLEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEH  379 (415)
T ss_pred             eeccceecccCC-cHHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHH
Confidence            999999886532 21222 111211111001111100                 000   00001111111   123455


Q ss_pred             HHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          826 GELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       826 ~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .++++++.+|+..||.+|+|+.|++.+
T Consensus       380 ~~LfDLl~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  380 VQLFDLLRRMLEFDPARRITLREALSH  406 (415)
T ss_pred             hHHHHHHHHHHccCccccccHHHHhcC
Confidence            679999999999999999999999876

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.98  E-value=9.8e-33  Score=297.69  Aligned_cols=240  Identities=21%  Similarity=0.269  Sum_probs=193.3

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcceEEEe
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      +..|+....+|.|+|++|-.+... +++..+||++...    ..+-.+|+.++... +|||+++..+.+.+..+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            456777788999999999999854 7889999999755    23345566665554 79999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEe-cCCCCEEEcccccc
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL-NDDMTALVSDFGIA  712 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl-~~~~~~kl~Dfg~a  712 (885)
                      ++.++-+.+.+...+.         . ...+..|+.+|+.|+.|||++|   |||||+||+|||+ +..++++|+|||.+
T Consensus       397 ~l~g~ell~ri~~~~~---------~-~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a  463 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPE---------F-CSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFW  463 (612)
T ss_pred             hccccHHHHHHHhcch---------h-HHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechh
Confidence            9999988877765542         2 2667789999999999999998   9999999999999 58999999999999


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~  792 (885)
                      +.....              ....+-|..|+|||+.....|+++||+||||++||+|++|+.||.....+ ..+..   .
T Consensus       464 ~~~~~~--------------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~---~  525 (612)
T KOG0603|consen  464 SELERS--------------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHT---R  525 (612)
T ss_pred             hhCchh--------------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHH---h
Confidence            866321              23346688999999999999999999999999999999999999763222 11111   1


Q ss_pred             hhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       793 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ......                      ...++.+..+++.+|++.||.+||+|.++.++
T Consensus       526 i~~~~~----------------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  526 IQMPKF----------------------SECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             hcCCcc----------------------ccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence            000000                      02356789999999999999999999999886

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-32  Score=286.26  Aligned_cols=263  Identities=23%  Similarity=0.384  Sum_probs=208.0

Q ss_pred             cceecccCcceEEEEEeC-CCCEEEEEEeeec--CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCC
Q 002746          562 QRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANG  638 (885)
Q Consensus       562 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g  638 (885)
                      .++||+|-||+||-|..+ +|+.||||++.+.  ..+...++..|+++|+.++||.||.+..-|+.++..++|||.+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            378999999999999955 7999999998643  3344688999999999999999999999999999999999999655


Q ss_pred             ccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCC---CCEEEcccccceee
Q 002746          639 SLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDD---MTALVSDFGIAKLV  715 (885)
Q Consensus       639 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~---~~~kl~Dfg~a~~~  715 (885)
                      =|.-.+....        ..+++..-.-++.||+-||.|||.++   |||+|+||+|||+.+.   -.+||||||+|+.+
T Consensus       649 MLEMILSsEk--------gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiI  717 (888)
T KOG4236|consen  649 MLEMILSSEK--------GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARII  717 (888)
T ss_pred             HHHHHHHhhc--------ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeec
Confidence            4544443322        24788888889999999999999998   9999999999999743   47999999999988


Q ss_pred             ecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhc
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~  795 (885)
                      ++            .+....++|||.|.|||++..+.|...-|+||+||++|--++|..||...    +++.+       
T Consensus       718 gE------------ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd----EdInd-------  774 (888)
T KOG4236|consen  718 GE------------KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED----EDIND-------  774 (888)
T ss_pred             ch------------hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc----cchhH-------
Confidence            54            23445678999999999999999999999999999999999999999652    11111       


Q ss_pred             chhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH-----------HHHHHHHHhcCCC
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAAD-----------DLDRLKRYLGEKH  864 (885)
Q Consensus       796 ~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~-----------~L~~l~~~~~~~~  864 (885)
                               .+..+.....+   ..|.+.+.+..++|...++..-.+|-+....+.           .|+++...++++.
T Consensus       775 ---------QIQNAaFMyPp---~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~~igeRy  842 (888)
T KOG4236|consen  775 ---------QIQNAAFMYPP---NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEVRIGERY  842 (888)
T ss_pred             ---------HhhccccccCC---CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHHHhhCcce
Confidence                     11111111111   136667788899999999999999988876543           4566777777666


Q ss_pred             CCCccc
Q 002746          865 MPSKMN  870 (885)
Q Consensus       865 ~~~~~~  870 (885)
                      +..+++
T Consensus       843 iThesD  848 (888)
T KOG4236|consen  843 ITHESD  848 (888)
T ss_pred             ecCcch
Confidence            655554

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=9.5e-32  Score=312.47  Aligned_cols=267  Identities=26%  Similarity=0.420  Sum_probs=209.5

Q ss_pred             HhhCCcccceecccCcceEEEEEeC----C----CCEEEEEEeeecC-CcchhhHHHHHHHHhhc-CCcccceeeeeeec
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ----D----GTAIAVKVLQLQS-GNFTKSFNRECQVLKRI-RHRNLMRIITACSL  624 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  624 (885)
                      ..++..+.+.+|+|+||.|++|...    .    ...||||.++... ....+.+..|++++..+ +|+|++.++|+|..
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            3445566679999999999999843    1    4569999988543 34567899999999998 79999999999999


Q ss_pred             CCcceEEEecccCCccccccccCC-ccccCCCC------CCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceE
Q 002746          625 PDFKALVLPYMANGSLDSHLYPHS-ETEFGSGS------SDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVL  697 (885)
Q Consensus       625 ~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIL  697 (885)
                      .+..++|+||+..|+|..+++..+ ...+...+      ..++....+.++.|||.|++||+++.   +||||+.++|||
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVL  450 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEE
Confidence            999999999999999999998877 11211111      24889999999999999999999997   999999999999


Q ss_pred             ecCCCCEEEcccccceeeecccCCCCCCCCCCCCcccccc--ccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCC
Q 002746          698 LNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC--GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRR  774 (885)
Q Consensus       698 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~  774 (885)
                      +.++..+||+|||+|+.....+...          .....  -...|||||.+....++.++|||||||+|||++| |..
T Consensus       451 i~~~~~~kIaDFGlar~~~~~~~y~----------~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~  520 (609)
T KOG0200|consen  451 ITKNKVIKIADFGLARDHYNKDYYR----------TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGT  520 (609)
T ss_pred             ecCCCEEEEccccceeccCCCCceE----------ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCC
Confidence            9999999999999999664322111          01111  2346999999999999999999999999999999 888


Q ss_pred             CCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHH
Q 002746          775 PTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       775 P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                      ||.... .               ..+++ +.+..+.+...|.      .|..++.++|+.||+.+|++||++.|+.+.++
T Consensus       521 PYp~~~-~---------------~~~l~-~~l~~G~r~~~P~------~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~  577 (609)
T KOG0200|consen  521 PYPGIP-P---------------TEELL-EFLKEGNRMEQPE------HCSDEIYDLMKSCWNADPEDRPTFSECVEFFE  577 (609)
T ss_pred             CCCCCC-c---------------HHHHH-HHHhcCCCCCCCC------CCCHHHHHHHHHHhCCCcccCCCHHHHHHHHH
Confidence            885410 0               11111 1333344433332      36788999999999999999999999999999


Q ss_pred             HHH
Q 002746          855 RLK  857 (885)
Q Consensus       855 ~l~  857 (885)
                      ...
T Consensus       578 ~~l  580 (609)
T KOG0200|consen  578 KHL  580 (609)
T ss_pred             HHH
Confidence            853

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=1.3e-31  Score=316.62  Aligned_cols=146  Identities=27%  Similarity=0.435  Sum_probs=130.3

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ++|.+.+.||+|+||.||+|... +++.||||+++...   ......+..|+.++..++||||+++++++......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57899999999999999999976 68999999987432   223467889999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+.+++|.+++....         .+++..++.|+.||+.||+|||.++   ||||||||+|||++.++.+||+|||++
T Consensus        84 Ey~~g~~L~~li~~~~---------~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls  151 (669)
T cd05610          84 EYLIGGDVKSLLHIYG---------YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLS  151 (669)
T ss_pred             eCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCC
Confidence            9999999999886432         2778889999999999999999998   999999999999999999999999998


Q ss_pred             ee
Q 002746          713 KL  714 (885)
Q Consensus       713 ~~  714 (885)
                      +.
T Consensus       152 ~~  153 (669)
T cd05610         152 KV  153 (669)
T ss_pred             cc
Confidence            63

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=9.6e-32  Score=297.35  Aligned_cols=260  Identities=25%  Similarity=0.379  Sum_probs=211.0

Q ss_pred             HHHHHHHhhCCcccceecccCcceEEEEE-eCCCCEEEEEEeeecCCcchhhHHHHHHHHhhc-CCcccceeeeeee---
Q 002746          549 YRELLEATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLMRIITACS---  623 (885)
Q Consensus       549 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~---  623 (885)
                      ++.+...++-|++.++||.|.+|.||+++ .++++.+|+|+..... ...++...|.++++.. .|||++.+||++.   
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            33344456778999999999999999999 4578999999987553 3357788899999887 7999999999984   


Q ss_pred             --cCCcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCC
Q 002746          624 --LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDD  701 (885)
Q Consensus       624 --~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~  701 (885)
                        .+++.+||||||.+|+..++++...       +..+.|..+..|+..++.|+.+||...   ++|||||-.|||++.+
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-------g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e  159 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-------GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTEN  159 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhc-------ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEecc
Confidence              3678899999999999999887543       335899999999999999999999997   9999999999999999


Q ss_pred             CCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC-----CCCccccchhhHHHHHHHHcCCCCC
Q 002746          702 MTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-----NTSTKGDVYSFGILVLEMVTRRRPT  776 (885)
Q Consensus       702 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~vl~elltg~~P~  776 (885)
                      +.+|++|||.+..+..           .........||+.|||||++.+.     .|+.++|+||+|++..||.-|.+|+
T Consensus       160 ~~VKLvDFGvSaQlds-----------T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl  228 (953)
T KOG0587|consen  160 AEVKLVDFGVSAQLDS-----------TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPL  228 (953)
T ss_pred             CcEEEeeeeeeeeeec-----------ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCc
Confidence            9999999999876633           23344567899999999998764     4678999999999999999999999


Q ss_pred             CccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          777 DDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       777 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .++....                     .+....+.+.|.+.+ +.....++.++|..|+..|-.+||++.+++++
T Consensus       229 ~DmHPmr---------------------aLF~IpRNPPPkLkr-p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  229 CDMHPMR---------------------ALFLIPRNPPPKLKR-PKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             cCcchhh---------------------hhccCCCCCCccccc-hhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence            7754321                     111222233333322 34567889999999999999999999998875

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.1e-31  Score=279.49  Aligned_cols=236  Identities=28%  Similarity=0.362  Sum_probs=189.7

Q ss_pred             ecccCcceEEEEEeC-CCCEEEEEEeeecCC---cchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCCcc
Q 002746          565 LGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG---NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSL  640 (885)
Q Consensus       565 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL  640 (885)
                      ||+|++|.||++... +++.+|+|++.....   .....+..|++++++++|+|++++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999976 589999999875432   2345788999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecccC
Q 002746          641 DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGV  720 (885)
Q Consensus       641 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~  720 (885)
                      .+++....         .+++.....++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        81 ~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-  147 (250)
T cd05123          81 FSHLSKEG---------RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-  147 (250)
T ss_pred             HHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-
Confidence            99886543         3789999999999999999999988   9999999999999999999999999998653211 


Q ss_pred             CCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhhh
Q 002746          721 GNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEK  800 (885)
Q Consensus       721 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  800 (885)
                                .......++..|+|||...+...+.++|+||||+++|++++|+.||.....     .........     
T Consensus       148 ----------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~-----  207 (250)
T cd05123         148 ----------SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILK-----  207 (250)
T ss_pred             ----------CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhc-----
Confidence                      112334678899999999888899999999999999999999999964211     111111110     


Q ss_pred             hhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 002746          801 VIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLD  848 (885)
Q Consensus       801 ~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e  848 (885)
                              .......       ..+.++.+++.+||..||++||++++
T Consensus       208 --------~~~~~~~-------~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         208 --------DPLRFPE-------FLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             --------CCCCCCC-------CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence                    0000000       12456889999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-32  Score=275.10  Aligned_cols=244  Identities=23%  Similarity=0.322  Sum_probs=194.1

Q ss_pred             HHhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcc
Q 002746          554 EATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFK  628 (885)
Q Consensus       554 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  628 (885)
                      ....+|....+||+|+||.|.+|..+ +.+.+|||+++...   ..+.+--+.|-++|+.. +-|.++++..+|+.-+..
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            34467999999999999999999865 56789999998552   22233345677777766 678999999999999999


Q ss_pred             eEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcc
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSD  708 (885)
Q Consensus       629 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D  708 (885)
                      |.||||+.||+|-.+++....         +.++.+.-+|.+||-||-|||++|   |++||+|.+|||+|.+|++||+|
T Consensus       426 yFVMEyvnGGDLMyhiQQ~Gk---------FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~D  493 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQVGK---------FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIAD  493 (683)
T ss_pred             eeEEEEecCchhhhHHHHhcc---------cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeee
Confidence            999999999999888876543         777888899999999999999999   99999999999999999999999


Q ss_pred             cccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHH
Q 002746          709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~  788 (885)
                      ||+++.-.           .+.......+|||.|+|||.+...+|+...|.|||||+||||+.|++||+...+  ..+- 
T Consensus       494 FGmcKEni-----------~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE--~elF-  559 (683)
T KOG0696|consen  494 FGMCKENI-----------FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--DELF-  559 (683)
T ss_pred             cccccccc-----------cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH--HHHH-
Confidence            99987421           123445568999999999999999999999999999999999999999975211  1111 


Q ss_pred             HHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC
Q 002746          789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT  845 (885)
Q Consensus       789 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt  845 (885)
                                     ..+.........       ..+.+...++...+...|.+|-.
T Consensus       560 ---------------~aI~ehnvsyPK-------slSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  560 ---------------QAIMEHNVSYPK-------SLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ---------------HHHHHccCcCcc-------cccHHHHHHHHHHhhcCCccccC
Confidence                           111111111111       24567888888899999999853

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-32  Score=279.66  Aligned_cols=264  Identities=27%  Similarity=0.368  Sum_probs=200.4

Q ss_pred             hhCCcccceecccCcceEEEEE-eCCCCEEEEEEeeecC-------CcchhhHHHHHHHHhhcCCcccceeeeeeecC-C
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQS-------GNFTKSFNRECQVLKRIRHRNLMRIITACSLP-D  626 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~  626 (885)
                      .++|-..+.||+|||+.||+|. +...+.||||+-...+       ....+...+|.++-+.++||.||++|+||.-+ +
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            4577788999999999999998 4468899999876432       22345677899999999999999999999755 4


Q ss_pred             cceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEec---CCCC
Q 002746          627 FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN---DDMT  703 (885)
Q Consensus       627 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~---~~~~  703 (885)
                      ..+-|+|||+|.+|+-+++.++.         +++..+..|+.||+.||.||.+.. ++|||-|+||.|||+.   ..|.
T Consensus       542 sFCTVLEYceGNDLDFYLKQhkl---------mSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGe  611 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHKL---------MSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGE  611 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhhh---------hhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccce
Confidence            56789999999999999987764         889999999999999999999986 5799999999999996   4589


Q ss_pred             EEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC----CCCccccchhhHHHHHHHHcCCCCCCcc
Q 002746          704 ALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS----NTSTKGDVYSFGILVLEMVTRRRPTDDM  779 (885)
Q Consensus       704 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~vl~elltg~~P~~~~  779 (885)
                      +||+|||+++.+....+...    .+..-....+||..|.+||.+--+    .++.|.||||+||++|..+.|+.||...
T Consensus       612 IKITDFGLSKIMdddSy~~v----dGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn  687 (775)
T KOG1151|consen  612 IKITDFGLSKIMDDDSYNSV----DGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN  687 (775)
T ss_pred             eEeeecchhhhccCCccCcc----cceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence            99999999999865433211    112222345799999999975332    4688999999999999999999999642


Q ss_pred             ccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          780 FAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       780 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                          ......+..           ..+..+..-..|..    +.++.+...+|++|+++--++|.+..++..+
T Consensus       688 ----qsQQdILqe-----------NTIlkAtEVqFP~K----PvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  688 ----QSQQDILQE-----------NTILKATEVQFPPK----PVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             ----hhHHHHHhh-----------hchhcceeccCCCC----CccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence                111111110           01111111111111    1245678899999999999999998888654

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=5.6e-32  Score=272.39  Aligned_cols=275  Identities=24%  Similarity=0.324  Sum_probs=216.3

Q ss_pred             HHHHHHhhCCcccceecccCcceEEEEEeCC------CCEEEEEEeeecC-CcchhhHHHHHHHHhhcCCcccceeeeee
Q 002746          550 RELLEATAEFDEQRLLGTGSYGRVYKGILQD------GTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITAC  622 (885)
Q Consensus       550 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~  622 (885)
                      .++.....++.....+-+|.||.||.|.|++      .+.|-||.++... .-....+.+|.-.+..+.|||+..+.+.+
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            3444455667777889999999999998763      3345667665332 23456688898888899999999999988


Q ss_pred             ecC-CcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCC
Q 002746          623 SLP-DFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDD  701 (885)
Q Consensus       623 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~  701 (885)
                      .++ +..+.+|.++.-|+|..++...+..+ ......+...+...++.|++.|++|||+++   |||.||.++|+++|+.
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~-~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDD-PSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ  432 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCC-CccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence            654 56688999999999999998555322 334456888899999999999999999999   9999999999999999


Q ss_pred             CCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc-CCCCCCccc
Q 002746          702 MTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMF  780 (885)
Q Consensus       702 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~P~~~~~  780 (885)
                      ..+||+|=.+++.+.+.+++.-|..+         .-...||+||.+....|+.++|||||||++|||+| |+.|+.+..
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnE---------nRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID  503 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNE---------NRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID  503 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCC---------CCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC
Confidence            99999999999999887665544322         23568999999999999999999999999999999 999987531


Q ss_pred             cCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 002746          781 AGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYL  860 (885)
Q Consensus       781 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~  860 (885)
                      .              .+...    -+.++++-..|.      .|+.+++.+|..||+.+|++||+++|++.-|.+++.++
T Consensus       504 P--------------fEm~~----ylkdGyRlaQP~------NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql  559 (563)
T KOG1024|consen  504 P--------------FEMEH----YLKDGYRLAQPF------NCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL  559 (563)
T ss_pred             H--------------HHHHH----HHhccceecCCC------CCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence            1              11111    112222222221      38889999999999999999999999999999998776


Q ss_pred             c
Q 002746          861 G  861 (885)
Q Consensus       861 ~  861 (885)
                      +
T Consensus       560 t  560 (563)
T KOG1024|consen  560 T  560 (563)
T ss_pred             h
Confidence            4

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-33  Score=269.94  Aligned_cols=253  Identities=22%  Similarity=0.220  Sum_probs=185.9

Q ss_pred             ceecccCcceEEEEEeC-CCCEEEEEEeeecCC-cchhhHHHHHHHHhhc-CCcccceeeeeeecCCcceEEEecccCCc
Q 002746          563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFKALVLPYMANGS  639 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~gs  639 (885)
                      ..||.|+||+|++-.++ .|+..|||+++.... ...+++..|.+...+- +.|+||++||++..++..++.||.| .-+
T Consensus        70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~S  148 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DIS  148 (361)
T ss_pred             HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhh
Confidence            46999999999998865 799999999986543 4567788888875554 7899999999999999999999999 446


Q ss_pred             cccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeeccc
Q 002746          640 LDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVG  719 (885)
Q Consensus       640 L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~  719 (885)
                      ++.+......    .....+++...-.|..-.+.||.||-+.-  +|+|||+||+|||++..|.+||||||.+-.+..  
T Consensus       149 lDklYk~vy~----vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--  220 (361)
T KOG1006|consen  149 LDKLYKRVYS----VQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--  220 (361)
T ss_pred             HHHHHHHHHH----HHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH--
Confidence            6544322110    01223777777788888999999998764  599999999999999999999999999854421  


Q ss_pred             CCCCCCCCCCCCccccccccccccCCcccCCC--CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcch
Q 002746          720 VGNDGAENMGNSTANMLCGSIGYMAPEYGFGS--NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR  797 (885)
Q Consensus       720 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  797 (885)
                                +...+.-+|...|||||.+...  .|+-+|||||+|++|||+.||..|+.....--++    +..+..+.
T Consensus       221 ----------SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeq----l~~Vv~gd  286 (361)
T KOG1006|consen  221 ----------SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQ----LCQVVIGD  286 (361)
T ss_pred             ----------HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHH----HHHHHcCC
Confidence                      2223344788999999987543  5899999999999999999999998652111111    11111111


Q ss_pred             hhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          798 LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       798 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .+.+..     ..    .     .-..+..+..++..|+.+|-..||...++.++
T Consensus       287 pp~l~~-----~~----~-----~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  287 PPILLF-----DK----E-----CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             CCeecC-----cc----c-----ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            111100     00    0     01134568899999999999999999988765

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=2.6e-31  Score=275.95  Aligned_cols=220  Identities=21%  Similarity=0.195  Sum_probs=174.3

Q ss_pred             cCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCCcccccccc
Q 002746          568 GSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYP  646 (885)
Q Consensus       568 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~  646 (885)
                      |.+|.||+++.. +++.||+|+++...     .+..|...+....|||++++++++...+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999965 68999999987432     234455555566799999999999999999999999999999998864


Q ss_pred             CCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecccCCCCCCC
Q 002746          647 HSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE  726 (885)
Q Consensus       647 ~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  726 (885)
                      ..         .+++..+..++.|+++||+|||+++   |+||||||+||+++.++.++++|||.+..+...        
T Consensus        79 ~~---------~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--------  138 (237)
T cd05576          79 FL---------NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--------  138 (237)
T ss_pred             hc---------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc--------
Confidence            42         2789999999999999999999998   999999999999999999999999987654221        


Q ss_pred             CCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhhhhhhhhh
Q 002746          727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSL  806 (885)
Q Consensus       727 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  806 (885)
                            .....++..|+|||+..+..++.++||||+|+++|||++|+.|+......               .....  .+
T Consensus       139 ------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------------~~~~~--~~  195 (237)
T cd05576         139 ------CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---------------INTHT--TL  195 (237)
T ss_pred             ------cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------------ccccc--cc
Confidence                  11234567899999998888999999999999999999999887531100               00000  00


Q ss_pred             hhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 002746          807 LRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTML  847 (885)
Q Consensus       807 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  847 (885)
                            ..+      ...+.++.+++.+|++.||++||++.
T Consensus       196 ------~~~------~~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         196 ------NIP------EWVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             ------CCc------ccCCHHHHHHHHHHccCCHHHhcCCC
Confidence                  000      01345688999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=4.8e-32  Score=257.64  Aligned_cols=284  Identities=21%  Similarity=0.331  Sum_probs=200.7

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEee--ecCCcchhhHHHHHHHHhhcCCcccceeeeeeecC--------
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLP--------  625 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------  625 (885)
                      +.|+...+||+|.||.||+|+.+ .|++||+|+.-  ..+........+|+++|..++|+|++.+++.|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            45666788999999999999955 68889998753  34555667788999999999999999999887432        


Q ss_pred             CcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEE
Q 002746          626 DFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL  705 (885)
Q Consensus       626 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~k  705 (885)
                      ...++||++|+. +|.-.+.....        .++...+.+++.++.+||.|+|...   |+|||+||+|+|++.+|.+|
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~v--------r~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilk  164 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKV--------RFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILK  164 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccc--------cccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEE
Confidence            246899999964 55555543322        3788899999999999999999987   99999999999999999999


Q ss_pred             EcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCC-CCCCccccchhhHHHHHHHHcCCCCCCccccCCc
Q 002746          706 VSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGL  784 (885)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~  784 (885)
                      |+|||+|+.+....       +......+.++-|..|.+||.+.| ..|+++.|||+-|||+.||+||.+-++...  ..
T Consensus       165 lADFGlar~fs~~~-------n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt--eq  235 (376)
T KOG0669|consen  165 LADFGLARAFSTSK-------NVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT--EQ  235 (376)
T ss_pred             eeccccccceeccc-------ccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh--HH
Confidence            99999998774321       111223455677999999998776 468999999999999999999998876421  11


Q ss_pred             cHHHHHHHhhc----chhhhhhhhhhhhcc------CCChHHHHHHHH--HHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          785 SLHKWVKNHYH----GRLEKVIDSSLLRAS------RDQSPEVKRMWD--VAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       785 ~~~~~~~~~~~----~~~~~~~d~~~~~~~------~~~~~~~~~~~~--~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ...+.+.....    +-++....-.+....      ......++....  .-.++..+++..++..||.+|+++.+++.+
T Consensus       236 qql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  236 QQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             HHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            12222222221    112211111111111      000001110000  012367889999999999999999999986


Q ss_pred             HHHHHHHhcCCCCC
Q 002746          853 LDRLKRYLGEKHMP  866 (885)
Q Consensus       853 L~~l~~~~~~~~~~  866 (885)
                           .++..+.+|
T Consensus       316 -----~~F~kdp~p  324 (376)
T KOG0669|consen  316 -----DFFWKDPMP  324 (376)
T ss_pred             -----hhhhcCCcc
Confidence                 455555555

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.97  E-value=5.8e-33  Score=308.17  Aligned_cols=413  Identities=30%  Similarity=0.376  Sum_probs=317.1

Q ss_pred             CCcccccCCccccCCCCCcEEeCCCCcccccCchhhhCCCCCcEEEccCcccccCCchhhhcCCCCCCEEEcCCCccccc
Q 002746            4 DNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGK   83 (885)
Q Consensus         4 ~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~f~~l~~L~~L~Ls~N~l~~~   83 (885)
                      .|+..+..|..+..+.+|+.|.++.|-|. ..|.+...+.+|++|+|.+|.+. .+|.+ +..+++|++||+|+|++. .
T Consensus        53 snn~~~~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~-~~~lknl~~LdlS~N~f~-~  128 (1081)
T KOG0618|consen   53 SNNQISSFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPAS-ISELKNLQYLDLSFNHFG-P  128 (1081)
T ss_pred             cccccccCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchh-HHhhhcccccccchhccC-C
Confidence            35566788999999999999999999998 78899999999999999999998 89976 799999999999999998 6


Q ss_pred             CCccCCCCCCCcEEEcccc-------------------cCcccCCcccccCccc-eEecccccccCCCChhhhcCCCCCc
Q 002746           84 IPEEIGNCPNLWTLSLYNN-------------------QLTGQLPASLINTSMY-NLDVEYNHLSGELPSDIMSKLPSLT  143 (885)
Q Consensus        84 ~~~~~~~l~~L~~L~L~~N-------------------~l~~~~~~~~~~~~L~-~L~l~~n~l~~~~~~~~~~~l~~L~  143 (885)
                      .|..+..+..+..+..++|                   .+.+.++...  ..++ .|||++|.+. .+.   ...+++|+
T Consensus       129 ~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i--~~l~~~ldLr~N~~~-~~d---ls~~~~l~  202 (1081)
T KOG0618|consen  129 IPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDI--YNLTHQLDLRYNEME-VLD---LSNLANLE  202 (1081)
T ss_pred             CchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcch--hhhheeeecccchhh-hhh---hhhccchh
Confidence            6777777777777777766                   2222222111  2344 4999999996 222   47899999


Q ss_pred             EEECCCCcccCCCCCCCcccccccCCCCCCCcEEEecCcccCccCCCccccccccEEEccCCcccccCCccccCCCCCCe
Q 002746          144 YLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLIS  223 (885)
Q Consensus       144 ~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~p~~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~  223 (885)
                      .|+...|++..+..            ..++|+.|+.+.|.+. ..-..+...+++.++++.|+++. +|+++..+.+|+.
T Consensus       203 ~l~c~rn~ls~l~~------------~g~~l~~L~a~~n~l~-~~~~~p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~  268 (1081)
T KOG0618|consen  203 VLHCERNQLSELEI------------SGPSLTALYADHNPLT-TLDVHPVPLNLQYLDISHNNLSN-LPEWIGACANLEA  268 (1081)
T ss_pred             hhhhhhcccceEEe------------cCcchheeeeccCcce-eeccccccccceeeecchhhhhc-chHHHHhcccceE
Confidence            99999999988653            3468899999999987 33334445589999999999994 5689999999999


Q ss_pred             eeccccccccccchhhcCCCCCCeEecccccccccCcccccCCCCCCeeecccccccccCCccccCCCc-ccEEEccCCc
Q 002746          224 LNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQ-IYSLFLNNNQ  302 (885)
Q Consensus       224 L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~l~~N~  302 (885)
                      |+..+|.++ ..|..+....+|+.|++..|.++ -+|....+++.|+.|+|..|+|...++..|.-+.. |+.|+.+.|+
T Consensus       269 l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~  346 (1081)
T KOG0618|consen  269 LNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNK  346 (1081)
T ss_pred             ecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcc
Confidence            999999997 77888888999999999999999 67778888999999999999998555544444443 6777777777


Q ss_pred             cCCCCCc-ccCCCCCCCEEECcCCcCcccCCccccCccceeeeeeccCCcCCCCchhhhcCCCCcceeecCCCccccccc
Q 002746          303 LSRSIPP-TLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIF  381 (885)
Q Consensus       303 l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~  381 (885)
                      ++ ..|. .=..++.|+.|++.+|.++...-..+.+..+|+ .|+|++|+|...+...+.+++.|++|+||+|+++ .+|
T Consensus       347 l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLK-VLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp  423 (1081)
T KOG0618|consen  347 LS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLK-VLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLP  423 (1081)
T ss_pred             cc-ccccccchhhHHHHHHHHhcCcccccchhhhcccccee-eeeecccccccCCHHHHhchHHhHHHhcccchhh-hhh
Confidence            76 3331 112345677788888888766666677777774 4788888887666667777888888888888887 466


Q ss_pred             cccccCccccEEEecCCccCCCCCCccccccccccccccCcccccccCcccCCCceecEEEccccc
Q 002746          382 IQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNE  447 (885)
Q Consensus       382 ~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~  447 (885)
                      ..+..|..|+.|..-+|+|. ..| .+..++.|+.+|+|.|+|+...-.....-++|++|||++|.
T Consensus       424 ~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  424 DTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT  487 (1081)
T ss_pred             HHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence            77777888888888888877 556 77777888888888888774332222233778888888886

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=235.75  Aligned_cols=271  Identities=21%  Similarity=0.267  Sum_probs=194.5

Q ss_pred             CCcccceecccCcceEEEEE-eCCCCEEEEEEeeecC--CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      +|+..++||+|.||+||+|+ +.+++.||+|..+...  ........+|+-+++.++|+|||++++....+....+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            46677899999999999999 5578899999998653  34467789999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      |. .+|..+.....        ..++......++.|+.+|+.|+|+++   +.|||+||.|.+++.+|+.|++|||+|+.
T Consensus        83 cd-qdlkkyfdsln--------g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglara  150 (292)
T KOG0662|consen   83 CD-QDLKKYFDSLN--------GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARA  150 (292)
T ss_pred             hh-HHHHHHHHhcC--------CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhh
Confidence            94 35665554332        34888899999999999999999998   99999999999999999999999999987


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCCC-CCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      ++-           +........-|..|.+|.++.|.. |+...|+||-||++.|+.....|.-...+-.+++....+..
T Consensus       151 fgi-----------pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~l  219 (292)
T KOG0662|consen  151 FGI-----------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL  219 (292)
T ss_pred             cCC-----------ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHh
Confidence            631           223444556789999999988865 78899999999999999986555321111112222221111


Q ss_pred             hc---chhhh---hhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          794 YH---GRLEK---VIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       794 ~~---~~~~~---~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..   +.++.   .-|-.....+.. .....++.+.....=.+++...+.-+|.+|.++++.+++
T Consensus       220 g~p~ed~wps~t~lpdyk~yp~ypa-ttswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  220 GTPTEDQWPSMTKLPDYKPYPIYPA-TTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CCCccccCCccccCCCCcccCCccc-cchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            10   01111   111111111100 011111112222234567777888899999999998875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-31  Score=277.82  Aligned_cols=256  Identities=21%  Similarity=0.309  Sum_probs=201.1

Q ss_pred             CCcccceecccCcceEEEEEeCCCC-EEEEEEeeec---CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEe
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQDGT-AIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      +++....||-||||.|=++..+... .+|+|+++..   .....+....|-.+|...+.|.||++|..|.++.+.|+.||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            3455678999999999999876433 4888888644   34445678889999999999999999999999999999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      -|-||.+...++....         ++.....-++..+.+|++|||.+|   ||+||+||+|.++|.+|-+||.|||+|+
T Consensus       501 aClGGElWTiLrdRg~---------Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAK  568 (732)
T KOG0614|consen  501 ACLGGELWTILRDRGS---------FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAK  568 (732)
T ss_pred             hhcCchhhhhhhhcCC---------cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHH
Confidence            9999999999986543         777888889999999999999999   9999999999999999999999999999


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHh
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~  793 (885)
                      .+..            +...-..+|||.|.|||++.+...+.+.|.||+|+++||+++|.+||...... ..+....+. 
T Consensus       569 ki~~------------g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-ktYn~ILkG-  634 (732)
T KOG0614|consen  569 KIGS------------GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM-KTYNLILKG-  634 (732)
T ss_pred             Hhcc------------CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHhh-
Confidence            8843            22333579999999999999999999999999999999999999999763111 111111111 


Q ss_pred             hcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHHHHHHHHHhcCCCC
Q 002746          794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT-----MLDAADDLDRLKRYLGEKHM  865 (885)
Q Consensus       794 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~L~~l~~~~~~~~~  865 (885)
                              +|..-       .|      ........+++++..+..|.+|-.     +.|+.+|     +|+..-.|
T Consensus       635 --------id~i~-------~P------r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH-----~Wf~gfdw  685 (732)
T KOG0614|consen  635 --------IDKIE-------FP------RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH-----RWFEGFDW  685 (732)
T ss_pred             --------hhhhh-------cc------cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh-----hhhhcCCh
Confidence                    11100       00      113445778999999999999975     5555554     45554444

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-30  Score=255.46  Aligned_cols=201  Identities=25%  Similarity=0.398  Sum_probs=176.0

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec---CCcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcceE
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFKAL  630 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  630 (885)
                      ..+|...++||+|+|+.|..+++. +.+.+|+|+++..   ..+.....+.|-.+..+. +||.+|.+..+|..+...+.
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            357899999999999999999965 6788999999854   344556777888887776 79999999999999999999


Q ss_pred             EEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccc
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG  710 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg  710 (885)
                      |.||+++|+|--++++.+.         +++..+.-+...|.-||.|||++|   |++||+|.+|+|+|..|++|++|||
T Consensus       329 vieyv~ggdlmfhmqrqrk---------lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdyg  396 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYG  396 (593)
T ss_pred             EEEEecCcceeeehhhhhc---------CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccc
Confidence            9999999999888876653         889999999999999999999999   9999999999999999999999999


Q ss_pred             cceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCcc
Q 002746          711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM  779 (885)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~  779 (885)
                      +++.--.           +.......+|||.|.|||.+.+..|+...|.|++||+++||+.|+.||+-.
T Consensus       397 mcke~l~-----------~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv  454 (593)
T KOG0695|consen  397 MCKEGLG-----------PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV  454 (593)
T ss_pred             hhhcCCC-----------CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence            9873211           123345679999999999999999999999999999999999999999753

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=4.9e-30  Score=286.94  Aligned_cols=272  Identities=17%  Similarity=0.204  Sum_probs=182.9

Q ss_pred             hhCCcccceecccCcceEEEEEe-----------------CCCCEEEEEEeeecCCcchh--------------hHHHHH
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGIL-----------------QDGTAIAVKVLQLQSGNFTK--------------SFNREC  604 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~--------------~~~~E~  604 (885)
                      .++|++.++||+|+||+||+|..                 .+++.||||+++.......+              .+..|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            56899999999999999999964                 23568999998754332222              334577


Q ss_pred             HHHhhcCCccc-----ceeeeeeec--------CCcceEEEecccCCccccccccCCccc---------------cCCCC
Q 002746          605 QVLKRIRHRNL-----MRIITACSL--------PDFKALVLPYMANGSLDSHLYPHSETE---------------FGSGS  656 (885)
Q Consensus       605 ~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~~~---------------~~~~~  656 (885)
                      .++.+++|.++     ++++++|..        .+..++||||+++|+|.++++......               .....
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777776654     667777753        356799999999999999887432110               00011


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecccCCCCCCCCCCCCccccc
Q 002746          657 SDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML  736 (885)
Q Consensus       657 ~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~  736 (885)
                      ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..+....          .......
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~----------~~~~~~g  370 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI----------NFNPLYG  370 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCC----------ccCcccc
Confidence            23578889999999999999999998   9999999999999999999999999997542210          0111122


Q ss_pred             cccccccCCcccCCCCC----------------------CccccchhhHHHHHHHHcCCC-CCCccccCCccHHHHHHHh
Q 002746          737 CGSIGYMAPEYGFGSNT----------------------STKGDVYSFGILVLEMVTRRR-PTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       737 ~gt~~y~aPE~~~~~~~----------------------~~~~Dv~slG~vl~elltg~~-P~~~~~~~~~~~~~~~~~~  793 (885)
                      .+|+.|+|||.+.....                      ..+.||||+||++|+|++|.. ||.........+..     
T Consensus       371 ~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~-----  445 (507)
T PLN03224        371 MLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ-----  445 (507)
T ss_pred             CCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh-----
Confidence            35789999998754321                      134799999999999999975 76532110000000     


Q ss_pred             hcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCC---CCCCCHHHHHHH
Q 002746          794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESP---STRPTMLDAADD  852 (885)
Q Consensus       794 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPt~~ev~~~  852 (885)
                      +......+ .. ......+. +    .++..+++..+++.+|+..+|   .+|+|++|+++|
T Consensus       446 ~~~~~~~~-r~-~~~~~~~~-~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        446 YDNDLNRW-RM-YKGQKYDF-S----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             ccchHHHH-Hh-hcccCCCc-c----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            00000000 00 00000000 0    133355678899999999766   689999999986

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=5.8e-30  Score=294.54  Aligned_cols=271  Identities=20%  Similarity=0.210  Sum_probs=170.5

Q ss_pred             HhhCCcccceecccCcceEEEEEeC-C----CCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeee------ee
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ-D----GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA------CS  623 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------~~  623 (885)
                      ..++|++.+.||+|+||.||+|++. +    +..||||++.....  .+.+..|  .+....+.++..++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4578999999999999999999975 4    68999998763221  1111111  1122222233222221      24


Q ss_pred             cCCcceEEEecccCCccccccccCCcc----cc--C-----CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCC
Q 002746          624 LPDFKALVLPYMANGSLDSHLYPHSET----EF--G-----SGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLK  692 (885)
Q Consensus       624 ~~~~~~lV~e~~~~gsL~~~l~~~~~~----~~--~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk  692 (885)
                      .+...++||||+++++|.+++......    ++  +     ..........+..++.|++.||+|||+++   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            566789999999999999888643210    00  0     00001223445679999999999999998   9999999


Q ss_pred             CCceEecC-CCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC--------------------
Q 002746          693 PSNVLLND-DMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS--------------------  751 (885)
Q Consensus       693 p~NILl~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------------------  751 (885)
                      |+|||++. ++.+||+|||+|+.+...          .........+++.|+|||.+...                    
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~----------~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~  352 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVG----------INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLW  352 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccc----------cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhc
Confidence            99999985 589999999999865321          01122345789999999964322                    


Q ss_pred             --CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcc--hhhhhhhhhhhhccCCChHHHH---HHHHHH
Q 002746          752 --NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHG--RLEKVIDSSLLRASRDQSPEVK---RMWDVA  824 (885)
Q Consensus       752 --~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~~~~~~~~~~~~~~~---~~~~~~  824 (885)
                        .++.++|||||||++|||+++..|++..      ...+.......  ....+. ......   ..+...   ...+..
T Consensus       353 ~~~~~~k~DVwSlGviL~el~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~-~~~~~~---~~~~~~~~~~~~d~~  422 (566)
T PLN03225        353 QLNLPDRFDIYSAGLIFLQMAFPNLRSDSN------LIQFNRQLKRNDYDLVAWR-KLVEPR---ASPDLRRGFEVLDLD  422 (566)
T ss_pred             cccCCCCcccHHHHHHHHHHHhCcCCCchH------HHHHHHHHHhcCCcHHHHH-Hhhccc---cchhhhhhhhhcccc
Confidence              2345679999999999999987775431      11111110000  000000 000000   001101   111112


Q ss_pred             HHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          825 IGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       825 ~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .....+++.+|++.||++|||++|+++|
T Consensus       423 ~~~~~dLi~~mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        423 GGAGWELLKSMMRFKGRQRISAKAALAH  450 (566)
T ss_pred             chHHHHHHHHHccCCcccCCCHHHHhCC
Confidence            2345689999999999999999999996

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=8.6e-30  Score=265.59  Aligned_cols=239  Identities=27%  Similarity=0.374  Sum_probs=191.2

Q ss_pred             CcceEEEEEeC-CCCEEEEEEeeecCCcc-hhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCCcccccccc
Q 002746          569 SYGRVYKGILQ-DGTAIAVKVLQLQSGNF-TKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYP  646 (885)
Q Consensus       569 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~  646 (885)
                      +||.||+|... +++.+|+|++....... .+.+.+|++.+++++|++++++++++......++|+||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999987 48999999997654433 68899999999999999999999999998999999999999999998864


Q ss_pred             CCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecccCCCCCCC
Q 002746          647 HSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE  726 (885)
Q Consensus       647 ~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  726 (885)
                      ...         +++..++.++.+++.++.|||+.+   |+|+||+|+||+++.++.++++|||.+.......       
T Consensus        81 ~~~---------~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-------  141 (244)
T smart00220       81 RGR---------LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-------  141 (244)
T ss_pred             ccC---------CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc-------
Confidence            331         788999999999999999999998   9999999999999999999999999998764311       


Q ss_pred             CCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhhhhhhhhh
Q 002746          727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSL  806 (885)
Q Consensus       727 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  806 (885)
                           ......++..|++||...+..++.++||||||+++|++++|..||.....    ..........           
T Consensus       142 -----~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~----~~~~~~~~~~-----------  201 (244)
T smart00220      142 -----LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ----LLELFKKIGK-----------  201 (244)
T ss_pred             -----ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHhc-----------
Confidence                 22334678899999999888899999999999999999999999865211    1111111000           


Q ss_pred             hhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          807 LRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       807 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                        ........    ...++.++.+++.+|+..+|++||++.+++++
T Consensus       202 --~~~~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      202 --PKPPFPPP----EWKISPEAKDLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             --cCCCCccc----cccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence              00000000    00034568999999999999999999999873

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=1e-30  Score=241.85  Aligned_cols=211  Identities=27%  Similarity=0.319  Sum_probs=167.4

Q ss_pred             HHHHhhCCcccceecccCcceEEEEEe-CCCCEEEEEEeeecC-CcchhhHHHHHHHHhh-cCCcccceeeeeeecCCcc
Q 002746          552 LLEATAEFDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQS-GNFTKSFNRECQVLKR-IRHRNLMRIITACSLPDFK  628 (885)
Q Consensus       552 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~  628 (885)
                      +....+.......||+|++|.|-+-++ .+|...|+|.++... .+..++...|+.+..+ ...|.+|.+||........
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            333445556667899999999988875 479999999998553 3345667778887544 4799999999999999999


Q ss_pred             eEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcc
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSD  708 (885)
Q Consensus       629 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~D  708 (885)
                      ++.||.| .-||+.+.+..-.     .+..+++...-+||..+.+||.|||++-  .|+|||+||+|||++.+|++|+||
T Consensus       121 wIcME~M-~tSldkfy~~v~~-----~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCD  192 (282)
T KOG0984|consen  121 WICMELM-DTSLDKFYRKVLK-----KGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICD  192 (282)
T ss_pred             EEeHHHh-hhhHHHHHHHHHh-----cCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcc
Confidence            9999999 4577665543211     2334888889999999999999999974  699999999999999999999999


Q ss_pred             cccceeeecccCCCCCCCCCCCCccccccccccccCCcccCC----CCCCccccchhhHHHHHHHHcCCCCCCccccC
Q 002746          709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG----SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAG  782 (885)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~  782 (885)
                      ||.+-.+..            +...+.-.|...|||||.+..    ..|+-|+||||+|+.+.||.+++.||+..+..
T Consensus       193 FGIsG~L~d------------SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp  258 (282)
T KOG0984|consen  193 FGISGYLVD------------SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP  258 (282)
T ss_pred             cccceeehh------------hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence            999876632            122223568889999997643    47899999999999999999999999864333

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=2.2e-30  Score=243.01  Aligned_cols=267  Identities=20%  Similarity=0.286  Sum_probs=202.6

Q ss_pred             hhCCcccceecccCcceEEEEE-eCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcC-CcccceeeeeeecCC--cceEE
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIR-HRNLMRIITACSLPD--FKALV  631 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~~~lV  631 (885)
                      .++|++.+++|+|.++.||.|. ..+.++++||++++-   ..+.+.+|+.+|..++ ||||+++++.+.++.  ...+|
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            4688999999999999999998 557899999999843   3578899999999997 999999999997765  44699


Q ss_pred             EecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecC-CCCEEEcccc
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND-DMTALVSDFG  710 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfg  710 (885)
                      +||+.+.+......            .++...+...+.+++.||.|+|++|   |+|||+||.|+|+|. .-.++|+|+|
T Consensus       114 FE~v~n~Dfk~ly~------------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWG  178 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYP------------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWG  178 (338)
T ss_pred             hhhhccccHHHHhh------------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecc
Confidence            99998877766543            2667778889999999999999999   999999999999994 5679999999


Q ss_pred             cceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHH
Q 002746          711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKW  789 (885)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~  789 (885)
                      +|.++.+            ......++.+..|-.||.+-.- .|+..-|+|||||++..|+..+.||-...+.-+++.+.
T Consensus       179 LAEFYHp------------~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkI  246 (338)
T KOG0668|consen  179 LAEFYHP------------GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKI  246 (338)
T ss_pred             hHhhcCC------------CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHH
Confidence            9998854            2233445677889999987554 57888999999999999999999986544444555555


Q ss_pred             HHHhhcchhhhhhh-------hhhhh----ccCCChHHHHH--HHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          790 VKNHYHGRLEKVID-------SSLLR----ASRDQSPEVKR--MWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       790 ~~~~~~~~~~~~~d-------~~~~~----~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ++-...+++...+.       +...+    ..+..-.....  --.-+.+++.+++...+..|..+|||++|+.++
T Consensus       247 akVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  247 AKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            44444433333222       11111    11100000000  001134678999999999999999999999886

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=7e-30  Score=271.07  Aligned_cols=215  Identities=21%  Similarity=0.275  Sum_probs=174.7

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      .-|..++.||-|+||.|.+++.. +...||+|.++..+   .......+.|-+||+.-+.+=||++|..|.+.+..|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            45777889999999999999844 46678999887543   233456788999999999999999999999999999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||++||++-.+|.+...         +.+..+.-++.++..|+++.|+.|   +|||||||+|||+|.||++||+|||++
T Consensus       709 dYIPGGDmMSLLIrmgI---------FeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLC  776 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGI---------FEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLC  776 (1034)
T ss_pred             eccCCccHHHHHHHhcc---------CHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccc
Confidence            99999999888875542         777777888889999999999999   999999999999999999999999999


Q ss_pred             eeeecc--------cCCCCCCC-----------------------CCCCCccccccccccccCCcccCCCCCCccccchh
Q 002746          713 KLVMTV--------GVGNDGAE-----------------------NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYS  761 (885)
Q Consensus       713 ~~~~~~--------~~~~~~~~-----------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s  761 (885)
                      +-+...        +.+.....                       ......+-..+||+.|+|||++....++.-||+||
T Consensus       777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws  856 (1034)
T KOG0608|consen  777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWS  856 (1034)
T ss_pred             ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhH
Confidence            765421        11110000                       00011112357999999999999999999999999


Q ss_pred             hHHHHHHHHcCCCCCCccccCC
Q 002746          762 FGILVLEMVTRRRPTDDMFAGG  783 (885)
Q Consensus       762 lG~vl~elltg~~P~~~~~~~~  783 (885)
                      .|||||||+.|+.||.+...++
T Consensus       857 ~gvil~em~~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  857 VGVILYEMLVGQPPFLADTPGE  878 (1034)
T ss_pred             hhHHHHHHhhCCCCccCCCCCc
Confidence            9999999999999997754443

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-29  Score=266.23  Aligned_cols=197  Identities=21%  Similarity=0.363  Sum_probs=170.8

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC--------cchhhHHHHHHHHhhcC---Ccccceeeeeee
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG--------NFTKSFNRECQVLKRIR---HRNLMRIITACS  623 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~~~~~~~  623 (885)
                      -.+|...+.+|+|+||.|+.|.++ +...|+||.+.+.+-        ........|+++|+.++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            356888999999999999999977 466788998864421        11223457999999997   999999999999


Q ss_pred             cCCcceEEEeccc-CCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCC
Q 002746          624 LPDFKALVLPYMA-NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDM  702 (885)
Q Consensus       624 ~~~~~~lV~e~~~-~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~  702 (885)
                      +++.++++||-.. +-+|.+++..+..         +++..+..|++||+.|+++||++|   |||||||-+||.++.+|
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp~---------m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g  707 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKPR---------MDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNG  707 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccCc---------cchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCC
Confidence            9999999999864 4588888876653         889999999999999999999999   99999999999999999


Q ss_pred             CEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCC-CccccchhhHHHHHHHHcCCCCCC
Q 002746          703 TALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRRRPTD  777 (885)
Q Consensus       703 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~P~~  777 (885)
                      -+||+|||.|...             ++.+....+||.+|.|||++.|..| +...|||++|++||.++....||-
T Consensus       708 ~~klidfgsaa~~-------------ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  708 FVKLIDFGSAAYT-------------KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eEEEeeccchhhh-------------cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999999999765             4567778899999999999999988 677899999999999999999974

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=7.2e-30  Score=281.26  Aligned_cols=248  Identities=26%  Similarity=0.391  Sum_probs=186.8

Q ss_pred             cccceecccCcc-eEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcceEEEecccC
Q 002746          560 DEQRLLGTGSYG-RVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       560 ~~~~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~  637 (885)
                      .-.+++|.|+.| .||+|... |+.||||++-   .+......+|+..++.- +|||||++++.-.++...|++.|.| .
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll---~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~  586 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVYE-GREVAVKRLL---EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-A  586 (903)
T ss_pred             ccHHHcccCCCCcEEEEEeeC-CceehHHHHh---hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-h
Confidence            344678999997 68999986 8899999875   33345678999999887 6999999999988899999999999 5


Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecC---C--CCEEEcccccc
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND---D--MTALVSDFGIA  712 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~--~~~kl~Dfg~a  712 (885)
                      .+|.+++... ..++..    ......+.+..|+++||++||+.+   ||||||||.|||++.   +  ..++|+|||++
T Consensus       587 ~sL~dlie~~-~~d~~~----~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls  658 (903)
T KOG1027|consen  587 CSLQDLIESS-GLDVEM----QSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLS  658 (903)
T ss_pred             hhHHHHHhcc-ccchhh----cccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccc
Confidence            6999988764 111111    111344678899999999999988   999999999999975   3  57899999999


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcC-CCCCCccccCCccHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg-~~P~~~~~~~~~~~~~~~~  791 (885)
                      +.+....      .  .-.......||-||+|||++....-+.+.||||+||++|+.++| .+||.+....+..   .+.
T Consensus       659 Kkl~~~~------s--S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N---Il~  727 (903)
T KOG1027|consen  659 KKLAGGK------S--SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN---ILT  727 (903)
T ss_pred             cccCCCc------c--hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh---hhc
Confidence            9885421      1  11224566899999999999999889999999999999999996 8999764222100   000


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..+          .+. ..       ... +.+  +..++|.+|+.+||..||++.+|+.|
T Consensus       728 ~~~----------~L~-~L-------~~~-~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  728 GNY----------TLV-HL-------EPL-PDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             Ccc----------cee-ee-------ccC-chH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            000          000 00       000 011  68899999999999999999999864

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-28  Score=254.60  Aligned_cols=133  Identities=25%  Similarity=0.427  Sum_probs=111.5

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcC-----C---cccceeeeeeec--
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIR-----H---RNLMRIITACSL--  624 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~--  624 (885)
                      ..+|.+.++||.|.|++||+|.+. ..+.||+|+.+. .....+....|+++|++++     |   .+||+++++|.-  
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            478999999999999999999954 678899999873 3455677889999999983     3   369999999853  


Q ss_pred             --CCcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEec
Q 002746          625 --PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN  699 (885)
Q Consensus       625 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~  699 (885)
                        ..+.+||+|++ |.+|..++......       .++.....+|+.||+.||.|||.++  +|||.||||+|||+.
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~Yr-------Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYR-------GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCC-------CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence              45789999998 66777777654432       2899999999999999999999987  699999999999993

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.95  E-value=2.4e-30  Score=261.61  Aligned_cols=413  Identities=20%  Similarity=0.230  Sum_probs=225.5

Q ss_pred             ccccCCccccCCCCCcEEeCCCCcccccCchhhhCCCCCcEEEccCcccccCCchhhhcCCCCCCEEEcCC-CcccccCC
Q 002746            7 LFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQ-NFFTGKIP   85 (885)
Q Consensus         7 ~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~f~~l~~L~~L~Ls~-N~l~~~~~   85 (885)
                      -..++|..+..  ....+.|..|+|+.+.+.+|+.+++|++||||+|+|+ .+...+|.++.+|..|-+-+ |+|+.+..
T Consensus        57 GL~eVP~~LP~--~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is-~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k  133 (498)
T KOG4237|consen   57 GLTEVPANLPP--ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNIS-FIAPDAFKGLASLLSLVLYGNNKITDLPK  133 (498)
T ss_pred             CcccCcccCCC--cceEEEeccCCcccCChhhccchhhhceecccccchh-hcChHhhhhhHhhhHHHhhcCCchhhhhh
Confidence            34445555443  4566667777776666666777777777777777776 45555666666665554444 67766666


Q ss_pred             ccCCCCCCCcEEEcccccCcccCCccccc-CccceEecccccccCCCChhhhcCCCCCcEEECCCCcccCCCCCCCccc-
Q 002746           86 EEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVP-  163 (885)
Q Consensus        86 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~-  163 (885)
                      ++|++|..|+.|.+.-|++.-...+.+.. .++..|.+-+|.+. .++...|..+..++.+++..|.+.....-.++.. 
T Consensus       134 ~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~  212 (498)
T KOG4237|consen  134 GAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADD  212 (498)
T ss_pred             hHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchhhhH
Confidence            66777777777777666666333333332 23333333444443 5555556666666666666665332211110000 


Q ss_pred             ---ccccCCCCCCCcEEEecCcccCccCCCccccc--cccEEEccCCcccccCC-ccccCCCCCCeeeccccccccccch
Q 002746          164 ---FFNSLGNCTDLEELELAGMDLGGTLPDSIGRL--NLTQLLLQENKITGSIP-PHIGNLSNLISLNLSSNLLSGTISA  237 (885)
Q Consensus       164 ---~~~~l~~l~~L~~L~l~~~~l~~~~p~~~~~~--~L~~L~l~~n~i~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~  237 (885)
                         ....++......-..+...++.+.-+.-+...  .+..=..+.+...++-| ..|..+++|++|+|++|+|+++.+.
T Consensus       213 ~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~  292 (498)
T KOG4237|consen  213 LAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDG  292 (498)
T ss_pred             HhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhh
Confidence               01122233333333333333333322222211  11111122232322333 3467777777777777777777777


Q ss_pred             hhcCCCCCCeEecccccccccCcccccCCCCCCeeecccccccccCCccccCCCcccEEEccCCccC-------------
Q 002746          238 EISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLS-------------  304 (885)
Q Consensus       238 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-------------  304 (885)
                      +|.++..+++|.|..|+|..+-...|.++..|+.|+|++|+|+...|.+|..+..|.+|+|-.|.+.             
T Consensus       293 aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr  372 (498)
T KOG4237|consen  293 AFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLR  372 (498)
T ss_pred             hhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHh
Confidence            7777777777777777777666667777777777777777777777777777777777777766652             


Q ss_pred             --CCC-CcccCCCCCCCEEECcCCcCcc---cCCccccCccceeeeeeccCCcCCCCchhhhcCCCCcce-eecCCCccc
Q 002746          305 --RSI-PPTLGRCTDLYKLDLSYNRLTG---SIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQE-IDLSSNKFT  377 (885)
Q Consensus       305 --~~~-~~~~~~l~~L~~L~l~~N~l~~---~~~~~~~~l~~l~~~L~L~~N~l~~~~p~~~~~l~~L~~-L~Ls~N~l~  377 (885)
                        +.. ..--++-..++.++++.+.+..   ..|+...-             .-++.-|.   ..+-+.+ ..-|++.++
T Consensus       373 ~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~-------------~~s~~cP~---~c~c~~tVvRcSnk~lk  436 (498)
T KOG4237|consen  373 KKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGC-------------LTSSPCPP---PCTCLDTVVRCSNKLLK  436 (498)
T ss_pred             hCCCCCCCCCCCCchhccccchhccccccccCCccccCC-------------CCCCCCCC---CcchhhhhHhhcccchh
Confidence              000 0001112234455555544431   11111110             00011111   1122222 223333333


Q ss_pred             cccccccccCccccEEEecCCccCCCCCCccccccccccccccCcccccccCcccCCCceecEEEcccc
Q 002746          378 GNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFN  446 (885)
Q Consensus       378 ~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N  446 (885)
                       .+|..+.  .....|++.+|.++ .+|+.  .+..| .+|+++|+|...-...|.++..|.+|-|++|
T Consensus       437 -~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  437 -LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             -hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence             3444332  24556777788877 56665  56677 8888888888777778888888888888876

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.95  E-value=6.9e-30  Score=258.37  Aligned_cols=400  Identities=22%  Similarity=0.262  Sum_probs=263.2

Q ss_pred             EeCCCCcccccCchhhhCCCCCcEEEccCcccccCCchhhhcCCCCCCEEEcCCCcccccCCccCCCCCCCcEEEccc-c
Q 002746           24 LQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYN-N  102 (885)
Q Consensus        24 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~f~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N  102 (885)
                      .+-++-.++ .+|..+-  ..-+.++|..|+|+ .+|..+|+.+.+|+.||||+|.|+.+.|++|.+|++|.+|-+.+ |
T Consensus        51 VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N  126 (498)
T KOG4237|consen   51 VDCRGKGLT-EVPANLP--PETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN  126 (498)
T ss_pred             EEccCCCcc-cCcccCC--CcceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence            455666676 6676554  56788999999999 89999999999999999999999999999999999998888877 9


Q ss_pred             cCcccCCccccc-CccceEecccccccCCCChhhhcCCCCCcEEECCCCcccCCCCCCCcccccccCCCCCCCcEEEecC
Q 002746          103 QLTGQLPASLIN-TSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAG  181 (885)
Q Consensus       103 ~l~~~~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~l~~  181 (885)
                      +|+......|.. .+++.|.+.-|++. .++.++|..|++|..|.+.+|.+.++..++        |..+..++.+++..
T Consensus       127 kI~~l~k~~F~gL~slqrLllNan~i~-Cir~~al~dL~~l~lLslyDn~~q~i~~~t--------f~~l~~i~tlhlA~  197 (498)
T KOG4237|consen  127 KITDLPKGAFGGLSSLQRLLLNANHIN-CIRQDALRDLPSLSLLSLYDNKIQSICKGT--------FQGLAAIKTLHLAQ  197 (498)
T ss_pred             chhhhhhhHhhhHHHHHHHhcChhhhc-chhHHHHHHhhhcchhcccchhhhhhcccc--------ccchhccchHhhhc
Confidence            999666666665 67889999999998 899999999999999999999999988763        78888889888888


Q ss_pred             cccC------------ccCCCcccccc-ccEEEccCCcccccCCccccC-CCCCCe-eeccccccccccchhhcCCCCCC
Q 002746          182 MDLG------------GTLPDSIGRLN-LTQLLLQENKITGSIPPHIGN-LSNLIS-LNLSSNLLSGTISAEISWLSQLE  246 (885)
Q Consensus       182 ~~l~------------~~~p~~~~~~~-L~~L~l~~n~i~~~~~~~~~~-l~~L~~-L~l~~N~l~~~~~~~~~~l~~L~  246 (885)
                      |.+.            ...|-.++... ..-..+.+.++..+.+..|.. +..+.+ +.-..+.....+...|..+++|+
T Consensus       198 np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~  277 (498)
T KOG4237|consen  198 NPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLR  277 (498)
T ss_pred             CccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccce
Confidence            7731            11222222111 112223334444333333321 112211 12222223323334577777777


Q ss_pred             eEecccccccccCcccccCCCCCCeeecccccccccCCccccCCCcccEEEccCCccCCCCCcccCCCCCCCEEECcCCc
Q 002746          247 QLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNR  326 (885)
Q Consensus       247 ~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~  326 (885)
                      .|+|++|+|+.+-+.+|.++..+++|.|..|+|..+....|.++..|+.|+|.+|+|+..-|.+|..+..|.+|+|-.|.
T Consensus       278 ~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np  357 (498)
T KOG4237|consen  278 KLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNP  357 (498)
T ss_pred             EeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCc
Confidence            77777777777777777777777777777777776666677777777777777777776667777777777777777776


Q ss_pred             CcccCCccccCccceeeeeeccCCcCCCCchhhhcCCCCcceeecCCCcccc---cccccc---------ccCcccc-EE
Q 002746          327 LTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTG---NIFIQI---------SNCIAVR-LI  393 (885)
Q Consensus       327 l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~---~~~~~~---------~~l~~L~-~L  393 (885)
                      +.-.     ..+.-+..+  |..+.-.|.+|  -+.=..++.+.++.+.+..   ..|...         ..++-+. ..
T Consensus       358 ~~Cn-----C~l~wl~~W--lr~~~~~~~~~--Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVv  428 (498)
T KOG4237|consen  358 FNCN-----CRLAWLGEW--LRKKSVVGNPR--CQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVV  428 (498)
T ss_pred             ccCc-----cchHHHHHH--HhhCCCCCCCC--CCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhH
Confidence            6411     001001111  11222111111  1112245566666665531   122221         1233333 23


Q ss_pred             EecCCccCCCCCCccccccccccccccCcccccccCcccCCCceecEEEcccccccccC
Q 002746          394 NISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMI  452 (885)
Q Consensus       394 ~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  452 (885)
                      ..|++.++ .+|..+-  ..-++|++.+|.++ .+|..  .+.+| .+|+++|++..+-
T Consensus       429 RcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Ls  480 (498)
T KOG4237|consen  429 RCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLS  480 (498)
T ss_pred             hhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhh
Confidence            45666665 5665443  45788999999999 66666  67788 8999999998653

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.7e-29  Score=241.36  Aligned_cols=268  Identities=21%  Similarity=0.297  Sum_probs=189.4

Q ss_pred             cccceecccCcceEEEEEeC-CCCEEEEEEeeec--CCcchhhHHHHHHHHhhcCCcccceeeeeeecCC-----cceEE
Q 002746          560 DEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPD-----FKALV  631 (885)
Q Consensus       560 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lV  631 (885)
                      +-.+.||.|+||+||.+++. +|+.||.|++...  .-...+.+.+|.+++.-++|.|++..++....+.     +.|+|
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            44578999999999999954 8999999988633  2234577889999999999999998887765442     45678


Q ss_pred             EecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccc
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       632 ~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~  711 (885)
                      +|.|. .+|...+-.-         ..++.....-+..||.+||.|||+.+   |.||||||-|.|++.+..+||||||+
T Consensus       136 TELmQ-SDLHKIIVSP---------Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGL  202 (449)
T KOG0664|consen  136 TELMQ-SDLHKIIVSP---------QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGL  202 (449)
T ss_pred             HHHHH-hhhhheeccC---------CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccc
Confidence            88884 4666655422         23777788889999999999999998   99999999999999999999999999


Q ss_pred             ceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHH
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~  790 (885)
                      |+.....          .....+...-|..|.|||.+.|. .|+.+.||||+||++.|++..+.-|+....  ....+.+
T Consensus       203 ARvee~d----------~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P--iqQL~lI  270 (449)
T KOG0664|consen  203 ARTWDQR----------DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP--IEQLQMI  270 (449)
T ss_pred             ccccchh----------hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh--HHHHHHH
Confidence            9875332          12223334568899999998886 589999999999999999998888865211  1112222


Q ss_pred             HHhhcchhhhhhh-------hhhhhccCCChHHHHHHHH-----HHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 002746          791 KNHYHGRLEKVID-------SSLLRASRDQSPEVKRMWD-----VAIGELIELGILCTQESPSTRPTMLDAADDL  853 (885)
Q Consensus       791 ~~~~~~~~~~~~d-------~~~~~~~~~~~~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  853 (885)
                      .+.......+...       ..+.+... ..|.....+.     ..-.+...+...++..||+.|.+.++.+.+.
T Consensus       271 tdLLGTPs~EaMr~ACEGAk~H~LR~~~-k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  271 IDLLGTPSQEAMKYACEGAKNHVLRAGL-RAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHHhCCCcHHHHHHHhhhhHHHhhccCC-CCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            2222221111111       11111111 1111111111     1123466778889999999999999998875

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-27  Score=236.71  Aligned_cols=263  Identities=22%  Similarity=0.279  Sum_probs=194.3

Q ss_pred             hCCcccceecccCcceEEEEEeC-CCCEEEEEEeeec--CCcchhhHHHHHHHHhhcCCcccceeeeeeecCC------c
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPD------F  627 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~  627 (885)
                      .+|.-.+.+|.|+- .|..|.+. .++.||+|+....  .....++..+|..++..++|+|+++++.+|....      .
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46777788998888 66666543 6889999987533  2344677889999999999999999999986543      5


Q ss_pred             ceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEc
Q 002746          628 KALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVS  707 (885)
Q Consensus       628 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~  707 (885)
                      .|+||||| .++|...+...           ++-.....|..|+..|++|||+.|   |+||||||+||++..++.+||.
T Consensus        96 ~y~v~e~m-~~nl~~vi~~e-----------lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~  160 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVILME-----------LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKIL  160 (369)
T ss_pred             HHHHHHhh-hhHHHHHHHHh-----------cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeec
Confidence            68999999 56777776622           667788899999999999999999   9999999999999999999999


Q ss_pred             ccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHH
Q 002746          708 DFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH  787 (885)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~  787 (885)
                      |||+|+.-..            .-..+....|..|.|||++.+..+.+..||||+||++.||++|+.-|.    +...+.
T Consensus       161 dfg~ar~e~~------------~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~----g~d~id  224 (369)
T KOG0665|consen  161 DFGLARTEDT------------DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP----GKDHID  224 (369)
T ss_pred             cchhhcccCc------------ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec----CchHHH
Confidence            9999974311            123445678999999999999999999999999999999999998774    455666


Q ss_pred             HHHHHhhcch--hhhhhhhhhhh---ccCCChHH-----HHHH-----H-------HHHHHHHHHHHhhhcCCCCCCCCC
Q 002746          788 KWVKNHYHGR--LEKVIDSSLLR---ASRDQSPE-----VKRM-----W-------DVAIGELIELGILCTQESPSTRPT  845 (885)
Q Consensus       788 ~~~~~~~~~~--~~~~~d~~~~~---~~~~~~~~-----~~~~-----~-------~~~~~~l~~l~~~cl~~dP~~RPt  845 (885)
                      +|.+....-.  -..+.+ .+..   .+....++     ..+.     |       ..-...+.+++.+|+..+|++|.+
T Consensus       225 Q~~ki~~~lgtpd~~F~~-qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ris  303 (369)
T KOG0665|consen  225 QWNKIIEQLGTPDPSFMK-QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRIS  303 (369)
T ss_pred             HHHHHHHHhcCCCHHHHH-HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhccc
Confidence            6654332111  011111 0000   00000000     0000     0       011234789999999999999999


Q ss_pred             HHHHHHH
Q 002746          846 MLDAADD  852 (885)
Q Consensus       846 ~~ev~~~  852 (885)
                      +++++.|
T Consensus       304 v~daL~H  310 (369)
T KOG0665|consen  304 VDDALRH  310 (369)
T ss_pred             HHHHhcC
Confidence            9999986

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.5e-27  Score=229.80  Aligned_cols=252  Identities=19%  Similarity=0.273  Sum_probs=188.8

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhc-CCcccceeee-eeecCCcceEEE
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLMRIIT-ACSLPDFKALVL  632 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~-~~~~~~~~~lV~  632 (885)
                      .+.|.+.+.+|+|.||.+-+|.++ +.+.+|+|.++... ...++|.+|.-.=-.+ .|.||+.-|+ .|+..+.++.++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            467999999999999999999976 67889999887432 2357788887764444 6899998875 567778888999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEec--CCCCEEEcccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN--DDMTALVSDFG  710 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~--~~~~~kl~Dfg  710 (885)
                      ||++.|+|.+-+...          .+.+.....++.|+++|+.|||++.   +||||||.+|||+-  +..++|+||||
T Consensus       102 E~aP~gdL~snv~~~----------GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG  168 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAA----------GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFG  168 (378)
T ss_pred             ccCccchhhhhcCcc----------cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecc
Confidence            999999998877543          2667778899999999999999998   99999999999994  44689999999


Q ss_pred             cceeeecccCCCCCCCCCCCCccccccccccccCCcccCCC-----CCCccccchhhHHHHHHHHcCCCCCCccccCCcc
Q 002746          711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-----NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLS  785 (885)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~  785 (885)
                      ..+..+.              ......-+..|.+||.....     .+.+.+|||.||+++|.++||+.||+...-.+..
T Consensus       169 ~t~k~g~--------------tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~  234 (378)
T KOG1345|consen  169 LTRKVGT--------------TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP  234 (378)
T ss_pred             cccccCc--------------eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch
Confidence            9986532              11222345679999974432     3478899999999999999999999875555566


Q ss_pred             HHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          786 LHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       786 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      +.+|.+-....                 .+.+++.+...++.+..+.++-+.++|++|=...++.++
T Consensus       235 Y~~~~~w~~rk-----------------~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  235 YWEWEQWLKRK-----------------NPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             HHHHHHHhccc-----------------CccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence            66654322111                 011122223345567888888999999999444444443

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=3e-26  Score=233.16  Aligned_cols=210  Identities=31%  Similarity=0.549  Sum_probs=180.6

Q ss_pred             ecccCcceEEEEEeCC-CCEEEEEEeeecCCc-chhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCCcccc
Q 002746          565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGN-FTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDS  642 (885)
Q Consensus       565 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL~~  642 (885)
                      ||+|++|.||++.... ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999764 899999998755332 34779999999999999999999999999899999999999999999


Q ss_pred             ccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecC-CCCEEEcccccceeeecccCC
Q 002746          643 HLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND-DMTALVSDFGIAKLVMTVGVG  721 (885)
Q Consensus       643 ~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~~kl~Dfg~a~~~~~~~~~  721 (885)
                      ++....        ..+++..+..++.++++++++||+.+   ++|+||+|.||+++. ++.++|+|||.+.......  
T Consensus        81 ~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~--  147 (215)
T cd00180          81 LLKENE--------GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK--  147 (215)
T ss_pred             HHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc--
Confidence            886542        13788999999999999999999998   999999999999999 8999999999998663211  


Q ss_pred             CCCCCCCCCCccccccccccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhhh
Q 002746          722 NDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEK  800 (885)
Q Consensus       722 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  800 (885)
                               .......+...|++||..... ..+.++|+|++|++++++                               
T Consensus       148 ---------~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------  187 (215)
T cd00180         148 ---------SLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------  187 (215)
T ss_pred             ---------chhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------
Confidence                     012234577899999998877 788999999999999999                               


Q ss_pred             hhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          801 VIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       801 ~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                                               ..+.+++.+|++.+|++||++.+++++
T Consensus       188 -------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -------------------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                                     137788899999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=7.1e-28  Score=258.52  Aligned_cols=253  Identities=23%  Similarity=0.368  Sum_probs=201.4

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      ..+|+..+.+|.|.+|.||+|+.. +++..|||+++........-..+|+-+++..+|||||.++|.+...+..+++|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            357888999999999999999954 7999999999988888888889999999999999999999999999999999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      |.+|+|.+..+...         ++++.++..+++...+|++|||.+|   -+|||||-.||++++.|.+|++|||.+-.
T Consensus        94 cgggslQdiy~~Tg---------plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaq  161 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQ  161 (829)
T ss_pred             cCCCcccceeeecc---------cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhh
Confidence            99999998876433         4899999999999999999999998   89999999999999999999999998865


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCccc---CCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYG---FGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      +...           -.......||+.|||||+.   ..+.|...+|||+.|+...|+-.-++|.-+....   ..-++.
T Consensus       162 itat-----------i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm---r~l~Lm  227 (829)
T KOG0576|consen  162 ITAT-----------IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM---RALFLM  227 (829)
T ss_pred             hhhh-----------hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH---HHHHHh
Confidence            5321           1223456899999999974   4567899999999999999998888885332111   000000


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAAD  851 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~  851 (885)
                      ..      ...++.-.     ..+   .   ...+-+-++++.|+..+|++||+++.++.
T Consensus       228 Tk------S~~qpp~l-----kDk---~---kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  228 TK------SGFQPPTL-----KDK---T---KWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             hc------cCCCCCcc-----cCC---c---cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            00      00010000     000   0   13445889999999999999999987765

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=2e-27  Score=244.30  Aligned_cols=284  Identities=23%  Similarity=0.298  Sum_probs=204.2

Q ss_pred             HHHHhhCCcccceecccCcceEEEEEeC----CCCEEEEEEeeecCCcchhhHHHHHHHHhhc-CCcccceeeeeeecCC
Q 002746          552 LLEATAEFDEQRLLGTGSYGRVYKGILQ----DGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLMRIITACSLPD  626 (885)
Q Consensus       552 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  626 (885)
                      +......|.+.++||+|.|++||+|.+.    .++.||+|.+....  ...+...|+++|..+ -+.||+++.+++...+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3445667899999999999999999844    47889999886443  346789999999998 5899999999999999


Q ss_pred             cceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecC-CCCEE
Q 002746          627 FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND-DMTAL  705 (885)
Q Consensus       627 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~-~~~~k  705 (885)
                      ...+|+||++...-.++...            ++...+...++.+..||.++|..|   ||||||||.|++.+. -+.-.
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~------------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~  173 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS------------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGV  173 (418)
T ss_pred             eeEEEecccCccCHHHHHhc------------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCce
Confidence            99999999998887776652            667888899999999999999999   999999999999984 47789


Q ss_pred             EcccccceeeecccCC------------C-CC-----------------C---CCCCCCccccccccccccCCcccCCC-
Q 002746          706 VSDFGIAKLVMTVGVG------------N-DG-----------------A---ENMGNSTANMLCGSIGYMAPEYGFGS-  751 (885)
Q Consensus       706 l~Dfg~a~~~~~~~~~------------~-~~-----------------~---~~~~~~~~~~~~gt~~y~aPE~~~~~-  751 (885)
                      |+|||+|.........            . .+                 .   ..+.......++||+||.|||++... 
T Consensus       174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~  253 (418)
T KOG1167|consen  174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP  253 (418)
T ss_pred             EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence            9999999843211000            0 00                 0   01111222346899999999987654 


Q ss_pred             CCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhhhh---------hh-------hhh---------
Q 002746          752 NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKV---------ID-------SSL---------  806 (885)
Q Consensus       752 ~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---------~d-------~~~---------  806 (885)
                      ..+++.||||.||+++-+++++.||-...+....+.+.+.-..+..+.+.         +.       +..         
T Consensus       254 ~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~  333 (418)
T KOG1167|consen  254 RQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHI  333 (418)
T ss_pred             CcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccCh
Confidence            46899999999999999999999996644444444443322222111110         00       000         


Q ss_pred             hhccCCCh--HHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          807 LRASRDQS--PEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       807 ~~~~~~~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ........  .......+..+..+.+++.+|+..+|.+|.|++|++++
T Consensus       334 ~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  334 ESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             hhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            00000000  01112223334468999999999999999999999876

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=2.1e-27  Score=247.50  Aligned_cols=209  Identities=22%  Similarity=0.299  Sum_probs=173.3

Q ss_pred             CCCcCHHHHHHHhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcC------Ccccc
Q 002746          544 FPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIR------HRNLM  616 (885)
Q Consensus       544 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv  616 (885)
                      +-++-+.|+  ...+|.+....|+|-|++|.+|... .|..||||+++.. ....+.-..|+++|++++      -.|.+
T Consensus       421 YYrv~igE~--LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hcl  497 (752)
T KOG0670|consen  421 YYRVRIGEL--LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCL  497 (752)
T ss_pred             eEEEehhhh--hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHH
Confidence            334444443  5679999999999999999999965 5889999999854 234566788999999994      35899


Q ss_pred             eeeeeeecCCcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCce
Q 002746          617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNV  696 (885)
Q Consensus       617 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NI  696 (885)
                      +++..|....+.+||+|-+ ..+|.+.+......      ..+...+...++.|+.-||..|-..|   |+|.||||+||
T Consensus       498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~n------vGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNi  567 (752)
T KOG0670|consen  498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRN------VGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNI  567 (752)
T ss_pred             HHHHHhhhcceeEEEehhh-hchHHHHHHHhCcc------cceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccce
Confidence            9999999999999999987 56888888766532      23778888999999999999999998   99999999999


Q ss_pred             EecCC-CCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCC
Q 002746          697 LLNDD-MTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP  775 (885)
Q Consensus       697 Ll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P  775 (885)
                      |+++. ..+||||||.|.....             ...+.+.-+..|.|||++.|.+|+...|+||+||.|||++||+.-
T Consensus       568 LVNE~k~iLKLCDfGSA~~~~e-------------neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIl  634 (752)
T KOG0670|consen  568 LVNESKNILKLCDFGSASFASE-------------NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKIL  634 (752)
T ss_pred             EeccCcceeeeccCcccccccc-------------ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeecccee
Confidence            99965 6789999999987633             222334456789999999999999999999999999999999988


Q ss_pred             CCc
Q 002746          776 TDD  778 (885)
Q Consensus       776 ~~~  778 (885)
                      |..
T Consensus       635 FpG  637 (752)
T KOG0670|consen  635 FPG  637 (752)
T ss_pred             cCC
Confidence            754

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=1.7e-25  Score=230.36  Aligned_cols=199  Identities=28%  Similarity=0.461  Sum_probs=170.9

Q ss_pred             CcccceecccCcceEEEEEeCC-CCEEEEEEeeecCCc-chhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEeccc
Q 002746          559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGN-FTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMA  636 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~  636 (885)
                      |.+.+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5667899999999999999764 899999999865444 56789999999999999999999999999999999999999


Q ss_pred             CCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeee
Q 002746          637 NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM  716 (885)
Q Consensus       637 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~  716 (885)
                      +++|.+++.....        .+++.....++.+++.++.+||+.+   ++|+|++|+||+++.++.++|+|||.+....
T Consensus        81 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~  149 (225)
T smart00221       81 GGDLFDYLRKKGG--------KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIH  149 (225)
T ss_pred             CCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence            9999998865431        1678899999999999999999998   9999999999999999999999999998764


Q ss_pred             cccCCCCCCCCCCCCccccccccccccCCccc-CCCCCCccccchhhHHHHHHHHcCCCCCCc
Q 002746          717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYG-FGSNTSTKGDVYSFGILVLEMVTRRRPTDD  778 (885)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~vl~elltg~~P~~~  778 (885)
                      ...          ........++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus       150 ~~~----------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      150 RDL----------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             Ccc----------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            321          0012234577889999998 667788899999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN03210 Resistant to P

Probab=99.91  E-value=1.8e-23  Score=261.47  Aligned_cols=345  Identities=23%  Similarity=0.258  Sum_probs=212.6

Q ss_pred             CccccCCCCCcEEeCCCCc------ccccCchhhhCC-CCCcEEEccCcccccCCchhhhcCCCCCCEEEcCCCcccccC
Q 002746           12 PPEFSKLRRLRHLQLDGNN------LHGQIPESLALL-SNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKI   84 (885)
Q Consensus        12 p~~~~~l~~L~~L~L~~n~------l~~~~~~~~~~l-~~L~~L~L~~N~i~~~~~~~~f~~l~~L~~L~Ls~N~l~~~~   84 (885)
                      +.+|.+|++|+.|.+..+.      +...+|+.|..+ .+|+.|++.+|.++ .+|.. | ...+|++|+|++|+|. .+
T Consensus       551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~-f-~~~~L~~L~L~~s~l~-~L  626 (1153)
T PLN03210        551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSN-F-RPENLVKLQMQGSKLE-KL  626 (1153)
T ss_pred             HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCc-C-CccCCcEEECcCcccc-cc
Confidence            4568888888888886553      333567777766 46888888888887 77754 4 4678888888888887 56


Q ss_pred             CccCCCCCCCcEEEcccccCcccCCcccccCccceEecccccccCCCChhhhcCCCCCcEEECCCC-cccCCCCCCCccc
Q 002746           85 PEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYN-NMVSHDDNTNLVP  163 (885)
Q Consensus        85 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~  163 (885)
                      +..+..+++|+.|+|++|.....+|.....++|+.|+|++|.....+|.. +..+++|++|++++| .+..++..     
T Consensus       627 ~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~s-i~~L~~L~~L~L~~c~~L~~Lp~~-----  700 (1153)
T PLN03210        627 WDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSS-IQYLNKLEDLDMSRCENLEILPTG-----  700 (1153)
T ss_pred             ccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchh-hhccCCCCEEeCCCCCCcCccCCc-----
Confidence            77778888888888887754445565444567777777776655466654 467777777777765 34443321     


Q ss_pred             ccccCCCCCCCcEEEecCcccCccCCCccccccccEEEccCCcccccCCccccCCCCCCeeeccccccccccchhhcCCC
Q 002746          164 FFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLS  243 (885)
Q Consensus       164 ~~~~l~~l~~L~~L~l~~~~l~~~~p~~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  243 (885)
                           .++++|+.|++++|.....+|...  .+|+.|++++|.++ .+|..+ .+++|++|++.++..... .       
T Consensus       701 -----i~l~sL~~L~Lsgc~~L~~~p~~~--~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l-~-------  763 (1153)
T PLN03210        701 -----INLKSLYRLNLSGCSRLKSFPDIS--TNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKL-W-------  763 (1153)
T ss_pred             -----CCCCCCCEEeCCCCCCcccccccc--CCcCeeecCCCccc-cccccc-cccccccccccccchhhc-c-------
Confidence                 145666666666665443444321  13455555555544 233322 344444444443222100 0       


Q ss_pred             CCCeEecccccccccCcccccCCCCCCeeecccccccccCCccccCCCcccEEEccCCccCCCCCcccCCCCCCCEEECc
Q 002746          244 QLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLS  323 (885)
Q Consensus       244 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  323 (885)
                               +.+....+..+...++|+.|+|++|.....+|..++++++|+.|+|++|...+.+|..+ .+++|+.|+++
T Consensus       764 ---------~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls  833 (1153)
T PLN03210        764 ---------ERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLS  833 (1153)
T ss_pred             ---------ccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECC
Confidence                     00111112222334567777777776655667777777777777777765444566554 57777777777


Q ss_pred             CCcCcccCCccccCccceeeeeeccCCcCCCCchhhhcCCCCcceeecCC-CccccccccccccCccccEEEecCCc
Q 002746          324 YNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSS-NKFTGNIFIQISNCIAVRLINISHNA  399 (885)
Q Consensus       324 ~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~ls~N~  399 (885)
                      +|..-..+|...   .++ +.|+|++|.++ .+|..+..+++|+.|+|++ |+++ .+|..+..+++|+.+++++|.
T Consensus       834 ~c~~L~~~p~~~---~nL-~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        834 GCSRLRTFPDIS---TNI-SDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             CCCccccccccc---ccc-CEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence            765443555432   233 34777888777 5777788888888888887 4555 356667777888888877764

syringae 6; Provisional

>PLN03210 Resistant to P

Probab=99.91  E-value=2.3e-23  Score=260.40  Aligned_cols=338  Identities=21%  Similarity=0.271  Sum_probs=185.8

Q ss_pred             CchhhhcCCCCCCEEEcCCCcc------cccCCccCCCCC-CCcEEEcccccCcccCCcccccCccceEecccccccCCC
Q 002746           59 LPISFFHNCTSLRNVDLSQNFF------TGKIPEEIGNCP-NLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGEL  131 (885)
Q Consensus        59 ~~~~~f~~l~~L~~L~Ls~N~l------~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~n~l~~~~  131 (885)
                      +...+|.++.+|+.|.+..+..      ...+|..|..++ +|+.|++.+|.++ .+|..+...+|++|++++|++. .+
T Consensus       549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f~~~~L~~L~L~~s~l~-~L  626 (1153)
T PLN03210        549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNFRPENLVKLQMQGSKLE-KL  626 (1153)
T ss_pred             ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcCCccCCcEEECcCcccc-cc
Confidence            4456677888888888765542      234566666664 5888888888876 4555566677777777777776 56


Q ss_pred             ChhhhcCCCCCcEEECCCCc-ccCCCCCCCcccccccCCCCCCCcEEEecCcccCccCCCccccc-cccEEEccCCcccc
Q 002746          132 PSDIMSKLPSLTYLHLSYNN-MVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQLLLQENKITG  209 (885)
Q Consensus       132 ~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~p~~~~~~-~L~~L~l~~n~i~~  209 (885)
                      +.++ ..+++|++|+|++|. +..++          .++.+++|+.|++.+|.....+|..+..+ +|+.|++++|....
T Consensus       627 ~~~~-~~l~~Lk~L~Ls~~~~l~~ip----------~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~  695 (1153)
T PLN03210        627 WDGV-HSLTGLRNIDLRGSKNLKEIP----------DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLE  695 (1153)
T ss_pred             cccc-ccCCCCCEEECCCCCCcCcCC----------ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcC
Confidence            6553 678888888888764 44333          25667777777777776555666666554 56777776654333


Q ss_pred             cCCccccCCCCCCeeeccccccccccchhhcCCCCCCeEecccccccccCcccccCCCCCCeeecccccccc-------c
Q 002746          210 SIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSG-------E  282 (885)
Q Consensus       210 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-------~  282 (885)
                      .+|..+ ++++|++|++++|......|..   ..+|++|+|++|.++ .+|..+ .+++|+.|++.++....       .
T Consensus       696 ~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l  769 (1153)
T PLN03210        696 ILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPL  769 (1153)
T ss_pred             ccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhcccccccc
Confidence            455444 5666777777666544333322   345666666666665 445443 45566666665533211       1


Q ss_pred             CCccccCCCcccEEEccCCccCCCCCcccCCCCCCCEEECcCCcCcccCCccccCccceeeeeeccCCcCCCCchhhhcC
Q 002746          283 IPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSK  362 (885)
Q Consensus       283 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~p~~~~~  362 (885)
                      .+..+...++|+.|+|++|.....+|..++++++|+.|++++|..-+.+|..+                          .
T Consensus       770 ~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~--------------------------~  823 (1153)
T PLN03210        770 TPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI--------------------------N  823 (1153)
T ss_pred             chhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC--------------------------C
Confidence            11111223445555555554444455555555555555555543222344333                          3


Q ss_pred             CCCcceeecCCCccccccccccccCccccEEEecCCccCCCCCCccccccccccccccCc-ccccccCcccCCCceecEE
Q 002746          363 LENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGN-HLSGIIPISLNKIHTLTFI  441 (885)
Q Consensus       363 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L  441 (885)
                      +++|+.|++++|..-...|..   ..+|+.|+|++|.++ .+|.++..+++|+.|+|++| ++. .+|..+..+++|+.+
T Consensus       824 L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L  898 (1153)
T PLN03210        824 LESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETV  898 (1153)
T ss_pred             ccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCee
Confidence            444444444444322122211   234444555555554 34444555555555555542 333 344444455555555


Q ss_pred             Ecccc
Q 002746          442 NLSFN  446 (885)
Q Consensus       442 ~l~~N  446 (885)
                      +++++
T Consensus       899 ~l~~C  903 (1153)
T PLN03210        899 DFSDC  903 (1153)
T ss_pred             ecCCC
Confidence            55544

syringae 6; Provisional

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=4.2e-24  Score=210.87  Aligned_cols=169  Identities=18%  Similarity=0.173  Sum_probs=125.1

Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      |+|.+++....        ..+++..++.|+.|++.||+|||+++         ||+||+++.++.+|+  ||.+.....
T Consensus         1 GsL~~~l~~~~--------~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~   61 (176)
T smart00750        1 VSLADILEVRG--------RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTP   61 (176)
T ss_pred             CcHHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecc
Confidence            56777775432        13899999999999999999999975         999999999999999  999886532


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcch
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR  797 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  797 (885)
                      .                ...||+.|+|||++.+..++.++|||||||++|||++|+.||.........+..+......  
T Consensus        62 ~----------------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--  123 (176)
T smart00750       62 E----------------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA--  123 (176)
T ss_pred             c----------------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc--
Confidence            1                1258899999999999999999999999999999999999996532211111111111100  


Q ss_pred             hhhhhhhhhhhccCCChHHHHHHHHHHH--HHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 002746          798 LEKVIDSSLLRASRDQSPEVKRMWDVAI--GELIELGILCTQESPSTRPTMLDAADDLDRLKR  858 (885)
Q Consensus       798 ~~~~~d~~~~~~~~~~~~~~~~~~~~~~--~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~  858 (885)
                                 ......+.    .....  .++.+++.+||..+|++||++.|+++++..+..
T Consensus       124 -----------~~~~~~~~----~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      124 -----------DDPRDRSN----LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             -----------CCcccccc----HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence                       00000000    01122  268999999999999999999999999887754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=1.3e-24  Score=264.02  Aligned_cols=206  Identities=15%  Similarity=0.202  Sum_probs=137.6

Q ss_pred             hcCC-cccceeeeee-------ecCCcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 002746          609 RIRH-RNLMRIITAC-------SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH  680 (885)
Q Consensus       609 ~l~h-~niv~~~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~  680 (885)
                      .++| +||++++++|       ..++..+.++||+ +++|.+++....        ..+++..++.++.||++||+|||+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--------~~~~~~~~~~i~~qi~~al~~lH~   98 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--------RSVDAFECFHVFRQIVEIVNAAHS   98 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--------ccccHHHHHHHHHHHHHHHHHHHh
Confidence            3455 5777888877       2334567788887 669999986432        238899999999999999999999


Q ss_pred             cCCCceEecCCCCCceEecCCCC-------------------EEEcccccceeeecccCCC--CCCCCCC---CCccccc
Q 002746          681 HSPVRVIHCDLKPSNVLLNDDMT-------------------ALVSDFGIAKLVMTVGVGN--DGAENMG---NSTANML  736 (885)
Q Consensus       681 ~~~~~ivH~Dlkp~NILl~~~~~-------------------~kl~Dfg~a~~~~~~~~~~--~~~~~~~---~~~~~~~  736 (885)
                      +|   |+||||||+|||++..+.                   +|++|||+++.........  .......   .......
T Consensus        99 ~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (793)
T PLN00181         99 QG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILA  175 (793)
T ss_pred             CC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccccc
Confidence            98   999999999999965444                   5555555554321100000  0000000   0011124


Q ss_pred             cccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHH
Q 002746          737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPE  816 (885)
Q Consensus       737 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  816 (885)
                      .||+.|||||++.+..++.++|||||||++|||++|..|+....       ..+.....    ....+..          
T Consensus       176 ~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-------~~~~~~~~----~~~~~~~----------  234 (793)
T PLN00181        176 MEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-------RTMSSLRH----RVLPPQI----------  234 (793)
T ss_pred             CCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-------HHHHHHHH----hhcChhh----------
Confidence            68999999999999999999999999999999999988864310       01100000    0000000          


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          817 VKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       817 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                           .....+...++.+||+++|.+||+|.|++++
T Consensus       235 -----~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        235 -----LLNWPKEASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             -----hhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence                 0012335678889999999999999999875

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.8e-24  Score=208.18  Aligned_cols=250  Identities=26%  Similarity=0.398  Sum_probs=190.6

Q ss_pred             cccceecccCcceEEEEEeCCCCEEEEEEeeec--CCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccC
Q 002746          560 DEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       560 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~  637 (885)
                      ...-+|.+...|..|+|+|+ |..+++|++...  .....++|..|.-.++-+.||||.+++|+|..+....++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            34456889999999999998 777888887644  344567899999999999999999999999999999999999999


Q ss_pred             CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       638 gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      |+|...++....       ...+..++.+++..+|+|++|||+..+. |.--.+.+..+++|++.+++|+ ++-+++.  
T Consensus       272 gslynvlhe~t~-------vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltaris-mad~kfs--  340 (448)
T KOG0195|consen  272 GSLYNVLHEQTS-------VVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARIS-MADTKFS--  340 (448)
T ss_pred             hHHHHHHhcCcc-------EEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhhee-cccceee--
Confidence            999999986542       3477889999999999999999998732 4455689999999999988873 2222211  


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCCCC---CccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhh
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNT---STKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY  794 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~  794 (885)
                                   -........|.||+||.++..+-   ..++|+|||++++||+.|...||.+....+..+        
T Consensus       341 -------------fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm--------  399 (448)
T KOG0195|consen  341 -------------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM--------  399 (448)
T ss_pred             -------------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh--------
Confidence                         11122345789999999887654   467999999999999999999998753322111        


Q ss_pred             cchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 002746          795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLK  857 (885)
Q Consensus       795 ~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~  857 (885)
                           ++.-+.+   .....|.       .+..+.+++.-|...||.+||.+..++-.|+++.
T Consensus       400 -----kialegl---rv~ippg-------is~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  400 -----KIALEGL---RVHIPPG-------ISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             -----hhhhccc---cccCCCC-------ccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                 1111111   1111222       3445677888899999999999999999988764

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=3.5e-23  Score=239.36  Aligned_cols=267  Identities=30%  Similarity=0.401  Sum_probs=168.5

Q ss_pred             CCcEEeCCCCcccccCchhhhCCCCCcEEEccCcccccCCchhhhcCCCCCCEEEcCCCcccccCCccCCCCCCCcEEEc
Q 002746           20 RLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSL   99 (885)
Q Consensus        20 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~f~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L   99 (885)
                      .-..|+|++|+|+ .+|..+.  ++|+.|++++|+|+ .+|.    .+++|++|+|++|+|+. +|..   .++|+.|+|
T Consensus       202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~----lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~L  269 (788)
T PRK15387        202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLTS-LPVL---PPGLLELSI  269 (788)
T ss_pred             CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC----CCCCCcEEEecCCccCc-ccCc---ccccceeec
Confidence            3567888888887 5677665  47888888888888 6663    25788888888888884 4432   357888888


Q ss_pred             ccccCcccCCcccccCccceEecccccccCCCChhhhcCCCCCcEEECCCCcccCCCCCCCcccccccCCCCCCCcEEEe
Q 002746          100 YNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELEL  179 (885)
Q Consensus       100 ~~N~l~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~l  179 (885)
                      ++|+|+. +|..  ..+|..|++++|+++ .+|.    .+++|++|+|++|+|+.++..            ..       
T Consensus       270 s~N~L~~-Lp~l--p~~L~~L~Ls~N~Lt-~LP~----~p~~L~~LdLS~N~L~~Lp~l------------p~-------  322 (788)
T PRK15387        270 FSNPLTH-LPAL--PSGLCKLWIFGNQLT-SLPV----LPPGLQELSVSDNQLASLPAL------------PS-------  322 (788)
T ss_pred             cCCchhh-hhhc--hhhcCEEECcCCccc-cccc----cccccceeECCCCccccCCCC------------cc-------
Confidence            8888873 3321  245666777777766 5554    235677777777766654321            01       


Q ss_pred             cCcccCccCCCccccccccEEEccCCcccccCCccccCCCCCCeeeccccccccccchhhcCCCCCCeEecccccccccC
Q 002746          180 AGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEI  259 (885)
Q Consensus       180 ~~~~l~~~~p~~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~  259 (885)
                                      +|+.|++++|++++ +|..   ..+|++|+|++|+|+. +|..   ..+|+.|++++|+|+ .+
T Consensus       323 ----------------~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~L  377 (788)
T PRK15387        323 ----------------ELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SL  377 (788)
T ss_pred             ----------------cccccccccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhccccc-cC
Confidence                            34455555666653 3321   1356677777777763 3322   245666677777776 34


Q ss_pred             cccccCCCCCCeeecccccccccCCccccCCCcccEEEccCCccCCCCCcccCCCCCCCEEECcCCcCcccCCccccCcc
Q 002746          260 PAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIR  339 (885)
Q Consensus       260 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  339 (885)
                      |..   ..+|+.|+|++|+|++ +|..   .++|+.|++++|+++ .+|..   ..+|+.|++++|+|+ .+|..+..+.
T Consensus       378 P~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~  445 (788)
T PRK15387        378 PAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLT-RLPESLIHLS  445 (788)
T ss_pred             ccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-CCCcc---hhhhhhhhhccCccc-ccChHHhhcc
Confidence            443   2456777777777763 3332   246777777777776 35543   245677777777777 6777777777


Q ss_pred             ceeeeeeccCCcCCCCchhhhcCC
Q 002746          340 EIRIFLNLSHNQLEGPLPIELSKL  363 (885)
Q Consensus       340 ~l~~~L~L~~N~l~~~~p~~~~~l  363 (885)
                      .+ ..|+|++|.|++..+..+..+
T Consensus       446 ~L-~~LdLs~N~Ls~~~~~~L~~l  468 (788)
T PRK15387        446 SE-TTVNLEGNPLSERTLQALREI  468 (788)
T ss_pred             CC-CeEECCCCCCCchHHHHHHHH
Confidence            77 357778888777666666443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=6.8e-23  Score=194.47  Aligned_cols=271  Identities=20%  Similarity=0.309  Sum_probs=208.8

Q ss_pred             HhhCCcccceecccCcceEEEEE-eCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCC-cccceeeeeeecCCcceEEE
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRH-RNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lV~  632 (885)
                      ....|.+.++||.|+||.+|.|. ..+|++||+|+-+...  ..-++..|..+++.+++ ..|..+..|..+..+.++||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            45789999999999999999998 6689999999865332  23567889999999976 67777778888888999999


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecC---CCCEEEccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND---DMTALVSDF  709 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~---~~~~kl~Df  709 (885)
                      +.. |.+|.+.+.-+.+        .++..+.+-+|.|++.-++|+|.++   +|||||||+|+|+.-   ...+.++||
T Consensus        91 dLL-GPsLEdLfnfC~R--------~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDF  158 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSR--------RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDF  158 (341)
T ss_pred             ecc-CccHHHHHHHHhh--------hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEec
Confidence            998 8899888865543        3788899999999999999999999   999999999999974   356889999


Q ss_pred             ccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHH
Q 002746          710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKW  789 (885)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~  789 (885)
                      |+|+.+.......    ..+-.......||.+|.+-....+.+.+.+.|+-|+|.++...-.|..||+......      
T Consensus       159 GLaKky~d~~t~~----HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t------  228 (341)
T KOG1163|consen  159 GLAKKYRDIRTRQ----HIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT------  228 (341)
T ss_pred             cchhhhccccccc----cCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh------
Confidence            9999885432111    111222334679999999998888888999999999999999999999998753221      


Q ss_pred             HHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 002746          790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYL  860 (885)
Q Consensus       790 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~  860 (885)
                      -++    ....+.+..+       ...++..+.+.|.++.-.+..|-..--++-|+..-+.+.+.-+.+.+
T Consensus       229 k~Q----KyEkI~EkK~-------s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l  288 (341)
T KOG1163|consen  229 KKQ----KYEKISEKKM-------STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL  288 (341)
T ss_pred             HHH----HHHHHHHhhc-------CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence            000    1111211111       12244556667788999999999999999999888887777665543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.2e-22  Score=217.98  Aligned_cols=182  Identities=23%  Similarity=0.218  Sum_probs=134.9

Q ss_pred             HHhhCCcccceecccCcceEEEEEeC--CCCEEEEEEeeec-----CCcchhhHHHHHHHHhhcCCcccceeeeeeecCC
Q 002746          554 EATAEFDEQRLLGTGSYGRVYKGILQ--DGTAIAVKVLQLQ-----SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPD  626 (885)
Q Consensus       554 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  626 (885)
                      ....+|.+.+.||+|+||+||+|++.  +++.||||++...     .....+.+.+|++++++++|+++++.+..+   +
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence            34578999999999999999999865  5777899986532     122345689999999999999998533222   4


Q ss_pred             cceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCC-CCCceEecCCCCEE
Q 002746          627 FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDL-KPSNVLLNDDMTAL  705 (885)
Q Consensus       627 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-kp~NILl~~~~~~k  705 (885)
                      ..++||||+++++|... ..            ..   ...++.++++||.|||++|   |+|||| ||+|||++.++.+|
T Consensus        92 ~~~LVmE~~~G~~L~~~-~~------------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ik  152 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA-RP------------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAA  152 (365)
T ss_pred             CcEEEEEccCCCCHHHh-Cc------------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEE
Confidence            57999999999999631 10            01   1357889999999999998   999999 99999999999999


Q ss_pred             EcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCC------Cccccch
Q 002746          706 VSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNT------STKGDVY  760 (885)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~Dv~  760 (885)
                      |+|||+|+.+...+...   .-..........+++.|+|||++...+.      +..+|-|
T Consensus       153 LiDFGlA~~~~~~~~~~---~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        153 VIDFQLASVFRRRGALY---RIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             EEECccceecccCcchh---hhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            99999999875422110   0001112235678899999998765432      3346666

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=6.9e-22  Score=213.91  Aligned_cols=271  Identities=19%  Similarity=0.268  Sum_probs=198.6

Q ss_pred             CCcccceecccCcceEEEEEeCCC--CEEEEEEeeecCCcchhhHHHHHHHHhhcCC----cccceeeeee-ecCCcceE
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQDG--TAIAVKVLQLQSGNFTKSFNRECQVLKRIRH----RNLMRIITAC-SLPDFKAL  630 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~-~~~~~~~l  630 (885)
                      +|.+.+.||+|+||.||.|.....  ..+|+|.-..........+..|..++..+..    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999997653  4788888775543333378899999998863    6889999888 57888899


Q ss_pred             EEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCC-----CCEE
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDD-----MTAL  705 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-----~~~k  705 (885)
                      ||+.+ |.+|.++......       ..++..+..+|+.|++.+|+++|+.|   ++||||||+|+++...     ..+.
T Consensus        99 VM~l~-G~sL~dl~~~~~~-------~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~  167 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPP-------GRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLY  167 (322)
T ss_pred             EEecc-CccHHHHHHhCCC-------CCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEE
Confidence            99987 7899887654431       24889999999999999999999999   9999999999999854     4689


Q ss_pred             EcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCcc
Q 002746          706 VSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLS  785 (885)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~  785 (885)
                      +.|||+|+.+...+..... ............||..|+++....+.+.+.+.|+||++.++.|+..|..||........ 
T Consensus       168 llDfGlar~~~~~~~~~~~-~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-  245 (322)
T KOG1164|consen  168 LLDFGLARRFKYVGDSGGN-LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-  245 (322)
T ss_pred             EEecCCCccccccCCCCcc-cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-
Confidence            9999999844322111110 00011112456799999999999999999999999999999999999999965322111 


Q ss_pred             HHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHh
Q 002746          786 LHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYL  860 (885)
Q Consensus       786 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~  860 (885)
                      ..+.....    .......     .          ....+.++.++...+-..+..++|....+...+++.....
T Consensus       246 ~~~~~~~~----~~~~~~~-----~----------~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  246 KSKFEKDP----RKLLTDR-----F----------GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             HHHHHHHh----hhhcccc-----c----------cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            11110000    0000000     0          0112345666666677789999999999999988876654

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.88  E-value=3e-22  Score=231.70  Aligned_cols=265  Identities=27%  Similarity=0.354  Sum_probs=131.0

Q ss_pred             CCCcEEEccCcccccCCchhhhcCCCCCCEEEcCCCcccccCCccCCCCCCCcEEEcccccCcccCCcccccCccceEec
Q 002746           43 SNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDV  122 (885)
Q Consensus        43 ~~L~~L~L~~N~i~~~~~~~~f~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l  122 (885)
                      ..-..|+|++|.++ .+|....   ++|+.|++++|+|+ .+|.   .+++|++|+|++|+|+                 
T Consensus       201 ~~~~~LdLs~~~Lt-sLP~~l~---~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lt-----------------  255 (788)
T PRK15387        201 NGNAVLNVGESGLT-TLPDCLP---AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-----------------  255 (788)
T ss_pred             CCCcEEEcCCCCCC-cCCcchh---cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccC-----------------
Confidence            44667777777777 6675432   36777777777777 3443   2466777777777776                 


Q ss_pred             ccccccCCCChhhhcCCCCCcEEECCCCcccCCCCCCCcccccccCCCCCCCcEEEecCcccCccCCCccccccccEEEc
Q 002746          123 EYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLL  202 (885)
Q Consensus       123 ~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~p~~~~~~~L~~L~l  202 (885)
                             .+|.    ..++|+.|+|++|.|+.++..            ..                       +|+.|++
T Consensus       256 -------sLP~----lp~sL~~L~Ls~N~L~~Lp~l------------p~-----------------------~L~~L~L  289 (788)
T PRK15387        256 -------SLPV----LPPGLLELSIFSNPLTHLPAL------------PS-----------------------GLCKLWI  289 (788)
T ss_pred             -------cccC----cccccceeeccCCchhhhhhc------------hh-----------------------hcCEEEC
Confidence                   2332    123444444544444432210            01                       2223333


Q ss_pred             cCCcccccCCccccCCCCCCeeeccccccccccchhhcCCCCCCeEecccccccccCcccccCCCCCCeeeccccccccc
Q 002746          203 QENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGE  282 (885)
Q Consensus       203 ~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~  282 (885)
                      ++|+++. +|.   .+++|++|++++|+|+++ |..   ..+|+.|++++|.|++ +|..   ..+|+.|+|++|+|+. 
T Consensus       290 s~N~Lt~-LP~---~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-  356 (788)
T PRK15387        290 FGNQLTS-LPV---LPPGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-  356 (788)
T ss_pred             cCCcccc-ccc---cccccceeECCCCccccC-CCC---cccccccccccCcccc-cccc---ccccceEecCCCccCC-
Confidence            3333331 121   123344444444444422 211   1234444444444442 2321   1244555555555542 


Q ss_pred             CCccccCCCcccEEEccCCccCCCCCcccCCCCCCCEEECcCCcCcccCCccccCccceeeeeeccCCcCCCCchhhhcC
Q 002746          283 IPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSK  362 (885)
Q Consensus       283 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~p~~~~~  362 (885)
                      +|..   ..+|+.|++++|+|+ .+|..   ..+|+.|++++|+|+ .+|...   ..+ ..|++++|+|++ +|..+  
T Consensus       357 LP~l---p~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt-~LP~l~---s~L-~~LdLS~N~Lss-IP~l~--  421 (788)
T PRK15387        357 LPTL---PSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLT-SLPVLP---SEL-KELMVSGNRLTS-LPMLP--  421 (788)
T ss_pred             CCCC---Ccccceehhhccccc-cCccc---ccccceEEecCCccc-CCCCcc---cCC-CEEEccCCcCCC-CCcch--
Confidence            2221   123444555555554 23332   234556666666655 344322   223 235666666653 44322  


Q ss_pred             CCCcceeecCCCccccccccccccCccccEEEecCCccCCCCCCcc
Q 002746          363 LENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSL  408 (885)
Q Consensus       363 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~  408 (885)
                       .+|+.|++++|+|+ .+|..+..+.+|+.|+|++|.|++..+..+
T Consensus       422 -~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L  465 (788)
T PRK15387        422 -SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL  465 (788)
T ss_pred             -hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence             34566777777776 456666677777777777777776555544

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=1.9e-21  Score=193.22  Aligned_cols=272  Identities=17%  Similarity=0.256  Sum_probs=212.0

Q ss_pred             hhCCcccceecccCcceEEEEE-eCCCCEEEEEEeeecCCcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcceEEEe
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e  633 (885)
                      .-.|.+.++||+|+||+++.|+ +-+++.||||.-...+  ..-++..|...++.+ ..+.|..+|.|..+..+..||+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            3478999999999999999999 5579999999754222  245678888888888 46899999999888889999999


Q ss_pred             cccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecC-----CCCEEEcc
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND-----DMTALVSD  708 (885)
Q Consensus       634 ~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~-----~~~~kl~D  708 (885)
                      .+ |-+|.+++.-+.+        .++..+...||.|++.-++|+|++.   .|.|||||+|+|+..     ...+.++|
T Consensus       105 LL-GPSLEDLFD~CgR--------~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiD  172 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCGR--------RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIID  172 (449)
T ss_pred             hh-CcCHHHHHHHhcC--------cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEe
Confidence            98 7788887754443        3899999999999999999999998   999999999999963     34689999


Q ss_pred             cccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHH
Q 002746          709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~  788 (885)
                      ||+|+.+..... .   ...+-.......||.+||+-....|.+.+.+-|.=|+|-|+.+.+.|..||+......  ..+
T Consensus       173 FGmAK~YrDp~T-k---qHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t--nK~  246 (449)
T KOG1165|consen  173 FGMAKEYRDPKT-K---QHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT--NKE  246 (449)
T ss_pred             ccchhhhcCccc-c---ccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc--hHH
Confidence            999998854211 1   1112223345679999999999999999999999999999999999999998753321  111


Q ss_pred             HHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHHHHhcC
Q 002746          789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGE  862 (885)
Q Consensus       789 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~  862 (885)
                              +..     .+...  .....+..++...+.++...+...-..+-.+-|+.+-+...+.++....++
T Consensus       247 --------kYe-----KIGe~--Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~  305 (449)
T KOG1165|consen  247 --------KYE-----KIGET--KRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE  305 (449)
T ss_pred             --------HHH-----Hhccc--cccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence                    011     11111  122345556677888899998888889999999999998888888776554

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=3.2e-22  Score=229.23  Aligned_cols=257  Identities=23%  Similarity=0.297  Sum_probs=191.6

Q ss_pred             cccceecccCcceEEEEEeC-CCCEEEEEEeeec--CCc----chhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          560 DEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ--SGN----FTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       560 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ...+++|.|++|.|+.+... ....++.|.++..  ...    ....+..|+-+-..+.|+|++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34578999999988877743 3444555544311  111    1222556777788889999998888777766666669


Q ss_pred             ecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccc
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a  712 (885)
                      |||+. +|...+....         .+....+..+++|+..|++|+|..|   |.|||+|++|++++.+|.+||+|||.+
T Consensus       401 E~~~~-Dlf~~~~~~~---------~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~  467 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG---------KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAA  467 (601)
T ss_pred             hcccH-HHHHHHhccc---------ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcc
Confidence            99999 9988886542         2677788889999999999999999   999999999999999999999999999


Q ss_pred             eeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCcc-ccchhhHHHHHHHHcCCCCCCccccCCccHHHHHH
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTK-GDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~  791 (885)
                      .......      +. ........+|+..|+|||+..+.+|.++ .||||.|+++..|++|+.||......+..+.   .
T Consensus       468 ~vf~~~~------e~-~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~---~  537 (601)
T KOG0590|consen  468 SVFRYPW------EK-NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK---T  537 (601)
T ss_pred             eeeccCc------ch-hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh---h
Confidence            8764321      11 1234456789999999999999999754 7999999999999999999976543332220   0


Q ss_pred             HhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       792 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..+             ........+..+++...+.+...++.+++++||.+|.|+++|++.
T Consensus       538 ~~~-------------~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  538 NNY-------------SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             hcc-------------ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            000             111112223445666778889999999999999999999999875

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.85  E-value=2.3e-21  Score=226.15  Aligned_cols=99  Identities=28%  Similarity=0.389  Sum_probs=44.0

Q ss_pred             CCCeeecccccccccCCccccCCCcccEEEccCCccCCCCCcccCCCCCCCEEECcCCcCcccCCccccCccceeeeeec
Q 002746          268 HLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNL  347 (885)
Q Consensus       268 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~L~L  347 (885)
                      +|+.|++++|.++. +|..+.  ++|+.|++++|+|+ .+|..+.  ++|+.|++++|+|+ .+|..+..  .+ ..|++
T Consensus       326 sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~~--sL-~~LdL  395 (754)
T PRK15370        326 GLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLPA--AL-QIMQA  395 (754)
T ss_pred             cceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHHH--HH-HHHhh
Confidence            34444444444442 222221  34555555555554 3343332  45666666666665 34433321  22 23455


Q ss_pred             cCCcCCCCchh----hhcCCCCcceeecCCCccc
Q 002746          348 SHNQLEGPLPI----ELSKLENVQEIDLSSNKFT  377 (885)
Q Consensus       348 ~~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~  377 (885)
                      ++|+|+ .+|.    .++.++++..|++.+|.++
T Consensus       396 s~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        396 SRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             ccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            555554 2232    2233345555555555554

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.84  E-value=9.3e-21  Score=221.14  Aligned_cols=246  Identities=26%  Similarity=0.349  Sum_probs=143.5

Q ss_pred             CCcEEEcccccCcccCCcccccCccceEecccccccCCCChhhhcCCCCCcEEECCCCcccCCCCCCCcccccccCCCCC
Q 002746           93 NLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCT  172 (885)
Q Consensus        93 ~L~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~  172 (885)
                      +...|+|++++++. +|..+ ...++.|+|++|+|+ .+|...+   ++|++|+|++|++++++..              
T Consensus       179 ~~~~L~L~~~~Lts-LP~~I-p~~L~~L~Ls~N~Lt-sLP~~l~---~nL~~L~Ls~N~LtsLP~~--------------  238 (754)
T PRK15370        179 NKTELRLKILGLTT-IPACI-PEQITTLILDNNELK-SLPENLQ---GNIKTLYANSNQLTSIPAT--------------  238 (754)
T ss_pred             CceEEEeCCCCcCc-CCccc-ccCCcEEEecCCCCC-cCChhhc---cCCCEEECCCCccccCChh--------------
Confidence            34555555555552 22222 123444445555444 5665543   4677777777766654321              


Q ss_pred             CCcEEEecCcccCccCCCccccccccEEEccCCcccccCCccccCCCCCCeeeccccccccccchhhcCCCCCCeEeccc
Q 002746          173 DLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSH  252 (885)
Q Consensus       173 ~L~~L~l~~~~l~~~~p~~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~  252 (885)
                                         +. .+|+.|+|++|+++ .+|..+.  ++|++|++++|+|+ .+|..+.  ++|+.|+|++
T Consensus       239 -------------------l~-~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~  292 (754)
T PRK15370        239 -------------------LP-DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYD  292 (754)
T ss_pred             -------------------hh-ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCC
Confidence                               10 03555556666665 3444443  46777777777777 3455443  4788888888


Q ss_pred             ccccccCcccccCCCCCCeeecccccccccCCccccCCCcccEEEccCCccCCCCCcccCCCCCCCEEECcCCcCcccCC
Q 002746          253 NLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIP  332 (885)
Q Consensus       253 N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  332 (885)
                      |+++ .+|..+.  ++|+.|++++|+++. +|..+.  ++|+.|++++|.++. +|..+.  ++|+.|++++|+|+ .+|
T Consensus       293 N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP  362 (754)
T PRK15370        293 NSIR-TLPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLP  362 (754)
T ss_pred             Cccc-cCcccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCC
Confidence            8877 3454433  467888888888874 343332  578888888888873 565553  67888888888887 566


Q ss_pred             ccccCccceeeeeeccCCcCCCCchhhhcCCCCcceeecCCCccccccccc----cccCccccEEEecCCccC
Q 002746          333 AEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQ----ISNCIAVRLINISHNALQ  401 (885)
Q Consensus       333 ~~~~~l~~l~~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~----~~~l~~L~~L~ls~N~l~  401 (885)
                      ..+.  +.| +.|+|++|+|++ +|..+.  ..|+.|++++|+|+. +|..    +..++.+..|++.+|.++
T Consensus       363 ~~lp--~~L-~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        363 ETLP--PTI-TTLDVSRNALTN-LPENLP--AALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             hhhc--CCc-CEEECCCCcCCC-CCHhHH--HHHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCcc
Confidence            5443  344 447777777773 444443  256677777777663 3332    223355556666666654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.83  E-value=1.2e-19  Score=199.18  Aligned_cols=264  Identities=27%  Similarity=0.379  Sum_probs=195.4

Q ss_pred             CcccceecccCcceEEEEEeCCCCEEEEEEeeecCCc---chhhHHHHHHHHhhcCCc-ccceeeeeeecCCcceEEEec
Q 002746          559 FDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGN---FTKSFNRECQVLKRIRHR-NLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lV~e~  634 (885)
                      |.+.+.||.|+||.||++...  ..+|+|.+......   ....+.+|+.+++.+.|+ +++++++++......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667789999999999999987  78899998755332   367899999999999988 799999999777778999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCC-CEEEcccccce
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDM-TALVSDFGIAK  713 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~-~~kl~Dfg~a~  713 (885)
                      +.++++.+++......      ..+.......++.|++.++.|+|+.+   ++|||+||+||+++..+ .++++|||.++
T Consensus        80 ~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~  150 (384)
T COG0515          80 VDGGSLEDLLKKIGRK------GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAK  150 (384)
T ss_pred             CCCCcHHHHHHhcccc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcce
Confidence            9999999655543211      23788889999999999999999998   99999999999999888 79999999998


Q ss_pred             eeecccCCCCCCCCCCCCccccccccccccCCcccCC---CCCCccccchhhHHHHHHHHcCCCCCCccccC--CccHHH
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG---SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAG--GLSLHK  788 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~--~~~~~~  788 (885)
                      .+.........     ........||..|+|||...+   ..+....|+||+|++++++++|..||......  ......
T Consensus       151 ~~~~~~~~~~~-----~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~  225 (384)
T COG0515         151 LLPDPGSTSSI-----PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK  225 (384)
T ss_pred             ecCCCCccccc-----cccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHH
Confidence            55332100000     013355689999999999887   57889999999999999999999997653211  011111


Q ss_pred             HHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       789 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .+......        ..........+      ......+.+++..|+..+|..|.++.+....
T Consensus       226 ~~~~~~~~--------~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         226 IILELPTP--------SLASPLSPSNP------ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHhcCCc--------ccccccCcccc------chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            11110000        00000000000      1123457889999999999999999988776

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=1.6e-20  Score=186.82  Aligned_cols=171  Identities=12%  Similarity=0.139  Sum_probs=132.5

Q ss_pred             HhhCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchh---------hHHHHHHHHhhcCCcccceeeeeeecC
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTK---------SFNRECQVLKRIRHRNLMRIITACSLP  625 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~---------~~~~E~~~l~~l~h~niv~~~~~~~~~  625 (885)
                      ...+|.+.+++|.|+||.||.+.. ++..+|+|+++........         .+.+|+..+.+++|++|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            468999999999999999999766 5778999999755332222         268999999999999999998886543


Q ss_pred             --------CcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceE
Q 002746          626 --------DFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVL  697 (885)
Q Consensus       626 --------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NIL  697 (885)
                              ...++||||++|.+|.++..             ++.    ....+++.++..+|+.|   ++|||+||+||+
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nil  167 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFI  167 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-------------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEE
Confidence                    35789999999999977631             222    24569999999999999   999999999999


Q ss_pred             ecCCCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHH
Q 002746          698 LNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV  770 (885)
Q Consensus       698 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ell  770 (885)
                      ++.++ ++++|||........                       .....+.....+..++|+||||+.+.-..
T Consensus       168 i~~~g-i~liDfg~~~~~~e~-----------------------~a~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        168 VSKNG-LRIIDLSGKRCTAQR-----------------------KAKDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EeCCC-EEEEECCCcccccch-----------------------hhHHHHHHHhHhcccccccceeEeehHHH
Confidence            99988 999999987644110                       00011344455678999999999876543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.82  E-value=4.5e-20  Score=182.43  Aligned_cols=139  Identities=17%  Similarity=0.187  Sum_probs=107.6

Q ss_pred             cceecccCcceEEEEEeCCCCEEEEEEeeecCCc--c-------h-----------------hhHHHHHHHHhhcCCccc
Q 002746          562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGN--F-------T-----------------KSFNRECQVLKRIRHRNL  615 (885)
Q Consensus       562 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ni  615 (885)
                      ...||+|++|.||+|...+|+.||||+++.....  .       .                 .....|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999878999999999754211  0       1                 122359999999988877


Q ss_pred             ceeeeeeecCCcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHh-hccCCCceEecCCCCC
Q 002746          616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL-HHHSPVRVIHCDLKPS  694 (885)
Q Consensus       616 v~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivH~Dlkp~  694 (885)
                      .....+..  ...++||||++++++.......         ..++......++.|++.+|.|+ |+.|   |+||||||+
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~---------~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~  147 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD---------APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEY  147 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH
Confidence            44433322  2348999999988765442211         1378888999999999999999 6888   999999999


Q ss_pred             ceEecCCCCEEEcccccceee
Q 002746          695 NVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       695 NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      |||++ ++.++|+|||+|...
T Consensus       148 NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         148 NLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             HEEEE-CCcEEEEEccccccC
Confidence            99998 478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=2.1e-19  Score=174.44  Aligned_cols=196  Identities=17%  Similarity=0.093  Sum_probs=140.2

Q ss_pred             cccceecccCcceEEEEEeCCCCEEEEEEeeecCCc----chhhHHHHHHHHhhcC-CcccceeeeeeecCCcceEEEec
Q 002746          560 DEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGN----FTKSFNRECQVLKRIR-HRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       560 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      .+...|++|+||+||.+.. .+.+++.+.+.....-    ....+.+|+++++++. |+++++++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4567899999999997766 5888887777643221    1225889999999995 5889999886    346999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCC-CCCceEecCCCCEEEcccccce
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDL-KPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dl-kp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      +.|.+|......                ....++.|++.++.++|+.|   |+|||| ||+|||++.++.++|+|||+|.
T Consensus        80 I~G~~L~~~~~~----------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~  140 (218)
T PRK12274         80 LAGAAMYQRPPR----------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAV  140 (218)
T ss_pred             ecCccHHhhhhh----------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCce
Confidence            999888643210                01347789999999999999   999999 7999999999999999999998


Q ss_pred             eeecccCCCC--CCCCCCCCccccccccccccCCcccCC--CCCCccccchhhHHHHHHHHcCCCCCCcc
Q 002746          714 LVMTVGVGND--GAENMGNSTANMLCGSIGYMAPEYGFG--SNTSTKGDVYSFGILVLEMVTRRRPTDDM  779 (885)
Q Consensus       714 ~~~~~~~~~~--~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~vl~elltg~~P~~~~  779 (885)
                      .....+.-..  ..++...........+++|++|+...-  ...-.+.+.++-|+-+|.++||+.|+...
T Consensus       141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            5432110000  000000000112346788888885322  23336779999999999999999987553

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.80  E-value=4.9e-19  Score=176.06  Aligned_cols=139  Identities=20%  Similarity=0.243  Sum_probs=109.4

Q ss_pred             cceecccCcceEEEEEeCCCCEEEEEEeeecCCcc--------------------------hhhHHHHHHHHhhcCCccc
Q 002746          562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNF--------------------------TKSFNRECQVLKRIRHRNL  615 (885)
Q Consensus       562 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~ni  615 (885)
                      .+.||+|++|.||+|+..+|+.||||+++......                          ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46899999999999997789999999987542110                          1224578999999999987


Q ss_pred             ceeeeeeecCCcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCceEecCCCCC
Q 002746          616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH-HSPVRVIHCDLKPS  694 (885)
Q Consensus       616 v~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~  694 (885)
                      .....+...  ..++||||++++++.......         ..++.....+++.|++.++.++|+ .|   |+||||||+
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---------~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~  147 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---------VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEY  147 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh---------ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChh
Confidence            544443332  248999999988654332111         126677889999999999999999 88   999999999


Q ss_pred             ceEecCCCCEEEcccccceee
Q 002746          695 NVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       695 NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ||+++ ++.++|+|||+|+.+
T Consensus       148 NIll~-~~~~~liDFG~a~~~  167 (190)
T cd05145         148 NILYH-DGKPYIIDVSQAVEL  167 (190)
T ss_pred             hEEEE-CCCEEEEEcccceec
Confidence            99999 889999999999865

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.77  E-value=9.2e-19  Score=190.84  Aligned_cols=220  Identities=25%  Similarity=0.360  Sum_probs=163.8

Q ss_pred             HhhcCCcccceeeeeeecCCcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCce
Q 002746          607 LKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRV  686 (885)
Q Consensus       607 l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  686 (885)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+....        ..++|.....+.+.|+.|++|+|...   |
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--------~~~d~~F~~s~~rdi~~Gl~ylh~s~---i   69 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--------IKLDYFFILSFIRDISKGLAYLHNSP---I   69 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--------cCccHHHHHHHHHHHHHHHHHHhcCc---c
Confidence            356799999999999999999999999999999999997643        24899999999999999999999975   4


Q ss_pred             -EecCCCCCceEecCCCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCC-------CCcccc
Q 002746          687 -IHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN-------TSTKGD  758 (885)
Q Consensus       687 -vH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~D  758 (885)
                       .|+.+++.|+++|..+.+|++|||+........         .........-..-|.|||.+.+..       .+.++|
T Consensus        70 ~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~---------~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gd  140 (484)
T KOG1023|consen   70 GYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETA---------EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGD  140 (484)
T ss_pred             eeeeeeccccceeeeeEEEEechhhhcccccccc---------cccccchhHHHHhccCHHHhcccccccccccccccCC
Confidence             899999999999999999999999987653200         001111112345699999887641       467799


Q ss_pred             chhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCC
Q 002746          759 VYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQE  838 (885)
Q Consensus       759 v~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  838 (885)
                      |||||++++|+++.+.||+........ .+.+.....            .......|.+... .+..+++..++..||..
T Consensus       141 iYs~~ii~~ei~~r~~~~~~~~~~~~~-~eii~~~~~------------~~~~~~rP~i~~~-~e~~~~l~~l~~~cw~e  206 (484)
T KOG1023|consen  141 IYSFGIIMYEILFRSGPFDLRNLVEDP-DEIILRVKK------------GGSNPFRPSIELL-NELPPELLLLVARCWEE  206 (484)
T ss_pred             eehHHHHHHHHHhccCccccccccCCh-HHHHHHHHh------------cCCCCcCcchhhh-hhcchHHHHHHHHhccc
Confidence            999999999999999999864332221 122111110            0111111211111 13455799999999999


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHh
Q 002746          839 SPSTRPTMLDAADDLDRLKRYL  860 (885)
Q Consensus       839 dP~~RPt~~ev~~~L~~l~~~~  860 (885)
                      +|.+||++++|...++.+.+..
T Consensus       207 ~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  207 IPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             ChhhCccHHHHHhhhhhhcccc
Confidence            9999999999999888876644

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.77  E-value=6.2e-19  Score=180.82  Aligned_cols=237  Identities=19%  Similarity=0.226  Sum_probs=146.9

Q ss_pred             CCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCC---cchhhHHHHHHHHhhcCC----------cccceeeeeee
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG---NFTKSFNRECQVLKRIRH----------RNLMRIITACS  623 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------~niv~~~~~~~  623 (885)
                      .+...+.||.|+++.||.+++. +++++|||++.....   ...+.+++|.-....+.+          -.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4456789999999999999977 589999999875432   234556666655544322          12222222211


Q ss_pred             c---------C---C-----cceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCce
Q 002746          624 L---------P---D-----FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRV  686 (885)
Q Consensus       624 ~---------~---~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  686 (885)
                      .         .   .     ..+++|+-+ .++|...+..-....  .....+....+..+..|+++.+++||..|   +
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~--~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---l  166 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRA--QTHSPLAFAARLSLTVQMIRLVANLHSYG---L  166 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHT--TTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcc--cccchhHHHHHHHHHHHHHHHHHHHhhcc---e
Confidence            1         1   1     224566666 567766543211100  00123556677888899999999999999   9


Q ss_pred             EecCCCCCceEecCCCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCC--------CCCCcccc
Q 002746          687 IHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG--------SNTSTKGD  758 (885)
Q Consensus       687 vH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~D  758 (885)
                      ||+||||+|++++.+|.++|+||+.....+..              ......+..|.+||....        ..++.+.|
T Consensus       167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~--------------~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~D  232 (288)
T PF14531_consen  167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR--------------YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATD  232 (288)
T ss_dssp             EEST-SGGGEEE-TTS-EEE--GGGEEETTEE--------------EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHH
T ss_pred             EecccceeeEEEcCCCCEEEcChHHHeecCce--------------eeccCCCcccCChhhhhhhcccCcccceeeeccC
Confidence            99999999999999999999999987754221              111234577999997533        25788999


Q ss_pred             chhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCC
Q 002746          759 VYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQE  838 (885)
Q Consensus       759 v~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  838 (885)
                      .|++|+++|.|++|+.||+........              +   ..+.. .+           ..++.+..+|..++++
T Consensus       233 aW~LG~~ly~lWC~~lPf~~~~~~~~~--------------~---~~f~~-C~-----------~~Pe~v~~LI~~lL~~  283 (288)
T PF14531_consen  233 AWQLGITLYSLWCGRLPFGLSSPEADP--------------E---WDFSR-CR-----------DMPEPVQFLIRGLLQR  283 (288)
T ss_dssp             HHHHHHHHHHHHHSS-STCCCGGGSTS--------------G---GGGTT-SS--------------HHHHHHHHHHT-S
T ss_pred             HHHHHHHHHHHHHccCCCCCCCccccc--------------c---ccchh-cC-----------CcCHHHHHHHHHHccC
Confidence            999999999999999999753221100              0   01111 11           2466799999999999


Q ss_pred             CCCCC
Q 002746          839 SPSTR  843 (885)
Q Consensus       839 dP~~R  843 (885)
                      +|.+|
T Consensus       284 ~~~~R  288 (288)
T PF14531_consen  284 NPEDR  288 (288)
T ss_dssp             SGGGS
T ss_pred             CcccC
Confidence            99988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.76  E-value=1.4e-19  Score=196.40  Aligned_cols=186  Identities=26%  Similarity=0.359  Sum_probs=155.2

Q ss_pred             eecccCcceEEEEE----eCCCCEEEEEEeeecC--CcchhhHHHHHHHHhhcC-CcccceeeeeeecCCcceEEEeccc
Q 002746          564 LLGTGSYGRVYKGI----LQDGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIR-HRNLMRIITACSLPDFKALVLPYMA  636 (885)
Q Consensus       564 ~lg~G~~g~V~~~~----~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lV~e~~~  636 (885)
                      ++|+|+||.|+.++    ...|..+|+|+.+...  .........|..++...+ ||.+|++..+++.+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999765    2347788999886442  122235667888899886 9999999999999999999999999


Q ss_pred             CCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeee
Q 002746          637 NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM  716 (885)
Q Consensus       637 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~  716 (885)
                      +|.+...+.....         ++..........++-+++++|+.+   |+|||+|++||+++.+|++++.|||+++...
T Consensus        81 gg~lft~l~~~~~---------f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v  148 (612)
T KOG0603|consen   81 GGDLFTRLSKEVM---------FDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAV  148 (612)
T ss_pred             cchhhhccccCCc---------hHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhH
Confidence            9999988875543         556666677788999999999999   9999999999999999999999999998653


Q ss_pred             cccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCc
Q 002746          717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD  778 (885)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~  778 (885)
                      ..               ...+||..|||||++.  ....+.|.||||++++||+||..||..
T Consensus       149 ~~---------------~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  149 KE---------------KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             hh---------------hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            21               1128999999999988  567899999999999999999999964

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=4.2e-18  Score=198.32  Aligned_cols=200  Identities=22%  Similarity=0.258  Sum_probs=162.0

Q ss_pred             HHHHhhCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcC---CcccceeeeeeecCCcc
Q 002746          552 LLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIR---HRNLMRIITACSLPDFK  628 (885)
Q Consensus       552 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~  628 (885)
                      +......|.+.+.||+|+||.||+|...+|+.||+|+-+....   -+|.--.+++.+++   -+.|..+..++...+..
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            3445567889999999999999999988899999998764432   12222233444444   34566666777778888


Q ss_pred             eEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEec-------CC
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN-------DD  701 (885)
Q Consensus       629 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~-------~~  701 (885)
                      ++|+||.+.|+|.+++...+         .++|...+.++.|++..+++||..+   ||||||||+|+|+.       +.
T Consensus       770 ~lv~ey~~~Gtlld~~N~~~---------~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~  837 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINTNK---------VMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDS  837 (974)
T ss_pred             eeeeeccccccHHHhhccCC---------CCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcc
Confidence            99999999999999998333         3889999999999999999999999   99999999999994       23


Q ss_pred             CCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCC
Q 002746          702 MTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP  775 (885)
Q Consensus       702 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P  775 (885)
                      .-++|+|||.+..+....         +.......++|-++-.+|...|+.++...|.|.++.+++-|+.|+.-
T Consensus       838 ~~l~lIDfG~siDm~lfp---------~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  838 KGLYLIDFGRSIDMKLFP---------DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             cceEEEecccceeeeEcC---------CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            458999999998875432         12456677899999999999999999999999999999999999763

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.76  E-value=1.3e-18  Score=176.84  Aligned_cols=201  Identities=26%  Similarity=0.256  Sum_probs=135.4

Q ss_pred             CCcccceeeeeeecC---------------------------CcceEEEecccCCccccccccCCccccCCCCCCCCHHH
Q 002746          611 RHRNLMRIITACSLP---------------------------DFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQ  663 (885)
Q Consensus       611 ~h~niv~~~~~~~~~---------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~  663 (885)
                      +|||||++.++|.+.                           ...|+||.-+ ..+|.+++....          .+...
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~----------~s~r~  342 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH----------RSYRT  342 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC----------CchHH
Confidence            699999999887442                           2446676655 346666665432          45566


Q ss_pred             HHHHHHHHHHHHHHhhccCCCceEecCCCCCceEec--CCC--CEEEcccccceeeecccCCCCCCCCCCCCcccccccc
Q 002746          664 RVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN--DDM--TALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS  739 (885)
Q Consensus       664 ~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~--~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt  739 (885)
                      +.-|..|+.+|+.|||++|   |.|||+|++|||+.  +|+  .+.++|||.+--....+..-..     .+..-..-|.
T Consensus       343 ~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy-----~S~~Vd~GGN  414 (598)
T KOG4158|consen  343 GRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPY-----ESDEVDLGGN  414 (598)
T ss_pred             HHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeecccccccccc-----ccccccCCCc
Confidence            6778999999999999999   99999999999994  443  4689999987543222111110     0111123466


Q ss_pred             ccccCCcccCCCCC------CccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCC
Q 002746          740 IGYMAPEYGFGSNT------STKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQ  813 (885)
Q Consensus       740 ~~y~aPE~~~~~~~------~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  813 (885)
                      -.-||||+....+.      ..|+|.|+.|.+.||+++...||-.-.+...+...+-++                     
T Consensus       415 a~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~---------------------  473 (598)
T KOG4158|consen  415 AKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQES---------------------  473 (598)
T ss_pred             ceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhh---------------------
Confidence            67899998765432      478999999999999999999996522221121111111                     


Q ss_pred             hHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 002746          814 SPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDL  853 (885)
Q Consensus       814 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  853 (885)
                        +++.+-+.+++.+.+++...+++||++||++.-....+
T Consensus       474 --qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  474 --QLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             --hCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence              11112233667799999999999999999876554443

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.75  E-value=4.8e-20  Score=200.82  Aligned_cols=287  Identities=24%  Similarity=0.293  Sum_probs=151.0

Q ss_pred             EecccccccCCCChhhhcCCCCCcEEECCCCcccCCCCCCCcccccccCCCCCCCcEEEecCcccCccCCCccccccccE
Q 002746          120 LDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQ  199 (885)
Q Consensus       120 L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~p~~~~~~~L~~  199 (885)
                      |+|..+.+++.--...|..+.+|++|++++|.++....    ..+...+...+.|+.+++.++.+.. .+          
T Consensus         3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~----~~i~~~l~~~~~l~~l~l~~~~~~~-~~----------   67 (319)
T cd00116           3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAA----KALASALRPQPSLKELCLSLNETGR-IP----------   67 (319)
T ss_pred             cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHH----HHHHHHHhhCCCceEEeccccccCC-cc----------
Confidence            45555555534344566777778888888887643110    1112224444455555555444321 00          


Q ss_pred             EEccCCcccccCCccccCCCCCCeeeccccccccccchhhcCCCC---CCeEecccccccc----cCcccccCC-CCCCe
Q 002746          200 LLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQ---LEQLFLSHNLFSG----EIPAALGKL-HHLGL  271 (885)
Q Consensus       200 L~l~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~---L~~L~L~~N~i~~----~~~~~~~~l-~~L~~  271 (885)
                           ..+ ..++..+..+++|++|++++|.+.+..+..+..+.+   |++|++++|.+++    .+...+..+ ++|+.
T Consensus        68 -----~~~-~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~  141 (319)
T cd00116          68 -----RGL-QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEK  141 (319)
T ss_pred             -----hHH-HHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceE
Confidence                 001 123345566777888888877776555555555544   7777777777662    222344455 66677


Q ss_pred             eeccccccccc----CCccccCCCcccEEEccCCccCCC----CCcccCCCCCCCEEECcCCcCcccCCccccCccceee
Q 002746          272 LDLSFNKLSGE----IPVSLGNLVQIYSLFLNNNQLSRS----IPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRI  343 (885)
Q Consensus       272 L~Ls~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~  343 (885)
                      |++++|.+++.    .+..+..+.+|++|++++|.+++.    ++..+..+++|+.|++++|.+++....          
T Consensus       142 L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~----------  211 (319)
T cd00116         142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGAS----------  211 (319)
T ss_pred             EEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHH----------
Confidence            77777766532    222344445555666655555421    122333344555555555555421110          


Q ss_pred             eeeccCCcCCCCchhhhcCCCCcceeecCCCccccccccccc-----cCccccEEEecCCccCC----CCCCcccccccc
Q 002746          344 FLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQIS-----NCIAVRLINISHNALQG----NLPDSLGDLKNL  414 (885)
Q Consensus       344 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~ls~N~l~~----~~~~~~~~l~~L  414 (885)
                                 .++..+..+++|++|++++|.+++.....+.     ....|+.|++++|.++.    .+...+..+++|
T Consensus       212 -----------~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L  280 (319)
T cd00116         212 -----------ALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESL  280 (319)
T ss_pred             -----------HHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCc
Confidence                       1233445566677777777766643222222     12566666666666652    123344445667


Q ss_pred             ccccccCcccccc----cCcccCCC-ceecEEEcccccc
Q 002746          415 EAIDVSGNHLSGI----IPISLNKI-HTLTFINLSFNEF  448 (885)
Q Consensus       415 ~~L~l~~N~l~~~----~~~~~~~l-~~L~~L~l~~N~l  448 (885)
                      +.+++++|+++..    ....+... +.|+.+++.+|++
T Consensus       281 ~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         281 LELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             cEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            7777777777633    33344444 5666666666653

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.74  E-value=6.7e-20  Score=165.15  Aligned_cols=165  Identities=28%  Similarity=0.538  Sum_probs=120.2

Q ss_pred             CCCCCCeEecccccccccCcccccCCCCCCeeecccccccccCCccccCCCcccEEEccCCccCCCCCcccCCCCCCCEE
Q 002746          241 WLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKL  320 (885)
Q Consensus       241 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L  320 (885)
                      .+++.+.|.||+|+++ .+|..++.+.+|+.|++++|+|. ..|.+++.++.|+.|+++-|++. ..|..|+.++.|+.|
T Consensus        31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl  107 (264)
T KOG0617|consen   31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL  107 (264)
T ss_pred             chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence            4566777777888877 66777788888888888888887 67777888888888888888886 788899999999999


Q ss_pred             ECcCCcCcccCCccccCccceeeeeeccCCcCCCCchhhhcCCCCcceeecCCCccccccccccccCccccEEEecCCcc
Q 002746          321 DLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNAL  400 (885)
Q Consensus       321 ~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l  400 (885)
                      ||.+|++..                        ..+|+.|..++.|+.|+|++|.+. .+|..++.+.+|+.|.+..|.+
T Consensus       108 dltynnl~e------------------------~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndl  162 (264)
T KOG0617|consen  108 DLTYNNLNE------------------------NSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDL  162 (264)
T ss_pred             hcccccccc------------------------ccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCch
Confidence            999988862                        134555555556666666666665 4555566666666666666665


Q ss_pred             CCCCCCccccccccccccccCcccccccCcccCCC
Q 002746          401 QGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKI  435 (885)
Q Consensus       401 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l  435 (885)
                      - .+|..++.+.+|++|.+.+|+++ .+|..++++
T Consensus       163 l-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l  195 (264)
T KOG0617|consen  163 L-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANL  195 (264)
T ss_pred             h-hCcHHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence            5 57788888888888888888888 566555543

>PRK10345 hypothetical protein; Provisional

Probab=99.74  E-value=8.8e-18  Score=167.29  Aligned_cols=137  Identities=18%  Similarity=0.284  Sum_probs=106.0

Q ss_pred             cccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhc-----CCcccceeeeeeecCC---cce-E
Q 002746          560 DEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-----RHRNLMRIITACSLPD---FKA-L  630 (885)
Q Consensus       560 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~~~-l  630 (885)
                      .-.+.||+|++|.||. ...++.. +||++........+.+.+|+++++.+     .||||++++|+++++.   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3457899999999996 3334444 79988765444567899999999999     5799999999998874   323 7


Q ss_pred             EEec--ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHH-HHhhccCCCceEecCCCCCceEecC----CCC
Q 002746          631 VLPY--MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM-AYLHHHSPVRVIHCDLKPSNVLLND----DMT  703 (885)
Q Consensus       631 V~e~--~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~ivH~Dlkp~NILl~~----~~~  703 (885)
                      |+||  +.+|+|.+++....          +++.  ..++.+++.++ +|||+++   ||||||||+|||++.    ++.
T Consensus        83 I~e~~G~~~~tL~~~l~~~~----------~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~  147 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQCR----------YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVI  147 (210)
T ss_pred             EecCCCCcchhHHHHHHccc----------ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCc
Confidence            8999  55899999996431          3444  35677888777 9999998   999999999999973    348


Q ss_pred             EEEcc-cccce
Q 002746          704 ALVSD-FGIAK  713 (885)
Q Consensus       704 ~kl~D-fg~a~  713 (885)
                      ++|+| ||.+.
T Consensus       148 ~~LiDg~G~~~  158 (210)
T PRK10345        148 PVVCDNIGEST  158 (210)
T ss_pred             EEEEECCCCcc
Confidence            99999 55443

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.74  E-value=1.5e-18  Score=197.10  Aligned_cols=252  Identities=19%  Similarity=0.191  Sum_probs=174.4

Q ss_pred             CCcccceecccCcceEEEEEeCCCCEEEEEEeeecC-CcchhhHHHHHHH--HhhcCCcccceeeeeeecCCcceEEEec
Q 002746          558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQS-GNFTKSFNRECQV--LKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       558 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      +|...+.+|++.|=.|.+|++++|. |+||++-... .-..+.|.++++-  ...++|||.+++.-+-..+...|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5666788999999999999998777 9999986554 2334445443333  4456999999998887777778888888


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +. -+|.+.+.-++         -+...+.+-|+.|+..|+..+|+.|   |+|||||.+|||++.=.=+.|+||..-+.
T Consensus       103 vk-hnLyDRlSTRP---------FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen  103 VK-HNLYDRLSTRP---------FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             Hh-hhhhhhhccch---------HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCC
Confidence            84 47777775433         2667777889999999999999999   99999999999999877789999986543


Q ss_pred             eecccCCCCCCCCCCCCccccccccccccCCcccCCC----------C-CCccccchhhHHHHHHHHc-CCCCCCccccC
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS----------N-TSTKGDVYSFGILVLEMVT-RRRPTDDMFAG  782 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~Dv~slG~vl~ellt-g~~P~~~~~~~  782 (885)
                      ..-.   .+...+. ....+...--..|.|||.+-..          . .+++.||||+||++.|+++ |++||.-    
T Consensus       170 tYLP---eDNPadf-~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----  241 (1431)
T KOG1240|consen  170 TYLP---EDNPADF-TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----  241 (1431)
T ss_pred             ccCC---CCCcccc-eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----
Confidence            3210   0000000 1112222223469999975331          2 4678999999999999998 6777753    


Q ss_pred             CccHHHHHHHhhcch-hhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          783 GLSLHKWVKNHYHGR-LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       783 ~~~~~~~~~~~~~~~-~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                          .+.......+. ..+    ......             ....+++++..|++.||++|-++++.++.
T Consensus       242 ----SQL~aYr~~~~~~~e----~~Le~I-------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  242 ----SQLLAYRSGNADDPE----QLLEKI-------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ----HHHHhHhccCccCHH----HHHHhC-------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence                22111111000 000    000000             12248899999999999999999999887

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.72  E-value=9.1e-20  Score=164.33  Aligned_cols=178  Identities=24%  Similarity=0.418  Sum_probs=142.7

Q ss_pred             CCCcccEEEccCCccCCCCCcccCCCCCCCEEECcCCcCcccCCccccCccceeeeeeccCCcCCCCchhhhcCCCCcce
Q 002746          289 NLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQE  368 (885)
Q Consensus       289 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~p~~~~~l~~L~~  368 (885)
                      ++.+++.|.|++|+++ .+|..+..+.+|+.|++++|+|. .+|..++.++.++ .|+++-|++. .+|..|+.++.|+.
T Consensus        31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr-~lnvgmnrl~-~lprgfgs~p~lev  106 (264)
T KOG0617|consen   31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLR-ILNVGMNRLN-ILPRGFGSFPALEV  106 (264)
T ss_pred             chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhh-heecchhhhh-cCccccCCCchhhh
Confidence            4455666666666665 55666666777777777777776 6666777777764 4777777776 78999999999999


Q ss_pred             eecCCCcccc-ccccccccCccccEEEecCCccCCCCCCccccccccccccccCcccccccCcccCCCceecEEEccccc
Q 002746          369 IDLSSNKFTG-NIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNE  447 (885)
Q Consensus       369 L~Ls~N~l~~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~  447 (885)
                      |||.+|++.+ ..|..|..+..|+-|+|+.|.+. .+|..++++++|+.|.+.+|.+- .+|..++.+..|+.|.+.+|+
T Consensus       107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr  184 (264)
T KOG0617|consen  107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR  184 (264)
T ss_pred             hhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence            9999999975 56788999999999999999998 89999999999999999999999 899999999999999999999


Q ss_pred             ccccCCCCCccCCC---CccccccCccc
Q 002746          448 FKGMIPSGGIFNSA---TKMSFVGNQHL  472 (885)
Q Consensus       448 l~~~~p~~~~~~~~---~~~~~~~n~~~  472 (885)
                      ++-.||..+.+.-.   .....+.|||.
T Consensus       185 l~vlppel~~l~l~~~k~v~r~E~NPwv  212 (264)
T KOG0617|consen  185 LTVLPPELANLDLVGNKQVMRMEENPWV  212 (264)
T ss_pred             eeecChhhhhhhhhhhHHHHhhhhCCCC
Confidence            99999986543322   23345666664

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.71  E-value=6.7e-19  Score=191.77  Aligned_cols=251  Identities=25%  Similarity=0.259  Sum_probs=166.6

Q ss_pred             EEccCCccc-ccCCccccCCCCCCeeeccccccccc----cchhhcCCCCCCeEecccccccc------cCcccccCCCC
Q 002746          200 LLLQENKIT-GSIPPHIGNLSNLISLNLSSNLLSGT----ISAEISWLSQLEQLFLSHNLFSG------EIPAALGKLHH  268 (885)
Q Consensus       200 L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~L~~N~i~~------~~~~~~~~l~~  268 (885)
                      |+|..+.++ ......+..+.+|++|++++|.++..    ++..+...++|++|+++++.+.+      .++..+..+++
T Consensus         3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~   82 (319)
T cd00116           3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG   82 (319)
T ss_pred             cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence            444555554 22333445566677777777776432    33445556667777777776651      23345666777


Q ss_pred             CCeeecccccccccCCccccCCCc---ccEEEccCCccCC----CCCcccCCC-CCCCEEECcCCcCccc----CCcccc
Q 002746          269 LGLLDLSFNKLSGEIPVSLGNLVQ---IYSLFLNNNQLSR----SIPPTLGRC-TDLYKLDLSYNRLTGS----IPAEIS  336 (885)
Q Consensus       269 L~~L~Ls~N~l~~~~~~~~~~l~~---L~~L~l~~N~l~~----~~~~~~~~l-~~L~~L~l~~N~l~~~----~~~~~~  336 (885)
                      |+.|++++|.+.+..+..+..+..   |++|++++|+++.    .+...+..+ ++|++|++++|.+++.    ++..+.
T Consensus        83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~  162 (319)
T cd00116          83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR  162 (319)
T ss_pred             eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHH
Confidence            777777777776555555554444   7777777777752    222344555 7788888888887732    233444


Q ss_pred             CccceeeeeeccCCcCCCC----chhhhcCCCCcceeecCCCcccccc----ccccccCccccEEEecCCccCCCCCCcc
Q 002746          337 GIREIRIFLNLSHNQLEGP----LPIELSKLENVQEIDLSSNKFTGNI----FIQISNCIAVRLINISHNALQGNLPDSL  408 (885)
Q Consensus       337 ~l~~l~~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~ls~N~l~~~~~~~~  408 (885)
                      .+..+ +.|++++|.+++.    ++..+..+++|++|++++|.+++..    ...+..+++|+.|++++|.+++.....+
T Consensus       163 ~~~~L-~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l  241 (319)
T cd00116         163 ANRDL-KELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL  241 (319)
T ss_pred             hCCCc-CEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence            55566 3478888887742    3445666779999999999997543    3446678899999999999986433333


Q ss_pred             cc-----ccccccccccCcccc----cccCcccCCCceecEEEccccccccc
Q 002746          409 GD-----LKNLEAIDVSGNHLS----GIIPISLNKIHTLTFINLSFNEFKGM  451 (885)
Q Consensus       409 ~~-----l~~L~~L~l~~N~l~----~~~~~~~~~l~~L~~L~l~~N~l~~~  451 (885)
                      ..     .+.|+.|++++|.++    ..+...+..+++|+++++++|+++..
T Consensus       242 ~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~  293 (319)
T cd00116         242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE  293 (319)
T ss_pred             HHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHH
Confidence            32     379999999999997    23445667778999999999999854

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>smart00090 RIO RIO-like kinase

Probab=99.70  E-value=7.6e-17  Score=165.02  Aligned_cols=148  Identities=20%  Similarity=0.241  Sum_probs=113.3

Q ss_pred             HHHHhhCCcccceecccCcceEEEEE--eCCCCEEEEEEeeecCCc------------------------chhhHHHHHH
Q 002746          552 LLEATAEFDEQRLLGTGSYGRVYKGI--LQDGTAIAVKVLQLQSGN------------------------FTKSFNRECQ  605 (885)
Q Consensus       552 ~~~~~~~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~  605 (885)
                      +.....-|.+.+.||+|++|.||+|.  ..+|+.||+|+++.....                        ....+..|++
T Consensus        23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  102 (237)
T smart00090       23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR  102 (237)
T ss_pred             HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence            33344468888999999999999998  558999999998743210                        1123568999


Q ss_pred             HHhhcCCcc--cceeeeeeecCCcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCC
Q 002746          606 VLKRIRHRN--LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP  683 (885)
Q Consensus       606 ~l~~l~h~n--iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~  683 (885)
                      .+.++.+..  +.+++++    ...++||||++++++........         .........++.|++.++++||+.| 
T Consensus       103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~g-  168 (237)
T smart00090      103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---------EPEEEEEFELYDDILEEMRKLYKEG-  168 (237)
T ss_pred             HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---------CcchHHHHHHHHHHHHHHHHHHhcC-
Confidence            999997533  3444443    23589999999988876543221         1445566789999999999999986 


Q ss_pred             CceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       684 ~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                       +|+||||||+||+++ ++.++++|||.|...
T Consensus       169 -~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      169 -ELVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             -CEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence             499999999999999 889999999998754

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.66  E-value=3e-16  Score=157.54  Aligned_cols=142  Identities=21%  Similarity=0.262  Sum_probs=110.7

Q ss_pred             HHHHhhCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCCc----------------------chhhHHHHHHHHhh
Q 002746          552 LLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGN----------------------FTKSFNRECQVLKR  609 (885)
Q Consensus       552 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~  609 (885)
                      +.....-|.+.+.||+|+||.||+|...+|+.||||+++.....                      ....+..|..++.+
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            33334447888999999999999999888999999987643210                      11236678889999


Q ss_pred             cCCcc--cceeeeeeecCCcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceE
Q 002746          610 IRHRN--LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVI  687 (885)
Q Consensus       610 l~h~n--iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv  687 (885)
                      +.|++  +.+.++.    ...++||||+++++|......               .....++.+++.++.++|+.+   |+
T Consensus        90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------------~~~~~~~~~i~~~l~~lh~~g---i~  147 (198)
T cd05144          90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------------EDPEEVLDEILEEIVKAYKHG---II  147 (198)
T ss_pred             HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------------ccHHHHHHHHHHHHHHHHHCC---CC
Confidence            88774  4444442    345899999999998764321               224578899999999999998   99


Q ss_pred             ecCCCCCceEecCCCCEEEcccccceee
Q 002746          688 HCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       688 H~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ||||||+||++++++.++|+|||.|...
T Consensus       148 H~Dl~p~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         148 HGDLSEFNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             cCCCCcccEEEcCCCcEEEEECCccccC
Confidence            9999999999999999999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.66  E-value=3.4e-16  Score=159.26  Aligned_cols=134  Identities=21%  Similarity=0.346  Sum_probs=112.6

Q ss_pred             ceecccCcceEEEEEeCCCCEEEEEEeeecCCc--------chhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGN--------FTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      +.||+|++|.||+|.+ .|..|++|+.......        ....+.+|++++..++|+++.....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999988 5778999986543221        124577899999999999988877777777888999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      ++|++|.+++...            .+ .+..++.+++.++.++|+.+   ++|||++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~------------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999998877432            12 67889999999999999998   99999999999999 78999999998863

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.63  E-value=9.8e-16  Score=154.27  Aligned_cols=130  Identities=23%  Similarity=0.349  Sum_probs=105.9

Q ss_pred             eecccCcceEEEEEeCCCCEEEEEEeeecCCc--------chhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecc
Q 002746          564 LLGTGSYGRVYKGILQDGTAIAVKVLQLQSGN--------FTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       564 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~  635 (885)
                      .||+|++|.||+|.+. |..|++|........        ...++.+|++++..++|+++.....++..++..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            4899999999999964 788999986533211        1255778999999999888766655666677779999999


Q ss_pred             cCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       636 ~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      ++++|.+.+....                ..++.+++.++.++|+.+   ++|||++|.||+++ ++.++++|||.+..
T Consensus        80 ~g~~l~~~~~~~~----------------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----------------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----------------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999987664211                078999999999999998   99999999999999 88999999998864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.63  E-value=8.5e-16  Score=177.93  Aligned_cols=145  Identities=22%  Similarity=0.285  Sum_probs=114.4

Q ss_pred             CHHHHHHHhhCCcccceecccCcceEEEEEeCCCCEEEEEEeeec--CC------cchhhHHHHHHHHhhcCCcccceee
Q 002746          548 TYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQ--SG------NFTKSFNRECQVLKRIRHRNLMRII  619 (885)
Q Consensus       548 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~------~~~~~~~~E~~~l~~l~h~niv~~~  619 (885)
                      +|.........|...+.||+|+||+||+|.+... .+++|+....  ..      ...+.+.+|+++++.++|++++...
T Consensus       324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~  402 (535)
T PRK09605        324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV  402 (535)
T ss_pred             eeccccccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence            3433333445567789999999999999997644 3444432211  11      1235688999999999999999888


Q ss_pred             eeeecCCcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEec
Q 002746          620 TACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN  699 (885)
Q Consensus       620 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~  699 (885)
                      .++..+...++||||+++++|.+++.                 ....++.++++++.|||+.+   |+|||+||+||++ 
T Consensus       403 ~~~~~~~~~~lv~E~~~g~~L~~~l~-----------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-  461 (535)
T PRK09605        403 IYDVDPEEKTIVMEYIGGKDLKDVLE-----------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-  461 (535)
T ss_pred             EEEEeCCCCEEEEEecCCCcHHHHHH-----------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-
Confidence            88877778899999999999987663                 24678999999999999998   9999999999999 


Q ss_pred             CCCCEEEccccccee
Q 002746          700 DDMTALVSDFGIAKL  714 (885)
Q Consensus       700 ~~~~~kl~Dfg~a~~  714 (885)
                      .++.++|+|||+|+.
T Consensus       462 ~~~~~~liDFGla~~  476 (535)
T PRK09605        462 RDDRLYLIDFGLGKY  476 (535)
T ss_pred             ECCcEEEEeCccccc
Confidence            677999999999874

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.62  E-value=9.5e-17  Score=171.18  Aligned_cols=128  Identities=26%  Similarity=0.427  Sum_probs=106.4

Q ss_pred             cceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEE
Q 002746          627 FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALV  706 (885)
Q Consensus       627 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl  706 (885)
                      +.++.|++|..++|.+|+...+..+      ..++.....++.|++.|+.|   ++   .+|+|+||.||+...+..+||
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e------~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kI  397 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGE------ERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKI  397 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCccc------ccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhh
Confidence            5679999999999999997554322      36788889999999999999   66   899999999999999999999


Q ss_pred             cccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHc
Q 002746          707 SDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT  771 (885)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt  771 (885)
                      +|||+.+.......   .  .......+.-.||..||+||.+.+..|+.++||||+|++++|+++
T Consensus       398 gDFgl~ts~~~~~~---~--~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  398 GDFGLVTSQDKDET---V--APAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             hhhhheeecccCCc---c--cchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            99999987654320   0  001122334579999999999999999999999999999999997

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.61  E-value=3.5e-16  Score=178.16  Aligned_cols=221  Identities=21%  Similarity=0.311  Sum_probs=141.7

Q ss_pred             hhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      ..+|+.++.|..|++|.||.++++ ..+.+|+|+-+..      .+.+-  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee------------------
Confidence            368899999999999999999876 4677888543311      11110  22222223222                  


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                         |+=...++...         .++.        +++.+++|+|+.|   |||||+||+|.+++.-|++|++|||+.+.
T Consensus       136 ---gDc~tllk~~g---------~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~  192 (1205)
T KOG0606|consen  136 ---GDCATLLKNIG---------PLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKK  192 (1205)
T ss_pred             ---chhhhhcccCC---------CCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhh
Confidence               22222232211         1222        2378999999999   99999999999999999999999999865


Q ss_pred             eecccCC---CCCCCCCCC-CccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHH
Q 002746          715 VMTVGVG---NDGAENMGN-STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       715 ~~~~~~~---~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~  790 (885)
                      --.....   ..+.+.... .....++||+.|.|||++....|+...|+|++|+++||.+.|+.||.....     .+. 
T Consensus       193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp-----eel-  266 (1205)
T KOG0606|consen  193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----EEL-  266 (1205)
T ss_pred             hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH-----HHH-
Confidence            4321100   001111111 122346899999999999999999999999999999999999999964211     000 


Q ss_pred             HHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 002746          791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTML  847 (885)
Q Consensus       791 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  847 (885)
                             +..++...+..-.  ..       +..+.++.+++.+.++.+|..|-...
T Consensus       267 -------fg~visd~i~wpE--~d-------ea~p~Ea~dli~~LL~qnp~~Rlgt~  307 (1205)
T KOG0606|consen  267 -------FGQVISDDIEWPE--ED-------EALPPEAQDLIEQLLRQNPLCRLGTG  307 (1205)
T ss_pred             -------Hhhhhhhhccccc--cC-------cCCCHHHHHHHHHHHHhChHhhcccc
Confidence                   1111111111000  00       11356788999999999999994433

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.56  E-value=1.4e-14  Score=144.26  Aligned_cols=136  Identities=24%  Similarity=0.330  Sum_probs=98.1

Q ss_pred             cceecccCcceEEEEEeCCCCEEEEEEeeecCCcc--hhh----------------------HHHHHHHHhhcCCcc--c
Q 002746          562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNF--TKS----------------------FNRECQVLKRIRHRN--L  615 (885)
Q Consensus       562 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~n--i  615 (885)
                      .+.||+|+||+||+|...+|+.||||+++......  ...                      ...|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999998889999999987532211  111                      134556666664433  4


Q ss_pred             ceeeeeeecCCcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCceEecCCCCC
Q 002746          616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH-HSPVRVIHCDLKPS  694 (885)
Q Consensus       616 v~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlkp~  694 (885)
                      .+.+++    ...++||||++++.+.........         .. .....++.+++.++.++|. .+   |+||||||+
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---------~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~  144 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---------LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEY  144 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---------hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChh
Confidence            444443    245899999999664322111100         11 4567899999999999999 87   999999999


Q ss_pred             ceEecCCCCEEEcccccceee
Q 002746          695 NVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       695 NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ||+++ ++.++++|||.|...
T Consensus       145 Nili~-~~~~~liDfg~a~~~  164 (187)
T cd05119         145 NILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             hEEEE-CCcEEEEECcccccc
Confidence            99999 899999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.56  E-value=4.7e-16  Score=178.69  Aligned_cols=256  Identities=26%  Similarity=0.369  Sum_probs=190.6

Q ss_pred             hCCcccceecccCcceEEEEEeCC--CCEEEEEEeeecC--CcchhhHHHHHHHHhhcC-CcccceeeeeeecCCcceEE
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQD--GTAIAVKVLQLQS--GNFTKSFNRECQVLKRIR-HRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lV  631 (885)
                      ..|.+.+.||+|+|+.|-.+....  ...+|+|.+....  ....+....|..+-..+. |+|++.+++....++..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            456777889999999998887543  3445666654332  233444556777777776 99999999999999999999


Q ss_pred             EecccCCccccccc-cCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhh-ccCCCceEecCCCCCceEecCCC-CEEEcc
Q 002746          632 LPYMANGSLDSHLY-PHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLH-HHSPVRVIHCDLKPSNVLLNDDM-TALVSD  708 (885)
Q Consensus       632 ~e~~~~gsL~~~l~-~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivH~Dlkp~NILl~~~~-~~kl~D  708 (885)
                      .+|..+|++..-+. ....        ..+.......+.|+..++.|+| +.+   ++|+|+||+|.+++..+ ..+++|
T Consensus       100 ~~~s~g~~~f~~i~~~~~~--------~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~d  168 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDST--------GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIAD  168 (601)
T ss_pred             cCcccccccccccccCCcc--------CCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCC
Confidence            99999999988873 2210        1444556678999999999999 887   99999999999999999 999999


Q ss_pred             cccceeeec-ccCCCCCCCCCCCCccccccc-cccccCCcccCCC-CCCccccchhhHHHHHHHHcCCCCCCccccCCcc
Q 002746          709 FGIAKLVMT-VGVGNDGAENMGNSTANMLCG-SIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLS  785 (885)
Q Consensus       709 fg~a~~~~~-~~~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~  785 (885)
                      ||+|+.+.. .+         ........+| ++.|+|||...+. -..+..|+||.|+++.-+++|..|++........
T Consensus       169 f~~At~~~~~~g---------~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~  239 (601)
T KOG0590|consen  169 FGLATAYRNKNG---------AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR  239 (601)
T ss_pred             chhhccccccCC---------cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc
Confidence            999998754 21         1223334567 9999999998885 4467889999999999999999999876555544


Q ss_pred             HHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          786 LHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       786 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                      +..|........                    ...|........++..+++..+|..|.+.+++...
T Consensus       240 ~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  240 YSSWKSNKGRFT--------------------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             ceeecccccccc--------------------cCccccCChhhhhcccccccCCchhcccccccccc
Confidence            444443321100                    00122234456777888998999999998887664

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.54  E-value=5.9e-14  Score=134.52  Aligned_cols=135  Identities=21%  Similarity=0.314  Sum_probs=113.7

Q ss_pred             ccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCC--cccceeeeeeecCCcceEEEecccCC
Q 002746          561 EQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRH--RNLMRIITACSLPDFKALVLPYMANG  638 (885)
Q Consensus       561 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lV~e~~~~g  638 (885)
                      +.+.||+|.++.||++...+ ..+++|..+....  ...+..|+.++..++|  ..++++++++..++..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            35679999999999999864 7899998864432  4678999999999976  58999999988888899999999887


Q ss_pred             ccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          639 SLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       639 sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      .+...                +......++.+++++++++|.....+++|+|++|+||+++.++.++++|||.+..
T Consensus        79 ~~~~~----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77643                3455677899999999999996434599999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.52  E-value=7.5e-14  Score=143.30  Aligned_cols=135  Identities=21%  Similarity=0.237  Sum_probs=104.4

Q ss_pred             cceec-ccCcceEEEEEeCCCCEEEEEEeeecC-------------CcchhhHHHHHHHHhhcCCccc--ceeeeeeecC
Q 002746          562 QRLLG-TGSYGRVYKGILQDGTAIAVKVLQLQS-------------GNFTKSFNRECQVLKRIRHRNL--MRIITACSLP  625 (885)
Q Consensus       562 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~  625 (885)
                      ..+|| .||.|+||.+... +..+|||.+....             ......+.+|++++.+++|+++  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35788 8999999999876 7789999885311             1223567889999999998885  6677664432


Q ss_pred             Cc----ceEEEecccC-CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecC
Q 002746          626 DF----KALVLPYMAN-GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND  700 (885)
Q Consensus       626 ~~----~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~  700 (885)
                      ..    .++||||+++ .+|.+++....          ++..    .+.+++.++.+||+.|   |+||||||.|||++.
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~----------l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~  177 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEAP----------LSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDP  177 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcCC----------CCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcC
Confidence            22    2499999997 68887764321          3332    3678999999999999   999999999999999


Q ss_pred             CCCEEEccccccee
Q 002746          701 DMTALVSDFGIAKL  714 (885)
Q Consensus       701 ~~~~kl~Dfg~a~~  714 (885)
                      ++.++|+|||.++.
T Consensus       178 ~~~v~LIDfg~~~~  191 (239)
T PRK01723        178 DGKFWLIDFDRGEL  191 (239)
T ss_pred             CCCEEEEECCCccc
Confidence            89999999998864

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.49  E-value=9.9e-16  Score=163.15  Aligned_cols=192  Identities=28%  Similarity=0.370  Sum_probs=111.1

Q ss_pred             eeccccccccccchhh-cCCCCCCeEecccccccccCcccccCCCCCCeeecccccccccCCccccCCCcccEEEccCCc
Q 002746          224 LNLSSNLLSGTISAEI-SWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQ  302 (885)
Q Consensus       224 L~l~~N~l~~~~~~~~-~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~  302 (885)
                      |.|++-++.......+ ..+..-...||+.|++. .+|..++.+..|+.+.|+.|.+. .+|..++++..|++|+|+.|+
T Consensus        55 l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~Nq  132 (722)
T KOG0532|consen   55 LLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQ  132 (722)
T ss_pred             cccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccch
Confidence            4455555553322222 23455566677777777 66777777777777777777776 566667777777777777777


Q ss_pred             cCCCCCcccCCCCCCCEEECcCCcCcccCCccccCccceeeeeeccCCcCCCCchhhhcCCCCcceeecCCCcccccccc
Q 002746          303 LSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFI  382 (885)
Q Consensus       303 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~  382 (885)
                      ++ .+|..++.|+ |+.|-+++|+++ .+|+.++.+..+. .||.+.|++. .+|..+.++.+|+.|++..|++.. .|.
T Consensus       133 lS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~-~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~-lp~  206 (722)
T KOG0532|consen  133 LS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLA-HLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLED-LPE  206 (722)
T ss_pred             hh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHH-Hhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhh-CCH
Confidence            76 5666666655 666666666666 5666666555552 3555666655 455555555555555555555552 333


Q ss_pred             ccccCccccEEEecCCccCCCCCCccccccccccccccCcccc
Q 002746          383 QISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLS  425 (885)
Q Consensus       383 ~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  425 (885)
                      .+. .-.|..||+|.|+++ .+|-.|.+|+.|++|-|.+|.|.
T Consensus       207 El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  207 ELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ  247 (722)
T ss_pred             HHh-CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence            333 334445555555554 44555555555555555555555

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.44  E-value=4.7e-15  Score=158.08  Aligned_cols=180  Identities=33%  Similarity=0.532  Sum_probs=100.5

Q ss_pred             CCCCCeeeccccccccccchhhcCCCCCCeEecccccccccCcccccCCCCCCeeecccccccccCCccccCCCcccEEE
Q 002746          218 LSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLF  297 (885)
Q Consensus       218 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  297 (885)
                      +..-...|++.|++. .+|..++.+..|+.|.|.+|.|. .+|.+++.+..|++|||+.|+++ ..|..++.+ -|+.|.
T Consensus        74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~l-pLkvli  149 (722)
T KOG0532|consen   74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDL-PLKVLI  149 (722)
T ss_pred             ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcC-cceeEE
Confidence            344445555666655 45555555555666666666655 55555566666666666666655 444444444 255556


Q ss_pred             ccCCccCCCCCcccCCCCCCCEEECcCCcCcccCCccccCccceeeeeeccCCcCCCCchhhhcCCCCcceeecCCCccc
Q 002746          298 LNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFT  377 (885)
Q Consensus       298 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  377 (885)
                      +++|+++ .+|+.++.+..|..||.+.|.+. .+|..+.++..++. |++..|++. .+|..+..| .|..||+|.|+++
T Consensus       150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~-l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis  224 (722)
T KOG0532|consen  150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRD-LNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS  224 (722)
T ss_pred             EecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHH-HHHhhhhhh-hCCHHHhCC-ceeeeecccCcee
Confidence            6666654 55555555555666666666655 55555555555533 555555555 445555533 4555666666665


Q ss_pred             cccccccccCccccEEEecCCccCCCCCCcc
Q 002746          378 GNIFIQISNCIAVRLINISHNALQGNLPDSL  408 (885)
Q Consensus       378 ~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~  408 (885)
                       .+|-.|..+..|+.|-|.+|.|+ ..|..+
T Consensus       225 -~iPv~fr~m~~Lq~l~LenNPLq-SPPAqI  253 (722)
T KOG0532|consen  225 -YLPVDFRKMRHLQVLQLENNPLQ-SPPAQI  253 (722)
T ss_pred             -ecchhhhhhhhheeeeeccCCCC-CChHHH
Confidence             35555666666666666666655 344333

>PLN03150 hypothetical protein; Provisional

Probab=99.41  E-value=3.2e-13  Score=158.00  Aligned_cols=119  Identities=34%  Similarity=0.602  Sum_probs=94.4

Q ss_pred             CcceeecCCCccccccccccccCccccEEEecCCccCCCCCCccccccccccccccCcccccccCcccCCCceecEEEcc
Q 002746          365 NVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLS  444 (885)
Q Consensus       365 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  444 (885)
                      .++.|+|++|.+++.+|..+..+.+|+.|+|++|.++|.+|..++.+++|+.|+|++|++++.+|..+.++++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            36778888888888888888888888888888888888888888888888888888888888888888888888888888


Q ss_pred             cccccccCCCC--CccCCCCccccccCcccccCCCCCCCCCC
Q 002746          445 FNEFKGMIPSG--GIFNSATKMSFVGNQHLCGTVPGMPICPP  484 (885)
Q Consensus       445 ~N~l~~~~p~~--~~~~~~~~~~~~~n~~~c~~~~~~~~~~~  484 (885)
                      +|+++|.+|..  ..+.++..+.+.+|+.+|+.+ +.+.|..
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p-~l~~C~~  539 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP-GLRACGP  539 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCC-CCCCCcc
Confidence            88888888763  223345567789999999854 3466754

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.38  E-value=6.2e-13  Score=149.09  Aligned_cols=180  Identities=36%  Similarity=0.531  Sum_probs=82.5

Q ss_pred             CCCCeEecccccccccCcccccCCC-CCCeeecccccccccCCccccCCCcccEEEccCCccCCCCCcccCCCCCCCEEE
Q 002746          243 SQLEQLFLSHNLFSGEIPAALGKLH-HLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLD  321 (885)
Q Consensus       243 ~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  321 (885)
                      +.++.|++.+|.++ .++.....+. +|+.|++++|++. ..|..+..+++|+.|++++|+++ .+|...+.+++|+.|+
T Consensus       116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~  192 (394)
T COG4886         116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD  192 (394)
T ss_pred             cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence            33444444444443 2333333332 4444444444443 22233344444444444444443 2233222344444444


Q ss_pred             CcCCcCcccCCccccCccceeeeeeccCCcCCCCchhhhcCCCCcceeecCCCccccccccccccCccccEEEecCCccC
Q 002746          322 LSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQ  401 (885)
Q Consensus       322 l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~  401 (885)
                      +++|+++ .+|........+ ..|.+++|.+. ..+..+..+.++..|.+++|++.. .+..+..+.+++.|++++|+++
T Consensus       193 ls~N~i~-~l~~~~~~~~~L-~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~~~~~l~~l~~L~~s~n~i~  268 (394)
T COG4886         193 LSGNKIS-DLPPEIELLSAL-EELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQIS  268 (394)
T ss_pred             ccCCccc-cCchhhhhhhhh-hhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccchhccccccceecccccccc
Confidence            4444444 333332222223 22444444332 344455555555555566665552 2445555556666666666665


Q ss_pred             CCCCCccccccccccccccCcccccccCcc
Q 002746          402 GNLPDSLGDLKNLEAIDVSGNHLSGIIPIS  431 (885)
Q Consensus       402 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  431 (885)
                      .. +. ++.+.+|+.|++++|.+...+|..
T Consensus       269 ~i-~~-~~~~~~l~~L~~s~n~~~~~~~~~  296 (394)
T COG4886         269 SI-SS-LGSLTNLRELDLSGNSLSNALPLI  296 (394)
T ss_pred             cc-cc-ccccCccCEEeccCccccccchhh
Confidence            32 22 666666666666666666444433

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.38  E-value=1.6e-12  Score=145.20  Aligned_cols=141  Identities=20%  Similarity=0.271  Sum_probs=100.0

Q ss_pred             cceecccCcceEEEEEeCCCCEEEEEEeeecCCcc----------------------------------------hhhHH
Q 002746          562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNF----------------------------------------TKSFN  601 (885)
Q Consensus       562 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~  601 (885)
                      .+.||.|++|.||+|++++|+.||||+.+......                                        .-+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36899999999999999999999999986431100                                        01244


Q ss_pred             HHHHHHhhcC-----CcccceeeeeeecCCcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHH-HH
Q 002746          602 RECQVLKRIR-----HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE-GM  675 (885)
Q Consensus       602 ~E~~~l~~l~-----h~niv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~-~L  675 (885)
                      .|++.+.+++     ++++.-..-+.......++||||++|+++.+.......        ..   .+.+++..++. .+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--------~~---~~~~ia~~~~~~~l  270 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--------GL---DRKALAENLARSFL  270 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--------CC---CHHHHHHHHHHHHH
Confidence            5666655552     33332222222334567999999999999886542210        01   23456666666 47


Q ss_pred             HHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeee
Q 002746          676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM  716 (885)
Q Consensus       676 ~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~  716 (885)
                      ..+|..|   ++|+|++|.||++++++.++++|||++..+.
T Consensus       271 ~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       271 NQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            8889988   9999999999999999999999999997663

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.36  E-value=9e-13  Score=147.79  Aligned_cols=180  Identities=36%  Similarity=0.547  Sum_probs=86.8

Q ss_pred             CCCCCeeeccccccccccchhhcCCC-CCCeEecccccccccCcccccCCCCCCeeecccccccccCCccccCCCcccEE
Q 002746          218 LSNLISLNLSSNLLSGTISAEISWLS-QLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSL  296 (885)
Q Consensus       218 l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  296 (885)
                      ++.++.|++.+|.++ .++.....+. +|+.|++++|.+. .+|..++.+++|+.|++++|+++ ..|.....++.|+.|
T Consensus       115 ~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L  191 (394)
T COG4886         115 LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNL  191 (394)
T ss_pred             ccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhe
Confidence            344455555555554 2233333332 4555555555554 33344445555555555555554 233333344455555


Q ss_pred             EccCCccCCCCCcccCCCCCCCEEECcCCcCcccCCccccCccceeeeeeccCCcCCCCchhhhcCCCCcceeecCCCcc
Q 002746          297 FLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKF  376 (885)
Q Consensus       297 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  376 (885)
                      ++++|++. .+|.....+..|++|++++|++. ..+..+..+..+. .+.+++|++. ..+..++.+++++.|++++|++
T Consensus       192 ~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~-~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i  267 (394)
T COG4886         192 DLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLS-GLELSNNKLE-DLPESIGNLSNLETLDLSNNQI  267 (394)
T ss_pred             eccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhccccc-ccccCCceee-eccchhccccccceeccccccc
Confidence            55555554 34443333444555555555433 3444444444442 2445555554 2344555555566666666666


Q ss_pred             ccccccccccCccccEEEecCCccCCCCCC
Q 002746          377 TGNIFIQISNCIAVRLINISHNALQGNLPD  406 (885)
Q Consensus       377 ~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~  406 (885)
                      +....  +..+..++.|++++|.+....|.
T Consensus       268 ~~i~~--~~~~~~l~~L~~s~n~~~~~~~~  295 (394)
T COG4886         268 SSISS--LGSLTNLRELDLSGNSLSNALPL  295 (394)
T ss_pred             ccccc--ccccCccCEEeccCccccccchh
Confidence            53322  55556666666666665544433

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.28  E-value=1.7e-12  Score=129.92  Aligned_cols=207  Identities=21%  Similarity=0.293  Sum_probs=139.0

Q ss_pred             HhhcCCcccceeeeeeecCC-----cceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhcc
Q 002746          607 LKRIRHRNLMRIITACSLPD-----FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH  681 (885)
Q Consensus       607 l~~l~h~niv~~~~~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~  681 (885)
                      +-.+.|.|+|++..|+.+..     +..++.|||..|++..+|++....     ...+......+|+.||..||.|||+.
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~-----~~a~~~~~wkkw~tqIlsal~yLhs~  195 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN-----QKALFQKAWKKWCTQILSALSYLHSC  195 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh-----hhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence            44557999999999886543     457899999999999999865432     22467777789999999999999998


Q ss_pred             CCCceEecCCCCCceEecCCCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchh
Q 002746          682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYS  761 (885)
Q Consensus       682 ~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s  761 (885)
                      . ++|+|+++..+-|++..+|-+|++--.-..........++       .....-.+-++|.|||+-.....+.++|||+
T Consensus       196 ~-PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~-------~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~  267 (458)
T KOG1266|consen  196 D-PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTRE-------AEKSVNTSLPGFSAPESGTTTNTTGASDIYK  267 (458)
T ss_pred             C-CccccCCcchhheeecCCceEEecccCccccchhhhhhhH-------hhhhccccCCccccCCcCcccccccchhhhh
Confidence            6 6799999999999999999888843221111111100000       0011123568999999988878889999999


Q ss_pred             hHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCC
Q 002746          762 FGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPS  841 (885)
Q Consensus       762 lG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~  841 (885)
                      ||+..+||..|..--...   . +  ++       ...+.+...+.....              .-=...+..|+...|.
T Consensus       268 fgmcAlemailEiq~tns---e-S--~~-------~~ee~ia~~i~~len--------------~lqr~~i~kcl~~eP~  320 (458)
T KOG1266|consen  268 FGMCALEMAILEIQSTNS---E-S--KV-------EVEENIANVIIGLEN--------------GLQRGSITKCLEGEPN  320 (458)
T ss_pred             hhHHHHHHHHheeccCCC---c-c--ee-------ehhhhhhhheeeccC--------------ccccCcCcccccCCCC
Confidence            999999998876531110   0 0  00       000000000110000              0013456789999999


Q ss_pred             CCCCHHHHHHHH
Q 002746          842 TRPTMLDAADDL  853 (885)
Q Consensus       842 ~RPt~~ev~~~L  853 (885)
                      .||+|.+.+.|.
T Consensus       321 ~rp~ar~llfHp  332 (458)
T KOG1266|consen  321 GRPDARLLLFHP  332 (458)
T ss_pred             CCcchhhhhcCc
Confidence            999999987764

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.25  E-value=3.5e-11  Score=117.71  Aligned_cols=130  Identities=18%  Similarity=0.185  Sum_probs=97.9

Q ss_pred             cceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccc-eeeeeeecCCcceEEEecccCCcc
Q 002746          562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLM-RIITACSLPDFKALVLPYMANGSL  640 (885)
Q Consensus       562 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lV~e~~~~gsL  640 (885)
                      .+.++.|.++.||+++.. ++.|++|+...... ....+..|+.+++.+.+..++ +++.+.  ....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            356889999999999876 78899998764322 234578899999998765554 444443  3345899999999887


Q ss_pred             ccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccC--CCceEecCCCCCceEecCCCCEEEcccccce
Q 002746          641 DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS--PVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       641 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      ...-              .   ....++.+++++++.||..+  +..++|||++|.||+++ ++.++++|||.|.
T Consensus        79 ~~~~--------------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTED--------------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccc--------------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            6430              0   01235678999999999987  23469999999999999 6689999999885

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.25  E-value=1.2e-12  Score=128.95  Aligned_cols=137  Identities=23%  Similarity=0.302  Sum_probs=100.4

Q ss_pred             ccCCCCCCCEEECcCCcCcccCCccccCccceeeeeeccCCcCCCCchhhhcCCCCcceeecCCCccccccccccccCcc
Q 002746          310 TLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIA  389 (885)
Q Consensus       310 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  389 (885)
                      .+...+.|++||||+|.|+ .+.++..-++.++ .|++|+|.|. .+. .+..+++|+.||||+|.++. +..+-..+.+
T Consensus       279 ~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir-~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLGN  353 (490)
T KOG1259|consen  279 SADTWQELTELDLSGNLIT-QIDESVKLAPKLR-RLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLAE-CVGWHLKLGN  353 (490)
T ss_pred             ecchHhhhhhccccccchh-hhhhhhhhcccee-EEecccccee-eeh-hhhhcccceEeecccchhHh-hhhhHhhhcC
Confidence            3444566778888888887 6777777777773 5888888887 333 37888888888888888874 3344456778


Q ss_pred             ccEEEecCCccCCCCCCccccccccccccccCccccccc-CcccCCCceecEEEcccccccccCC
Q 002746          390 VRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGII-PISLNKIHTLTFINLSFNEFKGMIP  453 (885)
Q Consensus       390 L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~p  453 (885)
                      ++.|+|+.|.+..  -..+..|-+|..||+++|+|.... -..++++|.|+.+.|.+|++.+.+.
T Consensus       354 IKtL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd  416 (490)
T KOG1259|consen  354 IKTLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD  416 (490)
T ss_pred             EeeeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence            8888888888863  245667778888899999887422 2357888899999999999887665

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.23  E-value=1.8e-12  Score=123.89  Aligned_cols=130  Identities=30%  Similarity=0.394  Sum_probs=44.3

Q ss_pred             CCCCCcEEeCCCCcccccCchhhh-CCCCCcEEEccCcccccCCchhhhcCCCCCCEEEcCCCcccccCCccC-CCCCCC
Q 002746           17 KLRRLRHLQLDGNNLHGQIPESLA-LLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEI-GNCPNL   94 (885)
Q Consensus        17 ~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~i~~~~~~~~f~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L   94 (885)
                      +...+++|+|++|+|+.+  +.++ .+.+|+.|+|++|.|+ .++.  |..++.|++|++++|+|+.+. ..+ ..+++|
T Consensus        17 n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~-~l~~--l~~L~~L~~L~L~~N~I~~i~-~~l~~~lp~L   90 (175)
T PF14580_consen   17 NPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQIT-KLEG--LPGLPRLKTLDLSNNRISSIS-EGLDKNLPNL   90 (175)
T ss_dssp             ---------------------S--TT-TT--EEE-TTS--S---TT------TT--EEE--SS---S-C-HHHHHH-TT-
T ss_pred             cccccccccccccccccc--cchhhhhcCCCEEECCCCCCc-cccC--ccChhhhhhcccCCCCCCccc-cchHHhCCcC
Confidence            444577888888888743  3455 5778888888888887 4542  677788888888888887443 333 357788


Q ss_pred             cEEEcccccCcccCCcccccCccceEecccccccCCCChhhhcCCCCCcEEECCCCcccCCCCCCCcccccccCCCCCCC
Q 002746           95 WTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDL  174 (885)
Q Consensus        95 ~~L~L~~N~l~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L  174 (885)
                      ++|+|++|+|....                     .+  ..++.+++|++|+|.+|+++..+.-.     .-.+..+++|
T Consensus        91 ~~L~L~~N~I~~l~---------------------~l--~~L~~l~~L~~L~L~~NPv~~~~~YR-----~~vi~~lP~L  142 (175)
T PF14580_consen   91 QELYLSNNKISDLN---------------------EL--EPLSSLPKLRVLSLEGNPVCEKKNYR-----LFVIYKLPSL  142 (175)
T ss_dssp             -EEE-TTS---SCC---------------------CC--GGGGG-TT--EEE-TT-GGGGSTTHH-----HHHHHH-TT-
T ss_pred             CEEECcCCcCCChH---------------------Hh--HHHHcCCCcceeeccCCcccchhhHH-----HHHHHHcChh
Confidence            88888888886210                     11  23567788888888888877543211     1124556666


Q ss_pred             cEEEec
Q 002746          175 EELELA  180 (885)
Q Consensus       175 ~~L~l~  180 (885)
                      +.||-.
T Consensus       143 k~LD~~  148 (175)
T PF14580_consen  143 KVLDGQ  148 (175)
T ss_dssp             SEETTE
T ss_pred             heeCCE
Confidence            666643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.23  E-value=9.1e-12  Score=136.35  Aligned_cols=253  Identities=21%  Similarity=0.182  Sum_probs=176.9

Q ss_pred             hCCcccceecc--cCcceEEEEEe---CCCCEEEEEEeee--cCCcchhhHHHHHHHHhhc-CCcccceeeeeeecCCcc
Q 002746          557 AEFDEQRLLGT--GSYGRVYKGIL---QDGTAIAVKVLQL--QSGNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFK  628 (885)
Q Consensus       557 ~~~~~~~~lg~--G~~g~V~~~~~---~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  628 (885)
                      ..|.....+|.  |.+|.||.+..   .++..+|+|.-+.  ........=.+|+..-.++ .|++.++.+..++..+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            34666788999  99999999986   3688899998442  2223334445666666666 599999999999999999


Q ss_pred             eEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHH----HHHHhhccCCCceEecCCCCCceEecCC-CC
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE----GMAYLHHHSPVRVIHCDLKPSNVLLNDD-MT  703 (885)
Q Consensus       629 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~ivH~Dlkp~NILl~~~-~~  703 (885)
                      ++-+|++. .++..+.+....        -++....+.+..+..+    |+.++|..+   |+|-|+||+||++..+ ..
T Consensus       194 fiqtE~~~-~sl~~~~~~~~~--------~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s  261 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTPCN--------FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTS  261 (524)
T ss_pred             eeeecccc-chhHHhhhcccc--------cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccce
Confidence            99999985 666665543221        1556666777777777    999999998   9999999999999999 89


Q ss_pred             EEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCC
Q 002746          704 ALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGG  783 (885)
Q Consensus       704 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~  783 (885)
                      .+++|||+...+.........      .......|...|++||...+ .++.++|+|++|.+..+..+|..+...-..  
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~------~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--  332 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVF------KVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN--  332 (524)
T ss_pred             eecCCcceeEEccCCccccce------eeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC--
Confidence            999999999887543211110      11112257788999998765 668999999999999999998776543100  


Q ss_pred             ccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 002746          784 LSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  852 (885)
                         ..|.+.    +-..+-++.               ++....++...+..+++.+|..|++.+.+..+
T Consensus       333 ---~~W~~~----r~~~ip~e~---------------~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  333 ---SSWSQL----RQGYIPLEF---------------CEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             ---CCcccc----ccccCchhh---------------hcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence               111100    000000001               11122345558888999999999998887664

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.21  E-value=3.4e-12  Score=125.89  Aligned_cols=208  Identities=21%  Similarity=0.270  Sum_probs=126.7

Q ss_pred             CCccccCCCCCCeeeccccccccccchhhcCCCCCCeEecccccccccCcccccCCCCCCeeeccc-ccccccCCccccC
Q 002746          211 IPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSF-NKLSGEIPVSLGN  289 (885)
Q Consensus       211 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~  289 (885)
                      +|-.+..+++|..+.+|.+.-.. +.+....-+.|+++...+..++. .|. +-..+.+.-+.-+. .-..|..-.....
T Consensus       206 l~f~l~~f~~l~~~~~s~~~~~~-i~~~~~~kptl~t~~v~~s~~~~-~~~-l~pe~~~~D~~~~E~~t~~G~~~~~~dT  282 (490)
T KOG1259|consen  206 LSFNLNAFRNLKTLKFSALSTEN-IVDIELLKPTLQTICVHNTTIQD-VPS-LLPETILADPSGSEPSTSNGSALVSADT  282 (490)
T ss_pred             cccchHHhhhhheeeeeccchhh-eeceeecCchhheeeeecccccc-ccc-ccchhhhcCccCCCCCccCCceEEecch
Confidence            33344455666666666665442 22223334567777766655542 111 11111111111110 0111222222333


Q ss_pred             CCcccEEEccCCccCCCCCcccCCCCCCCEEECcCCcCcccCCccccCccceeeeeeccCCcCCCCchhhhcCCCCccee
Q 002746          290 LVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEI  369 (885)
Q Consensus       290 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~p~~~~~l~~L~~L  369 (885)
                      ...|++++|++|.|+ .+.+...-.++++.|++|+|.|. .+.. +..+.+| ..||||+|.++ ...++-.++.|++.|
T Consensus       283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L-~~LDLS~N~Ls-~~~Gwh~KLGNIKtL  357 (490)
T KOG1259|consen  283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQL-QLLDLSGNLLA-ECVGWHLKLGNIKTL  357 (490)
T ss_pred             Hhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccc-eEeecccchhH-hhhhhHhhhcCEeee
Confidence            456777777777776 45555666677777777777776 3332 6666666 45777777777 566677778888888


Q ss_pred             ecCCCccccccccccccCccccEEEecCCccCCC-CCCccccccccccccccCccccccc
Q 002746          370 DLSSNKFTGNIFIQISNCIAVRLINISHNALQGN-LPDSLGDLKNLEAIDVSGNHLSGII  428 (885)
Q Consensus       370 ~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~  428 (885)
                      .|+.|.|..  ...+..+-+|..||+++|++... -...+++||-|+.|.|.+|+|.+..
T Consensus       358 ~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  358 KLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             ehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence            888888863  45567778888899999988743 2357899999999999999999543

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.20  E-value=9.7e-12  Score=118.96  Aligned_cols=111  Identities=26%  Similarity=0.337  Sum_probs=40.8

Q ss_pred             hhCCCCCcEEEccCcccccCCchhhhc-CCCCCCEEEcCCCcccccCCccCCCCCCCcEEEcccccCcccCCcccccCcc
Q 002746           39 LALLSNLTLVTLHDNNLTGMLPISFFH-NCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSM  117 (885)
Q Consensus        39 ~~~l~~L~~L~L~~N~i~~~~~~~~f~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L  117 (885)
                      +.+..+++.|+|++|.|+ .+..  ++ .+.+|+.|||++|.|+.+  +.+..+++|++|++++|+|+            
T Consensus        15 ~~n~~~~~~L~L~~n~I~-~Ie~--L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~------------   77 (175)
T PF14580_consen   15 YNNPVKLRELNLRGNQIS-TIEN--LGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS------------   77 (175)
T ss_dssp             ----------------------S----TT-TT--EEE-TTS--S----TT----TT--EEE--SS---------------
T ss_pred             cccccccccccccccccc-cccc--hhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC------------
Confidence            344556788888888888 4542  34 477888888888888854  35777888888888888887            


Q ss_pred             ceEecccccccCCCChhhhcCCCCCcEEECCCCcccCCCCCCCcccccccCCCCCCCcEEEecCcccC
Q 002746          118 YNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLG  185 (885)
Q Consensus       118 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~  185 (885)
                                  .+...+...+++|++|+|++|+|.++.+-       ..++.+++|+.|++.+|.+.
T Consensus        78 ------------~i~~~l~~~lp~L~~L~L~~N~I~~l~~l-------~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   78 ------------SISEGLDKNLPNLQELYLSNNKISDLNEL-------EPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             ------------S-CHHHHHH-TT--EEE-TTS---SCCCC-------GGGGG-TT--EEE-TT-GGG
T ss_pred             ------------ccccchHHhCCcCCEEECcCCcCCChHHh-------HHHHcCCCcceeeccCCccc
Confidence                        66655556799999999999999887652       24666777777777777653

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.20  E-value=2.1e-10  Score=112.09  Aligned_cols=136  Identities=20%  Similarity=0.194  Sum_probs=98.2

Q ss_pred             cceecccCcceEEEEEeCC-------CCEEEEEEeeecC----------------------Ccchhh----HHHHHHHHh
Q 002746          562 QRLLGTGSYGRVYKGILQD-------GTAIAVKVLQLQS----------------------GNFTKS----FNRECQVLK  608 (885)
Q Consensus       562 ~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~----~~~E~~~l~  608 (885)
                      ..+||.|--+.||.|...+       +..+|||+.+...                      ....+.    ..+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999998543       5799999985221                      001122    237999999


Q ss_pred             hcCC--cccceeeeeeecCCcceEEEecccCCccccc-cccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHh-hccCCC
Q 002746          609 RIRH--RNLMRIITACSLPDFKALVLPYMANGSLDSH-LYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL-HHHSPV  684 (885)
Q Consensus       609 ~l~h--~niv~~~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~  684 (885)
                      ++..  -.+.+++++    ...++||||+.++.+... +...          .++......+..+++.++..+ |+.+  
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----------~~~~~~~~~i~~~i~~~l~~l~H~~g--  145 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----------KLNDEEMKNAYYQVLSMMKQLYKECN--  145 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----------ccCHHHHHHHHHHHHHHHHHHHHhCC--
Confidence            9854  455666654    456899999977544221 2111          134455667889999999999 7887  


Q ss_pred             ceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       685 ~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                       |||||+++.||+++ ++.+.++|||.|...
T Consensus       146 -lVHGDLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         146 -LVHADLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             -eecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence             99999999999997 468999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PLN03150 hypothetical protein; Provisional

Probab=99.19  E-value=5.9e-11  Score=139.04  Aligned_cols=111  Identities=32%  Similarity=0.506  Sum_probs=102.2

Q ss_pred             eeeeccCCcCCCCchhhhcCCCCcceeecCCCccccccccccccCccccEEEecCCccCCCCCCccccccccccccccCc
Q 002746          343 IFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGN  422 (885)
Q Consensus       343 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~l~~N  422 (885)
                      ..|+|++|.++|.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|+|++|++++.+|+.++.+++|+.|+|++|
T Consensus       421 ~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N  500 (623)
T PLN03150        421 DGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN  500 (623)
T ss_pred             EEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCC
Confidence            56999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCcccCCC-ceecEEEcccccccccCC
Q 002746          423 HLSGIIPISLNKI-HTLTFINLSFNEFKGMIP  453 (885)
Q Consensus       423 ~l~~~~~~~~~~l-~~L~~L~l~~N~l~~~~p  453 (885)
                      +++|.+|..+..+ .++..+++++|...+-.|
T Consensus       501 ~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        501 SLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             cccccCChHHhhccccCceEEecCCccccCCC
Confidence            9999999998764 567889999998655433

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.18  E-value=2.6e-12  Score=144.03  Aligned_cols=242  Identities=28%  Similarity=0.314  Sum_probs=120.5

Q ss_pred             CCCCCcEEEccCcccccCCchhhhcCCCCCCEEEcCCCcccccCCccCCCCCCCcEEEcccccCcccCCcccccCccceE
Q 002746           41 LLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNL  120 (885)
Q Consensus        41 ~l~~L~~L~L~~N~i~~~~~~~~f~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L  120 (885)
                      .+..++.+++..|.|.. +- ..+..+++|+.|++.+|+|..+ ...+..+++|++|+|++|+|+               
T Consensus        70 ~l~~l~~l~l~~n~i~~-~~-~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~---------------  131 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIAK-IL-NHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKIT---------------  131 (414)
T ss_pred             HhHhHHhhccchhhhhh-hh-cccccccceeeeeccccchhhc-ccchhhhhcchheeccccccc---------------
Confidence            34444444455555542 11 1134455555555555555522 222444555555555555554               


Q ss_pred             ecccccccCCCChhhhcCCCCCcEEECCCCcccCCCCCCCcccccccCCCCCCCcEEEecCcccCccCCC-ccccccccE
Q 002746          121 DVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPD-SIGRLNLTQ  199 (885)
Q Consensus       121 ~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~p~-~~~~~~L~~  199 (885)
                               .+..  +..++.|+.|++++|.|+.+..          +..++.|+.+++++|.+...-+. .-...+++.
T Consensus       132 ---------~i~~--l~~l~~L~~L~l~~N~i~~~~~----------~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~  190 (414)
T KOG0531|consen  132 ---------KLEG--LSTLTLLKELNLSGNLISDISG----------LESLKSLKLLDLSYNRIVDIENDELSELISLEE  190 (414)
T ss_pred             ---------cccc--hhhccchhhheeccCcchhccC----------CccchhhhcccCCcchhhhhhhhhhhhccchHH
Confidence                     2222  3445556666666666665443          33455555555555555432221 122225666


Q ss_pred             EEccCCcccccCCccccCCCCCCeeeccccccccccchhhcCCC--CCCeEecccccccccCcccccCCCCCCeeecccc
Q 002746          200 LLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLS--QLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFN  277 (885)
Q Consensus       200 L~l~~n~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~--~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N  277 (885)
                      +++.+|.+..+  ..+..+..+..+++..|.++...+  +..+.  +|+.+++++|.+. ..+..+..+..+..|++++|
T Consensus       191 l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n  265 (414)
T KOG0531|consen  191 LDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSN  265 (414)
T ss_pred             HhccCCchhcc--cchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhc
Confidence            66666666533  334445555555666676663322  12222  2667777777766 33355666666777777777


Q ss_pred             cccccCCccccCCCcccEEEccCCccCCC---CCcc-cCCCCCCCEEECcCCcCc
Q 002746          278 KLSGEIPVSLGNLVQIYSLFLNNNQLSRS---IPPT-LGRCTDLYKLDLSYNRLT  328 (885)
Q Consensus       278 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~---~~~~-~~~l~~L~~L~l~~N~l~  328 (885)
                      ++...  ..+.....+..+.+..|.+...   .... ....+.+..+.+.+|.+.
T Consensus       266 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (414)
T KOG0531|consen  266 RISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIR  318 (414)
T ss_pred             ccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccc
Confidence            66532  2234444555555555555411   1111 333445555555555554

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.13  E-value=5.3e-11  Score=134.27  Aligned_cols=145  Identities=19%  Similarity=0.260  Sum_probs=93.3

Q ss_pred             hCCcccceecccCcceEEEEEeCC-CCEEEEEEeeecCCc----------------------------------ch----
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGN----------------------------------FT----  597 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~----  597 (885)
                      .+|+. +.||+|++|.||+|++++ |+.||||+.++....                                  ..    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            35666 789999999999999887 999999999743100                                  01    


Q ss_pred             --hhHHHHHHHHhhcC----Ccccceeeeee-ecCCcceEEEecccCCcccccc--ccCCccccCCCCCCCCHHHHHHHH
Q 002746          598 --KSFNRECQVLKRIR----HRNLMRIITAC-SLPDFKALVLPYMANGSLDSHL--YPHSETEFGSGSSDLTLLQRVNIC  668 (885)
Q Consensus       598 --~~~~~E~~~l~~l~----h~niv~~~~~~-~~~~~~~lV~e~~~~gsL~~~l--~~~~~~~~~~~~~~l~~~~~~~i~  668 (885)
                        -++.+|+..+.+++    +...+.+-..+ ......++||||++|+.+.+.-  .....     ....+.......++
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~-----d~~~la~~~v~~~~  273 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT-----DMKLLAERGVEVFF  273 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC-----CHHHHHHHHHHHHH
Confidence              12444555555542    33333332222 2245678999999999997642  11110     00012222222233


Q ss_pred             HHHHHHHHHhhccCCCceEecCCCCCceEecCCC----CEEEcccccceeeec
Q 002746          669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDM----TALVSDFGIAKLVMT  717 (885)
Q Consensus       669 ~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~----~~kl~Dfg~a~~~~~  717 (885)
                      .|       ++..|   ++|+|+||.||+++.++    .++++|||++..+..
T Consensus       274 ~Q-------if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        274 TQ-------VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HH-------HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            33       34566   99999999999999888    999999999887743

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.13  E-value=8.7e-12  Score=129.70  Aligned_cols=207  Identities=25%  Similarity=0.253  Sum_probs=114.2

Q ss_pred             cCCCCCCeeeccccccccccc--hhhcCCCCCCeEecccccccccCc--ccccCCCCCCeeecccccccccCCcc-ccCC
Q 002746          216 GNLSNLISLNLSSNLLSGTIS--AEISWLSQLEQLFLSHNLFSGEIP--AALGKLHHLGLLDLSFNKLSGEIPVS-LGNL  290 (885)
Q Consensus       216 ~~l~~L~~L~l~~N~l~~~~~--~~~~~l~~L~~L~L~~N~i~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l  290 (885)
                      .++++|+...|.++.+. ..+  .....+++++.|||++|.+....+  .....+++|+.|+|+.|++....... -..+
T Consensus       118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l  196 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL  196 (505)
T ss_pred             hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence            35667777777777776 323  355667888888888887764222  34556788888888888876322211 1245


Q ss_pred             CcccEEEccCCccCC-CCCcccCCCCCCCEEECcCCcCcccCCccccCccceeeeeeccCCcCCCCch--hhhcCCCCcc
Q 002746          291 VQIYSLFLNNNQLSR-SIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLP--IELSKLENVQ  367 (885)
Q Consensus       291 ~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~p--~~~~~l~~L~  367 (885)
                      ++|+.|.|+.|.++- .+-.....+|+|+.|+|.+|...........-+..| +.|||++|++-. .+  ...+.++.|+
T Consensus       197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L-~~LdLs~N~li~-~~~~~~~~~l~~L~  274 (505)
T KOG3207|consen  197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTL-QELDLSNNNLID-FDQGYKVGTLPGLN  274 (505)
T ss_pred             hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHH-hhccccCCcccc-cccccccccccchh
Confidence            677788888887761 112234456778888888875322222223333344 346666666652 22  3455566666


Q ss_pred             eeecCCCcccccccccc------ccCccccEEEecCCccCCC-CCCccccccccccccccCcccc
Q 002746          368 EIDLSSNKFTGNIFIQI------SNCIAVRLINISHNALQGN-LPDSLGDLKNLEAIDVSGNHLS  425 (885)
Q Consensus       368 ~L~Ls~N~l~~~~~~~~------~~l~~L~~L~ls~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~  425 (885)
                      .|+++.+.++..-....      ..+++|+.|++++|++..- .-..+..+++|+.|.+..|.|+
T Consensus       275 ~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln  339 (505)
T KOG3207|consen  275 QLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN  339 (505)
T ss_pred             hhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence            66666666654322222      3344555555555555311 1122333344444444444444

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.12  E-value=1.2e-12  Score=132.61  Aligned_cols=262  Identities=22%  Similarity=0.299  Sum_probs=162.8

Q ss_pred             hcCCCCCcEEECCCCcccCCCCCCCcccccccCCCCCCCcEEEecCcccC---ccCCCccccccccEEEccCCcccccCC
Q 002746          136 MSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLG---GTLPDSIGRLNLTQLLLQENKITGSIP  212 (885)
Q Consensus       136 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~---~~~p~~~~~~~L~~L~l~~n~i~~~~~  212 (885)
                      ...+.++++|+|++|.+..-...    .....+.+.+.|+..++++.-.+   ..+|+.+.                .+.
T Consensus        26 ~~~~~s~~~l~lsgnt~G~EAa~----~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~----------------~l~   85 (382)
T KOG1909|consen   26 LEPMDSLTKLDLSGNTFGTEAAR----AIAKVLASKKELREVNLSDMFTGRLKDEIPEALK----------------MLS   85 (382)
T ss_pred             hcccCceEEEeccCCchhHHHHH----HHHHHHhhcccceeeehHhhhcCCcHHHHHHHHH----------------HHH
Confidence            45677888888888877543221    11223566667777776653321   11222211                112


Q ss_pred             ccccCCCCCCeeeccccccccccchh----hcCCCCCCeEecccccccccCcccccCCCCCCeeecccccccccCCcccc
Q 002746          213 PHIGNLSNLISLNLSSNLLSGTISAE----ISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLG  288 (885)
Q Consensus       213 ~~~~~l~~L~~L~l~~N~l~~~~~~~----~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  288 (885)
                      .++...++|++||||+|.+....+..    +..+..|++|.|.+|.+.-.--..+++  .|..|.  .|+.       .+
T Consensus        86 ~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~kk-------~~  154 (382)
T KOG1909|consen   86 KALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNKK-------AA  154 (382)
T ss_pred             HHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHhc-------cC
Confidence            34445567888888888776443333    345677777777777766222222222  222222  2222       22


Q ss_pred             CCCcccEEEccCCccCCC----CCcccCCCCCCCEEECcCCcCcccCCccccCccceeeeeeccCCcCCCCchhhhcCCC
Q 002746          289 NLVQIYSLFLNNNQLSRS----IPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLE  364 (885)
Q Consensus       289 ~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~p~~~~~l~  364 (885)
                      .-+.|+++..++|++...    +...|...+.|+.+.++.|.|.   |....                  .+-..|..++
T Consensus       155 ~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~---~eG~~------------------al~eal~~~~  213 (382)
T KOG1909|consen  155 SKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIR---PEGVT------------------ALAEALEHCP  213 (382)
T ss_pred             CCcceEEEEeeccccccccHHHHHHHHHhccccceEEEeccccc---CchhH------------------HHHHHHHhCC
Confidence            335778888888887532    2245667778888888888775   21110                  2345678888


Q ss_pred             CcceeecCCCccccc----cccccccCccccEEEecCCccCCCCCCccc-----cccccccccccCccccc----ccCcc
Q 002746          365 NVQEIDLSSNKFTGN----IFIQISNCIAVRLINISHNALQGNLPDSLG-----DLKNLEAIDVSGNHLSG----IIPIS  431 (885)
Q Consensus       365 ~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~-----~l~~L~~L~l~~N~l~~----~~~~~  431 (885)
                      +|+.|||.+|-|+..    ....++.+++|+.|+++.+.++.....+|.     ..|+|++|.+.+|.|+.    .+...
T Consensus       214 ~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~  293 (382)
T KOG1909|consen  214 HLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAAC  293 (382)
T ss_pred             cceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHH
Confidence            999999999988732    334567788899999999988765433332     25899999999999983    34455


Q ss_pred             cCCCceecEEEccccccc
Q 002746          432 LNKIHTLTFINLSFNEFK  449 (885)
Q Consensus       432 ~~~l~~L~~L~l~~N~l~  449 (885)
                      ....+.|..|+|++|.+.
T Consensus       294 ~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  294 MAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             HhcchhhHHhcCCccccc
Confidence            667899999999999984

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.11  E-value=1.5e-11  Score=137.93  Aligned_cols=247  Identities=27%  Similarity=0.267  Sum_probs=149.2

Q ss_pred             cCCCCCcEEeCCCCcccccCchhhhCCCCCcEEEccCcccccCCchhhhcCCCCCCEEEcCCCcccccCCccCCCCCCCc
Q 002746           16 SKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLW   95 (885)
Q Consensus        16 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~f~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   95 (885)
                      ..+..++.+.++.|.|. .+-..+..+++|+.|++.+|+|+ .+.. .+..+++|++|+|++|+|+.+.  .+..++.|+
T Consensus        69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~-~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~  143 (414)
T KOG0531|consen   69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIEN-LLSSLVNLQVLDLSFNKITKLE--GLSTLTLLK  143 (414)
T ss_pred             HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hccc-chhhhhcchheecccccccccc--chhhccchh
Confidence            35667888889999887 34456888899999999999998 4432 2567899999999999998653  467778899


Q ss_pred             EEEcccccCcccCCcccccCccceEecccccccCCCChhhhcCCCCCcEEECCCCcccCCCCCCCcccccccCCCCCCCc
Q 002746           96 TLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLE  175 (885)
Q Consensus        96 ~L~L~~N~l~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~  175 (885)
                      .|++++|.|+. +...-....|+.+++++|.+. .+.......+.+|+.+.+.+|.+..+..          +..+.   
T Consensus       144 ~L~l~~N~i~~-~~~~~~l~~L~~l~l~~n~i~-~ie~~~~~~~~~l~~l~l~~n~i~~i~~----------~~~~~---  208 (414)
T KOG0531|consen  144 ELNLSGNLISD-ISGLESLKSLKLLDLSYNRIV-DIENDELSELISLEELDLGGNSIREIEG----------LDLLK---  208 (414)
T ss_pred             hheeccCcchh-ccCCccchhhhcccCCcchhh-hhhhhhhhhccchHHHhccCCchhcccc----------hHHHH---
Confidence            99999999972 222111234444444444444 2222101344445555555554443321          11111   


Q ss_pred             EEEecCcccCccCCCccccccccEEEccCCcccccCCccccCCCC--CCeeeccccccccccchhhcCCCCCCeEecccc
Q 002746          176 ELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSN--LISLNLSSNLLSGTISAEISWLSQLEQLFLSHN  253 (885)
Q Consensus       176 ~L~l~~~~l~~~~p~~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~--L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N  253 (885)
                                          .+..+++..|.++.+.+  +..+..  |+.+++++|.+. ..+..+..+.++..|++.+|
T Consensus       209 --------------------~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n  265 (414)
T KOG0531|consen  209 --------------------KLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSN  265 (414)
T ss_pred             --------------------HHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhc
Confidence                                33444566666654322  222233  677777777776 33355666777777777777


Q ss_pred             cccccCcccccCCCCCCeeeccccccccc---CCcc-ccCCCcccEEEccCCccCCCC
Q 002746          254 LFSGEIPAALGKLHHLGLLDLSFNKLSGE---IPVS-LGNLVQIYSLFLNNNQLSRSI  307 (885)
Q Consensus       254 ~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~~-~~~l~~L~~L~l~~N~l~~~~  307 (885)
                      ++...  ..+.....+..+.+..|++...   .... ......++.+.+..|.+....
T Consensus       266 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
T KOG0531|consen  266 RISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKIS  321 (414)
T ss_pred             ccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCcccccc
Confidence            77632  2345556666777777766521   1111 445667777777777775433

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.10  E-value=2.3e-12  Score=130.52  Aligned_cols=89  Identities=26%  Similarity=0.307  Sum_probs=37.7

Q ss_pred             ccCCCCCCeeeccccccccc----CCccccCCCcccEEEccCCccCCCCCccc-----CCCCCCCEEECcCCcCcc----
Q 002746          263 LGKLHHLGLLDLSFNKLSGE----IPVSLGNLVQIYSLFLNNNQLSRSIPPTL-----GRCTDLYKLDLSYNRLTG----  329 (885)
Q Consensus       263 ~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~-----~~l~~L~~L~l~~N~l~~----  329 (885)
                      |..+++|+.|||.+|-++..    ....+..+++|+.|++++|.+...-..+|     ...++|++|.|.+|.|+.    
T Consensus       209 l~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~  288 (382)
T KOG1909|consen  209 LEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAAL  288 (382)
T ss_pred             HHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHH
Confidence            44444444444444444321    12233444445555555555442211111     124555555555555542    


Q ss_pred             cCCccccCccceeeeeeccCCcC
Q 002746          330 SIPAEISGIREIRIFLNLSHNQL  352 (885)
Q Consensus       330 ~~~~~~~~l~~l~~~L~L~~N~l  352 (885)
                      .+...+...+.|. .|+|++|.+
T Consensus       289 ~la~~~~ek~dL~-kLnLngN~l  310 (382)
T KOG1909|consen  289 ALAACMAEKPDLE-KLNLNGNRL  310 (382)
T ss_pred             HHHHHHhcchhhH-HhcCCcccc
Confidence            1122223344442 255555555

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.08  E-value=1.7e-11  Score=127.53  Aligned_cols=226  Identities=23%  Similarity=0.262  Sum_probs=130.8

Q ss_pred             EeCCCCcccccCchhh----hCCCCCcEEEccCcccccCCch-hhhcCCCCCCEEEcCCCcccccCC--ccCCCCCCCcE
Q 002746           24 LQLDGNNLHGQIPESL----ALLSNLTLVTLHDNNLTGMLPI-SFFHNCTSLRNVDLSQNFFTGKIP--EEIGNCPNLWT   96 (885)
Q Consensus        24 L~L~~n~l~~~~~~~~----~~l~~L~~L~L~~N~i~~~~~~-~~f~~l~~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~   96 (885)
                      +.+++-+++.+.-+.+    ..+.+|+...|.++.+. ..+. .....|++++.||||+|-+....+  .....||+|+.
T Consensus        98 ~si~nK~vE~iGfDki~akQsn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~  176 (505)
T KOG3207|consen   98 LSISNKQVEFIGFDKIAAKQSNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLEN  176 (505)
T ss_pred             hhhcCceeEEecHHHHHHHhhhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchh
Confidence            4455555544333333    35677888888887776 3332 345678888888888887774322  34566788888


Q ss_pred             EEcccccCcccCCccc--ccCccceEecccccccCCCChhhhcCCCCCcEEECCCCcccCCCCCCCcccccccCCCCCCC
Q 002746           97 LSLYNNQLTGQLPASL--INTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDL  174 (885)
Q Consensus        97 L~L~~N~l~~~~~~~~--~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L  174 (885)
                      |+|+.|++..-.....  ....++.|.|+.|.++..--..+...+|+|+.|+|.+|....+...        +...+.  
T Consensus       177 LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~--------~~~i~~--  246 (505)
T KOG3207|consen  177 LNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKAT--------STKILQ--  246 (505)
T ss_pred             cccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecc--------hhhhhh--
Confidence            8888888762111111  1133444444444443211122233444555555554421110000        011111  


Q ss_pred             cEEEecCcccCccCCCccccccccEEEccCCcccccC-CccccCCCCCCeeecccccccccc-chh-----hcCCCCCCe
Q 002746          175 EELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSI-PPHIGNLSNLISLNLSSNLLSGTI-SAE-----ISWLSQLEQ  247 (885)
Q Consensus       175 ~~L~l~~~~l~~~~p~~~~~~~L~~L~l~~n~i~~~~-~~~~~~l~~L~~L~l~~N~l~~~~-~~~-----~~~l~~L~~  247 (885)
                                           .|++|+|++|++.+.. -...+.++.|+.|+++.|.|..+- |+.     ...+++|++
T Consensus       247 ---------------------~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~  305 (505)
T KOG3207|consen  247 ---------------------TLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEY  305 (505)
T ss_pred             ---------------------HHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhccccccee
Confidence                                 5667777777766322 134677888888888888887542 222     245788999


Q ss_pred             EecccccccccCc--ccccCCCCCCeeeccccccccc
Q 002746          248 LFLSHNLFSGEIP--AALGKLHHLGLLDLSFNKLSGE  282 (885)
Q Consensus       248 L~L~~N~i~~~~~--~~~~~l~~L~~L~Ls~N~l~~~  282 (885)
                      |+++.|+|.. .+  ..+..+++|+.|.+..|.+...
T Consensus       306 L~i~~N~I~~-w~sl~~l~~l~nlk~l~~~~n~ln~e  341 (505)
T KOG3207|consen  306 LNISENNIRD-WRSLNHLRTLENLKHLRITLNYLNKE  341 (505)
T ss_pred             eecccCcccc-ccccchhhccchhhhhhccccccccc
Confidence            9999999863 33  4566778889999999998743

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.08  E-value=5.9e-10  Score=123.18  Aligned_cols=166  Identities=19%  Similarity=0.208  Sum_probs=124.8

Q ss_pred             eCCCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEecccCCccccccccCCccccCCCCC
Q 002746          578 LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSS  657 (885)
Q Consensus       578 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~  657 (885)
                      ..++.+|.|+..+...........+-++.++.+|||+|++++..++.++..|+|+|-+.-  |..++..           
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~-----------  100 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE-----------  100 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH-----------
Confidence            447889999998876665566778888899999999999999999999999999998742  2222321           


Q ss_pred             CCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecccCCCCCCCCCCCCcccccc
Q 002746          658 DLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC  737 (885)
Q Consensus       658 ~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~  737 (885)
                       +........+.||+.||.|||+.+  .++|++|.-+.|++++.|+.||++|.++......+.           ......
T Consensus       101 -l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-----------~~~~~~  166 (690)
T KOG1243|consen  101 -LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-----------PAKSLY  166 (690)
T ss_pred             -hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-----------ccccch
Confidence             223344557889999999999776  599999999999999999999999998865422110           111122


Q ss_pred             ccccccCCcccCCCCCCccccchhhHHHHHHHHcC
Q 002746          738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR  772 (885)
Q Consensus       738 gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg  772 (885)
                      ---.|..|+.+....  -..|.|.|||+++|++.|
T Consensus       167 ~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  167 LIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            233467777544332  346999999999999999

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.08  E-value=7.2e-10  Score=103.81  Aligned_cols=131  Identities=22%  Similarity=0.318  Sum_probs=102.8

Q ss_pred             ceecccCcceEEEEEeCCCCEEEEEEeeecCCc--------chhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEEec
Q 002746          563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGN--------FTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~  634 (885)
                      ..+++|+-+.+|.+.+. |..+++|.-..+...        ...+-.+|+.++.+++--.|.-.+-+..+++...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            45789999999999875 445666653222111        234566899999999877777777777788888999999


Q ss_pred             ccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccccee
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      ++|-.|.+.+...                +..++..+-.-+.-||..|   |||+|+.++||++..+. +.++|||++..
T Consensus        81 I~G~~lkd~l~~~----------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9998888777533                2457778888899999999   99999999999998765 99999999874

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.08  E-value=3.6e-09  Score=110.01  Aligned_cols=274  Identities=16%  Similarity=0.192  Sum_probs=164.2

Q ss_pred             ccceecccCcceEEEEEeCCCCEEEEEEeeecCCcchhhHHHHHHHHhhc-CCcccceeeee----e---ecCCcceEEE
Q 002746          561 EQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLMRIITA----C---SLPDFKALVL  632 (885)
Q Consensus       561 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~----~---~~~~~~~lV~  632 (885)
                      ..+.||+|+.+.+|..-  +-+..+.|+.+........   +.++.|... .||-+-.-+.|    .   .......+.|
T Consensus        15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecc--hhhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            45779999999999542  1223355776644332222   223333333 56654331111    0   1122245677


Q ss_pred             ecccCC-ccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEccccc
Q 002746          633 PYMANG-SLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       633 e~~~~g-sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~  711 (885)
                      ..+++. -+..++....+..-   -.-..|...++.++.+|.+.+.||+.|   .+-||+.++|+|+++++.+.+.|-..
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs---~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQS---YPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             ccCCCccchhhhcCchhhccc---CCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccc
Confidence            776554 12222222221111   112789999999999999999999999   88899999999999999999988665


Q ss_pred             ceeeecccCCCCCCCCCCCCccccccccccccCCcccC-----CCCCCccccchhhHHHHHHHHcC-CCCCCccccCCcc
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF-----GSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLS  785 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg-~~P~~~~~~~~~~  785 (885)
                      -....            .....-..+|...|.+||...     +-..+...|-|.+|+++++++.| ++||.........
T Consensus       164 fqi~~------------ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a  231 (637)
T COG4248         164 FQINA------------NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA  231 (637)
T ss_pred             eeecc------------CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC
Confidence            44321            112233457889999999754     34557889999999999999987 9999765332110


Q ss_pred             HHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCC--CCCCCCHHHHHHHHHHHHHHhc
Q 002746          786 LHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQES--PSTRPTMLDAADDLDRLKRYLG  861 (885)
Q Consensus       786 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d--P~~RPt~~ev~~~L~~l~~~~~  861 (885)
                      -.-.-..+-.+.+...-+..  ...+  .+....-|...++++..+..+|+...  +.-|||++.++..|..+...+.
T Consensus       232 p~p~E~~Ia~g~f~ya~~~~--~g~~--p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~  305 (637)
T COG4248         232 PNPLETDIAHGRFAYASDQR--RGLK--PPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK  305 (637)
T ss_pred             CCcchhhhhcceeeechhcc--CCCC--CCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence            00000000111111111110  0111  01111124556778889999999874  4579999999999988776543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.06  E-value=2e-09  Score=110.32  Aligned_cols=142  Identities=20%  Similarity=0.291  Sum_probs=109.2

Q ss_pred             ceecccCcceEEEEEeCCCCEEEEEEeeecCC-cchhhHHHHHHHHhhcCCcc--cceeeeeeecCC---cceEEEeccc
Q 002746          563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRN--LMRIITACSLPD---FKALVLPYMA  636 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~---~~~lV~e~~~  636 (885)
                      +.++.|.++.||++...+|+.+++|....... .....+..|+++++.+++.+  +.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999987778999998764322 23567899999999997644  566777766542   5689999999


Q ss_pred             CCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccC----------------------------------
Q 002746          637 NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS----------------------------------  682 (885)
Q Consensus       637 ~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----------------------------------  682 (885)
                      +.++...+...          .++...+..++.++++++.+||+..                                  
T Consensus        84 G~~l~~~~~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          84 GRVLRDRLLRP----------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             CEecCCCCCCC----------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            99887765311          2566677778888888888888521                                  


Q ss_pred             -------------------CCceEecCCCCCceEecC--CCCEEEccccccee
Q 002746          683 -------------------PVRVIHCDLKPSNVLLND--DMTALVSDFGIAKL  714 (885)
Q Consensus       683 -------------------~~~ivH~Dlkp~NILl~~--~~~~kl~Dfg~a~~  714 (885)
                                         +..++|+|+.|.||+++.  ++.+.++||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                               234799999999999998  66789999998863

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.04  E-value=1.2e-09  Score=101.46  Aligned_cols=143  Identities=22%  Similarity=0.284  Sum_probs=107.6

Q ss_pred             ccceecccCcceEEEEEeCCCCEEEEEEeeecC--------CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceEEE
Q 002746          561 EQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQS--------GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       561 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~  632 (885)
                      ...++.||+-+.|+++.+. |+...||.-....        .-...+..+|++.+.+++--.|.-..-++.+.....++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4578999999999999987 7776776532221        112456788999999987667666666677777789999


Q ss_pred             ecccC-CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCC---CEEEcc
Q 002746          633 PYMAN-GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDM---TALVSD  708 (885)
Q Consensus       633 e~~~~-gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~---~~kl~D  708 (885)
                      ||+++ .++.+++.......       ........++..|-+.+.-||..+   |+|||+..+||++..++   .+.++|
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-------~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lId  159 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-------SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILID  159 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-------ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEe
Confidence            99976 47777776554332       222233678899999999999998   99999999999997554   458999


Q ss_pred             ccccee
Q 002746          709 FGIAKL  714 (885)
Q Consensus       709 fg~a~~  714 (885)
                      ||++..
T Consensus       160 fgls~~  165 (229)
T KOG3087|consen  160 FGLSSV  165 (229)
T ss_pred             ecchhc
Confidence            999863

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.01  E-value=2.1e-10  Score=90.25  Aligned_cols=61  Identities=41%  Similarity=0.561  Sum_probs=43.0

Q ss_pred             CCCcEEEccCcccccCCchhhhcCCCCCCEEEcCCCcccccCCccCCCCCCCcEEEcccccC
Q 002746           43 SNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQL  104 (885)
Q Consensus        43 ~~L~~L~L~~N~i~~~~~~~~f~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  104 (885)
                      ++|++|++++|+|+ .+|.+.|.++++|++|+|++|+|+.+.+++|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            35667777777776 56666677777777777777777766667777777777777777764

...

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.00  E-value=1.3e-10  Score=133.41  Aligned_cols=212  Identities=21%  Similarity=0.262  Sum_probs=145.7

Q ss_pred             HhhCCcccceecccCcceEEEEEeC-CCCEEEEEEeeecC---CcchhhHHHHHHHHhhcCCcccceeeeeeecCCcceE
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKAL  630 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  630 (885)
                      ..+.|.+.+.+-+|+++.++.+.-. .|...+.|+.....   ....+....+-.+.-..++|.++....-+......++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            4466777888899999999987743 35444555443221   1112222233333323355666665555555667789


Q ss_pred             EEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccc
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG  710 (885)
Q Consensus       631 V~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg  710 (885)
                      |++|..++++..-++....         .+..........+..+.+|||...   +.|+|++|.|++...+++.+++|||
T Consensus       882 ~~~~~~~~~~~Skl~~~~~---------~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~  949 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGC---------LSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFG  949 (1205)
T ss_pred             hhHHhccCCchhhhhcCCC---------cccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccc
Confidence            9999999999888875542         233333445567888999999986   8999999999999999999999999


Q ss_pred             cceeeecccC----------------CCCCCCCC----CCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHH
Q 002746          711 IAKLVMTVGV----------------GNDGAENM----GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV  770 (885)
Q Consensus       711 ~a~~~~~~~~----------------~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ell  770 (885)
                      ..........                ..+.....    .........||+.|.+||...+......+|+|++|++++|.+
T Consensus       950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen  950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred             cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence            6554432200                00000000    001123457899999999999999999999999999999999


Q ss_pred             cCCCCCCc
Q 002746          771 TRRRPTDD  778 (885)
Q Consensus       771 tg~~P~~~  778 (885)
                      +|..||.+
T Consensus      1030 ~g~pp~na 1037 (1205)
T KOG0606|consen 1030 TGIPPFNA 1037 (1205)
T ss_pred             cCCCCCCC
Confidence            99999976

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.99  E-value=3.9e-10  Score=123.71  Aligned_cols=249  Identities=17%  Similarity=0.177  Sum_probs=172.5

Q ss_pred             HhhCCcccceecccCcceEEEEEeC--CCCEEEEEEeeecCCcchhh--HHHHHHHHhhc-CCcccceeeeeeecCCcce
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ--DGTAIAVKVLQLQSGNFTKS--FNRECQVLKRI-RHRNLMRIITACSLPDFKA  629 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  629 (885)
                      ...+|..+..||.|.|+.|+....+  ++..|++|...........+  -..|+.+...+ .|.++++.+..+...+..+
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            3467888899999999999998744  67889999876443332222  23455555555 6899999888887778888


Q ss_pred             EEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCC-CCEEEcc
Q 002746          630 LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDD-MTALVSD  708 (885)
Q Consensus       630 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~-~~~kl~D  708 (885)
                      +=-|||.+++......-.         ..++...++++..|++.++.++|++.   ++|+|+||+||++..+ +..+++|
T Consensus       343 ip~e~~~~~s~~l~~~~~---------~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~  410 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTS---------QMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGD  410 (524)
T ss_pred             CchhhhcCcchhhhhHHH---------HhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccc
Confidence            889999999887655211         12566677889999999999999988   9999999999999876 8889999


Q ss_pred             cccceeeecccCCCCCCCCCCCCcccccccccccc--CCcccCCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccH
Q 002746          709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM--APEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSL  786 (885)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~  786 (885)
                      ||.++.+.-             .. ....++-+++  +|+......+..+.|+||||.-+.|.++|..--..       .
T Consensus       411 ~~~~t~~~~-------------~~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-------~  469 (524)
T KOG0601|consen  411 FGCWTRLAF-------------SS-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-------G  469 (524)
T ss_pred             cccccccce-------------ec-ccccccccccccchhhccccccccccccccccccccccccCcccCcc-------c
Confidence            999874311             00 0111223344  55566667788999999999999999998653221       0


Q ss_pred             HHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHHHHH
Q 002746          787 HKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLK  857 (885)
Q Consensus       787 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~  857 (885)
                      .+|..              +....-...+.       ...++..+...+..+++..||.+.+...+.+-++
T Consensus       470 ~~~~~--------------i~~~~~p~~~~-------~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  470 VQSLT--------------IRSGDTPNLPG-------LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             cccee--------------eecccccCCCc-------hHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence            11100              00000000000       1244667777799999999999998877765543

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.92  E-value=6.5e-10  Score=87.43  Aligned_cols=61  Identities=39%  Similarity=0.546  Sum_probs=57.3

Q ss_pred             CCCcEEeCCCCcccccCchhhhCCCCCcEEEccCcccccCCchhhhcCCCCCCEEEcCCCcc
Q 002746           19 RRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFF   80 (885)
Q Consensus        19 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~f~~l~~L~~L~Ls~N~l   80 (885)
                      ++|++|++++|+|+.+.++.|.++++|++|++++|+|+ .++...|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~-~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLT-SIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSES-EEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccC-ccCHHHHcCCCCCCEEeCcCCcC
Confidence            47999999999999888899999999999999999999 78888899999999999999986

...

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.90  E-value=1e-08  Score=100.10  Aligned_cols=125  Identities=25%  Similarity=0.354  Sum_probs=81.9

Q ss_pred             eEEEEEeCCCCEEEEEEeeecCC-------------c-------------chhhHHHHHHHHhhcCCc--ccceeeeeee
Q 002746          572 RVYKGILQDGTAIAVKVLQLQSG-------------N-------------FTKSFNRECQVLKRIRHR--NLMRIITACS  623 (885)
Q Consensus       572 ~V~~~~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~E~~~l~~l~h~--niv~~~~~~~  623 (885)
                      .||.|...+|..+|||+.+....             .             ......+|++.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999998999999999853210             0             123466899999999766  455666542 


Q ss_pred             cCCcceEEEeccc--CCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHH-hhccCCCceEecCCCCCceEecC
Q 002746          624 LPDFKALVLPYMA--NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY-LHHHSPVRVIHCDLKPSNVLLND  700 (885)
Q Consensus       624 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~~ivH~Dlkp~NILl~~  700 (885)
                         ..++||||++  |..+.. +....          +.......++.+++..+.. +|..|   |||||+.+.||++++
T Consensus        80 ---~~~ivME~I~~~G~~~~~-l~~~~----------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~  142 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPR-LKDVD----------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDD  142 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGC-HHHCG----------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEET
T ss_pred             ---CCEEEEEecCCCccchhh-HHhcc----------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeec
Confidence               4589999998  444433 32211          1122345677788885555 57887   999999999999998


Q ss_pred             CCCEEEcccccceee
Q 002746          701 DMTALVSDFGIAKLV  715 (885)
Q Consensus       701 ~~~~kl~Dfg~a~~~  715 (885)
                      + .+.++|||.|...
T Consensus       143 ~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  143 G-KVYIIDFGQAVDS  156 (188)
T ss_dssp             T-CEEE--GTTEEET
T ss_pred             c-eEEEEecCcceec
Confidence            8 9999999998743

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.87  E-value=2.2e-09  Score=128.28  Aligned_cols=128  Identities=28%  Similarity=0.385  Sum_probs=102.8

Q ss_pred             CCCcEEeCCCCcccccCchhhhCCCCCcEEEccCcc--cccCCchhhhcCCCCCCEEEcCCCcccccCCccCCCCCCCcE
Q 002746           19 RRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNN--LTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWT   96 (885)
Q Consensus        19 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~--i~~~~~~~~f~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   96 (885)
                      ...++..+-+|++. .++..... ++|++|-+.+|.  +. .++..+|..++.|+.||||+|.=-+.+|..++.|-+||.
T Consensus       523 ~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry  599 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY  599 (889)
T ss_pred             hheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence            56888999999887 55555544 379999999996  55 677788999999999999998766789999999999999


Q ss_pred             EEcccccCcccCCccccc-CccceEecccccccCCCChhhhcCCCCCcEEECCCCc
Q 002746           97 LSLYNNQLTGQLPASLIN-TSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNN  151 (885)
Q Consensus        97 L~L~~N~l~~~~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~  151 (885)
                      |+|++..++ .+|..+.. ..|.+|++..+.-...+ +++...|.+|++|.+..-.
T Consensus       600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~-~~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESI-PGILLELQSLRVLRLPRSA  653 (889)
T ss_pred             ccccCCCcc-ccchHHHHHHhhheeccccccccccc-cchhhhcccccEEEeeccc
Confidence            999999998 56666655 67888888888765344 5666779999999887655

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.84  E-value=8.7e-08  Score=102.77  Aligned_cols=175  Identities=18%  Similarity=0.187  Sum_probs=130.3

Q ss_pred             cceEEEEEeC-CCCEEEEEEeeecCCcchhhHHHHHHHHhhcCCcccceeeeeee----cCCcceEEEecccC-Cccccc
Q 002746          570 YGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS----LPDFKALVLPYMAN-GSLDSH  643 (885)
Q Consensus       570 ~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~lV~e~~~~-gsL~~~  643 (885)
                      ..+.|+|... ||..|++|+++............-+++++++.|.|+|++..++.    .+...++||+|+++ ++|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            4688999854 89999999997554444444556788999999999999988876    34466899999876 466554


Q ss_pred             cccCCccc-----c-CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeec
Q 002746          644 LYPHSETE-----F-GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       644 l~~~~~~~-----~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      ........     + ...+...++...|.++.|++.||.++|+.|   ...+-+.+.+|+++.+.+++|+.-|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            43222111     1 123334788999999999999999999999   88899999999999998999988887765522


Q ss_pred             ccCCCCCCCCCCCCccccccccccccCCcccCCCCCCccccchhhHHHHHHHHcCCCC
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP  775 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~P  775 (885)
                      ..                       .  |.+   +--.+-|.-.||.+++.+.||..-
T Consensus       446 d~-----------------------~--~~l---e~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DP-----------------------T--EPL---ESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CC-----------------------C--cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence            10                       0  111   112466999999999999999664

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.82  E-value=1.9e-09  Score=128.96  Aligned_cols=274  Identities=21%  Similarity=0.223  Sum_probs=151.2

Q ss_pred             CCCcEEEecCcccCccCCCccccccccEEEccCCc--ccccCCccccCCCCCCeeeccccccccccchhhcCCCCCCeEe
Q 002746          172 TDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENK--ITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLF  249 (885)
Q Consensus       172 ~~L~~L~l~~~~l~~~~p~~~~~~~L~~L~l~~n~--i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  249 (885)
                      ...+...+.+|.+. .++......+|++|.+..|.  +.......|..++.|++|||++|.=-+..|..++.|-+|++|+
T Consensus       523 ~~~rr~s~~~~~~~-~~~~~~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~  601 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIE-HIAGSSENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLD  601 (889)
T ss_pred             hheeEEEEeccchh-hccCCCCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccc
Confidence            44455555555543 33344444467777777775  5545455577778888888887665557777788888888888


Q ss_pred             cccccccccCcccccCCCCCCeeecccccccccCCccccCCCcccEEEccCCccC--CCCCcccCCCCCCCEEECcCCcC
Q 002746          250 LSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLS--RSIPPTLGRCTDLYKLDLSYNRL  327 (885)
Q Consensus       250 L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~--~~~~~~~~~l~~L~~L~l~~N~l  327 (885)
                      |++..|+ .+|..+.+++.|.+||+..+.-...+|.....+.+|++|.+..-...  ...-..+..++.|+.+.......
T Consensus       602 L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~  680 (889)
T KOG4658|consen  602 LSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV  680 (889)
T ss_pred             ccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh
Confidence            8888877 67777888888888888777655555666667777887777554421  12222334445555554433222


Q ss_pred             cccCCccccCccce---eeeeeccCCcCCCCchhhhcCCCCcceeecCCCcccccccccccc------CccccEEEecCC
Q 002746          328 TGSIPAEISGIREI---RIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISN------CIAVRLINISHN  398 (885)
Q Consensus       328 ~~~~~~~~~~l~~l---~~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~------l~~L~~L~ls~N  398 (885)
                        .+-..+..+..+   ...+.+..+... ..+..+..+.+|+.|.+.++.+..........      ++++..+...++
T Consensus       681 --~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~  757 (889)
T KOG4658|consen  681 --LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNC  757 (889)
T ss_pred             --HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhcc
Confidence              011111222222   112222233333 45556777777777777777775432222111      111222222221


Q ss_pred             ccCCCCCCccccccccccccccCcccccccCcccCCCceecEEEccccccccc
Q 002746          399 ALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGM  451 (885)
Q Consensus       399 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  451 (885)
                      ..- ..+.+.-..++|+.|.+.++.....+......+..+..+-+..+.+.+.
T Consensus       758 ~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l  809 (889)
T KOG4658|consen  758 HML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGL  809 (889)
T ss_pred             ccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccc
Confidence            111 1222233446777777777766555555555566666555666665554

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.79  E-value=1.3e-09  Score=107.92  Aligned_cols=90  Identities=26%  Similarity=0.338  Sum_probs=47.8

Q ss_pred             CCCCCEEEcCCCcccc--cCCccCCCCCCCcEEEcccccCcccCCcc-cccCccceEecccccccCCCChhhhcCCCCCc
Q 002746           67 CTSLRNVDLSQNFFTG--KIPEEIGNCPNLWTLSLYNNQLTGQLPAS-LINTSMYNLDVEYNHLSGELPSDIMSKLPSLT  143 (885)
Q Consensus        67 l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~  143 (885)
                      .+.++.|||.+|+|+.  .+...+.+||.|++|+|+.|++...+... ....+|..|-|.+..+.-.-.......+|.++
T Consensus        70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt  149 (418)
T KOG2982|consen   70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT  149 (418)
T ss_pred             hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence            3455555555555552  22233445555555555555555322221 12234455555555444333344567888888


Q ss_pred             EEECCCCcccCCC
Q 002746          144 YLHLSYNNMVSHD  156 (885)
Q Consensus       144 ~L~L~~N~l~~~~  156 (885)
                      +|++|.|.+..+.
T Consensus       150 elHmS~N~~rq~n  162 (418)
T KOG2982|consen  150 ELHMSDNSLRQLN  162 (418)
T ss_pred             hhhhccchhhhhc
Confidence            8988888665543

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.78  E-value=3.5e-08  Score=98.29  Aligned_cols=152  Identities=21%  Similarity=0.256  Sum_probs=107.6

Q ss_pred             CCCCcCHHHHHHHhhCCcccceecccCcceEEEEEeCCCCEEEEEEeeecCC----------------------cchhhH
Q 002746          543 NFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSG----------------------NFTKSF  600 (885)
Q Consensus       543 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~  600 (885)
                      .+..+....+.....-..+...||-|--+.||.|..++|.++|||.-+....                      ......
T Consensus        77 GyD~LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A  156 (304)
T COG0478          77 GYDALALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAA  156 (304)
T ss_pred             chhHHHHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHH
Confidence            3344445555555545567789999999999999999999999997642110                      012346


Q ss_pred             HHHHHHHhhcCCc--ccceeeeeeecCCcceEEEecccCCccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 002746          601 NRECQVLKRIRHR--NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL  678 (885)
Q Consensus       601 ~~E~~~l~~l~h~--niv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L  678 (885)
                      ++|.++|.++...  .+.+.+++    +..++||||+++-.|...--              +......|+..|..-+.-.
T Consensus       157 ~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~--------------~~en~~~il~~il~~~~~~  218 (304)
T COG0478         157 EREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL--------------DVENPDEILDKILEEVRKA  218 (304)
T ss_pred             HHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeecccC--------------cccCHHHHHHHHHHHHHHH
Confidence            7899999998655  56666553    56789999998866654321              1222334555555555555


Q ss_pred             hccCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          679 HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       679 H~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      -..|   |||||+++-||++++||.+.++||-.+...
T Consensus       219 ~~~G---iVHGDlSefNIlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         219 YRRG---IVHGDLSEFNILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             HHcC---ccccCCchheEEEecCCCEEEEeCcccccC
Confidence            5666   999999999999999999999999987643

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.72  E-value=1e-10  Score=128.46  Aligned_cols=132  Identities=27%  Similarity=0.317  Sum_probs=102.6

Q ss_pred             CCCCEEECcCCcCcccCCccccCccceeeeeeccCCcCCCCchhhhcCCCCcceeecCCCccccccccccccCccccEEE
Q 002746          315 TDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLIN  394 (885)
Q Consensus       315 ~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  394 (885)
                      -+|...+.++|++. .....+.-++.+ .+|||++|+++..  ..+..+++|++|||++|.++.+.--...+|. |+.|+
T Consensus       164 n~L~~a~fsyN~L~-~mD~SLqll~al-e~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~  238 (1096)
T KOG1859|consen  164 NKLATASFSYNRLV-LMDESLQLLPAL-ESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLN  238 (1096)
T ss_pred             hhHhhhhcchhhHH-hHHHHHHHHHHh-hhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeee
Confidence            36788888899988 677777767777 5689999999843  2888999999999999999854444445566 99999


Q ss_pred             ecCCccCCCCCCccccccccccccccCcccccccC-cccCCCceecEEEcccccccccCC
Q 002746          395 ISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIP-ISLNKIHTLTFINLSFNEFKGMIP  453 (885)
Q Consensus       395 ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p  453 (885)
                      +++|.++..  ..+.+|++|+.|||++|-|.+.-. ..++.+..|+.|+|.+|++...+-
T Consensus       239 lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~  296 (1096)
T KOG1859|consen  239 LRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPW  296 (1096)
T ss_pred             ecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHH
Confidence            999999743  457889999999999998885332 235678888999999999876543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.69  E-value=9.9e-08  Score=99.03  Aligned_cols=141  Identities=15%  Similarity=0.081  Sum_probs=98.7

Q ss_pred             ceecccCcceEEEEEeCCCCEEEEEEeeecCC-----------cchhhHHHHHHHHhhcCCccc--ceeeeeeec-----
Q 002746          563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQSG-----------NFTKSFNRECQVLKRIRHRNL--MRIITACSL-----  624 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~-----  624 (885)
                      +.+-......|+++.+. |+.|.||.......           .....+.+|...+.++...+|  .+++++.+.     
T Consensus        28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            34444444557777664 78899997643221           111247899999988854443  344555533     


Q ss_pred             CCcceEEEecccCC-ccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecC---
Q 002746          625 PDFKALVLPYMANG-SLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND---  700 (885)
Q Consensus       625 ~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~---  700 (885)
                      ....++|+|++++. +|.+++.....       ...+...+..++.+++..+.-||..|   |+|+|++++|||++.   
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~-------~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~  176 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWAT-------NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFP  176 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcc-------cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEecccc
Confidence            23468999999876 78877642111       12445667789999999999999999   999999999999975   


Q ss_pred             ----CCCEEEccccccee
Q 002746          701 ----DMTALVSDFGIAKL  714 (885)
Q Consensus       701 ----~~~~kl~Dfg~a~~  714 (885)
                          ++.+.++||+.+..
T Consensus       177 ~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        177 GREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCCCCceEEEEECCcccc
Confidence                47899999998753

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.51  E-value=1.4e-06  Score=86.22  Aligned_cols=154  Identities=23%  Similarity=0.277  Sum_probs=102.9

Q ss_pred             CCCcCHHHHHHHhhCCcccce---ecccCcceEEEEEeCCCCEEEEEEeeecCCc------------------------c
Q 002746          544 FPRITYRELLEATAEFDEQRL---LGTGSYGRVYKGILQDGTAIAVKVLQLQSGN------------------------F  596 (885)
Q Consensus       544 ~~~~~~~~~~~~~~~~~~~~~---lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------------------------~  596 (885)
                      +...++..+.....+..+...   |++|--+.||+|...++..+|||+++.....                        .
T Consensus        32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv  111 (268)
T COG1718          32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV  111 (268)
T ss_pred             hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence            445566666666666666555   5566677999999888999999998643211                        1


Q ss_pred             hhhHHHHHHHHhhcC--CcccceeeeeeecCCcceEEEecccCCcc-ccccccCCccccCCCCCCCCHHHHHHHHHHHHH
Q 002746          597 TKSFNRECQVLKRIR--HRNLMRIITACSLPDFKALVLPYMANGSL-DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE  673 (885)
Q Consensus       597 ~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lV~e~~~~gsL-~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~  673 (885)
                      ..+..+|+.-|.++.  +=.+.+.+++.    ...|||||+..... .-.|.          +.++.......+..++++
T Consensus       112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk----------Dv~~e~~e~~~~~~~~v~  177 (268)
T COG1718         112 FAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK----------DVPLELEEAEGLYEDVVE  177 (268)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc----------cCCcCchhHHHHHHHHHH
Confidence            122345666666663  33444555543    34799999965421 11111          111223345667778888


Q ss_pred             HHHHhhc-cCCCceEecCCCCCceEecCCCCEEEcccccceee
Q 002746          674 GMAYLHH-HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       674 ~L~~LH~-~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      .+.-|-. .+   +||+|++.-|||+. ++.+.|+|||.|...
T Consensus       178 ~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         178 YMRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             HHHHHHHhcC---cccccchhhheEEE-CCeEEEEECcccccc
Confidence            8888877 44   99999999999999 889999999998754

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.48  E-value=5.8e-08  Score=108.15  Aligned_cols=159  Identities=19%  Similarity=0.298  Sum_probs=103.9

Q ss_pred             HHHHHHHHHhhccCCCceEecCCCCCceEecCCCCEEEcccccceeeecccCCCCCCCCCCCCccccccccccccCCccc
Q 002746          669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYG  748 (885)
Q Consensus       669 ~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  748 (885)
                      .+++.|+.|+|..-  ++||++|.|++|.++..+..||+.|+++....+..  .--....+........-...|.|||++
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~--~~p~~~yd~~lp~~~~~~~~f~apE~~  181 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPT--EYPFSEYDPPLPLLLQPHLNFLAPEYL  181 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCC--ccccccCCCCCChhhccCcccccchhh
Confidence            34559999999875  69999999999999999999999999886543210  000011111111122345689999999


Q ss_pred             CCCCCCccccchhhHHHHHHHHcCCCCCCccccCCccHHHHHHHhhcchhhhhhhhhhhhccCCChHHHHHHHHHHHHHH
Q 002746          749 FGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGEL  828 (885)
Q Consensus       749 ~~~~~~~~~Dv~slG~vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~l  828 (885)
                      .+...+.++|+||+|+.+|.+..|..+--......... ....  ...      +.... ++          ....+.++
T Consensus       182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~--~~~------~~~~~-~~----------s~~~p~el  241 (700)
T KOG2137|consen  182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSR--NLL------NAGAF-GY----------SNNLPSEL  241 (700)
T ss_pred             ccccccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhh--ccc------ccccc-cc----------cccCcHHH
Confidence            99889999999999999999996555532221111111 0000  000      00000 00          12356678


Q ss_pred             HHHHhhhcCCCCCCCCCHHHHHH
Q 002746          829 IELGILCTQESPSTRPTMLDAAD  851 (885)
Q Consensus       829 ~~l~~~cl~~dP~~RPt~~ev~~  851 (885)
                      .+=+.+++..++..||++.++..
T Consensus       242 ~~~l~k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  242 RESLKKLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HHHHHHHhcCCcccCcchhhhhc
Confidence            88899999999999998777654

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.44  E-value=5.4e-08  Score=96.75  Aligned_cols=212  Identities=25%  Similarity=0.267  Sum_probs=121.1

Q ss_pred             CCCCCCeeeccccccccccc-hhh-cCCCCCCeEecccccccc--cCcccccCCCCCCeeecccccccccCCccccCCCc
Q 002746          217 NLSNLISLNLSSNLLSGTIS-AEI-SWLSQLEQLFLSHNLFSG--EIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQ  292 (885)
Q Consensus       217 ~l~~L~~L~l~~N~l~~~~~-~~~-~~l~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  292 (885)
                      .+..++-|.+.++.|....- ..| ...+.++.|||.+|.|+.  .+...+.+|+.|+.|+|+.|++...+...-..+.+
T Consensus        43 s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~n  122 (418)
T KOG2982|consen   43 SLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKN  122 (418)
T ss_pred             cccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccc
Confidence            33445556666666653211 112 235677778888887773  23345667788888888888876433222246678


Q ss_pred             ccEEEccCCccC-CCCCcccCCCCCCCEEECcCCcCcccCCccccCccceeeeeeccCCcCCCCchh--hhcCCCCccee
Q 002746          293 IYSLFLNNNQLS-RSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPI--ELSKLENVQEI  369 (885)
Q Consensus       293 L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~p~--~~~~l~~L~~L  369 (885)
                      |++|.|.+..+. ......+..++.+++|.+|.|.+.               .+++..|.+....|.  .+..++.+..+
T Consensus       123 l~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~r---------------q~n~Dd~c~e~~s~~v~tlh~~~c~~~~  187 (418)
T KOG2982|consen  123 LRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLR---------------QLNLDDNCIEDWSTEVLTLHQLPCLEQL  187 (418)
T ss_pred             eEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhh---------------hhccccccccccchhhhhhhcCCcHHHH
Confidence            888888887774 122344566788888888888765               144455544432211  12223333333


Q ss_pred             ecCCCccccccccccccCccccEEEecCCccCCCC-CCccccccccccccccCcccccc-cCcccCCCceecEEEccccc
Q 002746          370 DLSSNKFTGNIFIQISNCIAVRLINISHNALQGNL-PDSLGDLKNLEAIDVSGNHLSGI-IPISLNKIHTLTFINLSFNE  447 (885)
Q Consensus       370 ~Ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~l~~N~  447 (885)
                      .++-|++..       -++++..+.+..|.|+..- -..+..++.+--|+|+.|+|.+. .-+++.+++.|..|.+++|+
T Consensus       188 w~~~~~l~r-------~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~P  260 (418)
T KOG2982|consen  188 WLNKNKLSR-------IFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENP  260 (418)
T ss_pred             HHHHHhHHh-------hcccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCc
Confidence            444444432       2345555666666555432 23445556666777777777642 22456777777777777777


Q ss_pred             ccc
Q 002746          448 FKG  450 (885)
Q Consensus       448 l~~  450 (885)
                      +..
T Consensus       261 l~d  263 (418)
T KOG2982|consen  261 LSD  263 (418)
T ss_pred             ccc
Confidence            654

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.40  E-value=8.9e-09  Score=113.60  Aligned_cols=130  Identities=31%  Similarity=0.347  Sum_probs=96.4

Q ss_pred             CCcEEeCCCCcccccCchhhhCCCCCcEEEccCcccccCCchhhhcCCCCCCEEEcCCCcccccCCccCCCCCCCcEEEc
Q 002746           20 RLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSL   99 (885)
Q Consensus        20 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~f~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L   99 (885)
                      .|..-+.+.|.+. ...++++-++.|+.|||++|+++ ..  +.+..|++|++|||++|++..+.--.-.++. |+.|+|
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~-~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~l  239 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFT-KV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNL  239 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhh-hh--HHHHhcccccccccccchhccccccchhhhh-heeeee
Confidence            3777888999997 78889999999999999999998 33  3578899999999999999944333344444 999999


Q ss_pred             ccccCcccCCcccccCccceEecccccccCCCChhhhcCCCCCcEEECCCCcccCC
Q 002746          100 YNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSH  155 (885)
Q Consensus       100 ~~N~l~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~  155 (885)
                      ++|.++. .-..-...+|..||+++|-|.+.-.-..+..|..|+.|+|.+|++..-
T Consensus       240 rnN~l~t-L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  240 RNNALTT-LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             cccHHHh-hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            9999872 222223356777888888776543334456677788888888877543

>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification]

Probab=98.39  E-value=4e-07  Score=86.01  Aligned_cols=131  Identities=27%  Similarity=0.315  Sum_probs=99.0

Q ss_pred             CcEEeCCCCcccccCchhhh-CCCCCcEEEccCcccccCCchhhhcCCCCCCEEEcCCCcccccCCccCCCCCCCcEEEc
Q 002746           21 LRHLQLDGNNLHGQIPESLA-LLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSL   99 (885)
Q Consensus        21 L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~i~~~~~~~~f~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L   99 (885)
                      =++++|.+.++..+ -. ++ .+.+...+||++|.|. .++  .|..++.|.+|.|++|+|+.+.|..-.-+++|+.|.|
T Consensus        21 e~e~~LR~lkip~i-en-lg~~~d~~d~iDLtdNdl~-~l~--~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~L   95 (233)
T KOG1644|consen   21 ERELDLRGLKIPVI-EN-LGATLDQFDAIDLTDNDLR-KLD--NLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLIL   95 (233)
T ss_pred             ccccccccccccch-hh-ccccccccceecccccchh-hcc--cCCCccccceEEecCCcceeeccchhhhccccceEEe
Confidence            57789999888733 22 33 3467889999999998 454  3888999999999999999888877777889999999


Q ss_pred             ccccCcccCCcccccCccceEecccccccCCCChhhhcCCCCCcEEECCCCcccCCCCCCCcccccccCCCCCCCcEEEe
Q 002746          100 YNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELEL  179 (885)
Q Consensus       100 ~~N~l~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~l~~l~~L~~L~l  179 (885)
                      .+|.|..                    +. .+.+  +..+|+|++|.+-+|+++....-.     .-.+..+++|+.||+
T Consensus        96 tnNsi~~--------------------l~-dl~p--La~~p~L~~Ltll~Npv~~k~~YR-----~yvl~klp~l~~LDF  147 (233)
T KOG1644|consen   96 TNNSIQE--------------------LG-DLDP--LASCPKLEYLTLLGNPVEHKKNYR-----LYVLYKLPSLRTLDF  147 (233)
T ss_pred             cCcchhh--------------------hh-hcch--hccCCccceeeecCCchhcccCce-----eEEEEecCcceEeeh
Confidence            9999972                    11 3333  467889999999999988754321     113677888888888


Q ss_pred             cCccc
Q 002746          180 AGMDL  184 (885)
Q Consensus       180 ~~~~l  184 (885)
                      ++-..
T Consensus       148 ~kVt~  152 (233)
T KOG1644|consen  148 QKVTR  152 (233)
T ss_pred             hhhhH
Confidence            76543

>PRK09902 hypothetical protein; Provisional

Probab=98.39  E-value=3.1e-06  Score=82.93  Aligned_cols=138  Identities=16%  Similarity=0.072  Sum_probs=100.5

Q ss_pred             ecccCcceEEEEEeCCCCEEEEEEeeecC------CcchhhHHHHHHHHhhcCCcc--cceeeeeee-c----CCcceEE
Q 002746          565 LGTGSYGRVYKGILQDGTAIAVKVLQLQS------GNFTKSFNRECQVLKRIRHRN--LMRIITACS-L----PDFKALV  631 (885)
Q Consensus       565 lg~G~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~-~----~~~~~lV  631 (885)
                      -|+||.+.|++.... |..+-+|.-....      +-....|.+|...+.++..-+  +.+++ ++. .    .-..+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            467899999998765 4568888764211      224567999999999985433  44444 332 1    1234799


Q ss_pred             EecccC-CccccccccCCccccCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCceEecCCCCCceEecCCCC--EEEcc
Q 002746          632 LPYMAN-GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMT--ALVSD  708 (885)
Q Consensus       632 ~e~~~~-gsL~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlkp~NILl~~~~~--~kl~D  708 (885)
                      +|-+.+ -+|.+++.....       .+.+...+..+..+++..++-||+.|   +.|+|+.+.||+++.++.  ++++|
T Consensus       104 Te~L~g~~~L~~~l~~~~~-------~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lID  173 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAV-------SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLD  173 (216)
T ss_pred             EEeCCCCccHHHHHhcCCc-------CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEE
Confidence            997754 477777754321       13567777899999999999999999   999999999999986666  99999


Q ss_pred             ccccee
Q 002746          709 FGIAKL  714 (885)
Q Consensus       709 fg~a~~  714 (885)
                      |.-++.
T Consensus       174 lEk~r~  179 (216)
T PRK09902        174 LEKSRR  179 (216)
T ss_pred             hhccch
Confidence            997764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	885
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-41
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		9e-41
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		9e-38
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		3e-23
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-37
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		5e-23
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-32
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-32
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-24
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-24
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-23
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-23
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-23
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-22
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-20
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-20
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-20
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-20
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-20
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-20
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-20
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-20
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-20
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-20
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-20
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-20
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-20
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-20
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-20
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-20
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-20
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-20
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-20
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-20
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-20
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-20
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-20
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-20
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		9e-20
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-19
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-19
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-19
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-19
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-19
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		7e-19
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-19
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-19
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-18
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-18
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-18
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-18
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-17
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		8e-17
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		8e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-16
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-16
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-16
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		9e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-15
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-15
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-15
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-15
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-15
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-15
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-15
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-15
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-15
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		8e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		9e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-14
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-14
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		7e-14
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-14
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		7e-14
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-14
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		8e-14
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-14
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		8e-14
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		9e-14
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		9e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		9e-14
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-13
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-13
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-13
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		6e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		6e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		7e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		7e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		7e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		8e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		9e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		9e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		9e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-12
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-12
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-12
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-12
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		6e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-12
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		7e-12
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		8e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-12
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		9e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		9e-12
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-11
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-11
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-11
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-11
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-11
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-11
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-11
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-11
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-11
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-11
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-11
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-11
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-11
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-11
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-11
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-11
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-11
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-11
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-11
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-11
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-11
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-11
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-11
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-11
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-11
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-11
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		7e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		8e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		8e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		8e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-11
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		8e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		9e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		9e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		9e-11
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-10
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-10
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-10
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-10
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-10
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		9e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		9e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		9e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-09
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		6e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		7e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		8e-09
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		8e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-08
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		8e-08
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-08
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-08
4fie_A	423	Full-Length Human Pak4 Length = 423		8e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		8e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		9e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		9e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		9e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		9e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		9e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		9e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		9e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		9e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		9e-08
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		7e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		7e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		8e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		8e-07
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		8e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		9e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		9e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		9e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		6e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		7e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		7e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		8e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		8e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		9e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		9e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		9e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-05
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-05
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		7e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		7e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		8e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		8e-05
3rfs_A	272	Design Of A Binding Scaffold Based On Variable Lymp		9e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		9e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-04
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		1e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-04
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-04
2z7x_A	549	Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu		1e-04
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-04
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		1e-04
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		1e-04
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-04
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-04
2z80_A	353	Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu		2e-04
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-04
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-04
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-04
2z63_A	570	Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A		4e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		4e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-04
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		6e-04
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		6e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		7e-04
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		8e-04
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  168 bits (425), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 111/317 (35%), Positives = 168/317 (52%), Gaps = 35/317 (11%)
Query: 538 PEL-MHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQ---LQS 593
           PE+ +    R + REL  A+  F  + +LG G +G+VYKG L DGT +AVK L+    Q 
Sbjct: 18  PEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQG 77
Query: 594 GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFG 653
           G     F  E +++    HRNL+R+   C  P  + LV PYMANGS+ S L    E++  
Sbjct: 78  GEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-- 133
Query: 654 SGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK 713
               D    QR+ + S  A G+AYLH H   ++IH D+K +N+LL+++  A+V DFG+AK
Sbjct: 134 -PPLDWPKRQRIALGS--ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 190
Query: 714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRR 773
           L+          +         + G+IG++APEY     +S K DV+ +G+++LE++T +
Sbjct: 191 LM----------DYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 240
Query: 774 RPTDDMFAG---GLSLHKWVKN-HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELI 829
           R  D         + L  WVK      +LE ++D  L    +D+  E          +LI
Sbjct: 241 RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVE----------QLI 290
Query: 830 ELGILCTQESPSTRPTM 846
           ++ +LCTQ SP  RP M
Sbjct: 291 QVALLCTQSSPMERPKM 307

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  165 bits (418), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 110/317 (34%), Positives = 166/317 (52%), Gaps = 35/317 (11%)
Query: 538 PEL-MHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQ---LQS 593
           PE+ +    R + REL  A+  F  + +LG G +G+VYKG L DG  +AVK L+    Q 
Sbjct: 10  PEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQG 69
Query: 594 GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFG 653
           G     F  E +++    HRNL+R+   C  P  + LV PYMANGS+ S L    E++  
Sbjct: 70  GEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-- 125
Query: 654 SGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK 713
               D    QR+ + S  A G+AYLH H   ++IH D+K +N+LL+++  A+V DFG+AK
Sbjct: 126 -PPLDWPKRQRIALGS--ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
Query: 714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRR 773
           L+          +         + G IG++APEY     +S K DV+ +G+++LE++T +
Sbjct: 183 LM----------DYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 232
Query: 774 RPTDDMFAG---GLSLHKWVKNHY-HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELI 829
           R  D         + L  WVK      +LE ++D  L    +D+  E          +LI
Sbjct: 233 RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVE----------QLI 282
Query: 830 ELGILCTQESPSTRPTM 846
           ++ +LCTQ SP  RP M
Sbjct: 283 QVALLCTQSSPMERPKM 299

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  155 bits (392), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 152/534 (28%), Positives = 226/534 (42%), Gaps = 66/534 (12%)
Query: 5   NHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPEXXXXXXXXXXXXXHDNNLTGMLPISFF 64
           N L G      S    L+ L +  N   G IP               +N  TG +P    
Sbjct: 230 NKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLA--ENKFTGEIPDFLS 287
Query: 65  HNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPAS--LINTSMYNLDV 122
             C +L  +DLS N F G +P   G+C  L +L+L +N  +G+LP    L    +  LD+
Sbjct: 288 GACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDL 347
Query: 123 EYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTD----LEELE 178
            +N  SGELP  + +   SL  L LS NN           P   +L  C +    L+EL 
Sbjct: 348 SFNEFSGELPESLTNLSASLLTLDLSSNNFSG--------PILPNL--CQNPKNTLQELY 397
Query: 179 LAGMDLGGTLPDSIGRLN-LTQLLLQENKITGSIPPHIGXXXXXXXXXXXXXXXXGTISA 237
           L      G +P ++   + L  L L  N ++G+IP  +G                G I  
Sbjct: 398 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ 457
Query: 238 EISWLSQLEQLFLSHNLFSGEIPAAXXXXXXXXXXXXSFNKLSGEIPVSLGNLVQIYSLF 297
           E+ ++  LE L L  N  +GEIP+             S N+L+GEIP  +G L  +  L 
Sbjct: 458 ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK 517
Query: 298 LNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAE------------ISGIREIRI-- 343
           L+NN  S +IP  LG C  L  LDL+ N   G+IPA             I+G R + I  
Sbjct: 518 LSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKN 577
Query: 344 --FLNLSHN-----QLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINIS 396
                  H      + +G    +L++L      +++S  + G+      N  ++  +++S
Sbjct: 578 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMS 637
Query: 397 HNAL------------------------QGNLPDSLGDLKNLEAIDVSGNHLSGIIPISL 432
           +N L                         G++PD +GDL+ L  +D+S N L G IP ++
Sbjct: 638 YNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAM 697
Query: 433 NKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPGMPICPPKQ 486
           + +  LT I+LS N   G IP  G F +     F+ N  LCG    +P C P  
Sbjct: 698 SALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP--LPRCDPSN 749

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 119/435 (27%), Positives = 183/435 (42%), Gaps = 67/435 (15%)
Query: 99  LYNNQLTGQLPASLINTSMYNLDVEYNHLSG------------------------ELPSD 134
           L N+ + G +     + S+ +LD+  N LSG                        + P  
Sbjct: 81  LSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGK 140
Query: 135 IMS--KLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSI 192
           +    KL SL  L LS N++       N+V +  S G C +L+ L ++G  + G + D  
Sbjct: 141 VSGGLKLNSLEVLDLSANSI----SGANVVGWVLSDG-CGELKHLAISGNKISGDV-DVS 194
Query: 193 GRLNLTQLLLQENKITGSIPPHIGXXXXXXXXXXXXXXXXGTISAEISWLSQLEQLFLSH 252
             +NL  L +  N  +  I P +G                G  S  IS  ++L+ L +S 
Sbjct: 195 RCVNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISS 253
Query: 253 NLFSGEIPAAXXXXXXXXXXXXSFNKLSGEIPVSL-GNLVQIYSLFLNNNQLSRSIPPTL 311
           N F G IP                NK +GEIP  L G    +  L L+ N    ++PP  
Sbjct: 254 NQFVGPIPPLPLKSLQYLSLAE--NKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFF 311
Query: 312 G-------------------------RCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLN 346
           G                         +   L  LDLS+N  +G +P  ++ +    + L+
Sbjct: 312 GSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLD 371
Query: 347 LSHNQLEGPLPIELSK--LENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNL 404
           LS N   GP+   L +     +QE+ L +N FTG I   +SNC  +  +++S N L G +
Sbjct: 372 LSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTI 431
Query: 405 PDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKM 464
           P SLG L  L  + +  N L G IP  L  + TL  + L FN+  G IPSG   ++ T +
Sbjct: 432 PSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSG--LSNCTNL 489
Query: 465 SFV--GNQHLCGTVP 477
           +++   N  L G +P
Sbjct: 490 NWISLSNNRLTGEIP 504

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  154 bits (390), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 152/534 (28%), Positives = 226/534 (42%), Gaps = 66/534 (12%)
Query: 5   NHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPEXXXXXXXXXXXXXHDNNLTGMLPISFF 64
           N L G      S    L+ L +  N   G IP               +N  TG +P    
Sbjct: 233 NKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLA--ENKFTGEIPDFLS 290
Query: 65  HNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPAS--LINTSMYNLDV 122
             C +L  +DLS N F G +P   G+C  L +L+L +N  +G+LP    L    +  LD+
Sbjct: 291 GACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDL 350
Query: 123 EYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTD----LEELE 178
            +N  SGELP  + +   SL  L LS NN           P   +L  C +    L+EL 
Sbjct: 351 SFNEFSGELPESLTNLSASLLTLDLSSNNFSG--------PILPNL--CQNPKNTLQELY 400
Query: 179 LAGMDLGGTLPDSIGRLN-LTQLLLQENKITGSIPPHIGXXXXXXXXXXXXXXXXGTISA 237
           L      G +P ++   + L  L L  N ++G+IP  +G                G I  
Sbjct: 401 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ 460
Query: 238 EISWLSQLEQLFLSHNLFSGEIPAAXXXXXXXXXXXXSFNKLSGEIPVSLGNLVQIYSLF 297
           E+ ++  LE L L  N  +GEIP+             S N+L+GEIP  +G L  +  L 
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK 520
Query: 298 LNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAE------------ISGIREIRI-- 343
           L+NN  S +IP  LG C  L  LDL+ N   G+IPA             I+G R + I  
Sbjct: 521 LSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKN 580
Query: 344 --FLNLSHN-----QLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINIS 396
                  H      + +G    +L++L      +++S  + G+      N  ++  +++S
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMS 640
Query: 397 HNAL------------------------QGNLPDSLGDLKNLEAIDVSGNHLSGIIPISL 432
           +N L                         G++PD +GDL+ L  +D+S N L G IP ++
Sbjct: 641 YNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAM 700
Query: 433 NKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPGMPICPPKQ 486
           + +  LT I+LS N   G IP  G F +     F+ N  LCG    +P C P  
Sbjct: 701 SALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP--LPRCDPSN 752

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  106 bits (265), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 119/435 (27%), Positives = 183/435 (42%), Gaps = 67/435 (15%)
Query: 99  LYNNQLTGQLPASLINTSMYNLDVEYNHLSG------------------------ELPSD 134
           L N+ + G +     + S+ +LD+  N LSG                        + P  
Sbjct: 84  LSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGK 143
Query: 135 IMS--KLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSI 192
           +    KL SL  L LS N++       N+V +  S G C +L+ L ++G  + G + D  
Sbjct: 144 VSGGLKLNSLEVLDLSANSI----SGANVVGWVLSDG-CGELKHLAISGNKISGDV-DVS 197
Query: 193 GRLNLTQLLLQENKITGSIPPHIGXXXXXXXXXXXXXXXXGTISAEISWLSQLEQLFLSH 252
             +NL  L +  N  +  I P +G                G  S  IS  ++L+ L +S 
Sbjct: 198 RCVNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISS 256
Query: 253 NLFSGEIPAAXXXXXXXXXXXXSFNKLSGEIPVSL-GNLVQIYSLFLNNNQLSRSIPPTL 311
           N F G IP                NK +GEIP  L G    +  L L+ N    ++PP  
Sbjct: 257 NQFVGPIPPLPLKSLQYLSLAE--NKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFF 314
Query: 312 G-------------------------RCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLN 346
           G                         +   L  LDLS+N  +G +P  ++ +    + L+
Sbjct: 315 GSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLD 374
Query: 347 LSHNQLEGPLPIELSK--LENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNL 404
           LS N   GP+   L +     +QE+ L +N FTG I   +SNC  +  +++S N L G +
Sbjct: 375 LSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTI 434
Query: 405 PDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKM 464
           P SLG L  L  + +  N L G IP  L  + TL  + L FN+  G IPSG   ++ T +
Sbjct: 435 PSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSG--LSNCTNL 492
Query: 465 SFV--GNQHLCGTVP 477
           +++   N  L G +P
Sbjct: 493 NWISLSNNRLTGEIP 507

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  138 bits (348), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 96/305 (31%), Positives = 159/305 (52%), Gaps = 33/305 (10%)
Query: 546 RITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQ 605
           R+   +L EAT  FD + L+G G +G+VYKG+L+DG  +A+K    +S    + F  E +
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 606 VLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSG--SSDLTLLQ 663
            L   RH +L+ +I  C   +   L+  YM NG+L  HLY       GS   +  ++  Q
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY-------GSDLPTMSMSWEQ 140
Query: 664 RVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
           R+ IC   A G+ YLH  +   +IH D+K  N+LL+++    ++DFGI+K          
Sbjct: 141 RLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK---------K 188
Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP-TDDMFAG 782
           G E        ++ G++GY+ PEY      + K DVYSFG+++ E++  R      +   
Sbjct: 189 GTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
Query: 783 GLSLHKW-VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPS 841
            ++L +W V++H +G+LE+++D +L    R +S  +++  D A+         C   S  
Sbjct: 249 MVNLAEWAVESHNNGQLEQIVDPNLADKIRPES--LRKFGDTAVK--------CLALSSE 298
Query: 842 TRPTM 846
            RP+M
Sbjct: 299 DRPSM 303

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  138 bits (348), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 96/305 (31%), Positives = 159/305 (52%), Gaps = 33/305 (10%)
Query: 546 RITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQ 605
           R+   +L EAT  FD + L+G G +G+VYKG+L+DG  +A+K    +S    + F  E +
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 606 VLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSG--SSDLTLLQ 663
            L   RH +L+ +I  C   +   L+  YM NG+L  HLY       GS   +  ++  Q
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY-------GSDLPTMSMSWEQ 140
Query: 664 RVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
           R+ IC   A G+ YLH  +   +IH D+K  N+LL+++    ++DFGI+K          
Sbjct: 141 RLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK---------K 188
Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP-TDDMFAG 782
           G E        ++ G++GY+ PEY      + K DVYSFG+++ E++  R      +   
Sbjct: 189 GTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
Query: 783 GLSLHKW-VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPS 841
            ++L +W V++H +G+LE+++D +L    R +S  +++  D A+         C   S  
Sbjct: 249 MVNLAEWAVESHNNGQLEQIVDPNLADKIRPES--LRKFGDTAVK--------CLALSSE 298
Query: 842 TRPTM 846
            RP+M
Sbjct: 299 DRPSM 303

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 92/321 (28%), Positives = 145/321 (45%), Gaps = 56/321 (17%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           E + + ++G G++G V K   +   A  V + Q++S +  K+F  E + L R+ H N+++
Sbjct: 10  EIEVEEVVGRGAFGVVCKAKWR---AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVK 66
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +  AC  P    LV+ Y   GSL + L+      + + +  ++       C   ++G+AY
Sbjct: 67  LYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAY 118
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           LH   P  +IH DLKP N+LL    T L + DFG A  + T         +M N+     
Sbjct: 119 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---------HMTNNK---- 165
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM----FAGGLSLHKWVKN 792
            GS  +MAPE   GSN S K DV+S+GI++ E++TRR+P D++    F    ++H   + 
Sbjct: 166 -GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP 224
Query: 793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMXXXXXX 852
                L K I+S + R                          C  + PS RP+M      
Sbjct: 225 PLIKNLPKPIESLMTR--------------------------CWSKDPSQRPSMEEIVKI 258
Query: 853 XXRLKRYLGEKHMPSKMNALH 873
              L RY      P +    H
Sbjct: 259 MTHLMRYFPGADEPLQYPCQH 279

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 92/321 (28%), Positives = 145/321 (45%), Gaps = 56/321 (17%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           E + + ++G G++G V K   +   A  V + Q++S +  K+F  E + L R+ H N+++
Sbjct: 9   EIEVEEVVGRGAFGVVCKAKWR---AKDVAIKQIESESERKAFIVELRQLSRVNHPNIVK 65
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +  AC  P    LV+ Y   GSL + L+      + + +  ++       C   ++G+AY
Sbjct: 66  LYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAY 117
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           LH   P  +IH DLKP N+LL    T L + DFG A  + T         +M N+     
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---------HMTNNK---- 164
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM----FAGGLSLHKWVKN 792
            GS  +MAPE   GSN S K DV+S+GI++ E++TRR+P D++    F    ++H   + 
Sbjct: 165 -GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP 223
Query: 793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMXXXXXX 852
                L K I+S + R                          C  + PS RP+M      
Sbjct: 224 PLIKNLPKPIESLMTR--------------------------CWSKDPSQRPSMEEIVKI 257
Query: 853 XXRLKRYLGEKHMPSKMNALH 873
              L RY      P +    H
Sbjct: 258 MTHLMRYFPGADEPLQYPCQH 278

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  108 bits (269), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 129/255 (50%), Gaps = 39/255 (15%)
Query: 530 ETRSKPITPELMHNFPRITYRELLEATAEFDEQRL------LGTGSYGRVYKGILQDGTA 583
           E +S  ++    H+F   ++ EL   T  FDE+ +      +G G +G VYKG + + T 
Sbjct: 1   ENKSLEVSDTRFHSF---SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTT 56
Query: 584 IAVKVL----QLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGS 639
           +AVK L     + +    + F++E +V+ + +H NL+ ++   S  D   LV  YM NGS
Sbjct: 57  VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGS 116
Query: 640 LDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLH--HHSPVRVIHCDLKPSNVL 697
           L   L          G+  L+   R  I    A G+ +LH  HH     IH D+K +N+L
Sbjct: 117 LLDRL------SCLDGTPPLSWHMRCKIAQGAANGINFLHENHH-----IHRDIKSANIL 165
Query: 698 LNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST-ANMLCGSIGYMAPEYGFGSNTSTK 756
           L++  TA +SDFG+A+           +E    +   + + G+  YMAPE   G  T  K
Sbjct: 166 LDEAFTAKISDFGLAR----------ASEKFAQTVMXSRIVGTTAYMAPEALRGEITP-K 214
Query: 757 GDVYSFGILVLEMVT 771
            D+YSFG+++LE++T
Sbjct: 215 SDIYSFGVVLLEIIT 229

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  107 bits (267), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 128/255 (50%), Gaps = 39/255 (15%)
Query: 530 ETRSKPITPELMHNFPRITYRELLEATAEFDEQRL------LGTGSYGRVYKGILQDGTA 583
           E +S  ++    H+F   ++ EL   T  FDE+ +      +G G +G VYKG + + T 
Sbjct: 1   ENKSLEVSDTRFHSF---SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTT 56
Query: 584 IAVKVL----QLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGS 639
           +AVK L     + +    + F++E +V+ + +H NL+ ++   S  D   LV  YM NGS
Sbjct: 57  VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGS 116
Query: 640 LDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLH--HHSPVRVIHCDLKPSNVL 697
           L   L          G+  L+   R  I    A G+ +LH  HH     IH D+K +N+L
Sbjct: 117 LLDRL------SCLDGTPPLSWHMRCKIAQGAANGINFLHENHH-----IHRDIKSANIL 165
Query: 698 LNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST-ANMLCGSIGYMAPEYGFGSNTSTK 756
           L++  TA +SDFG+A+           +E    +     + G+  YMAPE   G  T  K
Sbjct: 166 LDEAFTAKISDFGLAR----------ASEKFAQTVMXXRIVGTTAYMAPEALRGEITP-K 214
Query: 757 GDVYSFGILVLEMVT 771
            D+YSFG+++LE++T
Sbjct: 215 SDIYSFGVVLLEIIT 229

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  106 bits (265), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 114/213 (53%), Gaps = 21/213 (9%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITAC 622
           +G GS+G V++     G+ +AVK+L  Q         F RE  ++KR+RH N++  + A 
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
           + P   ++V  Y++ GSL   L+     E       L   +R+++  D+A+GM YLH+ +
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGARE------QLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 683 PVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGY 742
           P  ++H DLK  N+L++   T  V DFG+++L  +  + +  A            G+  +
Sbjct: 158 PP-IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXA-----------AGTPEW 205
Query: 743 MAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           MAPE      ++ K DVYSFG+++ E+ T ++P
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  105 bits (263), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 114/213 (53%), Gaps = 21/213 (9%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITAC 622
           +G GS+G V++     G+ +AVK+L  Q         F RE  ++KR+RH N++  + A 
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
           + P   ++V  Y++ GSL   L+     E       L   +R+++  D+A+GM YLH+ +
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGARE------QLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 683 PVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGY 742
           P  ++H +LK  N+L++   T  V DFG+++L  +  + +  A            G+  +
Sbjct: 158 PP-IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA-----------AGTPEW 205
Query: 743 MAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           MAPE      ++ K DVYSFG+++ E+ T ++P
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  104 bits (260), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/241 (32%), Positives = 120/241 (49%), Gaps = 36/241 (14%)
Query: 544 FPRITYRELLEATAEFDEQRL------LGTGSYGRVYKGILQDGTAIAVKVL----QLQS 593
           F   ++ EL   T  FDE+ +      +G G +G VYKG + + T +AVK L     + +
Sbjct: 6   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 64
Query: 594 GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFG 653
               + F++E +V+ + +H NL+ ++   S  D   LV  YM NGSL   L         
Sbjct: 65  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL------SCL 118
Query: 654 SGSSDLTLLQRVNICSDIAEGMAYLH--HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI 711
            G+  L+   R  I    A G+ +LH  HH     IH D+K +N+LL++  TA +SDFG+
Sbjct: 119 DGTPPLSWHMRCKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAKISDFGL 173
Query: 712 AKLVMTVGVGNDGAENMGNST-ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
           A+           +E          + G+  YMAPE   G  T  K D+YSFG+++LE++
Sbjct: 174 AR----------ASEKFAQXVMXXRIVGTTAYMAPEALRGEITP-KSDIYSFGVVLLEII 222
Query: 771 T 771
           T
Sbjct: 223 T 223

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 141/283 (49%), Gaps = 42/283 (14%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           +G+GS+G VYKG      A+ +  +   +    ++F  E  VL++ RH N++  +   + 
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
           P   A+V  +    SL  HL+  SET+F        + + ++I    A GM YLH  S  
Sbjct: 92  PQL-AIVTQWCEGSSLYHHLHA-SETKF-------EMKKLIDIARQTARGMDYLHAKS-- 140
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
            +IH DLK +N+ L++D T  + DFG+A          + +   G+     L GSI +MA
Sbjct: 141 -IIHRDLKSNNIFLHEDNTVKIGDFGLA---------TEKSRWSGSHQFEQLSGSILWMA 190
Query: 745 PEYGFGSNT---STKGDVYSFGILVLEMVTRRRPTDDM----------FAGGLS--LHKW 789
           PE     ++   S + DVY+FGI++ E++T + P  ++            G LS  L K 
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK- 249
Query: 790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELG 832
           V+++   R+++++ +  L+  RD+ P   R+    + E+ EL 
Sbjct: 250 VRSNCPKRMKRLM-AECLKKKRDERPSFPRI----LAEIEELA 287

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 141/283 (49%), Gaps = 42/283 (14%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           +G+GS+G VYKG      A+ +  +   +    ++F  E  VL++ RH N++  +   + 
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 91
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
           P   A+V  +    SL  HL+  SET+F        + + ++I    A GM YLH  S  
Sbjct: 92  PQL-AIVTQWCEGSSLYHHLHA-SETKF-------EMKKLIDIARQTARGMDYLHAKS-- 140
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
            +IH DLK +N+ L++D T  + DFG+A          + +   G+     L GSI +MA
Sbjct: 141 -IIHRDLKSNNIFLHEDNTVKIGDFGLA---------TEKSRWSGSHQFEQLSGSILWMA 190
Query: 745 PEYGFGSNT---STKGDVYSFGILVLEMVTRRRPTDDM----------FAGGLS--LHKW 789
           PE     ++   S + DVY+FGI++ E++T + P  ++            G LS  L K 
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK- 249
Query: 790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELG 832
           V+++   R+++++ +  L+  RD+ P   R+    + E+ EL 
Sbjct: 250 VRSNCPKRMKRLM-AECLKKKRDERPSFPRI----LAEIEELA 287

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/241 (31%), Positives = 117/241 (48%), Gaps = 36/241 (14%)
Query: 544 FPRITYRELLEATAEFDEQRL------LGTGSYGRVYKGILQDGTAIAVKVL----QLQS 593
           F   ++ EL   T  FDE+ +       G G +G VYKG + + T +AVK L     + +
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 61
Query: 594 GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFG 653
               + F++E +V  + +H NL+ ++   S  D   LV  Y  NGSL   L         
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL------SCL 115
Query: 654 SGSSDLTLLQRVNICSDIAEGMAYLH--HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI 711
            G+  L+   R  I    A G+ +LH  HH     IH D+K +N+LL++  TA +SDFG+
Sbjct: 116 DGTPPLSWHXRCKIAQGAANGINFLHENHH-----IHRDIKSANILLDEAFTAKISDFGL 170
Query: 712 AKLVMTVGVGNDGAENMGNST-ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
           A+           +E        + + G+  Y APE   G  T  K D+YSFG+++LE++
Sbjct: 171 AR----------ASEKFAQXVXXSRIVGTTAYXAPEALRGEITP-KSDIYSFGVVLLEII 219
Query: 771 T 771
           T
Sbjct: 220 T 220

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 24/211 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLMRIITACS 623
           LG G +G V+ G     T +A+K L+   G  + ++F +E QV+K++RH  L+++    S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +V  YM+ GSL   L        G     L L Q V++ + IA GMAY+     
Sbjct: 250 EEPI-YIVTEYMSKGSLLDFLK-------GETGKYLRLPQLVDMAAQIASGMAYVER--- 298
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
           +  +H DL+ +N+L+ +++   V+DFG+A+L+       +  E      A      I + 
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLI-------EDNEYTARQGAKF---PIKWT 348
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           APE       + K DV+SFGIL+ E+ T+ R
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 24/211 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLMRIITACS 623
           LG G +G V+ G     T +A+K L+   G  + ++F +E QV+K++RH  L+++    S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +V  YM+ GSL   L        G     L L Q V++ + IA GMAY+     
Sbjct: 250 EEPI-YIVTEYMSKGSLLDFLK-------GETGKYLRLPQLVDMAAQIASGMAYVER--- 298
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
           +  +H DL+ +N+L+ +++   V+DFG+A+L+       +  E      A      I + 
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLI-------EDNEYTARQGAKF---PIKWT 348
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           APE       + K DV+SFGIL+ E+ T+ R
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 24/211 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLMRIITACS 623
           LG G +G V+ G     T +A+K L+   GN + ++F +E QV+K++RH  L+++    S
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLK--PGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +V  YM+ GSL   L        G     L L Q V++ + IA GMAY+     
Sbjct: 251 EEPI-YIVTEYMSKGSLLDFLK-------GEMGKYLRLPQLVDMAAQIASGMAYVER--- 299
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
           +  +H DL+ +N+L+ +++   V+DFG+ +L+       +  E      A      I + 
Sbjct: 300 MNYVHRDLRAANILVGENLVCKVADFGLGRLI-------EDNEYTARQGAKF---PIKWT 349
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           APE       + K DV+SFGIL+ E+ T+ R
Sbjct: 350 APEAALYGRFTIKSDVWSFGILLTELTTKGR 380

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 111/214 (51%), Gaps = 24/214 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           +G+GS+G VYKG      A+ +  +   +    ++F  E  VL++ RH N++  +   + 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
           P   A+V  +    SL  HL+   ET+F        +++ ++I    A+GM YLH  S  
Sbjct: 76  PQL-AIVTQWCEGSSLYHHLHI-IETKF-------EMIKLIDIARQTAQGMDYLHAKS-- 124
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
            +IH DLK +N+ L++D+T  + DFG+A          + +   G+     L GSI +MA
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLA---------TEKSRWSGSHQFEQLSGSILWMA 174
Query: 745 PEYGFGSNT---STKGDVYSFGILVLEMVTRRRP 775
           PE     +    S + DVY+FGI++ E++T + P
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 141/283 (49%), Gaps = 42/283 (14%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           +G+GS+G VYKG      A+ +  +   +    ++F  E  VL++ RH N++  +   + 
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 79
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
           P   A+V  +    SL  HL+  SET+F        + + ++I    A GM YLH  S  
Sbjct: 80  PQL-AIVTQWCEGSSLYHHLHA-SETKF-------EMKKLIDIARQTARGMDYLHAKS-- 128
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
            +IH DLK +N+ L++D T  + DFG+A +          +   G+     L GSI +MA
Sbjct: 129 -IIHRDLKSNNIFLHEDNTVKIGDFGLATV---------KSRWSGSHQFEQLSGSILWMA 178
Query: 745 PEYGFGSNT---STKGDVYSFGILVLEMVTRRRPTDDM----------FAGGLS--LHKW 789
           PE     ++   S + DVY+FGI++ E++T + P  ++            G LS  L K 
Sbjct: 179 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK- 237
Query: 790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELG 832
           V+++   R+++++ +  L+  RD+ P   R+    + E+ EL 
Sbjct: 238 VRSNCPKRMKRLM-AECLKKKRDERPSFPRI----LAEIEELA 275

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 128/282 (45%), Gaps = 45/282 (15%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           LG G +G V+ G     T +AVK L+ Q      +F  E  ++K+++H+ L+R+    + 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
                ++  YM NGSL   L   S          LT+ + +++ + IAEGMA++   +  
Sbjct: 75  EPI-YIITEYMENGSLVDFLKTPS-------GIKLTINKLLDMAAQIAEGMAFIEERN-- 124
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
             IH DL+ +N+L++D ++  ++DFG+A+L+       +  E      A      I + A
Sbjct: 125 -YIHRDLRAANILVSDTLSCKIADFGLARLI-------EDNEYTAREGAKF---PIKWTA 173
Query: 745 PEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDS 804
           PE       + K DV+SFGIL+ E+VT  R                   Y G     +  
Sbjct: 174 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIP-----------------YPGMTNPEVIQ 216
Query: 805 SLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTM 846
           +L R  R   P      D    EL +L  LC +E P  RPT 
Sbjct: 217 NLERGYRMVRP------DNCPEELYQLMRLCWKERPEDRPTF 252

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 111/214 (51%), Gaps = 24/214 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           +G+GS+G VYKG      A+ +  +   +    ++F  E  VL++ RH N++  +   + 
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 95
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
           P   A+V  +    SL  HL+   ET+F        +++ ++I    A+GM YLH  S  
Sbjct: 96  PQL-AIVTQWCEGSSLYHHLHI-IETKF-------EMIKLIDIARQTAQGMDYLHAKS-- 144
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
            +IH DLK +N+ L++D+T  + DFG+A          + +   G+     L GSI +MA
Sbjct: 145 -IIHRDLKSNNIFLHEDLTVKIGDFGLA---------TEKSRWSGSHQFEQLSGSILWMA 194
Query: 745 PEYGFGSNT---STKGDVYSFGILVLEMVTRRRP 775
           PE     +    S + DVY+FGI++ E++T + P
Sbjct: 195 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 113/218 (51%), Gaps = 24/218 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           +G+GS+G VYKG      A+ +  +   +    ++F  E  VL++ RH N++  +   + 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
           P   A+V  +    SL  HL+   ET+F        +++ ++I    A+GM YLH  S  
Sbjct: 76  PQL-AIVTQWCEGSSLYHHLHI-IETKF-------EMIKLIDIARQTAQGMDYLHAKS-- 124
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
            +IH DLK +N+ L++D+T  + DFG+A +          +   G+     L GSI +MA
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLATV---------KSRWSGSHQFEQLSGSILWMA 174
Query: 745 PEYGFGSNT---STKGDVYSFGILVLEMVTRRRPTDDM 779
           PE     +    S + DVY+FGI++ E++T + P  ++
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 24/211 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLMRIITACS 623
           LG G +G V+ G     T +A+K L+   G  + ++F +E QV+K++RH  L+++    S
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +V  YM+ GSL   L        G     L L Q V++ + IA GMAY+     
Sbjct: 333 EEPI-YIVTEYMSKGSLLDFLK-------GETGKYLRLPQLVDMAAQIASGMAYVER--- 381
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
           +  +H DL+ +N+L+ +++   V+DFG+A+L+       +  E      A      I + 
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLI-------EDNEYTARQGAKF---PIKWT 431
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           APE       + K DV+SFGIL+ E+ T+ R
Sbjct: 432 APEAALYGRFTIKSDVWSFGILLTELTTKGR 462

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 130/285 (45%), Gaps = 47/285 (16%)
Query: 563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLMRIITA 621
           + LG G +G V+ G     T +A+K L+   G  + +SF  E Q++K+++H  L+++   
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTLK--PGTMSPESFLEEAQIMKKLKHDKLVQLYAV 72
Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
            S      +V  YM  GSL   L      + G G + L L   V++ + +A GMAY+   
Sbjct: 73  VSEEPI-YIVTEYMNKGSLLDFL------KDGEGRA-LKLPNLVDMAAQVAAGMAYIER- 123
Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIG 741
             +  IH DL+ +N+L+ + +   ++DFG+A+L+       +  E      A      I 
Sbjct: 124 --MNYIHRDLRSANILVGNGLICKIADFGLARLI-------EDNEXTARQGAKF---PIK 171
Query: 742 YMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKV 801
           + APE       + K DV+SFGIL+ E+VT+ R                   Y G   + 
Sbjct: 172 WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP-----------------YPGMNNRE 214
Query: 802 IDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTM 846
           +   + R  R   P+     D  I  L EL I C ++ P  RPT 
Sbjct: 215 VLEQVERGYRMPCPQ-----DCPIS-LHELMIHCWKKDPEERPTF 253

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Composition-based stats.
 Identities = 85/286 (29%), Positives = 133/286 (46%), Gaps = 55/286 (19%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           LG G  G V+ G     T +AVK L+ Q      +F  E  ++K+++H+ L+R+    + 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
                ++  YM NGSL   L   S  +       LT+ + +++ + IAEGMA++   +  
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEERN-- 129
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
             IH DL+ +N+L++D ++  ++DFG+A+L+       + AE      A      I + A
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLI-------EDAEXTAREGAKF---PIKWTA 178
Query: 745 PE-YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVID 803
           PE   +G+ T  K DV+SFGIL+ E+VT  R                   Y G     + 
Sbjct: 179 PEAINYGTFT-IKSDVWSFGILLTEIVTHGRIP-----------------YPGMTNPEVI 220
Query: 804 SSLLRASR----DQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
            +L R  R    D  PE          EL +L  LC +E P  RPT
Sbjct: 221 QNLERGYRMVRPDNCPE----------ELYQLMRLCWKERPEDRPT 256

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 113/218 (51%), Gaps = 24/218 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           +G+GS+G VYKG      A+ +  +   +    ++F  E  VL++ RH N++  +   + 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
           P   A+V  +    SL  HL+   ET+F        +++ ++I    A+GM YLH  S  
Sbjct: 76  PQL-AIVTQWCEGSSLYHHLHI-IETKF-------EMIKLIDIARQTAQGMDYLHAKS-- 124
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
            +IH DLK +N+ L++D+T  + DFG+A +          +   G+     L GSI +MA
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLATV---------KSRWSGSHQFEQLSGSILWMA 174
Query: 745 PEYGFGSNT---STKGDVYSFGILVLEMVTRRRPTDDM 779
           PE     +    S + DVY+FGI++ E++T + P  ++
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 24/211 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLMRIITACS 623
           LG G +G V+ G     T +A+K L+   G  + ++F +E QV+K++RH  L+++    S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +V  YM+ GSL   L        G     L L Q V++ + IA GMAY+     
Sbjct: 250 EEPI-YIVGEYMSKGSLLDFLK-------GETGKYLRLPQLVDMAAQIASGMAYVER--- 298
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
           +  +H DL+ +N+L+ +++   V+DFG+A+L+       +  E      A      I + 
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLI-------EDNEYTARQGAKF---PIKWT 348
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           APE       + K DV+SFGIL+ E+ T+ R
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 111/214 (51%), Gaps = 24/214 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           +G+GS+G VYKG      A+ +  +   +    ++F  E  VL++ RH N++  +   + 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
           P   A+V  +    SL  HL+   ET+F        +++ ++I    A+GM YLH  S  
Sbjct: 104 PQL-AIVTQWCEGSSLYHHLHI-IETKF-------EMIKLIDIARQTAQGMDYLHAKS-- 152
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
            +IH DLK +N+ L++D+T  + DFG+A          + +   G+     L GSI +MA
Sbjct: 153 -IIHRDLKSNNIFLHEDLTVKIGDFGLA---------TEKSRWSGSHQFEQLSGSILWMA 202
Query: 745 PEYGFGSNT---STKGDVYSFGILVLEMVTRRRP 775
           PE     +    S + DVY+FGI++ E++T + P
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Composition-based stats.
 Identities = 84/286 (29%), Positives = 133/286 (46%), Gaps = 55/286 (19%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           LG G +G V+ G     T +AVK L+ Q      +F  E  ++K+++H+ L+R+    + 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
                ++  YM NGSL   L   S  +       LT+ + +++ + IAEGMA++   +  
Sbjct: 88  EPI-YIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEERN-- 137
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
             IH DL+ +N+L++D ++  ++DFG+A+L+       +  E      A      I + A
Sbjct: 138 -YIHRDLRAANILVSDTLSCKIADFGLARLI-------EDNEXTAREGAKF---PIKWTA 186
Query: 745 PE-YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVID 803
           PE   +G+ T  K DV+SFGIL+ E+VT  R                   Y G     + 
Sbjct: 187 PEAINYGTFT-IKSDVWSFGILLTEIVTHGRIP-----------------YPGMTNPEVI 228
Query: 804 SSLLRASR----DQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
            +L R  R    D  PE          EL +L  LC +E P  RPT
Sbjct: 229 QNLERGYRMVRPDNCPE----------ELYQLMRLCWKERPEDRPT 264

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Composition-based stats.
 Identities = 84/286 (29%), Positives = 133/286 (46%), Gaps = 55/286 (19%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           LG G +G V+ G     T +AVK L+ Q      +F  E  ++K+++H+ L+R+    + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
                ++  YM NGSL   L   S  +       LT+ + +++ + IAEGMA++   +  
Sbjct: 86  EPI-YIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEERN-- 135
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
             IH DL+ +N+L++D ++  ++DFG+A+L+       +  E      A      I + A
Sbjct: 136 -YIHRDLRAANILVSDTLSCKIADFGLARLI-------EDNEXTAREGAKF---PIKWTA 184
Query: 745 PE-YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVID 803
           PE   +G+ T  K DV+SFGIL+ E+VT  R                   Y G     + 
Sbjct: 185 PEAINYGTFT-IKSDVWSFGILLTEIVTHGRIP-----------------YPGMTNPEVI 226
Query: 804 SSLLRASR----DQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
            +L R  R    D  PE          EL +L  LC +E P  RPT
Sbjct: 227 QNLERGYRMVRPDNCPE----------ELYQLMRLCWKERPEDRPT 262

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Composition-based stats.
 Identities = 84/286 (29%), Positives = 133/286 (46%), Gaps = 55/286 (19%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           LG G +G V+ G     T +AVK L+ Q      +F  E  ++K+++H+ L+R+    + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
                ++  YM NGSL   L   S  +       LT+ + +++ + IAEGMA++   +  
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEERN-- 129
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
             IH DL+ +N+L++D ++  ++DFG+A+L+       +  E      A      I + A
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLI-------EDNEXTAREGAKF---PIKWTA 178
Query: 745 PE-YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVID 803
           PE   +G+ T  K DV+SFGIL+ E+VT  R                   Y G     + 
Sbjct: 179 PEAINYGTFT-IKSDVWSFGILLTEIVTHGRIP-----------------YPGMTNPEVI 220
Query: 804 SSLLRASR----DQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
            +L R  R    D  PE          EL +L  LC +E P  RPT
Sbjct: 221 QNLERGYRMVRPDNCPE----------ELYQLMRLCWKERPEDRPT 256

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Composition-based stats.
 Identities = 84/286 (29%), Positives = 133/286 (46%), Gaps = 55/286 (19%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           LG G +G V+ G     T +AVK L+ Q      +F  E  ++K+++H+ L+R+    + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
                ++  YM NGSL   L   S  +       LT+ + +++ + IAEGMA++   +  
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEERN-- 129
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
             IH DL+ +N+L++D ++  ++DFG+A+L+       +  E      A      I + A
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLI-------EDNEXTAREGAKF---PIKWTA 178
Query: 745 PE-YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVID 803
           PE   +G+ T  K DV+SFGIL+ E+VT  R                   Y G     + 
Sbjct: 179 PEAINYGTFT-IKSDVWSFGILLTEIVTHGRIP-----------------YPGMTNPEVI 220
Query: 804 SSLLRASR----DQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
            +L R  R    D  PE          EL +L  LC +E P  RPT
Sbjct: 221 QNLERGYRMVRPDNCPE----------ELYQLMRLCWKERPEDRPT 256

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 113/218 (51%), Gaps = 24/218 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           +G+GS+G VYKG      A+ +  +   +    ++F  E  VL++ RH N++  +   + 
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 77
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
           P   A+V  +    SL  HL+   ET+F        +++ ++I    A+GM YLH  S  
Sbjct: 78  PQL-AIVTQWCEGSSLYHHLHI-IETKF-------EMIKLIDIARQTAQGMDYLHAKS-- 126
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
            +IH DLK +N+ L++D+T  + DFG+A +          +   G+     L GSI +MA
Sbjct: 127 -IIHRDLKSNNIFLHEDLTVKIGDFGLATV---------KSRWSGSHQFEQLSGSILWMA 176
Query: 745 PEYGFGSNT---STKGDVYSFGILVLEMVTRRRPTDDM 779
           PE     +    S + DVY+FGI++ E++T + P  ++
Sbjct: 177 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 214

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Composition-based stats.
 Identities = 84/286 (29%), Positives = 133/286 (46%), Gaps = 55/286 (19%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           LG G +G V+ G     T +AVK L+ Q      +F  E  ++K+++H+ L+R+    + 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
                ++  YM NGSL   L   S  +       LT+ + +++ + IAEGMA++   +  
Sbjct: 89  EPI-YIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEERN-- 138
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
             IH DL+ +N+L++D ++  ++DFG+A+L+       +  E      A      I + A
Sbjct: 139 -YIHRDLRAANILVSDTLSCKIADFGLARLI-------EDNEXTAREGAKF---PIKWTA 187
Query: 745 PE-YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVID 803
           PE   +G+ T  K DV+SFGIL+ E+VT  R                   Y G     + 
Sbjct: 188 PEAINYGTFT-IKSDVWSFGILLTEIVTHGRIP-----------------YPGMTNPEVI 229
Query: 804 SSLLRASR----DQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
            +L R  R    D  PE          EL +L  LC +E P  RPT
Sbjct: 230 QNLERGYRMVRPDNCPE----------ELYQLMRLCWKERPEDRPT 265

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Composition-based stats.
 Identities = 84/286 (29%), Positives = 133/286 (46%), Gaps = 55/286 (19%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           LG G +G V+ G     T +AVK L+ Q      +F  E  ++K+++H+ L+R+    + 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
                ++  YM NGSL   L   S  +       LT+ + +++ + IAEGMA++   +  
Sbjct: 81  EPI-YIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEERN-- 130
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
             IH DL+ +N+L++D ++  ++DFG+A+L+       +  E      A      I + A
Sbjct: 131 -YIHRDLRAANILVSDTLSCKIADFGLARLI-------EDNEXTAREGAKF---PIKWTA 179
Query: 745 PE-YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVID 803
           PE   +G+ T  K DV+SFGIL+ E+VT  R                   Y G     + 
Sbjct: 180 PEAINYGTFT-IKSDVWSFGILLTEIVTHGRIP-----------------YPGMTNPEVI 221
Query: 804 SSLLRASR----DQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
            +L R  R    D  PE          EL +L  LC +E P  RPT
Sbjct: 222 QNLERGYRMVRPDNCPE----------ELYQLMRLCWKERPEDRPT 257

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Composition-based stats.
 Identities = 84/286 (29%), Positives = 133/286 (46%), Gaps = 55/286 (19%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           LG G +G V+ G     T +AVK L+ Q      +F  E  ++K+++H+ L+R+    + 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
                ++  YM NGSL   L   S  +       LT+ + +++ + IAEGMA++   +  
Sbjct: 82  EPI-YIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEERN-- 131
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
             IH DL+ +N+L++D ++  ++DFG+A+L+       +  E      A      I + A
Sbjct: 132 -YIHRDLRAANILVSDTLSCKIADFGLARLI-------EDNEXTAREGAKF---PIKWTA 180
Query: 745 PE-YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVID 803
           PE   +G+ T  K DV+SFGIL+ E+VT  R                   Y G     + 
Sbjct: 181 PEAINYGTFT-IKSDVWSFGILLTEIVTHGRIP-----------------YPGMTNPEVI 222
Query: 804 SSLLRASR----DQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
            +L R  R    D  PE          EL +L  LC +E P  RPT
Sbjct: 223 QNLERGYRMVRPDNCPE----------ELYQLMRLCWKERPEDRPT 258

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 111/214 (51%), Gaps = 24/214 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           +G+GS+G VYKG      A+ +  +   +    ++F  E  VL++ RH N++  +   + 
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
           P   A+V  +    SL  HL+   ET+F        +++ ++I    A+GM YLH  S  
Sbjct: 81  PQL-AIVTQWCEGSSLYHHLHI-IETKF-------EMIKLIDIARQTAQGMDYLHAKS-- 129
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
            +IH DLK +N+ L++D+T  + DFG+A +          +   G+     L GSI +MA
Sbjct: 130 -IIHRDLKSNNIFLHEDLTVKIGDFGLATV---------KSRWSGSHQFEQLSGSILWMA 179
Query: 745 PEYGFGSNT---STKGDVYSFGILVLEMVTRRRP 775
           PE     +    S + DVY+FGI++ E++T + P
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 111/214 (51%), Gaps = 24/214 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           +G+GS+G VYKG      A+ +  +   +    ++F  E  VL++ RH N++  +   + 
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
           P   A+V  +    SL  HL+   ET+F        +++ ++I    A+GM YLH  S  
Sbjct: 81  PQL-AIVTQWCEGSSLYHHLHI-IETKF-------EMIKLIDIARQTAQGMDYLHAKS-- 129
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
            +IH DLK +N+ L++D+T  + DFG+A +          +   G+     L GSI +MA
Sbjct: 130 -IIHRDLKSNNIFLHEDLTVKIGDFGLATV---------KSRWSGSHQFEQLSGSILWMA 179
Query: 745 PEYGFGSNT---STKGDVYSFGILVLEMVTRRRP 775
           PE     +    S + DVY+FGI++ E++T + P
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Composition-based stats.
 Identities = 84/286 (29%), Positives = 133/286 (46%), Gaps = 55/286 (19%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           LG G +G V+ G     T +AVK L+ Q      +F  E  ++K+++H+ L+R+    + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
                ++  YM NGSL   L   S  +       LT+ + +++ + IAEGMA++   +  
Sbjct: 86  EPI-YIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEERN-- 135
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
             IH DL+ +N+L++D ++  ++DFG+A+L+       +  E      A      I + A
Sbjct: 136 -YIHRDLRAANILVSDTLSCKIADFGLARLI-------EDNEYTAREGAKF---PIKWTA 184
Query: 745 PE-YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVID 803
           PE   +G+ T  K DV+SFGIL+ E+VT  R                   Y G     + 
Sbjct: 185 PEAINYGTFT-IKSDVWSFGILLTEIVTHGRIP-----------------YPGMTNPEVI 226
Query: 804 SSLLRASR----DQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
            +L R  R    D  PE          EL +L  LC +E P  RPT
Sbjct: 227 QNLERGYRMVRPDNCPE----------ELYQLMRLCWKERPEDRPT 262

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Composition-based stats.
 Identities = 84/286 (29%), Positives = 133/286 (46%), Gaps = 55/286 (19%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           LG G +G V+ G     T +AVK L+ Q      +F  E  ++K+++H+ L+R+    + 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
                ++  YM NGSL   L   S  +       LT+ + +++ + IAEGMA++   +  
Sbjct: 90  EPI-YIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEERN-- 139
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
             IH DL+ +N+L++D ++  ++DFG+A+L+       +  E      A      I + A
Sbjct: 140 -YIHRDLRAANILVSDTLSCKIADFGLARLI-------EDNEYTAREGAKF---PIKWTA 188
Query: 745 PE-YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVID 803
           PE   +G+ T  K DV+SFGIL+ E+VT  R                   Y G     + 
Sbjct: 189 PEAINYGTFT-IKSDVWSFGILLTEIVTHGRIP-----------------YPGMTNPEVI 230
Query: 804 SSLLRASR----DQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
            +L R  R    D  PE          EL +L  LC +E P  RPT
Sbjct: 231 QNLERGYRMVRPDNCPE----------ELYQLMRLCWKERPEDRPT 266

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Composition-based stats.
 Identities = 84/286 (29%), Positives = 133/286 (46%), Gaps = 55/286 (19%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           LG G +G V+ G     T +AVK L+ Q      +F  E  ++K+++H+ L+R+    + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
                ++  YM NGSL   L   S  +       LT+ + +++ + IAEGMA++   +  
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEERN-- 129
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
             IH DL+ +N+L++D ++  ++DFG+A+L+       +  E      A      I + A
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLI-------EDNEYTAREGAKF---PIKWTA 178
Query: 745 PE-YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVID 803
           PE   +G+ T  K DV+SFGIL+ E+VT  R                   Y G     + 
Sbjct: 179 PEAINYGTFT-IKSDVWSFGILLTEIVTHGRIP-----------------YPGMTNPEVI 220
Query: 804 SSLLRASR----DQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
            +L R  R    D  PE          EL +L  LC +E P  RPT
Sbjct: 221 QNLERGYRMVRPDNCPE----------ELYQLMRLCWKERPEDRPT 256

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Composition-based stats.
 Identities = 84/286 (29%), Positives = 133/286 (46%), Gaps = 55/286 (19%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           LG G +G V+ G     T +AVK L+ Q      +F  E  ++K+++H+ L+R+    + 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
                ++  YM NGSL   L   S  +       LT+ + +++ + IAEGMA++   +  
Sbjct: 85  EPI-YIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEERN-- 134
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
             IH DL+ +N+L++D ++  ++DFG+A+L+       +  E      A      I + A
Sbjct: 135 -YIHRDLRAANILVSDTLSCKIADFGLARLI-------EDNEYTAREGAKF---PIKWTA 183
Query: 745 PE-YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVID 803
           PE   +G+ T  K DV+SFGIL+ E+VT  R                   Y G     + 
Sbjct: 184 PEAINYGTFT-IKSDVWSFGILLTEIVTHGRIP-----------------YPGMTNPEVI 225
Query: 804 SSLLRASR----DQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
            +L R  R    D  PE          EL +L  LC +E P  RPT
Sbjct: 226 QNLERGYRMVRPDNCPE----------ELYQLMRLCWKERPEDRPT 261

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 111/214 (51%), Gaps = 24/214 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           +G+GS+G VYKG      A+ +  +   +    ++F  E  VL++ RH N++  +   + 
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 102
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
           P   A+V  +    SL  HL+   ET+F        +++ ++I    A+GM YLH  S  
Sbjct: 103 PQL-AIVTQWCEGSSLYHHLHI-IETKF-------EMIKLIDIARQTAQGMDYLHAKS-- 151
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
            +IH DLK +N+ L++D+T  + DFG+A +          +   G+     L GSI +MA
Sbjct: 152 -IIHRDLKSNNIFLHEDLTVKIGDFGLATV---------KSRWSGSHQFEQLSGSILWMA 201
Query: 745 PEYGFGSNT---STKGDVYSFGILVLEMVTRRRP 775
           PE     +    S + DVY+FGI++ E++T + P
Sbjct: 202 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 96.7 bits (239), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 111/214 (51%), Gaps = 24/214 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           +G+GS+G VYKG      A+ +  +   +    ++F  E  VL++ RH N++  +   + 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
           P   A+V  +    SL  HL+   ET+F        +++ ++I    A+GM YLH  S  
Sbjct: 104 PQL-AIVTQWCEGSSLYHHLHI-IETKF-------EMIKLIDIARQTAQGMDYLHAKS-- 152
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
            +IH DLK +N+ L++D+T  + DFG+A +          +   G+     L GSI +MA
Sbjct: 153 -IIHRDLKSNNIFLHEDLTVKIGDFGLATV---------KSRWSGSHQFEQLSGSILWMA 202
Query: 745 PEYGFGSNT---STKGDVYSFGILVLEMVTRRRP 775
           PE     +    S + DVY+FGI++ E++T + P
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 95.9 bits (237), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 128/282 (45%), Gaps = 45/282 (15%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           LG G +G V+ G     T +AVK L+ Q      +F  E  ++K+++H+ L+R+    + 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
                ++  YM NGSL   L   S          LT+ + +++ + IAEGMA++   +  
Sbjct: 76  EPI-YIITEYMENGSLVDFLKTPS-------GIKLTINKLLDMAAQIAEGMAFIEERN-- 125
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
             IH +L+ +N+L++D ++  ++DFG+A+L+       +  E      A      I + A
Sbjct: 126 -YIHRNLRAANILVSDTLSCKIADFGLARLI-------EDNEYTAREGAKF---PIKWTA 174
Query: 745 PEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDS 804
           PE       + K DV+SFGIL+ E+VT  R                   Y G     +  
Sbjct: 175 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIP-----------------YPGMTNPEVIQ 217
Query: 805 SLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTM 846
           +L R  R   P      D    EL +L  LC +E P  RPT 
Sbjct: 218 NLERGYRMVRP------DNCPEELYQLMRLCWKERPEDRPTF 253

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Composition-based stats.
 Identities = 66/211 (31%), Positives = 108/211 (51%), Gaps = 24/211 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLMRIITACS 623
           LG G +G V+ G     T +A+K L+   G  + ++F +E QV+K++RH  L+++    S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +V+ YM+ GSL   L        G     L L Q V++ + IA GMAY+     
Sbjct: 84  EEPI-YIVIEYMSKGSLLDFLK-------GEMGKYLRLPQLVDMAAQIASGMAYVER--- 132
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
           +  +H DL+ +N+L+ +++   V+DFG+A+L+       +  E      A      I + 
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLARLI-------EDNEXTARQGAKF---PIKWT 182
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           APE       + K DV+SFGIL+ E+ T+ R
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Composition-based stats.
 Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 24/211 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLMRIITACS 623
           LG G +G V+ G     T +A+K L+   G  + ++F +E QV+K++RH  L+++    S
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +V  YM+ GSL   L        G     L L Q V++ + IA GMAY+     
Sbjct: 74  EEPI-XIVTEYMSKGSLLDFLK-------GETGKYLRLPQLVDMAAQIASGMAYVER--- 122
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
           +  +H DL+ +N+L+ +++   V+DFG+A+L+       +  E      A      I + 
Sbjct: 123 MNYVHRDLRAANILVGENLVCKVADFGLARLI-------EDNEXTARQGAKF---PIKWT 172
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           APE       + K DV+SFGIL+ E+ T+ R
Sbjct: 173 APEAALYGRFTIKSDVWSFGILLTELTTKGR 203

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Composition-based stats.
 Identities = 66/211 (31%), Positives = 108/211 (51%), Gaps = 24/211 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLMRIITACS 623
           LG G +G V+ G     T +A+K L+   G  + ++F +E QV+K++RH  L+++    S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +V+ YM+ GSL   L        G     L L Q V++ + IA GMAY+     
Sbjct: 84  EEPI-YIVIEYMSKGSLLDFLK-------GEMGKYLRLPQLVDMAAQIASGMAYVER--- 132
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
           +  +H DL+ +N+L+ +++   V+DFG+A+L+       +  E      A      I + 
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLARLI-------EDNEYTARQGAKF---PIKWT 182
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           APE       + K DV+SFGIL+ E+ T+ R
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-19,   Method: Composition-based stats.
 Identities = 67/211 (31%), Positives = 107/211 (50%), Gaps = 24/211 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLMRIITACS 623
           LG G +G V+ G     T +A+K L+   G  + ++F +E QV+K+IRH  L+++    S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +V  YM+ GSL   L        G     L L Q V++ + IA GMAY+     
Sbjct: 84  EEPI-YIVTEYMSKGSLLDFLK-------GEMGKYLRLPQLVDMAAQIASGMAYVER--- 132
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
           +  +H DL+ +N+L+ +++   V+DFG+A+L+       +  E      A      I + 
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLARLI-------EDNEYTARQGAKF---PIKWT 182
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           APE       + K DV+SFGIL+ E+ T+ R
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Composition-based stats.
 Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 24/211 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLMRIITACS 623
           LG G +G V+ G     T +A+K L+   G  + ++F +E QV+K++RH  L+++    S
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +V  YM+ GSL   L        G     L L Q V++ + IA GMAY+     
Sbjct: 77  EEPI-YIVTEYMSKGSLLDFLK-------GETGKYLRLPQLVDMAAQIASGMAYVER--- 125
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
           +  +H DL+ +N+L+ +++   V+DFG+A+L+       +  E      A      I + 
Sbjct: 126 MNYVHRDLRAANILVGENLVCKVADFGLARLI-------EDNEYTARQGAKF---PIKWT 175
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           APE       + K DV+SFGIL+ E+ T+ R
Sbjct: 176 APEAALYGRFTIKSDVWSFGILLTELTTKGR 206

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Composition-based stats.
 Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 24/211 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLMRIITACS 623
           LG G +G V+ G     T +A+K L+   G  + ++F +E QV+K++RH  L+++    S
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +V  YM+ GSL   L        G     L L Q V++ + IA GMAY+     
Sbjct: 73  EEPI-YIVTEYMSKGSLLDFLK-------GEMGKYLRLPQLVDMAAQIASGMAYVER--- 121
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
           +  +H DL+ +N+L+ +++   V+DFG+A+L+       +  E      A      I + 
Sbjct: 122 MNYVHRDLRAANILVGENLVCKVADFGLARLI-------EDNEYTARQGAKF---PIKWT 171
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           APE       + K DV+SFGIL+ E+ T+ R
Sbjct: 172 APEAALYGRFTIKSDVWSFGILLTELTTKGR 202

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Composition-based stats.
 Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 24/211 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLMRIITACS 623
           LG G +G V+ G     T +A+K L+   G  + ++F +E QV+K++RH  L+++    S
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +V  YM+ GSL   L        G     L L Q V++ + IA GMAY+     
Sbjct: 75  EEPI-YIVTEYMSKGSLLDFLK-------GEMGKYLRLPQLVDMAAQIASGMAYVER--- 123
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
           +  +H DL+ +N+L+ +++   V+DFG+A+L+       +  E      A      I + 
Sbjct: 124 MNYVHRDLRAANILVGENLVCKVADFGLARLI-------EDNEYTARQGAKF---PIKWT 173
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           APE       + K DV+SFGIL+ E+ T+ R
Sbjct: 174 APEAALYGRFTIKSDVWSFGILLTELTTKGR 204

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Composition-based stats.
 Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 24/211 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLMRIITACS 623
           LG G +G V+ G     T +A+K L+   G  + ++F +E QV+K++RH  L+++    S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +V  YM+ GSL   L        G     L L Q V++ + IA GMAY+     
Sbjct: 84  EEPI-YIVTEYMSKGSLLDFLK-------GEMGKYLRLPQLVDMAAQIASGMAYVER--- 132
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
           +  +H DL+ +N+L+ +++   V+DFG+A+L+       +  E      A      I + 
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLARLI-------EDNEYTARQGAKF---PIKWT 182
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           APE       + K DV+SFGIL+ E+ T+ R
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Composition-based stats.
 Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 24/211 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLMRIITACS 623
           LG G +G V+ G     T +A+K L+   G  + ++F +E QV+K++RH  L+++    S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +V  YM+ GSL   L        G     L L Q V++ + IA GMAY+     
Sbjct: 84  EEPI-YIVCEYMSKGSLLDFLK-------GEMGKYLRLPQLVDMAAQIASGMAYVER--- 132
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
           +  +H DL+ +N+L+ +++   V+DFG+A+L+       +  E      A      I + 
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLARLI-------EDNEYTARQGAKF---PIKWT 182
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           APE       + K DV+SFGIL+ E+ T+ R
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Composition-based stats.
 Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 24/211 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLMRIITACS 623
           LG G +G V+ G     T +A+K L+   G  + ++F +E QV+K++RH  L+++    S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +V+ YM+ G L   L        G     L L Q V++ + IA GMAY+     
Sbjct: 84  EEPI-YIVMEYMSKGCLLDFLK-------GEMGKYLRLPQLVDMAAQIASGMAYVER--- 132
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
           +  +H DL+ +N+L+ +++   V+DFG+A+L+       +  E      A      I + 
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLARLI-------EDNEYTARQGAKF---PIKWT 182
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           APE       + K DV+SFGIL+ E+ T+ R
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Composition-based stats.
 Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 24/211 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLMRIITACS 623
           LG G +G V+ G     T +A+K L+   G  + ++F +E QV+K++RH  L+++    S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +V  YM  GSL   L        G     L L Q V++ + IA GMAY+     
Sbjct: 81  EEPI-YIVTEYMNKGSLLDFLK-------GETGKYLRLPQLVDMSAQIASGMAYVER--- 129
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
           +  +H DL+ +N+L+ +++   V+DFG+A+L+       +  E      A      I + 
Sbjct: 130 MNYVHRDLRAANILVGENLVCKVADFGLARLI-------EDNEYTARQGAKF---PIKWT 179
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           APE       + K DV+SFGIL+ E+ T+ R
Sbjct: 180 APEAALYGRFTIKSDVWSFGILLTELTTKGR 210

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 22/220 (10%)
Query: 562 QRLLGTGSYGRVYKGIL------QDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNL 615
           +R LG G++G+V+          QD   +AVK L+  S N  K F+RE ++L  ++H ++
Sbjct: 18  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 77
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEF----GSGSSDLTLLQRVNICSDI 671
           ++    C   D   +V  YM +G L+  L  H         G+  ++LT  Q ++I   I
Sbjct: 78  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A GM YL   +    +H DL   N L+ +++   + DFG+++ V +      G   M   
Sbjct: 138 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM--- 191
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                   I +M PE       +T+ DV+S G+++ E+ T
Sbjct: 192 ------LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Composition-based stats.
 Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 24/211 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLMRIITACS 623
           LG G +G V+ G     T +A+K L+   G  + ++F +E QV+K++RH  L+++    S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +V  YM+ GSL   L        G     L L Q V++ + IA GMAY+     
Sbjct: 84  EEPI-YIVTEYMSKGSLLDFLK-------GEMGKYLRLPQLVDMAAQIASGMAYVER--- 132
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
           +  +H DL  +N+L+ +++   V+DFG+A+L+       +  E      A      I + 
Sbjct: 133 MNYVHRDLAAANILVGENLVCKVADFGLARLI-------EDNEYTARQGAKF---PIKWT 182
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           APE       + K DV+SFGIL+ E+ T+ R
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Composition-based stats.
 Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 24/211 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLMRIITACS 623
           LG G +G V+ G     T +A+K L+   G  + ++F +E QV+K++RH  L+++    S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +V  YM  GSL   L        G     L L Q V++ + IA GMAY+     
Sbjct: 81  EEPI-YIVTEYMNKGSLLDFLK-------GETGKYLRLPQLVDMSAQIASGMAYVER--- 129
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
           +  +H DL+ +N+L+ +++   V+DFG+A+L+      N+     G          I + 
Sbjct: 130 MNYVHRDLRAANILVGENLVCKVADFGLARLIED----NEWTARQGAKF------PIKWT 179
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           APE       + K DV+SFGIL+ E+ T+ R
Sbjct: 180 APEAALYGRFTIKSDVWSFGILLTELTTKGR 210

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 111/215 (51%), Gaps = 26/215 (12%)
Query: 565 LGTGSYGRVYKGILQDGTAIAV-KVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           +G+GS+G VYKG      A+ + KV+      F ++F  E  VL++ RH N++ +     
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQF-QAFRNEVAVLRKTRHVNIL-LFMGYM 101
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
             D  A+V  +    SL  HL+   ET+F        + Q ++I    A+GM YLH  + 
Sbjct: 102 TKDNLAIVTQWCEGSSLYKHLHVQ-ETKF-------QMFQLIDIARQTAQGMDYLHAKN- 152
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
             +IH D+K +N+ L++ +T  + DFG+A    TV     G++ +   T     GS+ +M
Sbjct: 153 --IIHRDMKSNNIFLHEGLTVKIGDFGLA----TVKSRWSGSQQVEQPT-----GSVLWM 201
Query: 744 APEYGFGSNT---STKGDVYSFGILVLEMVTRRRP 775
           APE     +    S + DVYS+GI++ E++T   P
Sbjct: 202 APEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 24/211 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNLMRIITACS 623
           LG G +G V+ G     T +A+K L+   G  + ++F +E QV+K++RH  L+++    S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +V  YM+ G L   L        G     L L Q V++ + IA GMAY+     
Sbjct: 84  EEPI-YIVTEYMSKGCLLDFLK-------GEMGKYLRLPQLVDMAAQIASGMAYVER--- 132
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
           +  +H DL+ +N+L+ +++   V+DFG+A+L+       +  E      A      I + 
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLARLI-------EDNEYTARQGAKF---PIKWT 182
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           APE       + K DV+SFGIL+ E+ T+ R
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 81/282 (28%), Positives = 134/282 (47%), Gaps = 46/282 (16%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           LG G +G V+ G   + T +AVK L+  + +  ++F  E  ++K ++H  L+R+    + 
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
            +   ++  YMA GSL   L      E G     + L + ++  + IAEGMAY+   +  
Sbjct: 80  EEPIYIITEYMAKGSLLDFL---KSDEGGK----VLLPKLIDFSAQIAEGMAYIERKN-- 130
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
             IH DL+ +NVL+++ +   ++DFG+A+++       +  E      A      I + A
Sbjct: 131 -YIHRDLRAANVLVSESLMCKIADFGLARVI-------EDNEYTAREGAKF---PIKWTA 179
Query: 745 PE-YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVID 803
           PE   FG  T  K DV+SFGIL+ E+VT                 + K  Y GR    + 
Sbjct: 180 PEAINFGCFT-IKSDVWSFGILLYEIVT-----------------YGKIPYPGRTNADVM 221
Query: 804 SSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
           ++L +  R   P V+   D    EL ++  +C +E    RPT
Sbjct: 222 TALSQGYR--MPRVENCPD----ELYDIMKMCWKEKAEERPT 257

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 136/296 (45%), Gaps = 53/296 (17%)
Query: 563 RLLGTGSYGRVYKGIL--QDGTA--IAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLM 616
           ++LG G +G V +G L  +DGT+  +AVK ++L   S    + F  E   +K   H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 617 RIITAC------SLPDFKALVLPYMANGSLDSHL-YPHSETEFGSGSSDLTLLQRVNICS 669
           R++  C       +P    ++LP+M  G L ++L Y   ET    G   + L   +    
Sbjct: 100 RLLGVCIEMSSQGIPK-PMVILPFMKYGDLHTYLLYSRLET----GPKHIPLQTLLKFMV 154
Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           DIA GM YL + +    +H DL   N +L DDMT  V+DFG++K + +      G     
Sbjct: 155 DIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG----- 206
Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKW 789
              A M    + ++A E       ++K DV++FG+ + E+ TR          G++ +  
Sbjct: 207 -RIAKM---PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR----------GMTPYPG 252
Query: 790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
           V+NH        +   LL   R + PE        + EL E+   C +  P  RPT
Sbjct: 253 VQNHE-------MYDYLLHGHRLKQPE------DCLDELYEIMYSCWRTDPLDRPT 295

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 119/249 (47%), Gaps = 5/249 (2%)
Query: 235 ISAEISWLSQLEQLFLSH-NLFSGEIPAAXXXXXXXXXXXXSFNKLSGEIPVSLGNLVQI 293
           I + ++ L  L  L++   N   G IP A            +   +SG IP  L  +  +
Sbjct: 68  IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 294 YSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLE 353
            +L  + N LS ++PP++    +L  +    NR++G+IP       ++   + +S N+L 
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 354 GPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKN 413
           G +P   + L N+  +DLS N   G+  +   +    + I+++ N+L  +L   +G  KN
Sbjct: 188 GKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKN 245
Query: 414 LEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLC 473
           L  +D+  N + G +P  L ++  L  +N+SFN   G IP GG        ++  N+ LC
Sbjct: 246 LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLC 305
Query: 474 GTVPGMPIC 482
           G+   +P C
Sbjct: 306 GSP--LPAC 312

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Composition-based stats.
 Identities = 79/282 (28%), Positives = 134/282 (47%), Gaps = 46/282 (16%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           LG G +G V+ G   + T +AVK L+  + +  ++F  E  ++K ++H  L+R+    + 
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
            +   ++  +MA GSL   L      E G     + L + ++  + IAEGMAY+   +  
Sbjct: 79  EEPIYIITEFMAKGSLLDFL---KSDEGGK----VLLPKLIDFSAQIAEGMAYIERKN-- 129
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
             IH DL+ +NVL+++ +   ++DFG+A+++       +  E      A      I + A
Sbjct: 130 -YIHRDLRAANVLVSESLMCKIADFGLARVI-------EDNEYTAREGAKF---PIKWTA 178
Query: 745 PE-YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVID 803
           PE   FG  T  K +V+SFGIL+ E+VT                 + K  Y GR    + 
Sbjct: 179 PEAINFGCFT-IKSNVWSFGILLYEIVT-----------------YGKIPYPGRTNADVM 220
Query: 804 SSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
           S+L +  R   P ++   D    EL ++  +C +E    RPT
Sbjct: 221 SALSQGYR--MPRMENCPD----ELYDIMKMCWKEKAEERPT 256

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 109/216 (50%), Gaps = 25/216 (11%)
Query: 562 QRLLGTGSYGRVYKGILQDGTA---IAVKVLQLQSGNFTKS---FNRECQVLKRIRHRNL 615
           Q+++G G +G VYKG+L+  +    + V +  L++G   K    F  E  ++ +  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +R+    S      ++  YM NG+LD  L    + EF       ++LQ V +   IA GM
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEF-------SVLQLVGMLRGIAAGM 160
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL +   +  +H DL   N+L+N ++   VSDFG+++++       D  E    ++   
Sbjct: 161 KYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL------EDDPEATYTTSGGK 211
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           +   I + APE       ++  DV+SFGI++ E++T
Sbjct: 212 I--PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 15/213 (7%)
Query: 564 LLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITAC 622
           +LG G +G+  K   ++ G  + +K L        ++F +E +V++ + H N+++ I   
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
                   +  Y+  G+L   +         S  S     QRV+   DIA GMAYLH   
Sbjct: 77  YKDKRLNFITEYIKGGTLRGII--------KSMDSQYPWSQRVSFAKDIASGMAYLHS-- 126
Query: 683 PVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIG- 741
            + +IH DL   N L+ ++   +V+DFG+A+L++      +G  ++           +G 
Sbjct: 127 -MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 742 --YMAPEYGFGSNTSTKGDVYSFGILVLEMVTR 772
             +MAPE   G +   K DV+SFGI++ E++ R
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 104/219 (47%), Gaps = 24/219 (10%)
Query: 565 LGTGSYGRVYKGIL------QDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRI 618
           LG G++G+V+          QD   +AVK L+  S +  + F RE ++L  ++H++++R 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 619 ITACSLPDFKALVLPYMANGSLDSHLYPHS-ETEFGSGSSD-----LTLLQRVNICSDIA 672
              C+      +V  YM +G L+  L  H  + +  +G  D     L L Q + + S +A
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
            GM YL   + +  +H DL   N L+   +   + DFG+++ + +      G   M    
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM---- 198
Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                  I +M PE       +T+ DV+SFG+++ E+ T
Sbjct: 199 -----LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 104/219 (47%), Gaps = 24/219 (10%)
Query: 565 LGTGSYGRVYKGIL------QDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRI 618
           LG G++G+V+          QD   +AVK L+  S +  + F RE ++L  ++H++++R 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 619 ITACSLPDFKALVLPYMANGSLDSHLYPHS-ETEFGSGSSD-----LTLLQRVNICSDIA 672
              C+      +V  YM +G L+  L  H  + +  +G  D     L L Q + + S +A
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
            GM YL   + +  +H DL   N L+   +   + DFG+++ + +      G   M    
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM---- 192
Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                  I +M PE       +T+ DV+SFG+++ E+ T
Sbjct: 193 -----LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 25/223 (11%)
Query: 562 QRLLGTGSYGRVYKGIL------QDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNL 615
           +R LG G++G+V+          +D   +AVK L+  +    K F RE ++L  ++H ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHS-------ETEFGSGSSDLTLLQRVNIC 668
           ++    C   D   +V  YM +G L+  L  H        + +      +L L Q ++I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
           S IA GM YL   +    +H DL   N L+  ++   + DFG+++ V +      G   M
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 729 GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                      I +M PE       +T+ DV+SFG+++ E+ T
Sbjct: 197 ---------LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 104/219 (47%), Gaps = 24/219 (10%)
Query: 565 LGTGSYGRVYKGIL------QDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRI 618
           LG G++G+V+          QD   +AVK L+  S +  + F RE ++L  ++H++++R 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 619 ITACSLPDFKALVLPYMANGSLDSHLYPHS-ETEFGSGSSD-----LTLLQRVNICSDIA 672
              C+      +V  YM +G L+  L  H  + +  +G  D     L L Q + + S +A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
            GM YL   + +  +H DL   N L+   +   + DFG+++ + +      G   M    
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM---- 221
Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                  I +M PE       +T+ DV+SFG+++ E+ T
Sbjct: 222 -----LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 114/231 (49%), Gaps = 34/231 (14%)
Query: 563 RLLGTGSYGRVYK----GIL--QDGTAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNL 615
           R +G G++GRV++    G+L  +  T +AVK+L+ + S +    F RE  ++    + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLY---PHSETEF------------GSGSSDLT 660
           ++++  C++     L+  YMA G L+  L    PH+                  G   L+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 661 LLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGV 720
             +++ I   +A GMAYL      + +H DL   N L+ ++M   ++DFG+++ + +   
Sbjct: 173 CAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA-- 227
Query: 721 GNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
             D  +  GN         I +M PE  F +  +T+ DV+++G+++ E+ +
Sbjct: 228 --DYYKADGNDAI-----PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 29/219 (13%)
Query: 565 LGTGSYGRVYKGILQ-DGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNLMRIIT 620
           LG G++G+V  G  Q  G  +AVK+L   +++S +      RE Q LK  RH +++++  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
             S P    +V+ Y++ G L  ++  H   E          ++   +   I   + Y H 
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVE---------EMEARRLFQQILSAVDYCHR 129
Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
           H    V+H DLKP NVLL+  M A ++DFG++ ++      +DG E + +S     CGS 
Sbjct: 130 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM------SDG-EFLRDS-----CGSP 174
Query: 741 GYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDD 778
            Y APE   G      + D++S G+++  ++    P DD
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 65/230 (28%), Positives = 113/230 (49%), Gaps = 24/230 (10%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTK-SFNRECQVLKRIRHRNLMRIITACS 623
           LG+G +G V  G  +    +AVK+++   G+ ++  F +E Q + ++ H  L++    CS
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK--EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +V  Y++NG L ++L  H     G G     LL+   +C D+ EGMA+L  H  
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSH-----GKGLEPSQLLE---MCYDVCEGMAFLESH-- 123
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
            + IH DL   N L++ D+   VSDFG+ + V+     +    ++G          + + 
Sbjct: 124 -QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD----DQYVSSVGTKF------PVKWS 172
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH 793
           APE       S+K DV++FGIL+ E+ +  +   D++     + K  + H
Sbjct: 173 APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH 222

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 120/244 (49%), Gaps = 30/244 (12%)
Query: 534 KPITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGI-LQDGTAI----AVKV 588
           +P+TP      P      +L+ T E    ++LG+G++G VYKGI + +G  +    A+K+
Sbjct: 18  EPLTPS--GTAPNQAQLRILKET-ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKI 74
Query: 589 LQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPH 647
           L   +G      F  E  ++  + H +L+R++  C  P  + LV   M +G L  +++ H
Sbjct: 75  LNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEH 133
Query: 648 SETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVS 707
            +     GS  L     +N C  IA+GM YL      R++H DL   NVL+       ++
Sbjct: 134 KDN---IGSQLL-----LNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKIT 182
Query: 708 DFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVL 767
           DFG+A+L+       +G E   N+    +   I +MA E       + + DV+S+G+ + 
Sbjct: 183 DFGLARLL-------EGDEKEYNADGGKM--PIKWMALECIHYRKFTHQSDVWSYGVTIW 233
Query: 768 EMVT 771
           E++T
Sbjct: 234 ELMT 237

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 24/214 (11%)
Query: 562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           ++ LG G +G V+       T +AVK ++  S +  ++F  E  V+K ++H  L+++  A
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKL-HA 250
Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
               +   ++  +MA GSL   L    +++ GS      L + ++  + IAEGMA++   
Sbjct: 251 VVTKEPIYIITEFMAKGSLLDFL----KSDEGSKQP---LPKLIDFSAQIAEGMAFIEQR 303
Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIG 741
           +    IH DL+ +N+L++  +   ++DFG+A+++       +  E      A      I 
Sbjct: 304 N---YIHRDLRAANILVSASLVCKIADFGLARVI-------EDNEYTAREGAKF---PIK 350
Query: 742 YMAPEY-GFGSNTSTKGDVYSFGILVLEMVTRRR 774
           + APE   FGS T  K DV+SFGIL++E+VT  R
Sbjct: 351 WTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGR 383

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 29/219 (13%)
Query: 565 LGTGSYGRVYKGILQ-DGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNLMRIIT 620
           LG G++G+V  G  Q  G  +AVK+L   +++S +      RE Q LK  RH +++++  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
             S P    +V+ Y++ G L  ++  H   E          ++   +   I   + Y H 
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVE---------EMEARRLFQQILSAVDYCHR 129
Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
           H    V+H DLKP NVLL+  M A ++DFG++ ++      +DG E +  S     CGS 
Sbjct: 130 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM------SDG-EFLRTS-----CGSP 174
Query: 741 GYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDD 778
            Y APE   G      + D++S G+++  ++    P DD
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 110/220 (50%), Gaps = 27/220 (12%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAI----AVKVLQLQSG-NFTKSFNRECQVLKRIR 611
           E    ++LG+G++G VYKGI + +G  +    A+K+L   +G      F  E  ++  + 
Sbjct: 16  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 75
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           H +L+R++  C  P  + LV   M +G L  +++ H +     GS  L     +N C  I
Sbjct: 76  HPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDN---IGSQLL-----LNWCVQI 126
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+A+L+       +G E   N+
Sbjct: 127 AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL-------EGDEKEYNA 176
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               +   I +MA E       + + DV+S+G+ + E++T
Sbjct: 177 DGGKM--PIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 557 AEFDEQRL-----LGTGSYGRV---YKGILQD--GTAIAVKVLQLQSGNFTKSFNRECQV 606
            +F+E+ L     LG G++G V       LQD  G  +AVK LQ  +    + F RE ++
Sbjct: 4   TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 63
Query: 607 LKRIRHRNLMRIITACSLPDFK--ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           LK ++H N+++    C     +   L++ Y+  GSL  +L  H E         + LLQ 
Sbjct: 64  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQ- 117
Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
               S I +GM YL      R IH DL   N+L+ ++    + DFG+ K V+        
Sbjct: 118 --YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXK 171
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            +  G S        I + APE    S  S   DV+SFG+++ E+ T
Sbjct: 172 VKEPGES-------PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 557 AEFDEQRL-----LGTGSYGRV---YKGILQD--GTAIAVKVLQLQSGNFTKSFNRECQV 606
            +F+E+ L     LG G++G V       LQD  G  +AVK LQ  +    + F RE ++
Sbjct: 3   TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 62
Query: 607 LKRIRHRNLMRIITACSLPDFK--ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           LK ++H N+++    C     +   L++ Y+  GSL  +L  H E         + LLQ 
Sbjct: 63  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQ- 116
Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
               S I +GM YL      R IH DL   N+L+ ++    + DFG+ K V+        
Sbjct: 117 --YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXK 170
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            +  G S        I + APE    S  S   DV+SFG+++ E+ T
Sbjct: 171 VKEPGES-------PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 557 AEFDEQRL-----LGTGSYGRV---YKGILQD--GTAIAVKVLQLQSGNFTKSFNRECQV 606
            +F+E+ L     LG G++G V       LQD  G  +AVK LQ  +    + F RE ++
Sbjct: 8   TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 67
Query: 607 LKRIRHRNLMRIITACSLPDFK--ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           LK ++H N+++    C     +   L++ Y+  GSL  +L  H+E         + LLQ 
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER-----IDHIKLLQ- 121
Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
               S I +GM YL      R IH DL   N+L+ ++    + DFG+ K V+        
Sbjct: 122 --YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXK 175
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            +  G S        I + APE    S  S   DV+SFG+++ E+ T
Sbjct: 176 VKEPGES-------PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 557 AEFDEQRL-----LGTGSYGRV---YKGILQD--GTAIAVKVLQLQSGNFTKSFNRECQV 606
            +F+E+ L     LG G++G V       LQD  G  +AVK LQ  +    + F RE ++
Sbjct: 9   TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 68
Query: 607 LKRIRHRNLMRIITACSLPDFK--ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           LK ++H N+++    C     +   L++ Y+  GSL  +L  H E         + LLQ 
Sbjct: 69  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQ- 122
Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
               S I +GM YL      R IH DL   N+L+ ++    + DFG+ K V+        
Sbjct: 123 --YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXK 176
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            +  G S        I + APE    S  S   DV+SFG+++ E+ T
Sbjct: 177 VKEPGES-------PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 557 AEFDEQRL-----LGTGSYGRV---YKGILQD--GTAIAVKVLQLQSGNFTKSFNRECQV 606
            +F+E+ L     LG G++G V       LQD  G  +AVK LQ  +    + F RE ++
Sbjct: 5   TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 64
Query: 607 LKRIRHRNLMRIITACSLPDFK--ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           LK ++H N+++    C     +   L++ Y+  GSL  +L  H E         + LLQ 
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQ- 118
Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
               S I +GM YL      R IH DL   N+L+ ++    + DFG+ K V+        
Sbjct: 119 --YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXK 172
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            +  G S        I + APE    S  S   DV+SFG+++ E+ T
Sbjct: 173 VKEPGES-------PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 557 AEFDEQRL-----LGTGSYGRV---YKGILQD--GTAIAVKVLQLQSGNFTKSFNRECQV 606
            +F+E+ L     LG G++G V       LQD  G  +AVK LQ  +    + F RE ++
Sbjct: 23  TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 82
Query: 607 LKRIRHRNLMRIITACSLPDFK--ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           LK ++H N+++    C     +   L++ Y+  GSL  +L  H E         + LLQ 
Sbjct: 83  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQ- 136
Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
               S I +GM YL      R IH DL   N+L+ ++    + DFG+ K V+        
Sbjct: 137 --YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXK 190
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            +  G S        I + APE    S  S   DV+SFG+++ E+ T
Sbjct: 191 VKEPGES-------PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 557 AEFDEQRL-----LGTGSYGRV---YKGILQD--GTAIAVKVLQLQSGNFTKSFNRECQV 606
            +F+E+ L     LG G++G V       LQD  G  +AVK LQ  +    + F RE ++
Sbjct: 10  TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 69
Query: 607 LKRIRHRNLMRIITACSLPDFK--ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           LK ++H N+++    C     +   L++ Y+  GSL  +L  H E         + LLQ 
Sbjct: 70  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQ- 123
Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
               S I +GM YL      R IH DL   N+L+ ++    + DFG+ K V+        
Sbjct: 124 --YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXK 177
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            +  G S        I + APE    S  S   DV+SFG+++ E+ T
Sbjct: 178 VKEPGES-------PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 557 AEFDEQRL-----LGTGSYGRV---YKGILQD--GTAIAVKVLQLQSGNFTKSFNRECQV 606
            +F+E+ L     LG G++G V       LQD  G  +AVK LQ  +    + F RE ++
Sbjct: 8   TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 67
Query: 607 LKRIRHRNLMRIITACSLPDFK--ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           LK ++H N+++    C     +   L++ Y+  GSL  +L  H E         + LLQ 
Sbjct: 68  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQ- 121
Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
               S I +GM YL      R IH DL   N+L+ ++    + DFG+ K V+        
Sbjct: 122 --YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXK 175
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            +  G S        I + APE    S  S   DV+SFG+++ E+ T
Sbjct: 176 VKEPGES-------PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 110/243 (45%), Gaps = 33/243 (13%)
Query: 536 ITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRV---YKGILQD--GTAIAVKVLQ 590
           + P   HN  +   R L     +F +Q  LG G++G V       LQD  G  +AVK LQ
Sbjct: 14  LVPRGSHNMTQFEERHL-----KFLQQ--LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ 66
Query: 591 LQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFK--ALVLPYMANGSLDSHLYPHS 648
             +    + F RE ++LK ++H N+++    C     +   L++ Y+  GSL  +L  H 
Sbjct: 67  HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK 126
Query: 649 ETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSD 708
           E         + LLQ     S I +GM YL      R IH DL   N+L+ ++    + D
Sbjct: 127 ER-----IDHIKLLQ---YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGD 175
Query: 709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLE 768
           FG+ K V+         +  G S        I + APE    S  S   DV+SFG+++ E
Sbjct: 176 FGLTK-VLPQDKEXXKVKEPGES-------PIFWYAPESLTESKFSVASDVWSFGVVLYE 227
Query: 769 MVT 771
           + T
Sbjct: 228 LFT 230

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 557 AEFDEQRL-----LGTGSYGRV---YKGILQD--GTAIAVKVLQLQSGNFTKSFNRECQV 606
            +F+E+ L     LG G++G V       LQD  G  +AVK LQ  +    + F RE ++
Sbjct: 36  TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 95
Query: 607 LKRIRHRNLMRIITACSLPDFK--ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           LK ++H N+++    C     +   L++ Y+  GSL  +L  H E         + LLQ 
Sbjct: 96  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQ- 149
Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
               S I +GM YL      R IH DL   N+L+ ++    + DFG+ K V+        
Sbjct: 150 --YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXK 203
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            +  G S        I + APE    S  S   DV+SFG+++ E+ T
Sbjct: 204 VKEPGES-------PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 557 AEFDEQRL-----LGTGSYGRV---YKGILQD--GTAIAVKVLQLQSGNFTKSFNRECQV 606
            +F+E+ L     LG G++G V       LQD  G  +AVK LQ  +    + F RE ++
Sbjct: 5   TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 64
Query: 607 LKRIRHRNLMRIITACSLPDFK--ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           LK ++H N+++    C     +   L++ Y+  GSL  +L  H E         + LLQ 
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQ- 118
Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
               S I +GM YL      R IH DL   N+L+ ++    + DFG+ K V+        
Sbjct: 119 --YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXK 172
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            +  G S        I + APE    S  S   DV+SFG+++ E+ T
Sbjct: 173 VKEPGES-------PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 557 AEFDEQRL-----LGTGSYGRV---YKGILQD--GTAIAVKVLQLQSGNFTKSFNRECQV 606
            +F+E+ L     LG G++G V       LQD  G  +AVK LQ  +    + F RE ++
Sbjct: 12  TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 71
Query: 607 LKRIRHRNLMRIITACSLPDFK--ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           LK ++H N+++    C     +   L++ Y+  GSL  +L  H E         + LLQ 
Sbjct: 72  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQ- 125
Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
               S I +GM YL      R IH DL   N+L+ ++    + DFG+ K V+        
Sbjct: 126 --YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXK 179
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            +  G S        I + APE    S  S   DV+SFG+++ E+ T
Sbjct: 180 VKEPGES-------PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 557 AEFDEQRL-----LGTGSYGRV---YKGILQD--GTAIAVKVLQLQSGNFTKSFNRECQV 606
            +F+E+ L     LG G++G V       LQD  G  +AVK LQ  +    + F RE ++
Sbjct: 11  TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 70
Query: 607 LKRIRHRNLMRIITACSLPDFK--ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           LK ++H N+++    C     +   L++ Y+  GSL  +L  H E         + LLQ 
Sbjct: 71  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQ- 124
Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
               S I +GM YL      R IH DL   N+L+ ++    + DFG+ K V+        
Sbjct: 125 --YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXK 178
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            +  G S        I + APE    S  S   DV+SFG+++ E+ T
Sbjct: 179 VKEPGES-------PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 118/248 (47%), Gaps = 32/248 (12%)
Query: 540 LMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGIL------QDGTAIAVKVLQLQS 593
           L++   +   +E+  +   F E+  LG   +G+VYKG L      +   A+A+K L+ ++
Sbjct: 11  LINQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA 68
Query: 594 -GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLY---PHSE 649
            G   + F  E  +  R++H N++ ++   +     +++  Y ++G L   L    PHS+
Sbjct: 69  EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSD 128
Query: 650 TEFGSGSSDLTLLQR------VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMT 703
              GS   D T+         V++ + IA GM YL  H    V+H DL   NVL+ D + 
Sbjct: 129 V--GSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183
Query: 704 ALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFG 763
             +SD G+ + V       D  + +GNS        I +MAPE       S   D++S+G
Sbjct: 184 VKISDLGLFREVYAA----DYYKLLGNSLL-----PIRWMAPEAIMYGKFSIDSDIWSYG 234
Query: 764 ILVLEMVT 771
           +++ E+ +
Sbjct: 235 VVLWEVFS 242

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 78/285 (27%), Positives = 131/285 (45%), Gaps = 47/285 (16%)
Query: 562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           ++ LG G +G V+       T +AVK ++  S +  ++F  E  V+K ++H  L+++  A
Sbjct: 20  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKL-HA 77
Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
               +   ++  +MA GSL   L    +++ GS      L + ++  + IAEGMA++   
Sbjct: 78  VVTKEPIYIITEFMAKGSLLDFL----KSDEGSKQP---LPKLIDFSAQIAEGMAFIEQR 130
Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIG 741
           +    IH DL+ +N+L++  +   ++DFG+A+++       +  E      A      I 
Sbjct: 131 N---YIHRDLRAANILVSASLVCKIADFGLARVI-------EDNEYTAREGAKF---PIK 177
Query: 742 YMAPE-YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEK 800
           + APE   FGS T  K DV+SFGIL++E+VT  R                   Y G    
Sbjct: 178 WTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIP-----------------YPGMSNP 219
Query: 801 VIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
            +  +L R  R   PE          EL  + + C +  P  RPT
Sbjct: 220 EVIRALERGYRMPRPE------NCPEELYNIMMRCWKNRPEERPT 258

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 24/209 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNLMRIITACS 623
           +G+G +G V+ G   +   +A+K ++   G+ ++  F  E +V+ ++ H  L+++   C 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIK--EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 LV  +M +G L  +L     T+ G  +++ TLL    +C D+ EGMAYL     
Sbjct: 93  EQAPICLVFEFMEHGCLSDYL----RTQRGLFAAE-TLL---GMCLDVCEGMAYLEEAC- 143
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
             VIH DL   N L+ ++    VSDFG+ + V+         +   +ST       + + 
Sbjct: 144 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--------DQYTSSTGTKF--PVKWA 191
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTR 772
           +PE    S  S+K DV+SFG+L+ E+ + 
Sbjct: 192 SPEVFSFSRYSSKSDVWSFGVLMWEVFSE 220

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 131/293 (44%), Gaps = 47/293 (16%)
Query: 563 RLLGTGSYGRVYKGILQD------GTAIAVKVLQLQSGNFTK--SFNRECQVLKRIRHRN 614
           R LG GS+G VY+G  +D       T +AVK +  +S +  +   F  E  V+K     +
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFLNEASVMKGFTCHH 78
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYP-HSETEFGSGSSDLTLLQRVNICSDIAE 673
           ++R++   S      +V+  MA+G L S+L     E E   G    TL + + + ++IA+
Sbjct: 79  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 138
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           GMAYL+     + +H DL   N ++  D T  + DFG+ + +        G + +     
Sbjct: 139 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGL----- 190
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKN 792
                 + +MAPE       +T  D++SFG+++ E+ +   +P       GLS  + +K 
Sbjct: 191 ----LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ-----GLSNEQVLKF 241
Query: 793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
                   V+D   L    D  PE           + +L  +C Q +P  RPT
Sbjct: 242 --------VMDGGYLDQP-DNCPE----------RVTDLMRMCWQFNPKMRPT 275

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 132/293 (45%), Gaps = 47/293 (16%)
Query: 563 RLLGTGSYGRVYKGILQD------GTAIAVKVLQLQSGNFTK--SFNRECQVLKRIRHRN 614
           R LG GS+G VY+G  +D       T +AVK +  +S +  +   F  E  V+K     +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFLNEASVMKGFTCHH 81
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYP-HSETEFGSGSSDLTLLQRVNICSDIAE 673
           ++R++   S      +V+  MA+G L S+L     E E   G    TL + + + ++IA+
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           GMAYL+     + +H DL   N ++  D T  + DFG+ + +        G + +     
Sbjct: 142 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGL----- 193
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKN 792
                 + +MAPE       +T  D++SFG+++ E+ +   +P       GLS  + +K 
Sbjct: 194 ----LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ-----GLSNEQVLKF 244
Query: 793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
                   V+D   L    D  PE           + +L  +C Q +P+ RPT
Sbjct: 245 --------VMDGGYLDQP-DNCPE----------RVTDLMRMCWQFNPNMRPT 278

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 131/293 (44%), Gaps = 47/293 (16%)
Query: 563 RLLGTGSYGRVYKGILQD------GTAIAVKVLQLQSGNFTK--SFNRECQVLKRIRHRN 614
           R LG GS+G VY+G  +D       T +AVK +  +S +  +   F  E  V+K     +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFLNEASVMKGFTCHH 81
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYP-HSETEFGSGSSDLTLLQRVNICSDIAE 673
           ++R++   S      +V+  MA+G L S+L     E E   G    TL + + + ++IA+
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           GMAYL+     + +H DL   N ++  D T  + DFG+ + +        G + +     
Sbjct: 142 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGL----- 193
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKN 792
                 + +MAPE       +T  D++SFG+++ E+ +   +P       GLS  + +K 
Sbjct: 194 ----LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ-----GLSNEQVLKF 244
Query: 793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
                   V+D   L    D  PE           + +L  +C Q +P  RPT
Sbjct: 245 --------VMDGGYLDQP-DNCPE----------RVTDLMRMCWQFNPKMRPT 278

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 131/293 (44%), Gaps = 47/293 (16%)
Query: 563 RLLGTGSYGRVYKGILQD------GTAIAVKVLQLQSGNFTK--SFNRECQVLKRIRHRN 614
           R LG GS+G VY+G  +D       T +AVK +  +S +  +   F  E  V+K     +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFLNEASVMKGFTCHH 81
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYP-HSETEFGSGSSDLTLLQRVNICSDIAE 673
           ++R++   S      +V+  MA+G L S+L     E E   G    TL + + + ++IA+
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           GMAYL+     + +H DL   N ++  D T  + DFG+ + +        G + +     
Sbjct: 142 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGL----- 193
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKN 792
                 + +MAPE       +T  D++SFG+++ E+ +   +P       GLS  + +K 
Sbjct: 194 ----LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ-----GLSNEQVLKF 244
Query: 793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
                   V+D   L    D  PE           + +L  +C Q +P  RPT
Sbjct: 245 --------VMDGGYLDQP-DNCPE----------RVTDLMRMCWQFNPKMRPT 278

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 100/216 (46%), Gaps = 26/216 (12%)
Query: 563 RLLGTGSYGRV---YKGILQD--GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           R LG G++G V       LQD  G  +AVK LQ  +    + F RE ++LK ++H N+++
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 618 IITACSLPDFK--ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
               C     +   L++ ++  GSL  +L  H E         + LLQ     S I +GM
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER-----IDHIKLLQ---YTSQICKGM 130
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL      R IH DL   N+L+ ++    + DFG+ K V+         +  G S    
Sbjct: 131 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGES---- 182
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               I + APE    S  S   DV+SFG+++ E+ T
Sbjct: 183 ---PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 21/222 (9%)
Query: 553 LEATAEFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFN-RECQVLKRI 610
           + ++++F +   LG G+Y  VYKG+ +  G  +A+K ++L S   T S   RE  ++K +
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           +H N++R+       +   LV  +M N   D   Y  S T  G+    L L         
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDN---DLKKYMDSRT-VGNTPRGLELNLVKYFQWQ 116
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           + +G+A+ H +   +++H DLKP N+L+N      + DFG+A+           A  +  
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR-----------AFGIPV 162
Query: 731 STANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVT 771
           +T +    ++ Y AP+   GS T ST  D++S G ++ EM+T
Sbjct: 163 NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 117/246 (47%), Gaps = 30/246 (12%)
Query: 545 PRITYRELLEATAEFDE-----QRLLGTGSYGRVYKGILQ----DGTAIAVKVLQL-QSG 594
           PR + + + E   E D       +++G G +G V  G L+       ++A+K L++  + 
Sbjct: 16  PRGSTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 75
Query: 595 NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGS 654
              + F  E  ++ +  H N++R+    +      +V  YM NGSLDS L  H       
Sbjct: 76  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD------ 129
Query: 655 GSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL 714
             +  T++Q V +   IA GM YL   S +  +H DL   N+L+N ++   VSDFG++++
Sbjct: 130 --AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRV 184
Query: 715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-R 773
           +       D  E    +    +   I + +PE       ++  DV+S+GI++ E+++   
Sbjct: 185 L------EDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE 236
Query: 774 RPTDDM 779
           RP  +M
Sbjct: 237 RPYWEM 242

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 111/224 (49%), Gaps = 25/224 (11%)
Query: 562 QRLLGTGSYGRVYKGILQ----DGTAIAVKVLQL-QSGNFTKSFNRECQVLKRIRHRNLM 616
           +R++G G +G V  G L+       A+A+K L++  +    + F  E  ++ +  H N++
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
            +    +      +V+ +M NG+LD+ L  H            T++Q V +   IA GM 
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLRKHD--------GQFTVIQLVGMLRGIAAGMR 159
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL   + +  +H DL   N+L+N ++   VSDFG+++++       D  E +  +T   +
Sbjct: 160 YL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVI------EDDPEAVYTTTGGKI 210
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
              + + APE       ++  DV+S+GI++ E+++   RP  DM
Sbjct: 211 --PVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 252

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 109/223 (48%), Gaps = 25/223 (11%)
Query: 563 RLLGTGSYGRVYKGILQ----DGTAIAVKVLQL-QSGNFTKSFNRECQVLKRIRHRNLMR 617
           +++G G +G V  G L+       ++A+K L++  +    + F  E  ++ +  H N++R
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +    +      +V  YM NGSLDS L  H         +  T++Q V +   IA GM Y
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--------AQFTVIQLVGMLRGIASGMKY 162
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L   S +  +H DL   N+L+N ++   VSDFG+A+++       D  E    +    + 
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVL------EDDPEAAYTTRGGKI- 212
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
             I + +PE       ++  DV+S+GI++ E+++   RP  +M
Sbjct: 213 -PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 131/294 (44%), Gaps = 47/294 (15%)
Query: 563 RLLGTGSYGRVYKGILQD------GTAIAVKVLQLQSGNFTK--SFNRECQVLKRIRHRN 614
           R LG GS+G VY+G  +D       T +AVK +  +S +  +   F  E  V+K     +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFLNEASVMKGFTCHH 81
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYP-HSETEFGSGSSDLTLLQRVNICSDIAE 673
           ++R++   S      +V+  MA+G L S+L     E E   G    TL + + + ++IA+
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           GMAYL+     + +H DL   N ++  D T  + DFG+ + +        G + +     
Sbjct: 142 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL----- 193
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKN 792
                 + +MAPE       +T  D++SFG+++ E+ +   +P       GLS  + +K 
Sbjct: 194 ----LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ-----GLSNEQVLKF 244
Query: 793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTM 846
                   V+D   L    D  PE           + +L  +C Q +P  RPT 
Sbjct: 245 --------VMDGGYLDQP-DNCPE----------RVTDLMRMCWQFNPKMRPTF 279

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 60/207 (28%), Positives = 104/207 (50%), Gaps = 22/207 (10%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           +G+G +G V+ G   +   +A+K ++ +     + F  E +V+ ++ H  L+++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
                LV  +M +G L  +L     T+ G  +++ TLL    +C D+ EGMAYL   S  
Sbjct: 74  QAPICLVFEFMEHGCLSDYL----RTQRGLFAAE-TLL---GMCLDVCEGMAYLEEAS-- 123
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
            VIH DL   N L+ ++    VSDFG+ + V+         +   +ST       + + +
Sbjct: 124 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--------DQYTSSTGTKF--PVKWAS 172
Query: 745 PEYGFGSNTSTKGDVYSFGILVLEMVT 771
           PE    S  S+K DV+SFG+L+ E+ +
Sbjct: 173 PEVFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 557 AEFDEQRL-----LGTGSYGRV---YKGILQD--GTAIAVKVLQLQSGNFTKSFNRECQV 606
            +F+E+ L     LG G++G V       LQD  G  +AVK LQ  +    + F RE ++
Sbjct: 5   TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 64
Query: 607 LKRIRHRNLMRIITACSLPDFK--ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           LK ++H N+++    C     +   L++ Y+  GSL  +L  H E         + LLQ 
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQ- 118
Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
               S I +GM YL      R IH DL   N+L+ ++    + DFG+ K V+        
Sbjct: 119 --YTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEFFK 172
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            +  G S        I + APE    S  S   DV+SFG+++ E+ T
Sbjct: 173 VKEPGES-------PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 117/247 (47%), Gaps = 34/247 (13%)
Query: 548 TYRELLEATAEFDEQ---------RLLGTGSYGRVYKGILQ----DGTAIAVKVLQL-QS 593
           TY +  +   EF ++         +++G G +G V  G L+       ++A+K L++  +
Sbjct: 27  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 594 GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFG 653
               + F  E  ++ +  H N++R+    +      +V  YM NGSLDS L  H      
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD----- 141
Query: 654 SGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK 713
              +  T++Q V +   IA GM YL   S +  +H DL   N+L+N ++   VSDFG+++
Sbjct: 142 ---AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSR 195
Query: 714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR- 772
           ++       D  E    +    +   I + +PE       ++  DV+S+GI++ E+++  
Sbjct: 196 VL------EDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 773 RRPTDDM 779
            RP  +M
Sbjct: 248 ERPYWEM 254

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 117/247 (47%), Gaps = 34/247 (13%)
Query: 548 TYRELLEATAEFDEQ---------RLLGTGSYGRVYKGILQ----DGTAIAVKVLQL-QS 593
           TY +  +   EF ++         +++G G +G V  G L+       ++A+K L++  +
Sbjct: 25  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 84
Query: 594 GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFG 653
               + F  E  ++ +  H N++R+    +      +V  YM NGSLDS L  H      
Sbjct: 85  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD----- 139
Query: 654 SGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK 713
              +  T++Q V +   IA GM YL   S +  +H DL   N+L+N ++   VSDFG+++
Sbjct: 140 ---AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSR 193
Query: 714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR- 772
           ++       D  E    +    +   I + +PE       ++  DV+S+GI++ E+++  
Sbjct: 194 VL------EDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 245
Query: 773 RRPTDDM 779
            RP  +M
Sbjct: 246 ERPYWEM 252

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 117/247 (47%), Gaps = 34/247 (13%)
Query: 548 TYRELLEATAEFDEQ---------RLLGTGSYGRVYKGILQ----DGTAIAVKVLQL-QS 593
           TY +  +   EF ++         +++G G +G V  G L+       ++A+K L++  +
Sbjct: 27  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 594 GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFG 653
               + F  E  ++ +  H N++R+    +      +V  YM NGSLDS L  H      
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD----- 141
Query: 654 SGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK 713
              +  T++Q V +   IA GM YL   S +  +H DL   N+L+N ++   VSDFG+++
Sbjct: 142 ---AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSR 195
Query: 714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR- 772
           ++       D  E    +    +   I + +PE       ++  DV+S+GI++ E+++  
Sbjct: 196 VL------EDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 773 RRPTDDM 779
            RP  +M
Sbjct: 248 ERPYWEM 254

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 111/214 (51%), Gaps = 34/214 (15%)
Query: 562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           ++ LG G +G V+       T +AVK ++  S +  ++F  E  V+K ++H  L+++  A
Sbjct: 187 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKL-HA 244
Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
               +   ++  +MA GSL   L    +++ GS      L + ++  + IAEGMA++   
Sbjct: 245 VVTKEPIYIITEFMAKGSLLDFL----KSDEGSKQP---LPKLIDFSAQIAEGMAFIEQR 297
Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIG 741
           +    IH DL+ +N+L++  +   ++DFG+A++         GA+             I 
Sbjct: 298 N---YIHRDLRAANILVSASLVCKIADFGLARV---------GAKF-----------PIK 334
Query: 742 YMAPEY-GFGSNTSTKGDVYSFGILVLEMVTRRR 774
           + APE   FGS T  K DV+SFGIL++E+VT  R
Sbjct: 335 WTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGR 367

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 131/293 (44%), Gaps = 47/293 (16%)
Query: 563 RLLGTGSYGRVYKGILQD------GTAIAVKVLQLQSGNFTK--SFNRECQVLKRIRHRN 614
           R LG GS+G VY+G  +D       T +AVK +  +S +  +   F  E  V+K     +
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFLNEASVMKGFTCHH 80
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYP-HSETEFGSGSSDLTLLQRVNICSDIAE 673
           ++R++   S      +V+  MA+G L S+L     E E   G    TL + + + ++IA+
Sbjct: 81  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 140
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           GMAYL+     + +H DL   N ++  D T  + DFG+ + +        G + +     
Sbjct: 141 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL----- 192
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKN 792
                 + +MAPE       +T  D++SFG+++ E+ +   +P       GLS  + +K 
Sbjct: 193 ----LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ-----GLSNEQVLKF 243
Query: 793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
                   V+D   L    D  PE           + +L  +C Q +P  RPT
Sbjct: 244 --------VMDGGYLDQP-DNCPE----------RVTDLMRMCWQFNPKMRPT 277

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 114/236 (48%), Gaps = 35/236 (14%)
Query: 551 ELLEATAEFDE---QRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQV 606
           +LLE   E+DE   + +LG G+YG VY G  L +   IA+K +  +   +++  + E  +
Sbjct: 13  DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIAL 72
Query: 607 LKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN 666
            K ++H+N+++ + + S   F  + +  +  GSL + L     +++G    +   +    
Sbjct: 73  HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIGFYT 128
Query: 667 ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGA 725
               I EG+ YLH +   +++H D+K  NVL+N     L +SDFG +K +  +       
Sbjct: 129 --KQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI------- 176
Query: 726 ENMGNSTANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
               N       G++ YMAPE       G+G       D++S G  ++EM T + P
Sbjct: 177 ----NPCTETFTGTLQYMAPEIIDKGPRGYGK----AADIWSLGCTIIEMATGKPP 224

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 25/223 (11%)
Query: 563 RLLGTGSYGRVYKGILQ----DGTAIAVKVLQL-QSGNFTKSFNRECQVLKRIRHRNLMR 617
           +++G G +G V  G L+       ++A+K L++  +    + F  E  ++ +  H N++R
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +    +      +V  YM NGSLDS L  H         +  T++Q V +   IA GM Y
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--------AQFTVIQLVGMLRGIASGMKY 162
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L   S +  +H DL   N+L+N ++   VSDFG+++++       D  E    +    + 
Sbjct: 163 L---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVL------EDDPEAAYTTRGGKI- 212
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
             I + +PE       ++  DV+S+GI++ E+++   RP  +M
Sbjct: 213 -PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 29/219 (13%)
Query: 565 LGTGSYGRVYKGILQ-DGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNLMRIIT 620
           LG G++G+V  G  +  G  +AVK+L   +++S +      RE Q LK  RH +++++  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
             S P    +V+ Y++ G L          ++   +  L   +   +   I  G+ Y H 
Sbjct: 84  VISTPSDIFMVMEYVSGGEL---------FDYICKNGRLDEKESRRLFQQILSGVDYCHR 134
Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
           H    V+H DLKP NVLL+  M A ++DFG++ ++      +DG E +  S     CGS 
Sbjct: 135 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM------SDG-EFLRXS-----CGSP 179
Query: 741 GYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDD 778
            Y APE   G      + D++S G+++  ++    P DD
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 25/223 (11%)
Query: 563 RLLGTGSYGRVYKGILQ----DGTAIAVKVLQL-QSGNFTKSFNRECQVLKRIRHRNLMR 617
           +++G G +G V  G L+       ++A+K L++  +    + F  E  ++ +  H N++R
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +    +      +V  YM NGSLDS L  H         +  T++Q V +   IA GM Y
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--------AQFTVIQLVGMLRGIASGMKY 162
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L   S +  +H DL   N+L+N ++   VSDFG+++++       D  E    +    + 
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL------EDDPEAAYTTRGGKI- 212
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
             I + +PE       ++  DV+S+GI++ E+++   RP  +M
Sbjct: 213 -PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Composition-based stats.
 Identities = 66/238 (27%), Positives = 114/238 (47%), Gaps = 32/238 (13%)
Query: 550 RELLEATAEFDEQRLLGTGSYGRVYKGIL------QDGTAIAVKVLQLQS-GNFTKSFNR 602
           +E+  +   F E+  LG   +G+VYKG L      +   A+A+K L+ ++ G   + F  
Sbjct: 4   KEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH 61
Query: 603 ECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLY---PHSETEFGSGSSDL 659
           E  +  R++H N++ ++   +     +++  Y ++G L   L    PHS+   GS   D 
Sbjct: 62  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDV--GSTDDDR 119
Query: 660 TLLQR------VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK 713
           T+         V++ + IA GM YL  H    V+H DL   NVL+ D +   +SD G+ +
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFR 176
Query: 714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            V       D  + +GNS        I +MAPE       S   D++S+G+++ E+ +
Sbjct: 177 EVYAA----DYYKLLGNSLL-----PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 25/223 (11%)
Query: 563 RLLGTGSYGRVYKGILQ----DGTAIAVKVLQL-QSGNFTKSFNRECQVLKRIRHRNLMR 617
           +++G G +G V  G L+       ++A+K L++  +    + F  E  ++ +  H N++R
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +    +      +V  YM NGSLDS L  H         +  T++Q V +   IA GM Y
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--------AQFTVIQLVGMLRGIASGMKY 162
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L   S +  +H DL   N+L+N ++   VSDFG+++++       D  E    +    + 
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL------EDDPEAAYTTRGGKI- 212
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
             I + +PE       ++  DV+S+GI++ E+++   RP  +M
Sbjct: 213 -PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 89/333 (26%), Positives = 143/333 (42%), Gaps = 69/333 (20%)
Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLM 616
           F+   L+G G+YG+VYKG  ++ G   A+KV+ + +G+  +   +E  +LK+   HRN+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 617 RIITAC------SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR--VNIC 668
               A        + D   LV+ +   GS+         T+    +   TL +     IC
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSV---------TDLIKNTKGNTLKEEWIAYIC 135
Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI-AKLVMTVGVGNDGAEN 727
            +I  G+++LH H   +VIH D+K  NVLL ++    + DFG+ A+L  TVG        
Sbjct: 136 REILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-------- 184
Query: 728 MGNSTANMLCGSIGYMAPEY-----GFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMF-- 780
                 N   G+  +MAPE         +    K D++S GI  +EM     P  DM   
Sbjct: 185 ----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240
Query: 781 ----------AGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIE 830
                     A  L   KW K     + +  I+S L++ +  Q P        A  +L++
Sbjct: 241 RALFLIPRNPAPRLKSKKWSK-----KFQSFIESCLVK-NHSQRP--------ATEQLMK 286
Query: 831 LGILCTQESPSTRPTMXXXXXXXXRLKRYLGEK 863
              +  ++ P+ R           R K+  GEK
Sbjct: 287 HPFI--RDQPNERQVRIQLKDHIDRTKKKRGEK 317

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 109/223 (48%), Gaps = 25/223 (11%)
Query: 563 RLLGTGSYGRVYKGILQ----DGTAIAVKVLQL-QSGNFTKSFNRECQVLKRIRHRNLMR 617
           +++G G +G V  G L+       ++A+K L++  +    + F  E  ++ +  H N++R
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +    +      +V  YM NGSLDS L  H         +  T++Q V +   IA GM Y
Sbjct: 82  LEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--------AQFTVIQLVGMLRGIASGMKY 133
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L   S +  +H DL   N+L+N ++   VSDFG+++++       D  E    +    + 
Sbjct: 134 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL------EDDPEAAYTTRGGKI- 183
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
             I + +PE       ++  DV+S+GI++ E+++   RP  +M
Sbjct: 184 -PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 225

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 108/223 (48%), Gaps = 25/223 (11%)
Query: 563 RLLGTGSYGRVYKGILQ----DGTAIAVKVLQL-QSGNFTKSFNRECQVLKRIRHRNLMR 617
           +++G G +G V  G L+       ++A+K L++  +    + F  E  ++ +  H N++R
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +    +      +V  YM NGSLDS L  H         +  T++Q V +   IA GM Y
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--------AQFTVIQLVGMLRGIASGMKY 162
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L   S +  +H DL   N+L+N ++   VSDFG+ +++       D  E    +    + 
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL------EDDPEAAYTTRGGKI- 212
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
             I + +PE       ++  DV+S+GI++ E+++   RP  +M
Sbjct: 213 -PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 557 AEFDEQRL-----LGTGSYGRV---YKGILQD--GTAIAVKVLQLQSGNFTKSFNRECQV 606
            +F+E+ L     LG G++G V       LQD  G  +AVK LQ  +    + F RE ++
Sbjct: 6   TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 65
Query: 607 LKRIRHRNLMRIITACSLPDFK--ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           LK ++H N+++    C     +   L++ Y+  GSL  +L  H E         + LLQ 
Sbjct: 66  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQ- 119
Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
               S I +GM YL      R IH +L   N+L+ ++    + DFG+ K V+        
Sbjct: 120 --YTSQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTK-VLPQDKEYYK 173
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            +  G S        I + APE    S  S   DV+SFG+++ E+ T
Sbjct: 174 VKEPGES-------PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 24/215 (11%)
Query: 562 QRLLGTGSYGRVYKGIL----QDGTAIAVKVLQL-QSGNFTKSFNRECQVLKRIRHRNLM 616
           ++++G+G  G V  G L    Q    +A+K L+   +    + F  E  ++ +  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           R+    +      +V  YM NGSLD+ L  H            T++Q V +   +  GM 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTH--------DGQFTIMQLVGMLRGVGAGMR 165
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL   S +  +H DL   NVL++ ++   VSDFG+++++       D  +    +T   +
Sbjct: 166 YL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL------EDDPDAAXTTTGGKI 216
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              I + APE       S+  DV+SFG+++ E++ 
Sbjct: 217 --PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 132/293 (45%), Gaps = 47/293 (16%)
Query: 563 RLLGTGSYGRVYKGILQD------GTAIAVKVLQLQSGNFTK--SFNRECQVLKRIRHRN 614
           R LG GS+G VY+G  +D       T +AVK +  +S +  +   F  E  V+K     +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFLNEASVMKGFTCHH 81
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYP-HSETEFGSGSSDLTLLQRVNICSDIAE 673
           ++R++   S      +V+  MA+G L S+L     E E   G    TL + + + ++IA+
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           GMAYL+     + +H +L   N ++  D T  + DFG+ + +        G + +     
Sbjct: 142 GMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL----- 193
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKN 792
                 + +MAPE       +T  D++SFG+++ E+ +   +P       GLS  + +K 
Sbjct: 194 ----LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ-----GLSNEQVLKF 244
Query: 793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
                   V+D   L    D  PE           + +L  +C Q +P+ RPT
Sbjct: 245 --------VMDGGYLDQP-DNCPE----------RVTDLMRMCWQFNPNMRPT 278

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 132/294 (44%), Gaps = 47/294 (15%)
Query: 563 RLLGTGSYGRVYKGILQD------GTAIAVKVLQLQSGNFTK--SFNRECQVLKRIRHRN 614
           R LG GS+G VY+G  +D       T +AVK +  +S +  +   F  E  V+K     +
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFLNEASVMKGFTCHH 82
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYP-HSETEFGSGSSDLTLLQRVNICSDIAE 673
           ++R++   S      +V+  MA+G L S+L     E E   G    TL + + + ++IA+
Sbjct: 83  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 142
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           GMAYL+     + +H +L   N ++  D T  + DFG+ + +        G + +     
Sbjct: 143 GMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGL----- 194
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKN 792
                 + +MAPE       +T  D++SFG+++ E+ +   +P       GLS  + +K 
Sbjct: 195 ----LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ-----GLSNEQVLKF 245
Query: 793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTM 846
                   V+D   L    D  PE           + +L  +C Q +P+ RPT 
Sbjct: 246 --------VMDGGYLDQP-DNCPE----------RVTDLMRMCWQFNPNMRPTF 280

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           +G+G +G V+ G   +   +A+K ++ +     + F  E +V+ ++ H  L+++   C  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
                LV  +M +G L  +L     T+ G  +++ TLL    +C D+ EGMAYL      
Sbjct: 72  QAPICLVFEFMEHGCLSDYL----RTQRGLFAAE-TLL---GMCLDVCEGMAYLEEAC-- 121
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
            VIH DL   N L+ ++    VSDFG+ + V+         +   +ST       + + +
Sbjct: 122 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--------DQYTSSTGTKF--PVKWAS 170
Query: 745 PEYGFGSNTSTKGDVYSFGILVLEMVT 771
           PE    S  S+K DV+SFG+L+ E+ +
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFS 197

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           +G+G +G V+ G   +   +A+K ++ +     + F  E +V+ ++ H  L+++   C  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
                LV  +M +G L  +L     T+ G  +++ TLL    +C D+ EGMAYL      
Sbjct: 77  QAPICLVFEFMEHGCLSDYL----RTQRGLFAAE-TLL---GMCLDVCEGMAYLEEAC-- 126
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
            VIH DL   N L+ ++    VSDFG+ + V+         +   +ST       + + +
Sbjct: 127 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--------DQYTSSTGTKF--PVKWAS 175
Query: 745 PEYGFGSNTSTKGDVYSFGILVLEMVT 771
           PE    S  S+K DV+SFG+L+ E+ +
Sbjct: 176 PEVFSFSRYSSKSDVWSFGVLMWEVFS 202

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           +G+G +G V+ G   +   +A+K ++ +     + F  E +V+ ++ H  L+++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
                LV  +M +G L  +L     T+ G  +++ TLL    +C D+ EGMAYL      
Sbjct: 74  QAPICLVFEFMEHGCLSDYL----RTQRGLFAAE-TLL---GMCLDVCEGMAYLEEAC-- 123
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
            VIH DL   N L+ ++    VSDFG+ + V+         +   +ST       + + +
Sbjct: 124 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--------DQYTSSTGTKF--PVKWAS 172
Query: 745 PEYGFGSNTSTKGDVYSFGILVLEMVT 771
           PE    S  S+K DV+SFG+L+ E+ +
Sbjct: 173 PEVFSFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTK-SFNRECQVLKRIRHRNLMRIITACS 623
           LGTG +G V  G  +    +A+K+++   G+ ++  F  E +V+  + H  L+++   C+
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  YMANG L ++L                  Q + +C D+ E M YL     
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHR--------FQTQQLLEMCKDVCEAMEYLESK-- 139
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
            + +H DL   N L+ND     VSDFG+++ V+     ++   ++G+         + + 
Sbjct: 140 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEETSSVGSKFP------VRWS 188
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
            PE    S  S+K D+++FG+L+ E+ +
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 24/215 (11%)
Query: 562 QRLLGTGSYGRVYKGIL----QDGTAIAVKVLQL-QSGNFTKSFNRECQVLKRIRHRNLM 616
           ++++G+G  G V  G L    Q    +A+K L+   +    + F  E  ++ +  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           R+    +      +V  YM NGSLD+ L  H            T++Q V +   +  GM 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTH--------DGQFTIMQLVGMLRGVGAGMR 165
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL   S +  +H DL   NVL++ ++   VSDFG+++++       D  +    +T   +
Sbjct: 166 YL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL------EDDPDAAYTTTGGKI 216
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              I + APE       S+  DV+SFG+++ E++ 
Sbjct: 217 --PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTK-SFNRECQVLKRIRHRNLMRIITACS 623
           LGTG +G V  G  +    +A+K+++   G+ ++  F  E +V+  + H  L+++   C+
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  YMANG L ++L                  Q + +C D+ E M YL     
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHR--------FQTQQLLEMCKDVCEAMEYLESK-- 139
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
            + +H DL   N L+ND     VSDFG+++ V+     ++   ++G+         + + 
Sbjct: 140 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEYTSSVGSKFP------VRWS 188
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
            PE    S  S+K D+++FG+L+ E+ +
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 112/234 (47%), Gaps = 35/234 (14%)
Query: 553 LEATAEFDE---QRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLK 608
           LE   E+DE   + +LG G+YG VY G  L +   IA+K +  +   +++  + E  + K
Sbjct: 1   LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHK 60
Query: 609 RIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNIC 668
            ++H+N+++ + + S   F  + +  +  GSL + L     +++G    +   +      
Sbjct: 61  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIGFYT-- 114
Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAEN 727
             I EG+ YLH +   +++H D+K  NVL+N     L +SDFG +K +  +         
Sbjct: 115 KQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--------- 162
Query: 728 MGNSTANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
             N       G++ YMAPE       G+G       D++S G  ++EM T + P
Sbjct: 163 --NPCTETFTGTLQYMAPEIIDKGPRGYGK----AADIWSLGCTIIEMATGKPP 210

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 86/312 (27%), Positives = 130/312 (41%), Gaps = 56/312 (17%)
Query: 564 LLGTGSYGRVYKGILQDGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRII--- 619
           L+G G YG VYKG L D   +AVKV    +  NF    N     +  + H N+ R I   
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKN--IYRVPLMEHDNIARFIVGD 76
Query: 620 ---TACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
              TA    ++  LV+ Y  NGSL  +L  H+     S            +   +  G+A
Sbjct: 77  ERVTADGRMEY-LLVMEYYPNGSLXKYLSLHTSDWVSS----------CRLAHSVTRGLA 125
Query: 677 YLH-------HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           YLH       H+ P  + H DL   NVL+ +D T ++SDFG++  +    +   G E   
Sbjct: 126 YLHTELPRGDHYKPA-ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE--- 181
Query: 730 NSTANMLCGSIGYMAPEYGFGS-------NTSTKGDVYSFGILVLEMVTRRRPTDDMFAG 782
           ++ A    G+I YMAPE   G+       +   + D+Y+ G++  E+  R     D+F G
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR---CTDLFPG 238
Query: 783 ------GLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWD---VAIGELIELGI 833
                  ++    V NH         D  +L +   Q P+    W    +A+  L E   
Sbjct: 239 ESVPEYQMAFQTEVGNH-----PTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 834 LCTQESPSTRPT 845
            C  +    R T
Sbjct: 294 DCWDQDAEARLT 305

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 111/232 (47%), Gaps = 39/232 (16%)
Query: 562 QRLLGTGSYGRVYKGILQ----DGTAIAVKVLQLQSGNFT----KSFNRECQVLKRIRHR 613
           + ++G G +G V +G L+      + +A+K L+   G +T    + F  E  ++ +  H 
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLK---GGYTERQRREFLSEASIMGQFEHP 77
Query: 614 NLMRI--ITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           N++R+  +   S+P    ++  +M NG+LDS L  +            T++Q V +   I
Sbjct: 78  NIIRLEGVVTNSMPVM--ILTEFMENGALDSFLRLND--------GQFTVIQLVGMLRGI 127
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A GM YL   S    +H DL   N+L+N ++   VSDFG+++ +          EN  + 
Sbjct: 128 ASGMRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFL---------EENSSDP 175
Query: 732 TANMLCGS---IGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDM 779
           T     G    I + APE       ++  D +S+GI++ E+++   RP  DM
Sbjct: 176 TETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDM 227

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           +G+G +G V+ G   +   +A+K ++ +     + F  E +V+ ++ H  L+++   C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
                LV  +M +G L  +L     T+ G  +++ TLL    +C D+ EGMAYL      
Sbjct: 75  QAPICLVTEFMEHGCLSDYL----RTQRGLFAAE-TLL---GMCLDVCEGMAYLEEAC-- 124
Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
            VIH DL   N L+ ++    VSDFG+ + V+         +   +ST       + + +
Sbjct: 125 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--------DQYTSSTGTKF--PVKWAS 173
Query: 745 PEYGFGSNTSTKGDVYSFGILVLEMVT 771
           PE    S  S+K DV+SFG+L+ E+ +
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFS 200

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G YG VY G+ +     +AVK L+  +    + F +E  V+K I+H NL++++  C+
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
           L     +V  YM  G+L  +L   +  E       +T +  + + + I+  M YL   + 
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNREE-------VTAVVLLYMATQISSAMEYLEKKN- 150
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
              IH DL   N L+ ++    V+DFG+++L+        G     ++ A      I + 
Sbjct: 151 --FIHRDLAARNCLVGENHVVKVADFGLSRLMT-------GDTYTAHAGAKF---PIKWT 198
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
           APE    +  S K DV++FG+L+ E+ T
Sbjct: 199 APESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 132/292 (45%), Gaps = 45/292 (15%)
Query: 563 RLLGTGSYGRVY----KGILQDG--TAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG GS+G VY    KG+++D   T +A+K + +  S      F  E  V+K     ++
Sbjct: 16  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 75
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYP-HSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +R++   S      +++  M  G L S+L     E E     +  +L + + +  +IA+G
Sbjct: 76  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 135
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           MAYL+ +   + +H DL   N ++ +D T  + DFG+ + +        G + +      
Sbjct: 136 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGL------ 186
Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNH 793
                + +M+PE       +T  DV+SFG+++ E+ T   +P       GLS  +     
Sbjct: 187 ---LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ-----GLSNEQ----- 233
Query: 794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
               L  V++  LL    D  P++          L+EL  +C Q +P  RP+
Sbjct: 234 ---VLRFVMEGGLLDKP-DNCPDM----------LLELMRMCWQYNPKMRPS 271

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 111/232 (47%), Gaps = 39/232 (16%)
Query: 562 QRLLGTGSYGRVYKGILQ----DGTAIAVKVLQLQSGNFT----KSFNRECQVLKRIRHR 613
           + ++G G +G V +G L+      + +A+K L+   G +T    + F  E  ++ +  H 
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLK---GGYTERQRREFLSEASIMGQFEHP 75
Query: 614 NLMRI--ITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           N++R+  +   S+P    ++  +M NG+LDS L  +            T++Q V +   I
Sbjct: 76  NIIRLEGVVTNSMPVM--ILTEFMENGALDSFLRLND--------GQFTVIQLVGMLRGI 125
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A GM YL   S    +H DL   N+L+N ++   VSDFG+++ +          EN  + 
Sbjct: 126 ASGMRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFL---------EENSSDP 173
Query: 732 TANMLCGS---IGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDM 779
           T     G    I + APE       ++  D +S+GI++ E+++   RP  DM
Sbjct: 174 TYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDM 225

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 565 LGTGSYGRVY---KGILQDGTAI-AVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIIT 620
           LG G    VY     IL    AI A+ +   +     K F RE     ++ H+N++ +I 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
                D   LV+ Y+   +L  ++  H           L++   +N  + I +G+ + H 
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYIESHGP---------LSVDTAINFTNQILDGIKHAHD 129
Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
              +R++H D+KP N+L++ + T  + DFGIAK +    +          +  N + G++
Sbjct: 130 ---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL----------TQTNHVLGTV 176
Query: 741 GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            Y +PE   G  T    D+YS GI++ EM+    P
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 116/247 (46%), Gaps = 34/247 (13%)
Query: 548 TYRELLEATAEFDEQ---------RLLGTGSYGRVYKGILQ----DGTAIAVKVLQL-QS 593
           TY +  +   EF ++         +++G G +G V  G L+       ++A+K L++  +
Sbjct: 27  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 594 GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFG 653
               + F  E  ++ +  H N++R+    +      +V   M NGSLDS L  H      
Sbjct: 87  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD----- 141
Query: 654 SGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK 713
              +  T++Q V +   IA GM YL   S +  +H DL   N+L+N ++   VSDFG+++
Sbjct: 142 ---AQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSR 195
Query: 714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR- 772
           ++       D  E    +    +   I + +PE       ++  DV+S+GI++ E+++  
Sbjct: 196 VL------EDDPEAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYG 247
Query: 773 RRPTDDM 779
            RP  +M
Sbjct: 248 ERPYWEM 254

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 565 LGTGSYGRVYKGILQDGT-AIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G YG VY+G+ +  +  +AVK L+  +    + F +E  V+K I+H NL++++  C+
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  +M  G+L  +L   +  E  +    + LL    + + I+  M YL   + 
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNRQEVNA----VVLLY---MATQISSAMEYLEKKN- 144
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
              IH DL   N L+ ++    V+DFG+++L+     G+    + G          I + 
Sbjct: 145 --FIHRDLAARNCLVGENHLVKVADFGLSRLM----TGDTYTAHAGAKF------PIKWT 192
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
           APE    +  S K DV++FG+L+ E+ T
Sbjct: 193 APESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 108/223 (48%), Gaps = 25/223 (11%)
Query: 563 RLLGTGSYGRVYKGILQ----DGTAIAVKVLQL-QSGNFTKSFNRECQVLKRIRHRNLMR 617
           +++G G +G V  G L+       ++A+K L++  +    + F  E  ++ +  H N++R
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +    +      +V   M NGSLDS L  H         +  T++Q V +   IA GM Y
Sbjct: 111 LEGVVTKSKPVMIVTEXMENGSLDSFLRKHD--------AQFTVIQLVGMLRGIASGMKY 162
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L   S +  +H DL   N+L+N ++   VSDFG+++++       D  E    +    + 
Sbjct: 163 L---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVL------EDDPEAAYTTRGGKI- 212
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
             I + +PE       ++  DV+S+GI++ E+++   RP  +M
Sbjct: 213 -PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 131/292 (44%), Gaps = 45/292 (15%)
Query: 563 RLLGTGSYGRVY----KGILQDG--TAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG GS+G VY    KG+++D   T +A+K + +  S      F  E  V+K     ++
Sbjct: 25  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 84
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYP-HSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +R++   S      +++  M  G L S+L     E E     +  +L + + +  +IA+G
Sbjct: 85  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 144
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           MAYL+ +   + +H DL   N ++ +D T  + DFG+ + +        G + +      
Sbjct: 145 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGL------ 195
Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNH 793
                + +M+PE       +T  DV+SFG+++ E+ T   +P       GLS  +     
Sbjct: 196 ---LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ-----GLSNEQ----- 242
Query: 794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
               L  V++  LL    D  P++          L EL  +C Q +P  RP+
Sbjct: 243 ---VLRFVMEGGLLDKP-DNCPDM----------LFELMRMCWQYNPKMRPS 280

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 131/292 (44%), Gaps = 45/292 (15%)
Query: 563 RLLGTGSYGRVY----KGILQDG--TAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG GS+G VY    KG+++D   T +A+K + +  S      F  E  V+K     ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYP-HSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +R++   S      +++  M  G L S+L     E E     +  +L + + +  +IA+G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 150
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           MAYL+ +   + +H DL   N ++ +D T  + DFG+ + +        G + +      
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL------ 201
Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNH 793
                + +M+PE       +T  DV+SFG+++ E+ T   +P       GLS  +     
Sbjct: 202 ---LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ-----GLSNEQ----- 248
Query: 794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
               L  V++  LL    D  P++          L EL  +C Q +P  RP+
Sbjct: 249 ---VLRFVMEGGLLDKP-DNCPDM----------LFELMRMCWQYNPKMRPS 286

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 131/292 (44%), Gaps = 45/292 (15%)
Query: 563 RLLGTGSYGRVY----KGILQDG--TAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG GS+G VY    KG+++D   T +A+K + +  S      F  E  V+K     ++
Sbjct: 53  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 112
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYP-HSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +R++   S      +++  M  G L S+L     E E     +  +L + + +  +IA+G
Sbjct: 113 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 172
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           MAYL+ +   + +H DL   N ++ +D T  + DFG+ + +        G + +      
Sbjct: 173 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL------ 223
Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNH 793
                + +M+PE       +T  DV+SFG+++ E+ T   +P       GLS  +     
Sbjct: 224 ---LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ-----GLSNEQ----- 270
Query: 794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
               L  V++  LL    D  P++          L EL  +C Q +P  RP+
Sbjct: 271 ---VLRFVMEGGLLDKP-DNCPDM----------LFELMRMCWQYNPKMRPS 308

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 102/216 (47%), Gaps = 32/216 (14%)
Query: 571 GRVYKGILQDGTAIAVKVLQLQSGNFTKS--FNRECQVLKRIRHRNLMRIITACSLP--D 626
           G ++KG  Q G  I VKVL+++  +  KS  FN EC  L+   H N++ ++ AC  P   
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 627 FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRV 686
              L+  +M  GSL + L  H  T F    S     Q V    D+A GMA+LH   P+  
Sbjct: 83  HPTLITHWMPYGSLYNVL--HEGTNFVVDQS-----QAVKFALDMARGMAFLHTLEPLIP 135
Query: 687 IHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPE 746
            H  L   +V++++DMTA +S   +A +  +             S   M   +  ++APE
Sbjct: 136 RHA-LNSRSVMIDEDMTARIS---MADVKFSF-----------QSPGRMYAPA--WVAPE 178
Query: 747 YGFGSNTST---KGDVYSFGILVLEMVTRRRPTDDM 779
                   T     D++SF +L+ E+VTR  P  D+
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 131/292 (44%), Gaps = 45/292 (15%)
Query: 563 RLLGTGSYGRVY----KGILQDG--TAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG GS+G VY    KG+++D   T +A+K + +  S      F  E  V+K     ++
Sbjct: 24  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 83
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYP-HSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +R++   S      +++  M  G L S+L     E E     +  +L + + +  +IA+G
Sbjct: 84  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 143
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           MAYL+ +   + +H DL   N ++ +D T  + DFG+ + +        G + +      
Sbjct: 144 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL------ 194
Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNH 793
                + +M+PE       +T  DV+SFG+++ E+ T   +P       GLS  +     
Sbjct: 195 ---LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ-----GLSNEQ----- 241
Query: 794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
               L  V++  LL    D  P++          L EL  +C Q +P  RP+
Sbjct: 242 ---VLRFVMEGGLLDKP-DNCPDM----------LFELMRMCWQYNPKMRPS 279

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 30/225 (13%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRHRNLMRIIT 620
           LG GS+G+V      +    +A+K +    L+  +      RE   LK +RH +++++  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
             + P    +V+ Y A G L  ++          G       Q++ IC+     + Y H 
Sbjct: 77  VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRR---FFQQI-ICA-----IEYCHR 126
Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
           H   +++H DLKP N+LL+D++   ++DFG++  +MT G       N   ++    CGS 
Sbjct: 127 H---KIVHRDLKPENLLLDDNLNVKIADFGLSN-IMTDG-------NFLKTS----CGSP 171
Query: 741 GYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGL 784
            Y APE   G      + DV+S GI++  M+  R P DD F   L
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL 216

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 131/292 (44%), Gaps = 45/292 (15%)
Query: 563 RLLGTGSYGRVY----KGILQDG--TAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG GS+G VY    KG+++D   T +A+K + +  S      F  E  V+K     ++
Sbjct: 24  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 83
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYP-HSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +R++   S      +++  M  G L S+L     E E     +  +L + + +  +IA+G
Sbjct: 84  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 143
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           MAYL+ +   + +H DL   N ++ +D T  + DFG+ + +        G + +      
Sbjct: 144 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL------ 194
Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNH 793
                + +M+PE       +T  DV+SFG+++ E+ T   +P       GLS  +     
Sbjct: 195 ---LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ-----GLSNEQ----- 241
Query: 794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
               L  V++  LL    D  P++          L EL  +C Q +P  RP+
Sbjct: 242 ---VLRFVMEGGLLDKP-DNCPDM----------LFELMRMCWQYNPKMRPS 279

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 131/292 (44%), Gaps = 45/292 (15%)
Query: 563 RLLGTGSYGRVY----KGILQDG--TAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG GS+G VY    KG+++D   T +A+K + +  S      F  E  V+K     ++
Sbjct: 22  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 81
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYP-HSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +R++   S      +++  M  G L S+L     E E     +  +L + + +  +IA+G
Sbjct: 82  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 141
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           MAYL+ +   + +H DL   N ++ +D T  + DFG+ + +        G + +      
Sbjct: 142 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL------ 192
Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNH 793
                + +M+PE       +T  DV+SFG+++ E+ T   +P       GLS  +     
Sbjct: 193 ---LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ-----GLSNEQ----- 239
Query: 794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
               L  V++  LL    D  P++          L EL  +C Q +P  RP+
Sbjct: 240 ---VLRFVMEGGLLDKP-DNCPDM----------LFELMRMCWQYNPKMRPS 277

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 131/292 (44%), Gaps = 45/292 (15%)
Query: 563 RLLGTGSYGRVY----KGILQDG--TAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG GS+G VY    KG+++D   T +A+K + +  S      F  E  V+K     ++
Sbjct: 18  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 77
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYP-HSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +R++   S      +++  M  G L S+L     E E     +  +L + + +  +IA+G
Sbjct: 78  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 137
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           MAYL+ +   + +H DL   N ++ +D T  + DFG+ + +        G + +      
Sbjct: 138 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL------ 188
Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNH 793
                + +M+PE       +T  DV+SFG+++ E+ T   +P       GLS  +     
Sbjct: 189 ---LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ-----GLSNEQ----- 235
Query: 794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
               L  V++  LL    D  P++          L EL  +C Q +P  RP+
Sbjct: 236 ---VLRFVMEGGLLDKP-DNCPDM----------LFELMRMCWQYNPKMRPS 273

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 108/223 (48%), Gaps = 25/223 (11%)
Query: 563 RLLGTGSYGRVYKGILQ----DGTAIAVKVLQL-QSGNFTKSFNRECQVLKRIRHRNLMR 617
           +++G G +G V  G L+       ++A+K L++  +    + F  E  ++ +  H N++R
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +    +      +V   M NGSLDS L  H         +  T++Q V +   IA GM Y
Sbjct: 82  LEGVVTKSKPVMIVTEXMENGSLDSFLRKHD--------AQFTVIQLVGMLRGIASGMKY 133
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L   S +  +H DL   N+L+N ++   VSDFG+++++       D  E    +    + 
Sbjct: 134 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL------EDDPEAAYTTRGGKI- 183
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
             I + +PE       ++  DV+S+GI++ E+++   RP  +M
Sbjct: 184 -PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 225

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 131/292 (44%), Gaps = 45/292 (15%)
Query: 563 RLLGTGSYGRVY----KGILQDG--TAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG GS+G VY    KG+++D   T +A+K + +  S      F  E  V+K     ++
Sbjct: 25  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 84
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYP-HSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +R++   S      +++  M  G L S+L     E E     +  +L + + +  +IA+G
Sbjct: 85  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 144
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           MAYL+ +   + +H DL   N ++ +D T  + DFG+ + +        G + +      
Sbjct: 145 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL------ 195
Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNH 793
                + +M+PE       +T  DV+SFG+++ E+ T   +P       GLS  +     
Sbjct: 196 ---LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ-----GLSNEQ----- 242
Query: 794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
               L  V++  LL    D  P++          L EL  +C Q +P  RP+
Sbjct: 243 ---VLRFVMEGGLLDKP-DNCPDM----------LFELMRMCWQYNPKMRPS 280

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G +   L   S+ +    ++ +T         +
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYIT---------E 121
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 122 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 165
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 166 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 104/230 (45%), Gaps = 33/230 (14%)
Query: 558 EFDEQRLLGTGSYGRVYKGIL--QDGTAIAVKVLQLQSGNFTKS----FNRECQVLKRIR 611
           +F   R+LG G +G V +  L  +DG+ + V V  L++     S    F RE   +K   
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 612 HRNLMRIITACSLPDFKA------LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRV 665
           H ++ +++        K       ++LP+M +G L + L     +  G    +L L   V
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA---SRIGENPFNLPLQTLV 140
Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGA 725
               DIA GM YL   S    IH DL   N +L +DMT  V+DFG+++ + +      G 
Sbjct: 141 RFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQG- 196
Query: 726 ENMGNSTANMLCGS---IGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR 772
                      C S   + ++A E    +  +   DV++FG+ + E++TR
Sbjct: 197 -----------CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G YG VY+G+ +     +AVK L+  +    + F +E  V+K I+H NL++++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +++ +M  G+L  +L   +  E     S + LL    + + I+  M YL   + 
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEV----SAVVLLY---MATQISSAMEYLEKKN- 129
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
              IH DL   N L+ ++    V+DFG+++L+        G     ++ A      I + 
Sbjct: 130 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-------GDTXTAHAGAKF---PIKWT 177
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
           APE    +  S K DV++FG+L+ E+ T
Sbjct: 178 APESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 114/247 (46%), Gaps = 34/247 (13%)
Query: 548 TYRELLEATAEFDEQ---------RLLGTGSYGRVYKGILQ----DGTAIAVKVLQL-QS 593
           TY +  +A  EF ++         R++G G +G V  G L+        +A+K L++  +
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 594 GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFG 653
               + F  E  ++ +  H N++ +    +      +V  YM NGSLD+ L         
Sbjct: 64  EKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFL--------K 115
Query: 654 SGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK 713
                 T++Q V +   I+ GM YL   S +  +H DL   N+L+N ++   VSDFG+++
Sbjct: 116 KNDGQFTVIQLVGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSR 172
Query: 714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR- 772
           ++       D  E    +    +   I + APE       ++  DV+S+GI++ E+V+  
Sbjct: 173 VL------EDDPEAAYTTRGGKI--PIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYG 224
Query: 773 RRPTDDM 779
            RP  +M
Sbjct: 225 ERPYWEM 231

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 131/292 (44%), Gaps = 45/292 (15%)
Query: 563 RLLGTGSYGRVY----KGILQDG--TAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG GS+G VY    KG+++D   T +A+K + +  S      F  E  V+K     ++
Sbjct: 18  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 77
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYP-HSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +R++   S      +++  M  G L S+L     E E     +  +L + + +  +IA+G
Sbjct: 78  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 137
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           MAYL+ +   + +H DL   N  + +D T  + DFG+ + +        G + +      
Sbjct: 138 MAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL------ 188
Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNH 793
                + +M+PE       +T  DV+SFG+++ E+ T   +P       GLS  +     
Sbjct: 189 ---LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ-----GLSNEQ----- 235
Query: 794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
               L  V++  LL    D  P++          L+EL  +C Q +P  RP+
Sbjct: 236 ---VLRFVMEGGLLDKP-DNCPDM----------LLELMRMCWQYNPKMRPS 273

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 29/218 (13%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  R LG G +G VY     Q    +A+KVL   QL+         RE ++   +RH 
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           N++R+           L+L Y   G++   L   S  +    ++ +T         ++A 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT---------ELAN 123
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            ++Y H     RVIH D+KP N+LL  +    ++DFG +              +  +S  
Sbjct: 124 ALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSV-------------HAPSSRR 167
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           + LCG++ Y+ PE   G     K D++S G+L  E + 
Sbjct: 168 DTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 205

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 24/219 (10%)
Query: 563 RLLGTGSYGRVYKGIL--QDGTAI--AVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
            ++G G +G VY G L   DG  I  AVK L ++        F  E  ++K   H N++ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 618 IITACSLPDFKALV-LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           ++  C   +   LV LPYM +G L +  +  +ET       + T+   +     +A+GM 
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETH------NPTVKDLIGFGLQVAKGMK 146
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL   +  + +H DL   N +L++  T  V+DFG+A+      + +    ++ N T   L
Sbjct: 147 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEXXSVHNKTGAKL 198
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              + +MA E       +TK DV+SFG+L+ E++TR  P
Sbjct: 199 --PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 109/219 (49%), Gaps = 24/219 (10%)
Query: 563 RLLGTGSYGRVYKGIL--QDGTAI--AVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
            ++G G +G VY G L   DG  I  AVK L ++        F  E  ++K   H N++ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 618 IITACSLPDFKALV-LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           ++  C   +   LV LPYM +G L +  +  +ET       + T+   +     +A+GM 
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETH------NPTVKDLIGFGLQVAKGMK 148
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           +L   +  + +H DL   N +L++  T  V+DFG+A+ ++     +   +++ N T   L
Sbjct: 149 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDML-----DKEFDSVHNKTGAKL 200
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              + +MA E       +TK DV+SFG+L+ E++TR  P
Sbjct: 201 --PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 104/234 (44%), Gaps = 42/234 (17%)
Query: 557 AEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQS----GNFTKSFNRECQVLKRIRH 612
           AE   + ++G G +G+VY+     G  +AVK  +           ++  +E ++   ++H
Sbjct: 7   AELTLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 613 RNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSS---DLTLLQRVNICS 669
            N++ +   C       LV+ +   G L+  L         SG     D+     VN   
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVL---------SGKRIPPDIL----VNWAV 112
Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLL-----NDDMT---ALVSDFGIAKLVMTVGVG 721
            IA GM YLH  + V +IH DLK SN+L+     N D++     ++DFG+A+        
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-------- 164
Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    +T     G+  +MAPE    S  S   DV+S+G+L+ E++T   P
Sbjct: 165 -----EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 28/211 (13%)
Query: 565 LGTGSYGRVYKGILQDGT-AIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G YG VY+G+ +  +  +AVK L+  +    + F +E  V+K I+H NL++++  C+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  +M  G+L  +L   +  E     S + LL    + + I+  M YL   + 
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEV----SAVVLLY---MATQISSAMEYLEKKN- 338
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS---I 740
              IH +L   N L+ ++    V+DFG+++L             M   T     G+   I
Sbjct: 339 --FIHRNLAARNCLVGENHLVKVADFGLSRL-------------MTGDTYTAHAGAKFPI 383
Query: 741 GYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            + APE    +  S K DV++FG+L+ E+ T
Sbjct: 384 KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 117
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 118 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 161
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S  + LCG++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 162 SRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G YG VY+G+ +     +AVK L+  +    + F +E  V+K I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +++ +M  G+L  +L   +  E     S + LL    + + I+  M YL   + 
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEV----SAVVLLY---MATQISSAMEYLEKKN- 131
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
              IH DL   N L+ ++    V+DFG+++L+        G     ++ A      I + 
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-------GDTYTAHAGAKF---PIKWT 179
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
           APE    +  S K DV++FG+L+ E+ T
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G YG VY+G+ +     +AVK L+  +    + F +E  V+K I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +++ +M  G+L  +L   +  E     S + LL    + + I+  M YL   + 
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEV----SAVVLLY---MATQISSAMEYLEKKN- 131
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
              IH DL   N L+ ++    V+DFG+++L+        G     ++ A      I + 
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-------GDTYTAHAGAKF---PIKWT 179
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
           APE    +  S K DV++FG+L+ E+ T
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 111/244 (45%), Gaps = 47/244 (19%)
Query: 537 TPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QS 593
           +PE M NF ++                 +G G+YG VYK   +  G  +A+K ++L  ++
Sbjct: 5   SPEFMENFQKV---------------EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET 49
Query: 594 GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFG 653
                +  RE  +LK + H N+++++      +   LV  ++           H + +  
Sbjct: 50  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-----------HQDLKKF 98
Query: 654 SGSSDLTLLQRVNICS---DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG 710
             +S LT +    I S    + +G+A+ H H   RV+H DLKP N+L+N +    ++DFG
Sbjct: 99  MDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFG 155
Query: 711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEM 769
           +A+           A  +   T      ++ Y APE   G    ST  D++S G +  EM
Sbjct: 156 LAR-----------AFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEM 204
Query: 770 VTRR 773
           VTRR
Sbjct: 205 VTRR 208

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G YG VY+G+ +     +AVK L+  +    + F +E  V+K I+H NL++++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +++ +M  G+L  +L   +  E  +    + LL    + + I+  M YL   + 
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNRQEVNA----VVLLY---MATQISSAMEYLEKKN- 132
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
              IH DL   N L+ ++    V+DFG+++L+        G     ++ A      I + 
Sbjct: 133 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-------GDTXTAHAGAKF---PIKWT 180
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
           APE    +  S K DV++FG+L+ E+ T
Sbjct: 181 APESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 116
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 117 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 160
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 161 SRRTXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 111/244 (45%), Gaps = 47/244 (19%)
Query: 537 TPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QS 593
           +PE M NF ++                 +G G+YG VYK   +  G  +A+K ++L  ++
Sbjct: 5   SPEFMENFQKV---------------EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET 49
Query: 594 GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFG 653
                +  RE  +LK + H N+++++      +   LV  ++           H + +  
Sbjct: 50  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-----------HQDLKKF 98
Query: 654 SGSSDLTLLQRVNICS---DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG 710
             +S LT +    I S    + +G+A+ H H   RV+H DLKP N+L+N +    ++DFG
Sbjct: 99  MDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFG 155
Query: 711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEM 769
           +A+           A  +   T      ++ Y APE   G    ST  D++S G +  EM
Sbjct: 156 LAR-----------AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 204
Query: 770 VTRR 773
           VTRR
Sbjct: 205 VTRR 208

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 24/219 (10%)
Query: 563 RLLGTGSYGRVYKGIL--QDGTAI--AVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
            ++G G +G VY G L   DG  I  AVK L ++        F  E  ++K   H N++ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 618 IITACSLPDFKALV-LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           ++  C   +   LV LPYM +G L + +   +ET       + T+   +     +A+GM 
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETH------NPTVKDLIGFGLQVAKGMK 145
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL   +  + +H DL   N +L++  T  V+DFG+A+      + +    ++ N T   L
Sbjct: 146 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEYYSVHNKTGAKL 197
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              + +MA E       +TK DV+SFG+L+ E++TR  P
Sbjct: 198 --PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 115
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 116 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 159
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 160 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 29/218 (13%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  R LG G +G VY     Q    +A+KVL   QL+         RE ++   +RH 
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           N++R+           L+L Y   G++   L   S  +    ++ +T         ++A 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT---------ELAN 123
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            ++Y H     RVIH D+KP N+LL  +    ++DFG +              +  +S  
Sbjct: 124 ALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSV-------------HAPSSRR 167
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
             LCG++ Y+ PE   G     K D++S G+L  E + 
Sbjct: 168 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 205

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 142
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 143 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 186
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P
Sbjct: 187 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 24/219 (10%)
Query: 563 RLLGTGSYGRVYKGIL--QDGTAI--AVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
            ++G G +G VY G L   DG  I  AVK L ++        F  E  ++K   H N++ 
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 618 IITACSLPDFKALV-LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           ++  C   +   LV LPYM +G L + +   +ET       + T+   +     +A+GM 
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETH------NPTVKDLIGFGLQVAKGMK 166
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL   +  + +H DL   N +L++  T  V+DFG+A+      + +    ++ N T   L
Sbjct: 167 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEYYSVHNKTGAKL 218
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              + +MA E       +TK DV+SFG+L+ E++TR  P
Sbjct: 219 --PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 117/262 (44%), Gaps = 38/262 (14%)
Query: 536 ITPELMHNFPRITYRELLEATAEFDEQ---------RLLGTGSYGRVYKGILQ--DGTAI 584
           +TP +       T+ +  EA  EF ++         +++G G +G V  G L+      I
Sbjct: 3   MTPGMKIFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREI 62
Query: 585 AVKVLQLQSGNFTKS---FNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLD 641
            V +  L+SG   K    F  E  ++ +  H N++ +    +      ++  +M NGSLD
Sbjct: 63  FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD 122
Query: 642 SHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDD 701
           S L               T++Q V +   IA GM YL   + +  +H DL   N+L+N +
Sbjct: 123 SFLR--------QNDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSN 171
Query: 702 MTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS---IGYMAPEYGFGSNTSTKGD 758
           +   VSDFG+++ +          ++  + T     G    I + APE       ++  D
Sbjct: 172 LVCKVSDFGLSRFL---------EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASD 222
Query: 759 VYSFGILVLEMVTR-RRPTDDM 779
           V+S+GI++ E+++   RP  DM
Sbjct: 223 VWSYGIVMWEVMSYGERPYWDM 244

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 24/219 (10%)
Query: 563 RLLGTGSYGRVYKGIL--QDGTAI--AVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
            ++G G +G VY G L   DG  I  AVK L ++        F  E  ++K   H N++ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 618 IITACSLPDFKALV-LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           ++  C   +   LV LPYM +G L + +   +ET       + T+   +     +A+GM 
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETH------NPTVKDLIGFGLQVAKGMK 146
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL   +  + +H DL   N +L++  T  V+DFG+A+      + +    ++ N T   L
Sbjct: 147 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEYYSVHNKTGAKL 198
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              + +MA E       +TK DV+SFG+L+ E++TR  P
Sbjct: 199 --PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 119
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 120 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 163
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S  + LCG++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 164 SRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 116
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 117 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 160
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 161 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 120
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 121 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 164
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 165 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 211

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 24/219 (10%)
Query: 563 RLLGTGSYGRVYKGIL--QDGTAI--AVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
            ++G G +G VY G L   DG  I  AVK L ++        F  E  ++K   H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 618 IITACSLPDFKALV-LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           ++  C   +   LV LPYM +G L + +   +ET       + T+   +     +A+GM 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETH------NPTVKDLIGFGLQVAKGMK 147
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL   +  + +H DL   N +L++  T  V+DFG+A+      + +    ++ N T   L
Sbjct: 148 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEYYSVHNKTGAKL 199
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              + +MA E       +TK DV+SFG+L+ E++TR  P
Sbjct: 200 --PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 24/219 (10%)
Query: 563 RLLGTGSYGRVYKGIL--QDGTAI--AVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
            ++G G +G VY G L   DG  I  AVK L ++        F  E  ++K   H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 618 IITACSLPDFKALV-LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           ++  C   +   LV LPYM +G L + +   +ET       + T+   +     +A+GM 
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETH------NPTVKDLIGFGLQVAKGMK 142
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL   +  + +H DL   N +L++  T  V+DFG+A+      + +    ++ N T   L
Sbjct: 143 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEYYSVHNKTGAKL 194
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              + +MA E       +TK DV+SFG+L+ E++TR  P
Sbjct: 195 --PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 29/225 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 142
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 143 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 186
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           S  + LCG++ Y+ PE   G     K D++S G+L  E +  + P
Sbjct: 187 SRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 24/219 (10%)
Query: 563 RLLGTGSYGRVYKGIL--QDGTAI--AVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
            ++G G +G VY G L   DG  I  AVK L ++        F  E  ++K   H N++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 618 IITACSLPDFKALV-LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           ++  C   +   LV LPYM +G L + +   +ET       + T+   +     +A+GM 
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETH------NPTVKDLIGFGLQVAKGMK 144
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL   +  + +H DL   N +L++  T  V+DFG+A+      + +    ++ N T   L
Sbjct: 145 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEYYSVHNKTGAKL 196
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              + +MA E       +TK DV+SFG+L+ E++TR  P
Sbjct: 197 --PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 119
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 120 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 163
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 164 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 116
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 117 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 160
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 161 SRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 119
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 120 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 163
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 164 SRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 119
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 120 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 163
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 164 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G YG VY+G+ +     +AVK L+  +    + F +E  V+K I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +++ +M  G+L  +L   +  E  +    + LL    + + I+  M YL   + 
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNRQEVNA----VVLLY---MATQISSAMEYLEKKN- 136
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
              IH DL   N L+ ++    V+DFG+++L+        G     ++ A      I + 
Sbjct: 137 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-------GDTYTAHAGAKF---PIKWT 184
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
           APE    +  S K DV++FG+L+ E+ T
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 24/218 (11%)
Query: 564 LLGTGSYGRVYKGIL--QDGTAI--AVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMRI 618
           ++G G +G VY G L   DG  I  AVK L ++        F  E  ++K   H N++ +
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 619 ITACSLPDFKALV-LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +  C   +   LV LPYM +G L + +   +ET       + T+   +     +A+GM Y
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFI--RNETH------NPTVKDLIGFGLQVAKGMKY 140
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L   +  + +H DL   N +L++  T  V+DFG+A+      + +    ++ N T   L 
Sbjct: 141 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEYYSVHNKTGAKL- 191
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
             + +MA E       +TK DV+SFG+L+ E++TR  P
Sbjct: 192 -PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 24/219 (10%)
Query: 563 RLLGTGSYGRVYKGIL--QDGTAI--AVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
            ++G G +G VY G L   DG  I  AVK L ++        F  E  ++K   H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 618 IITACSLPDFKALV-LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           ++  C   +   LV LPYM +G L + +   +ET       + T+   +     +A+GM 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETH------NPTVKDLIGFGLQVAKGMK 147
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL   +  + +H DL   N +L++  T  V+DFG+A+      + +    ++ N T   L
Sbjct: 148 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEYYSVHNKTGAKL 199
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              + +MA E       +TK DV+SFG+L+ E++TR  P
Sbjct: 200 --PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY     Q    +A+KVL   QL+         RE ++   +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 113
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 114 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 157
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 158 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 24/219 (10%)
Query: 563 RLLGTGSYGRVYKGIL--QDGTAI--AVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
            ++G G +G VY G L   DG  I  AVK L ++        F  E  ++K   H N++ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 618 IITACSLPDFKALV-LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           ++  C   +   LV LPYM +G L +  +  +ET       + T+   +     +A+GM 
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETH------NPTVKDLIGFGLQVAKGMK 148
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           +L   +  + +H DL   N +L++  T  V+DFG+A+      + +   +++ N T   L
Sbjct: 149 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEFDSVHNKTGAKL 200
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              + +MA E       +TK DV+SFG+L+ E++TR  P
Sbjct: 201 --PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 24/219 (10%)
Query: 563 RLLGTGSYGRVYKGIL--QDGTAI--AVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
            ++G G +G VY G L   DG  I  AVK L ++        F  E  ++K   H N++ 
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 100
Query: 618 IITACSLPDFKALV-LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           ++  C   +   LV LPYM +G L +  +  +ET       + T+   +     +A+GM 
Sbjct: 101 LLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETH------NPTVKDLIGFGLQVAKGMK 152
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           +L   +  + +H DL   N +L++  T  V+DFG+A+      + +   +++ N T   L
Sbjct: 153 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEFDSVHNKTGAKL 204
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              + +MA E       +TK DV+SFG+L+ E++TR  P
Sbjct: 205 --PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 133
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 134 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 177
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P
Sbjct: 178 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 24/219 (10%)
Query: 563 RLLGTGSYGRVYKGIL--QDGTAI--AVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
            ++G G +G VY G L   DG  I  AVK L ++        F  E  ++K   H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 618 IITACSLPDFKALV-LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           ++  C   +   LV LPYM +G L +  +  +ET       + T+   +     +A+GM 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETH------NPTVKDLIGFGLQVAKGMK 147
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           +L   +  + +H DL   N +L++  T  V+DFG+A+      + +   +++ N T   L
Sbjct: 148 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEFDSVHNKTGAKL 199
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              + +MA E       +TK DV+SFG+L+ E++TR  P
Sbjct: 200 --PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 24/219 (10%)
Query: 563 RLLGTGSYGRVYKGIL--QDGTAI--AVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
            ++G G +G VY G L   DG  I  AVK L ++        F  E  ++K   H N++ 
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 618 IITACSLPDFKALV-LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           ++  C   +   LV LPYM +G L + +   +ET       + T+   +     +A+GM 
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETH------NPTVKDLIGFGLQVAKGMK 165
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL   +  + +H DL   N +L++  T  V+DFG+A+      + +    ++ N T   L
Sbjct: 166 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEYYSVHNKTGAKL 217
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              + +MA E       +TK DV+SFG+L+ E++TR  P
Sbjct: 218 --PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 24/219 (10%)
Query: 563 RLLGTGSYGRVYKGIL--QDGTAI--AVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
            ++G G +G VY G L   DG  I  AVK L ++        F  E  ++K   H N++ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 618 IITACSLPDFKALV-LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           ++  C   +   LV LPYM +G L +  +  +ET       + T+   +     +A+GM 
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETH------NPTVKDLIGFGLQVAKGMK 145
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           +L   +  + +H DL   N +L++  T  V+DFG+A+      + +   +++ N T   L
Sbjct: 146 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEFDSVHNKTGAKL 197
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              + +MA E       +TK DV+SFG+L+ E++TR  P
Sbjct: 198 --PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 28/211 (13%)
Query: 565 LGTGSYGRVYKGILQDGT-AIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G YG VY+G+ +  +  +AVK L+  +    + F +E  V+K I+H NL++++  C+
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  +M  G+L  +L   +  E  +    + LL    + + I+  M YL   + 
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQEVNA----VVLLY---MATQISSAMEYLEKKN- 377
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS---I 740
              IH +L   N L+ ++    V+DFG+++L             M   T     G+   I
Sbjct: 378 --FIHRNLAARNCLVGENHLVKVADFGLSRL-------------MTGDTYTAHAGAKFPI 422
Query: 741 GYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            + APE    +  S K DV++FG+L+ E+ T
Sbjct: 423 KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 121
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 122 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 165
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 166 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 562 QRLLGTGSYGRVYKGILQ--DGTAIAVKVLQLQSGNFTKS---FNRECQVLKRIRHRNLM 616
           ++++G G +G V  G L+      I V +  L++G   K    F  E  ++ +  H N++
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 617 R---IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
               ++T C       ++  YM NGSLD+ L  +            T++Q V +   I  
Sbjct: 94  HLEGVVTKCKPV---MIITEYMENGSLDAFLRKND--------GRFTVIQLVGMLRGIGS 142
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           GM YL   S V   H DL   N+L+N ++   VSDFG+++++       D  E    +  
Sbjct: 143 GMKYLSDMSAV---HRDLAARNILVNSNLVCKVSDFGMSRVL------EDDPEAAYTTRG 193
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
             +   I + APE       ++  DV+S+GI++ E+++   RP  DM
Sbjct: 194 GKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 238

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 118
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 119 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 162
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 163 SRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 121/259 (46%), Gaps = 31/259 (11%)
Query: 534 KPITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGIL---QDGTAIAVKVLQ 590
           +P+TP      P      +L+ T EF + ++LG+G++G VYKG+     +   I V +++
Sbjct: 29  EPLTPS--GEAPNQALLRILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIME 85
Query: 591 LQSGNFTKSFNR---ECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPH 647
           L+     K+      E  V+  + + ++ R++  C L     L+   M  G L  ++  H
Sbjct: 86  LREATSPKANKEILDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH 144
Query: 648 SETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVS 707
            +     GS  L     +N C  IA+GM YL      R++H DL   NVL+       ++
Sbjct: 145 KDN---IGSQYL-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT 193
Query: 708 DFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVL 767
           DFG+AKL+        GAE      A      I +MA E       + + DV+S+G+ V 
Sbjct: 194 DFGLAKLL--------GAEE-KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 244
Query: 768 EMVT-RRRPTDDMFAGGLS 785
           E++T   +P D + A  +S
Sbjct: 245 ELMTFGSKPYDGIPASEIS 263

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 116
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 117 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 160
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 161 SRRTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 106/220 (48%), Gaps = 27/220 (12%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGT----AIAVKVLQLQ-SGNFTKSFNRECQVLKRIR 611
           E  + ++LG+G++G VYKGI + DG      +A+KVL+   S    K    E  V+  + 
Sbjct: 18  ELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 77
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
              + R++  C L     LV   M  G L  H+    E     GS DL     +N C  I
Sbjct: 78  SPYVSRLLGIC-LTSTVQLVTQLMPYGCLLDHV---RENRGRLGSQDL-----LNWCMQI 128
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM+YL     VR++H DL   NVL+       ++DFG+A+L+       D  E   ++
Sbjct: 129 AKGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLL-------DIDETEYHA 178
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               +   I +MA E       + + DV+S+G+ V E++T
Sbjct: 179 DGGKV--PIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 24/219 (10%)
Query: 563 RLLGTGSYGRVYKGIL--QDGTAI--AVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
            ++G G +G VY G L   DG  I  AVK L ++        F  E  ++K   H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 618 IITACSLPDFKALV-LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           ++  C   +   LV LPYM +G L + +   +ET       + T+   +     +A+GM 
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETH------NPTVKDLIGFGLQVAKGMK 147
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           +L   +  + +H DL   N +L++  T  V+DFG+A+      + +   +++ N T   L
Sbjct: 148 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEFDSVHNKTGAKL 199
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              + +MA E       +TK DV+SFG+L+ E++TR  P
Sbjct: 200 --PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G YG VY+G+ +     +AVK L+  +    + F +E  V+K I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  +M  G+L  +L   +  E     S + LL    + + I+  M YL   + 
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEV----SAVVLLY---MATQISSAMEYLEKKN- 131
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
              IH DL   N L+ ++    V+DFG+++L+        G     ++ A      I + 
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-------GDTYTAHAGAKF---PIKWT 179
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
           APE    +  S K DV++FG+L+ E+ T
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G YG VY+G+ +     +AVK L+  +    + F +E  V+K I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  +M  G+L  +L   +  E     S + LL    + + I+  M YL   + 
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEV----SAVVLLY---MATQISSAMEYLEKKN- 131
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
              IH DL   N L+ ++    V+DFG+++L+        G     ++ A      I + 
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-------GDTYTAHAGAKF---PIKWT 179
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
           APE    +  S K DV++FG+L+ E+ T
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G YG VY+G+ +     +AVK L+  +    + F +E  V+K I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  +M  G+L  +L   +  E     S + LL    + + I+  M YL   + 
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEV----SAVVLLY---MATQISSAMEYLEKKN- 136
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
              IH DL   N L+ ++    V+DFG+++L+        G     ++ A      I + 
Sbjct: 137 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-------GDTYTAHAGAKF---PIKWT 184
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
           APE    +  S K DV++FG+L+ E+ T
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 119
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 120 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 163
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 164 SRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 116
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 117 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 160
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 161 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 30/221 (13%)
Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRHRNLMRI 618
           + LG GS+G+V        G  +A+K++    L   +      RE   L+ +RH +++++
Sbjct: 10  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 69
Query: 619 ITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
                  D   +V+ Y  N   D          +      ++  +       I   + Y 
Sbjct: 70  YDVIKSKDEIIMVIEYAGNELFD----------YIVQRDKMSEQEARRFFQQIISAVEYC 119
Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCG 738
           H H   +++H DLKP N+LL++ +   ++DFG++  +MT G       N   ++    CG
Sbjct: 120 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSN-IMTDG-------NFLKTS----CG 164
Query: 739 SIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDD 778
           S  Y APE   G      + DV+S G+++  M+ RR P DD
Sbjct: 165 SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 205

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 106/228 (46%), Gaps = 27/228 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNL 615
           +++ Q ++G+G+   V           +A+K + L+    +     +E Q + +  H N+
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 616 MRIITACSLPDFKALVLPYMANGS-LDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +   T+  + D   LV+  ++ GS LD   +  ++ E  SG  D + +    I  ++ EG
Sbjct: 76  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI--ATILREVLEG 133
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           + YLH +     IH D+K  N+LL +D +  ++DFG++  + T      G +   N    
Sbjct: 134 LEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLAT------GGDITRNKVRK 184
Query: 735 MLCGSIGYMAPE-------YGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              G+  +MAPE       Y F      K D++SFGI  +E+ T   P
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDF------KADIWSFGITAIELATGAAP 226

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 24/219 (10%)
Query: 563 RLLGTGSYGRVYKGIL--QDGTAI--AVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
            ++G G +G VY G L   DG  I  AVK L ++        F  E  ++K   H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 618 IITACSLPDFKALV-LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           ++  C   +   LV LPYM +G L + +   +ET       + T+   +     +A+GM 
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETH------NPTVKDLIGFGLQVAKGMK 206
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           +L   +  + +H DL   N +L++  T  V+DFG+A+      + +   +++ N T   L
Sbjct: 207 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-----DMYDKEFDSVHNKTGAKL 258
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              + +MA E       +TK DV+SFG+L+ E++TR  P
Sbjct: 259 --PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 32/213 (15%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           +G G +G V  G  + G  +AVK ++  +    ++F  E  V+ ++RH NL++++    +
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGV--I 255
Query: 625 PDFKA---LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
            + K    +V  YMA GSL  +L     +  G    D  L   +++C    E M YL  +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG---GDCLLKFSLDVC----EAMEYLEGN 308
Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIG 741
           +    +H DL   NVL+++D  A VSDFG+ K                +ST +     + 
Sbjct: 309 N---FVHRDLAARNVLVSEDNVAKVSDFGLTK--------------EASSTQDTGKLPVK 351
Query: 742 YMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           + APE       STK DV+SFGIL+ E+ +  R
Sbjct: 352 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 384

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G YG VY+G+ +     +AVK L+  +    + F +E  V+K I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  +M  G+L  +L   +  E  +    + LL    + + I+  M YL   + 
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNA----VVLLY---MATQISSAMEYLEKKN- 136
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
              IH DL   N L+ ++    V+DFG+++L+        G     ++ A      I + 
Sbjct: 137 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-------GDTXTAHAGAKF---PIKWT 184
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
           APE    +  S K DV++FG+L+ E+ T
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 565 LGTGSYGRVYKGILQ-DGTAIAVK-VLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITAC 622
           +G G++G V+ G L+ D T +AVK   +    +    F +E ++LK+  H N++R+I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
           +      +V+  +  G   + L     TE G+     TLLQ V    D A GM YL    
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL----RTE-GARLRVKTLLQMVG---DAAAGMEYLESKC 233
Query: 683 PVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGY 742
               IH DL   N L+ +     +SDFG+++         + A+ +  ++  +    + +
Sbjct: 234 ---CIHRDLAARNCLVTEKNVLKISDFGMSR---------EEADGVXAASGGLRQVPVKW 281
Query: 743 MAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            APE       S++ DV+SFGIL+ E  +
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G YG VY+G+ +     +AVK L+  +    + F +E  V+K I+H NL++++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  +M  G+L  +L   +  E     S + LL    + + I+  M YL   + 
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEV----SAVVLLY---MATQISSAMEYLEKKN- 129
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
              IH DL   N L+ ++    V+DFG+++L+     G+    + G          I + 
Sbjct: 130 --FIHRDLAARNCLVGENHLVKVADFGLSRLM----TGDTFTAHAGAKF------PIKWT 177
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
           APE    +  S K DV++FG+L+ E+ T
Sbjct: 178 APESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 116
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 117 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 160
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 161 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 54/208 (25%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTK-SFNRECQVLKRIRHRNLMRIITACS 623
           LGTG +G V  G  +    +A+K+++   G+ ++  F  E +V+  + H  L+++   C+
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  YMANG L ++L                  Q + +C D+ E M YL     
Sbjct: 81  KQRPIFIITEYMANGCLLNYLREMRHR--------FQTQQLLEMCKDVCEAMEYLESK-- 130
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
            + +H DL   N L+ND     VSDFG+++ V+     ++   ++G+         + + 
Sbjct: 131 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEYTSSVGSKF------PVRWS 179
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
            PE    S  S+K D+++FG+L+ E+ +
Sbjct: 180 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 54/208 (25%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTK-SFNRECQVLKRIRHRNLMRIITACS 623
           LGTG +G V  G  +    +A+K+++   G+ ++  F  E +V+  + H  L+++   C+
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  YMANG L ++L                  Q + +C D+ E M YL     
Sbjct: 74  KQRPIFIITEYMANGCLLNYLREMRHR--------FQTQQLLEMCKDVCEAMEYLESK-- 123
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
            + +H DL   N L+ND     VSDFG+++ V+     ++   ++G+         + + 
Sbjct: 124 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEYTSSVGSKF------PVRWS 172
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
            PE    S  S+K D+++FG+L+ E+ +
Sbjct: 173 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 54/208 (25%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTK-SFNRECQVLKRIRHRNLMRIITACS 623
           LGTG +G V  G  +    +A+K+++   G+ ++  F  E +V+  + H  L+++   C+
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  YMANG L ++L                  Q + +C D+ E M YL     
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHR--------FQTQQLLEMCKDVCEAMEYLESK-- 124
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
            + +H DL   N L+ND     VSDFG+++ V+     ++   ++G+         + + 
Sbjct: 125 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEYTSSVGSKF------PVRWS 173
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
            PE    S  S+K D+++FG+L+ E+ +
Sbjct: 174 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 30/221 (13%)
Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRHRNLMRI 618
           + LG GS+G+V        G  +A+K++    L   +      RE   L+ +RH +++++
Sbjct: 20  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 79
Query: 619 ITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
                  D   +V+ Y  N   D          +      ++  +       I   + Y 
Sbjct: 80  YDVIKSKDEIIMVIEYAGNELFD----------YIVQRDKMSEQEARRFFQQIISAVEYC 129
Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCG 738
           H H   +++H DLKP N+LL++ +   ++DFG++  +MT G       N   ++    CG
Sbjct: 130 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSN-IMTDG-------NFLKTS----CG 174
Query: 739 SIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDD 778
           S  Y APE   G      + DV+S G+++  M+ RR P DD
Sbjct: 175 SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 215

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 54/208 (25%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTK-SFNRECQVLKRIRHRNLMRIITACS 623
           LGTG +G V  G  +    +A+K+++   G+ ++  F  E +V+  + H  L+++   C+
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  YMANG L ++L                  Q + +C D+ E M YL     
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRHR--------FQTQQLLEMCKDVCEAMEYLESK-- 119
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
            + +H DL   N L+ND     VSDFG+++ V+     ++   ++G+         + + 
Sbjct: 120 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEYTSSVGSKF------PVRWS 168
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
            PE    S  S+K D+++FG+L+ E+ +
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 117
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 118 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 161
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 162 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 128/299 (42%), Gaps = 67/299 (22%)
Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQL---QSGNFTKSFNRECQVLKRIRHRN 614
           F + R +G GS+G VY    +++   +A+K +     QS    +   +E + L+++RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 615 LMRIITACSLPDFKA-LVLPYM---ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
            ++    C L +  A LV+ Y    A+  L+ H  P  E E  +            +   
Sbjct: 77  TIQY-RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA------------VTHG 123
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
             +G+AYLH H+   +IH D+K  N+LL++     + DFG A ++               
Sbjct: 124 ALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM--------------- 165
Query: 731 STANMLCGSIGYMAPEYGFGSNTST---KGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH 787
           + AN   G+  +MAPE     +      K DV+S GI  +E+  R+ P  +M A      
Sbjct: 166 APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----- 220
Query: 788 KWVKNHYHGRLEKVIDSSLLRASRDQSPEVKR-MWDVAIGELIELGILCTQESPSTRPT 845
                           S+L   ++++SP ++   W       ++    C Q+ P  RPT
Sbjct: 221 ----------------SALYHIAQNESPALQSGHWSEYFRNFVD---SCLQKIPQDRPT 260

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 562 QRLLGTGSYGRVYKGILQ--DGTAIAVKVLQLQSGNFTKS---FNRECQVLKRIRHRNLM 616
           ++++G G +G V  G L+      I V +  L++G   K    F  E  ++ +  H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 617 R---IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
               ++T C       ++  YM NGSLD+ L  +            T++Q V +   I  
Sbjct: 73  HLEGVVTKCKPV---MIITEYMENGSLDAFLRKND--------GRFTVIQLVGMLRGIGS 121
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           GM YL   S    +H DL   N+L+N ++   VSDFG+++++       D  E    +  
Sbjct: 122 GMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRVL------EDDPEAAYTTRG 172
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
             +   I + APE       ++  DV+S+GI++ E+++   RP  DM
Sbjct: 173 GKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 217

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 562 QRLLGTGSYGRVYKGILQ--DGTAIAVKVLQLQSGNFTKS---FNRECQVLKRIRHRNLM 616
           ++++G G +G V  G L+      I V +  L++G   K    F  E  ++ +  H N++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 617 R---IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
               ++T C       ++  YM NGSLD+ L  +            T++Q V +   I  
Sbjct: 79  HLEGVVTKCKPV---MIITEYMENGSLDAFLRKND--------GRFTVIQLVGMLRGIGS 127
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           GM YL   S    +H DL   N+L+N ++   VSDFG+++++       D  E    +  
Sbjct: 128 GMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRVL------EDDPEAAYTTRG 178
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
             +   I + APE       ++  DV+S+GI++ E+++   RP  DM
Sbjct: 179 GKI--PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 223

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 30/221 (13%)
Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRHRNLMRI 618
           + LG GS+G+V        G  +A+K++    L   +      RE   L+ +RH +++++
Sbjct: 14  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 73
Query: 619 ITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
                  D   +V+ Y  N   D          +      ++  +       I   + Y 
Sbjct: 74  YDVIKSKDEIIMVIEYAGNELFD----------YIVQRDKMSEQEARRFFQQIISAVEYC 123
Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCG 738
           H H   +++H DLKP N+LL++ +   ++DFG++  +MT G       N   ++    CG
Sbjct: 124 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSN-IMTDG-------NFLKTS----CG 168
Query: 739 SIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDD 778
           S  Y APE   G      + DV+S G+++  M+ RR P DD
Sbjct: 169 SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 209

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 30/221 (13%)
Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRHRNLMRI 618
           + LG GS+G+V        G  +A+K++    L   +      RE   L+ +RH +++++
Sbjct: 19  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 78
Query: 619 ITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
                  D   +V+ Y  N   D          +      ++  +       I   + Y 
Sbjct: 79  YDVIKSKDEIIMVIEYAGNELFD----------YIVQRDKMSEQEARRFFQQIISAVEYC 128
Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCG 738
           H H   +++H DLKP N+LL++ +   ++DFG++  +MT G       N   ++    CG
Sbjct: 129 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSN-IMTDG-------NFLKTS----CG 173
Query: 739 SIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDD 778
           S  Y APE   G      + DV+S G+++  M+ RR P DD
Sbjct: 174 SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 110/235 (46%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGIL---QDGTAIAVKVLQLQSGNFTKSFNR---ECQVLKRIR 611
           EF + ++LG+G++G VYKG+     +   I V + +L+     K+      E  V+  + 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L+   M  G L  ++  H +     GS  L     +N C  I
Sbjct: 73  NPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 123
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           AEGM YL      R++H DL   NVL+       ++DFG+AKL+        GAE     
Sbjct: 124 AEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--------GAEE-KEY 171
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 172 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 226

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 121
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 122 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 165
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 166 SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 111/235 (47%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL-----QLQSGNFTKSFNRECQVLKRIR 611
           EF + ++LG+G++G VYKG+ + +G  + + V      +  S    K    E  V+  + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L++  M  G L  ++  H +     GS  L     +N C  I
Sbjct: 77  NPHVCRLLGIC-LTSTVQLIMQLMPFGXLLDYVREHKDN---IGSQYL-----LNWCVQI 127
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+AKL+        GAE     
Sbjct: 128 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--------GAEE-KEY 175
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 176 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 111/235 (47%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL-----QLQSGNFTKSFNRECQVLKRIR 611
           EF + ++LG+G++G VYKG+ + +G  + + V      +  S    K    E  V+  + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L++  M  G L  ++  H +     GS  L     +N C  I
Sbjct: 80  NPHVCRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 130
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+AKL+        GAE     
Sbjct: 131 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--------GAEE-KEY 178
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 179 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 111/235 (47%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL-----QLQSGNFTKSFNRECQVLKRIR 611
           EF + ++LG+G++G VYKG+ + +G  + + V      +  S    K    E  V+  + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L++  M  G L  ++  H +     GS  L     +N C  I
Sbjct: 77  NPHVCRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 127
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+AKL+        GAE     
Sbjct: 128 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--------GAEE-KEY 175
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 176 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 128/299 (42%), Gaps = 67/299 (22%)
Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQL---QSGNFTKSFNRECQVLKRIRHRN 614
           F + R +G GS+G VY    +++   +A+K +     QS    +   +E + L+++RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 615 LMRIITACSLPDFKA-LVLPYM---ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
            ++    C L +  A LV+ Y    A+  L+ H  P  E E  +            +   
Sbjct: 116 TIQY-RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA------------VTHG 162
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
             +G+AYLH H+   +IH D+K  N+LL++     + DFG A ++               
Sbjct: 163 ALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM--------------- 204
Query: 731 STANMLCGSIGYMAPEYGFGSNTST---KGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH 787
           + AN   G+  +MAPE     +      K DV+S GI  +E+  R+ P  +M A      
Sbjct: 205 APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----- 259
Query: 788 KWVKNHYHGRLEKVIDSSLLRASRDQSPEVKR-MWDVAIGELIELGILCTQESPSTRPT 845
                           S+L   ++++SP ++   W       ++    C Q+ P  RPT
Sbjct: 260 ----------------SALYHIAQNESPALQSGHWSEYFRNFVD---SCLQKIPQDRPT 299

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G YG VY+G+ +     +AVK L+  +    + F +E  V+K I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  +M  G+L  +L   +  E  +    + LL    + + I+  M YL   + 
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNA----VVLLY---MATQISSAMEYLEKKN- 136
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
              IH DL   N L+ ++    V+DFG+++L+        G     ++ A      I + 
Sbjct: 137 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-------GDTYTAHAGAKF---PIKWT 184
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
           APE    +  S K DV++FG+L+ E+ T
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G YG VY+G+ +     +AVK L+  +    + F +E  V+K I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  +M  G+L  +L   +  E  +    + LL    + + I+  M YL   + 
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNA----VVLLY---MATQISSAMEYLEKKN- 136
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
              IH DL   N L+ ++    V+DFG+++L+        G     ++ A      I + 
Sbjct: 137 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-------GDTYTAHAGAKF---PIKWT 184
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
           APE    +  S K DV++FG+L+ E+ T
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G YG VY+G+ +     +AVK L+  +    + F +E  V+K I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  +M  G+L  +L   +  E  +    + LL    + + I+  M YL   + 
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNA----VVLLY---MATQISSAMEYLEKKN- 131
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
              IH DL   N L+ ++    V+DFG+++L+        G     ++ A      I + 
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-------GDTYTAHAGAKF---PIKWT 179
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
           APE    +  S K DV++FG+L+ E+ T
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G YG VY+G+ +     +AVK L+  +    + F +E  V+K I+H NL++++  C+
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  +M  G+L  +L   +  E  +    + LL    + + I+  M YL   + 
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNRQEVNA----VVLLY---MATQISSAMEYLEKKN- 135
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
              IH DL   N L+ ++    V+DFG+++L+        G     ++ A      I + 
Sbjct: 136 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-------GDTYTAHAGAKF---PIKWT 183
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
           APE    +  S K DV++FG+L+ E+ T
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G YG VY+G+ +     +AVK L+  +    + F +E  V+K I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  +M  G+L  +L   +  E  +    + LL    + + I+  M YL   + 
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNA----VVLLY---MATQISSAMEYLEKKN- 131
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
              IH DL   N L+ ++    V+DFG+++L+        G     ++ A      I + 
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-------GDTYTAHAGAKF---PIKWT 179
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
           APE    +  S K DV++FG+L+ E+ T
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G YG VY+G+ +     +AVK L+  +    + F +E  V+K I+H NL++++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  +M  G+L  +L   +  E  +    + LL    + + I+  M YL   + 
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNA----VVLLY---MATQISSAMEYLEKKN- 133
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
              IH DL   N L+ ++    V+DFG+++L+        G     ++ A      I + 
Sbjct: 134 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-------GDTYTAHAGAKF---PIKWT 181
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
           APE    +  S K DV++FG+L+ E+ T
Sbjct: 182 APESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G YG VY+G+ +     +AVK L+  +    + F +E  V+K I+H NL++++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  +M  G+L  +L   +  E  +    + LL    + + I+  M YL   + 
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNA----VVLLY---MATQISSAMEYLEKKN- 133
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
              IH DL   N L+ ++    V+DFG+++L+        G     ++ A      I + 
Sbjct: 134 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-------GDTYTAHAGAKF---PIKWT 181
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
           APE    +  S K DV++FG+L+ E+ T
Sbjct: 182 APESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 159
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 160 YTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 111/235 (47%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL-----QLQSGNFTKSFNRECQVLKRIR 611
           EF + ++LG+G++G VYKG+ + +G  + + V      +  S    K    E  V+  + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L++  M  G L  ++  H +     GS  L     +N C  I
Sbjct: 79  NPHVCRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 129
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+AKL+        GAE     
Sbjct: 130 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--------GAEE-KEY 177
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 178 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 111/235 (47%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGIL---QDGTAIAVKVLQLQSGNFTKSFNR---ECQVLKRIR 611
           EF + ++LG+G++G VYKG+     +   I V + +L+     K+      E  V+  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L++  M  G L  ++  H +     GS  L     +N C  I
Sbjct: 76  NPHVCRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 126
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+AKL+        GAE     
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--------GAEE-KEY 174
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 111/235 (47%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL-----QLQSGNFTKSFNRECQVLKRIR 611
           EF + ++LG+G++G VYKG+ + +G  + + V      +  S    K    E  V+  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L++  M  G L  ++  H +     GS  L     +N C  I
Sbjct: 78  NPHVCRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 128
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+AKL+        GAE     
Sbjct: 129 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--------GAEE-KEY 176
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 177 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 112/258 (43%), Gaps = 51/258 (19%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNREC---QVLKRIRHRN 614
           ++ +  LGTG +G V + I QD G  +A+K  Q +     K+  R C   Q++K++ H N
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIK--QCRQELSPKNRERWCLEIQIMKKLNHPN 73
Query: 615 LMRIITACSLPD---------FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRV 665
              +++A  +PD            L + Y   G L  +L   ++ E   G  +  +    
Sbjct: 74  ---VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL---NQFENCCGLKEGPIR--- 124
Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVS---DFGIAKLVMTVGVGN 722
            + SDI+  + YLH +   R+IH DLKP N++L      L+    D G AK +       
Sbjct: 125 TLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL------- 174
Query: 723 DGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAG 782
           D  E           G++ Y+APE       +   D +SFG L  E +T  RP       
Sbjct: 175 DQGE-----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF------ 223
Query: 783 GLSLHKWVKNHYHGRLEK 800
              L  W    +HG++ +
Sbjct: 224 ---LPNWQPVQWHGKVRE 238

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Composition-based stats.
 Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY     Q    +A+KVL   QL+         RE ++   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 121
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 122 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 165
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P
Sbjct: 166 SRRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 113 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 158
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 117
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 118 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 163
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 164 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 159
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 160 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 115 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 160
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 161 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 113 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 158
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 112/258 (43%), Gaps = 51/258 (19%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNREC---QVLKRIRHRN 614
           ++ +  LGTG +G V + I QD G  +A+K  Q +     K+  R C   Q++K++ H N
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIK--QCRQELSPKNRERWCLEIQIMKKLNHPN 74
Query: 615 LMRIITACSLPD---------FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRV 665
              +++A  +PD            L + Y   G L  +L   ++ E   G  +  +    
Sbjct: 75  ---VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL---NQFENCCGLKEGPIR--- 125
Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVS---DFGIAKLVMTVGVGN 722
            + SDI+  + YLH +   R+IH DLKP N++L      L+    D G AK +       
Sbjct: 126 TLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL------- 175
Query: 723 DGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAG 782
           D  E           G++ Y+APE       +   D +SFG L  E +T  RP       
Sbjct: 176 DQGE-----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF------ 224
Query: 783 GLSLHKWVKNHYHGRLEK 800
              L  W    +HG++ +
Sbjct: 225 ---LPNWQPVQWHGKVRE 239

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    ++   I A+KVL   QL+         RE ++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 116
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     +VIH D+KP N+LL       ++DFG +              +  +
Sbjct: 117 LANALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 160
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 161 SRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G YG VY+G+ +     +AVK L+  +    + F +E  V+K I+H NL++++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  +M  G+L  +L   +  E  +    + LL    + + I+  M YL   + 
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNRQEVNA----VVLLY---MATQISSAMEYLEKKN- 132
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS---I 740
              IH DL   N L+ ++    V+DFG+++L             M   T     G+   I
Sbjct: 133 --FIHRDLAARNCLVGENHLVKVADFGLSRL-------------MTGDTYTAPAGAKFPI 177
Query: 741 GYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            + APE    +  S K DV++FG+L+ E+ T
Sbjct: 178 KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G YG VY+G+ +     +AVK L+  +    + F +E  V+K I+H NL++++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  +M  G+L  +L   +  E  +    + LL    + + I+  M YL   + 
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNA----VVLLY---MATQISSAMEYLEKKN- 133
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS---I 740
              IH DL   N L+ ++    V+DFG+++L             M   T     G+   I
Sbjct: 134 --FIHRDLAARNCLVGENHLVKVADFGLSRL-------------MTGDTYTAPAGAKFPI 178
Query: 741 GYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            + APE    +  S K DV++FG+L+ E+ T
Sbjct: 179 KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 565 LGTGSYGRVYKGILQ-DGTAIAVK-VLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITAC 622
           +G G++G V+ G L+ D T +AVK   +    +    F +E ++LK+  H N++R+I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
           +      +V+  +  G   + L     TE G+     TLLQ V    D A GM YL    
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL----RTE-GARLRVKTLLQMVG---DAAAGMEYLESKC 233
Query: 683 PVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGY 742
               IH DL   N L+ +     +SDFG+++         + A+ +  ++  +    + +
Sbjct: 234 ---CIHRDLAARNCLVTEKNVLKISDFGMSR---------EEADGVYAASGGLRQVPVKW 281
Query: 743 MAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            APE       S++ DV+SFGIL+ E  +
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 159
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 160 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-----------HQDLKTFMDASALTGIPLPLIKSYLFQLL 116
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 117 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 162
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 163 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 117 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 162
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 163 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 116 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 161
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 162 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 119
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       +++FG +              +  +
Sbjct: 120 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSV-------------HAPS 163
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 164 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 117
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 118 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 163
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 164 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G +G VY+G+ +     +AVK L+  +    + F +E  V+K I+H NL++++  C+
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  +M  G+L  +L   +  E     S + LL    + + I+  M YL   + 
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEV----SAVVLLY---MATQISSAMEYLEKKN- 129
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
              IH DL   N L+ ++    V+DFG+++L+        G     ++ A      I + 
Sbjct: 130 --FIHRDLAARNCLVGENHLVKVADFGLSRLMT-------GDTXTAHAGAKF---PIKWT 177
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
           APE    +  S K DV++FG+L+ E+ T
Sbjct: 178 APESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTK-SFNRECQVLKRIRHRNLMRIITACS 623
           LGTG +G V  G  +    +A+K+++   G+ ++  F  E +V+  + H  L+++   C+
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 ++  YMANG L ++L                  Q + +C D+ E M YL     
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHR--------FQTQQLLEMCKDVCEAMEYLESK-- 124
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
            + +H DL   N L+ND     VSDFG+++ V+     ++   + G+         + + 
Sbjct: 125 -QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEYTSSRGSKF------PVRWS 173
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVT 771
            PE    S  S+K D+++FG+L+ E+ +
Sbjct: 174 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 117 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 162
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 163 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 159
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 160 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 159
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 160 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 116 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 161
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 162 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 113 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 158
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 159 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 113 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 158
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 159 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 116 QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-----------AFGVPVRT 161
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 162 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 159
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 160 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 115 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 160
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 161 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 34/232 (14%)
Query: 554 EATAEFDEQRLLGTGSYGRVYKG-ILQDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKR 609
           E   +F    LLG GS+  VY+   +  G  +A+K++    +      +    E ++  +
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 610 IRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLY----PHSETEFGSGSSDLTLLQRV 665
           ++H +++ +       ++  LVL    NG ++ +L     P SE E              
Sbjct: 68  LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENE------------AR 115
Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGA 725
           +    I  GM YLH H    ++H DL  SN+LL  +M   ++DFG+A  +          
Sbjct: 116 HFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQL---------- 162
Query: 726 ENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
             M +     LCG+  Y++PE    S    + DV+S G +   ++  R P D
Sbjct: 163 -KMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 115 QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-----------AFGVPVRT 160
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 161 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 115 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 160
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 161 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 73/298 (24%), Positives = 131/298 (43%), Gaps = 42/298 (14%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFT-KSFNRECQVLKRIRHRNL 615
           +++ Q ++G+G+   V           +A+K + L+    +     +E Q + +  H N+
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 616 MRIITACSLPDFKALVLPYMANGS-LDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +   T+  + D   LV+  ++ GS LD   +  ++ E  SG  D + +    I  ++ EG
Sbjct: 71  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI--ATILREVLEG 128
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           + YLH +     IH D+K  N+LL +D +  ++DFG++  + T      G +   N    
Sbjct: 129 LEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLAT------GGDITRNKVRK 179
Query: 735 MLCGSIGYMAPE-------YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH 787
              G+  +MAPE       Y F      K D++SFGI  +E+ T          G    H
Sbjct: 180 TFVGTPCWMAPEVMEQVRGYDF------KADIWSFGITAIELAT----------GAAPYH 223
Query: 788 KWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
           K+          +    SL    +D+  E+ + +  +  ++I    LC Q+ P  RPT
Sbjct: 224 KYPPMKVLMLTLQNDPPSLETGVQDK--EMLKKYGKSFRKMIS---LCLQKDPEKRPT 276

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 100/227 (44%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 118
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       +++FG +              +  +
Sbjct: 119 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSV-------------HAPS 162
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 163 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 159
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 160 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-----------HQDLKDFMDASALTGIPLPLIKSYLFQLL 113
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 114 QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-----------AFGVPVRT 159
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 160 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 22/233 (9%)
Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFN 601
           P +   ++ +    +     +G G+YG V   Y  + +   AI  K+   +   + +   
Sbjct: 11  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-KISPFEHQTYCQRTL 69
Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           RE ++L R RH N++ I      P  + +   Y+    +++ LY   +T+  S       
Sbjct: 70  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 129
Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
           L +      I  G+ Y+H      V+H DLKPSN+LLN      + DFG+A+      V 
Sbjct: 130 LYQ------ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR------VA 174
Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           +   ++ G  T  +   +  Y APE    S   TK  D++S G ++ EM++ R
Sbjct: 175 DPDHDHTGFLTEYV--ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 64  VKLLDVIHTENKLYLVFEHV-----------HQDLKTFMDASALTGIPLPLIKSYLFQLL 112
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 113 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 158
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 103/233 (44%), Gaps = 22/233 (9%)
Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFN 601
           P +   ++ +    +     +G G+YG V   Y  + +   AI  K+   +   + +   
Sbjct: 11  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-KISPFEHQTYCQRTL 69
Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           RE ++L R RH N++ I      P  + +   Y+    +++ LY   +T+  S       
Sbjct: 70  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 129
Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
           L +      I  G+ Y+H      V+H DLKPSN+LLN      + DFG+A+      V 
Sbjct: 130 LYQ------ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLAR------VA 174
Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           +   ++ G  T      +  Y APE    S   TK  D++S G ++ EM++ R
Sbjct: 175 DPDHDHTGFLTE--YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 103/233 (44%), Gaps = 22/233 (9%)
Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFN 601
           P +   ++ +    +     +G G+YG V   Y  + +   AI  K+   +   + +   
Sbjct: 11  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-KISPFEHQTYCQRTL 69
Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           RE ++L R RH N++ I      P  + +   Y+    +++ LY   +T+  S       
Sbjct: 70  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 129
Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
           L +      I  G+ Y+H      V+H DLKPSN+LLN      + DFG+A+      V 
Sbjct: 130 LYQ------ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR------VA 174
Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           +   ++ G  T      +  Y APE    S   TK  D++S G ++ EM++ R
Sbjct: 175 DPDHDHTGFLTE--YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY     Q    +A+KVL   QL+         RE ++   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 116
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 117 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 160
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           S    LCG++ Y+ PE   G     K D++S G+L  E +  + P
Sbjct: 161 SRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 22/233 (9%)
Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFN 601
           P +   ++ +    +     +G G+YG V   Y  + +   AI  K+   +   + +   
Sbjct: 11  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-KISPFEHQTYCQRTL 69
Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           RE ++L R RH N++ I      P  + +   Y+    +++ LY   +T+  S       
Sbjct: 70  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 129
Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
           L +      I  G+ Y+H      V+H DLKPSN+LLN      + DFG+A+      V 
Sbjct: 130 LYQ------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR------VA 174
Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           +   ++ G  T  +   +  Y APE    S   TK  D++S G ++ EM++ R
Sbjct: 175 DPDHDHTGFLTEYV--ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL-----QLQSGNFTKSFNRECQVLKRIR 611
           EF + ++LG+G++G VYKG+ + +G  + + V      +  S    K    E  V+  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L+   M  G L  ++  H +     GS  L     +N C  I
Sbjct: 76  NPHVCRLLGIC-LTSTVQLITQLMPFGXLLDYVREHKDN---IGSQYL-----LNWCVQI 126
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+AKL+        GAE     
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--------GAEE-KEY 174
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 32/213 (15%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           +G G +G V  G  + G  +AVK ++  +    ++F  E  V+ ++RH NL++++    +
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGV--I 68
Query: 625 PDFKA---LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
            + K    +V  YMA GSL  +L     +  G    D  L   +++C    E M YL  +
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG---GDCLLKFSLDVC----EAMEYLEGN 121
Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIG 741
           +    +H DL   NVL+++D  A VSDFG+ K                +ST +     + 
Sbjct: 122 N---FVHRDLAARNVLVSEDNVAKVSDFGLTK--------------EASSTQDTGKLPVK 164
Query: 742 YMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           + APE       STK DV+SFGIL+ E+ +  R
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 32/213 (15%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           +G G +G V  G  + G  +AVK ++  +    ++F  E  V+ ++RH NL++++    +
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGV--I 83
Query: 625 PDFKA---LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
            + K    +V  YMA GSL  +L     +  G    D  L   +++C    E M YL  +
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG---GDCLLKFSLDVC----EAMEYLEGN 136
Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIG 741
           +    +H DL   NVL+++D  A VSDFG+ K                +ST +     + 
Sbjct: 137 N---FVHRDLAARNVLVSEDNVAKVSDFGLTK--------------EASSTQDTGKLPVK 179
Query: 742 YMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           + APE       STK DV+SFGIL+ E+ +  R
Sbjct: 180 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 212

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 32/213 (15%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL 624
           +G G +G V  G  + G  +AVK ++  +    ++F  E  V+ ++RH NL++++    +
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGV--I 74
Query: 625 PDFKA---LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
            + K    +V  YMA GSL  +L     +  G    D  L   +++C    E M YL  +
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG---GDCLLKFSLDVC----EAMEYLEGN 127
Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIG 741
           +    +H DL   NVL+++D  A VSDFG+ K                +ST +     + 
Sbjct: 128 N---FVHRDLAARNVLVSEDNVAKVSDFGLTK--------------EASSTQDTGKLPVK 170
Query: 742 YMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRR 774
           + APE    +  STK DV+SFGIL+ E+ +  R
Sbjct: 171 WTAPEALREAAFSTKSDVWSFGILLWEIYSFGR 203

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 22/233 (9%)
Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFN 601
           P +   ++ +    +     +G G+YG V   Y  + +   AI  K+   +   + +   
Sbjct: 13  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-KISPFEHQTYCQRTL 71
Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           RE ++L R RH N++ I      P  + +   Y+    +++ LY   +T+  S       
Sbjct: 72  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 131
Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
           L +      I  G+ Y+H      V+H DLKPSN+LLN      + DFG+A+      V 
Sbjct: 132 LYQ------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR------VA 176
Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           +   ++ G  T  +   +  Y APE    S   TK  D++S G ++ EM++ R
Sbjct: 177 DPDHDHTGFLTEYV--ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 99/217 (45%), Gaps = 29/217 (13%)
Query: 563 RLLGTGSYGRVYKGILQ---DGTA--IAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNLM 616
           R LG G +G+V         DGT   +AVK L+  +G   +S + +E  +L+ + H +++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 617 RIITACSLPDFKAL--VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +    C      +L  V+ Y+  GSL  +L  HS          + L Q +     I EG
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----------IGLAQLLLFAQQICEG 146
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           MAYLH       IH DL   NVLL++D    + DFG+AK V   G         G+S   
Sbjct: 147 MAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEXYRVREDGDS--- 199
Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                + + APE           DV+SFG+ + E++T
Sbjct: 200 ----PVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 22/233 (9%)
Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFN 601
           P +   ++ +    +     +G G+YG V   Y  + +   AI  K+   +   + +   
Sbjct: 19  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-KISPFEHQTYCQRTL 77
Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           RE ++L R RH N++ I      P  + +   Y+    +++ LY   +T+  S       
Sbjct: 78  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 137
Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
           L +      I  G+ Y+H      V+H DLKPSN+LLN      + DFG+A+      V 
Sbjct: 138 LYQ------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR------VA 182
Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           +   ++ G  T  +   +  Y APE    S   TK  D++S G ++ EM++ R
Sbjct: 183 DPDHDHTGFLTEYV--ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 22/233 (9%)
Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFN 601
           P +   ++ +    +     +G G+YG V   Y  + +   AI  K+   +   + +   
Sbjct: 11  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-KISPFEHQTYCQRTL 69
Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           RE ++L R RH N++ I      P  + +   Y+    +++ LY   +T+  S       
Sbjct: 70  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 129
Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
           L +      I  G+ Y+H      V+H DLKPSN+LLN      + DFG+A+      V 
Sbjct: 130 LYQ------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR------VA 174
Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           +   ++ G  T  +   +  Y APE    S   TK  D++S G ++ EM++ R
Sbjct: 175 DPDHDHTGFLTEYV--ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL-----QLQSGNFTKSFNRECQVLKRIR 611
           EF + ++LG+G++G VYKG+ + +G  + + V      +  S    K    E  V+  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L+   M  G L  ++  H +     GS  L     +N C  I
Sbjct: 76  NPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 126
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+AKL+        GAE     
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--------GAEE-KEY 174
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGIL---QDGTAIAVKVLQLQSGNFTKSFNR---ECQVLKRIR 611
           EF + ++LG+G++G VYKG+     +   I V + +L+     K+      E  V+  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L+   M  G L  ++  H +     GS  L     +N C  I
Sbjct: 76  NPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 126
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+AKL+        GAE     
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--------GAEE-KEY 174
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 22/233 (9%)
Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFN 601
           P +   ++ +    +     +G G+YG V   Y  + +   AI  K+   +   + +   
Sbjct: 31  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-KISPFEHQTYCQRTL 89
Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           RE ++L R RH N++ I      P  + +   Y+    +++ LY   +T+  S       
Sbjct: 90  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 149
Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
           L +      I  G+ Y+H      V+H DLKPSN+LLN      + DFG+A+      V 
Sbjct: 150 LYQ------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR------VA 194
Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           +   ++ G  T  +   +  Y APE    S   TK  D++S G ++ EM++ R
Sbjct: 195 DPDHDHTGFLTEYV--ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGIL---QDGTAIAVKVLQLQSGNFTKSFNR---ECQVLKRIR 611
           EF + ++LG+G++G VYKG+     +   I V + +L+     K+      E  V+  + 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L+   M  G L  ++  H +     GS  L     +N C  I
Sbjct: 86  NPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 136
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+AKL+        GAE     
Sbjct: 137 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--------GAEE-KEY 184
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 185 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 239

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL-----QLQSGNFTKSFNRECQVLKRIR 611
           EF + ++LG+G++G VYKG+ + +G  + + V      +  S    K    E  V+  + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L+   M  G L  ++  H +     GS  L     +N C  I
Sbjct: 79  NPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 129
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+AKL+        GAE     
Sbjct: 130 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--------GAEE-KEY 177
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 178 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+++ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 114 QGLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 159
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 160 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGIL---QDGTAIAVKVLQLQSGNFTKSFNR---ECQVLKRIR 611
           EF + ++LG+G++G VYKG+     +   I V + +L+     K+      E  V+  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L+   M  G L  ++  H +     GS  L     +N C  I
Sbjct: 78  NPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 128
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+AKL+        GAE     
Sbjct: 129 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--------GAEE-KEY 176
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 177 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL-----QLQSGNFTKSFNRECQVLKRIR 611
           EF + ++LG+G++G VYKG+ + +G  + + V      +  S    K    E  V+  + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L+   M  G L  ++  H +     GS  L     +N C  I
Sbjct: 79  NPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 129
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+AKL+        GAE     
Sbjct: 130 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--------GAEE-KEY 177
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 178 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL-----QLQSGNFTKSFNRECQVLKRIR 611
           EF + ++LG+G++G VYKG+ + +G  + + V      +  S    K    E  V+  + 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L+   M  G L  ++  H +     GS  L     +N C  I
Sbjct: 82  NPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 132
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+AKL+        GAE     
Sbjct: 133 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--------GAEE-KEY 180
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 181 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 235

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 22/233 (9%)
Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFN 601
           P +   ++ +    +     +G G+YG V   Y  + +   AI  K+   +   + +   
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-KISPFEHQTYCQRTL 73
Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           RE ++L R RH N++ I      P  + +   Y+    +++ LY   +T+  S       
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 133
Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
           L +      I  G+ Y+H      V+H DLKPSN+LLN      + DFG+A+      V 
Sbjct: 134 LYQ------ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR------VA 178
Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           +   ++ G  T  +   +  Y APE    S   TK  D++S G ++ EM++ R
Sbjct: 179 DPDHDHTGFLTEYV--ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL-----QLQSGNFTKSFNRECQVLKRIR 611
           EF + ++LG+G++G VYKG+ + +G  + + V      +  S    K    E  V+  + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L+   M  G L  ++  H +     GS  L     +N C  I
Sbjct: 79  NPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 129
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+AKL+        GAE     
Sbjct: 130 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--------GAEE-KEY 177
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 178 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 26/219 (11%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++++      +   LV  ++   S+D   +  +     S  + + L    +    + +G+
Sbjct: 68  VKLLDVIHTENKLYLVFEFL---SMDLKKFMDA-----SALTGIPLPLIKSYLFQLLQGL 119
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
           A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T   
Sbjct: 120 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-----------AFGVPVRTYXH 165
Query: 736 LCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
              ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 166 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL-----QLQSGNFTKSFNRECQVLKRIR 611
           EF + ++LG+G++G VYKG+ + +G  + + V      +  S    K    E  V+  + 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L+   M  G L  ++  H +     GS  L     +N C  I
Sbjct: 101 NPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 151
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+AKL+        GAE     
Sbjct: 152 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--------GAEE-KEY 199
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 200 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 254

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 26/219 (11%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++++      +   LV  ++   S+D   +  +     S  + + L    +    + +G+
Sbjct: 66  VKLLDVIHTENKLYLVFEFL---SMDLKKFMDA-----SALTGIPLPLIKSYLFQLLQGL 117
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
           A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T   
Sbjct: 118 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-----------AFGVPVRTYXH 163
Query: 736 LCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
              ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 164 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 103/233 (44%), Gaps = 22/233 (9%)
Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFN 601
           P +   ++ +    +     +G G+YG V   Y  + +   AI  K+   +   + +   
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-KISPFEHQTYXQRTL 73
Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           RE ++L R RH N++ I      P  + +   Y+    +++ LY   +T+  S       
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 133
Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
           L +      I  G+ Y+H      V+H DLKPSN+LLN      + DFG+A+      V 
Sbjct: 134 LYQ------ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR------VA 178
Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           +   ++ G  T      +  Y APE    S   TK  D++S G ++ EM++ R
Sbjct: 179 DPDHDHTGFLTE--YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL-----QLQSGNFTKSFNRECQVLKRIR 611
           EF + ++LG+G++G VYKG+ + +G  + + V      +  S    K    E  V+  + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L+   M  G L  ++  H +     GS  L     +N C  I
Sbjct: 83  NPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 133
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+AKL+        GAE     
Sbjct: 134 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--------GAEE-KEY 181
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 182 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 22/233 (9%)
Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFN 601
           P +   ++ +    +     +G G+YG V   Y  + +   AI  K+   +   + +   
Sbjct: 9   PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-KISPFEHQTYCQRTL 67
Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           RE ++L R RH N++ I      P  + +   Y+    +++ LY   +T+  S       
Sbjct: 68  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 127
Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
           L +      I  G+ Y+H      V+H DLKPSN+LLN      + DFG+A+      V 
Sbjct: 128 LYQ------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR------VA 172
Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           +   ++ G  T  +   +  Y APE    S   TK  D++S G ++ EM++ R
Sbjct: 173 DPDHDHTGFLTEYV--ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 130/292 (44%), Gaps = 45/292 (15%)
Query: 563 RLLGTGSYGRVY----KGILQDG--TAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG GS+G VY    KG+++D   T +A+K + +  S      F  E  V+K     ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGS-SDLTLLQRVNICSDIAEG 674
           +R++   S      +++  M  G L S+L         +   +  +L + + +  +IA+G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           MAYL+ +   + +H DL   N ++ +D T  + DFG+ + +        G + +      
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL------ 201
Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNH 793
                + +M+PE       +T  DV+SFG+++ E+ T   +P       GLS  +     
Sbjct: 202 ---LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ-----GLSNEQ----- 248
Query: 794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
               L  V++  LL    D  P++          L EL  +C Q +P  RP+
Sbjct: 249 ---VLRFVMEGGLLDKP-DNCPDM----------LFELMRMCWQYNPKMRPS 286

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 22/233 (9%)
Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFN 601
           P +   ++ +    +     +G G+YG V   Y  + +   AI  K+   +   + +   
Sbjct: 16  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-KISPFEHQTYCQRTL 74
Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           RE ++L R RH N++ I      P  + +   Y+    +++ LY   +T+  S       
Sbjct: 75  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 134
Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
           L +      I  G+ Y+H      V+H DLKPSN+LLN      + DFG+A+      V 
Sbjct: 135 LYQ------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR------VA 179
Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           +   ++ G  T  +   +  Y APE    S   TK  D++S G ++ EM++ R
Sbjct: 180 DPDHDHTGFLTEYV--ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 22/233 (9%)
Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFN 601
           P +   ++ +    +     +G G+YG V   Y  + +   AI  K+   +   + +   
Sbjct: 17  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-KISPFEHQTYCQRTL 75
Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           RE ++L R RH N++ I      P  + +   Y+    +++ LY   +T+  S       
Sbjct: 76  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 135
Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
           L +      I  G+ Y+H      V+H DLKPSN+LLN      + DFG+A+      V 
Sbjct: 136 LYQ------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR------VA 180
Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           +   ++ G  T  +   +  Y APE    S   TK  D++S G ++ EM++ R
Sbjct: 181 DPDHDHTGFLTEYV--ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 22/233 (9%)
Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFN 601
           P +   ++ +    +     +G G+YG V   Y  + +   AI  K+   +   + +   
Sbjct: 8   PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-KISPFEHQTYCQRTL 66
Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           RE ++L R RH N++ I      P  + +   Y+    +++ LY   +T+  S       
Sbjct: 67  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 126
Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
           L +      I  G+ Y+H      V+H DLKPSN+LLN      + DFG+A+      V 
Sbjct: 127 LYQ------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR------VA 171
Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           +   ++ G  T  +   +  Y APE    S   TK  D++S G ++ EM++ R
Sbjct: 172 DPDHDHTGFLTEYV--ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 22/233 (9%)
Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFN 601
           P +   ++ +    +     +G G+YG V   Y  + +   AI  K+   +   + +   
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-KISPFEHQTYCQRTL 73
Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           RE ++L R RH N++ I      P  + +   Y+    +++ LY   +T+  S       
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 133
Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
           L +      I  G+ Y+H      V+H DLKPSN+LLN      + DFG+A+      V 
Sbjct: 134 LYQ------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR------VA 178
Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           +   ++ G  T  +   +  Y APE    S   TK  D++S G ++ EM++ R
Sbjct: 179 DPDHDHTGFLTEYV--ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGIL---QDGTAIAVKVLQLQSGNFTKSFNR---ECQVLKRIR 611
           EF + ++LG+G++G VYKG+     +   I V + +L+     K+      E  V+  + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L+   M  G L  ++  H +     GS  L     +N C  I
Sbjct: 70  NPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 120
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+AKL+        GAE     
Sbjct: 121 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--------GAEE-KEY 168
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 169 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL-----QLQSGNFTKSFNRECQVLKRIR 611
           EF + ++LG+G++G VYKG+ + +G  + + V      +  S    K    E  V+  + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L++  M  G L  ++  H +     GS  L     +N C  I
Sbjct: 80  NPHVCRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 130
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG AKL+        GAE     
Sbjct: 131 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL--------GAEE-KEY 178
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 179 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 22/233 (9%)
Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFN 601
           P +   ++ +    +     +G G+YG V   Y  + +   AI  K+   +   + +   
Sbjct: 9   PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-KISPFEHQTYCQRTL 67
Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           RE ++L R RH N++ I      P  + +   Y+    +++ LY   +T+  S       
Sbjct: 68  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 127
Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
           L +      I  G+ Y+H      V+H DLKPSN+LLN      + DFG+A+      V 
Sbjct: 128 LYQ------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR------VA 172
Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           +   ++ G  T  +   +  Y APE    S   TK  D++S G ++ EM++ R
Sbjct: 173 DPDHDHTGFLTEYV--ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 127/280 (45%), Gaps = 43/280 (15%)
Query: 559 FDEQRLLGTGSYGRVYK----GILQDGTAIAVKVLQ----LQSGNFTKSFNRECQVLKRI 610
           F+  R+LG G YG+V++         G   A+KVL+    +++   T     E  +L+ +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           +H  ++ +I A        L+L Y++ G L   L    E  F   ++   L       ++
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDTACFYL-------AE 129
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I+  + +LH      +I+ DLKP N++LN      ++DFG+ K  +     +DG      
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESI-----HDG------ 175
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT---------RRRPTDDMFA 781
           +  +  CG+I YMAPE    S  +   D +S G L+ +M+T         R++  D +  
Sbjct: 176 TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235
Query: 782 GGLSLHKWVKNHYHGRLEKVID---SSLLRASRDQSPEVK 818
             L+L  ++       L+K++    +S L A    + EV+
Sbjct: 236 CKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQ 275

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 112/222 (50%), Gaps = 27/222 (12%)
Query: 562 QRLLGTGSYGRVYKG-ILQDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHR-NLM 616
           Q ++G G++G+V K  I +DG  +   + +++   S +  + F  E +VL ++ H  N++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYP----HSETEFG---SGSSDLTLLQRVNICS 669
            ++ AC    +  L + Y  +G+L   L       ++  F    S +S L+  Q ++  +
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           D+A GM YL   S  + IH DL   N+L+ ++  A ++DFG+++          G E   
Sbjct: 140 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----------GQEVYV 186
Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
             T   L   + +MA E    S  +T  DV+S+G+L+ E+V+
Sbjct: 187 KKTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 127/280 (45%), Gaps = 43/280 (15%)
Query: 559 FDEQRLLGTGSYGRVYK----GILQDGTAIAVKVLQ----LQSGNFTKSFNRECQVLKRI 610
           F+  R+LG G YG+V++         G   A+KVL+    +++   T     E  +L+ +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           +H  ++ +I A        L+L Y++ G L   L    E  F   ++   L       ++
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDTACFYL-------AE 129
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I+  + +LH      +I+ DLKP N++LN      ++DFG+ K  +     +DG      
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESI-----HDG------ 175
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT---------RRRPTDDMFA 781
           +  +  CG+I YMAPE    S  +   D +S G L+ +M+T         R++  D +  
Sbjct: 176 TVTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235
Query: 782 GGLSLHKWVKNHYHGRLEKVID---SSLLRASRDQSPEVK 818
             L+L  ++       L+K++    +S L A    + EV+
Sbjct: 236 CKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQ 275

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL-----QLQSGNFTKSFNRECQVLKRIR 611
           EF + ++LG+G++G VYKG+ + +G  + + V      +  S    K    E  V+  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L++  M  G L  ++  H +     GS  L     +N C  I
Sbjct: 78  NPHVCRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 128
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG AKL+        GAE     
Sbjct: 129 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL--------GAEE-KEY 176
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 177 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 112/222 (50%), Gaps = 27/222 (12%)
Query: 562 QRLLGTGSYGRVYKG-ILQDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHR-NLM 616
           Q ++G G++G+V K  I +DG  +   + +++   S +  + F  E +VL ++ H  N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYP----HSETEFG---SGSSDLTLLQRVNICS 669
            ++ AC    +  L + Y  +G+L   L       ++  F    S +S L+  Q ++  +
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           D+A GM YL   S  + IH DL   N+L+ ++  A ++DFG+++          G E   
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----------GQEVYV 196
Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
             T   L   + +MA E    S  +T  DV+S+G+L+ E+V+
Sbjct: 197 KKTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGIL---QDGTAIAVKVLQLQSGNFTKSFNR---ECQVLKRIR 611
           EF + ++LG+G++G VYKG+     +   I V + +L+     K+      E  V+  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L++  M  G L  ++  H +     GS  L     +N C  I
Sbjct: 78  NPHVCRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 128
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG AKL+        GAE     
Sbjct: 129 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL--------GAEE-KEY 176
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 177 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 26/219 (11%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++++      +   LV  ++   S+D   +  +     S  + + L    +    + +G+
Sbjct: 68  VKLLDVIHTENKLYLVFEFL---SMDLKDFMDA-----SALTGIPLPLIKSYLFQLLQGL 119
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
           A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T   
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRTYXH 165
Query: 736 LCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
              ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 166 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 104/228 (45%), Gaps = 29/228 (12%)
Query: 547 ITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGN--FTKSFNREC 604
           + ++ L+E   + ++   +G G+YG VYK     G  +A+K ++L + +     +  RE 
Sbjct: 14  LYFQGLMEKYQKLEK---VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREI 70
Query: 605 QVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
            +LK + H N++ +I          LV  +M        +   ++T        + L Q 
Sbjct: 71  SLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDL--KKVLDENKTGLQDSQIKIYLYQ- 127
Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
                 +  G+A+ H H   R++H DLKP N+L+N D    ++DFG+A+           
Sbjct: 128 ------LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR----------- 167
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVT 771
           A  +   +      ++ Y AP+   GS   ST  D++S G +  EM+T
Sbjct: 168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 130/292 (44%), Gaps = 45/292 (15%)
Query: 563 RLLGTGSYGRVY----KGILQDG--TAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG GS+G VY    KG+++D   T +A+K + +  S      F  E  V+K     ++
Sbjct: 21  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 80
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGS-SDLTLLQRVNICSDIAEG 674
           +R++   S      +++  M  G L S+L         +   +  +L + + +  +IA+G
Sbjct: 81  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 140
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           MAYL+ +   + +H DL   N ++ +D T  + DFG+ + +        G + +      
Sbjct: 141 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL------ 191
Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNH 793
                + +M+PE       +T  DV+SFG+++ E+ T   +P       GLS  +     
Sbjct: 192 ---LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ-----GLSNEQ----- 238
Query: 794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
               L  V++  LL    D  P++          L EL  +C Q +P  RP+
Sbjct: 239 ---VLRFVMEGGLLDKP-DNCPDM----------LFELMRMCWQYNPKMRPS 276

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 104/228 (45%), Gaps = 29/228 (12%)
Query: 547 ITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGN--FTKSFNREC 604
           + ++ L+E   + ++   +G G+YG VYK     G  +A+K ++L + +     +  RE 
Sbjct: 14  LYFQGLMEKYQKLEK---VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREI 70
Query: 605 QVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
            +LK + H N++ +I          LV  +M        +   ++T        + L Q 
Sbjct: 71  SLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDL--KKVLDENKTGLQDSQIKIYLYQ- 127
Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
                 +  G+A+ H H   R++H DLKP N+L+N D    ++DFG+A+           
Sbjct: 128 ------LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR----------- 167
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVT 771
           A  +   +      ++ Y AP+   GS   ST  D++S G +  EM+T
Sbjct: 168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 22/233 (9%)
Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFN 601
           P +   ++ +    +     +G G+YG V   Y  + +   AI  K+   +   + +   
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIR-KISPFEHQTYCQRTL 73
Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           RE ++L R RH N++ I      P  + +   Y+    +++ LY   +T+  S       
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 133
Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
           L +      I  G+ Y+H      V+H DLKPSN+LLN      + DFG+A+      V 
Sbjct: 134 LYQ------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR------VA 178
Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           +   ++ G  T  +   +  Y APE    S   TK  D++S G ++ EM++ R
Sbjct: 179 DPDHDHTGFLTEYV--ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 26/219 (11%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++++      +   LV  ++   S+D   +  +     S  + + L    +    + +G+
Sbjct: 67  VKLLDVIHTENKLYLVFEFL---SMDLKDFMDA-----SALTGIPLPLIKSYLFQLLQGL 118
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
           A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T   
Sbjct: 119 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRTYXH 164
Query: 736 LCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
              ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 165 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+  ++L  ++     +  RE  +LK + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 114 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 159
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 160 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 32/222 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+  ++L  ++     +  RE  +LK + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS---DIA 672
           ++++      +   LV  ++           H + +    +S LT +    I S    + 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-----------HQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T
Sbjct: 113 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRT 158
Query: 733 ANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
                 ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G +   L   S+ +    ++ +T         +
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYIT---------E 121
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 122 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPS 165
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S    L G++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 166 SRRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 99/217 (45%), Gaps = 29/217 (13%)
Query: 563 RLLGTGSYGRVYKGILQ---DGTA--IAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNLM 616
           R LG G +G+V         DGT   +AVK L+   G   +S + +E  +L+ + H +++
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 617 RIITACSLPDFKAL--VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +    C     K+L  V+ Y+  GSL  +L  HS          + L Q +     I EG
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS----------IGLAQLLLFAQQICEG 129
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           MAYLH       IH +L   NVLL++D    + DFG+AK V   G         G+S   
Sbjct: 130 MAYLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDS--- 182
Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                + + APE           DV+SFG+ + E++T
Sbjct: 183 ----PVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 99/217 (45%), Gaps = 29/217 (13%)
Query: 563 RLLGTGSYGRVYKGILQ---DGTA--IAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNLM 616
           R LG G +G+V         DGT   +AVK L+   G   +S + +E  +L+ + H +++
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 617 RIITACSLPDFKAL--VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +    C     K+L  V+ Y+  GSL  +L  HS          + L Q +     I EG
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS----------IGLAQLLLFAQQICEG 129
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           MAYLH       IH +L   NVLL++D    + DFG+AK V   G         G+S   
Sbjct: 130 MAYLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDS--- 182
Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                + + APE           DV+SFG+ + E++T
Sbjct: 183 ----PVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 102/233 (43%), Gaps = 22/233 (9%)
Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFN 601
           P +   ++ +    +     +G G+YG V   Y  + +   AI  K+   +   + +   
Sbjct: 31  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-KISPFEHQTYCQRTL 89
Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           RE ++L R RH N++ I      P  + +   Y+    + + LY   +T+  S       
Sbjct: 90  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYF 149
Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
           L +      I  G+ Y+H      V+H DLKPSN+LLN      + DFG+A+      V 
Sbjct: 150 LYQ------ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR------VA 194
Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           +   ++ G  T      +  Y APE    S   TK  D++S G ++ EM++ R
Sbjct: 195 DPDHDHTGFLTE--YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 29/222 (13%)
Query: 553 LEATAEFDEQRLLGTGSYGRVYKGILQD-GTAIAVK-VLQLQSGNFTKSFN-RECQVLKR 609
            ++  +++   L+G GSYG V K   +D G  +A+K  L+       K    RE ++LK+
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 610 IRHRNLMRIITACSLPDFKALVLPYMANGSLDS-HLYPHSETEFGSGSSDLTLLQRVNIC 668
           +RH NL+ ++  C       LV  ++ +  LD   L+P+          D  ++Q+    
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--------LDYQVVQKYLF- 131
Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
             I  G+ + H H+   +IH D+KP N+L++      + DFG A+ +   G   D     
Sbjct: 132 -QIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--- 184
Query: 729 GNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEM 769
                     +  Y APE   G     K  DV++ G LV EM
Sbjct: 185 --------VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEM 218

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 106/246 (43%), Gaps = 37/246 (15%)
Query: 538 PELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVLQLQSGNF 596
           PEL    P +  +  +E   +F+  ++LG GS+G+V+    +      A+K L+      
Sbjct: 2   PELNKERPSLQIKLKIE---DFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALK--KDVV 56
Query: 597 TKSFNREC-QVLKRI-----RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSET 650
               + EC  V KR+      H  L  +       +    V+ Y+  G L  H+      
Sbjct: 57  LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI------ 110
Query: 651 EFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG 710
                     L +     ++I  G+ +LH      +++ DLK  N+LL+ D    ++DFG
Sbjct: 111 ---QSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFG 164
Query: 711 IAKLVMTVGVGNDGAENM-GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEM 769
           + K            ENM G++  N  CG+  Y+APE   G   +   D +SFG+L+ EM
Sbjct: 165 MCK------------ENMLGDAKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEM 212
Query: 770 VTRRRP 775
           +  + P
Sbjct: 213 LIGQSP 218

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 110/235 (46%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGIL---QDGTAIAVKVLQLQSGNFTKSFNR---ECQVLKRIR 611
           EF + ++L +G++G VYKG+     +   I V + +L+     K+      E  V+  + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L++  M  G L  ++  H +     GS  L     +N C  I
Sbjct: 83  NPHVCRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 133
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+AKL+        GAE     
Sbjct: 134 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--------GAEE-KEY 181
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 182 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 105/219 (47%), Gaps = 26/219 (11%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK   +  G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++++      +   LV  ++     D  L    +    +G   L L++  +    + +G+
Sbjct: 68  VKLLDVIHTENKLYLVFEHV-----DQDLKKFMDASALTGIP-LPLIK--SYLFQLLQGL 119
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
           A+ H H   RV+H DLKP N+L+N +    ++DFG+A+           A  +   T   
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----------AFGVPVRTYXH 165
Query: 736 LCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRR 773
              ++ Y APE   G    ST  D++S G +  EMVTRR
Sbjct: 166 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 107/224 (47%), Gaps = 29/224 (12%)
Query: 565 LGTGSYGRVYK----GILQDG--TAIAVKVLQLQSGNFTKSFN---RECQVLKRI-RHRN 614
           LG G++G+V      GI +D    A+ V V  L+     K  +    E +++K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY----PHSETEFGSG---SSDLTLLQRVNI 667
           ++ ++ AC+      +++ Y + G+L  +L     P  E  +         +T    V+ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
              +A GM YL      + IH DL   NVL+ ++    ++DFG+A+ +  +       + 
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI-------DY 212
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
             N+T   L   + +MAPE  F    + + DV+SFG+L+ E+ T
Sbjct: 213 YKNTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 109/235 (46%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL-----QLQSGNFTKSFNRECQVLKRIR 611
           EF + ++LG+G++G VYKG+ + +G  + + V      +  S    K    E  V+  + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L+   M  G L  ++  H +     GS  L     +N C  I
Sbjct: 76  NPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 126
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG AKL+        GAE     
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL--------GAEE-KEY 174
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 32/221 (14%)
Query: 563 RLLGTGSYGRVY--KGILQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + +G G++ +V   + IL  G  +A+K++   QL   +  K F RE +++K + H N+++
Sbjct: 18  KTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVK 75
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +           L++ Y + G +  +L  H   +     S             I   + Y
Sbjct: 76  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF---------RQIVSAVQY 126
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
            H     R++H DLK  N+LL+ DM   ++DFG +    TVG              +  C
Sbjct: 127 CHQK---RIVHRDLKAENLLLDADMNIKIADFGFSN-EFTVG-----------GKLDTFC 171
Query: 738 GSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTD 777
           GS  Y APE   G      + DV+S G+++  +V+   P D
Sbjct: 172 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 103/233 (44%), Gaps = 22/233 (9%)
Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFN 601
           P +   ++ +    +     +G G+YG V   Y  + +   AI  K+   +   + +   
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-KISPFEHQTYCQRTL 73
Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           RE ++L R RH N++ I      P  + +   Y+    +++ LY   +T+  S       
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 133
Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
           L +      I  G+ Y+H      V+H DLKPSN+LLN      + DFG+A+      V 
Sbjct: 134 LYQ------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR------VA 178
Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           +   ++ G     +   +  Y APE    S   TK  D++S G ++ EM++ R
Sbjct: 179 DPDHDHTGFLXEXV--ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 103/233 (44%), Gaps = 22/233 (9%)
Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFN 601
           P +   ++ +    +     +G G+YG V   Y  + +   AI  K+   +   + +   
Sbjct: 16  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-KISPFEHQTYCQRTL 74
Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           RE ++L R RH N++ I      P  + +   Y+    +++ LY   +T+  S       
Sbjct: 75  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 134
Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
           L +      I  G+ Y+H      V+H DLKPSN+LLN      + DFG+A+      V 
Sbjct: 135 LYQ------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR------VA 179
Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           +   ++ G     +   +  Y APE    S   TK  D++S G ++ EM++ R
Sbjct: 180 DPDHDHTGFLXEXV--ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 99/221 (44%), Gaps = 28/221 (12%)
Query: 563 RLLGTGSYGRVYKGILQ------DGTAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG G++G VY+G +           +AVK L ++ S      F  E  ++ +  H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 616 MRIITAC--SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           +R I     SLP F  ++L  MA G L S L         S  S L +L  +++  DIA 
Sbjct: 137 VRCIGVSLQSLPRF--ILLELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           G  YL  +     IH D+   N LL        A + DFG+A+ +   G    G      
Sbjct: 193 GCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG----- 244
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               ML   + +M PE       ++K D +SFG+L+ E+ +
Sbjct: 245 --CAML--PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 108/235 (45%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGIL---QDGTAIAVKVLQLQSGNFTKSFNR---ECQVLKRIR 611
           EF + ++LG+G++G VYKG+     +   I V + +L+     K+      E  V+  + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L+   M  G L  ++  H +     GS  L     +N C  I
Sbjct: 78  NPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 128
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG AKL+        GAE     
Sbjct: 129 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL--------GAEEKEYH 177
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
                   I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 178 AEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 99/227 (43%), Gaps = 29/227 (12%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRI 610
           A  +F+  R LG G +G VY    +    I A+KVL   QL+         RE ++   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH N++R+           L+L Y   G++   L   S+ +    ++ +T         +
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---------E 117
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +A  ++Y H     RVIH D+KP N+LL       ++DFG +              +  +
Sbjct: 118 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSC-------------HAPS 161
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           S    L G++ Y+ PE   G     K D++S G+L  E +  + P +
Sbjct: 162 SRRTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 108/235 (45%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGIL---QDGTAIAVKVLQLQSGNFTKSFNR---ECQVLKRIR 611
           EF + ++LG+G++G VYKG+     +   I V + +L+     K+      E  V+  + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L+   M  G L  ++  H +     GS  L     +N C  I
Sbjct: 83  NPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 133
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG AKL+        GAE     
Sbjct: 134 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL--------GAEEKEYH 182
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
                   I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 183 AEGGKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 104/227 (45%), Gaps = 29/227 (12%)
Query: 562 QRLLGTGSYGRVYKGILQ--DGTAIAVKVLQLQSGNFTKS---FNRECQVLKRIRHRNLM 616
           ++++G G +G V  G L+      I V +  L+SG   K    F  E  ++ +  H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
            +    +      ++  +M NGSLDS L               T++Q V +   IA GM 
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLR--------QNDGQFTVIQLVGMLRGIAAGMK 123
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL   + +  +H  L   N+L+N ++   VSDFG+++ +          ++  + T    
Sbjct: 124 YL---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFL---------EDDTSDPTYTSA 171
Query: 737 CGS---IGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
            G    I + APE       ++  DV+S+GI++ E+++   RP  DM
Sbjct: 172 LGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 218

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 103/233 (44%), Gaps = 22/233 (9%)
Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFN 601
           P +   ++ +    +     +G G+YG V   Y  + +   AI  K+   +   + +   
Sbjct: 15  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-KISPFEHQTYCQRTL 73
Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           RE ++L R RH N++ I      P  + +   Y+    +++ LY   + +  S       
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYF 133
Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
           L +      I  G+ Y+H      V+H DLKPSN+LLN      + DFG+A+      V 
Sbjct: 134 LYQ------ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR------VA 178
Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           +   ++ G  T  +   +  Y APE    S   TK  D++S G ++ EM++ R
Sbjct: 179 DPDHDHTGFLTEYV--ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 99/221 (44%), Gaps = 28/221 (12%)
Query: 563 RLLGTGSYGRVYKGILQ------DGTAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG G++G VY+G +           +AVK L ++ S      F  E  ++ +  H+N+
Sbjct: 54  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 113
Query: 616 MRIITAC--SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           +R I     SLP F  ++L  MA G L S L         S  S L +L  +++  DIA 
Sbjct: 114 VRCIGVSLQSLPRF--ILLELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHVARDIAC 169
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           G  YL  +     IH D+   N LL        A + DFG+A+ +   G    G      
Sbjct: 170 GCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG----- 221
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               ML   + +M PE       ++K D +SFG+L+ E+ +
Sbjct: 222 --CAML--PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 109/235 (46%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL-----QLQSGNFTKSFNRECQVLKRIR 611
           EF + ++L +G++G VYKG+ + +G  + + V      +  S    K    E  V+  + 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L+   M  G L  ++  H +     GS  L     +N C  I
Sbjct: 76  NPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 126
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+AKL+        GAE     
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--------GAEE-KEY 174
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 112/222 (50%), Gaps = 27/222 (12%)
Query: 562 QRLLGTGSYGRVYKG-ILQDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHR-NLM 616
           Q ++G G++G+V K  I +DG  +   + +++   S +  + F  E +VL ++ H  N++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYP----HSETEFG---SGSSDLTLLQRVNICS 669
            ++ AC    +  L + Y  +G+L   L       ++  F    S +S L+  Q ++  +
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           D+A GM YL   S  + IH +L   N+L+ ++  A ++DFG+++          G E   
Sbjct: 147 DVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR----------GQEVYV 193
Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
             T   L   + +MA E    S  +T  DV+S+G+L+ E+V+
Sbjct: 194 KKTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 106/224 (47%), Gaps = 29/224 (12%)
Query: 565 LGTGSYGRVYK----GILQDG--TAIAVKVLQLQSGNFTKSFN---RECQVLKRI-RHRN 614
           LG G++G+V      GI +D    A+ V V  L+     K  +    E +++K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY----PHSETEFGSG---SSDLTLLQRVNI 667
           ++ ++ AC+      +++ Y + G+L  +L     P  E  +         +T    V+ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
              +A GM YL      + IH DL   NVL+ ++    ++DFG+A+ +  +       + 
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI-------DX 212
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              +T   L   + +MAPE  F    + + DV+SFG+L+ E+ T
Sbjct: 213 XKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 99/232 (42%), Gaps = 50/232 (21%)
Query: 558 EFDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  + LGTGS+GRV    +K   + G   A+K+L  Q          +   LK+I H 
Sbjct: 29  QFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQ----------KVVKLKQIEHT 75
Query: 614 -NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD-- 670
            N  RI+ A + P    L   +  N +L      +   E+ +G    + L+R+   S+  
Sbjct: 76  LNEKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPH 129
Query: 671 -------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
                  I     YLH    + +I+ DLKP N+L+++     V+DFG AK V        
Sbjct: 130 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV-------- 178
Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                       LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 179 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 32/222 (14%)
Query: 562 QRLLGTGSYGRVY--KGILQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNLM 616
           Q+ +G G++ +V   + +L  G  +AVK++   QL   +  K F RE +++K + H N++
Sbjct: 20  QKTIGKGNFAKVKLARHVLT-GREVAVKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIV 77
Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           ++           LV+ Y + G +  +L  H   +     +             I   + 
Sbjct: 78  KLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---------RQIVSAVQ 128
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           Y H      ++H DLK  N+LL+ DM   ++DFG +    TVG           +  +  
Sbjct: 129 YCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSN-EFTVG-----------NKLDTF 173
Query: 737 CGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTD 777
           CGS  Y APE   G      + DV+S G+++  +V+   P D
Sbjct: 174 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 32/221 (14%)
Query: 563 RLLGTGSYGRVY--KGILQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + +G G++ +V   + IL  G  +A+K++   QL   +  K F RE +++K + H N+++
Sbjct: 21  KTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVK 78
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +           L++ Y + G +  +L  H   +     S             I   + Y
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF---------RQIVSAVQY 129
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
            H     R++H DLK  N+LL+ DM   ++DFG +    TVG              +  C
Sbjct: 130 CHQK---RIVHRDLKAENLLLDADMNIKIADFGFSN-EFTVG-----------GKLDAFC 174
Query: 738 GSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTD 777
           G+  Y APE   G      + DV+S G+++  +V+   P D
Sbjct: 175 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 108/224 (48%), Gaps = 29/224 (12%)
Query: 565 LGTGSYGRVYK----GILQDG----TAIAVKVLQLQSGNFTKS-FNRECQVLKRI-RHRN 614
           LG G++G+V      G+ +D     T +AVK+L+  +     S    E +++K I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY----PHSETEFGSG---SSDLTLLQRVNI 667
           ++ ++ AC+      +++ Y + G+L  +L     P  E  F         L+    V+ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
              +A GM YL   +  + IH DL   NVL+ +D    ++DFG+A+ +  +    D  + 
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI----DXXKK 208
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
             N         + +MAPE  F    + + DV+SFG+L+ E+ T
Sbjct: 209 TTNGRL-----PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 105/246 (42%), Gaps = 37/246 (15%)
Query: 538 PELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVLQLQSGNF 596
           PEL    P +  +  +E   +F   ++LG GS+G+V+    +      A+K L+      
Sbjct: 1   PELNKERPSLQIKLKIE---DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK--KDVV 55
Query: 597 TKSFNREC-QVLKRI-----RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSET 650
               + EC  V KR+      H  L  +       +    V+ Y+  G L  H+      
Sbjct: 56  LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI------ 109
Query: 651 EFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG 710
                     L +     ++I  G+ +LH      +++ DLK  N+LL+ D    ++DFG
Sbjct: 110 ---QSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFG 163
Query: 711 IAKLVMTVGVGNDGAENM-GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEM 769
           + K            ENM G++  N  CG+  Y+APE   G   +   D +SFG+L+ EM
Sbjct: 164 MCK------------ENMLGDAKTNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEM 211
Query: 770 VTRRRP 775
           +  + P
Sbjct: 212 LIGQSP 217

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 103/233 (44%), Gaps = 22/233 (9%)
Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFN 601
           P +   ++ +    +     +G G+YG V   Y  + +   AI  K+   +   + +   
Sbjct: 13  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-KISPFEHQTYCQRTL 71
Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           RE ++L   RH N++ I      P  + +   Y+    +++ LY   +T+  S       
Sbjct: 72  REIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 131
Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
           L +      I  G+ Y+H      V+H DLKPSN+LLN      + DFG+A+      V 
Sbjct: 132 LYQ------ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR------VA 176
Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           +   ++ G  T  +   +  Y APE    S   TK  D++S G ++ EM++ R
Sbjct: 177 DPDHDHTGFLTEYV--ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 112/222 (50%), Gaps = 25/222 (11%)
Query: 563 RLLGTGSYGRVYK----GILQDGTAIAVKVLQLQS---GNFTKSFNRECQVLKRI-RHRN 614
           + LG G++G+V +    G+ ++   + V V  L+S    +  ++   E +++  + +H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHS---ETE--FGSGSSDLTLLQRVNICS 669
           ++ ++ AC+      ++  Y   G L + L   S   ET+  F   +S L+    ++  S
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSS 171
Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
            +A+GMA+L   +    IH D+   NVLL +   A + DFG+A+ +M     ND +  + 
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM-----ND-SNYIV 222
Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              A +    + +MAPE  F    + + DV+S+GIL+ E+ +
Sbjct: 223 KGNARL---PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 136/311 (43%), Gaps = 57/311 (18%)
Query: 558 EFDEQRL-----LGTGSYGRVYK----GILQDGTAIAVKVLQLQSGNFTKSFNR----EC 604
           EF   RL     LG G++G+V +    GI +  T   V V  L+ G  T S +R    E 
Sbjct: 25  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSEL 83
Query: 605 QVLKRIRHR-NLMRIITACSLPDFKALVL-PYMANGSLDSHL-------YPHSETEFGSG 655
           ++L  I H  N++ ++ AC+ P    +V+  +   G+L ++L        P+ E      
Sbjct: 84  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLY 143
Query: 656 SSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
              LTL   +     +A+GM +L   +  + IH DL   N+LL++     + DFG+A+ +
Sbjct: 144 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 200
Query: 716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                     + +    A +    + +MAPE  F    + + DV+SFG+L+ E       
Sbjct: 201 YK------DPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWE------- 244
Query: 776 TDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILC 835
              +F+ G S +  VK      +++     L   +R ++P      D    E+ +  + C
Sbjct: 245 ---IFSLGASPYPGVK------IDEEFCRRLKEGTRMRAP------DYTTPEMYQTMLDC 289
Query: 836 TQESPSTRPTM 846
               PS RPT 
Sbjct: 290 WHGEPSQRPTF 300

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 109/235 (46%), Gaps = 28/235 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL-----QLQSGNFTKSFNRECQVLKRIR 611
           EF + ++L +G++G VYKG+ + +G  + + V      +  S    K    E  V+  + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C L     L+   M  G L  ++  H +     GS  L     +N C  I
Sbjct: 83  NPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYL-----LNWCVQI 133
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+AKL+        GAE     
Sbjct: 134 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--------GAEE-KEY 181
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLS 785
            A      I +MA E       + + DV+S+G+ V E++T   +P D + A  +S
Sbjct: 182 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 106/224 (47%), Gaps = 29/224 (12%)
Query: 565 LGTGSYGRVYK----GILQDG--TAIAVKVLQLQSGNFTKSFN---RECQVLKRI-RHRN 614
           LG G++G+V      GI +D    A+ V V  L+     K  +    E +++K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY----PHSETEFGSG---SSDLTLLQRVNI 667
           ++ ++ AC+      +++ Y + G+L  +L     P  E  +         +T    V+ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
              +A GM YL      + IH DL   NVL+ ++    ++DFG+A+ +  +       + 
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI-------DX 212
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              +T   L   + +MAPE  F    + + DV+SFG+L+ E+ T
Sbjct: 213 XKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 108/218 (49%), Gaps = 21/218 (9%)
Query: 563 RLLGTGSYGRVYK----GILQDGTAIAVKVLQLQS---GNFTKSFNRECQVLKRI-RHRN 614
           + LG G++G+V +    G+ ++   + V V  L+S    +  ++   E +++  + +H N
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 103
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSD-LTLLQRVNICSDIAE 673
           ++ ++ AC+      ++  Y   G L + L   +E +        L L   ++  S +A+
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 163
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           GMA+L   +    IH D+   NVLL +   A + DFG+A+ +M     ND +  +    A
Sbjct: 164 GMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM-----ND-SNYIVKGNA 214
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            +    + +MAPE  F    + + DV+S+GIL+ E+ +
Sbjct: 215 RL---PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 25/218 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHR 613
           +F   ++LG GS+  V     L      A+K+L+ +     N      RE  V+ R+ H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
             +++       +     L Y  NG L  ++      + GS     T      I S    
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYI-----RKIGSFDETCTRFYTAEIVS---- 143
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + YLH      +IH DLKP N+LLN+DM   ++DFG AK++         +     + A
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL---------SPESKQARA 191
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           N   G+  Y++PE     + S   D+++ G ++ ++V 
Sbjct: 192 NSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVA 229

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 111/246 (45%), Gaps = 31/246 (12%)
Query: 541 MHNFPRITYRELLEATAE------FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQS 593
           + N PR   ++L E +        FD    LG GSYG VYK I ++ G  +A+K + ++S
Sbjct: 7   LRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES 66
Query: 594 GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFG 653
               +   +E  ++++    ++++   +        +V+ Y   GS+   +   ++T   
Sbjct: 67  D--LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT--- 121
Query: 654 SGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK 713
                LT  +   I     +G+ YLH    +R IH D+K  N+LLN +  A ++DFG+A 
Sbjct: 122 -----LTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVA- 172
Query: 714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRR 773
                     G      +  N + G+  +MAPE       +   D++S GI  +EM   +
Sbjct: 173 ----------GQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
Query: 774 RPTDDM 779
            P  D+
Sbjct: 223 PPYADI 228

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 98/232 (42%), Gaps = 50/232 (21%)
Query: 558 EFDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  + LGTGS+GRV    +K   + G   A+K+L  Q          +   LK+I H 
Sbjct: 63  QFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQ----------KVVKLKQIEHT 109
Query: 614 -NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD-- 670
            N  RI+ A + P    L   +  N +L      +   E+ +G    + L+R+   S+  
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPH 163
Query: 671 -------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
                  I     YLH    + +I+ DLKP N+L++      V+DFG AK V        
Sbjct: 164 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-------- 212
Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                       LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 213 ------KGATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 102/233 (43%), Gaps = 22/233 (9%)
Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFN 601
           P +   ++ +    +     +G G+YG V   Y  + +   AI  K+   +   + +   
Sbjct: 13  PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIK-KISPFEHQTYCQRTL 71
Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           RE ++L   RH N++ I      P  + +   Y+    +++ LY   +T+  S       
Sbjct: 72  REIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 131
Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
           L +      I  G+ Y+H      V+H DLKPSN+LLN      + DFG+A+      V 
Sbjct: 132 LYQ------ILRGLKYIHS---ANVLHRDLKPSNLLLNTTSDLKICDFGLAR------VA 176
Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           +   ++ G  T      +  Y APE    S   TK  D++S G ++ EM++ R
Sbjct: 177 DPDHDHTGFLTE--YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 108/218 (49%), Gaps = 21/218 (9%)
Query: 563 RLLGTGSYGRVYK----GILQDGTAIAVKVLQLQS---GNFTKSFNRECQVLKRI-RHRN 614
           + LG G++G+V +    G+ ++   + V V  L+S    +  ++   E +++  + +H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSD-LTLLQRVNICSDIAE 673
           ++ ++ AC+      ++  Y   G L + L   +E +        L L   ++  S +A+
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 171
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           GMA+L   +    IH D+   NVLL +   A + DFG+A+ +M     ND +  +    A
Sbjct: 172 GMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM-----ND-SNYIVKGNA 222
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            +    + +MAPE  F    + + DV+S+GIL+ E+ +
Sbjct: 223 RL---PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 32/221 (14%)
Query: 563 RLLGTGSYGRVY--KGILQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + +G G++ +V   + IL  G  +AVK++   QL S +  K F RE +++K + H N+++
Sbjct: 20  KTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLF-REVRIMKVLNHPNIVK 77
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +           LV+ Y + G +  +L  H   +     +             I   + Y
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---------RQIVSAVQY 128
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
            H      ++H DLK  N+LL+ DM   ++DFG +                GN   +  C
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF-----------TFGNKL-DTFC 173
Query: 738 GSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTD 777
           GS  Y APE   G      + DV+S G+++  +V+   P D
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           +G G+ G VY  + +  G  +A++ + LQ     +    E  V++  ++ N++  + +  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
           + D   +V+ Y+A GSL   +   +ET    G       Q   +C +  + + +LH +  
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV---TETCMDEG-------QIAAVCRECLQALEFLHSN-- 135
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
            +VIH D+K  N+LL  D +  ++DFG    +               S  + + G+  +M
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-----------EQSKRSXMVGTPYWM 183
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           APE         K D++S GI+ +EM+    P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           +G G+ G VY  + +  G  +A++ + LQ     +    E  V++  ++ N++  + +  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
           + D   +V+ Y+A GSL   +   +ET    G       Q   +C +  + + +LH +  
Sbjct: 89  VGDELWVVMEYLAGGSLTDVV---TETCMDEG-------QIAAVCRECLQALEFLHSN-- 136
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
            +VIH D+K  N+LL  D +  ++DFG    +               S  + + G+  +M
Sbjct: 137 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-----------EQSKRSXMVGTPYWM 184
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           APE         K D++S GI+ +EM+    P
Sbjct: 185 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 105/219 (47%), Gaps = 24/219 (10%)
Query: 563 RLLGTGSYGRVYKGIL----QDGTAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           R++G G +G VY G      Q+    A+K L ++      ++F RE  +++ + H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 618 IITACSLPD-FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           +I     P+    ++LPYM +G L   +         S   + T+   ++    +A GM 
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFI--------RSPQRNPTVKDLISFGLQVARGME 138
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL   +  + +H DL   N +L++  T  V+DFG+A+ ++      +      +  A + 
Sbjct: 139 YL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL----DREYYSVQQHRHARL- 190
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              + + A E       +TK DV+SFG+L+ E++TR  P
Sbjct: 191 --PVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 32/221 (14%)
Query: 563 RLLGTGSYGRVY--KGILQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + +G G++ +V   + IL  G  +AVK++   QL S +  K F RE +++K + H N+++
Sbjct: 20  KTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLF-REVRIMKVLNHPNIVK 77
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +           LV+ Y + G +  +L  H   +     +             I   + Y
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---------RQIVSAVQY 128
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
            H      ++H DLK  N+LL+ DM   ++DFG +                GN   +  C
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF-----------TFGNKL-DTFC 173
Query: 738 GSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTD 777
           GS  Y APE   G      + DV+S G+++  +V+   P D
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVY-KGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 92
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNL------YMVMEYAPGGEMFSHLRRIGRFSEPHARF 146
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N++++      V+DFG AK V           
Sbjct: 147 YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----------- 192
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 193 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 98/232 (42%), Gaps = 50/232 (21%)
Query: 558 EFDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  + LGTGS+GRV    +K   + G   A+K+L  Q          +   LK+I H 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQ----------KVVKLKQIEHT 88
Query: 614 -NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD-- 670
            N  RI+ A + P    L   +  N +L      +   E+ +G    + L+R+   S+  
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 671 -------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
                  I     YLH    + +I+ DLKP N+L++      V+DFG AK V        
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-------- 191
Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                       LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 98/232 (42%), Gaps = 50/232 (21%)
Query: 558 EFDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  + LGTGS+GRV    +K   + G   A+K+L  Q          +   LK+I H 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQ----------KVVKLKQIEHT 88
Query: 614 -NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD-- 670
            N  RI+ A + P    L   +  N +L      +   E+ +G    + L+R+   S+  
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 671 -------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
                  I     YLH    + +I+ DLKP N+L++      V+DFG AK V        
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-------- 191
Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                       LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           +G G+ G VY  + +  G  +A++ + LQ     +    E  V++  ++ N++  + +  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
           + D   +V+ Y+A GSL   +   +ET    G       Q   +C +  + + +LH +  
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV---TETCMDEG-------QIAAVCRECLQALEFLHSN-- 135
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
            +VIH D+K  N+LL  D +  ++DFG    +               S  + + G+  +M
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-----------EQSKRSTMVGTPYWM 183
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           APE         K D++S GI+ +EM+    P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 98/232 (42%), Gaps = 50/232 (21%)
Query: 558 EFDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  + LGTGS+GRV    +K   + G   A+K+L  Q          +   LK+I H 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQ----------KVVKLKQIEHT 88
Query: 614 -NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD-- 670
            N  RI+ A + P    L   +  N +L      +   E+ +G    + L+R+   S+  
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 671 -------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
                  I     YLH    + +I+ DLKP N+L++      V+DFG AK V        
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-------- 191
Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                       LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 98/232 (42%), Gaps = 50/232 (21%)
Query: 558 EFDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  + LGTGS+GRV    +K   + G   A+K+L  Q          +   LK+I H 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQ----------KVVKLKQIEHT 88
Query: 614 -NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD-- 670
            N  RI+ A + P    L   +  N +L      +   E+ +G    + L+R+   S+  
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 671 -------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
                  I     YLH    + +I+ DLKP N+L++      V+DFG AK V        
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-------- 191
Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                       LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 98/232 (42%), Gaps = 50/232 (21%)
Query: 558 EFDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  + LGTGS+GRV    +K   + G   A+K+L  Q          +   LK+I H 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQ----------KVVKLKQIEHT 88
Query: 614 -NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD-- 670
            N  RI+ A + P    L   +  N +L      +   E+ +G    + L+R+   S+  
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 671 -------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
                  I     YLH    + +I+ DLKP N+L++      V+DFG AK V        
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-------- 191
Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                       LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 96/228 (42%), Gaps = 50/228 (21%)
Query: 558 EFDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  + LGTGS+GRV    +K   + G   A+K+L  Q          +   LK+I H 
Sbjct: 37  QFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQ----------KVVKLKQIEHT 83
Query: 614 -NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ 666
            N  RI+ A + P    L   +  N +L      +   E+ +G    + L+R+       
Sbjct: 84  LNEKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFXEPH 137
Query: 667 ---ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
                + I     YLH    + +I+ DLKP N+L++      V+DFG AK V        
Sbjct: 138 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-------- 186
Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                       LCG+  Y+APE       +   D ++ G+L+ EM  
Sbjct: 187 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 228

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVY-KGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 92
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNL------YMVMEYAPGGEMFSHLRRIGRFSEPHARF 146
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N++++      V+DFG AK V           
Sbjct: 147 YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----------- 192
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 193 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 98/232 (42%), Gaps = 50/232 (21%)
Query: 558 EFDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  + LGTGS+GRV    +K   + G   A+K+L  Q          +   LK+I H 
Sbjct: 43  QFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQ----------KVVKLKQIEHT 89
Query: 614 -NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD-- 670
            N  RI+ A + P    L   +  N +L      +   E+ +G    + L+R+   S+  
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPH 143
Query: 671 -------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
                  I     YLH    + +I+ DLKP N+L++      V+DFG AK V        
Sbjct: 144 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-------- 192
Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                       LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 193 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 109/229 (47%), Gaps = 39/229 (17%)
Query: 565 LGTGSYGRVYK----GILQDG----TAIAVKVLQLQSGNFTKS-FNRECQVLKRI-RHRN 614
           LG G++G+V      G+ +D     T +AVK+L+  +     S    E +++K I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY------------PHSETEFGSGSSDLTLL 662
           ++ ++ AC+      +++ Y + G+L  +L             P    E    S DL   
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL--- 137
Query: 663 QRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGN 722
             V+    +A GM YL   +  + IH DL   NVL+ +D    ++DFG+A+ +  +    
Sbjct: 138 --VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI---- 188
Query: 723 DGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              +    +T   L   + +MAPE  F    + + DV+SFG+L+ E+ T
Sbjct: 189 ---DYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 97/232 (41%), Gaps = 50/232 (21%)
Query: 558 EFDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  + LGTGS+GRV    +K   + G   A+K+L  Q          +   LK+I H 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQ----------KVVKLKQIEHT 88
Query: 614 -NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ 666
            N  RI+ A + P    L   +  N +L      +   E+ +G    + L+R+       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFXEPH 142
Query: 667 ---ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
                + I     YLH    + +I+ DLKP N+L++      V+DFG AK V        
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-------- 191
Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                       LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 22/219 (10%)
Query: 559 FDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNL 615
           + + + +G G+YG V   Y  + +   AI  K+   +   + +   RE Q+L R RH N+
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIK-KISPFEHQTYCQRTLREIQILLRFRHENV 103
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           + I         +A+   Y+    +++ LY   +++  S       L +      I  G+
Sbjct: 104 IGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQ------ILRGL 157
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            Y+H      V+H DLKPSN+L+N      + DFG+A+      + +   ++ G  T  +
Sbjct: 158 KYIHS---ANVLHRDLKPSNLLINTTCDLKICDFGLAR------IADPEHDHTGFLTEXV 208
Query: 736 LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
              +  Y APE    S   TK  D++S G ++ EM++ R
Sbjct: 209 --ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 95/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVY-KGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 92
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN--------- 666
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+          
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNL------YMVMEYAPGGEMFSHLRRIGRFXEPHARF 146
Query: 667 ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
             + I     YLH    + +I+ DLKP N++++      V+DFG AK V           
Sbjct: 147 YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----------- 192
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 193 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 97/232 (41%), Gaps = 50/232 (21%)
Query: 558 EFDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  + LGTGS+GRV    +K   + G   A+K+L  Q          +   LK+I H 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQ----------KVVKLKQIEHT 88
Query: 614 -NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ 666
            N  RI+ A + P    L   +  N +L      +   E+ +G    + L+R+       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFXEPH 142
Query: 667 ---ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
                + I     YLH    + +I+ DLKP N+L++      V+DFG AK V        
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-------- 191
Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                       LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 97/232 (41%), Gaps = 50/232 (21%)
Query: 558 EFDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  + LGTGS+GRV    +K   + G   A+K+L  Q          +   LK+I H 
Sbjct: 63  QFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQ----------KVVKLKQIEHT 109
Query: 614 -NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ 666
            N  RI+ A + P    L   +  N +L      +   E+ +G    + L+R+       
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFXEPH 163
Query: 667 ---ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
                + I     YLH    + +I+ DLKP N+L++      V+DFG AK V        
Sbjct: 164 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-------- 212
Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                       LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 213 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 38/227 (16%)
Query: 568 GSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA----CS 623
           G +G V+K  L +   +AVK+  LQ     +S  RE      ++H NL++ I A     +
Sbjct: 26  GRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
           L     L+  +   GSL  +L            + +T  +  ++   ++ G++YLH   P
Sbjct: 84  LEVELWLITAFHDKGSLTDYL----------KGNIITWNELCHVAETMSRGLSYLHEDVP 133
Query: 684 V--------RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
                     + H D K  NVLL  D+TA+++DFG+A       V  +  +  G++   +
Sbjct: 134 WCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLA-------VRFEPGKPPGDTHGQV 186
Query: 736 LCGSIGYMAPEY-----GFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
             G+  YMAPE       F  +   + D+Y+ G+++ E+V+R +  D
Sbjct: 187 --GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 97/232 (41%), Gaps = 50/232 (21%)
Query: 558 EFDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  + LGTGS+GRV    +K   + G   A+K+L  Q          +   LK+I H 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQ----------KVVKLKQIEHT 88
Query: 614 -NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ 666
            N  RI+ A + P    L   +  N +L      +   E+ +G    + L+R+       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFAEPH 142
Query: 667 ---ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
                + I     YLH    + +I+ DLKP N+L++      V+DFG AK V        
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-------- 191
Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                       LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 106/224 (47%), Gaps = 29/224 (12%)
Query: 565 LGTGSYGRVYK----GILQDG--TAIAVKVLQLQSGNFTKSFN---RECQVLKRI-RHRN 614
           LG G++G+V      GI +D    A+ V V  L+     K  +    E +++K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY----PHSETEFGSG---SSDLTLLQRVNI 667
           ++ ++ AC+      +++ Y + G+L  +L     P  E  +         +T    V+ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
              +A GM YL      + IH DL   NVL+ ++    ++DFG+A+ +  +       + 
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDINNI-------DY 212
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              +T   L   + +MAPE  F    + + DV+SFG+L+ E+ T
Sbjct: 213 YKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 32/221 (14%)
Query: 563 RLLGTGSYGRVY--KGILQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + +G G++ +V   + IL  G  +AVK++   QL S +  K F RE +++K + H N+++
Sbjct: 13  KTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLF-REVRIMKVLNHPNIVK 70
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +           LV+ Y + G +  +L  H   +     +             I   + Y
Sbjct: 71  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKF---------RQIVSAVQY 121
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
            H      ++H DLK  N+LL+ DM   ++DFG +             E    +  +  C
Sbjct: 122 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN------------EFTFGNKLDTFC 166
Query: 738 GSIGYMAPEYGFGSNTS-TKGDVYSFGILVLEMVTRRRPTD 777
           GS  Y APE   G      + DV+S G+++  +V+   P D
Sbjct: 167 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 28/221 (12%)
Query: 563 RLLGTGSYGRVYKGILQ------DGTAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG G++G VY+G +           +AVK L ++ S      F  E  ++ ++ H+N+
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNI 96
Query: 616 MRIITAC--SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           +R I     SLP F  ++L  MA G L S L         S  S L +L  +++  DIA 
Sbjct: 97  VRCIGVSLQSLPRF--ILLELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHVARDIAC 152
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           G  YL  +     IH D+   N LL        A + DFG+A+ +        G      
Sbjct: 153 GCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG----- 204
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               ML   + +M PE       ++K D +SFG+L+ E+ +
Sbjct: 205 --CAML--PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 26/217 (11%)
Query: 565 LGTGSYGRVYKGIL-QDGTAIAVKVLQLQSGNFTKSF-NRECQVLKRIRHRNLMRIITAC 622
           +G GS+G VYKGI       +A+K++ L+          +E  VL +     + R   + 
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
                  +++ Y+  GS    L P        G  + T +    I  +I +G+ YLH   
Sbjct: 87  LKSTKLWIIMEYLGGGSALDLLKP--------GPLEETYI--ATILREILKGLDYLHSE- 135
Query: 683 PVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGY 742
             R IH D+K +NVLL++     ++DFG+A  +    +             N   G+  +
Sbjct: 136 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR-----------NXFVGTPFW 182
Query: 743 MAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
           MAPE    S    K D++S GI  +E+     P  D+
Sbjct: 183 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 219

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 106/224 (47%), Gaps = 29/224 (12%)
Query: 565 LGTGSYGRVYK----GILQDG--TAIAVKVLQLQSGNFTKSFN---RECQVLKRI-RHRN 614
           LG G++G+V      GI +D    A+ V V  L+     K  +    E +++K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY----PHSETEFGSG---SSDLTLLQRVNI 667
           ++ ++ AC+      +++ Y + G+L  +L     P  E  +         +T    V+ 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
              +A GM YL      + IH DL   NVL+ ++    ++DFG+A+ +  +       + 
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI-------DY 212
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              +T   L   + +MAPE  F    + + DV+SFG+L+ E+ T
Sbjct: 213 YKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 106/224 (47%), Gaps = 29/224 (12%)
Query: 565 LGTGSYGRVYK----GILQDG--TAIAVKVLQLQSGNFTKSFN---RECQVLKRI-RHRN 614
           LG G++G+V      GI +D    A+ V V  L+     K  +    E +++K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY----PHSETEFGSG---SSDLTLLQRVNI 667
           ++ ++ AC+      +++ Y + G+L  +L     P  E  +         +T    V+ 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
              +A GM YL      + IH DL   NVL+ ++    ++DFG+A+ +  +       + 
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI-------DY 212
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              +T   L   + +MAPE  F    + + DV+SFG+L+ E+ T
Sbjct: 213 YKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 129/308 (41%), Gaps = 61/308 (19%)
Query: 563 RLLGTGSYGRVYKGIL------QDGTAIAVKVLQL-QSGNFTKSFNRECQVLKRIRHRNL 615
           + LG G +G+V K            T +AVK+L+   S +  +    E  VLK++ H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSG-----------------SSD 658
           +++  ACS      L++ Y   GSL   L      + G G                    
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFL--RESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 659 LTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV 718
           LT+   ++    I++GM YL   + ++++H DL   N+L+ +     +SDFG+++ V   
Sbjct: 147 LTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY-- 201
Query: 719 GVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
               +    +  S   +    + +MA E  F    +T+ DV+SFG+L+ E+VT       
Sbjct: 202 ----EEDSXVKRSQGRI---PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT------- 247
Query: 779 MFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQE 838
              GG        N Y G   + + + L    R + P      D    E+  L + C ++
Sbjct: 248 --LGG--------NPYPGIPPERLFNLLKTGHRMERP------DNCSEEMYRLMLQCWKQ 291
Query: 839 SPSTRPTM 846
            P  RP  
Sbjct: 292 EPDKRPVF 299

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           +G G+ G VY  + +  G  +A++ + LQ     +    E  V++  ++ N++  + +  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
           + D   +V+ Y+A GSL   +   +ET    G       Q   +C +  + + +LH +  
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV---TETCMDEG-------QIAAVCRECLQALEFLHSN-- 135
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
            +VIH D+K  N+LL  D +  ++DFG    +               S  + + G+  +M
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-----------EQSKRSEMVGTPYWM 183
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           APE         K D++S GI+ +EM+    P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 97/229 (42%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVY-KGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 91
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+ +G    + L+R+   S+     
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N+L++      V+DFG AK V           
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----------- 191
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 97/232 (41%), Gaps = 50/232 (21%)
Query: 558 EFDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  + LGTGS+GRV    +K   + G   A+K+L  Q          +   LK+I H 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQ----------KVVKLKQIEHT 88
Query: 614 -NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ 666
            N  RI+ A + P    L   +  N +L      +   E+ +G    + L+R+       
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFXEPH 142
Query: 667 ---ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
                + I     YLH    + +I+ DLKP N+L++      V+DFG AK V        
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-------- 191
Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                       LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 106/224 (47%), Gaps = 29/224 (12%)
Query: 565 LGTGSYGRVYK----GILQDG--TAIAVKVLQLQSGNFTKSFN---RECQVLKRI-RHRN 614
           LG G++G+V      GI +D    A+ V V  L+     K  +    E +++K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY----PHSETEFGSG---SSDLTLLQRVNI 667
           ++ ++ AC+      +++ Y + G+L  +L     P  E  +         +T    V+ 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
              +A GM YL      + IH DL   NVL+ ++    ++DFG+A+ +  +       + 
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI-------DY 212
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              +T   L   + +MAPE  F    + + DV+SFG+L+ E+ T
Sbjct: 213 YKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 30/218 (13%)
Query: 565 LGTGSYGRVYKGILQDGTAIAV-KVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G++G+VYK   ++ + +A  KV+  +S    + +  E  +L    H N+++++ A  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
             +   +++ + A G++D+ +              LT  Q   +C    + + YLH +  
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERP--------LTESQIQVVCKQTLDALNYLHDN-- 154
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGI-AKLVMTVGVGNDGAENMGNSTANMLCGSIGY 742
            ++IH DLK  N+L   D    ++DFG+ AK   T+               +   G+  +
Sbjct: 155 -KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI------------QRRDSFIGTPYW 201
Query: 743 MAPEYGFGSNTST-----KGDVYSFGILVLEMVTRRRP 775
           MAPE      +       K DV+S GI ++EM     P
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 109/229 (47%), Gaps = 39/229 (17%)
Query: 565 LGTGSYGRVYK----GILQDG----TAIAVKVLQLQSGNFTKS-FNRECQVLKRI-RHRN 614
           LG G++G+V      G+ +D     T +AVK+L+  +     S    E +++K I +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY------------PHSETEFGSGSSDLTLL 662
           ++ ++ AC+      +++ Y + G+L  +L             P    E    S DL   
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL--- 141
Query: 663 QRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGN 722
             V+    +A GM YL   +  + IH DL   NVL+ +D    ++DFG+A+ +  +    
Sbjct: 142 --VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI---- 192
Query: 723 DGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              +    +T   L   + +MAPE  F    + + DV+SFG+L+ E+ T
Sbjct: 193 ---DYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 109/229 (47%), Gaps = 39/229 (17%)
Query: 565 LGTGSYGRVYK----GILQDG----TAIAVKVLQLQSGNFTKS-FNRECQVLKRI-RHRN 614
           LG G++G+V      G+ +D     T +AVK+L+  +     S    E +++K I +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY------------PHSETEFGSGSSDLTLL 662
           ++ ++ AC+      +++ Y + G+L  +L             P    E    S DL   
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL--- 145
Query: 663 QRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGN 722
             V+    +A GM YL   +  + IH DL   NVL+ +D    ++DFG+A+ +  +    
Sbjct: 146 --VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI---- 196
Query: 723 DGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              +    +T   L   + +MAPE  F    + + DV+SFG+L+ E+ T
Sbjct: 197 ---DYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 109/229 (47%), Gaps = 39/229 (17%)
Query: 565 LGTGSYGRVYK----GILQDG----TAIAVKVLQLQSGNFTKS-FNRECQVLKRI-RHRN 614
           LG G++G+V      G+ +D     T +AVK+L+  +     S    E +++K I +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY------------PHSETEFGSGSSDLTLL 662
           ++ ++ AC+      +++ Y + G+L  +L             P    E    S DL   
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL--- 144
Query: 663 QRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGN 722
             V+    +A GM YL   +  + IH DL   NVL+ +D    ++DFG+A+ +  +    
Sbjct: 145 --VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI---- 195
Query: 723 DGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              +    +T   L   + +MAPE  F    + + DV+SFG+L+ E+ T
Sbjct: 196 ---DYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 28/221 (12%)
Query: 563 RLLGTGSYGRVYKGILQ------DGTAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG G++G VY+G +           +AVK L ++ S      F  E  ++ ++ H+N+
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNI 110
Query: 616 MRIITAC--SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           +R I     SLP F  ++L  MA G L S L         S  S L +L  +++  DIA 
Sbjct: 111 VRCIGVSLQSLPRF--ILLELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHVARDIAC 166
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           G  YL  +     IH D+   N LL        A + DFG+A+ +        G      
Sbjct: 167 GCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG----- 218
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               ML   + +M PE       ++K D +SFG+L+ E+ +
Sbjct: 219 --CAML--PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVY-KGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK I H  N 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ----------KVVKLKEIEHTLNE 91
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYAPGGEMFSHLRRIGRFSEPHARF 145
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N++++      V+DFG+AK V           
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV----------- 191
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVY-KGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK I H  N 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ----------KVVKLKEIEHTLNE 91
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYAPGGEMFSHLRRIGRFSEPHARF 145
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N++++      V+DFG+AK V           
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRV----------- 191
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVY-KGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 91
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYAPGGEMFSHLRRIGRFSEPHARF 145
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N++++      V+DFG AK V           
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV----------- 191
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 28/221 (12%)
Query: 563 RLLGTGSYGRVYKGILQ------DGTAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG G++G VY+G +           +AVK L ++ S      F  E  ++ +  H+N+
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNI 110
Query: 616 MRIITAC--SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           +R I     SLP F  ++L  MA G L S L         S  S L +L  +++  DIA 
Sbjct: 111 VRCIGVSLQSLPRF--ILLELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHVARDIAC 166
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           G  YL  +     IH D+   N LL        A + DFG+A+ +        G      
Sbjct: 167 GCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG----- 218
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               ML   + +M PE       ++K D +SFG+L+ E+ +
Sbjct: 219 --CAML--PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVY-KGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 91
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYAPGGEMFSHLRRIGRFSEPHARF 145
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N++++      V+DFG AK V           
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----------- 191
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 25/218 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHR 613
           +F   ++LG GS+  V     L      A+K+L+ +     N      RE  V+ R+ H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
             +++       +     L Y  NG L  ++      + GS     T      I S    
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVS---- 143
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + YLH      +IH DLKP N+LLN+DM   ++DFG AK++         +     + A
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL---------SPESKQARA 191
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           N   G+  Y++PE     +     D+++ G ++ ++V 
Sbjct: 192 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 229

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 109/229 (47%), Gaps = 39/229 (17%)
Query: 565 LGTGSYGRVYK----GILQDG----TAIAVKVLQLQSGNFTKS-FNRECQVLKRI-RHRN 614
           LG G++G+V      G+ +D     T +AVK+L+  +     S    E +++K I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY------------PHSETEFGSGSSDLTLL 662
           ++ ++ AC+      +++ Y + G+L  +L             P    E    S DL   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL--- 152
Query: 663 QRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGN 722
             V+    +A GM YL   +  + IH DL   NVL+ +D    ++DFG+A+ +  +    
Sbjct: 153 --VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI---- 203
Query: 723 DGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              +    +T   L   + +MAPE  F    + + DV+SFG+L+ E+ T
Sbjct: 204 ---DYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 27/219 (12%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHR 613
           +F   ++LG GS+  V     L      A+K+L+ +     N      RE  V+ R+ H 
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 614 NLMRIITACSLPDFKALV-LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIA 672
             +++   C   D K    L Y  NG L  ++      + GS     T      I S   
Sbjct: 98  FFVKLYF-CFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVS--- 148
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
             + YLH      +IH DLKP N+LLN+DM   ++DFG AK++         +     + 
Sbjct: 149 -ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL---------SPESKQAR 195
Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           AN   G+  Y++PE     +     D+++ G ++ ++V 
Sbjct: 196 ANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 234

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 25/218 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHR 613
           +F   ++LG GS+  V     L      A+K+L+ +     N      RE  V+ R+ H 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
             +++       +     L Y  NG L  ++      + GS     T      I S    
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVS---- 141
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + YLH      +IH DLKP N+LLN+DM   ++DFG AK++         +     + A
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL---------SPESKQARA 189
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           N   G+  Y++PE     +     D+++ G ++ ++V 
Sbjct: 190 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 25/218 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHR 613
           +F   ++LG GS+  V     L      A+K+L+ +     N      RE  V+ R+ H 
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
             +++       +     L Y  NG L  ++      + GS     T      I S    
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVS---- 140
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + YLH      +IH DLKP N+LLN+DM   ++DFG AK++         +     + A
Sbjct: 141 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL---------SPESKQARA 188
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           N   G+  Y++PE     +     D+++ G ++ ++V 
Sbjct: 189 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 226

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 109/229 (47%), Gaps = 39/229 (17%)
Query: 565 LGTGSYGRVYK----GILQDG----TAIAVKVLQLQSGNFTKS-FNRECQVLKRI-RHRN 614
           LG G++G+V      G+ +D     T +AVK+L+  +     S    E +++K I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY------------PHSETEFGSGSSDLTLL 662
           ++ ++ AC+      +++ Y + G+L  +L             P    E    S DL   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL--- 152
Query: 663 QRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGN 722
             V+    +A GM YL   +  + IH DL   NVL+ +D    ++DFG+A+ +  +    
Sbjct: 153 --VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI---- 203
Query: 723 DGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              +    +T   L   + +MAPE  F    + + DV+SFG+L+ E+ T
Sbjct: 204 ---DYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 109/229 (47%), Gaps = 39/229 (17%)
Query: 565 LGTGSYGRVYK----GILQDG----TAIAVKVLQLQSGNFTKS-FNRECQVLKRI-RHRN 614
           LG G++G+V      G+ +D     T +AVK+L+  +     S    E +++K I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY------------PHSETEFGSGSSDLTLL 662
           ++ ++ AC+      +++ Y + G+L  +L             P    E    S DL   
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL--- 152
Query: 663 QRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGN 722
             V+    +A GM YL   +  + IH DL   NVL+ +D    ++DFG+A+ +  +    
Sbjct: 153 --VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI---- 203
Query: 723 DGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              +    +T   L   + +MAPE  F    + + DV+SFG+L+ E+ T
Sbjct: 204 ---DYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 111/253 (43%), Gaps = 24/253 (9%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNL 615
           ++D  + LG G+YG V   + +    A+AVK++ ++   +  ++  +E  + K + H N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++        + + L L Y + G L   + P    + G    D    QR      +  G+
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDA---QR--FFHQLMAGV 118
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH    + + H D+KP N+LL++     +SDFG+A +            N      N 
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY---------NNRERLLNK 166
Query: 736 LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
           +CG++ Y+APE         +  DV+S GI++  M+    P D           W +   
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226
Query: 795 HGRLEKVIDSSLL 807
           +    K IDS+ L
Sbjct: 227 YLNPWKKIDSAPL 239

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 25/218 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHR 613
           +F   ++LG GS+  V     L      A+K+L+ +     N      RE  V+ R+ H 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
             +++       +     L Y  NG L  ++      + GS     T      I S    
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVS---- 141
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + YLH      +IH DLKP N+LLN+DM   ++DFG AK++         +     + A
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL---------SPESKQARA 189
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           N   G+  Y++PE     +     D+++ G ++ ++V 
Sbjct: 190 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 25/218 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHR 613
           +F   ++LG GS+  V     L      A+K+L+ +     N      RE  V+ R+ H 
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
             +++       +     L Y  NG L  ++      + GS     T      I S    
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVS---- 144
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + YLH      +IH DLKP N+LLN+DM   ++DFG AK++         +     + A
Sbjct: 145 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL---------SPESKQARA 192
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           N   G+  Y++PE     +     D+++ G ++ ++V 
Sbjct: 193 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 230

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 111/253 (43%), Gaps = 24/253 (9%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNL 615
           ++D  + LG G+YG V   + +    A+AVK++ ++   +  ++  +E  + K + H N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++        + + L L Y + G L   + P    + G    D    QR      +  G+
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDA---QR--FFHQLMAGV 117
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH    + + H D+KP N+LL++     +SDFG+A +            N      N 
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY---------NNRERLLNK 165
Query: 736 LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
           +CG++ Y+APE         +  DV+S GI++  M+    P D           W +   
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 225
Query: 795 HGRLEKVIDSSLL 807
           +    K IDS+ L
Sbjct: 226 YLNPWKKIDSAPL 238

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 25/218 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHR 613
           +F   ++LG GS+  V     L      A+K+L+ +     N      RE  V+ R+ H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
             +++       +     L Y  NG L  ++      + GS     T      I S    
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVS---- 143
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + YLH      +IH DLKP N+LLN+DM   ++DFG AK++         +     + A
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL---------SPESKQARA 191
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           N   G+  Y++PE     +     D+++ G ++ ++V 
Sbjct: 192 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 229

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 26/209 (12%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNLMRIITAC 622
           +G G+YG VYK     G   A+K ++L+  +     +  RE  +LK ++H N++++    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
                K LVL +         L    E    S ++   LLQ +N       G+AY H   
Sbjct: 70  HTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLN-------GIAYCHDR- 119
Query: 683 PVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGY 742
             RV+H DLKP N+L+N +    ++DFG+A+     G+       +   T  ++  ++ Y
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLAR---AFGIP------VRKYTHEIV--TLWY 166
Query: 743 MAPEYGFGSNT-STKGDVYSFGILVLEMV 770
            AP+   GS   ST  D++S G +  EMV
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 28/221 (12%)
Query: 563 RLLGTGSYGRVYKGILQ------DGTAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG G++G VY+G +           +AVK L ++ S      F  E  ++ +  H+N+
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 616 MRIITAC--SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           +R I     SLP F  ++L  MA G L S L         S  S L +L  +++  DIA 
Sbjct: 97  VRCIGVSLQSLPRF--ILLELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHVARDIAC 152
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           G  YL  +     IH D+   N LL        A + DFG+A+ +        G      
Sbjct: 153 GCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG----- 204
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               ML   + +M PE       ++K D +SFG+L+ E+ +
Sbjct: 205 --CAML--PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 28/221 (12%)
Query: 563 RLLGTGSYGRVYKGILQ------DGTAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG G++G VY+G +           +AVK L ++ S      F  E  ++ +  H+N+
Sbjct: 63  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 122
Query: 616 MRIITAC--SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           +R I     SLP F  ++L  MA G L S L         S  S L +L  +++  DIA 
Sbjct: 123 VRCIGVSLQSLPRF--ILLELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHVARDIAC 178
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           G  YL  +     IH D+   N LL        A + DFG+A+ +        G      
Sbjct: 179 GCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG----- 230
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               ML   + +M PE       ++K D +SFG+L+ E+ +
Sbjct: 231 --CAML--PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 26/209 (12%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNLMRIITAC 622
           +G G+YG VYK     G   A+K ++L+  +     +  RE  +LK ++H N++++    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
                K LVL +         L    E    S ++   LLQ +N       G+AY H   
Sbjct: 70  HTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLN-------GIAYCHDR- 119
Query: 683 PVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGY 742
             RV+H DLKP N+L+N +    ++DFG+A+    + V     E +          ++ Y
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEVV----------TLWY 166
Query: 743 MAPEYGFGSNT-STKGDVYSFGILVLEMV 770
            AP+   GS   ST  D++S G +  EMV
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 28/221 (12%)
Query: 563 RLLGTGSYGRVYKGILQ------DGTAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG G++G VY+G +           +AVK L ++ S      F  E  ++ +  H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 616 MRIITAC--SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           +R I     SLP F  ++L  MA G L S L         S  S L +L  +++  DIA 
Sbjct: 96  VRCIGVSLQSLPRF--ILLELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           G  YL  +     IH D+   N LL        A + DFG+A+ +        G      
Sbjct: 152 GCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG----- 203
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               ML   + +M PE       ++K D +SFG+L+ E+ +
Sbjct: 204 --CAML--PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 25/218 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHR 613
           +F   ++LG GS+  V     L      A+K+L+ +     N      RE  V+ R+ H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
             +++       +     L Y  NG L  ++      + GS     T      I S    
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVS---- 143
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + YLH      +IH DLKP N+LLN+DM   ++DFG AK++         +     + A
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL---------SPESKQARA 191
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           N   G+  Y++PE     +     D+++ G ++ ++V 
Sbjct: 192 NXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVA 229

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 129/308 (41%), Gaps = 61/308 (19%)
Query: 563 RLLGTGSYGRVYKGIL------QDGTAIAVKVLQL-QSGNFTKSFNRECQVLKRIRHRNL 615
           + LG G +G+V K            T +AVK+L+   S +  +    E  VLK++ H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSG-----------------SSD 658
           +++  ACS      L++ Y   GSL   L      + G G                    
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFL--RESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 659 LTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV 718
           LT+   ++    I++GM YL   + ++++H DL   N+L+ +     +SDFG+++ V   
Sbjct: 147 LTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY-- 201
Query: 719 GVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
               +    +  S   +    + +MA E  F    +T+ DV+SFG+L+ E+VT       
Sbjct: 202 ----EEDSYVKRSQGRI---PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT------- 247
Query: 779 MFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQE 838
              GG        N Y G   + + + L    R + P      D    E+  L + C ++
Sbjct: 248 --LGG--------NPYPGIPPERLFNLLKTGHRMERP------DNCSEEMYRLMLQCWKQ 291
Query: 839 SPSTRPTM 846
            P  RP  
Sbjct: 292 EPDKRPVF 299

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 32/221 (14%)
Query: 563 RLLGTGSYGRVY--KGILQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + +G G++ +V   + IL  G  +AVK++   QL S +  K F RE +++K + H N+++
Sbjct: 20  KTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLF-REVRIMKVLNHPNIVK 77
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +           LV+ Y + G +  +L  H   +     +             I   + Y
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---------RQIVSAVQY 128
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
            H      ++H DLK  N+LL+ DM   ++DFG +                GN   +  C
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF-----------TFGNKL-DAFC 173
Query: 738 GSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTD 777
           G+  Y APE   G      + DV+S G+++  +V+   P D
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 25/218 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHR 613
           +F   ++LG GS+  V     L      A+K+L+ +     N      RE  V+ R+ H 
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
             +++       +     L Y  NG L  ++      + GS     T      I S    
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVS---- 141
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + YLH      +IH DLKP N+LLN+DM   ++DFG AK++         +     + A
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL---------SPESKQARA 189
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           N   G+  Y++PE     +     D+++ G ++ ++V 
Sbjct: 190 NAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 28/221 (12%)
Query: 563 RLLGTGSYGRVYKGILQ------DGTAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG G++G VY+G +           +AVK L ++ S      F  E  ++ +  H+N+
Sbjct: 53  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 112
Query: 616 MRIITAC--SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           +R I     SLP F  ++L  MA G L S L         S  S L +L  +++  DIA 
Sbjct: 113 VRCIGVSLQSLPRF--ILLELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHVARDIAC 168
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           G  YL  +     IH D+   N LL        A + DFG+A+ +        G      
Sbjct: 169 GCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG----- 220
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               ML   + +M PE       ++K D +SFG+L+ E+ +
Sbjct: 221 --CAML--PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 111/253 (43%), Gaps = 24/253 (9%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNL 615
           ++D  + LG G+YG V   + +    A+AVK++ ++   +  ++  +E  + K + H N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++        + + L L Y + G L   + P    + G    D    QR      +  G+
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDA---QR--FFHQLMAGV 118
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH    + + H D+KP N+LL++     +SDFG+A +            N      N 
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY---------NNRERLLNK 166
Query: 736 LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
           +CG++ Y+APE         +  DV+S GI++  M+    P D           W +   
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226
Query: 795 HGRLEKVIDSSLL 807
           +    K IDS+ L
Sbjct: 227 YLNPWKKIDSAPL 239

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 26/209 (12%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNLMRIITAC 622
           +G G+YG VYK     G   A+K ++L+  +     +  RE  +LK ++H N++++    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
                K LVL +         L    E    S ++   LLQ +N       G+AY H   
Sbjct: 70  HTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLN-------GIAYCHDR- 119
Query: 683 PVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGY 742
             RV+H DLKP N+L+N +    ++DFG+A+    + V     E +          ++ Y
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEVV----------TLWY 166
Query: 743 MAPEYGFGSNT-STKGDVYSFGILVLEMV 770
            AP+   GS   ST  D++S G +  EMV
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 111/253 (43%), Gaps = 24/253 (9%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNL 615
           ++D  + LG G+YG V   + +    A+AVK++ ++   +  ++  +E  + K + H N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++        + + L L Y + G L   + P    + G    D    QR      +  G+
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDA---QR--FFHQLMAGV 118
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH    + + H D+KP N+LL++     +SDFG+A +            N      N 
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY---------NNRERLLNK 166
Query: 736 LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
           +CG++ Y+APE         +  DV+S GI++  M+    P D           W +   
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226
Query: 795 HGRLEKVIDSSLL 807
           +    K IDS+ L
Sbjct: 227 YLNPWKKIDSAPL 239

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 95/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVY-KGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 91
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN--------- 666
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+          
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYAPGGEMFSHLRRIGRFXEPHARF 145
Query: 667 ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
             + I     YLH    + +I+ DLKP N++++      V+DFG AK V           
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----------- 191
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 28/221 (12%)
Query: 563 RLLGTGSYGRVYKGILQ------DGTAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG G++G VY+G +           +AVK L ++ S      F  E  ++ +  H+N+
Sbjct: 43  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 102
Query: 616 MRIITAC--SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           +R I     SLP F  ++L  MA G L S L         S  S L +L  +++  DIA 
Sbjct: 103 VRCIGVSLQSLPRF--ILLELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHVARDIAC 158
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           G  YL  +     IH D+   N LL        A + DFG+A+ +        G      
Sbjct: 159 GCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG----- 210
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               ML   + +M PE       ++K D +SFG+L+ E+ +
Sbjct: 211 --CAML--PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 28/221 (12%)
Query: 563 RLLGTGSYGRVYKGILQ------DGTAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG G++G VY+G +           +AVK L ++ S      F  E  ++ +  H+N+
Sbjct: 28  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 87
Query: 616 MRIITAC--SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           +R I     SLP F  ++L  MA G L S L         S  S L +L  +++  DIA 
Sbjct: 88  VRCIGVSLQSLPRF--ILLELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHVARDIAC 143
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           G  YL  +     IH D+   N LL        A + DFG+A+ +        G      
Sbjct: 144 GCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG----- 195
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               ML   + +M PE       ++K D +SFG+L+ E+ +
Sbjct: 196 --CAML--PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 32/221 (14%)
Query: 563 RLLGTGSYGRVY--KGILQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + +G G++ +V   + IL  G  +AV+++   QL S +  K F RE +++K + H N+++
Sbjct: 20  KTIGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLF-REVRIMKVLNHPNIVK 77
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +           LV+ Y + G +  +L  H   +     +             I   + Y
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---------RQIVSAVQY 128
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
            H      ++H DLK  N+LL+ DM   ++DFG +                GN   +  C
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF-----------TFGNKL-DTFC 173
Query: 738 GSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTD 777
           GS  Y APE   G      + DV+S G+++  +V+   P D
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 25/218 (11%)
Query: 558 EFDEQRLLGTGSYGR-VYKGILQDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHR 613
           +F   ++LG GS+   V    L      A+K+L+ +     N      RE  V+ R+ H 
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
             +++       +     L Y  NG L  ++      + GS     T      I S    
Sbjct: 91  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVS---- 141
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + YLH      +IH DLKP N+LLN+DM   ++DFG AK++         +     + A
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL---------SPESKQARA 189
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           N   G+  Y++PE     +     D+++ G ++ ++V 
Sbjct: 190 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 47/270 (17%)
Query: 558 EFDEQRLLGTGSYGRVYKGIL----QDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRI 610
           +FD  +LLG G++G+V   IL      G   A+K+L+ +   + +       E +VL+  
Sbjct: 6   DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH  L  +  A    D    V+ Y   G L  HL         S     T  +     ++
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---------SRERVFTEERARFYGAE 113
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I   + YLH      V++ D+K  N++L+ D    ++DFG+ K     G+ +DGA     
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK----EGI-SDGA----- 160
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV 790
            T    CG+  Y+APE    ++     D +  G+++ EM+  R P               
Sbjct: 161 -TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--------------F 205
Query: 791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRM 820
            N  H RL ++I    +R  R  SPE K +
Sbjct: 206 YNQDHERLFELILMEEIRFPRTLSPEAKSL 235

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 109/229 (47%), Gaps = 39/229 (17%)
Query: 565 LGTGSYGRVYK----GILQDG----TAIAVKVLQLQSGNFTKS-FNRECQVLKRI-RHRN 614
           LG G++G+V      G+ +D     T +AVK+L+  +     S    E +++K I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY------------PHSETEFGSGSSDLTLL 662
           ++ ++ AC+      +++ Y + G+L  +L             P    E    S DL   
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL--- 193
Query: 663 QRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGN 722
             V+    +A GM YL   +  + IH DL   NVL+ +D    ++DFG+A+ +  +    
Sbjct: 194 --VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI---- 244
Query: 723 DGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              +    +T   L   + +MAPE  F    + + DV+SFG+L+ E+ T
Sbjct: 245 ---DYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 47/270 (17%)
Query: 558 EFDEQRLLGTGSYGRVYKGIL----QDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRI 610
           +FD  +LLG G++G+V   IL      G   A+K+L+ +   + +       E +VL+  
Sbjct: 6   DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH  L  +  A    D    V+ Y   G L  HL         S     T  +     ++
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---------SRERVFTEERARFYGAE 113
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I   + YLH      V++ D+K  N++L+ D    ++DFG+ K     G+ +DGA     
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK----EGI-SDGA----- 160
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV 790
            T    CG+  Y+APE    ++     D +  G+++ EM+  R P               
Sbjct: 161 -TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--------------F 205
Query: 791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRM 820
            N  H RL ++I    +R  R  SPE K +
Sbjct: 206 YNQDHERLFELILMEEIRFPRTLSPEAKSL 235

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 105/224 (46%), Gaps = 29/224 (12%)
Query: 565 LGTGSYGRVYK----GILQDG--TAIAVKVLQLQSGNFTKSFN---RECQVLKRI-RHRN 614
           LG G +G+V      GI +D    A+ V V  L+     K  +    E +++K I +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY----PHSETEFGSG---SSDLTLLQRVNI 667
           ++ ++ AC+      +++ Y + G+L  +L     P  E  +         +T    V+ 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
              +A GM YL      + IH DL   NVL+ ++    ++DFG+A+ +  +       + 
Sbjct: 209 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI-------DY 258
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              +T   L   + +MAPE  F    + + DV+SFG+L+ E+ T
Sbjct: 259 YKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 25/218 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHR 613
           +F   ++LG GS+  V     L      A+K+L+ +     N      RE  V+ R+ H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
             +++       +     L Y  NG L  ++      + GS     T      I S    
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVS---- 143
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + YLH      +IH DLKP N+LLN+DM   ++DFG AK++         +     + A
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL---------SPESKQARA 191
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           N   G+  Y++PE     +     D+++ G ++ ++V 
Sbjct: 192 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 229

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 32/221 (14%)
Query: 563 RLLGTGSYGRVY--KGILQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + +G G++ +V   + IL  G  +AV+++   QL S +  K F RE +++K + H N+++
Sbjct: 20  KTIGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLF-REVRIMKVLNHPNIVK 77
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +           LV+ Y + G +  +L  H   +     +             I   + Y
Sbjct: 78  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKF---------RQIVSAVQY 128
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
            H      ++H DLK  N+LL+ DM   ++DFG +        GN   E          C
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN---EFTFGNKLDE---------FC 173
Query: 738 GSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTD 777
           GS  Y APE   G      + DV+S G+++  +V+   P D
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 47/270 (17%)
Query: 558 EFDEQRLLGTGSYGRVYKGIL----QDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRI 610
           +FD  +LLG G++G+V   IL      G   A+K+L+ +   + +       E +VL+  
Sbjct: 6   DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH  L  +  A    D    V+ Y   G L  HL         S     T  +     ++
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---------SRERVFTEERARFYGAE 113
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I   + YLH      V++ D+K  N++L+ D    ++DFG+ K     G+ +DGA     
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK----EGI-SDGA----- 160
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV 790
            T    CG+  Y+APE    ++     D +  G+++ EM+  R P               
Sbjct: 161 -TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--------------F 205
Query: 791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRM 820
            N  H RL ++I    +R  R  SPE K +
Sbjct: 206 YNQDHERLFELILMEEIRFPRTLSPEAKSL 235

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 47/270 (17%)
Query: 558 EFDEQRLLGTGSYGRVYKGIL----QDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRI 610
           +FD  +LLG G++G+V   IL      G   A+K+L+ +   + +       E +VL+  
Sbjct: 11  DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 67
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH  L  +  A    D    V+ Y   G L  HL         S     T  +     ++
Sbjct: 68  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---------SRERVFTEERARFYGAE 118
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I   + YLH      V++ D+K  N++L+ D    ++DFG+ K     G+ +DGA     
Sbjct: 119 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK----EGI-SDGA----- 165
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV 790
            T    CG+  Y+APE    ++     D +  G+++ EM+  R P               
Sbjct: 166 -TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--------------F 210
Query: 791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRM 820
            N  H RL ++I    +R  R  SPE K +
Sbjct: 211 YNQDHERLFELILMEEIRFPRTLSPEAKSL 240

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 47/270 (17%)
Query: 558 EFDEQRLLGTGSYGRVYKGIL----QDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRI 610
           +FD  +LLG G++G+V   IL      G   A+K+L+ +   + +       E +VL+  
Sbjct: 6   DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH  L  +  A    D    V+ Y   G L  HL         S     T  +     ++
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---------SRERVFTEERARFYGAE 113
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I   + YLH      V++ D+K  N++L+ D    ++DFG+ K     G+ +DGA     
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK----EGI-SDGA----- 160
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV 790
            T    CG+  Y+APE    ++     D +  G+++ EM+  R P               
Sbjct: 161 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--------------F 205
Query: 791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRM 820
            N  H RL ++I    +R  R  SPE K +
Sbjct: 206 YNQDHERLFELILMEEIRFPRTLSPEAKSL 235

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVY-KGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 28  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 77
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 78  KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHARF 131
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N+L++      V+DFG AK V           
Sbjct: 132 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----------- 177
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 178 ---KGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 223

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 47/270 (17%)
Query: 558 EFDEQRLLGTGSYGRVYKGIL----QDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRI 610
           +FD  +LLG G++G+V   IL      G   A+K+L+ +   + +       E +VL+  
Sbjct: 6   DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH  L  +  A    D    V+ Y   G L  HL         S     T  +     ++
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---------SRERVFTEERARFYGAE 113
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I   + YLH      V++ D+K  N++L+ D    ++DFG+ K     G+ +DGA     
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK----EGI-SDGA----- 160
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV 790
            T    CG+  Y+APE    ++     D +  G+++ EM+  R P               
Sbjct: 161 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--------------F 205
Query: 791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRM 820
            N  H RL ++I    +R  R  SPE K +
Sbjct: 206 YNQDHERLFELILMEEIRFPRTLSPEAKSL 235

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 25/218 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHR 613
           +F   ++LG GS+  V     L      A+K+L+ +     N      RE  V+ R+ H 
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
             +++       +     L Y  NG L  ++      + GS     T      I S    
Sbjct: 96  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVS---- 146
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + YLH      +IH DLKP N+LLN+DM   ++DFG AK++         +     + A
Sbjct: 147 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL---------SPESKQARA 194
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           N   G+  Y++PE     +     D+++ G ++ ++V 
Sbjct: 195 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 232

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 106/224 (47%), Gaps = 29/224 (12%)
Query: 565 LGTGSYGRVYK----GILQDG--TAIAVKVLQLQSGNFTKSFN---RECQVLKRI-RHRN 614
           LG G++G+V      GI +D    A+ V V  L+     K  +    E +++K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY----PHSETEFGSG---SSDLTLLQRVNI 667
           ++ ++ AC+      +++ Y + G+L  +L     P  E  +         +T    V+ 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
              +A GM YL      + IH DL   NVL+ ++    ++DFG+A+ +  +       + 
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI-------DY 212
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              +T   L   + +MAPE  F    + + DV+SFG+L+ E+ T
Sbjct: 213 YKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 102/243 (41%), Gaps = 30/243 (12%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHR 613
           +F   ++LG GS+  V     L      A+K+L+ +     N      RE  V+ R+ H 
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
             +++       +     L Y  NG L  ++      + GS     T      I S    
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVS---- 143
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + YLH      +IH DLKP N+LLN+DM   ++DFG AK++         +     + A
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL---------SPESKQARA 191
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAG--GLSLHKWVK 791
           N   G+  Y++PE     +     D+++ G ++ ++V    P     AG  GL   K +K
Sbjct: 192 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP---FRAGNEGLIFAKIIK 248
Query: 792 NHY 794
             Y
Sbjct: 249 LEY 251

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 105/224 (46%), Gaps = 29/224 (12%)
Query: 565 LGTGSYGRVYK----GILQDG--TAIAVKVLQLQSGNFTKSFN---RECQVLKRI-RHRN 614
           LG G +G+V      GI +D    A+ V V  L+     K  +    E +++K I +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY----PHSETEFGSG---SSDLTLLQRVNI 667
           ++ ++ AC+      +++ Y + G+L  +L     P  E  +         +T    V+ 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
              +A GM YL      + IH DL   NVL+ ++    ++DFG+A+ +  +       + 
Sbjct: 152 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI-------DY 201
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              +T   L   + +MAPE  F    + + DV+SFG+L+ E+ T
Sbjct: 202 YKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 25/218 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHR 613
           +F   ++LG GS+  V     L      A+K+L+ +     N      RE  V+ R+ H 
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
             +++       +     L Y  NG L  ++      + GS     T      I S    
Sbjct: 94  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVS---- 144
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + YLH      +IH DLKP N+LLN+DM   ++DFG AK++         +     + A
Sbjct: 145 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL---------SPESKQARA 192
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           N   G+  Y++PE     +     D+++ G ++ ++V 
Sbjct: 193 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 230

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVY-KGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 92
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHARF 146
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N+L++      V+DFG AK V           
Sbjct: 147 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----------- 192
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 193 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVY-KGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 91
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHARF 145
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N+L++      V+DFG AK V           
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----------- 191
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 28/221 (12%)
Query: 563 RLLGTGSYGRVYKGILQ------DGTAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG G++G VY+G +           +AVK L ++ S      F  E  ++ +  H+N+
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 616 MRIITAC--SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           +R I     SLP F  ++L  MA G L S L         S  S L +L  +++  DIA 
Sbjct: 97  VRCIGVSLQSLPRF--ILLELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHVARDIAC 152
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           G  YL  +     IH D+   N LL        A + DFG+A+ +        G      
Sbjct: 153 GCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGG----- 204
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               ML   + +M PE       ++K D +SFG+L+ E+ +
Sbjct: 205 --CAML--PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 47/270 (17%)
Query: 558 EFDEQRLLGTGSYGRVYKGIL----QDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRI 610
           +FD  +LLG G++G+V   IL      G   A+K+L+ +   + +       E +VL+  
Sbjct: 9   DFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 65
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH  L  +  A    D    V+ Y   G L  HL         S     T  +     ++
Sbjct: 66  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---------SRERVFTEERARFYGAE 116
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I   + YLH      V++ D+K  N++L+ D    ++DFG+ K     G+ +DGA     
Sbjct: 117 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK----EGI-SDGA----- 163
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV 790
            T    CG+  Y+APE    ++     D +  G+++ EM+  R P               
Sbjct: 164 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--------------F 208
Query: 791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRM 820
            N  H RL ++I    +R  R  SPE K +
Sbjct: 209 YNQDHERLFELILMEEIRFPRTLSPEAKSL 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVY-KGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 91
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHARF 145
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N+L++      V+DFG AK V           
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----------- 191
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 50/232 (21%)
Query: 558 EFDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  + LGTGS+GRV    +K   + G   A+K+L  Q          +   LK+I H 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQ----------KVVKLKQIEHT 88
Query: 614 -NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD-- 670
            N  RI+ A + P    L   +  N +L      +   E+ +G    + L+R+   S+  
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 671 -------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
                  I     YLH    + +I+ DLKP N++++      V+DFG AK V        
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV-------- 191
Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                       LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ------KGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVY-KGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 92
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHARF 146
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N+L++      V+DFG AK V           
Sbjct: 147 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----------- 192
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 193 ---KGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 78/310 (25%), Positives = 126/310 (40%), Gaps = 65/310 (20%)
Query: 563 RLLGTGSYGRVYKGIL------QDGTAIAVKVLQL-QSGNFTKSFNRECQVLKRIRHRNL 615
           + LG G +G+V K            T +AVK+L+   S +  +    E  VLK++ H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSG-----------------SSD 658
           +++  ACS      L++ Y   GSL   L      + G G                    
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFL--RESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 659 LTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV 718
           LT+   ++    I++GM YL   S   ++H DL   N+L+ +     +SDFG+++ V   
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSRDVYE- 202
Query: 719 GVGNDGAENMGNSTANMLCGSI--GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPT 776
                      +S      G I   +MA E  F    +T+ DV+SFG+L+ E+VT     
Sbjct: 203 ----------EDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----- 247
Query: 777 DDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCT 836
                GG        N Y G   + + + L    R + P      D    E+  L + C 
Sbjct: 248 ----LGG--------NPYPGIPPERLFNLLKTGHRMERP------DNCSEEMYRLMLQCW 289
Query: 837 QESPSTRPTM 846
           ++ P  RP  
Sbjct: 290 KQEPDKRPVF 299

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 105/224 (46%), Gaps = 29/224 (12%)
Query: 565 LGTGSYGRVYK----GILQDG--TAIAVKVLQLQSGNFTKSFN---RECQVLKRI-RHRN 614
           LG G +G+V      GI +D    A+ V V  L+     K  +    E +++K I +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY----PHSETEFGSG---SSDLTLLQRVNI 667
           ++ ++ AC+      +++ Y + G+L  +L     P  E  +         +T    V+ 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
              +A GM YL      + IH DL   NVL+ ++    ++DFG+A+ +  +       + 
Sbjct: 150 TYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDINNI-------DY 199
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              +T   L   + +MAPE  F    + + DV+SFG+L+ E+ T
Sbjct: 200 YKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 25/218 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHR 613
           +F   ++LG GS+  V     L      A+K+L+ +     N      RE  V+ R+ H 
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
             +++       +     L Y  NG L  ++      + GS     T      I S    
Sbjct: 90  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTRFYTAEIVS---- 140
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + YLH      +IH DLKP N+LLN+DM   ++DFG AK++         +     + A
Sbjct: 141 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL---------SPESKQARA 188
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           N   G+  Y++PE     +     D+++ G ++ ++V 
Sbjct: 189 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 226

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVY-KGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 91
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHARF 145
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N+L++      V+DFG AK V           
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----------- 191
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 79/309 (25%), Positives = 134/309 (43%), Gaps = 55/309 (17%)
Query: 558 EFDEQRL-----LGTGSYGRVYK----GILQDGTAIAVKVLQLQSGNFTKSFNR----EC 604
           EF   RL     LG G++G+V +    GI +  T   V V  L+ G  T S +R    E 
Sbjct: 25  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGA-THSEHRALMSEL 83
Query: 605 QVLKRIRHR-NLMRIITACSLPDFKALVL-PYMANGSLDSHLYPHSETEFGSGSSDL--- 659
           ++L  I H  N++ ++ AC+ P    +V+  +   G+L ++L             DL   
Sbjct: 84  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKD 143
Query: 660 --TLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT 717
             TL   +     +A+GM +L   +  + IH DL   N+LL++     + DFG+A+ +  
Sbjct: 144 FLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXK 200
Query: 718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
                   + +    A +    + +MAPE  F    + + DV+SFG+L+ E         
Sbjct: 201 ------DPDXVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWE--------- 242
Query: 778 DMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQ 837
            +F+ G S +  VK      +++     L   +R ++P      D    E+ +  + C  
Sbjct: 243 -IFSLGASPYPGVK------IDEEFCRRLKEGTRMRAP------DYTTPEMYQTMLDCWH 289
Query: 838 ESPSTRPTM 846
             PS RPT 
Sbjct: 290 GEPSQRPTF 298

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 106/224 (47%), Gaps = 29/224 (12%)
Query: 565 LGTGSYGRVY--------KGILQDGTAIAVKVLQLQSGNFTKS-FNRECQVLKRI-RHRN 614
           LG G++G+V         K   ++   +AVK+L+  +     S    E +++K I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY----PHSETEFGSG---SSDLTLLQRVNI 667
           ++ ++ AC+      +++ Y + G+L  +L     P  E  +         +T    V+ 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
              +A GM YL      + IH DL   NVL+ ++    ++DFG+A+ +  +       + 
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI-------DY 212
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              +T   L   + +MAPE  F    + + DV+SFG+L+ E+ T
Sbjct: 213 YKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 563 RLLGTGSYGRVYK----GILQDGTAIAVKVLQLQS---GNFTKSFNRECQVLKRI-RHRN 614
           + LG G++G+V +    G+ ++   + V V  L+S    +  ++   E +++  + +H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHS---ETE--FGSGSSDLTLLQRVNICS 669
           ++ ++ AC+      ++  Y   G L + L   S   ET+  F   +S  +    ++  S
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
            +A+GMA+L   +    IH D+   NVLL +   A + DFG+A+ +M     ND +  + 
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM-----ND-SNYIV 222
Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              A +    + +MAPE  F    + + DV+S+GIL+ E+ +
Sbjct: 223 KGNARL---PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 50/232 (21%)
Query: 558 EFDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  + LGTGS+GRV    +K   + G   A+K+L  Q          +   LK+I H 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQ----------KVVKLKQIEHT 88
Query: 614 -NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD-- 670
            N  RI+ A + P    L   +  N +L      +   E+ +G    + L+R+   S+  
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 671 -------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
                  I     YLH    + +I+ DLKP N+L++      V+DFG AK V        
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-------- 191
Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                       LCG+  Y+APE       +   D ++ G+L+ +M     P
Sbjct: 192 ------KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPP 237

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 98/218 (44%), Gaps = 30/218 (13%)
Query: 565 LGTGSYGRVYKGILQDGTAIAV-KVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G++G+VYK   ++ + +A  KV+  +S    + +  E  +L    H N+++++ A  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
             +   +++ + A G++D+ +              LT  Q   +C    + + YLH +  
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERP--------LTESQIQVVCKQTLDALNYLHDN-- 154
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN-STANMLCGSIGY 742
            ++IH DLK  N+L   D    ++DFG++            A+N       +   G+  +
Sbjct: 155 -KIIHRDLKAGNILFTLDGDIKLADFGVS------------AKNTRXIQRRDXFIGTPYW 201
Query: 743 MAPEYGFGSNTST-----KGDVYSFGILVLEMVTRRRP 775
           MAPE      +       K DV+S GI ++EM     P
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 95/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVY-KGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 92
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN--------- 666
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+          
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFXEPHARF 146
Query: 667 ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
             + I     YLH    + +I+ DLKP N+L++      V+DFG AK V           
Sbjct: 147 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----------- 192
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 193 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 95/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVY-KGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 91
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN--------- 666
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+          
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFXEPHARF 145
Query: 667 ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
             + I     YLH    + +I+ DLKP N+L++      V+DFG AK V           
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----------- 191
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 105/224 (46%), Gaps = 29/224 (12%)
Query: 565 LGTGSYGRVYK----GILQDG--TAIAVKVLQLQSGNFTKSFN---RECQVLKRI-RHRN 614
           LG G +G+V      GI +D    A+ V V  L+     K  +    E +++K I +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY----PHSETEFGSG---SSDLTLLQRVNI 667
           ++ ++ AC+      +++ Y + G+L  +L     P  E  +         +T    V+ 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
              +A GM YL      + IH DL   NVL+ ++    ++DFG+A+ +  +       + 
Sbjct: 155 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI-------DY 204
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              +T   L   + +MAPE  F    + + DV+SFG+L+ E+ T
Sbjct: 205 YKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 121/284 (42%), Gaps = 39/284 (13%)
Query: 557 AEFDEQRLLGTGSYGRVYKG-ILQDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRH 612
           A F  ++ +G G +  VY+   L DG  +A+K +Q   L          +E  +LK++ H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 613 RNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIA 672
            N+++   +    +   +VL     G L S +  H + +             V +CS   
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDL-SRMIKHFKKQKRLIPERTVWKYFVQLCS--- 147
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
              A  H HS  RV+H D+KP+NV +       + D G+ +   +             + 
Sbjct: 148 ---ALEHMHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-----------KTTA 192
Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK- 791
           A+ L G+  YM+PE    +  + K D++S G L+ EM   + P    +   ++L+   K 
Sbjct: 193 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKK 249
Query: 792 -----------NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVA 824
                      +HY   L ++++   +    ++ P+V  ++DVA
Sbjct: 250 IEQCDYPPLPSDHYSEELRQLVNMC-INPDPEKRPDVTYVYDVA 292

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 95/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVY-KGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 91
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN--------- 666
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+          
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFXEPHARF 145
Query: 667 ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
             + I     YLH    + +I+ DLKP N+L++      V+DFG AK V           
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----------- 191
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 114/231 (49%), Gaps = 34/231 (14%)
Query: 563 RLLGTGSYGRVYK----GILQDGTAI--AVKVLQLQSGNFTK-SFNRECQVLKRI-RHRN 614
           ++LG+G++G+V      GI + G +I  AVK+L+ ++ +  + +   E +++ ++  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHL------YPHSETEFGSGS-----SDLTLLQ 663
           ++ ++ AC+L     L+  Y   G L ++L      +   E E+ +        DL +L 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 664 RVNI---CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGV 720
             ++      +A+GM +L   S    +H DL   NVL+       + DFG+A+ +M+   
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMS--- 224
Query: 721 GNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            +      GN+        + +MAPE  F    + K DV+S+GIL+ E+ +
Sbjct: 225 -DSNYVVRGNARL-----PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNL 615
           +F++   LG G+ G V+K   +  G  +A K++ L+          RE QVL       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +    A       ++ + +M  GSLD  L         +G     +L +V+I   + +G+
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLK-------KAGRIPEQILGKVSIA--VIKGL 117
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL      +++H D+KPSN+L+N      + DFG++  ++             +S AN 
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------------DSMANS 162
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
             G+  YM+PE   G++ S + D++S G+ ++EM   R P
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 28/221 (12%)
Query: 563 RLLGTGSYGRVYKGILQ------DGTAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG G++G VY+G +           +AVK L ++ S      F  E  ++ +  H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 616 MRIITAC--SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           +R I     SLP F  +++  MA G L S L         S  S L +L  +++  DIA 
Sbjct: 96  VRCIGVSLQSLPRF--ILMELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           G  YL  +     IH D+   N LL        A + DFG+A+ +        G      
Sbjct: 152 GCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG----- 203
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               ML   + +M PE       ++K D +SFG+L+ E+ +
Sbjct: 204 --CAML--PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNL 615
           +F++   LG G+ G V+K   +  G  +A K++ L+          RE QVL       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +    A       ++ + +M  GSLD  L         +G     +L +V+I   + +G+
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKK-------AGRIPEQILGKVSIA--VIKGL 117
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL      +++H D+KPSN+L+N      + DFG++  ++             +S AN 
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------------DSMANS 162
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
             G+  YM+PE   G++ S + D++S G+ ++EM   R P
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 559 FDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQSGNFTKSF-NRECQVLKRIRHRNLM 616
           F +   +G GS+G V+KGI  +    +A+K++ L+          +E  VL +     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           +   +        +++ Y+  GS    L      EF          Q   +  +I +G+ 
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEF----------QIATMLKEILKGLD 134
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YLH     + IH D+K +NVLL++     ++DFG+A  +    +             N  
Sbjct: 135 YLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR-----------NTF 180
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
            G+  +MAPE    S   +K D++S GI  +E+     P  DM
Sbjct: 181 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 223

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 135/307 (43%), Gaps = 53/307 (17%)
Query: 558 EFDEQRL-----LGTGSYGRVYK----GILQDGTAIAVKVLQLQSGNFTKSFNR----EC 604
           EF   RL     LG G++G+V +    GI +  T   V V  L+ G  T S +R    E 
Sbjct: 23  EFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGA-THSEHRALMSEL 81
Query: 605 QVLKRIRHR-NLMRIITACSLPDFKALVL-PYMANGSLDSHLYPHSE--TEFGSGSSD-L 659
           ++L  I H  N++ ++ AC+ P    +V+  +   G+L ++L         +     D L
Sbjct: 82  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFL 141
Query: 660 TLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVG 719
           TL   +     +A+GM +L   +  + IH DL   N+LL++     + DFG+A+ +    
Sbjct: 142 TLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYK-- 196
Query: 720 VGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
                 + +    A +    + +MAPE  F    + + DV+SFG+L+ E          +
Sbjct: 197 ----DPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWE----------I 239
Query: 780 FAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQES 839
           F+ G S +  VK      +++     L   +R ++P      D    E+ +  + C    
Sbjct: 240 FSLGASPYPGVK------IDEEFXRRLKEGTRMRAP------DYTTPEMYQTMLDCWHGE 287
Query: 840 PSTRPTM 846
           PS RPT 
Sbjct: 288 PSQRPTF 294

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNL 615
           +F++   LG G+ G V+K   +  G  +A K++ L+          RE QVL       +
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 128
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +    A       ++ + +M  GSLD  L         +G     +L +V+I   + +G+
Sbjct: 129 VGFYGAFYSDGEISICMEHMDGGSLDQVLK-------KAGRIPEQILGKVSIA--VIKGL 179
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL      +++H D+KPSN+L+N      + DFG++  ++             +S AN 
Sbjct: 180 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------------DSMANS 224
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
             G+  YM+PE   G++ S + D++S G+ ++EM   R P
Sbjct: 225 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNL 615
           +F++   LG G+ G V+K   +  G  +A K++ L+          RE QVL       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +    A       ++ + +M  GSLD  L         +G     +L +V+I   + +G+
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKK-------AGRIPEQILGKVSIA--VIKGL 117
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL      +++H D+KPSN+L+N      + DFG++  ++             +S AN 
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------------DSMANS 162
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
             G+  YM+PE   G++ S + D++S G+ ++EM   R P
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 109/231 (47%), Gaps = 26/231 (11%)
Query: 552 LLEATAEFDEQRLLGTGSYGRVYKG--ILQDGTAIAVKVLQLQSGN--FTKSFNRECQVL 607
           L  A  +++    +G G+YG+V+K   +   G  +A+K +++Q+G      S  RE  VL
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 608 KRIR---HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           + +    H N++R+   C++          +    +D  L  + +     G    T+   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI--- 122
Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
            ++   +  G+ +LH H   RV+H DLKP N+L+       ++DFG+A++          
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--------- 170
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           +  M  ++  +   ++ Y APE    S+ +T  D++S G +  EM  RR+P
Sbjct: 171 SFQMALTSVVV---TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 217

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNL 615
           +F++   LG G+ G V+K   +  G  +A K++ L+          RE QVL       +
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +    A       ++ + +M  GSLD  L         +G     +L +V+I   + +G+
Sbjct: 94  VGFYGAFYSDGEISICMEHMDGGSLDQVLKK-------AGRIPEQILGKVSIA--VIKGL 144
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL      +++H D+KPSN+L+N      + DFG++  ++             +S AN 
Sbjct: 145 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------------DSMANS 189
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
             G+  YM+PE   G++ S + D++S G+ ++EM   R P
Sbjct: 190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 28/221 (12%)
Query: 563 RLLGTGSYGRVYKGILQ------DGTAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
           R LG G++G VY+G +           +AVK L ++ S      F  E  ++ +  H+N+
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 110
Query: 616 MRIITAC--SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           +R I     SLP F  +++  MA G L S L         S  S L +L  +++  DIA 
Sbjct: 111 VRCIGVSLQSLPRF--ILMELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHVARDIAC 166
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           G  YL  +     IH D+   N LL        A + DFG+A+ +        G      
Sbjct: 167 GCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG----- 218
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               ML   + +M PE       ++K D +SFG+L+ E+ +
Sbjct: 219 --CAML--PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/300 (24%), Positives = 122/300 (40%), Gaps = 52/300 (17%)
Query: 549 YRELLEATAEFDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQSGNFTKSF-NRECQV 606
           Y + ++    F +   +G GS+G V+KGI  +    +A+K++ L+          +E  V
Sbjct: 19  YFQSMDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV 78
Query: 607 LKRIRHRNLMRIITACSLPDFK-ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRV 665
           L +     + +      L D K  +++ Y+  GS    L P        G  D T  Q  
Sbjct: 79  LSQCDSPYVTKYY-GSYLKDTKLWIIMEYLGGGSALDLLEP--------GPLDET--QIA 127
Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGA 725
            I  +I +G+ YLH     + IH D+K +NVLL++     ++DFG+A  +    +     
Sbjct: 128 TILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--- 181
Query: 726 ENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLS 785
                   N   G+  +MAPE    S   +K D++S GI  +E+     P          
Sbjct: 182 --------NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP---------- 223
Query: 786 LHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
                    H  L  +    L    ++  P ++  +   + E +E    C  + PS RPT
Sbjct: 224 ---------HSELHPM--KVLFLIPKNNPPTLEGNYSKPLKEFVE---ACLNKEPSFRPT 269

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNL 615
           +F++   LG G+ G V+K   +  G  +A K++ L+          RE QVL       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +    A       ++ + +M  GSLD  L         +G     +L +V+I   + +G+
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKK-------AGRIPEQILGKVSIA--VIKGL 117
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL      +++H D+KPSN+L+N      + DFG++  ++             +S AN 
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------------DSMANS 162
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
             G+  YM+PE   G++ S + D++S G+ ++EM   R P
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNL 615
           +F++   LG G+ G V+K   +  G  +A K++ L+          RE QVL       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +    A       ++ + +M  GSLD  L         +G     +L +V+I   + +G+
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKK-------AGRIPEQILGKVSIA--VIKGL 117
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL      +++H D+KPSN+L+N      + DFG++  ++             +S AN 
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------------DSMANS 162
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
             G+  YM+PE   G++ S + D++S G+ ++EM   R P
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 98/218 (44%), Gaps = 30/218 (13%)
Query: 565 LGTGSYGRVYKGILQDGTAIAV-KVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G++G+VYK   ++ + +A  KV+  +S    + +  E  +L    H N+++++ A  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
             +   +++ + A G++D+ +              LT  Q   +C    + + YLH +  
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERP--------LTESQIQVVCKQTLDALNYLHDN-- 154
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN-STANMLCGSIGY 742
            ++IH DLK  N+L   D    ++DFG++            A+N       +   G+  +
Sbjct: 155 -KIIHRDLKAGNILFTLDGDIKLADFGVS------------AKNTRXIQRRDSFIGTPYW 201
Query: 743 MAPEYGFGSNTST-----KGDVYSFGILVLEMVTRRRP 775
           MAPE      +       K DV+S GI ++EM     P
Sbjct: 202 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNR---ECQVLKRIRHRNLMRI 618
           R+LG G +G V+   ++  G   A K L  +     K +     E ++L ++  R ++ +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 619 ITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
             A        LV+  M  G +  H+Y   E   G         + +   + I  G+ +L
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP-----RAIFYTAQIVSGLEHL 305
Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCG 738
           H  +   +I+ DLKP NVLL+DD    +SD G+A  +             G +      G
Sbjct: 306 HQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL-----------KAGQTKTKGYAG 351
Query: 739 SIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           + G+MAPE   G       D ++ G+ + EM+  R P
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 109/231 (47%), Gaps = 26/231 (11%)
Query: 552 LLEATAEFDEQRLLGTGSYGRVYKG--ILQDGTAIAVKVLQLQSGN--FTKSFNRECQVL 607
           L  A  +++    +G G+YG+V+K   +   G  +A+K +++Q+G      S  RE  VL
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 608 KRIR---HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           + +    H N++R+   C++          +    +D  L  + +     G    T+   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI--- 122
Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
            ++   +  G+ +LH H   RV+H DLKP N+L+       ++DFG+A++          
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--------- 170
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           +  M  ++  +   ++ Y APE    S+ +T  D++S G +  EM  RR+P
Sbjct: 171 SFQMALTSVVV---TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 217

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 98/230 (42%), Gaps = 40/230 (17%)
Query: 558 EFDEQRLLGTGSYGRVYK-GILQDGTAIAVKVLQLQSGNFTKSF---NRECQVLKRIRHR 613
           +F   R LGTGS+GRV+      +G   A+KVL+ +     K     N E  +L  + H 
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 614 NLMRIITACSLPDFKALVLPYMANGSL-----DSHLYPHSETEFGSGSSDLTLLQRVNIC 668
            ++R+           +++ Y+  G L      S  +P+   +F                
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF--------------YA 112
Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
           +++   + YLH      +I+ DLKP N+LL+ +    ++DFG AK V  V          
Sbjct: 113 AEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---------- 159
Query: 729 GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
                  LCG+  Y+APE       +   D +SFGIL+ EM+    P  D
Sbjct: 160 ----TYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 205

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 94/225 (41%), Gaps = 44/225 (19%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  R LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 43  QFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 92
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI  A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 93  KRIQQAVNFPFLVKLEFSFKDNSNL------YMVLEYAPGGEMFSHLRRIGRFSEPHARF 146
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N+L++      V+DFG AK V           
Sbjct: 147 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----------- 192
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                    LCG+  Y+APE       +   D ++ G+L+ EM  
Sbjct: 193 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNR---ECQVLKRIRHRNLMRI 618
           R+LG G +G V+   ++  G   A K L  +     K +     E ++L ++  R ++ +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 619 ITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
             A        LV+  M  G +  H+Y   E   G         + +   + I  G+ +L
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP-----RAIFYTAQIVSGLEHL 305
Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCG 738
           H  +   +I+ DLKP NVLL+DD    +SD G+A  +             G +      G
Sbjct: 306 HQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL-----------KAGQTKTKGYAG 351
Query: 739 SIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           + G+MAPE   G       D ++ G+ + EM+  R P
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 135/311 (43%), Gaps = 57/311 (18%)
Query: 558 EFDEQRL-----LGTGSYGRVYK----GILQDGTAIAVKVLQLQSGNFTKSFNR----EC 604
           EF   RL     LG G++G+V +    GI +  T   V V  L+ G  T S +R    E 
Sbjct: 23  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSEL 81
Query: 605 QVLKRIRHR-NLMRIITACSLPDFKALVL-PYMANGSLDSHL-------YPHSETEFGSG 655
           ++L  I H  N++ ++ AC+ P    +V+  +   G+L ++L        P+        
Sbjct: 82  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 656 SSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
              LTL   +     +A+GM +L   +  + IH DL   N+LL++     + DFG+A+ +
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                     + +    A +    + +MAPE  F    + + DV+SFG+L+ E       
Sbjct: 199 YK------DPDXVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWE------- 242
Query: 776 TDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILC 835
              +F+ G S +  VK      +++     L   +R ++P      D    E+ +  + C
Sbjct: 243 ---IFSLGASPYPGVK------IDEEFCRRLKEGTRMRAP------DYTTPEMYQTMLDC 287
Query: 836 TQESPSTRPTM 846
               PS RPT 
Sbjct: 288 WHGEPSQRPTF 298

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNL 615
           +F++   LG G+ G V+K   +  G  +A K++ L+          RE QVL       +
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 85
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +    A       ++ + +M  GSLD  L         +G     +L +V+I   + +G+
Sbjct: 86  VGFYGAFYSDGEISICMEHMDGGSLDQVLKK-------AGRIPEQILGKVSIA--VIKGL 136
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL      +++H D+KPSN+L+N      + DFG++  ++             +S AN 
Sbjct: 137 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------------DSMANS 181
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
             G+  YM+PE   G++ S + D++S G+ ++EM   R P
Sbjct: 182 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/212 (24%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           +G G+ G VY  + +  G  +A++ + LQ     +    E  V++  ++ N++  + +  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
           + D   +V+ Y+A GSL   +   +ET    G       Q   +C +  + + +LH +  
Sbjct: 89  VGDELWVVMEYLAGGSLTDVV---TETCMDEG-------QIAAVCRECLQALEFLHSN-- 136
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
            +VIH ++K  N+LL  D +  ++DFG    +               S  + + G+  +M
Sbjct: 137 -QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITP-----------EQSKRSTMVGTPYWM 184
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           APE         K D++S GI+ +EM+    P
Sbjct: 185 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNR---ECQVLKRIRHRNLMRI 618
           R+LG G +G V+   ++  G   A K L  +     K +     E ++L ++  R ++ +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 619 ITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
             A        LV+  M  G +  H+Y   E   G         + +   + I  G+ +L
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP-----RAIFYTAQIVSGLEHL 305
Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCG 738
           H  +   +I+ DLKP NVLL+DD    +SD G+A  +             G +      G
Sbjct: 306 HQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL-----------KAGQTKTKGYAG 351
Query: 739 SIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           + G+MAPE   G       D ++ G+ + EM+  R P
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 135/311 (43%), Gaps = 57/311 (18%)
Query: 558 EFDEQRL-----LGTGSYGRVYK----GILQDGTAIAVKVLQLQSGNFTKSFNR----EC 604
           EF   RL     LG G++G+V +    GI +  T   V V  L+ G  T S +R    E 
Sbjct: 14  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSEL 72
Query: 605 QVLKRIRHR-NLMRIITACSLPDFKALVL-PYMANGSLDSHL-------YPHSETEFGSG 655
           ++L  I H  N++ ++ AC+ P    +V+  +   G+L ++L        P+        
Sbjct: 73  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 656 SSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
              LTL   +     +A+GM +L   +  + IH DL   N+LL++     + DFG+A+ +
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 189
Query: 716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                     + +    A +    + +MAPE  F    + + DV+SFG+L+ E       
Sbjct: 190 XK------DPDXVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWE------- 233
Query: 776 TDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILC 835
              +F+ G S +  VK      +++     L   +R ++P      D    E+ +  + C
Sbjct: 234 ---IFSLGASPYPGVK------IDEEFCRRLKEGTRMRAP------DYTTPEMYQTMLDC 278
Query: 836 TQESPSTRPTM 846
               PS RPT 
Sbjct: 279 WHGEPSQRPTF 289

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 135/311 (43%), Gaps = 57/311 (18%)
Query: 558 EFDEQRL-----LGTGSYGRVYK----GILQDGTAIAVKVLQLQSGNFTKSFNR----EC 604
           EF   RL     LG G++G+V +    GI +  T   V V  L+ G  T S +R    E 
Sbjct: 23  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSEL 81
Query: 605 QVLKRIRHR-NLMRIITACSLPDFKALVL-PYMANGSLDSHL-------YPHSETEFGSG 655
           ++L  I H  N++ ++ AC+ P    +V+  +   G+L ++L        P+        
Sbjct: 82  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 656 SSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
              LTL   +     +A+GM +L   +  + IH DL   N+LL++     + DFG+A+ +
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                     + +    A +    + +MAPE  F    + + DV+SFG+L+ E       
Sbjct: 199 XK------DPDXVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWE------- 242
Query: 776 TDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILC 835
              +F+ G S +  VK      +++     L   +R ++P      D    E+ +  + C
Sbjct: 243 ---IFSLGASPYPGVK------IDEEFCRRLKEGTRMRAP------DYTTPEMYQTMLDC 287
Query: 836 TQESPSTRPTM 846
               PS RPT 
Sbjct: 288 WHGEPSQRPTF 298

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 109/231 (47%), Gaps = 26/231 (11%)
Query: 552 LLEATAEFDEQRLLGTGSYGRVYKG--ILQDGTAIAVKVLQLQSGN--FTKSFNRECQVL 607
           L  A  +++    +G G+YG+V+K   +   G  +A+K +++Q+G      S  RE  VL
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 608 KRIR---HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           + +    H N++R+   C++          +    +D  L  + +     G    T+   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI--- 122
Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
            ++   +  G+ +LH H   RV+H DLKP N+L+       ++DFG+A++          
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--------- 170
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           +  M  ++  +   ++ Y APE    S+ +T  D++S G +  EM  RR+P
Sbjct: 171 SFQMALTSVVV---TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 217

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 103/230 (44%), Gaps = 42/230 (18%)
Query: 554 EATAEFDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRI 610
           E  A + + + +G+G+YG V   +  + G  +A+K L    QS  F K   RE ++LK +
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 81
Query: 611 RHRNLMRIITACS----LPDFK--ALVLPYMAN--GSLDSHLYPHSETEFGSGSSDLTLL 662
           RH N++ ++   +    L DF    LV+P+M    G L  H       + G       + 
Sbjct: 82  RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH------EKLGEDRIQFLVY 135
Query: 663 QRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGN 722
           Q       + +G+ Y+H      +IH DLKP N+ +N+D    + DFG+A+         
Sbjct: 136 Q-------MLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR--------- 176
Query: 723 DGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVT 771
                  +S       +  Y APE        T+  D++S G ++ EM+T
Sbjct: 177 -----QADSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 221

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVY-KGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + +GTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 91
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHARF 145
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N+L++      V+DFG AK V           
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----------- 191
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 28/222 (12%)
Query: 559 FDEQRLLGTGSYGRVYK-GILQDGTAIAVKVLQLQSGNFTK----SFNRECQVLKRIRHR 613
           F + R+LG G +G V    +   G   A K L+ +     K    + N E Q+L+++  R
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-EKQILEKVNSR 244
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
            ++ +  A    D   LVL  M  G L  H+Y   +  F    +       V   ++I  
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA-------VFYAAEICC 297
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           G+  LH     R+++ DLKP N+LL+D     +SD G+A  V                T 
Sbjct: 298 GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE------------GQTI 342
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
               G++GYMAPE       +   D ++ G L+ EM+  + P
Sbjct: 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 136/311 (43%), Gaps = 58/311 (18%)
Query: 558 EFDEQRL-----LGTGSYGRVYK----GILQDGTAIAVKVLQLQSGNFTKSFNR----EC 604
           EF   RL     LG G++G+V +    GI +  T   V V  L+ G  T S +R    E 
Sbjct: 24  EFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSEL 82
Query: 605 QVLKRIRHR-NLMRIITACSLPDFKALVL-PYMANGSLDSHLYPHSETEFGSGSSD---- 658
           ++L  I H  N++ ++ AC+ P    +V+  +   G+L ++L      EF    +     
Sbjct: 83  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-SKRNEFVPYKTPEDLY 141
Query: 659 ---LTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
              LTL   +     +A+GM +L   +  + IH DL   N+LL++     + DFG+A+ +
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                     + +    A +    + +MAPE  F    + + DV+SFG+L+ E       
Sbjct: 199 XK------DPDXVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWE------- 242
Query: 776 TDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILC 835
              +F+ G S +  VK      +++     L   +R ++P      D    E+ +  + C
Sbjct: 243 ---IFSLGASPYPGVK------IDEEFCRRLKEGTRMRAP------DYTTPEMYQTMLDC 287
Query: 836 TQESPSTRPTM 846
               PS RPT 
Sbjct: 288 WHGEPSQRPTF 298

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 27/220 (12%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAI----AVKVLQLQSGNFT-KSFNRECQVLKRIR 611
           E  + ++LG+G +G V+KG+ + +G +I     +KV++ +SG  + ++       +  + 
Sbjct: 32  ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 91
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           H +++R++  C     + LV  Y+  GSL  H+  H     G+    L L    N    I
Sbjct: 92  HAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHR----GALGPQLLL----NWGVQI 142
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL  H    ++H +L   NVLL       V+DFG+A L+       D  + + + 
Sbjct: 143 AKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP-----DDKQLLYSE 194
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                   I +MA E       + + DV+S+G+ V E++T
Sbjct: 195 AKT----PIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 135/311 (43%), Gaps = 57/311 (18%)
Query: 558 EFDEQRL-----LGTGSYGRVYK----GILQDGTAIAVKVLQLQSGNFTKSFNR----EC 604
           EF   RL     LG G++G+V +    GI +  T   V V  L+ G  T S +R    E 
Sbjct: 14  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSEL 72
Query: 605 QVLKRIRHR-NLMRIITACSLPDFKALVL-PYMANGSLDSHL-------YPHSETEFGSG 655
           ++L  I H  N++ ++ AC+ P    +V+  +   G+L ++L        P+        
Sbjct: 73  KILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 656 SSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
              LTL   +     +A+GM +L   +  + IH DL   N+LL++     + DFG+A+ +
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 189
Query: 716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                     + +    A +    + +MAPE  F    + + DV+SFG+L+ E       
Sbjct: 190 XK------DPDXVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWE------- 233
Query: 776 TDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILC 835
              +F+ G S +  VK      +++     L   +R ++P      D    E+ +  + C
Sbjct: 234 ---IFSLGASPYPGVK------IDEEFCRRLKEGTRMRAP------DYTTPEMYQTMLDC 278
Query: 836 TQESPSTRPTM 846
               PS RPT 
Sbjct: 279 WHGEPSQRPTF 289

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVY-KGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + +GTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 91
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYMPGGDMFSHLRRIGRFSEPHARF 145
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N+L++      V+DFG AK V           
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----------- 191
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 27/220 (12%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAI----AVKVLQLQSGNFT-KSFNRECQVLKRIR 611
           E  + ++LG+G +G V+KG+ + +G +I     +KV++ +SG  + ++       +  + 
Sbjct: 14  ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           H +++R++  C     + LV  Y+  GSL  H+  H     G+    L L    N    I
Sbjct: 74  HAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHR----GALGPQLLL----NWGVQI 124
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL  H    ++H +L   NVLL       V+DFG+A L+       D  + + + 
Sbjct: 125 AKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP-----DDKQLLYSE 176
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                   I +MA E       + + DV+S+G+ V E++T
Sbjct: 177 AKT----PIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 135/311 (43%), Gaps = 57/311 (18%)
Query: 558 EFDEQRL-----LGTGSYGRVYK----GILQDGTAIAVKVLQLQSGNFTKSFNR----EC 604
           EF   RL     LG G++G+V +    GI +  T   V V  L+ G  T S +R    E 
Sbjct: 23  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSEL 81
Query: 605 QVLKRIRHR-NLMRIITACSLPDFKALVL-PYMANGSLDSHL-------YPHSETEFGSG 655
           ++L  I H  N++ ++ AC+ P    +V+  +   G+L ++L        P+        
Sbjct: 82  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 656 SSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
              LTL   +     +A+GM +L   +  + IH DL   N+LL++     + DFG+A+ +
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                     + +    A +    + +MAPE  F    + + DV+SFG+L+ E       
Sbjct: 199 YK------DPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWE------- 242
Query: 776 TDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILC 835
              +F+ G S +  VK      +++     L   +R ++P      D    E+ +  + C
Sbjct: 243 ---IFSLGASPYPGVK------IDEEFCRRLKEGTRMRAP------DYTTPEMYQTMLDC 287
Query: 836 TQESPSTRPTM 846
               PS RPT 
Sbjct: 288 WHGEPSQRPTF 298

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNR---ECQVLKRIRHRNLMRI 618
           R+LG G +G V+   ++  G   A K L  +     K +     E ++L ++  R ++ +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 619 ITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
             A        LV+  M  G +  H+Y   E   G         + +   + I  G+ +L
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP-----RAIFYTAQIVSGLEHL 305
Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCG 738
           H  +   +I+ DLKP NVLL+DD    +SD G+A  +             G +      G
Sbjct: 306 HQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL-----------KAGQTKTKGYAG 351
Query: 739 SIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           + G+MAPE   G       D ++ G+ + EM+  R P
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 26/224 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNL 615
           +F++   LG G+ G V+K   +  G  +A K++ L+          RE QVL       +
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 69
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +    A       ++ + +M  GSLD  L         +G     +L +V+I   + +G+
Sbjct: 70  VGFYGAFYSDGEISICMEHMDGGSLDQVLKK-------AGRIPEQILGKVSIA--VIKGL 120
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL      +++H D+KPSN+L+N      + DFG++  ++             +  AN 
Sbjct: 121 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------------DEMANE 165
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
             G+  YM+PE   G++ S + D++S G+ ++EM   R P   M
Sbjct: 166 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPM 209

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVY-KGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + +GTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 91
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYMPGGDMFSHLRRIGRFSEPHARF 145
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N+L++      V+DFG AK V           
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV----------- 191
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 92
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYAPGGEMFSHLRRIGRFSEPHARF 146
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N++++      V+DFG AK V           
Sbjct: 147 YAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV----------- 192
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 193 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 28/224 (12%)
Query: 559 FDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQSGNFTKSF-NRECQVLKRIRHRNLM 616
           F +   +G GS+G V+KGI  +    +A+K++ L+          +E  VL +     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 617 RIITACSLPDFK-ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +      L D K  +++ Y+  GS    L P        G  D T  Q   I  +I +G+
Sbjct: 69  KYY-GSYLKDTKLWIIMEYLGGGSALDLLEP--------GPLDET--QIATILREILKGL 117
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH     + IH D+K +NVLL++     ++DFG+A  +    +             N 
Sbjct: 118 DYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-----------NX 163
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
             G+  +MAPE    S   +K D++S GI  +E+     P  ++
Sbjct: 164 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 28/224 (12%)
Query: 559 FDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQSGNFTKSF-NRECQVLKRIRHRNLM 616
           F +   +G GS+G V+KGI  +    +A+K++ L+          +E  VL +     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 617 RIITACSLPDFK-ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +      L D K  +++ Y+  GS    L P        G  D T  Q   I  +I +G+
Sbjct: 69  KYY-GSYLKDTKLWIIMEYLGGGSALDLLEP--------GPLDET--QIATILREILKGL 117
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH     + IH D+K +NVLL++     ++DFG+A  +    +             N 
Sbjct: 118 DYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-----------NT 163
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
             G+  +MAPE    S   +K D++S GI  +E+     P  ++
Sbjct: 164 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 40/229 (17%)
Query: 562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI--RHRNLMRII 619
           Q  +G G +G V++G  + G  +AVK+    S    +S+ RE ++ + +  RH N++  I
Sbjct: 47  QESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFI 102
Query: 620 TACSLPDFKA----LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
            A +  +       LV  Y  +GSL  +L  ++ T  G           + +    A G+
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM----------IKLALSTASGL 152
Query: 676 AYLH------HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           A+LH         P  + H DLK  N+L+  + T  ++D G+A       V +D A +  
Sbjct: 153 AHLHMEIVGTQGKPA-IAHRDLKSKNILVKKNGTCCIADLGLA-------VRHDSATDTI 204
Query: 730 NSTANMLCGSIGYMAPEYGFGS------NTSTKGDVYSFGILVLEMVTR 772
           +   N   G+  YMAPE    S       +  + D+Y+ G++  E+  R
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 135/311 (43%), Gaps = 57/311 (18%)
Query: 558 EFDEQRL-----LGTGSYGRVYK----GILQDGTAIAVKVLQLQSGNFTKSFNR----EC 604
           EF   RL     LG G++G+V +    GI +  T   V V  L+ G  T S +R    E 
Sbjct: 14  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSEL 72
Query: 605 QVLKRIRHR-NLMRIITACSLPDFKALVL-PYMANGSLDSHL-------YPHSETEFGSG 655
           ++L  I H  N++ ++ AC+ P    +V+  +   G+L ++L        P+        
Sbjct: 73  KILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 656 SSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
              LTL   +     +A+GM +L   +  + IH DL   N+LL++     + DFG+A+ +
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 189
Query: 716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                     + +    A +    + +MAPE  F    + + DV+SFG+L+ E       
Sbjct: 190 YK------DPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWE------- 233
Query: 776 TDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILC 835
              +F+ G S +  VK      +++     L   +R ++P      D    E+ +  + C
Sbjct: 234 ---IFSLGASPYPGVK------IDEEFCRRLKEGTRMRAP------DYTTPEMYQTMLDC 278
Query: 836 TQESPSTRPTM 846
               PS RPT 
Sbjct: 279 WHGEPSQRPTF 289

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 135/311 (43%), Gaps = 57/311 (18%)
Query: 558 EFDEQRL-----LGTGSYGRVYK----GILQDGTAIAVKVLQLQSGNFTKSFNR----EC 604
           EF   RL     LG G++G+V +    GI +  T   V V  L+ G  T S +R    E 
Sbjct: 60  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSEL 118
Query: 605 QVLKRIRHR-NLMRIITACSLPDFKALVL-PYMANGSLDSHL-------YPHSETEFGSG 655
           ++L  I H  N++ ++ AC+ P    +V+  +   G+L ++L        P+        
Sbjct: 119 KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 178
Query: 656 SSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
              LTL   +     +A+GM +L   +  + IH DL   N+LL++     + DFG+A+ +
Sbjct: 179 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 235
Query: 716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                     + +    A +    + +MAPE  F    + + DV+SFG+L+ E       
Sbjct: 236 YK------DPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWE------- 279
Query: 776 TDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILC 835
              +F+ G S +  VK      +++     L   +R ++P      D    E+ +  + C
Sbjct: 280 ---IFSLGASPYPGVK------IDEEFCRRLKEGTRMRAP------DYTTPEMYQTMLDC 324
Query: 836 TQESPSTRPTM 846
               PS RPT 
Sbjct: 325 WHGEPSQRPTF 335

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 28/224 (12%)
Query: 559 FDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQSGNFTKSF-NRECQVLKRIRHRNLM 616
           F +   +G GS+G V+KGI  +    +A+K++ L+          +E  VL +     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 617 RIITACSLPDFK-ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +      L D K  +++ Y+  GS    L P        G  D T  Q   I  +I +G+
Sbjct: 84  KYY-GSYLKDTKLWIIMEYLGGGSALDLLEP--------GPLDET--QIATILREILKGL 132
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH     + IH D+K +NVLL++     ++DFG+A  +    +             N 
Sbjct: 133 DYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-----------NX 178
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
             G+  +MAPE    S   +K D++S GI  +E+     P  ++
Sbjct: 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 28/222 (12%)
Query: 559 FDEQRLLGTGSYGRVYK-GILQDGTAIAVKVLQLQSGNFTK----SFNRECQVLKRIRHR 613
           F + R+LG G +G V    +   G   A K L+ +     K    + N E Q+L+++  R
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-EKQILEKVNSR 244
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
            ++ +  A    D   LVL  M  G L  H+Y   +  F    +       V   ++I  
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA-------VFYAAEICC 297
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           G+  LH     R+++ DLKP N+LL+D     +SD G+A  V                T 
Sbjct: 298 GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE------------GQTI 342
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
               G++GYMAPE       +   D ++ G L+ EM+  + P
Sbjct: 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 97/232 (41%), Gaps = 50/232 (21%)
Query: 558 EFDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  + LGTGS+GRV    +K   + G   A+K+L  Q          +   LK+I H 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQ----------KVVKLKQIEHT 88
Query: 614 -NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD-- 670
            N  RI+ A + P    L   +  N +L      +   E+ +G    + L+R+   S+  
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 671 -------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
                  I     YLH    + +I+ DLKP N+L++      V+DFG AK V        
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-------- 191
Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                       LCG+  Y+AP        +   D ++ G+L+ EM     P
Sbjct: 192 ------KGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 31/226 (13%)
Query: 557 AEFDEQRLLGTGSYGRVY---KGILQD-GTAIAVKVLQ---LQSGNFTKSFNRECQVLKR 609
           + F+  ++LG GS+G+V+   K    D G   A+KVL+   L+  +  ++   E  +L  
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT-KMERDILAD 86
Query: 610 IRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS 669
           + H  ++++  A        L+L ++  G L + L    E  F        L       +
Sbjct: 87  VNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL--SKEVMFTEEDVKFYL-------A 137
Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           ++A G+ +LH    + +I+ DLKP N+LL+++    ++DFG++K  +             
Sbjct: 138 ELALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAID-----------H 183
Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              A   CG++ YMAPE       S   D +S+G+L+ EM+T   P
Sbjct: 184 EKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 40/229 (17%)
Query: 562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI--RHRNLMRII 619
           Q  +G G +G V++G  + G  +AVK+    S    +S+ RE ++ + +  RH N++  I
Sbjct: 9   QESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFI 64
Query: 620 TACSLPDFKA----LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
            A +  +       LV  Y  +GSL  +L  ++ T  G           + +    A G+
Sbjct: 65  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM----------IKLALSTASGL 114
Query: 676 AYLH------HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           A+LH         P  + H DLK  N+L+  + T  ++D G+A       V +D A +  
Sbjct: 115 AHLHMEIVGTQGKPA-IAHRDLKSKNILVKKNGTCCIADLGLA-------VRHDSATDTI 166
Query: 730 NSTANMLCGSIGYMAPEYGFGS------NTSTKGDVYSFGILVLEMVTR 772
           +   N   G+  YMAPE    S       +  + D+Y+ G++  E+  R
Sbjct: 167 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 215

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 135/311 (43%), Gaps = 57/311 (18%)
Query: 558 EFDEQRL-----LGTGSYGRVYK----GILQDGTAIAVKVLQLQSGNFTKSFNR----EC 604
           EF   RL     LG G++G+V +    GI +  T   V V  L+ G  T S +R    E 
Sbjct: 14  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSEL 72
Query: 605 QVLKRIRHR-NLMRIITACSLPDFKALVL-PYMANGSLDSHL-------YPHSETEFGSG 655
           ++L  I H  N++ ++ AC+ P    +V+  +   G+L ++L        P+        
Sbjct: 73  KILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 656 SSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
              LTL   +     +A+GM +L   +  + IH DL   N+LL++     + DFG+A+ +
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 189
Query: 716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                     + +    A +    + +MAPE  F    + + DV+SFG+L+ E       
Sbjct: 190 YK------DPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWE------- 233
Query: 776 TDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILC 835
              +F+ G S +  VK      +++     L   +R ++P      D    E+ +  + C
Sbjct: 234 ---IFSLGASPYPGVK------IDEEFCRRLKEGTRMRAP------DYTTPEMYQTMLDC 278
Query: 836 TQESPSTRPTM 846
               PS RPT 
Sbjct: 279 WHGEPSQRPTF 289

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 23/219 (10%)
Query: 564 LLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           L+G G +G+VY G      AI +  ++  + +  K+F RE    ++ RH N++  + AC 
Sbjct: 40  LIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN----ICSDIAEGMAYLH 679
            P   A++       +L S +             D  ++  VN    I  +I +GM YLH
Sbjct: 100 SPPHLAIITSLCKGRTLYSVV------------RDAKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 680 HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL--VMTVGVGNDGAENMGNSTANMLC 737
                 ++H DLK  NV   D+   +++DFG+  +  V+  G   D          ++  
Sbjct: 148 AKG---ILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 738 GSIGYMAPEYGFGSNTSTK-GDVYSFGILVLEMVTRRRP 775
             I  ++P+        +K  DV++ G +  E+  R  P
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 40/229 (17%)
Query: 562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI--RHRNLMRII 619
           Q  +G G +G V++G  + G  +AVK+    S    +S+ RE ++ + +  RH N++  I
Sbjct: 8   QESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFI 63
Query: 620 TACSLPDFKA----LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
            A +  +       LV  Y  +GSL  +L  ++ T  G           + +    A G+
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM----------IKLALSTASGL 113
Query: 676 AYLH------HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           A+LH         P  + H DLK  N+L+  + T  ++D G+A       V +D A +  
Sbjct: 114 AHLHMEIVGTQGKPA-IAHRDLKSKNILVKKNGTCCIADLGLA-------VRHDSATDTI 165
Query: 730 NSTANMLCGSIGYMAPEYGFGS------NTSTKGDVYSFGILVLEMVTR 772
           +   N   G+  YMAPE    S       +  + D+Y+ G++  E+  R
Sbjct: 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 214

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 40/229 (17%)
Query: 562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI--RHRNLMRII 619
           Q  +G G +G V++G  + G  +AVK+    S    +S+ RE ++ + +  RH N++  I
Sbjct: 11  QESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFI 66
Query: 620 TACSLPDFKA----LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
            A +  +       LV  Y  +GSL  +L  ++ T  G           + +    A G+
Sbjct: 67  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM----------IKLALSTASGL 116
Query: 676 AYLH------HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           A+LH         P  + H DLK  N+L+  + T  ++D G+A       V +D A +  
Sbjct: 117 AHLHMEIVGTQGKPA-IAHRDLKSKNILVKKNGTCCIADLGLA-------VRHDSATDTI 168
Query: 730 NSTANMLCGSIGYMAPEYGFGS------NTSTKGDVYSFGILVLEMVTR 772
           +   N   G+  YMAPE    S       +  + D+Y+ G++  E+  R
Sbjct: 169 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 217

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 35  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 84
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 85  KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHARF 138
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N+L++      V+DFG AK V           
Sbjct: 139 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----------- 184
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 185 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 40/229 (17%)
Query: 562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI--RHRNLMRII 619
           Q  +G G +G V++G  + G  +AVK+    S    +S+ RE ++ + +  RH N++  I
Sbjct: 34  QESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFI 89
Query: 620 TACSLPDFKA----LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
            A +  +       LV  Y  +GSL  +L  ++ T  G           + +    A G+
Sbjct: 90  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM----------IKLALSTASGL 139
Query: 676 AYLH------HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           A+LH         P  + H DLK  N+L+  + T  ++D G+A       V +D A +  
Sbjct: 140 AHLHMEIVGTQGKPA-IAHRDLKSKNILVKKNGTCCIADLGLA-------VRHDSATDTI 191
Query: 730 NSTANMLCGSIGYMAPEYGFGS------NTSTKGDVYSFGILVLEMVTR 772
           +   N   G+  YMAPE    S       +  + D+Y+ G++  E+  R
Sbjct: 192 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 240

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 26/219 (11%)
Query: 564 LLGTGSYGRVYKGI-LQDGTAIAVKVLQL---QSGNFTKSFNRECQVLKRIRHRNLMRII 619
           +LG G    V+    L+D   +AVKVL+    +  +F   F RE Q    + H  ++ + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 620 TACSLPDFKALVLPYMANGSLDS---HLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
                 +  A  LPY+    +D        H+E         +T  + + + +D  + + 
Sbjct: 79  DTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIADACQALN 130
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           + H +    +IH D+KP+N+L++      V DFGIA+ +   G       N    TA ++
Sbjct: 131 FSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSG-------NSVXQTAAVI 180
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            G+  Y++PE   G +   + DVYS G ++ E++T   P
Sbjct: 181 -GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 92
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHARF 146
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N+L++      V+DFG AK V           
Sbjct: 147 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----------- 192
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 193 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 92
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHARF 146
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N+L++      V+DFG AK V           
Sbjct: 147 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----------- 192
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 193 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 63  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 112
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHARF 166
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N+L++      V+DFG AK V           
Sbjct: 167 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----------- 212
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 213 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 92
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHARF 146
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N+L++      V+DFG AK V           
Sbjct: 147 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----------- 192
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 193 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 15/222 (6%)
Query: 556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQ-LQSGNFTKSFNRECQVLKRIRHR 613
           +++F  + LLG G+YG V     +  G  +A+K ++      F     RE ++LK  +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           N++ I        F+     Y+    + + L+    T+  S       + +      +  
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           G           VIH DLKPSN+L+N +    V DFG+A+++       D +E  G  + 
Sbjct: 130 GS---------NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA--DNSEPTGQQSG 178
Query: 734 NM-LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
            +    +  Y APE    S   ++  DV+S G ++ E+  RR
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQ----------KVVKLKQIEHTLNE 91
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 92  KRILQAVNFPFLVKLEYSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHARF 145
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N+L++      V+DFG AK V           
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----------- 191
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 105/229 (45%), Gaps = 43/229 (18%)
Query: 568 GSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQV--LKRIRHRNLMRIITA---- 621
           G +G V+K  L +   +AVK+  +Q     +S+  E +V  L  ++H N+++ I A    
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRG 90
Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH- 680
            S+     L+  +   GSL   L           ++ ++  +  +I   +A G+AYLH  
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFL----------KANVVSWNELCHIAETMARGLAYLHED 140
Query: 681 -------HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
                  H P  + H D+K  NVLL +++TA ++DFG+A   +    G    +  G    
Sbjct: 141 IPGLKDGHKPA-ISHRDIKSKNVLLKNNLTACIADFGLA---LKFEAGKSAGDTHGQ--- 193
Query: 734 NMLCGSIGYMAPEY-----GFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
               G+  YMAPE       F  +   + D+Y+ G+++ E+ +R    D
Sbjct: 194 ---VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 135/307 (43%), Gaps = 53/307 (17%)
Query: 558 EFDEQRL-----LGTGSYGRVYK----GILQDGTAIAVKVLQLQSGNFTKSFNR----EC 604
           EF   RL     LG G++G+V +    GI +  T   V V  L+ G  T S +R    E 
Sbjct: 23  EFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGA-THSEHRALMSEL 81
Query: 605 QVLKRIRHR-NLMRIITACSLPDFKALVL-PYMANGSLDSHLYPHSE--TEFGSGSSD-L 659
           ++L  I H  N++ ++ AC+ P    +V+  +   G+L ++L         +     D L
Sbjct: 82  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFL 141
Query: 660 TLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVG 719
           TL   +     +A+GM +L   +  + IH DL   N+LL++     + DFG+A+ +    
Sbjct: 142 TLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYK-- 196
Query: 720 VGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
                 + +    A +    + +MAPE  F    + + DV+SFG+L+ E          +
Sbjct: 197 ----DPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWE----------I 239
Query: 780 FAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQES 839
           F+ G S +  VK      +++     L   +R ++P      D    E+ +  + C    
Sbjct: 240 FSLGASPYPGVK------IDEEFCRRLKEGTRMRAP------DYTTPEMYQTMLDCWHGE 287
Query: 840 PSTRPTM 846
           PS RPT 
Sbjct: 288 PSQRPTF 294

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQ----------KVVKLKQIEHTLNE 91
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 92  KRILQAVNFPFLVKLEYSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHARF 145
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N+L++      V+DFG AK V           
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----------- 191
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 40/229 (17%)
Query: 562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI--RHRNLMRII 619
           Q  +G G +G V++G  + G  +AVK+    S    +S+ RE ++ + +  RH N++  I
Sbjct: 14  QESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFI 69
Query: 620 TACSLPDFKA----LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
            A +  +       LV  Y  +GSL  +L  ++ T  G           + +    A G+
Sbjct: 70  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM----------IKLALSTASGL 119
Query: 676 AYLH------HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           A+LH         P  + H DLK  N+L+  + T  ++D G+A       V +D A +  
Sbjct: 120 AHLHMEIVGTQGKPA-IAHRDLKSKNILVKKNGTCCIADLGLA-------VRHDSATDTI 171
Query: 730 NSTANMLCGSIGYMAPEYGFGS------NTSTKGDVYSFGILVLEMVTR 772
           +   N   G+  YMAPE    S       +  + D+Y+ G++  E+  R
Sbjct: 172 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 220

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 95/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 35  QFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQ----------KVVKLKQIEHTLNE 84
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN--------- 666
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+          
Sbjct: 85  KRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFXEPHARF 138
Query: 667 ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
             + I     YLH    + +I+ DLKP N+L++      V+DFG AK V           
Sbjct: 139 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----------- 184
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 185 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 44/229 (19%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR-NL 615
           +F+  + LGTGS+GRV     ++ G   A+K+L  Q          +   LK+I H  N 
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQ----------KVVKLKQIEHTLNE 91
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
            RI+ A + P    L   +  N +L      +   E+  G    + L+R+   S+     
Sbjct: 92  KRILQAVNFPFLVKLEYSFKDNSNL------YMVMEYVPGGEMFSHLRRIGRFSEPHARF 145
Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I     YLH    + +I+ DLKP N+L++      V+DFG AK V           
Sbjct: 146 YAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----------- 191
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                    LCG+  Y+APE       +   D ++ G+L+ EM     P
Sbjct: 192 ---KGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 557 AEFDEQRLLGTGSYGRVYKGILQDGTA----IAVKVLQ---LQSGNFTKSFNRECQVLKR 609
           ++F+  ++LG GS+G+V+      G+      A+KVL+   L+  +  ++   E  +L  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVE 82
Query: 610 IRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS 669
           + H  ++++  A        L+L ++  G L + L            S   +    ++  
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL------------SKEVMFTEEDVKF 130
Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
            +AE    L H   + +I+ DLKP N+LL+++    ++DFG++K            E++ 
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK------------ESID 178
Query: 730 N-STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           +   A   CG++ YMAPE       +   D +SFG+L+ EM+T
Sbjct: 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 33/228 (14%)
Query: 559 FDEQRLLGTGSYGRVY--KGIL--QDGTAIAVKVLQ----LQSGNFTKSFNRECQVLKRI 610
           F+  ++LGTG+YG+V+  + I     G   A+KVL+    +Q    T+    E QVL+ I
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 611 RHRNLMRIITACSLPDFKA-LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS 669
           R    +  +      + K  L+L Y+  G L +HL         S     T  +      
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL---------SQRERFTEHEVQIYVG 166
Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           +I   + +LH    + +I+ D+K  N+LL+ +   +++DFG++K  +      D  E   
Sbjct: 167 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-----DETER-- 216
Query: 730 NSTANMLCGSIGYMAPE--YGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              A   CG+I YMAP+   G  S      D +S G+L+ E++T   P
Sbjct: 217 ---AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 108/231 (46%), Gaps = 34/231 (14%)
Query: 563 RLLGTGSYGRVYK----GILQDGTAIAVKVLQLQS---GNFTKSFNRECQVLKRI-RHRN 614
           + LG G++G+V +    G+ ++   + V V  L+S    +  ++   E +++  + +H N
Sbjct: 37  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 96
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFG--------------SGSSDLT 660
           ++ ++ AC+      ++  Y   G L + L   +E   G                   L 
Sbjct: 97  IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLE 156
Query: 661 LLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGV 720
           L   ++  S +A+GMA+L   +    IH D+   NVLL +   A + DFG+A+ +M    
Sbjct: 157 LRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIM---- 209
Query: 721 GNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            ND +  +    A +    + +MAPE  F    + + DV+S+GIL+ E+ +
Sbjct: 210 -ND-SNYIVKGNARL---PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 557 AEFDEQRLLGTGSYGRVYKGILQDGTA----IAVKVLQ---LQSGNFTKSFNRECQVLKR 609
           ++F+  ++LG GS+G+V+      G+      A+KVL+   L+  +  ++   E  +L  
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVE 83
Query: 610 IRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS 669
           + H  ++++  A        L+L ++  G L + L            S   +    ++  
Sbjct: 84  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL------------SKEVMFTEEDVKF 131
Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
            +AE    L H   + +I+ DLKP N+LL+++    ++DFG++K            E++ 
Sbjct: 132 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK------------ESID 179
Query: 730 N-STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           +   A   CG++ YMAPE       +   D +SFG+L+ EM+T
Sbjct: 180 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 222

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/259 (22%), Positives = 115/259 (44%), Gaps = 42/259 (16%)
Query: 543 NFPRITYRELLEATAEFDEQRLLGTGSYGRVYKG-ILQDGTAIAVKVLQLQSGNFT---- 597
            FP+     L +   E+++Q  +G G +G V+KG +++D + +A+K L L          
Sbjct: 7   EFPKSRLPTLADNEIEYEKQ--IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 598 ---KSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGS 654
              + F RE  ++  + H N++++      P    +V+ ++  G L   L          
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLL--------D 114
Query: 655 GSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL-----NDDMTALVSDF 709
            +  +    ++ +  DIA G+ Y+ + +P  ++H DL+  N+ L     N  + A V+DF
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTS--TKGDVYSFGILVL 767
           G+++  +               + + L G+  +MAPE       S   K D YSF +++ 
Sbjct: 174 GLSQQSV--------------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILY 219
Query: 768 EMVTRRRPTDDMFAGGLSL 786
            ++T   P D+   G +  
Sbjct: 220 TILTGEGPFDEYSYGKIKF 238

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 27/217 (12%)
Query: 563 RLLGTGSYGRVYKGILQ-----DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLM 616
           R LG G +G+V            G  +AVK L+ +SG N      +E ++L+ + H N++
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 617 RIITACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +    C+        L++ ++ +GSL  +L P ++ +       + L Q++     I +G
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNK-------INLKQQLKYAVQICKG 126
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           M YL      + +H DL   NVL+  +    + DFG+ K + T        +    +  +
Sbjct: 127 MDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET--------DKEXXTVKD 175
Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                + + APE    S      DV+SFG+ + E++T
Sbjct: 176 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 105/222 (47%), Gaps = 31/222 (13%)
Query: 557 AEFDEQRLLGTGSYGRVY--KGIL-QDGTAI-AVKVLQ---LQSGNFTKSFNRECQVLKR 609
           ++F+  ++LG GS+G+V+  K I   D   + A+KVL+   L+  +  ++   E  +L  
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVE 82
Query: 610 IRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS 669
           + H  ++++  A        L+L ++  G L + L            S   +    ++  
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL------------SKEVMFTEEDVKF 130
Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
            +AE    L H   + +I+ DLKP N+LL+++    ++DFG++K  +             
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID-----------H 179
Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              A   CG++ YMAPE       +   D +SFG+L+ EM+T
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 29/224 (12%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  R LG G +G VY     Q+   +A+KVL   QL+         RE ++   +RH 
Sbjct: 15  DFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           N++R+           L+L +   G L   L  H   +    ++ +          ++A+
Sbjct: 75  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM---------EELAD 125
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + Y H     +VIH D+KP N+L+       ++DFG +    ++               
Sbjct: 126 ALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-------------RR 169
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
             +CG++ Y+ PE   G     K D++  G+L  E +    P D
Sbjct: 170 RXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 55/224 (24%), Positives = 94/224 (41%), Gaps = 29/224 (12%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  R LG G +G VY     Q+   +A+KVL   QL+         RE ++   +RH 
Sbjct: 16  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 75
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           N++R+           L+L +   G L   L  H   +    ++ +          ++A+
Sbjct: 76  NILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM---------EELAD 126
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + Y H     +VIH D+KP N+L+       ++DFG +    ++               
Sbjct: 127 ALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-------------RR 170
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
             +CG++ Y+ PE   G     K D++  G+L  E +    P D
Sbjct: 171 RXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 27/217 (12%)
Query: 563 RLLGTGSYGRVYKGILQ-----DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLM 616
           R LG G +G+V            G  +AVK L+ +SG N      +E ++L+ + H N++
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 617 RIITACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +    C+        L++ ++ +GSL  +L P ++ +       + L Q++     I +G
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNK-------INLKQQLKYAVQICKG 138
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           M YL      + +H DL   NVL+  +    + DFG+ K + T        +    +  +
Sbjct: 139 MDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET--------DKEXXTVKD 187
Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                + + APE    S      DV+SFG+ + E++T
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 26/219 (11%)
Query: 564 LLGTGSYGRVY-KGILQDGTAIAVKVLQL---QSGNFTKSFNRECQVLKRIRHRNLMRII 619
           +LG G    V+    L+D   +AVKVL+    +  +F   F RE Q    + H  ++ + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 620 TACSLPDFKALVLPYMANGSLDS---HLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
                 +  A  LPY+    +D        H+E         +T  + + + +D  + + 
Sbjct: 79  DTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIADACQALN 130
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           + H +    +IH D+KP+N++++      V DFGIA+ +   G       N    TA ++
Sbjct: 131 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG-------NSVTQTAAVI 180
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            G+  Y++PE   G +   + DVYS G ++ E++T   P
Sbjct: 181 -GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 26/219 (11%)
Query: 564 LLGTGSYGRVYKGI-LQDGTAIAVKVLQL---QSGNFTKSFNRECQVLKRIRHRNLMRII 619
           +LG G    V+    L+D   +AVKVL+    +  +F   F RE Q    + H  ++ + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 620 TACSLPDFKALVLPYMANGSLDS---HLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
                 +  A  LPY+    +D        H+E         +T  + + + +D  + + 
Sbjct: 79  DTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIADACQALN 130
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           + H +    +IH D+KP+N++++      V DFGIA+ +   G       N    TA ++
Sbjct: 131 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG-------NSVTQTAAVI 180
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            G+  Y++PE   G +   + DVYS G ++ E++T   P
Sbjct: 181 -GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 106/234 (45%), Gaps = 28/234 (11%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIR 611
           AT+ ++    +G G+YG VYK      G  +A+K +++ +G      S  RE  +L+R+ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 612 ---HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNIC 668
              H N++R++  C+       +   +    +D  L  + +     G    T+    ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI---KDLM 118
Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
                G+ +LH +    ++H DLKP N+L+    T  ++DFG+A++              
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY----------- 164
Query: 729 GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAG 782
                + +  ++ Y APE    S  +T  D++S G +  EM  RR+P   +F G
Sbjct: 165 -QMALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP---LFCG 213

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 96/228 (42%), Gaps = 50/228 (21%)
Query: 558 EFDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  + LGTGS+GRV    +K   + G   A+K+L  Q          +   LK+I H 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQ----------KVVKLKQIEHT 88
Query: 614 -NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD-- 670
            N  RI+ A + P    L   +  N +L      +   E+ +G    + L+R+   S+  
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 671 -------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
                  I     YLH    + +I+ DLKP N+L++      V+DFG AK V        
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-------- 191
Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                       L G+  Y+APE       +   D ++ G+L+ EM  
Sbjct: 192 ------KGRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 67/222 (30%), Positives = 100/222 (45%), Gaps = 39/222 (17%)
Query: 563 RLLGTGSYGRVY---KGILQDGTA--IAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNLM 616
           R LG G +G+V         DGT   +AVK L+   G   +S + RE ++L+ + H +++
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 73
Query: 617 RIITACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +    C     K+  LV+ Y+  GSL  +L  H           + L Q +     I EG
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----------VGLAQLLLFAQQICEG 123
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM-----G 729
           MAYLH       IH  L   NVLL++D    + DFG+AK V       +G E       G
Sbjct: 124 MAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAV------PEGHEYYRVREDG 174
Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           +S        + + APE           DV+SFG+ + E++T
Sbjct: 175 DS-------PVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 67/222 (30%), Positives = 100/222 (45%), Gaps = 39/222 (17%)
Query: 563 RLLGTGSYGRVY---KGILQDGTA--IAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNLM 616
           R LG G +G+V         DGT   +AVK L+   G   +S + RE ++L+ + H +++
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 74
Query: 617 RIITACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +    C     K+  LV+ Y+  GSL  +L  H           + L Q +     I EG
Sbjct: 75  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----------VGLAQLLLFAQQICEG 124
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM-----G 729
           MAYLH       IH  L   NVLL++D    + DFG+AK V       +G E       G
Sbjct: 125 MAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAV------PEGHEYYRVREDG 175
Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           +S        + + APE           DV+SFG+ + E++T
Sbjct: 176 DS-------PVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 97/232 (41%), Gaps = 50/232 (21%)
Query: 558 EFDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  + LGTGS+GRV    +K   + G   A+K+L  Q          +   LK+I H 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQ----------KVVKLKQIEHT 88
Query: 614 -NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD-- 670
            N  RI+ A + P    L   +  N +L      +   E+ +G    + L+R+   S+  
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 671 -------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
                  I     YLH    + +I+ DLKP N+L++      V+DFG AK V        
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-------- 191
Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                       LCG+   +APE       +   D ++ G+L+ EM     P
Sbjct: 192 ------KGRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 30/218 (13%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G++G+VYK   ++ G   A KV++ +S    + +  E ++L    H  +++++ A  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +++ +   G++D+ +      E   G   LT  Q   +C  + E + +LH    
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIML-----ELDRG---LTEPQIQVVCRQMLEALNFLHSK-- 136
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN-STANMLCGSIGY 742
            R+IH DLK  NVL+  +    ++DFG++            A+N+      +   G+  +
Sbjct: 137 -RIIHRDLKAGNVLMTLEGDIRLADFGVS------------AKNLKTLQKRDSFIGTPYW 183
Query: 743 MAPEYGFGSNTST-----KGDVYSFGILVLEMVTRRRP 775
           MAPE              K D++S GI ++EM     P
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 15/222 (6%)
Query: 556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQ-LQSGNFTKSFNRECQVLKRIRHR 613
           +++F  + LLG G+YG V     +  G  +A+K ++      F     RE ++LK  +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           N++ I        F+     Y+    + + L+    T+  S       + +      +  
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           G           VIH DLKPSN+L+N +    V DFG+A+++       D +E  G  + 
Sbjct: 130 GS---------NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA--DNSEPTGQQSG 178
Query: 734 -NMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
                 +  Y APE    S   ++  DV+S G ++ E+  RR
Sbjct: 179 MTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/240 (22%), Positives = 101/240 (42%), Gaps = 50/240 (20%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLM 616
           +F E  L+G+G +G+V+K   + DG    ++ ++  +    +   RE + L ++ H N++
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN----EKAEREVKALAKLDHVNIV 68
Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNIC-------- 668
                    D+     P  ++ SL+S  Y    ++  S S    L  ++  C        
Sbjct: 69  HYNGCWDGFDYD----PETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQW 124
Query: 669 ------------------SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG 710
                               I +G+ Y+H     ++IH DLKPSN+ L D     + DFG
Sbjct: 125 IEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFG 181
Query: 711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
                +   + NDG             G++ YM+PE     +   + D+Y+ G+++ E++
Sbjct: 182 -----LVTSLKNDGKRTRSK-------GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 15/222 (6%)
Query: 556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQ-LQSGNFTKSFNRECQVLKRIRHR 613
           +++F  + LLG G+YG V     +  G  +A+K ++      F     RE ++LK  +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           N++ I        F+     Y+    + + L+    T+  S       + +      +  
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH 129
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           G           VIH DLKPSN+L+N +    V DFG+A+++       D +E  G  + 
Sbjct: 130 GS---------NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA--DNSEPTGQQSG 178
Query: 734 -NMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
                 +  Y APE    S   ++  DV+S G ++ E+  RR
Sbjct: 179 MTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 25/222 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRHR 613
           +F   ++LG GS+  V     L      A+K+L+   +   N      RE  V+ R+ H 
Sbjct: 8   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 67
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
             +++       +     L Y  NG L  ++          GS D T  +     ++I  
Sbjct: 68  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-------IGSFDETCTRFYT--AEIVS 118
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + YLH      +IH DLKP N+LLN+DM   ++DFG AK++         +     + A
Sbjct: 119 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL---------SPESKQARA 166
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           N   G+  Y++PE     +     D+++ G ++ ++V    P
Sbjct: 167 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 25/222 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRHR 613
           +F   ++LG GS+  V     L      A+K+L+   +   N      RE  V+ R+ H 
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
             +++       +     L Y  NG L  ++          GS D T  +     ++I  
Sbjct: 75  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-------IGSFDETCTRFYT--AEIVS 125
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + YLH      +IH DLKP N+LLN+DM   ++DFG AK++         +     + A
Sbjct: 126 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL---------SPESKQARA 173
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           N   G+  Y++PE     +     D+++ G ++ ++V    P
Sbjct: 174 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 25/222 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRHR 613
           +F   ++LG GS+  V     L      A+K+L+   +   N      RE  V+ R+ H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
             +++       +     L Y  NG L  ++          GS D T  +     ++I  
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-------IGSFDETCTRFYT--AEIVS 119
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + YLH      +IH DLKP N+LLN+DM   ++DFG AK++         +     + A
Sbjct: 120 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL---------SPESKQARA 167
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           N   G+  Y++PE     +     D+++ G ++ ++V    P
Sbjct: 168 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 25/222 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRHR 613
           +F   ++LG GS+  V     L      A+K+L+   +   N      RE  V+ R+ H 
Sbjct: 10  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 69
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
             +++       +     L Y  NG L  ++          GS D T  +     ++I  
Sbjct: 70  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-------IGSFDETCTRFYT--AEIVS 120
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + YLH      +IH DLKP N+LLN+DM   ++DFG AK++         +     + A
Sbjct: 121 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL---------SPESKQARA 168
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           N   G+  Y++PE     +     D+++ G ++ ++V    P
Sbjct: 169 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 25/222 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRHR 613
           +F   ++LG GS+  V     L      A+K+L+   +   N      RE  V+ R+ H 
Sbjct: 11  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 70
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
             +++       +     L Y  NG L  ++          GS D T  +     ++I  
Sbjct: 71  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-------IGSFDETCTRFYT--AEIVS 121
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + YLH      +IH DLKP N+LLN+DM   ++DFG AK++         +     + A
Sbjct: 122 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL---------SPESKQARA 169
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           N   G+  Y++PE     +     D+++ G ++ ++V    P
Sbjct: 170 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 109/234 (46%), Gaps = 28/234 (11%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIR 611
           AT+ ++    +G G+YG VYK      G  +A+K +++ +G      S  RE  +L+R+ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 612 ---HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNIC 668
              H N++R++  C+       +   +    +D  L  + +     G    T+    ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI---KDLM 118
Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
                G+ +LH +    ++H DLKP N+L+    T  ++DFG+A++            + 
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY-----------SY 164
Query: 729 GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAG 782
             + A ++  ++ Y APE    S  +T  D++S G +  EM  RR+P   +F G
Sbjct: 165 QMALAPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP---LFCG 213

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/259 (22%), Positives = 114/259 (44%), Gaps = 42/259 (16%)
Query: 543 NFPRITYRELLEATAEFDEQRLLGTGSYGRVYKG-ILQDGTAIAVKVLQLQSGNFT---- 597
            FP+     L +   E+++Q  +G G +G V+KG +++D + +A+K L L          
Sbjct: 7   EFPKSRLPTLADNEIEYEKQ--IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 598 ---KSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGS 654
              + F RE  ++  + H N++++      P    +V+ ++  G L   L          
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLL--------D 114
Query: 655 GSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL-----NDDMTALVSDF 709
            +  +    ++ +  DIA G+ Y+ + +P  ++H DL+  N+ L     N  + A V+DF
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTS--TKGDVYSFGILVL 767
           G ++  +               + + L G+  +MAPE       S   K D YSF +++ 
Sbjct: 174 GTSQQSV--------------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILY 219
Query: 768 EMVTRRRPTDDMFAGGLSL 786
            ++T   P D+   G +  
Sbjct: 220 TILTGEGPFDEYSYGKIKF 238

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 96/228 (42%), Gaps = 50/228 (21%)
Query: 558 EFDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  + LGTGS+GRV    +K   + G   A+K+L  Q          +   LK+I H 
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQ----------KVVKLKQIEHT 88
Query: 614 -NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD-- 670
            N  RI+ A + P    L   +  N +L      +   E+ +G    + L+R+   S+  
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNL------YMVMEYVAGGEMFSHLRRIGRFSEPH 142
Query: 671 -------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
                  I     YLH    + +I+ DLKP N+L++      V+DFG AK V        
Sbjct: 143 ARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-------- 191
Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                       L G+  Y+APE       +   D ++ G+L+ EM  
Sbjct: 192 ------KGRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 30/218 (13%)
Query: 561 EQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIR-HRNLMRI 618
           ++ +LG G++ RV   I L      AVK+++ Q G+      RE ++L + + HRN++ +
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 619 ITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
           I      D   LV   M  GS+ SH+  H    F         L+   +  D+A  + +L
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHI--HKRRHFNE-------LEASVVVQDVASALDFL 127
Query: 679 HHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
           H+     + H DLKP N+L    N      + DFG+   +   G      +    ST  +
Sbjct: 128 HNKG---IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNG------DCSPISTPEL 178
Query: 736 L--CGSIGYMAPEY--GFGSNTS---TKGDVYSFGILV 766
           L  CGS  YMAPE    F    S    + D++S G+++
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 30/220 (13%)
Query: 557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQ----LQSGNFTKSFNRECQVLKRIR 611
           ++F   +++G GS+G+V     + +    AVKVLQ    L+        +    +LK ++
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           H  L+ +  +    D    VL Y+  G L  HL    E  F    +           ++I
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARF-------YAAEI 148
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG-N 730
           A  + YLH    + +++ DLKP N+LL+     +++DFG+ K            EN+  N
Sbjct: 149 ASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK------------ENIEHN 193
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
           ST +  CG+  Y+APE           D +  G ++ EM+
Sbjct: 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 233

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 25/198 (12%)
Query: 584 IAVKVLQL---QSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSL 640
           +AVKVL+    +  +F   F RE Q    + H  ++  + A    +  A  LPY+    +
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV-AVYATGEAETPAGPLPYIVMEYV 98
Query: 641 DS---HLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVL 697
           D        H+E         +T  + + + +D  + + + H +    +IH D+KP+N++
Sbjct: 99  DGVTLRDIVHTE-------GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIM 148
Query: 698 LNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG 757
           ++      V DFGIA+ +   G       N    TA ++ G+  Y++PE   G +   + 
Sbjct: 149 ISATNAVKVMDFGIARAIADSG-------NSVTQTAAVI-GTAQYLSPEQARGDSVDARS 200
Query: 758 DVYSFGILVLEMVTRRRP 775
           DVYS G ++ E++T   P
Sbjct: 201 DVYSLGCVLYEVLTGEPP 218

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + + +++G GS+G VY+  L D G  +A+K + LQ   F    NRE Q+++++ H N++R
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 77
Query: 618 I----ITACSLPD--FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           +     ++    D  +  LVL Y+                +      L ++        +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVY------RVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGN 730
              +AY+H      + H D+KP N+LL+ D   L + DFG AK ++            G 
Sbjct: 132 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-----------RGE 177
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
              + +C S  Y APE  FG+   T   DV+S G ++ E++
Sbjct: 178 PNVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 109/236 (46%), Gaps = 30/236 (12%)
Query: 553 LEATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIR 611
           L   ++F+E  +LG G++G+V K     D    A+K ++      +   + E  +L  + 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS-EVMLLASLN 60
Query: 612 H-------------RNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSD 658
           H             RN ++ +TA        + + Y  NG+L   +  HSE         
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEY 118
Query: 659 LTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV-MT 717
             L ++      I E ++Y+H      +IH DLKP N+ +++     + DFG+AK V  +
Sbjct: 119 WRLFRQ------ILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 718 VGVGNDGAENMGNSTANMLC--GSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMV 770
           + +    ++N+  S+ N+    G+  Y+A E   G+ + + K D+YS GI+  EM+
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 24/216 (11%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + + +++G GS+G VY+  L D G  +A+K + LQ   F    NRE Q+++++ H N++R
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 77
Query: 618 I-ITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           +     S  + K +V   +    +   +Y      +      L ++        +   +A
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
           Y+H      + H D+KP N+LL+ D   L + DFG AK ++            G    + 
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-----------RGEPNVSX 182
Query: 736 LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
           +C S  Y APE  FG+   T   DV+S G ++ E++
Sbjct: 183 IC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + + +++G GS+G VY+  L D G  +A+K + LQ   F    NRE Q+++++ H N++R
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 78
Query: 618 I----ITACSLPD--FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           +     ++    D  +  LVL Y+                +      L ++        +
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETVY------RVARHYSRAKQTLPVIYVKLYMYQL 132
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGN 730
              +AY+H      + H D+KP N+LL+ D   L + DFG AK ++            G 
Sbjct: 133 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-----------RGE 178
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
              + +C S  Y APE  FG+   T   DV+S G ++ E++
Sbjct: 179 PNVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 218

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 63/253 (24%), Positives = 111/253 (43%), Gaps = 24/253 (9%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNL 615
           ++D  + LG G+YG V   + +    A+AVK++ ++   +  ++  +E  + K + H N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++        + + L L Y + G L   + P    + G    D    QR      +  G+
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDA---QR--FFHQLMAGV 117
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH    + + H D+KP N+LL++     +SDFG+A +            N      N 
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY---------NNRERLLNK 165
Query: 736 LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
           +CG++ Y+APE         +  DV+S GI++  M+    P D           W +   
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 225
Query: 795 HGRLEKVIDSSLL 807
           +    K IDS+ L
Sbjct: 226 YLNPWKKIDSAPL 238

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + + +++G GS+G VY+  L D G  +A+K + LQ   F    NRE Q+++++ H N++R
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 77
Query: 618 I----ITACSLPD--FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           +     ++    D  +  LVL Y+                +      L ++        +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVY------RVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGN 730
              +AY+H      + H D+KP N+LL+ D   L + DFG AK ++            G 
Sbjct: 132 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-----------RGE 177
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
              + +C S  Y APE  FG+   T   DV+S G ++ E++
Sbjct: 178 PNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + + +++G GS+G VY+  L D G  +A+K + LQ   F    NRE Q+++++ H N++R
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 77
Query: 618 I----ITACSLPD--FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           +     ++    D  +  LVL Y+                +      L ++        +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVY------RVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGN 730
              +AY+H      + H D+KP N+LL+ D   L + DFG AK ++            G 
Sbjct: 132 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-----------RGE 177
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
              + +C S  Y APE  FG+   T   DV+S G ++ E++
Sbjct: 178 PNVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 113/241 (46%), Gaps = 34/241 (14%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFT--KSFNRECQVLKRIRHRN 614
           E++    +G G+YG V     +  G  +A+K +       T  K   RE ++LK  +H N
Sbjct: 55  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDN 114
Query: 615 LMRI--ITACSLP--DFKAL--VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNIC 668
           ++ I  I   ++P  +FK++  VL  M +   D H   HS       S  LTL       
Sbjct: 115 IIAIKDILRPTVPYGEFKSVYVVLDLMES---DLHQIIHS-------SQPLTLEHVRYFL 164
Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
             +  G+ Y+H     +VIH DLKPSN+L+N++    + DFG+A+     G+    AE+ 
Sbjct: 165 YQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMAR-----GLCTSPAEHQ 216
Query: 729 GNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLH 787
              T      +  Y APE     +  T+  D++S G +  EM+ RR+    +F G   +H
Sbjct: 217 YFMTE--YVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ----LFPGKNYVH 270
Query: 788 K 788
           +
Sbjct: 271 Q 271

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + + +++G GS+G VY+  L D G  +A+K + LQ   F    NRE Q+++++ H N++R
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 90
Query: 618 I----ITACSLPD--FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           +     ++    D  +  LVL Y+                +      L ++        +
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPETVY------RVARHYSRAKQTLPVIYVKLYMYQL 144
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGN 730
              +AY+H      + H D+KP N+LL+ D   L + DFG AK ++            G 
Sbjct: 145 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-----------RGE 190
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
              + +C S  Y APE  FG+   T   DV+S G ++ E++
Sbjct: 191 PNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 230

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + + +++G GS+G VY+  L D G  +A+K + LQ   F    NRE Q+++++ H N++R
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 85
Query: 618 I----ITACSLPD--FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           +     ++    D  +  LVL Y+                +      L ++        +
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPETVY------RVARHYSRAKQTLPVIYVKLYMYQL 139
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGN 730
              +AY+H      + H D+KP N+LL+ D   L + DFG AK ++            G 
Sbjct: 140 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-----------RGE 185
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
              + +C S  Y APE  FG+   T   DV+S G ++ E++
Sbjct: 186 PNVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 225

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 114/241 (47%), Gaps = 34/241 (14%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFT--KSFNRECQVLKRIRHRN 614
           E++    +G G+YG V     +  G  +A+K +       T  K   RE ++LK  +H N
Sbjct: 56  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDN 115
Query: 615 LMRI--ITACSLP--DFKAL--VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNIC 668
           ++ I  I   ++P  +FK++  VL  M +   D H   HS       S  LTL       
Sbjct: 116 IIAIKDILRPTVPYGEFKSVYVVLDLMES---DLHQIIHS-------SQPLTLEHVRYFL 165
Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
             +  G+ Y+H     +VIH DLKPSN+L+N++    + DFG+A+     G+    AE+ 
Sbjct: 166 YQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMAR-----GLCTSPAEHQ 217
Query: 729 GNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLH 787
              T  +   +  Y APE     +  T+  D++S G +  EM+ RR+    +F G   +H
Sbjct: 218 YFMTEYV--ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ----LFPGKNYVH 271
Query: 788 K 788
           +
Sbjct: 272 Q 272

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 24/215 (11%)
Query: 561 EQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIR-HRNLMRI 618
           ++ +LG G++ RV   I L      AVK+++ Q G+      RE ++L + + HRN++ +
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 619 ITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
           I      D   LV   M  GS+ SH+  H    F         L+   +  D+A  + +L
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHI--HKRRHFNE-------LEASVVVQDVASALDFL 127
Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML-- 736
           H+     + H DLKP N+L   +    VS   I    +  G+  +G +    ST  +L  
Sbjct: 128 HNKG---IAHRDLKPENILC--EHPNQVSPVKICDFDLGSGIKLNG-DCSPISTPELLTP 181
Query: 737 CGSIGYMAPEY--GFGSNTS---TKGDVYSFGILV 766
           CGS  YMAPE    F    S    + D++S G+++
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 105/234 (44%), Gaps = 28/234 (11%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIR 611
           AT+ ++    +G G+YG VYK      G  +A+K +++ +G      S  RE  +L+R+ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 612 ---HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNIC 668
              H N++R++  C+       +   +    +D  L  + +     G    T+    ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI---KDLM 118
Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
                G+ +LH +    ++H DLKP N+L+    T  ++DFG+A++              
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY----------- 164
Query: 729 GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAG 782
                  +  ++ Y APE    S  +T  D++S G +  EM  RR+P   +F G
Sbjct: 165 -QMALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP---LFCG 213

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + + +++G GS+G VY+  L D G  +A+K + LQ   F    NRE Q+++++ H N++R
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 96
Query: 618 I----ITACSLPD--FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           +     ++    D  +  LVL Y+                +      L ++        +
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPETVY------RVARHYSRAKQTLPVIYVKLYMYQL 150
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGN 730
              +AY+H      + H D+KP N+LL+ D   L + DFG AK ++            G 
Sbjct: 151 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-----------RGE 196
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
              + +C S  Y APE  FG+   T   DV+S G ++ E++
Sbjct: 197 PNVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 236

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + + +++G GS+G VY+  L D G  +A+K + LQ   F    NRE Q+++++ H N++R
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 89
Query: 618 I----ITACSLPD--FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           +     ++    D  +  LVL Y+                +      L ++        +
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVY------RVARHYSRAKQTLPVIYVKLYMYQL 143
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGN 730
              +AY+H      + H D+KP N+LL+ D   L + DFG AK ++            G 
Sbjct: 144 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-----------RGE 189
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
              + +C S  Y APE  FG+   T   DV+S G ++ E++
Sbjct: 190 PNVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + + +++G GS+G VY+  L D G  +A+K + LQ   F    NRE Q+++++ H N++R
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 89
Query: 618 I----ITACSLPD--FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           +     ++    D  +  LVL Y+                +      L ++        +
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVY------RVARHYSRAKQTLPVIYVKLYMYQL 143
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGN 730
              +AY+H      + H D+KP N+LL+ D   L + DFG AK ++            G 
Sbjct: 144 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-----------RGE 189
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
              + +C S  Y APE  FG+   T   DV+S G ++ E++
Sbjct: 190 PNVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + + +++G GS+G VY+  L D G  +A+K + LQ   F    NRE Q+++++ H N++R
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 81
Query: 618 I----ITACSLPD--FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           +     ++    D  +  LVL Y+                +      L ++        +
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPETVY------RVARHYSRAKQTLPVIYVKLYMYQL 135
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGN 730
              +AY+H      + H D+KP N+LL+ D   L + DFG AK ++            G 
Sbjct: 136 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-----------RGE 181
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
              + +C S  Y APE  FG+   T   DV+S G ++ E++
Sbjct: 182 PNVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 221

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 32/221 (14%)
Query: 563 RLLGTGSYGRVY--KGILQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + +G G++ +V   + IL  G  +AVK++   QL S +  K F RE ++ K + H N+++
Sbjct: 20  KTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLF-REVRIXKVLNHPNIVK 77
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +           LV  Y + G +  +L  H   +     +             I   + Y
Sbjct: 78  LFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKF---------RQIVSAVQY 128
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
            H      ++H DLK  N+LL+ D    ++DFG +                GN   +  C
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEF-----------TFGNKL-DAFC 173
Query: 738 GSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTD 777
           G+  Y APE   G      + DV+S G+++  +V+   P D
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + + +++G GS+G VY+  L D G  +A+K + LQ   F    NRE Q+++++ H N++R
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 82
Query: 618 I----ITACSLPD--FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           +     ++    D  +  LVL Y+                +      L ++        +
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVY------RVARHYSRAKQTLPVIYVKLYMYQL 136
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGN 730
              +AY+H      + H D+KP N+LL+ D   L + DFG AK ++            G 
Sbjct: 137 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-----------RGE 182
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
              + +C S  Y APE  FG+   T   DV+S G ++ E++
Sbjct: 183 PNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 222

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + + +++G GS+G VY+  L D G  +A+K + LQ   F    NRE Q+++++ H N++R
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 111
Query: 618 I----ITACSLPD--FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           +     ++    D  +  LVL Y+                +      L ++        +
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVY------RVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGN 730
              +AY+H      + H D+KP N+LL+ D   L + DFG AK ++            G 
Sbjct: 166 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-----------RGE 211
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
              + +C S  Y APE  FG+   T   DV+S G ++ E++
Sbjct: 212 PNVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + + +++G GS+G VY+  L D G  +A+K + LQ   F    NRE Q+++++ H N++R
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQGKAFK---NRELQIMRKLDHCNIVR 77
Query: 618 I----ITACSLPD--FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           +     ++    D  +  LVL Y+                +      L ++        +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVY------RVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGN 730
              +AY+H      + H D+KP N+LL+ D   L + DFG AK ++            G 
Sbjct: 132 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-----------RGE 177
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
              + +C S  Y APE  FG+   T   DV+S G ++ E++
Sbjct: 178 PNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/259 (22%), Positives = 114/259 (44%), Gaps = 42/259 (16%)
Query: 543 NFPRITYRELLEATAEFDEQRLLGTGSYGRVYKG-ILQDGTAIAVKVLQLQSGNFT---- 597
            FP+     L +   E+++Q  +G G +G V+KG +++D + +A+K L L          
Sbjct: 7   EFPKSRLPTLADNEIEYEKQ--IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 598 ---KSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGS 654
              + F RE  ++  + H N++++      P    +V+ ++  G L   L          
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLL--------D 114
Query: 655 GSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL-----NDDMTALVSDF 709
            +  +    ++ +  DIA G+ Y+ + +P  ++H DL+  N+ L     N  + A V+DF
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTS--TKGDVYSFGILVL 767
            +++  +               + + L G+  +MAPE       S   K D YSF +++ 
Sbjct: 174 SLSQQSV--------------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILY 219
Query: 768 EMVTRRRPTDDMFAGGLSL 786
            ++T   P D+   G +  
Sbjct: 220 TILTGEGPFDEYSYGKIKF 238

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + + +++G GS+G VY+  L D G  +A+K + LQ   F    NRE Q+++++ H N++R
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQGKAFK---NRELQIMRKLDHCNIVR 77
Query: 618 I----ITACSLPD--FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           +     ++    D  +  LVL Y+                +      L ++        +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVY------RVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGN 730
              +AY+H      + H D+KP N+LL+ D   L + DFG AK ++            G 
Sbjct: 132 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-----------RGE 177
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
              + +C S  Y APE  FG+   T   DV+S G ++ E++
Sbjct: 178 PNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 31/225 (13%)
Query: 559 FDEQRL-----LGTGSYGRV----YKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLK 608
           F+E+ L     LG G++G V    Y  +  + G  +AVK LQ    +  + F RE Q+LK
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 609 RIRHRNLMRIITACSLPDFKAL--VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN 666
            +    +++       P  ++L  V+ Y+ +G L   L  H         + L   + + 
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR--------ARLDASRLLL 119
Query: 667 ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
             S I +GM YL      R +H DL   N+L+  +    ++DFG+AKL + +        
Sbjct: 120 YSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL-LPLDKDYYVVR 175
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
             G S        I + APE    +  S + DV+SFG+++ E+ T
Sbjct: 176 EPGQSP-------IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + + +++G GS+G VY+  L D G  +A+K + LQ   F    NRE Q+++++ H N++R
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 111
Query: 618 I----ITACSLPD--FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           +     ++    D  +  LVL Y+                +      L ++        +
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVY------RVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGN 730
              +AY+H      + H D+KP N+LL+ D   L + DFG AK ++            G 
Sbjct: 166 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-----------RGE 211
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
              + +C S  Y APE  FG+   T   DV+S G ++ E++
Sbjct: 212 PNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 34/221 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + + +++G GS+G VY+  L D G  +A+K + LQ   F    NRE Q+++++ H N++R
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQGKAFK---NRELQIMRKLDHCNIVR 77
Query: 618 I----ITACSLPD--FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           +     ++    D  +  LVL Y+      + +Y      +      L ++        +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVP-----ATVY-RVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGN 730
              +AY+H      + H D+KP N+LL+ D   L + DFG AK ++            G 
Sbjct: 132 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-----------RGE 177
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
              + +C S  Y APE  FG+   T   DV+S G ++ E++
Sbjct: 178 PNVSXIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 31/225 (13%)
Query: 559 FDEQRL-----LGTGSYGRV----YKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLK 608
           F+E+ L     LG G++G V    Y  +  + G  +AVK LQ    +  + F RE Q+LK
Sbjct: 7   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 66
Query: 609 RIRHRNLMRIITACSLPDFKAL--VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN 666
            +    +++       P  ++L  V+ Y+ +G L   L  H         + L   + + 
Sbjct: 67  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR--------ARLDASRLLL 118
Query: 667 ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
             S I +GM YL      R +H DL   N+L+  +    ++DFG+AKL + +        
Sbjct: 119 YSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL-LPLDKDYYVVR 174
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
             G S        I + APE    +  S + DV+SFG+++ E+ T
Sbjct: 175 EPGQSP-------IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + + +++G GS+G VY+  L D G  +A+K + LQ   F    NRE Q+++++ H N++R
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 105
Query: 618 I----ITACSLPD--FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           +     ++    D  +  LVL Y+                +      L ++        +
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVY------RVARHYSRAKQTLPVIYVKLYMYQL 159
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGN 730
              +AY+H      + H D+KP N+LL+ D   L + DFG AK ++            G 
Sbjct: 160 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-----------RGE 205
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
              + +C S  Y APE  FG+   T   DV+S G ++ E++
Sbjct: 206 PNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 245

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 108/224 (48%), Gaps = 27/224 (12%)
Query: 563 RLLGTGSYGRVYK----GILQDGTAIAVKVLQLQS---GNFTKSFNRECQVLKRI-RHRN 614
           + LG G++G+V +    G+ ++   + V V  L+S    +  ++   E +++  + +H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY----PHSETEFGSG---SSDLTLLQRVNI 667
           ++ ++ AC+      ++  Y   G L + L     P  E  +         L+    ++ 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHF 171
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
            S +A+GMA+L   +    IH D+   NVLL +   A + DFG+A+ +M     ND +  
Sbjct: 172 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM-----ND-SNY 222
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           +    A +    + +MAPE  F    + + DV+S+GIL+ E+ +
Sbjct: 223 IVKGNARL---PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 63/253 (24%), Positives = 111/253 (43%), Gaps = 24/253 (9%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNL 615
           ++D  + LG G+YG V   + +    A+AVK++ ++   +  ++  +E  + K + H N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++        + + L L Y + G L   + P    + G    D    QR      +  G+
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDA---QR--FFHQLMAGV 118
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH    + + H D+KP N+LL++     +SDFG+A +            N      N 
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY---------NNRERLLNK 166
Query: 736 LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
           +CG++ Y+APE         +  DV+S GI++  M+    P D           W +   
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226
Query: 795 HGRLEKVIDSSLL 807
           +    K IDS+ L
Sbjct: 227 YLNPWKKIDSAPL 239

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 63/253 (24%), Positives = 111/253 (43%), Gaps = 24/253 (9%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNL 615
           ++D  + LG G+YG V   + +    A+AVK++ ++   +  ++  +E  + K + H N+
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++        + + L L Y + G L   + P    + G    D    QR      +  G+
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDA---QR--FFHQLMAGV 116
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH    + + H D+KP N+LL++     +SDFG+A +            N      N 
Sbjct: 117 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY---------NNRERLLNK 164
Query: 736 LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
           +CG++ Y+APE         +  DV+S GI++  M+    P D           W +   
Sbjct: 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 224
Query: 795 HGRLEKVIDSSLL 807
           +    K IDS+ L
Sbjct: 225 YLNPWKKIDSAPL 237

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 63/253 (24%), Positives = 111/253 (43%), Gaps = 24/253 (9%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNL 615
           ++D  + LG G+YG V   + +    A+AVK++ ++   +  ++  +E  + K + H N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++        + + L L Y + G L   + P    + G    D    QR      +  G+
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDA---QR--FFHQLMAGV 117
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH    + + H D+KP N+LL++     +SDFG+A +            N      N 
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY---------NNRERLLNK 165
Query: 736 LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
           +CG++ Y+APE         +  DV+S GI++  M+    P D           W +   
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 225
Query: 795 HGRLEKVIDSSLL 807
           +    K IDS+ L
Sbjct: 226 YLNPWKKIDSAPL 238

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 63/253 (24%), Positives = 111/253 (43%), Gaps = 24/253 (9%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNL 615
           ++D  + LG G+YG V   + +    A+AVK++ ++   +  ++  +E  + K + H N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++        + + L L Y + G L   + P    + G    D    QR      +  G+
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDA---QR--FFHQLMAGV 117
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH    + + H D+KP N+LL++     +SDFG+A +            N      N 
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY---------NNRERLLNK 165
Query: 736 LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
           +CG++ Y+APE         +  DV+S GI++  M+    P D           W +   
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 225
Query: 795 HGRLEKVIDSSLL 807
           +    K IDS+ L
Sbjct: 226 YLNPWKKIDSAPL 238

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 63/253 (24%), Positives = 111/253 (43%), Gaps = 24/253 (9%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNL 615
           ++D  + LG G+YG V   + +    A+AVK++ ++   +  ++  +E  + K + H N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++        + + L L Y + G L   + P    + G    D    QR      +  G+
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDA---QR--FFHQLMAGV 118
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH    + + H D+KP N+LL++     +SDFG+A +            N      N 
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY---------NNRERLLNK 166
Query: 736 LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
           +CG++ Y+APE         +  DV+S GI++  M+    P D           W +   
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226
Query: 795 HGRLEKVIDSSLL 807
           +    K IDS+ L
Sbjct: 227 YLNPWKKIDSAPL 239

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 63/253 (24%), Positives = 111/253 (43%), Gaps = 24/253 (9%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNL 615
           ++D  + LG G+YG V   + +    A+AVK++ ++   +  ++  +E  + K + H N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++        + + L L Y + G L   + P    + G    D    QR      +  G+
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDA---QR--FFHQLMAGV 117
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH    + + H D+KP N+LL++     +SDFG+A +            N      N 
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY---------NNRERLLNK 165
Query: 736 LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
           +CG++ Y+APE         +  DV+S GI++  M+    P D           W +   
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 225
Query: 795 HGRLEKVIDSSLL 807
           +    K IDS+ L
Sbjct: 226 YLNPWKKIDSAPL 238

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 63/253 (24%), Positives = 111/253 (43%), Gaps = 24/253 (9%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNL 615
           ++D  + LG G+YG V   + +    A+AVK++ ++   +  ++  +E  + K + H N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++        + + L L Y + G L   + P    + G    D    QR      +  G+
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDA---QR--FFHQLMAGV 117
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH    + + H D+KP N+LL++     +SDFG+A +            N      N 
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY---------NNRERLLNK 165
Query: 736 LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
           +CG++ Y+APE         +  DV+S GI++  M+    P D           W +   
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 225
Query: 795 HGRLEKVIDSSLL 807
           +    K IDS+ L
Sbjct: 226 YLNPWKKIDSAPL 238

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 63/253 (24%), Positives = 111/253 (43%), Gaps = 24/253 (9%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNL 615
           ++D  + LG G+YG V   + +    A+AVK++ ++   +  ++  +E  + K + H N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++        + + L L Y + G L   + P    + G    D    QR      +  G+
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDA---QR--FFHQLMAGV 117
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH    + + H D+KP N+LL++     +SDFG+A +            N      N 
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY---------NNRERLLNK 165
Query: 736 LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
           +CG++ Y+APE         +  DV+S GI++  M+    P D           W +   
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 225
Query: 795 HGRLEKVIDSSLL 807
           +    K IDS+ L
Sbjct: 226 YLNPWKKIDSAPL 238

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 63/253 (24%), Positives = 111/253 (43%), Gaps = 24/253 (9%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNL 615
           ++D  + LG G+YG V   + +    A+AVK++ ++   +  ++  +E  + K + H N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++        + + L L Y + G L   + P    + G    D    QR      +  G+
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDA---QR--FFHQLMAGV 118
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH    + + H D+KP N+LL++     +SDFG+A +            N      N 
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY---------NNRERLLNK 166
Query: 736 LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
           +CG++ Y+APE         +  DV+S GI++  M+    P D           W +   
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226
Query: 795 HGRLEKVIDSSLL 807
           +    K IDS+ L
Sbjct: 227 YLNPWKKIDSAPL 239

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + + +++G GS+G VY+  L D G  +A+K + LQ   F    NRE Q+++++ H N++R
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 115
Query: 618 I----ITACSLPD--FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           +     ++    D  +  LVL Y+                +      L ++        +
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVY------RVARHYSRAKQTLPVIYVKLYMYQL 169
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGN 730
              +AY+H      + H D+KP N+LL+ D   L + DFG AK ++            G 
Sbjct: 170 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-----------RGE 215
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
              + +C S  Y APE  FG+   T   DV+S G ++ E++
Sbjct: 216 PNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 255

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + + +++G GS+G VY+  L D G  +A+K + LQ   F    NRE Q+++++ H N++R
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 113
Query: 618 I----ITACSLPD--FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           +     ++    D  +  LVL Y+                +      L ++        +
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVY------RVARHYSRAKQTLPVIYVKLYMYQL 167
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGN 730
              +AY+H      + H D+KP N+LL+ D   L + DFG AK ++            G 
Sbjct: 168 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-----------RGE 213
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
              + +C S  Y APE  FG+   T   DV+S G ++ E++
Sbjct: 214 PNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 253

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 25/198 (12%)
Query: 584 IAVKVLQL---QSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSL 640
           +AVKVL+    +  +F   F RE Q    + H  ++ +       +  A  LPY+    +
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYV 98
Query: 641 DS---HLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVL 697
           D        H+E         +T  + + + +D  + + + H +    +IH D+KP+N++
Sbjct: 99  DGVTLRDIVHTE-------GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIM 148
Query: 698 LNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG 757
           ++      V DFGIA+ +   G       N    TA ++ G+  Y++PE   G +   + 
Sbjct: 149 ISATNAVKVMDFGIARAIADSG-------NSVTQTAAVI-GTAQYLSPEQARGDSVDARS 200
Query: 758 DVYSFGILVLEMVTRRRP 775
           DVYS G ++ E++T   P
Sbjct: 201 DVYSLGCVLYEVLTGEPP 218

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 105/222 (47%), Gaps = 45/222 (20%)
Query: 563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITAC 622
           +++G GS+G V++  L +   +A+K + LQ   F    NRE Q+++ ++H N++      
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKV-LQDKRFK---NRELQIMRIVKHPNVV------ 95
Query: 623 SLPDFKALVLPYMANGSLDSHLYPH------SETEFGSGSSDLTLLQRVNIC------SD 670
              D KA    + +NG     ++ +       ET + +      L Q + +         
Sbjct: 96  ---DLKAF---FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMG 729
           +   +AY+H    + + H D+KP N+LL+     L + DFG AK+++            G
Sbjct: 150 LLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA-----------G 195
Query: 730 NSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMV 770
               + +C S  Y APE  FG+ N +T  D++S G ++ E++
Sbjct: 196 EPNVSXIC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELM 236

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + + +++G GS+G VY+  L D G  +A+K + LQ   F    NRE Q+++++ H N++R
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFK---NRELQIMRKLDHCNIVR 156
Query: 618 I----ITACSLPD--FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           +     ++    D  +  LVL Y+                +      L ++        +
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVY------RVARHYSRAKQTLPVIYVKLYMYQL 210
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGN 730
              +AY+H      + H D+KP N+LL+ D   L + DFG AK ++            G 
Sbjct: 211 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-----------RGE 256
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
              + +C S  Y APE  FG+   T   DV+S G ++ E++
Sbjct: 257 PNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 296

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNL 615
           +F+    LG G+ G V K   +  G  +A K++ L+          RE QVL       +
Sbjct: 17  DFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 76
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +    A       ++ + +M  GSLD  L                +L +V+I   +  G+
Sbjct: 77  VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRI-------PEEILGKVSIA--VLRGL 127
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
           AYL      +++H D+KPSN+L+N      + DFG++  ++             +S AN 
Sbjct: 128 AYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------------DSMANS 172
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
             G+  YMAPE   G++ S + D++S G+ ++E+   R P
Sbjct: 173 FVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 92/218 (42%), Gaps = 29/218 (13%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRIRHR 613
           +F+  R LG G +G VY    +    I A+KVL   Q++         RE ++   + H 
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHP 83
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           N++R+           L+L Y   G L   L           S      +   I  ++A+
Sbjct: 84  NILRLYNYFYDRRRIYLILEYAPRGELYKEL---------QKSCTFDEQRTATIMEELAD 134
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + Y H     +VIH D+KP N+LL       ++DFG +            A ++   T 
Sbjct: 135 ALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWSV----------HAPSLRRKT- 180
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
             +CG++ Y+ PE   G   + K D++  G+L  E++ 
Sbjct: 181 --MCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLV 216

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 31/225 (13%)
Query: 559 FDEQRL-----LGTGSYGRV----YKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLK 608
           F+E+ L     LG G++G V    Y  +  + G  +AVK LQ    +  + F RE Q+LK
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 79
Query: 609 RIRHRNLMRIITACSLPDFKAL--VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN 666
            +    +++       P  ++L  V+ Y+ +G L   L  H         + L   + + 
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR--------ARLDASRLLL 131
Query: 667 ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
             S I +GM YL      R +H DL   N+L+  +    ++DFG+AKL + +        
Sbjct: 132 YSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL-LPLDKDYYVVR 187
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
             G S        I + APE    +  S + DV+SFG+++ E+ T
Sbjct: 188 EPGQSP-------IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 39/218 (17%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD----GTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHR 613
           F+ +  LGTG++  V   +L +    G   AVK +  ++      S   E  VL++I+H 
Sbjct: 24  FEFKETLGTGAFSEV---VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHE 80
Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           N++ +      P+   LV+  ++ G L   +    E  F +     TL+++V       +
Sbjct: 81  NIVALEDIYESPNHLYLVMQLVSGGELFDRIV---EKGFYTEKDASTLIRQV------LD 131
Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
            + YLH    + ++H DLKP N+L    +++   ++SDFG++K+           E  G+
Sbjct: 132 AVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM-----------EGKGD 177
Query: 731 --STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
             STA   CG+ GY+APE       S   D +S G++ 
Sbjct: 178 VMSTA---CGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 212

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 114/270 (42%), Gaps = 46/270 (17%)
Query: 558 EFDEQRLLGTGSYGRVYKGIL----QDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRI 610
           EF+  +LLG G++G+V   IL      G   A+K+L+ +   + +       E +VL+  
Sbjct: 152 EFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 208
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH  L  +  +    D    V+ Y   G L  HL    E  F    +           ++
Sbjct: 209 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARF-------YGAE 259
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I   + YLH  S   V++ DLK  N++L+ D    ++DFG+ K     G+  DGA     
Sbjct: 260 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGI-KDGA----- 307
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV 790
            T    CG+  Y+APE    ++     D +  G+++ EM+  R P               
Sbjct: 308 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--------------F 352
Query: 791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRM 820
            N  H +L ++I    +R  R   PE K +
Sbjct: 353 YNQDHEKLFELILMEEIRFPRTLGPEAKSL 382

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 114/270 (42%), Gaps = 46/270 (17%)
Query: 558 EFDEQRLLGTGSYGRVYKGIL----QDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRI 610
           EF+  +LLG G++G+V   IL      G   A+K+L+ +   + +       E +VL+  
Sbjct: 9   EFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 65
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH  L  +  +    D    V+ Y   G L  HL    E  F    +           ++
Sbjct: 66  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARF-------YGAE 116
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I   + YLH  S   V++ DLK  N++L+ D    ++DFG+ K     G+  DGA     
Sbjct: 117 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGI-KDGA----- 164
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV 790
            T    CG+  Y+APE    ++     D +  G+++ EM+  R P               
Sbjct: 165 -TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--------------F 209
Query: 791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRM 820
            N  H +L ++I    +R  R   PE K +
Sbjct: 210 YNQDHEKLFELILMEEIRFPRTLGPEAKSL 239

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 118/283 (41%), Gaps = 53/283 (18%)
Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRVYKGIL----QDGTAIAVKVLQLQ---SGNFT 597
           PR+T         EF+  +LLG G++G+V   IL      G   A+K+L+ +   + +  
Sbjct: 5   PRVT-------MNEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEV 54
Query: 598 KSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSS 657
                E +VL+  RH  L  +  +    D    V+ Y   G L  HL    E  F    +
Sbjct: 55  AHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRA 112
Query: 658 DLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT 717
                      ++I   + YLH  S   V++ DLK  N++L+ D    ++DFG+ K    
Sbjct: 113 RF-------YGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---- 159
Query: 718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
            G+  DGA      T    CG+  Y+APE    ++     D +  G+++ EM+  R P  
Sbjct: 160 EGI-KDGA------TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP-- 210
Query: 778 DMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRM 820
                         N  H +L ++I    +R  R   PE K +
Sbjct: 211 ------------FYNQDHEKLFELILMEEIRFPRTLGPEAKSL 241

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 114/270 (42%), Gaps = 46/270 (17%)
Query: 558 EFDEQRLLGTGSYGRVYKGIL----QDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRI 610
           EF+  +LLG G++G+V   IL      G   A+K+L+ +   + +       E +VL+  
Sbjct: 10  EFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 66
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH  L  +  +    D    V+ Y   G L  HL    E  F    +           ++
Sbjct: 67  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARF-------YGAE 117
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I   + YLH  S   V++ DLK  N++L+ D    ++DFG+ K     G+  DGA     
Sbjct: 118 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGI-KDGA----- 165
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV 790
            T    CG+  Y+APE    ++     D +  G+++ EM+  R P               
Sbjct: 166 -TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--------------F 210
Query: 791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRM 820
            N  H +L ++I    +R  R   PE K +
Sbjct: 211 YNQDHEKLFELILMEEIRFPRTLGPEAKSL 240

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 114/270 (42%), Gaps = 46/270 (17%)
Query: 558 EFDEQRLLGTGSYGRVYKGIL----QDGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRI 610
           EF+  +LLG G++G+V   IL      G   A+K+L+ +   + +       E +VL+  
Sbjct: 149 EFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           RH  L  +  +    D    V+ Y   G L  HL    E  F    +           ++
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARF-------YGAE 256
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I   + YLH  S   V++ DLK  N++L+ D    ++DFG+ K     G+  DGA     
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGI-KDGA----- 304
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV 790
            T    CG+  Y+APE    ++     D +  G+++ EM+  R P               
Sbjct: 305 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--------------F 349
Query: 791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRM 820
            N  H +L ++I    +R  R   PE K +
Sbjct: 350 YNQDHEKLFELILMEEIRFPRTLGPEAKSL 379

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 21/196 (10%)
Query: 584 IAVKVLQL---QSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSL 640
           +AVKVL+    +  +F   F RE Q    + H  ++ +       +  A  LPY+    +
Sbjct: 57  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYV 115
Query: 641 DS-HLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN 699
           D   L     TE       +T  + + + +D  + + + H +    +IH D+KP+N++++
Sbjct: 116 DGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMIS 167
Query: 700 DDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDV 759
                 V DFGIA+ +   G       N    TA ++ G+  Y++PE   G +   + DV
Sbjct: 168 ATNAVKVMDFGIARAIADSG-------NSVTQTAAVI-GTAQYLSPEQARGDSVDARSDV 219
Query: 760 YSFGILVLEMVTRRRP 775
           YS G ++ E++T   P
Sbjct: 220 YSLGCVLYEVLTGEPP 235

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 61/227 (26%), Positives = 94/227 (41%), Gaps = 48/227 (21%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKS----FNRECQVLKRIRHRNLMRIIT 620
           +G GS+  VYKG L   T + V   +LQ    TKS    F  E + LK ++H N++R   
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 621 A--CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI---------CS 669
           +   ++   K +VL                 TE  +  +  T L+R  +         C 
Sbjct: 93  SWESTVKGKKCIVLV----------------TELXTSGTLKTYLKRFKVXKIKVLRSWCR 136
Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENM 728
            I +G+ +LH  +P  +IH DLK  N+ +     ++ + D G+A L              
Sbjct: 137 QILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----------- 184
Query: 729 GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
             S A  + G+  + APE  +        DVY+FG   LE  T   P
Sbjct: 185 --SFAKAVIGTPEFXAPEX-YEEKYDESVDVYAFGXCXLEXATSEYP 228

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 66/227 (29%), Positives = 103/227 (45%), Gaps = 35/227 (15%)
Query: 559 FDEQRL-----LGTGSYGRV----YKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLK 608
           F+E+ L     LG G++G V    Y  +  + G  +AVK LQ    +  + F RE Q+LK
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 609 RIRHRNLMRIITACSL----PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
            + H + +      S     P+ + LV+ Y+ +G L   L  H        +S L L   
Sbjct: 64  AL-HSDFIVKYRGVSYGPGRPELR-LVMEYLPSGCLRDFLQRHRAR---LDASRLLLYS- 117
Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
               S I +GM YL      R +H DL   N+L+  +    ++DFG+AKL + +      
Sbjct: 118 ----SQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL-LPLDKDXXV 169
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               G S        I + APE    +  S + DV+SFG+++ E+ T
Sbjct: 170 VREPGQS-------PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 108/231 (46%), Gaps = 20/231 (8%)
Query: 553 LEATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIR 611
           L   ++F+E  +LG G++G+V K     D    A+K ++      +   + E  +L  + 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS-EVMLLASLN 60
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD- 670
           H+ ++R   A    + +  V P M      S L+   E        DL   + +N   D 
Sbjct: 61  HQYVVRYYAAW--LERRNFVKP-MTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE 117
Query: 671 -------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV-MTVGVGN 722
                  I E ++Y+H      +IH DLKP N+ +++     + DFG+AK V  ++ +  
Sbjct: 118 YWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 723 DGAENMGNSTANMLC--GSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMV 770
             ++N+  S+ N+    G+  Y+A E   G+ + + K D+YS GI+  EM+
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 36/214 (16%)
Query: 562 QRLLGTGSYGRVYKGILQD---GTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNL 615
           QR+LG GS+G V   + +D   G   AVKV+   Q++     +S  RE Q+LK++ H N+
Sbjct: 37  QRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 94
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           M++        +  LV      G L   +               + +    I   +  G+
Sbjct: 95  MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---------FSEVDAARIIRQVLSGI 145
Query: 676 AYLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
            Y+H +   +++H DLKP N+LL   + D    + DFG++          + ++ M +  
Sbjct: 146 TYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFEASKKMKDK- 194
Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
                G+  Y+APE   G+    K DV+S G+++
Sbjct: 195 ----IGTAYYIAPEVLHGT-YDEKCDVWSTGVIL 223

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 36/214 (16%)
Query: 562 QRLLGTGSYGRVYKGILQD---GTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNL 615
           QR+LG GS+G V   + +D   G   AVKV+   Q++     +S  RE Q+LK++ H N+
Sbjct: 31  QRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           M++        +  LV      G L   +               + +    I   +  G+
Sbjct: 89  MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---------FSEVDAARIIRQVLSGI 139
Query: 676 AYLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
            Y+H +   +++H DLKP N+LL   + D    + DFG++          + ++ M +  
Sbjct: 140 TYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-------EASKKMKDK- 188
Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
                G+  Y+APE   G+    K DV+S G+++
Sbjct: 189 ----IGTAYYIAPEVLHGT-YDEKCDVWSTGVIL 217

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 36/214 (16%)
Query: 562 QRLLGTGSYGRVYKGILQD---GTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNL 615
           QR+LG GS+G V   + +D   G   AVKV+   Q++     +S  RE Q+LK++ H N+
Sbjct: 54  QRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 111
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           M++        +  LV      G L   +               + +    I   +  G+
Sbjct: 112 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---------FSEVDAARIIRQVLSGI 162
Query: 676 AYLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
            Y+H +   +++H DLKP N+LL   + D    + DFG++          + ++ M +  
Sbjct: 163 TYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-------EASKKMKDK- 211
Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
                G+  Y+APE   G+    K DV+S G+++
Sbjct: 212 ----IGTAYYIAPEVLHGT-YDEKCDVWSTGVIL 240

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 36/214 (16%)
Query: 562 QRLLGTGSYGRVYKGILQD---GTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNL 615
           QR+LG GS+G V   + +D   G   AVKV+   Q++     +S  RE Q+LK++ H N+
Sbjct: 55  QRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 112
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           M++        +  LV      G L   +               + +    I   +  G+
Sbjct: 113 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---------FSEVDAARIIRQVLSGI 163
Query: 676 AYLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
            Y+H +   +++H DLKP N+LL   + D    + DFG++          + ++ M +  
Sbjct: 164 TYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-------EASKKMKDK- 212
Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
                G+  Y+APE   G+    K DV+S G+++
Sbjct: 213 ----IGTAYYIAPEVLHGT-YDEKCDVWSTGVIL 241

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 25/212 (11%)
Query: 565 LGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           +G GS G V     +  G  +AVK++ L+     +    E  +++  +H N++ +  +  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
           + +   +++ ++  G+L         T+  S    L   Q   +C  + + +AYLH    
Sbjct: 113 VGEELWVLMEFLQGGAL---------TDIVS-QVRLNEEQIATVCEAVLQALAYLHAQG- 161
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
             VIH D+K  ++LL  D    +SDFG         +  D  +         L G+  +M
Sbjct: 162 --VIHRDIKSDSILLTLDGRVKLSDFGFC-----AQISKDVPKR------KXLVGTPYWM 208
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           APE    S  +T+ D++S GI+V+EMV    P
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 39/217 (17%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V   I  + G  +A+K L    QS  F K   RE  +LK ++H N++ ++  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 621 ---ACSLPDFK--ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
              A SL +F    LV+P+M      + L      EF        + Q       + +G+
Sbjct: 110 FTPASSLRNFYDFYLVMPFM-----QTDLQKIMGMEFSEEKIQYLVYQ-------MLKGL 157
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            Y+H      V+H DLKP N+ +N+D    + DFG+A+        +  AE  G      
Sbjct: 158 KYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVTRW 206
Query: 736 LCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVT 771
                 Y APE      + +   D++S G ++ EM+T
Sbjct: 207 ------YRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 237

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 108/237 (45%), Gaps = 31/237 (13%)
Query: 555 ATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTK-----SFNRECQVLK 608
           AT+ ++    +G G+YG VYK      G  +A+K +++ +G         S  RE  +L+
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 609 RIR---HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRV 665
           R+    H N++R++  C+       +   +    +D  L  + +     G    T+    
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI---K 123
Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGA 725
           ++      G+ +LH +    ++H DLKP N+L+    T  ++DFG+A++          +
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---------S 171
Query: 726 ENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAG 782
             M  +   +   ++ Y APE    S  +T  D++S G +  EM  RR+P   +F G
Sbjct: 172 YQMALTPVVV---TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP---LFCG 221

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 62/253 (24%), Positives = 110/253 (43%), Gaps = 24/253 (9%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNL 615
           ++D  + LG G+YG V   + +    A+AVK++ ++   +  ++  +E  +   + H N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENV 67
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++        + + L L Y + G L   + P    + G    D    QR      +  G+
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDA---QR--FFHQLMAGV 118
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH    + + H D+KP N+LL++     +SDFG+A +            N      N 
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY---------NNRERLLNK 166
Query: 736 LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
           +CG++ Y+APE         +  DV+S GI++  M+    P D           W +   
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226
Query: 795 HGRLEKVIDSSLL 807
           +    K IDS+ L
Sbjct: 227 YLNPWKKIDSAPL 239

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 121/292 (41%), Gaps = 45/292 (15%)
Query: 517 IHRIKLIISSGKSET-------------RSKPITPELMHNFPRITYRELLEATAEFDE-- 561
           +H ++  +SSG++ +             RS+  +P+   N   +   +L     E+ E  
Sbjct: 14  VHALQGSVSSGQAHSLTSLAKTWAARGSRSREPSPKTEDNEGVLLTEKLKPVDYEYREEV 73
Query: 562 -----QRLLGTGSYGRVYK-GILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNL 615
                Q  LG GS+G V++    Q G   AVK ++L+   F       C  L   R   +
Sbjct: 74  HWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEV--FRAEELMACAGLTSPR---I 128
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           + +  A     +  + +  +  GSL   +      E G    D  L           EG+
Sbjct: 129 VPLYGAVREGPWVNIFMELLEGGSLGQLV-----KEQGCLPEDRALY----YLGQALEGL 179
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMT-ALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
            YLH     R++H D+K  NVLL+ D + A + DFG A  +   G+G D        T +
Sbjct: 180 EYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKD------LLTGD 230
Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSL 786
            + G+  +MAPE   G +   K DV+S   ++L M+    P    F G L L
Sbjct: 231 YIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCL 282

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 101/230 (43%), Gaps = 38/230 (16%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVLQLQSGNFTKSFN---RECQVLKRIRHR 613
           +FD  R++G GSY +V    L+    I A+KV++ +  N  +  +    E  V ++  + 
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 614 NLMRIITACSLPDFKAL-VLPYMANGSLDSHLY-----PHSETEFGSGSSDLTLLQRVNI 667
             +  + +C   + +   V+ Y+  G L  H+      P     F S             
Sbjct: 70  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS------------- 116
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
            ++I+  + YLH      +I+ DLK  NVLL+ +    ++D+G+ K  +  G        
Sbjct: 117 -AEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-------- 164
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
               T +  CG+  Y+APE   G +     D ++ G+L+ EM+  R P D
Sbjct: 165 ---DTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 108/237 (45%), Gaps = 36/237 (15%)
Query: 558 EFDEQRL-----LGTGSYGRVYK----GILQDGTAIAVKVLQLQ-SGNFTK--SFNRECQ 605
           EF   RL     LG G++G+V +    G+++   A+ V V  L+ S + T+  +   E +
Sbjct: 35  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 94
Query: 606 VLKRI-RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           VL  +  H N++ ++ AC++     ++  Y   G L + L    ++   S +S   +   
Sbjct: 95  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 154
Query: 665 V---------NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
                     +    +A+GMA+L   +    IH DL   N+LL       + DFG+A+  
Sbjct: 155 ELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR-- 209
Query: 716 MTVGVGNDGAENM-GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               + ND    + GN+        + +MAPE  F    + + DV+S+GI + E+ +
Sbjct: 210 ---DIKNDSNYVVKGNARL-----PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 65/288 (22%), Positives = 125/288 (43%), Gaps = 52/288 (18%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G++G+VYK   ++ G   A KV++ +S    + +  E ++L    H  +++++ A  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 +++ +   G++D+ +      E   G   LT  Q   +C  + E + +LH    
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIML-----ELDRG---LTEPQIQVVCRQMLEALNFLHSK-- 128
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN-STANMLCGSIGY 742
            R+IH DLK  NVL+  +    ++DFG++            A+N+      +   G+  +
Sbjct: 129 -RIIHRDLKAGNVLMTLEGDIRLADFGVS------------AKNLKTLQKRDSFIGTPYW 175
Query: 743 MAPEYGFGSNTST-----KGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR 797
           MAPE              K D++S GI ++EM     P  ++    + L          +
Sbjct: 176 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL----------K 225
Query: 798 LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
           + K    +LL  S+         W V   + +++ +    ++P TRP+
Sbjct: 226 IAKSDPPTLLTPSK---------WSVEFRDFLKIAL---DKNPETRPS 261

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 101/230 (43%), Gaps = 38/230 (16%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVLQLQSGNFTKSFN---RECQVLKRIRHR 613
           +FD  R++G GSY +V    L+    I A+KV++ +  N  +  +    E  V ++  + 
Sbjct: 6   DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 65
Query: 614 NLMRIITACSLPDFKAL-VLPYMANGSLDSHLY-----PHSETEFGSGSSDLTLLQRVNI 667
             +  + +C   + +   V+ Y+  G L  H+      P     F S             
Sbjct: 66  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS------------- 112
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
            ++I+  + YLH      +I+ DLK  NVLL+ +    ++D+G+ K  +  G        
Sbjct: 113 -AEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-------- 160
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
               T +  CG+  Y+APE   G +     D ++ G+L+ EM+  R P D
Sbjct: 161 ---DTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 102/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  +L    AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 622 CS----LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
            +    L +F+ +   Y+    +D++L    + E         L Q       +  G+ +
Sbjct: 92  FTPQKTLEEFQDV---YLVMELMDANLXQVIQMELDHERMSYLLYQ-------MLXGIKH 141
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAG------------TSFMMT 183
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EMV  +     +F G   + +W K
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 236

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 108/237 (45%), Gaps = 36/237 (15%)
Query: 558 EFDEQRL-----LGTGSYGRVYK----GILQDGTAIAVKVLQLQ-SGNFTK--SFNRECQ 605
           EF   RL     LG G++G+V +    G+++   A+ V V  L+ S + T+  +   E +
Sbjct: 37  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 96
Query: 606 VLKRI-RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           VL  +  H N++ ++ AC++     ++  Y   G L + L    ++   S +S   +   
Sbjct: 97  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 156
Query: 665 V---------NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
                     +    +A+GMA+L   +    IH DL   N+LL       + DFG+A+  
Sbjct: 157 ELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR-- 211
Query: 716 MTVGVGNDGAENM-GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               + ND    + GN+        + +MAPE  F    + + DV+S+GI + E+ +
Sbjct: 212 ---DIKNDSNYVVKGNARL-----PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 101/230 (43%), Gaps = 38/230 (16%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVLQLQSGNFTKSFN---RECQVLKRIRHR 613
           +FD  R++G GSY +V    L+    I A+KV++ +  N  +  +    E  V ++  + 
Sbjct: 21  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 80
Query: 614 NLMRIITACSLPDFKAL-VLPYMANGSLDSHLY-----PHSETEFGSGSSDLTLLQRVNI 667
             +  + +C   + +   V+ Y+  G L  H+      P     F S             
Sbjct: 81  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS------------- 127
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
            ++I+  + YLH      +I+ DLK  NVLL+ +    ++D+G+ K  +  G        
Sbjct: 128 -AEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-------- 175
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
               T +  CG+  Y+APE   G +     D ++ G+L+ EM+  R P D
Sbjct: 176 ---DTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 102/238 (42%), Gaps = 35/238 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQ----LQSGNFTKSFNRECQVLKRIR-H 612
           F+  R+LG GS+G+V    +++ G   AVKVL+    LQ  +   +   E ++L   R H
Sbjct: 25  FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMT-EKRILSLARNH 83
Query: 613 RNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIA 672
             L ++      PD    V+ ++  G L  H+       F    +           ++I 
Sbjct: 84  PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARF-------YAAEII 134
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
             + +LH      +I+ DLK  NVLL+ +    ++DFG+ K  +  GV           T
Sbjct: 135 SALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV-----------T 180
Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP-----TDDMFAGGLS 785
               CG+  Y+APE           D ++ G+L+ EM+    P      DD+F   L+
Sbjct: 181 TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 238

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/238 (22%), Positives = 109/238 (45%), Gaps = 48/238 (20%)
Query: 554 EATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFT--------KSFNREC 604
           E   ++D + ++G G    V + + +  G   AVK++++ +   +        ++  RE 
Sbjct: 91  EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRET 150
Query: 605 QVLKRIR-HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQ 663
            +L+++  H +++ +I +     F  LV   M  G L  +L         +    L+  +
Sbjct: 151 HILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---------TEKVALSEKE 201
Query: 664 RVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGND 723
             +I   + E +++LH ++   ++H DLKP N+LL+D+M   +SDFG +     +  G  
Sbjct: 202 TRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFS---CHLEPGEK 255
Query: 724 GAENMGNSTANMLCGSIGYMAPEY----------GFGSNTSTKGDVYSFGILVLEMVT 771
             E         LCG+ GY+APE           G+G       D+++ G+++  ++ 
Sbjct: 256 LRE---------LCGTPGYLAPEILKCSMDETHPGYGKEV----DLWACGVILFTLLA 300

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 108/237 (45%), Gaps = 36/237 (15%)
Query: 558 EFDEQRL-----LGTGSYGRVYK----GILQDGTAIAVKVLQLQ-SGNFTK--SFNRECQ 605
           EF   RL     LG G++G+V +    G+++   A+ V V  L+ S + T+  +   E +
Sbjct: 42  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 101
Query: 606 VLKRI-RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           VL  +  H N++ ++ AC++     ++  Y   G L + L    ++   S +S   +   
Sbjct: 102 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 161
Query: 665 V---------NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
                     +    +A+GMA+L   +    IH DL   N+LL       + DFG+A+  
Sbjct: 162 ELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR-- 216
Query: 716 MTVGVGNDGAENM-GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               + ND    + GN+        + +MAPE  F    + + DV+S+GI + E+ +
Sbjct: 217 ---DIKNDSNYVVKGNARL-----PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  +L    AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 622 CS----LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
            +    L +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 92  FTPQKTLEEFQDV---YLVMELMDANLXQVIQMELDHERMSYLLYQM--LC-----GIKH 141
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAG------------TSFMMT 183
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EMV  +     +F G   + +W K
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 236

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 108/237 (45%), Gaps = 36/237 (15%)
Query: 558 EFDEQRL-----LGTGSYGRVYK----GILQDGTAIAVKVLQLQ-SGNFTK--SFNRECQ 605
           EF   RL     LG G++G+V +    G+++   A+ V V  L+ S + T+  +   E +
Sbjct: 19  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 606 VLKRI-RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           VL  +  H N++ ++ AC++     ++  Y   G L + L    ++   S +S   +   
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 665 V---------NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
                     +    +A+GMA+L   +    IH DL   N+LL       + DFG+A+  
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR-- 193
Query: 716 MTVGVGNDGAENM-GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               + ND    + GN+        + +MAPE  F    + + DV+S+GI + E+ +
Sbjct: 194 ---DIKNDSNYVVKGNARL-----PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 565 LGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNR----ECQVLKRIRHRNLMR-- 617
           +GTGSYGR  K   + DG  +  K  +L  G+ T++  +    E  +L+ ++H N++R  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWK--ELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 618 --IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR---VNICSDIA 672
             II   +   +  +V+ Y   G L S +          G+ +   L     + + + + 
Sbjct: 72  DRIIDRTNTTLY--IVMEYCEGGDLASVI--------TKGTKERQYLDEEFVLRVMTQLT 121
Query: 673 EGMAYLHHHSPV--RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
             +   H  S     V+H DLKP+NV L+      + DFG+A+++           N   
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-----------NHDT 170
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEM 769
           S A    G+  YM+PE     + + K D++S G L+ E+
Sbjct: 171 SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 565 LGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNR----ECQVLKRIRHRNLMR-- 617
           +GTGSYGR  K   + DG  +  K  +L  G+ T++  +    E  +L+ ++H N++R  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWK--ELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 618 --IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR---VNICSDIA 672
             II   +   +  +V+ Y   G L S +          G+ +   L     + + + + 
Sbjct: 72  DRIIDRTNTTLY--IVMEYCEGGDLASVI--------TKGTKERQYLDEEFVLRVMTQLT 121
Query: 673 EGMAYLHHHSPV--RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
             +   H  S     V+H DLKP+NV L+      + DFG+A+++           N   
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-----------NHDT 170
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEM 769
           S A    G+  YM+PE     + + K D++S G L+ E+
Sbjct: 171 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 28/210 (13%)
Query: 559 FDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRI 618
           F+ +  LG G+   VY+   Q GT     +  L+     K    E  VL R+ H N++++
Sbjct: 55  FEVESELGRGATSIVYR-CKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKL 113
Query: 619 ITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
                 P   +LVL  +  G L   +      E G  S         +    I E +AYL
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRI-----VEKGYYSER----DAADAVKQILEAVAYL 164
Query: 679 HHHSPVRVIHCDLKPSNVLLND---DMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
           H +    ++H DLKP N+L      D    ++DFG++K+V                    
Sbjct: 165 HENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH------------QVLMKT 209
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGIL 765
           +CG+ GY APE   G     + D++S GI+
Sbjct: 210 VCGTPGYCAPEILRGCAYGPEVDMWSVGII 239

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 108/237 (45%), Gaps = 36/237 (15%)
Query: 558 EFDEQRL-----LGTGSYGRVYK----GILQDGTAIAVKVLQLQ-SGNFTK--SFNRECQ 605
           EF   RL     LG G++G+V +    G+++   A+ V V  L+ S + T+  +   E +
Sbjct: 42  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 101
Query: 606 VLKRI-RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           VL  +  H N++ ++ AC++     ++  Y   G L + L    ++   S +S   +   
Sbjct: 102 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 161
Query: 665 V---------NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
                     +    +A+GMA+L   +    IH DL   N+LL       + DFG+A+  
Sbjct: 162 ELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR-- 216
Query: 716 MTVGVGNDGAENM-GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               + ND    + GN+        + +MAPE  F    + + DV+S+GI + E+ +
Sbjct: 217 ---HIKNDSNYVVKGNARL-----PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 107/226 (47%), Gaps = 33/226 (14%)
Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVL--QLQSGNFTKSFNRECQVLKRIR-HRNLMRI 618
           + LG G+YG V+K I  + G  +AVK +    Q+    +   RE  +L  +  H N++ +
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 619 ITACSLPDFKALVLPYMANGSLDSHL-YPHSETEFGS--GSSDLTLLQRVNICSDIAEGM 675
           +                A+   D +L + + ET+  +   ++ L  + +  +   + + +
Sbjct: 75  LNVLR------------ADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVI 122
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV-GVGNDGAENMGNSTAN 734
            YLH      ++H D+KPSN+LLN +    V+DFG+++  + +  V N+   ++  +T N
Sbjct: 123 KYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 735 M---------LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
                        +  Y APE   GS   TKG D++S G ++ E++
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  IL+   AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 622 C----SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
                SL +F+ +   Y+    +D++L    + E         L Q       +  G+ +
Sbjct: 92  FTPQKSLEEFQDV---YIVMELMDANLSQVIQMELDHERMSYLLYQ-------MLVGIKH 141
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR---TAG------------TSFMMT 183
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G+++ EM+        +F G   + +W K
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIK----GGVLFPGTDHIDQWNK 236

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  IL+   AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 622 C----SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
                SL +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 92  FTPQKSLEEFQDV---YIVMELMDANLCQVIQMELDHERMSYLLYQM--LC-----GIKH 141
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG------------TSFMME 183
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EMV  +     +F G   + +W K
Sbjct: 184 PEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKI----LFPGRDYIDQWNK 236

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 62/253 (24%), Positives = 110/253 (43%), Gaps = 24/253 (9%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNL 615
           ++D  + LG G+YG V   + +    A+AVK++ ++   +  ++  +E  + K + H N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 66
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++        + + L L Y + G L   + P    + G    D    QR      +  G+
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDA---QR--FFHQLMAGV 117
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH    + + H D+KP N+LL++     +SDFG+A +            N      N 
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY---------NNRERLLNK 165
Query: 736 LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
           + G++ Y+APE         +  DV+S GI++  M+    P D           W +   
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 225
Query: 795 HGRLEKVIDSSLL 807
           +    K IDS+ L
Sbjct: 226 YLNPWKKIDSAPL 238

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 62/253 (24%), Positives = 110/253 (43%), Gaps = 24/253 (9%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNL 615
           ++D  + LG G+ G V   + +    A+AVK++ ++   +  ++  +E  + K + H N+
Sbjct: 7   DWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++        + + L L Y + G L   + P    + G    D    QR      +  G+
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDA---QR--FFHQLMAGV 117
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH    + + H D+KP N+LL++     +SDFG+A +            N      N 
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY---------NNRERLLNK 165
Query: 736 LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
           +CG++ Y+APE         +  DV+S GI++  M+    P D           W +   
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 225
Query: 795 HGRLEKVIDSSLL 807
           +    K IDS+ L
Sbjct: 226 YLNPWKKIDSAPL 238

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 62/253 (24%), Positives = 110/253 (43%), Gaps = 24/253 (9%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNL 615
           ++D  + LG G+YG V   + +    A+AVK++ ++   +  ++  +E  + K + H N+
Sbjct: 8   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENV 67
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++        + + L L Y + G L   + P    + G    D    QR      +  G+
Sbjct: 68  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDA---QR--FFHQLMAGV 118
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH    + + H D+KP N+LL++     +SDFG+A +            N      N 
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY---------NNRERLLNK 166
Query: 736 LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
           + G++ Y+APE         +  DV+S GI++  M+    P D           W +   
Sbjct: 167 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226
Query: 795 HGRLEKVIDSSLL 807
           +    K IDS+ L
Sbjct: 227 YLNPWKKIDSAPL 239

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 63/216 (29%), Positives = 93/216 (43%), Gaps = 32/216 (14%)
Query: 571 GRVYKGILQDGTAIAVKVLQLQSGNFTKS--FNRECQVLKRIRHRNLMRIITACSLP--D 626
           G ++KG  Q G  I VKVL+++  +  KS  FN EC  L+   H N++ ++ AC  P   
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 627 FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRV 686
              L+  +   GSL + L  H  T F    S     Q V    D A G A+LH   P+  
Sbjct: 83  HPTLITHWXPYGSLYNVL--HEGTNFVVDQS-----QAVKFALDXARGXAFLHTLEPLIP 135
Query: 687 IHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPE 746
            H  L   +V +++D TA +S   +     + G     A                ++APE
Sbjct: 136 RHA-LNSRSVXIDEDXTARISXADVKFSFQSPGRXYAPA----------------WVAPE 178
Query: 747 YGFGSNTSTK---GDVYSFGILVLEMVTRRRPTDDM 779
                   T     D +SF +L+ E+VTR  P  D+
Sbjct: 179 ALQKKPEDTNRRSADXWSFAVLLWELVTREVPFADL 214

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  +L    AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNV 91
Query: 622 CS----LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
            +    L +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 92  FTPQKTLEEFQDV---YLVMELMDANLCQVIQMELDHERMSYLLYQM--LC-----GIKH 141
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAG------------TSFMMT 183
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EMV  +     +F G   + +W K
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 236

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 25/207 (12%)
Query: 565 LGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           +G GS G V     +  G  +AVK + L+     +    E  +++   H N++ + ++  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
           + D   +V+ ++  G+L + +  H+          +   Q   +C  +   ++YLH+   
Sbjct: 113 VGDELWVVMEFLEGGAL-TDIVTHTR---------MNEEQIATVCLSVLRALSYLHNQG- 161
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
             VIH D+K  ++LL  D    +SDFG    V           +        L G+  +M
Sbjct: 162 --VIHRDIKSDSILLTSDGRIKLSDFGFCAQV-----------SKEVPKRKXLVGTPYWM 208
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMV 770
           APE        T+ D++S GI+V+EM+
Sbjct: 209 APEVISRLPYGTEVDIWSLGIMVIEMI 235

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  IL+   AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 622 C----SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
                SL +F+ +   Y+    +D++L    + E         L Q       +  G+ +
Sbjct: 92  FTPQKSLEEFQDV---YIVMELMDANLSQVIQMELDHERMSYLLYQ-------MLVGIKH 141
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR---TAG------------TSFMMT 183
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G+++ EM+        +F G   + +W K
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIK----GGVLFPGTDHIDQWNK 236

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 565 LGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTK-SFNRECQVLKRIRHRNLMRIITAC 622
           LG G+Y  VYKG  +     +A+K ++L+       +  RE  +LK ++H N++ +    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI-CSDIAEGMAYLHHH 681
                  LV  Y     LD  L      ++     ++  +  V +    +  G+AY H  
Sbjct: 70  HTEKSLTLVFEY-----LDKDL-----KQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIG 741
              +V+H DLKP N+L+N+     ++DFG+A+           A+++   T +    ++ 
Sbjct: 120 ---KVLHRDLKPQNLLINERGELKLADFGLAR-----------AKSIPTKTYDNEVVTLW 165
Query: 742 YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           Y  P+   GS + ST+ D++  G +  EM T R
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 565 LGTGSYGRVYKGIL---QDGTAIAVKVLQLQSGNF-TKSFNRECQVLKRIRHRNLMRIIT 620
           LG G++G V +G+    +    +A+KVL+  +    T+   RE Q++ ++ +  ++R+I 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
            C     +AL+L     G    H +   + E    S+   LL +V++      GM YL  
Sbjct: 404 VCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM------GMKYLEE 454
Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
            +    +H +L   NVLL +   A +SDFG++K      +G D +     S        +
Sbjct: 455 KN---FVHRNLAARNVLLVNRHYAKISDFGLSK-----ALGADDSYYTARSAGKW---PL 503
Query: 741 GYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            + APE       S++ DV+S+G+ + E ++
Sbjct: 504 KWYAPECINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 102/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  +L    AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 622 CS----LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
            +    L +F+ +   Y+    +D++L    + E         L Q       +  G+ +
Sbjct: 85  FTPQKTLEEFQDV---YLVMELMDANLXQVIQMELDHERMSYLLYQ-------MLXGIKH 134
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAG------------TSFMMT 176
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EMV  +     +F G   + +W K
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 229

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 38/230 (16%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVLQLQSGNFTKSFN---RECQVLKRIRHR 613
           +FD  R++G GSY +V    L+    I A++V++ +  N  +  +    E  V ++  + 
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 614 NLMRIITACSLPDFKAL-VLPYMANGSLDSHLY-----PHSETEFGSGSSDLTLLQRVNI 667
             +  + +C   + +   V+ Y+  G L  H+      P     F S             
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS------------- 159
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
            ++I+  + YLH      +I+ DLK  NVLL+ +    ++D+G+ K  +  G        
Sbjct: 160 -AEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-------- 207
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
               T +  CG+  Y+APE   G +     D ++ G+L+ EM+  R P D
Sbjct: 208 ---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 102/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  +L    AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 622 CS----LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
            +    L +F+ +   Y+    +D++L    + E         L Q       +  G+ +
Sbjct: 92  FTPQKTLEEFQDV---YLVMELMDANLXQVIQMELDHERMSYLLYQ-------MLXGIKH 141
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAG------------TSFMMT 183
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EMV  +     +F G   + +W K
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 236

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIR-HRNLMRIIT 620
            LLG G+Y +V   + LQ+G   AVK+++ Q+G+      RE + L + + ++N++ +I 
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIE 78
Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
                    LV   +  GS+ +H+    +  F    +         +  D+A  + +LH 
Sbjct: 79  FFEDDTRFYLVFEKLQGGSILAHI--QKQKHFNEREAS-------RVVRDVAAALDFLHT 129
Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG-NDGAENMGNSTANMLCGS 739
                + H DLKP N+L   +    VS   I    +  G+  N+    +        CGS
Sbjct: 130 KG---IAHRDLKPENILC--ESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGS 184
Query: 740 IGYMAPEY-----GFGSNTSTKGDVYSFGILVLEMVTRRRP 775
             YMAPE         +    + D++S G+++  M++   P
Sbjct: 185 AEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  IL+   AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 26  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 85
Query: 622 C----SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
                SL +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 86  FTPQKSLEEFQDV---YIVMELMDANLCQVIQMELDHERMSYLLYQM--LC-----GIKH 135
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 136 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG------------TSFMMT 177
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EMV  +     +F G   + +W K
Sbjct: 178 PYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKI----LFPGRDYIDQWNK 230

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 39/217 (17%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRN---LMRI 618
           +G+G+YG V   I  + G  +A+K L    QS  F K   RE  +LK ++H N   L+ +
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 619 IT-ACSLPDFK--ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
            T A SL +F    LV+P+M            SE +               +   + +G+
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY------------LVYQMLKGL 139
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            Y+H      V+H DLKP N+ +N+D    + DFG+A+        +  AE  G      
Sbjct: 140 KYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVTRW 188
Query: 736 LCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVT 771
                 Y APE      + +   D++S G ++ EM+T
Sbjct: 189 ------YRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 219

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 76/310 (24%), Positives = 125/310 (40%), Gaps = 65/310 (20%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI--RHRNLMRIITAC 622
           +G G YG V++G  Q G  +AVK+    S    KS+ RE ++   +  RH N++  I + 
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 623 SLPDFKA----LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN---ICSDIAEGM 675
                 +    L+  Y   GSL  +L              LT L  V+   I   IA G+
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYL-------------QLTTLDTVSCLRIVLSIASGL 118
Query: 676 AYLH-----HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           A+LH           + H DLK  N+L+  +    ++D G+A       V +  + N  +
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-------VMHSQSTNQLD 171
Query: 731 STANMLCGSIGYMAPEYGFGS------NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGL 784
              N   G+  YMAPE    +      ++  + D+++FG+++ E+  R      M + G 
Sbjct: 172 VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR------MVSNG- 224
Query: 785 SLHKWVKNHYHGRLEKVI-------DSSLLRASRDQSPEVKRMW--DVAIGELIELGILC 835
                +   Y      V+       D   +     Q P +   W  D  +  L +L   C
Sbjct: 225 -----IVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKEC 279
Query: 836 TQESPSTRPT 845
             ++PS R T
Sbjct: 280 WYQNPSARLT 289

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 97  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 142 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 181
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           TA+ + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  IL+   AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 37  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 96
Query: 622 C----SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
                SL +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 97  FTPQKSLEEFQDV---YIVMELMDANLCQVIQMELDHERMSYLLYQM--LC-----GIKH 146
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 147 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG------------TSFMMT 188
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EMV  +     +F G   + +W K
Sbjct: 189 PYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKI----LFPGRDYIDQWNK 241

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 62/253 (24%), Positives = 110/253 (43%), Gaps = 24/253 (9%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNL 615
           ++D  + LG G+YG V   + +    A+AVK++ ++   +  ++  +E  + K + H N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++        + + L L Y + G L   + P    + G    D    QR      +  G+
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDA---QR--FFHQLMAGV 117
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH    + + H D+KP N+LL++     +SDFG+A +            N      N 
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY---------NNRERLLNK 165
Query: 736 LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
           + G++ Y+APE         +  DV+S GI++  M+    P D           W +   
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKT 225
Query: 795 HGRLEKVIDSSLL 807
           +    K IDS+ L
Sbjct: 226 YLNPWKKIDSAPL 238

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 126/311 (40%), Gaps = 67/311 (21%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI--RHRNLMRIITAC 622
           +G G YG V++G  Q G  +AVK+    S    KS+ RE ++   +  RH N++  I + 
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 623 SLPDFKA----LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN---ICSDIAEGM 675
                 +    L+  Y   GSL  +L              LT L  V+   I   IA G+
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYL-------------QLTTLDTVSCLRIVLSIASGL 118
Query: 676 AYLH------HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           A+LH         P  + H DLK  N+L+  +    ++D G+A       V +  + N  
Sbjct: 119 AHLHIEIFGTQGKPA-IAHRDLKSKNILVKKNGQCCIADLGLA-------VMHSQSTNQL 170
Query: 730 NSTANMLCGSIGYMAPEYGFGS------NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGG 783
           +   N   G+  YMAPE    +      ++  + D+++FG+++ E+  R      M + G
Sbjct: 171 DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR------MVSNG 224
Query: 784 LSLHKWVKNHYHGRLEKVI-------DSSLLRASRDQSPEVKRMW--DVAIGELIELGIL 834
                 +   Y      V+       D   +     Q P +   W  D  +  L +L   
Sbjct: 225 ------IVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKE 278
Query: 835 CTQESPSTRPT 845
           C  ++PS R T
Sbjct: 279 CWYQNPSARLT 289

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 97  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 142 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 181
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           TA+ + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 31/224 (13%)
Query: 559 FDEQRLLGTGSYGRVYKGILQDGTAI-AVKVLQLQS---GNFTKSFNRECQVLKRIRHRN 614
           F+  R +G GS+G+V      D   + A+K +  Q     N  ++  +E Q+++ + H  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           L+ +  +    +   +V+  +  G L  HL       F   +  L       IC ++   
Sbjct: 77  LVNLWYSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLF------IC-ELVMA 127
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           + YL +    R+IH D+KP N+LL++     ++DF IA ++               +   
Sbjct: 128 LDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR------------ETQIT 172
Query: 735 MLCGSIGYMAPEY---GFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            + G+  YMAPE      G+  S   D +S G+   E++  RRP
Sbjct: 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 97  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 142 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 181
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           TA+ + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  IL+   AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 622 C----SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
                SL +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 92  FTPQKSLEEFQDV---YIVMELMDANLCQVIQMELDHERMSYLLYQM--LC-----GIKH 141
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG------------TSFMME 183
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EMV  +     +F G   + +W K
Sbjct: 184 PEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKI----LFPGRDYIDQWNK 236

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 83/317 (26%), Positives = 114/317 (35%), Gaps = 59/317 (18%)
Query: 565 LGTGSYGRVYKGILQ----DGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRHRNLMR 617
           LG GS+G V +G          ++AVK L+   L        F RE   +  + HRNL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +      P  K +V      GSL   L  H       G   L  L R  +   +AEGM Y
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAV--QVAEGMGY 130
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L      R IH DL   N+LL       + DFG+ + +      ND    M         
Sbjct: 131 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ----NDDHYVMQEHRKV--- 180
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR 797
               + APE       S   D + FG+ + EM T  +       G   LHK         
Sbjct: 181 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK--------- 230
Query: 798 LEKVIDSSLLRASR-DQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMXXXXXXXXRL 856
               ID    R  R +  P+          ++  + + C    P  RPT          L
Sbjct: 231 ----IDKEGERLPRPEDCPQ----------DIYNVMVQCWAHKPEDRPTFVA-------L 269
Query: 857 KRYLGEKHMPSKMNALH 873
           + +L E   P+ M AL 
Sbjct: 270 RDFLLEAQ-PTDMRALQ 285

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 62/253 (24%), Positives = 110/253 (43%), Gaps = 24/253 (9%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNL 615
           ++D  + LG G+YG V   + +    A+AVK++ ++   +  ++  +E  + K + H N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++        + + L L Y + G L   + P    + G    D    QR      +  G+
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDA---QR--FFHQLMAGV 117
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH    + + H D+KP N+LL++     +SDFG+A +            N      N 
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY---------NNRERLLNK 165
Query: 736 LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
           + G++ Y+APE         +  DV+S GI++  M+    P D           W +   
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 225
Query: 795 HGRLEKVIDSSLL 807
           +    K IDS+ L
Sbjct: 226 YLNPWKKIDSAPL 238

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 62/253 (24%), Positives = 110/253 (43%), Gaps = 24/253 (9%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNL 615
           ++D  + LG G+YG V   + +    A+AVK++ ++   +  ++  +E  + K + H N+
Sbjct: 7   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 66
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++        + + L L Y + G L   + P    + G    D    QR      +  G+
Sbjct: 67  VKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDA---QR--FFHQLMAGV 117
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH    + + H D+KP N+LL++     +SDFG+A +            N      N 
Sbjct: 118 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY---------NNRERLLNK 165
Query: 736 LCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
           + G++ Y+APE         +  DV+S GI++  M+    P D           W +   
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 225
Query: 795 HGRLEKVIDSSLL 807
           +    K IDS+ L
Sbjct: 226 YLNPWKKIDSAPL 238

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 76/310 (24%), Positives = 125/310 (40%), Gaps = 65/310 (20%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI--RHRNLMRIITAC 622
           +G G YG V++G  Q G  +AVK+    S    KS+ RE ++   +  RH N++  I + 
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 623 SLPDFKA----LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN---ICSDIAEGM 675
                 +    L+  Y   GSL  +L              LT L  V+   I   IA G+
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYL-------------QLTTLDTVSCLRIVLSIASGL 147
Query: 676 AYLH-----HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           A+LH           + H DLK  N+L+  +    ++D G+A       V +  + N  +
Sbjct: 148 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-------VMHSQSTNQLD 200
Query: 731 STANMLCGSIGYMAPEYGFGS------NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGL 784
              N   G+  YMAPE    +      ++  + D+++FG+++ E+  R      M + G 
Sbjct: 201 VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR------MVSNG- 253
Query: 785 SLHKWVKNHYHGRLEKVI-------DSSLLRASRDQSPEVKRMW--DVAIGELIELGILC 835
                +   Y      V+       D   +     Q P +   W  D  +  L +L   C
Sbjct: 254 -----IVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKEC 308
Query: 836 TQESPSTRPT 845
             ++PS R T
Sbjct: 309 WYQNPSARLT 318

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  +L    AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 622 CS----LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
            +    L +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 85  FTPQKTLEEFQDV---YLVMELMDANLCQVIQMELDHERMSYLLYQM--LC-----GIKH 134
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG------------TSFMMT 176
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EMV  +     +F G   + +W K
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 229

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  +L    AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 31  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 90
Query: 622 CS----LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
            +    L +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 91  FTPQKTLEEFQDV---YLVMELMDANLCQVIQMELDHERMSYLLYQM--LC-----GIKH 140
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 141 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG------------TSFMMT 182
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EMV  +     +F G   + +W K
Sbjct: 183 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 235

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  +L    AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 622 CS----LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
            +    L +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 92  FTPQKTLEEFQDV---YLVMELMDANLCQVIQMELDHERMSYLLYQM--LC-----GIKH 141
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG------------TSFMMT 183
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EMV  +     +F G   + +W K
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 236

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  +L    AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 622 CS----LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
            +    L +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 86  FTPQKTLEEFQDV---YLVMELMDANLCQVIQMELDHERMSYLLYQM--LC-----GIKH 135
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 136 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG------------TSFMMT 177
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EMV  +     +F G   + +W K
Sbjct: 178 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 230

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  +L    AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 91
Query: 622 CS----LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
            +    L +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 92  FTPQKTLEEFQDV---YLVMELMDANLCQVIQMELDHERMSYLLYQM--LC-----GIKH 141
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG------------TSFMMT 183
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EMV  +     +F G   + +W K
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 236

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 91/216 (42%), Gaps = 36/216 (16%)
Query: 565 LGTGSYGRVYKGIL----QDGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRI 618
           +G GS+G   K IL    +DG    +K + +   S    +   RE  VL  ++H N+++ 
Sbjct: 32  IGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 619 ITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
             +        +V+ Y   G L   +       F     D  L   V IC      +A  
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLF---QEDQILDWFVQIC------LALK 139
Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCG 738
           H H   +++H D+K  N+ L  D T  + DFGIA+++              NST  +   
Sbjct: 140 HVHDR-KILHRDIKSQNIFLTKDGTVQLGDFGIARVL--------------NSTVELARA 184
Query: 739 SIG---YMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            IG   Y++PE       + K D+++ G ++ E+ T
Sbjct: 185 CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 37/219 (16%)
Query: 565 LGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNR----ECQVLKRIRHRNLMR-- 617
           +GTGSYGR  K   + DG  +  K  +L  G+ T++  +    E  +L+ ++H N++R  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWK--ELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 618 --IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR---VNICSDIA 672
             II   +   +  +V+ Y   G L S +          G+ +   L     + + + + 
Sbjct: 72  DRIIDRTNTTLY--IVMEYCEGGDLASVI--------TKGTKERQYLDEEFVLRVMTQLT 121
Query: 673 EGMAYLHHHSPV--RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
             +   H  S     V+H DLKP+NV L+      + DFG+A+++           N   
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-----------NHDE 170
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEM 769
             A    G+  YM+PE     + + K D++S G L+ E+
Sbjct: 171 DFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  +L    AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 622 CS----LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
            +    L +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 93  FTPQKTLEEFQDV---YLVMELMDANLCQVIQMELDHERMSYLLYQM--LC-----GIKH 142
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 143 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG------------TSFMMT 184
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EMV  +     +F G   + +W K
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 237

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  +L    AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 622 CS----LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
            +    L +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 86  FTPQKTLEEFQDV---YLVMELMDANLCQVIQMELDHERMSYLLYQM--LC-----GIKH 135
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 136 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG------------TSFMMT 177
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EMV  +     +F G   + +W K
Sbjct: 178 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 230

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V     ++ G  IAVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 119 FTPATSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 163
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 164 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 203
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 204 TDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  IL+   AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 622 C----SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
                SL +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 92  FTPQKSLEEFQDV---YIVMELMDANLSQVIQMELDHERMSYLLYQM--LC-----GIKH 141
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR---TAG------------TSFMMT 183
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EM+        +F G   + +W K
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNK 236

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  +L    AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 33  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 92
Query: 622 CS----LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
            +    L +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 93  FTPQKTLEEFQDV---YLVMELMDANLCQVIQMELDHERMSYLLYQM--LC-----GIKH 142
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 143 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG------------TSFMMT 184
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EMV  +     +F G   + +W K
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 237

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 120/292 (41%), Gaps = 45/292 (15%)
Query: 517 IHRIKLIISSGKSET-------------RSKPITPELMHNFPRITYRELLEATAEFDE-- 561
           +H ++  +SSG++ +             RS+  +P+   N   +   +L     E+ E  
Sbjct: 33  VHALQGSVSSGQAHSLTSLAKTWAARGSRSREPSPKTEDNEGVLLTEKLKPVDYEYREEV 92
Query: 562 -----QRLLGTGSYGRVYK-GILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNL 615
                Q  LG GS+G V++    Q G   AVK ++L+   F       C  L   R   +
Sbjct: 93  HWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEV--FRAEELMACAGLTSPR---I 147
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           + +  A     +  + +  +  GSL   +      E G    D  L           EG+
Sbjct: 148 VPLYGAVREGPWVNIFMELLEGGSLGQLV-----KEQGCLPEDRALY----YLGQALEGL 198
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMT-ALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
            YLH     R++H D+K  NVLL+ D + A + DFG A  +   G+G          T +
Sbjct: 199 EYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKS------LLTGD 249
Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSL 786
            + G+  +MAPE   G +   K DV+S   ++L M+    P    F G L L
Sbjct: 250 YIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCL 301

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  IL+   AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 622 C----SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
                SL +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 92  FTPQKSLEEFQDV---YIVMELMDANLCQVIQMELDHERMSYLLYQM--LC-----GIKH 141
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG------------TSFMMT 183
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EM+        +F G   + +W K
Sbjct: 184 PEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNK 236

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 53/103 (51%), Gaps = 14/103 (13%)
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+ YLH++   RVIH DLK  N+ LNDDM   + DFG+A       +  DG        
Sbjct: 153 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERK----- 199
Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              LCG+  Y+APE       S + D++S G ++  ++  + P
Sbjct: 200 -KTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 53/103 (51%), Gaps = 14/103 (13%)
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+ YLH++   RVIH DLK  N+ LNDDM   + DFG+A       +  DG        
Sbjct: 153 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERK----- 199
Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              LCG+  Y+APE       S + D++S G ++  ++  + P
Sbjct: 200 -KXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 106/231 (45%), Gaps = 20/231 (8%)
Query: 553 LEATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIR 611
           L   ++F+E  +LG G++G+V K     D    A+K ++      +   + E  +L  + 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS-EVXLLASLN 60
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD- 670
           H+ ++R   A    + +  V P  A     S L+   E        DL   + +N   D 
Sbjct: 61  HQYVVRYYAAW--LERRNFVKPXTAVKK-KSTLFIQXEYCENRTLYDLIHSENLNQQRDE 117
Query: 671 -------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV-MTVGVGN 722
                  I E ++Y+H      +IH +LKP N+ +++     + DFG+AK V  ++ +  
Sbjct: 118 YWRLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 723 DGAENMGNSTANMLC--GSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMV 770
             ++N+  S+ N+    G+  Y+A E   G+ + + K D YS GI+  E +
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 565 LGTGSYGRVYKGIL---QDGTAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMRIIT 620
           LG G++G V +G+    +    +A+KVL Q      T+   RE Q++ ++ +  ++R+I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
            C     +AL+L     G    H +   + E    S+   LL +V++      GM YL  
Sbjct: 78  VCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM------GMKYLEE 128
Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
            +    +H DL   NVLL +   A +SDFG++K      +G D +     S        +
Sbjct: 129 KN---FVHRDLAARNVLLVNRHYAKISDFGLSK-----ALGADDSYYTARSAGKW---PL 177
Query: 741 GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
            + APE       S++ DV+S+G+ + E ++  ++P   M
Sbjct: 178 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  IL+   AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 622 C----SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
                SL +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 92  FTPQKSLEEFQDV---YIVMELMDANLSQVIQMELDHERMSYLLYQM--LC-----GIKH 141
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR---TAG------------TSFMMT 183
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EM+        +F G   + +W K
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNK 236

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  +L    AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 622 CS----LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
            +    L +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 130 FTPQKTLEEFQDV---YLVMELMDANLCQVIQMELDHERMSYLLYQM--LC-----GIKH 179
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 180 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG------------TSFMMT 221
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EMV  +     +F G   + +W K
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 274

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 102/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  IL+   AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNV 91
Query: 622 C----SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
                SL +F+ +   Y+    +D++L    + E         L Q       +  G+ +
Sbjct: 92  FTPQKSLEEFQDV---YIVMELMDANLSQVIQMELDHERMSYLLYQ-------MLVGIKH 141
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR---TAG------------TSFMMT 183
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EM+        +F G   + +W K
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNK 236

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 53/241 (21%), Positives = 97/241 (40%), Gaps = 65/241 (26%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLM 616
           +F E  L+G+G +G+V+K   + DG    +K ++  +    +   RE + L ++ H N++
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIV 67
Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLY-PHSETEFGSGSSDLTLLQRVNIC------- 668
                               NG  D   Y P + ++  S S    L  ++  C       
Sbjct: 68  HY------------------NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQ 109
Query: 669 -------------------SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDF 709
                                I +G+ Y+H     ++I+ DLKPSN+ L D     + DF
Sbjct: 110 WIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDF 166
Query: 710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEM 769
           G     +   + NDG             G++ YM+PE     +   + D+Y+ G+++ E+
Sbjct: 167 G-----LVTSLKNDGKRXRSK-------GTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214
Query: 770 V 770
           +
Sbjct: 215 L 215

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 90  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 174
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE    + + +   D++S G ++ E++T R
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 53/103 (51%), Gaps = 14/103 (13%)
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+ YLH++   RVIH DLK  N+ LNDDM   + DFG+A       +  DG        
Sbjct: 137 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKD--- 185
Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              LCG+  Y+APE       S + D++S G ++  ++  + P
Sbjct: 186 ---LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 106/229 (46%), Gaps = 30/229 (13%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVLQLQSGN--FTKSFNRECQVLKRIRHRN 614
           ++++   +G G+YG V+K   ++   I A+K ++L   +     S  RE  +LK ++H+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           ++R+           LV  +      D  L  +    F S + DL      +    + +G
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFC-----DQDLKKY----FDSCNGDLDPEIVKSFLFQLLKG 113
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           + + H  +   V+H DLKP N+L+N +    ++DFG+A+    + V    AE +      
Sbjct: 114 LGFCHSRN---VLHRDLKPQNLLINRNGELKLADFGLAR-AFGIPVRCYSAEVV------ 163
Query: 735 MLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTDDMFAG 782
               ++ Y  P+  FG+   ST  D++S G +  E+    RP   +F G
Sbjct: 164 ----TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARP---LFPG 205

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  IL+   AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 622 C----SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
                SL +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 92  FTPQKSLEEFQDV---YIVMELMDANLSQVIQMELDHERMSYLLYQM--LC-----GIKH 141
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG------------TSFMMT 183
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EM+        +F G   + +W K
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNK 236

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  IL+   AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 622 C----SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
                SL +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 92  FTPQKSLEEFQDV---YIVMELMDANLCQVIQMELDHERMSYLLYQM--LC-----GIKH 141
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG------------TSFMMT 183
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EM+        +F G   + +W K
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNK 236

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  +L    AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 622 CS----LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
            +    L +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 130 FTPQKTLEEFQDV---YLVMELMDANLCQVIQMELDHERMSYLLYQM--LC-----GIKH 179
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 180 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG------------TSFMMT 221
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EMV  +     +F G   + +W K
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQWNK 274

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 101/232 (43%), Gaps = 30/232 (12%)
Query: 557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTK-SFNRECQVLKRIRHRN 614
            +F+  + LG G +G V++   + D    A+K ++L +    +    RE + L ++ H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSE-------TEFGSGSSDLTLLQR--- 664
           ++R   A    +    + P     S   +LY   +        ++ +G   +   +R   
Sbjct: 65  IVRYFNAWLEKNTTEKLQP----SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
           ++I   IAE + +LH      ++H DLKPSN+    D    V DFG     +   +  D 
Sbjct: 121 LHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFG-----LVTAMDQDE 172
Query: 725 AENM------GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
            E          +      G+  YM+PE   G++ S K D++S G+++ E++
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 90  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKXQKLTDDHVQFLIYQI 134
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR-----------------H 174
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 53/103 (51%), Gaps = 14/103 (13%)
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           +G+ YLH++   RVIH DLK  N+ LNDDM   + DFG+A       +  DG        
Sbjct: 153 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKD--- 201
Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              LCG+  Y+APE       S + D++S G ++  ++  + P
Sbjct: 202 ---LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 95  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 139
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 140 LRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR-----------------H 179
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 180 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  IL+   AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 622 C----SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
                SL +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 92  FTPQKSLEEFQDV---YIVMELMDANLCQVIQMELDHERMSYLLYQM--LC-----GIKH 141
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG------------TSFMMT 183
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EM+        +F G   + +W K
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNK 236

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  IL+   AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 34  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 93
Query: 622 C----SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
                SL +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 94  FTPQKSLEEFQDV---YIVMELMDANLCQVIQMELDHERMSYLLYQM--LC-----GIKH 143
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 144 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG------------TSFMMV 185
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EM+        +F G   + +W K
Sbjct: 186 PFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNK 238

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 42/237 (17%)
Query: 565 LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +G+G+ G V   Y  IL+   AI       Q+    K   RE  ++K + H+N++ ++  
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 622 C----SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
                SL +F+ +   Y+    +D++L    + E         L Q   +C     G+ +
Sbjct: 93  FTPQKSLEEFQDV---YIVMELMDANLCQVIQMELDHERMSYLLYQM--LC-----GIKH 142
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      +IH DLKPSN+++  D T  + DFG+A+   T G            T+ M+ 
Sbjct: 143 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG------------TSFMMT 184
Query: 738 GSI---GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
             +    Y APE   G       D++S G ++ EM+        +F G   + +W K
Sbjct: 185 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQWNK 237

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 95  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 139
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 140 LRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR-----------------H 179
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 180 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 36/214 (16%)
Query: 562 QRLLGTGSYGRVYKGILQD---GTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNL 615
           QR+LG GS+G V   + +D   G   AVKV+   Q++     +S  RE Q+LK++ H N+
Sbjct: 31  QRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
            ++        +  LV      G L   +               + +    I   +  G+
Sbjct: 89  XKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---------FSEVDAARIIRQVLSGI 139
Query: 676 AYLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
            Y H +   +++H DLKP N+LL   + D    + DFG++          D         
Sbjct: 140 TYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK-------- 188
Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
                G+  Y+APE   G+    K DV+S G+++
Sbjct: 189 ----IGTAYYIAPEVLHGT-YDEKCDVWSTGVIL 217

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 34/222 (15%)
Query: 564 LLGTGSYGRVYKGILQD--GTAIAVKVLQLQSGNFTKSFNREC-QVLKRI-----RHRNL 615
           +LG GS+G+V   +L D  GT     +  L+     +  + EC  V KR+     +   L
Sbjct: 26  VLGKGSFGKV---MLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFL 82
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
            ++ +     D    V+ Y+  G L  H+                  Q V   ++I+ G+
Sbjct: 83  TQLHSCFQTVDRLYFVMEYVNGGDLMYHI---------QQVGKFKEPQAVFYAAEISIGL 133
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            +LH      +I+ DLK  NV+L+ +    ++DFG+ K  M  GV           T   
Sbjct: 134 FFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV-----------TTRE 179
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
            CG+  Y+APE           D +++G+L+ EM+  + P D
Sbjct: 180 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 90  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKXQKLTDDHVQFLIYQI 134
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 174
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 90/207 (43%), Gaps = 25/207 (12%)
Query: 565 LGTGSYGRV-YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           +G GS G V    +   G  +AVK + L+     +    E  +++  +H N++ +  +  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
           + D   +V+ ++  G+L + +  H+          +   Q   +C  + + ++ LH    
Sbjct: 97  VGDELWVVMEFLEGGAL-TDIVTHTR---------MNEEQIAAVCLAVLQALSVLHAQG- 145
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
             VIH D+K  ++LL  D    +SDFG    V           +        L G+  +M
Sbjct: 146 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-----------SKEVPRRKXLVGTPYWM 192
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMV 770
           APE         + D++S GI+V+EMV
Sbjct: 193 APELISRLPYGPEVDIWSLGIMVIEMV 219

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 33/209 (15%)
Query: 563 RLLGTGSYGRVY--KGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIIT 620
            +LG+G++  V+  K  L  G   A+K ++        S   E  VLK+I+H N++ +  
Sbjct: 15  EVLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 621 ACSLPDFKALVLPYMANGSL-DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLH 679
                    LV+  ++ G L D  L     TE      D +L     +   +   + YLH
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRILERGVYTE-----KDASL-----VIQQVLSAVKYLH 123
Query: 680 HHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
            +    ++H DLKP N+L     ++   +++DFG++K+           +N   STA   
Sbjct: 124 ENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM----------EQNGIMSTA--- 167
Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGIL 765
           CG+ GY+APE       S   D +S G++
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVI 196

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 96  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 140
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 141 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 180
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 96  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 140
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 141 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 180
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 75/153 (49%), Gaps = 14/153 (9%)
Query: 564 LLGTGSYGRVYK-GILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITAC 622
           +LG G +G+V+K      G  +A K+++ +     +    E  V+ ++ H NL+++  A 
Sbjct: 96  ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
              +   LV+ Y+  G L   +   S         +LT L  +     I EG+ ++H   
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDES--------YNLTELDTILFMKQICEGIRHMHQ-- 205
Query: 683 PVRVIHCDLKPSNVL-LNDDMTAL-VSDFGIAK 713
            + ++H DLKP N+L +N D   + + DFG+A+
Sbjct: 206 -MYILHLDLKPENILCVNRDAKQIKIIDFGLAR 237

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 90/207 (43%), Gaps = 25/207 (12%)
Query: 565 LGTGSYGRV-YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           +G GS G V    +   G  +AVK + L+     +    E  +++  +H N++ +  +  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
           + D   +V+ ++  G+L + +  H+          +   Q   +C  + + ++ LH    
Sbjct: 99  VGDELWVVMEFLEGGAL-TDIVTHTR---------MNEEQIAAVCLAVLQALSVLHAQG- 147
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
             VIH D+K  ++LL  D    +SDFG    V           +        L G+  +M
Sbjct: 148 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-----------SKEVPRRKXLVGTPYWM 194
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMV 770
           APE         + D++S GI+V+EMV
Sbjct: 195 APELISRLPYGPEVDIWSLGIMVIEMV 221

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 32/215 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRN 614
           +D +  LG G++  V + + +  G   A K++   +L + +F K   RE ++ ++++H N
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHPN 89
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           ++R+  +     F  LV   +  G L   +      EF S +     +Q+      I E 
Sbjct: 90  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQ------ILES 140
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL---VSDFGIAKLVMTVGVGNDGAENMGNS 731
           +AY H +    ++H +LKP N+LL          ++DFG+A  V      ND     G  
Sbjct: 141 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV------NDSEAWHG-- 189
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
                 G+ GY++PE       S   D+++ G+++
Sbjct: 190 ----FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 101 FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 145
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 146 LRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLAR-----------------H 185
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 186 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 53/107 (49%), Gaps = 14/107 (13%)
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I  G  YLH +   RVIH DLK  N+ LN+D+   + DFG+A       V  DG      
Sbjct: 124 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERK--- 172
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
               +LCG+  Y+APE       S + DV+S G ++  ++  + P +
Sbjct: 173 ---KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 565 LGTGSYGRV-YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           +G GS G V    +   G  +AVK + L+     +    E  +++  +H N++ +  +  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
           + D   +V+ ++  G+L + +  H+          +   Q   +C  + + ++ LH    
Sbjct: 92  VGDELWVVMEFLEGGAL-TDIVTHTR---------MNEEQIAAVCLAVLQALSVLHAQG- 140
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
             VIH D+K  ++LL  D    +SDFG    V           +        L G+  +M
Sbjct: 141 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-----------SKEVPRRKXLVGTPYWM 187
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           APE         + D++S GI+V+EMV    P
Sbjct: 188 APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 96  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 140
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 141 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 180
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 90/207 (43%), Gaps = 25/207 (12%)
Query: 565 LGTGSYGRV-YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           +G GS G V    +   G  +AVK + L+     +    E  +++  +H N++ +  +  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
           + D   +V+ ++  G+L + +  H+          +   Q   +C  + + ++ LH    
Sbjct: 219 VGDELWVVMEFLEGGAL-TDIVTHTR---------MNEEQIAAVCLAVLQALSVLHAQG- 267
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
             VIH D+K  ++LL  D    +SDFG    V           +        L G+  +M
Sbjct: 268 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-----------SKEVPRRKXLVGTPYWM 314
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMV 770
           APE         + D++S GI+V+EMV
Sbjct: 315 APELISRLPYGPEVDIWSLGIMVIEMV 341

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 52/105 (49%), Gaps = 14/105 (13%)
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I  G  YLH +   RVIH DLK  N+ LN+D+   + DFG+A       V  DG      
Sbjct: 148 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERK--- 196
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
               +LCG+  Y+APE       S + DV+S G ++  ++  + P
Sbjct: 197 ---KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 238

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 52/105 (49%), Gaps = 14/105 (13%)
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I  G  YLH +   RVIH DLK  N+ LN+D+   + DFG+A       V  DG      
Sbjct: 150 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERK--- 198
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
               +LCG+  Y+APE       S + DV+S G ++  ++  + P
Sbjct: 199 ---KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 90/207 (43%), Gaps = 25/207 (12%)
Query: 565 LGTGSYGRV-YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           +G GS G V    +   G  +AVK + L+     +    E  +++  +H N++ +  +  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
           + D   +V+ ++  G+L + +  H+          +   Q   +C  + + ++ LH    
Sbjct: 88  VGDELWVVMEFLEGGAL-TDIVTHTR---------MNEEQIAAVCLAVLQALSVLHAQG- 136
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
             VIH D+K  ++LL  D    +SDFG    V           +        L G+  +M
Sbjct: 137 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-----------SKEVPRRKXLVGTPYWM 183
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMV 770
           APE         + D++S GI+V+EMV
Sbjct: 184 APELISRLPYGPEVDIWSLGIMVIEMV 210

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 96  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 140
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 141 LRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLAR-----------------H 180
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 90  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 174
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 175 TDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 90  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 174
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 90  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 174
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 92  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 136
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 137 LRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLAR-----------------H 176
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 90  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 174
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 95  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 139
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 140 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 179
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 180 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 92  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 136
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 137 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 176
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 90  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 174
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 109 FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 153
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 154 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 193
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 194 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 90  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 174
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 90  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 174
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 97  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 141
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 142 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 181
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 182 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 90/207 (43%), Gaps = 25/207 (12%)
Query: 565 LGTGSYGRV-YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           +G GS G V    +   G  +AVK + L+     +    E  +++  +H N++ +  +  
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
           + D   +V+ ++  G+L + +  H+          +   Q   +C  + + ++ LH    
Sbjct: 142 VGDELWVVMEFLEGGAL-TDIVTHTR---------MNEEQIAAVCLAVLQALSVLHAQG- 190
Query: 684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
             VIH D+K  ++LL  D    +SDFG    V           +        L G+  +M
Sbjct: 191 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQV-----------SKEVPRRKXLVGTPYWM 237
Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMV 770
           APE         + D++S GI+V+EMV
Sbjct: 238 APELISRLPYGPEVDIWSLGIMVIEMV 264

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 95  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 139
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 140 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 179
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 180 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 90  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 174
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 175 TDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 89  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 133
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 134 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 173
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 174 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 98/240 (40%), Gaps = 49/240 (20%)
Query: 549 YRELLEATAEFDEQRL-----LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSF 600
           YR+ L  T     QRL     +G+G+YG V   Y   L+   A+       QS    +  
Sbjct: 15  YRQELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRT 74
Query: 601 NRECQVLKRIRHRNLMRIIT----ACSLPDFKALVLPYMANGS-----LDSHLYPHSETE 651
            RE ++LK ++H N++ ++     A S+ DF  + L     G+     + S        +
Sbjct: 75  YRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQ 134
Query: 652 FGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI 711
           F              +   +  G+ Y+H      +IH DLKPSNV +N+D    + DFG+
Sbjct: 135 F--------------LVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGL 177
Query: 712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMV 770
           A+            E M    A        Y APE      + +   D++S G ++ E++
Sbjct: 178 AR---------QADEEMTGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 92  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 136
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 137 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 176
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 87  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 131
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 132 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 171
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 172 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 110 FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 154
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 155 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 194
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 195 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 90  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 174
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 87  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 131
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 132 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 171
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 172 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 113 FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 157
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 158 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 197
Query: 732 TANMLCGSIG---YMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 198 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 90  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 174
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 175 TDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 92  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 136
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 137 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 176
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 100/237 (42%), Gaps = 20/237 (8%)
Query: 565 LGTG--SYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITAC 622
           LG G  SY  + +G L DG   A+K +        +   RE  + +   H N++R++  C
Sbjct: 37  LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 623 ----SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
                      L+LP+   G+L + +            + LT  Q + +   I  G+  +
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEI-----ERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCG 738
           H        H DLKP+N+LL D+   ++ D G          G+  A  + +  A     
Sbjct: 151 HAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC-- 205
Query: 739 SIGYMAPE-YGFGSNT--STKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN 792
           +I Y APE +   S+     + DV+S G ++  M+    P D +F  G S+   V+N
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN 262

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 99/244 (40%), Gaps = 57/244 (23%)
Query: 549 YRELLEATAEFDEQRL-----LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSF 600
           YR+ L  T     QRL     +G+G+YG V   Y   L+   A+       QS    +  
Sbjct: 7   YRQELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRT 66
Query: 601 NRECQVLKRIRHRNLMRIIT----ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGS 656
            RE ++LK ++H N++ ++     A S+ DF  + L     G+                 
Sbjct: 67  YRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGA----------------- 109
Query: 657 SDLTLLQRVNICSD---------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVS 707
            DL  + +    SD         +  G+ Y+H      +IH DLKPSNV +N+D    + 
Sbjct: 110 -DLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRIL 165
Query: 708 DFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILV 766
           DFG+A+            E M    A        Y APE      + +   D++S G ++
Sbjct: 166 DFGLAR---------QADEEMTGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIM 211
Query: 767 LEMV 770
            E++
Sbjct: 212 AELL 215

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 99/244 (40%), Gaps = 57/244 (23%)
Query: 549 YRELLEATAEFDEQRL-----LGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSF 600
           YR+ L  T     QRL     +G+G+YG V   Y   L+   A+       QS    +  
Sbjct: 15  YRQELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRT 74
Query: 601 NRECQVLKRIRHRNLMRIIT----ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGS 656
            RE ++LK ++H N++ ++     A S+ DF  + L     G+                 
Sbjct: 75  YRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGA----------------- 117
Query: 657 SDLTLLQRVNICSD---------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVS 707
            DL  + +    SD         +  G+ Y+H      +IH DLKPSNV +N+D    + 
Sbjct: 118 -DLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRIL 173
Query: 708 DFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILV 766
           DFG+A+            E M    A        Y APE      + +   D++S G ++
Sbjct: 174 DFGLAR---------QADEEMTGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIM 219
Query: 767 LEMV 770
            E++
Sbjct: 220 AELL 223

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 86  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 131 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 170
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 90  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 174
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 110 FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 154
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 155 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 194
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 195 TDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 101 FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 145
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 146 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 185
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 186 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 110 FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 154
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 155 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 194
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 195 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 102 FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 146
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 147 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 186
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 187 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 88  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 132
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 133 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 172
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 173 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 102 FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 146
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 147 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 186
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 187 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 100 FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 144
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 145 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 184
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 185 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 102 FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 146
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 147 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 186
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 187 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 113 FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 157
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 158 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 197
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 198 TDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 51/105 (48%), Gaps = 14/105 (13%)
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I  G  YLH +   RVIH DLK  N+ LN+D+   + DFG+A       V  DG      
Sbjct: 126 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERK--- 174
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                LCG+  Y+APE       S + DV+S G ++  ++  + P
Sbjct: 175 ---KTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 109 FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 153
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 154 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 193
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 194 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 52/107 (48%), Gaps = 14/107 (13%)
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I  G  YLH +   RVIH DLK  N+ LN+D+   + DFG+A       V  DG      
Sbjct: 126 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERK--- 174
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
                LCG+  Y+APE       S + DV+S G ++  ++  + P +
Sbjct: 175 ---KTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 43/220 (19%)
Query: 559 FDEQRLLGTGSYGRVYKGILQDGT---------AIAVKVLQLQSGNFTKSFNRECQVLKR 609
           +D + +LGTG++  V   IL +            IA K L+ + G    S   E  VL +
Sbjct: 20  YDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEG----SMENEIAVLHK 72
Query: 610 IRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS 669
           I+H N++ +           L++  ++ G L   +    E  F +      L+ +V    
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQV---- 125
Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVL---LNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
              + + YLH    + ++H DLKP N+L   L++D   ++SDFG++K+           E
Sbjct: 126 --LDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-----------E 169
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
           + G S  +  CG+ GY+APE       S   D +S G++ 
Sbjct: 170 DPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 208

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 52/107 (48%), Gaps = 14/107 (13%)
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I  G  YLH +   RVIH DLK  N+ LN+D+   + DFG+A       V  DG      
Sbjct: 130 IVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERK--- 178
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
                LCG+  Y+APE       S + DV+S G ++  ++  + P +
Sbjct: 179 ---KTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 222

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 95/234 (40%), Gaps = 52/234 (22%)
Query: 563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT---KSFNRECQVLKRI--RHRNLMR 617
           + +G G YG V+ G  + G  +AVKV       FT    S+ RE ++ + +  RH N++ 
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVF------FTTEEASWFRETEIYQTVLMRHENILG 95
Query: 618 IITACSLPDFKA--------LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS 669
            I A    D K         L+  Y  NGSL  +L           S+ L     + +  
Sbjct: 96  FIAA----DIKGTGSWTQLYLITDYHENGSLYDYL----------KSTTLDAKSMLKLAY 141
Query: 670 DIAEGMAYLHH-----HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
               G+ +LH           + H DLK  N+L+  + T  ++D G+A       V    
Sbjct: 142 SSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-------VKFIS 194
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGS------NTSTKGDVYSFGILVLEMVTR 772
             N  +   N   G+  YM PE    S       +    D+YSFG+++ E+  R
Sbjct: 195 DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 86  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 131 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 170
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 171 TDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 86  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+                  
Sbjct: 131 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------H 170
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 31/222 (13%)
Query: 564 LLGTGSYGRVYKGILQDGTAIAVKVLQLQSG------NFTKSFNRECQVLKRIRHRNLMR 617
           LLG GSYG+V K +L   T     V  L+        N   +  +E Q+L+R+RH+N+++
Sbjct: 12  LLGEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 618 IITACSLPDFKAL--VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++      + + +  V+ Y   G +   L    E  F        + Q       + +G+
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRF-------PVCQAHGYFCQLIDGL 122
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH      ++H D+KP N+LL    T  +S  G+A+ +              + T   
Sbjct: 123 EYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA---------DDTCRT 170
Query: 736 LCGSIGYMAPEYGFGSNTST--KGDVYSFGILVLEMVTRRRP 775
             GS  +  PE   G +T +  K D++S G+ +  + T   P
Sbjct: 171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 66/231 (28%), Positives = 88/231 (38%), Gaps = 27/231 (11%)
Query: 565 LGTGSYGRVYKGILQ----DGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRHRNLMR 617
           LG GS+G V +G          ++AVK L+   L        F RE   +  + HRNL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +      P  K +V      GSL   L  H       G   L  L R  +   +AEGM Y
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAV--QVAEGMGY 136
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L      R IH DL   N+LL       + DFG+ + +      ND    M         
Sbjct: 137 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ----NDDHXVMQEHRKV--- 186
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK 788
               + APE       S   D + FG+ + EM T  +       G   LHK
Sbjct: 187 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 236

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 66/231 (28%), Positives = 88/231 (38%), Gaps = 27/231 (11%)
Query: 565 LGTGSYGRVYKGILQ----DGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRHRNLMR 617
           LG GS+G V +G          ++AVK L+   L        F RE   +  + HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +      P  K +V      GSL   L  H       G   L  L R  +   +AEGM Y
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAV--QVAEGMGY 126
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L      R IH DL   N+LL       + DFG+ + +      ND    M         
Sbjct: 127 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ----NDDHXVMQEHRKV--- 176
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK 788
               + APE       S   D + FG+ + EM T  +       G   LHK
Sbjct: 177 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 226

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 28/232 (12%)
Query: 559 FDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNL 615
           ++ + L+GTGSYG V   Y  + +   AI   +   +     K   RE  +L R+ H ++
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++++      D +     Y+     DS        +       LT L    +  ++  G+
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADSDF-----KKLFRTPVYLTELHIKTLLYNLLVGV 169
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG------AENMG 729
            Y+H      ++H DLKP+N L+N D +  V DFG+A+ V     GN         ++M 
Sbjct: 170 KYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 730 NST-------ANMLCGSI---GYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
             T          L G +    Y APE        T+  DV+S G +  E++
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 31/209 (14%)
Query: 564 LLGTGSYGRVYK---GILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIIT 620
           +LG GS+G V K    I Q   A+ V          T +  RE ++LK++ H N+M++  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
                    +V      G L   +       F    +         I   +  G+ Y+H 
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDA-------ARIIKQVFSGITYMHK 139
Query: 681 HSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           H+   ++H DLKP N+LL     D    + DFG++                 N+      
Sbjct: 140 HN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ------------NTKMKDRI 184
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
           G+  Y+APE   G+    K DV+S G+++
Sbjct: 185 GTAYYIAPEVLRGT-YDEKCDVWSAGVIL 212

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 101/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 90  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + D+G+A+                  
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLAR-----------------H 174
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 66/231 (28%), Positives = 88/231 (38%), Gaps = 27/231 (11%)
Query: 565 LGTGSYGRVYKGILQ----DGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRHRNLMR 617
           LG GS+G V +G          ++AVK L+   L        F RE   +  + HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +      P  K +V      GSL   L  H       G   L  L R  +   +AEGM Y
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAV--QVAEGMGY 126
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L      R IH DL   N+LL       + DFG+ + +      ND    M         
Sbjct: 127 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ----NDDHYVMQEHRKV--- 176
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK 788
               + APE       S   D + FG+ + EM T  +       G   LHK
Sbjct: 177 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 226

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 66/231 (28%), Positives = 88/231 (38%), Gaps = 27/231 (11%)
Query: 565 LGTGSYGRVYKGILQ----DGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRHRNLMR 617
           LG GS+G V +G          ++AVK L+   L        F RE   +  + HRNL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +      P  K +V      GSL   L  H       G   L  L R  +   +AEGM Y
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAV--QVAEGMGY 130
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L      R IH DL   N+LL       + DFG+ + +      ND    M         
Sbjct: 131 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ----NDDHYVMQEHRKV--- 180
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK 788
               + APE       S   D + FG+ + EM T  +       G   LHK
Sbjct: 181 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 230

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 66/231 (28%), Positives = 88/231 (38%), Gaps = 27/231 (11%)
Query: 565 LGTGSYGRVYKGILQ----DGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRHRNLMR 617
           LG GS+G V +G          ++AVK L+   L        F RE   +  + HRNL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +      P  K +V      GSL   L  H       G   L  L R  +   +AEGM Y
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAV--QVAEGMGY 126
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L      R IH DL   N+LL       + DFG+ + +      ND    M         
Sbjct: 127 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ----NDDHYVMQEHRKV--- 176
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK 788
               + APE       S   D + FG+ + EM T  +       G   LHK
Sbjct: 177 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 226

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 66/231 (28%), Positives = 88/231 (38%), Gaps = 27/231 (11%)
Query: 565 LGTGSYGRVYKGILQ----DGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRHRNLMR 617
           LG GS+G V +G          ++AVK L+   L        F RE   +  + HRNL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +      P  K +V      GSL   L  H       G   L  L R  +   +AEGM Y
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAV--QVAEGMGY 136
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L      R IH DL   N+LL       + DFG+ + +      ND    M         
Sbjct: 137 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ----NDDHYVMQEHRKV--- 186
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK 788
               + APE       S   D + FG+ + EM T  +       G   LHK
Sbjct: 187 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 236

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 98/222 (44%), Gaps = 30/222 (13%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVLQL-----QSGNFTKSFNRECQVLKRIR 611
            +++   LG G +  VYK   ++   I A+K ++L           ++  RE ++L+ + 
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           H N++ ++ A       +LV  +M             E      S  LT           
Sbjct: 71  HPNIIGLLDAFGHKSNISLVFDFMET---------DLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
            +G+ YLH H    ++H DLKP+N+LL+++    ++DFG+AK   + G  N    +    
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK---SFGSPNRAYXHQ--- 172
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTR 772
                  +  Y APE  FG+     G D+++ G ++ E++ R
Sbjct: 173 -----VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 209

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 29/212 (13%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVK-VLQLQSGNFTKSFN-RECQVLKRIRHRNLMRIITA 621
           +G GSYG V+K   +D G  +A+K  L+ +     K    RE ++LK+++H NL+ ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 622 CSLPDFKALVLPYMANGSL-DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
                   LV  Y  +  L +   Y     E    S     LQ VN C          H 
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC----------HK 120
Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM-TVGVGNDGAENMGNSTANMLCGS 739
           H+    IH D+KP N+L+       + DFG A+L+       +D        +  +L G 
Sbjct: 121 HN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGD 177
Query: 740 IGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
             Y  P            DV++ G +  E+++
Sbjct: 178 TQYGPP-----------VDVWAIGCVFAELLS 198

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 106/229 (46%), Gaps = 30/229 (13%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVLQLQSGN--FTKSFNRECQVLKRIRHRN 614
           ++++   +G G+YG V+K   ++   I A+K ++L   +     S  RE  +LK ++H+N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           ++R+           LV  +      D  L  +    F S + DL      +    + +G
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFC-----DQDLKKY----FDSCNGDLDPEIVKSFLFQLLKG 113
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           + + H  +   V+H DLKP N+L+N +    +++FG+A+    + V    AE +      
Sbjct: 114 LGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVRCYSAEVV------ 163
Query: 735 MLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTDDMFAG 782
               ++ Y  P+  FG+   ST  D++S G +  E+    RP   +F G
Sbjct: 164 ----TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPG 205

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/227 (21%), Positives = 106/227 (46%), Gaps = 23/227 (10%)
Query: 554 EATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVK--VLQLQSGNFTKSFNRECQVLKRI 610
           +  +++++   +G G++G V+K    + G  +A+K  +++ +   F  +  RE ++L+ +
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 74
Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDL----TLLQRVN 666
           +H N++ +I  C     +    PY    +    ++   E +     S++    TL +   
Sbjct: 75  KHENVVNLIEIC-----RTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 129
Query: 667 ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
           +   +  G+ Y+H +   +++H D+K +NVL+  D    ++DFG+A+             
Sbjct: 130 VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSL------AKN 180
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTR 772
           +  N   N +  ++ Y  PE   G  +     D++  G ++ EM TR
Sbjct: 181 SQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 559 FDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHR 613
           + + + +G+G+ G V   +  +L  G  +AVK L    Q+    K   RE  +LK + H+
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 83
Query: 614 NLMRIITACS----LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS 669
           N++ ++   +    L +F+ +   Y+    +D++L      E         L Q   +C 
Sbjct: 84  NIISLLNVFTPQKTLEEFQDV---YLVMELMDANLCQVIHMELDHERMSYLLYQM--LC- 137
Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
               G+ +LH      +IH DLKPSN+++  D T  + DFG+A+   T            
Sbjct: 138 ----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACT------------ 178
Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
           N        +  Y APE   G   +   D++S G ++ E+V
Sbjct: 179 NFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELV 219

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 93/224 (41%), Gaps = 23/224 (10%)
Query: 562 QRLLGTGSYGRVYKGILQDGTA-IAVKVLQLQSGNFT--KSFNRECQVLKRIRHRNLMRI 618
           + L+G GSYG VY    ++    +A+K +     +    K   RE  +L R++   ++R+
Sbjct: 31  KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRL 90
Query: 619 ITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
                  D       Y+     DS L    +T        LT      I  ++  G  ++
Sbjct: 91  YDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIF-----LTEEHIKTILYNLLLGENFI 145
Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT---VGVGNDGAEN-----MGN 730
           H      +IH DLKP+N LLN D +  V DFG+A+ + +     + ND  EN        
Sbjct: 146 HESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 731 STANMLCGSI---GYMAPEYGFGSNTSTKG-DVYSFGILVLEMV 770
           +    L   +    Y APE        TK  D++S G +  E++
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 102/231 (44%), Gaps = 23/231 (9%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG G  G V+  +  D    +A+K + L      K   RE ++++R+ H N++++     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 624 LPDFKALVLPYMANGSLDSH--LYPHSETEFGSGSSDLTLLQRVN--ICSDIAEGMAYLH 679
            P    L     +   L+S   +  + ET+  +      LL+         +  G+ Y+H
Sbjct: 79  -PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIH 137
Query: 680 HHSPVRVIHCDLKPSNVLLN-DDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCG 738
                 V+H DLKP+N+ +N +D+   + DFG+A+ +M     + G  + G  T      
Sbjct: 138 ---SANVLHRDLKPANLFINTEDLVLKIGDFGLAR-IMDPHYSHKGHLSEGLVTK----- 188
Query: 739 SIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGGLSLHK 788
              Y +P      N  TK  D+++ G +  EM+T +     +FAG   L +
Sbjct: 189 --WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT----LFAGAHELEQ 233

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 43/220 (19%)
Query: 559 FDEQRLLGTGSYGRVYKGILQDGT---------AIAVKVLQLQSGNFTKSFNRECQVLKR 609
           +D + +LGTG++  V   IL +            IA + L+ + G    S   E  VL +
Sbjct: 20  YDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEG----SMENEIAVLHK 72
Query: 610 IRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS 669
           I+H N++ +           L++  ++ G L   +    E  F +      L+ +V    
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQV---- 125
Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVL---LNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
              + + YLH    + ++H DLKP N+L   L++D   ++SDFG++K+           E
Sbjct: 126 --LDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-----------E 169
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
           + G S  +  CG+ GY+APE       S   D +S G++ 
Sbjct: 170 DPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 208

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/228 (21%), Positives = 108/228 (47%), Gaps = 25/228 (10%)
Query: 554 EATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVK--VLQLQSGNFTKSFNRECQVLKRI 610
           +  +++++   +G G++G V+K    + G  +A+K  +++ +   F  +  RE ++L+ +
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 74
Query: 611 RHRNLMRIITACSLPDFKALVLPY-MANGSLDSHLYPHSETEFGSGSSDL----TLLQRV 665
           +H N++ +I  C     +    PY    GS+   ++   E +     S++    TL +  
Sbjct: 75  KHENVVNLIEIC-----RTKASPYNRCKGSI-YLVFDFCEHDLAGLLSNVLVKFTLSEIK 128
Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGA 725
            +   +  G+ Y+H +   +++H D+K +NVL+  D    ++DFG+A+            
Sbjct: 129 RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSL------AK 179
Query: 726 ENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTR 772
            +  N   N +  ++ Y  PE   G  +     D++  G ++ EM TR
Sbjct: 180 NSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 43/220 (19%)
Query: 559 FDEQRLLGTGSYGRVYKGILQDGT---------AIAVKVLQLQSGNFTKSFNRECQVLKR 609
           +D + +LGTG++  V   IL +            IA + L+ + G    S   E  VL +
Sbjct: 20  YDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEG----SMENEIAVLHK 72
Query: 610 IRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS 669
           I+H N++ +           L++  ++ G L   +    E  F +      L+ +V    
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQV---- 125
Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVL---LNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
              + + YLH    + ++H DLKP N+L   L++D   ++SDFG++K+           E
Sbjct: 126 --LDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-----------E 169
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
           + G S  +  CG+ GY+APE       S   D +S G++ 
Sbjct: 170 DPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 208

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/228 (21%), Positives = 108/228 (47%), Gaps = 25/228 (10%)
Query: 554 EATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVK--VLQLQSGNFTKSFNRECQVLKRI 610
           +  +++++   +G G++G V+K    + G  +A+K  +++ +   F  +  RE ++L+ +
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 73
Query: 611 RHRNLMRIITACSLPDFKALVLPY-MANGSLDSHLYPHSETEFGSGSSDL----TLLQRV 665
           +H N++ +I  C     +    PY    GS+   ++   E +     S++    TL +  
Sbjct: 74  KHENVVNLIEIC-----RTKASPYNRCKGSI-YLVFDFCEHDLAGLLSNVLVKFTLSEIK 127
Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGA 725
            +   +  G+ Y+H +   +++H D+K +NVL+  D    ++DFG+A+            
Sbjct: 128 RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSL------AK 178
Query: 726 ENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTR 772
            +  N   N +  ++ Y  PE   G  +     D++  G ++ EM TR
Sbjct: 179 NSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/228 (21%), Positives = 108/228 (47%), Gaps = 25/228 (10%)
Query: 554 EATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVK--VLQLQSGNFTKSFNRECQVLKRI 610
           +  +++++   +G G++G V+K    + G  +A+K  +++ +   F  +  RE ++L+ +
Sbjct: 15  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 74
Query: 611 RHRNLMRIITACSLPDFKALVLPY-MANGSLDSHLYPHSETEFGSGSSDL----TLLQRV 665
           +H N++ +I  C     +    PY    GS+   ++   E +     S++    TL +  
Sbjct: 75  KHENVVNLIEIC-----RTKASPYNRCKGSI-YLVFDFCEHDLAGLLSNVLVKFTLSEIK 128
Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGA 725
            +   +  G+ Y+H +   +++H D+K +NVL+  D    ++DFG+A+            
Sbjct: 129 RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSL------AK 179
Query: 726 ENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTR 772
            +  N   N +  ++ Y  PE   G  +     D++  G ++ EM TR
Sbjct: 180 NSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 90  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKSQKLTDDHVQFLIYQI 134
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DFG+ +                  
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCR-----------------H 174
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 31/209 (14%)
Query: 564 LLGTGSYGRVYK---GILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIIT 620
           +LG GS+G V K    I Q   A+ V          T +  RE ++LK++ H N+M++  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
                    +V      G L   +       F    +         I   +  G+ Y+H 
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDA-------ARIIKQVFSGITYMHK 139
Query: 681 HSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           H+   ++H DLKP N+LL     D    + DFG++                 N+      
Sbjct: 140 HN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ------------NTKMKDRI 184
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
           G+  Y+APE   G+    K DV+S G+++
Sbjct: 185 GTAYYIAPEVLRGT-YDEKCDVWSAGVIL 212

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 31/209 (14%)
Query: 564 LLGTGSYGRVYK---GILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIIT 620
           +LG GS+G V K    I Q   A+ V          T +  RE ++LK++ H N+M++  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
                    +V      G L   +       F    +         I   +  G+ Y+H 
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDA-------ARIIKQVFSGITYMHK 139
Query: 681 HSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           H+   ++H DLKP N+LL     D    + DFG++                 N+      
Sbjct: 140 HN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ------------NTKMKDRI 184
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
           G+  Y+APE   G+    K DV+S G+++
Sbjct: 185 GTAYYIAPEVLRGT-YDEKCDVWSAGVIL 212

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 43/219 (19%)
Query: 559 FDEQRLLGTGSYGRVYKGILQDGT---------AIAVKVLQLQSGNFTKSFNRECQVLKR 609
           +D + +LGTG++  V   IL +            IA + L+ + G    S   E  VL +
Sbjct: 20  YDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEG----SMENEIAVLHK 72
Query: 610 IRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS 669
           I+H N++ +           L++  ++ G L   +    E  F +      L+ +V    
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQV---- 125
Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVL---LNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
              + + YLH    + ++H DLKP N+L   L++D   ++SDFG++K+           E
Sbjct: 126 --LDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM-----------E 169
Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGIL 765
           + G S  +  CG+ GY+APE       S   D +S G++
Sbjct: 170 DPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 32/215 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRN 614
           +D +  LG G++  V + + +  G   A K++   +L + +F K   RE ++ ++++H N
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHPN 66
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           ++R+  +     F  LV   +  G L   +      EF S +     +Q+      I E 
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQ------ILES 117
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL---VSDFGIAKLVMTVGVGNDGAENMGNS 731
           +AY H +    ++H +LKP N+LL          ++DFG+A  V      ND     G  
Sbjct: 118 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV------NDSEAWHG-- 166
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
                 G+ GY++PE       S   D+++ G+++
Sbjct: 167 ----FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 32/215 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRN 614
           +D +  LG G++  V + + +  G   A K++   +L + +F K   RE ++ ++++H N
Sbjct: 7   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHPN 65
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           ++R+  +     F  LV   +  G L   +      EF S +     +Q+      I E 
Sbjct: 66  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQ------ILES 116
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL---VSDFGIAKLVMTVGVGNDGAENMGNS 731
           +AY H +    ++H +LKP N+LL          ++DFG+A  V      ND     G  
Sbjct: 117 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV------NDSEAWHG-- 165
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
                 G+ GY++PE       S   D+++ G+++
Sbjct: 166 ----FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 196

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 32/215 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRN 614
           +D +  LG G++  V + + +  G   A K++   +L + +F K   RE ++ ++++H N
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHPN 66
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           ++R+  +     F  LV   +  G L   +      EF S +     +Q+      I E 
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQ------ILES 117
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL---VSDFGIAKLVMTVGVGNDGAENMGNS 731
           +AY H +    ++H +LKP N+LL          ++DFG+A  V      ND     G  
Sbjct: 118 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV------NDSEAWHG-- 166
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
                 G+ GY++PE       S   D+++ G+++
Sbjct: 167 ----FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 107/245 (43%), Gaps = 46/245 (18%)
Query: 545 PRITYRELLEATAEFDEQRL----LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFT 597
           P    +EL +   E  E+      +G+G+YG V      + G  +AVK L    QS    
Sbjct: 2   PTFYRQELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA 61
Query: 598 KSFNRECQVLKRIRHRNLMRIIT----ACSLPDFKALVL-PYMANGSLDSHLYPHSETEF 652
           K   RE ++LK ++H N++ ++     A SL +F  + L  ++    L++ +        
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-------- 113
Query: 653 GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA 712
               + LT      +   I  G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A
Sbjct: 114 --KCAKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA 168
Query: 713 KLVMTVGVGNDGAENMGNSTANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLE 768
           +                  T + + G +    Y APE      + +   D++S G ++ E
Sbjct: 169 R-----------------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211
Query: 769 MVTRR 773
           ++T R
Sbjct: 212 LLTGR 216

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 104/242 (42%), Gaps = 40/242 (16%)
Query: 559 FDEQRLLGTGSYGRV---YKGILQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHR 613
           + + + +G+G+ G V   +  +L  G  +AVK L    Q+    K   RE  +LK + H+
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 81
Query: 614 NLMRIITACS----LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS 669
           N++ ++   +    L +F+ +   Y+    +D++L      E         L Q   +C 
Sbjct: 82  NIISLLNVFTPQKTLEEFQDV---YLVMELMDANLCQVIHMELDHERMSYLLYQM--LC- 135
Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
               G+ +LH      +IH DLKPSN+++  D T  + DFG+A+   T            
Sbjct: 136 ----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAST------------ 176
Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKW 789
           N        +  Y APE   G       D++S G ++ E+V        +F G   + +W
Sbjct: 177 NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVK----GSVIFQGTDHIDQW 232
Query: 790 VK 791
            K
Sbjct: 233 NK 234

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 54/112 (48%), Gaps = 14/112 (12%)
Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
           ++I   IAE + +LH      ++H DLKPSN+    D    V DFG+        +  D 
Sbjct: 167 LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLV-----TAMDQDE 218
Query: 725 AENM------GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
            E          +T     G+  YM+PE   G+N S K D++S G+++ E++
Sbjct: 219 EEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 38/230 (16%)
Query: 548 TYR-ELLEATAEFDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQLQS---GNFTKS 599
           T+R E +E   E  E+  LG+G +  V     KG  ++  A  +K  +L S   G   + 
Sbjct: 4   TFRQEDVEDHYEMGEE--LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREE 61
Query: 600 FNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDL 659
             RE  +L+ IRH N++ +           L+L  ++ G L          +F +    L
Sbjct: 62  IEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGEL---------FDFLAEKESL 112
Query: 660 TLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA----LVSDFGIAKLV 715
           T  +       I +G+ YLH     R+ H DLKP N++L D         + DFGIA  +
Sbjct: 113 TEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 169
Query: 716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGIL 765
                        GN   N+  G+  ++APE         + D++S G++
Sbjct: 170 -----------EAGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 96/228 (42%), Gaps = 37/228 (16%)
Query: 549 YRELLEATAEFDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQLQS---GNFTKSFN 601
           ++ ++E   E  E+  LG+G +  V     KG  ++  A  +K  +L S   G   +   
Sbjct: 20  FQSMVEDHYEMGEE--LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIE 77
Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           RE  +L+ IRH N++ +           L+L  ++ G L          +F +    LT 
Sbjct: 78  REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGEL---------FDFLAEKESLTE 128
Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA----LVSDFGIAKLVMT 717
            +       I +G+ YLH     R+ H DLKP N++L D         + DFGIA  +  
Sbjct: 129 DEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-- 183
Query: 718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGIL 765
                      GN   N+  G+  ++APE         + D++S G++
Sbjct: 184 ---------EAGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 221

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 107/224 (47%), Gaps = 36/224 (16%)
Query: 559 FDEQRLLGTGSYGR-VYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLM 616
           F  + +LG G+ G  VY+G+  D   +AVK +  +  +F    +RE Q+L+    H N++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECFSFA---DREVQLLRESDEHPNVI 81
Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGS-GSSDLTLLQRVNICSDIAEGM 675
           R         F+ + +   A  +L  ++    + +F   G   +TLLQ+         G+
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYV---EQKDFAHLGLEPITLLQQTT------SGL 131
Query: 676 AYLHHHSPVRVIHCDLKPSNVLL-----NDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           A+LH    + ++H DLKP N+L+     +  + A++SDFG+ K    + VG         
Sbjct: 132 AHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK---KLAVGRHSF----- 180
Query: 731 STANMLCGSIGYMAPEY---GFGSNTSTKGDVYSFGILVLEMVT 771
           S  + + G+ G++APE        N +   D++S G +   +++
Sbjct: 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 56/115 (48%), Gaps = 10/115 (8%)
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMT-ALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           EG+ YLH     R++H D+K  NVLL+ D + A + DFG A  +   G+G          
Sbjct: 177 EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS------LL 227
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSL 786
           T + + G+  +MAPE   G     K D++S   ++L M+    P    F G L L
Sbjct: 228 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 282

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 127/278 (45%), Gaps = 24/278 (8%)
Query: 550 RELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVL-QLQSGNFTKSFNRECQVLK 608
           RE +E   E++  ++ G G+YG VYK   +DG       L Q++    + S  RE  +L+
Sbjct: 15  RERVEDLFEYEGCKV-GRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLR 73
Query: 609 RIRHRNLMRIITA-CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI 667
            ++H N++ +     S  D K  +L   A   L   +  H  ++       L      ++
Sbjct: 74  ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL----NDDMTALVSDFGIAKLVMTVGVGND 723
              I +G+ YLH +    V+H DLKP+N+L+     +     ++D G A+L       N 
Sbjct: 134 LYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLF------NS 184
Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAG 782
             + + +   + +  +  Y APE   G+   TK  D+++ G +  E++T    ++ +F  
Sbjct: 185 PLKPLAD--LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT----SEPIFHC 238
Query: 783 GLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRM 820
                K    ++H +L+++ +     A +D   ++K+M
Sbjct: 239 RQEDIKTSNPYHHDQLDRIFNVMGFPADKDWE-DIKKM 275

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 90  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    +  FG+A+                  
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLAR-----------------H 174
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 90  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + DF +A+                  
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLAR-----------------H 174
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 56/115 (48%), Gaps = 10/115 (8%)
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMT-ALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           EG+ YLH     R++H D+K  NVLL+ D + A + DFG A  +   G+G          
Sbjct: 175 EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS------LL 225
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSL 786
           T + + G+  +MAPE   G     K D++S   ++L M+    P    F G L L
Sbjct: 226 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 280

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 56/115 (48%), Gaps = 10/115 (8%)
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMT-ALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           EG+ YLH     R++H D+K  NVLL+ D + A + DFG A  +   G+G          
Sbjct: 161 EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS------LL 211
Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSL 786
           T + + G+  +MAPE   G     K D++S   ++L M+    P    F G L L
Sbjct: 212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 266

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 34/188 (18%)
Query: 659 LTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV 718
           LTL   +     +A+GM +L   +  + IH DL   N+LL++     + DFG+A+ +   
Sbjct: 190 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK- 245
Query: 719 GVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
                  + +    A +    + +MAPE  F    + + DV+SFG+L+ E          
Sbjct: 246 -----DPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWE---------- 287
Query: 779 MFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQE 838
           +F+ G S +  VK      +++     L   +R ++P      D    E+ +  + C   
Sbjct: 288 IFSLGASPYPGVK------IDEEFCRRLKEGTRMRAP------DYTTPEMYQTMLDCWHG 335
Query: 839 SPSTRPTM 846
            PS RPT 
Sbjct: 336 EPSQRPTF 343

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 106/233 (45%), Gaps = 54/233 (23%)
Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI--RHRNLMRII--- 619
           +G G YG V++G L  G ++AVK+    S    +S+ RE ++   +  RH N++  I   
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIF---SSRDEQSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 620 -TACSLPDFKALVLPYMANGSL-----DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
            T+ +      L+  Y  +GSL        L PH             L  R+ + +  A 
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPH-------------LALRLAVSA--AC 116
Query: 674 GMAYLH------HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
           G+A+LH         P  + H D K  NVL+  ++   ++D G+A  VM    G+D   +
Sbjct: 117 GLAHLHVEIFGTQGKPA-IAHRDFKSRNVLVKSNLQCCIADLGLA--VMH-SQGSDYL-D 171
Query: 728 MGNSTANMLCGSIGYMAPEY--------GFGSNTSTKGDVYSFGILVLEMVTR 772
           +GN   N   G+  YMAPE          F S   T  D+++FG+++ E+  R
Sbjct: 172 IGN---NPRVGTKRYMAPEVLDEQIRTDCFESYKWT--DIWAFGLVLWEIARR 219

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 35/212 (16%)
Query: 565 LGTGSYGRV----YKGILQDGTAIAVKVLQLQS---GNFTKSFNRECQVLKRIRHRNLMR 617
           LG+G +  V     KG  ++  A  +K  +L S   G   +   RE  +L+ IRH N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +           L+L  ++ G L          +F +    LT  +       I +G+ Y
Sbjct: 73  LHDIFENKTDVVLILELVSGGEL---------FDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTA----LVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           LH     R+ H DLKP N++L D         + DFGIA  +             GN   
Sbjct: 124 LHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-----------EAGNEFK 169
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGIL 765
           N+  G+  ++APE         + D++S G++
Sbjct: 170 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 200

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 34/188 (18%)
Query: 659 LTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV 718
           LTL   +     +A+GM +L   +  + IH DL   N+LL++     + DFG+A+ +   
Sbjct: 188 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK- 243
Query: 719 GVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
                  + +    A +    + +MAPE  F    + + DV+SFG+L+ E          
Sbjct: 244 -----DPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWE---------- 285
Query: 779 MFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQE 838
           +F+ G S +  VK      +++     L   +R ++P      D    E+ +  + C   
Sbjct: 286 IFSLGASPYPGVK------IDEEFCRRLKEGTRMRAP------DYTTPEMYQTMLDCWHG 333
Query: 839 SPSTRPTM 846
            PS RPT 
Sbjct: 334 EPSQRPTF 341

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 34/188 (18%)
Query: 659 LTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV 718
           LTL   +     +A+GM +L   +  + IH DL   N+LL++     + DFG+A+ +   
Sbjct: 197 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK- 252
Query: 719 GVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
                  + +    A +    + +MAPE  F    + + DV+SFG+L+ E          
Sbjct: 253 -----DPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWE---------- 294
Query: 779 MFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQE 838
           +F+ G S +  VK      +++     L   +R ++P      D    E+ +  + C   
Sbjct: 295 IFSLGASPYPGVK------IDEEFCRRLKEGTRMRAP------DYTTPEMYQTMLDCWHG 342
Query: 839 SPSTRPTM 846
            PS RPT 
Sbjct: 343 EPSQRPTF 350

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 90  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + D G+A+                  
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLAR-----------------H 174
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 34/188 (18%)
Query: 659 LTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV 718
           LTL   +     +A+GM +L   +  + IH DL   N+LL++     + DFG+A+ +   
Sbjct: 195 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK- 250
Query: 719 GVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
                  + +    A +    + +MAPE  F    + + DV+SFG+L+ E          
Sbjct: 251 -----DPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWE---------- 292
Query: 779 MFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQE 838
           +F+ G S +  VK      +++     L   +R ++P      D    E+ +  + C   
Sbjct: 293 IFSLGASPYPGVK------IDEEFCRRLKEGTRMRAP------DYTTPEMYQTMLDCWHG 340
Query: 839 SPSTRPTM 846
            PS RPT 
Sbjct: 341 EPSQRPTF 348

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 90  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + D G+A+                  
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLAR-----------------H 174
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 84/186 (45%), Gaps = 34/186 (18%)
Query: 659 LTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV 718
           +T+   ++    +A GM +L   S  + IH DL   N+LL+++    + DFG+A+ +   
Sbjct: 196 ITMEDLISYSFQVARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYK- 251
Query: 719 GVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
              N      G++        + +MAPE  F    STK DV+S+G+L+ E          
Sbjct: 252 ---NPDYVRKGDTRL-----PLKWMAPESIFDKIYSTKSDVWSYGVLLWE---------- 293
Query: 779 MFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQE 838
           +F+ G S +  V+      +++   S L    R ++PE       +  E+ ++ + C   
Sbjct: 294 IFSLGGSPYPGVQ------MDEDFCSRLREGMRMRAPE------YSTPEIYQIMLDCWHR 341
Query: 839 SPSTRP 844
            P  RP
Sbjct: 342 DPKERP 347

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 38/110 (34%), Positives = 55/110 (50%), Gaps = 24/110 (21%)
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
           A  H HS + VIH D+KPSNVL+N      + DFGI+  ++     +D A+++       
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV-----DDVAKDID------ 169
Query: 736 LCGSIGYMAPEY--------GFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
             G   YMAPE         G+    S K D++S GI ++E+   R P D
Sbjct: 170 -AGCKPYMAPERINPELNQKGY----SVKSDIWSLGITMIELAILRFPYD 214

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 52/226 (23%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNLMRIIT- 620
           +G+G+YG V      + G  +AVK L    QS    K   RE ++LK ++H N++ ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 621 ---ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN------ICSDI 671
              A SL +F  + L         +HL        G+  +++   Q++       +   I
Sbjct: 90  FTPARSLEEFNDVYLV--------THL-------MGADLNNIVKCQKLTDDHVQFLIYQI 134
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
             G+ Y+H      +IH DLKPSN+ +N+D    + D G+A+                  
Sbjct: 135 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLAR-----------------H 174
Query: 732 TANMLCGSIG---YMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRR 773
           T + + G +    Y APE      + +   D++S G ++ E++T R
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 91/221 (41%), Gaps = 42/221 (19%)
Query: 563 RLLGTGSYGRVYKGILQDG-TAIAVKVL---QLQSG----------NFTKSFNRECQVLK 608
           R LG+G+YG V     ++G +  A+KV+   Q   G           F +    E  +LK
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 609 RIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNIC 668
            + H N++++        +  LV  +   G L   +    + +    +         NI 
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA---------NIM 152
Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL---VSDFGIAKLVMTVGVGNDGA 725
             I  G+ YLH H+   ++H D+KP N+LL +  + L   + DFG++             
Sbjct: 153 KQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK-------- 201
Query: 726 ENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
               +       G+  Y+APE       + K DV+S G+++
Sbjct: 202 ----DYKLRDRLGTAYYIAPEV-LKKKYNEKCDVWSCGVIM 237

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 561 EQRLLGTGSYGRVYKGILQ---DGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNL 615
           E + LG+G++G V KG  Q       +AVK+L+ ++ +         E  V++++ +  +
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +R+I  C    +  LV+     G L+ +L  +   +      D  +++ V+    ++ GM
Sbjct: 433 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVK------DKNIIELVH---QVSMGM 482
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL   +    +H DL   NVLL     A +SDFG++K +          EN   +  + 
Sbjct: 483 KYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA-------DENYYKAQTHG 532
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               + + APE       S+K DV+SFG+L+ E  +
Sbjct: 533 KW-PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 561 EQRLLGTGSYGRVYKGILQ---DGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNL 615
           E + LG+G++G V KG  Q       +AVK+L+ ++ +         E  V++++ +  +
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +R+I  C    +  LV+     G L+ +L  +   +      D  +++ V+    ++ GM
Sbjct: 434 VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVK------DKNIIELVH---QVSMGM 483
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL   +    +H DL   NVLL     A +SDFG++K +          EN   +  + 
Sbjct: 484 KYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA-------DENYYKAQTHG 533
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               + + APE       S+K DV+SFG+L+ E  +
Sbjct: 534 KW-PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 26/216 (12%)
Query: 561 EQRLLGTGSYGRVYKGILQ---DGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNL 615
           E + LG+G++G V KG  Q       +AVK+L+ ++ +         E  V++++ +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +R+I  C    +  LV+     G L+ +L  +   +      D  +++ V+    ++ GM
Sbjct: 91  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVK------DKNIIELVH---QVSMGM 140
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL   +    +H DL   NVLL     A +SDFG++K  +        A+  G      
Sbjct: 141 KYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGK----- 191
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               + + APE       S+K DV+SFG+L+ E  +
Sbjct: 192 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/224 (21%), Positives = 99/224 (44%), Gaps = 43/224 (19%)
Query: 565 LGTGSYGRVYKGILQD--------GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLM 616
           LG G++ +++KG+ ++         T + +KVL     N+++SF     ++ ++ H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
                C   D   LV  ++  GSLD++L  +           + +L ++ +   +A  M 
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC--------INILWKLEVAKQLAAAMH 127
Query: 677 YLHHHSPVRVIHCDLKPSNVLL---NDDMTA-----LVSDFGIAKLVMTVGVGNDGAENM 728
           +L  ++   +IH ++   N+LL    D  T       +SD GI+  V+            
Sbjct: 128 FLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL------------ 172
Query: 729 GNSTANMLCGSIGYMAPE-YGFGSNTSTKGDVYSFGILVLEMVT 771
                ++L   I ++ PE      N +   D +SFG  + E+ +
Sbjct: 173 ---PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 53/111 (47%), Gaps = 26/111 (23%)
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
           A  H HS + VIH D+KPSNVL+N      + DFGI+  ++             +S A  
Sbjct: 165 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV-------------DSVAKT 211
Query: 736 L-CGSIGYMAPEY--------GFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
           +  G   YMAPE         G+    S K D++S GI ++E+   R P D
Sbjct: 212 IDAGCKPYMAPERINPELNQKGY----SVKSDIWSLGITMIELAILRFPYD 258

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 38/214 (17%)
Query: 563 RLLGTGSYGRVYKGILQD---GTAIAVKVLQLQSGNFTK---SFNRECQVLKRIRHRNLM 616
           + LG+G+YG V   + +D   G   A+K+++  S   T    +   E  VLK++ H N+M
Sbjct: 10  KKLGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIM 67
Query: 617 RIITACSLPDFKALVLPYMANGSL-DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++           LV+     G L D  +     +E  +            I   +  G 
Sbjct: 68  KLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV----------IMKQVLSGT 117
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLND---DMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
            YLH H+   ++H DLKP N+LL     D    + DFG++       VG    E +G + 
Sbjct: 118 TYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLS---AHFEVGGKMKERLGTAY 171
Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
                    Y+APE         K DV+S G+++
Sbjct: 172 ---------YIAPEV-LRKKYDEKCDVWSCGVIL 195

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/224 (21%), Positives = 99/224 (44%), Gaps = 43/224 (19%)
Query: 565 LGTGSYGRVYKGILQD--------GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLM 616
           LG G++ +++KG+ ++         T + +KVL     N+++SF     ++ ++ H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
                C   D   LV  ++  GSLD++L  +           + +L ++ +   +A  M 
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNC--------INILWKLEVAKQLAWAMH 127
Query: 677 YLHHHSPVRVIHCDLKPSNVLL---NDDMTA-----LVSDFGIAKLVMTVGVGNDGAENM 728
           +L  ++   +IH ++   N+LL    D  T       +SD GI+  V+            
Sbjct: 128 FLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL------------ 172
Query: 729 GNSTANMLCGSIGYMAPE-YGFGSNTSTKGDVYSFGILVLEMVT 771
                ++L   I ++ PE      N +   D +SFG  + E+ +
Sbjct: 173 ---PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 99/217 (45%), Gaps = 30/217 (13%)
Query: 562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTK----SFNRECQVLKRIRHRNLMR 617
           +R LG+G++G V+  ++++ ++   +V++  + + ++        E +VLK + H N+++
Sbjct: 27  KRKLGSGAFGDVH--LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           I           +V+     G L   +   S    G   S+  + +   +   +   +AY
Sbjct: 85  IFEVFEDYHNMYIVMETCEGGELLERIV--SAQARGKALSEGYVAE---LMKQMMNALAY 139
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDD---MTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
            H      V+H DLKP N+L  D        + DFG+A+L  +     + A         
Sbjct: 140 FHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--------- 187
Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
              G+  YMAPE  F  + + K D++S G+++  ++T
Sbjct: 188 ---GTALYMAPEV-FKRDVTFKCDIWSAGVVMYFLLT 220

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/210 (20%), Positives = 86/210 (40%), Gaps = 26/210 (12%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           +D    LGTG++G V++   +  G   A K +     +  ++  +E Q +  +RH  L+ 
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 112
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +  A    +   ++  +M+ G L    +     E    S D  +     +C    +G+ +
Sbjct: 113 LHDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVC----KGLCH 164
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVS--DFGIAKLVMTVGVGNDGAENMGNSTANM 735
           +H ++    +H DLKP N++     +  +   DFG+             A      +  +
Sbjct: 165 MHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT------------AHLDPKQSVKV 209
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGIL 765
             G+  + APE   G       D++S G+L
Sbjct: 210 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 239

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 44/225 (19%)
Query: 564 LLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNREC-QVLKRI-----RHRNLMR 617
           +LG GS+G+V     + GT     V  L+     +  + EC  V KR+     +   L +
Sbjct: 27  VLGKGSFGKVMLS-ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLY-------PHSETEFGSGSSDLTLLQRVNICSD 670
           + +     D    V+ Y+  G L  H+        PH+                V   ++
Sbjct: 86  LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA----------------VFYAAE 129
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           IA G+ +L       +I+ DLK  NV+L+ +    ++DFG+ K  +  GV          
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---------- 176
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            T    CG+  Y+APE           D ++FG+L+ EM+  + P
Sbjct: 177 -TTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 93/228 (40%), Gaps = 35/228 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQS------GNFTKSFNRECQVLKRIR 611
           +D    LG+G +  V K   +  G   A K ++ +       G   +   RE  +LK I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           H N++ +           L+L  +A G L          +F +    LT  +       I
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL---------FDFLAEKESLTEEEATEFLKQI 123
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA----LVSDFGIAKLVMTVGVGNDGAEN 727
             G+ YLH    +++ H DLKP N++L D         + DFG+A  +           +
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-----------D 169
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            GN   N+  G+  ++APE         + D++S G++   +++   P
Sbjct: 170 FGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 93/228 (40%), Gaps = 35/228 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQS------GNFTKSFNRECQVLKRIR 611
           +D    LG+G +  V K   +  G   A K ++ +       G   +   RE  +LK I+
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           H N++ +           L+L  +A G L          +F +    LT  +       I
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGEL---------FDFLAEKESLTEEEATEFLKQI 122
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA----LVSDFGIAKLVMTVGVGNDGAEN 727
             G+ YLH    +++ H DLKP N++L D         + DFG+A  +           +
Sbjct: 123 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-----------D 168
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            GN   N+  G+  ++APE         + D++S G++   +++   P
Sbjct: 169 FGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/238 (22%), Positives = 101/238 (42%), Gaps = 49/238 (20%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG---------NFTKSFNRECQVLK 608
           ++ + +LG G    V + I +      AVK++ +  G            ++  +E  +L+
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 609 RIR-HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI 667
           ++  H N++++        F  LV   M  G L  +L         +    L+  +   I
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---------TEKVTLSEKETRKI 129
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
              + E +  LH    + ++H DLKP N+LL+DDM   ++DFG +  +       D  E 
Sbjct: 130 MRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-------DPGEK 179
Query: 728 MGNSTANMLCGSIGYMAPEY----------GFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           + +     +CG+  Y+APE           G+G       D++S G+++  ++    P
Sbjct: 180 LRS-----VCGTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 228

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 93/228 (40%), Gaps = 35/228 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQS------GNFTKSFNRECQVLKRIR 611
           +D    LG+G +  V K   +  G   A K ++ +       G   +   RE  +LK I+
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           H N++ +           L+L  +A G L          +F +    LT  +       I
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL---------FDFLAEKESLTEEEATEFLKQI 123
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA----LVSDFGIAKLVMTVGVGNDGAEN 727
             G+ YLH    +++ H DLKP N++L D         + DFG+A  +           +
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-----------D 169
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            GN   N+  G+  ++APE         + D++S G++   +++   P
Sbjct: 170 FGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/238 (22%), Positives = 100/238 (42%), Gaps = 49/238 (20%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG---------NFTKSFNRECQVLK 608
           ++ + +LG G    V + I +      AVK++ +  G            ++  +E  +L+
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 609 RIR-HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI 667
           ++  H N++++        F  LV   M  G L  +L         +    L+  +   I
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---------TEKVTLSEKETRKI 129
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
              + E +  LH    + ++H DLKP N+LL+DDM   ++DFG +  +       D  E 
Sbjct: 130 MRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-------DPGEK 179
Query: 728 MGNSTANMLCGSIGYMAPEY----------GFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           +       +CG+  Y+APE           G+G       D++S G+++  ++    P
Sbjct: 180 LRE-----VCGTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 228

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/238 (22%), Positives = 100/238 (42%), Gaps = 49/238 (20%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG---------NFTKSFNRECQVLK 608
           ++ + +LG G    V + I +      AVK++ +  G            ++  +E  +L+
Sbjct: 6   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 65
Query: 609 RIR-HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI 667
           ++  H N++++        F  LV   M  G L  +L         +    L+  +   I
Sbjct: 66  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---------TEKVTLSEKETRKI 116
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
              + E +  LH    + ++H DLKP N+LL+DDM   ++DFG +  +       D  E 
Sbjct: 117 MRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-------DPGEK 166
Query: 728 MGNSTANMLCGSIGYMAPEY----------GFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           +       +CG+  Y+APE           G+G       D++S G+++  ++    P
Sbjct: 167 LRE-----VCGTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 215

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 93/228 (40%), Gaps = 35/228 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQS------GNFTKSFNRECQVLKRIR 611
           +D    LG+G +  V K   +  G   A K ++ +       G   +   RE  +LK I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           H N++ +           L+L  +A G L          +F +    LT  +       I
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL---------FDFLAEKESLTEEEATEFLKQI 123
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA----LVSDFGIAKLVMTVGVGNDGAEN 727
             G+ YLH    +++ H DLKP N++L D         + DFG+A  +           +
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-----------D 169
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            GN   N+  G+  ++APE         + D++S G++   +++   P
Sbjct: 170 FGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 94/241 (39%), Gaps = 43/241 (17%)
Query: 551 ELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVK----------VLQLQSGNF-TKS 599
           EL    + +  QR + +GSYG V  G+  +G  +A+K           + + S +F  K 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 600 FNRECQVLKRIRHRNLMRIITACSLPD-FKALVLPYMANGSLDSHLYPHSETEFGSGSSD 658
             RE ++L    H N++       L D F     P M    L + L     T+      D
Sbjct: 76  VLREIRLLNHFHHPNIL------GLRDIFVHFEEPAMHKLYLVTELM---RTDLAQVIHD 126
Query: 659 LTLLQRVNICSDIAEGMAY-----LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK 713
               QR+ I     +   Y     LH      V+H DL P N+LL D+    + DF +A+
Sbjct: 127 ----QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR 182
Query: 714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTK-GDVYSFGILVLEMVTR 772
                       E+  ++          Y APE        TK  D++S G ++ EM  R
Sbjct: 183 ------------EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
Query: 773 R 773
           +
Sbjct: 231 K 231

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 94/241 (39%), Gaps = 43/241 (17%)
Query: 551 ELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVK----------VLQLQSGNF-TKS 599
           EL    + +  QR + +GSYG V  G+  +G  +A+K           + + S +F  K 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 600 FNRECQVLKRIRHRNLMRIITACSLPD-FKALVLPYMANGSLDSHLYPHSETEFGSGSSD 658
             RE ++L    H N++       L D F     P M    L + L     T+      D
Sbjct: 76  VLREIRLLNHFHHPNIL------GLRDIFVHFEEPAMHKLYLVTELM---RTDLAQVIHD 126
Query: 659 LTLLQRVNICSDIAEGMAY-----LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK 713
               QR+ I     +   Y     LH      V+H DL P N+LL D+    + DF +A+
Sbjct: 127 ----QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR 182
Query: 714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTK-GDVYSFGILVLEMVTR 772
                       E+  ++          Y APE        TK  D++S G ++ EM  R
Sbjct: 183 ------------EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
Query: 773 R 773
           +
Sbjct: 231 K 231

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/210 (20%), Positives = 86/210 (40%), Gaps = 26/210 (12%)
Query: 559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           +D    LGTG++G V++   +  G   A K +     +  ++  +E Q +  +RH  L+ 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +  A    +   ++  +M+ G L    +     E    S D  +     +C    +G+ +
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVC----KGLCH 270
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVS--DFGIAKLVMTVGVGNDGAENMGNSTANM 735
           +H ++    +H DLKP N++     +  +   DFG+             A      +  +
Sbjct: 271 MHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT------------AHLDPKQSVKV 315
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGIL 765
             G+  + APE   G       D++S G+L
Sbjct: 316 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 345

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 93/217 (42%), Gaps = 29/217 (13%)
Query: 556 TAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRH 612
           T E+     +G G++  V + + L  G   A K++  +  S    +   RE ++ + ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 613 RNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIA 672
            N++R+  + S   F  LV   +  G L   +      E+ S +     +Q++       
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR---EYYSEADASHCIQQIL------ 113
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL---VSDFGIAKLVMTVGVGNDGAENMG 729
              A LH H  + V+H DLKP N+LL          ++DFG+A     + V  D     G
Sbjct: 114 --EAVLHCHQ-MGVVHRDLKPENLLLASKCKGAAVKLADFGLA-----IEVQGDQQAWFG 165
Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
                   G+ GY++PE           D+++ G+++
Sbjct: 166 ------FAGTPGYLSPEVLRKEAYGKPVDIWACGVIL 196

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 93/228 (40%), Gaps = 35/228 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQS------GNFTKSFNRECQVLKRIR 611
           +D    LG+G +  V K   +  G   A K ++ +       G   +   RE  +LK I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           H N++ +           L+L  +A G L          +F +    LT  +       I
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL---------FDFLAEKESLTEEEATEFLKQI 123
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA----LVSDFGIAKLVMTVGVGNDGAEN 727
             G+ YLH    +++ H DLKP N++L D         + DFG+A  +           +
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-----------D 169
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            GN   N+  G+  ++APE         + D++S G++   +++   P
Sbjct: 170 FGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 561 EQRLLGTGSYGRVYKGILQ---DGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNL 615
           E + LG+G++G V KG  Q       +AVK+L+ ++ +         E  V++++ +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +R+I  C    +  LV+     G L+ +L  +   +      D  +++ V+    ++ GM
Sbjct: 75  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVK------DKNIIELVH---QVSMGM 124
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL   +    +H DL   NVLL     A +SDFG++K  +        A+  G      
Sbjct: 125 KYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENXYKAQTHGK----- 175
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLE 768
               + + APE       S+K DV+SFG+L+ E
Sbjct: 176 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWE 206

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 93/228 (40%), Gaps = 35/228 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQS------GNFTKSFNRECQVLKRIR 611
           +D    LG+G +  V K   +  G   A K ++ +       G   +   RE  +LK I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           H N++ +           L+L  +A G L          +F +    LT  +       I
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL---------FDFLAEKESLTEEEATEFLKQI 123
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA----LVSDFGIAKLVMTVGVGNDGAEN 727
             G+ YLH    +++ H DLKP N++L D         + DFG+A  +           +
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-----------D 169
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            GN   N+  G+  ++APE         + D++S G++   +++   P
Sbjct: 170 FGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 35/218 (16%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQS------GNFTKSFNRECQVLKRIR 611
           +D    LG+G +  V K   +  G   A K ++ +       G   +   RE  +LK I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           H N++ +           L+L  +A G L          +F +    LT  +       I
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL---------FDFLAEKESLTEEEATEFLKQI 123
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA----LVSDFGIAKLVMTVGVGNDGAEN 727
             G+ YLH    +++ H DLKP N++L D         + DFG+A  +           +
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-----------D 169
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGIL 765
            GN   N+  G+  ++APE         + D++S G++
Sbjct: 170 FGNEFKNIF-GTPAFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 95/217 (43%), Gaps = 33/217 (15%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           LG G+YG VYK I       +A+K ++L  +      +  RE  +LK ++HRN++ + + 
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
                   L+  Y  N             ++   + D+++    +    +  G+ + H  
Sbjct: 102 IHHNHRLHLIFEYAENDL----------KKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 682 SPVRVIHCDLKPSNVLL-----NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
              R +H DLKP N+LL     ++     + DFG+A+     G+       +   T  ++
Sbjct: 152 ---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR---AFGI------PIRQFTHEII 199
Query: 737 CGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTR 772
             ++ Y  PE   GS + ST  D++S   +  EM+ +
Sbjct: 200 --TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK 234

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 93/228 (40%), Gaps = 35/228 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQS------GNFTKSFNRECQVLKRIR 611
           +D    LG+G +  V K   +  G   A K ++ +       G   +   RE  +LK I+
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           H N++ +           L+L  +A G L          +F +    LT  +       I
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL---------FDFLAEKESLTEEEATEFLKQI 123
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA----LVSDFGIAKLVMTVGVGNDGAEN 727
             G+ YLH    +++ H DLKP N++L D         + DFG+A  +           +
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-----------D 169
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            GN   N+  G+  ++APE         + D++S G++   +++   P
Sbjct: 170 FGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 93/228 (40%), Gaps = 35/228 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQS------GNFTKSFNRECQVLKRIR 611
           +D    LG+G +  V K   +  G   A K ++ +       G   +   RE  +LK I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           H N++ +           L+L  +A G L          +F +    LT  +       I
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL---------FDFLAEKESLTEEEATEFLKQI 123
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA----LVSDFGIAKLVMTVGVGNDGAEN 727
             G+ YLH    +++ H DLKP N++L D         + DFG+A  +           +
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-----------D 169
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            GN   N+  G+  ++APE         + D++S G++   +++   P
Sbjct: 170 FGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 44/225 (19%)
Query: 564 LLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNREC-QVLKRI-----RHRNLMR 617
           +LG GS+G+V     + GT     V  L+     +  + EC  V KR+     +   L +
Sbjct: 348 VLGKGSFGKVMLS-ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLY-------PHSETEFGSGSSDLTLLQRVNICSD 670
           + +     D    V+ Y+  G L  H+        PH+                V   ++
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA----------------VFYAAE 450
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           IA G+ +L       +I+ DLK  NV+L+ +    ++DFG+ K  +  GV          
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---------- 497
Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            T    CG+  Y+APE           D ++FG+L+ EM+  + P
Sbjct: 498 -TTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 43/231 (18%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVL-----QLQSGNFTKSFNRECQVLKRIR 611
           +F   R++G G +G VY     D G   A+K L     +++ G  T + N E  +L  + 
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-TLALN-ERIMLSLVS 247
Query: 612 HRNLMRIIT---ACSLPDFKALVLPYMANGSLDSHLYPH---SETEFGSGSSDLTLLQRV 665
             +   I+    A   PD  + +L  M  G L  HL  H   SE +    ++++ L    
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL---- 303
Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGA 725
                   G+ ++H+     V++ DLKP+N+LL++     +SD G+A             
Sbjct: 304 --------GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC------------ 340
Query: 726 ENMGNSTANMLCGSIGYMAPEY-GFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            +      +   G+ GYMAPE    G    +  D +S G ++ +++    P
Sbjct: 341 -DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 93/228 (40%), Gaps = 35/228 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQS------GNFTKSFNRECQVLKRIR 611
           +D    LG+G +  V K   +  G   A K ++ +       G   +   RE  +LK I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           H N++ +           L+L  +A G L          +F +    LT  +       I
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL---------FDFLAEKESLTEEEATEFLKQI 123
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA----LVSDFGIAKLVMTVGVGNDGAEN 727
             G+ YLH    +++ H DLKP N++L D         + DFG+A  +           +
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-----------D 169
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            GN   N+  G+  ++APE         + D++S G++   +++   P
Sbjct: 170 FGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 43/231 (18%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVL-----QLQSGNFTKSFNRECQVLKRIR 611
           +F   R++G G +G VY     D G   A+K L     +++ G  T + N E  +L  + 
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-TLALN-ERIMLSLVS 247
Query: 612 HRNLMRIIT---ACSLPDFKALVLPYMANGSLDSHLYPH---SETEFGSGSSDLTLLQRV 665
             +   I+    A   PD  + +L  M  G L  HL  H   SE +    ++++ L    
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL---- 303
Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGA 725
                   G+ ++H+     V++ DLKP+N+LL++     +SD G+A             
Sbjct: 304 --------GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC------------ 340
Query: 726 ENMGNSTANMLCGSIGYMAPEY-GFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            +      +   G+ GYMAPE    G    +  D +S G ++ +++    P
Sbjct: 341 -DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 43/231 (18%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVL-----QLQSGNFTKSFNRECQVLKRIR 611
           +F   R++G G +G VY     D G   A+K L     +++ G  T + N E  +L  + 
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-TLALN-ERIMLSLVS 247
Query: 612 HRNLMRIIT---ACSLPDFKALVLPYMANGSLDSHLYPH---SETEFGSGSSDLTLLQRV 665
             +   I+    A   PD  + +L  M  G L  HL  H   SE +    ++++ L    
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL---- 303
Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGA 725
                   G+ ++H+     V++ DLKP+N+LL++     +SD G+A             
Sbjct: 304 --------GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC------------ 340
Query: 726 ENMGNSTANMLCGSIGYMAPEY-GFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            +      +   G+ GYMAPE    G    +  D +S G ++ +++    P
Sbjct: 341 -DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 561 EQRLLGTGSYGRVYKGILQ---DGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNL 615
           E + LG+G++G V KG  Q       +AVK+L+ ++ +         E  V++++ +  +
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +R+I  C    +  LV+     G L+ +L  +   +      D  +++ V+    ++ GM
Sbjct: 69  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVK------DKNIIELVH---QVSMGM 118
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL   +    +H DL   NVLL     A +SDFG++K  +        A+  G      
Sbjct: 119 KYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGK----- 169
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLE 768
               + + APE       S+K DV+SFG+L+ E
Sbjct: 170 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWE 200

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 561 EQRLLGTGSYGRVYKGILQ---DGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNL 615
           E + LG+G++G V KG  Q       +AVK+L+ ++ +         E  V++++ +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +R+I  C    +  LV+     G L+ +L  +   +      D  +++ V+    ++ GM
Sbjct: 91  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVK------DKNIIELVH---QVSMGM 140
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL   +    +H DL   NVLL     A +SDFG++K  +        A+  G      
Sbjct: 141 KYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGK----- 191
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLE 768
               + + APE       S+K DV+SFG+L+ E
Sbjct: 192 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWE 222

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 561 EQRLLGTGSYGRVYKGILQ---DGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNL 615
           E + LG+G++G V KG  Q       +AVK+L+ ++ +         E  V++++ +  +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +R+I  C    +  LV+     G L+ +L  +   +      D  +++ V+    ++ GM
Sbjct: 81  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVK------DKNIIELVH---QVSMGM 130
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL   +    +H DL   NVLL     A +SDFG++K  +        A+  G      
Sbjct: 131 KYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGK----- 181
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLE 768
               + + APE       S+K DV+SFG+L+ E
Sbjct: 182 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWE 212

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 561 EQRLLGTGSYGRVYKGILQ---DGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNL 615
           E + LG+G++G V KG  Q       +AVK+L+ ++ +         E  V++++ +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +R+I  C    +  LV+     G L+ +L  +   +      D  +++ V+    ++ GM
Sbjct: 75  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVK------DKNIIELVH---QVSMGM 124
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL   +    +H DL   NVLL     A +SDFG++K  +        A+  G      
Sbjct: 125 KYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGK----- 175
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLE 768
               + + APE       S+K DV+SFG+L+ E
Sbjct: 176 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWE 206

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 561 EQRLLGTGSYGRVYKGILQ---DGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNL 615
           E + LG+G++G V KG  Q       +AVK+L+ ++ +         E  V++++ +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +R+I  C    +  LV+     G L+ +L  +   +      D  +++ V+    ++ GM
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVK------DKNIIELVH---QVSMGM 120
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL   +    +H DL   NVLL     A +SDFG++K  +        A+  G      
Sbjct: 121 KYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGK----- 171
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLE 768
               + + APE       S+K DV+SFG+L+ E
Sbjct: 172 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWE 202

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 561 EQRLLGTGSYGRVYKGILQ---DGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNL 615
           E + LG+G++G V KG  Q       +AVK+L+ ++ +         E  V++++ +  +
Sbjct: 29  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +R+I  C    +  LV+     G L+ +L  +   +      D  +++ V+    ++ GM
Sbjct: 89  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVK------DKNIIELVH---QVSMGM 138
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL   +    +H DL   NVLL     A +SDFG++K  +        A+  G      
Sbjct: 139 KYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGK----- 189
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLE 768
               + + APE       S+K DV+SFG+L+ E
Sbjct: 190 --WPVKWYAPECINYYKFSSKSDVWSFGVLMWE 220

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 43/231 (18%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVL-----QLQSGNFTKSFNRECQVLKRIR 611
           +F   R++G G +G VY     D G   A+K L     +++ G  T + N E  +L  + 
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-TLALN-ERIMLSLVS 246
Query: 612 HRNLMRIIT---ACSLPDFKALVLPYMANGSLDSHLYPH---SETEFGSGSSDLTLLQRV 665
             +   I+    A   PD  + +L  M  G L  HL  H   SE +    ++++ L    
Sbjct: 247 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL---- 302
Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGA 725
                   G+ ++H+     V++ DLKP+N+LL++     +SD G+A             
Sbjct: 303 --------GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC------------ 339
Query: 726 ENMGNSTANMLCGSIGYMAPEY-GFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            +      +   G+ GYMAPE    G    +  D +S G ++ +++    P
Sbjct: 340 -DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 38/212 (17%)
Query: 565 LGTGSYGRVYKGILQD---GTAIAVKVLQLQSGNFTK---SFNRECQVLKRIRHRNLMRI 618
           LG+G+YG V   + +D   G   A+K+++  S   T    +   E  VLK++ H N+M++
Sbjct: 29  LGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 86
Query: 619 ITACSLPDFKALVLPYMANGSL-DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
                      LV+     G L D  +     +E  +            I   +  G  Y
Sbjct: 87  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV----------IMKQVLSGTTY 136
Query: 678 LHHHSPVRVIHCDLKPSNVLLND---DMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           LH H+   ++H DLKP N+LL     D    + DFG++       VG    E +G +   
Sbjct: 137 LHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSA---HFEVGGKMKERLGTAY-- 188
Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
                  Y+APE         K DV+S G+++
Sbjct: 189 -------YIAPEV-LRKKYDEKCDVWSCGVIL 212

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 35/218 (16%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQS------GNFTKSFNRECQVLKRIR 611
           +D    LG+G +  V K   +  G   A K ++ +       G   +   RE  +LK I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           H N++ +           L+L  +A G L          +F +    LT  +       I
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL---------FDFLAEKESLTEEEATEFLKQI 123
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA----LVSDFGIAKLVMTVGVGNDGAEN 727
             G+ YLH    +++ H DLKP N++L D         + DFG+A  +           +
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-----------D 169
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGIL 765
            GN   N+  G+  ++APE         + D++S G++
Sbjct: 170 FGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 71/160 (44%), Gaps = 11/160 (6%)
Query: 559 FDEQRLLGTGSYGRVYKGILQDGTA-IAVKVLQLQSGNF--TKSFNRECQVLKRIRHRNL 615
           ++ + L+G GSYG VY    ++    +A+K +     +    K   RE  +L R++   +
Sbjct: 30  YEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 89
Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +R+       D       Y+     DS L    +T        LT      I  ++  G 
Sbjct: 90  IRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIF-----LTEQHVKTILYNLLLGE 144
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
            ++H      +IH DLKP+N LLN D +  + DFG+A+ +
Sbjct: 145 KFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTI 181

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 52/110 (47%), Gaps = 24/110 (21%)
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
           A  H HS + VIH D+KPSNVL+N        DFGI+  ++     +D A+++       
Sbjct: 148 ALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLV-----DDVAKDID------ 196
Query: 736 LCGSIGYMAPEY--------GFGSNTSTKGDVYSFGILVLEMVTRRRPTD 777
             G   Y APE         G+    S K D++S GI  +E+   R P D
Sbjct: 197 -AGCKPYXAPERINPELNQKGY----SVKSDIWSLGITXIELAILRFPYD 241

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 35/218 (16%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQS------GNFTKSFNRECQVLKRIR 611
           +D    LG+G +  V K   +  G   A K ++ +       G   +   RE  +LK I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           H N++ +           L+L  +A G L          +F +    LT  +       I
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGEL---------FDFLAEKESLTEEEATEFLKQI 123
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA----LVSDFGIAKLVMTVGVGNDGAEN 727
             G+ YLH    +++ H DLKP N++L D         + DFG+A  +           +
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-----------D 169
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGIL 765
            GN   N+  G+  ++APE         + D++S G++
Sbjct: 170 FGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/216 (21%), Positives = 91/216 (42%), Gaps = 31/216 (14%)
Query: 563 RLLGTGSYGRVYKGILQD--GTAIAVKVLQLQSG---NFTKSFNRECQVLKRIRHRNLMR 617
           R+LG G +G VY+G+  +  G  I V V   +     +  + F  E  ++K + H ++++
Sbjct: 30  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 89
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSET--EFGSGSSDLTLLQRVNICSDIAEGM 675
           +I          ++            LYP+ E         + L +L  V     I + M
Sbjct: 90  LIGIIEEEPTWIIM-----------ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 138
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
           AYL     +  +H D+   N+L+       + DFG+++ +          E+     A++
Sbjct: 139 AYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYI----------EDEDYYKASV 185
Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
               I +M+PE       +T  DV+ F + + E+++
Sbjct: 186 TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 221

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/258 (24%), Positives = 101/258 (39%), Gaps = 55/258 (21%)
Query: 552 LLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFN--------RE 603
           LLE   ++  +  +G GSYG V   I  +    A++ +++ + N  +  N         E
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAI--ENQTRAIRAIKIMNKNKIRQINPKDVERIKTE 78
Query: 604 CQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHL------------------- 644
            +++K++ H N+ R+        +  LV+     G L   L                   
Sbjct: 79  VRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQ 138
Query: 645 ---YPHSETEFGSGS-----SDLTLLQR----VNICSDIAEGMAYLHHHSPVRVIHCDLK 692
               P    E  +GS       L  +QR     NI   I   + YLH+     + H D+K
Sbjct: 139 ICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIK 195
Query: 693 PSNVLL--NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG 750
           P N L   N      + DFG++K    +  G    E  G +T     G+  ++APE    
Sbjct: 196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNG----EYYGMTTK---AGTPYFVAPEVLNT 248
Query: 751 SNTST--KGDVYSFGILV 766
           +N S   K D +S G+L+
Sbjct: 249 TNESYGPKCDAWSAGVLL 266

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/209 (22%), Positives = 85/209 (40%), Gaps = 31/209 (14%)
Query: 565 LGTGSYGRVYKGILQDGTA-IAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           LG G++  V + + +  T   A K++  +  S    +   RE ++ + ++H N++R+  +
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
            S   F  LV   +  G L   +           S         +    I E + ++H H
Sbjct: 99  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---------HCIHQILESVNHIHQH 149
Query: 682 SPVRVIHCDLKPSNVLLNDDMTAL---VSDFGIAKLVMTVGVGNDGAENMGNSTANM-LC 737
               ++H DLKP N+LL          ++DFG+A             E  G   A     
Sbjct: 150 D---IVHRDLKPENLLLASKCKGAAVKLADFGLA------------IEVQGEQQAWFGFA 194
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
           G+ GY++PE           D+++ G+++
Sbjct: 195 GTPGYLSPEVLRKDPYGKPVDIWACGVIL 223

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 563 RLLGTGSYGRVYKGILQD----GTAIAVKVLQ-LQSGNFTKSFNRECQVLKRIRHRNLMR 617
           R +G G +G V++GI         A+A+K  +   S +  + F +E   +++  H ++++
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +I   +  +   +++     G L S L      +    S DL  L  +     ++  +AY
Sbjct: 76  LIGVIT-ENPVWIIMELCTLGELRSFL------QVRKFSLDLASL--ILYAYQLSTALAY 126
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L      R +H D+   NVL++ +    + DFG+++ +          E+     A+   
Sbjct: 127 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM----------EDSTXXKASKGK 173
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
             I +MAPE       ++  DV+ FG+ + E++
Sbjct: 174 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 53/228 (23%), Positives = 93/228 (40%), Gaps = 35/228 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQS------GNFTKSFNRECQVLKRIR 611
           +D    LG+G +  V K   +  G   A K ++ +       G   +   RE  +LK I+
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           H N++ +           L+L  +A G L          +F +    LT  +       I
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGEL---------FDFLAEKESLTEEEATEFLKQI 122
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA----LVSDFGIAKLVMTVGVGNDGAEN 727
             G+ YLH    +++ H DLKP N++L D         + DFG+A  +           +
Sbjct: 123 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-----------D 168
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            GN   N+  G+  ++APE         + D++S G++   +++   P
Sbjct: 169 FGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/238 (20%), Positives = 96/238 (40%), Gaps = 34/238 (14%)
Query: 563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNLMRIIT 620
           + +G+G   +V++ + +     A+K + L+  +     S+  E   L +++  +  +II 
Sbjct: 18  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIR 76
Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
                     +   M  G++D +        +      +   +R +   ++ E +  +H 
Sbjct: 77  LYDYEITDQYIYMVMECGNIDLN-------SWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 129
Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
           H    ++H DLKP+N L+ D M  L+ DFGIA         N    +  +   +   G++
Sbjct: 130 HG---IVHSDLKPANFLIVDGMLKLI-DFGIA---------NQMQPDTTSVVKDSQVGTV 176
Query: 741 GYMAPEYGFGSNTSTKG-----------DVYSFGILVLEMVTRRRPTDDMFAGGLSLH 787
            YM PE     ++S +            DV+S G ++  M   + P   +      LH
Sbjct: 177 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 234

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 86/213 (40%), Gaps = 27/213 (12%)
Query: 562 QRL--LGTGSYGRVYK-GILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRI 618
           QRL  LG GSYG V+K    +DG   AVK        F    +R  ++ +   H  + + 
Sbjct: 60  QRLSRLGHGSYGEVFKVRSKEDGRLYAVKR---SMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 619 ITACSLPD-FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
                L   ++   + Y+        L  H E    +  + L   Q      D    +A+
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCGPSLQQHCE----AWGASLPEAQVWGYLRDTLLALAH 172
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH      ++H D+KP+N+ L       + DFG+   + T G G             +  
Sbjct: 173 LHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG------------EVQE 217
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
           G   YMAPE   GS   T  DV+S G+ +LE+ 
Sbjct: 218 GDPRYMAPELLQGS-YGTAADVFSLGLTILEVA 249

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/238 (20%), Positives = 96/238 (40%), Gaps = 34/238 (14%)
Query: 563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNLMRIIT 620
           + +G+G   +V++ + +     A+K + L+  +     S+  E   L +++  +  +II 
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIR 92
Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
                     +   M  G++D +        +      +   +R +   ++ E +  +H 
Sbjct: 93  LYDYEITDQYIYMVMECGNIDLN-------SWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
           H    ++H DLKP+N L+ D M  L+ DFGIA         N    +  +   +   G++
Sbjct: 146 HG---IVHSDLKPANFLIVDGMLKLI-DFGIA---------NQMQPDTTSVVKDSQVGTV 192
Query: 741 GYMAPEYGFGSNTSTKG-----------DVYSFGILVLEMVTRRRPTDDMFAGGLSLH 787
            YM PE     ++S +            DV+S G ++  M   + P   +      LH
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 250

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 42/226 (18%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNREC----------QVL 607
           E+   + LG+G+ G V K   +  T   V +  +    F     RE           ++L
Sbjct: 136 EYIMSKTLGSGACGEV-KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 608 KRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI 667
           K++ H  +++I       D+  +VL  M  G L   +  +        +  L   Q    
Sbjct: 195 KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQ---- 247
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFGIAKLVMTVGVGNDG 724
              +   + YLH +    +IH DLKP NVLL+   +D    ++DFG +K++         
Sbjct: 248 ---MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET------ 295
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG---DVYSFGILVL 767
                 S    LCG+  Y+APE      T+      D +S G+++ 
Sbjct: 296 ------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 335

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/252 (21%), Positives = 109/252 (43%), Gaps = 29/252 (11%)
Query: 524 ISSGKSETRSKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQD--- 580
           +S  +++  ++ I  E  +  P     E+     E    R +G G +G V++GI      
Sbjct: 359 VSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELG--RCIGEGQFGDVHQGIYMSPEN 416
Query: 581 -GTAIAVKVLQ-LQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANG 638
              A+A+K  +   S +  + F +E   +++  H +++++I   +  +   +++     G
Sbjct: 417 PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLG 475
Query: 639 SLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL 698
            L S L      +    S DL  L  +     ++  +AYL      R +H D+   NVL+
Sbjct: 476 ELRSFL------QVRKFSLDLASL--ILYAYQLSTALAYLESK---RFVHRDIAARNVLV 524
Query: 699 NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGD 758
           + +    + DFG+++ +          E+     A+     I +MAPE       ++  D
Sbjct: 525 SSNDCVKLGDFGLSRYM----------EDSTYYKASKGKLPIKWMAPESINFRRFTSASD 574
Query: 759 VYSFGILVLEMV 770
           V+ FG+ + E++
Sbjct: 575 VWMFGVCMWEIL 586

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 49/102 (48%), Gaps = 18/102 (17%)
Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA-KLVMTVGVGNDGAENMGNSTANMLC 737
           H    +++IH D+KPSN+LL+      + DFGI+ +LV ++    D              
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA------------- 186
Query: 738 GSIGYMAPEYGFGSNT----STKGDVYSFGILVLEMVTRRRP 775
           G   YMAPE    S +      + DV+S GI + E+ T R P
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 42/226 (18%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNREC----------QVL 607
           E+   + LG+G+ G V K   +  T   V +  +    F     RE           ++L
Sbjct: 11  EYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 608 KRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI 667
           K++ H  +++I       D+  +VL  M  G L   +  +        +  L   Q +  
Sbjct: 70  KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLL- 125
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFGIAKLVMTVGVGNDG 724
                  + YLH +    +IH DLKP NVLL+   +D    ++DFG +K++         
Sbjct: 126 ------AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE------- 169
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTS---TKGDVYSFGILVL 767
                 S    LCG+  Y+APE      T+      D +S G+++ 
Sbjct: 170 -----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 210

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 42/226 (18%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNREC----------QVL 607
           E+   + LG+G+ G V K   +  T   V +  +    F     RE           ++L
Sbjct: 10  EYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 608 KRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI 667
           K++ H  +++I       D+  +VL  M  G L   +  +        +  L   Q +  
Sbjct: 69  KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLL- 124
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFGIAKLVMTVGVGNDG 724
                  + YLH +    +IH DLKP NVLL+   +D    ++DFG +K++         
Sbjct: 125 ------AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE------- 168
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTS---TKGDVYSFGILVL 767
                 S    LCG+  Y+APE      T+      D +S G+++ 
Sbjct: 169 -----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 209

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 42/226 (18%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNREC----------QVL 607
           E+   + LG+G+ G V K   +  T   V +  +    F     RE           ++L
Sbjct: 11  EYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 608 KRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI 667
           K++ H  +++I       D+  +VL  M  G L   +  +        +  L   Q +  
Sbjct: 70  KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLL- 125
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFGIAKLVMTVGVGNDG 724
                  + YLH +    +IH DLKP NVLL+   +D    ++DFG +K++         
Sbjct: 126 ------AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE------- 169
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTS---TKGDVYSFGILVL 767
                 S    LCG+  Y+APE      T+      D +S G+++ 
Sbjct: 170 -----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 210

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 42/226 (18%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNREC----------QVL 607
           E+   + LG+G+ G V K   +  T   V +  +    F     RE           ++L
Sbjct: 150 EYIMSKTLGSGACGEV-KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 608 KRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI 667
           K++ H  +++I       D+  +VL  M  G L   +  +        +  L   Q    
Sbjct: 209 KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQ---- 261
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFGIAKLVMTVGVGNDG 724
              +   + YLH +    +IH DLKP NVLL+   +D    ++DFG +K++         
Sbjct: 262 ---MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET------ 309
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG---DVYSFGILVL 767
                 S    LCG+  Y+APE      T+      D +S G+++ 
Sbjct: 310 ------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 349

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 104/250 (41%), Gaps = 39/250 (15%)
Query: 541 MHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGT--AIAVKVLQLQSGNFTK 598
           +H+  +  +R  ++ T  ++ +  +G GSY  V K  +   T    AVK++     + T+
Sbjct: 6   VHSIVQQLHRNSIQFTDGYEVKEDIGVGSYS-VCKRCIHKATNMEFAVKIIDKSKRDPTE 64
Query: 599 SFNRECQVLKRI-RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSS 657
               E ++L R  +H N++ +        +  +V   M  G L   +    +  F    +
Sbjct: 65  ----EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL--RQKFFSEREA 118
Query: 658 DLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDM----TALVSDFGIAK 713
              L         I + + YLH      V+H DLKPSN+L  D+     +  + DFG AK
Sbjct: 119 SAVLFT-------ITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
Query: 714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRR 773
            +         AEN    T    C +  ++APE           D++S G+L+  M+T  
Sbjct: 169 QLR--------AENGLLMTP---CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGY 217
Query: 774 RPTDDMFAGG 783
            P    FA G
Sbjct: 218 TP----FANG 223

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 552 LLEATAEFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQS-----GNFTKSFNRECQ 605
           L E   E  E  ++G G++  V + I ++ G   AVK++ +       G  T+   RE  
Sbjct: 21  LFEDVYELCE--VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78
Query: 606 VLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRV 665
           +   ++H +++ ++   S      +V  +M    L   +   ++  F    +  +   R 
Sbjct: 79  ICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR- 137
Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGN 722
                I E + Y H ++   +IH D+KP NVLL    +     + DFG+A     + +G 
Sbjct: 138 ----QILEALRYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVA-----IQLGE 185
Query: 723 DGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVL 767
            G        A    G+  +MAPE           DV+  G+++ 
Sbjct: 186 SGL------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILF 224

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 42/226 (18%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNREC----------QVL 607
           E+   + LG+G+ G V K   +  T   V +  +    F     RE           ++L
Sbjct: 11  EYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 608 KRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI 667
           K++ H  +++I       D+  +VL  M  G L   +  +        +  L   Q +  
Sbjct: 70  KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLL- 125
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFGIAKLVMTVGVGNDG 724
                  + YLH +    +IH DLKP NVLL+   +D    ++DFG +K++         
Sbjct: 126 ------AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE------- 169
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTS---TKGDVYSFGILVL 767
                 S    LCG+  Y+APE      T+      D +S G+++ 
Sbjct: 170 -----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 210

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 42/226 (18%)
Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNREC----------QVL 607
           E+   + LG+G+ G V K   +  T   V +  +    F     RE           ++L
Sbjct: 17  EYIMSKTLGSGACGEV-KLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 608 KRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI 667
           K++ H  +++I       D+  +VL  M  G L   +  +        +  L   Q +  
Sbjct: 76  KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLL- 131
Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFGIAKLVMTVGVGNDG 724
                  + YLH +    +IH DLKP NVLL+   +D    ++DFG +K++         
Sbjct: 132 ------AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE------- 175
Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTS---TKGDVYSFGILVL 767
                 S    LCG+  Y+APE      T+      D +S G+++ 
Sbjct: 176 -----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 216

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/238 (20%), Positives = 96/238 (40%), Gaps = 34/238 (14%)
Query: 563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNLMRIIT 620
           + +G+G   +V++ + +     A+K + L+  +     S+  E   L +++  +  +II 
Sbjct: 14  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIR 72
Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
                     +   M  G++D +        +      +   +R +   ++ E +  +H 
Sbjct: 73  LYDYEITDQYIYMVMECGNIDLN-------SWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 125
Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
           H    ++H DLKP+N L+ D M  L+ DFGIA         N    +  +   +   G++
Sbjct: 126 HG---IVHSDLKPANFLIVDGMLKLI-DFGIA---------NQMQPDTTSVVKDSQVGTV 172
Query: 741 GYMAPEYGFGSNTSTKG-----------DVYSFGILVLEMVTRRRPTDDMFAGGLSLH 787
            YM PE     ++S +            DV+S G ++  M   + P   +      LH
Sbjct: 173 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 230

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/238 (20%), Positives = 95/238 (39%), Gaps = 34/238 (14%)
Query: 563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNLMRIIT 620
           + +G+G   +V++ + +     A+K + L+  +     S+  E   L +++  +  +II 
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIR 92
Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
                     +   M  G++D +        +      +   +R +   ++ E +  +H 
Sbjct: 93  LYDYEITDQYIYMVMECGNIDLN-------SWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
           H    ++H DLKP+N L+ D M  L+ DFGIA         N    +      +   G++
Sbjct: 146 HG---IVHSDLKPANFLIVDGMLKLI-DFGIA---------NQMQPDXXXVVKDSQVGTV 192
Query: 741 GYMAPEYGFGSNTSTKG-----------DVYSFGILVLEMVTRRRPTDDMFAGGLSLH 787
            YM PE     ++S +            DV+S G ++  M   + P   +      LH
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 250

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 37/214 (17%)
Query: 563 RLLGTGSYGRVYKGILQDGTA---IAVKVLQLQSGNFTKSFN--RECQVLKRIRHRNLMR 617
           + LG+G+YG V   + +D       A+K+++  S + + +     E  VLK + H N+M+
Sbjct: 43  KKLGSGAYGEVL--LCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 618 IITACSLPDFKALVLPYMANGSL-DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           +           LV+     G L D  ++     E  +            I   +  G+ 
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV----------IIKQVLSGVT 150
Query: 677 YLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           YLH H+   ++H DLKP N+LL     D    + DFG++ +           EN      
Sbjct: 151 YLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF----------ENQKKMKE 197
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVL 767
            +  G+  Y+APE         K DV+S G+++ 
Sbjct: 198 RL--GTAYYIAPEV-LRKKYDEKCDVWSIGVILF 228

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/239 (20%), Positives = 97/239 (40%), Gaps = 36/239 (15%)
Query: 563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT--KSFNRECQVLKRIR-HRNLMRII 619
           + +G+G   +V++ + +     A+K + L+  +     S+  E   L +++ H + +  +
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 620 TACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLH 679
               + D    ++    N  L+S L              +   +R +   ++ E +  +H
Sbjct: 75  YDYEITDQYIYMVMECGNIDLNSWL---------KKKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 680 HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS 739
            H    ++H DLKP+N L+ D M  L+ DFGIA         N    +  +   +   G+
Sbjct: 126 QHG---IVHSDLKPANFLIVDGMLKLI-DFGIA---------NQMQPDTTSVVKDSQVGT 172
Query: 740 IGYMAPEYGFGSNTSTKG-----------DVYSFGILVLEMVTRRRPTDDMFAGGLSLH 787
           + YM PE     ++S +            DV+S G ++  M   + P   +      LH
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 231

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 84/184 (45%), Gaps = 33/184 (17%)
Query: 602 RECQVLKRIRHRNLMRIITACSLP--DFKALVLPYMANGSLDS--HLYPHSETEFGSGSS 657
           +E  +LK++ H N+++++     P  D   +V   +  G +     L P SE        
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED------- 137
Query: 658 DLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT 717
                Q      D+ +G+ YLH+    ++IH D+KPSN+L+ +D    ++DFG++     
Sbjct: 138 -----QARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEF-- 187
Query: 718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG---DVYSFGILVLEMVTRRR 774
                 G++ + ++T     G+  +MAPE    +     G   DV++ G+ +   V  + 
Sbjct: 188 -----KGSDALLSNTV----GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238
Query: 775 PTDD 778
           P  D
Sbjct: 239 PFMD 242

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/228 (22%), Positives = 92/228 (40%), Gaps = 35/228 (15%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQS------GNFTKSFNRECQVLKRIR 611
           +D    LG+G +  V K   +  G   A K ++ +       G   +   RE  +LK I+
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           H N++ +           L+   +A G L          +F +    LT  +       I
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGEL---------FDFLAEKESLTEEEATEFLKQI 123
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA----LVSDFGIAKLVMTVGVGNDGAEN 727
             G+ YLH    +++ H DLKP N++L D         + DFG+A  +           +
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-----------D 169
Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            GN   N+  G+  ++APE         + D++S G++   +++   P
Sbjct: 170 FGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 563 RLLGTGSYGRVYKGILQD----GTAIAVKVLQ-LQSGNFTKSFNRECQVLKRIRHRNLMR 617
           R +G G +G V++GI         A+A+K  +   S +  + F +E   +++  H ++++
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +I   +  +   +++     G L S L      +    S DL  L  +     ++  +AY
Sbjct: 76  LIGVIT-ENPVWIIMELCTLGELRSFL------QVRKYSLDLASL--ILYAYQLSTALAY 126
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L      R +H D+   NVL++ +    + DFG+++ +          E+     A+   
Sbjct: 127 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM----------EDSTYYKASKGK 173
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
             I +MAPE       ++  DV+ FG+ + E++
Sbjct: 174 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 563 RLLGTGSYGRVYKGILQD----GTAIAVKVLQ-LQSGNFTKSFNRECQVLKRIRHRNLMR 617
           R +G G +G V++GI         A+A+K  +   S +  + F +E   +++  H ++++
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +I   +  +   +++     G L S L      +    S DL  L  +     ++  +AY
Sbjct: 76  LIGVIT-ENPVWIIMELCTLGELRSFL------QVRKYSLDLASL--ILYAYQLSTALAY 126
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L      R +H D+   NVL++ +    + DFG+++ +          E+     A+   
Sbjct: 127 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM----------EDSTYYKASKGK 173
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
             I +MAPE       ++  DV+ FG+ + E++
Sbjct: 174 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 116/247 (46%), Gaps = 48/247 (19%)
Query: 562 QRLLGTGSYGRV-YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVL-KRIRHRNLMRII 619
           +++LG GS G V ++G  Q G  +AVK + +   +F      E ++L +   H N++R  
Sbjct: 20  EKILGYGSSGTVVFQGSFQ-GRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYY 75
Query: 620 TACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR----VNICSDIAEGM 675
            + +   F  + L  + N +L          E  + S +   LQ+    +++   IA G+
Sbjct: 76  CSETTDRFLYIALE-LCNLNL------QDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLN-------------DDMTALVSDFGIAKLVMTVGVGN 722
           A+LH    +++IH DLKP N+L++             +++  L+SDFG+ K +       
Sbjct: 129 AHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL------- 178
Query: 723 DGAENMGNSTANMLCGSIGYMAPEYGFGSNT-STKG------DVYSFGILVLEMVTR-RR 774
           D  ++   +  N   G+ G+ APE    SN   TK       D++S G +   ++++ + 
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
Query: 775 PTDDMFA 781
           P  D ++
Sbjct: 239 PFGDKYS 245

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 563 RLLGTGSYGRVYKGILQD----GTAIAVKVLQ-LQSGNFTKSFNRECQVLKRIRHRNLMR 617
           R +G G +G V++GI         A+A+K  +   S +  + F +E   +++  H ++++
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +I   +  +   +++     G L S L      +    S DL  L  +     ++  +AY
Sbjct: 73  LIGVIT-ENPVWIIMELCTLGELRSFL------QVRKYSLDLASL--ILYAYQLSTALAY 123
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L      R +H D+   NVL++ +    + DFG+++ +          E+     A+   
Sbjct: 124 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM----------EDSTYYKASKGK 170
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
             I +MAPE       ++  DV+ FG+ + E++
Sbjct: 171 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 563 RLLGTGSYGRVYKGILQD----GTAIAVKVLQ-LQSGNFTKSFNRECQVLKRIRHRNLMR 617
           R +G G +G V++GI         A+A+K  +   S +  + F +E   +++  H ++++
Sbjct: 44  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +I   +  +   +++     G L S L      +    S DL  L  +     ++  +AY
Sbjct: 104 LIGVIT-ENPVWIIMELCTLGELRSFL------QVRKYSLDLASL--ILYAYQLSTALAY 154
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L      R +H D+   NVL++ +    + DFG+++ +          E+     A+   
Sbjct: 155 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM----------EDSTYYKASKGK 201
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
             I +MAPE       ++  DV+ FG+ + E++
Sbjct: 202 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 85/171 (49%), Gaps = 16/171 (9%)
Query: 318 YKLDLSYNRLTGSIPAEISGIREIR--IFLNLSHNQLEGPLPIELSKLENVQEIDLSSNK 375
           Y  ++ Y  L G+   +IS ++E+    +L L+ NQL+        KL N++E+ L  N+
Sbjct: 61  YLPNVRYLALGGNKLHDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQ 120
Query: 376 FTG---NIFIQISNCIAVRLINISHNALQGNLPDSLGD-LKNLEAIDVSGNHLSGIIPIS 431
                  +F +++N   +  +N++HN LQ  LP  + D L NL  +D+S N L  +    
Sbjct: 121 LQSLPDGVFDKLTN---LTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQLQSLPEGV 176
Query: 432 LNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFV---GNQHLCGTVPGM 479
            +K+  L  + L  N+ K +    G+F+  T + ++    N   C T PG+
Sbjct: 177 FDKLTQLKDLRLYQNQLKSV--PDGVFDRLTSLQYIWLHDNPWDC-TCPGI 224

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 563 RLLGTGSYGRVYKGILQD----GTAIAVKVLQ-LQSGNFTKSFNRECQVLKRIRHRNLMR 617
           R +G G +G V++GI         A+A+K  +   S +  + F +E   +++  H ++++
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +I   +  +   +++     G L S L      +    S DL  L  +     ++  +AY
Sbjct: 78  LIGVIT-ENPVWIIMELCTLGELRSFL------QVRKYSLDLASL--ILYAYQLSTALAY 128
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L      R +H D+   NVL++ +    + DFG+++ +          E+     A+   
Sbjct: 129 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM----------EDSTYYKASKGK 175
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
             I +MAPE       ++  DV+ FG+ + E++
Sbjct: 176 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 563 RLLGTGSYGRVYKGILQD----GTAIAVKVLQ-LQSGNFTKSFNRECQVLKRIRHRNLMR 617
           R +G G +G V++GI         A+A+K  +   S +  + F +E   +++  H ++++
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +I   +  +   +++     G L S L      +    S DL  L  +     ++  +AY
Sbjct: 79  LIGVIT-ENPVWIIMELCTLGELRSFL------QVRKYSLDLASL--ILYAYQLSTALAY 129
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L      R +H D+   NVL++ +    + DFG+++ +          E+     A+   
Sbjct: 130 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM----------EDSTYYKASKGK 176
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
             I +MAPE       ++  DV+ FG+ + E++
Sbjct: 177 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 89/340 (26%), Positives = 155/340 (45%), Gaps = 39/340 (11%)
Query: 235 ISAEISWLSQLEQLFLSHNLFSGEIPAAXXXXXXXXXXXXSFNKLSGEIPVSLGNLVQIY 294
           ISA +S L+ L+QL  S N  +   P A            S NK+S +I V L  L  + 
Sbjct: 144 ISA-LSGLTSLQQLSFSSNQVTDLKPLANLTTLERLDI--SSNKVS-DISV-LAKLTNLE 198
Query: 295 SLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLT--GSIPAEISGIREIRIFLNLSHNQL 352
           SL   NNQ+S   P  LG  T+L +L L+ N+L   G++ A ++ + +    L+L++NQ+
Sbjct: 199 SLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTL-ASLTNLTD----LDLANNQI 251
Query: 353 EGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLK 412
               P  LS L  + E+ L +N+ +      ++   A+  + ++ N L+   P  + +LK
Sbjct: 252 SNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLEDISP--ISNLK 305
Query: 413 NLEAIDVSGNHLSGIIPI-SLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFV--GN 469
           NL  + +  N++S I P+ SL K+  L F N   ++   +        + T ++++  G+
Sbjct: 306 NLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDVSSLA-------NLTNINWLSAGH 358
Query: 470 QHLCGTVPGMPICPPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKS 529
             +    P   +    Q  L+ + +    V   +  +  +T+  VTG       IS G S
Sbjct: 359 NQISDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGS 418
Query: 530 ETRSKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGS 569
            T      P++  N P  T     E +  F +   +G G+
Sbjct: 419 YTE-----PDITWNLPSYTN----EVSYTFSQPVTIGKGT 449

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 94/217 (43%), Gaps = 29/217 (13%)
Query: 556 TAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRH 612
           T E+     LG G++  V + + +  G   A K++  +  S    +   RE ++ + ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 613 RNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIA 672
            N++R+  + S   F  LV   +  G L   +      E+ S +     +Q+      I 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR---EYYSEADASHCIQQ------IL 113
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           E + + H +    ++H DLKP N+LL   +      ++DFG+A     + V  D     G
Sbjct: 114 ESVNHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLA-----IEVQGDQQAWFG 165
Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
                   G+ GY++PE           D+++ G+++
Sbjct: 166 ------FAGTPGYLSPEVLRKDPYGKPVDMWACGVIL 196

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/217 (22%), Positives = 94/217 (43%), Gaps = 29/217 (13%)
Query: 556 TAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRH 612
           T E+     LG G++  V + + +  G   A K++  +  S    +   RE ++ + ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 613 RNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIA 672
            N++R+  + S   F  LV   +  G L   +      E+ S +     +Q+      I 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR---EYYSEADASHCIQQ------IL 113
Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           E + + H +    ++H DLKP N+LL   +      ++DFG+A     + V  D     G
Sbjct: 114 ESVNHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLA-----IEVQGDQQAWFG 165
Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
                   G+ GY++PE           D+++ G+++
Sbjct: 166 ------FAGTPGYLSPEVLRKDPYGKPVDMWACGVIL 196

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 563 RLLGTGSYGRVYKGILQD----GTAIAVKVLQ-LQSGNFTKSFNRECQVLKRIRHRNLMR 617
           R +G G +G V++GI         A+A+K  +   S +  + F +E   +++  H ++++
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +I   +  +   +++     G L S L      +    S DL  L  +     ++  +AY
Sbjct: 81  LIGVIT-ENPVWIIMELCTLGELRSFL------QVRKYSLDLASL--ILYAYQLSTALAY 131
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L      R +H D+   NVL++ +    + DFG+++ +          E+     A+   
Sbjct: 132 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM----------EDSTYYKASKGK 178
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
             I +MAPE       ++  DV+ FG+ + E++
Sbjct: 179 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/226 (20%), Positives = 93/226 (41%), Gaps = 34/226 (15%)
Query: 563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT--KSFNRECQVLKRIRHRNLMRIIT 620
           + +G+G   +V++ + +     A+K + L+  +     S+  E   L +++  +  +II 
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIR 120
Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
                     +   M  G++D + +   +             +R +   ++ E +  +H 
Sbjct: 121 LYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDP-------WERKSYWKNMLEAVHTIHQ 173
Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
           H    ++H DLKP+N L+ D M  L+ DFGIA         N    +  +   +   G++
Sbjct: 174 HG---IVHSDLKPANFLIVDGMLKLI-DFGIA---------NQMQPDTTSVVKDSQVGTV 220
Query: 741 GYMAPEYGFGSNTSTKG-----------DVYSFGILVLEMVTRRRP 775
            YM PE     ++S +            DV+S G ++  M   + P
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|2Z7X|A Chain A, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 549

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 57/108 (52%), Gaps = 3/108 (2%)
Query: 364 ENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNH 423
           E V+ +DLS+N+ T      +  C+ ++ + ++ N +     DS   L +LE +D+S N+
Sbjct: 26  EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 85
Query: 424 LSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSF--VGN 469
           LS +       + +LTF+NL  N +K +     +F+  TK+    VGN
Sbjct: 86  LSNLSSSWFKPLSSLTFLNLLGNPYKTL-GETSLFSHLTKLQILRVGN 132

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/252 (21%), Positives = 108/252 (42%), Gaps = 29/252 (11%)
Query: 524 ISSGKSETRSKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQD--- 580
           +S  +++  ++ I  E  +  P     E+     E    R +G G +G V++GI      
Sbjct: 359 VSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELG--RCIGEGQFGDVHQGIYMSPEN 416
Query: 581 -GTAIAVKVLQ-LQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANG 638
              A+A+K  +   S +  + F +E   +++  H +++++I   +  +   +++     G
Sbjct: 417 PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLG 475
Query: 639 SLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL 698
            L S L      +    S DL  L  +     ++  +AYL      R +H D+   NVL+
Sbjct: 476 ELRSFL------QVRKFSLDLASL--ILYAYQLSTALAYLESK---RFVHRDIAARNVLV 524
Query: 699 NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGD 758
           +      + DFG+++ +          E+     A+     I +MAPE       ++  D
Sbjct: 525 SATDCVKLGDFGLSRYM----------EDSTYYKASKGKLPIKWMAPESINFRRFTSASD 574
Query: 759 VYSFGILVLEMV 770
           V+ FG+ + E++
Sbjct: 575 VWMFGVCMWEIL 586

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/247 (25%), Positives = 114/247 (46%), Gaps = 48/247 (19%)
Query: 562 QRLLGTGSYGRV-YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVL-KRIRHRNLMRII 619
           +++LG GS G V ++G  Q G  +AVK + +   +F      E ++L +   H N++R  
Sbjct: 20  EKILGYGSSGTVVFQGSFQ-GRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYY 75
Query: 620 TACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR----VNICSDIAEGM 675
            + +   F  + L  + N +L          E  + S +   LQ+    +++   IA G+
Sbjct: 76  CSETTDRFLYIALE-LCNLNL------QDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLN-------------DDMTALVSDFGIAKLVMTVGVGN 722
           A+LH    +++IH DLKP N+L++             +++  L+SDFG+ K +       
Sbjct: 129 AHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL------- 178
Query: 723 DGAENMGNSTANMLCGSIGYMAPEYGFGSNT-STKG------DVYSFGILVLEMVTR-RR 774
           D  +       N   G+ G+ APE    SN   TK       D++S G +   ++++ + 
Sbjct: 179 DSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
Query: 775 PTDDMFA 781
           P  D ++
Sbjct: 239 PFGDKYS 245

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 89/340 (26%), Positives = 155/340 (45%), Gaps = 39/340 (11%)
Query: 235 ISAEISWLSQLEQLFLSHNLFSGEIPAAXXXXXXXXXXXXSFNKLSGEIPVSLGNLVQIY 294
           ISA +S L+ L+QL  S N  +   P A            S NK+S +I V L  L  + 
Sbjct: 144 ISA-LSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDI--SSNKVS-DISV-LAKLTNLE 198
Query: 295 SLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLT--GSIPAEISGIREIRIFLNLSHNQL 352
           SL   NNQ+S   P  LG  T+L +L L+ N+L   G++ A ++ + +    L+L++NQ+
Sbjct: 199 SLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTL-ASLTNLTD----LDLANNQI 251
Query: 353 EGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLK 412
               P  LS L  + E+ L +N+ +      ++   A+  + ++ N L+   P  + +LK
Sbjct: 252 SNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLEDISP--ISNLK 305
Query: 413 NLEAIDVSGNHLSGIIPI-SLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFV--GN 469
           NL  + +  N++S I P+ SL K+  L F N   ++   +        + T ++++  G+
Sbjct: 306 NLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDVSSLA-------NLTNINWLSAGH 358
Query: 470 QHLCGTVPGMPICPPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKS 529
             +    P   +    Q  L+ + +    V   +  +  +T+  VTG       IS G S
Sbjct: 359 NQISDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGS 418
Query: 530 ETRSKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGS 569
            T      P++  N P  T     E +  F +   +G G+
Sbjct: 419 YTE-----PDITWNLPSYTN----EVSYTFSQPVTIGKGT 449

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 89/340 (26%), Positives = 155/340 (45%), Gaps = 39/340 (11%)
Query: 235 ISAEISWLSQLEQLFLSHNLFSGEIPAAXXXXXXXXXXXXSFNKLSGEIPVSLGNLVQIY 294
           ISA +S L+ L+QL  S N  +   P A            S NK+S +I V L  L  + 
Sbjct: 144 ISA-LSGLTSLQQLSFSSNQVTDLKPLANLTTLERLDI--SSNKVS-DISV-LAKLTNLE 198
Query: 295 SLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLT--GSIPAEISGIREIRIFLNLSHNQL 352
           SL   NNQ+S   P  LG  T+L +L L+ N+L   G++ A ++ + +    L+L++NQ+
Sbjct: 199 SLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTL-ASLTNLTD----LDLANNQI 251
Query: 353 EGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLK 412
               P  LS L  + E+ L +N+ +      ++   A+  + ++ N L+   P  + +LK
Sbjct: 252 SNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLEDISP--ISNLK 305
Query: 413 NLEAIDVSGNHLSGIIPI-SLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFV--GN 469
           NL  + +  N++S I P+ SL K+  L F N   ++   +        + T ++++  G+
Sbjct: 306 NLTYLTLYFNNISDISPVSSLTKLQRLFFSNNKVSDVSSLA-------NLTNINWLSAGH 358
Query: 470 QHLCGTVPGMPICPPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKLIISSGKS 529
             +    P   +    Q  L+ + +    V   +  +  +T+  VTG       IS G S
Sbjct: 359 NQISDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGS 418
Query: 530 ETRSKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGS 569
            T      P++  N P  T     E +  F +   +G G+
Sbjct: 419 YTE-----PDITWNLPSYTN----EVSYTFSQPVTIGKGT 449

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 94/213 (44%), Gaps = 27/213 (12%)
Query: 563 RLLGTGSYGRVYKGILQD----GTAIAVKVLQ-LQSGNFTKSFNRECQVLKRIRHRNLMR 617
           R +G G +G V++GI         A+A+K  +   S +  + F +E   +++  H ++++
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +I   +  +   +++     G L S L      +    S DL  L  +     ++  +AY
Sbjct: 76  LIGVIT-ENPVWIIMELCTLGELRSFL------QVRKFSLDLASL--ILYAYQLSTALAY 126
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L      R +H D+   NVL++      + DFG+++ +          E+     A+   
Sbjct: 127 LESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYM----------EDSTYYKASKGK 173
Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
             I +MAPE       ++  DV+ FG+ + E++
Sbjct: 174 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/267 (21%), Positives = 112/267 (41%), Gaps = 51/267 (19%)
Query: 538 PELMHNFPRITY--RELLEATAEFDEQRLLGTGSYGRVYKGIL--QDGTAIAVKVLQL-- 591
            +++ N+  + Y  + + E     ++ R++ T + G+  K IL  +D    A+K  +   
Sbjct: 7   KDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSL 66
Query: 592 --QSGNFTKS-------------FNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMA 636
             +  +FTKS             F  E Q++  I++   +      +  D   ++  YM 
Sbjct: 67  LEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYME 126
Query: 637 NGSL---DSHLYPHSETEFGSGSSDLTLLQRVN-ICSDIAEGMAYLHHHSPVRVIHCDLK 692
           N S+   D + +           +    +Q +  I   +    +Y+H+     + H D+K
Sbjct: 127 NDSILKFDEYFFV-----LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NICHRDVK 179
Query: 693 PSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN 752
           PSN+L++ +    +SDFG ++ ++   +   G+            G+  +M PE  F SN
Sbjct: 180 PSNILMDKNGRVKLSDFGESEYMVDKKIK--GSR-----------GTYEFMPPE--FFSN 224
Query: 753 TST----KGDVYSFGILVLEMVTRRRP 775
            S+    K D++S GI +  M     P
Sbjct: 225 ESSYNGAKVDIWSLGICLYVMFYNVVP 251

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/227 (20%), Positives = 94/227 (41%), Gaps = 36/227 (15%)
Query: 563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT--KSFNRECQVLKRIR-HRNLMRII 619
           + +G+G   +V++ + +     A+K + L+  +     S+  E   L +++ H + +  +
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 620 TACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLH 679
               + D    ++    N  L+S L              +   +R +   ++ E +  +H
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWL---------KKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 680 HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS 739
            H    ++H DLKP+N L+ D M  L+ DFGIA         N    +  +   +   G+
Sbjct: 173 QHG---IVHSDLKPANFLIVDGMLKLI-DFGIA---------NQMQPDTTSVVKDSQVGA 219
Query: 740 IGYMAPEYGFGSNTSTKG-----------DVYSFGILVLEMVTRRRP 775
           + YM PE     ++S +            DV+S G ++  M   + P
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/227 (20%), Positives = 94/227 (41%), Gaps = 36/227 (15%)
Query: 563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT--KSFNRECQVLKRIR-HRNLMRII 619
           + +G+G   +V++ + +     A+K + L+  +     S+  E   L +++ H + +  +
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 620 TACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLH 679
               + D    ++    N  L+S L              +   +R +   ++ E +  +H
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWL---------KKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 680 HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS 739
            H    ++H DLKP+N L+ D M  L+ DFGIA         N    +  +   +   G+
Sbjct: 173 QHG---IVHSDLKPANFLIVDGMLKLI-DFGIA---------NQMQPDTTSVVKDSQVGT 219
Query: 740 IGYMAPEYGFGSNTSTKG-----------DVYSFGILVLEMVTRRRP 775
           + YM PE     ++S +            DV+S G ++  M   + P
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 83/160 (51%), Gaps = 21/160 (13%)
Query: 564 LLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFN---RECQVLKRIRHRNLMRI- 618
           +LG G+   V++G   + G   A+KV    S  F +  +   RE +VLK++ H+N++++ 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNIS--FLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 619 -ITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
            I   +    K L++ +   GSL + L   S   +G   S+  ++ R     D+  GM +
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLR-----DVVGGMNH 127
Query: 678 LHHHSPVRVIHCDLKPSNVL--LNDDMTAL--VSDFGIAK 713
           L  +    ++H ++KP N++  + +D  ++  ++DFG A+
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164

>pdb|2Z80|A Chain A, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 57/108 (52%), Gaps = 3/108 (2%)
Query: 364 ENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNH 423
           E V+ +DLS+N+ T      +  C+ ++ + ++ N +     DS   L +LE +D+S N+
Sbjct: 52  EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111
Query: 424 LSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSF--VGN 469
           LS +       + +LTF+NL  N +K +     +F+  TK+    VGN
Sbjct: 112 LSNLSSSWFKPLSSLTFLNLLGNPYKTL-GETSLFSHLTKLQILRVGN 158

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 83/160 (51%), Gaps = 21/160 (13%)
Query: 564 LLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFN---RECQVLKRIRHRNLMRI- 618
           +LG G+   V++G   + G   A+KV    S  F +  +   RE +VLK++ H+N++++ 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNIS--FLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 619 -ITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
            I   +    K L++ +   GSL + L   S   +G   S+  ++ R     D+  GM +
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLR-----DVVGGMNH 127
Query: 678 LHHHSPVRVIHCDLKPSNVL--LNDDMTAL--VSDFGIAK 713
           L  +    ++H ++KP N++  + +D  ++  ++DFG A+
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 29/151 (19%)
Query: 630 LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHC 689
           L+L Y A G + S   P    E  S +  + L+++      I EG+ YLH ++   ++H 
Sbjct: 106 LILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQ------ILEGVYYLHQNN---IVHL 155
Query: 690 DLKPSNVLLND-----DMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
           DLKP N+LL+      D+   + DFG+++    +G   +  E MG            Y+A
Sbjct: 156 DLKPQNILLSSIYPLGDIK--IVDFGMSR---KIGHACELREIMGTPE---------YLA 201
Query: 745 PEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           PE       +T  D+++ GI+   ++T   P
Sbjct: 202 PEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 48/217 (22%), Positives = 92/217 (42%), Gaps = 33/217 (15%)
Query: 563 RLLGTGSYGRVYKGILQD--GTAIAVKVLQLQSG---NFTKSFNRECQVLKRIRHRNLMR 617
           R+LG G +G VY+G+  +  G  I V V   +     +  + F  E  ++K + H ++++
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 618 IITAC-SLPDFKALVLPYMANGSLDSHLYPHSET--EFGSGSSDLTLLQRVNICSDIAEG 674
           +I      P +  +             LYP+ E         + L +L  V     I + 
Sbjct: 74  LIGIIEEEPTWIIM------------ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 121
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           MAYL     +  +H D+   N+L+       + DFG+++ +          E+     A+
Sbjct: 122 MAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYI----------EDEDYYKAS 168
Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           +    I +M+PE       +T  DV+ F + + E+++
Sbjct: 169 VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 205

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 48/217 (22%), Positives = 92/217 (42%), Gaps = 33/217 (15%)
Query: 563 RLLGTGSYGRVYKGILQD--GTAIAVKVLQLQSG---NFTKSFNRECQVLKRIRHRNLMR 617
           R+LG G +G VY+G+  +  G  I V V   +     +  + F  E  ++K + H ++++
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 618 IITAC-SLPDFKALVLPYMANGSLDSHLYPHSET--EFGSGSSDLTLLQRVNICSDIAEG 674
           +I      P +  +             LYP+ E         + L +L  V     I + 
Sbjct: 78  LIGIIEEEPTWIIM------------ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 125
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           MAYL     +  +H D+   N+L+       + DFG+++ +          E+     A+
Sbjct: 126 MAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYI----------EDEDYYKAS 172
Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           +    I +M+PE       +T  DV+ F + + E+++
Sbjct: 173 VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209

>pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 83/157 (52%), Gaps = 16/157 (10%)
Query: 315 TDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLE--GPLPIELSKLENVQEIDLS 372
           T L  LDLS+N +  ++ +   G+ ++   L+  H+ L+      + LS L N+  +D+S
Sbjct: 373 TSLKYLDLSFNGVI-TMSSNFLGLEQLE-HLDFQHSNLKQMSEFSVFLS-LRNLIYLDIS 429
Query: 373 SN----KFTGNIFIQISNCIAVRLINISHNALQGN-LPDSLGDLKNLEAIDVSGNHLSGI 427
                  F G IF  +S   ++ ++ ++ N+ Q N LPD   +L+NL  +D+S   L  +
Sbjct: 430 HTHTRVAFNG-IFNGLS---SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485
Query: 428 IPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKM 464
            P + N + +L  +N++ N+ K  +P  GIF+  T +
Sbjct: 486 SPTAFNSLSSLQVLNMASNQLKS-VPD-GIFDRLTSL 520

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 113/246 (45%), Gaps = 50/246 (20%)
Query: 562 QRLLGTGSYGRV-YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVL-KRIRHRNLMRII 619
           +++LG GS G V ++G  Q G  +AVK + +   +F      E ++L +   H N++R  
Sbjct: 38  EKILGYGSSGTVVFQGSFQ-GRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYY 93
Query: 620 TACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR----VNICSDIAEGM 675
            + +   F  + L  + N +L          E  + S +   LQ+    +++   IA G+
Sbjct: 94  CSETTDRFLYIALE-LCNLNL------QDLVESKNVSDENLKLQKEYNPISLLRQIASGV 146
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLN-------------DDMTALVSDFGIAKLVMTVGVGN 722
           A+LH    +++IH DLKP N+L++             +++  L+SDFG+ K +       
Sbjct: 147 AHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL------- 196
Query: 723 DGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG------DVYSFGILVLEMVTR-RRP 775
           D  +       N   G+ G+ APE       STK       D++S G +   ++++ + P
Sbjct: 197 DSGQXXFRXNLNNPSGTSGWRAPEL---LEESTKRRLTRSIDIFSMGCVFYYILSKGKHP 253
Query: 776 TDDMFA 781
             D ++
Sbjct: 254 FGDKYS 259

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 105/259 (40%), Gaps = 57/259 (22%)
Query: 541 MHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGT--AIAVKVLQLQSGNFTK 598
           +H+  +  +R  ++ T  ++ +  +G GSY  V K  +   T    AVK++     + T+
Sbjct: 6   VHSIVQQLHRNSIQFTDGYEVKEDIGVGSYS-VCKRCIHKATNXEFAVKIIDKSKRDPTE 64
Query: 599 SFNRECQVLKRI-RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSS 657
               E ++L R  +H N++      +L D              D   Y +  TE   G  
Sbjct: 65  ----EIEILLRYGQHPNII------TLKDV------------YDDGKYVYVVTELXKGGE 102
Query: 658 DLTLLQRVNICSD---------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDM----TA 704
            L  + R    S+         I + + YLH      V+H DLKPSN+L  D+     + 
Sbjct: 103 LLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESI 159
Query: 705 LVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGI 764
            + DFG AK +         AEN    T    C +  ++APE           D++S G+
Sbjct: 160 RICDFGFAKQLR--------AENGLLXTP---CYTANFVAPEVLERQGYDAACDIWSLGV 208
Query: 765 LVLEMVTRRRPTDDMFAGG 783
           L+   +T   P    FA G
Sbjct: 209 LLYTXLTGYTP----FANG 223

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 113/246 (45%), Gaps = 50/246 (20%)
Query: 562 QRLLGTGSYGRV-YKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVL-KRIRHRNLMRII 619
           +++LG GS G V ++G  Q G  +AVK + +   +F      E ++L +   H N++R  
Sbjct: 38  EKILGYGSSGTVVFQGSFQ-GRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYY 93
Query: 620 TACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR----VNICSDIAEGM 675
            + +   F  + L  + N +L          E  + S +   LQ+    +++   IA G+
Sbjct: 94  CSETTDRFLYIALE-LCNLNL------QDLVESKNVSDENLKLQKEYNPISLLRQIASGV 146
Query: 676 AYLHHHSPVRVIHCDLKPSNVLLN-------------DDMTALVSDFGIAKLVMTVGVGN 722
           A+LH    +++IH DLKP N+L++             +++  L+SDFG+ K +       
Sbjct: 147 AHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL------- 196
Query: 723 DGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG------DVYSFGILVLEMVTR-RRP 775
           D  +       N   G+ G+ APE       STK       D++S G +   ++++ + P
Sbjct: 197 DSGQXXFRXNLNNPSGTSGWRAPEL---LEESTKRRLTRSIDIFSMGCVFYYILSKGKHP 253
Query: 776 TDDMFA 781
             D ++
Sbjct: 254 FGDKYS 259

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 53/110 (48%), Gaps = 19/110 (17%)
Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I + + YL     V  IH D+KPSN+LL++     + DFGI+  ++     +D A++   
Sbjct: 133 IVKALYYLKEKHGV--IHRDVKPSNILLDERGQIKLCDFGISGRLV-----DDKAKDRS- 184
Query: 731 STANMLCGSIGYMAPEY-----GFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                  G   YMAPE          +   + DV+S GI ++E+ T + P
Sbjct: 185 ------AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/212 (21%), Positives = 88/212 (41%), Gaps = 35/212 (16%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTK------SFNRECQVLKRIRHRNLMR 617
           LG+G +  V K   +  G   A K ++ +    ++         RE  +L+++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +           L+L  ++ G L          +F +    L+  +  +    I +G+ Y
Sbjct: 80  LHDVYENRTDVVLILELVSGGEL---------FDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTAL----VSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           LH     ++ H DLKP N++L D    +    + DFG+A  +       DG E       
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI------EDGVEFKN---- 177
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGIL 765
             + G+  ++APE         + D++S G++
Sbjct: 178 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/212 (21%), Positives = 88/212 (41%), Gaps = 35/212 (16%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTK------SFNRECQVLKRIRHRNLMR 617
           LG+G +  V K   +  G   A K ++ +    ++         RE  +L+++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +           L+L  ++ G L          +F +    L+  +  +    I +G+ Y
Sbjct: 80  LHDVYENRTDVVLILELVSGGEL---------FDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTAL----VSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           LH     ++ H DLKP N++L D    +    + DFG+A  +       DG E       
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI------EDGVEFKN---- 177
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGIL 765
             + G+  ++APE         + D++S G++
Sbjct: 178 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/212 (21%), Positives = 88/212 (41%), Gaps = 35/212 (16%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTK------SFNRECQVLKRIRHRNLMR 617
           LG+G +  V K   +  G   A K ++ +    ++         RE  +L+++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +           L+L  ++ G L          +F +    L+  +  +    I +G+ Y
Sbjct: 80  LHDVYENRTDVVLILELVSGGEL---------FDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTAL----VSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           LH     ++ H DLKP N++L D    +    + DFG+A  +       DG E       
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI------EDGVEFKN---- 177
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGIL 765
             + G+  ++APE         + D++S G++
Sbjct: 178 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/212 (21%), Positives = 88/212 (41%), Gaps = 35/212 (16%)
Query: 565 LGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTK------SFNRECQVLKRIRHRNLMR 617
           LG+G +  V K   +  G   A K ++ +    ++         RE  +L+++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +           L+L  ++ G L          +F +    L+  +  +    I +G+ Y
Sbjct: 80  LHDVYENRTDVVLILELVSGGEL---------FDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTAL----VSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           LH     ++ H DLKP N++L D    +    + DFG+A  +       DG E       
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI------EDGVEFKN---- 177
Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGIL 765
             + G+  ++APE         + D++S G++
Sbjct: 178 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/151 (20%), Positives = 66/151 (43%), Gaps = 14/151 (9%)
Query: 565 LGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACS 623
           LG+G++G V++ + +  G     K +         +   E  ++ ++ H  L+ +  A  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 624 LPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP 683
                 L+L +++ G L   +         +    ++  + +N      EG+ ++H HS 
Sbjct: 119 DKYEMVLILEFLSGGELFDRI--------AAEDYKMSEAEVINYMRQACEGLKHMHEHS- 169
Query: 684 VRVIHCDLKPSNVLLNDDMTALVS--DFGIA 712
             ++H D+KP N++      + V   DFG+A
Sbjct: 170 --IVHLDIKPENIMCETKKASSVKIIDFGLA 198

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 104/223 (46%), Gaps = 32/223 (14%)
Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRI---RHRN 614
           F  +R+ G G++G V  G  +  G ++A+K + +Q   F    NRE Q+++ +    H N
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFR---NRELQIMQDLAVLHHPN 80
Query: 615 LMRI---ITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           ++++          D + + L  +     D+ L+      +    +   +L +V +   +
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQ-L 138
Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLND-DMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
              +  LH  S V V H D+KP NVL+N+ D T  + DFG AK              +  
Sbjct: 139 IRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAK-------------KLSP 184
Query: 731 STANM--LCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMV 770
           S  N+  +C S  Y APE  FG+ + +T  D++S G +  EM+
Sbjct: 185 SEPNVAYIC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 139/300 (46%), Gaps = 36/300 (12%)
Query: 275 SFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLT--GSIP 332
           S NK+S +I V L  L  + SL   NNQ+S   P  LG  T+L +L L+ N+L   G++ 
Sbjct: 184 SSNKVS-DISV-LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTL- 238
Query: 333 AEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRL 392
           A ++ + +    L+L++NQ+    P  LS L  + E+ L +N+ +      ++   A+  
Sbjct: 239 ASLTNLTD----LDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTN 290
Query: 393 INISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPI-SLNKIHTLTFINLSFNEFKGM 451
           + ++ N L+   P  + +LKNL  + +  N++S I P+ SL K+  L F N   ++   +
Sbjct: 291 LELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSDVSSL 348
Query: 452 IPSGGIFNSATKMSFV--GNQHLCGTVPGMPICPPKQHWLHTRMYFIIFVLVISISAFLS 509
                   + T ++++  G+  +    P   +    Q  L+ + +    V   +  +  +
Sbjct: 349 A-------NLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPN 401
Query: 510 TICLVTGIHRIKLIISSGKSETRSKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGS 569
           T+  VTG       IS G S T      P++  N P  T     E +  F +   +G G+
Sbjct: 402 TVKNVTGALIAPATISDGGSYTE-----PDITWNLPSYTN----EVSYTFSQPVTIGKGT 452

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 25/84 (29%), Positives = 44/84 (52%), Gaps = 10/84 (11%)
Query: 688 HCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEY 747
           H D+KP N+L++ D  A + DFGIA         ++    +GN+      G++ Y APE 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATT-----DEKLTQLGNT-----VGTLYYXAPER 206
Query: 748 GFGSNTSTKGDVYSFGILVLEMVT 771
              S+ + + D+Y+   ++ E +T
Sbjct: 207 FSESHATYRADIYALTCVLYECLT 230

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 139/300 (46%), Gaps = 36/300 (12%)
Query: 275 SFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLT--GSIP 332
           S NK+S +I V L  L  + SL   NNQ+S   P  LG  T+L +L L+ N+L   G++ 
Sbjct: 185 SSNKVS-DISV-LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTL- 239
Query: 333 AEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRL 392
           A ++ + +    L+L++NQ+    P  LS L  + E+ L +N+ +      ++   A+  
Sbjct: 240 ASLTNLTD----LDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTN 291
Query: 393 INISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPI-SLNKIHTLTFINLSFNEFKGM 451
           + ++ N L+   P  + +LKNL  + +  N++S I P+ SL K+  L F N   ++   +
Sbjct: 292 LELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDVSSL 349
Query: 452 IPSGGIFNSATKMSFV--GNQHLCGTVPGMPICPPKQHWLHTRMYFIIFVLVISISAFLS 509
                   + T ++++  G+  +    P   +    Q  L+ + +    V   +  +  +
Sbjct: 350 A-------NLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPN 402
Query: 510 TICLVTGIHRIKLIISSGKSETRSKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGS 569
           T+  VTG       IS G S T      P++  N P  T     E +  F +   +G G+
Sbjct: 403 TVKNVTGALIAPATISDGGSYTE-----PDITWNLPSYTN----EVSYTFSQPVTIGKGT 453

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 87/216 (40%), Gaps = 31/216 (14%)
Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIR-HRNLMRIITAC 622
           LG GS+    K +  +   A AVK++   S     +  +E   LK    H N++++    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
                  LV+  +  G L   +    +  F    +   + + V+  S          H  
Sbjct: 76  HDQLHTFLVMELLNGGELFERI--KKKKHFSETEASYIMRKLVSAVS----------HMH 123
Query: 683 PVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS 739
            V V+H DLKP N+L    ND++   + DFG A+L           +   N      C +
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL-----------KPPDNQPLKTPCFT 172
Query: 740 IGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           + Y APE    +      D++S G+++  M++ + P
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 48/222 (21%), Positives = 88/222 (39%), Gaps = 35/222 (15%)
Query: 565 LGTGSYGRVYKGILQDGTAIAV-------KVLQ---LQSGNFTKSFNRECQVLKRIRHRN 614
           LG+G++G V+  + ++     V       KVL+   ++     K    E  +L R+ H N
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK-VTLEIAILSRVEHAN 90
Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +++++       F  LV+    +G LD   +           +     Q V+        
Sbjct: 91  IIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFRQLVS-------A 142
Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           + YL       +IH D+K  N+++ +D T  + DFG A  +                   
Sbjct: 143 VGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLER------------GKLFY 187
Query: 735 MLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRP 775
             CG+I Y APE   G+     + +++S G+ +  +V    P
Sbjct: 188 TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	885
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-142
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-128
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-125
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-118
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-115
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-52
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-30
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-92
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-76
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-47
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-19
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-89
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-84
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-83
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-82
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-75
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-74
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-70
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-36
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-83
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-82
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-82
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-79
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-76
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-73
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-62
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-51
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-42
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-82
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-70
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-65
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-62
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-56
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-37
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-27
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-18
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-78
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-74
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-74
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-72
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-69
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-66
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-65
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-57
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-56
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-45
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-30
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-25
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-70
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-69
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-45
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-34
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-28
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-20
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-04
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-68
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-64
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-58
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-47
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-41
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-63
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-60
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-58
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-56
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-55
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-54
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-38
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-04
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-56
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-55
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-55
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-54
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-54
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	9e-54
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-43
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-39
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-33
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-28
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-53
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-53
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-51
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-50
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-49
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-42
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-15
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-50
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-50
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-49
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-46
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-43
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-49
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-49
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-49
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-48
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-28
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-49
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-39
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-35
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-35
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-48
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-45
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-44
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-32
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-29
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-17
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-47
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-45
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-44
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-36
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-07
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-44
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-30
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-23
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-16
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-42
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-40
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-29
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-21
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-16
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-41
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-40
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	8e-40
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-28
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-40
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-32
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-24
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-14
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-40
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-40
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	9e-37
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-35
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-21
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-04
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-40
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-38
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-33
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-23
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-20
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-38
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-37
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	9e-34
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-32
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-26
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-18
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-36
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	9e-20
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-14
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-07
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-36
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-36
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-36
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-36
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-36
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-36
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-36
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-36
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	9e-36
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-35
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-35
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-35
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-35
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-35
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-35
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-35
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-35
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-35
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-35
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-35
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-35
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-34
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-34
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-34
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-34
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-34
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-34
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-34
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-34
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-34
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-34
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-34
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-34
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-34
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	9e-34
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-33
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-33
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-33
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-33
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-33
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-33
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	7e-29
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-23
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-16
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-32
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-32
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-32
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-32
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-32
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-31
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-31
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-30
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-29
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-18
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-11
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-07
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-31
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-31
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	5e-31
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-31
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-31
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-31
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-31
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-31
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	9e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	9e-31
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	9e-31
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-27
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-24
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-18
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-30
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-30
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-30
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-30
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-30
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	7e-30
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-29
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-29
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-29
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-27
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-10
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-08
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-29
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-29
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-29
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-29
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-28
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-28
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-28
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-27
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-25
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-22
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-28
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-28
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-28
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-28
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-24
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-20
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-09
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	8e-28
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-28
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-27
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-27
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-27
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-26
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-26
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-25
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-24
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-17
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-14
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-26
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-26
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-26
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-26
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-26
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-24
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-16
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	9e-26
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-25
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-23
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-18
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-25
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-24
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-18
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-10
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-25
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-25
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-25
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-25
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-25
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-24
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-22
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-16
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-25
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-25
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-25
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-25
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-24
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-15
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-08
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	8e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-24
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-24
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-24
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-24
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-24
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-24
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-23
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-19
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-18
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	9e-16
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-23
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-22
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-22
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	5e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-19
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-19
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-07
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-05
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	8e-22
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-21
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-21
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-20
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-10
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-04
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-21
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-21
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-21
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-21
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-21
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-21
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-21
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-21
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-05
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-20
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-06
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-05
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-20
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-20
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-20
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-20
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-20
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-19
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-19
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-19
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-19
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-19
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-19
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-19
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-19
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-19
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-04
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-19
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-19
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-19
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-19
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-18
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-08
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-18
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-18
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-18
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-18
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-18
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-18
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-14
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-08
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-18
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-18
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-18
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-18
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-18
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-17
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-17
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-17
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-16
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-09
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-07
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-17
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-17
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	6e-17
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	6e-17
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-07
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-05
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-17
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	9e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-16
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-16
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-16
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-16
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-16
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-16
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-15
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-15
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-15
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	9e-15
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-14
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	8e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-08
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-06
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-14
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-14
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-14
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-14
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	8e-14
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-13
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	5e-13
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	5e-08
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	8e-13
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-12
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-07
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-04
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-12
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-12
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	8e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-05
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	7e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-04
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	5e-11
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	3e-10
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	1e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-10
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	4e-10
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	3e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-10
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	8e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	5e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	6e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	7e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	7e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	8e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	6e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	6e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	5e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-07
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	7e-07
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	2e-05
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	5e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	8e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	4e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	7e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	9e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-05
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	8e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	4e-04
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	6e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-04
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	3e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	8e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	9e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  440 bits (1133), Expect = e-142
 Identities = 146/491 (29%), Positives = 233/491 (47%), Gaps = 24/491 (4%)

Query: 2   LVDNHLFGAIPPE-FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLP 60
           L +N   G IP         L  L L GN+ +G +P      S L  + L  NN +G LP
Sbjct: 276 LAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELP 335

Query: 61  ISFFHNCTSLRNVDLSQNFFTGKIPEEIGNC-PNLWTLSLYNNQLTGQLPASLINTSMYN 119
           +        L+ +DLS N F+G++PE + N   +L TL L +N  +G +  +L       
Sbjct: 336 MDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395

Query: 120 L---DVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEE 176
           L    ++ N  +G++P  + S    L  LHLS+N +      +  +P  +SLG+ + L +
Sbjct: 396 LQELYLQNNGFTGKIPPTL-SNCSELVSLHLSFNYL------SGTIP--SSLGSLSKLRD 446

Query: 177 LELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTI 235
           L+L    L G +P  +  +  L  L+L  N +TG IP  + N +NL  ++LS+N L+G I
Sbjct: 447 LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI 506

Query: 236 SAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYS 295
              I  L  L  L LS+N FSG IPA LG    L  LDL+ N  +G IP ++       S
Sbjct: 507 PKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----S 562

Query: 296 LFLNNNQLSRSIPPTLGRCTDLYKLDLSYN--RLTGSIPAEISGIREIRIFLNLSHNQLE 353
             +  N ++      +       +   + N     G    +++ +       N++     
Sbjct: 563 GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNP-CNITSRVYG 621

Query: 354 GPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKN 413
           G          ++  +D+S N  +G I  +I +   + ++N+ HN + G++PD +GDL+ 
Sbjct: 622 GHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRG 681

Query: 414 LEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLC 473
           L  +D+S N L G IP +++ +  LT I+LS N   G IP  G F +     F+ N  LC
Sbjct: 682 LNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLC 741

Query: 474 GTVPGMPICPP 484
           G    +P C P
Sbjct: 742 G--YPLPRCDP 750

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  402 bits (1036), Expect = e-128
 Identities = 140/461 (30%), Positives = 222/461 (48%), Gaps = 25/461 (5%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           +  N+    IP        L+HL + GN L G    +++  + L L+ +  N   G +P 
Sbjct: 207 VSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP 265

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLIN-TSMYN 119
                  SL+ + L++N FTG+IP+ + G C  L  L L  N   G +P    + + + +
Sbjct: 266 L---PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLES 322

Query: 120 LDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCT-DLEELE 178
           L +  N+ SGELP D + K+  L  L LS+N                SL N +  L  L+
Sbjct: 323 LALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSG--------ELPESLTNLSASLLTLD 374

Query: 179 LAGMDLGGTLPDSIGRL---NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTI 235
           L+  +  G +  ++ +     L +L LQ N  TG IPP + N S L+SL+LS N LSGTI
Sbjct: 375 LSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTI 434

Query: 236 SAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYS 295
            + +  LS+L  L L  N+  GEIP  L  +  L  L L FN L+GEIP  L N   +  
Sbjct: 435 PSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNW 494

Query: 296 LFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGP 355
           + L+NN+L+  IP  +GR  +L  L LS N  +G+IPAE+   R +   L+L+ N   G 
Sbjct: 495 ISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIW-LDLNTNLFNGT 553

Query: 356 LPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQ--GNLPDSLGDLKN 413
           +P  + K        +++N   G  ++ I N    +  + + N L+  G   + L  L  
Sbjct: 554 IPAAMFKQSG----KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLST 609

Query: 414 LEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPS 454
               +++     G    + +   ++ F+++S+N   G IP 
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPK 650

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  394 bits (1014), Expect = e-125
 Identities = 144/463 (31%), Positives = 217/463 (46%), Gaps = 24/463 (5%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLAL--LSNLTLVTLHDNNLTGML 59
           L ++H+ G++   F     L  L L  N+L G +    +L   S L  + +  N L    
Sbjct: 84  LSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPG 142

Query: 60  PISFFHNCTSLRNVDLSQNFFTGKIPEEI---GNCPNLWTLSLYNNQLTGQLPASLINTS 116
            +S      SL  +DLS N  +G           C  L  L++  N+++G +  S    +
Sbjct: 143 KVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRC-VN 201

Query: 117 MYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEE 176
           +  LDV  N+ S  +P   +    +L +L +S N +           F  ++  CT+L+ 
Sbjct: 202 LEFLDVSSNNFSTGIPF--LGDCSALQHLDISGNKLSG--------DFSRAISTCTELKL 251

Query: 177 LELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHI-GNLSNLISLNLSSNLLSGTI 235
           L ++     G +P    + +L  L L ENK TG IP  + G    L  L+LS N   G +
Sbjct: 252 LNISSNQFVGPIPPLPLK-SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAV 310

Query: 236 SAEISWLSQLEQLFLSHNLFSGEIPA-ALGKLHHLGLLDLSFNKLSGEIPVSLGNL-VQI 293
                  S LE L LS N FSGE+P   L K+  L +LDLSFN+ SGE+P SL NL   +
Sbjct: 311 PPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASL 370

Query: 294 YSLFLNNNQLSRSIPPTLGRC--TDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQ 351
            +L L++N  S  I P L +     L +L L  N  TG IP  +S   E+   L+LS N 
Sbjct: 371 LTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELV-SLHLSFNY 429

Query: 352 LEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDL 411
           L G +P  L  L  ++++ L  N   G I  ++     +  + +  N L G +P  L + 
Sbjct: 430 LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC 489

Query: 412 KNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPS 454
            NL  I +S N L+G IP  + ++  L  + LS N F G IP+
Sbjct: 490 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  376 bits (967), Expect = e-118
 Identities = 127/461 (27%), Positives = 210/461 (45%), Gaps = 26/461 (5%)

Query: 5   NHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISF- 63
           N  F A+      L  L  L L  ++++G +       ++LT + L  N+L+G +     
Sbjct: 63  NVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLTS 121

Query: 64  FHNCTSLRNVDLSQNFFTGKIPEEIG-NCPNLWTLSLYNNQLTGQLPASLIN----TSMY 118
             +C+ L+ +++S N          G    +L  L L  N ++G      +       + 
Sbjct: 122 LGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELK 181

Query: 119 NLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELE 178
           +L +  N +SG++    +S+  +L +L +S NN  +       +P    LG+C+ L+ L+
Sbjct: 182 HLAISGNKISGDVD---VSRCVNLEFLDVSSNNFSTG------IP---FLGDCSALQHLD 229

Query: 179 LAGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISA 237
           ++G  L G    +I     L  L +  N+  G IPP    L +L  L+L+ N  +G I  
Sbjct: 230 ISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPD 287

Query: 238 EISW-LSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPV-SLGNLVQIYS 295
            +S     L  L LS N F G +P   G    L  L LS N  SGE+P+ +L  +  +  
Sbjct: 288 FLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKV 347

Query: 296 LFLNNNQLSRSIPPTLGRCT-DLYKLDLSYNRLTGSIPAEISGIREIRI-FLNLSHNQLE 353
           L L+ N+ S  +P +L   +  L  LDLS N  +G I   +    +  +  L L +N   
Sbjct: 348 LDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFT 407

Query: 354 GPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKN 413
           G +P  LS    +  + LS N  +G I   + +   +R + +  N L+G +P  L  +K 
Sbjct: 408 GKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKT 467

Query: 414 LEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPS 454
           LE + +  N L+G IP  L+    L +I+LS N   G IP 
Sbjct: 468 LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 508

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  369 bits (949), Expect = e-115
 Identities = 142/475 (29%), Positives = 224/475 (47%), Gaps = 33/475 (6%)

Query: 19  RRLRHLQLDGNNLH---GQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDL 75
            ++  + L    L+     +  SL  L+ L  + L ++++ G   +S F    SL ++DL
Sbjct: 50  DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHING--SVSGFKCSASLTSLDL 107

Query: 76  SQNFFTGKIPE--EIGNCPNLWTLSLYNNQLTGQLPASLIN--TSMYNLDVEYNHLSGEL 131
           S+N  +G +     +G+C  L  L++ +N L      S      S+  LD+  N +SG  
Sbjct: 108 SRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGAN 167

Query: 132 PSDI--MSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLP 189
                       L +L +S N +      +  V     +  C +LE L+++  +    +P
Sbjct: 168 VVGWVLSDGCGELKHLAISGNKI------SGDVD----VSRCVNLEFLDVSSNNFSTGIP 217

Query: 190 DSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQL 248
             +G    L  L +  NK++G     I   + L  LN+SSN   G I      L  L+ L
Sbjct: 218 -FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYL 274

Query: 249 FLSHNLFSGEIPAAL-GKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSI 307
            L+ N F+GEIP  L G    L  LDLS N   G +P   G+   + SL L++N  S  +
Sbjct: 275 SLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGEL 334

Query: 308 PP-TLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIEL--SKLE 364
           P  TL +   L  LDLS+N  +G +P  ++ +    + L+LS N   GP+   L  +   
Sbjct: 335 PMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKN 394

Query: 365 NVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHL 424
            +QE+ L +N FTG I   +SNC  +  +++S N L G +P SLG L  L  + +  N L
Sbjct: 395 TLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNML 454

Query: 425 SGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSF--VGNQHLCGTVP 477
            G IP  L  + TL  + L FN+  G IPS G+ N  T +++  + N  L G +P
Sbjct: 455 EGEIPQELMYVKTLETLILDFNDLTGEIPS-GLSNC-TNLNWISLSNNRLTGEIP 507

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  193 bits (494), Expect = 7e-52
 Identities = 76/271 (28%), Positives = 132/271 (48%), Gaps = 17/271 (6%)

Query: 217 NLSNLISLNLSSNLLS---GTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLD 273
               + S++LSS  L+     +S+ +  L+ LE LFLS++  +G +         L  LD
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLD 106

Query: 274 LSFNKLSGEIP--VSLGNLVQIYSLFLNNNQLSRSIP-PTLGRCTDLYKLDLSYNRLTGS 330
           LS N LSG +    SLG+   +  L +++N L          +   L  LDLS N ++G+
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166

Query: 331 IPAEISGIREIR--IFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCI 388
                           L +S N++ G + +  S+  N++ +D+SSN F+  I   + +C 
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGI-PFLGDCS 223

Query: 389 AVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEF 448
           A++ ++IS N L G+   ++     L+ +++S N   G IP     + +L +++L+ N+F
Sbjct: 224 ALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKF 281

Query: 449 KGMIPS--GGIFNSATKMSFVGNQHLCGTVP 477
            G IP    G  ++ T +   GN H  G VP
Sbjct: 282 TGEIPDFLSGACDTLTGLDLSGN-HFYGAVP 311

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  127 bits (322), Expect = 2e-30
 Identities = 44/154 (28%), Positives = 67/154 (43%), Gaps = 5/154 (3%)

Query: 1   MLVDNHLFGAIPPEFSKLRRLRHLQLDGN--NLHGQIPESLALLSNLTLVTLHDNNLTGM 58
            +  N + G            +     GN     G   E L  LS      +      G 
Sbjct: 564 KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGH 623

Query: 59  LPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSM 117
              +F  N  S+  +D+S N  +G IP+EIG+ P L+ L+L +N ++G +P  + +   +
Sbjct: 624 TSPTFD-NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL 682

Query: 118 YNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNN 151
             LD+  N L G +P   MS L  LT + LS NN
Sbjct: 683 NILDLSSNKLDGRIPQA-MSALTMLTEIDLSNNN 715

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  294 bits (754), Expect = 1e-92
 Identities = 76/281 (27%), Positives = 133/281 (47%), Gaps = 7/281 (2%)

Query: 205 NKITGSIPPHIGNLSNLISLNLSSNLLSGT--ISAEISWLSQLEQLFLSH-NLFSGEIPA 261
               G +         + +L+LS   L     I + ++ L  L  L++   N   G IP 
Sbjct: 36  RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95

Query: 262 ALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLD 321
           A+ KL  L  L ++   +SG IP  L  +  + +L  + N LS ++PP++    +L  + 
Sbjct: 96  AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155

Query: 322 LSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIF 381
              NR++G+IP       ++   + +S N+L G +P   + L N+  +DLS N   G+  
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDAS 214

Query: 382 IQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFI 441
           +   +    + I+++ N+L  +L   +G  KNL  +D+  N + G +P  L ++  L  +
Sbjct: 215 VLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL 273

Query: 442 NLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPGMPIC 482
           N+SFN   G IP GG        ++  N+ LCG    +P C
Sbjct: 274 NVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG--SPLPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  250 bits (642), Expect = 1e-76
 Identities = 82/316 (25%), Positives = 128/316 (40%), Gaps = 41/316 (12%)

Query: 4   DNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQ--IPESLALLSNLTLVTLHD-NNLTGMLP 60
           +    G +    ++  R+ +L L G NL     IP SLA L  L  + +   NNL G +P
Sbjct: 35  NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94

Query: 61  ISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYN 119
            +     T L  + ++    +G IP+ +     L TL    N L+G LP S+ +  ++  
Sbjct: 95  PAIA-KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153

Query: 120 LDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELEL 179
           +  + N +SG +P    S     T + +S N                             
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNR---------------------------- 185

Query: 180 AGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEI 239
               L G +P +   LNL  + L  N + G      G+  N   ++L+ N L+  +  ++
Sbjct: 186 ----LTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KV 240

Query: 240 SWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLN 299
                L  L L +N   G +P  L +L  L  L++SFN L GEIP   GNL +       
Sbjct: 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYA 299

Query: 300 NNQLSRSIPPTLGRCT 315
           NN+     P  L  CT
Sbjct: 300 NNKCLCGSP--LPACT 313

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  170 bits (432), Expect = 3e-47
 Identities = 57/231 (24%), Positives = 91/231 (39%), Gaps = 40/231 (17%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           +   ++ GAIP   S+++ L  L    N L G +P S++ L NL  +T   N ++G +P 
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167

Query: 62  SFFHNCTSLRNV-DLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYN 119
           S+  + + L     +S+N  TGKIP    N  NL  + L  N L G       +  +   
Sbjct: 168 SYG-SFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQK 225

Query: 120 LDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELEL 179
           + +  N L+ +L    +    +L  L L  N                             
Sbjct: 226 IHLAKNSLAFDLGK--VGLSKNLNGLDLRNNR---------------------------- 255

Query: 180 AGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSN 229
               + GTLP  + +L  L  L +  N + G IP   GNL        ++N
Sbjct: 256 ----IYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANN 301

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 89.9 bits (224), Expect = 1e-19
 Identities = 27/113 (23%), Positives = 50/113 (44%), Gaps = 3/113 (2%)

Query: 345 LNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFI--QISNCIAVRLINISH-NALQ 401
            +  +    G L    ++   V  +DLS         I   ++N   +  + I   N L 
Sbjct: 31  TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90

Query: 402 GNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPS 454
           G +P ++  L  L  + ++  ++SG IP  L++I TL  ++ S+N   G +P 
Sbjct: 91  GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPP 143

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  285 bits (732), Expect = 3e-89
 Identities = 111/335 (33%), Positives = 170/335 (50%), Gaps = 41/335 (12%)

Query: 538 PELMHNFPRI-TYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNF 596
           PE+     +  + REL  A+  F  + +LG G +G+VYKG L DGT +AVK L+ +    
Sbjct: 10  PEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG 69

Query: 597 TKS-FNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSG 655
            +  F  E +++    HRNL+R+   C  P  + LV PYMANGS+ S L           
Sbjct: 70  GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL-------RERP 122

Query: 656 SSDLTL--LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK 713
            S   L   +R  I    A G+AYLH H   ++IH D+K +N+LL+++  A+V DFG+AK
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182

Query: 714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRR 773
           L+          ++   +TA    G+IG++APEY     +S K DV+ +G+++LE++T +
Sbjct: 183 LM--------DYKDTHVTTAVR--GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ 232

Query: 774 RPTDDMFAGG---LSLHKWVKNHY-HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELI 829
           R  D         + L  WVK      +LE ++D  L      +  EV+++  VA     
Sbjct: 233 RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL--QGNYKDEEVEQLIQVA----- 285

Query: 830 ELGILCTQESPSTRPTM------LDAADDLDRLKR 858
              +LCTQ SP  RP M      L+     +R + 
Sbjct: 286 ---LLCTQSSPMERPKMSEVVRMLEGDGLAERWEE 317

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  281 bits (720), Expect = 7e-84
 Identities = 72/480 (15%), Positives = 160/480 (33%), Gaps = 63/480 (13%)

Query: 1   MLVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLP 60
            +  +    +I        +   +    NN+   + +++  L+ L    + ++       
Sbjct: 165 CINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENI 223

Query: 61  ISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNL 120
                 C +  N +            +  N  +L  + +YN     +LP  L        
Sbjct: 224 ------CEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL-------- 269

Query: 121 DVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELA 180
                             LP +  ++++ N  +S +   +             ++ + + 
Sbjct: 270 ----------------KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIG 313

Query: 181 GMDL-GGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAE 238
             +L    +  S+ ++  L  L    N++ G   P  G+   L SLNL+ N ++   +  
Sbjct: 314 YNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANF 372

Query: 239 ISWLSQLEQLFLSHNLFSGEIPAAL--GKLHHLGLLDLSFNKLSG-------EIPVSLGN 289
             +  Q+E L  +HN     IP       +  +  +D S+N++          +  +   
Sbjct: 373 CGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFK 431

Query: 290 LVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTG-------SIPAEISGIREIR 342
            + + S+ L+NNQ+S+         + L  ++L  N LT                   + 
Sbjct: 432 GINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLT 491

Query: 343 IFLNLSHNQLEG-PLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISH---- 397
             ++L  N+L         + L  +  IDLS N F+     Q  N   ++   I +    
Sbjct: 492 S-IDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDA 549

Query: 398 --NALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSG 455
             N      P+ +    +L  + +  N +  +          ++ +++  N    +  S 
Sbjct: 550 QGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPN---ISVLDIKDNPNISIDLSY 606

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  279 bits (715), Expect = 4e-83
 Identities = 74/474 (15%), Positives = 158/474 (33%), Gaps = 50/474 (10%)

Query: 2   LVDNHLFGAIPPEFSKLR--RLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGML 59
            +  H          +     L    ++ +     I +S  +    T +    NN+T  +
Sbjct: 140 KMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-V 198

Query: 60  PISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMY 118
             +     T LR   +  + F  +   E          +    Q          N   + 
Sbjct: 199 SKAVM-RLTKLRQFYMGNSPFVAENICEAWEN-----ENSEYAQQYKTEDLKWDNLKDLT 252

Query: 119 NLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELE 178
           +++V       +LP+ +   LP +  ++++ N  +S +   +             ++ + 
Sbjct: 253 DVEVYNCPNLTKLPTFL-KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY 311

Query: 179 LAGMDL-GGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTIS 236
           +   +L    +  S+ ++  L  L    N++ G   P  G+   L SLNL+ N ++   +
Sbjct: 312 IGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPA 370

Query: 237 AEISWLSQLEQLFLSHNLFSGEIPAAL--GKLHHLGLLDLSFNKLSGEIPVSLGNLVQIY 294
               +  Q+E L  +HN     IP       +  +  +D S+N++      +        
Sbjct: 371 NFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP----- 424

Query: 295 SLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEG 354
                       + PT  +  ++  ++LS N+++       S    +   +NL  N L  
Sbjct: 425 ------------LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLS-SINLMGNMLTE 471

Query: 355 -------PLPIELSKLENVQEIDLSSNKFTGNIF-IQISNCIAVRLINISHNALQGNLPD 406
                             +  IDL  NK T      + +    +  I++S+N+     P 
Sbjct: 472 IPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPT 530

Query: 407 SLGDLKNLEAI------DVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPS 454
              +   L+        D  GN      P  +    +LT + +  N+ + +   
Sbjct: 531 QPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEK 584

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  275 bits (705), Expect = 9e-82
 Identities = 75/485 (15%), Positives = 165/485 (34%), Gaps = 72/485 (14%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQ----IPESLALLSNLTLVTLHDNNLTG 57
           L      G +P    +L  L  L L  +          P+ ++   +         +   
Sbjct: 88  LEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQK 147

Query: 58  -MLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTS 116
             +      + + L    ++ +     I +          +   +N +T  +  ++    
Sbjct: 148 TFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAV---- 202

Query: 117 MYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEE 176
                                +L  L   ++  +              F +   C   E 
Sbjct: 203 --------------------MRLTKLRQFYMGNSP-------------FVAENICEAWEN 229

Query: 177 LELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLL---- 231
                     T       L +LT + +        +P  +  L  +  +N++ N      
Sbjct: 230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGE 289

Query: 232 ----SGTISAEISWLSQLEQLFLSHN-LFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVS 286
                    A+     +++ +++ +N L +  +  +L K+  LG+L+  +N+L G++P +
Sbjct: 290 QLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-A 348

Query: 287 LGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTG-SIPAEISGIREIRIFL 345
            G+ +++ SL L  NQ++       G    +  L  ++N+L       +   +  +   +
Sbjct: 349 FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSA-I 407

Query: 346 NLSHNQLEG-------PLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHN 398
           + S+N++         PL     K  NV  I+LS+N+ +       S    +  IN+  N
Sbjct: 408 DFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGN 467

Query: 399 ALQG-------NLPDSLGDLKNLEAIDVSGNHLSGIIP-ISLNKIHTLTFINLSFNEFKG 450
            L         +  ++  +   L +ID+  N L+ +        +  L  I+LS+N F  
Sbjct: 468 MLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK 527

Query: 451 MIPSG 455
             P+ 
Sbjct: 528 -FPTQ 531

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  257 bits (659), Expect = 3e-75
 Identities = 67/473 (14%), Positives = 147/473 (31%), Gaps = 64/473 (13%)

Query: 14  EFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISF---FHNCTSL 70
             +   R+  L L+G    G++P+++  L+ L ++ L  +       +          S 
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135

Query: 71  RNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGE 130
                 +  +     +     P      L  + +                    +     
Sbjct: 136 EQKQKMRMHYQKTFVDYD---PREDFSDLIKDCINS------------------DPQQKS 174

Query: 131 LPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPD 190
           +           T +    NN+         V    ++   T L +  +           
Sbjct: 175 IKKSS-RITLKDTQIGQLSNNITF-------VS--KAVMRLTKLRQFYMGNSPFVAENIC 224

Query: 191 SIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFL 250
                       +  +   +      NL +L  + + +      +   +  L +++ + +
Sbjct: 225 EAWEN----ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINV 280

Query: 251 SHNLF--------SGEIPAALGKLHHLGLLDLSFNKL-SGEIPVSLGNLVQIYSLFLNNN 301
           + N            +  A       + ++ + +N L +  +  SL  + ++  L    N
Sbjct: 281 ACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYN 340

Query: 302 QLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEG-PLPIEL 360
           QL     P  G    L  L+L+YN++T           ++   L+ +HN+L+  P   + 
Sbjct: 341 QLE-GKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVE-NLSFAHNKLKYIPNIFDA 398

Query: 361 SKLENVQEIDLSSNKFTG-------NIFIQISNCIAVRLINISHNALQGNLPDSLGDLKN 413
             +  +  ID S N+           +       I V  IN+S+N +     +       
Sbjct: 399 KSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP 458

Query: 414 LEAIDVSGNHLSGI-------IPISLNKIHTLTFINLSFNEFKGMIPSGGIFN 459
           L +I++ GN L+ I          +    + LT I+L FN+   +        
Sbjct: 459 LSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATT 511

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  254 bits (652), Expect = 3e-74
 Identities = 64/424 (15%), Positives = 140/424 (33%), Gaps = 54/424 (12%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
                 +     ++  L+ L  +++       ++P  L  L  + L+ +  N       +
Sbjct: 232 SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQL 291

Query: 62  -------SFFHNCTSLRNVDLSQN-FFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLI 113
                  +       ++ + +  N   T  +   +     L  L    NQL G    +  
Sbjct: 292 KDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFG 350

Query: 114 N-TSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCT 172
           +   + +L++ YN ++  +P++       +  L  ++N +         +P      + +
Sbjct: 351 SEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKY-------IPNIFDAKSVS 402

Query: 173 DLEELELAGMDLGG-------TLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISL 224
            +  ++ +  ++G         L  +  +  N++ + L  N+I+          S L S+
Sbjct: 403 VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSI 462

Query: 225 NLSSNLLSG-------TISAEISWLSQLEQLFLSHNLFSGEIPA--ALGKLHHLGLLDLS 275
           NL  N+L+          +        L  + L  N  +  +        L +L  +DLS
Sbjct: 463 NLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLS 521

Query: 276 FNKLSGEIPVSLGNLVQIYSLFLNN------NQLSRSIPPTLGRCTDLYKLDLSYNRLTG 329
           +N  S   P    N   +    + N      N+  R  P  +  C  L +L +  N +  
Sbjct: 522 YNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR- 579

Query: 330 SIPAEI-SGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCI 388
            +  +I   I      L++  N         +          L  +K        I  C 
Sbjct: 580 KVNEKITPNISV----LDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ-----DIRGCD 630

Query: 389 AVRL 392
           A+ +
Sbjct: 631 ALDI 634

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  243 bits (621), Expect = 7e-70
 Identities = 64/422 (15%), Positives = 135/422 (31%), Gaps = 38/422 (9%)

Query: 52  DNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPAS 111
           + ++ G  P    ++   +  + L     +G++P+ IG    L  L+L ++         
Sbjct: 65  ELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLF 124

Query: 112 LI-----NTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFN 166
                  N S         H             P   +  L  + + S   +        
Sbjct: 125 GPKGISANMSDEQKQKMRMHYQKTFVDY----DPREDFSDLIKDCINS---DPQQKSIKK 177

Query: 167 SLGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLN 225
           S        ++     ++   +  ++ RL  L Q  +  +                   N
Sbjct: 178 SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN-----EN 231

Query: 226 LSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKL------ 279
                   T   +   L  L  + + +     ++P  L  L  + L++++ N+       
Sbjct: 232 SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQL 291

Query: 280 --SGEIPVSLGNLVQIYSLFLNNNQLSR-SIPPTLGRCTDLYKLDLSYNRLTGSIPAEIS 336
               +         +I  +++  N L    +  +L +   L  L+  YN+L G +P    
Sbjct: 292 KDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFG 350

Query: 337 GIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGN-IFIQISNCIAVRLINI 395
              ++   LNL++NQ+           E V+ +  + NK           +   +  I+ 
Sbjct: 351 SEIKLAS-LNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDF 409

Query: 396 SHNALQG-------NLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEF 448
           S+N +          L  +     N+ +I++S N +S       +    L+ INL  N  
Sbjct: 410 SYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML 469

Query: 449 KG 450
             
Sbjct: 470 TE 471

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  144 bits (366), Expect = 3e-36
 Identities = 28/261 (10%), Positives = 68/261 (26%), Gaps = 37/261 (14%)

Query: 215 IGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSG----EIPAALGKLHHLG 270
           + +   +  L+L     SG +   I  L++LE L L  +          P  +       
Sbjct: 77  LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136

Query: 271 LLDLSFNKLSGEIPVSLGNLV--QIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLT 328
                                   +    +N++   +SI  +        ++    N +T
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196

Query: 329 GSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCI 388
                                      +   + +L  +++  + ++ F      +     
Sbjct: 197 F--------------------------VSKAVMRLTKLRQFYMGNSPFVAENICEAWE-- 228

Query: 389 AVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEF 448
                N  +            +LK+L  ++V        +P  L  +  +  IN++ N  
Sbjct: 229 ---NENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285

Query: 449 KGMIPSGGIFNSATKMSFVGN 469
                    + +         
Sbjct: 286 ISGEQLKDDWQALADAPVGEK 306

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 99.0 bits (247), Expect = 2e-21
 Identities = 24/208 (11%), Positives = 59/208 (28%), Gaps = 27/208 (12%)

Query: 273 DLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTG--- 329
           +   +    +  VSL +  ++  L L     S  +P  +G+ T+L  L L  +       
Sbjct: 63  NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122

Query: 330 -SIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLE--NVQEIDLSSNKFTGNIFIQISN 386
              P  IS                +        + +  ++ +  ++S+    +I      
Sbjct: 123 LFGPKGISANMSDEQ-KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI 181

Query: 387 CIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSG-------------------I 427
            +    I    N +   +  ++  L  L    +  +                        
Sbjct: 182 TLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT 240

Query: 428 IPISLNKIHTLTFINLSFNEFKGMIPSG 455
             +  + +  LT + +        +P+ 
Sbjct: 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTF 268

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  281 bits (722), Expect = 1e-83
 Identities = 110/484 (22%), Positives = 185/484 (38%), Gaps = 44/484 (9%)

Query: 4   DNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLH--DNNLTGMLPI 61
            N L         +L  L+ L L  N +     E L + +N +L  L    N +      
Sbjct: 130 HNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE-FSP 188

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEIG---NCPNLWTLSLYNNQLTGQLPASLINTSMY 118
             FH    L  + L+       + E++       ++  LSL N+QL+     + +     
Sbjct: 189 GCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWT 248

Query: 119 N---LDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLE 175
           N   LD+ YN+L+  + +D  + LP L Y  L YNN+       +L    +SL    ++ 
Sbjct: 249 NLTMLDLSYNNLNV-VGNDSFAWLPQLEYFFLEYNNI------QHLFS--HSLHGLFNVR 299

Query: 176 ELELAGMDLGGTL---------PDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLN 225
            L L       ++           S   L  L  L +++N I G        L NL  L+
Sbjct: 300 YLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLS 359

Query: 226 LSSNLLSGTISAEISW----LSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSG 281
           LS++  S       ++     S L  L L+ N  S     A   L HL +LDL  N++  
Sbjct: 360 LSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQ 419

Query: 282 EIPVS-LGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTG--SIPAEISGI 338
           E+       L  I+ ++L+ N+  +    +      L +L L    L    S P+    +
Sbjct: 420 ELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPL 479

Query: 339 REIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFT--------GNIFIQISNCIAV 390
           R + I L+LS+N +       L  LE ++ +DL  N           G     +     +
Sbjct: 480 RNLTI-LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHL 538

Query: 391 RLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKG 450
            ++N+  N       +   DL  L+ ID+  N+L+ +     N   +L  +NL  N    
Sbjct: 539 HILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITS 598

Query: 451 MIPS 454
           +   
Sbjct: 599 VEKK 602

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  278 bits (713), Expect = 2e-82
 Identities = 96/476 (20%), Positives = 174/476 (36%), Gaps = 32/476 (6%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           L  N L       F++  +L  L +  N +    PE    L  L ++ L  N L+  L  
Sbjct: 32  LTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQ-LSD 90

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNL 120
             F  CT+L  + L  N              NL TL L +N L+     + +   ++  L
Sbjct: 91  KTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQEL 150

Query: 121 DVEYNHLSGELPSDI-MSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELEL 179
            +  N +      ++ +    SL  L LS N +                     L  L L
Sbjct: 151 LLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSP--------GCFHAIGRLFGLFL 202

Query: 180 AGMDLGGTLPDSIGR----LNLTQLLLQENKITGSIPPHIGNL--SNLISLNLSSNLLSG 233
             + LG +L + +       ++  L L  ++++ +       L  +NL  L+LS N L+ 
Sbjct: 203 NNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV 262

Query: 234 TISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDL---------SFNKLSGEIP 284
             +   +WL QLE  FL +N        +L  L ++  L+L         S   L     
Sbjct: 263 VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDD 322

Query: 285 VSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLT-GSIPAEI-SGIREIR 342
            S   L  +  L + +N +            +L  L LS +  +  ++  E    +    
Sbjct: 323 FSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSP 382

Query: 343 I-FLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNI-FIQISNCIAVRLINISHNAL 400
           +  LNL+ N++        S L +++ +DL  N+    +   +      +  I +S+N  
Sbjct: 383 LHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKY 442

Query: 401 QGNLPDSLGDLKNLEAIDVSGNHLSGI--IPISLNKIHTLTFINLSFNEFKGMIPS 454
                +S   + +L+ + +    L  +   P     +  LT ++LS N    +   
Sbjct: 443 LQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD 498

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  276 bits (708), Expect = 9e-82
 Identities = 104/484 (21%), Positives = 175/484 (36%), Gaps = 40/484 (8%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           L+ N +       F K + L  L L  N L      +   L NL  + L +N +  +   
Sbjct: 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163

Query: 62  SF-FHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLI----NTS 116
                  +SL+ ++LS N      P        L+ L L N QL   L   L     NTS
Sbjct: 164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTS 223

Query: 117 MYNLDVEYNHLSGELPSDIMS-KLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLE 175
           + NL +  + LS    +  +  K  +LT L LSYNN+        +    +S      LE
Sbjct: 224 IRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNL------NVVGN--DSFAWLPQLE 275

Query: 176 ELELAGMDLGGTLPDSIGRL----------NLTQLLLQENKITGSIPPHIGNLSNLISLN 225
              L   ++      S+  L          + T+  +    +          L  L  LN
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLN 335

Query: 226 LSSNLLSGTISAEISWLSQLEQLFLSHNLFSGE--IPAALGKLHHLGL--LDLSFNKLSG 281
           +  N + G  S   + L  L+ L LS++  S           L H  L  L+L+ NK+S 
Sbjct: 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK 395

Query: 282 EIPVSLGNLVQIYSLFLNNNQLSRSIPP-TLGRCTDLYKLDLSYNRLTGSIPAEISGIRE 340
               +   L  +  L L  N++ + +         +++++ LSYN+         + +  
Sbjct: 396 IESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPS 455

Query: 341 IRIFLNLSHNQLEG--PLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHN 398
           ++  L L    L+     P     L N+  +DLS+N         +     + ++++ HN
Sbjct: 456 LQR-LMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHN 514

Query: 399 ALQ--------GNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKG 450
            L         G     L  L +L  +++  N    I       +  L  I+L  N    
Sbjct: 515 NLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNT 574

Query: 451 MIPS 454
           +  S
Sbjct: 575 LPAS 578

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  269 bits (691), Expect = 2e-79
 Identities = 106/497 (21%), Positives = 175/497 (35%), Gaps = 27/497 (5%)

Query: 5   NHLFGAIPPEFS--KLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPIS 62
           N +      E        L+ L+L  N +    P     +  L  + L++  L   L   
Sbjct: 155 NKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEK 214

Query: 63  FFHNC--TSLRNVDLSQNFFTGKIPEEIGNC--PNLWTLSLYNNQLTGQLPASLIN-TSM 117
                  TS+RN+ LS +  +             NL  L L  N L      S      +
Sbjct: 215 LCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQL 274

Query: 118 YNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPF-FNSLGNCTDLEE 176
               +EYN++   L S  +  L ++ YL+L  +         +L      S      LE 
Sbjct: 275 EYFFLEYNNIQH-LFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEH 333

Query: 177 LELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIG----NLSNLISLNLSSNLL 231
           L +   D+ G   +    L NL  L L  +  +     +        S L  LNL+ N +
Sbjct: 334 LNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKI 393

Query: 232 SGTISAEISWLSQLEQLFLSHNLFSGEIPA-ALGKLHHLGLLDLSFNKLSGEIPVSLGNL 290
           S   S   SWL  LE L L  N    E+       L ++  + LS+NK       S   +
Sbjct: 394 SKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALV 453

Query: 291 VQIYSLFLNNNQLSR--SIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLS 348
             +  L L    L    S P       +L  LDLS N +       + G+ ++ I L+L 
Sbjct: 454 PSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEI-LDLQ 512

Query: 349 HNQLE--------GPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNAL 400
           HN L         G     L  L ++  ++L SN F         +   +++I++  N L
Sbjct: 513 HNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNL 572

Query: 401 QGNLPDSLGDLKNLEAIDVSGNHLSGIIPISL-NKIHTLTFINLSFNEFKGMIPSGGIFN 459
                    +  +L+++++  N ++ +           LT +++ FN F     S   F 
Sbjct: 573 NTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFV 632

Query: 460 SATKMSFVGNQHLCGTV 476
           +    +      L    
Sbjct: 633 NWINETHTNIPELSSHY 649

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  262 bits (671), Expect = 2e-76
 Identities = 88/481 (18%), Positives = 171/481 (35%), Gaps = 33/481 (6%)

Query: 4   DNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISF 63
              L   +P +      +  L L  N L      +    S LT + +  N ++  L    
Sbjct: 13  HLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK-LEPEL 68

Query: 64  FHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNLDV 122
                 L+ ++L  N  +    +    C NL  L L +N +        +   ++  LD+
Sbjct: 69  CQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128

Query: 123 EYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGM 182
            +N LS         +L +L  L LS N +        L      +   + L++LEL+  
Sbjct: 129 SHNGLSS-TKLGTQVQLENLQELLLSNNKI------QALKSEELDIFANSSLKKLELSSN 181

Query: 183 DLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIG---NLSNLISLNLSSNLLSGTISAE 238
            +    P     +  L  L L   ++  S+   +      +++ +L+LS++ LS T +  
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241

Query: 239 ISWL--SQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSL 296
              L  + L  L LS+N  +     +   L  L    L +N +      SL  L  +  L
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301

Query: 297 FLNNN---------QLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNL 347
            L  +          L +    +      L  L++  N + G      +G+  ++ +L+L
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLK-YLSL 360

Query: 348 SHNQLEGPLPIELS----KLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGN 403
           S++          +        +  ++L+ NK +       S    + ++++  N +   
Sbjct: 361 SNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQE 420

Query: 404 LP-DSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSAT 462
           L       L+N+  I +S N    +   S   + +L  + L     K +  S   F    
Sbjct: 421 LTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480

Query: 463 K 463
            
Sbjct: 481 N 481

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  252 bits (647), Expect = 4e-73
 Identities = 91/458 (19%), Positives = 162/458 (35%), Gaps = 39/458 (8%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLAL---LSNLTLVTLHDNNLTGM 58
           L  N +    P  F  + RL  L L+   L   + E L L    +++  ++L ++ L+  
Sbjct: 178 LSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTT 237

Query: 59  LPISFFH-NCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TS 116
              +F     T+L  +DLS N       +     P L    L  N +      SL    +
Sbjct: 238 SNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFN 297

Query: 117 MYNLDVEYNHLSG--------ELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSL 168
           +  L+++ +            ++       L  L +L++  N++     N          
Sbjct: 298 VRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNM--------F 349

Query: 169 GNCTDLEELELAG-----MDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLIS 223
               +L+ L L+        L      S+    L  L L +NKI+         L +L  
Sbjct: 350 TGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEV 409

Query: 224 LNLSSNLLSGTISA-EISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSG- 281
           L+L  N +   ++  E   L  + +++LS+N +      +   +  L  L L    L   
Sbjct: 410 LDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNV 469

Query: 282 -EIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLT--------GSIP 332
              P     L  +  L L+NN ++      L     L  LDL +N L         G   
Sbjct: 470 DSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPI 529

Query: 333 AEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRL 392
             + G+  + I LNL  N  +         L  ++ IDL  N          +N ++++ 
Sbjct: 530 YFLKGLSHLHI-LNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKS 588

Query: 393 INISHNALQGNLPDSLGD-LKNLEAIDVSGNHLSGIIP 429
           +N+  N +        G   +NL  +D+  N       
Sbjct: 589 LNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  222 bits (569), Expect = 2e-62
 Identities = 87/432 (20%), Positives = 155/432 (35%), Gaps = 58/432 (13%)

Query: 44  NLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQ 103
           +  +       LT  +P       T++  ++L+ N               L +L +  N 
Sbjct: 5   SHEVADCSHLKLTQ-VPDDLP---TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 104 LTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVP 163
           ++                         L  ++  KLP L  L+L +N +      + L  
Sbjct: 61  ISK------------------------LEPELCQKLPMLKVLNLQHNEL------SQLSD 90

Query: 164 FFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLI 222
              +   CT+L EL L    +     +   +  NL  L L  N ++ +       L NL 
Sbjct: 91  --KTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQ 148

Query: 223 SLNLSSNLLSGTISAEISWL--SQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLS 280
            L LS+N +    S E+     S L++L LS N      P     +  L  L L+  +L 
Sbjct: 149 ELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLG 208

Query: 281 GEIPVSLG---NLVQIYSLFLNNNQLSRSIPPTLG--RCTDLYKLDLSYNRLTGSIPAEI 335
             +   L        I +L L+N+QLS +   T    + T+L  LDLSYN L        
Sbjct: 209 PSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF 268

Query: 336 SGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQ---------ISN 386
           + + ++     L +N ++      L  L NV+ ++L  +    +I +             
Sbjct: 269 AWLPQLEY-FFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQW 327

Query: 387 CIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLN----KIHTLTFIN 442
              +  +N+  N + G   +    L NL+ + +S +  S     +          L  +N
Sbjct: 328 LKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILN 387

Query: 443 LSFNEFKGMIPS 454
           L+ N+   +   
Sbjct: 388 LTKNKISKIESD 399

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  190 bits (486), Expect = 3e-51
 Identities = 62/291 (21%), Positives = 117/291 (40%), Gaps = 9/291 (3%)

Query: 171 CT-DLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSN 229
           CT   E  + + + L   +PD +   N+T L L  N++      +    S L SL++  N
Sbjct: 2   CTVSHEVADCSHLKLT-QVPDDLPT-NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59

Query: 230 LLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGN 289
            +S         L  L+ L L HN  S           +L  L L  N +          
Sbjct: 60  TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119

Query: 290 LVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRI-FLNLS 348
              + +L L++N LS +   T  +  +L +L LS N++      E+       +  L LS
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179

Query: 349 HNQLEGPLPIELSKLENVQEIDLSSNKFTGNI---FIQISNCIAVRLINISHNALQGNLP 405
            NQ++   P     +  +  + L++ +   ++           ++R +++S++ L     
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239

Query: 406 DSLGDLK--NLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPS 454
            +   LK  NL  +D+S N+L+ +   S   +  L +  L +N  + +   
Sbjct: 240 TTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH 290

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  162 bits (413), Expect = 6e-42
 Identities = 54/301 (17%), Positives = 100/301 (33%), Gaps = 33/301 (10%)

Query: 18  LRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQ 77
              L  L L  N +     ++ + L +L ++ L  N +   L    +    ++  + LS 
Sbjct: 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY 439

Query: 78  NFFTGKIPEEIGNCPNLWTLSLYNNQLTG--QLPASLIN-TSMYNLDVEYNHLSGELPSD 134
           N +           P+L  L L    L      P+      ++  LD+  N+++  +  D
Sbjct: 440 NKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN-INDD 498

Query: 135 IMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGR 194
           ++  L  L  L L +NN+     + N       L   +                      
Sbjct: 499 MLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLS---------------------- 536

Query: 195 LNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNL 254
            +L  L L+ N           +L  L  ++L  N L+   ++  +    L+ L L  NL
Sbjct: 537 -HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNL 595

Query: 255 FSGEIPAALGK-LHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGR 313
            +       G    +L  LD+ FN        S+   V     ++N    +     +   
Sbjct: 596 ITSVEKKVFGPAFRNLTELDMRFNPFDCTCE-SIAWFVN----WINETHTNIPELSSHYL 650

Query: 314 C 314
           C
Sbjct: 651 C 651

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  274 bits (704), Expect = 7e-82
 Identities = 94/485 (19%), Positives = 165/485 (34%), Gaps = 38/485 (7%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           L  N +       FS L  L+ L     NL       +  L  L  + +  N +      
Sbjct: 83  LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNL----WTLSLYNNQLTGQLPASLINTSM 117
            +F N T+L ++DLS N        ++     +     +L L  N +    P +     +
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL 202

Query: 118 YNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCT--DLE 175
           + L +  N  S  +    +  L  L    L      +           ++L       +E
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE--GNLEKFDKSALEGLCNLTIE 260

Query: 176 ELELAGMDL-GGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLS- 232
           E  LA +D     + D    L N++   L    I                L L +     
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQ 318

Query: 233 ------------------GTISAEISWLSQLEQLFLSHN--LFSGEIPAALGKLHHLGLL 272
                             G  +     L  LE L LS N   F G    +      L  L
Sbjct: 319 FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378

Query: 273 DLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPP-TLGRCTDLYKLDLSYNRLTGSI 331
           DLSFN +   +  +   L Q+  L   ++ L +           +L  LD+S+     + 
Sbjct: 379 DLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437

Query: 332 PAEISGIREIRIFLNLSHNQLEGPL-PIELSKLENVQEIDLSSNKFTGNIFIQISNCIAV 390
               +G+  + + L ++ N  +    P   ++L N+  +DLS  +         ++  ++
Sbjct: 438 NGIFNGLSSLEV-LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 496

Query: 391 RLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHT-LTFINLSFNEFK 449
           +++N+SHN            L +L+ +D S NH+       L    + L F+NL+ N+F 
Sbjct: 497 QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 556

Query: 450 GMIPS 454
                
Sbjct: 557 CTCEH 561

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  244 bits (624), Expect = 1e-70
 Identities = 87/473 (18%), Positives = 161/473 (34%), Gaps = 40/473 (8%)

Query: 4   DNHL-FGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVT----LHDNNLTGM 58
            N +    +P  FS L  L HL L  N +       L +L  + L+     L  N +  +
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI 192

Query: 59  LPISFFHNCTSLRNVDLSQNFFTGKIPEE-IGNCPNLWTLSLYNNQLTGQLP-------- 109
            P +F      L  + L  NF +  + +  I     L    L   +   +          
Sbjct: 193 QPGAF--KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250

Query: 110 -ASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSL 168
              L N ++    + Y     +   D+ + L +++   L    +    D +         
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN------- 303

Query: 169 GNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSS 228
                 + LEL     G      +  L      L      G       +L +L  L+LS 
Sbjct: 304 ---FGWQHLELVNCKFGQFPTLKLKSL----KRLTFTSNKGGNAFSEVDLPSLEFLDLSR 356

Query: 229 NLLS--GTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVS 286
           N LS  G  S      + L+ L LS N     + +    L  L  LD   + L      S
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFS 415

Query: 287 -LGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEI-SGIREIRIF 344
              +L  +  L +++     +        + L  L ++ N    +   +I + +R +   
Sbjct: 416 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF- 474

Query: 345 LNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNL 404
           L+LS  QLE   P   + L ++Q +++S N F            ++++++ S N +  + 
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 534

Query: 405 PDSLGDL-KNLEAIDVSGNHLSGIIPIS--LNKIHTLTFINLSFNEFKGMIPS 454
              L     +L  ++++ N  +        L  I     + +     +   PS
Sbjct: 535 KQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS 587

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  229 bits (585), Expect = 3e-65
 Identities = 85/472 (18%), Positives = 156/472 (33%), Gaps = 43/472 (9%)

Query: 5   NHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFF 64
           N L       F     L+ L L    +      +   LS+L+ + L  N +   L +  F
Sbjct: 38  NPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS-LALGAF 96

Query: 65  HNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTG-QLPASLIN-TSMYNLDV 122
              +SL+ +   +          IG+   L  L++ +N +   +LP    N T++ +LD+
Sbjct: 97  SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156

Query: 123 EYNHLSGELPSDIMSKLPSLTY----LHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELE 178
             N +     +D+   L  +      L LS N M                     L +L 
Sbjct: 157 SSNKIQSIYCTDL-RVLHQMPLLNLSLDLSLNPMNFIQPGA---------FKEIRLHKLT 206

Query: 179 LAGMDLGGTLPDSI--GRLNLTQLLLQENKITGSI---PPHIGNLSNLISLNLSSNLLS- 232
           L        +  +   G   L    L   +              L  L +L +    L+ 
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266

Query: 233 -----GTISAEISWLSQLEQLFLSHNLFSGEIPAA-LGKLHHLGLLDLSFNKLSGEIPVS 286
                  I    + L+ +    L           +      HL L++  F +       S
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKS 326

Query: 287 LGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLT--GSIPAEISGIREIRIF 344
           L          L           +      L  LDLS N L+  G       G   ++ +
Sbjct: 327 L--------KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK-Y 377

Query: 345 LNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQI-SNCIAVRLINISHNALQGN 403
           L+LS N +   +      LE ++ +D   +         +  +   +  ++ISH   +  
Sbjct: 378 LDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436

Query: 404 LPDSLGDLKNLEAIDVSGNHLSG-IIPISLNKIHTLTFINLSFNEFKGMIPS 454
                  L +LE + ++GN      +P    ++  LTF++LS  + + + P+
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  219 bits (561), Expect = 7e-62
 Identities = 87/465 (18%), Positives = 159/465 (34%), Gaps = 53/465 (11%)

Query: 28  GNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEE 87
             N + +IP++L    +   + L  N L  +   SF  +   L+ +DLS+          
Sbjct: 16  ELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSF-FSFPELQVLDLSRCEIQTIEDGA 71

Query: 88  IGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNLDVEYNHLSGELPSDIMSKLPSLTYLH 146
             +  +L TL L  N +      +    +S+  L     +L+  L +  +  L +L  L+
Sbjct: 72  YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELN 130

Query: 147 LSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-----NLTQLL 201
           +++N + S               N T+LE L+L+   +       +  L         L 
Sbjct: 131 VAHNLIQS-------FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183

Query: 202 LQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAE-ISWLSQLEQLFLSHNLFSGE-- 258
           L  N +   I P       L  L L +N  S  +    I  L+ LE   L    F  E  
Sbjct: 184 LSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242

Query: 259 ----IPAALGKLHHLGLLDLSFNKLS---GEIPVSLGNLVQIYSLFLNNNQLSRSIPPTL 311
                 +AL  L +L + +     L     +I      L  + S  L +  + R      
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--F 300

Query: 312 GRCTDLYKLDLSYNRLTGSIPAEISGIREIRI------------------FLNLSHNQL- 352
                   L+L   +       ++  ++ +                    FL+LS N L 
Sbjct: 301 SYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLS 360

Query: 353 -EGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDS-LGD 410
            +G          +++ +DLS N     +         +  ++  H+ L+     S    
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419

Query: 411 LKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSG 455
           L+NL  +D+S  H         N + +L  + ++ N F+      
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  205 bits (523), Expect = 1e-56
 Identities = 76/405 (18%), Positives = 139/405 (34%), Gaps = 29/405 (7%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPE-SLALLSNLTLVTLHDNNLTGMLP 60
           L  N +    P  F ++R L  L L  N     + +  +  L+ L +  L          
Sbjct: 184 LSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242

Query: 61  ISF--FHNCTSLRNVDLSQN------FFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASL 112
           +          L N+ + +       ++   I +      N+ + SL +  +      S 
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY 302

Query: 113 INTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLV---------- 162
            N    +L++         P+  +  L  LT+      N  S  D  +L           
Sbjct: 303 -NFGWQHLELVNCKFGQ-FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLS 360

Query: 163 ---PFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHI-GNL 218
                  S    T L+ L+L+   +     + +G   L  L  Q + +       +  +L
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 420

Query: 219 SNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEI-PAALGKLHHLGLLDLSFN 277
            NLI L++S        +   + LS LE L ++ N F     P    +L +L  LDLS  
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480

Query: 278 KLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISG 337
           +L    P +  +L  +  L +++N               L  LD S N +  S   E+  
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 540

Query: 338 IREIRIFLNLSHNQLEGPLPIE--LSKLENVQEIDLSSNKFTGNI 380
                 FLNL+ N        +  L  +++ +++ +   +     
Sbjct: 541 FPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECAT 585

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  148 bits (376), Expect = 1e-37
 Identities = 50/270 (18%), Positives = 88/270 (32%), Gaps = 18/270 (6%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLH--GQIPESLALLSNLTLVTLHDNNLTGML 59
           L      G        L  L  L L  N L   G   +S    ++L  + L  N +  M 
Sbjct: 330 LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMS 389

Query: 60  PISFFHNCTSLRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLIN-TSM 117
               F     L ++D   +         +  +  NL  L + +              +S+
Sbjct: 390 SN--FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447

Query: 118 YNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEEL 177
             L +  N        DI ++L +LT+L LS   +              +  + + L+ L
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT--------AFNSLSSLQVL 499

Query: 178 ELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNL-SNLISLNLSSNLLSGTI 235
            ++  +           L +L  L    N I  S    + +  S+L  LNL+ N  + T 
Sbjct: 500 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 559

Query: 236 SAE--ISWLSQLEQLFLSHNLFSGEIPAAL 263
             +  + W+    QL +         P+  
Sbjct: 560 EHQSFLQWIKDQRQLLVEVERMECATPSDK 589

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  116 bits (293), Expect = 3e-27
 Identities = 38/232 (16%), Positives = 76/232 (32%), Gaps = 32/232 (13%)

Query: 1   MLVDNHLFGAIPPE-FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGML 59
               ++L        F  LR L +L +   +           LS+L ++ +  N+     
Sbjct: 402 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 461

Query: 60  PISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMY 118
               F    +L  +DLSQ       P    +  +L  L++ +N              S+ 
Sbjct: 462 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ 521

Query: 119 NLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELE 178
            LD   NH+      ++     SL +L+L+ N+            F   +          
Sbjct: 522 VLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF---ACTCEHQSFLQWI---------- 568

Query: 179 LAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNL 230
                            +  QLL++  ++  + P     +  ++SLN++  +
Sbjct: 569 ----------------KDQRQLLVEVERMECATPSDKQGMP-VLSLNITCQM 603

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 87.8 bits (218), Expect = 5e-18
 Identities = 21/142 (14%), Positives = 46/142 (32%), Gaps = 6/142 (4%)

Query: 319 KLDLSYNRLTGSIPAEI-SGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFT 377
                       IP  +    +     L+LS N L             +Q +DLS  +  
Sbjct: 11  TYQCMELNFY-KIPDNLPFSTKN----LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ 65

Query: 378 GNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHT 437
                   +   +  + ++ N +Q     +   L +L+ +     +L+ +    +  + T
Sbjct: 66  TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125

Query: 438 LTFINLSFNEFKGMIPSGGIFN 459
           L  +N++ N  +         N
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSN 147

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  256 bits (657), Expect = 1e-78
 Identities = 93/332 (28%), Positives = 159/332 (47%), Gaps = 40/332 (12%)

Query: 525 SSGKSETRSKPITPELMHNFPR-ITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTA 583
           S   +       +  L+      +   +L EAT  FD + L+G G +G+VYKG+L+DG  
Sbjct: 6   SKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK 65

Query: 584 IAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSH 643
           +A+K    +S    + F  E + L   RH +L+ +I  C   +   L+  YM NG+L  H
Sbjct: 66  VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH 125

Query: 644 LYPHSETEFGSGSSDLTL--LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDD 701
           LY       GS    +++   QR+ IC   A G+ YLH  +   +IH D+K  N+LL+++
Sbjct: 126 LY-------GSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDEN 175

Query: 702 MTALVSDFGIAKLVMTVG---VGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGD 758
               ++DFGI+K    +    +          ST     G++GY+ PEY      + K D
Sbjct: 176 FVPKITDFGISKKGTELDQTHL----------STVVK--GTLGYIDPEYFIKGRLTEKSD 223

Query: 759 VYSFGILVLEMVTRRRPTDDMFAGG-LSLHKWVKNHYH-GRLEKVIDSSLLRASRDQSPE 816
           VYSFG+++ E++  R           ++L +W    ++ G+LE+++D +L  A + +   
Sbjct: 224 VYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL--ADKIRPES 281

Query: 817 VKRMWDVAIGELIELGILCTQESPSTRPTMLD 848
           +++          +  + C   S   RP+M D
Sbjct: 282 LRKF--------GDTAVKCLALSSEDRPSMGD 305

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  245 bits (627), Expect = 2e-74
 Identities = 87/329 (26%), Positives = 142/329 (43%), Gaps = 50/329 (15%)

Query: 543 NFPRITYRELLEATAEFDEQR------LLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNF 596
            F   ++ EL   T  FDE+        +G G +G VYKG + + T +AVK  +L +   
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVK--KLAAMVD 67

Query: 597 TKS------FNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSET 650
             +      F++E +V+ + +H NL+ ++   S  D   LV  YM NGSL   L      
Sbjct: 68  ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL------ 121

Query: 651 EFG-SGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDF 709
                G+  L+   R  I    A G+ +LH +     IH D+K +N+LL++  TA +SDF
Sbjct: 122 -SCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDF 177

Query: 710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEM 769
           G+A+        ++       ++  +  G+  YMAPE   G   + K D+YSFG+++LE+
Sbjct: 178 GLARA-------SEKFAQTVMTSRIV--GTTAYMAPEALRG-EITPKSDIYSFGVVLLEI 227

Query: 770 VTRRRPTDDMFAGGLSLHKWVKNHYH--GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGE 827
           +T     D+       L    +        +E  ID  +  A       V+ M       
Sbjct: 228 ITGLPAVDEHREPQ-LLLDIKEEIEDEEKTIEDYIDKKMNDADST---SVEAM------- 276

Query: 828 LIELGILCTQESPSTRPTMLDAADDLDRL 856
              +   C  E  + RP +      L  +
Sbjct: 277 -YSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  253 bits (647), Expect = 7e-74
 Identities = 90/462 (19%), Positives = 166/462 (35%), Gaps = 21/462 (4%)

Query: 4   DNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISF 63
            N L        S  + L+HL      +       L     L  + L  N+++  + +  
Sbjct: 90  ANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS-IKLPK 148

Query: 64  FHNCTSLRNVDLSQNFFTGKIPEEIGNCPNL--WTLSLYNNQLTGQLPASLINTSMYNLD 121
                 L+ +D   N       E++ +       +L+L  N + G  P +  +    +L+
Sbjct: 149 GFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLN 208

Query: 122 VEYNHLSGELPSDIM-SKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELA 180
                    +   +  S + SL        +             F  L   + +E + L 
Sbjct: 209 FGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV-----FEGLCEMS-VESINLQ 262

Query: 181 GMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEI 239
                    ++      L +L L    ++  +P  +  LS L  L LS+N          
Sbjct: 263 KHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISA 321

Query: 240 SWLSQLEQLFLSHNLFSGEI-PAALGKLHHLGLLDLSFNKL--SGEIPVSLGNLVQIYSL 296
           S    L  L +  N    E+    L  L +L  LDLS + +  S    + L NL  + SL
Sbjct: 322 SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSL 381

Query: 297 FLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIP-AEISGIREIRIFLNLSHNQLEGP 355
            L+ N+           C  L  LDL++ RL      +    +  +++ LNLSH+ L+  
Sbjct: 382 NLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV-LNLSHSLLDIS 440

Query: 356 LPIELSKLENVQEIDLSSNKFTGNIFIQ---ISNCIAVRLINISHNALQGNLPDSLGDLK 412
                  L  +Q ++L  N F      +   +     + ++ +S   L      +   LK
Sbjct: 441 SEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLK 500

Query: 413 NLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPS 454
            +  +D+S N L+     +L+ +  +  +NL+ N    ++PS
Sbjct: 501 MMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPS 541

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  249 bits (637), Expect = 2e-72
 Identities = 93/483 (19%), Positives = 175/483 (36%), Gaps = 34/483 (7%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
              N L       FS+L  L  L L    ++    ++      L  + L  N L   +  
Sbjct: 40  FSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIF-MAE 98

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNL 120
           +      +L+++   Q   +      + N   L +L L +N ++            +  L
Sbjct: 99  TALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVL 158

Query: 121 DVEYNHLSGELPSDIMSKLPSLT--YLHLSYNNM---------------VSHDDNTNLVP 163
           D + N +   L  + MS L   T   L+L+ N++               ++     NL+ 
Sbjct: 159 DFQNNAIH-YLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLV 217

Query: 164 FFNSLGNCT--DLEELELAGM---DLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNL 218
            F  L N T   L       M   D+   + + +  +++  + LQ++             
Sbjct: 218 IFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCF 277

Query: 219 SNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNK 278
           S L  L+L++  LS  + + +  LS L++L LS N F      +      L  L +  N 
Sbjct: 278 SGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNT 336

Query: 279 LSGEI-PVSLGNLVQIYSLFLNNNQLSRS--IPPTLGRCTDLYKLDLSYNRLTGSIPAEI 335
              E+    L NL  +  L L+++ +  S      L   + L  L+LSYN          
Sbjct: 337 KRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAF 396

Query: 336 SGIREIRIFLNLSHNQLEG-PLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLIN 394
               ++ + L+L+  +L+          L  ++ ++LS +    +         A++ +N
Sbjct: 397 KECPQLEL-LDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLN 455

Query: 395 ISHNALQGN---LPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGM 451
           +  N          +SL  L  LE + +S   LS I   +   +  +  ++LS N     
Sbjct: 456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSS 515

Query: 452 IPS 454
              
Sbjct: 516 SIE 518

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  239 bits (611), Expect = 7e-69
 Identities = 90/462 (19%), Positives = 168/462 (36%), Gaps = 29/462 (6%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
            +   +           + L  L L  N++             L ++   +N +   L  
Sbjct: 112 FIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY-LSK 170

Query: 62  SFFHNCTSLRNV--DLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYN 119
               +     N+  +L+ N   G I     +     +L+    Q    +   L N+++ +
Sbjct: 171 EDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQS 229

Query: 120 L---DVEYNHLSGELPSDIMSKLP--SLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDL 174
           L     E      ++   +   L   S+  ++L  +   +   N        +    + L
Sbjct: 230 LWLGTFEDMDDE-DISPAVFEGLCEMSVESINLQKHYFFNISSN--------TFHCFSGL 280

Query: 175 EELELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSG 233
           +EL+L    L   LP  +  L  L +L+L  NK          N  +L  L++  N    
Sbjct: 281 QELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRL 339

Query: 234 TISAE-ISWLSQLEQLFLSHN--LFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNL 290
            +    +  L  L +L LSH+    S      L  L HL  L+LS+N+       +    
Sbjct: 340 ELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKEC 399

Query: 291 VQIYSLFLNNNQLSRSIPPT-LGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSH 349
            Q+  L L   +L      +       L  L+LS++ L  S      G+  ++  LNL  
Sbjct: 400 PQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQH-LNLQG 458

Query: 350 NQLEGPLPIE---LSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPD 406
           N        +   L  L  ++ + LS    +       ++   +  +++SHN L  +  +
Sbjct: 459 NHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIE 518

Query: 407 SLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEF 448
           +L  LK +  ++++ NH+S I+P  L  +     INL  N  
Sbjct: 519 ALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPL 559

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  232 bits (595), Expect = 1e-66
 Identities = 85/454 (18%), Positives = 151/454 (33%), Gaps = 21/454 (4%)

Query: 10  AIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTS 69
            IP           L+   N L      + + L NLT + L    +   +    F +   
Sbjct: 26  EIPGTLPNS--TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW-IHEDTFQSQHR 82

Query: 70  LRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNLDVEYNHLS 128
           L  + L+ N         +     L  L      ++      L N  ++ +L +  NH+S
Sbjct: 83  LDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS 142

Query: 129 GELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTL 188
             +          L  L    N +             +SL   T+L  L L G D+ G  
Sbjct: 143 S-IKLPKGFPTEKLKVLDFQNNAIHYLSKED-----MSSLQQATNL-SLNLNGNDIAGIE 195

Query: 189 PDSIGRLNLTQLLLQENKITGSIPPHIGN--LSNLISLNLSSNLLSGTISAEISWLS--Q 244
           P +        L     +    I   + N  + +L               A    L    
Sbjct: 196 PGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMS 255

Query: 245 LEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLS 304
           +E + L  + F             L  LDL+   LS E+P  L  L  +  L L+ N+  
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFE 314

Query: 305 RSIPPTLGRCTDLYKLDLSYNRLTGSIPAE-ISGIREIRIFLNLSHNQLE--GPLPIELS 361
                +      L  L +  N     +    +  +  +R  L+LSH+ +E      ++L 
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLR-ELDLSHDDIETSDCCNLQLR 373

Query: 362 KLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDS-LGDLKNLEAIDVS 420
            L ++Q ++LS N+           C  + L++++   L+     S   +L  L+ +++S
Sbjct: 374 NLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLS 433

Query: 421 GNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPS 454
            + L        + +  L  +NL  N F      
Sbjct: 434 HSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQ 467

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  229 bits (586), Expect = 2e-65
 Identities = 90/439 (20%), Positives = 174/439 (39%), Gaps = 27/439 (6%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLH--DNNLTGML 59
           L  NH+     P+     +L+ L    N +H    E ++ L   T ++L+   N++ G+ 
Sbjct: 136 LGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIE 195

Query: 60  PISFFHNCTSLRNVDLSQNFFTGKIPEEIGNC--PNLWTLSLYNNQLTG---QLPASLIN 114
           P +F  +    ++++         I + + N    +LW  +  +         +   L  
Sbjct: 196 PGAF--DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253

Query: 115 TSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDL 174
            S+ +++++ ++    + S+       L  L L+  ++             + L   + L
Sbjct: 254 MSVESINLQKHYFFN-ISSNTFHCFSGLQELDLTATHLSE---------LPSGLVGLSTL 303

Query: 175 EELELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPH-IGNLSNLISLNLSSNLL- 231
           ++L L+          S     +LT L ++ N     +    + NL NL  L+LS + + 
Sbjct: 304 KKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363

Query: 232 -SGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVS-LGN 289
            S   + ++  LS L+ L LS+N        A  +   L LLDL+F +L  +   S   N
Sbjct: 364 TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQN 423

Query: 290 LVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIR--IFLNL 347
           L  +  L L+++ L  S          L  L+L  N        + + ++ +     L L
Sbjct: 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483

Query: 348 SHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDS 407
           S   L        + L+ +  +DLS N+ T +    +S+   + L N++ N +   LP  
Sbjct: 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYL-NLASNHISIILPSL 542

Query: 408 LGDLKNLEAIDVSGNHLSG 426
           L  L     I++  N L  
Sbjct: 543 LPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  207 bits (528), Expect = 2e-57
 Identities = 74/420 (17%), Positives = 143/420 (34%), Gaps = 29/420 (6%)

Query: 48  VTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQ 107
               +  L   +P +  ++   L   + S N              NL  L L   Q+   
Sbjct: 17  YNCENLGLNE-IPGTLPNSTECL---EFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72

Query: 108 LPASLIN-TSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFN 166
              +  +   +  L +  N L   +    +S   +L +L      + S D          
Sbjct: 73  HEDTFQSQHRLDTLVLTANPLIF-MAETALSGPKALKHLFFIQTGISSIDFIP------- 124

Query: 167 SLGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNL--IS 223
            L N   LE L L    +             L  L  Q N I       + +L     +S
Sbjct: 125 -LHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS 183

Query: 224 LNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALG-----KLHHLGLLDLSFNK 278
           LNL+ N ++  I       +  + L          I   L       L      D+    
Sbjct: 184 LNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED 242

Query: 279 LSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGI 338
           +S  +   L  +  + S+ L  +        T    + L +LDL+   L+  +P+ + G+
Sbjct: 243 ISPAVFEGLCEM-SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGL 300

Query: 339 REIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQ-ISNCIAVRLINISH 397
             ++  L LS N+ E    I  S   ++  + +  N     +    + N   +R +++SH
Sbjct: 301 STLK-KLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSH 359

Query: 398 NALQ--GNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSG 455
           + ++        L +L +L+++++S N    +   +  +   L  ++L+F   K      
Sbjct: 360 DDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQS 419

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  202 bits (516), Expect = 8e-56
 Identities = 92/389 (23%), Positives = 144/389 (37%), Gaps = 23/389 (5%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLAL--LSNLTLVTLHDNNLTGML 59
           L  N +   I P        + L   G      I + L    + +L L T  D +   + 
Sbjct: 186 LNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDIS 244

Query: 60  PISFFHNC-TSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSM 117
           P  F   C  S+ +++L +++F             L  L L    L+ +LP+ L+  +++
Sbjct: 245 PAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTL 303

Query: 118 YNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEEL 177
             L +  N     L     S  PSLT+L +  N          L      L N  +L EL
Sbjct: 304 KKLVLSANKFEN-LCQISASNFPSLTHLSIKGNTK-----RLELGT--GCLENLENLREL 355

Query: 178 ELAGMDLG--GTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGT 234
           +L+  D+         +  L +L  L L  N+              L  L+L+   L   
Sbjct: 356 DLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVK 415

Query: 235 IS-AEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPV---SLGNL 290
            + +    L  L+ L LSH+L           L  L  L+L  N           SL  L
Sbjct: 416 DAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL 475

Query: 291 VQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHN 350
            ++  L L+   LS            +  +DLS+NRLT S    +S ++   I+LNL+ N
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK--GIYLNLASN 533

Query: 351 QLEGPLPIELSKLENVQEIDLSSNKFTGN 379
            +   LP  L  L   + I+L  N     
Sbjct: 534 HISIILPSLLPILSQQRTINLRQNPLDCT 562

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  173 bits (440), Expect = 1e-45
 Identities = 74/381 (19%), Positives = 123/381 (32%), Gaps = 66/381 (17%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           L   HL   +P     L  L+ L L  N        S +   +LT +++  N     L  
Sbjct: 285 LTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT 343

Query: 62  SFFHNCTSLRNVDLSQNFFT--GKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYN 119
               N  +LR +DLS +          ++ N  +L +L+L  N+                
Sbjct: 344 GCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLS------------- 390

Query: 120 LDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELEL 179
                      L ++   + P L  L L++  +   D  +     F +L           
Sbjct: 391 -----------LKTEAFKECPQLELLDLAFTRLKVKDAQS----PFQNLH---------- 425

Query: 180 AGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTI---S 236
                            L  L L  + +  S       L  L  LNL  N         +
Sbjct: 426 ----------------LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT 469

Query: 237 AEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSL 296
             +  L +LE L LS    S     A   L  +  +DLS N+L+     +L +L  IY L
Sbjct: 470 NSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-L 528

Query: 297 FLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPL 356
            L +N +S  +P  L   +    ++L  N L  +             +   +  +LE   
Sbjct: 529 NLASNHISIILPSLLPILSQQRTINLRQNPLDCTC-----SNIYFLEWYKENMQKLEDTE 583

Query: 357 PIELSKLENVQEIDLSSNKFT 377
                    ++ + LS    +
Sbjct: 584 DTLCENPPLLRGVRLSDVTLS 604

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  127 bits (320), Expect = 1e-30
 Identities = 41/276 (14%), Positives = 86/276 (31%), Gaps = 32/276 (11%)

Query: 200 LLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEI 259
              +   +   IP  +   ++   L  S N+L    +   S L  L  L L+        
Sbjct: 17  YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73

Query: 260 PAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYK 319
                  H L  L L+ N L      +L     +  LF     +S      L     L  
Sbjct: 74  EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133

Query: 320 LDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGN 379
           L L  N ++     +     ++++ L+  +N +      ++S L+    + L        
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKV-LDFQNNAIHYLSKEDMSSLQQATNLSL-------- 184

Query: 380 IFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPI-----SLNK 434
                         N++ N + G +     D    ++++  G     +I       ++  
Sbjct: 185 --------------NLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQS 229

Query: 435 IHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQ 470
           +   TF ++   +    +  G    S   ++   + 
Sbjct: 230 LWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHY 265

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  111 bits (279), Expect = 2e-25
 Identities = 39/210 (18%), Positives = 76/210 (36%), Gaps = 6/210 (2%)

Query: 272 LDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSI 331
            +     L+ EIP +L N  +   L  + N L      T  R  +L  LDL+  ++    
Sbjct: 17  YNCENLGLN-EIPGTLPNSTE--CLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73

Query: 332 PAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVR 391
                    +   L L+ N L       LS  + ++ +       +   FI + N   + 
Sbjct: 74  EDTFQSQHRLDT-LVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132

Query: 392 LINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFI--NLSFNEFK 449
            + +  N +           + L+ +D   N +  +    ++ +   T +  NL+ N+  
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192

Query: 450 GMIPSGGIFNSATKMSFVGNQHLCGTVPGM 479
           G+ P          ++F G Q+L     G+
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGL 222

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  249 bits (636), Expect = 2e-70
 Identities = 76/489 (15%), Positives = 152/489 (31%), Gaps = 85/489 (17%)

Query: 11  IPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSL 70
           I     +L +L+ +    +             +N                +S + N   L
Sbjct: 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDY-----AKQYENEELS-WSNLKDL 493

Query: 71  RNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGE 130
            +V+L       ++P+ + + P L +L++  N+           T               
Sbjct: 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR-------------- 539

Query: 131 LPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPD 190
           L  D     P +   ++ YNN+          P   SL                      
Sbjct: 540 LADDE-DTGPKIQIFYMGYNNLEE-------FPASASLQKMV------------------ 573

Query: 191 SIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEI-SWLSQLEQLF 249
                 L  L    NK+        G    L  L L  N +   I  +  ++  Q+E L 
Sbjct: 574 -----KLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLG 625

Query: 250 LSHNLFSGEIP--AALGKLHHLGLLDLSFNKLSG---EIPVSLG--NLVQIYSLFLNNNQ 302
            SHN     IP       ++ +G +D S+NK+      I  S+     +   ++ L+ N+
Sbjct: 626 FSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNE 684

Query: 303 LSRSIPPTLGRCTDLYKLDLSYNRLT-------GSIPAEISGIREIRIFLNLSHNQLEG- 354
           + +         + +  + LS N +T                   +   ++L  N+L   
Sbjct: 685 IQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTT-IDLRFNKLTSL 743

Query: 355 PLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISH------NALQGNLPDSL 408
                 + L  +  +D+S N F+     Q  N   ++   I H      N +    P  +
Sbjct: 744 SDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGI 802

Query: 409 GDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPS---GGIFNSATKMS 465
               +L  + +  N +  +      +++ L   +++ N    +  +     I      + 
Sbjct: 803 TTCPSLIQLQIGSNDIRKVDEKLTPQLYIL---DIADNPNISIDVTSVCPYIEAGMYVLL 859

Query: 466 FVGNQHLCG 474
           +   Q + G
Sbjct: 860 YDKTQDIRG 868

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  245 bits (628), Expect = 3e-69
 Identities = 85/480 (17%), Positives = 152/480 (31%), Gaps = 54/480 (11%)

Query: 14  EFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNV 73
           +     R+  L L G    G++P+++  L+ L +++   ++ T    +      T   + 
Sbjct: 318 DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSE 377

Query: 74  DLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQL------PASLINTSMYNLDVEYNHL 127
           +             +     L    L  + +            S I+     +    N +
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI 437

Query: 128 SGELPSDIMSKLPSLTYLHLSYNN-----------MVSHDDNTNLVPFFNSLGNCTDLEE 176
           +  +   I  +L  L  ++ + +              + D          S  N  DL +
Sbjct: 438 TF-ISKAI-QRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTD 495

Query: 177 LELAGMDLGGTLPDSIGRL-NLTQLLLQENKITG---------SIPPHIGNLSNLISLNL 226
           +EL        LPD +  L  L  L +  N+             +         +    +
Sbjct: 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYM 555

Query: 227 SSNLLSG-TISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPV 285
             N L     SA +  + +L  L   HN     +  A G    L  L L +N++  EIP 
Sbjct: 556 GYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPE 612

Query: 286 SLG-NLVQIYSLFLNNNQLSRSIPPT--LGRCTDLYKLDLSYNRLTGSIPAEISGIREIR 342
                  Q+  L  ++N+L   IP          +  +D SYN++  S    IS   +  
Sbjct: 613 DFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIG-SEGRNISCSMDDY 670

Query: 343 -----IFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFT-------GNIFIQISNCIAV 390
                  + LS+N+++       +    +  I LS+N  T               N   +
Sbjct: 671 KGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLL 730

Query: 391 RLINISHNALQGNLPDSL--GDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEF 448
             I++  N L   L D      L  L  +DVS N  S   P        L    +     
Sbjct: 731 TTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRD 788

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  173 bits (440), Expect = 7e-45
 Identities = 58/362 (16%), Positives = 109/362 (30%), Gaps = 87/362 (24%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESL-ALLSNLTLVTLHDNNLTGMLP 60
            V N +       F    +L  L+LD N +  +IPE   A    +  +    N L  +  
Sbjct: 580 CVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPN 636

Query: 61  ISFFHNCTSLRNVDLSQNFFTGKIPEEIG------NCPNLWTLSLYNNQLTGQLPASLIN 114
           I    +   + +VD S N         I          N  T++L  N++          
Sbjct: 637 IFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQK-------- 687

Query: 115 TSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDL 174
                            P+++ +    ++ + LS N                       +
Sbjct: 688 ----------------FPTELFATGSPISTIILSNNL----------------------M 709

Query: 175 EELELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHI--GNLSNLISLNLSSNLL 231
             +     +       +      LT + L+ NK+T S+        L  L ++++S N  
Sbjct: 710 TSIPE---NSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCF 765

Query: 232 SGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLV 291
           S +   +    SQL+   + H                    D   N++  + P  +    
Sbjct: 766 S-SFPTQPLNSSQLKAFGIRHQ------------------RDAEGNRILRQWPTGITTCP 806

Query: 292 QIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLT-GSIPAEISGIREIRIFLNLSHN 350
            +  L + +N +   +   L     LY LD++ N      + +    I      L     
Sbjct: 807 SLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT 863

Query: 351 QL 352
           Q 
Sbjct: 864 QD 865

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  138 bits (350), Expect = 8e-34
 Identities = 38/304 (12%), Positives = 93/304 (30%), Gaps = 47/304 (15%)

Query: 186 GTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQL 245
               ++           + +         + N   +  L+L+     G +   I  L++L
Sbjct: 290 SGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTEL 349

Query: 246 EQLFLSHNLFSGEIPA-------------------------ALGKLHHLGLLDLSFNKLS 280
           + L    +  +                               L     L L DL  + ++
Sbjct: 350 KVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN 409

Query: 281 GE---IPVSLGNLVQIYSLFLNN--NQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEI 335
                 P+   + + +    + N  N+++  I   + R T L  +  + +  T    A  
Sbjct: 410 RNPEMKPIKKDSRISLKDTQIGNLTNRIT-FISKAIQRLTKLQIIYFANSPFTYDNIAVD 468

Query: 336 SGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINI 395
                     N  + +      +  S L+++ +++L +      +   + +   ++ +NI
Sbjct: 469 W------EDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNI 522

Query: 396 SHNALQG---------NLPDSLGDLKNLEAIDVSGNHLSGI-IPISLNKIHTLTFINLSF 445
           + N              L D       ++   +  N+L       SL K+  L  ++   
Sbjct: 523 ACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVH 582

Query: 446 NEFK 449
           N+ +
Sbjct: 583 NKVR 586

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  120 bits (303), Expect = 5e-28
 Identities = 43/260 (16%), Positives = 78/260 (30%), Gaps = 26/260 (10%)

Query: 2   LVDNHLFGAIPPEFS--KLRRLRHLQLDGNNLHGQIPESLALLS-----NLTLVTLHDNN 54
              N L   IP  F+   +  +  +    N +  +       +      N + VTL  N 
Sbjct: 626 FSHNKL-KYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNE 684

Query: 55  LTGMLPISFFHNCTSLRNVDLSQNFFT-------GKIPEEIGNCPNLWTLSLYNNQLTGQ 107
           +    P   F   + +  + LS N  T               N   L T+ L  N+LT  
Sbjct: 685 IQK-FPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS- 742

Query: 108 LPASLINTSMYNL---DVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPF 164
           L      T++  L   DV YN  S   P+        L    + +      +      P 
Sbjct: 743 LSDDFRATTLPYLSNMDVSYNCFS-SFPTQP-LNSSQLKAFGIRHQRDAEGNRILRQWP- 799

Query: 165 FNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISL 224
              +  C  L +L++   D+   + + +    L  L + +N         +         
Sbjct: 800 -TGITTCPSLIQLQIGSNDIR-KVDEKLTP-QLYILDIADNPNISIDVTSVCPYIEAGMY 856

Query: 225 NLSSNLLSGTISAEISWLSQ 244
            L  +        +   + +
Sbjct: 857 VLLYDKTQDIRGCDALGIER 876

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 96.5 bits (240), Expect = 2e-20
 Identities = 29/208 (13%), Positives = 62/208 (29%), Gaps = 25/208 (12%)

Query: 272 LDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSI 331
            +   +    +  V L N  ++  L L        +P  +G+ T+L  L    +  T S 
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363

Query: 332 PAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGN---IFIQISNCI 388
                      +     H        + L   + +   DL  +    N     I+  + I
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRI 423

Query: 389 AVRL--INISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGI------------------- 427
           +++   I    N +   +  ++  L  L+ I  + +  +                     
Sbjct: 424 SLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYEN 482

Query: 428 IPISLNKIHTLTFINLSFNEFKGMIPSG 455
             +S + +  LT + L        +P  
Sbjct: 483 EELSWSNLKDLTDVELYNCPNMTQLPDF 510

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 43.7 bits (103), Expect = 3e-04
 Identities = 10/93 (10%), Positives = 27/93 (29%)

Query: 393 INISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMI 452
            N   +         L +   +  + ++G    G +P ++ ++  L  ++   +      
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363

Query: 453 PSGGIFNSATKMSFVGNQHLCGTVPGMPICPPK 485
              G       MS      +      M +   +
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQ 396

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  237 bits (607), Expect = 3e-68
 Identities = 91/477 (19%), Positives = 155/477 (32%), Gaps = 40/477 (8%)

Query: 4   DNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISF 63
            N +    P  FS L  L +L      L       +  L  L  + +  N +      ++
Sbjct: 89  GNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAY 148

Query: 64  FHNCTSLRNVDLSQNFFTGKIPEEIGNCPNL----WTLSLYNNQLTGQLPASLINTSMYN 119
           F N T+L +VDLS N+       ++           +L +  N +      +     ++ 
Sbjct: 149 FSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHE 208

Query: 120 LDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDD---------------------- 157
           L +  N  S  +    +  L  L    L         +                      
Sbjct: 209 LTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL 268

Query: 158 --NTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHI 215
               +            ++  + LAG+ +   L D         L +   ++    P   
Sbjct: 269 TYTNDFSDDIVKFHCLANVSAMSLAGVSI-KYLEDVPKHFKWQSLSIIRCQLK-QFPT-- 324

Query: 216 GNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAAL--GKLHHLGLLD 273
            +L  L SL L+ N  S  IS +   L  L  L LS N  S     +      + L  LD
Sbjct: 325 LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLD 382

Query: 274 LSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPP-TLGRCTDLYKLDLSYNRLTGSIP 332
           LSFN     +  +   L ++  L   ++ L R            L  LD+SY        
Sbjct: 383 LSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD 441

Query: 333 AEISGIREIRIFLNLSHNQLEGPLPIE-LSKLENVQEIDLSSNKFTGNIFIQISNCIAVR 391
               G+  +   L ++ N  +        +   N+  +DLS  +     +        ++
Sbjct: 442 GIFLGLTSLNT-LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQ 500

Query: 392 LINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEF 448
           L+N+SHN L          L +L  +D S N +     I  +   +L F NL+ N  
Sbjct: 501 LLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  227 bits (580), Expect = 1e-64
 Identities = 86/488 (17%), Positives = 164/488 (33%), Gaps = 46/488 (9%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           L    +       +  L  L +L L GN +    P S + L++L  +   +  L   L  
Sbjct: 63  LSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS-LES 121

Query: 62  SFFHNCTSLRNVDLSQNFFTG-KIPEEIGNCPNLWTLSLYNNQLTG----------QLPA 110
                  +L+ ++++ NF    K+P    N  NL  + L  N +            + P 
Sbjct: 122 FPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQ 181

Query: 111 SLI------------------NTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNM 152
             +                     ++ L +  N  S  +    +  L  L    L     
Sbjct: 182 VNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEF 241

Query: 153 VSHDDNTNLVP-FFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGS 210
               +     P     L + T ++E  L   +           L N++ + L    I   
Sbjct: 242 KDERNLEIFEPSIMEGLCDVT-IDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY- 299

Query: 211 IPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLG 270
               +       SL++    L          L  L+ L L+ N  S  I      L  L 
Sbjct: 300 -LEDVPKHFKWQSLSIIRCQLKQF---PTLDLPFLKSLTLTMNKGS--ISFKKVALPSLS 353

Query: 271 LLDLSFNKLS--GEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLT 328
            LDLS N LS  G    S      +  L L+ N     +        +L  LD  ++ L 
Sbjct: 354 YLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLK 412

Query: 329 GSIPAE-ISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQI-SN 386
                     + ++  +L++S+   +         L ++  + ++ N F  N    + +N
Sbjct: 413 RVTEFSAFLSLEKLL-YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN 471

Query: 387 CIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFN 446
              +  +++S   L+         L  L+ +++S N+L  +     N++++L+ ++ SFN
Sbjct: 472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN 531

Query: 447 EFKGMIPS 454
             +     
Sbjct: 532 RIETSKGI 539

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  208 bits (532), Expect = 5e-58
 Identities = 78/460 (16%), Positives = 158/460 (34%), Gaps = 31/460 (6%)

Query: 10  AIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTS 69
            +P +       +++ L  N L      S +  S L  + L    +   +    +H    
Sbjct: 25  KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET-IEDKAWHGLHH 81

Query: 70  LRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNLDVEYNHLS 128
           L N+ L+ N      P       +L  L     +L       +    ++  L+V +N + 
Sbjct: 82  LSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIH 141

Query: 129 GELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTD-LEELELAGMDLGGT 187
                   S L +L ++ LSYN + +   N         L         L+++   +   
Sbjct: 142 SCKLPAYFSNLTNLVHVDLSYNYIQTITVND-----LQFLRENPQVNLSLDMSLNPIDFI 196

Query: 188 LPDSIGRLNLTQLLLQENKITGSIPPH-IGNLSNLISLNLSSNLLSGTISAEISWLS--- 243
              +   + L +L L+ N  + +I    + NL+ L    L         + EI   S   
Sbjct: 197 QDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIME 256

Query: 244 -----QLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFL 298
                 +++  L++     +       L ++  + L+   +       +    +  SL +
Sbjct: 257 GLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSI 314

Query: 299 NNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLE--GPL 356
              QL +     L     L  L L+ N+   SI  +   +  +  +L+LS N L   G  
Sbjct: 315 IRCQLKQFPTLDLPF---LKSLTLTMNKG--SISFKKVALPSLS-YLDLSRNALSFSGCC 368

Query: 357 PIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDS-LGDLKNLE 415
                   +++ +DLS N     +         ++ ++  H+ L+     S    L+ L 
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLL 427

Query: 416 AIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSG 455
            +D+S  +           + +L  + ++ N FK    S 
Sbjct: 428 YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  178 bits (453), Expect = 2e-47
 Identities = 78/459 (16%), Positives = 147/459 (32%), Gaps = 55/459 (11%)

Query: 33  GQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCP 92
           G +   + ++ N+T     D  L+  +P       +S +N+DLS N           N  
Sbjct: 2   GSLNPCIEVVPNIT-YQCMDQKLSK-VPDDIP---SSTKNIDLSFNPLKILKSYSFSNFS 56

Query: 93  NLWTLSLYNNQLTGQLPASLIN-TSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNN 151
            L  L L   ++      +      + NL +  N +         S L SL  L      
Sbjct: 57  ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS-FSPGSFSGLTSLENLVAVETK 115

Query: 152 MVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGG-TLPDSIGRL-NLTQLLLQENKITG 209
           + S +           +G    L++L +A   +    LP     L NL  + L  N I  
Sbjct: 116 LASLESFP--------IGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167

Query: 210 SIPPHIGNLSNL----ISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPA-ALG 264
                +  L       +SL++S N +   I  +     +L +L L  N  S  I    L 
Sbjct: 168 ITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQ 226

Query: 265 KLHHLGLLDLSFNKLSGEIPVS------LGNLVQIY--SLFLNNNQLSRSIPPTLGRCTD 316
            L  L +  L   +   E  +       +  L  +      L                 +
Sbjct: 227 NLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLAN 286

Query: 317 LYKLDLSYNRLTGSIP-AEISGIREIRI-----------------FLNLSHNQLEGPLPI 358
           +  + L+   +       +    + + I                  L L+ N+       
Sbjct: 287 VSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFK- 345

Query: 359 ELSKLENVQEIDLSSNKFT--GNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEA 416
               L ++  +DLS N  +  G          ++R +++S N     +  +   L+ L+ 
Sbjct: 346 -KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQH 403

Query: 417 IDVSGNHLSGIIPIS-LNKIHTLTFINLSFNEFKGMIPS 454
           +D   + L  +   S    +  L ++++S+   K     
Sbjct: 404 LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDG 442

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  160 bits (406), Expect = 3e-41
 Identities = 59/308 (19%), Positives = 113/308 (36%), Gaps = 22/308 (7%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           L   + F     +F  L  +  + L G ++  +  E +        +++    L    P 
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQ-FP- 323

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYN-- 119
               +   L+++ L+ N   G I  +    P+L  L L  N L+     S  +    +  
Sbjct: 324 --TLDLPFLKSLTLTMN--KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLR 379

Query: 120 -LDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELE 178
            LD+ +N     + S     L  L +L   ++ +         V  F++  +   L  L+
Sbjct: 380 HLDLSFNGAI--IMSANFMGLEELQHLDFQHSTLKR-------VTEFSAFLSLEKLLYLD 430

Query: 179 LAGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHI-GNLSNLISLNLSSNLLSGTIS 236
           ++  +           L +L  L +  N    +   ++  N +NL  L+LS   L     
Sbjct: 431 ISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISW 490

Query: 237 AEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSL 296
                L +L+ L +SHN       +   +L+ L  LD SFN++     +       +   
Sbjct: 491 GVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFF 550

Query: 297 FLNNNQLS 304
            L NN ++
Sbjct: 551 NLTNNSVA 558

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  214 bits (547), Expect = 5e-63
 Identities = 69/334 (20%), Positives = 132/334 (39%), Gaps = 51/334 (15%)

Query: 547 ITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQV 606
           +    L   +       +   G +G V+K  L     +AVK+  +Q      S+  E +V
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ---SWQNEYEV 69

Query: 607 --LKRIRHRNLMRIITACSLPDFKA----LVLPYMANGSLDSHLYPHSETEFGSGSSDLT 660
             L  ++H N+++ I A            L+  +   GSL   L  +           ++
Sbjct: 70  YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----------VS 119

Query: 661 LLQRVNICSDIAEGMAYLHHHSPV-------RVIHCDLKPSNVLLNDDMTALVSDFGIAK 713
             +  +I   +A G+AYLH   P         + H D+K  NVLL +++TA ++DFG+A 
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179

Query: 714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEY-----GFGSNTSTKGDVYSFGILVLE 768
                    +  ++ G++   +  G+  YMAPE       F  +   + D+Y+ G+++ E
Sbjct: 180 KF-------EAGKSAGDTHGQV--GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE 230

Query: 769 MVTRRRPTDDMFAGG-LSLHKWVKNHY-HGRLEKVIDSSLLRASRDQSPEVKRMW--DVA 824
           + +R    D       L   + +  H     +++V+     R      P ++  W     
Sbjct: 231 LASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKR------PVLRDYWQKHAG 284

Query: 825 IGELIELGILCTQESPSTRPTMLDAADDLDRLKR 858
           +  L E    C       R +     + + +++R
Sbjct: 285 MAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  207 bits (528), Expect = 1e-60
 Identities = 87/317 (27%), Positives = 138/317 (43%), Gaps = 48/317 (15%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           E + + ++G G++G V K   +    +A+K ++  S +  K+F  E + L R+ H N+++
Sbjct: 9   EIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVK 65

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +  AC  P    LV+ Y   GSL + L+              T    ++ C   ++G+AY
Sbjct: 66  LYGACLNP--VCLVMEYAEGGSLYNVLHGAEPL------PYYTAAHAMSWCLQCSQGVAY 117

Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           LH   P  +IH DLKP N+LL    T L + DFG A  +               +     
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI--------------QTHMTNN 163

Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHG 796
            GS  +MAPE   GSN S K DV+S+GI++ E++TRR+P D++      +   V N    
Sbjct: 164 KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR- 222

Query: 797 RLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL 856
                             P + +     I  L+     C  + PS RP+M +    +  L
Sbjct: 223 ------------------PPLIKNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHL 261

Query: 857 KRYLGEKHMPSKMNALH 873
            RY      P +    H
Sbjct: 262 MRYFPGADEPLQYPCQH 278

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  200 bits (511), Expect = 4e-58
 Identities = 75/303 (24%), Positives = 137/303 (45%), Gaps = 44/303 (14%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNL 615
           + + +  +G GS+G V++     G+ +AVK+L  Q         F RE  ++KR+RH N+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +  + A + P   ++V  Y++ GSL   L+     E       L   +R+++  D+A+GM
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE------QLDERRRLSMAYDVAKGM 150

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH+ +P  ++H +LK  N+L++   T  V DFG+++L           +     ++  
Sbjct: 151 NYLHNRNPP-IVHRNLKSPNLLVDKKYTVKVCDFGLSRL-----------KASTFLSSKS 198

Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH 795
             G+  +MAPE      ++ K DVYSFG+++ E+ T ++P  ++                
Sbjct: 199 AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL---------------- 242

Query: 796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDR 855
                          + +  E+ R  +  +  +IE    C    P  RP+     D L  
Sbjct: 243 ----NPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE---GCWTNEPWKRPSFATIMDLLRP 295

Query: 856 LKR 858
           L +
Sbjct: 296 LIK 298

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  199 bits (507), Expect = 8e-56
 Identities = 95/447 (21%), Positives = 172/447 (38%), Gaps = 49/447 (10%)

Query: 15  FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVD 74
            + L       L   N+   +      L  +T +      +     I       +L  ++
Sbjct: 20  DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS---IDGVEYLNNLTQIN 74

Query: 75  LSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLP-ASLINTSMYNLDVEYNHLSGELPS 133
            S N  T   P  + N   L  + + NNQ+    P A+L  T++  L +  N ++     
Sbjct: 75  FSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANL--TNLTGLTLFNNQITD---I 127

Query: 134 DIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIG 193
           D +  L +L  L LS N +             ++L   T L++L              + 
Sbjct: 128 DPLKNLTNLNRLELSSNTISD----------ISALSGLTSLQQLSFGNQVTD---LKPLA 174

Query: 194 RL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSH 252
            L  L +L +  NK++      +  L+NL SL  ++N +S      +  L+ L++L L+ 
Sbjct: 175 NLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDIT--PLGILTNLDELSLNG 230

Query: 253 NLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLG 312
           N         L  L +L  LDL+ N++S   P  L  L ++  L L  NQ+S +I P L 
Sbjct: 231 NQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS-NISP-LA 284

Query: 313 RCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLS 372
             T L  L+L+ N+L    P  IS ++ +   L L  N +       +S L  +Q +   
Sbjct: 285 GLTALTNLELNENQLEDISP--ISNLKNLTY-LTLYFNNISDI--SPVSSLTKLQRLFFY 339

Query: 373 SNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISL 432
           +NK +      ++N   +  ++  HN +       L +L  +  + ++    +       
Sbjct: 340 NNKVSD--VSSLANLTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQAWTNAPVNYK 395

Query: 433 NKIHTLTFINLSFNEFKGMIPSGGIFN 459
                ++  N   N    +I    I +
Sbjct: 396 AN---VSIPNTVKNVTGALIAPATISD 419

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  196 bits (501), Expect = 5e-55
 Identities = 102/436 (23%), Positives = 190/436 (43%), Gaps = 44/436 (10%)

Query: 12  PPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLR 71
               + L ++  LQ D   +  +  + +  L+NLT +   +N LT    I+   N T L 
Sbjct: 39  TVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTD---ITPLKNLTKLV 93

Query: 72  NVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGEL 131
           ++ ++ N         + N  NL  L+L+NNQ+T  +      T++  L++  N +S  +
Sbjct: 94  DILMNNNQIAD--ITPLANLTNLTGLTLFNNQITD-IDPLKNLTNLNRLELSSNTISD-I 149

Query: 132 PSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDS 191
            +  +S L SL  L             T+L P    L N T LE L+++   +  +    
Sbjct: 150 SA--LSGLTSLQQLSFGNQV-------TDLKP----LANLTTLERLDISSNKV--SDISV 194

Query: 192 IGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFL 250
           + +L NL  L+   N+I+   P  +G L+NL  L+L+ N L   I   ++ L+ L  L L
Sbjct: 195 LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IGT-LASLTNLTDLDL 250

Query: 251 SHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPT 310
           ++N  S   P  L  L  L  L L  N++S   P  L  L  + +L LN NQL    P  
Sbjct: 251 ANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP-- 304

Query: 311 LGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEID 370
           +    +L  L L +N ++   P  +S + +++  L   +N++       L+ L N+  + 
Sbjct: 305 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQR-LFFYNNKVSDV--SSLANLTNINWLS 359

Query: 371 LSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPI 430
              N+ +      ++N   +  + ++  A      +   ++     +      L  I P 
Sbjct: 360 AGHNQISD--LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPA 415

Query: 431 SLNKIHTLTFINLSFN 446
           +++   + T  ++++N
Sbjct: 416 TISDGGSYTEPDITWN 431

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  195 bits (499), Expect = 1e-54
 Identities = 103/436 (23%), Positives = 191/436 (43%), Gaps = 45/436 (10%)

Query: 20  RLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNF 79
            L    +  +    QI  +   L+      L   N+T  +  +   +   +  +   +  
Sbjct: 2   PLGSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRLG 57

Query: 80  FTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKL 139
                 + +    NL  ++  NNQLT  +      T + ++ +  N ++   P   ++ L
Sbjct: 58  IK--SIDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQIADITP---LANL 111

Query: 140 PSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-NLT 198
            +LT L L  N +      T++ P    L N T+L  LEL+   +  +   ++  L +L 
Sbjct: 112 TNLTGLTLFNNQI------TDIDP----LKNLTNLNRLELSSNTI--SDISALSGLTSLQ 159

Query: 199 QLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGE 258
           QL    N++T   P  + NL+ L  L++SSN +S  IS  ++ L+ LE L  ++N  S  
Sbjct: 160 QLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD-ISV-LAKLTNLESLIATNNQISDI 214

Query: 259 IPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLY 318
            P  LG L +L  L L+ N+L      +L +L  +  L L NNQ+S   P  L   T L 
Sbjct: 215 TP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLT 268

Query: 319 KLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTG 378
           +L L  N+++   P  ++G+  +   L L+ NQLE      +S L+N+  + L  N  + 
Sbjct: 269 ELKLGANQISNISP--LAGLTALTN-LELNENQLEDI--SPISNLKNLTYLTLYFNNISD 323

Query: 379 NIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTL 438
                +S+   ++ +   +N +      SL +L N+  +    N +S + P++   +  +
Sbjct: 324 --ISPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLA--NLTRI 377

Query: 439 TFINLSFNEFKGMIPS 454
           T + L+   +     +
Sbjct: 378 TQLGLNDQAWTNAPVN 393

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  146 bits (371), Expect = 9e-38
 Identities = 78/318 (24%), Positives = 123/318 (38%), Gaps = 33/318 (10%)

Query: 12  PPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLR 71
               S L  L+ L   GN +    P  LA L+ L  + +  N ++    IS     T+L 
Sbjct: 149 ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVSD---ISVLAKLTNLE 202

Query: 72  NVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGEL 131
           ++  + N  +   P  +G   NL  LSL  NQL   +      T++ +LD+  N +S   
Sbjct: 203 SLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLA 259

Query: 132 PSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDS 191
           P   +S L  LT L L  N + +           + L   T L  LEL    L       
Sbjct: 260 P---LSGLTKLTELKLGANQISN----------ISPLAGLTALTNLELNENQL--EDISP 304

Query: 192 IGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFL 250
           I  L NLT L L  N I+   P  + +L+ L  L   +N +S      ++ L+ +  L  
Sbjct: 305 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVS--SLANLTNINWLSA 360

Query: 251 SHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPT 310
            HN  S   P  L  L  +  L L+    +        N+    ++      L    P T
Sbjct: 361 GHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPAT 416

Query: 311 LGRCTDLYKLDLSYNRLT 328
           +       + D+++N  +
Sbjct: 417 ISDGGSYTEPDITWNLPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 42.3 bits (100), Expect = 5e-04
 Identities = 17/100 (17%), Positives = 28/100 (28%), Gaps = 4/100 (4%)

Query: 13  PEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRN 72
              + L R+  L L+            A +S    V      L     IS   +  S   
Sbjct: 369 TPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATIS---DGGSYTE 425

Query: 73  VDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASL 112
            D++ N  +    E         T+       +G +   L
Sbjct: 426 PDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVTQPL 464

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  195 bits (496), Expect = 9e-56
 Identities = 82/351 (23%), Positives = 131/351 (37%), Gaps = 43/351 (12%)

Query: 547 ITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQV 606
               E            L+G G YG VYKG L D   +AVKV    +    ++F  E  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNI 58

Query: 607 --LKRIRHRNLMRIITACSLPDFKA-----LVLPYMANGSLDSHLYPHSETEFGSGSSDL 659
             +  + H N+ R I               LV+ Y  NGSL  +L  H+           
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----------S 108

Query: 660 TLLQRVNICSDIAEGMAYLH------HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK 713
             +    +   +  G+AYLH       H    + H DL   NVL+ +D T ++SDFG++ 
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168

Query: 714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-------NTSTKGDVYSFGILV 766
            +    +   G E+          G+I YMAPE   G+       +   + D+Y+ G++ 
Sbjct: 169 RLTGNRLVRPGEEDNAA---ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225

Query: 767 LEMVTR---RRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDV 823
            E+  R     P + +    ++    V N  H   E +         R + PE  +   +
Sbjct: 226 WEIFMRCTDLFPGESVPEYQMAFQTEVGN--HPTFEDMQVLVSREKQRPKFPEAWKENSL 283

Query: 824 AIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYL-GEKHMPSKMNALH 873
           A+  L E    C  +    R T   A + +  L       K +    +  H
Sbjct: 284 AVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHHH 334

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  193 bits (493), Expect = 1e-55
 Identities = 68/310 (21%), Positives = 122/310 (39%), Gaps = 37/310 (11%)

Query: 563 RLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
            +LG G +G+  K    + G  + +K L        ++F +E +V++ + H N+++ I  
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
                    +  Y+  G+L   +   S        S     QRV+   DIA GMAYLH  
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGII--KSM------DSQYPWSQRVSFAKDIASGMAYLHSM 127

Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM---LCG 738
           +   +IH DL   N L+ ++   +V+DFG+A+L++      +G  ++          + G
Sbjct: 128 N---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184

Query: 739 SIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRL 798
           +  +MAPE   G +   K DV+SFGI++ E++ R     D     +     V+       
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL--DR 242

Query: 799 EKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR 858
               +                    +   +      C    P  RP+ +     L+ L+ 
Sbjct: 243 YCPPN-----------------CPPSFFPITV---RCCDLDPEKRPSFVKLEHWLETLRM 282

Query: 859 YLGEKHMPSK 868
           +L        
Sbjct: 283 HLAGHLPLGP 292

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  190 bits (485), Expect = 5e-55
 Identities = 73/308 (23%), Positives = 127/308 (41%), Gaps = 55/308 (17%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNL 615
           + +    L     G ++KG  Q G  I VKVL+++  S   ++ FN EC  L+   H N+
Sbjct: 11  QLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69

Query: 616 MRIITACSLPDFK--ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           + ++ AC  P      L+  +M  GSL + L  H  T F      +   Q V    D+A 
Sbjct: 70  LPVLGACQSPPAPHPTLITHWMPYGSLYNVL--HEGTNF-----VVDQSQAVKFALDMAR 122

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           GMA+LH   P+ +    L   +V++++DMTA +S   +     + G              
Sbjct: 123 GMAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR------------- 168

Query: 734 NMLCGSIGYMAPE--YGFGSNTST-KGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV 790
                +  ++APE       +T+    D++SF +L+ E+VTR  P  D+    + +   V
Sbjct: 169 ---MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL--SNMEIGMKV 223

Query: 791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAA 850
                             A     P +       + +L++   +C  E P+ RP      
Sbjct: 224 ------------------ALEGLRPTIPPGISPHVSKLMK---ICMNEDPAKRPKFDMIV 262

Query: 851 DDLDRLKR 858
             L++++ 
Sbjct: 263 PILEKMQD 270

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  189 bits (482), Expect = 1e-54
 Identities = 69/311 (22%), Positives = 119/311 (38%), Gaps = 59/311 (18%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFT----KSFNRECQVLKRIRHR 613
           E   + ++G G +G+VY+     G  +AVK  +           ++  +E ++   ++H 
Sbjct: 8   ELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66

Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           N++ +   C       LV+ +   G L+  L              +     VN    IA 
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----------IPPDILVNWAVQIAR 116

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL--------VSDFGIAKLVMTVGVGNDGA 725
           GM YLH  + V +IH DLK SN+L+   +           ++DFG+A+            
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-------HRT 169

Query: 726 ENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLS 785
             M         G+  +MAPE    S  S   DV+S+G+L+ E++T   P   +   GL+
Sbjct: 170 TKMSA------AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI--DGLA 221

Query: 786 LHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
           +   V                  A    +  +         +L+E    C    P +RP+
Sbjct: 222 VAYGV------------------AMNKLALPIPSTCPEPFAKLME---DCWNPDPHSRPS 260

Query: 846 MLDAADDLDRL 856
             +  D L  +
Sbjct: 261 FTNILDQLTTI 271

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  188 bits (480), Expect = 4e-54
 Identities = 64/314 (20%), Positives = 125/314 (39%), Gaps = 61/314 (19%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGN-------FTKSFNRECQVLKR 609
           E + ++ +G G +G V+KG L  D + +A+K L L             + F RE  ++  
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79

Query: 610 IRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS 669
           + H N++++      P    +V+ ++  G L   L    +      +  +    ++ +  
Sbjct: 80  LNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRL--LDK------AHPIKWSVKLRLML 129

Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLL-----NDDMTALVSDFGIAKLVMTVGVGNDG 724
           DIA G+ Y+ + +P  ++H DL+  N+ L     N  + A V+DFG+++           
Sbjct: 130 DIALGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----------- 177

Query: 725 AENMGNSTANMLCGSIGYMAPE--YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAG 782
            +++ + +     G+  +MAPE       + + K D YSF +++  ++T   P D+   G
Sbjct: 178 -QSVHSVSGL--LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234

Query: 783 GLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPST 842
            +     +                        P +       +  +IE   LC    P  
Sbjct: 235 KIKFINMI------------------REEGLRPTIPEDCPPRLRNVIE---LCWSGDPKK 273

Query: 843 RPTMLDAADDLDRL 856
           RP       +L  L
Sbjct: 274 RPHFSYIVKELSEL 287

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  195 bits (498), Expect = 9e-54
 Identities = 85/460 (18%), Positives = 159/460 (34%), Gaps = 25/460 (5%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           L  N +       FS L  L+ L     NL       +  L  L  + +  N +      
Sbjct: 83  LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNL----WTLSLYNNQLTGQLPASLINTSM 117
            +F N T+L ++DLS N        ++     +     +L L  N +    P +     +
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL 202

Query: 118 YNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVP-FFNSLGNCTDLEE 176
           + L +  N  S  +    +  L  L    L      +  +           L N T +EE
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT-IEE 261

Query: 177 LELAGMDLGGTLPDSI--GRLNLTQLLLQENKITGSIPPHIG--NLSNLISLNLSSNLLS 232
             LA +D        +     N++   L    I   +          +L  +N       
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFP 320

Query: 233 GTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLS--GEIPVSLGNL 290
                    L  L++L  + N       + +  L  L  LDLS N LS  G    S    
Sbjct: 321 TLK------LKSLKRLTFTSNKGG-NAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGT 372

Query: 291 VQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEI-SGIREIRIFLNLSH 349
             +  L L+ N +  ++         L  LD  ++ L       +   +R +   L++SH
Sbjct: 373 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY-LDISH 430

Query: 350 NQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQI-SNCIAVRLINISHNALQGNLPDSL 408
                      + L +++ + ++ N F  N    I +    +  +++S   L+   P + 
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490

Query: 409 GDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEF 448
             L +L+ ++++ N L  +     +++ +L  I L  N +
Sbjct: 491 NSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  165 bits (420), Expect = 2e-43
 Identities = 86/470 (18%), Positives = 161/470 (34%), Gaps = 59/470 (12%)

Query: 26  LDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIP 85
               N + +IP++L    +   + L  N L   L    F +   L+ +DLS+        
Sbjct: 14  CMELNFY-KIPDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIED 69

Query: 86  EEIGNCPNLWTLSLYNNQLTGQLPASLIN--TSMYNLDVEYNHLSGELPSDIMSKLPSLT 143
               +  +L TL L  N +   L     +  +S+  L     +L+  L +  +  L +L 
Sbjct: 70  GAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLK 127

Query: 144 YLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLN-----LT 198
            L++++N + S               N T+LE L+L+   +       +  L+       
Sbjct: 128 ELNVAHNLIQS-------FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180

Query: 199 QLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISW-LSQLEQL------FLS 251
            L L  N +   I P       L  L L +N  S  +       L+ LE        F +
Sbjct: 181 SLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239

Query: 252 HNLFSGEIPAALGKLHHLGLLDLSFNKLSG---EIPVSLGNLVQIYSLFLNNNQLSRSIP 308
                    +AL  L +L + +     L     +I      L  + S  L +  +   + 
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVK 298

Query: 309 P--------------------TLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLS 348
                                   +   L +L  + N+   +  +E+  +  +  FL+LS
Sbjct: 299 DFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG-NAFSEV-DLPSLE-FLDLS 355

Query: 349 HNQLE--GPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPD 406
            N L   G          +++ +DLS N     +         +  ++  H+ L+     
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEF 414

Query: 407 S-LGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSG 455
           S    L+NL  +D+S  H         N + +L  + ++ N F+      
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  152 bits (386), Expect = 5e-39
 Identities = 77/409 (18%), Positives = 138/409 (33%), Gaps = 37/409 (9%)

Query: 2   LVDNHL-FGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVT----LHDNNLT 56
           +  N +    +P  FS L  L HL L  N +       L +L  + L+     L  N + 
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

Query: 57  GMLPISFFHNCTSLRNVDLSQNFFTGKIPEE-IGNCPNLWTLSLYNNQLTGQ-------- 107
             +    F     L  + L  NF +  + +  I     L    L   +   +        
Sbjct: 191 F-IQPGAFKE-IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248

Query: 108 -LPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNT------- 159
                L N ++    + Y     +   D+ + L +++   L    +    D +       
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQH 308

Query: 160 ----NLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKIT--GSIPP 213
               N             L+ L       G      +   +L  L L  N ++  G    
Sbjct: 309 LELVNCKFGQFPTLKLKSLKRLTFTSNKGG-NAFSEVDLPSLEFLDLSRNGLSFKGCCSQ 367

Query: 214 HIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPA-ALGKLHHLGLL 272
                ++L  L+LS N +  T+S+    L QLE L   H+             L +L  L
Sbjct: 368 SDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426

Query: 273 DLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPP-TLGRCTDLYKLDLSYNRLTGSI 331
           D+S              L  +  L +  N    +  P       +L  LDLS  +L   +
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QL 485

Query: 332 PAEI-SGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGN 379
                + +  +++ LN++ NQL+        +L ++Q+I L +N +  +
Sbjct: 486 SPTAFNSLSSLQV-LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  134 bits (339), Expect = 4e-33
 Identities = 83/366 (22%), Positives = 135/366 (36%), Gaps = 32/366 (8%)

Query: 2   LVDNHLFGAIPPE-FSKLRRLRHLQL------DGNNLHGQIPESLALLSNLTLVTLHDN- 53
           L +N     +       L  L   +L      +  NL      +L  L NLT+       
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266

Query: 54  -NLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASL 112
            +      I  F+  T++ +  L       ++ +   N      L L N +   Q P +L
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFP-TL 322

Query: 113 INTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCT 172
              S+  L    N       S++   LPSL +L LS N +      +       S    T
Sbjct: 323 KLKSLKRLTFTSNKGG-NAFSEV--DLPSLEFLDLSRNGLSFKGCCSQ------SDFGTT 373

Query: 173 DLEELELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHI--GNLSNLISLNLSSN 229
            L+ L+L+   +  T+  +   L  L  L  Q + +   +       +L NLI L++S  
Sbjct: 374 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHT 431

Query: 230 LLSGTISAEISWLSQLEQLFLSHNLFSGEIPA-ALGKLHHLGLLDLSFNKLSGEIPVSLG 288
                 +   + LS LE L ++ N F          +L +L  LDLS  +L    P +  
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491

Query: 289 NLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLS 348
           +L  +  L + +NQL         R T L K+ L  N    S P     I  +  +LN +
Sbjct: 492 SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP----RIDYLSRWLNKN 547

Query: 349 HNQLEG 354
             + +G
Sbjct: 548 SQKEQG 553

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  120 bits (302), Expect = 2e-28
 Identities = 52/298 (17%), Positives = 103/298 (34%), Gaps = 17/298 (5%)

Query: 188 LPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQ 247
           +PD++   +   L L  N +         +   L  L+LS   +          LS L  
Sbjct: 22  IPDNLPF-STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLST 80

Query: 248 LFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSR-S 306
           L L+ N        A   L  L  L      L+      +G+L  +  L + +N +    
Sbjct: 81  LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK 140

Query: 307 IPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIF---LNLSHNQLEGPLPIELSKL 363
           +P      T+L  LDLS N++      ++  + ++ +    L+LS N +   +     K 
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKE 199

Query: 364 ENVQEIDLSSNKFTGNI----FIQISNCIAVRLI---NISHNALQGNLPDSLGDLKNLEA 416
             + ++ L +N  + N+       ++     RL+     +   L+     +L  L NL  
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259

Query: 417 IDVSGNHLSGI---IPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQH 471
            +    +L      I    N +  ++  +L     +  +           +  V  + 
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKF 316

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  186 bits (474), Expect = 3e-53
 Identities = 79/306 (25%), Positives = 136/306 (44%), Gaps = 47/306 (15%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNL 615
           +    + +G+GS+G VYKG       +AVK+L +   +    ++F  E  VL++ RH N+
Sbjct: 25  QITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +  +   + P   A+V  +    SL  HL  H+        +   + + ++I    A GM
Sbjct: 83  LLFMGYSTAPQL-AIVTQWCEGSSLYHHL--HAS------ETKFEMKKLIDIARQTARGM 133

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH  S   +IH DLK +N+ L++D T  + DFG+A            +   G+     
Sbjct: 134 DYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEK---------SRWSGSHQFEQ 181

Query: 736 LCGSIGYMAPE---YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN 792
           L GSI +MAPE       +  S + DVY+FGI++ E++T + P  ++            N
Sbjct: 182 LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI------------N 229

Query: 793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD 852
           +    +E V   SL         +V+      +  L+     C ++    RP+      +
Sbjct: 230 NRDQIIEMVGRGSL----SPDLSKVRSNCPKRMKRLMA---ECLKKKRDERPSFPRILAE 282

Query: 853 LDRLKR 858
           ++ L R
Sbjct: 283 IEELAR 288

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  182 bits (464), Expect = 4e-51
 Identities = 73/404 (18%), Positives = 160/404 (39%), Gaps = 62/404 (15%)

Query: 45  LTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQL 104
              +      +  + P +   +        L +   T  +        ++  L +   ++
Sbjct: 2   AATLATLPAPINQIFPDA---DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV 56

Query: 105 TGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPF 164
                                 + G      +  L +L YL+L+ N +      T++ P 
Sbjct: 57  A--------------------SIQG------IEYLTNLEYLNLNGNQI------TDISP- 83

Query: 165 FNSLGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLIS 223
              L N   L  L +    +  T   ++  L NL +L L E+ I+   P  + NL+ + S
Sbjct: 84  ---LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP--LANLTKMYS 136

Query: 224 LNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEI 283
           LNL +N     +S  +S ++ L  L ++ +      P  +  L  L  L L++N++    
Sbjct: 137 LNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDIS 193

Query: 284 PVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRI 343
           P  L +L  ++      NQ++   P  +   T L  L +  N++T   P  ++ + ++  
Sbjct: 194 P--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLT- 246

Query: 344 FLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGN 403
           +L +  NQ+       +  L  ++ +++ SN+ +      ++N   +  + +++N L   
Sbjct: 247 WLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNE 302

Query: 404 LPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNE 447
             + +G L NL  + +S NH++ I P++   +  +   + +   
Sbjct: 303 DMEVIGGLTNLTTLFLSQNHITDIRPLA--SLSKMDSADFANQV 344

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  180 bits (458), Expect = 2e-50
 Identities = 75/363 (20%), Positives = 145/363 (39%), Gaps = 36/363 (9%)

Query: 16  SKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDL 75
           + L       L   ++      +   L ++T + +    +     I      T+L  ++L
Sbjct: 19  ADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVAS---IQGIEYLTNLEYLNL 73

Query: 76  SQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDI 135
           + N  T   P  + N   L  L +  N++T  + A    T++  L +  +++S   P   
Sbjct: 74  NGNQITDISP--LSNLVKLTNLYIGTNKIT-DISALQNLTNLRELYLNEDNISDISP--- 127

Query: 136 MSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL 195
           ++ L  +  L+L  N+ +S             L N T L  L +    +       I  L
Sbjct: 128 LANLTKMYSLNLGANHNLSDLSP---------LSNMTGLNYLTVTESKV--KDVTPIANL 176

Query: 196 -NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNL 254
            +L  L L  N+I    P  + +L++L       N ++      ++ +++L  L + +N 
Sbjct: 177 TDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNK 232

Query: 255 FSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRC 314
            +   P  L  L  L  L++  N++S  I  ++ +L ++  L + +NQ+S  I   L   
Sbjct: 233 ITDLSP--LANLSQLTWLEIGTNQISD-IN-AVKDLTKLKMLNVGSNQIS-DISV-LNNL 286

Query: 315 TDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSN 374
           + L  L L+ N+L       I G+  +   L LS N +    P  L+ L  +   D ++ 
Sbjct: 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTT-LFLSQNHITDIRP--LASLSKMDSADFANQ 343

Query: 375 KFT 377
              
Sbjct: 344 VIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  176 bits (449), Expect = 5e-49
 Identities = 85/343 (24%), Positives = 150/343 (43%), Gaps = 34/343 (9%)

Query: 12  PPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLR 71
                +L  +  L + G  +     + +  L+NL  + L+ N +T + P+S   N   L 
Sbjct: 37  VVTQEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITDISPLS---NLVKLT 91

Query: 72  NVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGEL 131
           N+ +  N  T      + N  NL  L L  + ++  +      T MY+L++  NH   +L
Sbjct: 92  NLYIGTNKIT--DISALQNLTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHNLSDL 148

Query: 132 PSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDS 191
               +S +  L YL ++ + +       ++ P      N TDL  L L    +       
Sbjct: 149 SP--LSNMTGLNYLTVTESKV------KDVTPI----ANLTDLYSLSLNYNQI--EDISP 194

Query: 192 IGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFL 250
           +  L +L       N+IT   P  + N++ L SL + +N ++      ++ LSQL  L +
Sbjct: 195 LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEI 250

Query: 251 SHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPT 310
             N  S     A+  L  L +L++  N++S      L NL Q+ SLFLNNNQL       
Sbjct: 251 GTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEV 306

Query: 311 LGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLE 353
           +G  T+L  L LS N +T   P  ++ + ++    + ++  ++
Sbjct: 307 IGGLTNLTTLFLSQNHITDIRP--LASLSKMDS-ADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  156 bits (396), Expect = 5e-42
 Identities = 76/305 (24%), Positives = 133/305 (43%), Gaps = 31/305 (10%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           L  N +    P   S L +L +L +  N +      +L  L+NL  + L+++N++    I
Sbjct: 73  LNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISD---I 125

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLD 121
           S   N T + +++L  N         + N   L  L++  +++   +      T +Y+L 
Sbjct: 126 SPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD-VTPIANLTDLYSLS 183

Query: 122 VEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAG 181
           + YN +    P   ++ L SL Y     N +               + N T L  L++  
Sbjct: 184 LNYNQIEDISP---LASLTSLHYFTAYVNQITD----------ITPVANMTRLNSLKIGN 230

Query: 182 MDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEIS 240
             +  T    +  L  LT L +  N+I+  I   + +L+ L  LN+ SN +S  IS  ++
Sbjct: 231 NKI--TDLSPLANLSQLTWLEIGTNQIS-DINA-VKDLTKLKMLNVGSNQISD-ISV-LN 284

Query: 241 WLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNN 300
            LSQL  LFL++N    E    +G L +L  L LS N ++   P  L +L ++ S    N
Sbjct: 285 NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFAN 342

Query: 301 NQLSR 305
             + +
Sbjct: 343 QVIKK 347

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 77.6 bits (192), Expect = 2e-15
 Identities = 31/199 (15%), Positives = 68/199 (34%), Gaps = 37/199 (18%)

Query: 272 LDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSI 331
           L      ++   P    +L +     L    ++     T      + KL ++  ++  SI
Sbjct: 5   LATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA-SI 59

Query: 332 PAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVR 391
              I  +  +   LNL+ NQ+       LS L  +  + + +NK T              
Sbjct: 60  QG-IEYLTNLEY-LNLNGNQITDI--SPLSNLVKLTNLYIGTNKITD------------- 102

Query: 392 LINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGM 451
                          +L +L NL  + ++ +++S I P++   +  +  +NL  N     
Sbjct: 103 -------------ISALQNLTNLRELYLNEDNISDISPLA--NLTKMYSLNLGANHNLSD 147

Query: 452 IPSGGIFNSATKMSFVGNQ 470
           +           ++   ++
Sbjct: 148 LSPLSNMTGLNYLTVTESK 166

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  179 bits (455), Expect = 1e-50
 Identities = 72/333 (21%), Positives = 130/333 (39%), Gaps = 58/333 (17%)

Query: 546 RITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQ 605
           R   R++        E   +G G YG V++G  Q G  +AVK+   +     KS+ RE +
Sbjct: 4   RTVARDI-----TLLEC--VGKGRYGEVWRGSWQ-GENVAVKIFSSRD---EKSWFRETE 52

Query: 606 V--LKRIRHRNLMRIITACSLPDFKA----LVLPYMANGSLDSHLYPHSETEFGSGSSDL 659
           +     +RH N++  I +       +    L+  Y   GSL  +L   +          L
Sbjct: 53  LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----------L 102

Query: 660 TLLQRVNICSDIAEGMAYLH-----HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL 714
             +  + I   IA G+A+LH           + H DLK  N+L+  +    ++D G+A +
Sbjct: 103 DTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM 162

Query: 715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGILVLE 768
                     + N  +   N   G+  YMAPE           ++  + D+++FG+++ E
Sbjct: 163 H-------SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWE 215

Query: 769 MVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDV----- 823
           +  R      +       +  V N      E +     +   R   P +   W       
Sbjct: 216 VARRMVSNGIVEDYKPPFYDVVPNDP--SFEDMRKVVCVDQQR---PNIPNRWFSDPTLT 270

Query: 824 AIGELIELGILCTQESPSTRPTMLDAADDLDRL 856
           ++ +L++    C  ++PS R T L     L ++
Sbjct: 271 SLAKLMK---ECWYQNPSARLTALRIKKTLTKI 300

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  179 bits (456), Expect = 3e-50
 Identities = 76/357 (21%), Positives = 128/357 (35%), Gaps = 61/357 (17%)

Query: 529 SETRSKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKV 588
             + S    P L+    R   +++     +  +Q  +G G YG V+ G  + G  +AVKV
Sbjct: 19  QSSGSGSGLPLLVQ---RTIAKQI-----QMVKQ--IGKGRYGEVWMGKWR-GEKVAVKV 67

Query: 589 LQLQSGNFTKSFNRECQV--LKRIRHRNLMRIITACSLPDFK----ALVLPYMANGSLDS 642
                     S+ RE ++     +RH N++  I A            L+  Y  NGSL  
Sbjct: 68  FFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYD 124

Query: 643 HLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLH-----HHSPVRVIHCDLKPSNVL 697
           +L   +          L     + +      G+ +LH           + H DLK  N+L
Sbjct: 125 YLKSTT----------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL 174

Query: 698 LNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPE-----YGFGSN 752
           +  + T  ++D G+A              N  +   N   G+  YM PE           
Sbjct: 175 VKKNGTCCIADLGLAVKF-------ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF 227

Query: 753 TST-KGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASR 811
            S    D+YSFG+++ E+  R      +    L  H  V +      E + +   ++  R
Sbjct: 228 QSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS--YEDMREIVCIKKLR 285

Query: 812 DQSPEVKRMW-----DVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGEK 863
              P     W        +G+L+     C   +P++R T L     L ++      K
Sbjct: 286 ---PSFPNRWSSDECLRQMGKLMT---ECWAHNPASRLTALRVKKTLAKMSESQDIK 336

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  188 bits (479), Expect = 1e-49
 Identities = 93/495 (18%), Positives = 187/495 (37%), Gaps = 38/495 (7%)

Query: 2   LVDNHLFGAIPPE-FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLT-GML 59
           L   +    I  E F  L  LR L L  + ++   P++   L +L  + L+   L+  +L
Sbjct: 55  LGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVL 114

Query: 60  PISFFHNCTSLRNVDLSQNFFTG-KIPEEIGNCPNLWTLSLYNNQLTGQLP---ASLINT 115
              +F N  +L  +DLS+N      +    G   +L ++   +NQ+          L   
Sbjct: 115 KDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGK 174

Query: 116 SMYNLDVEYNHLSGELPSDIMS-----KLPSLTYLHLSYNNMVSHDDNTNLVPF----FN 166
           ++    +  N L   +  D        +   L  L +S N                    
Sbjct: 175 TLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAF 234

Query: 167 SLGNCTDLEELELAGMDLGGTLPDSIG---RLNLTQLLLQENKITGSIPPHI-GNLSNLI 222
           SL     +        ++     ++     R ++  L L    +  S+   +   L +L 
Sbjct: 235 SLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLK 293

Query: 223 SLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGE 282
            LNL+ N ++         L  L+ L LS+NL      +    L  +  +DL  N ++  
Sbjct: 294 VLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAII 353

Query: 283 IPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIR 342
              +   L ++ +L L +N L+     T+     +  + LS N+L       ++      
Sbjct: 354 QDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTANL--- 405

Query: 343 IFLNLSHNQLEG-PLPIELSKLENVQEIDLSSNKFTGNIFIQI-SNCIAVRLINISHNAL 400
             ++LS N+LE   +   L ++ ++Q + L+ N+F+     Q  S   ++  + +  N L
Sbjct: 406 --IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENML 463

Query: 401 QGN-----LPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSG 455
           Q         D    L +L+ + ++ N+L+ + P   + +  L  ++L+ N    ++   
Sbjct: 464 QLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHN 522

Query: 456 GIFNSATKMSFVGNQ 470
            +  +   +    NQ
Sbjct: 523 DLPANLEILDISRNQ 537

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  178 bits (452), Expect = 3e-46
 Identities = 83/469 (17%), Positives = 151/469 (32%), Gaps = 46/469 (9%)

Query: 15  FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVD 74
              L     L L  N +      S   L  L L+ L        +    F N  +LR +D
Sbjct: 20  PQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILD 79

Query: 75  LSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLT-GQLPASLIN--TSMYNLDVEYNHLSGE 130
           L  +     +  +      +L+ L LY   L+   L         ++  LD+  N +   
Sbjct: 80  LGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSL 138

Query: 131 LPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLG----- 185
                  KL SL  +  S N +    ++         L   T L    LA   L      
Sbjct: 139 YLHPSFGKLNSLKSIDFSSNQIFLVCEHE-----LEPLQGKT-LSFFSLAANSLYSRVSV 192

Query: 186 --GTLPDSIGRLNLTQLLLQENKIT------------GSIPPHIGNLSNLISLNLSSNLL 231
             G   +    + L  L +  N  T             S    +    +++      + +
Sbjct: 193 DWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNI 252

Query: 232 SGTISAEI---SWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLG 288
                         S +  L LSH             L  L +L+L++NK++     +  
Sbjct: 253 K-DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFY 311

Query: 289 NLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLS 348
            L  +  L L+ N L             +  +DL  N +          + +++  L+L 
Sbjct: 312 GLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQ-TLDLR 370

Query: 349 HNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDS- 407
            N L       +  + ++ +I LS NK      I ++      LI++S N L+       
Sbjct: 371 DNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTA----NLIHLSENRLENLDILYF 421

Query: 408 LGDLKNLEAIDVSGNHLSGIIPISL-NKIHTLTFINLSFNEFKGMIPSG 455
           L  + +L+ + ++ N  S        ++  +L  + L  N  +    + 
Sbjct: 422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETE 470

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  168 bits (427), Expect = 3e-43
 Identities = 115/586 (19%), Positives = 193/586 (32%), Gaps = 83/586 (14%)

Query: 2   LVDNHLFGAIPPE-FSKLRRLRHLQLDGNNLHGQI--PESLALLSNLTLVTLHDNNLTGM 58
           L  + +   + P+ F  L  L  L+L    L   +        L  LT + L  N +  +
Sbjct: 80  LGSSKI-YFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSL 138

Query: 59  LPISFFHNCTSLRNVDLSQNFFTGKIPEEIGN--CPNLWTLSLYNNQLT-------GQLP 109
                F    SL+++D S N        E+       L   SL  N L        G+  
Sbjct: 139 YLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCM 198

Query: 110 ASLINTSMYNLDVEYNHLSGELPSDI-----------MSKLPSLTYLHLSYNNMVSHDDN 158
               N  +  LDV  N  + ++  +            +     +      ++N+   D N
Sbjct: 199 NPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQN 258

Query: 159 TNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGN 217
           T     F  L   + +  L+L+   +          L +L  L L  NKI          
Sbjct: 259 T-----FAGLARSS-VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYG 312

Query: 218 LSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFN 277
           L NL  LNLS NLL    S+    L ++  + L  N  +         L  L  LDL  N
Sbjct: 313 LDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDN 372

Query: 278 KLSGEIPVSLGNLVQIYSLFLNNNQLSR---------------------SIPPTLGRCTD 316
            L+     ++  +  I  +FL+ N+L                        I   L R   
Sbjct: 373 ALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPH 427

Query: 317 LYKLDLSYNRLTG-SIPAEISGIREIRIFLNLSHNQLEGPLPIELSK-----LENVQEID 370
           L  L L+ NR +  S     S    +   L L  N L+     EL       L ++Q + 
Sbjct: 428 LQILILNQNRFSSCSGDQTPSENPSLEQ-LFLGENMLQLAWETELCWDVFEGLSHLQVLY 486

Query: 371 LSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPI 430
           L+ N          S+  A+R ++++ N L     + L    NLE +D+S N L    P 
Sbjct: 487 LNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPD 544

Query: 431 SLNKIHTLTFINLSFNEFKGMIPSGGIFN----SATKMSFVGNQHLCGT---VPGMPI-- 481
                  L+ ++++ N+F          N    +   ++       C       G+ +  
Sbjct: 545 VFVS---LSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFS 601

Query: 482 -----CPPKQHWLHTRMYFIIFVLVISISAFLSTICLVTGIHRIKL 522
                C  ++     +    I   V      ++ + +        +
Sbjct: 602 LSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGFCFI 647

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  176 bits (448), Expect = 3e-49
 Identities = 61/312 (19%), Positives = 117/312 (37%), Gaps = 54/312 (17%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNL 615
           + +   L+G G +G+VY G    G  +A++++ ++  + +  K+F RE    ++ RH N+
Sbjct: 34  QLEIGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENV 91

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +  + AC  P   A++       +L S +              L + +   I  +I +GM
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYSVV--RDAKI------VLDVNKTRQIAQEIVKGM 143

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH      ++H DLK  NV   D+   +++DFG+   +  V       + +       
Sbjct: 144 GYLHAKG---ILHKDLKSKNVFY-DNGKVVITDFGLFS-ISGVLQAGRREDKLRIQN--- 195

Query: 736 LCGSIGYMAPE---------YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSL 786
             G + ++APE                S   DV++ G +  E+  R  P           
Sbjct: 196 --GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ------- 246

Query: 787 HKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTM 846
                      + ++        S+    +        I +++     C       RPT 
Sbjct: 247 ------PAEAIIWQMGTGMKPNLSQIGMGK-------EISDILL---FCWAFEQEERPTF 290

Query: 847 LDAADDLDRLKR 858
               D L++L +
Sbjct: 291 TKLMDMLEKLPK 302

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  180 bits (459), Expect = 3e-49
 Identities = 70/452 (15%), Positives = 143/452 (31%), Gaps = 31/452 (6%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           + D+ L  A+         ++ L L GN L       LA  + L L+ L  N L      
Sbjct: 17  VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE---T 73

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLD 121
               + ++LR +DL+ N+       E+   P++ TL   NN ++ ++  S       N+ 
Sbjct: 74  LDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS-RGQGKKNIY 126

Query: 122 VEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAG 181
           +  N ++  L          + YL L  N + +       V F     +   LE L L  
Sbjct: 127 LANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDT-------VNFAELAASSDTLEHLNLQY 178

Query: 182 MDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISW 241
             +   +   +    L  L L  NK+   + P   + + +  ++L +N L   I   + +
Sbjct: 179 NFI-YDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRF 235

Query: 242 LSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNN 301
              LE   L  N F            +  +  ++   +      +               
Sbjct: 236 SQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAY 294

Query: 302 QLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRI---FLNLSHNQLEGPLPI 358
                  P   R   L + + +     GS    +   RE +     ++    Q    +  
Sbjct: 295 CCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQ 354

Query: 359 ELSKLENVQEIDLSSNKFTG---NIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLE 415
              + +    ++           N     +         +    LQ +  +    L+ L 
Sbjct: 355 VTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQ-HATEEQSPLQLLR 413

Query: 416 AIDVSGNHLSGIIPISLNKIHTLTFINLSFNE 447
           AI      +   +     + + +   ++  ++
Sbjct: 414 AIVKRYEEMY--VEQQSVQNNAIRDWDMYQHK 443

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  176 bits (449), Expect = 8e-48
 Identities = 70/425 (16%), Positives = 135/425 (31%), Gaps = 55/425 (12%)

Query: 35  IPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNL 94
           I E     +   +  + D++L      S   +  +++ +DLS N  +     ++     L
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQ-ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 95  WTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVS 154
             L+L +N L  +       +++  LD+  N++  EL        PS+  LH + NN+  
Sbjct: 61  ELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQ-ELLV-----GPSIETLHAANNNI-- 111

Query: 155 HDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPH 214
                                            +  S G+     + L  NKIT      
Sbjct: 112 -------------------------------SRVSCSRGQ-GKKNIYLANNKITMLRDLD 139

Query: 215 IGNLSNLISLNLSSNLLSG-TISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLD 273
            G  S +  L+L  N +     +   +    LE L L +N    ++   +     L  LD
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLD 197

Query: 274 LSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRL-TGSIP 332
           LS NKL+  +     +   +  + L NN+L   I   L    +L   DL  N    G++ 
Sbjct: 198 LSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLR 255

Query: 333 AEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRL 392
              S  + ++    ++   ++        +          +              IA++ 
Sbjct: 256 DFFSKNQRVQ---TVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKR 312

Query: 393 INISHNALQGN----LPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEF 448
              +  + QG+    L     +      ID        +I     +      +       
Sbjct: 313 KEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKAL 372

Query: 449 KGMIP 453
              + 
Sbjct: 373 DEQVS 377

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  119 bits (301), Expect = 1e-28
 Identities = 42/372 (11%), Positives = 105/372 (28%), Gaps = 23/372 (6%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
             +N++   +    S+ +  +++ L  N +           S +  + L  N +  +   
Sbjct: 106 AANNNI-SRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNL 120
               +  +L +++L  NF    +  ++     L TL L +N+L   +     +   +  +
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWI 219

Query: 121 DVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELA 180
            +  N L   +   +     +L +  L  N          L  FF+       + +  + 
Sbjct: 220 SLRNNKLV-LIEKAL-RFSQNLEHFDLRGNGF----HCGTLRDFFSKNQRVQTVAKQTVK 273

Query: 181 GMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSG----TIS 236
            +    T  +       T              P    L  L     +     G     + 
Sbjct: 274 KL----TGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLE 329

Query: 237 AEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSL 296
            E    ++  ++      +   I     +      L+     L  ++        ++   
Sbjct: 330 CERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGT 389

Query: 297 FLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPL 356
                     +       + L  L     R       + S         ++  ++    L
Sbjct: 390 LQQAVGQI-ELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET-QL 447

Query: 357 PIELSKLENVQE 368
             E ++L+ +  
Sbjct: 448 AEENARLKKLNG 459

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 44.8 bits (106), Expect = 9e-05
 Identities = 16/69 (23%), Positives = 30/69 (43%)

Query: 391 RLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKG 450
           ++  ++ ++L+  L        N++ +D+SGN LS I    L     L  +NLS N    
Sbjct: 13  KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE 72

Query: 451 MIPSGGIFN 459
            +    +  
Sbjct: 73  TLDLESLST 81

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  181 bits (462), Expect = 4e-49
 Identities = 90/458 (19%), Positives = 168/458 (36%), Gaps = 33/458 (7%)

Query: 11  IPPE-FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTS 69
           I  + F  L  L HL L  N+L          LS+L  + L  N    +   S F N T+
Sbjct: 65  IEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTN 124

Query: 70  LRNVDLSQNFFTGKIPEE-IGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNLDVEYNHL 127
           L+ + +       +I         +L  L +    L      SL +   +++L +  +  
Sbjct: 125 LQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES 184

Query: 128 SGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGT 187
           +  L       L S+ YL L   N+     +   V   +S           L        
Sbjct: 185 A-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243

Query: 188 LPDSIGRLNLTQLLLQENKITG---------SIPPHIGNLS--NLISLNLSSNLLSGTIS 236
           L      L L+++   +  + G          +   +G +    +  L++    L   +S
Sbjct: 244 LKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLS 303

Query: 237 AEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEI---PVSLGNLVQI 293
              S L +++++ + ++       +    L  L  LDLS N +  E        G    +
Sbjct: 304 TVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL 363

Query: 294 YSLFLNNNQLSRSIPPTLGRCTDLYKL---DLSYNRLTGSIPAEISGIREIRIFLNLSHN 350
            +L L+ N L  S+  T      L  L   D+S N     +P       ++R  LNLS  
Sbjct: 364 QTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRF-LNLSST 420

Query: 351 QLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGD 410
            +     ++    + ++ +D+S+N    +  + +     ++ + IS N L+  LPD+   
Sbjct: 421 GIRV---VKTCIPQTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLK-TLPDASL- 471

Query: 411 LKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEF 448
              L  + +S N L  +     +++ +L  I L  N +
Sbjct: 472 FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  154 bits (390), Expect = 1e-39
 Identities = 70/454 (15%), Positives = 155/454 (34%), Gaps = 32/454 (7%)

Query: 26  LDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIP 85
               +    IP  L   + +  + L  N +T +        C +L+ + L  +     I 
Sbjct: 12  GRSRSFT-SIPSGL--TAAMKSLDLSFNKITYI-GHGDLRACANLQVLILKSSRIN-TIE 66

Query: 86  EEI-GNCPNLWTLSLYNNQLTGQLPASLIN--TSMYNLDVEYNHLSGELPSDIMSKLPSL 142
            +   +  +L  L L +N L+  L +S     +S+  L++  N       + +   L +L
Sbjct: 67  GDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNL 125

Query: 143 TYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQLL 201
             L +      S                 T L ELE+  + L      S+  + ++  L 
Sbjct: 126 QTLRIGNVETFSEIRR-------IDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178

Query: 202 LQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPA 261
           L  ++    +      LS++  L L    L+    + +        +       S     
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238

Query: 262 ALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLD 321
           +  +L  L    L  +++         +         N ++              + +L 
Sbjct: 239 SFNELLKLLRYILELSEV------EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLH 292

Query: 322 LSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIF 381
           +    L   +    S + +++  + + ++++          L++++ +DLS N       
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKR-ITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYL 351

Query: 382 IQ---ISNCIAVRLINISHNALQ--GNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIH 436
                     +++ + +S N L+      + L  LKNL ++D+S N     +P S     
Sbjct: 352 KNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPE 410

Query: 437 TLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQ 470
            + F+NLS    + ++ +  I  +   +    N 
Sbjct: 411 KMRFLNLSSTGIR-VVKT-CIPQTLEVLDVSNNN 442

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  141 bits (358), Expect = 2e-35
 Identities = 75/418 (17%), Positives = 147/418 (35%), Gaps = 44/418 (10%)

Query: 66  NCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNLDVEY 124
           +C +    D     FT  IP  +     + +L L  N++T      L    ++  L ++ 
Sbjct: 3   SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59

Query: 125 NHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDL 184
           + ++  +  D    L SL +L LS N++ S   +          G  + L+ L L G   
Sbjct: 60  SRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSW--------FGPLSSLKYLNLMGNPY 110

Query: 185 GG-TLPDSIGRL-NLTQLLLQENKITGSIPPH-IGNLSNLISLNLSSNLLSGTISAEISW 241
               +      L NL  L +   +    I       L++L  L + +  L    S  +  
Sbjct: 111 QTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKS 170

Query: 242 LSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNN 301
           +  +  L L  +  +  +      L  +  L+L    L+      L        +     
Sbjct: 171 IRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAF 230

Query: 302 QLSR----------SIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRI-------F 344
           + S            +   +   +++   D + N L    P+E   + E+          
Sbjct: 231 RGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRR 290

Query: 345 LNLSHNQLEGPLPIELSKLENVQEIDLSSNKFT---GNIFIQISNCIAVRLINISHNALQ 401
           L++    L   L    S LE V+ I + ++K      +    + +   +  +++S N + 
Sbjct: 291 LHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKS---LEFLDLSENLMV 347

Query: 402 GNLPDS---LGDLKNLEAIDVSGNHLSGI--IPISLNKIHTLTFINLSFNEFKGMIPS 454
                +    G   +L+ + +S NHL  +      L  +  LT +++S N F  M  S
Sbjct: 348 EEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDS 405

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  141 bits (356), Expect = 2e-35
 Identities = 69/397 (17%), Positives = 139/397 (35%), Gaps = 34/397 (8%)

Query: 90  NCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSY 149
           +C         +   T  +P+  +  +M +LD+ +N ++  +    +    +L  L L  
Sbjct: 3   SCDASGVCDGRSRSFT-SIPSG-LTAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKS 59

Query: 150 NNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQLLLQENKIT 208
           + + + + +      F SLG+   LE L+L+   L        G L +L  L L  N   
Sbjct: 60  SRINTIEGDA-----FYSLGS---LEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ 111

Query: 209 G-SIPPHIGNLSNLISLNLSSNLLSGTISAE-ISWLSQLEQLFLSHNLFSGEIPAALGKL 266
              +     NL+NL +L + +      I     + L+ L +L +           +L  +
Sbjct: 112 TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSI 171

Query: 267 HHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNR 326
             +  L L  ++ +  + +    L  +  L L +  L+R     L        +     R
Sbjct: 172 RDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFR 231

Query: 327 LTGSIPAEISGIREIRI---------FLNLSHNQLEGPLPIE---LSKLENVQEIDLSSN 374
            +       + + ++           F + + N L    P E   +S+L  V+ + +   
Sbjct: 232 GSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRL 291

Query: 375 KFTGNIFIQI-----SNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGII- 428
                          S    V+ I + ++ +          LK+LE +D+S N +     
Sbjct: 292 HIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYL 351

Query: 429 --PISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATK 463
                     +L  + LS N  + M  +G I  +   
Sbjct: 352 KNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKN 388

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  177 bits (452), Expect = 2e-48
 Identities = 77/469 (16%), Positives = 151/469 (32%), Gaps = 77/469 (16%)

Query: 11  IPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHN---- 66
           +P E   ++         +      P        + +  L D        +   +     
Sbjct: 26  MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS 85

Query: 67  ----CTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDV 122
                  L ++  S N  T ++PE   +  +L   +     L+  LP  L       L V
Sbjct: 86  LPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS-DLPPLLEY-----LGV 138

Query: 123 EYNHLSGELPSDIMSKLPSLTYLHLSYN----------NMVSHDDNTNLVPFFNSLGNCT 172
             N L  +LP   +     L  + +  N          ++       N +     L N  
Sbjct: 139 SNNQLE-KLPE--LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLP 195

Query: 173 DLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLS 232
            L  +      L   LPD     +L  ++   N +     P + NL  L ++   +NLL 
Sbjct: 196 FLTAIYADNNSLK-KLPDLPL--SLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK 250

Query: 233 GTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQ 292
            T+         LE L +  N  + ++P     L  L + +  F+ LS   P        
Sbjct: 251 -TLP---DLPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------N 298

Query: 293 IYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQL 352
           +Y L  ++N++  S+         L +L++S N+L   +PA    +      L  S N L
Sbjct: 299 LYYLNASSNEIR-SLCDLPPS---LEELNVSNNKLI-ELPALPPRLER----LIASFNHL 349

Query: 353 EGPLPIELSKLENVQEIDLSSNKFT--------------GNIFIQISNCIA-VRLINISH 397
              +P     L   +++ +  N                  +   ++      ++ +++  
Sbjct: 350 AE-VPELPQNL---KQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVET 405

Query: 398 NALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFN 446
           N L+   PD    +++L    ++   +      +      L       +
Sbjct: 406 NPLR-EFPDIPESVEDL---RMNSERVVDPYEFAHETTDKLEDDVFEHH 450

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  169 bits (429), Expect = 2e-45
 Identities = 87/489 (17%), Positives = 160/489 (32%), Gaps = 104/489 (21%)

Query: 11  IPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHN---- 66
           I P       L+      +NL  ++P     + + T      +      P          
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 67  --------CTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSM 117
                         ++L+    +  +PE      +L +L    N LT +LP    +  S+
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSL 116

Query: 118 YNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEEL 177
              +     LS +LP       P L YL +S N +         +P    L N + L+ +
Sbjct: 117 LVDNNNLKALS-DLP-------PLLEYLGVSNNQLEK-------LP---ELQNSSFLKII 158

Query: 178 ELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISA 237
           ++    L   LPD     +L  +    N++     P + NL  L ++   +N L      
Sbjct: 159 DVDNNSL-KKLPDLPP--SLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKL--- 210

Query: 238 EISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLF 297
                  LE +   +N+        L  L  L  +    N L   +P    +L    +L 
Sbjct: 211 -PDLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLE---ALN 263

Query: 298 LNNNQLSRSIPPTLGRCTDLY-----------------KLDLSYNRLTGSIPAEISGIRE 340
           + +N L+  +P      T L                   L+ S N +  S+      + E
Sbjct: 264 VRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIR-SLCDLPPSLEE 321

Query: 341 IRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNAL 400
               LN+S+N+L   LP    +L   + +  S N     +     N    + +++ +N L
Sbjct: 322 ----LNVSNNKLIE-LPALPPRL---ERLIASFNHLA-EVPELPQNL---KQLHVEYNPL 369

Query: 401 QGNLPDSLGDLK----------------NLEAIDVSGNHLSGIIPISLNKIHTLTFINLS 444
           +   PD    ++                NL+ + V  N L    P   +   ++  + ++
Sbjct: 370 R-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFP---DIPESVEDLRMN 424

Query: 445 FNEFKGMIP 453
                    
Sbjct: 425 SERVVDPYE 433

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  166 bits (423), Expect = 1e-44
 Identities = 85/426 (19%), Positives = 149/426 (34%), Gaps = 69/426 (16%)

Query: 11  IPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSL 70
           +P        L  L    N+L  ++PE    L +L +   +   L+ + P         L
Sbjct: 86  LPEL---PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP--------LL 133

Query: 71  RNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGE 130
             + +S N    K+PE + N   L  + + NN L  +LP      S+  +    N L  E
Sbjct: 134 EYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLP--PSLEFIAAGNNQLE-E 187

Query: 131 LPSDIMSKLPSLTYLHLSYNNMVSHDD----------NTNLVPFFNSLGNCTDLEELELA 180
           LP   +  LP LT ++   N++    D            N++     L N   L  +   
Sbjct: 188 LPE--LQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 245

Query: 181 GMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEIS 240
              L  TLPD     +L  L +++N +T  +P    +L+ L       + LS        
Sbjct: 246 NNLLK-TLPDLPP--SLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLS-------E 294

Query: 241 WLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNN 300
               L  L  S N     +      L  L   ++S NKL  E+P     L     L  + 
Sbjct: 295 LPPNLYYLNASSNEIR-SLCDLPPSLEEL---NVSNNKLI-ELPALPPRL---ERLIASF 346

Query: 301 NQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIEL 360
           N L+  +P          +L + YN L    P     + ++R+  +L+       +P   
Sbjct: 347 NHLA-EVPELPQNLK---QLHVEYNPLR-EFPDIPESVEDLRMNSHLAE------VPELP 395

Query: 361 SKLENVQEIDLSSNKFTGNIFIQISNCIA-VRLINISHNALQGNLPDSLGDLKNLEAIDV 419
             L   +++ + +N        +  +    V  + ++   +      +      LE    
Sbjct: 396 QNL---KQLHVETNPLR-----EFPDIPESVEDLRMNSERVVDPYEFAHETTDKLEDDVF 447

Query: 420 SGNHLS 425
             +H  
Sbjct: 448 EHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  128 bits (325), Expect = 7e-32
 Identities = 53/294 (18%), Positives = 90/294 (30%), Gaps = 48/294 (16%)

Query: 189 PDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEIS-------- 240
           P ++    L + L   + +T  +P    N+ +      + +                   
Sbjct: 5   PRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVS 63

Query: 241 -----WLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYS 295
                   Q  +L L++   S  +P     L     L  S N L+ E+P    +L  +  
Sbjct: 64  RLRDCLDRQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLV 118

Query: 296 LFLNNNQLSRSIP---------------PTLGRCTDLYKLDLSYNRLTGSIPAEISGIRE 340
              N   LS   P               P L   + L  +D+  N L   +P     +  
Sbjct: 119 DNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEF 177

Query: 341 IRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNAL 400
               +   +NQLE  LP EL  L  +  I   +N     +     +      I   +N L
Sbjct: 178 ----IAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLK-KLPDLPLSL---ESIVAGNNIL 227

Query: 401 QGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPS 454
           +      L +L  L  I    N L   +P     +  L   +    +   +  S
Sbjct: 228 E--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDLPELPQS 278

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  120 bits (304), Expect = 4e-29
 Identities = 61/319 (19%), Positives = 105/319 (32%), Gaps = 61/319 (19%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
             +N L     PE   L  L  +  D N+L  ++P+      +L  +   +N L     +
Sbjct: 180 AGNNQL--EELPELQNLPFLTAIYADNNSLK-KLPDLP---LSLESIVAGNNILEE---L 230

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLD 121
               N   L  +    N     +P+   +   L  L++ +N LT  LP      S+  LD
Sbjct: 231 PELQNLPFLTTIYADNNLLK-TLPDLPPS---LEALNVRDNYLT-DLPELP--QSLTFLD 283

Query: 122 VEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAG 181
           V  N  SG     +    P+L YL+ S N + S           +   +   LEEL ++ 
Sbjct: 284 VSENIFSG-----LSELPPNLYYLNASSNEIRS---------LCDLPPS---LEELNVSN 326

Query: 182 MDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEIS- 240
             L   LP       L +L+   N +   +P    NL     L++  N L          
Sbjct: 327 NKLI-ELPALPP--RLERLIASFNHLA-EVPELPQNLK---QLHVEYNPLR-EFPDIPES 378

Query: 241 ---------------WLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPV 285
                              L+QL +  N    E P     +  L    ++  ++      
Sbjct: 379 VEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVEDL---RMNSERVVDPYEF 434

Query: 286 SLGNLVQIYSLFLNNNQLS 304
           +     ++      ++   
Sbjct: 435 AHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 85.8 bits (213), Expect = 1e-17
 Identities = 37/219 (16%), Positives = 74/219 (33%), Gaps = 41/219 (18%)

Query: 266 LHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLG------------- 312
              L       + L+ E+PV   N+      +   ++  R+ PP  G             
Sbjct: 10  NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68

Query: 313 RCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLS 372
                ++L+L+   L+ S+P     +      L  S N L   LP     L+++   + +
Sbjct: 69  LDRQAHELELNNLGLS-SLPELPPHLES----LVASCNSLT-ELPELPQSLKSLLVDNNN 122

Query: 373 SNKFTGNI---------------FIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAI 417
               +                    ++ N   +++I++ +N+L+  LPD    L+ +   
Sbjct: 123 LKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFI--- 178

Query: 418 DVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGG 456
               N L  +  +    +  LT I    N  K +     
Sbjct: 179 AAGNNQLEELPELQ--NLPFLTAIYADNNSLKKLPDLPL 215

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  170 bits (433), Expect = 4e-47
 Identities = 73/341 (21%), Positives = 132/341 (38%), Gaps = 54/341 (15%)

Query: 545 PRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNREC 604
           P +  R +         Q  +G G +G V++G  + G  +AVK+   +     +S+ RE 
Sbjct: 33  PLLVQRTIAR---TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREA 85

Query: 605 QV--LKRIRHRNLMRIITACSLPDFKA----LVLPYMANGSLDSHLYPHSETEFGSGSSD 658
           ++     +RH N++  I A +  +       LV  Y  +GSL  +L  +  T        
Sbjct: 86  EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYT-------- 135

Query: 659 LTLLQRVNICSDIAEGMAYLHHHSPVR-----VIHCDLKPSNVLLNDDMTALVSDFGIAK 713
           +T+   + +    A G+A+LH           + H DLK  N+L+  + T  ++D G+A 
Sbjct: 136 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 195

Query: 714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPE-----YGFGSNTST-KGDVYSFGILVL 767
                    D A +  +   N   G+  YMAPE            S  + D+Y+ G++  
Sbjct: 196 RH-------DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 248

Query: 768 EMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMW-----D 822
           E+  R           L  +  V +     +E++      +  R   P +   W      
Sbjct: 249 EIARRCSIGGIHEDYQLPYYDLVPSDPS--VEEMRKVVCEQKLR---PNIPNRWQSCEAL 303

Query: 823 VAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGEK 863
             + +++     C   + + R T L     L +L +  G K
Sbjct: 304 RVMAKIMR---ECWYANGAARLTALRIKKTLSQLSQQEGIK 341

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  164 bits (418), Expect = 3e-45
 Identities = 63/348 (18%), Positives = 113/348 (32%), Gaps = 42/348 (12%)

Query: 8   FGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNC 67
            G+            +L   G+       + L+             +           N 
Sbjct: 1   MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYN-----ADRNRWHSAWRQANS 55

Query: 68  TSLRNVDLSQNFFTGKIPEEIGNC--PNLWTLSLYNNQLTGQLPASLIN-TSMYNLDVEY 124
            + +    +         + + +   P    L L +  L  Q P      + + ++ ++ 
Sbjct: 56  NNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDA 113

Query: 125 NHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDL 184
             L  ELP  +  +   L  L L+ N + +       +P   S+ +   L EL +     
Sbjct: 114 AGLM-ELPDTM-QQFAGLETLTLARNPLRA-------LP--ASIASLNRLRELSIRACPE 162

Query: 185 GGTLPDSIGRL----------NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGT 234
              LP+ +             NL  L L+   I  S+P  I NL NL SL + ++ LS  
Sbjct: 163 LTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-A 220

Query: 235 ISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLS-FNKLSGEIPVSLGNLVQI 293
           +   I  L +LE+L L         P   G    L  L L   + L   +P+ +  L Q+
Sbjct: 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQL 279

Query: 294 YSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLT-------GSIPAE 334
             L L        +P  + +      + +  +           + PAE
Sbjct: 280 EKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  162 bits (412), Expect = 2e-44
 Identities = 56/326 (17%), Positives = 113/326 (34%), Gaps = 35/326 (10%)

Query: 63  FFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDV 122
             H+ +   N+    +       + +      +           +        +  N  +
Sbjct: 7   HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA------NSNNPQI 60

Query: 123 EYNHLSG--ELPSDI-MSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELEL 179
           E             +  +  P    L L    +          P  +     + L+ + +
Sbjct: 61  ETRTGRALKATADLLEDATQPGRVALELRSVPLPQ-------FP--DQAFRLSHLQHMTI 111

Query: 180 AGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSN--------- 229
               L   LPD++ +   L  L L  N +  ++P  I +L+ L  L++ +          
Sbjct: 112 DAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEP 169

Query: 230 LLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGN 289
           L S   S E   L  L+ L L        +PA++  L +L  L +  + LS  +  ++ +
Sbjct: 170 LASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHH 227

Query: 290 LVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLS-YNRLTGSIPAEISGIREIRIFLNLS 348
           L ++  L L      R+ PP  G    L +L L   + L  ++P +I  + ++   L+L 
Sbjct: 228 LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEK-LDLR 285

Query: 349 HNQLEGPLPIELSKLENVQEIDLSSN 374
                  LP  +++L     I +  +
Sbjct: 286 GCVNLSRLPSLIAQLPANCIILVPPH 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  138 bits (350), Expect = 5e-36
 Identities = 43/297 (14%), Positives = 98/297 (32%), Gaps = 17/297 (5%)

Query: 167 SLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNL 226
              + +  E L   G        D + +        +             N +N      
Sbjct: 7   HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW---HSAWRQANSNNPQIETR 63

Query: 227 SSNLLSGTISA-EISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPV 285
           +   L  T    E +       L L       + P    +L HL  + +    L  E+P 
Sbjct: 64  TGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPD 121

Query: 286 SLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIF- 344
           ++     + +L L  N L R++P ++     L +L +        +P  ++         
Sbjct: 122 TMQQFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180

Query: 345 -------LNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISH 397
                  L L    +   LP  ++ L+N++ + + ++  +  +   I +   +  +++  
Sbjct: 181 GLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRG 238

Query: 398 NALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPS 454
                N P   G    L+ + +        +P+ ++++  L  ++L        +PS
Sbjct: 239 CTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 51.9 bits (125), Expect = 4e-07
 Identities = 18/114 (15%), Positives = 29/114 (25%), Gaps = 28/114 (24%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           L         PP F     L+ L L   +    +P  +                      
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIH--------------------- 274

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNN---QLTGQLPASL 112
                 T L  +DL       ++P  I   P    + +  +   QL    P + 
Sbjct: 275 ----RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  164 bits (418), Expect = 1e-44
 Identities = 77/399 (19%), Positives = 148/399 (37%), Gaps = 40/399 (10%)

Query: 8   FGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNC 67
           +  I            + +D              L+N  +VT  ++ +   LP +   + 
Sbjct: 10  YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSF 68

Query: 68  TSLRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLIN--TSMYNLDVEY 124
             +  ++L+      +I          +  L +  N +   LP  +      +  L +E 
Sbjct: 69  RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLER 126

Query: 125 NHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDL 184
           N LS  LP  I    P LT L +S NN+   +D+T            T L+ L+L+   L
Sbjct: 127 NDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDT--------FQATTSLQNLQLSSNRL 177

Query: 185 GGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQ 244
              +  S+   +L    +  N ++      +     +  L+ S N ++  +   +    +
Sbjct: 178 -THVDLSLIP-SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVE 227

Query: 245 LEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLS 304
           L  L L HN  + +    L     L  +DLS+N+L   +      + ++  L+++NN+L 
Sbjct: 228 LTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285

Query: 305 RSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLE 364
            ++         L  LDLS+N L   +         +   L L HN +     ++LS   
Sbjct: 286 -ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN-LYLDHNSIV---TLKLSTHH 339

Query: 365 NVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGN 403
            ++ + LS N +         N +     N++  A+   
Sbjct: 340 TLKNLTLSHNDWD-------CNSLRALFRNVARPAVDDA 371

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  123 bits (310), Expect = 2e-30
 Identities = 57/313 (18%), Positives = 114/313 (36%), Gaps = 24/313 (7%)

Query: 141 SLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQ 199
           +L Y  + Y+     D  T  V F        + + +      +       +     +  
Sbjct: 16  NLQYDCVFYDV--HIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVEL 73

Query: 200 LLLQENKITGSIPPHI-GNLSNLISLNLSSNLLSGTISAEI-SWLSQLEQLFLSHNLFSG 257
           L L + +I   I  +       +  L +  N +   +   +   +  L  L L  N  S 
Sbjct: 74  LNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS- 130

Query: 258 EIPA-ALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTD 316
            +P         L  L +S N L      +      + +L L++N+L+  +         
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPS 187

Query: 317 LYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKF 376
           L+  ++SYN L+ ++   I+ + E    L+ SHN +     +       +  + L  N  
Sbjct: 188 LFHANVSYNLLS-TLAIPIA-VEE----LDASHNSINV---VRGPVNVELTILKLQHNNL 238

Query: 377 TGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIH 436
           T      + N   +  +++S+N L+  +      ++ LE + +S N L   + +    I 
Sbjct: 239 TD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 295

Query: 437 TLTFINLSFNEFK 449
           TL  ++LS N   
Sbjct: 296 TLKVLDLSHNHLL 308

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  101 bits (254), Expect = 4e-23
 Identities = 46/241 (19%), Positives = 91/241 (37%), Gaps = 16/241 (6%)

Query: 210 SIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHL 269
            I  ++        +++           E   L+  + +   ++       A L     +
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71

Query: 270 GLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPP-TLGRCTDLYKLDLSYNRLT 328
            LL+L+  ++      +      I  L++  N +   +PP        L  L L  N L+
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130

Query: 329 GSIPAEI-SGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNC 387
            S+P  I     ++   L++S+N LE           ++Q + LSSN+ T    + +S  
Sbjct: 131 -SLPRGIFHNTPKLTT-LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDLSLI 185

Query: 388 IAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNE 447
            ++   N+S+N L      +L     +E +D S N ++ +      +   LT + L  N 
Sbjct: 186 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVE---LTILKLQHNN 237

Query: 448 F 448
            
Sbjct: 238 L 238

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 80.9 bits (200), Expect = 3e-16
 Identities = 41/206 (19%), Positives = 77/206 (37%), Gaps = 24/206 (11%)

Query: 14  EFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNV 73
             +    +  L    N+++  +   +     LT++ L  NNLT     ++  N   L  V
Sbjct: 200 TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT---DTAWLLNYPGLVEV 253

Query: 74  DLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNLDVEYNHLSGEL 131
           DLS N    KI          L  L + NN+L   L        ++  LD+ +NHL   +
Sbjct: 254 DLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HV 310

Query: 132 PSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDS 191
             +   +   L  L+L +N++V+       +           L+ L L+  D       +
Sbjct: 311 ERNQ-PQFDRLENLYLDHNSIVT-------LKL----STHHTLKNLTLSHNDWDCNSLRA 358

Query: 192 IGRLNLTQLLLQENKITGSIPPHIGN 217
           + R N+ +  + +      I   + +
Sbjct: 359 LFR-NVARPAVDDADQHCKIDYQLEH 383

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  162 bits (412), Expect = 3e-42
 Identities = 78/413 (18%), Positives = 151/413 (36%), Gaps = 40/413 (9%)

Query: 8   FGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNC 67
           +  I            + +D              L+N  +VT  ++ +   LP +   + 
Sbjct: 16  YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSF 74

Query: 68  TSLRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLIN--TSMYNLDVEY 124
             +  ++L+      +I          +  L +  N +   LP  +      +  L +E 
Sbjct: 75  RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLER 132

Query: 125 NHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDL 184
           N LS  LP  I    P LT L +S NN+   +D+T            T L+ L+L+   L
Sbjct: 133 NDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDT--------FQATTSLQNLQLSSNRL 183

Query: 185 GGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQ 244
              +  S+   +L    +  N ++      +     +  L+ S N ++  +   +    +
Sbjct: 184 -THVDLSLIP-SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVE 233

Query: 245 LEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLS 304
           L  L L HN  + +    L     L  +DLS+N+L   +      + ++  L+++NN+L 
Sbjct: 234 LTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291

Query: 305 RSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLE 364
            ++         L  LDLS+N L   +         +   L L HN +     ++LS   
Sbjct: 292 -ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN-LYLDHNSIV---TLKLSTHH 345

Query: 365 NVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAI 417
            ++ + LS N +         N +     N++  A+         D +    +
Sbjct: 346 TLKNLTLSHNDWD-------CNSLRALFRNVARPAVDDADQHCKIDYQLEHGL 391

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  155 bits (394), Expect = 6e-40
 Identities = 87/436 (19%), Positives = 164/436 (37%), Gaps = 43/436 (9%)

Query: 2   LVDNHLFGAIPPE-FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLP 60
             ++ +   +P       R++  L L+   +      + A    +  + +  N +   LP
Sbjct: 58  FKNSTM-RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLP 115

Query: 61  ISFFHNCTSLRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLIN--TSM 117
              F N   L  + L +N  +  +P  I  N P L TLS+ NN L  ++        TS+
Sbjct: 116 PHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSL 173

Query: 118 YNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEEL 177
            NL +  N L+  +   +   +PSL + ++SYN               ++L     +EEL
Sbjct: 174 QNLQLSSNRLT-HVDLSL---IPSLFHANVSYNL-------------LSTLAIPIAVEEL 216

Query: 178 ELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISA 237
           + +   +   +   +    LT L LQ N +T      + N   L+ ++LS N L   I  
Sbjct: 217 DASHNSI-NVVRGPVNV-ELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KIMY 271

Query: 238 EI-SWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSL 296
                + +LE+L++S+N     +      +  L +LDLS N L   +  +     ++ +L
Sbjct: 272 HPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 329

Query: 297 FLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTG-SIPAEISGIREIRIFLNLSHNQLEGP 355
           +L++N +  ++         L  L LS+N     S+ A    +    +     H +++  
Sbjct: 330 YLDHNSIV-TLKL--STHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQ 386

Query: 356 LPIEL------SKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLG 409
           L   L          +     ++       +      C A   IN   +           
Sbjct: 387 LEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGV 446

Query: 410 DLKNLEAIDVSGNHLS 425
            L+  E ++   N L 
Sbjct: 447 PLQGNEQLEAEVNELR 462

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  123 bits (310), Expect = 2e-29
 Identities = 57/313 (18%), Positives = 114/313 (36%), Gaps = 24/313 (7%)

Query: 141 SLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQ 199
           +L Y  + Y+     D  T  V F        + + +      +       +     +  
Sbjct: 22  NLQYDCVFYDV--HIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVEL 79

Query: 200 LLLQENKITGSIPPHI-GNLSNLISLNLSSNLLSGTISAEI-SWLSQLEQLFLSHNLFSG 257
           L L + +I   I  +       +  L +  N +   +   +   +  L  L L  N  S 
Sbjct: 80  LNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS- 136

Query: 258 EIPA-ALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTD 316
            +P         L  L +S N L      +      + +L L++N+L+  +         
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPS 193

Query: 317 LYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKF 376
           L+  ++SYN L+ ++   I+ + E    L+ SHN +     +       +  + L  N  
Sbjct: 194 LFHANVSYNLLS-TLAIPIA-VEE----LDASHNSINV---VRGPVNVELTILKLQHNNL 244

Query: 377 TGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIH 436
           T      + N   +  +++S+N L+  +      ++ LE + +S N L   + +    I 
Sbjct: 245 TD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 301

Query: 437 TLTFINLSFNEFK 449
           TL  ++LS N   
Sbjct: 302 TLKVLDLSHNHLL 314

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 98.8 bits (246), Expect = 2e-21
 Identities = 46/239 (19%), Positives = 91/239 (38%), Gaps = 16/239 (6%)

Query: 210 SIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHL 269
            I  ++        +++           E   L+  + +   ++       A L     +
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77

Query: 270 GLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPP-TLGRCTDLYKLDLSYNRLT 328
            LL+L+  ++      +      I  L++  N +   +PP        L  L L  N L+
Sbjct: 78  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 136

Query: 329 GSIPAEI-SGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNC 387
            S+P  I     ++   L++S+N LE           ++Q + LSSN+ T    + +S  
Sbjct: 137 -SLPRGIFHNTPKLTT-LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT---HVDLSLI 191

Query: 388 IAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFN 446
            ++   N+S+N L      +L     +E +D S N ++ +      +   LT + L  N
Sbjct: 192 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVE---LTILKLQHN 242

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 83.1 bits (205), Expect = 1e-16
 Identities = 70/413 (16%), Positives = 134/413 (32%), Gaps = 51/413 (12%)

Query: 14  EFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNV 73
             +    +  L    N+++  +   +     LT++ L  NNLT     ++  N   L  V
Sbjct: 206 TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT---DTAWLLNYPGLVEV 259

Query: 74  DLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNLDVEYNHLSGEL 131
           DLS N    KI          L  L + NN+L   L        ++  LD+ +NHL   +
Sbjct: 260 DLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HV 316

Query: 132 PSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDS 191
             +   +   L  L+L +N++V+       +           L+ L L+  D       +
Sbjct: 317 ERNQ-PQFDRLENLYLDHNSIVT-------LKL----STHHTLKNLTLSHNDWDCNSLRA 364

Query: 192 IGRLNLTQLLLQENKITGSIPPHIGN----------LSNLISLNLSSNLLSGTISAEISW 241
           + R N+ +  + +      I   + +            + +   ++   +   +      
Sbjct: 365 LFR-NVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGR 423

Query: 242 LSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLF---- 297
            S  + +    +L           L     L+   N+L  E+       +Q   L     
Sbjct: 424 CSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLH 483

Query: 298 -----------LNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLN 346
                      L  + L+RS        T L +      R T +   E    ++    L 
Sbjct: 484 AEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEADAKQKETEDLE 543

Query: 347 LSHNQLEGPLPIE-LSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHN 398
             +  LE  L  +   + E  QE  L   K    +  + +     R ++  H+
Sbjct: 544 QENIALEKQLDNKRAKQAELRQETSLKRQKVK-QLEAKKNRNPDTRRVSHHHH 595

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  159 bits (404), Expect = 4e-41
 Identities = 76/381 (19%), Positives = 132/381 (34%), Gaps = 59/381 (15%)

Query: 40  ALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSL 99
            L +   ++ + ++ LT  LP     + T+L    +  N  T  +P        L TL +
Sbjct: 37  CLNNGNAVLNVGESGLT-TLPDCLPAHITTL---VIPDNNLT-SLPALPP---ELRTLEV 88

Query: 100 YNNQLTGQLPASLIN-TSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDN 158
             NQLT  LP        +        HL   LPS        L  L +  N + S    
Sbjct: 89  SGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPS-------GLCKLWIFGNQLTS---- 135

Query: 159 TNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNL 218
                          L+EL ++   L  +LP       L +L    N++T S+P     L
Sbjct: 136 -----LPVLPPG---LQELSVSDNQL-ASLPALPS--ELCKLWAYNNQLT-SLPMLPSGL 183

Query: 219 SNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNK 278
                L++S N L+ ++       S+L +L+  +N  +  +PA    L     L +S N+
Sbjct: 184 Q---ELSVSDNQLA-SLPTLP---SELYKLWAYNNRLT-SLPALPSGLKE---LIVSGNR 232

Query: 279 LSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGI 338
           L+  +PV    L     L ++ N+L  S+P           L +  N+LT  +P  +  +
Sbjct: 233 LT-SLPVLPSELK---ELMVSGNRL-TSLPMLPSGLL---SLSVYRNQLT-RLPESLIHL 283

Query: 339 REIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFT-GNIFIQISNCIAVRLINISH 397
                 +NL  N L     ++  +   +      S      ++    +      L   + 
Sbjct: 284 SSETT-VNLEGNPLS-ERTLQALR--EITSAPGYSGPIIRFDMAGASAPRETRALHLAAA 339

Query: 398 NALQGNLPDSLGDLKNLEAID 418
           + L                  
Sbjct: 340 DWLVPAREGEPAPADRWHMFG 360

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  155 bits (394), Expect = 7e-40
 Identities = 82/361 (22%), Positives = 134/361 (37%), Gaps = 47/361 (13%)

Query: 18  LRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQ 77
                 L +  + L   +P+ L   +++T + + DNNLT  LP         LR +++S 
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTS-LPALP----PELRTLEVSG 90

Query: 78  NFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMS 137
           N  T  +P        L   S     L   LP+ L       L +  N L+  LP     
Sbjct: 91  NQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCK-----LWIFGNQLT-SLPVLP-- 140

Query: 138 KLPSLTYLHLSYNNMVSHDDN----TNLVPFFNSL----GNCTDLEELELAGMDLGGTLP 189
             P L  L +S N + S          L  + N L       + L+EL ++   L  +LP
Sbjct: 141 --PGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLA-SLP 197

Query: 190 DSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLF 249
                  L +L    N++T S+P     L     L +S N L+ ++    S   +L++L 
Sbjct: 198 TLPS--ELYKLWAYNNRLT-SLPALPSGLK---ELIVSGNRLT-SLPVLPS---ELKELM 247

Query: 250 LSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPP 309
           +S N  +  +P     L  L    +  N+L+  +P SL +L    ++ L  N LS     
Sbjct: 248 VSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSETTVNLEGNPLS---ER 299

Query: 310 TLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEI 369
           TL    ++         +     A  S  RE R     + + L      E +  +     
Sbjct: 300 TLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMF 359

Query: 370 D 370
            
Sbjct: 360 G 360

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  155 bits (394), Expect = 8e-40
 Identities = 87/390 (22%), Positives = 150/390 (38%), Gaps = 78/390 (20%)

Query: 67  CTSLRNVDLSQNFFTGKIPEEIGNC--PNLWTLSLYNNQLTGQLPASLINTSMYNLDVEY 124
               R     ++     + +++  C       L++  + LT  LP   +   +  L +  
Sbjct: 13  SAWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDC-LPAHITTLVIPD 70

Query: 125 NHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDL 184
           N+L+  LP+      P L  L +S N + S       +P         +L         L
Sbjct: 71  NNLT-SLPALP----PELRTLEVSGNQLTS-------LP--VLPPGLLELSIFSNPLTHL 116

Query: 185 GGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQ 244
              LP       L +L +  N++T S+P     L     L++S N L+ ++ A     S+
Sbjct: 117 -PALPS-----GLCKLWIFGNQLT-SLPVLPPGLQ---ELSVSDNQLA-SLPALP---SE 162

Query: 245 LEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLS 304
           L +L+  +N  +  +P     L     L +S N+L+  +P     L     L+  NN+L+
Sbjct: 163 LCKLWAYNNQLT-SLPMLPSGLQE---LSVSDNQLA-SLPTLPSELY---KLWAYNNRLT 214

Query: 305 RSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLE 364
            S+P        L +L +S NRLT S+P   S ++E    L +S N+L   LP+  S L 
Sbjct: 215 -SLPALPSG---LKELIVSGNRLT-SLPVLPSELKE----LMVSGNRLTS-LPMLPSGL- 263

Query: 365 NVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHL 424
               + +  N+ T                          LP+SL  L +   +++ GN L
Sbjct: 264 --LSLSVYRNQLT-------------------------RLPESLIHLSSETTVNLEGNPL 296

Query: 425 SGIIPISLNKIHTLTFINLSFNEFKGMIPS 454
           S     +L +I +    +     F     S
Sbjct: 297 SERTLQALREITSAPGYSGPIIRFDMAGAS 326

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  119 bits (299), Expect = 7e-28
 Identities = 69/320 (21%), Positives = 114/320 (35%), Gaps = 44/320 (13%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           +  N L  ++P     L  L        +L        AL S L  + +  N LT  LP+
Sbjct: 88  VSGNQL-TSLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLTS-LPV 138

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLD 121
                   L+ + +S N     +P        LW    YNNQLT  LP     + +  L 
Sbjct: 139 LP----PGLQELSVSDNQLA-SLPALPSELCKLW---AYNNQLT-SLPMLP--SGLQELS 187

Query: 122 VEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDN----TNLVPFFNSLGN----CTD 173
           V  N L+  LP+        L  L    N + S          L+   N L +     ++
Sbjct: 188 VSDNQLA-SLPTLP----SELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVLPSE 242

Query: 174 LEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSG 233
           L+EL ++G  L  +LP       L  L +  N++T  +P  + +LS+  ++NL  N LS 
Sbjct: 243 LKELMVSGNRLT-SLPMLPS--GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSE 298

Query: 234 TISAEISWLSQLEQL---FLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSG----EIPVS 286
                +  ++         +  ++     P     LH      L   +       +    
Sbjct: 299 RTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHM 358

Query: 287 LGNLVQIYSLFLNNNQLSRS 306
            G      +  L  ++LS +
Sbjct: 359 FGQEDNADAFSLFLDRLSET 378

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 65.7 bits (160), Expect = 4e-11
 Identities = 53/293 (18%), Positives = 103/293 (35%), Gaps = 49/293 (16%)

Query: 2   LVDNHLFGAIPPEFSKLRRL-----------------RHLQLDGNNLHGQIPESLALLSN 44
           + DN L  ++P   S+L +L                 + L + GN L   +P      S 
Sbjct: 188 VSDNQL-ASLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRL-TSLPVLP---SE 242

Query: 45  LTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQL 104
           L  + +  N LT  LP+      + L ++ + +N  T ++PE + +  +  T++L  N L
Sbjct: 243 LKELMVSGNRLT-SLPML----PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 296

Query: 105 TGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPF 164
           + +         + +       +         S       LHL+  + +         P 
Sbjct: 297 S-ERTLQ-ALREITSAPGYSGPII-RFDMAGASAPRETRALHLAAADWLVPAREGEPAPA 353

Query: 165 --FNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLI 222
             ++  G   + +                + RL+ T+  +++      I   +  L+   
Sbjct: 354 DRWHMFGQEDNADA-----------FSLFLDRLSETENFIKDAGFKAQISSWLAQLAEDE 402

Query: 223 SL--NLSSNLLSGTISAE---ISWLSQLEQLFLSHNLFSGEIPAALGKLHHLG 270
           +L  N  +     T S E     +L Q++ + L HN   G+    L  L   G
Sbjct: 403 ALRANTFAMATEATSSCEDRVTFFLHQMKNVQLVHNAEKGQYDNDLAALVATG 455

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  154 bits (391), Expect = 2e-40
 Identities = 86/447 (19%), Positives = 171/447 (38%), Gaps = 55/447 (12%)

Query: 21  LRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFF 80
                     +      S   L+ LT +  H++++T    ++     T L  +  + N  
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD---MTGIEKLTGLTKLICTSNNI 76

Query: 81  TGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLP 140
           T  +   +    NL  L+  +N+LT  L  +   T +  L+ + N L+       +S+ P
Sbjct: 77  T-TLD--LSQNTNLTYLACDSNKLT-NLDVTP-LTKLTYLNCDTNKLT----KLDVSQNP 127

Query: 141 SLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQL 200
            LTYL+ + N +   D           + + T L EL+        T  D   +  LT L
Sbjct: 128 LLTYLNCARNTLTEID-----------VSHNTQLTELDCHLNKK-ITKLDVTPQTQLTTL 175

Query: 201 LLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIP 260
               NKIT  +   +     L  LN  +N ++     +++   QL  L  S N  + EI 
Sbjct: 176 DCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT---KLDLNQNIQLTFLDCSSNKLT-EID 228

Query: 261 AALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKL 320
             +  L  L   D S N L+ E+ VS   L ++ +L      L   I   L   T L   
Sbjct: 229 --VTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL-EID--LTHNTQLIYF 280

Query: 321 DLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNI 380
                R    +  +++   ++ + L+     +     ++LS+   +  + L++ + T   
Sbjct: 281 QAEGCRKIKEL--DVTHNTQLYL-LDCQAAGIT---ELDLSQNPKLVYLYLNNTELTE-- 332

Query: 381 FIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIP--ISLNKIH-- 436
            + +S+   ++ ++  +  +Q +   S+G +  L     +      +    ++ N +   
Sbjct: 333 -LDVSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIA 389

Query: 437 -TLTFINLSFNEFKGMIPSGGIFNSAT 462
            +   ++   N        GG+++ AT
Sbjct: 390 VSPDLLDQFGNPMNIEPGDGGVYDQAT 416

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  129 bits (325), Expect = 8e-32
 Identities = 79/445 (17%), Positives = 152/445 (34%), Gaps = 76/445 (17%)

Query: 14  EFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNV 73
           + S+   L +L  D N L   +   +  L+ LT +    N LT  L +S       L  +
Sbjct: 80  DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTK-LDVS---QNPLLTYL 132

Query: 74  DLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPS 133
           + ++N  T +I   + +   L  L  + N+   +L  +   T +  LD  +N ++ EL  
Sbjct: 133 NCARNTLT-EID--VSHNTQLTELDCHLNKKITKLDVTP-QTQLTTLDCSFNKIT-ELD- 186

Query: 134 DIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIG 193
             +S+   L  L+   NN                      + +L+L              
Sbjct: 187 --VSQNKLLNRLNCDTNN----------------------ITKLDLNQN----------- 211

Query: 194 RLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHN 253
            + LT L    NK+T  I   +  L+ L   + S N L+     ++S LS+L  L     
Sbjct: 212 -IQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQT 264

Query: 254 LFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGR 313
                    +   H+  L+            + + +  Q+Y L      ++  +   L +
Sbjct: 265 DLL-----EIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQ 316

Query: 314 CTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSS 373
              L  L L+   LT  +   +S   +++  L+  +  ++      + K+  +     + 
Sbjct: 317 NPKLVYLYLNNTELT-ELD--VSHNTKLKS-LSCVNAHIQD-FS-SVGKIPALNNNFEAE 370

Query: 374 NKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLN 433
            +        ++N       N    A+  +L D  G+  N+E  D      +       N
Sbjct: 371 GQTITMPKETLTN-------NSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWEN 423

Query: 434 KIHTLTFINLSFNEFKGMIPSGGIF 458
                  +  +F    G I      
Sbjct: 424 LSTDNPAVTYTFTSENGAIVGTVTT 448

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  105 bits (263), Expect = 6e-24
 Identities = 51/263 (19%), Positives = 104/263 (39%), Gaps = 26/263 (9%)

Query: 187 TLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLE 246
           +  D     N    +    ++  +       L+ L SL+  ++ ++  ++  I  L+ L 
Sbjct: 10  SFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLT 67

Query: 247 QLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRS 306
           +L  + N  +  +   L +  +L  L    NKL+    + +  L ++  L  + N+L+  
Sbjct: 68  KLICTSNNIT-TLD--LSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLT-K 120

Query: 307 IPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENV 366
           +   + +   L  L+ + N LT  I   +S   ++   L+   N+    L +  +    +
Sbjct: 121 LD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLTE-LDCHLNKKITKLDV--TPQTQL 172

Query: 367 QEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSG 426
             +D S NK T    + +S    +  +N   N +   L   L     L  +D S N L+ 
Sbjct: 173 TTLDCSFNKITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE 226

Query: 427 IIPISLNKIHTLTFINLSFNEFK 449
            I ++      LT+ + S N   
Sbjct: 227 -IDVTPLT--QLTYFDCSVNPLT 246

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 75.5 bits (186), Expect = 2e-14
 Identities = 41/255 (16%), Positives = 82/255 (32%), Gaps = 31/255 (12%)

Query: 14  EFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNV 73
           + + L +L +     N L  ++  S   LS LT +     +L   + ++   + T L   
Sbjct: 228 DVTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLLE-IDLT---HNTQLIYF 280

Query: 74  DLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPS 133
                    ++  ++ +   L+ L      +T +L  S  N  +  L +    L+ EL  
Sbjct: 281 QAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-ELDLSQ-NPKLVYLYLNNTELT-ELD- 334

Query: 134 DIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIG 193
             +S    L  L     ++            F+S+G    L     A      T+P    
Sbjct: 335 --VSHNTKLKSLSCVNAHIQD----------FSSVGKIPALNNNFEAEGQT-ITMPKETL 381

Query: 194 RLNLTQLLLQENKITGS-----IPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQL 248
             N   + +  + +        I P  G + +  +  ++   LS    A     +     
Sbjct: 382 TNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENGA 441

Query: 249 FLSHNLFSGEIPAAL 263
            +       E P  +
Sbjct: 442 IVGTVTTPFEAPQPI 456

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  150 bits (381), Expect = 2e-40
 Identities = 58/322 (18%), Positives = 105/322 (32%), Gaps = 22/322 (6%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           + D+ L  A+         ++ L L GN L       LA  + L L+ L  N L      
Sbjct: 17  VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE---T 73

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLD 121
               + ++LR +DL+ N+       E+   P++ TL   NN ++ ++  S       N+ 
Sbjct: 74  LDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS-RGQGKKNIY 126

Query: 122 VEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAG 181
           +  N ++  L          + YL L  N + +       V F     +   LE L L  
Sbjct: 127 LANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDT-------VNFAELAASSDTLEHLNLQY 178

Query: 182 MDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISW 241
             +   +   +    L  L L  NK+   + P   + + +  ++L +N L   I   + +
Sbjct: 179 NFI-YDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRF 235

Query: 242 LSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNN 301
              LE   L  N F            +  +  ++   +      +               
Sbjct: 236 SQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAY 294

Query: 302 QLSRSIPPTLGRCTDLYKLDLS 323
                  P   R   L      
Sbjct: 295 CCEDLPAPFADRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  149 bits (378), Expect = 6e-40
 Identities = 67/361 (18%), Positives = 114/361 (31%), Gaps = 72/361 (19%)

Query: 10  AIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTS 69
           AI        R +  ++  ++L   +        N+  + L  N L+  +  +     T 
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ-ISAADLAPFTK 59

Query: 70  LRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSG 129
           L  ++LS N        ++ +   L TL L NN +                         
Sbjct: 60  LELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ------------------------ 93

Query: 130 ELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLP 189
           EL        PS+  LH + NN+                                   + 
Sbjct: 94  ELLV-----GPSIETLHAANNNI---------------------------------SRVS 115

Query: 190 DSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSG-TISAEISWLSQLEQL 248
            S G+     + L  NKIT       G  S +  L+L  N +     +   +    LE L
Sbjct: 116 CSRGQ-GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174

Query: 249 FLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIP 308
            L +N    ++   +     L  LDLS NKL+  +     +   +  + L NN+L   I 
Sbjct: 175 NLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIE 230

Query: 309 PTLGRCTDLYKLDLSYNRLT-GSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQ 367
             L    +L   DL  N    G++    S  + ++     +  +L G    E +      
Sbjct: 231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290

Query: 368 E 368
            
Sbjct: 291 Y 291

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  140 bits (354), Expect = 9e-37
 Identities = 49/255 (19%), Positives = 100/255 (39%), Gaps = 16/255 (6%)

Query: 196 NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLF 255
                 + ++ +  ++     +  N+  L+LS N LS   +A+++  ++LE L LS N+ 
Sbjct: 11  RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70

Query: 256 SGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCT 315
             E    L  L  L  LDL+ N +       L     I +L   NN +S  +  + G+  
Sbjct: 71  Y-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQ-- 120

Query: 316 DLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEG-PLPIELSKLENVQEIDLSSN 374
               + L+ N++T     +      ++  L+L  N+++        +  + ++ ++L  N
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQY-LDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179

Query: 375 KFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNK 434
                          ++ +++S N L   +         +  I +  N L  +I  +L  
Sbjct: 180 FIY--DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRF 235

Query: 435 IHTLTFINLSFNEFK 449
              L   +L  N F 
Sbjct: 236 SQNLEHFDLRGNGFH 250

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  136 bits (344), Expect = 2e-35
 Identities = 53/312 (16%), Positives = 112/312 (35%), Gaps = 53/312 (16%)

Query: 133 SDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSI 192
            +I           ++ +++         +   +   +  +++EL+L+G  L       +
Sbjct: 3   HEIKQNGNRYKIEKVTDSSL------KQALA--SLRQSAWNVKELDLSGNPLSQISAADL 54

Query: 193 GRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLS 251
                L  L L  N +       + +LS L +L+L++N +      E+     +E L  +
Sbjct: 55  APFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAA 107

Query: 252 HNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSR-SIPPT 310
           +N  S  +  + G+      + L+ NK++    +  G   ++  L L  N++   +    
Sbjct: 108 NNNIS-RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164

Query: 311 LGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEID 370
                 L  L+L YN +   +  ++    +++  L+LS N+L   +  E      V  I 
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKT-LDLSSNKLAF-MGPEFQSAAGVTWIS 220

Query: 371 LSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIP- 429
           L +NK                            +  +L   +NLE  D+ GN        
Sbjct: 221 LRNNKLV-------------------------LIEKALRFSQNLEHFDLRGNGFHCGTLR 255

Query: 430 ---ISLNKIHTL 438
                  ++ T+
Sbjct: 256 DFFSKNQRVQTV 267

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 93.5 bits (233), Expect = 6e-21
 Identities = 36/241 (14%), Positives = 73/241 (30%), Gaps = 19/241 (7%)

Query: 14  EFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNV 73
           E      +  L    NN+  ++  S         + L +N +T ML        + ++ +
Sbjct: 94  ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKIT-MLRDLDEGCRSRVQYL 149

Query: 74  DLSQNFFTG-KIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELP 132
           DL  N        E   +   L  L+L  N +   +   ++   +  LD+  N L+  + 
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FMG 207

Query: 133 SDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSI 192
            +       +T++ L  N +V        +    +L    +LE  +L G           
Sbjct: 208 PEF-QSAAGVTWISLRNNKLVL-------IE--KALRFSQNLEHFDLRGNGF-HCGTLRD 256

Query: 193 GRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEI-SWLSQLEQLFLS 251
                 ++     +    +         + +L          + A     L  L      
Sbjct: 257 FFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316

Query: 252 H 252
           H
Sbjct: 317 H 317

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 44.2 bits (105), Expect = 1e-04
 Identities = 16/66 (24%), Positives = 29/66 (43%)

Query: 391 RLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKG 450
           ++  ++ ++L+  L        N++ +D+SGN LS I    L     L  +NLS N    
Sbjct: 13  KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE 72

Query: 451 MIPSGG 456
            +    
Sbjct: 73  TLDLES 78

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  148 bits (375), Expect = 4e-38
 Identities = 72/324 (22%), Positives = 125/324 (38%), Gaps = 22/324 (6%)

Query: 10  AIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTS 69
           A+P         R L L  N +     +  A   +L  + L++N ++  +    F+N  +
Sbjct: 25  AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFN 81

Query: 70  LRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNLDVEYNHL 127
           LR + L  N     IP  +     NL  L +  N++   L     +  ++ +L+V  N L
Sbjct: 82  LRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL 140

Query: 128 SGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGT 187
              +     S L SL  L L   N+ S           + L     L  L L  +++   
Sbjct: 141 V-YISHRAFSGLNSLEQLTLEKCNLTSIPTEA-----LSHLHG---LIVLRLRHLNINAI 191

Query: 188 LPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAE-ISWLSQL 245
              S  RL  L  L +       ++ P+     NL SL+++   L+  +    +  L  L
Sbjct: 192 RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYL 250

Query: 246 EQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPV-SLGNLVQIYSLFLNNNQLS 304
             L LS+N  S    + L +L  L  + L   +L+  +   +   L  +  L ++ NQL+
Sbjct: 251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT 309

Query: 305 RSIPP-TLGRCTDLYKLDLSYNRL 327
            ++         +L  L L  N L
Sbjct: 310 -TLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  144 bits (365), Expect = 6e-37
 Identities = 74/309 (23%), Positives = 142/309 (45%), Gaps = 20/309 (6%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           L  N +      EF+    L  L+L+ N +    P +   L NL  + L  N L  ++P+
Sbjct: 39  LGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPL 97

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLIN--TSMY 118
             F   ++L  +D+S+N     + + +  +  NL +L + +N L   +     +   S+ 
Sbjct: 98  GVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLE 155

Query: 119 NLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELE 178
            L +E  +L+  +P++ +S L  L  L L + N+ +  D +              L+ LE
Sbjct: 156 QLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYS--------FKRLYRLKVLE 206

Query: 179 LAGMDLGGTLPDSIGR-LNLTQLLLQENKITGSIPPH-IGNLSNLISLNLSSNLLSGTIS 236
           ++      T+  +    LNLT L +    +T ++P   + +L  L  LNLS N +S TI 
Sbjct: 207 ISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIE 264

Query: 237 AEI-SWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYS 295
             +   L +L+++ L     +   P A   L++L +L++S N+L+        ++  + +
Sbjct: 265 GSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLET 324

Query: 296 LFLNNNQLS 304
           L L++N L+
Sbjct: 325 LILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  135 bits (341), Expect = 9e-34
 Identities = 76/409 (18%), Positives = 142/409 (34%), Gaps = 94/409 (22%)

Query: 22  RHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFT 81
           R +          +PE   + +   L+ L  N +   L    F +   L  ++L++N  +
Sbjct: 14  RAVLCHRKRFV-AVPE--GIPTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVS 69

Query: 82  GKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLP 140
             +      N  NL TL L +N+L                          +P  + + L 
Sbjct: 70  -AVEPGAFNNLFNLRTLGLRSNRLK------------------------LIPLGVFTGLS 104

Query: 141 SLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQL 200
           +LT L +S N +V   D       F  L N                          L  L
Sbjct: 105 NLTKLDISENKIVILLDYM-----FQDLYN--------------------------LKSL 133

Query: 201 LLQENKITGSIPPHI-GNLSNLISLNLSSNLLSGTISAEI-SWLSQLEQLFLSHNLFSGE 258
            + +N +   I       L++L  L L    L+ +I  E  S L  L  L L H   +  
Sbjct: 134 EVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAI 191

Query: 259 IPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPP-TLGRCTDL 317
              +  +L+ L +L++S       +  +    + + SL + +  L+ ++P   +     L
Sbjct: 192 RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYL 250

Query: 318 YKLDLSYNRLTGSIPAEI-SGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKF 376
             L+LSYN ++ +I   +   +  ++  + L   QL    P     L  ++ +++S N+ 
Sbjct: 251 RFLNLSYNPIS-TIEGSMLHELLRLQ-EIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQL 308

Query: 377 TGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLS 425
           T                 +  +            + NLE + +  N L+
Sbjct: 309 T----------------TLEESVFHS--------VGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  130 bits (329), Expect = 3e-32
 Identities = 70/355 (19%), Positives = 128/355 (36%), Gaps = 67/355 (18%)

Query: 96  TLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSH 155
            +  +  +    +P   I T    LD+  N +   L  D  +  P L  L L+ N + + 
Sbjct: 15  AVLCHRKRFV-AVPEG-IPTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAV 71

Query: 156 DDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHI 215
           +        FN+L N                          L  L L+ N++   IP  +
Sbjct: 72  EPGA-----FNNLFN--------------------------LRTLGLRSNRLK-LIPLGV 99

Query: 216 -GNLSNLISLNLSSNLLSGTISAEI-SWLSQLEQLFLSHNLFSGEIPA-ALGKLHHLGLL 272
              LSNL  L++S N +   +   +   L  L+ L +  N     I   A   L+ L  L
Sbjct: 100 FTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQL 157

Query: 273 DLSFNKLSGEIPV-SLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSI 331
            L    L+  IP  +L +L  +  L L +  ++     +  R   L  L++S+     ++
Sbjct: 158 TLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTM 216

Query: 332 PAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVR 391
                    +   L+++H  L     + +  L  ++ ++LS N  +              
Sbjct: 217 TPNCLYGLNLT-SLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-------------- 261

Query: 392 LINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFN 446
              I  + L          L  L+ I + G  L+ + P +   ++ L  +N+S N
Sbjct: 262 --TIEGSMLHE--------LLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN 306

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  111 bits (280), Expect = 5e-26
 Identities = 54/265 (20%), Positives = 100/265 (37%), Gaps = 36/265 (13%)

Query: 196 NLTQLLLQENKITGSIPPHI-GNLSNLISLNLSSNLLSGTISAEI-SWLSQLEQLFLSHN 253
               L L +N+I  ++      +  +L  L L+ N++S  +     + L  L  L L  N
Sbjct: 33  ETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSN 90

Query: 254 LFSGEIPA-ALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPP-TL 311
                IP      L +L  LD+S NK+   +     +L  + SL + +N L   I     
Sbjct: 91  RLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAF 148

Query: 312 GRCTDLYKLDLSYNRLTGSIPAEI-SGIREIRIFLNLSHNQLEGPLPIELSKLENVQEID 370
                L +L L    LT SIP E  S +  + + L L H  +         +L  ++ ++
Sbjct: 149 SGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIV-LRLRHLNINAIRDYSFKRLYRLKVLE 206

Query: 371 LSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPI 430
           +S   +   +                          +     NL ++ ++  +L+ +  +
Sbjct: 207 ISHWPYLDTM------------------------TPNCLYGLNLTSLSITHCNLTAVPYL 242

Query: 431 SLNKIHTLTFINLSFNEFKGMIPSG 455
           ++  +  L F+NLS+N     I   
Sbjct: 243 AVRHLVYLRFLNLSYNPIS-TIEGS 266

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 88.2 bits (219), Expect = 2e-18
 Identities = 38/203 (18%), Positives = 79/203 (38%), Gaps = 13/203 (6%)

Query: 258 EIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPP-TLGRCTD 316
            +P  +       LLDL  N++         +   +  L LN N +S ++ P       +
Sbjct: 25  AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFN 81

Query: 317 LYKLDLSYNRLTGSIPAEI-SGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNK 375
           L  L L  NRL   IP  + +G+  +   L++S N++   L      L N++ +++  N 
Sbjct: 82  LRTLGLRSNRLK-LIPLGVFTGLSNLTK-LDISENKIVILLDYMFQDLYNLKSLEVGDND 139

Query: 376 FT---GNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISL 432
                   F   S   ++  + +    L     ++L  L  L  + +   +++ I   S 
Sbjct: 140 LVYISHRAF---SGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSF 196

Query: 433 NKIHTLTFINLSFNEFKGMIPSG 455
            +++ L  + +S   +   +   
Sbjct: 197 KRLYRLKVLEISHWPYLDTMTPN 219

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  144 bits (365), Expect = 1e-36
 Identities = 77/466 (16%), Positives = 166/466 (35%), Gaps = 32/466 (6%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           +  N++      +   L +LR L +  N +             L  + L  N L   +  
Sbjct: 28  ISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-IS- 85

Query: 62  SFFHNCTSLRNVDLSQNFFTG-KIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNL 120
              H   +L+++DLS N F    I +E GN   L  L L    L            + +L
Sbjct: 86  --CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE-----KSSVLPIAHL 138

Query: 121 DVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELA 180
           ++    L              L   +    ++V   +         S+    +LE   + 
Sbjct: 139 NISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIK 198

Query: 181 GMDLGGTLPDSIGRL-------NLTQLLLQENKITGSIPPHIGNL---SNLISLNLSSNL 230
            +         +  L        L+ L L   + T +    I  L   + +   ++S+  
Sbjct: 199 CVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVK 258

Query: 231 LSGTISAEISWLS-----QLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPV 285
           L G +       S      L    +  ++F            ++ + + + +       +
Sbjct: 259 LQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHML 318

Query: 286 SLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIR--I 343
               +     L  +NN L+ ++    G  T+L  L L  N+L   +        +++   
Sbjct: 319 CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQ 377

Query: 344 FLNLSHNQLEGPLPIEL-SKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQG 402
            L++S N +         S  +++  +++SSN  T  IF  +     ++++++  N ++ 
Sbjct: 378 QLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNKIK- 434

Query: 403 NLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEF 448
           ++P  +  L+ L+ ++V+ N L  +     +++ +L  I L  N +
Sbjct: 435 SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 93.0 bits (231), Expect = 9e-20
 Identities = 72/386 (18%), Positives = 132/386 (34%), Gaps = 32/386 (8%)

Query: 96  TLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSH 155
            +    N L   +P   ++     L++  N++S EL +  +  L  L  L +S+N +   
Sbjct: 4   LVDRSKNGLI-HVPKD-LSQKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYL 60

Query: 156 DDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPH- 214
           D +      F       +LE L+L+   L           NL  L L  N    ++P   
Sbjct: 61  DISV-----FKFN---QELEYLDLSHNKLVKISCHPTV--NLKHLDLSFNAFD-ALPICK 109

Query: 215 -IGNLSNLISLNLSSNLLSGTISAEISWLSQLE-QLFLSHNLFSGEIPAAL-----GKLH 267
             GN+S L  L LS+  L  +    I+ L+  +  L L       E P  L       LH
Sbjct: 110 EFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLH 169

Query: 268 HLGLLDLSFNKLSGEIPVSLGNLVQI---YSLFLNNNQLSRSIPPTLGRCTDLYKLDLSY 324
            +   +  F+ +      ++ NL        L  N      SI   L     L  L L+ 
Sbjct: 170 IVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNN 229

Query: 325 NRLTGSIPAEISGIREIR--IFLNLSHNQLEGPLPIEL-----SKLENVQEIDLSSNKFT 377
              T +    I  +       + ++S+ +L+G L         + L+ +    + S+ F 
Sbjct: 230 IETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG 289

Query: 378 GNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHT 437
                       + + N + +  +         +     +D S N L+  +  +   +  
Sbjct: 290 FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTE 349

Query: 438 LTFINLSFNEFKGMIPSGGIFNSATK 463
           L  + L  N+ K +     +      
Sbjct: 350 LETLILQMNQLKELSKIAEMTTQMKS 375

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 75.3 bits (185), Expect = 3e-14
 Identities = 28/195 (14%), Positives = 74/195 (37%), Gaps = 7/195 (3%)

Query: 272 LDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSI 331
           L++S N +S      + +L ++  L +++N++            +L  LDLS+N+L    
Sbjct: 26  LNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKIS 85

Query: 332 PAEISGIREIRIFLNLSHNQLEG-PLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAV 390
                 ++     L+LS N  +  P+  E   +  ++ + LS+     +  + I++    
Sbjct: 86  CHPTVNLKH----LDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNIS 141

Query: 391 RLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKG 450
           +++ +          +    L++     +     +      +  +   T  NL  +  K 
Sbjct: 142 KVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKC 199

Query: 451 MIPSGGIFNSATKMS 465
           ++         + ++
Sbjct: 200 VLEDNKCSYFLSILA 214

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 35/198 (17%), Positives = 69/198 (34%), Gaps = 14/198 (7%)

Query: 320 LDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTG- 378
           +D S N L   +P ++S    I   LN+S N +      ++  L  ++ + +S N+    
Sbjct: 5   VDRSKNGLI-HVPKDLSQKTTI---LNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60

Query: 379 --NIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGI-IPISLNKI 435
             ++F        +  +++SHN L   +        NL+ +D+S N    + I      +
Sbjct: 61  DISVFKFNQE---LEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNM 114

Query: 436 HTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPGMPICPPKQHWLHTRMYF 495
             L F+ LS    +          + +K+  V  +          +       LH     
Sbjct: 115 SQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT 174

Query: 496 IIFVLVISISAFLSTICL 513
                 I   +  +   L
Sbjct: 175 NKEFHFILDVSVKTVANL 192

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  138 bits (350), Expect = 1e-36
 Identities = 73/299 (24%), Positives = 120/299 (40%), Gaps = 60/299 (20%)

Query: 564 LLGTGSYGRVYKGI-LQDGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNLMRIIT 620
            +G GS+  VYKG+  +    +A   LQ    + +  + F  E ++LK ++H N++R   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 621 ACSLPDFKA----LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           +            LV   M +G+L ++L       F      + +    + C  I +G+ 
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL-----KRFKV----MKIKVLRSWCRQILKGLQ 143

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALV--SDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           +LH  +P  +IH DLK  N+ +    T  V   D G+A L                S A 
Sbjct: 144 FLHTRTP-PIIHRDLKCDNIFITG-PTGSVKIGDLGLATL-------------KRASFAK 188

Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
            + G+  +MAPE  +        DVY+FG+ +LEM T   P  +       +++ V +  
Sbjct: 189 AVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSE-CQNAAQIYRRVTS-- 244

Query: 795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDL 853
            G      D           PEVK        E+IE    C +++   R +      DL
Sbjct: 245 -GVKPASFDK-------VAIPEVK--------EIIE---GCIRQNKDERYS----IKDL 280

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  138 bits (350), Expect = 2e-36
 Identities = 72/314 (22%), Positives = 124/314 (39%), Gaps = 57/314 (18%)

Query: 562 QRLLGTGSYGRVYKGILQDG----TAIAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNLM 616
             ++G G +G VY G L D        AVK L   +     S F  E  ++K   H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 617 RIITACSLPDFKAL-VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
            ++  C   +   L VLPYM +G L + +   +         + T+   +     +A+GM
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGM 141

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL      + +H DL   N +L++  T  V+DFG+A+ +      +    ++ N T   
Sbjct: 142 KYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY-----DKEYYSVHNKTGAK 193

Query: 736 LCGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLSLHKWV 790
           L   + +MA E      F    +TK DV+SFG+L+ E++TR   P  D+      +  ++
Sbjct: 194 L--PVKWMALESLQTQKF----TTKSDVWSFGVLLWELMTRGAPPYPDV--NTFDITVYL 245

Query: 791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAA 850
                 RL +                           L E+ + C       RP+  +  
Sbjct: 246 LQGR--RLLQPEYCP--------------------DPLYEVMLKCWHPKAEMRPSFSELV 283

Query: 851 DDLDRLKRYLGEKH 864
             +  +      +H
Sbjct: 284 SRISAIFSTFIGEH 297

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  138 bits (350), Expect = 2e-36
 Identities = 65/325 (20%), Positives = 130/325 (40%), Gaps = 63/325 (19%)

Query: 558 EFDEQRL-----LGTGSYGRVYKGIL-----QDGTAIAVKVLQLQSGNFTKS-FNRECQV 606
            F+++ L     LG G +G+V            G  +AVK L+ +SG    +   +E ++
Sbjct: 17  HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 76

Query: 607 LKRIRHRNLMRIITACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           L+ + H N+++    C+        L++ ++ +GSL  +L  +           + L Q+
Sbjct: 77  LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK--------INLKQQ 128

Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
           +     I +GM YL      + +H DL   NVL+  +    + DFG+ K    +    + 
Sbjct: 129 LKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA---IETDKEY 182

Query: 725 --AENMGNSTANMLCGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
              ++  +S        + + APE      F        DV+SFG+ + E++T     D 
Sbjct: 183 YTVKDDRDS-------PVFWYAPECLMQSKF----YIASDVWSFGVTLHELLTY---CDS 228

Query: 779 MFAGGLSLHKWVKNHYHG-RLEKVIDSSLLRASR----DQSPEVKRMWDVAIGELIELGI 833
             +      K +   +    + ++++ +L    R       P+          E+ +L  
Sbjct: 229 DSSPMALFLKMIGPTHGQMTVTRLVN-TLKEGKRLPCPPNCPD----------EVYQLMR 277

Query: 834 LCTQESPSTRPTMLDAADDLDRLKR 858
            C +  PS R +  +  +  + L +
Sbjct: 278 KCWEFQPSNRTSFQNLIEGFEALLK 302

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  137 bits (347), Expect = 5e-36
 Identities = 69/315 (21%), Positives = 131/315 (41%), Gaps = 57/315 (18%)

Query: 561 EQRLLGTGSYGRVYKGILQDG----TAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
             R++G G +G VY G   D        A+K L ++      ++F RE  +++ + H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 616 MRIITACSLPD-FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           + +I     P+    ++LPYM +G L   +             + T+   ++    +A G
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR--------NPTVKDLISFGLQVARG 136

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           M YL   +  + +H DL   N +L++  T  V+DFG+A+ ++     +    ++      
Sbjct: 137 MEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL-----DREYYSVQQHRHA 188

Query: 735 MLCGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLSLHKW 789
            L   + + A E      F    +TK DV+SFG+L+ E++TR   P   +      L  +
Sbjct: 189 RL--PVKWTALESLQTYRF----TTKSDVWSFGVLLWELLTRGAPPYRHI--DPFDLTHF 240

Query: 790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDA 849
           +      RL +           +  P+           L ++   C +  P+ RPT    
Sbjct: 241 LAQGR--RLPQP----------EYCPD----------SLYQVMQQCWEADPAVRPTFRVL 278

Query: 850 ADDLDRLKRYLGEKH 864
             +++++   L   H
Sbjct: 279 VGEVEQIVSALLGDH 293

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  138 bits (349), Expect = 6e-36
 Identities = 60/241 (24%), Positives = 103/241 (42%), Gaps = 47/241 (19%)

Query: 558 EFDEQRL-----LGTGSYGRVYKGILQDG-----TAIAVKVLQLQSGNFTKS-FNRECQV 606
            F E  L     LG+G +G V+KG+           + +KV++ +SG  +          
Sbjct: 9   IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68

Query: 607 LKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN 666
           +  + H +++R++  C     + LV  Y+  GSL  H+  H           L     +N
Sbjct: 69  IGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGA--------LGPQLLLN 119

Query: 667 ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               IA+GM YL  H    ++H +L   NVLL       V+DFG+A L+       D  +
Sbjct: 120 WGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL-----PPDDKQ 171

Query: 727 NMGNSTANMLCGS---IGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDD 778
            + +        +   I +MA E   +G +    + + DV+S+G+ V E++T    P   
Sbjct: 172 LLYS-------EAKTPIKWMALESIHFGKY----THQSDVWSYGVTVWELMTFGAEPYAG 220

Query: 779 M 779
           +
Sbjct: 221 L 221

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  136 bits (346), Expect = 6e-36
 Identities = 59/233 (25%), Positives = 82/233 (35%), Gaps = 42/233 (18%)

Query: 562 QRLLGTGSYGRVYKGILQ----DGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRHRN 614
              LG GS+G V +G          ++AVK L+   L        F RE   +  + HRN
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           L+R+      P  K +V      GSL   L  H             L         +AEG
Sbjct: 83  LIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH--------FLLGTLSRYAVQVAEG 133

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           M YL      R IH DL   N+LL       + DFG+ + +              +    
Sbjct: 134 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL-----------PQNDDHYV 179

Query: 735 MLCGS---IGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
           M         + APE      F    S   D + FG+ + EM T  + P   +
Sbjct: 180 MQEHRKVPFAWCAPESLKTRTF----SHASDTWMFGVTLWEMFTYGQEPWIGL 228

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  141 bits (358), Expect = 6e-36
 Identities = 67/300 (22%), Positives = 129/300 (43%), Gaps = 49/300 (16%)

Query: 562 QRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNLMRII 619
           +  LG G YG VY+G+ +     +AVK L+          F +E  V+K I+H NL++++
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNLVQLL 282

Query: 620 TACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLH 679
             C+      ++  +M  G+L  +L             +++ +  + + + I+  M YL 
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLREC-------NRQEVSAVVLLYMATQISSAMEYLE 335

Query: 680 HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS 739
                  IH +L   N L+ ++    V+DFG+++L+           +   + A      
Sbjct: 336 KK---NFIHRNLAARNCLVGENHLVKVADFGLSRLM---------TGDTYTAHAGAKF-P 382

Query: 740 IGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLSLHKWVKNHYHGRL 798
           I + APE    +  S K DV++FG+L+ E+ T    P   +      +++ ++  Y  R+
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDY--RM 438

Query: 799 EKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR 858
           E+           +  PE          ++ EL   C Q +PS RP+  +     + + +
Sbjct: 439 ERP----------EGCPE----------KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  137 bits (346), Expect = 6e-36
 Identities = 56/217 (25%), Positives = 102/217 (47%), Gaps = 24/217 (11%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
            +LG G+YG VY G  L +   IA+K +  +   +++  + E  + K ++H+N+++ + +
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
            S   F  + +  +  GSL + L     +++G    +   +        I EG+ YLH +
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIG--FYTKQILEGLKYLHDN 141

Query: 682 SPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
              +++H D+K  NVL+N     L +SDFG +K +  +           N       G++
Sbjct: 142 ---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI-----------NPCTETFTGTL 187

Query: 741 GYMAPE--YGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            YMAPE             D++S G  ++EM T + P
Sbjct: 188 QYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  137 bits (347), Expect = 9e-36
 Identities = 57/231 (24%), Positives = 102/231 (44%), Gaps = 42/231 (18%)

Query: 563 RLLGTGSYGRVYKGILQDG-----TAIAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNLM 616
           ++LG+G++G VYKG+           +A+K L+  +          E  V+  + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           R++  C     + L+   M  G L  ++  H +         +     +N C  IA+GM 
Sbjct: 81  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGMN 131

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL      R++H DL   NVL+       ++DFG+AKL+     G +  E          
Sbjct: 132 YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----GAEEKEYHAE------ 177

Query: 737 CGS---IGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
            G    I +MA E   +  +    + + DV+S+G+ V E++T   +P D +
Sbjct: 178 -GGKVPIKWMALESILHRIY----THQSDVWSYGVTVWELMTFGSKPYDGI 223

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  136 bits (344), Expect = 1e-35
 Identities = 60/233 (25%), Positives = 100/233 (42%), Gaps = 45/233 (19%)

Query: 558 EFDEQRL-----LGTGSYGRVYKGIL-----QDGTAIAVKVLQLQSGNFTKSFNRECQVL 607
           +F+E+ L     LG G++G V            G  +AVK LQ  +    + F RE ++L
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65

Query: 608 KRIRHRNLMRIITACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRV 665
           K ++H N+++    C     +   L++ Y+  GSL  +L  H E         +  ++ +
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--------IDHIKLL 117

Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGA 725
              S I +GM YL      R IH DL   N+L+ ++    + DFG+ K++          
Sbjct: 118 QYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-------- 166

Query: 726 ENMGNSTANMLCGS---IGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVT 771
                    +       I + APE      F    S   DV+SFG+++ E+ T
Sbjct: 167 ---DKEFFKVKEPGESPIFWYAPESLTESKF----SVASDVWSFGVVLYELFT 212

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  137 bits (346), Expect = 1e-35
 Identities = 76/346 (21%), Positives = 130/346 (37%), Gaps = 77/346 (22%)

Query: 558 EFDEQRL-----LGTGSYGRVYKGILQDG----TAIAVKVLQLQSGNFT--KSFNRECQV 606
              EQ+      LG G +G V +  L+        +AVK+L+      +  + F RE   
Sbjct: 19  LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAAC 78

Query: 607 LKRIRHRNLMRIITACSLPDFKA------LVLPYMANGSLDSHLYPHSETEFGSGSSDLT 660
           +K   H ++ +++        K       ++LP+M +G L + L      E      +L 
Sbjct: 79  MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE---NPFNLP 135

Query: 661 LLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGV 720
           L   V    DIA GM YL   S    IH DL   N +L +DMT  V+DFG+++ + +   
Sbjct: 136 LQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS--- 189

Query: 721 GNDGAENMGNSTANMLCGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRP 775
             D       S    L   + ++A E      +    +   DV++FG+ + E++TR + P
Sbjct: 190 -GDYYRQGCAS---KL--PVKWLALESLADNLY----TVHSDVWAFGVTMWEIMTRGQTP 239

Query: 776 TDDMFAGGLSLHKWVKNHYHGR-----LEKVIDSSLLRASRDQSPEVKR-MWDVAIGELI 829
                             Y G         +I  + L+   +   EV   M+        
Sbjct: 240 ------------------YAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQ------- 274

Query: 830 ELGILCTQESPSTRPTMLDAADDLDRLKRYLGEKHMPSKMNALHLE 875
                C    P  RP+      +L+ +  +L           +++E
Sbjct: 275 -----CWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYINIE 315

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  136 bits (345), Expect = 2e-35
 Identities = 66/265 (24%), Positives = 107/265 (40%), Gaps = 40/265 (15%)

Query: 523 IISSGKSETRSKPITPELMHNFPRITYRELLEATAEFDEQRL-----LGTGSYGRVYKGI 577
                       P T  L       +  E  + T +F+E+ L     LG G++G V    
Sbjct: 3   YYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPT-QFEERHLKFLQQLGKGNFGSVEMCR 61

Query: 578 L-----QDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKA--L 630
                   G  +AVK LQ  +    + F RE ++LK ++H N+++    C     +   L
Sbjct: 62  YDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 121

Query: 631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCD 690
           ++ Y+  GSL  +L  H E         +  ++ +   S I +GM YL      R IH D
Sbjct: 122 IMEYLPYGSLRDYLQKHKER--------IDHIKLLQYTSQICKGMEYLGTK---RYIHRD 170

Query: 691 LKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPE---Y 747
           L   N+L+ ++    + DFG+ K++          E             I + APE    
Sbjct: 171 LATRNILVENENRVKIGDFGLTKVL------PQDKEYYKVKEPGES--PIFWYAPESLTE 222

Query: 748 G-FGSNTSTKGDVYSFGILVLEMVT 771
             F    S   DV+SFG+++ E+ T
Sbjct: 223 SKF----SVASDVWSFGVVLYELFT 243

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  139 bits (352), Expect = 2e-35
 Identities = 75/307 (24%), Positives = 125/307 (40%), Gaps = 57/307 (18%)

Query: 562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
            + +G G +G V  G  + G  +AVK ++  +    ++F  E  V+ ++RH NL++++  
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGV 254

Query: 622 CSL--PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLH 679
                     +V  YMA GSL  +L          G S L     +    D+ E M YL 
Sbjct: 255 IVEEKGGL-YIVTEYMAKGSLVDYLRSR-------GRSVLGGDCLLKFSLDVCEAMEYLE 306

Query: 680 HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS 739
            +     +H DL   NVL+++D  A VSDFG+ K   +                      
Sbjct: 307 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-------------- 349

Query: 740 IGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLSLHKWVKNHYHGRL 798
           + + APE       STK DV+SFGIL+ E+ +  R P   +      +   V+  Y  ++
Sbjct: 350 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGY--KM 405

Query: 799 EKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR 858
           +            D  P            + ++   C     +TRPT L   + L+ ++ 
Sbjct: 406 DAP----------DGCPP----------AVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445

Query: 859 YLGEKHM 865
           +  E H+
Sbjct: 446 H--ELHL 450

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  137 bits (348), Expect = 2e-35
 Identities = 69/307 (22%), Positives = 121/307 (39%), Gaps = 61/307 (19%)

Query: 562 QRLLGTGSYGRVYKGILQ-DGTAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMRII 619
              +G G++G V+ G L+ D T +AVK   +    +    F +E ++LK+  H N++R+I
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 620 TACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLH 679
             C+      +V+  +  G   + L         +  + L +   + +  D A GM YL 
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL--------RTEGARLRVKTLLQMVGDAAAGMEYLE 230

Query: 680 HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS 739
                  IH DL   N L+ +     +SDFG+++         DG          +    
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE------ADGVYAASGGLRQV---P 278

Query: 740 IGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLSLH---KWVK 791
           + + APE   YG +    S++ DV+SFGIL+ E  +    P  ++     S     ++V+
Sbjct: 279 VKWTAPEALNYGRY----SSESDVWSFGILLWETFSLGASPYPNL-----SNQQTREFVE 329

Query: 792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAAD 851
                RL                PE      +    +  L   C    P  RP+      
Sbjct: 330 KGG--RLPC--------------PE------LCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367

Query: 852 DLDRLKR 858
           +L  +++
Sbjct: 368 ELQSIRK 374

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  135 bits (343), Expect = 2e-35
 Identities = 61/235 (25%), Positives = 104/235 (44%), Gaps = 39/235 (16%)

Query: 558 EFDEQRL-----LGTGSYGRVYKGILQDG----TAIAVKVLQLQSGNFT--KSFNRECQV 606
             D   L     LG G +G V +G L+        +AVK ++L + +    + F  E   
Sbjct: 30  VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAAC 89

Query: 607 LKRIRHRNLMRIITACSLPDFKA-----LVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
           +K   H N++R++  C     +      ++LP+M  G L ++L         +G   + L
Sbjct: 90  MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE---TGPKHIPL 146

Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
              +    DIA GM YL   S    +H DL   N +L DDMT  V+DFG++K + +    
Sbjct: 147 QTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYS---- 199

Query: 722 NDGAENMGNSTANMLCGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR 772
            D       +    +   + ++A E      +    ++K DV++FG+ + E+ TR
Sbjct: 200 GDYYRQGRIA---KM--PVKWIAIESLADRVY----TSKSDVWAFGVTMWEIATR 245

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  136 bits (344), Expect = 2e-35
 Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 43/232 (18%)

Query: 558 EFDEQRL-----LGTGSYGRVYKGIL-----QDGTAIAVKVLQLQSGNFTKSFNRECQVL 607
            F+E+ L     LG G++G V            G  +AVK LQ    +  + F RE Q+L
Sbjct: 19  IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 78

Query: 608 KRIRHRNLMRIITACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRV 665
           K +    +++       P  ++  LV+ Y+ +G L   L  H           L   + +
Sbjct: 79  KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--------LDASRLL 130

Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG- 724
              S I +GM YL      R +H DL   N+L+  +    ++DFG+AKL   + +  D  
Sbjct: 131 LYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL---LPLDKDYY 184

Query: 725 -AENMGNSTANMLCGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVT 771
                G S        I + APE      F    S + DV+SFG+++ E+ T
Sbjct: 185 VVREPGQS-------PIFWYAPESLSDNIF----SRQSDVWSFGVVLYELFT 225

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  135 bits (343), Expect = 3e-35
 Identities = 59/228 (25%), Positives = 105/228 (46%), Gaps = 33/228 (14%)

Query: 562 QRLLGTGSYGRVYKGILQDG----TAIAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNLM 616
           ++++G+G  G V  G L+        +A+K L+       +  F  E  ++ +  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           R+    +      +V  YM NGSLD+ L  H            T++Q V +   +  GM 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--------FTIMQLVGMLRGVGAGMR 165

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL        +H DL   NVL++ ++   VSDFG+++++       D  +    +T   +
Sbjct: 166 YLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE------DDPDAAYTTTGGKI 216

Query: 737 CGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
              I + APE   +  F    S+  DV+SFG+++ E++    RP  +M
Sbjct: 217 --PIRWTAPEAIAFRTF----SSASDVWSFGVVMWEVLAYGERPYWNM 258

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  138 bits (349), Expect = 5e-35
 Identities = 78/300 (26%), Positives = 126/300 (42%), Gaps = 49/300 (16%)

Query: 562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +  LG G +G V+ G     T +A+K L+       ++F +E QV+K++RH  L+++   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 622 CSL-PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
            S  P +  +V  YM+ GSL   L              L L Q V++ + IA GMAY+  
Sbjct: 248 VSEEPIY--IVTEYMSKGSLLDFLKGE-------TGKYLRLPQLVDMAAQIASGMAYVER 298

Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
                 +H DL+ +N+L+ +++   V+DFG+A+L+                        I
Sbjct: 299 M---NYVHRDLRAANILVGENLVCKVADFGLARLIE--------DNEYTARQGAKF--PI 345

Query: 741 GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLSLHKWVKNHYHGRLE 799
            + APE       + K DV+SFGIL+ E+ T+ R P   M      +   V+  Y  R+ 
Sbjct: 346 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVERGY--RMP 401

Query: 800 KVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRY 859
                        + PE           L +L   C ++ P  RPT       L+     
Sbjct: 402 CP----------PECPE----------SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  133 bits (338), Expect = 7e-35
 Identities = 71/303 (23%), Positives = 129/303 (42%), Gaps = 57/303 (18%)

Query: 563 RLLGTGSYGRVYKGILQDG-TAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
             LG G YG VY+G+ +     +AVK L+  +    + F +E  V+K I+H NL++++  
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
           C+      ++  +M  G+L  +L             +++ +  + + + I+  M YL   
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLREC-------NRQEVSAVVLLYMATQISSAMEYLEKK 130

Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIG 741
                IH DL   N L+ ++    V+DFG+++L+        G     ++ A      I 
Sbjct: 131 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLM-------TGDTYTAHAGAKF---PIK 177

Query: 742 YMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLSLHKWVKNHYHG 796
           + APE   Y  F    S K DV++FG+L+ E+ T    P   +      L +  +     
Sbjct: 178 WTAPESLAYNKF----SIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVYELLEKD 228

Query: 797 -RLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDR 855
            R+E+           +  PE          ++ EL   C Q +PS RP+  +     + 
Sbjct: 229 YRMER----------PEGCPE----------KVYELMRACWQWNPSDRPSFAEIHQAFET 268

Query: 856 LKR 858
           + +
Sbjct: 269 MFQ 271

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  133 bits (336), Expect = 7e-35
 Identities = 54/223 (24%), Positives = 102/223 (45%), Gaps = 31/223 (13%)

Query: 562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
            + +G+G +G V+ G   +   +A+K ++  + +  + F  E +V+ ++ H  L+++   
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
           C       LV  +M +G L  +L                    + +C D+ EGMAYL   
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRGL--------FAAETLLGMCLDVCEGMAYLEEA 123

Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIG 741
               VIH DL   N L+ ++    VSDFG+ + V+         +   +ST       + 
Sbjct: 124 ---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--------DQYTSSTGTKF--PVK 170

Query: 742 YMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
           + +PE   +  +    S+K DV+SFG+L+ E+ +  + P ++ 
Sbjct: 171 WASPEVFSFSRY----SSKSDVWSFGVLMWEVFSEGKIPYENR 209

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  136 bits (343), Expect = 8e-35
 Identities = 70/314 (22%), Positives = 124/314 (39%), Gaps = 57/314 (18%)

Query: 562 QRLLGTGSYGRVYKGILQDG----TAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLM 616
             ++G G +G VY G L D        AVK L ++        F  E  ++K   H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 617 RIITACSLPDFKAL-VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
            ++  C   +   L VLPYM +G L + +   +           T+   +     +A+GM
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--------PTVKDLIGFGLQVAKGM 205

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            +L      + +H DL   N +L++  T  V+DFG+A+ +      +   +++ N T   
Sbjct: 206 KFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY-----DKEFDSVHNKTGAK 257

Query: 736 LCGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLSLHKWV 790
           L   + +MA E      F    +TK DV+SFG+L+ E++TR   P  D+      +  ++
Sbjct: 258 L--PVKWMALESLQTQKF----TTKSDVWSFGVLLWELMTRGAPPYPDV--NTFDITVYL 309

Query: 791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAA 850
                 RL +                           L E+ + C       RP+  +  
Sbjct: 310 LQGR--RLLQPEYCP--------------------DPLYEVMLKCWHPKAEMRPSFSELV 347

Query: 851 DDLDRLKRYLGEKH 864
             +  +      +H
Sbjct: 348 SRISAIFSTFIGEH 361

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  133 bits (336), Expect = 1e-34
 Identities = 69/225 (30%), Positives = 114/225 (50%), Gaps = 35/225 (15%)

Query: 562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
              LG G +G V+ G     T +AVK L+  S +   +F  E  ++K+++H+ L+R+   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 622 CSL-PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
            +  P +  ++  YM NGSL   L              LT+ + +++ + IAEGMA++  
Sbjct: 77  VTQEPIY--IITEYMENGSLVDFLKTP-------SGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM-TVGVGNDGAENMGNSTANMLCGS 739
                 IH DL+ +N+L++D ++  ++DFG+A+L+        +GA+             
Sbjct: 128 R---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP----------- 173

Query: 740 IGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
           I + APE   YG F    + K DV+SFGIL+ E+VT  R P   M
Sbjct: 174 IKWTAPEAINYGTF----TIKSDVWSFGILLTEIVTHGRIPYPGM 214

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  133 bits (336), Expect = 1e-34
 Identities = 56/232 (24%), Positives = 96/232 (41%), Gaps = 41/232 (17%)

Query: 561 EQRLLGTGSYGRVYKGILQDG---TAIAVKVLQ--LQSGNFTKSFNRECQVLKRIRHRNL 615
           E + LG+G++G V KG  Q       +AVK+L+              E  V++++ +  +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +R+I  C    +  LV+     G L+ +L  +           +     + +   ++ GM
Sbjct: 81  VRMIGICEAESWM-LVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGM 130

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL        +H DL   NVLL     A +SDFG++K +               +    
Sbjct: 131 KYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL-----------RADENYYKA 176

Query: 736 LCGS---IGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
                  + + APE   Y  F    S+K DV+SFG+L+ E  +  ++P   M
Sbjct: 177 QTHGKWPVKWYAPECINYYKF----SSKSDVWSFGVLMWEAFSYGQKPYRGM 224

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  134 bits (339), Expect = 1e-34
 Identities = 60/260 (23%), Positives = 101/260 (38%), Gaps = 32/260 (12%)

Query: 525 SSGKSETRSKPITPELMHNFPRITYRELLEATAEFDE-------QRLLGTGSYGRVYKGI 577
           +      + + + PE   N   +   +L     E+ E       Q  +G GS+G V++  
Sbjct: 19  TWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMK 78

Query: 578 -LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMA 636
             Q G   AVK ++L+          E      +    ++ +  A     +  + +  + 
Sbjct: 79  DKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133

Query: 637 NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNV 696
            GSL   +      + G    D  L           EG+ YLH     R++H D+K  NV
Sbjct: 134 GGSLGQLI-----KQMGCLPEDRAL----YYLGQALEGLEYLHTR---RILHGDVKADNV 181

Query: 697 LLNDD-MTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTST 755
           LL+ D   A + DFG A  +   G+G          T + + G+  +MAPE   G     
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGK------SLLTGDYIPGTETHMAPEVVMGKPCDA 235

Query: 756 KGDVYSFGILVLEMVTRRRP 775
           K D++S   ++L M+    P
Sbjct: 236 KVDIWSSCCMMLHMLNGCHP 255

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  132 bits (334), Expect = 1e-34
 Identities = 63/226 (27%), Positives = 107/226 (47%), Gaps = 37/226 (16%)

Query: 562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
            + LG+G +G V  G  +    +AVK+++  S +    F +E Q + ++ H  L++    
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
           CS      +V  Y++NG L ++L  H +         L   Q + +C D+ EGMA+L  H
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYLRSHGKG--------LEPSQLLEMCYDVCEGMAFLESH 123

Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS-- 739
              + IH DL   N L++ D+   VSDFG+ + V+             +       G+  
Sbjct: 124 ---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL-------------DDQYVSSVGTKF 167

Query: 740 -IGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
            + + APE   Y  +    S+K DV++FGIL+ E+ +  + P D  
Sbjct: 168 PVKWSAPEVFHYFKY----SSKSDVWAFGILMWEVFSLGKMPYDLY 209

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  132 bits (334), Expect = 2e-34
 Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 33/224 (14%)

Query: 562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
            + LGTG +G V  G  +    +A+K+++  S +    F  E +V+  + H  L+++   
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
           C+      ++  YMANG L ++L                  Q + +C D+ E M YL   
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHR--------FQTQQLLEMCKDVCEAMEYLESK 139

Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM-TVGVGNDGAENMGNSTANMLCGSI 740
              + +H DL   N L+ND     VSDFG+++ V+      + G+              +
Sbjct: 140 ---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS---------KF--PV 185

Query: 741 GYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
            +  PE   Y  F    S+K D+++FG+L+ E+ +  + P +  
Sbjct: 186 RWSPPEVLMYSKF----SSKSDIWAFGVLMWEIYSLGKMPYERF 225

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  133 bits (338), Expect = 2e-34
 Identities = 63/229 (27%), Positives = 110/229 (48%), Gaps = 34/229 (14%)

Query: 562 QRLLGTGSYGRVYKGILQDGTA-----IAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNL 615
           Q+++G G +G VYKG+L+  +      +A+K L+       +  F  E  ++ +  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +R+    S      ++  YM NG+LD  L               ++LQ V +   IA GM
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQLVGMLRGIAAGM 160

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL +      +H DL   N+L+N ++   VSDFG+++++       D  E    ++   
Sbjct: 161 KYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE------DDPEATYTTSGGK 211

Query: 736 LCGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
           +   I + APE   Y  F    ++  DV+SFGI++ E++T   RP  ++
Sbjct: 212 I--PIRWTAPEAISYRKF----TSASDVWSFGIVMWEVMTYGERPYWEL 254

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  132 bits (334), Expect = 3e-34
 Identities = 77/320 (24%), Positives = 130/320 (40%), Gaps = 70/320 (21%)

Query: 563 RLLGTGSYGRVYKGIL------QDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLM 616
           R LG G++G+V+          +D   +AVK L+  +    K F RE ++L  ++H +++
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHS-------ETEFGSGSSDLTLLQRVNICS 669
           +    C   D   +V  YM +G L+  L  H        + +      +L L Q ++I S
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
            IA GM YL   +    +H DL   N L+  ++   + DFG+++ V +     D     G
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS----TDYYRVGG 193

Query: 730 NSTANMLCGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGL 784
           ++   ML   I +M PE   Y  F    +T+ DV+SFG+++ E+ T  ++P         
Sbjct: 194 HT---ML--PIRWMPPESIMYRKF----TTESDVWSFGVILWEIFTYGKQP--------- 235

Query: 785 SLHKWVKNHYHGR-----LEKVIDSSLLRASRDQSPEVKR-MWDVAIGELIELGILCTQE 838
                    +        +E +    +L   R    EV   M              C Q 
Sbjct: 236 ---------WFQLSNTEVIECITQGRVLERPRVCPKEVYDVMLG------------CWQR 274

Query: 839 SPSTRPTMLDAADDLDRLKR 858
            P  R  + +    L  L +
Sbjct: 275 EPQQRLNIKEIYKILHALGK 294

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  137 bits (347), Expect = 3e-34
 Identities = 79/300 (26%), Positives = 127/300 (42%), Gaps = 49/300 (16%)

Query: 562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           +  LG G +G V+ G     T +A+K L+       ++F +E QV+K++RH  L+++   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 622 CSL-PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
            S  P +  +V  YM+ GSL   L              L L Q V++ + IA GMAY+  
Sbjct: 331 VSEEPIY--IVTEYMSKGSLLDFLKGE-------TGKYLRLPQLVDMAAQIASGMAYVER 381

Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
                 +H DL+ +N+L+ +++   V+DFG+A+L+       D                I
Sbjct: 382 M---NYVHRDLRAANILVGENLVCKVADFGLARLI------EDNE--YTARQGAKF--PI 428

Query: 741 GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLSLHKWVKNHYHGRLE 799
            + APE       + K DV+SFGIL+ E+ T+ R P   M      +   V+  Y  R+ 
Sbjct: 429 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVERGY--RMP 484

Query: 800 KVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRY 859
                        + PE           L +L   C ++ P  RPT       L+     
Sbjct: 485 CP----------PECPE----------SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  134 bits (339), Expect = 3e-34
 Identities = 61/228 (26%), Positives = 106/228 (46%), Gaps = 33/228 (14%)

Query: 562 QRLLGTGSYGRVYKGILQ----DGTAIAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNLM 616
            +++G G +G V  G L+       ++A+K L++      +  F  E  ++ +  H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           R+    +      +V  YM NGSLDS L  H            T++Q V +   IA GM 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--------FTVIQLVGMLRGIASGMK 161

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL        +H DL   N+L+N ++   VSDFG+ +++       D  E    +    +
Sbjct: 162 YLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL------EDDPEAAYTTRGGKI 212

Query: 737 CGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
              I + +PE   Y  F    ++  DV+S+GI++ E+++   RP  +M
Sbjct: 213 --PIRWTSPEAIAYRKF----TSASDVWSYGIVLWEVMSYGERPYWEM 254

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  132 bits (335), Expect = 3e-34
 Identities = 70/323 (21%), Positives = 129/323 (39%), Gaps = 70/323 (21%)

Query: 558 EFDEQRL-----LGTGSYGRVYKGILQDG------TAIAVKVLQLQSGNFTKS-FNRECQ 605
           E   +++     LG GS+G VY+G+ +        T +A+K +   +    +  F  E  
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80

Query: 606 VLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHS-ETEFGSGSSDLTLLQR 664
           V+K     +++R++   S      +++  M  G L S+L             +  +L + 
Sbjct: 81  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140

Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
           + +  +IA+GMAYL+ +   + +H DL   N ++ +D T  + DFG+ + +       D 
Sbjct: 141 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE----TDY 193

Query: 725 AENMGNSTANMLCGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
               G     +L   + +M+PE    G F    +T  DV+SFG+++ E+ T   +P    
Sbjct: 194 YRKGGKG---LL--PVRWMSPESLKDGVF----TTYSDVWSFGVVLWEIATLAEQP---- 240

Query: 780 FAGGLSLHKWVKNHYHGR-----LEKVIDSSLLRASRDQSPEVKR-MWDVAIGELIELGI 833
                         Y G      L  V++  LL    +    +   M             
Sbjct: 241 --------------YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRM----------- 275

Query: 834 LCTQESPSTRPTMLDAADDLDRL 856
            C Q +P  RP+ L+    +   
Sbjct: 276 -CWQYNPKMRPSFLEIISSIKEE 297

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  131 bits (332), Expect = 3e-34
 Identities = 77/319 (24%), Positives = 128/319 (40%), Gaps = 68/319 (21%)

Query: 558 EFDEQRL-----LGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRH 612
             + + L     +G G +G V  G  + G  +AVK ++  +    ++F  E  V+ ++RH
Sbjct: 17  ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRH 73

Query: 613 RNLMRIITACSLPDFKA-LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
            NL++++           +V  YMA GSL  +L          G S L     +    D+
Sbjct: 74  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-------GRSVLGGDCLLKFSLDV 126

Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
            E M YL  +     +H DL   NVL+++D  A VSDFG+ K   +              
Sbjct: 127 CEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT---------- 173

Query: 732 TANMLCGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLSL 786
              +    + + APE      F    STK DV+SFGIL+ E+ +  R P   +      +
Sbjct: 174 -GKL---PVKWTAPEALREKKF----STKSDVWSFGILLWEIYSFGRVPYPRI--PLKDV 223

Query: 787 HKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTM 846
              V+  Y  +++            D  P            + E+   C     + RP+ 
Sbjct: 224 VPRVEKGY--KMDAP----------DGCPP----------AVYEVMKNCWHLDAAMRPSF 261

Query: 847 LDAADDLDRLKRYLGEKHM 865
           L   + L+ +K +  E H+
Sbjct: 262 LQLREQLEHIKTH--ELHL 278

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  133 bits (336), Expect = 3e-34
 Identities = 73/329 (22%), Positives = 127/329 (38%), Gaps = 74/329 (22%)

Query: 558 EFDEQRL-----LGTGSYGRVYKGILQDG------TAIAVKVLQLQSGNFTKSFNRECQV 606
               + +     LG G++G+V+     +         +AVK L+  S +  + F RE ++
Sbjct: 37  HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96

Query: 607 LKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHS------ETEFGSGSSDLT 660
           L  ++H++++R    C+      +V  YM +G L+  L  H                 L 
Sbjct: 97  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156

Query: 661 LLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGV 720
           L Q + + S +A GM YL        +H DL   N L+   +   + DFG+++ + +   
Sbjct: 157 LGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS--- 210

Query: 721 GNDGAENMGNSTANMLCGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRP 775
             D     G +   ML   I +M PE   Y  F    +T+ DV+SFG+++ E+ T  ++P
Sbjct: 211 -TDYYRVGGRT---ML--PIRWMPPESILYRKF----TTESDVWSFGVVLWEIFTYGKQP 260

Query: 776 TDDMFAGGLSLHKWVKNHYHGR-----LEKVIDSSLLRASRDQSPEVKR-MWDVAIGELI 829
                             ++       ++ +     L   R   PEV   M         
Sbjct: 261 ------------------WYQLSNTEAIDCITQGRELERPRACPPEVYAIMRG------- 295

Query: 830 ELGILCTQESPSTRPTMLDAADDLDRLKR 858
                C Q  P  R ++ D    L  L +
Sbjct: 296 -----CWQREPQQRHSIKDVHARLQALAQ 319

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  135 bits (341), Expect = 7e-34
 Identities = 59/219 (26%), Positives = 104/219 (47%), Gaps = 23/219 (10%)

Query: 562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           ++ LG G +G V+       T +AVK ++  S +  ++F  E  V+K ++H  L+++   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
            +      ++  +MA GSL   L            S   L + ++  + IAEGMA++   
Sbjct: 252 VTKEPI-YIITEFMAKGSLLDFLKSD-------EGSKQPLPKLIDFSAQIAEGMAFIEQR 303

Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIG 741
                IH DL+ +N+L++  +   ++DFG+A+++       D                I 
Sbjct: 304 ---NYIHRDLRAANILVSASLVCKIADFGLARVI------ED--NEYTAREGAKFP--IK 350

Query: 742 YMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
           + APE     + + K DV+SFGIL++E+VT  R P   M
Sbjct: 351 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  130 bits (329), Expect = 9e-34
 Identities = 47/229 (20%), Positives = 98/229 (42%), Gaps = 38/229 (16%)

Query: 562 QRLLGTGSYGRVYKGILQDG----TAIAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNLM 616
            R +G G +G V++GI         A+A+K  +  + +  +  F +E   +++  H +++
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 617 RIITACSL-PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++I   +  P +  +++     G L S L              L L   +     ++  +
Sbjct: 80  KLIGVITENPVW--IIMELCTLGELRSFLQVRK--------YSLDLASLILYAYQLSTAL 129

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
           AYL      R +H D+   NVL++ +    + DFG+++ +       D       ++   
Sbjct: 130 AYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM------EDSTYYK--ASKGK 178

Query: 736 LCGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
           L   I +MAPE   +  F    ++  DV+ FG+ + E++    +P   +
Sbjct: 179 L--PIKWMAPESINFRRF----TSASDVWMFGVCMWEILMHGVKPFQGV 221

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  130 bits (328), Expect = 1e-33
 Identities = 52/227 (22%), Positives = 95/227 (41%), Gaps = 39/227 (17%)

Query: 565 LGTGSYGRVYKGILQDG---TAIAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNLMRIIT 620
           LG G++G V +G+ +       +A+KVL+  +         RE Q++ ++ +  ++R+I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
            C       LV+     G L   L    E         + +     +   ++ GM YL  
Sbjct: 78  VCQAEALM-LVMEMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMKYLEE 128

Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS- 739
                 +H DL   NVLL +   A +SDFG++K +              +S         
Sbjct: 129 K---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL-----------GADDSYYTARSAGK 174

Query: 740 --IGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
             + + APE   +  F    S++ DV+S+G+ + E ++  ++P   M
Sbjct: 175 WPLKWYAPECINFRKF----SSRSDVWSYGVTMWEALSYGQKPYKKM 217

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  130 bits (329), Expect = 2e-33
 Identities = 79/323 (24%), Positives = 127/323 (39%), Gaps = 65/323 (20%)

Query: 558 EFDEQRL-----LGTGSYGRVYKGILQD-----GTAIAVKVLQLQSG-NFTKSFNRECQV 606
            F ++ L     LG G +G+V            G  +AVK L+  +G      + +E  +
Sbjct: 27  VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86

Query: 607 LKRIRHRNLMRIITACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           L+ + H ++++    C      +  LV+ Y+  GSL  +L  HS          + L Q 
Sbjct: 87  LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----------IGLAQL 136

Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
           +     I EGMAYLH       IH DL   NVLL++D    + DFG+AK    V  G++ 
Sbjct: 137 LLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA---VPEGHEY 190

Query: 725 --AENMGNSTANMLCGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
                 G+S        + + APE      F        DV+SFG+ + E++T     D 
Sbjct: 191 YRVREDGDS-------PVFWYAPECLKEYKF----YYASDVWSFGVTLYELLTH---CDS 236

Query: 779 MFAGGLSLHKWVKNHYHG-RLEKVIDSSLLRASR----DQSPEVKRMWDVAIGELIELGI 833
             +      + +        + ++ +  L R  R    D+ P           E+  L  
Sbjct: 237 SQSPPTKFLELIGIAQGQMTVLRLTE-LLERGERLPRPDKCPA----------EVYHLMK 285

Query: 834 LCTQESPSTRPTMLDAADDLDRL 856
            C +   S RPT  +    L  +
Sbjct: 286 NCWETEASFRPTFENLIPILKTV 308

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  130 bits (329), Expect = 2e-33
 Identities = 57/231 (24%), Positives = 102/231 (44%), Gaps = 42/231 (18%)

Query: 563 RLLGTGSYGRVYKGILQDG-----TAIAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNLM 616
           ++LG+G++G VYKG+           +A+K L+  +          E  V+  + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           R++  C     + L+   M  G L  ++  H +         +     +N C  IA+GM 
Sbjct: 81  RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGMN 131

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL      R++H DL   NVL+       ++DFG+AKL+     G +  E          
Sbjct: 132 YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----GAEEKEYHAE------ 177

Query: 737 CGS---IGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
            G    I +MA E   +  +    + + DV+S+G+ V E++T   +P D +
Sbjct: 178 -GGKVPIKWMALESILHRIY----THQSDVWSYGVTVWELMTFGSKPYDGI 223

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  129 bits (326), Expect = 2e-33
 Identities = 49/229 (21%), Positives = 97/229 (42%), Gaps = 38/229 (16%)

Query: 562 QRLLGTGSYGRVYKGILQDG----TAIAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNLM 616
            R+LG G +G VY+G+  +       +AVK  +       K  F  E  ++K + H +++
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 617 RIITACSL-PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++I      P +  +++     G L  +L  +  +        L +L  V     I + M
Sbjct: 77  KLIGIIEEEPTW--IIMELYPYGELGHYLERNKNS--------LKVLTLVLYSLQICKAM 126

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
           AYL        +H D+   N+L+       + DFG+++ +       D       ++   
Sbjct: 127 AYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI------EDEDYYK--ASVTR 175

Query: 736 LCGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
           L   I +M+PE   +  F    +T  DV+ F + + E+++  ++P   +
Sbjct: 176 L--PIKWMSPESINFRRF----TTASDVWMFAVCMWEILSFGKQPFFWL 218

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  129 bits (326), Expect = 3e-33
 Identities = 58/312 (18%), Positives = 120/312 (38%), Gaps = 70/312 (22%)

Query: 563 RLLGTGSYGRVYKGILQD--------GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRN 614
             LG G++ +++KG+ ++         T + +KVL     N+++SF     ++ ++ H++
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           L+     C   D   LV  ++  GSLD++L  +           + +L ++ +   +A  
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC--------INILWKLEVAKQLAAA 125

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL--------VSDFGIAKLVMTVGVGNDGAE 726
           M +L  +    +IH ++   N+LL  +            +SD GI+  V    +  D  +
Sbjct: 126 MHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV----LPKDILQ 178

Query: 727 NMGNSTANMLCGSIGYMAPE-YGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGL 784
                        I ++ PE      N +   D +SFG  + E+ +   +P   +     
Sbjct: 179 -----------ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL--DSQ 225

Query: 785 SLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP 844
              ++ ++ +  +L                P+   + +        L   C    P  RP
Sbjct: 226 RKLQFYEDRH--QLPA--------------PKAAELAN--------LINNCMDYEPDHRP 261

Query: 845 TMLDAADDLDRL 856
           +      DL+ L
Sbjct: 262 SFRAIIRDLNSL 273

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  132 bits (334), Expect = 5e-33
 Identities = 72/388 (18%), Positives = 137/388 (35%), Gaps = 44/388 (11%)

Query: 21  LRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFF 80
           + ++ L  N++      S + L +L  + +       ++  + F   +SL  + L  N F
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91

Query: 81  TGKIPEEI-GNCPNLWTLSLYNNQLTG-QLPASLIN--TSMYNLDVEYNHLSGELPSDIM 136
             ++         NL  L+L    L G  L  +     TS+  L +  N++    P+   
Sbjct: 92  L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150

Query: 137 SKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL- 195
             +     L L++N + S  +         +         L L+ + L       +G   
Sbjct: 151 LNMRRFHVLDLTFNKVKSICEED-----LLNFQG-KHFTLLRLSSITLQDMNEYWLGWEK 204

Query: 196 --------NLTQLLLQENKITGSIPPHIGNLSNLISL-----NLSSNLLSGTISAEISWL 242
                   ++T L L  N    S+     +      +     + S N+ S          
Sbjct: 205 CGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDP 264

Query: 243 ----------SQLEQLFLSHNLFSGEIPA-ALGKLHHLGLLDLSFNKLSGEIPV-SLGNL 290
                     S ++   LS +     +          L  L L+ N+++ +I   +   L
Sbjct: 265 DNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGL 322

Query: 291 VQIYSLFLNNNQLSRSIPP-TLGRCTDLYKLDLSYNRLTGSIPAEI-SGIREIRIFLNLS 348
             +  L L+ N L  SI          L  LDLSYN +  ++  +   G+  ++  L L 
Sbjct: 323 THLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKE-LALD 379

Query: 349 HNQLEGPLPIELSKLENVQEIDLSSNKF 376
            NQL+        +L ++Q+I L +N +
Sbjct: 380 TNQLKSVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  120 bits (302), Expect = 7e-29
 Identities = 77/329 (23%), Positives = 125/329 (37%), Gaps = 34/329 (10%)

Query: 2   LVDNHLFGAIPPE-FSKLRRLRHLQLDGNNLHGQI--PESLALLSNLTLVTLHDNNLTGM 58
           L  N     +    F+ L  L  L L   NL G +        L++L ++ L DNN+  +
Sbjct: 86  LDYNQF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKI 144

Query: 59  LPISFFHNCTSLRNVDLSQNFFTGKIPEEI---GNCPNLWTLSLYNNQLTGQLPASLI-- 113
            P SFF N      +DL+ N     I EE        +   L L +  L       L   
Sbjct: 145 QPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWE 203

Query: 114 -------NTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNM------VSHDDNTN 160
                  NTS+  LD+  N     +       +       L  +N         H +  +
Sbjct: 204 KCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKD 263

Query: 161 LVPFFNSLGNCTDLEELELAGMDLGGTLPDSI--GRLNLTQLLLQENKITGSIPPHI-GN 217
              F       + ++  +L+   +   L  S+     +L QL L +N+I   I  +    
Sbjct: 264 PDNFTFKGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWG 321

Query: 218 LSNLISLNLSSNLLSGTISAEI-SWLSQLEQLFLSHNLFSGEIPA-ALGKLHHLGLLDLS 275
           L++L+ LNLS N L  +I + +   L +LE L LS+N     +   +   L +L  L L 
Sbjct: 322 LTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALD 379

Query: 276 FNKLSGEIPVS-LGNLVQIYSLFLNNNQL 303
            N+L   +P      L  +  ++L+ N  
Sbjct: 380 TNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  102 bits (256), Expect = 4e-23
 Identities = 62/324 (19%), Positives = 106/324 (32%), Gaps = 62/324 (19%)

Query: 196 NLTQLLLQENKITGSIPPH-IGNLSNLISLNLSSNLLSGTISAEI-SWLSQLEQLFLSHN 253
           ++  + L  N I   +       L +L  L +        I       LS L  L L +N
Sbjct: 31  HVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 254 LFSGEIPA-ALGKLHHLGLLDLSFNKL-SGEIPV-SLGNLVQIYSLFLNNNQLSRSIPP- 309
            F  ++   A   L +L +L L+   L    +       L  +  L L +N + + I P 
Sbjct: 90  QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI-KKIQPA 147

Query: 310 -TLGRCTDLYKLDLSYNRLTGSIPAEI--SGIREIRIFLNLSHNQLEGPLPIELS----- 361
                    + LDL++N++  SI  E   +   +    L LS   L+      L      
Sbjct: 148 SFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCG 206

Query: 362 ---KLENVQEIDLSSNKFT--------------------------------GNIFIQISN 386
              K  ++  +DLS N F                                    F    N
Sbjct: 207 NPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDN 266

Query: 387 CI-------AVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLT 439
                     V+  ++S + +   L        +LE + ++ N ++ I   +   +  L 
Sbjct: 267 FTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLL 326

Query: 440 FINLSFNEFKGMIPSGGIFNSATK 463
            +NLS N     I S  +F +  K
Sbjct: 327 KLNLSQNFLG-SIDS-RMFENLDK 348

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 82.1 bits (203), Expect = 2e-16
 Identities = 49/257 (19%), Positives = 81/257 (31%), Gaps = 49/257 (19%)

Query: 1   MLVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLP 60
            + +  L         K   +  L L GN     + +        T +     + +  + 
Sbjct: 194 DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253

Query: 61  ISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNL 120
            SF H        D     F G           + T  L  +++                
Sbjct: 254 SSFGHTNFK----DPDNFTFKGL------EASGVKTCDLSKSKIF--------------- 288

Query: 121 DVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELA 180
                     L   + S    L  L L+ N +   DDN      F  L +   L +L L+
Sbjct: 289 ---------ALLKSVFSHFTDLEQLTLAQNEINKIDDNA-----FWGLTH---LLKLNLS 331

Query: 181 GMDLGGTLPDSI-GRL-NLTQLLLQENKITGSIPPHI-GNLSNLISLNLSSNLLSGTISA 237
              L G++   +   L  L  L L  N I  ++       L NL  L L +N L  ++  
Sbjct: 332 QNFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPD 388

Query: 238 EI-SWLSQLEQLFLSHN 253
            I   L+ L++++L  N
Sbjct: 389 GIFDRLTSLQKIWLHTN 405

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  127 bits (321), Expect = 1e-32
 Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 39/237 (16%)

Query: 558 EFDEQRL-----LGTGSYGRVYKGILQDG------TAIAVKVLQLQSGNFTKS-FNRECQ 605
           E     +     LG   +G+VYKG L          A+A+K L+ ++    +  F  E  
Sbjct: 5   EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64

Query: 606 VLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSD------- 658
           +  R++H N++ ++   +     +++  Y ++G L   L   S       + D       
Sbjct: 65  LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124

Query: 659 LTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV 718
           L     V++ + IA GM YL   S   V+H DL   NVL+ D +   +SD G+ + V   
Sbjct: 125 LEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA- 180

Query: 719 GVGNDGAENMGNSTANMLCGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVT 771
               D  + +GNS   +L   I +MAPE   YG F    S   D++S+G+++ E+ +
Sbjct: 181 ---ADYYKLLGNS---LL--PIRWMAPEAIMYGKF----SIDSDIWSYGVVLWEVFS 225

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  128 bits (323), Expect = 1e-32
 Identities = 73/315 (23%), Positives = 114/315 (36%), Gaps = 69/315 (21%)

Query: 563 RLLGTGSYGRVYKGILQDG------TAIAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNL 615
           R LG G++G VY+G +           +AVK L        +  F  E  ++ +  H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +R I        + +++  MA G L S L         S  S L +L  +++  DIA G 
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGC 153

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
            YL        IH D+   N LL        A + DFG+A+ +         A       
Sbjct: 154 QYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-------ASYYRKGG 203

Query: 733 ANMLCGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLSLH 787
             ML   + +M PE    G F    ++K D +SFG+L+ E+ +    P            
Sbjct: 204 CAML--PVKWMPPEAFMEGIF----TSKTDTWSFGVLLWEIFSLGYMP------------ 245

Query: 788 KWVKNHYHGR-----LEKVIDSSLLRASRDQSPEVKR-MWDVAIGELIELGILCTQESPS 841
                 Y  +     LE V     +   ++    V R M              C Q  P 
Sbjct: 246 ------YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQ------------CWQHQPE 287

Query: 842 TRPTMLDAADDLDRL 856
            RP      + ++  
Sbjct: 288 DRPNFAIILERIEYC 302

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  126 bits (318), Expect = 4e-32
 Identities = 75/337 (22%), Positives = 134/337 (39%), Gaps = 84/337 (24%)

Query: 558 EFDEQRL-----LGTGSYGRVYKGILQDG------TAIAVKVLQLQSGNFTKS-FNRECQ 605
           EF  + L     LG G +G+V K            T +AVK+L+  +          E  
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78

Query: 606 VLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHL---------------YPHSET 650
           VLK++ H +++++  ACS      L++ Y   GSL   L                 +S +
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138

Query: 651 EFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG 710
                   LT+   ++    I++GM YL   + ++++H DL   N+L+ +     +SDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFG 195

Query: 711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPE---YG-FGSNTSTKGDVYSFGILV 766
           +++ V       D            +   + +MA E      +    +T+ DV+SFG+L+
Sbjct: 196 LSRDVYE----EDSYVKRSQG---RI--PVKWMAIESLFDHIY----TTQSDVWSFGVLL 242

Query: 767 LEMVTRRRPTDDMFAG----GLSLH---KWVKNHYHGRLEKVIDSSLLRASRDQSPEVKR 819
            E+VT          G    G+        +K  +  R+E+              P+   
Sbjct: 243 WEIVT--------LGGNPYPGIPPERLFNLLKTGH--RMER--------------PD--- 275

Query: 820 MWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL 856
                  E+  L + C ++ P  RP   D + DL+++
Sbjct: 276 ---NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  127 bits (320), Expect = 5e-32
 Identities = 71/339 (20%), Positives = 136/339 (40%), Gaps = 84/339 (24%)

Query: 558 EFDEQRL-----LGTGSYGRVYKGILQDG------TAIAVKVL-QLQSGNFTKSFNRECQ 605
           E+    +     +G G++GRV++            T +AVK+L +  S +    F RE  
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102

Query: 606 VLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHS---------------ET 650
           ++    + N+++++  C++     L+  YMA G L+  L   S                 
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162

Query: 651 EFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG 710
               G   L+  +++ I   +A GMAYL   S  + +H DL   N L+ ++M   ++DFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFG 219

Query: 711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPE---YG-FGSNTSTKGDVYSFGILV 766
           +++ + +     D  +  GN     +   I +M PE   Y  +    +T+ DV+++G+++
Sbjct: 220 LSRNIYS----ADYYKADGND---AI--PIRWMPPESIFYNRY----TTESDVWAYGVVL 266

Query: 767 LEMVTR-RRPTDDMFAGGLSLHKWVKNHYHGR-----LEKVIDSSLLRASRDQSPEVKR- 819
            E+ +   +P                  Y+G      +  V D ++L    +   E+   
Sbjct: 267 WEIFSYGLQP------------------YYGMAHEEVIYYVRDGNILACPENCPLELYNL 308

Query: 820 MWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR 858
           M              C  + P+ RP+       L R+  
Sbjct: 309 MRL------------CWSKLPADRPSFCSIHRILQRMCE 335

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  125 bits (317), Expect = 6e-32
 Identities = 68/322 (21%), Positives = 120/322 (37%), Gaps = 58/322 (18%)

Query: 558 EFDEQRL-----LGTGSYGRVYKGIL------QDGTAIAVKVLQLQSGNFTKS-FNRECQ 605
           EF   RL     LG G++G+V +              +AVK+L+  +    +     E +
Sbjct: 19  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78

Query: 606 VLKRI-RHRNLMRIITACSLPDFKALVLPYMANGSLDSHL---------YPHSETEFGSG 655
           VL  +  H N++ ++ AC++     ++  Y   G L + L            S       
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 656 SSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
              L L   ++    +A+GMA+L   +    IH DL   N+LL       + DFG+A+ +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195

Query: 716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RR 774
                      N        L   + +MAPE  F    + + DV+S+GI + E+ +    
Sbjct: 196 KN-------DSNYVVKGNARL--PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246

Query: 775 PTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGIL 834
           P   M       +K +K  +  R+             + +P           E+ ++   
Sbjct: 247 PYPGM-PVDSKFYKMIKEGF--RMLSP----------EHAPA----------EMYDIMKT 283

Query: 835 CTQESPSTRPTMLDAADDLDRL 856
           C    P  RPT       +++ 
Sbjct: 284 CWDADPLKRPTFKQIVQLIEKQ 305

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  125 bits (316), Expect = 9e-32
 Identities = 69/325 (21%), Positives = 127/325 (39%), Gaps = 65/325 (20%)

Query: 558 EFDEQRL-----LGTGSYGRVYKGILQD------GTAIAVKVL-QLQSGNFTKSFNRECQ 605
           EF   RL     LG G++G+V +              +AVK+L +  + +  ++   E +
Sbjct: 23  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82

Query: 606 VLKRI-RHRNLMRIITACSLPDFKALV-LPYMANGSLDSHL-------YPHSETEFGSGS 656
           +L  I  H N++ ++ AC+ P    +V + +   G+L ++L        P+         
Sbjct: 83  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142

Query: 657 SDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM 716
             LTL   +     +A+GM +L      + IH DL   N+LL++     + DFG+A+ + 
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY 199

Query: 717 TVGVGNDGAENMGNSTANMLCGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR 772
                     +        L   + +MAPE      +    + + DV+SFG+L+ E+ + 
Sbjct: 200 K-------DPDYVRKGDARL--PLKWMAPETIFDRVY----TIQSDVWSFGVLLWEIFSL 246

Query: 773 -RRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIEL 831
              P   +        + +K     R+                P+          E+ + 
Sbjct: 247 GASPYPGVKIDEEFCRR-LKEGT--RMRA--------------PD------YTTPEMYQT 283

Query: 832 GILCTQESPSTRPTMLDAADDLDRL 856
            + C    PS RPT  +  + L  L
Sbjct: 284 MLDCWHGEPSQRPTFSELVEHLGNL 308

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  126 bits (318), Expect = 1e-31
 Identities = 74/315 (23%), Positives = 114/315 (36%), Gaps = 69/315 (21%)

Query: 563 RLLGTGSYGRVYKGILQDG------TAIAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNL 615
           R LG G++G VY+G +           +AVK L        +  F  E  ++ +  H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +R I        + ++L  MA G L S L         S  S L +L  +++  DIA G 
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGC 194

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
            YL        IH D+   N LL        A + DFG+A+ +         A       
Sbjct: 195 QYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-------AGYYRKGG 244

Query: 733 ANMLCGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLSLH 787
             ML   + +M PE    G F    ++K D +SFG+L+ E+ +    P            
Sbjct: 245 CAML--PVKWMPPEAFMEGIF----TSKTDTWSFGVLLWEIFSLGYMP------------ 286

Query: 788 KWVKNHYHGR-----LEKVIDSSLLRASRDQSPEVKR-MWDVAIGELIELGILCTQESPS 841
                 Y  +     LE V     +   ++    V R M              C Q  P 
Sbjct: 287 ------YPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQ------------CWQHQPE 328

Query: 842 TRPTMLDAADDLDRL 856
            RP      + ++  
Sbjct: 329 DRPNFAIILERIEYC 343

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  125 bits (316), Expect = 1e-31
 Identities = 70/349 (20%), Positives = 133/349 (38%), Gaps = 59/349 (16%)

Query: 90  NCP-----NLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTY 144
            CP     +L  +   +  L  ++P   +      LD++ N ++ E+       L +L  
Sbjct: 24  VCPFRCQCHLRVVQCSDLGLE-KVPKD-LPPDTALLDLQNNKIT-EIKDGDFKNLKNLHT 80

Query: 145 LHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQE 204
           L L  N +            F  L     LE L L+   L   LP+ + +  L +L + E
Sbjct: 81  LILINNKISKISPGA-----FAPLVK---LERLYLSKNQLK-ELPEKMPK-TLQELRVHE 130

Query: 205 NKITGSIPPHI-GNLSNLISLNLSSNLL-SGTISAEI-SWLSQLEQLFLSHNLFSGEIPA 261
           N+IT  +   +   L+ +I + L +N L S  I       + +L  + ++    +  IP 
Sbjct: 131 NEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ 188

Query: 262 ALGKLHHLGLLDLSFNKLSGEIPV-SLGNLVQIYSLFLNNNQLSRSIPP-TLGRCTDLYK 319
            L     L  L L  NK++ ++   SL  L  +  L L+ N +S ++   +L     L +
Sbjct: 189 GL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRE 244

Query: 320 LDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEG------PLPIELSKLENVQEIDLSS 373
           L L+ N+L   +P  ++  + I++ + L +N +          P   +K  +   + L S
Sbjct: 245 LHLNNNKLV-KVPGGLADHKYIQV-VYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS 302

Query: 374 NKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGN 422
           N               V+   I  +  +         +    A+ +   
Sbjct: 303 NP--------------VQYWEIQPSTFRC--------VYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  121 bits (305), Expect = 3e-30
 Identities = 63/327 (19%), Positives = 116/327 (35%), Gaps = 51/327 (15%)

Query: 10  AIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTS 69
            +P +         L L  N +          L NL  + L +N ++  +    F     
Sbjct: 45  KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVK 101

Query: 70  LRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSG 129
           L                          L L  NQL  +LP  +   ++  L V  N ++ 
Sbjct: 102 LE------------------------RLYLSKNQLK-ELPEKMP-KTLQELRVHENEIT- 134

Query: 130 ELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLP 189
           ++   + + L  +  + L  N + S          F  +     L  + +A  ++  T+P
Sbjct: 135 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGA---FQGMKK---LSYIRIADTNI-TTIP 187

Query: 190 DSIGRLNLTQLLLQENKITGSIPPHI-GNLSNLISLNLSSNLLSGTISAEISWLSQLEQL 248
             +   +LT+L L  NKIT  +       L+NL  L LS N +S   +  ++    L +L
Sbjct: 188 QGLPP-SLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL 245

Query: 249 FLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVS-------LGNLVQIYSLFLNNN 301
            L++N    ++P  L    ++ ++ L  N +S  I  +                + L +N
Sbjct: 246 HLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSN 303

Query: 302 QLS-RSIPPTLGRC-TDLYKLDLSYNR 326
            +    I P+  RC      + L   +
Sbjct: 304 PVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  120 bits (302), Expect = 1e-29
 Identities = 67/274 (24%), Positives = 117/274 (42%), Gaps = 29/274 (10%)

Query: 187 TLPDSIGRLNLTQLLLQENKITGSIPPHI-GNLSNLISLNLSSNLLSGTISAEI-SWLSQ 244
            +P  +   +   L LQ NKIT  I      NL NL +L L +N +S  IS    + L +
Sbjct: 45  KVPKDLPP-DTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVK 101

Query: 245 LEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQL- 303
           LE+L+LS N    E+P  +     L  L +  N+++         L Q+  + L  N L 
Sbjct: 102 LERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK 158

Query: 304 SRSIPP-TLGRCTDLYKLDLSYNRLTGSIPAEI-SGIREIRIFLNLSHNQLEGPLPIELS 361
           S  I          L  + ++   +T +IP  +   + E    L+L  N++       L 
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTE----LHLDGNKITKVDAASLK 213

Query: 362 KLENVQEIDLSSNKFTG---NIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAID 418
            L N+ ++ LS N  +          +N   +R +++++N L   +P  L D K ++ + 
Sbjct: 214 GLNNLAKLGLSFNSISAVDNGSL---ANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 269

Query: 419 VSGNHLSGI------IPISLNKIHTLTFINLSFN 446
           +  N++S I       P    K  + + ++L  N
Sbjct: 270 LHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 303

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 87.0 bits (216), Expect = 1e-18
 Identities = 51/240 (21%), Positives = 100/240 (41%), Gaps = 17/240 (7%)

Query: 220 NLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKL 279
           +L  +  S   L   +  ++        L L +N  +         L +L  L L  NK+
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 280 SGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEI-SGI 338
           S   P +   LV++  L+L+ NQL   +P  + +   L +L +  N +T  +   + +G+
Sbjct: 89  SKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK--TLQELRVHENEIT-KVRKSVFNGL 144

Query: 339 REIRIFLNLSHNQLEGPLPIE---LSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINI 395
            ++ + + L  N L+    IE      ++ +  I ++    T    I      ++  +++
Sbjct: 145 NQMIV-VELGTNPLK-SSGIENGAFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHL 199

Query: 396 SHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSG 455
             N +      SL  L NL  + +S N +S +   SL     L  ++L+ N+    +P G
Sbjct: 200 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 258

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 63.9 bits (156), Expect = 5e-11
 Identities = 24/156 (15%), Positives = 45/156 (28%), Gaps = 32/156 (20%)

Query: 2   LVDNHLFGAIPPE-FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLP 60
           L  N +   +       L  L  L L  N++      SLA   +L  + L++N L   +P
Sbjct: 199 LDGNKI-TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVP 256

Query: 61  ISFFHNCTSLRNVDLSQNFFTG------KIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN 114
                +   ++ V L  N  +         P       +   +SL++N +          
Sbjct: 257 GGLA-DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ--------- 306

Query: 115 TSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYN 150
                          E+       +     + L   
Sbjct: 307 -------------YWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 31/155 (20%), Positives = 64/155 (41%), Gaps = 14/155 (9%)

Query: 313 RCT-DLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDL 371
           RC   L  +  S   L   +P ++    +  + L+L +N++      +   L+N+  + L
Sbjct: 28  RCQCHLRVVQCSDLGLE-KVPKDLP--PDTAL-LDLQNNKITEIKDGDFKNLKNLHTLIL 83

Query: 372 SSNKFT---GNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGII 428
            +NK +      F   +  + +  + +S N L+  LP+ +   K L+ + V  N ++ + 
Sbjct: 84  INNKISKISPGAF---APLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVR 137

Query: 429 PISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATK 463
               N ++ +  + L  N  K      G F    K
Sbjct: 138 KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 172

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  125 bits (316), Expect = 2e-31
 Identities = 76/330 (23%), Positives = 133/330 (40%), Gaps = 75/330 (22%)

Query: 558 EFDEQRL-----LGTGSYGRVYKGILQD--------GTAIAVKVLQLQSGNFTKS-FNRE 603
           EF   +L     LG G++G+V                  +AVK+L+  +     S    E
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90

Query: 604 CQVLKRI-RHRNLMRIITACSLPDFKALVLPYMANGSLDSHL-------YPHSETEFGSG 655
            +++K I +H+N++ ++ AC+      +++ Y + G+L  +L         +S       
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150

Query: 656 SSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
              +T    V+    +A GM YL   +  + IH DL   NVL+ ++    ++DFG+A+ +
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207

Query: 716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVT 771
                     +    +T   L   + +MAPE      +    + + DV+SFG+L+ E+ T
Sbjct: 208 NN-------IDYYKKTTNGRL--PVKWMAPEALFDRVY----THQSDVWSFGVLMWEIFT 254

Query: 772 RRRPTDDMFAG----GLSLHKWVKNHYHG-RLEKVIDSSLLRASRDQSPEVKRMWDVAIG 826
                     G    G+ + +  K    G R++K              P           
Sbjct: 255 --------LGGSPYPGIPVEELFKLLKEGHRMDK--------------PA------NCTN 286

Query: 827 ELIELGILCTQESPSTRPTMLDAADDLDRL 856
           EL  +   C    PS RPT     +DLDR+
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  129 bits (326), Expect = 2e-31
 Identities = 67/424 (15%), Positives = 132/424 (31%), Gaps = 71/424 (16%)

Query: 29  NNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEI 88
           +  +     +        L   + N    +L             + L++   +  +P+ +
Sbjct: 23  SGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLI---NQFSELQLNRLNLS-SLPDNL 78

Query: 89  GNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLS 148
              P +  L +  N L   LP      S+  LD   N LS  LP        SL +L + 
Sbjct: 79  P--PQITVLEITQNALI-SLPELP--ASLEYLDACDNRLS-TLPELP----ASLKHLDVD 128

Query: 149 YNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKIT 208
            N +                                   LP+      L  +    N++T
Sbjct: 129 NNQLTM---------------------------------LPELPA--LLEYINADNNQLT 153

Query: 209 GSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHH 268
             +P    +L     L++ +N L+            LE L +S NL    +PA   + HH
Sbjct: 154 -MLPELPTSLE---VLSVRNNQLTFLPE----LPESLEALDVSTNLLE-SLPAVPVRNHH 204

Query: 269 L----GLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSY 324
                       N+++  IP ++ +L    ++ L +N LS  I  +L + T         
Sbjct: 205 SEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPR 263

Query: 325 NRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQI 384
              + S   +       R   +            ++S++ +  E +  +N F+       
Sbjct: 264 IYFSMSDGQQ---NTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS-----AF 315

Query: 385 SNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLS 444
            + ++  +   + +  +  +   L  L     +      ++     S      LT+ NL 
Sbjct: 316 LDRLSDTVSARNTSGFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLR 375

Query: 445 FNEF 448
               
Sbjct: 376 KTLL 379

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  128 bits (322), Expect = 5e-31
 Identities = 61/340 (17%), Positives = 109/340 (32%), Gaps = 77/340 (22%)

Query: 114 NTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTD 173
           N    + +  YN +S    +D  S         L   N          V           
Sbjct: 9   NNFSLSQNSFYNTIS-GTYADYFSAWDKWEKQALPGEN------RNEAV----------- 50

Query: 174 LEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSG 233
                        +L         ++L L    ++ S+P ++     +  L ++ N L  
Sbjct: 51  -------------SLLKECLINQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI- 93

Query: 234 TISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQI 293
           ++    +    LE L    N  S  +P     L HL   D+  N+L+  +P     L   
Sbjct: 94  SLPELPA---SLEYLDACDNRLS-TLPELPASLKHL---DVDNNQLT-MLPELPALLE-- 143

Query: 294 YSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLE 353
             +  +NNQL+  +P        L  L +  N+LT  +P     +      L++S N LE
Sbjct: 144 -YINADNNQLT-MLPELPTS---LEVLSVRNNQLT-FLPELPESLEA----LDVSTNLLE 193

Query: 354 GPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKN 413
             LP    +  + +E ++                          N +  ++P+++  L  
Sbjct: 194 S-LPAVPVRNHHSEETEIF--------------------FRCRENRIT-HIPENILSLDP 231

Query: 414 LEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIP 453
              I +  N LS  I  SL++       +     F     
Sbjct: 232 TCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDG 271

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  124 bits (314), Expect = 2e-31
 Identities = 74/308 (24%), Positives = 133/308 (43%), Gaps = 52/308 (16%)

Query: 562 QRLLGTGSYGRVYKGILQDG---TAIAVKVLQLQSGNFTKS-FNRECQVLKRI-RHRNLM 616
           Q ++G G++G+V K  ++        A+K ++  +       F  E +VL ++  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEF-------GSGSSDLTLLQRVNICS 669
            ++ AC    +  L + Y  +G+L   L      E         S +S L+  Q ++  +
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           D+A GM YL   S  + IH DL   N+L+ ++  A ++DFG+++       G +      
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKT 199

Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLSLHK 788
                 L   + +MA E    S  +T  DV+S+G+L+ E+V+    P   M      L++
Sbjct: 200 MG---RL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--TCAELYE 252

Query: 789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLD 848
            +   Y  RLEK ++                       E+ +L   C +E P  RP+   
Sbjct: 253 KLPQGY--RLEKPLNCDD--------------------EVYDLMRQCWREKPYERPSFAQ 290

Query: 849 AADDLDRL 856
               L+R+
Sbjct: 291 ILVSLNRM 298

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  125 bits (316), Expect = 2e-31
 Identities = 76/330 (23%), Positives = 129/330 (39%), Gaps = 75/330 (22%)

Query: 558 EFDEQRL-----LGTGSYGRVYKGILQD--------GTAIAVKVL-QLQSGNFTKSFNRE 603
           EF   +L     LG G +G+V                  +AVK+L    +         E
Sbjct: 77  EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136

Query: 604 CQVLKRI-RHRNLMRIITACSLPDFKALVLPYMANGSLDSHL-------YPHSETEFGSG 655
            +++K I +H+N++ ++ AC+      +++ Y + G+L  +L         +S       
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196

Query: 656 SSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
              +T    V+    +A GM YL      + IH DL   NVL+ ++    ++DFG+A+ +
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI 253

Query: 716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVT 771
                  D  +   N     L   + +MAPE      +    + + DV+SFG+L+ E+ T
Sbjct: 254 NN----IDYYKKTTNG---RL--PVKWMAPEALFDRVY----THQSDVWSFGVLMWEIFT 300

Query: 772 RRRPTDDMFAG----GLSLHKWVKNHYHG-RLEKVIDSSLLRASRDQSPEVKRMWDVAIG 826
                     G    G+ + +  K    G R++K              P           
Sbjct: 301 --------LGGSPYPGIPVEELFKLLKEGHRMDK--------------PA------NCTN 332

Query: 827 ELIELGILCTQESPSTRPTMLDAADDLDRL 856
           EL  +   C    PS RPT     +DLDR+
Sbjct: 333 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  124 bits (313), Expect = 4e-31
 Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 30/232 (12%)

Query: 558 EFDEQRL-----LGTGSYGRVYKGILQD------GTAIAVKVLQLQSGNFTKS-FNRECQ 605
           EF    L     LG G++G+V +              +AVK+L+  +    K     E +
Sbjct: 42  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101

Query: 606 VLKRI-RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETE-----FGSGSSDL 659
           ++  + +H N++ ++ AC+      ++  Y   G L + L   S        F   +S  
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161

Query: 660 TLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVG 719
           +    ++  S +A+GMA+L        IH D+   NVLL +   A + DFG+A+ +M   
Sbjct: 162 STRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN-- 216

Query: 720 VGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                  N        L   + +MAPE  F    + + DV+S+GIL+ E+ +
Sbjct: 217 -----DSNYIVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  128 bits (324), Expect = 4e-31
 Identities = 51/227 (22%), Positives = 95/227 (41%), Gaps = 39/227 (17%)

Query: 565 LGTGSYGRVYKGILQDG---TAIAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNLMRIIT 620
           LG G++G V +G+ +       +A+KVL+  +         RE Q++ ++ +  ++R+I 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
            C       LV+     G L   L    E         + +     +   ++ GM YL  
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMKYLEE 454

Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGS- 739
                 +H +L   NVLL +   A +SDFG++K +              +S         
Sbjct: 455 K---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA-----------DDSYYTARSAGK 500

Query: 740 --IGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVTR-RRPTDDM 779
             + + APE   +  F    S++ DV+S+G+ + E ++  ++P   M
Sbjct: 501 WPLKWYAPECINFRKF----SSRSDVWSYGVTMWEALSYGQKPYKKM 543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  125 bits (314), Expect = 4e-31
 Identities = 42/319 (13%), Positives = 77/319 (24%), Gaps = 62/319 (19%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNLMRI 618
             L  G    V+    ++     A+KV       S +  +  +       R+   +    
Sbjct: 68  EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127

Query: 619 ITACSL------------PDFKALVLPYMANGSLDSHL-YPHSETEFGSG---------- 655
                L            P F  L          +  L  P +  +              
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187

Query: 656 SSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
             D  +L    + + +    A L       ++H    P N+ +  D   ++ D      V
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244

Query: 716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNT--STKGDVYSFGILVLEMVTRR 773
                          +        + Y   E+   S    +   + +  G+ +  +    
Sbjct: 245 --------------GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

Query: 774 RPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGI 833
            P   +  G     K       G      DS    +       VK         LI    
Sbjct: 291 LPFGLVTPGIKGSWKRPSLRVPGT-----DSLAFGSCTPLPDFVKT--------LIG-RF 336

Query: 834 LCTQESPSTRPTMLDAADD 852
           L        R   L+A + 
Sbjct: 337 L--NFDRRRRLLPLEAMET 353

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  128 bits (323), Expect = 9e-31
 Identities = 63/341 (18%), Positives = 125/341 (36%), Gaps = 54/341 (15%)

Query: 524 ISSGKSETRSKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDG-- 581
           +S  +++  ++ I  E  +  P     E+     E    R +G G +G V++GI      
Sbjct: 359 VSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELG--RCIGEGQFGDVHQGIYMSPEN 416

Query: 582 --TAIAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANG 638
              A+A+K  +  + +  +  F +E   +++  H +++++I   +      +++     G
Sbjct: 417 PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLG 475

Query: 639 SLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL 698
            L S L     +        L L   +     ++  +AYL      R +H D+   NVL+
Sbjct: 476 ELRSFLQVRKFS--------LDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLV 524

Query: 699 NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGD 758
           + +    + DFG+++ +       D        +   L   I +MAPE       ++  D
Sbjct: 525 SSNDCVKLGDFGLSRYM------EDSTYYKA--SKGKL--PIKWMAPESINFRRFTSASD 574

Query: 759 VYSFGILVLEMVTR-RRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEV 817
           V+ FG+ + E++    +P   +      +   ++N    RL                P  
Sbjct: 575 VWMFGVCMWEILMHGVKPFQGV--KNNDVIGRIENGE--RLPMP----------PNCPP- 619

Query: 818 KRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR 858
                     L  L   C    PS RP   +    L  +  
Sbjct: 620 ---------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  124 bits (313), Expect = 9e-31
 Identities = 78/332 (23%), Positives = 134/332 (40%), Gaps = 79/332 (23%)

Query: 558 EFDEQRL-----LGTGSYGRVYKGILQD--------GTAIAVKVLQLQSGNFTKS-FNRE 603
           E    RL     LG G++G+V                T +AVK+L+  +     S    E
Sbjct: 65  ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124

Query: 604 CQVLKRI-RHRNLMRIITACSLPDFKALVLPYMANGSLDSHL-------YPHSETEFGSG 655
            +++K I +H+N++ ++ AC+      +++ Y + G+L  +L         +S     + 
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184

Query: 656 SSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
              L+    V+    +A GM YL      + IH DL   NVL+ +D    ++DFG+A+ +
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDI 241

Query: 716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPE---YG-FGSNTSTKGDVYSFGILVLEMVT 771
                     +    +T   L   + +MAPE      +    + + DV+SFG+L+ E+ T
Sbjct: 242 HH-------IDYYKKTTNGRL--PVKWMAPEALFDRIY----THQSDVWSFGVLLWEIFT 288

Query: 772 RRRPTDDMFAG----GLSLH---KWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVA 824
                     G    G+ +    K +K  +  R++K              P         
Sbjct: 289 --------LGGSPYPGVPVEELFKLLKEGH--RMDK--------------PS------NC 318

Query: 825 IGELIELGILCTQESPSTRPTMLDAADDLDRL 856
             EL  +   C    PS RPT     +DLDR+
Sbjct: 319 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  127 bits (320), Expect = 9e-31
 Identities = 79/458 (17%), Positives = 165/458 (36%), Gaps = 38/458 (8%)

Query: 12  PPEFSKLRRLRHLQLDGNNLHGQIPESL-ALLSNLTLVTLHDNNLTGMLPISFFHNCTSL 70
            P+ S L  LR L+L  N +   +   +     +L  + +  N L   +         SL
Sbjct: 69  MPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQN-IS---CCPMASL 123

Query: 71  RNVDLSQNFFTG-KIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSG 129
           R++DLS N F    + +E GN   L  L L   +        + +  +  + ++      
Sbjct: 124 RHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHI 183

Query: 130 ELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELEL-----AGMDL 184
           +       +  SL   + +  ++V H ++   V    S+     L+   +         L
Sbjct: 184 KG-----GETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRL 238

Query: 185 GGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNL---SNLISLNLSSNLLSGTISAEI-- 239
              L +      L  + LQ  + T      +        +  LN+ +  ++  I  E   
Sbjct: 239 MTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFT 298

Query: 240 ---SWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSL 296
              + L  L    + + +F     A       + +  LS +       V   +      L
Sbjct: 299 YSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFL 358

Query: 297 FLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQL---- 352
               N  + S+         L  L L  N L  +   +++ + +    L      L    
Sbjct: 359 NFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFF-KVALMTKNMSSLETLDVSLNSLN 416

Query: 353 EGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRL--INISHNALQGNLPDSLGD 410
                   +  E++  ++LSSN  TG++F     C+  ++  +++ +N +  ++P  +  
Sbjct: 417 SHAYDRTCAWAESILVLNLSSNMLTGSVF----RCLPPKVKVLDLHNNRIM-SIPKDVTH 471

Query: 411 LKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEF 448
           L+ L+ ++V+ N L  +     +++ +L +I L  N +
Sbjct: 472 LQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  114 bits (288), Expect = 8e-27
 Identities = 72/463 (15%), Positives = 157/463 (33%), Gaps = 60/463 (12%)

Query: 41  LLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEI-GNCPNLWTLSL 99
           L      ++L  N+++  L +      + LR + LS N     +   +     +L  L +
Sbjct: 50  LPPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDV 107

Query: 100 YNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNT 159
            +N+L   +    +  S+ +LD+ +N             L  LT+L LS           
Sbjct: 108 SHNRLQN-ISCCPM-ASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ----- 160

Query: 160 NLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLS 219
             +              L+L    + G   +S+   N T L L  +  +        +++
Sbjct: 161 --LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVN 218

Query: 220 NLISLNLSSNLLSGTISAEIS----------------------------------WLSQL 245
            L  L LS+  L+      +                                   W   +
Sbjct: 219 ALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPV 278

Query: 246 EQLFLSHNLFSGEIP-----AALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNN 300
           E L + +   +  I       +   L  L +  +                 ++    L+ 
Sbjct: 279 EYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSI 338

Query: 301 NQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLE--GPLPI 358
           +             +    L+ + N  T S+    S ++ ++  L L  N L+    + +
Sbjct: 339 SDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQT-LILQRNGLKNFFKVAL 397

Query: 359 ELSKLENVQEIDLSSNKFTGNIFIQISNCIA-VRLINISHNALQGNLPDSLGDLKNLEAI 417
               + +++ +D+S N    + + +       + ++N+S N L G++   L     ++ +
Sbjct: 398 MTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVL 455

Query: 418 DVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNS 460
           D+  N +   IP  +  +  L  +N++ N+ K  +P  G+F+ 
Sbjct: 456 DLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVP-DGVFDR 495

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  107 bits (268), Expect = 3e-24
 Identities = 69/382 (18%), Positives = 137/382 (35%), Gaps = 26/382 (6%)

Query: 11  IPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVT-LHDNNLTGMLPISFFHNCTS 69
           +  EF  L +L  L L            +A L    ++  L   ++ G    S     T+
Sbjct: 138 VCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTT 197

Query: 70  LRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTG--------QLPASLINTSMYNLD 121
           + ++    N           N   L  L L N +L           L       ++ N+ 
Sbjct: 198 VLHLVFHPNSLFSVQVNMSVN--ALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT 255

Query: 122 VEYNHLSGELPSDIMS--KLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELEL 179
           +++   + +    +        + YL++    +    D         +L     L    +
Sbjct: 256 LQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETAL---KSLMIEHV 312

Query: 180 AGMDLGGTLPDSIGRL--NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISA 237
                     +++  +   +   +L  +           + S+   LN + N+ + ++  
Sbjct: 313 KNQVF-LFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQ 371

Query: 238 EISWLSQLEQLFLSHNLFS--GEIPAALGKLHHLGLLDLSFNKL-SGEIPVSLGNLVQIY 294
             S L +L+ L L  N      ++      +  L  LD+S N L S     +      I 
Sbjct: 372 GCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL 431

Query: 295 SLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEG 354
            L L++N L+ S+   L     +  LDL  NR+  SIP +++ ++ ++  LN++ NQL+ 
Sbjct: 432 VLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQE-LNVASNQLKS 487

Query: 355 PLPIELSKLENVQEIDLSSNKF 376
                  +L ++Q I L  N +
Sbjct: 488 VPDGVFDRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 88.0 bits (218), Expect = 3e-18
 Identities = 62/417 (14%), Positives = 143/417 (34%), Gaps = 46/417 (11%)

Query: 67  CTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN--TSMYNLDVEY 124
                 VD S    T  +P+++   P    LSL  N ++ +L    I+  + +  L + +
Sbjct: 30  NELESMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSH 85

Query: 125 NHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDL 184
           N +   L   +      L YL +S+N + +       +           L  L+L+  D 
Sbjct: 86  NRIR-SLDFHVFLFNQDLEYLDVSHNRLQN-------ISC----CPMASLRHLDLSFNDF 133

Query: 185 GGTLPDS--IGRL-NLTQLLLQENKITGSIPPHIGNLS-NLISLNLSSNLLSGTISAEIS 240
              LP     G L  LT L L   K        + +L  + I L+L S  + G  +  + 
Sbjct: 134 D-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQ 192

Query: 241 WL--SQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQ----IY 294
               + L  +F  ++LFS ++  ++  L HL L ++  N  + +  ++  + +     + 
Sbjct: 193 IPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLL 252

Query: 295 SLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEG 354
           ++ L + + +      L +    +   + Y  +                 L ++      
Sbjct: 253 NVTLQHIETTWKCSVKLFQF--FWPRPVEYLNIYN---------------LTITERIDRE 295

Query: 355 PLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNL 414
                 + L+++    + +  F  +     S    + +  +S +              + 
Sbjct: 296 EFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSF 355

Query: 415 EAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQH 471
             ++ + N  +  +    + +  L  + L  N  K       +  + + +  +    
Sbjct: 356 TFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSL 412

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  121 bits (306), Expect = 2e-30
 Identities = 55/245 (22%), Positives = 95/245 (38%), Gaps = 20/245 (8%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           +   + LG G +  V     L DG   A+K +        +   RE  + +   H N++R
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90

Query: 618 IITACSLPDFKA----LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           ++  C           L+LP+   G+L + +    +       + LT  Q + +   I  
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKG-----NFLTEDQILWLLLGICR 145

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           G+  +H        H DLKP+N+LL D+   ++ D G          G+   + +     
Sbjct: 146 GLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGS--RQALTLQDW 200

Query: 734 NMLCGSIGYMAPE----YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKW 789
                +I Y APE             + DV+S G ++  M+    P D +F  G S+   
Sbjct: 201 AAQRCTISYRAPELFSVQS-HCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259

Query: 790 VKNHY 794
           V+N  
Sbjct: 260 VQNQL 264

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  121 bits (306), Expect = 2e-30
 Identities = 63/303 (20%), Positives = 118/303 (38%), Gaps = 68/303 (22%)

Query: 563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIIT 620
           + +G+G   +V++ + +     A+K + L+        S+  E   L +++  +  +II 
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKII- 91

Query: 621 ACSLPDFKA------LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
              L D++       +V+    N  L+S L      +  S    +   +R +   ++ E 
Sbjct: 92  --RLYDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKS----IDPWERKSYWKNMLEA 139

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           +  +H H    ++H DLKP+N L+ D M  L  DFGIA  +           +  +   +
Sbjct: 140 VHTIHQH---GIVHSDLKPANFLIVDGMLKL-IDFGIANQM---------QPDTTSVVKD 186

Query: 735 MLCGSIGYMAPE-----------YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGG 783
              G++ YM PE               S  S K DV+S G ++  M   + P    F   
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP----FQQ- 241

Query: 784 LSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTR 843
                 + N    +L  +ID        +   E     D+   +L ++   C +  P  R
Sbjct: 242 ------IINQIS-KLHAIIDP-------NHEIE---FPDIPEKDLQDVLKCCLKRDPKQR 284

Query: 844 PTM 846
            ++
Sbjct: 285 ISI 287

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  122 bits (308), Expect = 2e-30
 Identities = 55/263 (20%), Positives = 105/263 (39%), Gaps = 46/263 (17%)

Query: 563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIIT 620
           + +G+G   +V++ + +     A+K + L+        S+  E   L +++  +  +II 
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIR 73

Query: 621 ACSLPDFKA------LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
              L D++       +V+    N  L+S L      +  S    +   +R +   ++ E 
Sbjct: 74  ---LYDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKS----IDPWERKSYWKNMLEA 120

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           +  +H H    ++H DLKP+N L+ D M  L  DFGIA  +           +  +   +
Sbjct: 121 VHTIHQH---GIVHSDLKPANFLIVDGMLKL-IDFGIANQMQ---------PDTTSVVKD 167

Query: 735 MLCGSIGYMAPE-----------YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGG 783
              G++ YM PE               S  S K DV+S G ++  M   + P   +    
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 227

Query: 784 LSLHKWVKNHYHGRLEKVIDSSL 806
             LH  +  ++      + +  L
Sbjct: 228 SKLHAIIDPNHEIEFPDIPEKDL 250

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  120 bits (302), Expect = 4e-30
 Identities = 46/234 (19%), Positives = 97/234 (41%), Gaps = 33/234 (14%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLM 616
           +F E  L+G+G +G+V+K     DG    +K ++  +    +   RE + L ++ H N++
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIV 67

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR-----------V 665
                    D+        ++ S    L+   + EF    +    +++           +
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLF--IQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125

Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGA 725
            +   I +G+ Y+H     ++I+ DLKPSN+ L D     + DFG+   +          
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN-------- 174

Query: 726 ENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
               +       G++ YM+PE     +   + D+Y+ G+++ E++       + 
Sbjct: 175 ----DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET 224

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  121 bits (306), Expect = 4e-30
 Identities = 66/327 (20%), Positives = 125/327 (38%), Gaps = 63/327 (19%)

Query: 558 EFDEQRL-----LGTGSYGRVYKGILQDG------TAIAVKVLQLQSGNFTKS-FNRECQ 605
           EF  + L     LG+G++G+V                +AVK+L+ ++ +  +     E +
Sbjct: 41  EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100

Query: 606 VLKRI-RHRNLMRIITACSLPDFKALVLPYMANGSLDSHL--------------YPHSET 650
           ++ ++  H N++ ++ AC+L     L+  Y   G L ++L                    
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160

Query: 651 EFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG 710
           E     + LT    +     +A+GM +L        +H DL   NVL+       + DFG
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFG 217

Query: 711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
           +A+ +M+         N        L   + +MAPE  F    + K DV+S+GIL+ E+ 
Sbjct: 218 LARDIMS-------DSNYVVRGNARL--PVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268

Query: 771 TR-RRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELI 829
           +    P   +     + +K ++N +  ++++              P        A  E+ 
Sbjct: 269 SLGVNPYPGIPVDA-NFYKLIQNGF--KMDQ--------------PF------YATEEIY 305

Query: 830 ELGILCTQESPSTRPTMLDAADDLDRL 856
            +   C       RP+  +    L   
Sbjct: 306 IIMQSCWAFDSRKRPSFPNLTSFLGCQ 332

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  122 bits (308), Expect = 7e-30
 Identities = 48/231 (20%), Positives = 94/231 (40%), Gaps = 40/231 (17%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLM 616
            F  + +LG G+ G +    + D   +AVK +  +        +RE Q+L+    H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVI 81

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHL----YPHSETEFGSGSSDLTLLQRVNICSDIA 672
           R         F+ + +   A  +L  ++    + H   E             + +     
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE------------PITLLQQTT 128

Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLL-----NDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
            G+A+LH      ++H DLKP N+L+     +  + A++SDFG+ K +            
Sbjct: 129 SGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL--------AVGR 177

Query: 728 MGNSTANMLCGSIGYMAPEY---GFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              S  + + G+ G++APE        N +   D++S G +   +++    
Sbjct: 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  121 bits (305), Expect = 1e-29
 Identities = 50/259 (19%), Positives = 102/259 (39%), Gaps = 38/259 (14%)

Query: 563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNF--TKSFNRECQVLKRIRHRNL--MRI 618
           + +G+G   +V++ + +     A+K + L+  +     S+  E   L +++  +   +R+
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 619 ITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
                   +  +V+    N  L+S L      +  S    +   +R +   ++ E +  +
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL-----KKKKS----IDPWERKSYWKNMLEAVHTI 171

Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCG 738
           H H    ++H DLKP+N L+  D    + DFGIA  +           +  +   +   G
Sbjct: 172 HQH---GIVHSDLKPANFLI-VDGMLKLIDFGIANQM---------QPDTTSVVKDSQVG 218

Query: 739 SIGYMAPE-----------YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH 787
           ++ YM PE               S  S K DV+S G ++  M   + P   +      LH
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 278

Query: 788 KWVKNHYHGRLEKVIDSSL 806
             +  ++      + +  L
Sbjct: 279 AIIDPNHEIEFPDIPEKDL 297

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  119 bits (300), Expect = 2e-29
 Identities = 72/365 (19%), Positives = 124/365 (33%), Gaps = 78/365 (21%)

Query: 21  LRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFF 80
           LR +Q     L   +P+ ++   + TL+ L +N+++  L    F     L  + L  N  
Sbjct: 35  LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKI 90

Query: 81  TGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKL 139
           + KI E+       L  L +  N L  ++P +L  +S+  L +  N +  ++P  + S L
Sbjct: 91  S-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP-SSLVELRIHDNRIR-KVPKGVFSGL 146

Query: 140 PSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQ 199
            ++  + +  N                       LE             P +   L L  
Sbjct: 147 RNMNCIEMGGNP----------------------LENSGFE--------PGAFDGLKLNY 176

Query: 200 LLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEI 259
           L + E K+T  IP  +                             L +L L HN     I
Sbjct: 177 LRISEAKLT-GIPKDL--------------------------PETLNELHLDHNKIQ-AI 208

Query: 260 PA-ALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLY 318
               L +   L  L L  N++      SL  L  +  L L+NN+LS  +P  L     L 
Sbjct: 209 ELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQ 267

Query: 319 KLDLSYNRLTGSIPAE-ISGIREIRIF-----LNLSHNQLEGPL--PIELSKLENVQEID 370
            + L  N +T  +       +           ++L +N +      P     + +   I 
Sbjct: 268 VVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQ 326

Query: 371 LSSNK 375
             + K
Sbjct: 327 FGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  118 bits (297), Expect = 4e-29
 Identities = 67/328 (20%), Positives = 120/328 (36%), Gaps = 54/328 (16%)

Query: 10  AIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTS 69
           A+P E S       L L  N++     +    L +L  + L +N ++ +   +F      
Sbjct: 47  AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAF------ 98

Query: 70  LRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSG 129
                                   L  L +  N L  ++P +L  +S+  L +  N +  
Sbjct: 99  -------------------SPLRKLQKLYISKNHLV-EIPPNLP-SSLVELRIHDNRIR- 136

Query: 130 ELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLP 189
           ++P  + S L ++  + +  N + +          F+ L     L  L ++   L   +P
Sbjct: 137 KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGA---FDGLK----LNYLRISEAKL-TGIP 188

Query: 190 DSIGRLNLTQLLLQENKITGSIPP-HIGNLSNLISLNLSSNLLSGTISAEI-SWLSQLEQ 247
             +    L +L L  NKI  +I    +   S L  L L  N +   I     S+L  L +
Sbjct: 189 KDLPE-TLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRE 245

Query: 248 LFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVS-------LGNLVQIYSLFLNN 300
           L L +N  S  +PA L  L  L ++ L  N ++ ++ V+                + L N
Sbjct: 246 LHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFN 303

Query: 301 NQLS-RSIPPTLGRC-TDLYKLDLSYNR 326
           N +    + P   RC TD   +     +
Sbjct: 304 NPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  112 bits (283), Expect = 3e-27
 Identities = 67/303 (22%), Positives = 119/303 (39%), Gaps = 30/303 (9%)

Query: 170 NCT-DLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPH-IGNLSNLISLNLS 227
            C   L  ++ + + L   +P  I   + T L LQ N I+  +       L +L +L L 
Sbjct: 30  GCHCHLRVVQCSDLGLK-AVPKEISP-DTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLV 86

Query: 228 SNLLSGTISAEI-SWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVS 286
           +N +S  I  +  S L +L++L++S N    EIP  L     L  L +  N++       
Sbjct: 87  NNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGV 142

Query: 287 LGNLVQIYSLFLNNNQLSRS-IPPTLGRCTDLYKLDLSYNRLTGSIPAEI-SGIREIRIF 344
              L  +  + +  N L  S   P       L  L +S  +LT  IP ++   + E    
Sbjct: 143 FSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPETLNE---- 197

Query: 345 LNLSHNQLEGPLPIELSKLENVQEIDLSSNKFT---GNIFIQISNCIAVRLINISHNALQ 401
           L+L HN+++     +L +   +  + L  N+            S    +R +++ +N L 
Sbjct: 198 LHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSL---SFLPTLRELHLDNNKLS 254

Query: 402 GNLPDSLGDLKNLEAIDVSGNHLSGIIP------ISLNKIHTLTFINLSFNEFKGMIPSG 455
             +P  L DLK L+ + +  N+++ +            K      I+L  N         
Sbjct: 255 -RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313

Query: 456 GIF 458
             F
Sbjct: 314 ATF 316

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 60.4 bits (147), Expect = 7e-10
 Identities = 28/157 (17%), Positives = 46/157 (29%), Gaps = 34/157 (21%)

Query: 2   LVDNHLFGAIPPE-FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLP 60
           L  N +  AI  E   +  +L  L L  N +      SL+ L  L  + L +N L+  +P
Sbjct: 200 LDHNKI-QAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVP 257

Query: 61  ISFFHNCTSLRNVDLSQNFFTGKIPEEI-------GNCPNLWTLSLYNNQLTGQLPASLI 113
                +   L+ V L  N  T K+                   +SL+NN +         
Sbjct: 258 AGLP-DLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP-------- 307

Query: 114 NTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYN 150
                           E+       +     +     
Sbjct: 308 --------------YWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 54.6 bits (132), Expect = 5e-08
 Identities = 34/173 (19%), Positives = 66/173 (38%), Gaps = 20/173 (11%)

Query: 297 FLNNNQLSRSIPPTLG-----RCT-DLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHN 350
                 L  S+PPT        C   L  +  S   L  ++P EIS   +  + L+L +N
Sbjct: 10  TSGIPDL-DSLPPTYSAMCPFGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTL-LDLQNN 64

Query: 351 QLEGPLPIELSKLENVQEIDLSSNKFT---GNIFIQISNCIAVRLINISHNALQGNLPDS 407
            +      +   L+++  + L +NK +      F   S    ++ + IS N L   +P +
Sbjct: 65  DISELRKDDFKGLQHLYALVLVNNKISKIHEKAF---SPLRKLQKLYISKNHLV-EIPPN 120

Query: 408 LGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNS 460
           L    +L  + +  N +  +     + +  +  I +  N  +      G F+ 
Sbjct: 121 L--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG 171

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  118 bits (297), Expect = 3e-29
 Identities = 62/330 (18%), Positives = 105/330 (31%), Gaps = 71/330 (21%)

Query: 525 SSGKSETRSKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGI-LQDGTA 583
            S + E      +P    + P   +++       F     LG GSYG V+K    +DG  
Sbjct: 31  VSFRGEASETLQSPGYDPSRPESFFQQ------SFQRLSRLGHGSYGEVFKVRSKEDGRL 84

Query: 584 IAVKVLQLQSGNFTKSFN--RECQVLKRI-RHRNLMRIITACSLPDFKALVLPYMANGSL 640
            AVK                 E    +++ +H   +R+  A        L        SL
Sbjct: 85  YAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSL 143

Query: 641 DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND 700
             H        +G+   +  +        D    +A+LH      ++H D+KP+N+ L  
Sbjct: 144 QQHCE-----AWGASLPEAQVW---GYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGP 192

Query: 701 DMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPE-----YGFGSNTST 755
                + DFG+   + T                 +  G   YMAPE     YG       
Sbjct: 193 RGRCKLGDFGLLVELGT------------AGAGEVQEGDPRYMAPELLQGSYGT------ 234

Query: 756 KGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSP 815
             DV+S G+ +LE+            GG    +  + +        +           S 
Sbjct: 235 AADVFSLGLTILEVACNMEL----PHGGEGWQQLRQGYLPPEFTAGL-----------SS 279

Query: 816 EVKRMWDVAIGELIELGILCTQESPSTRPT 845
           E++         ++    +  +  P  R T
Sbjct: 280 ELR--------SVLV---MMLEPDPKLRAT 298

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  117 bits (296), Expect = 3e-29
 Identities = 48/222 (21%), Positives = 91/222 (40%), Gaps = 23/222 (10%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTK---SFNRECQVLKRIRHR 613
            F  ++ +G G +  VY+   L DG  +A+K +Q+      K      +E  +LK++ H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92

Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           N+++   +    +   +VL     G L   +       F      +           +  
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMI-----KHFKKQKRLIPERTVWKYFVQLCS 147

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + ++H     RV+H D+KP+NV +       + D G+ +   +             + A
Sbjct: 148 ALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-----------KTTAA 193

Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           + L G+  YM+PE    +  + K D++S G L+ EM   + P
Sbjct: 194 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  117 bits (295), Expect = 4e-29
 Identities = 56/279 (20%), Positives = 105/279 (37%), Gaps = 44/279 (15%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLM 616
           +F+E  +LG G++G+V K     D    A+K ++        +   E  +L  + H+ ++
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVV 65

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD------ 670
           R   A          +  +   S    L+   + E+    +   L+   N+         
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKS---TLF--IQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 671 ----IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               I E ++Y+H      +IH DLKP N+ +++     + DFG+AK V           
Sbjct: 121 LFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 727 NMGNSTANML---CGSIGYMAPE-------YGFGSNTSTKGDVYSFGILVLEMV------ 770
                +++ L    G+  Y+A E       Y        K D+YS GI+  EM+      
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNE------KIDMYSLGIIFFEMIYPFSTG 231

Query: 771 -TRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLR 808
             R      + +  +       ++     +K+I   L+ 
Sbjct: 232 MERVNILKKLRSVSIEFPPDFDDNKMKVEKKII-RLLID 269

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  116 bits (293), Expect = 6e-29
 Identities = 71/327 (21%), Positives = 127/327 (38%), Gaps = 56/327 (17%)

Query: 562 QRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGN---FTKSFNRECQVLKRIRHRNLMR 617
              LG G    VY          +A+K + +         K F RE     ++ H+N++ 
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +I      D   LV+ Y+   +L  ++  H           L++   +N  + I +G+ +
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIESHG---------PLSVDTAINFTNQILDGIKH 126

Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
            H     R++H D+KP N+L++ + T  + DFGIAK +    +          +  N + 
Sbjct: 127 AHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL----------TQTNHVL 173

Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR 797
           G++ Y +PE   G  T    D+YS GI++ EM+    P    F G               
Sbjct: 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP----FNG--------------- 214

Query: 798 LEKVIDSSL---LRASRDQSPEVKRMWDVAIGELIELGIL-CTQESPSTRPTMLDAADDL 853
                ++++   ++  +D  P V       I + +   IL  T++  + R       +  
Sbjct: 215 -----ETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYK--TIQEMK 267

Query: 854 DRLKRYLGEKHMPSKMNALHLEDIIAI 880
           D L   L E      +  L     IA+
Sbjct: 268 DDLSSVLHENRANEDVYELDKMKTIAV 294

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  116 bits (292), Expect = 1e-28
 Identities = 59/328 (17%), Positives = 112/328 (34%), Gaps = 57/328 (17%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQL-QSGNFTKSFNRECQVLKRIRHRNL 615
           +F+  + LG G +G V++     D    A+K ++L       +   RE + L ++ H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65

Query: 616 MRIITA----------CSLPDFKAL--VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQ 663
           +R   A                  L   +      +L   +             +     
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM------NGRCTIEERERSV 119

Query: 664 RVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK-LVMTVGVGN 722
            ++I   IAE + +LH      ++H DLKPSN+    D    V DFG+   +        
Sbjct: 120 CLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176

Query: 723 DGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAG 782
                   +      G+  YM+PE   G++ S K D++S G+++ E++         F+ 
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP-------FST 229

Query: 783 GLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPST 842
            +   +         L  V +         + P            +++        SP  
Sbjct: 230 QMERVR--------TLTDVRNLKFPPLFTQKYPCEY--------VMVQ---DMLSPSPME 270

Query: 843 RPTMLDAADDLDRLKR-YLGEKHMPSKM 869
           RP     A ++  ++     +   P K 
Sbjct: 271 RPE----AINI--IENAVFEDLDFPGKT 292

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  115 bits (291), Expect = 1e-28
 Identities = 61/264 (23%), Positives = 101/264 (38%), Gaps = 21/264 (7%)

Query: 96  TLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSH 155
            +   +  LT  +P   I +S   L++E N L   LP  +  KL  LT L LS N +   
Sbjct: 11  EIRCNSKGLT-SVPTG-IPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFK 67

Query: 156 DDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPH 214
              +          +   L+ L+L+   +  T+  +   L  L  L  Q + +   +   
Sbjct: 68  GCCSQS---DFGTTS---LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEF 119

Query: 215 --IGNLSNLISLNLSSNLLSGTISAEI-SWLSQLEQLFLSHNLFSGEIPA-ALGKLHHLG 270
               +L NLI L++S           I + LS LE L ++ N F          +L +L 
Sbjct: 120 SVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 178

Query: 271 LLDLSFNKLSGEIPV-SLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTG 329
            LDLS  +L  ++   +  +L  +  L +++N               L  LD S N +  
Sbjct: 179 FLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM- 236

Query: 330 SIPAEI-SGIREIRIFLNLSHNQL 352
           +   +          FLNL+ N  
Sbjct: 237 TSKKQELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  115 bits (289), Expect = 2e-28
 Identities = 62/289 (21%), Positives = 103/289 (35%), Gaps = 43/289 (14%)

Query: 22  RHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFT 81
             ++ +   L   +P  +   S+ T + L  N L   LP   F   T L  + LS N  +
Sbjct: 10  TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLS 65

Query: 82  GK--IPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNLDVEYNHLSGELPSDIMSK 138
            K    +      +L  L L  N +   + ++ +    + +LD ++++L       +   
Sbjct: 66  FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 124

Query: 139 LPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLT 198
           L +L YL +S+ +     +       FN L +                          L 
Sbjct: 125 LRNLIYLDISHTHTRVAFNGI-----FNGLSS--------------------------LE 153

Query: 199 QLLLQENKITGSIPPHI-GNLSNLISLNLSSNLLSGTISAEISW-LSQLEQLFLSHNLFS 256
            L +  N    +  P I   L NL  L+LS   L   +S      LS L+ L +SHN F 
Sbjct: 154 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF 212

Query: 257 GEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLV-QIYSLFLNNNQLS 304
                    L+ L +LD S N +       L +    +  L L  N  +
Sbjct: 213 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  112 bits (281), Expect = 3e-27
 Identities = 53/254 (20%), Positives = 93/254 (36%), Gaps = 20/254 (7%)

Query: 10  AIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGM-LPISFFHNCT 68
           ++P           L+L+ N L          L+ LT ++L  N L+            T
Sbjct: 21  SVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78

Query: 69  SLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN--TSMYNLDVEYNH 126
           SL+ +DLS N     +         L  L   ++ L      S+     ++  LD+ + H
Sbjct: 79  SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137

Query: 127 LSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGG 186
                 + I + L SL  L ++ N+   +          +      +L  L+L+   L  
Sbjct: 138 TR-VAFNGIFNGLSSLEVLKMAGNSFQENFLP-------DIFTELRNLTFLDLSQCQLEQ 189

Query: 187 TLPDSIGRL-NLTQLLLQENKITGSIPPHI-GNLSNLISLNLSSNLLSGTISAEI--SWL 242
             P +   L +L  L +  N    S+       L++L  L+ S N +  T   +    + 
Sbjct: 190 LSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFP 247

Query: 243 SQLEQLFLSHNLFS 256
           S L  L L+ N F+
Sbjct: 248 SSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  106 bits (267), Expect = 2e-25
 Identities = 56/277 (20%), Positives = 106/277 (38%), Gaps = 36/277 (12%)

Query: 196 NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHN-L 254
           + T++      +T S+P  I   S+   L L SN L          L+QL +L LS N L
Sbjct: 8   SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64

Query: 255 FSGEIPA-ALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPP-TLG 312
                 + +      L  LDLSFN +   +  +   L Q+  L   ++ L +        
Sbjct: 65  SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 123

Query: 313 RCTDLYKLDLSYNRLTGSIPAEI-SGIREIRIFLNLSHNQ-LEGPLPIELSKLENVQEID 370
              +L  LD+S+          I +G+  + + L ++ N   E  LP   ++L N+  +D
Sbjct: 124 SLRNLIYLDISHTHTR-VAFNGIFNGLSSLEV-LKMAGNSFQENFLPDIFTELRNLTFLD 181

Query: 371 LSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPI 430
           LS  +                   +S  A           L +L+ +++S N+   +   
Sbjct: 182 LSQCQLE----------------QLSPTAFNS--------LSSLQVLNMSHNNFFSLDTF 217

Query: 431 SLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFV 467
               +++L  ++ S N          + +  + ++F+
Sbjct: 218 PYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFL 253

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 97.4 bits (243), Expect = 3e-22
 Identities = 46/235 (19%), Positives = 73/235 (31%), Gaps = 42/235 (17%)

Query: 2   LVDNHL--FGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGML 59
           L  N L   G           L++L L  N +   +  +   L  L  +    +NL  M 
Sbjct: 59  LSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMS 117

Query: 60  PISFFHNCTSLRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLIN--TS 116
             S F +  +L  +D+S           I     +L  L +  N         +     +
Sbjct: 118 EFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 176

Query: 117 MYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEE 176
           +  LD+    L  +L     + L SL  L++S+NN  S D        +  L        
Sbjct: 177 LTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFP-----YKCLN------- 223

Query: 177 LELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHI--GNLSNLISLNLSSN 229
                              +L  L    N I  +          S+L  LNL+ N
Sbjct: 224 -------------------SLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  120 bits (303), Expect = 2e-28
 Identities = 38/223 (17%), Positives = 75/223 (33%), Gaps = 41/223 (18%)

Query: 562 QRLLGTGSYGRVYKG---ILQDGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMR 617
           +  +  G  G +Y      + +G  + +K L              E Q L  + H ++++
Sbjct: 85  KGCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143

Query: 618 IITACSLPDFKALVLPYMA----NG-SLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIA 672
           I       D     + Y+      G SL                  L + + +    +I 
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----------LPVAEAIAYLLEIL 192

Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
             ++YLH      +++ DLKP N++L ++    + D G     +               +
Sbjct: 193 PALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR-IN--------------S 233

Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              L G+ G+ APE       +   D+Y+ G  +  +      
Sbjct: 234 FGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPT 275

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  116 bits (292), Expect = 3e-28
 Identities = 44/309 (14%), Positives = 94/309 (30%), Gaps = 16/309 (5%)

Query: 520 IKLIISSGKSETRSKPITPELMHNFPRITYRELLEATAE-FDEQRLLGTGSYGRVYKGI- 577
           I  ++S       S P T E     P I  +   +  ++      LLG G++ +VY+   
Sbjct: 27  IFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQ 86

Query: 578 -----LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL 632
                 ++     +KV +  +        +  + LK       M+  +A    +   LV 
Sbjct: 87  GDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVG 146

Query: 633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLK 692
              + G+L + +  +  T        +     ++    +   +  +H      +IH D+K
Sbjct: 147 ELYSYGTLLNAINLYKNTPEK----VMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIK 199

Query: 693 PSNVLLNDDMTALVSDFGIAKLVMTV--GVGNDGAENMGNSTANMLCGSIGYMAPEYGFG 750
           P N +L +       +  ++  +  +  G   D       +     C + G+   E    
Sbjct: 200 PDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN 259

Query: 751 SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRAS 810
              + + D +     V  M+           G        +   H  +       +L   
Sbjct: 260 KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIP 319

Query: 811 RDQSPEVKR 819
                    
Sbjct: 320 DCHHLPSLD 328

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  117 bits (294), Expect = 3e-28
 Identities = 44/323 (13%), Positives = 84/323 (26%), Gaps = 75/323 (23%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRH------ 612
            +LG        +    + G +  V V    +    N  K    E   L+ +R       
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 613 -RNLMRIITACSLPDFKALVLPYMANGSLDSH-------LYPHSETEFGSG--------- 655
            +  +R I    L                          LYP  ++   +          
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 656 -SSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL 714
               L    R+ +   +   +A LHH+    ++H  L+P +++L+      ++ F     
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-----DVYSFGILVLEM 769
                V   G                   A                  D ++ G+ +  +
Sbjct: 261 DGASAVSPIG----------RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310

Query: 770 VTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELI 829
                P                +   G  E +      R+ ++    V+         L+
Sbjct: 311 WCADLP----NTD---------DAALGGSEWI-----FRSCKNIPQPVR--------ALL 344

Query: 830 ELGILCTQESPSTRPTMLDAADD 852
           E G L  +     R   L A + 
Sbjct: 345 E-GFL--RYPKEDRLLPLQAMET 364

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  114 bits (288), Expect = 5e-28
 Identities = 49/227 (21%), Positives = 89/227 (39%), Gaps = 34/227 (14%)

Query: 562 QRLLGTGSYGRVYKGILQD---GTAIAVKVLQLQSGN---FTKSFNRECQVLKRIRHRNL 615
           +RL+G G  G VY+   +D      +A+K++     +   F     RE +   R++  ++
Sbjct: 39  RRLVGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV 96

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           + I     +     + +  +    L + L        G     L   + V I   I   +
Sbjct: 97  VPIHDFGEIDGQLYVDMRLINGVDLAAML-----RRQGP----LAPPRAVAIVRQIGSAL 147

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
              H        H D+KP N+L++ D  A + DFGIA       +          +    
Sbjct: 148 DAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL----------TQLGN 194

Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAG 782
             G++ YMAPE    S+ + + D+Y+   ++ E +T   P    + G
Sbjct: 195 TVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP----YQG 237

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  117 bits (294), Expect = 6e-28
 Identities = 60/286 (20%), Positives = 99/286 (34%), Gaps = 42/286 (14%)

Query: 43  SNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNN 102
           +  + V      L+  +P     N   L   +L +N       +   +  +L  L L  N
Sbjct: 54  NQFSKVVCTRRGLSE-VPQGIPSNTRYL---NLMENNIQMIQADTFRHLHHLEVLQLGRN 109

Query: 103 QLTGQLPASLIN-TSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNL 161
            +      +     S+  L++  N L+  +PS     L  L  L L  N + S       
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYA-- 166

Query: 162 VPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHI-GNLSN 220
              FN + +   L  L+L  +                       K+   I       L N
Sbjct: 167 ---FNRVPS---LMRLDLGEL----------------------KKLE-YISEGAFEGLFN 197

Query: 221 LISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLS 280
           L  LNL    +   +   ++ L  LE+L +S N F    P +   L  L  L +  +++S
Sbjct: 198 LKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS 255

Query: 281 GEIPVSLGNLVQIYSLFLNNNQLSRSIPP-TLGRCTDLYKLDLSYN 325
                +   L  +  L L +N LS S+P         L +L L +N
Sbjct: 256 LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  112 bits (281), Expect = 3e-26
 Identities = 64/251 (25%), Positives = 110/251 (43%), Gaps = 25/251 (9%)

Query: 10  AIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTS 69
            +P         R+L L  NN+     ++   L +L ++ L  N++   + +  F+   S
Sbjct: 68  EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLAS 124

Query: 70  LRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLIN--TSMYNLDV-EYN 125
           L  ++L  N+ T  IP         L  L L NN +   +P+   N   S+  LD+ E  
Sbjct: 125 LNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELK 182

Query: 126 HLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLG 185
            L   +       L +L YL+L   N+         +P    L     LEELE++G    
Sbjct: 183 KLE-YISEGAFEGLFNLKYLNLGMCNIKD-------MPNLTPLVG---LEELEMSGNHFP 231

Query: 186 GTLPDSIGRL-NLTQLLLQENKITGSIPPH-IGNLSNLISLNLSSNLLSGTISAEI-SWL 242
              P S   L +L +L +  ++++  I  +    L++L+ LNL+ N LS ++  ++ + L
Sbjct: 232 EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPL 289

Query: 243 SQLEQLFLSHN 253
             L +L L HN
Sbjct: 290 RYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  111 bits (280), Expect = 4e-26
 Identities = 63/266 (23%), Positives = 109/266 (40%), Gaps = 22/266 (8%)

Query: 92  PNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNN 151
                +      L+ ++P   I ++   L++  N++   + +D    L  L  L L  N+
Sbjct: 54  NQFSKVVCTRRGLS-EVPQG-IPSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNS 110

Query: 152 MVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGS 210
           +   +        FN L +   L  LEL    L      +   L  L +L L+ N I  S
Sbjct: 111 IRQIEVGA-----FNGLAS---LNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-S 161

Query: 211 IPPHI-GNLSNLISLNLSSNLLSGTISAEI-SWLSQLEQLFLSHNLFSGEIPAALGKLHH 268
           IP +    + +L+ L+L        IS      L  L+ L L       ++P  L  L  
Sbjct: 162 IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVG 219

Query: 269 LGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPP-TLGRCTDLYKLDLSYNRL 327
           L  L++S N      P S   L  +  L++ N+Q+   I          L +L+L++N L
Sbjct: 220 LEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQV-SLIERNAFDGLASLVELNLAHNNL 278

Query: 328 TGSIPAEI-SGIREIRIFLNLSHNQL 352
           + S+P ++ + +R +   L+L HN  
Sbjct: 279 S-SLPHDLFTPLRYLV-ELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  105 bits (263), Expect = 6e-24
 Identities = 53/257 (20%), Positives = 94/257 (36%), Gaps = 38/257 (14%)

Query: 196 NLTQLLLQENKITGSIPPHI-GNLSNLISLNLSSNLLSGTISAEI-SWLSQLEQLFLSHN 253
           N   L L EN I   I      +L +L  L L  N +   I     + L+ L  L L  N
Sbjct: 76  NTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDN 133

Query: 254 LFSGEIPA-ALGKLHHLGLLDLSFNKLSGEIPV-SLGNLVQIYSLFL-NNNQLSRSIPP- 309
             +  IP+ A   L  L  L L  N +   IP  +   +  +  L L    +L   I   
Sbjct: 134 WLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISEG 190

Query: 310 TLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEI 369
                 +L  L+L    +   +P  ++ +  +   L +S N      P     L +++++
Sbjct: 191 AFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLE-ELEMSGNHFPEIRPGSFHGLSSLKKL 247

Query: 370 DLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIP 429
            + ++                ++  I  NA  G        L +L  ++++ N+LS +  
Sbjct: 248 WVMNS----------------QVSLIERNAFDG--------LASLVELNLAHNNLSSLPH 283

Query: 430 ISLNKIHTLTFINLSFN 446
                +  L  ++L  N
Sbjct: 284 DLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 95.2 bits (237), Expect = 1e-20
 Identities = 63/277 (22%), Positives = 111/277 (40%), Gaps = 41/277 (14%)

Query: 196 NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLF 255
             ++++     ++  +P  I   SN   LNL  N +    +     L  LE L L  N  
Sbjct: 55  QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111

Query: 256 SGEIPA-ALGKLHHLGLLDLSFNKLSGEIPV-SLGNLVQIYSLFLNNNQLSRSIPP-TLG 312
             +I   A   L  L  L+L  N L+  IP  +   L ++  L+L NN +  SIP     
Sbjct: 112 R-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFN 168

Query: 313 RCTDLYKLDLS-YNRLTGSIPAEI-SGIREIRIFLNLSHNQLEGPLPIELSKLENVQEID 370
           R   L +LDL    +L   I      G+  ++ +LNL    ++  +P  L+ L  ++E++
Sbjct: 169 RVPSLMRLDLGELKKLE-YISEGAFEGLFNLK-YLNLGMCNIKD-MP-NLTPLVGLEELE 224

Query: 371 LSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPI 430
           +S N F                  I   +  G        L +L+ + V  + +S I   
Sbjct: 225 MSGNHFP----------------EIRPGSFHG--------LSSLKKLWVMNSQVSLIERN 260

Query: 431 SLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFV 467
           + + + +L  +NL+ N     +P   +F     +  +
Sbjct: 261 AFDGLASLVELNLAHNNLS-SLP-HDLFTPLRYLVEL 295

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 60.5 bits (147), Expect = 1e-09
 Identities = 21/93 (22%), Positives = 44/93 (47%), Gaps = 3/93 (3%)

Query: 13  PEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRN 72
           P  + L  L  L++ GN+     P S   LS+L  + + ++ ++ ++  + F    SL  
Sbjct: 212 PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVE 270

Query: 73  VDLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQL 104
           ++L+ N  +  +P ++      L  L L++N  
Sbjct: 271 LNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  114 bits (286), Expect = 8e-28
 Identities = 59/345 (17%), Positives = 111/345 (32%), Gaps = 83/345 (24%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQL-QSGNFTKSFNRECQVLKRIRHRNL 615
           +F+  + +G G +G V++     D    A+K ++L       +   RE + L ++ H  +
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66

Query: 616 MRIITA------------------------CSLPDFKALVLPYMANGSLDSHLYPHSETE 651
           +R   A                          L     +  P +    +D     ++  +
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126

Query: 652 FGSGSSDL------------TLLQRV---------------NICSDIAEGMAYLHHHSPV 684
               S  +             L   +               +I   IAE + +LH     
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK--- 183

Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAK-LVMTVGVGNDGAENMGNSTANMLCGSIGYM 743
            ++H DLKPSN+    D    V DFG+   +                +T     G+  YM
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243

Query: 744 APEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVID 803
           +PE   G+N S K D++S G+++ E++       +                   +  V +
Sbjct: 244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR---------------IITDVRN 288

Query: 804 SSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLD 848
                    + P+           +++        SP+ RP   D
Sbjct: 289 LKFPLLFTQKYPQEH--------MMVQ---DMLSPSPTERPEATD 322

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  112 bits (283), Expect = 9e-28
 Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 39/229 (17%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRN 614
           F+  R LG G +G VY     Q    +A+KVL   QL+         RE ++   +RH N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHL-----YPHSETEFGSGSSDLTLLQRVNICS 669
           ++R+           L+L Y   G++   L     +    T                  +
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--------------YIT 116

Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           ++A  ++Y H     RVIH D+KP N+LL       ++DFG +                 
Sbjct: 117 ELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA-------------P 160

Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
           +S    LCG++ Y+ PE   G     K D++S G+L  E +  + P + 
Sbjct: 161 SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  112 bits (283), Expect = 1e-27
 Identities = 63/314 (20%), Positives = 112/314 (35%), Gaps = 48/314 (15%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRN 614
           +++    +GTGSYGR  K     DG  +  K L     +    +    E  +L+ ++H N
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66

Query: 615 LMRIITACSLPDFKAL--VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIA 672
           ++R            L  V+ Y   G L S +   ++         L     + + + + 
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLT 121

Query: 673 EGMAYLH--HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
             +   H        V+H DLKP+NV L+      + DFG+A+++           N   
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-----------NHDT 170

Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV 790
           S A    G+  YM+PE     + + K D++S G L+ E+     P    F          
Sbjct: 171 SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----FTA-------- 218

Query: 791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAA 850
                    K+ +    R     S E+         E+I             RP++ +  
Sbjct: 219 -FSQKELAGKIREGKFRRIPYRYSDELN--------EIIT---RMLNLKDYHRPSVEEIL 266

Query: 851 DDLDRLKRYLGEKH 864
           ++   +  +    H
Sbjct: 267 EN-PLILEHHHHHH 279

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  114 bits (286), Expect = 2e-27
 Identities = 46/221 (20%), Positives = 90/221 (40%), Gaps = 24/221 (10%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRN 614
           ++   + +G GS+G+       +DG    +K + +   S    +   RE  VL  ++H N
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +++   +        +V+ Y   G L   +       F     D  L    +    I   
Sbjct: 85  IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLF---QEDQIL----DWFVQICLA 137

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           + ++H     +++H D+K  N+ L  D T  + DFGIA+++           N     A 
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL-----------NSTVELAR 183

Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              G+  Y++PE       + K D+++ G ++ E+ T +  
Sbjct: 184 ACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  112 bits (283), Expect = 4e-27
 Identities = 49/232 (21%), Positives = 84/232 (36%), Gaps = 7/232 (3%)

Query: 2   LVDNHLFGAIPPE-FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLP 60
           L  N +   I  + FS L  L HL L  N L          LS+LT + L  N    +  
Sbjct: 83  LTSNGI-NTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGE 141

Query: 61  ISFFHNCTSLRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLIN-TSMY 118
            S F + T L+ + +       KI  +       L  L +  + L    P SL +  ++ 
Sbjct: 142 TSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVS 201

Query: 119 NLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELE 178
           +L +        L    +    S+  L L   ++ +   +       NSL        ++
Sbjct: 202 HLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVK 260

Query: 179 LAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHI-GNLSNLISLNLSSN 229
           +    L   +        L +L    N++  S+P  I   L++L  + L +N
Sbjct: 261 ITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  110 bits (277), Expect = 2e-26
 Identities = 61/264 (23%), Positives = 101/264 (38%), Gaps = 18/264 (6%)

Query: 196 NLTQLLLQENKITGSIPPHI-GNLSNLISLNLSSNLLSGTISAEI-SWLSQLEQLFLSHN 253
            +  L L  N+IT  I         NL +L L+SN ++ TI  +  S L  LE L LS+N
Sbjct: 53  AVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110

Query: 254 LFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSL-GNLVQIYSLFLNNNQLSRSIPP-TL 311
             S    +    L  L  L+L  N        SL  +L ++  L + N      I     
Sbjct: 111 YLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170

Query: 312 GRCTDLYKLDLSYNRLTGSIPAEI-SGIREIRIFLNLSHNQLEGPLPIELSKLENVQEID 370
              T L +L++  + L  S   +    I+ +   L L   Q    L I +    +V+ ++
Sbjct: 171 AGLTFLEELEIDASDLQ-SYEPKSLKSIQNVS-HLILHMKQHILLLEIFVDVTSSVECLE 228

Query: 371 LSSNKFTGNIFIQIS--------NCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGN 422
           L         F ++S             R + I+  +L   +   L  +  L  ++ S N
Sbjct: 229 LRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRN 287

Query: 423 HLSGIIPISLNKIHTLTFINLSFN 446
            L  +     +++ +L  I L  N
Sbjct: 288 QLKSVPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  109 bits (275), Expect = 4e-26
 Identities = 55/346 (15%), Positives = 122/346 (35%), Gaps = 74/346 (21%)

Query: 91  CPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYN 150
           C         +  L   +P+  +  ++ +LD+  N ++  + +  + +  +L  L L+ N
Sbjct: 30  CDRNGICKGSSGSLN-SIPSG-LTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSN 86

Query: 151 NMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGS 210
            + + ++++     F+SLG+                          L  L L  N ++ +
Sbjct: 87  GINTIEEDS-----FSSLGS--------------------------LEHLDLSYNYLS-N 114

Query: 211 IPPHI-GNLSNLISLNLSSNLLSGTISAEI--SWLSQLEQLFLSHNLFSGEIPA-ALGKL 266
           +       LS+L  LNL  N    T+      S L++L+ L + +     +I       L
Sbjct: 115 LSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL 173

Query: 267 HHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPP-TLGRCTDLYKLDLSYN 325
             L  L++  + L    P SL ++  +  L L+  Q    +    +   + +  L+L   
Sbjct: 174 TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDT 232

Query: 326 RLTGSIPAEISGIREIRI-------FLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTG 378
            L     +E+S      +        + ++   L   +   L+++  + E++ S N+   
Sbjct: 233 DLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK- 290

Query: 379 NIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHL 424
                          ++               L +L+ I +  N  
Sbjct: 291 ---------------SVPDGIFDR--------LTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  107 bits (269), Expect = 2e-25
 Identities = 54/313 (17%), Positives = 101/313 (32%), Gaps = 57/313 (18%)

Query: 21  LRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFF 80
           ++ L L  N +       L    NL  + L  N +   +    F +  SL ++DLS N+ 
Sbjct: 54  VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL 112

Query: 81  TGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLIN--TSMYNLDVEYNHLSGELPSDIMS 137
           +  +         +L  L+L  N        SL +  T +  L V       ++     +
Sbjct: 113 S-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171

Query: 138 KLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNL 197
            L  L  L +  +++ S++  +       S+                           N+
Sbjct: 172 GLTFLEELEIDASDLQSYEPKS-----LKSIQ--------------------------NV 200

Query: 198 TQLLLQENKITGSIPPHI-GNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFS 256
           + L+L   +    +        S++  L L    L     +E+S                
Sbjct: 201 SHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGE------------- 246

Query: 257 GEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPP-TLGRCT 315
                +L K      + ++   L  ++   L  +  +  L  + NQL  S+P     R T
Sbjct: 247 ---TNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLT 301

Query: 316 DLYKLDLSYNRLT 328
            L K+ L  N   
Sbjct: 302 SLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  102 bits (257), Expect = 8e-24
 Identities = 66/375 (17%), Positives = 119/375 (31%), Gaps = 83/375 (22%)

Query: 7   LFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHN 66
              +         R    +    +L+  IP    L   +  + L +N +T  +  S    
Sbjct: 19  KEESSNQASLSCDRNGICKGSSGSLN-SIPS--GLTEAVKSLDLSNNRIT-YISNSDLQR 74

Query: 67  CTSLRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYN 125
           C +L+ + L+ N     I E+   +  +L  L L  N L+                    
Sbjct: 75  CVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-------------------- 113

Query: 126 HLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLG 185
                L S     L SLT+L+L  N   +  + +     F+ L     L+ L +  MD  
Sbjct: 114 ----NLSSSWFKPLSSLTFLNLLGNPYKTLGETS----LFSHLTK---LQILRVGNMDTF 162

Query: 186 GTLPDSI--GRLNLTQLLLQENKITGSIPPHI-GNLSNLISLNLSSNLLSGTISAEISWL 242
             +      G   L +L +  + +  S  P    ++ N+  L L                
Sbjct: 163 TKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI---------- 211

Query: 243 SQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQ 302
                  L              +L    L    F++LS     SL       ++ + +  
Sbjct: 212 ------LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDES 265

Query: 303 LSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSK 362
           L   +   L + + L +L+ S N+L  S+P  I                          +
Sbjct: 266 L-FQVMKLLNQISGLLELEFSRNQLK-SVPDGI------------------------FDR 299

Query: 363 LENVQEIDLSSNKFT 377
           L ++Q+I L +N + 
Sbjct: 300 LTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 83.2 bits (206), Expect = 4e-17
 Identities = 30/160 (18%), Positives = 59/160 (36%), Gaps = 11/160 (6%)

Query: 1   MLVDNHLFGAIPPE-FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGML 59
            + +   F  I  + F+ L  L  L++D ++L    P+SL  + N++ + LH      +L
Sbjct: 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LL 213

Query: 60  PISFFHNCTSLRNVDLSQNFFTGKIPEEI--------GNCPNLWTLSLYNNQLTGQLPAS 111
              F    +S+  ++L           E+                + + +  L   +   
Sbjct: 214 LEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLL 273

Query: 112 LINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNN 151
              + +  L+   N L   +P  I  +L SL  + L  N 
Sbjct: 274 NQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNP 312

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 74.0 bits (182), Expect = 4e-14
 Identities = 43/272 (15%), Positives = 89/272 (32%), Gaps = 60/272 (22%)

Query: 210 SIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPA-ALGKLHH 268
           SIP  +     + SL+LS+N ++   ++++     L+ L L+ N  +  I   +   L  
Sbjct: 45  SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGS 101

Query: 269 LGLLDLSFNKLSGEIPVSL-GNLVQIYSLFLNNNQLSRSIPP--TLGRCTDLYKLDLSYN 325
           L  LDLS+N LS  +  S    L  +  L L  N    ++         T L  L +   
Sbjct: 102 LEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNM 159

Query: 326 RLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQIS 385
                I  +                          + L  ++E+++ ++           
Sbjct: 160 DTFTKIQRKD------------------------FAGLTFLEELEIDASDLQ-------- 187

Query: 386 NCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSF 445
                   +    +L+         ++N+  + +       ++ I ++   ++  + L  
Sbjct: 188 --------SYEPKSLKS--------IQNVSHLILHMKQHILLLEIFVDVTSSVECLELRD 231

Query: 446 NEFKGMIPS---GGIFNSATKMSFVGNQHLCG 474
            +      S    G  NS  K     N  +  
Sbjct: 232 TDLDTFHFSELSTGETNSLIKKFTFRNVKITD 263

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  113 bits (283), Expect = 5e-27
 Identities = 43/326 (13%), Positives = 89/326 (27%), Gaps = 86/326 (26%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIR------- 611
            +LG        +    + G +  V V    +    N  K    E   L+ +R       
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 612 ---HRNLMRIITACSLPDFKALVLPYMANGSLDSH----LYPHSETEFGSGSSDL----- 659
              H   +        P  K ++   +    +       LYP  ++   +    L     
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 660 -----TLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL 714
                    R+ +   +   +A LHH+    ++H  L+P +++L+      ++ F     
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEY-----------GFGSNTSTKGDVYSFG 763
                          +    +   S G+  PE               +  +   D ++ G
Sbjct: 256 ---------------DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300

Query: 764 ILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDV 823
           +++  +     P                              + R+ ++    V+     
Sbjct: 301 LVIYWIWCADLP------------------ITKDAALGGSEWIFRSCKNIPQPVRA---- 338

Query: 824 AIGELIELGILCTQESPSTRPTMLDA 849
               L+E G L        R   L A
Sbjct: 339 ----LLE-GFLRYP--KEDRLLPLQA 357

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  110 bits (276), Expect = 1e-26
 Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 27/224 (12%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNL 615
           +++ Q ++G+G+   V           +A+K + L+    +     +E Q + +  H N+
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +   T+  + D   LV+  ++ GS+   +  H   +    S  L       I  ++ EG+
Sbjct: 76  VSYYTSFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI-AKLVMTVGVGNDGAENMGNSTAN 734
            YLH +     IH D+K  N+LL +D +  ++DFG+ A L         G +   N    
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFL-------ATGGDITRNKVRK 184

Query: 735 MLCGSIGYMAPE-------YGFGSNTSTKGDVYSFGILVLEMVT 771
              G+  +MAPE       Y F      K D++SFGI  +E+ T
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDF------KADIWSFGITAIELAT 222

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  112 bits (283), Expect = 1e-26
 Identities = 53/238 (22%), Positives = 97/238 (40%), Gaps = 37/238 (15%)

Query: 559 FDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLMR 617
              +++LG GS G V       G  +AVK + +    F      E ++L     H N++R
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIR 73

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
              + +   F  + L    N +L   +   S+               +++   IA G+A+
Sbjct: 74  YYCSETTDRFLYIALELC-NLNLQDLV--ESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 678 LHHHSPVRVIHCDLKPSNVLL-------------NDDMTALVSDFGIAKLVMTVGVGNDG 724
           LH     ++IH DLKP N+L+              +++  L+SDFG+ K +       D 
Sbjct: 131 LHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL-------DS 180

Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-------DVYSFGILVLEMVTRRRP 775
            ++   +  N   G+ G+ APE    SN            D++S G +   ++++ + 
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  110 bits (277), Expect = 2e-26
 Identities = 47/230 (20%), Positives = 86/230 (37%), Gaps = 22/230 (9%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIR-HRNLMRIIT 620
           R+L  G +  VY+   +  G   A+K L        ++  +E   +K++  H N+++  +
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 621 ACSLP-------DFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           A S+          + L+L  +  G L   L              L+    + I      
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP------LSCDTVLKIFYQTCR 147

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK-LVMTVGVGNDGAENMGNST 732
            + ++H   P  +IH DLK  N+LL++  T  + DFG A  +                  
Sbjct: 148 AVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 733 ANMLCGSIGYMAPE----YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
                 +  Y  PE    Y        K D+++ G ++  +  R+ P +D
Sbjct: 207 EITRNTTPMYRTPEIIDLYS-NFPIGEKQDIWALGCILYLLCFRQHPFED 255

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  109 bits (273), Expect = 4e-26
 Identities = 52/315 (16%), Positives = 106/315 (33%), Gaps = 53/315 (16%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
            +    +LG G+   V++G   + G   A+KV   +          RE +VLK++ H+N+
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 616 MRI--ITACSLPDFKALVLPYMANGSLDSHLYPH------SETEFGSGSSDLTLLQRVNI 667
           +++  I   +    K L++ +   GSL + L          E+EF            + +
Sbjct: 70  VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF------------LIV 117

Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL----NDDMTALVSDFGIAKLVMTVGVGND 723
             D+  GM +L  +    ++H ++KP N++     +      ++DFG A+ +        
Sbjct: 118 LRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-------- 166

Query: 724 GAENMGNSTANMLCGSIGYMAPE--------YGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                 +     L G+  Y+ P+                   D++S G+      T   P
Sbjct: 167 ----EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

Query: 776 TDDMFAGGLS---LHKWVKNHYHGRLEKVIDSSLLRAS-RDQSPEVKRMWDVAIGELIEL 831
                    +   ++K +     G +  V  +           P    +       L  +
Sbjct: 223 FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPV 282

Query: 832 GILCTQESPSTRPTM 846
                +         
Sbjct: 283 LANILEADQEKCWGF 297

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  110 bits (278), Expect = 6e-26
 Identities = 66/251 (26%), Positives = 110/251 (43%), Gaps = 25/251 (9%)

Query: 10  AIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTS 69
            +P   S     R L L  N +      S   L +L ++ L  N++   + I  F+   +
Sbjct: 57  EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLAN 113

Query: 70  LRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLIN--TSMYNLDV-EYN 125
           L  ++L  N  T  IP         L  L L NN +   +P+   N   S+  LD+ E  
Sbjct: 114 LNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK 171

Query: 126 HLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLG 185
            LS  +       L +L YL+L+  N+         +P    L     L+EL+L+G  L 
Sbjct: 172 RLS-YISEGAFEGLSNLRYLNLAMCNLRE-------IPNLTPLIK---LDELDLSGNHLS 220

Query: 186 GTLPDSIGRL-NLTQLLLQENKITGSIPPH-IGNLSNLISLNLSSNLLSGTISAEI-SWL 242
              P S   L +L +L + +++I   I  +   NL +L+ +NL+ N L+  +  ++ + L
Sbjct: 221 AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPL 278

Query: 243 SQLEQLFLSHN 253
             LE++ L HN
Sbjct: 279 HHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  109 bits (273), Expect = 3e-25
 Identities = 70/266 (26%), Positives = 109/266 (40%), Gaps = 22/266 (8%)

Query: 92  PNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNN 151
                +      L  ++P   I+T+   L++  N +   +  +    L  L  L LS N+
Sbjct: 43  NQFSKVICVRKNLR-EVPDG-ISTNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNH 99

Query: 152 MVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGS 210
           + + +        FN L N   L  LEL    L      +   L  L +L L+ N I  S
Sbjct: 100 IRTIEIGA-----FNGLAN---LNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-S 150

Query: 211 IPPHI-GNLSNLISLNLSS-NLLSGTISAEI-SWLSQLEQLFLSHNLFSGEIPAALGKLH 267
           IP +    + +L  L+L     LS  IS      LS L  L L+      EIP  L  L 
Sbjct: 151 IPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLI 207

Query: 268 HLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPP-TLGRCTDLYKLDLSYNR 326
            L  LDLS N LS   P S   L+ +  L++  +Q+ + I          L +++L++N 
Sbjct: 208 KLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI-QVIERNAFDNLQSLVEINLAHNN 266

Query: 327 LTGSIPAEISGIREIRIFLNLSHNQL 352
           LT  +P ++         ++L HN  
Sbjct: 267 LT-LLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  104 bits (261), Expect = 9e-24
 Identities = 63/257 (24%), Positives = 111/257 (43%), Gaps = 17/257 (6%)

Query: 196 NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLF 255
             ++++     +   +P  I   +N   LNL  N +          L  LE L LS N  
Sbjct: 44  QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100

Query: 256 SGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPP-TLGRC 314
                 A   L +L  L+L  N+L+     +   L ++  L+L NN +  SIP     R 
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRI 159

Query: 315 TDLYKLDLS-YNRLTGSIPAEI-SGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLS 372
             L +LDL    RL+  I      G+  +R +LNL+   L   +P  L+ L  + E+DLS
Sbjct: 160 PSLRRLDLGELKRLS-YISEGAFEGLSNLR-YLNLAMCNLRE-IP-NLTPLIKLDELDLS 215

Query: 373 SNKFT---GNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIP 429
            N  +      F      + ++ + +  + +Q    ++  +L++L  I+++ N+L+ +  
Sbjct: 216 GNHLSAIRPGSF---QGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPH 272

Query: 430 ISLNKIHTLTFINLSFN 446
                +H L  I+L  N
Sbjct: 273 DLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 82.5 bits (204), Expect = 1e-16
 Identities = 39/182 (21%), Positives = 70/182 (38%), Gaps = 14/182 (7%)

Query: 2   LVDNHLFGAIPPE-FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLP 60
           L DN L   IP   F  L +L+ L L  N +      +   + +L  + L +      + 
Sbjct: 119 LFDNRL-TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYIS 177

Query: 61  ISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN-TSMYN 119
              F   ++LR ++L+      +IP  +     L  L L  N L+   P S      +  
Sbjct: 178 EGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQK 235

Query: 120 LDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELEL 179
           L +  + +   +  +    L SL  ++L++NN+     +      F  L +   LE + L
Sbjct: 236 LWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDL-----FTPLHH---LERIHL 286

Query: 180 AG 181
             
Sbjct: 287 HH 288

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  112 bits (281), Expect = 9e-26
 Identities = 46/254 (18%), Positives = 108/254 (42%), Gaps = 23/254 (9%)

Query: 197 LTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFS 256
           + + +     I   I P     +  I  NL    ++  ++   + L+ ++Q+  +++   
Sbjct: 1   MGETITVSTPIK-QIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56

Query: 257 GEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTD 316
             +   +  L ++  L L+ NKL+ +I   L NL  +  LFL+ N++   +   L     
Sbjct: 57  -SVQG-IQYLPNVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDENKIK-DLSS-LKDLKK 110

Query: 317 LYKLDLSYNRLTGSIPAEISGIREIR--IFLNLSHNQLEGPLPIELSKLENVQEIDLSSN 374
           L  L L +N ++     +I+G+  +     L L +N++       LS+L  +  + L  N
Sbjct: 111 LKSLSLEHNGIS-----DINGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDN 163

Query: 375 KFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNK 434
           + + +I + ++    ++ + +S N +  +L  +L  LKNL+ +++             + 
Sbjct: 164 QIS-DI-VPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSN 219

Query: 435 IHTLTFINLSFNEF 448
           +     +  +    
Sbjct: 220 LVVPNTVKNTDGSL 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  110 bits (275), Expect = 4e-25
 Identities = 60/309 (19%), Positives = 113/309 (36%), Gaps = 54/309 (17%)

Query: 21  LRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFF 80
           +         +  QI       +      L   ++T  +  +      S+  +  + +  
Sbjct: 1   MGETITVSTPIK-QI-FPDDAFAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDI 55

Query: 81  TGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLP 140
              + + I   PN+  L L  N+LT           +  L                + L 
Sbjct: 56  K-SV-QGIQYLPNVTKLFLNGNKLT----------DIKPL----------------TNLK 87

Query: 141 SLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQ 199
           +L +L L  N +       +L      L +   L+ L L    +  +  + +  L  L  
Sbjct: 88  NLGWLFLDENKI------KDLSS----LKDLKKLKSLSLEHNGI--SDINGLVHLPQLES 135

Query: 200 LLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEI 259
           L L  NKIT  I   +  L+ L +L+L  N +S  I   ++ L++L+ L+LS N  S ++
Sbjct: 136 LYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DL 190

Query: 260 PAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYK 319
            A L  L +L +L+L   +   +      NLV   ++   +  L    P  +    D  K
Sbjct: 191 RA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEK 247

Query: 320 LDLSYNRLT 328
            ++ ++   
Sbjct: 248 PNVKWHLPE 256

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  105 bits (262), Expect = 2e-23
 Identities = 63/282 (22%), Positives = 113/282 (40%), Gaps = 24/282 (8%)

Query: 168 LGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNL 226
                +  +  L    +  T   +   L ++ Q++   + I  S+   I  L N+  L L
Sbjct: 17  DDAFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFL 72

Query: 227 SSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVS 286
           + N L+  I   ++ L  L  LFL  N    ++ + L  L  L  L L  N +S +I   
Sbjct: 73  NGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DIN-G 126

Query: 287 LGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIR--IF 344
           L +L Q+ SL+L NN+++  I   L R T L  L L  N+++     +I  +  +     
Sbjct: 127 LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-----DIVPLAGLTKLQN 179

Query: 345 LNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNL 404
           L LS N +       L+ L+N+  ++L S +         SN +    +  +  +L    
Sbjct: 180 LYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT-- 235

Query: 405 PDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFN 446
           P+ + D  + E  +V  +       +S      +T       
Sbjct: 236 PEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKAR 277

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 89.0 bits (220), Expect = 2e-18
 Identities = 53/316 (16%), Positives = 111/316 (35%), Gaps = 74/316 (23%)

Query: 13  PEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRN 72
              ++L  +  +  + +++   + + +  L N+T + L+ N LT + P++   N  +L  
Sbjct: 37  VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTDIKPLT---NLKNLGW 91

Query: 73  VDLSQNFFTGKIP--EEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGE 130
           + L +N    KI     + +   L +LSL +N ++               D+        
Sbjct: 92  LFLDEN----KIKDLSSLKDLKKLKSLSLEHNGIS---------------DING------ 126

Query: 131 LPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPD 190
                +  LP L  L+L  N +                   TD+  L          L  
Sbjct: 127 -----LVHLPQLESLYLGNNKI-------------------TDITVLS--------RLT- 153

Query: 191 SIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFL 250
                 L  L L++N+I+  I P +  L+ L +L LS N +S  +   ++ L  L+ L L
Sbjct: 154 -----KLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLEL 204

Query: 251 SHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPT 310
                  +       L     +  +   L     +S     +  ++  +  + +  +   
Sbjct: 205 FSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFI 264

Query: 311 LGRCTDLYKLDLSYNR 326
             +   + K    ++ 
Sbjct: 265 FYQPVTIGKAKARFHG 280

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  107 bits (268), Expect = 1e-25
 Identities = 63/248 (25%), Positives = 95/248 (38%), Gaps = 41/248 (16%)

Query: 10  AIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTS 69
           A+P         + + L GN +      S     NLT++ LH N L   +  + F     
Sbjct: 25  AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLAL 81

Query: 70  LRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLS 128
           L  +DLS N     +          L TL L    L                        
Sbjct: 82  LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ----------------------- 118

Query: 129 GELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTL 188
            EL   +   L +L YL+L  N + +  D+T     F  LGN   L  L L G  +    
Sbjct: 119 -ELGPGLFRGLAALQYLYLQDNALQALPDDT-----FRDLGN---LTHLFLHGNRISSVP 169

Query: 189 PDSIGRL-NLTQLLLQENKITGSIPPHI-GNLSNLISLNLSSNLLSGTISAEI-SWLSQL 245
             +   L +L +LLL +N++   + PH   +L  L++L L +N LS  +  E  + L  L
Sbjct: 170 ERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRAL 227

Query: 246 EQLFLSHN 253
           + L L+ N
Sbjct: 228 QYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  103 bits (260), Expect = 1e-24
 Identities = 56/262 (21%), Positives = 93/262 (35%), Gaps = 44/262 (16%)

Query: 96  TLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSH 155
           T S     L   +P   I  +   + +  N +S  +P+       +LT L L  N +   
Sbjct: 15  TTSCPQQGLQ-AVPVG-IPAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARI 71

Query: 156 DDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHI 215
           D        F  L                            L QL L +N    S+ P  
Sbjct: 72  DAAA-----FTGLAL--------------------------LEQLDLSDNAQLRSVDPAT 100

Query: 216 -GNLSNLISLNLSSNLLSGTISAEI-SWLSQLEQLFLSHNLFSGEIPA-ALGKLHHLGLL 272
              L  L +L+L    L   +   +   L+ L+ L+L  N     +P      L +L  L
Sbjct: 101 FHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHL 158

Query: 273 DLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPP-TLGRCTDLYKLDLSYNRLTGSI 331
            L  N++S     +   L  +  L L+ N++   + P        L  L L  N L+ ++
Sbjct: 159 FLHGNRISSVPERAFRGLHSLDRLLLHQNRV-AHVHPHAFRDLGRLMTLYLFANNLS-AL 216

Query: 332 PAEI-SGIREIRIFLNLSHNQL 352
           P E  + +R ++ +L L+ N  
Sbjct: 217 PTEALAPLRALQ-YLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 99.7 bits (249), Expect = 3e-23
 Identities = 56/265 (21%), Positives = 82/265 (30%), Gaps = 42/265 (15%)

Query: 43  SNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNN 102
                 +     L   +P+        +    L  N  +         C NL  L L++N
Sbjct: 11  EPKVTTSCPQQGLQA-VPVGIPAASQRI---FLHGNRISHVPAASFRACRNLTILWLHSN 66

Query: 103 QLTGQLPASLIN-TSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNL 161
            L     A+      +  LD+  N     +       L  L  LHL    +         
Sbjct: 67  VLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGL-- 124

Query: 162 VPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHI-GNLSN 220
              F  L                            L  L LQ+N +  ++P     +L N
Sbjct: 125 ---FRGLA--------------------------ALQYLYLQDNALQ-ALPDDTFRDLGN 154

Query: 221 LISLNLSSNLLSGTISAEI-SWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKL 279
           L  L L  N +S ++       L  L++L L  N  +   P A   L  L  L L  N L
Sbjct: 155 LTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213

Query: 280 SGEIPVS-LGNLVQIYSLFLNNNQL 303
           S  +P   L  L  +  L LN+N  
Sbjct: 214 S-ALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 98.9 bits (247), Expect = 7e-23
 Identities = 54/256 (21%), Positives = 91/256 (35%), Gaps = 58/256 (22%)

Query: 196 NLTQLLLQENKITGSIPPHI-GNLSNLISLNLSSNLLSGTISAEI-SWLSQLEQLFLSHN 253
              ++ L  N+I+  +P        NL  L L SN+L+  I A   + L+ LEQL LS N
Sbjct: 33  ASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDN 90

Query: 254 LFSGEIPA-ALGKLHHLGLLDLSFNKLSGEIPV-SLGNLVQIYSLFLNNNQLSRSIPP-T 310
                +       L  L  L L    L  E+       L  +  L+L +N L  ++P  T
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDT 148

Query: 311 LGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEID 370
                +L  L L  NR++ S+P                              L ++  + 
Sbjct: 149 FRDLGNLTHLFLHGNRIS-SVPERA------------------------FRGLHSLDRLL 183

Query: 371 LSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPI 430
           L  N+                  ++  +A +         L  L  + +  N+LS +   
Sbjct: 184 LHQNRVA----------------HVHPHAFRD--------LGRLMTLYLFANNLSALPTE 219

Query: 431 SLNKIHTLTFINLSFN 446
           +L  +  L ++ L+ N
Sbjct: 220 ALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 43/228 (18%), Positives = 87/228 (38%), Gaps = 32/228 (14%)

Query: 243 SQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQ 302
           +  +++FL  N  S    A+     +L +L L  N L+     +   L  +  L L++N 
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 303 LSRSIPP-TLGRCTDLYKLDLSYNRLTGSIPAEI-SGIREIRIFLNLSHNQLEGPLPIE- 359
             RS+ P T      L+ L L    L   +   +  G+  ++ +L L  N L+  LP + 
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQ-YLYLQDNALQA-LPDDT 148

Query: 360 LSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDV 419
              L N+  + L  N+ +                ++   A +G        L +L+ + +
Sbjct: 149 FRDLGNLTHLFLHGNRIS----------------SVPERAFRG--------LHSLDRLLL 184

Query: 420 SGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFV 467
             N ++ + P +   +  L  + L  N     +P+         + ++
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPT-EALAPLRALQYL 230

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 60.0 bits (146), Expect = 7e-10
 Identities = 29/105 (27%), Positives = 42/105 (40%), Gaps = 5/105 (4%)

Query: 2   LVDNHLFGAIPPE-FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLP 60
           L DN L  A+P + F  L  L HL L GN +      +   L +L  + LH N +   + 
Sbjct: 136 LQDNAL-QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVH 193

Query: 61  ISFFHNCTSLRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQL 104
              F +   L  + L  N  +  +P E       L  L L +N  
Sbjct: 194 PHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  108 bits (272), Expect = 1e-25
 Identities = 43/239 (17%), Positives = 83/239 (34%), Gaps = 36/239 (15%)

Query: 559 FDEQRLLGTGSYGRVYKGILQDGTAIAVKVL---QLQSGNFTKSFN-------------- 601
           +   R L  G + ++     +D    A+K      L+        N              
Sbjct: 33  YRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFK 91

Query: 602 RECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTL 661
            E Q++  I++   +      +  D   ++  YM N S+          +  + +  + +
Sbjct: 92  NELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLD-KNYTCFIPI 150

Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
                I   +    +Y+H+     + H D+KPSN+L++ +    +SDFG ++        
Sbjct: 151 QVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEY------- 201

Query: 722 NDGAENMGNSTANMLCGSIGYMAPE--YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
                 M +       G+  +M PE      S    K D++S GI +  M     P   
Sbjct: 202 ------MVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  106 bits (268), Expect = 2e-25
 Identities = 52/229 (22%), Positives = 97/229 (42%), Gaps = 32/229 (13%)

Query: 562 QRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGN---FTKSFNRECQVLKRIRHRNLMR 617
             +LG G    V+    L+D   +AVKVL+        F   F RE Q    + H  ++ 
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 618 I----ITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           +               +V+ Y+   +L   +        G     +T  + + + +D  +
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-----HTEGP----MTPKRAIEVIADACQ 127

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + + H +    +IH D+KP+N++++      V DFGIA+ +       D   ++  +  
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI------ADSGNSV--TQT 176

Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAG 782
             + G+  Y++PE   G +   + DVYS G ++ E++T   P    F G
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTG 221

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  111 bits (278), Expect = 2e-25
 Identities = 60/268 (22%), Positives = 96/268 (35%), Gaps = 32/268 (11%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNLMRII- 619
             LGTG +G V + I    G  +A+K   Q  S    + +  E Q++K++ H N++    
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79

Query: 620 -----TACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
                   +  D   L + Y   G L  +L               TLL       DI+  
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS------DISSA 133

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           + YLH +   R+IH DLKP N++L      +   + D G AK +                
Sbjct: 134 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ------------GE 178

Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
                 G++ Y+APE       +   D +SFG L  E +T  RP    +       K  +
Sbjct: 179 LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238

Query: 792 NHYHGRLEKVIDSSLLRASRDQSPEVKR 819
                 +     +  ++ S         
Sbjct: 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHL 266

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  108 bits (270), Expect = 3e-25
 Identities = 52/327 (15%), Positives = 108/327 (33%), Gaps = 53/327 (16%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL-QLQSGNFTKSFNRECQVLKRIRHRNL 615
            +    +LG G+   V++G   + G   A+KV   +          RE +VLK++ H+N+
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 616 MRI--ITACSLPDFKALVLPYMANGSLDSHLYPH------SETEFGSGSSDLTLLQRVNI 667
           +++  I   +    K L++ +   GSL + L          E+EF            + +
Sbjct: 70  VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF------------LIV 117

Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL----NDDMTALVSDFGIAKLVMTVGVGND 723
             D+  GM +L  +    ++H ++KP N++     +      ++DFG A+ +        
Sbjct: 118 LRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED------ 168

Query: 724 GAENMGNSTANMLCGSIGYMAPE--------YGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                 +     L G+  Y+ P+                   D++S G+      T   P
Sbjct: 169 ------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

Query: 776 TDDMFAGGLS---LHKWVKNHYHGRLEKVIDSSLLRAS-RDQSPEVKRMWDVAIGELIEL 831
                    +   ++K +     G +  V  +           P    +       L  +
Sbjct: 223 FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPV 282

Query: 832 GILCTQESPSTRPTMLDAADDLDRLKR 858
                +              +   +  
Sbjct: 283 LANILEADQEKCWGFDQFFAETSDILH 309

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  106 bits (265), Expect = 4e-25
 Identities = 56/309 (18%), Positives = 100/309 (32%), Gaps = 33/309 (10%)

Query: 159 TNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIP-PHIGN 217
           ++  P ++S  NC    ++EL G           G  +L  LL + +          I  
Sbjct: 18  SDPKPDWSSAFNCLGAADVELYG-----------GGRSLEYLLKRVDTEADLGQFTDIIK 66

Query: 218 LSNLISLNLSSNLLSGTISAEIS---WLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDL 274
             +L  L + +  +   I         +S L++L L +   +G  P  L +     L  L
Sbjct: 67  SLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNIL 126

Query: 275 SFNKLSGEIPVSLGNLVQIY------SLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLT 328
           +   +S     +    +Q +       L +            +     L  LDLS N   
Sbjct: 127 NLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPEL 186

Query: 329 GSIPAEISGIREIR---IFLNLSHNQLE---GPLPIELSKLENVQEIDLSSNKFTGNI-F 381
           G      +           L L +  +E   G      +    +Q +DLS N        
Sbjct: 187 GERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246

Query: 382 IQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFI 441
                   +  +N+S   L+  +P  L     L  +D+S N L         ++  +  +
Sbjct: 247 PSCDWPSQLNSLNLSFTGLKQ-VPKGL--PAKLSVLDLSYNRLDRNPSPD--ELPQVGNL 301

Query: 442 NLSFNEFKG 450
           +L  N F  
Sbjct: 302 SLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  103 bits (258), Expect = 3e-24
 Identities = 58/317 (18%), Positives = 95/317 (29%), Gaps = 49/317 (15%)

Query: 54  NLTGMLPISFFHNCTSLRNVDLSQNFFTGKIP-EEIGNCPNLWTLSLYNNQLTGQLPASL 112
           N  G   +  +    SL  +    +         +I    +L  L++   ++  ++    
Sbjct: 29  NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA 88

Query: 113 IN----TSMYNLDVEYNHLSGELPSDIMS-KLPSLTYLHLSYNNMVSHDDNTNLVPFFNS 167
           +     + +  L +E   ++G  P  ++    P L  L+L   +            +   
Sbjct: 89  LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVS------WATRDAWLAE 142

Query: 168 LGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLS 227
           L                            L  L + +          +     L +L+LS
Sbjct: 143 LQQWLKP---------------------GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLS 181

Query: 228 SNLLSGTISAEIS----WLSQLEQLFLSHNLF---SGEIPAALGKLHHLGLLDLSFNKLS 280
            N   G      +        L+ L L +      SG   A       L  LDLS N L 
Sbjct: 182 DNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLR 241

Query: 281 GEIPVSL-GNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTG-SIPAEISGI 338
                       Q+ SL L+   L   +P  L     L  LDLSYNRL     P E+  +
Sbjct: 242 DAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLDRNPSPDELPQV 298

Query: 339 REIRIFLNLSHNQLEGP 355
                 L+L  N     
Sbjct: 299 GN----LSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 97.3 bits (242), Expect = 4e-22
 Identities = 52/306 (16%), Positives = 91/306 (29%), Gaps = 37/306 (12%)

Query: 108 LPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNS 167
           L A+ +        +EY     +  +D+      +  L L    + +    + ++     
Sbjct: 31  LGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALR 90

Query: 168 LGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLL---LQENKITG--SIPPHIGNLS--N 220
           +   + L+EL L  +++ GT P  +       L    L+        +    +       
Sbjct: 91  VLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPG 150

Query: 221 LISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIP----AALGKLHHLGLLDLSF 276
           L  L+++          ++     L  L LS N   GE          K   L +L L  
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRN 210

Query: 277 NKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEIS 336
             +                        S            L  LDLS+N L  +  A   
Sbjct: 211 AGM---------------------ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSC 249

Query: 337 GIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINIS 396
                   LNLS   L+  +P  L     +  +DLS N+   N          V  +++ 
Sbjct: 250 DWPSQLNSLNLSFTGLKQ-VPKGLPA--KLSVLDLSYNRLDRNPSPD--ELPQVGNLSLK 304

Query: 397 HNALQG 402
            N    
Sbjct: 305 GNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 88.4 bits (219), Expect = 4e-19
 Identities = 47/251 (18%), Positives = 77/251 (30%), Gaps = 37/251 (14%)

Query: 14  EFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNC-----T 68
               +  L+ L L+   + G  P  L   +   L  L+  N++     ++          
Sbjct: 90  RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKP 149

Query: 69  SLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLS 128
            L+ + ++Q        E++   P L TL L +N   G+                     
Sbjct: 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG------------------- 190

Query: 129 GELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTL 188
             + +    K P+L  L L    M      T              L+ L+L+   L    
Sbjct: 191 -LISALCPLKFPTLQVLALRNAGM-----ETPSGVCSALAAARVQLQGLDLSHNSLRDAA 244

Query: 189 PDSIGRL--NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLE 246
                     L  L L    +   +P  +   + L  L+LS N L    S     L Q+ 
Sbjct: 245 GAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDRNPS--PDELPQVG 299

Query: 247 QLFLSHNLFSG 257
            L L  N F  
Sbjct: 300 NLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 79.6 bits (196), Expect = 4e-16
 Identities = 41/246 (16%), Positives = 72/246 (29%), Gaps = 51/246 (20%)

Query: 2   LVDNHLFGAIPPEFSKL--RRLRHLQLDGNNLHGQIPESLAL----LSNLTLVTLHDNNL 55
           L +  + G  PP   +     L  L L   +   +      L       L ++++   + 
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS 161

Query: 56  TGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNC----PNLWTLSLYNNQLT---GQL 108
                        +L  +DLS N   G+       C    P L  L+L N  +    G  
Sbjct: 162 L-NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220

Query: 109 PASLIN-TSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNS 167
            A       +  LD+ +N L     +        L  L+LS+  +               
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ------------- 267

Query: 168 LGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLS 227
                               +P  +    L+ L L  N++  +  P    L  + +L+L 
Sbjct: 268 --------------------VPKGLPA-KLSVLDLSYNRLDRN--PSPDELPQVGNLSLK 304

Query: 228 SNLLSG 233
            N    
Sbjct: 305 GNPFLD 310

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  106 bits (266), Expect = 5e-25
 Identities = 57/264 (21%), Positives = 99/264 (37%), Gaps = 45/264 (17%)

Query: 525 SSGKSETRSKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGI-LQDGTA 583
            +      + P   E+    P +       +   +   R LG G + + ++         
Sbjct: 15  VAAPGAPAAAPPAKEI----PEVLVDP--RSRRRYVRGRFLGKGGFAKCFEISDADTKEV 68

Query: 584 IAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSL 640
            A K++    L   +  +  + E  + + + H++++         DF  +VL      SL
Sbjct: 69  FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL 128

Query: 641 DSHLYPH---SETE---FGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPS 694
                     +E E   +        L Q       I  G  YLH +   RVIH DLK  
Sbjct: 129 LELHKRRKALTEPEARYY--------LRQ-------IVLGCQYLHRN---RVIHRDLKLG 170

Query: 695 NVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTS 754
           N+ LN+D+   + DFG+A  V   G               +LCG+  Y+APE       S
Sbjct: 171 NLFLNEDLEVKIGDFGLATKVEYDG-----------ERKKVLCGTPNYIAPEVLSKKGHS 219

Query: 755 TKGDVYSFGILVLEMVTRRRPTDD 778
            + DV+S G ++  ++  + P + 
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFET 243

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  104 bits (263), Expect = 5e-25
 Identities = 58/224 (25%), Positives = 93/224 (41%), Gaps = 29/224 (12%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRN 614
           FD  R LG G +G VY     Q+   +A+KVL   QL+         RE ++   +RH N
Sbjct: 16  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           ++R+           L+L +   G L   L       F    S   + +       +A+ 
Sbjct: 76  ILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEE-------LADA 126

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           + Y H     +VIH D+KP N+L+       ++DFG +            A ++   T  
Sbjct: 127 LHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVH----------APSLRRRT-- 171

Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
            +CG++ Y+ PE   G     K D++  G+L  E +    P D 
Sbjct: 172 -MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  104 bits (263), Expect = 7e-25
 Identities = 54/226 (23%), Positives = 90/226 (39%), Gaps = 39/226 (17%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNLMRI 618
           R LG G + + ++          A K++    L   +  +  + E  + + + H++++  
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80

Query: 619 ITACSLPDFKALVLPYMANGSLDSHLYPH---SETE---FGSGSSDLTLLQRVNICSDIA 672
                  DF  +VL      SL          +E E   +        L Q       I 
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY--------LRQ-------IV 125

Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
            G  YLH +   RVIH DLK  N+ LN+D+   + DFG+A  V   G             
Sbjct: 126 LGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-----------ER 171

Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
             +LCG+  Y+APE       S + DV+S G ++  ++  + P + 
Sbjct: 172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  105 bits (263), Expect = 7e-25
 Identities = 49/269 (18%), Positives = 111/269 (41%), Gaps = 26/269 (9%)

Query: 196 NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLF 255
           N  ++   ++ +T ++     +L  + +L+     ++ TI   + +L+ L  L L  N  
Sbjct: 20  NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQI 75

Query: 256 SGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCT 315
           + ++   L  L  +  L+LS N L   +  ++  L  I +L L + Q++  + P L   +
Sbjct: 76  T-DLAP-LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQIT-DVTP-LAGLS 129

Query: 316 DLYKLDLSYNRLTGSIPAEISGIREIR--IFLNLSHNQLEGPLPIELSKLENVQEIDLSS 373
           +L  L L  N++T      IS +  +    +L++ + Q+    P  L+ L  +  +    
Sbjct: 130 NLQVLYLDLNQIT-----NISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADD 182

Query: 374 NKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLN 433
           NK +      +++   +  +++ +N +       L +  NL  + ++   ++       N
Sbjct: 183 NKISD--ISPLASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQTITNQPVFYNN 238

Query: 434 KIHTLTFINLSFNEFKGMIPSGGIFNSAT 462
               L   N+        I    I ++ T
Sbjct: 239 N---LVVPNVVKGPSGAPIAPATISDNGT 264

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  103 bits (260), Expect = 2e-24
 Identities = 54/270 (20%), Positives = 101/270 (37%), Gaps = 32/270 (11%)

Query: 37  ESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWT 96
                L+N   +    +N+T         +   +  +       T  I E +    NL  
Sbjct: 13  FPDPALANAIKIAAGKSNVTD---TVTQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIG 67

Query: 97  LSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDI--MSKLPSLTYLHLSYNNMVS 154
           L L +NQ+T  L      T +  L++  N L      ++  ++ L S+  L L+   +  
Sbjct: 68  LELKDNQIT-DLAPLKNLTKITELELSGNPL-----KNVSAIAGLQSIKTLDLTSTQITD 121

Query: 155 HDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPP 213
                        L   ++L+ L L    +  T    +  L NL  L +   +++  + P
Sbjct: 122 ----------VTPLAGLSNLQVLYLDLNQI--TNISPLAGLTNLQYLSIGNAQVS-DLTP 168

Query: 214 HIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLD 273
            + NLS L +L    N +S  IS  ++ L  L ++ L +N  S   P  L    +L ++ 
Sbjct: 169 -LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223

Query: 274 LSFNKLSGEIPVSLGNLVQIYSLFLNNNQL 303
           L+   ++ +      NLV    +   +   
Sbjct: 224 LTNQTITNQPVFYNNNLVVPNVVKGPSGAP 253

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 78.6 bits (194), Expect = 6e-16
 Identities = 51/246 (20%), Positives = 96/246 (39%), Gaps = 25/246 (10%)

Query: 13  PEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRN 72
                L ++  L+L GN L  +   ++A L ++  + L    +T    ++     ++L+ 
Sbjct: 79  APLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITD---VTPLAGLSNLQV 133

Query: 73  VDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELP 132
           + L  N  T  I   +    NL  LS+ N Q++  L      + +  L  + N +S ++ 
Sbjct: 134 LYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVS-DLTPLANLSKLTTLKADDNKIS-DIS 189

Query: 133 SDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSI 192
              ++ LP+L  +HL  N +             + L N ++L  + L    +  T     
Sbjct: 190 P--LASLPNLIEVHLKNNQISD----------VSPLANTSNLFIVTLTNQTI--TNQPVF 235

Query: 193 GRLNLTQLLLQENKITGSIPP-HIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLS 251
              NL    + +      I P  I +     S NL+ NL S   +   ++ +Q      +
Sbjct: 236 YNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTF-NQSVTFKNT 294

Query: 252 HNLFSG 257
              FSG
Sbjct: 295 TVPFSG 300

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 76.3 bits (188), Expect = 4e-15
 Identities = 56/318 (17%), Positives = 108/318 (33%), Gaps = 77/318 (24%)

Query: 13  PEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRN 72
                L  L  L+L  N +       L  L+ +T + L  N L     +S      S++ 
Sbjct: 57  EGVQYLNNLIGLELKDNQITD--LAPLKNLTKITELELSGNPLKN---VSAIAGLQSIKT 111

Query: 73  VDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELP 132
           +DL+    T   P  +    NL  L L  NQ+T                    ++S    
Sbjct: 112 LDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT--------------------NISP--- 146

Query: 133 SDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSI 192
              ++ L +L YL +    +                   +DL  L          L    
Sbjct: 147 ---LAGLTNLQYLSIGNAQV-------------------SDLTPLA--------NLS--- 173

Query: 193 GRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSH 252
               LT L   +NKI+  I P + +L NLI ++L +N +S  +S  ++  S L  + L++
Sbjct: 174 ---KLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTN 226

Query: 253 NLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLG 312
              + +       L    ++           P ++ +     +    +  L+ ++   + 
Sbjct: 227 QTITNQPVFYNNNLVVPNVVKGPSGAPI--APATISD-----NGTYASPNLTWNLTSFIN 279

Query: 313 RCTDLYKLDLSYNRLTGS 330
             +  +   +++   T  
Sbjct: 280 NVSYTFNQSVTFKNTTVP 297

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 23/150 (15%), Positives = 59/150 (39%), Gaps = 15/150 (10%)

Query: 298 LNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLP 357
                ++   P       +  K+    + +T ++    + +  I   L+     +     
Sbjct: 4   TQPTAINVIFP--DPALANAIKIAAGKSNVTDTVT--QADLDGIT-TLSAFGTGVTT--- 55

Query: 358 IE-LSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEA 416
           IE +  L N+  ++L  N+ T      + N   +  + +S N L+     ++  L++++ 
Sbjct: 56  IEGVQYLNNLIGLELKDNQITD--LAPLKNLTKITELELSGNPLKN--VSAIAGLQSIKT 111

Query: 417 IDVSGNHLSGIIPISLNKIHTLTFINLSFN 446
           +D++   ++ + P  L  +  L  + L  N
Sbjct: 112 LDLTSTQITDVTP--LAGLSNLQVLYLDLN 139

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  106 bits (265), Expect = 8e-25
 Identities = 66/318 (20%), Positives = 119/318 (37%), Gaps = 63/318 (19%)

Query: 558 EFDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNL 615
           +F++   LG G+ G V+K      G  +A K++ L+          RE QVL       +
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93

Query: 616 MR----IITACSLPDFKALVLPYMANGSLDSHL---YPHSETEFGSGSSDLTLLQRVNIC 668
           +       +   +    ++ + +M  GSLD  L       E   G             + 
Sbjct: 94  VGFYGAFYSDGEI----SICMEHMDGGSLDQVLKKAGRIPEQILGK------------VS 137

Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
             + +G+ YL      +++H D+KPSN+L+N      + DFG++               +
Sbjct: 138 IAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG-------------QL 182

Query: 729 GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK 788
            +S AN   G+  YM+PE   G++ S + D++S G+ ++EM   R P     A  L L  
Sbjct: 183 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242

Query: 789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGI--------------- 833
             +             +  R       + +    +AI EL++  +               
Sbjct: 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPP--MAIFELLDYIVNEPPPKLPSGVFSLE 300

Query: 834 ------LCTQESPSTRPT 845
                  C  ++P+ R  
Sbjct: 301 FQDFVNKCLIKNPAERAD 318

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  103 bits (260), Expect = 1e-24
 Identities = 51/223 (22%), Positives = 98/223 (43%), Gaps = 27/223 (12%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           +     +G G+ G VY  + +  G  +A++ + LQ     +    E  V++  ++ N++ 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
            + +  + D   +V+ Y+A GSL   +      E           Q   +C +  + + +
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE----------GQIAAVCRECLQALEF 131

Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI-AKLVMTVGVGNDGAENMGNSTANML 736
           LH +   +VIH D+K  N+LL  D +  ++DFG  A++                S  + +
Sbjct: 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ------------SKRSTM 176

Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
            G+  +MAPE         K D++S GI+ +EM+    P  + 
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  103 bits (260), Expect = 1e-24
 Identities = 66/302 (21%), Positives = 117/302 (38%), Gaps = 64/302 (21%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKS-FNRECQVLKRIRHRNLM 616
           F +   +G GS+G V+KGI  +    +A+K++ L+          +E  VL +     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           +   +        +++ Y+  GS    L P    E           Q   I  +I +G+ 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE----------TQIATILREILKGLD 133

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI-AKLVMTVGVGNDGAENMGNSTANM 735
           YLH     + IH D+K +NVLL++     ++DFG+  +L  T                N 
Sbjct: 134 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ------------IKRNT 178

Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH 795
             G+  +MAPE    S   +K D++S GI  +E+     P  ++                
Sbjct: 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-------------- 224

Query: 796 GRLEKVIDSSLLRA----SRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAAD 851
                      ++      ++  P ++  +   + E +E    C  + PS RPT    A 
Sbjct: 225 -----------MKVLFLIPKNNPPTLEGNYSKPLKEFVE---ACLNKEPSFRPT----AK 266

Query: 852 DL 853
           +L
Sbjct: 267 EL 268

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  105 bits (263), Expect = 3e-24
 Identities = 52/327 (15%), Positives = 88/327 (26%), Gaps = 70/327 (21%)

Query: 566 GTGSYGRVYKGI-LQDGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNLMRIITAC 622
           G      V        G  + V+ + L   S         E  V K   H N++      
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
              +   +V  +MA GS    L      +       +  L    I   + + + Y+HH  
Sbjct: 96  IADNELWVVTSFMAYGSA-KDLICTHFMD------GMNELAIAYILQGVLKALDYIHHM- 147

Query: 683 PVRVIHCDLKPSNVLLNDDMTALVSDFGI-AKLVMTVGVGNDGAENMGNSTANMLCGSIG 741
               +H  +K S++L++ D    +S       ++                  +    S+ 
Sbjct: 148 --GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG--------QRQRVVHDFPKYSVK 197

Query: 742 ---YMAPE--------YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM----------- 779
              +++PE        Y        K D+YS GI   E+     P  DM           
Sbjct: 198 VLPWLSPEVLQQNLQGYDA------KSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251

Query: 780 -------------FAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIG 826
                                     +          +         S    R +     
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311

Query: 827 ELIELGILCTQESPSTRPTMLDAADDL 853
             +E    C Q +P  RP+    A  L
Sbjct: 312 HFVE---QCLQRNPDARPS----ASTL 331

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  102 bits (257), Expect = 4e-24
 Identities = 53/228 (23%), Positives = 101/228 (44%), Gaps = 30/228 (13%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           ++    LG G++G+VYK    + G   A KV++ +S    + +  E ++L    H  +++
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           ++ A        +++ +   G++D+ +              LT  Q   +C  + E + +
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG--------LTEPQIQVVCRQMLEALNF 132

Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI-AKLVMTVGVGNDGAENMGNSTANML 736
           LH     R+IH DLK  NVL+  +    ++DFG+ AK + T+               +  
Sbjct: 133 LHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL------------QKRDSF 177

Query: 737 CGSIGYMAPE-----YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
            G+  +MAPE         +    K D++S GI ++EM     P  ++
Sbjct: 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  102 bits (256), Expect = 4e-24
 Identities = 56/305 (18%), Positives = 106/305 (34%), Gaps = 48/305 (15%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKV--LQLQSGNFTKSFNRECQVLKRI-RHR 613
           EF E   +G+G +G V+K +   DG   A+K     L      ++  RE      + +H 
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71

Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           +++R  +A +  D   +   Y   GSL   +     +E     S     +  ++   +  
Sbjct: 72  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-----SENYRIMSYFKEAELKDLLLQVGR 126

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST- 732
           G+ Y+H      ++H D+KPSN+ ++       +     +             ++G+ T 
Sbjct: 127 GLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183

Query: 733 ---ANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK 788
                +  G   ++A E    + T   K D+++  + V+               G   H+
Sbjct: 184 ISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL----PRNGDQWHE 239

Query: 789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLD 848
             +          I   L       S E          EL++   +     P  RP+   
Sbjct: 240 IRQGRL-----PRIPQVL-------SQEFT--------ELLK---VMIHPDPERRPS--- 273

Query: 849 AADDL 853
            A  L
Sbjct: 274 -AMAL 277

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  102 bits (257), Expect = 5e-24
 Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 27/214 (12%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
            D    +G GS G V        G  +AVK++ L+     +    E  +++  +H N++ 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +  +  + +   +++ ++  G+L   +      E           Q   +C  + + +AY
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNE----------EQIATVCEAVLQALAY 156

Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI-AKLVMTVGVGNDGAENMGNSTANML 736
           LH      VIH D+K  ++LL  D    +SDFG  A++   V                 L
Sbjct: 157 LHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV------------PKRKSL 201

Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMV 770
            G+  +MAPE    S  +T+ D++S GI+V+EMV
Sbjct: 202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMV 235

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score =  104 bits (262), Expect = 1e-23
 Identities = 90/481 (18%), Positives = 159/481 (33%), Gaps = 99/481 (20%)

Query: 21  LRHLQLDGNNL-HGQIPESLALLSNLTLVTLHDNNLT--GMLPISF-FHNCTSLRNVDLS 76
           ++ L +    L   +  E L LL    +V L D  LT      IS       +L  ++L 
Sbjct: 5   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64

Query: 77  QNFFTGKIPEEIGNC-----PNLWTLSLYNNQLTGQ----LPASLI-NTSMYNLDVEYNH 126
            N         +          +  LSL N  LTG     L ++L    ++  L +  N 
Sbjct: 65  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124

Query: 127 LSGE----LPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGM 182
           L       L   ++     L  L L Y ++       +  P  + L    D +EL ++  
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSL----SAASCEPLASVLRAKPDFKELTVSNN 180

Query: 183 DLGGT--------LPDSIGRLNLTQLLLQENKIT----GSIPPHIGNLSNLISLNLSSNL 230
           D+           L DS     L  L L+   +T      +   + + ++L  L L SN 
Sbjct: 181 DINEAGVRVLCQGLKDS--PCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK 238

Query: 231 LSGT-----ISAEISWLSQLEQLFLSHNLFSGE----IPAALGKLHHLGLLDLSFNKLSG 281
           L            +   S+L  L++     + +    +   L     L  L L+ N+L  
Sbjct: 239 LGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGD 298

Query: 282 EIPVSLGNLV-----QIYSLFLNNNQLS----RSIPPTLGRCTDLYKLDLSYNRLTGSIP 332
           E    L   +     Q+ SL++ +   +          L +   L +L +S NRL     
Sbjct: 299 EGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLED--- 355

Query: 333 AEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRL 392
              +G+RE+   L    + L                + L+    + +    ++       
Sbjct: 356 ---AGVRELCQGLGQPGSVLR--------------VLWLADCDVSDSSCSSLA------- 391

Query: 393 INISHNALQGNLPDSLGDLKNLEAIDVSGNHL--SGIIPISLNKIH---TLTFINLSFNE 447
                  L  N         +L  +D+S N L  +GI+ +  +       L  + L    
Sbjct: 392 -----ATLLAN--------HSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIY 438

Query: 448 F 448
           +
Sbjct: 439 W 439

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 91.2 bits (227), Expect = 2e-19
 Identities = 81/434 (18%), Positives = 136/434 (31%), Gaps = 94/434 (21%)

Query: 18  LRRLRHLQLDGNNLHGQ----IPESLALLSNLTLVTLHDNNLT--GMLPIS--FFHNCTS 69
           L++ + ++LD   L       I  +L +   L  + L  N L   G+  +          
Sbjct: 27  LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 86

Query: 70  LRNVDLSQNFFTGK----IPEEIGNCPNLWTLSLYNNQLTGQLPASL------INTSMYN 119
           ++ + L     TG     +   +   P L  L L +N L       L          +  
Sbjct: 87  IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEK 146

Query: 120 LDVEYNHLSGELPSDIMSKL---PSLTYLHLSYNNM-------------VSHDDNTNL-- 161
           L +EY  LS      + S L   P    L +S N++              S      L  
Sbjct: 147 LQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKL 206

Query: 162 ----------VPFFNSLGNCTDLEELELAGMDLGGT----LPDSIGRLN--LTQLLLQEN 205
                           + +   L EL L    LG      L   +   +  L  L + E 
Sbjct: 207 ESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWEC 266

Query: 206 KIT----GSIPPHIGNLSNLISLNLSSNLLSGT-----ISAEISWLSQLEQLFLSHNLFS 256
            IT    G +   +    +L  L+L+ N L            +    QLE L++    F+
Sbjct: 267 GITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFT 326

Query: 257 GE----IPAALGKLHHLGLLDLSFNKLSGEIPVSLG-----NLVQIYSLFLNNNQLS--- 304
                   + L +   L  L +S N+L       L          +  L+L +  +S   
Sbjct: 327 AACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS 386

Query: 305 -RSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKL 363
             S+  TL     L +LDLS N L        +GI ++   +      L           
Sbjct: 387 CSSLAATLLANHSLRELDLSNNCLGD------AGILQLVESVRQPGCLL----------- 429

Query: 364 ENVQEIDLSSNKFT 377
              +++ L    ++
Sbjct: 430 ---EQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 88.1 bits (219), Expect = 2e-18
 Identities = 63/387 (16%), Positives = 133/387 (34%), Gaps = 56/387 (14%)

Query: 113 INTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCT 172
           ++  + +LD++   LS    ++++  L     + L    +             ++L    
Sbjct: 1   MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGL----TEARCKDISSALRVNP 56

Query: 173 DLEELELAGMDLGGTLPDSIGR------LNLTQLLLQENKIT----GSIPPHIGNLSNLI 222
            L EL L   +LG      + +        + +L LQ   +T    G +   +  L  L 
Sbjct: 57  ALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQ 116

Query: 223 SLNLSSNLLSGT-----ISAEISWLSQLEQLFLSHNLFSGE----IPAALGKLHHLGLLD 273
            L+LS NLL            +    +LE+L L +   S      + + L        L 
Sbjct: 117 ELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELT 176

Query: 274 LSFNKLSGEIPVSLG-----NLVQIYSLFLNNNQLS----RSIPPTLGRCTDLYKLDLSY 324
           +S N ++      L      +  Q+ +L L +  ++    R +   +     L +L L  
Sbjct: 177 VSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGS 236

Query: 325 NRLTGS-----IPAEISGIREIRIFLNLSHNQLEGP----LPIELSKLENVQEIDLSSNK 375
           N+L         P  +     +R  L +    +       L   L   E+++E+ L+ N+
Sbjct: 237 NKLGDVGMAELCPGLLHPSSRLRT-LWIWECGITAKGCGDLCRVLRAKESLKELSLAGNE 295

Query: 376 FTGNIFIQISNCI-----AVRLINISHNALQG----NLPDSLGDLKNLEAIDVSGNHL-- 424
                   +   +      +  + +   +       +    L   + L  + +S N L  
Sbjct: 296 LGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLED 355

Query: 425 SGIIPIS--LNKIHT-LTFINLSFNEF 448
           +G+  +   L +  + L  + L+  + 
Sbjct: 356 AGVRELCQGLGQPGSVLRVLWLADCDV 382

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 80.0 bits (198), Expect = 9e-16
 Identities = 66/341 (19%), Positives = 105/341 (30%), Gaps = 50/341 (14%)

Query: 10  AIPPEFSKLRRLRHLQLDGNNLHGQIPESLA--LLSN---LTLVTLHDNNLT--GMLPIS 62
            +      L  L+ L L  N L     + L   LL     L  + L   +L+     P++
Sbjct: 104 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 163

Query: 63  F-FHNCTSLRNVDLSQNFFTGKIPEEIG-----NCPNLWTLSLYNNQLTGQLPASLI--- 113
                    + + +S N         +      +   L  L L +  +T      L    
Sbjct: 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIV 223

Query: 114 --NTSMYNLDVEYNHLSGE----LPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNS 167
               S+  L +  N L       L   ++     L  L +    +               
Sbjct: 224 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI----TAKGCGDLCRV 279

Query: 168 LGNCTDLEELELAGMDLGGT----LPDSIGRLN--LTQLLLQENKITG----SIPPHIGN 217
           L     L+EL LAG +LG      L +++      L  L ++    T          +  
Sbjct: 280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQ 339

Query: 218 LSNLISLNLSSNLLSGTISAEISWL-----SQLEQLFLSHNLFSGE----IPAALGKLHH 268
              L+ L +S+N L      E+        S L  L+L+    S      + A L   H 
Sbjct: 340 NRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHS 399

Query: 269 LGLLDLSFNKLSGEIPVSLGNLVQIY-----SLFLNNNQLS 304
           L  LDLS N L     + L   V+        L L +   S
Sbjct: 400 LRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  101 bits (253), Expect = 1e-23
 Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 34/228 (14%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRN 614
           F    LLG GS+  VY+   +  G  +A+K++    +      +    E ++  +++H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPH----SETEFGSGSSDLTLLQRVNICSD 670
           ++ +       ++  LVL    NG ++ +L       SE E     +   + Q       
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENE-----ARHFMHQ------- 120

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I  GM YLH H    ++H DL  SN+LL  +M   ++DFG+A  +              +
Sbjct: 121 IITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM-----------PH 166

Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
                LCG+  Y++PE    S    + DV+S G +   ++  R P D 
Sbjct: 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT 214

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  100 bits (252), Expect = 2e-23
 Identities = 52/222 (23%), Positives = 91/222 (40%), Gaps = 35/222 (15%)

Query: 559 FDEQRLLGTGSYGRVYKGILQDGTAI-AVKVLQ---LQSGNFTKSFNRECQVLKRIRHRN 614
           F   ++LG GS+  V        +   A+K+L+   +   N      RE  V+ R+ H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLY-----PHSETEFGSGSSDLTLLQRVNICS 669
            +++       +     L Y  NG L  ++        + T F                +
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF--------------YTA 137

Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           +I   + YLH      +IH DLKP N+LLN+DM   ++DFG AK++              
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES---------K 185

Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
            + AN   G+  Y++PE     +     D+++ G ++ ++V 
Sbjct: 186 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  101 bits (253), Expect = 2e-22
 Identities = 59/228 (25%), Positives = 94/228 (41%), Gaps = 40/228 (17%)

Query: 559 FDEQRLLGTGSYGRVYKGILQDGTAI-AVKVLQ---LQSGNFTKSFNRECQVLKRIRHRN 614
           F + R+LG G +G V    ++    + A K L+   ++          E Q+L+++  R 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI-CSDIAE 673
           ++ +  A    D   LVL  M  G L  H+Y   +  F           R     ++I  
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP--------EARAVFYAAEICC 297

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           G+  LH     R+++ DLKP N+LL+D     +SD G+A                   T 
Sbjct: 298 GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAV------------HVPEGQTI 342

Query: 734 NMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
               G++GYMAPE      Y F        D ++ G L+ EM+  + P
Sbjct: 343 KGRVGTVGYMAPEVVKNERYTFSP------DWWALGCLLYEMIAGQSP 384

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 95.9 bits (239), Expect = 7e-22
 Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 15/209 (7%)

Query: 170 NCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHI-GNLSNLISLNLSS 228
                 E+     +L   LP  + + + T L L EN +  +         + L  LNL  
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDLPK-DTTILHLSENLLY-TFSLATLMPYTRLTQLNLDR 64

Query: 229 NLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSL- 287
             L+  +  +   L  L  L LSHN     +P     L  L +LD+SFN+L+  +P+   
Sbjct: 65  AELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGAL 120

Query: 288 GNLVQIYSLFLNNNQLSRSIPP-TLGRCTDLYKLDLSYNRLTGSIPAEI-SGIREIRIFL 345
             L ++  L+L  N+L  ++PP  L     L KL L+ N LT  +PA + +G+  +   L
Sbjct: 121 RGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDT-L 177

Query: 346 NLSHNQLEGPLPIELSKLENVQEIDLSSN 374
            L  N L   +P        +    L  N
Sbjct: 178 LLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 90.2 bits (224), Expect = 5e-20
 Identities = 58/215 (26%), Positives = 83/215 (38%), Gaps = 21/215 (9%)

Query: 42  LSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYN 101
           +++   V     NLT  LP            + LS+N         +     L  L+L  
Sbjct: 9   VASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 102 NQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNL 161
            +LT +L        +  LD+ +N L   LP      LP+LT L +S+N + S       
Sbjct: 65  AELT-KLQVDGTLPVLGTLDLSHNQLQ-SLPLLG-QTLPALTVLDVSFNRLTSLPLGA-- 119

Query: 162 VPFFNSLGNCTDLEELELAGMDLGGTLPDSI-GRL-NLTQLLLQENKITGSIPPHI-GNL 218
                 L    +L+EL L G +L  TLP  +      L +L L  N +T  +P  +   L
Sbjct: 120 ---LRGL---GELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGL 171

Query: 219 SNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHN 253
            NL +L L  N L  TI         L   FL  N
Sbjct: 172 ENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 50/211 (23%), Positives = 70/211 (33%), Gaps = 40/211 (18%)

Query: 21  LRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFF 80
              L L  N L+     +L   + LT + L    LT    +        L  +DLS N  
Sbjct: 33  TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK---LQVDGTLPVLGTLDLSHNQL 89

Query: 81  TGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN--TSMYNLDVEYNHLSGELPSDIMSK 138
              +P      P L  L +  N+LT  LP   +     +  L ++ N L   LP  +++ 
Sbjct: 90  Q-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTP 146

Query: 139 LPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLT 198
            P L  L L+ NN+             N L                           NL 
Sbjct: 147 TPKLEKLSLANNNLTELPAGL-----LNGLE--------------------------NLD 175

Query: 199 QLLLQENKITGSIPPHIGNLSNLISLNLSSN 229
            LLLQEN +  +IP        L    L  N
Sbjct: 176 TLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 16/210 (7%)

Query: 217 NLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSF 276
            +++ + +N     L+  +  ++        L LS NL      A L     L  L+L  
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 277 NKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEI- 335
            +L+ ++ V  G L  + +L L++NQL +S+P        L  LD+S+NRLT S+P    
Sbjct: 65  AELT-KLQVD-GTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLT-SLPLGAL 120

Query: 336 SGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFT---GNIFIQISNCIAVRL 392
            G+ E++  L L  N+L+   P  L+    ++++ L++N  T     +   + N   +  
Sbjct: 121 RGLGELQ-ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN---LDT 176

Query: 393 INISHNALQGNLPDSLGDLKNLEAIDVSGN 422
           + +  N+L   +P        L    + GN
Sbjct: 177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 41/156 (26%), Positives = 63/156 (40%), Gaps = 10/156 (6%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           L +N L+           RL  L LD   L     +    L  L  + L  N L   LP 
Sbjct: 38  LSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQ-SLP- 93

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLIN--TSMY 118
                  +L  +D+S N  T  +P         L  L L  N+L   LP  L+     + 
Sbjct: 94  LLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLE 151

Query: 119 NLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVS 154
            L +  N+L+ ELP+ +++ L +L  L L  N++ +
Sbjct: 152 KLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT 186

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 51.6 bits (124), Expect = 4e-07
 Identities = 36/145 (24%), Positives = 60/145 (41%), Gaps = 11/145 (7%)

Query: 320 LDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTG- 378
           ++     LT ++P ++     I   L+LS N L       L     + +++L   + T  
Sbjct: 15  VNCDKRNLT-ALPPDLPKDTTI---LHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL 70

Query: 379 NIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTL 438
            +   +     + L   SHN LQ +LP     L  L  +DVS N L+ +   +L  +  L
Sbjct: 71  QVDGTLPVLGTLDL---SHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGEL 126

Query: 439 TFINLSFNEFKGMIPSGGIFNSATK 463
             + L  NE K  +P  G+     K
Sbjct: 127 QELYLKGNELK-TLPP-GLLTPTPK 149

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 25/79 (31%), Positives = 35/79 (44%), Gaps = 6/79 (7%)

Query: 2   LVDNHLFGAIPPE-FSKLRRLRHLQLDGNNLHGQIPESL-ALLSNLTLVTLHDNNLTGML 59
           L  N L   +PP   +   +L  L L  NNL  ++P  L   L NL  + L +N+L   +
Sbjct: 131 LKGNEL-KTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TI 187

Query: 60  PISFFHNCTSLRNVDLSQN 78
           P  FF +   L    L  N
Sbjct: 188 PKGFFGS-HLLPFAFLHGN 205

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 96.8 bits (241), Expect = 8e-22
 Identities = 49/270 (18%), Positives = 89/270 (32%), Gaps = 51/270 (18%)

Query: 547 ITYRELLEATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKV-----LQLQSGNFTKSF 600
                LLE   ++  +  +G GSYG V   I  Q     A+K+     ++  +    +  
Sbjct: 16  FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75

Query: 601 NRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSL------DSHLYPHSETEFGS 654
             E +++K++ H N+ R+        +  LV+     G L                    
Sbjct: 76  KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135

Query: 655 GSSDLTLLQRV-------------------------NICSDIAEGMAYLHHHSPVRVIHC 689
            +      +                           NI   I   + YLH+     + H 
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHR 192

Query: 690 DLKPSNVLLNDDMTALV--SDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPE- 746
           D+KP N L + + +  +   DFG++K             N          G+  ++APE 
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEF-------YKLNNGEYYGMTTKAGTPYFVAPEV 245

Query: 747 -YGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                 +   K D +S G+L+  ++    P
Sbjct: 246 LNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 95.5 bits (238), Expect = 1e-21
 Identities = 45/253 (17%), Positives = 107/253 (42%), Gaps = 23/253 (9%)

Query: 198 TQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSG 257
           ++ +     I   I       +  I  NL    ++  ++   + L+ ++Q+  +++    
Sbjct: 5   SETITVPTPIK-QIFS-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK- 59

Query: 258 EIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDL 317
            +   +  L ++  L L+ NKL+ +I   L NL  +  LFL+ N++   +   L     L
Sbjct: 60  SVQG-IQYLPNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDENKVK-DLSS-LKDLKKL 114

Query: 318 YKLDLSYNRLTGSIPAEISGIREIR--IFLNLSHNQLEGPLPIELSKLENVQEIDLSSNK 375
             L L +N ++     +I+G+  +     L L +N++       LS+L  +  + L  N+
Sbjct: 115 KSLSLEHNGIS-----DINGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQ 167

Query: 376 FTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKI 435
            + +I + ++    ++ + +S N +  +L  +L  LKNL+ +++             + +
Sbjct: 168 IS-DI-VPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNL 223

Query: 436 HTLTFINLSFNEF 448
                +  +    
Sbjct: 224 VVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 56/268 (20%), Positives = 101/268 (37%), Gaps = 50/268 (18%)

Query: 37  ESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWT 96
            S    +      L   ++T        +   S+  +  + +     + + I   PN+  
Sbjct: 18  FSDDAFAETIKDNLKKKSVTD---AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTK 72

Query: 97  LSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHD 156
           L L  N+LT           +  L                + L +L +L L  N +    
Sbjct: 73  LFLNGNKLT----------DIKPL----------------ANLKNLGWLFLDENKVKD-- 104

Query: 157 DNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHI 215
                    +SL +   L+ L L    +  +  + +  L  L  L L  NKIT  I   +
Sbjct: 105 --------LSSLKDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKIT-DITV-L 152

Query: 216 GNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLS 275
             L+ L +L+L  N +S  I   ++ L++L+ L+LS N  S ++ A L  L +L +L+L 
Sbjct: 153 SRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELF 208

Query: 276 FNKLSGEIPVSLGNLVQIYSLFLNNNQL 303
             +   +      NLV   ++   +  L
Sbjct: 209 SQECLNKPINHQSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 51/257 (19%), Positives = 108/257 (42%), Gaps = 21/257 (8%)

Query: 196 NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLF 255
              +  L++  +T ++      L+++  +  +++ +  ++   I +L  + +LFL+ N  
Sbjct: 25  ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKL 80

Query: 256 SGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCT 315
           + +I   L  L +LG L L  NK+  ++  SL +L ++ SL L +N +S  I   L    
Sbjct: 81  T-DIKP-LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLP 134

Query: 316 DLYKLDLSYNRLTGSIPAEISGIREIR--IFLNLSHNQLEGPLPIELSKLENVQEIDLSS 373
            L  L L  N++T     +I+ +  +     L+L  NQ+   +P  L+ L  +Q + LS 
Sbjct: 135 QLESLYLGNNKIT-----DITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187

Query: 374 NKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLN 433
           N  +      ++    + ++ +          +   +L     +  +   L     IS +
Sbjct: 188 NHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDD 245

Query: 434 KIHTLTFINLSFNEFKG 450
             +    +     EF  
Sbjct: 246 GDYEKPNVKWHLPEFTN 262

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 37/148 (25%), Positives = 63/148 (42%), Gaps = 15/148 (10%)

Query: 15  FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVD 74
            + L+ L  L LD N +   +  SL  L  L  ++L  N ++    I+   +   L ++ 
Sbjct: 86  LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGISD---INGLVHLPQLESLY 140

Query: 75  LSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSD 134
           L  N  T  I   +     L TLSL +NQ++  +      T + NL +  NH+     SD
Sbjct: 141 LGNNKIT-DI-TVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHI-----SD 192

Query: 135 I--MSKLPSLTYLHLSYNNMVSHDDNTN 160
           +  ++ L +L  L L     ++   N  
Sbjct: 193 LRALAGLKNLDVLELFSQECLNKPINHQ 220

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 19/91 (20%), Positives = 34/91 (37%), Gaps = 5/91 (5%)

Query: 15  FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVD 74
            S+L +L  L L+ N +   I   LA L+ L  + L  N+++    +       +L  ++
Sbjct: 152 LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHISD---LRALAGLKNLDVLE 206

Query: 75  LSQNFFTGKIPEEIGNCPNLWTLSLYNNQLT 105
           L       K      N     T+   +  L 
Sbjct: 207 LFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 95.9 bits (239), Expect = 1e-21
 Identities = 51/232 (21%), Positives = 88/232 (37%), Gaps = 32/232 (13%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSG-NFTKSFNRECQVLKR-IRHRN 614
           +  +   +G G+YG V K +    G  +AVK ++        K    +  V+ R      
Sbjct: 23  DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPY 82

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           +++   A        + +  M+  S D   Y +  +       +  L +   I     + 
Sbjct: 83  IVQFYGALFREGDCWICMELMS-TSFDK-FYKYVYSVLDDVIPEEILGK---ITLATVKA 137

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           + +L  +   ++IH D+KPSN+LL+      + DFGI+               + +S A 
Sbjct: 138 LNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISG-------------QLVDSIAK 182

Query: 735 MLCGSIG---YMAPE----YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
                 G   YMAPE             + DV+S GI + E+ T R P    
Sbjct: 183 --TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 55/230 (23%), Positives = 88/230 (38%), Gaps = 29/230 (12%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSG-NFTKSFNRECQVLKR-IRHRN 614
           + +    LG G+YG V K   +  G  +AVK ++        K    +  +  R +    
Sbjct: 8   DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPF 67

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
            +    A        + +  M + SLD   Y     +  +    +       I   I + 
Sbjct: 68  TVTFYGALFREGDVWICMELM-DTSLDK-FYKQVIDKGQT----IPEDILGKIAVSIVKA 121

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA- 733
           + +LH      VIH D+KPSNVL+N      + DFGI+               + +  A 
Sbjct: 122 LEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISG-------------YLVDDVAK 166

Query: 734 NMLCGSIGYMAPE----YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
           ++  G   YMAPE           S K D++S GI ++E+   R P D  
Sbjct: 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 97.9 bits (244), Expect = 3e-21
 Identities = 57/241 (23%), Positives = 97/241 (40%), Gaps = 44/241 (18%)

Query: 559 FDEQRLLGTGSYGRVYKGILQDGTAI-AVKVLQ---LQSGNFTKSFNRECQVLKRIRHRN 614
           F + R+LG G +G V+   ++    + A K L    L+     +    E ++L ++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           ++ +  A        LV+  M  G +  H+Y   E   G         + +   + I  G
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG-----FQEPRAIFYTAQIVSG 301

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           + +LH      +I+ DLKP NVLL+DD    +SD G+A  +             G +   
Sbjct: 302 LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA-----------GQTKTK 347

Query: 735 MLCGSIGYMAPE------YGFGSNTSTKGDVYSFGILVLEMVTRRRP---------TDDM 779
              G+ G+MAPE      Y F        D ++ G+ + EM+  R P           ++
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSV------DYFALGVTLYEMIAARGPFRARGEKVENKEL 401

Query: 780 F 780
            
Sbjct: 402 K 402

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 94.7 bits (236), Expect = 3e-21
 Identities = 58/223 (26%), Positives = 102/223 (45%), Gaps = 27/223 (12%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           FD    LG GSYG VYK I  + G  +A+K + ++S    +   +E  ++++    ++++
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
              +        +V+ Y   GS+   +   ++T        LT  +   I     +G+ Y
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT--------LTEDEIATILQSTLKGLEY 140

Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI-AKLVMTVGVGNDGAENMGNSTANML 736
           LH     R IH D+K  N+LLN +  A ++DFG+  +L  T+            +  N +
Sbjct: 141 LHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM------------AKRNTV 185

Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
            G+  +MAPE       +   D++S GI  +EM   + P  D+
Sbjct: 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 95.1 bits (237), Expect = 3e-21
 Identities = 41/212 (19%), Positives = 76/212 (35%), Gaps = 28/212 (13%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKV-----LQLQSGNFTKSFNRECQVLKRIRHRNLM 616
            ++G G +  V + I  + G   AVK+          G  T+   RE  +   ++H +++
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
            ++   S      +V  +M    L   +      +        +     +    I E + 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEI-----VKRADAGFVYSEAVASHYMRQILEALR 144

Query: 677 YLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           Y H +    +IH D+KP  VLL    +     +  FG+A  +       +     G    
Sbjct: 145 YCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL------GESGLVAGG--- 192

Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGIL 765
               G+  +MAPE           DV+  G++
Sbjct: 193 --RVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 94.3 bits (235), Expect = 4e-21
 Identities = 52/191 (27%), Positives = 81/191 (42%), Gaps = 27/191 (14%)

Query: 564 LLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIR-HRNLMRIITA 621
           +LG G++ RV   I L      AVK+++ Q G+      RE ++L + + HRN++ +I  
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 622 CSLPDFKALVLPYMANGSLDSHLYPH---SETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
               D   LV   M  GS+ SH++     +E E               +  D+A  + +L
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELE------------ASVVVQDVASALDFL 127

Query: 679 HHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
           H+     + H DLKP N+L    N      + DF +   +      N     +       
Sbjct: 128 HNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL----NGDCSPISTPELLT 180

Query: 736 LCGSIGYMAPE 746
            CGS  YMAPE
Sbjct: 181 PCGSAEYMAPE 191

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 94.0 bits (234), Expect = 5e-21
 Identities = 66/235 (28%), Positives = 102/235 (43%), Gaps = 37/235 (15%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLM 616
           F+   L+G G+YG+VYKG  ++ G   A+KV+ +      +   +E  +LK+   HRN+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 84

Query: 617 R-----IITACSLPDFKA-LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
                 I       D +  LV+ +   GS+   +              L       IC +
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-------LKEEWIAYICRE 137

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI-AKLVMTVGVGNDGAENMG 729
           I  G+++LH H   +VIH D+K  NVLL ++    + DFG+ A+L  TV           
Sbjct: 138 ILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV----------- 183

Query: 730 NSTANMLCGSIGYMAPE-----YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
               N   G+  +MAPE         +    K D++S GI  +EM     P  DM
Sbjct: 184 -GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 94.0 bits (234), Expect = 6e-21
 Identities = 50/240 (20%), Positives = 87/240 (36%), Gaps = 51/240 (21%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGN-FTKSFNRECQVLKR-IRHRN 614
           + +    +G+G+ G+V+K    + G  IAVK ++        K    +  V+ +      
Sbjct: 26  DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPY 85

Query: 615 LMRIITAC--SLPDFKA----LVLPYMANGSLDSHLY---PHSETEFGSGSSDLTLLQRV 665
               I  C  +          + +  M   +         P  E   G            
Sbjct: 86  ----IVQCFGTF--ITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK----------- 128

Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGA 725
            +   I + + YL       VIH D+KPSN+LL++     + DFGI+             
Sbjct: 129 -MTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISG------------ 173

Query: 726 ENMGNSTA-NMLCGSIGYMAPE-----YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
             + +  A +   G   YMAPE          +   + DV+S GI ++E+ T + P  + 
Sbjct: 174 -RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 90.4 bits (225), Expect = 7e-21
 Identities = 25/183 (13%), Positives = 70/183 (38%), Gaps = 8/183 (4%)

Query: 196 NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLF 255
                L      + +       +++L  + L++  ++  ++  I +   ++ L +++   
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHA 78

Query: 256 SGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCT 315
           +   P  +  L +L  L +    ++ +   +L  L  +  L ++++    SI   +    
Sbjct: 79  TNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP 136

Query: 316 DLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNK 375
            +  +DLSYN     I   +  + E++  LN+  + +       +     + ++   S  
Sbjct: 137 KVNSIDLSYNGAITDIMP-LKTLPELKS-LNIQFDGVHDYRG--IEDFPKLNQLYAFSQT 192

Query: 376 FTG 378
             G
Sbjct: 193 IGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 87.7 bits (218), Expect = 7e-20
 Identities = 36/182 (19%), Positives = 82/182 (45%), Gaps = 17/182 (9%)

Query: 125 NHLSGELPSDI-MSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMD 183
             L     ++I  +++ SLTY+ L+  N+      T+L      +    ++++L +  + 
Sbjct: 28  GLLGQSSTANITEAQMNSLTYITLANINV------TDLTG----IEYAHNIKDLTINNIH 77

Query: 184 LGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWL 242
              T  + I  L NL +L +    +T    P++  L++L  L++S +    +I  +I+ L
Sbjct: 78  A--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135

Query: 243 SQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQ 302
            ++  + LS+N    +I   L  L  L  L++ F+ +       + +  ++  L+  +  
Sbjct: 136 PKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQT 192

Query: 303 LS 304
           + 
Sbjct: 193 IG 194

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 22/166 (13%), Positives = 60/166 (36%), Gaps = 12/166 (7%)

Query: 284 PVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIR- 342
            ++   +  +  + L N  ++  +   +    ++  L ++    T       + I  +  
Sbjct: 37  NITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHAT-----NYNPISGLSN 89

Query: 343 -IFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQ 401
              L +    +       LS L ++  +D+S +    +I  +I+    V  I++S+N   
Sbjct: 90  LERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI 149

Query: 402 GNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNE 447
            ++   L  L  L+++++  + +     I       L  +      
Sbjct: 150 TDI-MPLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQT 192

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 79.6 bits (197), Expect = 4e-17
 Identities = 32/193 (16%), Positives = 68/193 (35%), Gaps = 23/193 (11%)

Query: 93  NLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDI--MSKLPSLTYLHLSYN 150
                 L  +       A +   S+  + +   +++     D+  +    ++  L ++  
Sbjct: 24  AYLNGLLGQSSTANITEAQM--NSLTYITLANINVT-----DLTGIEYAHNIKDLTINNI 76

Query: 151 NMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQLLLQENKITG 209
           +       TN  P    +   ++LE L + G D+      ++  L +LT L +  +    
Sbjct: 77  HA------TNYNP----ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDD 126

Query: 210 SIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHL 269
           SI   I  L  + S++LS N     I   +  L +L+ L +  +         +     L
Sbjct: 127 SILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKL 183

Query: 270 GLLDLSFNKLSGE 282
             L      + G+
Sbjct: 184 NQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 76.2 bits (188), Expect = 6e-16
 Identities = 30/220 (13%), Positives = 66/220 (30%), Gaps = 63/220 (28%)

Query: 14  EFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNV 73
             +++  L ++ L   N+       +    N+  +T+++ + T     +     ++L  +
Sbjct: 39  TEAQMNSLTYITLANINVTD--LTGIEYAHNIKDLTINNIHATN---YNPISGLSNLERL 93

Query: 74  DLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPS 133
            +     T      +    +L  L + ++     +   +                     
Sbjct: 94  RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI--------------------- 132

Query: 134 DIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIG 193
              + LP +  + LSYN  +                  TD+  L+        TLP    
Sbjct: 133 ---NTLPKVNSIDLSYNGAI------------------TDIMPLK--------TLP---- 159

Query: 194 RLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSG 233
              L  L +Q + +       I +   L  L   S  + G
Sbjct: 160 --ELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 65.8 bits (161), Expect = 2e-12
 Identities = 29/161 (18%), Positives = 64/161 (39%), Gaps = 13/161 (8%)

Query: 289 NLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIR--IFLN 346
                 +  L  +  +     T  +   L  + L+   +T     +++GI        L 
Sbjct: 21  TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-----DLTGIEYAHNIKDLT 72

Query: 347 LSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPD 406
           +++       P  +S L N++ + +     T +    +S   ++ L++ISH+A   ++  
Sbjct: 73  INNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130

Query: 407 SLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNE 447
            +  L  + +ID+S N     I   L  +  L  +N+ F+ 
Sbjct: 131 KINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDG 170

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 56.1 bits (136), Expect = 5e-09
 Identities = 16/105 (15%), Positives = 34/105 (32%), Gaps = 4/105 (3%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           ++   +     P  S L  L  L +  +     I   +  L  +  + L  N       I
Sbjct: 95  IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD--I 152

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTG 106
                   L+++++  +         I + P L  L  ++  + G
Sbjct: 153 MPLKTLPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 17/113 (15%), Positives = 46/113 (40%), Gaps = 7/113 (6%)

Query: 343 IFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQG 402
           +   L  +       I  +++ ++  I L++   T      I     ++ + I++     
Sbjct: 26  LNGLLGQSSTA---NITEAQMNSLTYITLANINVTD--LTGIEYAHNIKDLTINNIHATN 80

Query: 403 NLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSG 455
              + +  L NLE + + G  ++     +L+ + +LT +++S +     I + 
Sbjct: 81  --YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 42/225 (18%), Positives = 78/225 (34%), Gaps = 39/225 (17%)

Query: 11  IPPE-FSKLRRLRHLQLDGNNLHGQIPESL-ALLSNLTLVTLHDNNLTGMLPISFFHNCT 68
           +    F     L+ L L    +   I +     LS+L+ + L  N +   L +  F   +
Sbjct: 43  LGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLS 100

Query: 69  SLRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHL 127
           SL+ +   +      +     G+   L  L++ +N +                       
Sbjct: 101 SLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ---------------------- 137

Query: 128 SGELPS-DIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLE-ELELAGMDLG 185
                  +  S L +L +L LS N + S             L     L   L+L+   + 
Sbjct: 138 --SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD-----LRVLHQMPLLNLSLDLSLNPMN 190

Query: 186 GTLPDSIGRLNLTQLLLQENKITGSIPPHI-GNLSNLISLNLSSN 229
              P +   + L +L L  N++  S+P  I   L++L  + L +N
Sbjct: 191 FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 60/288 (20%), Positives = 89/288 (30%), Gaps = 86/288 (29%)

Query: 43  SNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYN 101
            +   + L  N L   L    F +   L+ +DLS+      I +    +  +L TL L  
Sbjct: 28  FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTG 85

Query: 102 NQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNL 161
           N +                          L     S L SL  L     N+ S ++    
Sbjct: 86  NPIQ------------------------SLALGAFSGLSSLQKLVAVETNLASLENFP-- 119

Query: 162 VPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPH--IGNLS 219
                 L                            L +L +  N I  S        NL+
Sbjct: 120 ---IGHLK--------------------------TLKELNVAHNLIQ-SFKLPEYFSNLT 149

Query: 220 NLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGL-LDLSFNK 278
           NL  L+LSSN +                  +            L ++  L L LDLS N 
Sbjct: 150 NLEHLDLSSNKIQ----------------SIYCTDLRV-----LHQMPLLNLSLDLSLNP 188

Query: 279 LSGEIPVSLGNLVQIYSLFLNNNQLSRSIPP-TLGRCTDLYKLDLSYN 325
           ++  I       +++  L L+ NQL  S+P     R T L K+ L  N
Sbjct: 189 MN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 84.3 bits (209), Expect = 6e-18
 Identities = 46/209 (22%), Positives = 80/209 (38%), Gaps = 11/209 (5%)

Query: 245 LEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSL-GNLVQIYSLFLNNNQL 303
            + L LS N        +      L +LDLS  ++   I      +L  + +L L  N +
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI 88

Query: 304 SRSIPP-TLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQL-EGPLPIELS 361
             S+        + L KL      L  S+     G  +    LN++HN +    LP   S
Sbjct: 89  Q-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146

Query: 362 KLENVQEIDLSSNKFT---GNIFIQISNCIAVRL-INISHNALQGNLPDSLGDLKNLEAI 417
            L N++ +DLSSNK           +     + L +++S N +   +         L+ +
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKEL 205

Query: 418 DVSGNHLSGIIPISLNKIHTLTFINLSFN 446
            +  N L  +     +++ +L  I L  N
Sbjct: 206 ALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 48.0 bits (115), Expect = 6e-06
 Identities = 33/150 (22%), Positives = 44/150 (29%), Gaps = 47/150 (31%)

Query: 2   LVDNHLFGAIPPE-FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLP 60
           +  N +     PE FS L  L HL L  N +       L +L  + L+ L          
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS--------- 181

Query: 61  ISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNL 120
                       +DLS N     I         L  L+L  NQL                
Sbjct: 182 ------------LDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK--------------- 213

Query: 121 DVEYNHLSGELPSDIMSKLPSLTYLHLSYN 150
                     +P  I  +L SL  + L  N
Sbjct: 214 ---------SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 29/156 (18%), Positives = 60/156 (38%), Gaps = 14/156 (8%)

Query: 315 TDLYKLDLSYNRLTGSIPAEI-SGIREIRIFLNLSHNQLEGPLPIEL-SKLENVQEIDLS 372
                LDLS+N L   + +       E++  L+LS  +++  +       L ++  + L+
Sbjct: 28  FSTKNLDLSFNPLR-HLGSYSFFSFPELQ-VLDLSRCEIQT-IEDGAYQSLSHLSTLILT 84

Query: 373 SNKFT---GNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGII- 428
            N         F   S   +++ +      L       +G LK L+ ++V+ N +     
Sbjct: 85  GNPIQSLALGAF---SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKL 141

Query: 429 PISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKM 464
           P   + +  L  ++LS N+ +  I          +M
Sbjct: 142 PEYFSNLTNLEHLDLSSNKIQ-SIYC-TDLRVLHQM 175

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 91.5 bits (228), Expect = 3e-20
 Identities = 47/211 (22%), Positives = 87/211 (41%), Gaps = 39/211 (18%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
            +LG+G++  V+       G   A+K ++        S   E  VLK+I+H N++ +   
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74

Query: 622 CSLPDFKALVLPYMANGSL-----DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
                   LV+  ++ G L     +  +Y  +E +               +   +   + 
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRILERGVY--TEKD------------ASLVIQQVLSAVK 120

Query: 677 YLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           YLH +    ++H DLKP N+L     ++   +++DFG++K+               N   
Sbjct: 121 YLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME-------------QNGIM 164

Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGI 764
           +  CG+ GY+APE       S   D +S G+
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGV 195

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 92.5 bits (230), Expect = 3e-20
 Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 40/231 (17%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQL---QSGNFTKSFNRECQVLKRIRHRN 614
           F + R +G GS+G VY    +++   +A+K +     QS    +   +E + L+++RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 615 LMRIITACSLPDFKALVLPYMANGSLD---SHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
            ++            LV+ Y    + D    H  P  E E  +            +    
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA------------VTHGA 163

Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
            +G+AYLH H    +IH D+K  N+LL++     + DFG A ++               +
Sbjct: 164 LQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM---------------A 205

Query: 732 TANMLCGSIGYMAPEYGFGSNTST---KGDVYSFGILVLEMVTRRRPTDDM 779
            AN   G+  +MAPE     +      K DV+S GI  +E+  R+ P  +M
Sbjct: 206 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 92.4 bits (230), Expect = 4e-20
 Identities = 53/226 (23%), Positives = 98/226 (43%), Gaps = 35/226 (15%)

Query: 559 FDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRIRHRN 614
           F+  R +G GS+G+V      D   + A+K +   +    N  ++  +E Q+++ + H  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
           L+ +  +    +   +V+  +  G L  HL       F   +       ++ IC ++   
Sbjct: 77  LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ--QNVHFKEETV------KLFIC-ELVMA 127

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           + YL +    R+IH D+KP N+LL++     ++DF IA                  +   
Sbjct: 128 LDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAA------------MLPRETQIT 172

Query: 735 MLCGSIGYMAPE-----YGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
            + G+  YMAPE      G G + +   D +S G+   E++  RRP
Sbjct: 173 TMAGTKPYMAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGRRP 216

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 90.0 bits (224), Expect = 8e-20
 Identities = 53/214 (24%), Positives = 83/214 (38%), Gaps = 51/214 (23%)

Query: 554 EATAEFDEQ----RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKS--------- 599
            +T  F E      +LG G    V + I        AVK++ +  G    +         
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 600 FNRECQVLKRI-RHRNLMRIITACSLPDFKALVLPYMANGSL-D-----SHLYPHSETEF 652
             +E  +L+++  H N++++        F  LV   M  G L D       L   SE E 
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL---SEKE- 125

Query: 653 GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA 712
                         I   + E +  LH      ++H DLKP N+LL+DDM   ++DFG +
Sbjct: 126 -----------TRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 171

Query: 713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPE 746
             +       D  E +       +CG+  Y+APE
Sbjct: 172 CQL-------DPGEKLRE-----VCGTPSYLAPE 193

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 90.5 bits (225), Expect = 2e-19
 Identities = 41/219 (18%), Positives = 83/219 (37%), Gaps = 38/219 (17%)

Query: 556 TAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRN 614
              +D    LG+G++G V++ +    G     K +         +   E  ++ ++ H  
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 615 LMRIITACSLPDFKALVLPYMANGSL------DSHLYPHSETEFGSGSSDLTLLQRVNIC 668
           L+ +  A        L+L +++ G L      + +    SE E             +N  
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKM--SEAE------------VINYM 155

Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALV--SDFGIAKLVMTVGVGNDGAE 726
               EG+ ++H H    ++H D+KP N++      + V   DFG+A  +       +  E
Sbjct: 156 RQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL-------NPDE 205

Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGIL 765
            +      +   +  + APE           D+++ G+L
Sbjct: 206 IV-----KVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 239

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 92.6 bits (230), Expect = 2e-19
 Identities = 52/228 (22%), Positives = 90/228 (39%), Gaps = 39/228 (17%)

Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQ---LQSGNFTKSFNRECQVLKRI---R 611
           F   R++G G +G VY     D G   A+K L    ++          E  +L  +    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250

Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI-CSD 670
              ++ +  A   PD  + +L  M  G L  HL       F            +    ++
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFS--------EADMRFYAAE 300

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I  G+ ++H+     V++ DLKP+N+LL++     +SD G+A                  
Sbjct: 301 IILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS-------------K 344

Query: 731 STANMLCGSIGYMAPE---YGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              +   G+ GYMAPE    G   ++S   D +S G ++ +++    P
Sbjct: 345 KKPHASVGTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGHSP 390

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 88.0 bits (219), Expect = 3e-19
 Identities = 54/248 (21%), Positives = 98/248 (39%), Gaps = 48/248 (19%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIIT 620
           + LG G+YG V   +      A+AVK++ ++   +  ++  +E  + K + H N+++   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPH---SETE----FGSGSSDLTLLQRVNICSDIAE 673
                + + L L Y + G L   + P     E +    F          Q       +  
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQ-------LMA 116

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           G+ YLH      + H D+KP N+LL++     +SDFG+A +                +  
Sbjct: 117 GVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF------RYNNRERLLNKM 167

Query: 734 NMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH 787
              CG++ Y+APE      +      +   DV+S GI++  M+    P D          
Sbjct: 168 ---CGTLPYVAPELLKRREF-----HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

Query: 788 KWVKNHYH 795
            W +   +
Sbjct: 220 DWKEKKTY 227

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 91.8 bits (228), Expect = 3e-19
 Identities = 45/221 (20%), Positives = 88/221 (39%), Gaps = 40/221 (18%)

Query: 556 TAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRN 614
              +D    LGTG++G V++      G   A K +     +  ++  +E Q +  +RH  
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 615 LMRIITACSLPDFKALVLPYMANGSL-------DSHLYPHSETEFGSGSSDLTLLQRVNI 667
           L+ +  A    +   ++  +M+ G L        + +   SE E             V  
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKM---SEDE------------AVEY 260

Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL-NDDMTAL-VSDFGIAKLVMTVGVGNDGA 725
              + +G+ ++H ++    +H DLKP N++        L + DFG+   +       D  
Sbjct: 261 MRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-------DPK 310

Query: 726 ENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILV 766
           +++      +  G+  + APE   G       D++S G+L 
Sbjct: 311 QSV-----KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 89.4 bits (222), Expect = 3e-19
 Identities = 47/217 (21%), Positives = 90/217 (41%), Gaps = 38/217 (17%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLM 616
              +  +LG G +G+V+K      G  +A K+++ +     +    E  V+ ++ H NL+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 617 RIITACSLPDFKALVLPYMANGSL------DSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           ++  A    +   LV+ Y+  G L      +S+    +E +             +     
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNL--TELD------------TILFMKQ 195

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLL--NDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
           I EG+ ++H      ++H DLKP N+L    D     + DFG+A+            E +
Sbjct: 196 ICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRY-------KPREKL 245

Query: 729 GNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGIL 765
                 +  G+  ++APE       S   D++S G++
Sbjct: 246 -----KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 90.5 bits (225), Expect = 4e-19
 Identities = 56/228 (24%), Positives = 92/228 (40%), Gaps = 48/228 (21%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNLMRI 618
           R+LG GS+G V        G   AVKV+   Q++     +S  RE Q+LK++ H N+M++
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91

Query: 619 ITACSLPDFKALVLPYMANGSLDSHL---YPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
                   +  LV      G L   +      SE +               I   +  G+
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA------------RIIRQVLSGI 139

Query: 676 AYLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
            Y+H +    ++H DLKP N+LL   + D    + DFG++                 +  
Sbjct: 140 TYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF------------EASKK 184

Query: 733 ANMLCGSIGYMAPE-----YGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                G+  Y+APE     Y        K DV+S G+++  +++   P
Sbjct: 185 MKDKIGTAYYIAPEVLHGTYD------EKCDVWSTGVILYILLSGCPP 226

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 90.5 bits (225), Expect = 4e-19
 Identities = 51/227 (22%), Positives = 85/227 (37%), Gaps = 47/227 (20%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRII 619
           + LG+G+YG V            A+K+++    S +       E  VLK + H N+M++ 
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102

Query: 620 TACSLPDFKALVLPYMANGSLDSHL---YPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
                     LV+     G L   +      +E +               I   +  G+ 
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA------------VIIKQVLSGVT 150

Query: 677 YLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           YLH H+   ++H DLKP N+LL     D    + DFG++ +                   
Sbjct: 151 YLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN------------QKKM 195

Query: 734 NMLCGSIGYMAPE-----YGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
               G+  Y+APE     Y        K DV+S G+++  ++    P
Sbjct: 196 KERLGTAYYIAPEVLRKKYD------EKCDVWSIGVILFILLAGYPP 236

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 89.0 bits (221), Expect = 5e-19
 Identities = 55/242 (22%), Positives = 97/242 (40%), Gaps = 50/242 (20%)

Query: 525 SSGKSETRSKPITPELMHNFPRITYRELLEATAEFDEQ----RLLGTGSYGRVYKGI-LQ 579
           +   ++ + K        +           A  EF ++     ++G G    V + +   
Sbjct: 58  AKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA 117

Query: 580 DGTAIAVKVL--------QLQSGNFTKSFNRECQVLKRIR-HRNLMRIITACSLPDFKAL 630
            G   AVK++          Q     ++  RE  +L+++  H +++ +I +     F  L
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL 177

Query: 631 VLPYMANGSL-D-----SHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPV 684
           V   M  G L D       L   SE E    +          I   + E +++LH +   
Sbjct: 178 VFDLMRKGELFDYLTEKVAL---SEKE----TRS--------IMRSLLEAVSFLHAN--- 219

Query: 685 RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMA 744
            ++H DLKP N+LL+D+M   +SDFG +  +       +  E +       LCG+ GY+A
Sbjct: 220 NIVHRDLKPENILLDDNMQIRLSDFGFSCHL-------EPGEKL-----RELCGTPGYLA 267

Query: 745 PE 746
           PE
Sbjct: 268 PE 269

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 86.2 bits (214), Expect = 6e-19
 Identities = 41/261 (15%), Positives = 87/261 (33%), Gaps = 44/261 (16%)

Query: 21  LRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFF 80
               ++   ++  +IP    L  +   + L + +L   +P   F N  ++  + +S +  
Sbjct: 13  EEDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVT 67

Query: 81  TGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKL 139
             ++      N   +  + + N                        +L+  +  D + +L
Sbjct: 68  LQQLESHSFYNLSKVTHIEIRNT----------------------RNLT-YIDPDALKEL 104

Query: 140 PSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSI--GRLNL 197
           P L +L +    +          P    + +      LE+       ++P +   G  N 
Sbjct: 105 PLLKFLGIFNTGLKM-------FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE 157

Query: 198 TQLL-LQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEI--SWLSQLEQLFLSHNL 254
           T  L L  N  T S+  +  N + L ++ L+ N     I  +      S    L +S   
Sbjct: 158 TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTS 216

Query: 255 FSGEIPA-ALGKLHHLGLLDL 274
            +  +P+  L  L  L   + 
Sbjct: 217 VT-ALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 74.3 bits (183), Expect = 6e-15
 Identities = 47/255 (18%), Positives = 80/255 (31%), Gaps = 57/255 (22%)

Query: 196 NLTQLLLQENKITGSIPPHI-GNLSNLISLNLSSNLLSGTISAEI-SWLSQLEQLFLSHN 253
           +   L L E  +  +IP H   NL N+  + +S ++    + +     LS++  + + + 
Sbjct: 32  STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90

Query: 254 LFSGEIPA-ALGKLHHLGLLDLSFNKLSGEIP--VSLGNLVQIYSLFLNNNQLSRSIPPT 310
                I   AL +L  L  L +    L    P    + +    + L + +N    SIP  
Sbjct: 91  RNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149

Query: 311 L--GRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQE 368
              G C +   L L  N  T S+            F                     +  
Sbjct: 150 AFQGLCNETLTLKLYNNGFT-SVQG--------YAFNGT-----------------KLDA 183

Query: 369 IDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGII 428
           + L+ NK                L  I  +A  G +      L      DVS   ++ + 
Sbjct: 184 VYLNKNK---------------YLTVIDKDAFGG-VYSGPSLL------DVSQTSVTALP 221

Query: 429 PISLNKIHTLTFINL 443
              L  +  L   N 
Sbjct: 222 SKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 27/159 (16%), Positives = 60/159 (37%), Gaps = 7/159 (4%)

Query: 2   LVDNHLFGAIPPE-FSKLRRLRHLQLDGNNLHGQIP-ESLALLSNLTLVTLHDNNLTGML 59
           +  +     +    F  L ++ H+++        I  ++L  L  L  + + +  L    
Sbjct: 62  VSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFP 121

Query: 60  PISFFHNCTSLRNVDLSQNFFTGKIPEEI--GNCPNLWTLSLYNNQLTGQLPASLIN-TS 116
            ++  ++      ++++ N +   IP     G C    TL LYNN  T  +     N T 
Sbjct: 122 DLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTK 180

Query: 117 MYNLDVEYNHLSGELPSDIMSKLPS-LTYLHLSYNNMVS 154
           +  + +  N     +  D    + S  + L +S  ++ +
Sbjct: 181 LDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA 219

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 65.4 bits (160), Expect = 6e-12
 Identities = 32/234 (13%), Positives = 76/234 (32%), Gaps = 44/234 (18%)

Query: 2   LVDNHLFGAIPPE-FSKLRRLRHLQLDGNNLHGQIPE-SLALLSNLTLVTLHDNNLTGML 59
           L++ HL   IP   FS L  +  + +  +    Q+   S   LS +T + + +      +
Sbjct: 38  LIETHL-RTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYI 96

Query: 60  PISFFHNCTSLRNVDLSQNFFTGKIPEE--IGNCPNLWTLSLYNNQLTGQLPASL---IN 114
                     L+ + +         P+   + +    + L + +N     +P +    + 
Sbjct: 97  DPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLC 155

Query: 115 TSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSH-DDNTNLVPFFNSLGNCTD 173
                L +  N  +  +     +    L  ++L+ N  ++  D +      F  + +   
Sbjct: 156 NETLTLKLYNNGFT-SVQGYAFN-GTKLDAVYLNKNKYLTVIDKDA-----FGGVYS--- 205

Query: 174 LEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHI-GNLSNLISLNL 226
                                   + L + +  +T ++P     +L  LI+ N 
Sbjct: 206 ----------------------GPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 30/223 (13%), Positives = 78/223 (34%), Gaps = 42/223 (18%)

Query: 267 HHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPP-TLGRCTDLYKLDLSYN 325
           H      ++   +   IP    +      L L    L  +IP        ++ ++ +S +
Sbjct: 11  HQEEDFRVTCKDIQ-RIPSLPPSTQT---LKLIETHLR-TIPSHAFSNLPNISRIYVSID 65

Query: 326 RLTGSIPA------------EISGIREIRI-------------FLNLSHNQLEG-PLPIE 359
                + +            EI   R +               FL + +  L+  P   +
Sbjct: 66  VTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTK 125

Query: 360 LSKLENVQEIDLSSNKFTGNI----FIQISNCIAVRLINISHNALQGNLPDSLGDLKNLE 415
           +   +    ++++ N +  +I    F  + N      + + +N    ++     +   L+
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCN--ETLTLKLYNNGFT-SVQGYAFNGTKLD 182

Query: 416 AIDVSGN-HLSGIIPISLNKIHT-LTFINLSFNEFKGMIPSGG 456
           A+ ++ N +L+ I   +   +++  + +++S       +PS G
Sbjct: 183 AVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG 224

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 88.5 bits (220), Expect = 6e-19
 Identities = 49/234 (20%), Positives = 93/234 (39%), Gaps = 56/234 (23%)

Query: 552 LLEATAEFDEQ----RLLGTGSYGRVYKGI-LQDGTAIAVKVL--QLQSGNFTKSFNREC 604
           ++ A+ +F +       LG G++  V + +    G   A K++  +  S    +   RE 
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79

Query: 605 QVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSL-----DSHLYPHSETEFGSGSSDL 659
           ++ ++++H N++R+  +     F  LV   +  G L         Y  SE +        
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY--SEAD-------- 129

Query: 660 TLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVM 716
                 +    I E +AY H +    ++H +LKP N+LL          ++DFG+A  V 
Sbjct: 130 ----ASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV- 181

Query: 717 TVGVGNDGAENMGNSTANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGI 764
                 + +E           G+ GY++PE      Y          D+++ G+
Sbjct: 182 ------NDSEAWHG-----FAGTPGYLSPEVLKKDPYS------KPVDIWACGV 218

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 89.4 bits (222), Expect = 6e-19
 Identities = 44/224 (19%), Positives = 85/224 (37%), Gaps = 51/224 (22%)

Query: 544 FPRITYRELLEATAEFDEQ----RLLGTGSYGRVYKGI-LQDGTAIAVKVL--------Q 590
           F  +T  +         ++    + LG+G+ G V      +    +A++++         
Sbjct: 118 FFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGS 177

Query: 591 LQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSL-----DSHLY 645
            +  +   +   E ++LK++ H  +++I       D+  +VL  M  G L      +   
Sbjct: 178 AREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRL 236

Query: 646 PHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL---NDDM 702
             +  +                   +   + YLH +    +IH DLKP NVLL    +D 
Sbjct: 237 KEATCK--------------LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDC 279

Query: 703 TALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPE 746
              ++DFG +K++    +               LCG+  Y+APE
Sbjct: 280 LIKITDFGHSKILGETSLMRT------------LCGTPTYLAPE 311

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 87.7 bits (218), Expect = 7e-19
 Identities = 36/223 (16%), Positives = 86/223 (38%), Gaps = 47/223 (21%)

Query: 556 TAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRN 614
             ++     LG G +G V++ +          K ++++  +      +E  +L   RHRN
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRN 62

Query: 615 LMRIITACSLPDFKALVLPYMANGSL-D---SHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           ++ +  +    +   ++  +++   + +   +  +  +E E             V+    
Sbjct: 63  ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNERE------------IVSYVHQ 110

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALV--SDFGIAKLVMTVGVGNDGAENM 728
           + E + +LH H+   + H D++P N++     ++ +   +FG A+ +          +N 
Sbjct: 111 VCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-------KPGDNF 160

Query: 729 GNSTANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGIL 765
                 +L  +  Y APE          +      D++S G L
Sbjct: 161 -----RLLFTAPEYYAPEVHQHDVVSTAT------DMWSLGTL 192

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 86.9 bits (216), Expect = 8e-19
 Identities = 59/245 (24%), Positives = 92/245 (37%), Gaps = 55/245 (22%)

Query: 540 LMHNFPRITYRELLEATAEFDEQ----RLLGTGSYGRVYKGI-LQDGTAIAVKVL--QLQ 592
           + H+    + RE L     F E+     +LG GS+G V K          AVKV+     
Sbjct: 1   MHHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA 60

Query: 593 SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSL-----DSHLYPH 647
               T +  RE ++LK++ H N+M++           +V      G L         +  
Sbjct: 61  KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF-- 118

Query: 648 SETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL---NDDMTA 704
           SE +               I   +  G+ Y+H H+   ++H DLKP N+LL     D   
Sbjct: 119 SEHD------------AARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDI 163

Query: 705 LVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPE-----YGFGSNTSTKGDV 759
            + DFG++                 N+      G+  Y+APE     Y        K DV
Sbjct: 164 KIIDFGLSTCF------------QQNTKMKDRIGTAYYIAPEVLRGTYD------EKCDV 205

Query: 760 YSFGI 764
           +S G+
Sbjct: 206 WSAGV 210

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 86.5 bits (215), Expect = 1e-18
 Identities = 50/232 (21%), Positives = 91/232 (39%), Gaps = 57/232 (24%)

Query: 556 TAEFDEQ----RLLGTGSYGRVYKGI-LQDGTAIAVKVL--QLQSGNFTKSFNRECQVLK 608
           + +F +       LG G++  V + +    G   A K++  +  S    +   RE ++ +
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 609 RIRHRNLMRIITACSLPDFKALVLPYMANGSL-----DSHLYPHSETEFGSGSSDLTLLQ 663
           +++H N++R+  +     F  LV   +  G L         Y  SE +            
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY--SEAD------------ 106

Query: 664 RVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGV 720
             +    I E +AY H +    ++H +LKP N+LL          ++DFG+A  V     
Sbjct: 107 ASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV----- 158

Query: 721 GNDGAENMGNSTANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFG-IL 765
             + +E           G+ GY++PE      Y          D+++ G IL
Sbjct: 159 --NDSEAWHG-----FAGTPGYLSPEVLKKDPYS------KPVDIWACGVIL 197

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 87.4 bits (217), Expect = 1e-18
 Identities = 54/248 (21%), Positives = 98/248 (39%), Gaps = 48/248 (19%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIIT 620
           + LG G+YG V   +      A+AVK++ ++   +  ++  +E  + K + H N+++   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPH---SETE----FGSGSSDLTLLQRVNICSDIAE 673
                + + L L Y + G L   + P     E +    F          Q       +  
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---------HQ-------LMA 116

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           G+ YLH      + H D+KP N+LL++     +SDFG+A +                +  
Sbjct: 117 GVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF------RYNNRERLLNKM 167

Query: 734 NMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH 787
              CG++ Y+APE      +      +   DV+S GI++  M+    P D          
Sbjct: 168 ---CGTLPYVAPELLKRREF-----HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

Query: 788 KWVKNHYH 795
            W +   +
Sbjct: 220 DWKEKKTY 227

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 87.4 bits (217), Expect = 1e-18
 Identities = 63/249 (25%), Positives = 97/249 (38%), Gaps = 40/249 (16%)

Query: 525 SSGKSETRSKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGI-LQDGTA 583
            S  S T S       +     I        +  F+ +  LG G+   VY+         
Sbjct: 21  QSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKP 80

Query: 584 IAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSL--- 640
            A+KVL+       K    E  VL R+ H N++++      P   +LVL  +  G L   
Sbjct: 81  YALKVLKKTVD--KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDR 138

Query: 641 --DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL 698
             +   Y  SE +              +    I E +AYLH +    ++H DLKP N+L 
Sbjct: 139 IVEKGYY--SERD------------AADAVKQILEAVAYLHEN---GIVHRDLKPENLLY 181

Query: 699 ---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTST 755
                D    ++DFG++K+V       +    M       +CG+ GY APE   G     
Sbjct: 182 ATPAPDAPLKIADFGLSKIV-------EHQVLMKT-----VCGTPGYCAPEILRGCAYGP 229

Query: 756 KGDVYSFGI 764
           + D++S GI
Sbjct: 230 EVDMWSVGI 238

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 64/227 (28%), Positives = 102/227 (44%), Gaps = 41/227 (18%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNLMRI 618
             LG G++G+V  G     G  +AVK+L   +++S +      RE Q LK  RH +++++
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 619 ITACSLPDFKALVLPYMANGSLDSHLYPH---SETEFGSGSSDLTLLQRVNICSDIAEGM 675
               S P    +V+ Y++ G L  ++  H    E E               +   I   +
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEME------------ARRLFQQILSAV 124

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            Y H H    V+H DLKP NVLL+  M A ++DFG++ + M+ G                
Sbjct: 125 DYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDG--------------EF 166

Query: 736 L---CGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTDD 778
           L   CGS  Y APE   G      + D++S G+++  ++    P DD
Sbjct: 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 87.8 bits (218), Expect = 2e-18
 Identities = 55/229 (24%), Positives = 99/229 (43%), Gaps = 35/229 (15%)

Query: 554 EATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVK-VLQLQSGNFTKSFNRECQVLKRIRH 612
           +    +   +++G GS+G V++  L +   +A+K VLQ       +  NRE Q+++ ++H
Sbjct: 37  QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKH 91

Query: 613 RNLMR----IITACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN 666
            N++       +     D     LVL Y+        +Y  S   +      + +L    
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLEYV-----PETVYRASRH-YAKLKQTMPMLLIKL 145

Query: 667 ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGA 725
               +   +AY+H      + H D+KP N+LL+     L + DFG AK            
Sbjct: 146 YMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK-----------I 191

Query: 726 ENMGNSTANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRR 773
              G    + +C S  Y APE  FG+   +T  D++S G ++ E++  +
Sbjct: 192 LIAGEPNVSYIC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 86.8 bits (215), Expect = 2e-18
 Identities = 48/294 (16%), Positives = 78/294 (26%), Gaps = 62/294 (21%)

Query: 10  AIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTS 69
            IP +    R    L+     L      + +   +L  + +  N++  ++    F N   
Sbjct: 23  EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80

Query: 70  LRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLS 128
           L  + + +      I  E   N PNL  L + N  +                        
Sbjct: 81  LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK----------------------- 117

Query: 129 GELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTL 188
             LP            L +  N  +                    +E     G+      
Sbjct: 118 -HLPDVHKIHSLQKVLLDIQDNINIHT------------------IERNSFVGL------ 152

Query: 189 PDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEI-SWLSQLEQ 247
                      L L +N I   I     N + L  LNLS N     +  ++    S    
Sbjct: 153 -----SFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVI 206

Query: 248 LFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNN 301
           L +S           L  L  L        K   ++P +L  LV +    L   
Sbjct: 207 LDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 80.3 bits (198), Expect = 3e-16
 Identities = 51/258 (19%), Positives = 91/258 (35%), Gaps = 18/258 (6%)

Query: 196 NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLF 255
           +    L QE+K+T  IP  +    N I L      L        S    LE++ +S N  
Sbjct: 10  SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66

Query: 256 SGEIPA-ALGKLHHLGLLDLS-FNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPP-TLG 312
              I A     L  L  + +   N L    P +  NL  +  L ++N  + + +P     
Sbjct: 67  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI-KHLPDVHKI 125

Query: 313 RCTDLYKLDLSYNRLTGSIPAE-ISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDL 371
                  LD+  N    +I      G+    + L L+ N ++       +  +  +    
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLS 185

Query: 372 SSNKFT---GNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGII 428
            +N       ++F   S      +++IS   +       L +LK L A      +L  + 
Sbjct: 186 DNNNLEELPNDVFHGASG---PVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLP 240

Query: 429 PISLNKIHTLTFINLSFN 446
              L K+  L   +L++ 
Sbjct: 241 T--LEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 54.4 bits (131), Expect = 7e-08
 Identities = 38/229 (16%), Positives = 72/229 (31%), Gaps = 34/229 (14%)

Query: 272 LDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPP-TLGRCTDLYKLDLSYNRLTGS 330
                +K++ EIP  L        L     +L   I         DL K+++S N +   
Sbjct: 14  FLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEV 69

Query: 331 IPAEI-SGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFT------------ 377
           I A++ S + ++        N L    P     L N+Q + +S+                
Sbjct: 70  IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 129

Query: 378 -------GNIFIQ-ISN------CIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNH 423
                   NI I  I             ++ ++ N +Q     +    +  E      N+
Sbjct: 130 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNN 189

Query: 424 LSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHL 472
           L  +     +       +++S       +PS G   +  K+      +L
Sbjct: 190 LEELPNDVFHGASGPVILDISRTRIH-SLPSYG-LENLKKLRARSTYNL 236

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 87.7 bits (218), Expect = 2e-18
 Identities = 47/232 (20%), Positives = 85/232 (36%), Gaps = 56/232 (24%)

Query: 556 TAEFDEQ----RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFT--KSFNRECQVLK 608
              F E+      LG G++  V + + +  G   A  ++  +  +    +   RE ++ +
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65

Query: 609 RIRHRNLMRIITACSLPDFKALVLPYMANGSL-----DSHLYPHSETEFGSGSSDLTLLQ 663
            ++H N++R+  + S      L+   +  G L         Y  SE +            
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYY--SEAD------------ 111

Query: 664 RVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGV 720
             +    I E + + H      V+H +LKP N+LL          ++DFG+A  V     
Sbjct: 112 ASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV----- 163

Query: 721 GNDGAENMGNSTANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFG-IL 765
                            G+ GY++PE      YG         D+++ G IL
Sbjct: 164 ------EGEQQAWFGFAGTPGYLSPEVLRKDPYG------KPVDLWACGVIL 203

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 47/202 (23%), Positives = 80/202 (39%), Gaps = 49/202 (24%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVL--------QLQSGNFTKSFNRECQVLKRIRHR 613
           + LG+G+ G V      +    +A+K++          +  +   +   E ++LK++ H 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75

Query: 614 NLMRIITACSLPDFKALVLPYMANGSL------DSHLYPHSETEFGSGSSDLTLLQRVNI 667
            +++I       D+  +VL  M  G L      +  L    E                  
Sbjct: 76  CIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRL---KEAT------------CKLY 119

Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDG 724
              +   + YLH +    +IH DLKP NVLL    +D    ++DFG +K++         
Sbjct: 120 FYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-------GE 169

Query: 725 AENMGNSTANMLCGSIGYMAPE 746
              M   T   LCG+  Y+APE
Sbjct: 170 TSLM--RT---LCGTPTYLAPE 186

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 45/212 (21%), Positives = 75/212 (35%), Gaps = 41/212 (19%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
             +G GS+G V   +        A K +          F +E +++K + H N++R+   
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74

Query: 622 CSLPDFKALVLPYMANGSL-DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
                   LV+     G L +  ++     E  +            I  D+   +AY H 
Sbjct: 75  FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA----------RIMKDVLSAVAYCHK 124

Query: 681 HSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
                V H DLKP N L    + D    + DFG+A             + M         
Sbjct: 125 L---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-------KPGKMM-----RTKV 169

Query: 738 GSIGYMAPE-----YGFGSNTSTKGDVYSFGI 764
           G+  Y++P+     YG       + D +S G+
Sbjct: 170 GTPYYVSPQVLEGLYG------PECDEWSAGV 195

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 52/242 (21%), Positives = 89/242 (36%), Gaps = 50/242 (20%)

Query: 542 HNFPRITYRELLEATAEFDEQ----RLLGTGSYGRVYKGI-LQDGTAIAVKVLQ-LQSGN 595
           H+    + RE L      D+     R LG+G++G V+       G    +K +   +S  
Sbjct: 3   HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62

Query: 596 FTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSL-----DSHLYPHSET 650
             +    E +VLK + H N+++I           +V+     G L      +     + +
Sbjct: 63  PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALS 122

Query: 651 EFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL---NDDMTALVS 707
           E               +   +   +AY H      V+H DLKP N+L    +      + 
Sbjct: 123 E----------GYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKII 169

Query: 708 DFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPE-----YGFGSNTSTKGDVYSF 762
           DFG+A+L  +            +  +    G+  YMAPE       F      K D++S 
Sbjct: 170 DFGLAELFKS------------DEHSTNAAGTALYMAPEVFKRDVTF------KCDIWSA 211

Query: 763 GI 764
           G+
Sbjct: 212 GV 213

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 86.3 bits (214), Expect = 3e-18
 Identities = 48/233 (20%), Positives = 85/233 (36%), Gaps = 59/233 (25%)

Query: 556 TAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL------QLQSGNFTKSFNRECQVLK 608
              +D    LG+G +  V K      G   A K +        + G   +   RE  +L+
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 609 RIRHRNLMRIITACSLPDFKALVLPYMANGSL------DSHLYPHSETEFGSGSSDLTLL 662
           ++ H N++ +           L+L  ++ G L         L   SE E           
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESL---SEEE----------- 116

Query: 663 QRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL---NDDMTAL-VSDFGIAKLVMTV 718
              +    I +G+ YLH      + H DLKP N++L   N  +  + + DFG+A  +   
Sbjct: 117 -ATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--- 169

Query: 719 GVGNDGAENMGNSTANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGIL 765
               +            + G+  ++APE       G  +      D++S G++
Sbjct: 170 ----EDGVEF-----KNIFGTPEFVAPEIVNYEPLGLEA------DMWSIGVI 207

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 84.3 bits (209), Expect = 4e-18
 Identities = 42/267 (15%), Positives = 84/267 (31%), Gaps = 71/267 (26%)

Query: 37  ESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWT 96
                L+N     L   ++T    +      + ++N +   +     +   +    NL  
Sbjct: 13  FPDPGLANAVKQNLGKQSVTD---LVSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKE 67

Query: 97  LSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHD 156
           L L +NQ+          + +  L                  L  L  L ++ N +    
Sbjct: 68  LHLSHNQI----------SDLSPL----------------KDLTKLEELSVNRNRL---- 97

Query: 157 DNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIG 216
                           +L  +                   L++L L  N++       + 
Sbjct: 98  ---------------KNLNGIPS---------------ACLSRLFLDNNELR-DTDS-LI 125

Query: 217 NLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSF 276
           +L NL  L++ +N L  +I   + +LS+LE L L  N  +      L +L  +  +DL+ 
Sbjct: 126 HLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTG 181

Query: 277 NKLSGEIPVSLGNLVQIYSLFLNNNQL 303
            K   E       L    ++   + + 
Sbjct: 182 QKCVNEPVKYQPELYITNTVKDPDGRW 208

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 44/265 (16%), Positives = 97/265 (36%), Gaps = 47/265 (17%)

Query: 199 QLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGE 258
           + + +   I   + P    L+N +  NL    ++     ++                   
Sbjct: 1   ESIQRPTPIN-QVFP-DPGLANAVKQNLGKQSVT-----DLV------------------ 35

Query: 259 IPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLY 318
              +  +L  +   +   + +   +   +     +  L L++NQ+S  + P L   T L 
Sbjct: 36  ---SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQIS-DLSP-LKDLTKLE 88

Query: 319 KLDLSYNRLTGSIPAEISGIREIRI-FLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFT 377
           +L ++ NRL       ++GI    +  L L +N+L       L  L+N++ + + +NK  
Sbjct: 89  ELSVNRNRLK-----NLNGIPSACLSRLFLDNNELRDTDS--LIHLKNLEILSIRNNKLK 141

Query: 378 GNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHT 437
            +I + +     + ++++  N +       L  LK +  ID++G      +   +     
Sbjct: 142 -SI-VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQK---CVNEPVKYQPE 194

Query: 438 LTFINLSFNEFKGMIPSGGIFNSAT 462
           L   N   +     I    I N  +
Sbjct: 195 LYITNTVKDPDGRWISPYYISNGGS 219

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 72.4 bits (178), Expect = 4e-14
 Identities = 45/245 (18%), Positives = 80/245 (32%), Gaps = 37/245 (15%)

Query: 16  SKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDL 75
             L       L   ++      S   LS +      ++N+     ++     T+L+ + L
Sbjct: 16  PGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQS---LAGMQFFTNLKELHL 70

Query: 76  SQNFFTGKIP--EEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPS 133
           S N    +I     + +   L  LS+  N+L       + +  +  L ++ N L      
Sbjct: 71  SHN----QISDLSPLKDLTKLEELSVNRNRLKN--LNGIPSACLSRLFLDNNEL-----R 119

Query: 134 DI--MSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDS 191
           D   +  L +L  L +  N + S             LG  + LE L+L G ++  T    
Sbjct: 120 DTDSLIHLKNLEILSIRNNKLKS----------IVMLGFLSKLEVLDLHGNEI--TNTGG 167

Query: 192 IGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAE-ISWLSQLEQLF 249
           + RL  +  + L   K        +     L   N   +     IS   IS         
Sbjct: 168 LTRLKKVNWIDLTGQKCV---NEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGC 224

Query: 250 LSHNL 254
           +   L
Sbjct: 225 VLWEL 229

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 26/144 (18%), Positives = 55/144 (38%), Gaps = 12/144 (8%)

Query: 15  FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVD 74
                 L+ L L  N +   +   L  L+ L  ++++ N L  +  I        L  + 
Sbjct: 59  MQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNLNGIPS----ACLSRLF 112

Query: 75  LSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSD 134
           L  N       + + +  NL  LS+ NN+L   +      + +  LD+  N ++      
Sbjct: 113 LDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGNEITNTGG-- 167

Query: 135 IMSKLPSLTYLHLSYNNMVSHDDN 158
            +++L  + ++ L+    V+    
Sbjct: 168 -LTRLKKVNWIDLTGQKCVNEPVK 190

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 87.4 bits (217), Expect = 4e-18
 Identities = 60/252 (23%), Positives = 96/252 (38%), Gaps = 51/252 (20%)

Query: 542 HNFPRITYRELLEATAEFDEQ----RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQ--SG 594
           H+    + RE L     F E+     +LG GS+G V K          AVKV+       
Sbjct: 3   HHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN 62

Query: 595 NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHL---YPHSETE 651
             T +  RE ++LK++ H N+M++           +V      G L   +      SE +
Sbjct: 63  KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD 122

Query: 652 FGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSD 708
                          I   +  G+ Y+H H    ++H DLKP N+LL     D    + D
Sbjct: 123 AA------------RIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIID 167

Query: 709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPE-----YGFGSNTSTKGDVYSFG 763
           FG++                 N+      G+  Y+APE     Y        K DV+S G
Sbjct: 168 FGLSTCFQQ------------NTKMKDRIGTAYYIAPEVLRGTYD------EKCDVWSAG 209

Query: 764 ILVLEMVTRRRP 775
           +++  +++   P
Sbjct: 210 VILYILLSGTPP 221

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 85.8 bits (213), Expect = 4e-18
 Identities = 47/226 (20%), Positives = 80/226 (35%), Gaps = 47/226 (20%)

Query: 530 ETRSKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKV 588
                 I  +L  N  + T          ++ +  +G GSY    + I        AVK+
Sbjct: 3   TVGVHSIVQQLHRNSIQFT--------DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI 54

Query: 589 LQLQSGNFTKSFNRECQVLKR-IRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPH 647
           +        +    E ++L R  +H N++ +        +  +V   M  G L   +   
Sbjct: 55  IDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ 110

Query: 648 ---SETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL---NDD 701
              SE E               +   I + + YLH      V+H DLKPSN+L    + +
Sbjct: 111 KFFSERE------------ASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGN 155

Query: 702 MTAL-VSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPE 746
             ++ + DFG AK +              N      C +  ++APE
Sbjct: 156 PESIRICDFGFAKQL-----------RAENGLLMTPCYTANFVAPE 190

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 85.8 bits (213), Expect = 5e-18
 Identities = 56/229 (24%), Positives = 92/229 (40%), Gaps = 44/229 (19%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  + LGTGS+GRV     ++     A+K+L   ++      +    E ++L+ +   
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLY-----PHSETEFGSGSSDLTLLQRVNIC 668
            L+++  +        +V+ Y+A G + SHL            F                
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF--------------YA 147

Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
           + I     YLH      +I+ DLKP N+L++      V+DFG AK V             
Sbjct: 148 AQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV------------- 191

Query: 729 GNSTANMLCGSIGYMAPE--YGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                  LCG+   +APE     G N +   D ++ G+L+ EM     P
Sbjct: 192 -KGRTWTLCGTPEALAPEIILSKGYNKAV--DWWALGVLIYEMAAGYPP 237

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 85.8 bits (212), Expect = 5e-18
 Identities = 75/371 (20%), Positives = 125/371 (33%), Gaps = 107/371 (28%)

Query: 558 EFDEQRL-----LGTGSYGRVYK----GILQDGTAIAVKVLQLQSG---NFTKSFNRECQ 605
           EF   RL     LG G++G+V +    GI +  T   V V  L+ G   +  ++   E +
Sbjct: 18  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 77

Query: 606 VLKRI-RHRN--------------LMRIITACSLPDFKALVLP----------------- 633
           +L  I  H N              LM I+  C   +    +                   
Sbjct: 78  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQ 137

Query: 634 ---YMANGSLDSHLYPHSETEFGSGSSD------------------------LTLLQRVN 666
              Y+    +D      S T   S +S                         LTL   + 
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLIC 197

Query: 667 ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
               +A+GM +L   +  + IH DL   N+LL++     + DFG+A+ +           
Sbjct: 198 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK-------DP 247

Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLS 785
           +        L   + +MAPE  F    + + DV+SFG+L+ E+ +    P   +      
Sbjct: 248 DYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEE 304

Query: 786 LHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT 845
             + +K     R+                P+          E+ +  + C    PS RPT
Sbjct: 305 FCRRLKEGT--RMRA--------------PD------YTTPEMYQTMLDCWHGEPSQRPT 342

Query: 846 MLDAADDLDRL 856
             +  + L  L
Sbjct: 343 FSELVEHLGNL 353

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 84.6 bits (210), Expect = 6e-18
 Identities = 53/232 (22%), Positives = 98/232 (42%), Gaps = 43/232 (18%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQ----LQSGNFTKSFNRECQVLKRIRHRNLMR 617
            LLG GSYG+V + +  +     AVK+L+     +  N   +  +E Q+L+R+RH+N+++
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 618 ---IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS----- 669
              ++          +V+ Y   G  +  +             D    +R  +C      
Sbjct: 71  LVDVLYNEE-KQKMYMVMEYCVCGMQE--ML------------DSVPEKRFPVCQAHGYF 115

Query: 670 -DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
             + +G+ YLH      ++H D+KP N+LL    T  +S  G+A+ +      +      
Sbjct: 116 CQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD------ 166

Query: 729 GNSTANMLCGSIGYMAPE--YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
              T     GS  +  PE   G  + +  K D++S G+ +  + T   P + 
Sbjct: 167 ---TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 85.0 bits (211), Expect = 6e-18
 Identities = 52/225 (23%), Positives = 94/225 (41%), Gaps = 36/225 (16%)

Query: 562 QRLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNLMR 617
            + +G G++ +V     +  G  +A+K++   QL   +  K F RE +++K + H N+++
Sbjct: 20  LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVK 78

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPH---SETEFGSGSSDLTLLQRVNICSDIAEG 674
           +           L++ Y + G +  +L  H    E E              +    I   
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE------------ARSKFRQIVSA 126

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           + Y H     R++H DLK  N+LL+ DM   ++DFG +                     +
Sbjct: 127 VQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV------------GGKLD 171

Query: 735 MLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTDD 778
             CG+  Y APE   G      + DV+S G+++  +V+   P D 
Sbjct: 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 84.5 bits (210), Expect = 7e-18
 Identities = 63/241 (26%), Positives = 97/241 (40%), Gaps = 55/241 (22%)

Query: 559 FDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL------QLQSGNFTKSFNRECQVLKRIR 611
           F   R LGTGS+GRV+    +      A+KVL      +L+    T     E  +L  + 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND---ERLMLSIVT 64

Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLY-----PHSETEFGSGSSDLTLLQRVN 666
           H  ++R+           +++ Y+  G L S L      P+   +F              
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-------------- 110

Query: 667 ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
             +++   + YLH      +I+ DLKP N+LL+ +    ++DFG AK V           
Sbjct: 111 YAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV----------- 156

Query: 727 NMGNSTANMLCGSIGYMAPE--YGFGSNTSTKGDVYSFGILVLEMVTRRRP-----TDDM 779
                    LCG+  Y+APE       N S   D +SFGIL+ EM+    P     T   
Sbjct: 157 ---PDVTYTLCGTPDYIAPEVVSTKPYNKSI--DWWSFGILIYEMLAGYTPFYDSNTMKT 211

Query: 780 F 780
           +
Sbjct: 212 Y 212

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 84.6 bits (210), Expect = 8e-18
 Identities = 49/233 (21%), Positives = 86/233 (36%), Gaps = 59/233 (25%)

Query: 556 TAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL------QLQSGNFTKSFNRECQVLK 608
              +D    LG+G +  V K      G   A K +        + G   +   RE  +L+
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 609 RIRHRNLMRIITACSLPDFKALVLPYMANGSL------DSHLYPHSETEFGSGSSDLTLL 662
           ++ H N++ +           L+L  ++ G L         L   SE E           
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESL---SEEE----------- 116

Query: 663 QRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL---NDDMTAL-VSDFGIAKLVMTV 718
              +    I +G+ YLH      + H DLKP N++L   N  +  + + DFG+A  +   
Sbjct: 117 -ATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--- 169

Query: 719 GVGNDGAENMGNSTANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGIL 765
               +      N     + G+  ++APE       G  +      D++S G++
Sbjct: 170 ----EDGVEFKN-----IFGTPEFVAPEIVNYEPLGLEA------DMWSIGVI 207

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 83.4 bits (207), Expect = 1e-17
 Identities = 50/226 (22%), Positives = 82/226 (36%), Gaps = 59/226 (26%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVL------QLQSGNFTKSFNRECQVLKRIRHRNL 615
             LG+G +  V K      G   A K +        + G   +   RE  +L+ IRH N+
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70

Query: 616 MRIITACSLPDFKALVLPYMANGSL------DSHLYPHSETEFGSGSSDLTLLQRVNICS 669
           + +           L+L  ++ G L         L   +E E                  
Sbjct: 71  ITLHDIFENKTDVVLILELVSGGELFDFLAEKESL---TEDE------------ATQFLK 115

Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLL---NDDMTAL-VSDFGIAKLVMTVGVGNDGA 725
            I +G+ YLH     R+ H DLKP N++L   N     + + DFGIA  +       +  
Sbjct: 116 QILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-------EAG 165

Query: 726 ENMGNSTANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGIL 765
                     + G+  ++APE       G  +      D++S G++
Sbjct: 166 NEF-----KNIFGTPEFVAPEIVNYEPLGLEA------DMWSIGVI 200

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 85.9 bits (213), Expect = 1e-17
 Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 33/232 (14%)

Query: 559 FDEQRLLGTGSYGRVYKGILQDGTAI-AVKVLQ---LQSGNFTKSFNRECQVLKRIRHRN 614
           F+  +LLG G++G+V     +      A+K+L+   + + +       E +VL+  RH  
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI-CSDIAE 673
           L  +  +    D    V+ Y   G L  HL    E  F           R     ++I  
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVF--------SEDRARFYGAEIVS 259

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + YLH  S   V++ DLK  N++L+ D    ++DFG+ K  +              +T 
Sbjct: 260 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-----------DGATM 306

Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP-----TDDMF 780
              CG+  Y+APE    ++     D +  G+++ EM+  R P      + +F
Sbjct: 307 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 86.0 bits (213), Expect = 1e-17
 Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 41/227 (18%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNLMRI 618
             LG G++G+V  G     G  +AVK+L   +++S +      RE Q LK  RH +++++
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 619 ITACSLPDFKALVLPYMANGSLDSHLYPH---SETEFGSGSSDLTLLQRVNICSDIAEGM 675
               S P    +V+ Y++ G L  ++  +    E E               +   I  G+
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKE------------SRRLFQQILSGV 129

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            Y H H    V+H DLKP NVLL+  M A ++DFG++ + M+ G                
Sbjct: 130 DYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNM-MSDG--------------EF 171

Query: 736 L---CGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTDD 778
           L   CGS  Y APE   G      + D++S G+++  ++    P DD
Sbjct: 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 83.9 bits (208), Expect = 1e-17
 Identities = 51/220 (23%), Positives = 84/220 (38%), Gaps = 53/220 (24%)

Query: 562 QRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIR-HRNLMRII 619
            + LG GS+    K +  +   A AVK++   S     +  +E   LK    H N++++ 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLCEGHPNIVKLH 72

Query: 620 TACSLPDFKALVLPYMANGSL-----DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
                     LV+  +  G L         +  SETE    +S         I   +   
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIKKKKHF--SETE----ASY--------IMRKLVSA 118

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           ++++H      V+H DLKP N+L    ND++   + DFG A+L               N 
Sbjct: 119 VSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK-----------PPDNQ 164

Query: 732 TANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGIL 765
                C ++ Y APE      Y          D++S G++
Sbjct: 165 PLKTPCFTLHYAAPELLNQNGYD------ESCDLWSLGVI 198

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 42/227 (18%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRNLMRI 618
             LG GS+G+V      +    +A+K +    L+  +      RE   LK +RH +++++
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 619 ITACSLPDFKALVLPYMANGSLDSHLYPH---SETEFGSGSSDLTLLQRVNICSDIAEGM 675
               + P    +V+ Y A G L  ++      +E E                   I   +
Sbjct: 75  YDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDE------------GRRFFQQIICAI 121

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            Y H H   +++H DLKP N+LL+D++   ++DFG++ + MT G              N 
Sbjct: 122 EYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNI-MTDG--------------NF 163

Query: 736 L---CGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTDD 778
           L   CGS  Y APE   G      + DV+S GI++  M+  R P DD
Sbjct: 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 54/251 (21%), Positives = 97/251 (38%), Gaps = 62/251 (24%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVL--------------------------QLQSGN 595
             +G GSYG V       D T  A+KVL                           +Q   
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 596 FTKSFNRECQVLKRIRHRNLMRIITACSLPDFKAL--VLPYMANGSL---DSHLYPHSET 650
             +   +E  +LK++ H N+++++     P+   L  V   +  G +    +   P SE 
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSED 137

Query: 651 EFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG 710
           +                  D+ +G+ YLH+    ++IH D+KPSN+L+ +D    ++DFG
Sbjct: 138 Q------------ARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFG 182

Query: 711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG---DVYSFGILVL 767
           ++                 ++  +   G+  +MAPE    +     G   DV++ G+ + 
Sbjct: 183 VSNEFKG-----------SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231

Query: 768 EMVTRRRPTDD 778
             V  + P  D
Sbjct: 232 CFVFGQCPFMD 242

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 82.2 bits (204), Expect = 3e-17
 Identities = 53/238 (22%), Positives = 93/238 (39%), Gaps = 62/238 (26%)

Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFN----RECQVLKRIRHRNLMRII 619
           +G G+YG V+K    +    +A+K ++L   +  +       RE  +LK ++H+N++R+ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRL--DDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 620 TACSLPDFKALVLPYMAN---GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
                     LV  +         DS           S      L Q       + +G+ 
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS-----FLFQ-------LLKGLG 115

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL-----------VMTVGVGNDGA 725
           + H      V+H DLKP N+L+N +    +++FG+A+            V+T        
Sbjct: 116 FCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVT-------- 164

Query: 726 ENMGNSTANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRRRPTDDMFAG 782
                         + Y  P+  FG+   ST  D++S G +  E+    RP   +F G
Sbjct: 165 --------------LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPG 205

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 54/215 (25%), Positives = 83/215 (38%), Gaps = 40/215 (18%)

Query: 43  SNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYN 101
           ++   + L  N L+  LP   FH  T LR + L+ N     +P  I     NL TL + +
Sbjct: 37  ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTD 94

Query: 102 NQLTGQLPASLIN--TSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNT 159
           N+L   LP  + +   ++  L ++ N L   LP  +   L  LTYL L YN + S     
Sbjct: 95  NKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGV 152

Query: 160 NLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHI-GNL 218
                F+ L                           +L +L L  N++   +P      L
Sbjct: 153 -----FDKLT--------------------------SLKELRLYNNQLK-RVPEGAFDKL 180

Query: 219 SNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHN 253
           + L +L L +N L          L +L+ L L  N
Sbjct: 181 TELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 18/213 (8%)

Query: 93  NLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNM 152
           N  ++   + +LT  +P++ I      LD++ N LS  LPS    +L  L  L+L+ N +
Sbjct: 17  NKNSVDCSSKKLT-AIPSN-IPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKL 73

Query: 153 VSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSI--GRLNLTQLLLQENKITGS 210
            +          F  L N   LE L +    L   LP  +    +NL +L L  N++  S
Sbjct: 74  QTLPAGI-----FKELKN---LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-S 123

Query: 211 IPPHI-GNLSNLISLNLSSNLLSGTISAEI-SWLSQLEQLFLSHNLFSGEIPAALGKLHH 268
           +PP +  +L+ L  L+L  N L  ++   +   L+ L++L L +N        A  KL  
Sbjct: 124 LPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTE 182

Query: 269 LGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNN 301
           L  L L  N+L      +  +L ++  L L  N
Sbjct: 183 LKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 48/169 (28%), Positives = 72/169 (42%), Gaps = 15/169 (8%)

Query: 11  IPPE-FSKLRRLRHLQLDGNNLHGQIPESL-ALLSNLTLVTLHDNNLTGMLPISFFHNCT 68
           +P + F +L +LR L L+ N L   +P  +   L NL  + + DN L   LPI  F    
Sbjct: 52  LPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLV 109

Query: 69  SLRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLIN--TSMYNLDVEYN 125
           +L  + L +N     +P  +  +   L  LSL  N+L   LP  + +  TS+  L +  N
Sbjct: 110 NLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNN 167

Query: 126 HLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDL 174
            L   +P     KL  L  L L  N +    +       F+SL     L
Sbjct: 168 QLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGA-----FDSLEKLKML 210

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 39/181 (21%), Positives = 83/181 (45%), Gaps = 13/181 (7%)

Query: 272 LDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTL-GRCTDLYKLDLSYNRLTGS 330
           LDL  NKLS     +   L ++  L+LN+N+L +++P  +     +L  L ++ N+L  +
Sbjct: 42  LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQ-A 99

Query: 331 IPAEI-SGIREIRIFLNLSHNQLEGPLPIEL-SKLENVQEIDLSSNKFT---GNIFIQIS 385
           +P  +   +  +   L L  NQL+  LP  +   L  +  + L  N+       +F +++
Sbjct: 100 LPIGVFDQLVNLA-ELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLT 157

Query: 386 NCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSF 445
           +   ++ + + +N L+     +   L  L+ + +  N L  +   + + +  L  + L  
Sbjct: 158 S---LKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQE 214

Query: 446 N 446
           N
Sbjct: 215 N 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 51/192 (26%), Positives = 94/192 (48%), Gaps = 23/192 (11%)

Query: 283 IPVSLGNLVQIYSLFLNNNQLSRSIPP-TLGRCTDLYKLDLSYNRLTGSIPAEI-SGIRE 340
           IP     L       L +N+LS S+P     R T L  L L+ N+L  ++PA I   ++ 
Sbjct: 35  IPADTKKL------DLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86

Query: 341 IRIFLNLSHNQLEGPLPIEL-SKLENVQEIDLSSNKFT---GNIFIQISNCIAVRLINIS 396
           +   L ++ N+L+  LPI +  +L N+ E+ L  N+       +F  ++    +  +++ 
Sbjct: 87  LE-TLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTK---LTYLSLG 141

Query: 397 HNALQGNLPDSLGD-LKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSG 455
           +N LQ +LP  + D L +L+ + +  N L  +   + +K+  L  + L  N+ K  +P  
Sbjct: 142 YNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVP-E 198

Query: 456 GIFNSATKMSFV 467
           G F+S  K+  +
Sbjct: 199 GAFDSLEKLKML 210

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 51.5 bits (124), Expect = 3e-07
 Identities = 28/103 (27%), Positives = 44/103 (42%), Gaps = 5/103 (4%)

Query: 2   LVDNHLFGAIPPE-FSKLRRLRHLQLDGNNLHGQIPESL-ALLSNLTLVTLHDNNLTGML 59
           L  N L  ++PP  F  L +L +L L  N L   +P+ +   L++L  + L++N L   +
Sbjct: 116 LDRNQL-KSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RV 172

Query: 60  PISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNN 102
           P   F   T L+ + L  N           +   L  L L  N
Sbjct: 173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 82.5 bits (204), Expect = 5e-17
 Identities = 46/233 (19%), Positives = 90/233 (38%), Gaps = 47/233 (20%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFN-----RECQVLKRIRHR 613
             LG+G++G V+  +  +    + VK +   ++    + +         E  +L R+ H 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 614 NLMRIITACSLPDFKALVLPYMANGS-LDSHLYPH---SETEFGSGSSDLTLLQRVNICS 669
           N+++++       F  LV+    +G  L + +  H    E                 I  
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL------------ASYIFR 137

Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
            +   + YL       +IH D+K  N+++ +D T  + DFG A   +  G          
Sbjct: 138 QLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAY-LERG---------- 183

Query: 730 NSTANML---CGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTDD 778
                +    CG+I Y APE   G+     + +++S G+ +  +V    P  +
Sbjct: 184 ----KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 82.2 bits (204), Expect = 5e-17
 Identities = 58/242 (23%), Positives = 100/242 (41%), Gaps = 50/242 (20%)

Query: 559 FDEQRLLGTGSYGRVY---KGILQDGTAI-AVKVLQ----LQSGNFTKSFNRECQVLKRI 610
           F+  R+LG G YG+V+   K    +   I A+KVL+    +++   T     E  +L+ +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78

Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI-CS 669
           +H  ++ +I A        L+L Y++ G L   L    E  F        +        +
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL--EREGIF--------MEDTACFYLA 128

Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           +I+  + +LH      +I+ DLKP N++LN      ++DFG+ K  +             
Sbjct: 129 EISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIH-----------D 174

Query: 730 NSTANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGILVLEMVTRRRP-----TDD 778
            +  +  CG+I YMAPE      +          D +S G L+ +M+T   P        
Sbjct: 175 GTVTHTFCGTIEYMAPEILMRSGHNRAV------DWWSLGALMYDMLTGAPPFTGENRKK 228

Query: 779 MF 780
             
Sbjct: 229 TI 230

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 83.6 bits (207), Expect = 5e-17
 Identities = 57/234 (24%), Positives = 102/234 (43%), Gaps = 48/234 (20%)

Query: 556 TAEFDEQRLLGTGSYGRVYKGILQD-GTAIAVK-VLQLQSGNFTKSFNRECQVLKRIRHR 613
              + + +++G GS+G VY+  L D G  +A+K VLQ       +  NRE Q+++++ H 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHC 107

Query: 614 NLMR----IITACSLPDFKAL--VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI 667
           N++R      ++    D   L  VL Y+        +Y  +   +      L ++     
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVAR-HYSRAKQTLPVIYVKLY 161

Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDGAE 726
              +   +AY+H      + H D+KP N+LL+ D   L + DFG AK +          E
Sbjct: 162 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-------VRGE 211

Query: 727 NMGNSTANMLCGSIGYM------APEYGFGSNT-STKGDVYSFGILVLEMVTRR 773
                        + Y+      APE  FG+   ++  DV+S G ++ E++  +
Sbjct: 212 PN-----------VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 84.4 bits (208), Expect = 6e-17
 Identities = 56/315 (17%), Positives = 101/315 (32%), Gaps = 37/315 (11%)

Query: 113 INTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCT 172
           + + M  L +  +     +           +++ L      S +D      F        
Sbjct: 267 VGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSD 326

Query: 173 DLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLS 232
             +E  L          DS     L +  L   K T  +   + +   L  L   +    
Sbjct: 327 SQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCL 385

Query: 233 GTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSF--NKLSGEIPVSLGNL 290
            TI   +  L  L     +   FS      L  +  +    L    +K   E  V     
Sbjct: 386 LTIILLMRALDPLLYEKETLQYFST-----LKAVDPMRAAYLDDLRSKFLLENSVLKMEY 440

Query: 291 VQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHN 350
             +  L L +  L+      L +   +  LDLS+NRL  ++P  ++ +R + + L  S N
Sbjct: 441 ADVRVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEV-LQASDN 496

Query: 351 QLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGD 410
            LE  +   ++ L  +QE+ L +N        ++    A+                 L  
Sbjct: 497 ALEN-VD-GVANLPRLQELLLCNN--------RLQQSAAI---------------QPLVS 531

Query: 411 LKNLEAIDVSGNHLS 425
              L  +++ GN L 
Sbjct: 532 CPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 84.0 bits (207), Expect = 6e-17
 Identities = 49/271 (18%), Positives = 84/271 (30%), Gaps = 19/271 (7%)

Query: 12  PPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLR 71
               S +          N+   Q    +    + +                       L 
Sbjct: 293 RNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLF 352

Query: 72  NVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGEL 131
             +LS    T  +  E+ +C  L  L   N      +        M  LD          
Sbjct: 353 RCELSVEKST-VLQSELESCKELQELEPENKWCLLTI-----ILLMRALDPLLYE----- 401

Query: 132 PSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDS 191
             + +    +L  +       +    +  L+          D+  L LA  DL  T+   
Sbjct: 402 -KETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCH 458

Query: 192 IGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFL 250
           + +L  +T L L  N++  ++PP +  L  L  L  S N L   +   ++ L +L++L L
Sbjct: 459 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLL 515

Query: 251 SHNLFSG-EIPAALGKLHHLGLLDLSFNKLS 280
            +N          L     L LL+L  N L 
Sbjct: 516 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 74.8 bits (183), Expect = 5e-14
 Identities = 53/337 (15%), Positives = 96/337 (28%), Gaps = 47/337 (13%)

Query: 120 LDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGN--CTDLEEL 177
           + V        +       + S     L   +              N   +    DL   
Sbjct: 248 VHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAA 307

Query: 178 ELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISA 237
            L       T        +  +  +                  L    LS    +  + +
Sbjct: 308 SLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQS 366

Query: 238 EISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLS---FNKLSGEIPVSLGNLVQIY 294
           E+    +L++L   +      I   +  L  L     +   F+ L    P+    L  + 
Sbjct: 367 ELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLR 426

Query: 295 SLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIF--LNLSHNQL 352
           S FL  N +            D+  L L++  LT      +  + ++ +   L+LSHN+L
Sbjct: 427 SKFLLENSV------LKMEYADVRVLHLAHKDLT-----VLCHLEQLLLVTHLDLSHNRL 475

Query: 353 EGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLK 412
              LP  L+ L  ++ +  S N                            N+   + +L 
Sbjct: 476 RA-LPPALAALRCLEVLQASDNALE-------------------------NVDG-VANLP 508

Query: 413 NLEAIDVSGNHLSGIIPI-SLNKIHTLTFINLSFNEF 448
            L+ + +  N L     I  L     L  +NL  N  
Sbjct: 509 RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 65.5 bits (159), Expect = 5e-11
 Identities = 22/138 (15%), Positives = 46/138 (33%), Gaps = 5/138 (3%)

Query: 20  RLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNF 79
           R  +L    +    +        +++ ++ L   +LT    +        + ++DLS N 
Sbjct: 418 RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV---LCHLEQLLLVTHLDLSHNR 474

Query: 80  FTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKL 139
               +P  +     L  L   +N L   +        +  L +  N L        +   
Sbjct: 475 LR-ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSC 532

Query: 140 PSLTYLHLSYNNMVSHDD 157
           P L  L+L  N++   + 
Sbjct: 533 PRLVLLNLQGNSLCQEEG 550

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 52.8 bits (126), Expect = 3e-07
 Identities = 36/238 (15%), Positives = 73/238 (30%), Gaps = 25/238 (10%)

Query: 220 NLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKL 279
           +   L++      G       WL  L    L+  L                   L  ++ 
Sbjct: 279 DEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRP 338

Query: 280 SGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIR 339
                 S     Q++   L+  + +  +   L  C +L +L+              +   
Sbjct: 339 ECWCRDS-ATDEQLFRCELSVEKSTV-LQSELESCKELQELEP------------ENKWC 384

Query: 340 EIRIFLNLSHNQLEGPLPIELSKLENVQEID--------LSSNKFTGNIFIQISNCIAVR 391
            + I L +            L     ++ +D           +KF     +       VR
Sbjct: 385 LLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVR 444

Query: 392 LINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFK 449
           +++++H  L   +   L  L  +  +D+S N L  + P +L  +  L  +  S N  +
Sbjct: 445 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALE 499

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 47.4 bits (112), Expect = 2e-05
 Identities = 21/88 (23%), Positives = 34/88 (38%), Gaps = 7/88 (7%)

Query: 11  IPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSL 70
           +PP  + LR L  LQ   N L  +  + +A L  L  + L +N L     I    +C  L
Sbjct: 478 LPPALAALRCLEVLQASDNAL--ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 535

Query: 71  RNVDLSQNFFTGKIPEEIGN----CPNL 94
             ++L  N    +            P++
Sbjct: 536 VLLNLQGNSLC-QEEGIQERLAEMLPSV 562

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 81.9 bits (203), Expect = 6e-17
 Identities = 51/226 (22%), Positives = 81/226 (35%), Gaps = 59/226 (26%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVL------QLQSGNFTKSFNRECQVLKRIRHRNL 615
             LG+G +  V K      G   A K +        + G   +   RE  +LK I+H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76

Query: 616 MRIITACSLPDFKALVLPYMANGSL------DSHLYPHSETEFGSGSSDLTLLQRVNICS 669
           + +           L+L  +A G L         L   +E E                  
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEE------------ATEFLK 121

Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLL---NDDMTAL-VSDFGIAKLVMTVGVGNDGA 725
            I  G+ YLH      + H DLKP N++L   N     + + DFG+A  +       D  
Sbjct: 122 QILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-------DFG 171

Query: 726 ENMGNSTANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGIL 765
               N     + G+  ++APE       G  +      D++S G++
Sbjct: 172 NEFKN-----IFGTPEFVAPEIVNYEPLGLEA------DMWSIGVI 206

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 80.9 bits (200), Expect = 7e-17
 Identities = 28/223 (12%), Positives = 52/223 (23%), Gaps = 68/223 (30%)

Query: 563 RLLGTGSYGRVYKGILQD---GTAIAVKVLQLQSGN---FTKSFNRECQVLKRIRHRNLM 616
              G     + ++    D      +A+  +  Q        +        L RI    + 
Sbjct: 37  IFHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 617 RIITACSLPDFKALVLPYMANGSL----DSHLYPHSETEFGSGSSDLTLLQRVNICSDIA 672
           R++          +V  ++  GSL    D+   P                  +     +A
Sbjct: 95  RVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPV---------------GAIRAMQSLA 139

Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
                 H      V      PS V ++ D        G   L                  
Sbjct: 140 AAADAAHRAG---VALSIDHPSRVRVSID--------GDVVL------------------ 170

Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                     M          + + D+   G  +  ++  R P
Sbjct: 171 -----AYPATMPD-------ANPQDDIRGIGASLYALLVNRWP 201

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 83.2 bits (206), Expect = 9e-17
 Identities = 52/238 (21%), Positives = 87/238 (36%), Gaps = 58/238 (24%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVL-------------QLQSGNFTKSFNRECQVLK 608
           R LG+G+YG V         +  A+KV+                   F +    E  +LK
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 609 RIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHL---YPHSETEFGSGSSDLTLLQRV 665
            + H N++++        +  LV  +   G L   +   +   E +              
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECD------------AA 149

Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGN 722
           NI   I  G+ YLH H    ++H D+KP N+LL   N  +   + DFG++          
Sbjct: 150 NIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK----- 201

Query: 723 DGAENMGNSTANMLCGSIGYMAPE-----YGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                  +       G+  Y+APE     Y        K DV+S G+++  ++    P
Sbjct: 202 -------DYKLRDRLGTAYYIAPEVLKKKYN------EKCDVWSCGVIMYILLCGYPP 246

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 82.1 bits (203), Expect = 1e-16
 Identities = 43/223 (19%), Positives = 87/223 (39%), Gaps = 32/223 (14%)

Query: 559 FDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRIRHRN 614
           F+  +++G G++G V    L++   + A+K+L   ++     T  F  E  VL     + 
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI-CSDIAE 673
           +  +  A    +   LV+ Y   G L + L    E             +      +++  
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKF-EDRL--------PEEMARFYLAEMVI 186

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            +  +H       +H D+KP N+L++ +    ++DFG    +M  G             +
Sbjct: 187 AIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG----------TVQS 233

Query: 734 NMLCGSIGYMAPEYGFGSNTSTKG-----DVYSFGILVLEMVT 771
           ++  G+  Y++PE                D +S G+ + EM+ 
Sbjct: 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 80.8 bits (200), Expect = 2e-16
 Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 43/229 (18%)

Query: 559 FDEQRLLGTGSYGRVY---KGILQDGTAI-AVKVLQ----LQSGNFTKSFNRECQVLKRI 610
           F+  ++LGTG+YG+V+   K    D   + A+KVL+    +Q    T+    E QVL+ I
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115

Query: 611 RHRN-LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI-C 668
           R    L+ +  A        L+L Y+  G L +HL       F            V I  
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS--QRERFT--------EHEVQIYV 165

Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
            +I   + +LH      +I+ D+K  N+LL+ +   +++DFG++K  +            
Sbjct: 166 GEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE--------- 213

Query: 729 GNSTANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGILVLEMVT 771
               A   CG+I YMAP+       G         D +S G+L+ E++T
Sbjct: 214 -TERAYDFCGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLT 257

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 80.0 bits (198), Expect = 3e-16
 Identities = 59/239 (24%), Positives = 98/239 (41%), Gaps = 48/239 (20%)

Query: 559 FDEQRLLGTGSYGRVYKGILQDGTAI-AVKVLQ---LQSGNFTKSFNRECQVLKRIRHRN 614
           FD  +LLG G++G+V     +      A+K+L+   + + +       E +VL+  RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI-CSDIAE 673
           L  +  A    D    V+ Y   G L  HL    E  F          +R     ++I  
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFT--------EERARFYGAEIVS 116

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG-NST 732
            + YLH      V++ D+K  N++L+ D    ++DFG+ K            E +   +T
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK------------EGISDGAT 161

Query: 733 ANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGILVLEMVTRRRP-----TDDMF 780
               CG+  Y+APE      YG         D +  G+++ EM+  R P      + +F
Sbjct: 162 MKTFCGTPEYLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLPFYNQDHERLF 214

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 79.7 bits (197), Expect = 3e-16
 Identities = 49/235 (20%), Positives = 87/235 (37%), Gaps = 51/235 (21%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFN---RECQVLKRIRHR-- 613
            LLG+G +G VY GI + D   +A+K +   ++       +      E  +LK++     
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108

Query: 614 NLMRIITACSLPDFKALVLPYMAN-GSLDSHLYPH---SETE----FGSGSSDLTLLQRV 665
            ++R++     PD   L+L        L   +       E      F          Q  
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW---------Q-- 157

Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGNDG 724
                + E + + H+     V+H D+K  N+L++ +   L + DFG   L          
Sbjct: 158 -----VLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL---------- 199

Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTDD 778
              + ++      G+  Y  PE+            V+S GIL+ +MV    P + 
Sbjct: 200 ---LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 80.4 bits (199), Expect = 3e-16
 Identities = 57/248 (22%), Positives = 94/248 (37%), Gaps = 66/248 (26%)

Query: 554 EATAEFDEQRLLGTGSYGRVYKGILQD-GTAIAVK-VLQLQSGNFTKSF-NRECQVLK-- 608
           +    F  +R+ G G++G V  G  +  G ++A+K V+Q         F NRE Q+++  
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ------DPRFRNRELQIMQDL 73

Query: 609 -RIRHRN---LMRIITACSLPDFK----ALVLPYMANGSLDSHLYPHSETEFGSGSSDLT 660
             + H N   L          D +     +V+ Y+        L+      +        
Sbjct: 74  AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLHRCCRN-YYRRQVAPP 127

Query: 661 LL-------QRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIA 712
            +       Q       +   +  LH  S V V H D+KP NVL+N+    L + DFG A
Sbjct: 128 PILIKVFLFQ-------LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179

Query: 713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYM------APEYGFGSNT-STKGDVYSFGIL 765
           K +         +E             + Y+      APE  FG+   +T  D++S G +
Sbjct: 180 KKL-------SPSEPN-----------VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCI 221

Query: 766 VLEMVTRR 773
             EM+   
Sbjct: 222 FAEMMLGE 229

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 79.9 bits (198), Expect = 3e-16
 Identities = 59/243 (24%), Positives = 104/243 (42%), Gaps = 54/243 (22%)

Query: 559 FDEQRLLGTGSYGRVY---KGILQDGTAI-AVKVLQ----LQSGNF-TKSFNRECQVLKR 609
           F+  ++LG GS+G+V+   K    D   + A+KVL+           TK    E  +L  
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM---ERDILVE 82

Query: 610 IRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI-C 668
           + H  ++++  A        L+L ++  G L + L    E  F          + V    
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS--KEVMF--------TEEDVKFYL 132

Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
           +++A  + +LH      +I+ DLKP N+LL+++    ++DFG++K  +            
Sbjct: 133 AELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID----------- 178

Query: 729 GNSTANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGILVLEMVTRRRP-----TD 777
               A   CG++ YMAPE      +   +      D +SFG+L+ EM+T   P       
Sbjct: 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSA------DWWSFGVLMFEMLTGTLPFQGKDRK 232

Query: 778 DMF 780
           +  
Sbjct: 233 ETM 235

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 79.7 bits (197), Expect = 3e-16
 Identities = 43/211 (20%), Positives = 77/211 (36%), Gaps = 37/211 (17%)

Query: 564 LLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLMRII-- 619
           +LG G  G+V +    + G   A+K+L       +    +E     +     +++ I+  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLL-----YDSPKARQEVDHHWQASGGPHIVCILDV 90

Query: 620 --TACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
                       +++  M  G L S +    +  F       T  +   I  DI   + +
Sbjct: 91  YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF-------TEREAAEIMRDIGTAIQF 143

Query: 678 LHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           LH H+   + H D+KP N+L      D    ++DFG AK                 +   
Sbjct: 144 LHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET-------------TQNALQ 187

Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGIL 765
             C +  Y+APE           D++S G++
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 80.6 bits (199), Expect = 4e-16
 Identities = 52/220 (23%), Positives = 98/220 (44%), Gaps = 26/220 (11%)

Query: 565 LGTGSYGRVYKGILQD---GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRN---LMRI 618
           +G G+YG VYK   +D       A+K  Q++    + S  RE  +L+ ++H N   L ++
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALK--QIEGTGISMSACREIALLRELKHPNVISLQKV 86

Query: 619 ITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYL 678
             + +      L+  Y  +  L   +  H  ++       L      ++   I +G+ YL
Sbjct: 87  FLSHADRKV-WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTAL----VSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           H +    V+H DLKP+N+L+  +        ++D G A+L       N   + + +    
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF------NSPLKPLADLDPV 195

Query: 735 MLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           ++  +  Y APE   G+   TK  D+++ G +  E++T  
Sbjct: 196 VV--TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 79.3 bits (196), Expect = 4e-16
 Identities = 47/237 (19%), Positives = 83/237 (35%), Gaps = 53/237 (22%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFN---RECQVLKRIR---- 611
            LLG G +G V+ G  L D   +A+KV+   ++   +          E  +L ++     
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 612 HRNLMRIITACSLPDFKALVLPYMANGS-LDSHLYPH---SETE----FGSGSSDLTLLQ 663
           H  ++R++      +   LVL        L  ++       E      FG         Q
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFG---------Q 147

Query: 664 RVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGN 722
                  +   + + H      V+H D+K  N+L++       + DFG   L        
Sbjct: 148 -------VVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGAL-------- 189

Query: 723 DGAENMGNSTANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTDD 778
                + +       G+  Y  PE+       +    V+S GIL+ +MV    P + 
Sbjct: 190 -----LHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 80.6 bits (199), Expect = 6e-16
 Identities = 60/284 (21%), Positives = 104/284 (36%), Gaps = 40/284 (14%)

Query: 525 SSGKSETRSKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGI-LQDGTA 583
           S  + + R +  + +   + PR       +    ++ + L+GTGSYG V +     +   
Sbjct: 23  SQQEGQQRKQHHSSKPTASMPR--PHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRV 80

Query: 584 IAVKVLQLQSGN--FTKSFNRECQVLKRIRHRN---LMRIITACSLPDFKA--LVLPYMA 636
           +A+K +     +    K   RE  +L R+ H +   ++ I+    +  F    +VL    
Sbjct: 81  VAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA- 139

Query: 637 NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNV 696
               D      +          LT L    +  ++  G+ Y+H      ++H DLKP+N 
Sbjct: 140 --DSDFKKLFRT-------PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANC 187

Query: 697 LLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIG--------------- 741
           L+N D +  V DFG+A+ V     GN             L                    
Sbjct: 188 LVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTR 247

Query: 742 -YMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAGG 783
            Y APE        T+  DV+S G +  E++   +      A  
Sbjct: 248 WYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR 291

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 78.8 bits (195), Expect = 6e-16
 Identities = 45/221 (20%), Positives = 80/221 (36%), Gaps = 51/221 (23%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVL--QLQSGNFTKSFNRECQVLKRIRHR-NLMRI 618
           + LG G +  V + I    G   A K L  + +  +       E  VL+  +    ++ +
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94

Query: 619 ITACSLPDFKALVLPYMANGSL-----DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
                      L+L Y A G +            SE +             + +   I E
Sbjct: 95  HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND------------VIRLIKQILE 142

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           G+ YLH +    ++H DLKP N+LL          + DFG+++ +         A  +  
Sbjct: 143 GVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-------GHACEL-- 190

Query: 731 STANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGIL 765
                + G+  Y+APE          +      D+++ GI+
Sbjct: 191 ---REIMGTPEYLAPEILNYDPITTAT------DMWNIGII 222

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 78.4 bits (194), Expect = 7e-16
 Identities = 58/235 (24%), Positives = 97/235 (41%), Gaps = 58/235 (24%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFN----RECQVLKRIRHR 613
           ++ +   +G G+YG VYK     G  +A+K ++L      +       RE  +LK + H 
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL--DAEDEGIPSTAIREISLLKELHHP 79

Query: 614 NLMRIITACSLPDFKALVLPYMAN---GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           N++ +I          LV  +M       LD +     +++         L Q       
Sbjct: 80  NIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKI-----YLYQ------- 127

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL-----------VMTVG 719
           +  G+A+ H H   R++H DLKP N+L+N D    ++DFG+A+            V+T  
Sbjct: 128 LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVT-- 182

Query: 720 VGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRR 773
                               + Y AP+   GS   ST  D++S G +  EM+T +
Sbjct: 183 --------------------LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 78.0 bits (193), Expect = 1e-15
 Identities = 59/239 (24%), Positives = 106/239 (44%), Gaps = 51/239 (21%)

Query: 553 LEATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQS--GNFTKSFNRECQVLKR 609
           + ++++F +   LG G+Y  VYKG+    G  +A+K ++L S  G    +  RE  ++K 
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG-TPSTAIREISLMKE 59

Query: 610 IRHRNLMRIITACSLPDFKALVLPYMAN---GSLDSHLYPHSETEFGSGSSDLTLLQRVN 666
           ++H N++R+       +   LV  +M N     +DS    ++              Q   
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ--- 116

Query: 667 ICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL-----------V 715
               + +G+A+ H +   +++H DLKP N+L+N      + DFG+A+            V
Sbjct: 117 ----LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV 169

Query: 716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRR 773
           +T                      + Y AP+   GS T ST  D++S G ++ EM+T +
Sbjct: 170 VT----------------------LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 79.0 bits (195), Expect = 1e-15
 Identities = 43/193 (22%), Positives = 77/193 (39%), Gaps = 36/193 (18%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLMRII- 619
           ++LG G  G+V +    +     A+K+LQ           RE ++  R  +  +++RI+ 
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD 122

Query: 620 ---TACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
                 +      +V+  +  G L S +    +  F       T  +   I   I E + 
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-------TEREASEIMKSIGEAIQ 175

Query: 677 YLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
           YLH  +   + H D+KP N+L      +    ++DFG AK             ++  +T 
Sbjct: 176 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-------TSHNSL--TTP 223

Query: 734 NMLCGSIGYMAPE 746
              C +  Y+APE
Sbjct: 224 ---CYTPYYVAPE 233

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 78.1 bits (193), Expect = 2e-15
 Identities = 62/270 (22%), Positives = 106/270 (39%), Gaps = 60/270 (22%)

Query: 554 EATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQ-LQSGNFTKSFNRECQVLKRIR 611
             +++F  + LLG G+YG V        G  +A+K ++      F     RE ++LK  +
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK 67

Query: 612 HRN---LMRIITACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVN 666
           H N   +  I    S  +F    ++   M             +T       DL  +    
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELM-------------QT-------DLHRVISTQ 107

Query: 667 ICSD---------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT 717
           + SD             +  LH      VIH DLKPSN+L+N +    V DFG+A+++  
Sbjct: 108 MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164

Query: 718 VGVGNDGAENMGNSTANMLCGSIG---YMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
               +    +      + +   +    Y APE    S   ++  DV+S G ++ E+   R
Sbjct: 165 ----SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-R 219

Query: 774 RPTDDMFAGGLSLHKWVKNHYHGRLEKVID 803
           RP   +F G        +++ H +L  +  
Sbjct: 220 RP---IFPG--------RDYRH-QLLLIFG 237

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 77.8 bits (192), Expect = 3e-15
 Identities = 58/246 (23%), Positives = 101/246 (41%), Gaps = 49/246 (19%)

Query: 554 EATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRI 610
               +++  + LG G+YG V+K I  + G  +AVK +    Q+    +   RE  +L  +
Sbjct: 6   HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTEL 65

Query: 611 R-HRNLMRIITACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI 667
             H N++ ++      + +   LV  YM             ET       DL  + R NI
Sbjct: 66  SGHENIVNLLNVLRADNDRDVYLVFDYM-------------ET-------DLHAVIRANI 105

Query: 668 CSD---------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTV 718
                       + + + YLH      ++H D+KPSN+LLN +    V+DFG+++  + +
Sbjct: 106 LEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162

Query: 719 GVGNDGAENMGNSTANMLCGSIGYM----------APEYGFGSNTSTKG-DVYSFGILVL 767
               +      N            +          APE   GS   TKG D++S G ++ 
Sbjct: 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG 222

Query: 768 EMVTRR 773
           E++  +
Sbjct: 223 EILCGK 228

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 77.8 bits (192), Expect = 3e-15
 Identities = 41/229 (17%), Positives = 86/229 (37%), Gaps = 47/229 (20%)

Query: 559 FDEQRLLGTGSYGRVYKGILQDGTAI-AVKVL---QLQSGNFTKSFNRECQVLKRIRHRN 614
           ++  +++G G++G V     +    + A+K+L   ++   + +  F  E  ++       
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD---- 670
           ++++  A     +  +V+ YM  G L                  + L+   ++       
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDL------------------VNLMSNYDVPEKWARF 172

Query: 671 -IAE---GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAE 726
             AE    +  +H       IH D+KP N+LL+      ++DFG    +           
Sbjct: 173 YTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-------- 221

Query: 727 NMGNSTANMLCGSIGYMAPE---YGFGSNTSTKG-DVYSFGILVLEMVT 771
             G    +   G+  Y++PE      G     +  D +S G+ + EM+ 
Sbjct: 222 --GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 77.3 bits (191), Expect = 3e-15
 Identities = 56/242 (23%), Positives = 85/242 (35%), Gaps = 41/242 (16%)

Query: 549 YRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVK--VLQLQSGNFTKSFN----- 601
             EL    + +  QR + +GSYG V  G+  +G  +A+K     +  G      +     
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73

Query: 602 ----RECQVLKRIRHRN---LMRIITACSLPDFKA--LVLPYMANGSLDSHLYPHSETEF 652
               RE ++L    H N   L  I      P      LV   M     D     H     
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT---DLAQVIHD---- 126

Query: 653 GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA 712
                 ++          I  G+  LH      V+H DL P N+LL D+    + DF +A
Sbjct: 127 --QRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLA 181

Query: 713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVT 771
           +        +    N  +   +       Y APE        TK  D++S G ++ EM  
Sbjct: 182 R-------EDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

Query: 772 RR 773
           R+
Sbjct: 230 RK 231

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 76.7 bits (189), Expect = 7e-15
 Identities = 45/249 (18%), Positives = 85/249 (34%), Gaps = 57/249 (22%)

Query: 559 FDEQRLLGTGSYGRVYKGILQDGTAI-AVKVLQ---LQSGNFTKSFNRECQVLKRIRHRN 614
           F+  +++G G++  V    ++    + A+K++    +        F  E  VL     R 
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD---- 670
           + ++  A    ++  LV+ Y   G L                  LTLL +          
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDL------------------LTLLSKFGERIPAEMA 164

Query: 671 ---IAE---GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
              +AE    +  +H       +H D+KP N+LL+      ++DFG    +         
Sbjct: 165 RFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRA------- 214

Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVY-------SFGILVLEMVTRRRP-- 775
               G   + +  G+  Y++PE             Y       + G+   EM   + P  
Sbjct: 215 ---DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY 271

Query: 776 ---TDDMFA 781
              T + + 
Sbjct: 272 ADSTAETYG 280

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 76.2 bits (188), Expect = 8e-15
 Identities = 66/283 (23%), Positives = 109/283 (38%), Gaps = 67/283 (23%)

Query: 541 MHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVK-VLQLQSGNFTK 598
               P +   ++ +    +     +G G+YG V       +   +A+K +   +   + +
Sbjct: 11  AAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ 70

Query: 599 SFNRECQVLKRIRHRN---LMRIITACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFG 653
              RE ++L R RH N   +  II A ++   K   +V   M             ET   
Sbjct: 71  RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-------------ET--- 114

Query: 654 SGSSDLTLLQRVNICSD---------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA 704
               DL  L +    S+         I  G+ Y+H      V+H DLKPSN+LLN     
Sbjct: 115 ----DLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDL 167

Query: 705 LVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIG---YMAPEYGFGSNTSTKG-DVY 760
            + DFG+A++            +  +     L   +    Y APE    S   TK  D++
Sbjct: 168 KICDFGLARVA-----------DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 216

Query: 761 SFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVID 803
           S G ++ EM++  RP   +F G          HY  +L  ++ 
Sbjct: 217 SVGCILAEMLS-NRP---IFPG---------KHYLDQLNHILG 246

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 77.8 bits (191), Expect = 8e-15
 Identities = 60/242 (24%), Positives = 100/242 (41%), Gaps = 53/242 (21%)

Query: 559 FDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRI- 610
           F+   +LG GS+G+V     KG        AVK+L+   +   +  +    E +VL    
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 399

Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           +   L ++ +     D    V+ Y+  G L  H+       F            V   ++
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRF-------KEPHAVFYAAE 450

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG- 729
           IA G+ +L       +I+ DLK  NV+L+ +    ++DFG+ K            EN+  
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK------------ENIWD 495

Query: 730 NSTANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGILVLEMVTRRRP-----TDD 778
             T    CG+  Y+APE      YG         D ++FG+L+ EM+  + P      D+
Sbjct: 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSV------DWWAFGVLLYEMLAGQAPFEGEDEDE 549

Query: 779 MF 780
           +F
Sbjct: 550 LF 551

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 74.9 bits (185), Expect = 9e-15
 Identities = 57/226 (25%), Positives = 91/226 (40%), Gaps = 54/226 (23%)

Query: 565 LGTGSYGRVYKGILQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNLMRIITAC 622
           +G G+YG VYK     G   A+K ++L+  +     +  RE  +LK ++H N++++    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69

Query: 623 SLPDFKALVLPYMAN---GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLH 679
                  LV  ++       LD            S      LLQ       +  G+AY H
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKS-----FLLQ-------LLNGIAYCH 117

Query: 680 HHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL-----------VMTVGVGNDGAENM 728
                RV+H DLKP N+L+N +    ++DFG+A+            ++T           
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT----------- 163

Query: 729 GNSTANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRR 773
                      + Y AP+   GS   ST  D++S G +  EMV   
Sbjct: 164 -----------LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 74.9 bits (185), Expect = 1e-14
 Identities = 53/240 (22%), Positives = 93/240 (38%), Gaps = 57/240 (23%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQS-GNFTKSFN----RECQVLKRIR 611
            ++    +G G+YG VYK      G  +A+K +++ + G           RE  +L+R+ 
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69

Query: 612 ---HRN---LMRIITACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQ 663
              H N   LM +             LV  ++    L ++L         + +    + Q
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 128

Query: 664 RVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK---------- 713
                     G+ +LH +    ++H DLKP N+L+    T  ++DFG+A+          
Sbjct: 129 -------FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178

Query: 714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRR 773
           +V+T                      + Y APE    S  +T  D++S G +  EM  R+
Sbjct: 179 VVVT----------------------LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 75.5 bits (186), Expect = 1e-14
 Identities = 49/232 (21%), Positives = 86/232 (37%), Gaps = 53/232 (22%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           + +G+G++G             +AVK ++  +    ++  RE    + +RH N++R    
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEV 84

Query: 622 CSLPDFKALVLPYMANGSLDSHLYPH---SETE----FGSGSSDLTLLQRVNICSDIAEG 674
              P   A+++ Y + G L   +      SE E    F                  +  G
Sbjct: 85  ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFF----------------QQLLSG 128

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLL--NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           ++Y H     ++ H DLK  N LL  +      + DFG +K  +             +S 
Sbjct: 129 VSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL------------HSQ 173

Query: 733 ANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD 778
                G+  Y+APE      Y          DV+S G+ +  M+    P +D
Sbjct: 174 PKSTVGTPAYIAPEVLLRQEY-----DGKIADVWSCGVTLYVMLVGAYPFED 220

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 75.3 bits (185), Expect = 2e-14
 Identities = 48/189 (25%), Positives = 75/189 (39%), Gaps = 20/189 (10%)

Query: 96  TLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSH 155
            LS    QL   +P S + +    LD+ +N+LS        ++L +L  L LS+N++   
Sbjct: 22  ILSCSKQQLP-NVPQS-LPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFI 79

Query: 156 DDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSI--GRLNLTQLLLQENKITGSIPP 213
                    F  + N   L  L+L+   L  TL + +      L  LLL  N I   +  
Sbjct: 80  SSEA-----FVPVPN---LRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHIV-VVDR 129

Query: 214 HI-GNLSNLISLNLSSNLLSGTISAEI----SWLSQLEQLFLSHNLFSGEIPAALGKLHH 268
           +   +++ L  L LS N +S     E+    + L +L  L LS N         L KL  
Sbjct: 130 NAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPA 188

Query: 269 LGLLDLSFN 277
                L  +
Sbjct: 189 WVKNGLYLH 197

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 74.5 bits (183), Expect = 3e-14
 Identities = 42/161 (26%), Positives = 64/161 (39%), Gaps = 13/161 (8%)

Query: 172 TDLEELELAGMDLGGTLPDSI--GRLNLTQLLLQENKITGSIPPHI-GNLSNLISLNLSS 228
           +    L+L+  +L     +       NL  LLL  N +   I       + NL  L+LSS
Sbjct: 39  SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97

Query: 229 NLLSGTISAEI-SWLSQLEQLFLSHNLFSGEIPA-ALGKLHHLGLLDLSFNKLSGEIP-- 284
           N L  T+   + S L  LE L L +N     +   A   +  L  L LS N++S   P  
Sbjct: 98  NHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVE 154

Query: 285 --VSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLS 323
                  L ++  L L++N+L +     L +     K  L 
Sbjct: 155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 73.3 bits (180), Expect = 6e-14
 Identities = 38/180 (21%), Positives = 68/180 (37%), Gaps = 29/180 (16%)

Query: 272 LDLSFNKLSGEIP--VSLGNLVQIYSLFLNNNQLSRSIPP-TLGRCTDLYKLDLSYNRLT 328
           LDLS N LS  +    +   L  ++SL L++N L+  I         +L  LDLS N L 
Sbjct: 44  LDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH 101

Query: 329 GSIPAEI-SGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNC 387
            ++   + S ++ + + L L +N +          +  +Q++ LS N             
Sbjct: 102 -TLDEFLFSDLQALEV-LLLYNNHIVVVDRNAFEDMAQLQKLYLSQN------------- 146

Query: 388 IAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNE 447
              ++       ++         L  L  +D+S N L  +    L K+       L  + 
Sbjct: 147 ---QISRFPVELIKD-----GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 73.0 bits (179), Expect = 8e-14
 Identities = 40/158 (25%), Positives = 64/158 (40%), Gaps = 13/158 (8%)

Query: 2   LVDNHLFGAIPPE--FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGML 59
           L  N+L   +  E   ++L  L  L L  N+L+    E+   + NL  + L  N+L   L
Sbjct: 46  LSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-TL 103

Query: 60  PISFFHNCTSLRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLIN---- 114
               F +  +L  + L  N     +      +   L  L L  NQ++ + P  LI     
Sbjct: 104 DEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNK 161

Query: 115 -TSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNN 151
              +  LD+  N L  +LP   + KLP+     L  +N
Sbjct: 162 LPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 72.6 bits (178), Expect = 1e-13
 Identities = 39/170 (22%), Positives = 58/170 (34%), Gaps = 16/170 (9%)

Query: 43  SNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYN 101
           S   L+ L  NNL+ +         T+L ++ LS N     I  E     PNL  L L +
Sbjct: 39  SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97

Query: 102 NQLTGQLPASLI--NTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNT 159
           N L   L   L     ++  L +  NH+   +  +    +  L  L+LS N +       
Sbjct: 98  NHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVEL 155

Query: 160 NLVPFFNSLGNCTDLEELELAGMDLGGTLP----DSIGRLNLTQLLLQEN 205
                         L  L+L+   L   LP      +       L L  N
Sbjct: 156 -----IKDGNKLPKLMLLDLSSNKL-KKLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 57.5 bits (139), Expect = 7e-09
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 18/160 (11%)

Query: 299 NNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEI--SGIREIRIFLNLSHNQLEGPL 356
           +  QL  ++P +L   T    LDLS+N L+  + AE   + +  +   L LSHN L   +
Sbjct: 26  SKQQLP-NVPQSLPSYTA--LLDLSHNNLS-RLRAEWTPTRLTNLH-SLLLSHNHLNF-I 79

Query: 357 PIE-LSKLENVQEIDLSSNKFT---GNIFIQISNCIAVRLINISHNALQGNLPDSLGDLK 412
             E    + N++ +DLSSN        +F   S+  A+ ++ + +N +     ++  D+ 
Sbjct: 80  SSEAFVPVPNLRYLDLSSNHLHTLDEFLF---SDLQALEVLLLYNNHIVVVDRNAFEDMA 136

Query: 413 NLEAIDVSGNHLSGIIP---ISLNKIHTLTFINLSFNEFK 449
            L+ + +S N +S          NK+  L  ++LS N+ K
Sbjct: 137 QLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 26/110 (23%), Positives = 42/110 (38%), Gaps = 8/110 (7%)

Query: 2   LVDNHLFGAIPPE-FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLP 60
           L  NHL   +    FS L+ L  L L  N++      +   ++ L  + L  N ++   P
Sbjct: 95  LSSNHL-HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFP 152

Query: 61  ISFFHNC---TSLRNVDLSQNFFTGKIPEEIGNCPNLW--TLSLYNNQLT 105
           +    +      L  +DLS N        ++   P      L L+NN L 
Sbjct: 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 34/151 (22%), Positives = 59/151 (39%), Gaps = 15/151 (9%)

Query: 320 LDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIE--LSKLENVQEIDLSSNKFT 377
           L  S  +L  ++P  +       + L+LSHN L   L  E   ++L N+  + LS N   
Sbjct: 23  LSCSKQQLP-NVPQSLP--SYTAL-LDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLN 77

Query: 378 ---GNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNK 434
                 F        +R +++S N L         DL+ LE + +  NH+  +   +   
Sbjct: 78  FISSEAF---VPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFED 134

Query: 435 IHTLTFINLSFNEFKGMIPSGGIFNSATKMS 465
           +  L  + LS N+     P   +     K+ 
Sbjct: 135 MAQLQKLYLSQNQIS-RFPV-ELIKDGNKLP 163

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 75.4 bits (186), Expect = 2e-14
 Identities = 65/242 (26%), Positives = 101/242 (41%), Gaps = 53/242 (21%)

Query: 559 FDEQRLLGTGSYGRVY----KGILQDGTAIAVKVLQ---LQSGNFTKSFNRECQVL-KRI 610
           F   +++G GS+G+V     K    +    AVKVLQ   +      K    E  VL K +
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV 96

Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI-CS 669
           +H  L+ +  +    D    VL Y+  G L  HL    E  F        L  R     +
Sbjct: 97  KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL--QRERCF--------LEPRARFYAA 146

Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           +IA  + YLH  +   +++ DLKP N+LL+     +++DFG+ K  +             
Sbjct: 147 EIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE-----------H 192

Query: 730 NSTANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGILVLEMVTRRRP-----TDD 778
           NST +  CG+  Y+APE      Y          D +  G ++ EM+    P     T +
Sbjct: 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTV------DWWCLGAVLYEMLYGLPPFYSRNTAE 246

Query: 779 MF 780
           M+
Sbjct: 247 MY 248

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 75.2 bits (185), Expect = 2e-14
 Identities = 47/257 (18%), Positives = 91/257 (35%), Gaps = 68/257 (26%)

Query: 559 FDEQRLLGTGSYGRVYKGILQD-GTAIAVK-VLQLQSGNFTKSFNRECQVLKRIRHRNLM 616
           +   + LGTGS+G V +    + G   A+K VLQ       +  NRE  ++K + H N++
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHVNII 63

Query: 617 RIITA-CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD----- 670
           +++    +  D +        + +              S   + +  + +N+  +     
Sbjct: 64  KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123

Query: 671 --------------------------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA 704
                                     +   + ++H      + H D+KP N+L+N     
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNT 180

Query: 705 L-VSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYM------APEYGFGSNTSTKG 757
           L + DFG AK           +E             + Y+      APE   G+   T  
Sbjct: 181 LKLCDFGSAK-------KLIPSEPS-----------VAYICSRFYRAPELMLGATEYTPS 222

Query: 758 -DVYSFGILVLEMVTRR 773
            D++S G +  E++  +
Sbjct: 223 IDLWSIGCVFGELILGK 239

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 74.6 bits (184), Expect = 3e-14
 Identities = 49/226 (21%), Positives = 96/226 (42%), Gaps = 41/226 (18%)

Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFN----RECQVLKRIRHRN---LM 616
           +G G++G V+K    + G  +A+K + ++  N  + F     RE ++L+ ++H N   L+
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLME--NEKEGFPITALREIKILQLLKHENVVNLI 82

Query: 617 RIITACSLPDFKA-----LVLPYMAN---GSLDSHLYPHSETEFGSGSSDLTLLQRVNIC 668
            I    + P  +      LV  +  +   G L + L   + +E         +       
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR-----VMQM----- 132

Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
             +  G+ Y+H +   +++H D+K +NVL+  D    ++DFG+A+               
Sbjct: 133 --LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA-----FSLAKNSQP 182

Query: 729 GNSTANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRR 773
              T  ++  ++ Y  PE   G        D++  G ++ EM TR 
Sbjct: 183 NRYTNRVV--TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 75.3 bits (185), Expect = 3e-14
 Identities = 59/291 (20%), Positives = 105/291 (36%), Gaps = 44/291 (15%)

Query: 495 FIIFVLVISISAFLSTICLVTGIHRIKLIISSGKSETRSKPITPELMHNFPRITYRELLE 554
            + F+   S       I    G  +   +    K    SK       ++           
Sbjct: 2   SLHFLYYCSEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVE--VGDSTFT 59

Query: 555 ATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRIR 611
               +   + +G+G+ G V           +A+K L    Q+    K   RE  ++K + 
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 119

Query: 612 HRN---LMRIITAC-SLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRV 665
           H+N   L+ + T   +L +F+   LV+  M     +                +L   +  
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQM---------ELDHERMS 167

Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGA 725
            +   +  G+ +LH      +IH DLKPSN+++  D T  + DFG+A+            
Sbjct: 168 YLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------ 212

Query: 726 ENMGNSTANMLCGSIG---YMAPEYGFGSNTSTKGDVYSFGILVLEMVTRR 773
                 T+ M+   +    Y APE   G       D++S G ++ EMV  +
Sbjct: 213 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 74.2 bits (183), Expect = 3e-14
 Identities = 60/236 (25%), Positives = 103/236 (43%), Gaps = 41/236 (17%)

Query: 559 FDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKR-I 610
           F   ++LG GS+G+V    +K         A+K L+   +   +  +    E +VL    
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 75

Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
            H  L  +       +    V+ Y+  G L  H+   S  +F        L +     ++
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKF-------DLSRATFYAAE 126

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM-G 729
           I  G+ +LH      +++ DLK  N+LL+ D    ++DFG+ K            ENM G
Sbjct: 127 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK------------ENMLG 171

Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP-----TDDMF 780
           ++  N  CG+  Y+APE   G   +   D +SFG+L+ EM+  + P      +++F
Sbjct: 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 73.8 bits (182), Expect = 4e-14
 Identities = 51/230 (22%), Positives = 94/230 (40%), Gaps = 58/230 (25%)

Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTK-SFN----RECQVLKRIRHRNLMRI 618
           LG G +  VYK         +A+K ++L   +  K   N    RE ++L+ + H N++ +
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 619 ITACSLPDFKALVLPYMAN---GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           + A       +LV  +M       +  +    + +   +      +L          +G+
Sbjct: 78  LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKA-----YMLM-------TLQGL 125

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK-----------LVMTVGVGNDG 724
            YLH H    ++H DLKP+N+LL+++    ++DFG+AK            V+T       
Sbjct: 126 EYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVT------- 175

Query: 725 AENMGNSTANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRR 773
                            Y APE  FG+       D+++ G ++ E++ R 
Sbjct: 176 ---------------RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 73.0 bits (180), Expect = 5e-14
 Identities = 56/234 (23%), Positives = 91/234 (38%), Gaps = 56/234 (23%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRN 614
            + +   LG G+Y  VYKG        +A+K ++L+   G    +  RE  +LK ++H N
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHAN 61

Query: 615 LMRIITACSLPDFKALVLPYMAN---GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           ++ +           LV  Y+       LD      +            L Q       +
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLF-----LFQ-------L 109

Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL-----------VMTVGV 720
             G+AY H     +V+H DLKP N+L+N+     ++DFG+A+            V+T   
Sbjct: 110 LRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVT--- 163

Query: 721 GNDGAENMGNSTANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRR 773
                              + Y  P+   GS   ST+ D++  G +  EM T R
Sbjct: 164 -------------------LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 73.0 bits (180), Expect = 5e-14
 Identities = 57/238 (23%), Positives = 101/238 (42%), Gaps = 55/238 (23%)

Query: 558 EFDEQRLLGTGSYGRVYKG--ILQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIR-- 611
           +++    +G G+YG+V+K   +   G  +A+K +++Q+G      S  RE  VL+ +   
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71

Query: 612 -HRN---LMRIITACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRV 665
            H N   L  + T           LV  ++ +  L ++L    E    + +    + Q  
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ-- 128

Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK----------LV 715
                +  G+ +LH H   RV+H DLKP N+L+       ++DFG+A+          +V
Sbjct: 129 -----LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 180

Query: 716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRR 773
           +T                      + Y APE    S+ +T  D++S G +  EM  R+
Sbjct: 181 VT----------------------LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 73.0 bits (180), Expect = 6e-14
 Identities = 61/243 (25%), Positives = 97/243 (39%), Gaps = 55/243 (22%)

Query: 559 FDEQRLLGTGSYGRVY----KGILQDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRI- 610
           F+  R+LG GS+G+V     K     G   AVKVL+   +   +  +    E ++L    
Sbjct: 25  FEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR 81

Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI-CS 669
            H  L ++      PD    V+ ++  G L  H+       F           R     +
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFD--------EARARFYAA 131

Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           +I   + +LH      +I+ DLK  NVLL+ +    ++DFG+ K            E + 
Sbjct: 132 EIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK------------EGIC 176

Query: 730 -NSTANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGILVLEMVTRRRP-----TD 777
              T    CG+  Y+APE      YG         D ++ G+L+ EM+    P      D
Sbjct: 177 NGVTTATFCGTPDYIAPEILQEMLYGPAV------DWWAMGVLLYEMLCGHAPFEAENED 230

Query: 778 DMF 780
           D+F
Sbjct: 231 DLF 233

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 72.3 bits (178), Expect = 8e-14
 Identities = 49/265 (18%), Positives = 104/265 (39%), Gaps = 48/265 (18%)

Query: 554 EATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRH 612
           +  + + + + LG G  G V+  +       +A+K + L      K   RE ++++R+ H
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDH 67

Query: 613 RNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD-- 670
            N++++         +              ++      E+    +DL  +       +  
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIV----QEYME--TDLANVLEQGPLLEEH 121

Query: 671 -------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLVMTVGVGN 722
                  +  G+ Y+H      V+H DLKP+N+ +N +   L + DFG+A+++       
Sbjct: 122 ARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIM------- 171

Query: 723 DGAENMGNSTANMLCGSIG---YMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDD 778
               +   S    L   +    Y +P      N  TK  D+++ G +  EM+T  +    
Sbjct: 172 ----DPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT-GKT--- 223

Query: 779 MFAGGLSLHKWVKNHYHGRLEKVID 803
           +FAG          H   +++ +++
Sbjct: 224 LFAG---------AHELEQMQLILE 239

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 72.3 bits (178), Expect = 9e-14
 Identities = 53/265 (20%), Positives = 91/265 (34%), Gaps = 58/265 (21%)

Query: 529 SETRSKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVK 587
             T           +         ++    +     LG G+YG VYK I       +A+K
Sbjct: 9   MGTLEAQTQGPGSMSVSAAPSATSID---RYRRITKLGEGTYGEVYKAIDTVTNETVAIK 65

Query: 588 VLQLQSGN--FTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLY 645
            ++L+        +  RE  +LK ++HRN++ + +         L+  Y      D   Y
Sbjct: 66  RIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA---ENDLKKY 122

Query: 646 PHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL 705
                +         L Q       +  G+ + H     R +H DLKP N+LL+    + 
Sbjct: 123 MDKNPDVSMRVIKSFLYQ-------LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASE 172

Query: 706 -----VSDFGIAKL-----------VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF 749
                + DFG+A+            ++T                      + Y  PE   
Sbjct: 173 TPVLKIGDFGLARAFGIPIRQFTHEIIT----------------------LWYRPPEILL 210

Query: 750 GSNT-STKGDVYSFGILVLEMVTRR 773
           GS   ST  D++S   +  EM+ + 
Sbjct: 211 GSRHYSTSVDIWSIACIWAEMLMKT 235

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 72.8 bits (179), Expect = 9e-14
 Identities = 55/250 (22%), Positives = 98/250 (39%), Gaps = 46/250 (18%)

Query: 554 EATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRI 610
                +   + +G+G+ G V           +A+K L    Q+    K   RE  ++K +
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 81

Query: 611 RHRN---LMRIITAC-SLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
            H+N   L+ + T   SL +F+   +V+  M     +                +L   + 
Sbjct: 82  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM---DANLCQVIQM---------ELDHERM 129

Query: 665 VNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDG 724
             +   +  G+ +LH      +IH DLKPSN+++  D T  + DFG+A+           
Sbjct: 130 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----------- 175

Query: 725 AENMGNSTANMLCGSIG---YMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFA 781
                  T+ M+   +    Y APE   G       D++S G ++ EM+        +F 
Sbjct: 176 ----TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFP 227

Query: 782 GGLSLHKWVK 791
           G   + +W K
Sbjct: 228 GTDHIDQWNK 237

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 72.6 bits (179), Expect = 1e-13
 Identities = 59/243 (24%), Positives = 99/243 (40%), Gaps = 55/243 (22%)

Query: 559 FDEQRLLGTGSYGRV----YKGILQDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRI- 610
           F+   +LG GS+G+V     KG        AVK+L+   +   +  +    E +VL    
Sbjct: 22  FNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 78

Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI-CS 669
           +   L ++ +     D    V+ Y+  G L  H+       F                 +
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFK--------EPHAVFYAA 128

Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM- 728
           +IA G+ +L       +I+ DLK  NV+L+ +    ++DFG+ K            EN+ 
Sbjct: 129 EIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK------------ENIW 173

Query: 729 GNSTANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGILVLEMVTRRRP-----TD 777
              T    CG+  Y+APE      YG         D ++FG+L+ EM+  + P      D
Sbjct: 174 DGVTTKTFCGTPDYIAPEIIAYQPYGKSV------DWWAFGVLLYEMLAGQAPFEGEDED 227

Query: 778 DMF 780
           ++F
Sbjct: 228 ELF 230

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 71.1 bits (175), Expect = 3e-13
 Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 50/233 (21%)

Query: 559 FDEQRLLGTGSYGRVY----KGILQDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRI- 610
           FD  R++G GSY +V     K         A+KV++   +           E  V ++  
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67

Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI-CS 669
            H  L+ + +          V+ Y+  G L  H+    + +           +      +
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKL--------PEEHARFYSA 117

Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM- 728
           +I+  + YLH      +I+ DLK  NVLL+ +    ++D+G+ K            E + 
Sbjct: 118 EISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK------------EGLR 162

Query: 729 GNSTANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              T +  CG+  Y+APE      YGF        D ++ G+L+ EM+  R P
Sbjct: 163 PGDTTSTFCGTPNYIAPEILRGEDYGFSV------DWWALGVLMFEMMAGRSP 209

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 71.6 bits (176), Expect = 3e-13
 Identities = 54/230 (23%), Positives = 95/230 (41%), Gaps = 44/230 (19%)

Query: 559 FDEQRLLGTGSYGRVYKGILQDGTAI-AVKVLQ---LQSGNFTKSFNRECQVLKRI-RHR 613
           FD  R++G GSY +V    L+    I A++V++   +           E  V ++   H 
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113

Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI-CSDIA 672
            L+ + +          V+ Y+  G L  H+    + +           +      ++I+
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLP--------EEHARFYSAEIS 163

Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG-NS 731
             + YLH      +I+ DLK  NVLL+ +    ++D+G+ K            E +    
Sbjct: 164 LALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK------------EGLRPGD 208

Query: 732 TANMLCGSIGYMAPE------YGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
           T +  CG+  Y+APE      YGF        D ++ G+L+ EM+  R P
Sbjct: 209 TTSTFCGTPNYIAPEILRGEDYGFSV------DWWALGVLMFEMMAGRSP 252

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 71.3 bits (175), Expect = 5e-13
 Identities = 55/249 (22%), Positives = 90/249 (36%), Gaps = 33/249 (13%)

Query: 554 EATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRI 610
                +  + L+G GSYG VY          +A+K +    +     K   RE  +L R+
Sbjct: 23  HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL 82

Query: 611 RHRN---LMRIITACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRV 665
           +      L  +I    L  F    +VL    +   D      +          LT     
Sbjct: 83  KSDYIIRLYDLIIPDDLLKFDELYIVLEIADS---DLKKLFKT-------PIFLTEEHIK 132

Query: 666 NICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGA 725
            I  ++  G  ++H      +IH DLKP+N LLN D +  V DFG+A+ + +    N   
Sbjct: 133 TILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189

Query: 726 ENMGNSTANMLCGSIG-----------YMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
           +   N        ++            Y APE        TK  D++S G +  E++   
Sbjct: 190 DLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249

Query: 774 RPTDDMFAG 782
           +   +    
Sbjct: 250 QSHINDPTN 258

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 70.0 bits (172), Expect = 5e-13
 Identities = 35/169 (20%), Positives = 63/169 (37%), Gaps = 38/169 (22%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLMRII- 619
           ++LG G  G+V +    +     A+K+L            RE ++  R  +  +++RI+ 
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVD 78

Query: 620 ---TACSLPDFKALVLPYMANGSL-------DSHLYPHSETEFGSGSSDLTLLQRVNICS 669
                 +      +V+  +  G L           +  +E E               I  
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF--TERE------------ASEIMK 124

Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAKLV 715
            I E + YLH  +   + H D+KP N+L      +    ++DFG AK  
Sbjct: 125 SIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 70.5 bits (173), Expect = 5e-13
 Identities = 61/356 (17%), Positives = 132/356 (37%), Gaps = 54/356 (15%)

Query: 23  HLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLT--GMLPIS--FFHNCTSLRNVDLSQN 78
           + +L  +     + E  ++   +T + L  NNL     + +   F +   S+ +++LS N
Sbjct: 2   NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGN 61

Query: 79  FFTGKIPEEIG-----NCPNLWTLSLYNNQLTGQ----LPASL--INTSMYNLDVEYNHL 127
               K  +E+         N+ +L+L  N L+ +    L  +L  I  ++  LD+ +N  
Sbjct: 62  SLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDF 121

Query: 128 SGE----LPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMD 183
           S +          +   S+T L+L  N++     +  L+    ++     +  L L G +
Sbjct: 122 SSKSSSEFKQAFSNLPASITSLNLRGNDL-GIKSSDELIQILAAI-PAN-VNSLNLRGNN 178

Query: 184 LGGT----LPDSIGRLN--LTQLLLQENKITGSIPPHIG-----NLSNLISLNLSSNLLS 232
           L       L   +  +   +T L L  N +       +        ++++SLNL  N L 
Sbjct: 179 LASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH 238

Query: 233 GT----ISAEISWLSQLEQLFLSHNLFSG-------EIPAALGKLHHLGLLDLSFNKLSG 281
           G     +      L  L+ ++L +++           + AA   +  + L+D +  ++  
Sbjct: 239 GPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298

Query: 282 EIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRC----------TDLYKLDLSYNRL 327
              + + NL++  S   +   L         +            +L +   +   L
Sbjct: 299 SHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 54.7 bits (132), Expect = 5e-08
 Identities = 54/294 (18%), Positives = 97/294 (32%), Gaps = 61/294 (20%)

Query: 196 NLTQLLLQENKITGSIPPHIG-----NLSNLISLNLSSNLLSGTISAEISWL-----SQL 245
            +T L L  N +       +        +++ SLNLS N L    S E+  +     + +
Sbjct: 23  GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82

Query: 246 EQLFLSHNLFSGE----IPAALGKLH-HLGLLDLSFNKLSGEIPVSLGNLVQ-----IYS 295
             L LS N  S +    +   L  +   + +LDL +N  S +               I S
Sbjct: 83  TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITS 142

Query: 296 LFLNNNQLS----RSIPPTLGRC-TDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHN 350
           L L  N L       +   L     ++  L+L  N L            E+  FL     
Sbjct: 143 LNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASK------NCAELAKFLASIPA 196

Query: 351 QLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQIS-----NCIAVRLINISHNALQG--- 402
            +                +DLS+N      + +++         V  +N+  N L G   
Sbjct: 197 SVT--------------SLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSL 242

Query: 403 -NLPDSLGDLKNLEAIDVSGNHLSGIIPI-------SLNKIHTLTFINLSFNEF 448
            NL      LK+L+ + +  + +  +          +   I  +  ++ +  E 
Sbjct: 243 ENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 57/365 (15%), Positives = 112/365 (30%), Gaps = 60/365 (16%)

Query: 99  LYNNQLTGQLPASL-----INTSMYNLDVEYNHLSGELPSDIMSKLP----SLTYLHLSY 149
           +            +     I   + +LD+  N+L      +++        S+T L+LS 
Sbjct: 1   MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60

Query: 150 NNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGT----LPDSIGRLN--LTQLLLQ 203
           N++    ++  LV    +     ++  L L+G  L       L  ++  +   +T L L 
Sbjct: 61  NSL-GFKNSDELVQILAA--IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLG 117

Query: 204 ENKITGSIPPHIGNL-----SNLISLNLSSNLLSGTISAEISWL-----SQLEQLFLSHN 253
            N  +               +++ SLNL  N L    S E+  +     + +  L L  N
Sbjct: 118 WNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGN 177

Query: 254 LFSGE----IPAALGKLH-HLGLLDLSFNKLSGEIPVSLG-----NLVQIYSLFLNNNQL 303
             + +    +   L  +   +  LDLS N L  +    L          + SL L  N L
Sbjct: 178 NLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCL 237

Query: 304 S----RSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIE 359
                 ++         L  + L Y+ +      +   +                     
Sbjct: 238 HGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAA------------------ 279

Query: 360 LSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDV 419
              ++ +  +D +  +   +  I ISN I          +L           +       
Sbjct: 280 FPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLN 339

Query: 420 SGNHL 424
             + L
Sbjct: 340 IPDEL 344

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 52.8 bits (127), Expect = 3e-07
 Identities = 46/296 (15%), Positives = 89/296 (30%), Gaps = 56/296 (18%)

Query: 19  RRLRHLQLDGNNLHGQIPESLA---LLSNLTLVTLH--DNNLT--GMLPIS--FFHNCTS 69
             +  L L GN L  +  + L         T+  L    N+ +          F +   S
Sbjct: 80  ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPAS 139

Query: 70  LRNVDLSQNFFTGKIPEEIG------NCPNLWTLSLYNNQLT----GQLPASL--INTSM 117
           + +++L  N    K  +E+          N+ +L+L  N L      +L   L  I  S+
Sbjct: 140 ITSLNLRGNDLGIKSSDELIQILAAIPA-NVNSLNLRGNNLASKNCAELAKFLASIPASV 198

Query: 118 YNLDVEYNHLSGE----LPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTD 173
            +LD+  N L  +    L     S    +  L+L  N +       +L        +   
Sbjct: 199 TSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCL----HGPSLENLKLLKDSLKH 254

Query: 174 LEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSG 233
           L+ + L    +      ++ +     L                N+  +I ++ +   +  
Sbjct: 255 LQTVYLDYDIVK-----NMSKEQCKALGAA-----------FPNIQKIILVDKNGKEIHP 298

Query: 234 TISAEIS-----WLSQLEQLFLSHNLFS-----GEIPAALGKLHHLGLLDLSFNKL 279
           + S  IS        + +   L +               L     L     +   L
Sbjct: 299 SHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 70.1 bits (172), Expect = 8e-13
 Identities = 54/324 (16%), Positives = 105/324 (32%), Gaps = 71/324 (21%)

Query: 16  SKLRRLRHLQLDGNNLHGQ----IPESLALLSNLTLVTLHDNNL--------TGMLPISF 63
            +   ++ + L GN +  +    + E++A   +L +    D             +  +  
Sbjct: 29  LEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQ 88

Query: 64  -FHNCTSLRNVDLSQNFFTGK----IPEEIGNCPNLWTLSLYNNQLT---GQLPASLINT 115
               C  L  V LS N F       + + +     L  L L+NN L    G   A  +  
Sbjct: 89  ALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQE 148

Query: 116 SMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLE 175
              N   +                P L  +    N +    +N ++  +  +  +   L 
Sbjct: 149 LAVNKKAKNA--------------PPLRSIICGRNRL----ENGSMKEWAKTFQSHRLLH 190

Query: 176 ELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGT- 234
            +++    +        G  +L    L   +              L  L+L  N  +   
Sbjct: 191 TVKMVQNGIR-----PEGIEHLLLEGLAYCQ-------------ELKVLDLQDNTFTHLG 232

Query: 235 ---ISAEISWLSQLEQLFLSHNLFSGE----IPAALGKLHHLGL--LDLSFNKLSGEIPV 285
              ++  +     L +L L+  L S      +  A  KL ++GL  L L +N++  +   
Sbjct: 233 SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVR 292

Query: 286 SLG-----NLVQIYSLFLNNNQLS 304
           +L       +  +  L LN N+ S
Sbjct: 293 TLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 59/350 (16%), Positives = 107/350 (30%), Gaps = 64/350 (18%)

Query: 69  SLRNVDLSQNFFTGK----IPEEIGNCPNLWTLSLYNNQLTGQLPASLI------NTSMY 118
           S+    L  +  T +    +   +    ++  + L  N + G   A  +         + 
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTI-GTEAARWLSENIASKKDLE 63

Query: 119 NLDVEYN---HLSGELPSDIMS------KLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLG 169
             +        +  E+P  +        K P L  + LS N        T   P  + L 
Sbjct: 64  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAF----GPTAQEPLIDFLS 119

Query: 170 NCTDLEELELAGMDLG--------------GTLPDSIGRLNLTQLLLQENKITGSIPPHI 215
             T LE L L    LG                   +     L  ++   N++        
Sbjct: 120 KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 179

Query: 216 G----NLSNLISLNLSSNLL-----SGTISAEISWLSQLEQLFLSHNLFSGE----IPAA 262
                +   L ++ +  N +        +   +++  +L+ L L  N F+      +  A
Sbjct: 180 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239

Query: 263 LGKLHHLGLLDLSFNKLSGE----IPVSLGNLV--QIYSLFLNNNQLSRSIPPTLGR--- 313
           L    +L  L L+   LS      +  +   L    + +L L  N++      TL     
Sbjct: 240 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 299

Query: 314 --CTDLYKLDLSYNRLT--GSIPAEISGIREIRIFLNLSHNQLEGPLPIE 359
               DL  L+L+ NR +    +  EI  +   R    L        L  E
Sbjct: 300 EKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEELTDE 349

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 56/319 (17%), Positives = 105/319 (32%), Gaps = 66/319 (20%)

Query: 192 IGRLNLTQLLLQENKITG----SIPPHIGNLSNLISLNLSSNLLSGT----ISAEISWLS 243
           + R ++    L+ + IT     S+   +    ++  + LS N +       +S  I+   
Sbjct: 1   MARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 60

Query: 244 QLEQLFLSHN---LFSGEIPA-------ALGKLHHLGLLDLSFNKLSGE----IPVSLGN 289
            LE    S         EIP        AL K   L  + LS N         +   L  
Sbjct: 61  DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 120

Query: 290 LVQIYSLFLNNNQLS-------------RSIPPTLGRCTDLYKLDLSYNRLT-------G 329
              +  L+L+NN L               ++         L  +    NRL         
Sbjct: 121 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 180

Query: 330 SIPAEISGIREIRIFLNLSHNQL-----EGPLPIELSKLENVQEIDLSSNKFTGN----I 380
                   +      + +  N +     E  L   L+  + ++ +DL  N FT      +
Sbjct: 181 KTFQSHRLLHT----VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL 236

Query: 381 FIQISNCIAVRLINISHNALQGN----LPDSLGDLKN--LEAIDVSGNHLS--GIIPIS- 431
            I + +   +R + ++   L       + D+   L+N  L+ + +  N +    +  +  
Sbjct: 237 AIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKT 296

Query: 432 --LNKIHTLTFINLSFNEF 448
               K+  L F+ L+ N F
Sbjct: 297 VIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 65.5 bits (160), Expect = 3e-11
 Identities = 55/319 (17%), Positives = 107/319 (33%), Gaps = 57/319 (17%)

Query: 136 MSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL 195
           M++  S+    L  + + + D        F  L     ++E+ L+G  +G      +   
Sbjct: 1   MARF-SIEGKSLKLDAITTED----EKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSEN 55

Query: 196 -----NLTQLLLQENKI----------TGSIPPHIGNLSNLISLNLSSNLLSGT----IS 236
                +L      +                +   +     L ++ LS N    T    + 
Sbjct: 56  IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLI 115

Query: 237 AEISWLSQLEQLFLSHNLFSGE----IPAALGKLH---------HLGLLDLSFNKLSGE- 282
             +S  + LE L+L +N    +    I  AL +L           L  +    N+L    
Sbjct: 116 DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGS 175

Query: 283 ---IPVSLGNLVQIYSLFLNNNQL-----SRSIPPTLGRCTDLYKLDLSYNRLTG----S 330
                 +  +   ++++ +  N +        +   L  C +L  LDL  N  T     +
Sbjct: 176 MKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSA 235

Query: 331 IPAEISGIREIRIFLNLSHNQL--EGPLPI--ELSKLEN--VQEIDLSSNKFTGNIFIQI 384
           +   +     +R  L L+   L   G   +    SKLEN  +Q + L  N+   +    +
Sbjct: 236 LAIALKSWPNLRE-LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTL 294

Query: 385 SNCIAVRLINISHNALQGN 403
              I  ++ ++    L GN
Sbjct: 295 KTVIDEKMPDLLFLELNGN 313

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 52.0 bits (125), Expect = 5e-07
 Identities = 37/258 (14%), Positives = 76/258 (29%), Gaps = 61/258 (23%)

Query: 10  AIPPEFSKLRRLRHLQLDGNNLHGQ----IPESLALLSNLTLVTLHDNN----------- 54
            +     K  +L  ++L  N         + + L+  + L  + LH+N            
Sbjct: 85  LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR 144

Query: 55  -LTGMLPISFFHNCTSLRNVDLSQNFFTGK----IPEEIGNCPNLWTLSLYNNQLTGQLP 109
            L  +       N   LR++   +N           +   +   L T+ +  N +  +  
Sbjct: 145 ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI 204

Query: 110 ASLI------NTSMYNLDVEYNHLSGE----LPSDIMSKLPSLTYLHLSYNNMVSHDDNT 159
             L+         +  LD++ N  +      L +  +   P+L  L L+   +       
Sbjct: 205 EHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL-AIALKSWPNLRELGLNDCLL----SAR 259

Query: 160 NLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIG--- 216
                 ++                           + L  L LQ N+I       +    
Sbjct: 260 GAAAVVDAFSKLE---------------------NIGLQTLRLQYNEIELDAVRTLKTVI 298

Query: 217 --NLSNLISLNLSSNLLS 232
              + +L+ L L+ N  S
Sbjct: 299 DEKMPDLLFLELNGNRFS 316

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 69.7 bits (171), Expect = 1e-12
 Identities = 62/242 (25%), Positives = 98/242 (40%), Gaps = 62/242 (25%)

Query: 554 EATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQL--QSGNFTKSFNRECQVLKRI 610
           E    +     +G+G+YG V      + G  +AVK L    QS    K   RE ++LK +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85

Query: 611 RHRN---LMRIITA-CSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           +H N   L+ + T   SL +F    LV   M                     +DL  + +
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--------------------GADLNNIVK 125

Query: 665 VNICSD---------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
               +D         I  G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A+  
Sbjct: 126 CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-- 180

Query: 716 MTVGVGNDGAENMGNSTANMLCGSIG---YMAPEYGFGSNTSTKG-DVYSFGILVLEMVT 771
                           TA+ + G +    Y APE         +  D++S G ++ E++T
Sbjct: 181 ---------------HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

Query: 772 RR 773
            R
Sbjct: 226 GR 227

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 68.4 bits (168), Expect = 2e-12
 Identities = 46/240 (19%), Positives = 89/240 (37%), Gaps = 49/240 (20%)

Query: 554 EATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIR- 611
               ++   R LG G Y  V++ I + +   + VK+L+       K   RE ++L+ +R 
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRG 89

Query: 612 HRNLMRII-TACSLPDFK-ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS 669
             N++ +            ALV  ++ N          ++ +         + +      
Sbjct: 90  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-----YMYE------ 138

Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL-VSDFGIAKLV-----MTVGVGND 723
            I + + Y H      ++H D+KP NV+++ +   L + D+G+A+         V V   
Sbjct: 139 -ILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--- 191

Query: 724 GAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRRRPTDDMFAG 782
                          S  +  PE            D++S G ++  M+ R+ P    F G
Sbjct: 192 --------------ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHG 234

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 51/172 (29%), Positives = 75/172 (43%), Gaps = 28/172 (16%)

Query: 13  PEFSKLRRLRHLQLDGNNLHGQIPESLAL---LSNLTLVTLHDNNLTGMLPISFFHNCTS 69
                L  +R+L L GN L       ++    L+NLT + L  N L   LP   F   T+
Sbjct: 57  QGIQYLPNVRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQS-LPNGVFDKLTN 110

Query: 70  LRNVDLSQNFFTGKIPEEIGNCP-NLWTLSLYNNQLTGQLPA----SLINTSMYNLDVEY 124
           L+ + L +N     +P+ + +   NL  L+L +NQL   LP      L  T++  LD+ Y
Sbjct: 111 LKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKL--TNLTELDLSY 166

Query: 125 NHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVP--FFNSLGNCTDL 174
           N L   LP  +  KL  L  L L  N + S       VP   F+ L +   +
Sbjct: 167 NQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-------VPDGVFDRLTSLQYI 210

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 51/193 (26%), Positives = 80/193 (41%), Gaps = 28/193 (14%)

Query: 46  TLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLT 105
               L   ++T        +   S+  +  + +         I   PN+  L+L  N+L 
Sbjct: 22  IKANLKKKSVTD---AVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKLH 76

Query: 106 GQLPA--SLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVP 163
             + A   L N +   L +  N L   LP+ +  KL +L  L L  N + S       +P
Sbjct: 77  -DISALKELTNLT--YLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQS-------LP 125

Query: 164 --FFNSLGNCTDLEELELAGMDLGGTLPDSI-GRL-NLTQLLLQENKITGSIPPHI-GNL 218
              F+ L   T+L  L LA   L  +LP  +  +L NLT+L L  N++  S+P  +   L
Sbjct: 126 DGVFDKL---TNLTYLNLAHNQL-QSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKL 180

Query: 219 SNLISLNLSSNLL 231
           + L  L L  N L
Sbjct: 181 TQLKDLRLYQNQL 193

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 51/190 (26%), Positives = 75/190 (39%), Gaps = 24/190 (12%)

Query: 172 TDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLL 231
            +  +  L    +           ++ Q++   + I  S+   I  L N+  L L  N L
Sbjct: 19  AETIKANLKKKSVT-DAVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKL 75

Query: 232 SGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLV 291
              ISA    L+ L  L L+ N           KL +L  L L  N+L          L 
Sbjct: 76  H-DISALKE-LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLT 133

Query: 292 QIYSLFLNNNQLSRSIPPTL-GRCTDLYKLDLSYNRLTGSIPAEISGIREIRIF------ 344
            +  L L +NQL  S+P  +  + T+L +LDLSYN+L  S+P          +F      
Sbjct: 134 NLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPE--------GVFDKLTQL 183

Query: 345 --LNLSHNQL 352
             L L  NQL
Sbjct: 184 KDLRLYQNQL 193

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 41/140 (29%), Positives = 64/140 (45%), Gaps = 8/140 (5%)

Query: 15  FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVD 74
             +L  L +L L GN L          L+NL  + L +N L   LP   F   T+L  ++
Sbjct: 81  LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLN 139

Query: 75  LSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLIN--TSMYNLDVEYNHLSGEL 131
           L+ N     +P+ +     NL  L L  NQL   LP  + +  T + +L +  N L   +
Sbjct: 140 LAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-V 196

Query: 132 PSDIMSKLPSLTYLHLSYNN 151
           P  +  +L SL Y+ L ++N
Sbjct: 197 PDGVFDRLTSLQYIWL-HDN 215

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 37/146 (25%), Positives = 58/146 (39%), Gaps = 14/146 (9%)

Query: 113 INTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCT 172
           +  ++  + +E N +   +P    S    L  + LS N +     +      F  L +  
Sbjct: 30  LPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDA-----FQGLRS-- 81

Query: 173 DLEELELAGMDLGGTLPDSI-GRL-NLTQLLLQENKITGSIPPHI-GNLSNLISLNLSSN 229
            L  L L G  +   LP S+   L +L  LLL  NKI   +      +L NL  L+L  N
Sbjct: 82  -LNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDN 138

Query: 230 LLSGTISAEISWLSQLEQLFLSHNLF 255
            L        S L  ++ + L+ N F
Sbjct: 139 KLQTIAKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 38/152 (25%), Positives = 61/152 (40%), Gaps = 30/152 (19%)

Query: 2   LVDNHLFGAIPPE-FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLP 60
           L  N +   IPP  FS  ++LR + L  N +    P++   L +L  + L+ N +T  LP
Sbjct: 39  LEQNTI-KVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE-LP 96

Query: 61  ISFFHNCTSLRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLINTSMYN 119
            S F    SL+ + L+ N     +  +   +  NL  LSLY+N+L               
Sbjct: 97  KSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-------------- 141

Query: 120 LDVEYNHLSGELPSDIMSKLPSLTYLHLSYNN 151
                      +     S L ++  +HL   N
Sbjct: 142 ----------TIAKGTFSPLRAIQTMHL-AQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 29/135 (21%), Positives = 54/135 (40%), Gaps = 12/135 (8%)

Query: 272 LDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPP-TLGRCTDLYKLDLSYNRLTGS 330
           + L  N +    P +     ++  + L+NNQ+   + P        L  L L  N++T  
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKIT-E 94

Query: 331 IPAEI-SGIREIRIFLNLSHNQLEGPLPIEL-SKLENVQEIDLSSNKFTGNIFIQISNCI 388
           +P  +  G+  +++ L L+ N++   L ++    L N+  + L  NK        I+   
Sbjct: 95  LPKSLFEGLFSLQL-LLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQ-----TIAKGT 147

Query: 389 AVRLINISHNALQGN 403
              L  I    L  N
Sbjct: 148 FSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 38/189 (20%), Positives = 63/189 (33%), Gaps = 60/189 (31%)

Query: 43  SNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYN 101
             +T + L  N +   +P   F     LR +DLS N  + ++  +      +L +L LY 
Sbjct: 32  ETITEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYG 89

Query: 102 NQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNL 161
           N++T                        ELP  +   L SL  L L+ N +     +   
Sbjct: 90  NKIT------------------------ELPKSLFEGLFSLQLLLLNANKINCLRVDA-- 123

Query: 162 VPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHI-GNLSN 220
              F  L                           NL  L L +NK+  +I       L  
Sbjct: 124 ---FQDLH--------------------------NLNLLSLYDNKLQ-TIAKGTFSPLRA 153

Query: 221 LISLNLSSN 229
           + +++L+ N
Sbjct: 154 IQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 49.6 bits (119), Expect = 8e-07
 Identities = 33/154 (21%), Positives = 62/154 (40%), Gaps = 31/154 (20%)

Query: 296 LFLNNNQLSRSIPPT-LGRCTDLYKLDLSYNRLTGSIPAEI-SGIREIRIFLNLSHNQLE 353
           + L  N +   IPP        L ++DLS N+++  +  +   G+R +   L L  N++ 
Sbjct: 37  IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLN-SLVLYGNKIT 93

Query: 354 GPLPIEL-SKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLK 412
             LP  L   L ++Q + L++NK                        +     D+  DL 
Sbjct: 94  E-LPKSLFEGLFSLQLLLLNANK------------------------INCLRVDAFQDLH 128

Query: 413 NLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFN 446
           NL  + +  N L  I   + + +  +  ++L+ N
Sbjct: 129 NLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 31/162 (19%), Positives = 64/162 (39%), Gaps = 33/162 (20%)

Query: 306 SIPPTLGRCTDLYKLDLSYNRLTGSIPAEI-SGIREIRIFLNLSHNQLEGPLPIEL-SKL 363
            IP  L     + ++ L  N +   IP    S  +++R  ++LS+NQ+   L  +    L
Sbjct: 25  EIPTNLP--ETITEIRLEQNTIK-VIPPGAFSPYKKLR-RIDLSNNQISE-LAPDAFQGL 79

Query: 364 ENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNH 423
            ++  + L  NK T                      L  +L + L  L+ L    ++ N 
Sbjct: 80  RSLNSLVLYGNKIT---------------------ELPKSLFEGLFSLQLL---LLNANK 115

Query: 424 LSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMS 465
           ++ +   +   +H L  ++L  N+ + +  + G F+    + 
Sbjct: 116 INCLRVDAFQDLHNLNLLSLYDNKLQTI--AKGTFSPLRAIQ 155

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 68.1 bits (167), Expect = 3e-12
 Identities = 62/242 (25%), Positives = 104/242 (42%), Gaps = 62/242 (25%)

Query: 554 EATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRI 610
           E  A + + + +G+G+YG V   +  + G  +A+K L    QS  F K   RE ++LK +
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 81

Query: 611 RHRN---LMRIITAC-SLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           RH N   L+ + T   +L DF    LV+P+M                     +DL  L +
Sbjct: 82  RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--------------------GTDLGKLMK 121

Query: 665 VNICSD---------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
                +         + +G+ Y+H      +IH DLKP N+ +N+D    + DFG+A+  
Sbjct: 122 HEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-- 176

Query: 716 MTVGVGNDGAENMGNSTANMLCGSIG---YMAPEYGFGSNTSTKG-DVYSFGILVLEMVT 771
                             + + G +    Y APE        T+  D++S G ++ EM+T
Sbjct: 177 ---------------QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 221

Query: 772 RR 773
            +
Sbjct: 222 GK 223

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 67.2 bits (165), Expect = 4e-12
 Identities = 54/224 (24%), Positives = 80/224 (35%), Gaps = 49/224 (21%)

Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNLMRIITA 621
           +G GSYG V K      G  +A+K       +    K   RE ++LK++RH NL+ ++  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
           C       LV  ++     D  +    E       + L           I  G+ + H H
Sbjct: 93  CKKKKRWYLVFEFV-----DHTILDDLE----LFPNGLDYQVVQKYLFQIINGIGFCHSH 143

Query: 682 SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL-----------VMTVGVGNDGAENMGN 730
               +IH D+KP N+L++      + DFG A+            V T             
Sbjct: 144 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVAT------------- 187

Query: 731 STANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRR 773
                      Y APE   G        DV++ G LV EM    
Sbjct: 188 ---------RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 67.3 bits (165), Expect = 5e-12
 Identities = 58/238 (24%), Positives = 96/238 (40%), Gaps = 55/238 (23%)

Query: 554 EATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQ--LQSGNFTKSFNRECQVLKRI 610
           E    +     +G+G+YG V   I  + G  +A+K L    QS  F K   RE  +LK +
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 80

Query: 611 RHRNLMRI----ITACSLPDFKA--LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQR 664
           +H N++ +      A SL +F    LV+P+M                     +DL  +  
Sbjct: 81  QHENVIGLLDVFTPASSLRNFYDFYLVMPFM--------------------QTDLQKIMG 120

Query: 665 VNICSD--------IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM 716
           +    +        + +G+ Y+H      V+H DLKP N+ +N+D    + DFG+A+   
Sbjct: 121 LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHA- 176

Query: 717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG-DVYSFGILVLEMVTRR 773
                      M             Y APE         +  D++S G ++ EM+T +
Sbjct: 177 --------DAEMTGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 65.9 bits (161), Expect = 6e-12
 Identities = 40/154 (25%), Positives = 60/154 (38%), Gaps = 12/154 (7%)

Query: 24  LQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGK 83
           L L    L      +   L+ LT + L  N L   L    F + T L  + L+ N     
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA-S 97

Query: 84  IPEEI-GNCPNLWTLSLYNNQLTGQLPASLIN--TSMYNLDVEYNHLSGELPSDIMSKLP 140
           +P  +  +   L  L L  NQL   LP+ + +  T +  L +  N L   +P+    KL 
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLT 155

Query: 141 SLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDL 174
           +L  L LS N + S          F+ LG    +
Sbjct: 156 NLQTLSLSTNQLQSVPHGA-----FDRLGKLQTI 184

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 44/138 (31%), Positives = 64/138 (46%), Gaps = 7/138 (5%)

Query: 198 TQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEI-SWLSQLEQLFLSHNLFS 256
            +L LQ   +          L+ L  LNL  N L  T+SA +   L++L  L L++N  +
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96

Query: 257 GEIPAALGKLHHLGLLDLSFNKLSGEIPVSL-GNLVQIYSLFLNNNQLSRSIPP-TLGRC 314
                    L  L  L L  N+L   +P  +   L ++  L LN NQL +SIP     + 
Sbjct: 97  SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKL 154

Query: 315 TDLYKLDLSYNRLTGSIP 332
           T+L  L LS N+L  S+P
Sbjct: 155 TNLQTLSLSTNQLQ-SVP 171

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 44/169 (26%), Positives = 65/169 (38%), Gaps = 21/169 (12%)

Query: 68  TSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN--TSMYNLDVEYN 125
                +DL                  L  L+L  NQL   L A + +  T +  L +  N
Sbjct: 35  ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANN 93

Query: 126 HLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVP--FFNSLGNCTDLEELELAGMD 183
            L+  LP  +   L  L  L+L  N + S       +P   F+ L   T L+EL L    
Sbjct: 94  QLA-SLPLGVFDHLTQLDKLYLGGNQLKS-------LPSGVFDRL---TKLKELRLNTNQ 142

Query: 184 LGGTLPDSI-GRL-NLTQLLLQENKITGSIPPHI-GNLSNLISLNLSSN 229
           L  ++P     +L NL  L L  N++  S+P      L  L ++ L  N
Sbjct: 143 L-QSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 53.5 bits (129), Expect = 8e-08
 Identities = 48/193 (24%), Positives = 75/193 (38%), Gaps = 38/193 (19%)

Query: 113 INTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCT 172
           I      LD++   L+  L       L  LT+L+L YN + +          F+ L   T
Sbjct: 33  IPADTEKLDLQSTGLA-TLSDATFRGLTKLTWLNLDYNQLQTLSAGV-----FDDL---T 83

Query: 173 DLEELELAGMDLGGTLPDSI-GRL-NLTQLLLQENKITGSIPPHI-GNLSNLISLNLSSN 229
           +L  L LA   L  +LP  +   L  L +L L  N++  S+P  +   L+ L  L L++N
Sbjct: 84  ELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTN 141

Query: 230 LLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGN 289
            L                  +    F         KL +L  L LS N+L      +   
Sbjct: 142 QLQS----------------IPAGAFD--------KLTNLQTLSLSTNQLQSVPHGAFDR 177

Query: 290 LVQIYSLFLNNNQ 302
           L ++ ++ L  NQ
Sbjct: 178 LGKLQTITLFGNQ 190

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 50.8 bits (122), Expect = 6e-07
 Identities = 42/186 (22%), Positives = 73/186 (39%), Gaps = 47/186 (25%)

Query: 272 LDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPP-TLGRCTDLYKLDLSYNRLTGS 330
           LDL    L+     +   L ++  L L+ NQL  ++        T+L  L L+ N+L  S
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-S 97

Query: 331 IPAEISGIREIRIF--------LNLSHNQLEGPLPIEL-SKLENVQEIDLSSNKFTGNIF 381
           +P          +F        L L  NQL+  LP  +  +L  ++E+ L++N+      
Sbjct: 98  LPL--------GVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ---- 144

Query: 382 IQISNCIAVRLINISHNALQGNLPDSLGD-LKNLEAIDVSGNHLSGIIPISLNKIHTLTF 440
                                ++P    D L NL+ + +S N L  +   + +++  L  
Sbjct: 145 ---------------------SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQT 183

Query: 441 INLSFN 446
           I L  N
Sbjct: 184 ITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 36/139 (25%), Positives = 47/139 (33%), Gaps = 30/139 (21%)

Query: 15  FSKLRRLRHLQLDGNNLHGQIPESL-ALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNV 73
           F  L  L  L L  N L   +P  +   L+ L  + L  N L   LP   F   T L+ +
Sbjct: 79  FDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKEL 136

Query: 74  DLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELP 132
            L+ N     IP        NL TLSL  NQL                          +P
Sbjct: 137 RLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQS------------------------VP 171

Query: 133 SDIMSKLPSLTYLHLSYNN 151
                +L  L  + L + N
Sbjct: 172 HGAFDRLGKLQTITL-FGN 189

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 66.8 bits (164), Expect = 6e-12
 Identities = 48/222 (21%), Positives = 79/222 (35%), Gaps = 45/222 (20%)

Query: 565 LGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNLMRIITA 621
           +G GSYG V+K      G  +A+K       +    K   RE ++LK+++H NL+ ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLT---LLQRVNICSDIAEGMAYL 678
                   LV  Y      D  +    +         L      Q         + + + 
Sbjct: 71  FRRKRRLHLVFEYC-----DHTVLHELDRYQRGVPEHLVKSITWQ-------TLQAVNFC 118

Query: 679 HHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL------VMTVGVGNDGAENMGNST 732
           H H     IH D+KP N+L+       + DFG A+L           V          +T
Sbjct: 119 HKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV----------AT 165

Query: 733 ANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRR 773
                    Y +PE   G        DV++ G +  E+++  
Sbjct: 166 -------RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 26/135 (19%), Positives = 51/135 (37%), Gaps = 11/135 (8%)

Query: 43  SNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYN 101
                + L++N  T +     F     LR ++ S N  T  I E        +  + L +
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTS 90

Query: 102 NQLTGQLPASLIN--TSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNT 159
           N+L   +   +     S+  L +  N ++  + +D    L S+  L L  N + +     
Sbjct: 91  NRLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGA 148

Query: 160 NLVPFFNSLGNCTDL 174
                F++L + + L
Sbjct: 149 -----FDTLHSLSTL 158

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 25/119 (21%), Positives = 46/119 (38%), Gaps = 10/119 (8%)

Query: 196 NLTQLLLQENKITGSIPPHIG--NLSNLISLNLSSNLLSGTISAEI-SWLSQLEQLFLSH 252
              +L L  N+ T  +        L  L  +N S+N ++  I        S + ++ L+ 
Sbjct: 33  YTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTS 90

Query: 253 NLFSGEIPA-ALGKLHHLGLLDLSFNKLSGEIPV-SLGNLVQIYSLFLNNNQLSRSIPP 309
           N     +       L  L  L L  N+++  +   S   L  +  L L +NQ+  ++ P
Sbjct: 91  NRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI-TTVAP 146

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 31/153 (20%), Positives = 51/153 (33%), Gaps = 31/153 (20%)

Query: 2   LVDNHLFGAIPPE--FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGML 59
           L +N     +     F KL +LR +    N +      +    S +  + L  N L   +
Sbjct: 39  LNNNEF-TVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN-V 96

Query: 60  PISFFHNCTSLRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLINTSMY 118
               F    SL+ + L  N  T  +  +      ++  LSLY+NQ+T             
Sbjct: 97  QHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT------------- 142

Query: 119 NLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNN 151
                       +       L SL+ L+L   N
Sbjct: 143 -----------TVAPGAFDTLHSLSTLNL-LAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 33/147 (22%), Positives = 57/147 (38%), Gaps = 15/147 (10%)

Query: 113 INTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCT 172
           I      L +  N  +    + I  KLP L  ++ S N +   ++       F       
Sbjct: 30  IPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGA-----FEGASG-- 82

Query: 173 DLEELELAGMDLGGTLPDSI--GRLNLTQLLLQENKITGSIPPHI-GNLSNLISLNLSSN 229
            + E+ L    L   +   +  G  +L  L+L+ N+IT  +       LS++  L+L  N
Sbjct: 83  -VNEILLTSNRL-ENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDN 139

Query: 230 LLSGTISAEI-SWLSQLEQLFLSHNLF 255
            ++ T++      L  L  L L  N F
Sbjct: 140 QIT-TVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 22/105 (20%), Positives = 37/105 (35%), Gaps = 5/105 (4%)

Query: 2   LVDNHLFGAIPPE-FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLP 60
             +N +   I    F     +  + L  N L     +    L +L  + L  N +T  + 
Sbjct: 64  FSNNKI-TDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVG 121

Query: 61  ISFFHNCTSLRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQL 104
              F   +S+R + L  N  T  +         +L TL+L  N  
Sbjct: 122 NDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 47.0 bits (112), Expect = 7e-06
 Identities = 28/145 (19%), Positives = 61/145 (42%), Gaps = 10/145 (6%)

Query: 306 SIPPTLGRCTDLYKLDLSYNRLTGSIP-AEISGIREIRIFLNLSHNQLEGPLPIELSKLE 364
            IP  +       +L L+ N  T          + ++R  +N S+N++            
Sbjct: 25  KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLR-KINFSNNKITDIEEGAFEGAS 81

Query: 365 NVQEIDLSSNKFT---GNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSG 421
            V EI L+SN+       +F  + +   ++ + +  N +     DS   L ++  + +  
Sbjct: 82  GVNEILLTSNRLENVQHKMFKGLES---LKTLMLRSNRITCVGNDSFIGLSSVRLLSLYD 138

Query: 422 NHLSGIIPISLNKIHTLTFINLSFN 446
           N ++ + P + + +H+L+ +NL  N
Sbjct: 139 NQITTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 22/79 (27%), Positives = 37/79 (46%), Gaps = 3/79 (3%)

Query: 1   MLVDNHLFGAIPPE-FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGML 59
           +L  N L   +  + F  L  L+ L L  N +     +S   LS++ L++L+DN +T  +
Sbjct: 87  LLTSNRL-ENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITT-V 144

Query: 60  PISFFHNCTSLRNVDLSQN 78
               F    SL  ++L  N
Sbjct: 145 APGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 32/150 (21%), Positives = 64/150 (42%), Gaps = 15/150 (10%)

Query: 321 DLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEG-PLPIELSKLENVQEIDLSSNKFTG- 378
           D S  +L   IP  I         L L++N+           KL  +++I+ S+NK T  
Sbjct: 17  DCSNQKLN-KIPEHIPQYTAE---LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDI 72

Query: 379 --NIFIQISNCIAVRLINISHNALQGNLPDSLGD-LKNLEAIDVSGNHLSGIIPISLNKI 435
               F   S    V  I ++ N L+ N+   +   L++L+ + +  N ++ +   S   +
Sbjct: 73  EEGAFEGASG---VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGL 128

Query: 436 HTLTFINLSFNEFKGMIPSGGIFNSATKMS 465
            ++  ++L  N+    +   G F++   +S
Sbjct: 129 SSVRLLSLYDNQITT-VAP-GAFDTLHSLS 156

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 65.3 bits (159), Expect = 5e-11
 Identities = 58/368 (15%), Positives = 118/368 (32%), Gaps = 56/368 (15%)

Query: 16  SKLRRLRHLQLDGNNLHGQIPESLALLSNL--TLVTL----HDNNLTGMLPISFFHNCTS 69
           +  R L+ L L  +++       L+   +   +LV+L      + ++          C +
Sbjct: 153 ATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPN 212

Query: 70  LRNVDLSQNFFTGKIPEEIGNCPNLWTLSL--YNNQLTGQLPASLIN-----TSMYNLDV 122
           L+++ L++     K+   +   P L  L    Y  ++   + + L         +  L  
Sbjct: 213 LKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSG 272

Query: 123 EYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHD-----------------DNTNLVPFF 165
            ++ +   LP+ + S    LT L+LSY  + S+D                 D        
Sbjct: 273 FWDAVPAYLPA-VYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLE 331

Query: 166 NSLGNCTDLEELELAGMDLGGTLPD-----------SIGRLNLTQLLLQENKITGSIPPH 214
                C DL EL +   +     P+           S+G   L  +L    ++T +    
Sbjct: 332 VLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALIT 391

Query: 215 IG-NLSNLISLNLSS-----------NLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAA 262
           I  N  N+    L               L     A +     L +L LS  L        
Sbjct: 392 IARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYI 451

Query: 263 LGKLHHLGLLDLSFNKLSGEIPVSLG-NLVQIYSLFLNNNQLS-RSIPPTLGRCTDLYKL 320
                 + +L ++F   S      +      +  L + +     +++     +   +  L
Sbjct: 452 GTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSL 511

Query: 321 DLSYNRLT 328
            +S   ++
Sbjct: 512 WMSSCSVS 519

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 62.6 bits (152), Expect = 3e-10
 Identities = 45/269 (16%), Positives = 90/269 (33%), Gaps = 19/269 (7%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
            V   ++  +    S  + LR L    + +   +P   ++ S LT + L    +     +
Sbjct: 248 EVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLV 307

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLP------ASLINT 115
                C  L+ + +        +      C +L  L ++ ++     P        L++ 
Sbjct: 308 KLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSV 367

Query: 116 SMYNLDVEYNHLSGELPSD-----IMSKLPSLTYLHLSYNNMVSHDDNTNLVP---FFNS 167
           SM    +E         ++     I    P++T   L      + D  T       F   
Sbjct: 368 SMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAI 427

Query: 168 LGNCTDLEELELAGMDLGGTLPDSIGRL--NLTQLLLQENKITGSIPPHIG-NLSNLISL 224
           + +C DL  L L+G+ L   + + IG     +  L +     +     H+     +L  L
Sbjct: 428 VEHCKDLRRLSLSGL-LTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKL 486

Query: 225 NLSS-NLLSGTISAEISWLSQLEQLFLSH 252
            +         + A  S L  +  L++S 
Sbjct: 487 EIRDCPFGDKALLANASKLETMRSLWMSS 515

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 57.6 bits (139), Expect = 1e-08
 Identities = 62/469 (13%), Positives = 141/469 (30%), Gaps = 66/469 (14%)

Query: 15  FSKLRRLRHLQLDGNNLHGQIPESLALLS----NLTLVTLHDNNLTGMLPISFFHNCTSL 70
                      L  +   G +   +  +S     L  + L    +T         +  + 
Sbjct: 73  LKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNF 132

Query: 71  RNVDLS--QNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMY-------NLD 121
           + + LS  + F T  +      C NL  L L  + +       L +           N+ 
Sbjct: 133 KVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNIS 192

Query: 122 VEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAG 181
              + +S      ++++ P+L  L L+    V  +    L      L     LEEL   G
Sbjct: 193 CLASEVSFSALERLVTRCPNLKSLKLNRA--VPLEKLATL------LQRAPQLEELGTGG 244

Query: 182 MDLGGTLPDSIGRLNLTQLLLQENKITG-------SIPPHIGNLSNLISLNLSS-NLLSG 233
                      G         +   ++G        +P      S L +LNLS   + S 
Sbjct: 245 YTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSY 304

Query: 234 TISAEISWLSQLEQLFLSHNLFSGEIPA---ALGKLHHLGLLDLSFNKLSGEIPVSLGNL 290
            +   +    +L++L++   +    +         L  L +       +   + ++   L
Sbjct: 305 DLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGL 364

Query: 291 VQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHN 350
           V +                    C  L  +     ++T +    I+  R       L   
Sbjct: 365 VSV-----------------SMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCII 407

Query: 351 QLEGPLPIE-----------LSKLENVQEIDLSSNKFTGNIFIQIS-NCIAVRLINISHN 398
           + + P  +            +   ++++ + LS    T  +F  I      + +++++  
Sbjct: 408 EPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGL-LTDKVFEYIGTYAKKMEMLSVAFA 466

Query: 399 ALQGNLPDSLGD-LKNLEAIDVSGNHLS--GIIPISLNKIHTLTFINLS 444
                    +     +L  +++         ++    +K+ T+  + +S
Sbjct: 467 GDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLAN-ASKLETMRSLWMS 514

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.0 bits (152), Expect = 1e-10
 Identities = 34/196 (17%), Positives = 58/196 (29%), Gaps = 40/196 (20%)

Query: 555 ATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQS--------GNFTKSFNRECQV 606
            T +      +G G +G V++ I  D T +A+K++ ++             +    E  +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 607 LKR---IRHRNLMRIITACSLPDF--------KALVLPYMA----NGSLDSHLYPHSET- 650
            K    +      R      L             L+  +       GS +       +  
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 651 -----EFGSGSSDL--------TLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVL 697
                EF  G  DL        +L    +I   +   +A       +R  H DL   NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGNVL 194

Query: 698 LNDDMTALVSDFGIAK 713
           L       +      K
Sbjct: 195 LKKTSLKKLHYTLNGK 210

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 62.7 bits (152), Expect = 4e-10
 Identities = 64/447 (14%), Positives = 139/447 (31%), Gaps = 47/447 (10%)

Query: 16  SKLRRLRHLQLDGNNLHGQIPESLALL--SNLTLVTLHD-NNLTGMLPISFFHNCTSLRN 72
           + LR+L+ +      +     + LA     +L  + L   +  T    +S   +C  ++ 
Sbjct: 109 NNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKT 168

Query: 73  VDLSQNFFTGKIPEEIG----NCPNLWTLSLYNNQLTGQLPASL--INTSMYNL-DVEYN 125
           + + ++ F+ K  + +     +  +L  L+ Y  +     P  L  I  +  +L  V+  
Sbjct: 169 LLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVG 228

Query: 126 HLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLG 185
                          +L           S +++  +   + +L     L  L L+ M   
Sbjct: 229 DFEILELVGFFKAAANLEEFCGG-----SLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN 283

Query: 186 GTLPDSIGRLNLTQLLLQE-NKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQ 244
                      + +L L      T      I    NL  L   + +    +     +  Q
Sbjct: 284 EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQ 343

Query: 245 LEQLFLSHNLFSGEIPAALGKLHHLGL------------LDLSFNKLSGE----IPVSLG 288
           L++L +        +    G +   GL            + +  + ++ E    I   L 
Sbjct: 344 LKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLK 403

Query: 289 NLVQIYSLFLNNNQ------LSRSIPPTLGRCTDLYKLDLSYN--RLTGSIPAEISGIRE 340
           NL     + L+  +      L   +   L  C  L +         LT    + I     
Sbjct: 404 NLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSP 463

Query: 341 IRIFLNLSHNQL--EGPLPIELSKLENVQEIDLSSNKFTGNIFIQI-SNCIAVRLINISH 397
              ++ L +     EG +        N+Q++++    F+        +   ++R + +  
Sbjct: 464 NVRWMLLGYVGESDEGLMEF-SRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQG 522

Query: 398 NALQGNLPDSLGDLK---NLEAIDVSG 421
                   D +   +   N+E I    
Sbjct: 523 YRASMTGQDLMQMARPYWNIELIPSRR 549

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 59.6 bits (144), Expect = 3e-09
 Identities = 57/428 (13%), Positives = 119/428 (27%), Gaps = 70/428 (16%)

Query: 15  FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVD 74
             +   LR L+L G              +   L+  +             +N   L++V 
Sbjct: 69  SRRFPNLRSLKLKGKPR----------AAMFNLIPENWGGYVTPWVTEISNNLRQLKSVH 118

Query: 75  LSQNFFTGKIPEEI--GNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELP 132
             +   +    + +      +L TL L                         +  + +  
Sbjct: 119 FRRMIVSDLDLDRLAKARADDLETLKLDKC----------------------SGFTTDGL 156

Query: 133 SDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSI 192
             I++    +  L +  ++    D             + T LE L     +     P  +
Sbjct: 157 LSIVTHCRKIKTLLMEESSFSEKDGKW----LHELAQHNTSLEVLNFYMTEFAKISPKDL 212

Query: 193 GRL-----NLTQLLLQENKIT--GSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQL 245
             +     +L  + + + +I           NL      +L+ ++        + +  +L
Sbjct: 213 ETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKL 272

Query: 246 EQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSL-GNLVQIYSLFLNNNQLS 304
            +L LS  +   E+P        +  LDL +  L  E   +L      +  L   N    
Sbjct: 273 CRLGLS-YMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGD 331

Query: 305 RSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLE 364
           R +      C  L +L +        +  E   + +  + + L+             +L 
Sbjct: 332 RGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGL-IALAQG---------CQEL- 380

Query: 365 NVQEIDLSSNKFTGNIFIQIS----NCIAVRLINISHNALQGNLPDSLG------DLKNL 414
             + + +  +  T      I     N    RL+ +       +LP   G        K L
Sbjct: 381 --EYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKL 438

Query: 415 EAIDVSGN 422
                   
Sbjct: 439 RRFAFYLR 446

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 61.6 bits (150), Expect = 4e-10
 Identities = 54/273 (19%), Positives = 103/273 (37%), Gaps = 52/273 (19%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIR--------HR 613
           R LG G +  V+    + + T +A+K+++     +T++   E ++L+R+           
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 614 NLMRIITACSLPDFKALVLPY--MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
               I+      + K     +  M    L  +L    +     G   L  +++  I   +
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP-LIYVKQ--ISKQL 140

Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL------VSDFGIAKLVMTVGVGNDGA 725
             G+ Y+H      +IH D+KP NVL+    +        ++D G A             
Sbjct: 141 LLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA------------- 185

Query: 726 ENMGNSTANMLCGSIG---YMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAG 782
                        SI    Y +PE   G+      D++S   L+ E++T     D +F  
Sbjct: 186 ----CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG----DFLFEP 237

Query: 783 GLSLHKWVKNHYH-GRLEKV---IDSSLLRASR 811
               H + K+  H  ++ ++   + S LLR  +
Sbjct: 238 D-EGHSYTKDDDHIAQIIELLGELPSYLLRNGK 269

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 59.8 bits (144), Expect = 2e-09
 Identities = 18/97 (18%), Positives = 30/97 (30%), Gaps = 3/97 (3%)

Query: 10  AIPPEFSKLRRLRHLQLDGNNLHGQIP-ESLALLSNLTLVTLHDNNLTGMLPISFFHNCT 68
                      L  L ++       +    L  L  L  +T+  + L   +    FH   
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80

Query: 69  SLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLT 105
            L  ++LS N     +  +     +L  L L  N L 
Sbjct: 81  RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.7 bits (131), Expect = 6e-08
 Identities = 20/95 (21%), Positives = 33/95 (34%), Gaps = 2/95 (2%)

Query: 210 SIPPHIGNLSNLISLNLSSNLLSGTISAE-ISWLSQLEQLFLSHNLFSGEIPAALGKLHH 268
               H+    NL  L + +      +    +  L +L  L +  +      P A      
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 269 LGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQL 303
           L  L+LSFN L   +       + +  L L+ N L
Sbjct: 82  LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 18/100 (18%), Positives = 34/100 (34%), Gaps = 2/100 (2%)

Query: 29  NNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEI 88
            +        L    NLT + + +      L +        LRN+ + ++     +  + 
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75

Query: 89  -GNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHL 127
               P L  L+L  N L      ++   S+  L +  N L
Sbjct: 76  FHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 51.7 bits (123), Expect = 5e-07
 Identities = 21/103 (20%), Positives = 39/103 (37%), Gaps = 5/103 (4%)

Query: 277 NKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPP-TLGRCTDLYKLDLSYNRLTGSIPAEI 335
              + +    L     +  L++ N Q  + +    L    +L  L +  + L   +  + 
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75

Query: 336 -SGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFT 377
                 +   LNLS N LE  L  +  +  ++QE+ LS N   
Sbjct: 76  FHFTPRLS-RLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 51.3 bits (122), Expect = 6e-07
 Identities = 19/97 (19%), Positives = 36/97 (37%), Gaps = 12/97 (12%)

Query: 258 EIPAALGKLHHLGLLDLSFNKLSGEIP-VSLGNLVQIYSLFLNNNQLSRSIPP-TLGRCT 315
           +    L    +L  L +   +    +    L  L ++ +L +  + L R + P       
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL-RFVAPDAFHFTP 80

Query: 316 DLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQL 352
            L +L+LS+N L  S+  +            LS  +L
Sbjct: 81  RLSRLNLSFNALE-SLSWK--------TVQGLSLQEL 108

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.8 bits (100), Expect = 3e-04
 Identities = 12/79 (15%), Positives = 26/79 (32%), Gaps = 2/79 (2%)

Query: 300 NNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAE-ISGIREIRIFLNLSHNQLEGPLPI 358
               +      L    +L +L +   +    +    + G+ E+R  L +  + L    P 
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN-LTIVKSGLRFVAPD 74

Query: 359 ELSKLENVQEIDLSSNKFT 377
                  +  ++LS N   
Sbjct: 75  AFHFTPRLSRLNLSFNALE 93

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.0 bits (98), Expect = 5e-04
 Identities = 18/118 (15%), Positives = 35/118 (29%), Gaps = 8/118 (6%)

Query: 91  CPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYN 150
                 L    +     L       ++  L +E       L    +  L  L  L +  +
Sbjct: 7   PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66

Query: 151 NMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKIT 208
            +     +      F+       L  L L+   L      ++  L+L +L+L  N + 
Sbjct: 67  GLRFVAPDA-----FHFTPR---LSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.0 bits (98), Expect = 6e-04
 Identities = 20/92 (21%), Positives = 33/92 (35%), Gaps = 9/92 (9%)

Query: 139 LPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-NL 197
             +LT L++     + H +          L    +L  L +    L    PD+      L
Sbjct: 30  AENLTELYIENQQHLQHLEL-------RDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82

Query: 198 TQLLLQENKITGSIPPHIGNLSNLISLNLSSN 229
           ++L L  N +  S+        +L  L LS N
Sbjct: 83  SRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 34/188 (18%), Positives = 75/188 (39%), Gaps = 22/188 (11%)

Query: 197 LTQLLLQENKITGSIPPHIGNLSNL--ISLNLSSNLLSGTISAEISWLSQLEQLFLSHNL 254
           + +    ++ I           +    + L+     +   + A +S L   + L LS N 
Sbjct: 1   MAKATTIKDAIRIFEERKSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNN 59

Query: 255 FSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRC 314
              +I ++L  + +L +L L  N +  +I         +  L+++ NQ++ S+   + + 
Sbjct: 60  IE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKL 114

Query: 315 TDLYKLDLSYNRLTGSIPAEISGIREIR--IFLNLSHNQLEGPLPIE----------LSK 362
            +L  L +S N++T     EI  +  +     L L+ N L                 + +
Sbjct: 115 VNLRVLYMSNNKITN--WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKR 172

Query: 363 LENVQEID 370
           L N++++D
Sbjct: 173 LPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 32/155 (20%), Positives = 59/155 (38%), Gaps = 38/155 (24%)

Query: 272 LDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSI 331
           L      +  ++  +L  L     L L+ N + + I   L    +L  L L  N +    
Sbjct: 30  LHGMIPPIE-KMDATLSTLKACKHLALSTNNIEK-ISS-LSGMENLRILSLGRNLIK--- 83

Query: 332 PAEISGIREIRI---FLNLSHNQLEGPLPIE-LSKLENVQEIDLSSNKFTGNIFIQISNC 387
             +I  +  +      L +S+NQ+     +  + KL N++ + +S+NK        I+N 
Sbjct: 84  --KIENLDAVADTLEELWISYNQIAS---LSGIEKLVNLRVLYMSNNK--------ITNW 130

Query: 388 IAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGN 422
             +               D L  L  LE + ++GN
Sbjct: 131 GEI---------------DKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.8 bits (127), Expect = 6e-08
 Identities = 34/159 (21%), Positives = 54/159 (33%), Gaps = 38/159 (23%)

Query: 23  HLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTG 82
            L      +   +  +L+ L     + L  NN+     IS      +LR + L +N    
Sbjct: 29  ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE---KISSLSGMENLRILSLGRNLIK- 83

Query: 83  KIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSL 142
           KI         L  L +  NQ+                      LSG      + KL +L
Sbjct: 84  KIENLDAVADTLEELWISYNQIA--------------------SLSG------IEKLVNL 117

Query: 143 TYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAG 181
             L++S N + +  +        + L     LE+L LAG
Sbjct: 118 RVLYMSNNKITNWGE-------IDKLAALDKLEDLLLAG 149

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 28/131 (21%), Positives = 47/131 (35%), Gaps = 19/131 (14%)

Query: 16  SKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDL 75
           S +  LR L L  N +  +I    A+   L  + +  N +     +S      +LR + +
Sbjct: 67  SGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS---LSGIEKLVNLRVLYM 122

Query: 76  SQNFFTG-KIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSD 134
           S N  T     +++     L  L L  N L      +       N   EY          
Sbjct: 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKEN-------NATSEYRIE------- 168

Query: 135 IMSKLPSLTYL 145
           ++ +LP+L  L
Sbjct: 169 VVKRLPNLKKL 179

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 31/134 (23%), Positives = 57/134 (42%), Gaps = 18/134 (13%)

Query: 319 KLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIE-LSKLENVQEIDLSSNKFT 377
           +L      +   + A +S ++  +  L LS N +E    I  LS +EN++ + L  N   
Sbjct: 29  ELHGMIPPIEK-MDATLSTLKACKH-LALSTNNIEK---ISSLSGMENLRILSLGRNLIK 83

Query: 378 GNIFIQISN----CIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPIS-L 432
                +I N       +  + IS+N +  +L   +  L NL  + +S N ++    I  L
Sbjct: 84  -----KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKL 136

Query: 433 NKIHTLTFINLSFN 446
             +  L  + L+ N
Sbjct: 137 AALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 33/190 (17%), Positives = 59/190 (31%), Gaps = 62/190 (32%)

Query: 66  NCTSLRNVDLSQNFFT-GKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEY 124
             T    V+L        K+   +        L+L  N +            + +L    
Sbjct: 21  VATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI----------EKISSLS--- 67

Query: 125 NHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDL 184
                         + +L  L L  N +                     +E L+      
Sbjct: 68  -------------GMENLRILSLGRNLI-------------------KKIENLD------ 89

Query: 185 GGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAE-ISWLS 243
              + D      L +L +  N+I  S+   I  L NL  L +S+N ++     + ++ L 
Sbjct: 90  --AVAD-----TLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALD 140

Query: 244 QLEQLFLSHN 253
           +LE L L+ N
Sbjct: 141 KLEDLLLAGN 150

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 57.8 bits (140), Expect = 8e-09
 Identities = 52/218 (23%), Positives = 93/218 (42%), Gaps = 35/218 (16%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR---NLMRI 618
           +++G GS+G+V K    +    +A+K+++ +   F +    E ++L+ +R +   N M +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNV 161

Query: 619 ITACSLPDFKA---LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           I       F+    +         L  +LY   +     G S L L+++      I + +
Sbjct: 162 IHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFS-LPLVRK--FAHSILQCL 213

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTAL--VSDFGIAKLVMTVGVGNDGAENMGNSTA 733
             LH +   R+IHCDLKP N+LL     +   V DFG +                 +   
Sbjct: 214 DALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--------------HQRV 256

Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                S  Y APE   G+      D++S G ++ E++T
Sbjct: 257 YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLT 294

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 52.7 bits (127), Expect = 5e-08
 Identities = 30/145 (20%), Positives = 47/145 (32%), Gaps = 27/145 (18%)

Query: 13  PEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRN 72
            +++   R R L L G  +   I    A L     +   DN +     +  F     L+ 
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR---KLDGFPLLRRLKT 68

Query: 73  VDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELP 132
           + ++ N             P+L  L L NN L                  E   L     
Sbjct: 69  LLVNNNRICRIGEGLDQALPDLTELILTNNSLV-----------------ELGDL----- 106

Query: 133 SDIMSKLPSLTYLHLSYNNMVSHDD 157
            D ++ L SLTYL +  N + +   
Sbjct: 107 -DPLASLKSLTYLCILRNPVTNKKH 130

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 28/131 (21%), Positives = 42/131 (32%), Gaps = 12/131 (9%)

Query: 202 LQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIP- 260
           L    I  +      N      L+L    +   I    + L Q + +  S N    EI  
Sbjct: 4   LTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDN----EIRK 56

Query: 261 -AALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLS--RSIPPTLGRCTDL 317
                 L  L  L ++ N++          L  +  L L NN L     + P L     L
Sbjct: 57  LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSL 115

Query: 318 YKLDLSYNRLT 328
             L +  N +T
Sbjct: 116 TYLCILRNPVT 126

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 46.6 bits (111), Expect = 6e-06
 Identities = 22/123 (17%), Positives = 39/123 (31%), Gaps = 14/123 (11%)

Query: 61  ISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLT--GQLPASLINTSMY 118
            + + N    R +DL        I            +   +N++      P       + 
Sbjct: 12  AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPL---LRRLK 67

Query: 119 NLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELE 178
            L V  N +   +   +   LP LT L L+ N++V   D        + L +   L  L 
Sbjct: 68  TLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLVELGD-------LDPLASLKSLTYLC 119

Query: 179 LAG 181
           +  
Sbjct: 120 ILR 122

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 20/105 (19%), Positives = 39/105 (37%), Gaps = 9/105 (8%)

Query: 345 LNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQ--G 402
           + L+   +E     + +     +E+DL   K    I    +       I+ S N ++   
Sbjct: 2   VKLTAELIEQAA--QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLD 58

Query: 403 NLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNE 447
             P     L+ L+ + V+ N +  I       +  LT + L+ N 
Sbjct: 59  GFPL----LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS 99

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 19/155 (12%), Positives = 49/155 (31%), Gaps = 37/155 (23%)

Query: 296 LFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRI---FLNLSHNQL 352
           + L    + ++            +LDL   ++       I  +         ++ S N  
Sbjct: 2   VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-----VIENLGATLDQFDAIDFSDN-- 52

Query: 353 EGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLK 412
                 E+ KL+                         ++ + +++N +          L 
Sbjct: 53  ------EIRKLDG------------------FPLLRRLKTLLVNNNRICRIGEGLDQALP 88

Query: 413 NLEAIDVSGNHLSGIIPIS-LNKIHTLTFINLSFN 446
           +L  + ++ N L  +  +  L  + +LT++ +  N
Sbjct: 89  DLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.9 bits (131), Expect = 1e-07
 Identities = 79/556 (14%), Positives = 164/556 (29%), Gaps = 176/556 (31%)

Query: 74  DLSQNFFTGKIPEEIGNCPN--------LWTLSLYNNQLTGQLPASLINTSMYNLDVEYN 125
           D+ ++  + +  + I    +         WTL     ++  +    +       L + Y 
Sbjct: 40  DMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEV-------LRINYK 92

Query: 126 HLSGELPSDIMSKLPSL-TYLHLSYNNMVSHDDNTNLVPF-------FNSLGNCTDLEEL 177
            L   + ++   + PS+ T +++   + + ++DN     +       +  L     L EL
Sbjct: 93  FLMSPIKTE--QRQPSMMTRMYIEQRDRL-YNDNQVFAKYNVSRLQPYLKLRQA--LLEL 147

Query: 178 E------LAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHI-----GN--------- 217
                  + G+   G      G+  +   +    K+   +   I      N         
Sbjct: 148 RPAKNVLIDGV--LG-----SGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLE 200

Query: 218 -LSNL---ISLNLSSNL-LSGTISAEISWLSQ-LEQLFLSH------------------N 253
            L  L   I  N +S    S  I   I  +   L +L  S                   N
Sbjct: 201 MLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWN 260

Query: 254 LFSG----------------------------EIPAALGKLHHLGL----LDLSFNKLSG 281
            F+                                  L       L    LD     L  
Sbjct: 261 AFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPR 320

Query: 282 EI----P--VSL-GNLVQI------YSLFLNNNQLSRSI-------PPTLGRCTDLYKLD 321
           E+    P  +S+    ++           +N ++L+  I        P   R   ++   
Sbjct: 321 EVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR--KMFD-R 377

Query: 322 LSYNRLTGSIPAEISGI-------REIRIFLNLSHNQ--LEGPLPIELSKLENVQEIDLS 372
           LS    +  IP  +  +        ++ + +N  H    +E         + ++  ++L 
Sbjct: 378 LSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY-LELK 436

Query: 373 SNKFTGNIFIQISNCIAV--RLINISHNALQGNLPDSLGDLKN----LEAIDVSGNHLSG 426
                    +++ N  A+   +++  +N  +    D L            I   G+HL  
Sbjct: 437 ---------VKLENEYALHRSIVD-HYNIPKTFDSDDLIPPYLDQYFYSHI---GHHLKN 483

Query: 427 IIPISLNKIHTLTFINLSFNEFK------GMIPSGGIFNSATKMSFVGNQHLCGTVPGMP 480
           I       +  + F++  F E K          SG I N+  ++ F    ++C       
Sbjct: 484 IEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYK-PYIC------D 536

Query: 481 ICPPKQHWLHTRMYFI 496
             P  +  ++  + F+
Sbjct: 537 NDPKYERLVNAILDFL 552

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 50.6 bits (120), Expect = 2e-06
 Identities = 63/459 (13%), Positives = 139/459 (30%), Gaps = 129/459 (28%)

Query: 518 HRIKLIISSGKSETRSKPITPELMHNFPR-ITYRELLEAT------AEFDE--------- 561
           H   +   +G+ + + K I       F      +++ +         E D          
Sbjct: 3   HHHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVS 62

Query: 562 --QRLL------GTGSYGRVYKGILQDG-----TAIAVKVLQ--LQSGNFTKSFNREC-- 604
              RL             +  + +L+       + I  +  Q  + +  + +  +R    
Sbjct: 63  GTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND 122

Query: 605 -QVLKRI---RHRNLMRIITA-CSLPDFKALVLPYM--------ANGSLDSHLYPHSETE 651
            QV  +    R +  +++  A   L   K +++  +        A     S+     + +
Sbjct: 123 NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYK-VQCKMD 181

Query: 652 FG--------SGSSDLTLLQRVNICSDIA-EGMAYLHHHSPVRVIHCDLKPS-------- 694
           F           S +  L     +   I     +   H S +++    ++          
Sbjct: 182 FKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK 241

Query: 695 ---NVLLN-DDMTALVSD------FGI-AKLVMT---VGVGND-GAENMGNSTANMLCGS 739
              N LL   +    V +      F +  K+++T     V +   A    + + +     
Sbjct: 242 PYENCLLVLLN----VQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHH--- 294

Query: 740 IGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD---------DMFAGGLS--LHK 788
                          T  +V S  +  L+   +  P +          + A  +   L  
Sbjct: 295 ------SMTL-----TPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLAT 343

Query: 789 W--VKNHYHGRLEKVIDSSLLRASRDQSP-EVKRM-WDVAI---GELIELGILCT--QES 839
           W   K+    +L  +I+SSL        P E ++M   +++      I   +L     + 
Sbjct: 344 WDNWKHVNCDKLTTIIESSL----NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDV 399

Query: 840 PSTRPTMLDAADDLDRLKRY-LGEKHMPSKMNALHLEDI 877
             +     D    +++L +Y L EK    K + + +  I
Sbjct: 400 IKS-----DVMVVVNKLHKYSLVEKQ--PKESTISIPSI 431

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 48.3 bits (114), Expect = 1e-05
 Identities = 94/682 (13%), Positives = 193/682 (28%), Gaps = 207/682 (30%)

Query: 267 HHL----GLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGR--CTDLYKL 320
           HH+    G     +  +   + V     V       +   +       L +     +   
Sbjct: 5   HHMDFETGEHQYQYKDI---LSVFEDAFVDN----FDCKDVQDMPKSILSKEEIDHIIMS 57

Query: 321 DLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNI 380
                         +SG    R+F  L            LSK E + +      KF   +
Sbjct: 58  -----------KDAVSGTL--RLFWTL------------LSKQEEMVQ------KFVEEV 86

Query: 381 FIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTF 440
                  +   +        +   P S+     +E  D   N        +++++     
Sbjct: 87  LRINYKFLMSPI------KTEQRQP-SMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLK 139

Query: 441 INLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPGMPICPPKQHWL----------H 490
           +  +  E +   P+  +                  + G+     K  W+           
Sbjct: 140 LRQALLELR---PAKNV-----------------LIDGVLGSG-KT-WVALDVCLSYKVQ 177

Query: 491 TRMYFIIFVLVI-------SISAFLSTICLVTGIHRIKLIISSGKSETRSKPITPELMHN 543
            +M F IF L +       ++   L  +      ++I    +S    + +  +    +  
Sbjct: 178 CKMDFKIFWLNLKNCNSPETVLEMLQKLL-----YQIDPNWTSRSDHSSNIKLRIHSIQA 232

Query: 544 FPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRE 603
             R                RLL +  Y      +L +          +Q+     +FN  
Sbjct: 233 ELR----------------RLLKSKPYENCLL-VLLN----------VQNAKAWNAFNLS 265

Query: 604 CQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETE--------FGSG 655
           C++L   R + +   ++A +               SLD H    +  E            
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTHI-----------SLDHHSMTLTPDEVKSLLLKYLDCR 314

Query: 656 SSDL-TLLQRVN--ICSDIAEGMA-YLHHHSPVRVIHCD-----LKPS-NVLLNDDMTAL 705
             DL   +   N    S IAE +   L      + ++CD     ++ S NVL   +   +
Sbjct: 315 PQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374

Query: 706 VSDFGI--------AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKG 757
                +          L+  +      ++ M      ++     Y   E     +T +  
Sbjct: 375 FDRLSVFPPSAHIPTILLSLIWFDVIKSDVM-----VVVNKLHKYSLVEKQPKESTISIP 429

Query: 758 DVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSS------------ 805
            +Y      LE+   +   ++ +A    LH+ + +HY   + K  DS             
Sbjct: 430 SIY------LEL---KVKLENEYA----LHRSIVDHY--NIPKTFDSDDLIPPYLDQYFY 474

Query: 806 ------LLRASRDQSPEVKRMW--DVAIGELIELGILCTQESPSTRPTMLDAADDLDRLK 857
                 L      +   + RM   D      +E  I     + +   ++L+    L   K
Sbjct: 475 SHIGHHLKNIEHPERMTLFRMVFLDF---RFLEQKIRHDSTAWNASGSILNTLQQLKFYK 531

Query: 858 RYLGEKH-MPSKMNALHLEDII 878
            Y+ +      ++    +  I+
Sbjct: 532 PYICDNDPKYERL----VNAIL 549

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.8 bits (105), Expect = 1e-04
 Identities = 77/592 (13%), Positives = 160/592 (27%), Gaps = 218/592 (36%)

Query: 145 LHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELE---LAGMDLGGTL--PDSIGRLN--L 197
               Y +++S         F ++  +C D++++    L+  ++   +   D++       
Sbjct: 14  HQYQYKDILSV----FEDAFVDNF-DCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLF 68

Query: 198 TQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAE--------ISWLSQLEQLF 249
             LL ++ ++   +   +  +     L ++   L   I  E          ++ Q ++L+
Sbjct: 69  WTLLSKQEEM---VQKFVEEV-----LRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY 120

Query: 250 LSHNLFS----------GEIPAAL-----------------GK--LHHLGLLDLSF-NKL 279
             + +F+           ++  AL                 GK  +     L      K+
Sbjct: 121 NDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKM 180

Query: 280 SGEIP-VSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGI 338
             +I  ++L N     ++     +L             LY++D ++   +         I
Sbjct: 181 DFKIFWLNLKNCNSPETVLEMLQKL-------------LYQIDPNWTSRSDHSSNIKLRI 227

Query: 339 REIRIFLN--LSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINIS 396
             I+  L   L     E  L +    L NVQ      N F  N+     +C   +++  +
Sbjct: 228 HSIQAELRRLLKSKPYENCLLV----LLNVQNAKAW-NAF--NL-----SC---KILLTT 272

Query: 397 HNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGG 456
                  + D L          +S +H S                  +    +       
Sbjct: 273 RFK---QVTDFLS---AATTTHISLDHHSM-----------------TLTPDEVK----S 305

Query: 457 IFNSATKMSFVGNQHL----CGTVPGMPICPPKQHWLHTRMYFIIFVLVIS-ISAFLSTI 511
           +            Q L      T P                        +S I+  +   
Sbjct: 306 LLLKYLDCRP---QDLPREVLTTNP----------------------RRLSIIAESI--- 337

Query: 512 CLVTGIHRIKLIISSGKSETRSKPITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYG 571
                               R    T +   N+  +   +L            L    Y 
Sbjct: 338 --------------------RDGLATWD---NWKHVNCDKLTTIIESSLNV--LEPAEYR 372

Query: 572 RVYK--GILQDGTAIAVKVLQL--------QSGNFTKSFNRECQVLKRIR---------- 611
           +++    +      I   +L L                 ++   V K+ +          
Sbjct: 373 KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY 432

Query: 612 -------------HRNLMRIITACSLP---DFKALVLPYMANGSLDSHLYPH 647
                        HR    I+   ++P   D   L+ PY     LD + Y H
Sbjct: 433 LELKVKLENEYALHR---SIVDHYNIPKTFDSDDLIPPY-----LDQYFYSH 476

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 39/112 (34%), Positives = 54/112 (48%), Gaps = 4/112 (3%)

Query: 198 TQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEI-SWLSQLEQLFLSHNLFS 256
             L L +N+IT   P    +L NL  L L SN L   +   +   L+QL  L L  N  +
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101

Query: 257 GEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIP 308
               A   +L HL  L +  NKL+ E+P  +  L  +  L L+ NQL +SIP
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL-KSIP 151

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 50.5 bits (121), Expect = 6e-07
 Identities = 29/113 (25%), Positives = 52/113 (46%), Gaps = 20/113 (17%)

Query: 272 LDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTL-GRCTDLYKLDLSYNRLTGS 330
           L L  N+++   P    +L+ +  L+L +NQL  ++P  +    T L  LDL  N+LT  
Sbjct: 45  LYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-V 102

Query: 331 IPAEISGIREIRIF--------LNLSHNQLEGPLPIELSKLENVQEIDLSSNK 375
           +P+         +F        L +  N+L   LP  + +L ++  + L  N+
Sbjct: 103 LPS--------AVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQ 146

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 50.1 bits (120), Expect = 7e-07
 Identities = 37/124 (29%), Positives = 56/124 (45%), Gaps = 6/124 (4%)

Query: 210 SIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHL 269
           S+P  I   +N   L L  N ++         L  L++L+L  N            L  L
Sbjct: 33  SVPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL 90

Query: 270 GLLDLSFNKLSGEIPVSL-GNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLT 328
            +LDL  N+L+  +P ++   LV +  LF+  N+L   +P  + R T L  L L  N+L 
Sbjct: 91  TVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLK 148

Query: 329 GSIP 332
            SIP
Sbjct: 149 -SIP 151

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 38/132 (28%), Positives = 59/132 (44%), Gaps = 7/132 (5%)

Query: 22  RHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFT 81
           + L L  N +    P     L NL  + L  N L   LP+  F + T L  +DL  N  T
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLT 101

Query: 82  GKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLIN-TSMYNLDVEYNHLSGELPSDIMSKL 139
             +P  +     +L  L +  N+LT  LP  +   T + +L ++ N L   +P     +L
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKS-IPHGAFDRL 158

Query: 140 PSLTYLHLSYNN 151
            SLT+ +L + N
Sbjct: 159 SSLTHAYL-FGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 47.0 bits (112), Expect = 7e-06
 Identities = 38/191 (19%), Positives = 65/191 (34%), Gaps = 59/191 (30%)

Query: 113 INTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCT 172
           I T+   L +  N ++ +L   +   L +L  L+L  N + +       +P         
Sbjct: 38  IPTNAQILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQLGA-------LP--------- 80

Query: 173 DLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHI-GNLSNLISLNLSSNLL 231
                   G      + DS+    LT L L  N++T  +P  +   L +L  L +  N  
Sbjct: 81  -------VG------VFDSLT--QLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCN-- 122

Query: 232 SGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLV 291
                       +L            E+P  + +L HL  L L  N+L      +   L 
Sbjct: 123 ------------KLT-----------ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159

Query: 292 QIYSLFLNNNQ 302
            +   +L  N 
Sbjct: 160 SLTHAYLFGNP 170

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 43.9 bits (104), Expect = 8e-05
 Identities = 44/166 (26%), Positives = 63/166 (37%), Gaps = 40/166 (24%)

Query: 68  TSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN--TSMYNLDVEYN 125
           T+ + + L  N  T   P    +  NL  L L +NQL   LP  + +  T +  LD+  N
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98

Query: 126 HLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLG 185
            L+  LPS +  +L  L  L +  N +                                 
Sbjct: 99  QLT-VLPSAVFDRLVHLKELFMCCNKLTE------------------------------- 126

Query: 186 GTLPDSIGRL-NLTQLLLQENKITGSIPPHI-GNLSNLISLNLSSN 229
             LP  I RL +LT L L +N++  SIP      LS+L    L  N
Sbjct: 127 --LPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 31/88 (35%), Positives = 46/88 (52%), Gaps = 4/88 (4%)

Query: 246 EQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSR 305
            +L+L  N F+  +P  L    HL L+DLS N++S     S  N+ Q+ +L L+ N+L R
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL-R 91

Query: 306 SIPP-TLGRCTDLYKLDLSYNRLTGSIP 332
            IPP T      L  L L  N ++  +P
Sbjct: 92  CIPPRTFDGLKSLRLLSLHGNDIS-VVP 118

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 35/112 (31%), Positives = 53/112 (47%), Gaps = 13/112 (11%)

Query: 198 TQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEI-SWLSQLEQLFLSHNLFS 256
           T+L L  N+ T  +P  + N  +L  ++LS+N +S T+S +  S ++QL  L LS+N   
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91

Query: 257 GEIPA-ALGKLHHLGLLDLSFNKLSGEIPV----SLGNLVQIYSLFLNNNQL 303
             IP      L  L LL L  N +S  +P      L  L  +    +  N L
Sbjct: 92  -CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLA---IGANPL 138

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 46.9 bits (112), Expect = 6e-06
 Identities = 27/82 (32%), Positives = 39/82 (47%), Gaps = 4/82 (4%)

Query: 24  LQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGK 83
           L LDGN     +P+ L+   +LTL+ L +N ++  L    F N T L  + LS N     
Sbjct: 36  LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRC- 92

Query: 84  IPEEI-GNCPNLWTLSLYNNQL 104
           IP        +L  LSL+ N +
Sbjct: 93  IPPRTFDGLKSLRLLSLHGNDI 114

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 30/111 (27%), Positives = 47/111 (42%), Gaps = 14/111 (12%)

Query: 68  TSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN--TSMYNLDVEYN 125
             +  + L  N FT  +P+E+ N  +L  + L NN+++  L     +  T +  L + YN
Sbjct: 31  RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYN 88

Query: 126 HLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVP--FFNSLGNCTDL 174
            L   +P      L SL  L L  N++         VP   FN L   + L
Sbjct: 89  RLR-CIPPRTFDGLKSLRLLSLHGNDISV-------VPEGAFNDLSALSHL 131

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 30/136 (22%), Positives = 45/136 (33%), Gaps = 38/136 (27%)

Query: 97  LSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHD 156
           L L  NQ T           +  +D+  N +S  L +   S +  L  L LSYN +    
Sbjct: 36  LYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRC-- 92

Query: 157 DNTNLVP--FFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPH 214
                +P   F+ L                           +L  L L  N I+  +P  
Sbjct: 93  -----IPPRTFDGLK--------------------------SLRLLSLHGNDIS-VVPEG 120

Query: 215 I-GNLSNLISLNLSSN 229
              +LS L  L + +N
Sbjct: 121 AFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 20/78 (25%), Positives = 42/78 (53%), Gaps = 3/78 (3%)

Query: 2   LVDNHLFGAIPPE-FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLP 60
           L +N +   +  + FS + +L  L L  N L    P +   L +L L++LH N+++ ++P
Sbjct: 61  LSNNRI-STLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVP 118

Query: 61  ISFFHNCTSLRNVDLSQN 78
              F++ ++L ++ +  N
Sbjct: 119 EGAFNDLSALSHLAIGAN 136

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 53.0 bits (126), Expect = 2e-07
 Identities = 34/190 (17%), Positives = 68/190 (35%), Gaps = 27/190 (14%)

Query: 117 MYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEE 176
             ++D E   +S     D+   L ++  L+   N  +   +N ++           +L+ 
Sbjct: 146 WGDIDFEEQEISWIEQVDLSPVLDAMPLLN---NLKIKGTNNLSIGKK-----PRPNLKS 197

Query: 177 LELAGMDLGGTLPDSIGRLNLTQL------LLQENKITGSIPPHI------GNLSNLISL 224
           LE+    L  ++ + I   +L  L      +  E+                    NL  L
Sbjct: 198 LEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWL 257

Query: 225 NLSSNLLSGTIS---AEISWLSQLEQLFLSHNLFSGE----IPAALGKLHHLGLLDLSFN 277
            +        +     E   L QLE + +S  + + E    +   + K+ HL  +++ +N
Sbjct: 258 GIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYN 317

Query: 278 KLSGEIPVSL 287
            LS E+   L
Sbjct: 318 YLSDEMKKEL 327

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 52.3 bits (124), Expect = 4e-07
 Identities = 31/212 (14%), Positives = 62/212 (29%), Gaps = 33/212 (15%)

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLD 121
             F         ++S       +   +   P L  L +                ++ +L+
Sbjct: 143 GLFWGDIDFEEQEIS-WIEQVDLSPVLDAMPLLNNLKIKGT--NNLSIGKKPRPNLKSLE 199

Query: 122 VEYNHLSGELPSDI-MSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELA 180
           +    L   +  DI  S LP+L  L L         D                   L   
Sbjct: 200 IISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGD-----------MNVFRPLFS- 247

Query: 181 GMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGN---LSNLISLNLSSNLLSGT--- 234
                   P      NL  L + + +    +         L  L ++++S+ +L+     
Sbjct: 248 ----KDRFP------NLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGAR 297

Query: 235 -ISAEISWLSQLEQLFLSHNLFSGEIPAALGK 265
            +   +  +  L+ + + +N  S E+   L K
Sbjct: 298 LLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 50.3 bits (119), Expect = 1e-06
 Identities = 33/220 (15%), Positives = 72/220 (32%), Gaps = 41/220 (18%)

Query: 148 SYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKI 207
                +S  +  +L P  +++    +L+      + +G        R NL  L +    +
Sbjct: 151 FEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGK-----KPRPNLKSLEIISGGL 205

Query: 208 TGSIPPHIG--NLSNLISLNL---SSNLLSGTISAEISWL------SQLEQLFLSHNLFS 256
             S+   I   +L NL  L L     +            L        L+ L +      
Sbjct: 206 PDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQ 265

Query: 257 GEIPAALGK---LHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGR 313
             +     +   L  L  +D+S   L+ E                     +R +   + +
Sbjct: 266 NVVVEMFLESDILPQLETMDISAGVLTDEG--------------------ARLLLDHVDK 305

Query: 314 CTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLE 353
              L  +++ YN L+  +  E+   + + + +++S +Q  
Sbjct: 306 IKHLKFINMKYNYLSDEMKKELQ--KSLPMKIDVSDSQEY 343

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.4 bits (114), Expect = 6e-06
 Identities = 27/164 (16%), Positives = 58/164 (35%), Gaps = 20/164 (12%)

Query: 2   LVDNHLFGAIPPEFSKLR--RLRHLQLDGNNLHGQIPESLA--LLSNLTLVTLH------ 51
           L +  + G       K     L+ L++    L   + E +    L NL  + L+      
Sbjct: 174 LNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDY 233

Query: 52  --DNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCP---NLWTLSLYNNQLTG 106
             D ++    P+       +L+ + +        + E          L T+ +    LT 
Sbjct: 234 GFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD 293

Query: 107 QLPASLI-----NTSMYNLDVEYNHLSGELPSDIMSKLPSLTYL 145
           +    L+        +  ++++YN+LS E+  ++   LP    +
Sbjct: 294 EGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDV 337

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 42.2 bits (98), Expect = 5e-04
 Identities = 18/123 (14%), Positives = 38/123 (30%), Gaps = 15/123 (12%)

Query: 16  SKLRRLRHLQLDGNNLHGQIPESLALLS---------NLTLVTLHDNNLT--GMLPISFF 64
           S L  L  L L            + +           NL  + + D       +      
Sbjct: 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLES 275

Query: 65  HNCTSLRNVDLSQNFFTGK----IPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNL 120
                L  +D+S    T +    + + +    +L  +++  N L+ ++   L  +    +
Sbjct: 276 DILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKI 335

Query: 121 DVE 123
           DV 
Sbjct: 336 DVS 338

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 53.0 bits (127), Expect = 3e-07
 Identities = 48/263 (18%), Positives = 93/263 (35%), Gaps = 63/263 (23%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIR-----HRNLM 616
           R LG G +  V+    +Q    +A+KV++    ++T++   E ++LK +R       N  
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNRE 101

Query: 617 RIITACSLPDFK---------ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI 667
            ++    L DFK          +V   + +  L   +      +       L  +++  I
Sbjct: 102 MVVQL--LDDFKISGVNGTHICMVFEVLGH-HLLKWII-----KSNYQGLPLPCVKK--I 151

Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDD------MTALVSDFGIAKLVMTVGVG 721
              + +G+ YLH  +  R+IH D+KP N+LL+ +      + A  +++  +      G  
Sbjct: 152 IQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209

Query: 722 NDGAENMGNSTANMLCGSIG-----------------------------YMAPEYGFGSN 752
              A     +                                       Y + E   GS 
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSG 269

Query: 753 TSTKGDVYSFGILVLEMVTRRRP 775
            +T  D++S   +  E+ T    
Sbjct: 270 YNTPADIWSTACMAFELATGDYL 292

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 49.4 bits (118), Expect = 5e-07
 Identities = 32/139 (23%), Positives = 55/139 (39%), Gaps = 28/139 (20%)

Query: 21  LRHLQLDGN-NLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNF 79
           +R L LD   +  G+I    A   NL  ++L +  L     +S       L+ ++LS+N 
Sbjct: 26  VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS---VSNLPKLPKLKKLELSENR 82

Query: 80  FTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKL 139
             G +       PNL  L+L  N+L                  + + L      + + KL
Sbjct: 83  IFGGLDMLAEKLPNLTHLNLSGNKLK-----------------DISTL------EPLKKL 119

Query: 140 PSLTYLHLSYNNMVSHDDN 158
             L  L L +N  V++ ++
Sbjct: 120 ECLKSLDL-FNCEVTNLND 137

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.4 bits (113), Expect = 2e-06
 Identities = 24/118 (20%), Positives = 47/118 (39%), Gaps = 10/118 (8%)

Query: 235 ISAEISW--LSQLEQLFLS-HNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLV 291
           I  E+     + + +L L       G+I     +  +L  L L    L   +  +L  L 
Sbjct: 14  IHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLP 71

Query: 292 QIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSH 349
           ++  L L+ N++   +     +  +L  L+LS N+L      +IS +  ++    L  
Sbjct: 72  KLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK-----DISTLEPLKKLECLKS 124

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 22/92 (23%), Positives = 37/92 (40%), Gaps = 8/92 (8%)

Query: 289 NLVQIYSLFLNNNQLSR-SIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIF--L 345
               +  L L+N + +   I        +L  L L    L       +S + ++     L
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-----SVSNLPKLPKLKKL 76

Query: 346 NLSHNQLEGPLPIELSKLENVQEIDLSSNKFT 377
            LS N++ G L +   KL N+  ++LS NK  
Sbjct: 77  ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.6 bits (103), Expect = 5e-05
 Identities = 28/117 (23%), Positives = 43/117 (36%), Gaps = 10/117 (8%)

Query: 66  NCTSLRNVDLSQNFFT-GKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEY 124
              ++R + L       GKI        NL  LSL N  L   +        +  L++  
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKLPKLKKLELSE 80

Query: 125 NHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAG 181
           N + G     +  KLP+LT+L+LS N +               L     L+ L+L  
Sbjct: 81  NRIFG-GLDMLAEKLPNLTHLNLSGNKLKDIST-------LEPLKKLECLKSLDLFN 129

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.6 bits (103), Expect = 5e-05
 Identities = 28/112 (25%), Positives = 38/112 (33%), Gaps = 7/112 (6%)

Query: 170 NCTDLEELELAGMDLGGTLPDSIG--RLNLTQLLLQENKITGSIPPHIGNLSNLISLNLS 227
               + EL L          + +    +NL  L L    +  S+   +  L  L  L LS
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79

Query: 228 SNLLSGTISAEISWLSQLEQLFLSHNLFS--GEIPAALGKLHHLGLLDLSFN 277
            N + G +      L  L  L LS N       +   L KL  L  LDL   
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.2 bits (102), Expect = 8e-05
 Identities = 17/64 (26%), Positives = 28/64 (43%)

Query: 15  FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVD 74
             KL +L+ L+L  N + G +      L NLT + L  N L  +  +        L+++D
Sbjct: 67  LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLD 126

Query: 75  LSQN 78
           L   
Sbjct: 127 LFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 28/93 (30%), Positives = 38/93 (40%), Gaps = 10/93 (10%)

Query: 166 NSLGNCTDLEELELAGMDLGGTLPDSIGRL----NLTQLLLQENKITGSIPPHIGNLSNL 221
                  +LE L L  + L      S+  L     L +L L EN+I G +      L NL
Sbjct: 43  GLTAEFVNLEFLSLINVGL-----ISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNL 97

Query: 222 ISLNLSSNLLSGTISAE-ISWLSQLEQLFLSHN 253
             LNLS N L    + E +  L  L+ L L + 
Sbjct: 98  THLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 51.6 bits (124), Expect = 6e-07
 Identities = 48/218 (22%), Positives = 84/218 (38%), Gaps = 33/218 (15%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR---NLMRI 618
            L+G GS+G+V K     +   +A+K+++ +   F      E ++L+ +          I
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYI 118

Query: 619 ITACSLPDFKA---LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +       F+    LV        L  +LY         G S L L ++      +   +
Sbjct: 119 VHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVS-LNLTRK--FAQQMCTAL 170

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTAL--VSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            +L     + +IHCDLKP N+LL +   +   + DFG +  +                  
Sbjct: 171 LFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--------------GQRI 215

Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
                S  Y +PE   G       D++S G +++EM T
Sbjct: 216 YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 51.4 bits (123), Expect = 7e-07
 Identities = 48/302 (15%), Positives = 92/302 (30%), Gaps = 57/302 (18%)

Query: 19  RRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQN 78
           + +   +   + +   + E  +      +   +       L       C+ L+N+ L   
Sbjct: 70  QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL-HGILSQCSKLQNLSLEGL 128

Query: 79  FFTGKIPEEIGNCPNLWTLSLYN-NQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMS 137
             +  I   +    NL  L+L   +  +          ++                 ++S
Sbjct: 129 RLSDPIVNTLAKNSNLVRLNLSGCSGFS--------EFAL---------------QTLLS 165

Query: 138 KLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNL 197
               L  L+LS+    +       V           + +L L+G            R NL
Sbjct: 166 SCSRLDELNLSWCFDFTEKHVQVAVA-----HVSETITQLNLSGY-----------RKNL 209

Query: 198 TQLLLQENKITGSIPPHIG-NLSNLISLNLSS-NLLSGTISAEISWLSQLEQLFLSH-NL 254
            +  L            +     NL+ L+LS   +L      E   L+ L+ L LS    
Sbjct: 210 QKSDLS----------TLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYD 259

Query: 255 FSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRC 314
              E    LG++  L  L +      G + +    L     L +N +  +    PT+G  
Sbjct: 260 IIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEAL---PHLQINCSHFTTIARPTIGNK 316

Query: 315 TD 316
            +
Sbjct: 317 KN 318

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 50/216 (23%), Positives = 87/216 (40%), Gaps = 21/216 (9%)

Query: 15  FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHD-NNLT--GMLPISFFHNCTSLR 71
            S+  +L++L L+G  L   I  +LA  SNL  + L   +  +   +  +    +C+ L 
Sbjct: 114 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL--SSCSRLD 171

Query: 72  NVDLSQNF-FTGKIPEEI--GNCPNLWTLSL--YNNQLTGQLPASLIN--TSMYNLDVEY 124
            ++LS  F FT K  +         +  L+L  Y   L     ++L+    ++ +LD+  
Sbjct: 172 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSD 231

Query: 125 NHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDL 184
           + +          +L  L +L LS    +     T        LG    L+ L++ G+  
Sbjct: 232 SVMLKNDCFQEFFQLNYLQHLSLSRCYDII--PET-----LLELGEIPTLKTLQVFGIVP 284

Query: 185 GGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSN 220
            GTL     +  L  L +  +  T    P IGN  N
Sbjct: 285 DGTLQLL--KEALPHLQINCSHFTTIARPTIGNKKN 318

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 45.3 bits (107), Expect = 5e-05
 Identities = 48/269 (17%), Positives = 97/269 (36%), Gaps = 21/269 (7%)

Query: 87  EIGNCPNLWT-LSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYL 145
            + +  +LW  L L    L   +   L++  +            + P         + ++
Sbjct: 41  RLASDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFR--CPRSFMDQPLAEHFSPFRVQHM 98

Query: 146 HLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQLLLQE 204
            LS + +       + +     L  C+ L+ L L G+ L   + +++ +  NL +L L  
Sbjct: 99  DLSNSVI--EVSTLHGI-----LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 151

Query: 205 -NKITGSIPPHIG-NLSNLISLNLS--SNLLSGTISAEISWLS-QLEQLFLS---HNLFS 256
            +  +      +  + S L  LNLS   +     +   ++ +S  + QL LS    NL  
Sbjct: 152 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQK 211

Query: 257 GEIPAALGKLHHLGLLDLSF-NKLSGEIPVSLGNLVQIYSLFLNN-NQLSRSIPPTLGRC 314
            ++   + +  +L  LDLS    L  +       L  +  L L+    +       LG  
Sbjct: 212 SDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEI 271

Query: 315 TDLYKLDLSYNRLTGSIPAEISGIREIRI 343
             L  L +      G++      +  ++I
Sbjct: 272 PTLKTLQVFGIVPDGTLQLLKEALPHLQI 300

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 49.7 bits (119), Expect = 8e-07
 Identities = 39/133 (29%), Positives = 62/133 (46%), Gaps = 8/133 (6%)

Query: 22  RHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFT 81
            +L L+ N+L          L++LT + L  N L   LP   F+  TSL  ++LS N   
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNLSTNQLQ 89

Query: 82  GKIPEEI-GNCPNLWTLSLYNNQLTGQLPASLIN--TSMYNLDVEYNHLSGELPSDIMSK 138
             +P  +      L  L+L  NQL   LP  + +  T + +L +  N L   +P  +  +
Sbjct: 90  -SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDR 146

Query: 139 LPSLTYLHLSYNN 151
           L SL Y+ L ++N
Sbjct: 147 LTSLQYIWL-HDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 33/113 (29%), Positives = 49/113 (43%), Gaps = 5/113 (4%)

Query: 198 TQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEI-SWLSQLEQLFLSHNLFS 256
           T L L+ N +          L++L  L L  N L  ++   + + L+ L  L LS N   
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89

Query: 257 GEIPAALGKLHHLGLLDLSFNKLSGEIPVSL-GNLVQIYSLFLNNNQLSRSIP 308
                   KL  L  L L+ N+L   +P  +   L Q+  L L  NQL +S+P
Sbjct: 90  SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL-KSVP 140

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 44/146 (30%), Positives = 66/146 (45%), Gaps = 18/146 (12%)

Query: 113 INTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVP--FFNSLGN 170
           I      LD+E N L   LP+ +  +L SLT L+L  N + S       +P   FN L  
Sbjct: 26  IPAQTTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQS-------LPNGVFNKL-- 75

Query: 171 CTDLEELELAGMDLGGTLPDSI-GRL-NLTQLLLQENKITGSIPPHI-GNLSNLISLNLS 227
            T L  L L+   L  +LP+ +  +L  L +L L  N++  S+P  +   L+ L  L L 
Sbjct: 76  -TSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLY 132

Query: 228 SNLLSGTISAEISWLSQLEQLFLSHN 253
            N L          L+ L+ ++L  N
Sbjct: 133 QNQLKSVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 33/114 (28%), Positives = 51/114 (44%), Gaps = 21/114 (18%)

Query: 272 LDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTL-GRCTDLYKLDLSYNRLTGS 330
           LDL  N L          L  +  L+L  N+L  S+P  +  + T L  L+LS N+L  S
Sbjct: 33  LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ-S 90

Query: 331 IPAEISGIREIRIF--------LNLSHNQLEGPLPIEL-SKLENVQEIDLSSNK 375
           +P          +F        L L+ NQL+  LP  +  KL  ++++ L  N+
Sbjct: 91  LPN--------GVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQ 135

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 38/167 (22%), Positives = 59/167 (35%), Gaps = 41/167 (24%)

Query: 68  TSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN--TSMYNLDVEYN 125
                +DL  N              +L  L L  N+L   LP  + N  TS+  L++  N
Sbjct: 28  AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86

Query: 126 HLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVP--FFNSLGNCTDLEELELAGMD 183
            L   LP+ +  KL  L  L L+ N + S       +P   F+ L               
Sbjct: 87  QLQ-SLPNGVFDKLTQLKELALNTNQLQS-------LPDGVFDKLT-------------- 124

Query: 184 LGGTLPDSIGRLNLTQLLLQENKITGSIPPHI-GNLSNLISLNLSSN 229
                        L  L L +N++  S+P  +   L++L  + L  N
Sbjct: 125 ------------QLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.1 bits (115), Expect = 1e-06
 Identities = 29/131 (22%), Positives = 56/131 (42%), Gaps = 10/131 (7%)

Query: 21  LRHLQLDGN-NLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNF 79
           ++ L LD + +  G++         L  ++  +  LT    I+       L+ ++LS N 
Sbjct: 19  VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS---IANLPKLNKLKKLELSDNR 75

Query: 80  FTGKIPEEIGNCPNLWTLSLYNNQLT--GQLPASLINTSMYNLDVEYNHLSGELP---SD 134
            +G +      CPNL  L+L  N++     +       ++ +LD+    ++  L     +
Sbjct: 76  VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT-NLNDYREN 134

Query: 135 IMSKLPSLTYL 145
           +   LP LTYL
Sbjct: 135 VFKLLPQLTYL 145

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.8 bits (109), Expect = 6e-06
 Identities = 30/114 (26%), Positives = 50/114 (43%), Gaps = 4/114 (3%)

Query: 217 NLSNLISLNLSSN-LLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLS 275
             S++  L L ++    G +        +LE L   +   +  I A L KL+ L  L+LS
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72

Query: 276 FNKLSGEIPVSLGNLVQIYSLFLNNNQLSR-SIPPTLGRCTDLYKLDLSYNRLT 328
            N++SG + V       +  L L+ N++   S    L +  +L  LDL    +T
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 44.3 bits (105), Expect = 2e-05
 Identities = 31/111 (27%), Positives = 41/111 (36%), Gaps = 5/111 (4%)

Query: 170 NCTDLEELELAGMDLG-GTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLS 227
             +D++EL L       G L         L  L      +T SI  ++  L+ L  L LS
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELS 72

Query: 228 SNLLSGTISAEISWLSQLEQLFLSHNLFSG-EIPAALGKLHHLGLLDLSFN 277
            N +SG +         L  L LS N          L KL +L  LDL   
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.5 bits (103), Expect = 4e-05
 Identities = 27/119 (22%), Positives = 45/119 (37%), Gaps = 14/119 (11%)

Query: 66  NCTSLRNVDLSQNFFT-GKIPEEIGNCPNLWTLSLYNNQLT--GQLPASLINTSMYNLDV 122
             + ++ + L  +    GK+         L  LS  N  LT    LP       +  L++
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPK---LNKLKKLEL 71

Query: 123 EYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAG 181
             N +SG     +  K P+LT+L+LS N +               L    +L+ L+L  
Sbjct: 72  SDNRVSG-GLEVLAEKCPNLTHLNLSGNKIKDLST-------IEPLKKLENLKSLDLFN 122

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.1 bits (102), Expect = 6e-05
 Identities = 20/92 (21%), Positives = 37/92 (40%), Gaps = 8/92 (8%)

Query: 289 NLVQIYSLFLNNNQLSR-SIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIF--L 345
               +  L L+N++ +   +        +L  L      LT      I+ + ++     L
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKL 69

Query: 346 NLSHNQLEGPLPIELSKLENVQEIDLSSNKFT 377
            LS N++ G L +   K  N+  ++LS NK  
Sbjct: 70  ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 16/64 (25%), Positives = 28/64 (43%)

Query: 15  FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVD 74
             KL +L+ L+L  N + G +        NLT + L  N +  +  I       +L+++D
Sbjct: 60  LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119

Query: 75  LSQN 78
           L   
Sbjct: 120 LFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 24/93 (25%), Positives = 37/93 (39%), Gaps = 10/93 (10%)

Query: 166 NSLGNCTDLEELELAGMDLGGTLPDSIGRL----NLTQLLLQENKITGSIPPHIGNLSNL 221
                  +LE L    + L      SI  L     L +L L +N+++G +        NL
Sbjct: 36  GLTDEFEELEFLSTINVGL-----TSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNL 90

Query: 222 ISLNLSSNLLSGTISAE-ISWLSQLEQLFLSHN 253
             LNLS N +    + E +  L  L+ L L + 
Sbjct: 91  THLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.8 bits (96), Expect = 3e-04
 Identities = 22/91 (24%), Positives = 42/91 (46%), Gaps = 7/91 (7%)

Query: 362 KLENVQEIDLSSNKFT-GNIFIQISNCIAVRLINISHNALQ--GNLPDSLGDLKNLEAID 418
              +V+E+ L +++   G +         +  ++  +  L    NLP     L  L+ ++
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLPK----LNKLKKLE 70

Query: 419 VSGNHLSGIIPISLNKIHTLTFINLSFNEFK 449
           +S N +SG + +   K   LT +NLS N+ K
Sbjct: 71  LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 31/122 (25%), Positives = 52/122 (42%), Gaps = 17/122 (13%)

Query: 113 INTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCT 172
           I      L +  N L       +  +LP L  L L  N +   + N      F      +
Sbjct: 27  IPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNA-----FEGA---S 78

Query: 173 DLEELELAGMDLGGTLPDSI-GRL-NLTQLLLQENKITGSIPPHIG---NLSNLISLNLS 227
            ++EL+L    +   + + +   L  L  L L +N+I+  + P  G   +L++L SLNL+
Sbjct: 79  HIQELQLGENKI-KEISNKMFLGLHQLKTLNLYDNQIS-CVMP--GSFEHLNSLTSLNLA 134

Query: 228 SN 229
           SN
Sbjct: 135 SN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 46.5 bits (111), Expect = 7e-06
 Identities = 22/90 (24%), Positives = 36/90 (40%), Gaps = 6/90 (6%)

Query: 246 EQLFLSHN-LFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSL-GNLVQIYSLFLNNNQL 303
            +L L+ N L         G+L HL  L+L  N+L+  I  +       I  L L  N++
Sbjct: 32  TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90

Query: 304 SRSIPP-TLGRCTDLYKLDLSYNRLTGSIP 332
              I          L  L+L  N+++  + 
Sbjct: 91  K-EISNKMFLGLHQLKTLNLYDNQIS-CVM 118

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 46.1 bits (110), Expect = 9e-06
 Identities = 23/105 (21%), Positives = 42/105 (40%), Gaps = 7/105 (6%)

Query: 50  LHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEI-GNCPNLWTLSLYNNQLTGQL 108
           L+DN L  +     F     L  ++L +N  T  I         ++  L L  N++  ++
Sbjct: 36  LNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-EI 93

Query: 109 PASLIN--TSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNN 151
              +      +  L++  N +S  +       L SLT L+L  +N
Sbjct: 94  SNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNL-ASN 136

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 47.7 bits (114), Expect = 1e-05
 Identities = 36/148 (24%), Positives = 61/148 (41%), Gaps = 22/148 (14%)

Query: 562 QRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR--NLMRI 618
            R +G G++GRV     + +    AVKV++     +T+S   E  +LK+I++   N   I
Sbjct: 40  IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNI 98

Query: 619 ITACSLPDFKA---LVLPYMANGSLDSHLYPHSETEF--GSGSSDLTLLQRVNICSDIAE 673
           +       +     L+        L   LY     E    +  +   +      C +I +
Sbjct: 99  VKYHGKFMYYDHMCLIFE-----PLGPSLY-----EIITRNNYNGFHIEDIKLYCIEILK 148

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDD 701
            + YL       + H DLKP N+LL+D 
Sbjct: 149 ALNYLRKM---SLTHTDLKPENILLDDP 173

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 35/156 (22%), Positives = 68/156 (43%), Gaps = 19/156 (12%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRH-RNLMRIIT 620
           R +G+GS+G +Y G  +  G  +A+K+  +++ +     + E ++ K ++    +  I  
Sbjct: 15  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 72

Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
             +  D+  +V+           L P  E  F   S   +L   + +   +   + Y+H 
Sbjct: 73  CGAEGDYNVMVMEL---------LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123

Query: 681 HSPVRVIHCDLKPSNVLL---NDDMTALVSDFGIAK 713
            +    IH D+KP N L+          + DFG+AK
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 45.8 bits (109), Expect = 4e-05
 Identities = 27/151 (17%), Positives = 61/151 (40%), Gaps = 28/151 (18%)

Query: 563 RLLGTGSYGRVYKGI--LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR---NLMR 617
             LG G++G+V + +   +  + +A+K+++     + ++   E  VLK+I+ +   N   
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFL 83

Query: 618 IITACSLPDFKA---LVLPYMANGSLDSHLYPHSETEF----GSGSSDLTLLQRVNICSD 670
            +      +F     +         L  + +     EF          L  ++   +   
Sbjct: 84  CVLMSDWFNFHGHMCIAFE-----LLGKNTF-----EFLKENNFQPYPLPHVRH--MAYQ 131

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDD 701
           +   + +LH +   ++ H DLKP N+L  + 
Sbjct: 132 LCHALRFLHEN---QLTHTDLKPENILFVNS 159

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 45.1 bits (107), Expect = 6e-05
 Identities = 35/163 (21%), Positives = 67/163 (41%), Gaps = 31/163 (19%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRH-RNLMRIIT 620
           + +G G++G +  G  L     +A+K+  ++S       + E +  K++     + ++  
Sbjct: 15  KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYY 72

Query: 621 ACSLPDFKALVLPYMANG-SLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA--- 676
                 + A+VL  +  G SL   L+   +  F    S  T+L        IA  +    
Sbjct: 73  FGPCGKYNAMVLELL--GPSL-EDLFDLCDRTF----SLKTVLM-------IAIQLISRM 118

Query: 677 -YLHHHSPVRVIHCDLKPSNVLL-----NDDMTALVSDFGIAK 713
            Y+H  +   +I+ D+KP N L+            + DF +AK
Sbjct: 119 EYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 44.7 bits (106), Expect = 8e-05
 Identities = 59/316 (18%), Positives = 100/316 (31%), Gaps = 65/316 (20%)

Query: 18  LRRLRHLQLDGNNLHGQIPESLA--LLSN---LTLVTLHDNNLT--GMLPI-SFFHNCTS 69
           L  LR L L G  +       +A  L S    L  V L    L   G+  +   F     
Sbjct: 71  LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARK 130

Query: 70  LRNVDLSQNFFTGKIPEEIG-----NCPNLWTLSLYNNQLTGQ----LPASLI-NTSMYN 119
           L    L  N    +  +++      +   + TL L NN LT      L   L  NTS+ +
Sbjct: 131 L---GLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTH 187

Query: 120 LDVEYNHLS---GELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEE 176
           L + +  L     EL +  + +   L  L+++YN       +T  +    +      LE 
Sbjct: 188 LSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGA----GDTAALALARAAREHPSLEL 243

Query: 177 LELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLS---- 232
           L L   +L        GR  L  L                  + ++        +S    
Sbjct: 244 LHLYFNELSSE-----GRQVLRDLGGAAE-----------GGARVVVSLTEGTAVSEYWS 287

Query: 233 GTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQ 292
             +S     L+  ++  +  +L              L L DL  ++ +   P     L++
Sbjct: 288 VILSEVQRNLNSWDRARVQRHL-------------ELLLRDLEDSRGATLNPWRKAQLLR 334

Query: 293 ----IYSLFLNNNQLS 304
               + +L        
Sbjct: 335 VEGEVRALLEQLGSSG 350

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 42.8 bits (101), Expect = 4e-04
 Identities = 46/271 (16%), Positives = 88/271 (32%), Gaps = 47/271 (17%)

Query: 200 LLLQEN-KITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGE 258
           LL   N  +   +   I NL  L +       L       +     L+ LF  +      
Sbjct: 6   LLSAHNRAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEF--QN 63

Query: 259 IPAALGKLHHLGLLDLSFNKLSGEIPVSLG-----NLVQIYSLFLNNNQLS----RSIPP 309
              +   L  L  L+L+  +++      +          +  + L + QL     R++ P
Sbjct: 64  QRFSAEVLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLP 123

Query: 310 TLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEI 369
              R     KL L  N L           +++R  L     Q+                +
Sbjct: 124 VFLRAR---KLGLQLNSLGP------EACKDLRDLLLHDQCQI--------------TTL 160

Query: 370 DLSSNKFTGNIFIQISNCIAV----RLINISHNALQGN----LPDSLGDLKNLEAIDVSG 421
            LS+N  T      +   +A       +++ H  L       L   L   + L+ ++V+ 
Sbjct: 161 RLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAY 220

Query: 422 NHL--SGIIPIS--LNKIHTLTFINLSFNEF 448
           N    +  + ++    +  +L  ++L FNE 
Sbjct: 221 NGAGDTAALALARAAREHPSLELLHLYFNEL 251

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 42.0 bits (99), Expect = 6e-04
 Identities = 39/274 (14%), Positives = 84/274 (30%), Gaps = 68/274 (24%)

Query: 96  TLSLYNNQLT---GQLPASLINTSMYN---LDVEYNHLSGELPSDIMSKLPSLTYLHLSY 149
            L+L   ++T     + A+++ +  +    +++    L       ++        L L  
Sbjct: 76  QLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQL 135

Query: 150 NNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMD-LGGTLPDSIGRLNLTQLLLQENKIT 208
           N+                         L       L   L     +  +T L L  N +T
Sbjct: 136 NS-------------------------LGPEACKDLRDLLLHD--QCQITTLRLSNNPLT 168

Query: 209 GSIPPHIGNL----SNLISLNLSSNLLSGT----ISAEISWLSQLEQLFLSHNLFSGE-- 258
            +    +       +++  L+L    L       ++A++    QL++L +++N       
Sbjct: 169 AAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAA 228

Query: 259 --IPAALGKLHHLGLLDLSFNKLS-------GEIPVSLGNLVQIYSLFLNNNQLS----- 304
             +  A  +   L LL L FN+LS        ++  +     ++         +S     
Sbjct: 229 LALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSV 288

Query: 305 ----------RSIPPTLGRCTDLYKLDLSYNRLT 328
                           + R  +L   DL  +R  
Sbjct: 289 ILSEVQRNLNSWDRARVQRHLELLLRDLEDSRGA 322

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 43.4 bits (103), Expect = 2e-04
 Identities = 61/337 (18%), Positives = 103/337 (30%), Gaps = 78/337 (23%)

Query: 562 QRLLGTGSYGRVYKGI--LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHR---NLM 616
              LG G++G+V + I     G  +AVK+++     + ++   E QVL+ +      +  
Sbjct: 19  VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTF 77

Query: 617 RIITACSLPDFKA---LVLPYMANGSLDSHLYPHSETEF--GSGSSDLTLLQRVNICSDI 671
           R +      +      +V        L    Y     +F   +G     L     +   I
Sbjct: 78  RCVQMLEWFEHHGHICIVFE-----LLGLSTY-----DFIKENGFLPFRLDHIRKMAYQI 127

Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
            + + +LH +   ++ H DLKP N+L                            E    +
Sbjct: 128 CKSVNFLHSN---KLTHTDLKPENILFVQS-----------DYTEAYNPKIKRDERTLIN 173

Query: 732 TANMLC--GSIG--------------YMAPEYGFGSNTSTKGDVYSFGILVLEMVT---- 771
               +   GS                Y APE       S   DV+S G +++E       
Sbjct: 174 PDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV 233

Query: 772 ----------------RRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSP 815
                                  M        +  K  +H RL+    SS  R       
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKT----RKRKYFHHDRLDWDEHSSAGRYVSRACK 289

Query: 816 EVKRMW---DVAIGELIELGILCTQESPSTRPTMLDA 849
            +K      DV    L +L     +  P+ R T+ +A
Sbjct: 290 PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREA 326

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 35/156 (22%), Positives = 69/156 (44%), Gaps = 19/156 (12%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLM-RIIT 620
           R +G+GS+G +Y G  +Q    +A+K+  +++ +       E ++ + ++    +  +  
Sbjct: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRW 70

Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
                D+  LV+  +   SL   L+     +     S  T+L   +   +  E   ++H 
Sbjct: 71  FGVEGDYNVLVMDLLGP-SL-EDLFNFCSRKL----SLKTVLMLADQMINRVE---FVHS 121

Query: 681 HSPVRVIHCDLKPSNVLLNDDMTA---LVSDFGIAK 713
            S    +H D+KP N L+     A    + DFG+AK
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 26/151 (17%), Positives = 52/151 (34%), Gaps = 12/151 (7%)

Query: 563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITAC 622
           +L+G G    V+    +      VK  ++   +F K   +E +    +    L       
Sbjct: 96  KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKV--KEKRDYGDLHFSVLAIRSAR- 152

Query: 623 SLPDFKALVLPYMANGSLDSHLYPHS---ETEFGSGSSDLTLLQRVNICSDIAEGMAYLH 679
              +F+AL                ++   E         + +     +   I E +A  +
Sbjct: 153 --NEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 210

Query: 680 HHSPVRVIHCDLKPSNVLLNDDMTALVSDFG 710
           H     ++H DL   NVL++++    + DF 
Sbjct: 211 HR---GIVHGDLSQYNVLVSEEG-IWIIDFP 237

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 42.3 bits (100), Expect = 4e-04
 Identities = 29/158 (18%), Positives = 55/158 (34%), Gaps = 21/158 (13%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRH-RNLMRIIT 620
           R +G GS+G +++G  L +   +A+K    +S         E +  K +     +  +  
Sbjct: 16  RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYY 73

Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
                    LV+           L P  E          ++         +   +  +H 
Sbjct: 74  FGQEGLHNVLVIDL---------LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 124

Query: 681 HSPVRVIHCDLKPSNVLLNDDMTA-----LVSDFGIAK 713
            S   +++ D+KP N L+    +       V DFG+ K
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 40.3 bits (95), Expect = 8e-04
 Identities = 28/111 (25%), Positives = 42/111 (37%), Gaps = 13/111 (11%)

Query: 68  TSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN--TSMYNLDVEYN 125
           +S   ++L  N               L  LSL  NQ+   LP  + +  T +  L +  N
Sbjct: 28  SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHEN 86

Query: 126 HLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVP--FFNSLGNCTDL 174
            L   LP+ +  KL  L  L L  N + S       VP   F+ L +   +
Sbjct: 87  KLQ-SLPNGVFDKLTQLKELALDTNQLKS-------VPDGIFDRLTSLQKI 129

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 40.3 bits (95), Expect = 9e-04
 Identities = 26/89 (29%), Positives = 41/89 (46%), Gaps = 5/89 (5%)

Query: 246 EQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSL-GNLVQIYSLFLNNNQLS 304
            +L L  N           KL  L  L LS N++   +P  +   L ++  L+L+ N+L 
Sbjct: 31  TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ 89

Query: 305 RSIPP-TLGRCTDLYKLDLSYNRLTGSIP 332
            S+P     + T L +L L  N+L  S+P
Sbjct: 90  -SLPNGVFDKLTQLKELALDTNQLK-SVP 116

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

No hit with probability above 80.00

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	885
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-62
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-55
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-53
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-51
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-51
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-51
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-50
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-50
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-50
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	8e-50
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-49
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-49
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-49
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-49
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-49
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-48
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-48
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-48
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	9e-48
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-47
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-47
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-47
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-47
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-46
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-46
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-45
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-44
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-43
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-43
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-42
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-42
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	8e-42
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-40
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-40
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-39
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-39
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-37
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-37
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-36
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-36
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-36
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-36
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-36
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-36
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-34
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-34
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-34
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-33
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-33
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-33
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-33
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-33
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-32
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-32
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-32
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-31
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-30
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-30
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-29
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-28
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-26
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-25
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-24
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-22
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-07
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-07
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-21
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-19
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-08
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-20
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	9e-16
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-19
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-16
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-14
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-13
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-12
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	9e-10
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-08
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-10
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	7e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	9e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.004
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.001
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-06
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	1e-07
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.002
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	5e-07
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	4e-05
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	5e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	5e-07
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	5e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.001
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.002
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	2e-06
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	1e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.004
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	7e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	6e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	8e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	6e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	6e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.002
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	2e-05
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	5e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.001

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (534), Expect = 3e-62
 Identities = 72/306 (23%), Positives = 131/306 (42%), Gaps = 43/306 (14%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           +    + +G+GS+G VYKG      A+ +  +   +    ++F  E  VL++ RH N++ 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
            +   + P   A+V  +    SL  HL+               +++ ++I    A+GM Y
Sbjct: 69  FMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETK--------FEMIKLIDIARQTAQGMDY 119

Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH  S   +IH DLK +N+ L++D+T  + DFG+A +          +   G+     L 
Sbjct: 120 LHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVK---------SRWSGSHQFEQLS 167

Query: 738 GSIGYMAPEYGFGSNT---STKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
           GSI +MAPE     +    S + DVY+FGI++ E++T + P  ++     +    +    
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI-----NNRDQIIFMV 222

Query: 795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD 854
                              SP++ ++       +  L   C ++    RP        ++
Sbjct: 223 GRGYL--------------SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

Query: 855 RLKRYL 860
            L R L
Sbjct: 269 LLARSL 274

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  191 bits (485), Expect = 3e-55
 Identities = 68/325 (20%), Positives = 129/325 (39%), Gaps = 54/325 (16%)

Query: 548 TYRELLEATAEFDE---------QRLLGTGSYGRVYKGIL----QDGTAIAVKVLQLQ-S 593
           T+ +  EA  EF +         ++++G G +G V  G L    +    +A+K L+   +
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 594 GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFG 653
               + F  E  ++ +  H N++ +    +      ++  +M NGSLDS L  +      
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-- 125

Query: 654 SGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK 713
                 T++Q V +   IA GM YL        +H DL   N+L+N ++   VSDFG+++
Sbjct: 126 ------TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 176

Query: 714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRR 773
            +       D   +   ++A      I + APE       ++  DV+S+GI++ E+++  
Sbjct: 177 FL------EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 230

Query: 774 RPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGI 833
                          +        +  +     L    D    +            +L +
Sbjct: 231 ERP------------YWDMTNQDVINAIEQDYRLPPPMDCPSALH-----------QLML 267

Query: 834 LCTQESPSTRPTMLDAADDLDRLKR 858
            C Q+  + RP      + LD++ R
Sbjct: 268 DCWQKDRNHRPKFGQIVNTLDKMIR 292

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 1e-53
 Identities = 74/297 (24%), Positives = 127/297 (42%), Gaps = 45/297 (15%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
                  LG G +G V+ G     T +AVK L+  S +   +F  E  ++K+++H+ L+R
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVR 72

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +    +      ++  YM NGSL   L              LT+ + +++ + IAEGMA+
Sbjct: 73  LYAVVTQEPI-YIITEYMENGSLVDFLKTP-------SGIKLTINKLLDMAAQIAEGMAF 124

Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           +   +    IH DL+ +N+L++D ++  ++DFG+A+L+          E+   +      
Sbjct: 125 IEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI----------EDNEYTAREGAK 171

Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR 797
             I + APE       + K DV+SFGIL+ E+VT  R           +    + +   R
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231

Query: 798 LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLD 854
            +   +                       EL +L  LC +E P  RPT       L+
Sbjct: 232 PDNCPE-----------------------ELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 1e-51
 Identities = 76/303 (25%), Positives = 121/303 (39%), Gaps = 51/303 (16%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           E    + +G G +G V  G    G  +AVK ++  +    ++F  E  V+ ++RH NL++
Sbjct: 8   ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQ 64

Query: 618 IITACSLPDFK-ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           ++           +V  YMA GSL  +L          G S L     +    D+ E M 
Sbjct: 65  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-------GRSVLGGDCLLKFSLDVCEAME 117

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL  +     +H DL   NVL+++D  A VSDFG+ K                +ST +  
Sbjct: 118 YLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--------------SSTQDTG 160

Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHG 796
              + + APE       STK DV+SFGIL+ E+ +  R         + L          
Sbjct: 161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV----PYPRIPLKDV------- 209

Query: 797 RLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL 856
            + +V     + A     P V            E+   C     + RP+ L   + L+ +
Sbjct: 210 -VPRVEKGYKMDAPDGCPPAVY-----------EVMKNCWHLDAAMRPSFLQLREQLEHI 257

Query: 857 KRY 859
           K +
Sbjct: 258 KTH 260

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 2e-51
 Identities = 66/313 (21%), Positives = 114/313 (36%), Gaps = 45/313 (14%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNL 615
           +F++   LG G+ G V+K      G  +A K++ L+          RE QVL       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +    A       ++ + +M  GSLD  L              +       +   + +G+
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGL 117

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL      +++H D+KPSN+L+N      + DFG++               + +S AN 
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ-------------LIDSMANS 162

Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK------- 788
             G+  YM+PE   G++ S + D++S G+ ++EM   R P     A  L L         
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222

Query: 789 ------------WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCT 836
                          + Y       +    L       P  K    V   E  +    C 
Sbjct: 223 AAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 282

Query: 837 QESPSTRPTMLDA 849
            ++P+ R  +   
Sbjct: 283 IKNPAERADLKQL 295

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 4e-51
 Identities = 68/317 (21%), Positives = 123/317 (38%), Gaps = 37/317 (11%)

Query: 562 QRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           Q  +G G +G V++G    G  +AVK+   +    +     E      +RH N++  I A
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAA 65

Query: 622 CSLPDFKA----LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
            +  +       LV  Y  +GSL  +L  ++          +T+   + +    A G+A+
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAH 115

Query: 678 LHHH-----SPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
           LH           + H DLK  N+L+  + T  ++D G+A          D A +  +  
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH-------DSATDTIDIA 168

Query: 733 ANMLCGSIGYMAPEYGFGSNT------STKGDVYSFGILVLEMVTRRRPTDDMFAGGLSL 786
            N   G+  YMAPE    S          + D+Y+ G++  E+  R           L  
Sbjct: 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228

Query: 787 HKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTM 846
           +  V +     +E++      +  R   P   +  + A+  + ++   C   + + R T 
Sbjct: 229 YDLVPSDPS--VEEMRKVVCEQKLRPNIPNRWQSCE-ALRVMAKIMRECWYANGAARLTA 285

Query: 847 LDAADDLDRLKRYLGEK 863
           L     L +L +  G K
Sbjct: 286 LRIKKTLSQLSQQEGIK 302

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 2e-50
 Identities = 76/311 (24%), Positives = 131/311 (42%), Gaps = 45/311 (14%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
               +  LG G +G V+ G     T +A+K L+  + +  ++F +E QV+K++RH  L++
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQ 76

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +    S      +V  YM+ GSL   L   +            L Q V++ + IA GMAY
Sbjct: 77  LYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYL-------RLPQLVDMAAQIASGMAY 128

Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           +        +H DL+ +N+L+ +++   V+DFG+A+L+          E+   +      
Sbjct: 129 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLI----------EDNEYTARQGAK 175

Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR 797
             I + APE       + K DV+SFGIL+ E+ T+ R                   Y G 
Sbjct: 176 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP-----------------YPGM 218

Query: 798 LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLK 857
           + + +   + R  R   P            L +L   C ++ P  RPT       L+   
Sbjct: 219 VNREVLDQVERGYRMPCPP------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272

Query: 858 RYLGEKHMPSK 868
                ++ P +
Sbjct: 273 TSTEPQYQPGE 283

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 3e-50
 Identities = 64/299 (21%), Positives = 117/299 (39%), Gaps = 45/299 (15%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           E    + +G+G +G V+ G   +   +A+K ++  + +  + F  E +V+ ++ H  L++
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQ 64

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +   C       LV  +M +G L  +L                    + +C D+ EGMAY
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--------AAETLLGMCLDVCEGMAY 116

Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L       VIH DL   N L+ ++    VSDFG+ + V+          +   +++    
Sbjct: 117 LEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL----------DDQYTSSTGTK 163

Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR 797
             + + +PE    S  S+K DV+SFG+L+ E+ +  +              +        
Sbjct: 164 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP------------YENRSNSEV 211

Query: 798 LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL 856
           +E +     L   R  S  V            ++   C +E P  RP        L  +
Sbjct: 212 VEDISTGFRLYKPRLASTHVY-----------QIMNHCWKERPEDRPAFSRLLRQLAEI 259

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 5e-50
 Identities = 62/296 (20%), Positives = 116/296 (39%), Gaps = 45/296 (15%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           +    + LGTG +G V  G  +    +A+K+++  S +    F  E +V+  + H  L++
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQ 63

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +   C+      ++  YMANG L ++L                  Q + +C D+ E M Y
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--------FQTQQLLEMCKDVCEAMEY 115

Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           L      + +H DL   N L+ND     VSDFG+++ V+          +   +++    
Sbjct: 116 LESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL----------DDEYTSSVGSK 162

Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR 797
             + +  PE    S  S+K D+++FG+L+ E+ +  +                   Y   
Sbjct: 163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP-----------------YERF 205

Query: 798 LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDL 853
                   + +  R   P       +A  ++  +   C  E    RPT      ++
Sbjct: 206 TNSETAEHIAQGLRLYRPH------LASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 8e-50
 Identities = 73/307 (23%), Positives = 128/307 (41%), Gaps = 48/307 (15%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQDGT-----AIAVKVLQLQ-SGNFTKSFNRECQVLKRIR 611
               Q+++G G +G VYKG+L+  +      +A+K L+   +      F  E  ++ +  
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           H N++R+    S      ++  YM NG+LD                + ++LQ V +   I
Sbjct: 68  HHNIIRLEGVISKYKPMMIITEYMENGALDKF--------LREKDGEFSVLQLVGMLRGI 119

Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A GM YL +      +H DL   N+L+N ++   VSDFG+++++          +     
Sbjct: 120 AAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--------DPEATY 168

Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
           T +     I + APE       ++  DV+SFGI++ E++T            LS H+   
Sbjct: 169 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER----PYWELSNHEV-- 222

Query: 792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAAD 851
                 ++ + D   L    D    +            +L + C Q+  + RP   D   
Sbjct: 223 ------MKAINDGFRLPTPMDCPSAIY-----------QLMMQCWQQERARRPKFADIVS 265

Query: 852 DLDRLKR 858
            LD+L R
Sbjct: 266 ILDKLIR 272

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  175 bits (443), Expect = 1e-49
 Identities = 67/321 (20%), Positives = 129/321 (40%), Gaps = 57/321 (17%)

Query: 558 EFDEQRLLGTGSYGRVYKGIL------QDGTAIAVKVLQLQ-SGNFTKSFNRECQVLKRI 610
             +  R +G G++GRV++         +  T +AVK+L+ + S +    F RE  ++   
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73

Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGS---------------G 655
            + N+++++  C++     L+  YMA G L+  L   S     S               G
Sbjct: 74  DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 656 SSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV 715
              L+  +++ I   +A GMAYL      + +H DL   N L+ ++M   ++DFG+++ +
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI 190

Query: 716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
                                   I +M PE  F +  +T+ DV+++G+++ E+ +    
Sbjct: 191 Y---------SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241

Query: 776 TDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILC 835
                        +    +   +  V D ++L    +              EL  L  LC
Sbjct: 242 P------------YYGMAHEEVIYYVRDGNILACPENCPL-----------ELYNLMRLC 278

Query: 836 TQESPSTRPTMLDAADDLDRL 856
             + P+ RP+       L R+
Sbjct: 279 WSKLPADRPSFCSIHRILQRM 299

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 2e-49
 Identities = 71/327 (21%), Positives = 133/327 (40%), Gaps = 57/327 (17%)

Query: 544 FPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQDG---TAIAVKVL-QLQSGNFTKS 599
           +P + + +          Q ++G G++G+V K  ++        A+K + +  S +  + 
Sbjct: 4   YPVLDWND-------IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56

Query: 600 FNRECQVLKRI-RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETE------- 651
           F  E +VL ++  H N++ ++ AC    +  L + Y  +G+L   L      E       
Sbjct: 57  FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116

Query: 652 FGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI 711
             S +S L+  Q ++  +D+A GM YL      + IH DL   N+L+ ++  A ++DFG+
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL 173

Query: 712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT 771
           ++                     M    + +MA E    S  +T  DV+S+G+L+ E+V+
Sbjct: 174 SRGQEV------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 221

Query: 772 RRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIEL 831
                      G++  +          EK+     L    +   EV            +L
Sbjct: 222 LGGT----PYCGMTCAEL--------YEKLPQGYRLEKPLNCDDEVY-----------DL 258

Query: 832 GILCTQESPSTRPTMLDAADDLDRLKR 858
              C +E P  RP+       L+R+  
Sbjct: 259 MRQCWREKPYERPSFAQILVSLNRMLE 285

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 3e-49
 Identities = 65/298 (21%), Positives = 111/298 (37%), Gaps = 49/298 (16%)

Query: 561 EQRLLGTGSYGRVYKGILQD---GTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNL 615
           E + LG+G++G V KG  Q       +AVK+L+ ++           E  V++++ +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +R+I  C    +  LV+     G L+ +L  +           +     + +   ++ GM
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGM 120

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YL        +H DL   NVLL     A +SDFG++K +         A+         
Sbjct: 121 KYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL--------RADENYYKAQTH 169

Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH 795
               + + APE       S+K DV+SFG+L+ E  +  +                   Y 
Sbjct: 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP-----------------YR 212

Query: 796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDL 853
           G     + + L +  R   P           E+ +L  LC       RP        L
Sbjct: 213 GMKGSEVTAMLEKGERMGCPA------GCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 3e-49
 Identities = 70/300 (23%), Positives = 121/300 (40%), Gaps = 56/300 (18%)

Query: 558 EFDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRN 614
           +FD +  +G GS+  VYKG+  +    +A   LQ +  + +  + F  E ++LK ++H N
Sbjct: 12  KFDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69

Query: 615 LMRIITACSLP----DFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           ++R   +            LV   M +G+L ++L              + +    + C  
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQ 120

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLND-DMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           I +G+ +LH  +P  +IH DLK  N+ +     +  + D G+A L               
Sbjct: 121 ILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL-------------KR 166

Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKW 789
            S A  + G+  +MAPE  +        DVY+FG+ +LEM T   P  +         + 
Sbjct: 167 ASFAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 225

Query: 790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDA 849
                    +KV             PEVK        E+IE    C +++   R ++ D 
Sbjct: 226 TSGVKPASFDKVA-----------IPEVK--------EIIE---GCIRQNKDERYSIKDL 263

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  173 bits (439), Expect = 8e-49
 Identities = 65/298 (21%), Positives = 109/298 (36%), Gaps = 57/298 (19%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHRN 614
           F + R +G GS+G VY    +++   +A+K +     QS    +   +E + L+++RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 615 LMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEG 674
            ++            LV+ Y    + D                 L  ++   +     +G
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---------LQEVEIAAVTHGALQG 127

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           +AYLH H    +IH D+K  N+LL++     + DFG A ++               + AN
Sbjct: 128 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM---------------APAN 169

Query: 735 MLCGSIGYMAPEYGFGSNT---STKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
              G+  +MAPE     +      K DV+S GI  +E+  R+ P  +M A    L+   +
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQ 228

Query: 792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDA 849
           N                                          C Q+ P  RPT    
Sbjct: 229 NESPALQSGHWSE----------------------YFRNFVDSCLQKIPQDRPTSEVL 264

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 1e-48
 Identities = 61/294 (20%), Positives = 113/294 (38%), Gaps = 49/294 (16%)

Query: 565 LGTGSYGRVYKGILQ---DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIIT 620
           LG G++G V +G+ +       +A+KVL+  +    T+   RE Q++ ++ +  ++R+I 
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
            C       LV+     G L   L    E         + +     +   ++ GM YL  
Sbjct: 77  VCQAEAL-MLVMEMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMKYLEE 127

Query: 681 HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSI 740
            +    +H DL   NVLL +   A +SDFG++K +        GA++   +  +     +
Sbjct: 128 KN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL--------GADDSYYTARSAGKWPL 176

Query: 741 GYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLSLHKWVKNHYHGRLE 799
            + APE       S++ DV+S+G+ + E ++  ++P   M   G  +  +++        
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAFIEQGKRMECP 234

Query: 800 KVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDL 853
                                      EL  L   C       RP  L     +
Sbjct: 235 PECPP----------------------ELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 5e-48
 Identities = 74/338 (21%), Positives = 129/338 (38%), Gaps = 51/338 (15%)

Query: 536 ITPELMHNFPRITYRELLEATAEFDEQRLLGTGSYGRVYKGILQD----GTAIAVKVL-Q 590
           + PEL+     +           F+E  ++G G +G VY G L D        AVK L +
Sbjct: 9   LNPELVQAVQHVVIGPS-SLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 65

Query: 591 LQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKA-LVLPYMANGSLDSHLYPHSE 649
           +        F  E  ++K   H N++ ++  C   +    +VLPYM +G L + +   + 
Sbjct: 66  ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET- 124

Query: 650 TEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDF 709
                   + T+   +     +A+GM +L      + +H DL   N +L++  T  V+DF
Sbjct: 125 -------HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADF 174

Query: 710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEM 769
           G+A+ +          E             + +MA E       +TK DV+SFG+L+ E+
Sbjct: 175 GLARDM-------YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 227

Query: 770 VTRRRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELI 829
           +TR  P        ++          GR             R   PE           L 
Sbjct: 228 MTRGAP----PYPDVNTFDITVYLLQGR-------------RLLQPE------YCPDPLY 264

Query: 830 ELGILCTQESPSTRPTMLDAADDLDR-LKRYLGEKHMP 866
           E+ + C       RP+  +    +      ++GE ++ 
Sbjct: 265 EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 302

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 6e-48
 Identities = 63/299 (21%), Positives = 107/299 (35%), Gaps = 47/299 (15%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRN 614
           +++    +GTGSYGR  K     DG  +  K L   S      +    E  +L+ ++H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 615 LMRIITACSLPDFKAL--VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIA 672
           ++R            L  V+ Y   G L S +   ++         L     + + + + 
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-----QYLDEEFVLRVMTQLT 119

Query: 673 EGMAYLHHHSPV--RVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
             +   H  S     V+H DLKP+NV L+      + DFG+A+++           N   
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-----------NHDT 168

Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV 790
           S A    G+  YM+PE     + + K D++S G L+ E+     P               
Sbjct: 169 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF----------- 217

Query: 791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDA 849
                    K+ +    R     S E+         E+I             RP++ + 
Sbjct: 218 --SQKELAGKIREGKFRRIPYRYSDELN--------EIIT---RMLNLKDYHRPSVEEI 263

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  169 bits (429), Expect = 9e-48
 Identities = 64/302 (21%), Positives = 125/302 (41%), Gaps = 45/302 (14%)

Query: 558 EFDEQRLLGTGSYGRVYKGILQD-GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLM 616
           +   +  LG G YG VY+G+ +     +AVK L+  +    + F +E  V+K I+H NL+
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 76

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           +++  C+      ++  +M  G+L  +L   +  E       ++ +  + + + I+  M 
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-------VSAVVLLYMATQISSAME 129

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YL        IH DL   N L+ ++    V+DFG+++L+               +     
Sbjct: 130 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM----------TGDTYTAHAGA 176

Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHG 796
              I + APE    +  S K DV++FG+L+ E+ T                         
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS-------------PYPGIDLS 223

Query: 797 RLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL 856
           ++ ++++        +  PE          ++ EL   C Q +PS RP+  +     + +
Sbjct: 224 QVYELLEKDYRMERPEGCPE----------KVYELMRACWQWNPSDRPSFAEIHQAFETM 273

Query: 857 KR 858
            +
Sbjct: 274 FQ 275

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 1e-47
 Identities = 59/316 (18%), Positives = 115/316 (36%), Gaps = 51/316 (16%)

Query: 558 EFDEQRLLGTGSYGRVYKGIL------QDGTAIAVKVLQLQSG-NFTKSFNRECQVLKRI 610
                + LG G++G+V +              +AVK+L+  +     ++   E +VL  +
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 611 -RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSD---------LT 660
             H N++ ++ AC++     ++  Y   G L + L    ++   S +S          L 
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 661 LLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGV 720
           L   ++    +A+GMA+L        IH DL   N+LL       + DFG+A+ +     
Sbjct: 144 LEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIK---- 196

Query: 721 GNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMF 780
                 +            + +MAPE  F    + + DV+S+GI + E+ +         
Sbjct: 197 -----NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251

Query: 781 AGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESP 840
                 +K +K  +     +   +                      E+ ++   C    P
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPA----------------------EMYDIMKTCWDADP 289

Query: 841 STRPTMLDAADDLDRL 856
             RPT       +++ 
Sbjct: 290 LKRPTFKQIVQLIEKQ 305

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 2e-47
 Identities = 63/351 (17%), Positives = 127/351 (36%), Gaps = 63/351 (17%)

Query: 519 RIKLIISSGKSETRSKPITPELMHNFPRITYRELLEATAE-FDEQRLLGTGSYGRVYKGI 577
           +++++  +G S+     +            Y    E   E  +  ++LG+G++G+V    
Sbjct: 4   QLQMVQVTGSSDNEYFYVDFR------EYEYDLKWEFPRENLEFGKVLGSGAFGKVMNAT 57

Query: 578 LQD------GTAIAVKVLQLQSG-NFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFKA 629
                       +AVK+L+ ++  +  ++   E +++ ++  H N++ ++ AC+L     
Sbjct: 58  AYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 117

Query: 630 LVLPYMANGSLDSHLYPHSET--------------EFGSGSSDLTLLQRVNICSDIAEGM 675
           L+  Y   G L ++L    E               E     + LT    +     +A+GM
Sbjct: 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM 177

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            +L        +H DL   NVL+       + DFG+A+ +M          +        
Sbjct: 178 EFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIM---------SDSNYVVRGN 225

Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH 795
               + +MAPE  F    + K DV+S+GIL+ E+ +             + +K ++N + 
Sbjct: 226 ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK 285

Query: 796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTM 846
                                          E+  +   C       RP+ 
Sbjct: 286 MDQPFYATE----------------------EIYIIMQSCWAFDSRKRPSF 314

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 6e-47
 Identities = 57/292 (19%), Positives = 109/292 (37%), Gaps = 47/292 (16%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           +     +G G+ G VY  + +  G  +A++ + LQ     +    E  V++  ++ N++ 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
            + +  + D   +V+ Y+A GSL   +      E           Q   +C +  + + +
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE----------GQIAAVCRECLQALEF 131

Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH +   +VIH D+K  N+LL  D +  ++DFG    +               S  + + 
Sbjct: 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-----------TPEQSKRSTMV 177

Query: 738 GSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGR 797
           G+  +MAPE         K D++S GI+ +EM+    P    +     L        +G 
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP----YLNENPLRALYLIATNGT 233

Query: 798 LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDA 849
            E      L       S   +        + +     C       R +  + 
Sbjct: 234 PELQNPEKL-------SAIFR--------DFLN---RCLDMDVEKRGSAKEL 267

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 7e-47
 Identities = 65/296 (21%), Positives = 112/296 (37%), Gaps = 54/296 (18%)

Query: 558 EFDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHR 613
           +F+  R LG G +G VY     Q    +A+KVL   QL+         RE ++   +RH 
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           N++R+           L+L Y   G++   L   S+             +     +++A 
Sbjct: 67  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---------FDEQRTATYITELAN 117

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            ++Y H     RVIH D+KP N+LL       ++DFG +              +  +S  
Sbjct: 118 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV-------------HAPSSRR 161

Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH 793
             LCG++ Y+ PE   G     K D++S G+L  E +  + P +       +  +  K  
Sbjct: 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKRI 216

Query: 794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDA 849
                               +   +        +LI       + +PS RP + + 
Sbjct: 217 SRVEFT---------FPDFVTEGAR--------DLIS---RLLKHNPSQRPMLREV 252

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (420), Expect = 1e-46
 Identities = 65/295 (22%), Positives = 117/295 (39%), Gaps = 46/295 (15%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQL-QSGNFTKSFNRECQVLKRIRHRNL 615
           ++D  + LG G+YG V   +      A+AVK++ + ++ +  ++  +E  + K + H N+
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++        + + L L Y + G L   + P            +           +  G+
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---------IGMPEPDAQRFFHQLMAGV 116

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            YLH      + H D+KP N+LL++     +SDFG+A +            N      N 
Sbjct: 117 VYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR---------YNNRERLLNK 164

Query: 736 LCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
           +CG++ Y+APE        +   DV+S GI++  M+    P D           W +   
Sbjct: 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 224

Query: 795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDA 849
           +    K IDS+ L         + ++                 E+PS R T+ D 
Sbjct: 225 YLNPWKKIDSAPLAL-------LHKIL---------------VENPSARITIPDI 257

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 1e-46
 Identities = 58/297 (19%), Positives = 111/297 (37%), Gaps = 50/297 (16%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           ++    LG G++G+VYK    +     A KV+  +S    + +  E  +L    H N+++
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           ++ A    +   +++ + A G++D+ +              LT  Q   +C    + + Y
Sbjct: 74  LLDAFYYENNLWILIEFCAGGAVDAVMLELERP--------LTESQIQVVCKQTLDALNY 125

Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLC 737
           LH +   ++IH DLK  N+L   D    ++DFG++                     +   
Sbjct: 126 LHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR-----------TIQRRDSFI 171

Query: 738 GSIGYMAPEYGFGSNT-----STKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN 792
           G+  +MAPE      +       K DV+S GI ++EM     P        L+  + +  
Sbjct: 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH-----ELNPMRVLLK 226

Query: 793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDA 849
                   +   S        S   K        + ++    C +++   R T    
Sbjct: 227 IAKSEPPTLAQPSRW------SSNFK--------DFLK---KCLEKNVDARWTTSQL 266

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 5e-45
 Identities = 65/304 (21%), Positives = 120/304 (39%), Gaps = 43/304 (14%)

Query: 558 EFDEQRLLGTGSYGRVYKGIL------QDGTAIAVKVLQL-QSGNFTKSFNRECQVLKRI 610
           +    R LG GS+G VY+G+       +  T +A+K +    S      F  E  V+K  
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80

Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSET-EFGSGSSDLTLLQRVNICS 669
              +++R++   S      +++  M  G L S+L             +  +L + + +  
Sbjct: 81  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140

Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
           +IA+GMAYL+ +   + +H DL   N ++ +D T  + DFG+ + +          E   
Sbjct: 141 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY---------ETDY 188

Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKW 789
                     + +M+PE       +T  DV+SFG+++ E+ T                 +
Sbjct: 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP------------Y 236

Query: 790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDA 849
                   L  V++  LL    +    +            EL  +C Q +P  RP+ L+ 
Sbjct: 237 QGLSNEQVLRFVMEGGLLDKPDNCPDMLF-----------ELMRMCWQYNPKMRPSFLEI 285

Query: 850 ADDL 853
              +
Sbjct: 286 ISSI 289

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 2e-44
 Identities = 67/307 (21%), Positives = 121/307 (39%), Gaps = 50/307 (16%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL-----QLQSGNFTKSFNRECQVLKRIR 611
           EF + ++LG+G++G VYKG+ + +G  + + V      +  S    K    E  V+  + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69

Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           + ++ R++  C     + L+   M  G L  ++  H +        ++     +N C  I
Sbjct: 70  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQI 120

Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           A+GM YL      R++H DL   NVL+       ++DFG+AKL+                
Sbjct: 121 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA---------EEKEY 168

Query: 732 TANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK 791
            A      I +MA E       + + DV+S+G+ V E++T                    
Sbjct: 169 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---------------- 212

Query: 792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAAD 851
             Y G     I S L +  R   P       +   ++  + + C      +RP   +   
Sbjct: 213 -PYDGIPASEISSILEKGERLPQPP------ICTIDVYMIMVKCWMIDADSRPKFRELII 265

Query: 852 DLDRLKR 858
           +  ++ R
Sbjct: 266 EFSKMAR 272

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 1e-43
 Identities = 71/307 (23%), Positives = 101/307 (32%), Gaps = 49/307 (15%)

Query: 558 EFDEQRLLGTGSYGRVYKGIL----QDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRI 610
           +      LG GS+G V +G          ++AVK L+   L        F RE   +  +
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
            HRNL+R+      P  K +V      GSL   L  H             L         
Sbjct: 69  DHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH--------FLLGTLSRYAVQ 119

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +AEGM YL      R IH DL   N+LL       + DFG+ + +           +   
Sbjct: 120 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL--------PQNDDHY 168

Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV 790
                      + APE       S   D + FG+ + EM T  +       G   LHK  
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 228

Query: 791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAA 850
           K     RL +  D                       ++  + + C    P  RPT +   
Sbjct: 229 KEGE--RLPRPEDCPQ--------------------DIYNVMVQCWAHKPEDRPTFVALR 266

Query: 851 DDLDRLK 857
           D L   +
Sbjct: 267 DFLLEAQ 273

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 3e-43
 Identities = 58/304 (19%), Positives = 105/304 (34%), Gaps = 50/304 (16%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHR 613
           +F   ++LG GS+  V     L      A+K+L    +   N      RE  V+ R+ H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
             +++       +     L Y  NG L  ++                        ++I  
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---------FDETCTRFYTAEIVS 119

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + YLH      +IH DLKP N+LLN+DM   ++DFG AK++               + A
Sbjct: 120 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLS---------PESKQARA 167

Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH 793
           N   G+  Y++PE     +     D+++ G ++ ++V    P    F  G + +   +  
Sbjct: 168 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAG-NEYLIFQKI 222

Query: 794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDL 853
                +               P+ +        +L+E          + R    +     
Sbjct: 223 IKLEYD---------FPEKFFPKAR--------DLVE---KLLVLDATKRLGCEEMEGYG 262

Query: 854 DRLK 857
               
Sbjct: 263 PLKA 266

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 1e-42
 Identities = 54/304 (17%), Positives = 112/304 (36%), Gaps = 50/304 (16%)

Query: 558 EFDEQRLLGTGSYGRVYKGIL----QDGTAIAVKVL-QLQSGNFTKSFNRECQVLKRIRH 612
             +  R +G G +G V++GI         A+A+K      S +  + F +E   +++  H
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67

Query: 613 RNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIA 672
            +++++I   +  +   +++     G L S L     +        L L   +     ++
Sbjct: 68  PHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYS--------LDLASLILYAYQLS 118

Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
             +AYL      R +H D+   NVL++ +    + DFG+++ +          E+     
Sbjct: 119 TALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM----------EDSTYYK 165

Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN 792
           A+     I +MAPE       ++  DV+ FG+ + E++                      
Sbjct: 166 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG------------V 213

Query: 793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD 852
             +  + ++ +   L    +  P +          L+     C    PS RP   +    
Sbjct: 214 KNNDVIGRIENGERLPMPPNCPPTLY--------SLMT---KCWAYDPSRRPRFTELKAQ 262

Query: 853 LDRL 856
           L  +
Sbjct: 263 LSTI 266

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  155 bits (392), Expect = 5e-42
 Identities = 48/294 (16%), Positives = 102/294 (34%), Gaps = 47/294 (15%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           +D    LGTG++G V++      G   A K +     +  ++  +E Q +  +RH  L+ 
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +  A    +   ++  +M+ G L   +              ++  + V     + +G+ +
Sbjct: 88  LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--------MSEDEAVEYMRQVCKGLCH 139

Query: 678 LHHHSPVRVIHCDLKPSNVLLNDDMTALV--SDFGIAKLVMTVGVGNDGAENMGNSTANM 735
           +H +     +H DLKP N++     +  +   DFG+   +                +  +
Sbjct: 140 MHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL------------DPKQSVKV 184

Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH 795
             G+  + APE   G       D++S G+L   +++   P                  + 
Sbjct: 185 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP------------------FG 226

Query: 796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDA 849
           G  +     ++     +              + I          P+TR T+  A
Sbjct: 227 GENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR---KLLLADPNTRMTIHQA 277

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 8e-42
 Identities = 71/317 (22%), Positives = 125/317 (39%), Gaps = 54/317 (17%)

Query: 558 EFDEQRLLGTGSYGRVYKGIL--------QDGTAIAVKVLQLQ-SGNFTKSFNRECQVLK 608
                + LG G++G+V                T +AVK+L+   +         E +++K
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73

Query: 609 RI-RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPH-------SETEFGSGSSDLT 660
            I +H+N++ ++ AC+      +++ Y + G+L  +L          S     +    L+
Sbjct: 74  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 661 LLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGV 720
               V+    +A GM YL      + IH DL   NVL+ +D    ++DFG+A+ +     
Sbjct: 134 SKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDI----- 185

Query: 721 GNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMF 780
                              + +MAPE  F    + + DV+SFG+L+ E+ T         
Sbjct: 186 ----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP-- 239

Query: 781 AGGLSLHKWVKNHYHG-RLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQES 839
             G+ + +  K    G R++K  + +                     EL  +   C    
Sbjct: 240 --GVPVEELFKLLKEGHRMDKPSNCT--------------------NELYMMMRDCWHAV 277

Query: 840 PSTRPTMLDAADDLDRL 856
           PS RPT     +DLDR+
Sbjct: 278 PSQRPTFKQLVEDLDRI 294

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  149 bits (377), Expect = 6e-40
 Identities = 51/294 (17%), Positives = 105/294 (35%), Gaps = 47/294 (15%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           +D    LG+G++G V++ +    G     K +         +   E  ++ ++ H  L+ 
Sbjct: 31  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90

Query: 618 IITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAY 677
           +  A        L+L +++ G L   +              ++  + +N      EG+ +
Sbjct: 91  LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--------MSEAEVINYMRQACEGLKH 142

Query: 678 LHHHSPVRVIHCDLKPSNVLL--NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
           +H H    ++H D+KP N++       +  + DFG+A  +              +    +
Sbjct: 143 MHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP------------DEIVKV 187

Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH 795
              +  + APE           D+++ G+L   +++   P            + ++N   
Sbjct: 188 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-----DDLETLQNVKR 242

Query: 796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDA 849
              E         A    SPE K        + I+      Q+ P  R T+ DA
Sbjct: 243 CDWE-----FDEDAFSSVSPEAK--------DFIK---NLLQKEPRKRLTVHDA 280

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 7e-40
 Identities = 62/315 (19%), Positives = 119/315 (37%), Gaps = 50/315 (15%)

Query: 558 EFDEQRLLGTGSYGRVYKGI------LQDGTAIAVKVLQLQSGN-FTKSFNRECQVLKRI 610
                + LG G++G+V +              +AVK+L+  + +   ++   E ++L  I
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 611 RHR-NLMRIITACSLPDFK-ALVLPYMANGSLDSHLY-------PHSETEFGSGSSDLTL 661
            H  N++ ++ AC+ P     +++ +   G+L ++L        P+           LTL
Sbjct: 74  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133

Query: 662 LQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVG 721
              +     +A+GM +L      + IH DL   N+LL++     + DFG+A+ +      
Sbjct: 134 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY----- 185

Query: 722 NDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFA 781
               ++            + +MAPE  F    + + DV+SFG+L+ E+ +          
Sbjct: 186 ----KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241

Query: 782 GGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPS 841
                 + +K     R                             E+ +  + C    PS
Sbjct: 242 IDEEFCRRLKEGTRMRAPDYTTP----------------------EMYQTMLDCWHGEPS 279

Query: 842 TRPTMLDAADDLDRL 856
            RPT  +  + L  L
Sbjct: 280 QRPTFSELVEHLGNL 294

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  144 bits (363), Expect = 5e-39
 Identities = 55/309 (17%), Positives = 113/309 (36%), Gaps = 50/309 (16%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRHRN 614
           ++   +LG G    V+    L+    +AVKVL+    +  +F   F RE Q    + H  
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 615 LMRIITACSLPDFKA----LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
           ++ +               +V+ Y+   +L   ++             +T  + + + +D
Sbjct: 69  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---------MTPKRAIEVIAD 119

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
             + + + H +    +IH D+KP+N++++      V DFGIA+ +               
Sbjct: 120 ACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD--------SGNSV 168

Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV 790
           +    + G+  Y++PE   G +   + DVYS G ++ E++T   P               
Sbjct: 169 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP--------------- 213

Query: 791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP-TMLDA 849
              + G     +    +R                +  ++        ++P  R  T  + 
Sbjct: 214 ---FTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVL---KALAKNPENRYQTAAEM 267

Query: 850 ADDLDRLKR 858
             DL R+  
Sbjct: 268 RADLVRVHN 276

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 6e-39
 Identities = 60/308 (19%), Positives = 115/308 (37%), Gaps = 26/308 (8%)

Query: 551 ELLEATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL-QLQSGNFTKSFNRECQVLK 608
           ++ +    +     +G G+YG V       +   +A+K +   +   + +   RE ++L 
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61

Query: 609 RIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNIC 668
           R RH N++ I      P  + +   Y+    + + LY   +T+       L+        
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH------LSNDHICYFL 115

Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
             I  G+ Y+H      V+H DLKPSN+LLN      + DFG+A++           ++ 
Sbjct: 116 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA--------DPDHD 164

Query: 729 GNSTANMLCGSIGYMAPEY-GFGSNTSTKGDVYSFGILVLEMVTRRRP------TDDMFA 781
                     +  Y APE        +   D++S G ++ EM++ R         D +  
Sbjct: 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH 224

Query: 782 GGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPS 841
               L    +   +  +     + LL           R++  A  + ++L       +P 
Sbjct: 225 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPH 284

Query: 842 TRPTMLDA 849
            R  +  A
Sbjct: 285 KRIEVEQA 292

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  140 bits (355), Expect = 1e-37
 Identities = 50/293 (17%), Positives = 101/293 (34%), Gaps = 44/293 (15%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLM 616
           +D + +LGTG++  V      +    +A+K +  ++      S   E  VL +I+H N++
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
            +           L++  ++ G L   +               T      +   + + + 
Sbjct: 71  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---------YTERDASRLIFQVLDAVK 121

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YLH    V             L++D   ++SDFG++K+                S  +  
Sbjct: 122 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP------------GSVLSTA 169

Query: 737 CGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHG 796
           CG+ GY+APE       S   D +S G++   ++    P                  ++ 
Sbjct: 170 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP------------------FYD 211

Query: 797 RLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDA 849
             +  +   +L+A  +           +  + I       ++ P  R T   A
Sbjct: 212 ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR---HLMEKDPEKRFTCEQA 261

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (355), Expect = 2e-37
 Identities = 48/303 (15%), Positives = 112/303 (36%), Gaps = 51/303 (16%)

Query: 550 RELLEATAEFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLK 608
           +EL E   ++     LG G +G V++ +          K ++++ G       +E  +L 
Sbjct: 1   KELYE---KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILN 56

Query: 609 RIRHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNIC 668
             RHRN++ +  +    +   ++  +++   +   +         + + +L   + V+  
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDIFERIN--------TSAFELNEREIVSYV 108

Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALV--SDFGIAKLVMTVGVGNDGAE 726
             + E + +LH H    + H D++P N++     ++ +   +FG A+ +           
Sbjct: 109 HQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--------- 156

Query: 727 NMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSL 786
                   +L  +  Y APE       ST  D++S G LV  +++   P           
Sbjct: 157 ---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP----------- 202

Query: 787 HKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTM 846
                  +     + I  +++ A      E  +   +   + ++       +   +R T 
Sbjct: 203 -------FLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD---RLLVKERKSRMTA 252

Query: 847 LDA 849
            +A
Sbjct: 253 SEA 255

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 1e-36
 Identities = 64/298 (21%), Positives = 115/298 (38%), Gaps = 53/298 (17%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKR-IRH 612
           +F   ++LG GS+G+V+     +     A+K L+   +   +  +    E +VL     H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 613 RNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIA 672
             L  +       +    V+ Y+  G L  H+    +           L +     ++I 
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEII 113

Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
            G+ +LH      +++ DLK  N+LL+ D    ++DFG+ K  M            G++ 
Sbjct: 114 LGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML-----------GDAK 159

Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN 792
            N  CG+  Y+APE   G   +   D +SFG+L+ EM+  + P                 
Sbjct: 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP----------------- 202

Query: 793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAA 850
            +HG+ E+     L  + R  +P   R  +    +L+          P  R  +    
Sbjct: 203 -FHGQDEE----ELFHSIRMDNPFYPRWLEKEAKDLLV---KLFVREPEKRLGVRGDI 252

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  137 bits (347), Expect = 2e-36
 Identities = 59/226 (26%), Positives = 93/226 (41%), Gaps = 30/226 (13%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQ---LQSGNFTKSFNRECQVLKRIRHR 613
           +F   R LGTGS+GRV+      +G   A+KVL+   +      +  N E  +L  + H 
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64

Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
            ++R+           +++ Y+  G L S L                        +++  
Sbjct: 65  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---------PNPVAKFYAAEVCL 115

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + YLH      +I+ DLKP N+LL+ +    ++DFG AK V                  
Sbjct: 116 ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV--------------PDVT 158

Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDM 779
             LCG+  Y+APE       +   D +SFGIL+ EM+    P  D 
Sbjct: 159 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 204

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  136 bits (343), Expect = 4e-36
 Identities = 47/298 (15%), Positives = 100/298 (33%), Gaps = 38/298 (12%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           R +G+GS+G +Y G  +  G  +A+K+  +++ +     + E ++ K ++    +  I  
Sbjct: 13  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 70

Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH 681
           C       +++  +   SL+      S           +L   + +   +   + Y+H  
Sbjct: 71  CGAEGDYNVMVMELLGPSLEDLFNFCSRK--------FSLKTVLLLADQMISRIEYIHSK 122

Query: 682 SPVRVIHCDLKPSNVLLND---DMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCG 738
                IH D+KP N L+          + DFG+AK            +++       L G
Sbjct: 123 ---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR----DARTHQHIPYRENKNLTG 175

Query: 739 SIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYHGRL 798
           +  Y +     G   S + D+ S G +++       P   + A   +  +  +     ++
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA--ATKRQKYERISEKKM 233

Query: 799 EKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL 856
              I+       +    E            +     C       +P           L
Sbjct: 234 STPIEV----LCKGYPSEFA--------TYLN---FCRSLRFDDKPDYSYLRQLFRNL 276

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  135 bits (341), Expect = 5e-36
 Identities = 56/308 (18%), Positives = 111/308 (36%), Gaps = 62/308 (20%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGN---------FTKSFNRECQVLK 608
           ++ + +LG G    V + I        AVK++ +  G            ++  +E  +L+
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 609 RIR-HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI 667
           ++  H N++++        F  LV   M  G L  +L              L+  +   I
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---------LSEKETRKI 115

Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
              + E +  LH      ++H DLKP N+LL+DDM   ++DFG +  +            
Sbjct: 116 MRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---------- 162

Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNT------STKGDVYSFGILVLEMVTRRRPTDDMFA 781
                   +CG+  Y+APE    S          + D++S G+++  ++    P      
Sbjct: 163 --GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP------ 214

Query: 782 GGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPS 841
                       +  R + ++   ++  +          +   + +L+          P 
Sbjct: 215 ------------FWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQ 259

Query: 842 TRPTMLDA 849
            R T  +A
Sbjct: 260 KRYTAEEA 267

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  135 bits (340), Expect = 7e-36
 Identities = 59/299 (19%), Positives = 108/299 (36%), Gaps = 32/299 (10%)

Query: 559 FDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNLM 616
           +     +G G+YG VYK     G   A+K ++L+  +     +  RE  +LK ++H N++
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
           ++           LV  ++                       L  +   +    +  G+A
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---------LESVTAKSFLLQLLNGIA 114

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           Y H     RV+H DLKP N+L+N +    ++DFG+A+              +        
Sbjct: 115 YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-----------GIPVRKYTHE 160

Query: 737 CGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH 795
             ++ Y AP+   GS   ST  D++S G +  EMV        +      L +  +    
Sbjct: 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGT 219

Query: 796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIG-----ELIELGILCTQESPSTRPTMLDA 849
              +   + + L          + +   +         I+L     +  P+ R T   A
Sbjct: 220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 9e-36
 Identities = 61/314 (19%), Positives = 123/314 (39%), Gaps = 32/314 (10%)

Query: 558 EFDEQRLLGTGSYGRVYKG--ILQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRI--- 610
           +++    +G G+YG+V+K   +   G  +A+K +++Q+G      S  RE  VL+ +   
Sbjct: 8   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67

Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
            H N++R+   C++          +    +D  L  + +     G   +      ++   
Sbjct: 68  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG---VPTETIKDMMFQ 124

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           +  G+ +LH H   RV+H DLKP N+L+       ++DFG+A++                
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF------------Q 169

Query: 731 STANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGL--SLHK 788
                +  ++ Y APE    S+ +T  D++S G +  EM  R+              +  
Sbjct: 170 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 229

Query: 789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLD 848
            +         + +           +  +++          +L + C   +P+ R +   
Sbjct: 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 289

Query: 849 AA-----DDLDRLK 857
           A       DL+R K
Sbjct: 290 ALSHPYFQDLERCK 303

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 2e-34
 Identities = 62/306 (20%), Positives = 114/306 (37%), Gaps = 42/306 (13%)

Query: 559 FDEQRLLGTGSYGRVYKGIL-QDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMR 617
           + + +++G GS+G VY+  L   G  +A+K +        +  NRE Q+++++ H N++R
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77

Query: 618 IITACSLPD------FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           +              +  LVL Y+         +      +      L ++        +
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH------YSRAKQTLPVIYVKLYMYQL 131

Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDD-MTALVSDFGIAKLVMTVGVGNDGAENMGN 730
              +AY+H      + H D+KP N+LL+ D     + DFG AK ++              
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------------G 176

Query: 731 STANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRRRP------TDDMFAGG 783
                   S  Y APE  FG+   ++  DV+S G ++ E++  +         D +    
Sbjct: 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236

Query: 784 LSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTR 843
             L    +           +    +      P  K        E I L     + +P+ R
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAH--PWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

Query: 844 PTMLDA 849
            T L+A
Sbjct: 295 LTPLEA 300

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  132 bits (333), Expect = 4e-34
 Identities = 59/305 (19%), Positives = 104/305 (34%), Gaps = 56/305 (18%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQL------QSGNFTKSFNRECQVLKRI 610
           +F   R++G G +G VY       G   A+K L        Q      +      ++   
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 611 RHRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSD 670
               ++ +  A   PD  + +L  M  G L  HL  H            +        ++
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---------SEADMRFYAAE 115

Query: 671 IAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGN 730
           I  G+ ++H+     V++ DLKP+N+LL++     +SD G+A              +   
Sbjct: 116 IILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC-------------DFSK 159

Query: 731 STANMLCGSIGYMAPEYGF-GSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKW 789
              +   G+ GYMAPE    G    +  D +S G ++ +++    P           H+ 
Sbjct: 160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH--KTKDKHEI 217

Query: 790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTML-D 848
            +      +E                    + D    EL  L     Q   + R   L  
Sbjct: 218 DRMTLTMAVE--------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGR 257

Query: 849 AADDL 853
            A ++
Sbjct: 258 GAQEV 262

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 6e-34
 Identities = 63/316 (19%), Positives = 115/316 (36%), Gaps = 40/316 (12%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQS-----GNFTKSFNRECQVLKRIRHRNLM 616
             LG G +  VYK         +A+K ++L           ++  RE ++L+ + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 617 RIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMA 676
            ++ A       +LV  +M                    S  LT            +G+ 
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVII---------KDNSLVLTPSHIKAYMLMTLQGLE 114

Query: 677 YLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANML 736
           YLH H    ++H DLKP+N+LL+++    ++DFG+AK   +            N      
Sbjct: 115 YLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-----------PNRAYTHQ 160

Query: 737 CGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH 795
             +  Y APE  FG+       D+++ G ++ E++ R             L +  +    
Sbjct: 161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGT 219

Query: 796 GRLEKVIDSSLLRA----SRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAAD 851
              E+  D   L             +  ++  A  +L++L       +P  R T   A  
Sbjct: 220 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

Query: 852 DLDRLKRYLGEKHMPS 867
                 +Y   +  P+
Sbjct: 280 M-----KYFSNRPGPT 290

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 1e-33
 Identities = 61/328 (18%), Positives = 121/328 (36%), Gaps = 43/328 (13%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNL 615
           +++   +G G++G V+K    + G  +A+K + +++    F  +  RE ++L+ ++H N+
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 616 MRIITACSLPDFKA--------LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNI 667
           + +I  C               LV  +  +           +          TL +   +
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---------FTLSEIKRV 122

Query: 668 CSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAEN 727
              +  G+ Y+H +   +++H D+K +NVL+  D    ++DFG+A+           A+N
Sbjct: 123 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF-------SLAKN 172

Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRRRP-----TDDMFA 781
              +       ++ Y  PE   G        D++  G ++ EM TR             A
Sbjct: 173 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 232

Query: 782 GGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMW--DVAIGELIELGILCTQES 839
               L   +       ++       L   + Q  +VK      V     ++L        
Sbjct: 233 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 292

Query: 840 PSTRPTMLDAADDLDRLKRYLGEKHMPS 867
           P+ R    DA +       +     MPS
Sbjct: 293 PAQRIDSDDALNH-----DFFWSDPMPS 315

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (321), Expect = 3e-33
 Identities = 62/300 (20%), Positives = 112/300 (37%), Gaps = 32/300 (10%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQL--QSGNFTKSFNRECQVLKRIRHRNL 615
           F +   +G G+YG VYK      G  +A+K ++L  ++     +  RE  +LK + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           ++++      +   LV  ++                     + + L    +    + +G+
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL--------TGIPLPLIKSYLFQLLQGL 115

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
           A+ H H   RV+H DLKP N+L+N +    ++DFG+A+                  T   
Sbjct: 116 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-----------PVRTYTH 161

Query: 736 LCGSIGYMAPE-YGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
              ++ Y APE        ST  D++S G +  EMVTRR            L +  +   
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLG 220

Query: 795 HGRLEKVIDSSLLRASRDQSPEVKR-----MWDVAIGELIELGILCTQESPSTRPTMLDA 849
                     + +   +   P+  R     +      +   L        P+ R +   A
Sbjct: 221 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 5e-33
 Identities = 55/298 (18%), Positives = 102/298 (34%), Gaps = 55/298 (18%)

Query: 562 QRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLMRII 619
            ++LG G  G+V +    +     A+K+LQ           RE ++  R  +  +++RI+
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIV 71

Query: 620 TACSLPDFKA----LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
                         +V+  +  G L S +          G    T  +   I   I E +
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRIQDR-------GDQAFTEREASEIMKSIGEAI 124

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
            YLH      + H D+KP N+L      +    ++DFG AK   +            +++
Sbjct: 125 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS------------HNS 169

Query: 733 ANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN 792
               C +  Y+APE           D++S G+++  ++    P                 
Sbjct: 170 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP----------------- 212

Query: 793 HYHGRLEKVIDSSLLRASRDQSPEVKR-MWDVAIGELIELGILCTQESPSTRPTMLDA 849
            ++      I   +    R    E     W     E+  L     +  P+ R T+ + 
Sbjct: 213 -FYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 6e-33
 Identities = 57/302 (18%), Positives = 105/302 (34%), Gaps = 56/302 (18%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQL------QSGNFTKSFNRECQVLKRIR 611
           +D    LG+G +  V K      G   A K ++       + G   +   RE  +LK I+
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 612 HRNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDI 671
           H N++ +           L+L  +A G L   L              LT  +       I
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---------SLTEEEATEFLKQI 122

Query: 672 AEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL----VSDFGIAKLVMTVGVGNDGAEN 727
             G+ YLH     ++ H DLKP N++L D         + DFG+A  +            
Sbjct: 123 LNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF---------- 169

Query: 728 MGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH 787
              +    + G+  ++APE         + D++S G++   +++   P            
Sbjct: 170 --GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP------------ 215

Query: 788 KWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTML 847
                 + G  ++   +++   + +   E          + I        + P  R T+ 
Sbjct: 216 ------FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR---RLLVKDPKKRMTIQ 266

Query: 848 DA 849
           D+
Sbjct: 267 DS 268

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 6e-33
 Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 27/222 (12%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  +LLG G++G+V        G   A+K+L    + + +       E +VL+  RH 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
            L  +  A    D    V+ Y   G L  HL               T  +     ++I  
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---------FTEERARFYGAEIVS 116

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
            + YLH      V++ D+K  N++L+ D    ++DFG+ K  +              +T 
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-----------SDGATM 162

Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
              CG+  Y+APE    ++     D +  G+++ EM+  R P
Sbjct: 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  126 bits (316), Expect = 1e-32
 Identities = 44/308 (14%), Positives = 94/308 (30%), Gaps = 40/308 (12%)

Query: 562 QRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIIT 620
            R +G GS+G +++G  L +   +A+K    +S         E +  K +     +  + 
Sbjct: 10  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVY 67

Query: 621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH 680
                    +++  +   SL+  L               ++         +   +  +H 
Sbjct: 68  YFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--------FSVKTVAMAAKQMLARVQSIHE 119

Query: 681 HSPVRVIHCDLKPSNVLLNDDMT-----ALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
                +++ D+KP N L+    +       V DFG+ K            +++       
Sbjct: 120 K---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR----DPVTKQHIPYREKKN 172

Query: 736 LCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH 795
           L G+  YM+     G   S + D+ + G + +  +    P   +               +
Sbjct: 173 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL-------KAATNKQKY 225

Query: 796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDR 855
            R+ +   S+ LR      PE          E  +        +    P          +
Sbjct: 226 ERIGEKKQSTPLRELCAGFPE----------EFYKYMHYARNLAFDATPDYDYLQGLFSK 275

Query: 856 LKRYLGEK 863
           +   L   
Sbjct: 276 VLERLNTT 283

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 2e-32
 Identities = 53/300 (17%), Positives = 110/300 (36%), Gaps = 32/300 (10%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGN--FTKSFNRECQVLKRIRHRNL 615
           +++   +G G+YG V+K    +    +A+K ++L   +     S  RE  +LK ++H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 616 MRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGM 675
           +R+           LV  +            + +                +    + +G+
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---------DPEIVKSFLFQLLKGL 114

Query: 676 AYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANM 735
            + H      V+H DLKP N+L+N +    +++FG+A+              +     + 
Sbjct: 115 GFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-----------GIPVRCYSA 160

Query: 736 LCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHY 794
              ++ Y  P+  FG+   ST  D++S G +  E+    RP          L +  +   
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220

Query: 795 HGRLEKVIDSSLLRASRDQSPEVKRMWDVAIG-----ELIELGILCTQESPSTRPTMLDA 849
               E+    + L   +           V +         +L     + +P  R +  +A
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  126 bits (318), Expect = 3e-32
 Identities = 54/222 (24%), Positives = 90/222 (40%), Gaps = 30/222 (13%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL---QLQSGNFTKSFNRECQVLKRIRHR 613
           +FD  + LGTGS+GRV      + G   A+K+L   ++      +    E ++L+ +   
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 614 NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
            L+++  +        +V+ Y+A G + SHL               +        + I  
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---------FSEPHARFYAAQIVL 152

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTA 733
              YLH      +I+ DLKP N+L++      V+DFG AK V                  
Sbjct: 153 TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------------GRT 195

Query: 734 NMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP 775
             LCG+   +APE       +   D ++ G+L+ EM     P
Sbjct: 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 1e-31
 Identities = 59/324 (18%), Positives = 107/324 (33%), Gaps = 71/324 (21%)

Query: 562 QRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGN------FTKSFNRECQVLKRIR--H 612
             LLG+G +G VY GI + D   +A+K ++    +             E  +LK++    
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68

Query: 613 RNLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIA 672
             ++R++     PD   L+L                          L      +    + 
Sbjct: 69  SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--------LQEELARSFFWQVL 120

Query: 673 EGMAYLHHHSPVRVIHCDLKPSNVLLN-DDMTALVSDFGIAKLVMTVGVGNDGAENMGNS 731
           E + + H+     V+H D+K  N+L++ +     + DFG   L             + ++
Sbjct: 121 EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL-------------LKDT 164

Query: 732 TANMLCGSIGYMAPEY-GFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV 790
                 G+  Y  PE+  +         V+S GIL+ +MV    P +             
Sbjct: 165 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH------------ 212

Query: 791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAA 850
                       D  ++R        V         E   L   C    PS RPT  +  
Sbjct: 213 ------------DEEIIRGQVFFRQRVSS-------ECQHLIRWCLALRPSDRPTFEEIQ 253

Query: 851 DDLDRLKRYLGEKHMPSKMNALHL 874
           +       ++ +  +P +   +HL
Sbjct: 254 NH-----PWMQDVLLPQETAEIHL 272

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 1e-30
 Identities = 67/320 (20%), Positives = 119/320 (37%), Gaps = 44/320 (13%)

Query: 548 TYRELLEATAEFDEQ----RLLGTGSYGRVYKGI-LQDGTAIAVKVL--QLQSGNFTKSF 600
             +E+ +   E        + +G+G+YG V   +  + G  +A+K L    QS  F K  
Sbjct: 5   YRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA 64

Query: 601 NRECQVLKRIRHRNLMRIITAC----SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGS 656
            RE ++LK +RH N++ ++       +L DF    L     G+    L  H +       
Sbjct: 65  YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK------- 117

Query: 657 SDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM 716
             L   +   +   + +G+ Y+H      +IH DLKP N+ +N+D    + DFG+A+   
Sbjct: 118 --LGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA- 171

Query: 717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRP 775
                        +S       +  Y APE        +   D++S G ++ EM+T +  
Sbjct: 172 -------------DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218

Query: 776 -TDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKR-----MWDVAIGELI 829
                    L     V         + + S   +      PE+++     +   A    +
Sbjct: 219 FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAV 278

Query: 830 ELGILCTQESPSTRPTMLDA 849
            L           R T  +A
Sbjct: 279 NLLEKMLVLDAEQRVTAGEA 298

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  120 bits (302), Expect = 2e-30
 Identities = 54/311 (17%), Positives = 109/311 (35%), Gaps = 49/311 (15%)

Query: 558 EFDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIR-HRNL 615
           ++   R LG G Y  V++ I + +   + VK+L+       K   RE ++L+ +R   N+
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNI 92

Query: 616 MRIITACSLPDFK--ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAE 673
           + +      P  +  ALV  ++ N          ++ +                  +I +
Sbjct: 93  ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD------------IRFYMYEILK 140

Query: 674 GMAYLHHHSPVRVIHCDLKPSNVLL-NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNST 732
            + Y H      ++H D+KP NV++ ++     + D+G+A+                   
Sbjct: 141 ALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP------------GQE 185

Query: 733 ANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDD-----------MF 780
            N+   S  +  PE            D++S G ++  M+ R+ P                
Sbjct: 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245

Query: 781 AGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEV--KRMWDVAIGELIELGILCTQE 838
             G        + Y+  L+   +  L R SR +           +   E ++      + 
Sbjct: 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 305

Query: 839 SPSTRPTMLDA 849
              +R T  +A
Sbjct: 306 DHQSRLTAREA 316

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 2e-29
 Identities = 59/340 (17%), Positives = 110/340 (32%), Gaps = 58/340 (17%)

Query: 559 FDEQRLLGTGSYGRVYKGI-LQDGTAIAVKVL--QLQSGNFTKSFNRECQVLKRIRHRNL 615
           +   + +G+G+ G V           +A+K L    Q+    K   RE  ++K + H+N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 616 MRIITACSLPDFK------ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICS 669
           + ++   +            LV+  M                           +   +  
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE------------RMSYLLY 126

Query: 670 DIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMG 729
            +  G+ +LH       IH DLKPSN+++  D T  + DFG+A+   T            
Sbjct: 127 QMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGT------------ 171

Query: 730 NSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGL----- 784
           +        +  Y APE   G       D++S G ++ EMV  +                
Sbjct: 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231

Query: 785 ------------SLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELG 832
                        L   V+N+   R +    +          P       +   +  +L 
Sbjct: 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291

Query: 833 ILCTQESPSTRPTMLDAADDLDRLKRYLGEKHMPSKMNAL 872
                  P+ R ++ DA         Y+   + P+++ A 
Sbjct: 292 SKMLVIDPAKRISVDDALQH-----PYINVWYDPAEVEAP 326

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 1e-28
 Identities = 69/308 (22%), Positives = 119/308 (38%), Gaps = 55/308 (17%)

Query: 558 EFDEQRLLGTGSYGRVYKGIL----QDGTAIAVKVLQ----LQSGNFTKSFNRECQVLKR 609
            F+  ++LGTG+YG+V+          G   A+KVL+    +Q    T+    E QVL+ 
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 610 IRHR-NLMRIITACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNIC 668
           IR    L+ +  A        L+L Y+  G L +HL                      + 
Sbjct: 85  IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR------------ERFTEHEVQ 132

Query: 669 SDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENM 728
             + E +  L H   + +I+ D+K  N+LL+ +   +++DFG++K  +            
Sbjct: 133 IYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV----------AD 182

Query: 729 GNSTANMLCGSIGYMAPEYGFGSNT--STKGDVYSFGILVLEMVTRRRPTDDMFAGGLSL 786
               A   CG+I YMAP+   G ++      D +S G+L+ E++T   P           
Sbjct: 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP----------- 231

Query: 787 HKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTM 846
                  +    EK   + + R      P   +       +LI+       + P  R   
Sbjct: 232 -------FTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQ---RLLMKDPKKRLGC 281

Query: 847 LDA-ADDL 853
               AD++
Sbjct: 282 GPRDADEI 289

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 2e-27
 Identities = 75/341 (21%), Positives = 124/341 (36%), Gaps = 49/341 (14%)

Query: 545 PRITYRELLEATAEFDEQ----RLLGTGSYGRVYKGI-LQDGTAIAVKVL--QLQSGNFT 597
           P    +EL +   E  E+      +G+G+YG V      + G  +AVK L    QS    
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61

Query: 598 KSFNRECQVLKRIRHRNLMRIITAC----SLPDFKALVLPYMANGSLDSHLYPHSETEFG 653
           K   RE ++LK ++H N++ ++       SL +F  + L     G+  +++    +    
Sbjct: 62  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---- 117

Query: 654 SGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK 713
                LT      +   I  G+ Y+H      +IH DLKPSN+ +N+D    + DFG+A 
Sbjct: 118 -----LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA- 168

Query: 714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTR 772
                           +        +  Y APE        +   D++S G ++ E++T 
Sbjct: 169 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

Query: 773 RRP-TDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRM-----WDVAIG 826
           R           L L   +       L K I S   R       ++ +M     +  A  
Sbjct: 216 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 275

Query: 827 ELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGEKHMPS 867
             ++L           R T   A         Y  + H P 
Sbjct: 276 LAVDLLEKMLVLDSDKRITAAQALAH-----AYFAQYHDPD 311

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  108 bits (270), Expect = 5e-26
 Identities = 48/318 (15%), Positives = 105/318 (33%), Gaps = 42/318 (13%)

Query: 563 RLLGTGSYGRVYKGI-LQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITA 621
           R LG G +  V+    + + T +A+K+++     +T++   E ++L+R+   +  +  + 
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 622 CSLPDFKALVLPYMANGSLDSHLYPHSETEFG-------SGSSDLTLLQRVNICSDIAEG 674
            +    K L        +    +                     + L+    I   +  G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 675 MAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTAN 734
           + Y+H    +  IH D+KP NVL+              + ++ + + + G     +    
Sbjct: 138 LDYMHRRCGI--IHTDIKPENVLMEIV--------DSPENLIQIKIADLGNACWYDEHYT 187

Query: 735 MLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTD----------------- 777
               +  Y +PE   G+      D++S   L+ E++T     +                 
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247

Query: 778 -----DMFAGGLSLHKWVKNHYHGR-LEKVIDSSLLRASRDQSPEVKRMWDVAIGELIEL 831
                ++ +  L   K+ +  ++ R L + I         D   E  +       E+ + 
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307

Query: 832 GILCTQESPSTRPTMLDA 849
                Q  P  R      
Sbjct: 308 LSPMLQLDPRKRADAGGL 325

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  105 bits (262), Expect = 8e-25
 Identities = 69/357 (19%), Positives = 129/357 (36%), Gaps = 36/357 (10%)

Query: 16  SKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDL 75
           + L ++  LQ D   +     + +  L+NLT +   +N LT + P+        +   + 
Sbjct: 41  TDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNN 98

Query: 76  SQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYN-LDVEYNHLSGELPSD 134
                T            L+   + +      L          N +              
Sbjct: 99  QIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQ 158

Query: 135 IMSKLPSLTYLHLSYN-NMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIG 193
           +           L+    +   D ++N V   + L   T+LE L      +    P  I 
Sbjct: 159 LSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL 218

Query: 194 RLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHN 253
             NL +L L  N++       + +L+NL  L+L++N +S      +S L++L +L L  N
Sbjct: 219 T-NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGAN 273

Query: 254 LFSGEIP--------------------AALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQI 293
             S   P                    + +  L +L  L L FN +S   P  + +L ++
Sbjct: 274 QISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKL 331

Query: 294 YSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHN 350
             LF  NN++  S   +L   T++  L   +N+++   P  ++ +  I   L L+  
Sbjct: 332 QRLFFANNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRIT-QLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  103 bits (256), Expect = 5e-24
 Identities = 63/390 (16%), Positives = 132/390 (33%), Gaps = 30/390 (7%)

Query: 16  SKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDL 75
           + L       L   N+   +  S   L  +T +      +     I       +L  ++ 
Sbjct: 19  TALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS---IDGVEYLNNLTQINF 73

Query: 76  SQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDI 135
           S N  T   P  + N   L  + + NNQ+    P + +                +   ++
Sbjct: 74  SNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 131

Query: 136 MSKLP------SLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLP 189
            +         +++ +            +                 E      +    + 
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191

Query: 190 DSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLF 249
                 NL  L+   N+I+   P  I   +NL  L+L+ N L    +  ++ L+ L  L 
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKDIGT--LASLTNLTDLD 247

Query: 250 LSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPP 309
           L++N  S   P  L  L  L  L L  N++S   P++    +    L  N  +       
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLE----DIS 301

Query: 310 TLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEI 369
            +    +L  L L +N ++   P  +S + +++  L  ++N++       L+ L N+  +
Sbjct: 302 PISNLKNLTYLTLYFNNISDISP--VSSLTKLQR-LFFANNKVSDV--SSLANLTNINWL 356

Query: 370 DLSSNKFTGNIFIQISNCIAVRLINISHNA 399
               N+ +      ++N   +  + ++  A
Sbjct: 357 SAGHNQISD--LTPLANLTRITQLGLNDQA 384

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 96.2 bits (238), Expect = 8e-22
 Identities = 75/413 (18%), Positives = 147/413 (35%), Gaps = 58/413 (14%)

Query: 42  LSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYN 101
           L+      L   N+T  +  +   +   +  +   +        + +    NL  ++  N
Sbjct: 21  LAEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 75

Query: 102 NQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNT-- 159
           NQLT   P                          +  L  L  + ++ N +         
Sbjct: 76  NQLTDITP--------------------------LKNLTKLVDILMNNNQIADITPLANL 109

Query: 160 ------NLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPP 213
                  L     +  +                T+ D      LT L         +   
Sbjct: 110 TNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLK 169

Query: 214 HIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLD 273
            + NL+ L  L++SSN    +  + ++ L+ LE L  ++N  S   P  +    +L  L 
Sbjct: 170 PLANLTTLERLDISSN--KVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELS 225

Query: 274 LSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPA 333
           L+ N+L      +L +L  +  L L NNQ+S   P  L   T L +L L  N+++   P 
Sbjct: 226 LNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP- 280

Query: 334 EISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLI 393
               +  +    NL  N+ +      +S L+N+  + L  N  +      +S+   ++ +
Sbjct: 281 ----LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRL 334

Query: 394 NISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFN 446
             ++N +      SL +L N+  +    N +S + P++   +  +T + L+  
Sbjct: 335 FFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLA--NLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.3 bits (124), Expect = 1e-07
 Identities = 18/77 (23%), Positives = 35/77 (45%), Gaps = 7/77 (9%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           L  N++    P   S L +L+ L    N +      SLA L+N+  ++   N ++ + P+
Sbjct: 314 LYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPL 369

Query: 62  SFFHNCTSLRNVDLSQN 78
           +   N T +  + L+  
Sbjct: 370 A---NLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.5 bits (122), Expect = 2e-07
 Identities = 46/296 (15%), Positives = 99/296 (33%), Gaps = 42/296 (14%)

Query: 196 NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLF 255
            +T L      I  SI   +  L+NL  +N S+N L+      +  L++L  + +++N  
Sbjct: 45  QVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 100

Query: 256 SGEIPAALGKLHHLGLLDLSFNKLSGEIPV------------SLGNLVQIYSLFLNNNQL 303
           +   P A         L  +       +              ++ ++  +  L       
Sbjct: 101 ADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLS 160

Query: 304 SRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKL 363
             +    L    +L  L+             +         L  ++NQ+    P+ +   
Sbjct: 161 FGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT- 219

Query: 364 ENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNH 423
            N+ E+ L+ N+        +++   +  +++++N +    P  L  L  L  + +  N 
Sbjct: 220 -NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 274

Query: 424 LSGIIPISLNKIHT--------------------LTFINLSFNEFKGMIPSGGIFN 459
           +S I P++     T                    LT++ L FN    + P   +  
Sbjct: 275 ISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTK 330

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 94.4 bits (233), Expect = 1e-21
 Identities = 64/270 (23%), Positives = 109/270 (40%), Gaps = 7/270 (2%)

Query: 216 GNLSNLISLNLSSNLLSG--TISAEISWLSQLEQLFLSHNL-FSGEIPAALGKLHHLGLL 272
                + +L+LS   L     I + ++ L  L  L++       G IP A+ KL  L  L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 273 DLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIP 332
            ++   +SG IP  L  +  + +L  + N LS ++PP++    +L  +    NR++G+IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 333 AEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRL 392
                  ++   + +S N+L G +P               S          +        
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPT--FANLNLAFVDLSRNMLEGDASVLFGSDKNTQ 224

Query: 393 INISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMI 452
                          +G  KNL  +D+  N + G +P  L ++  L  +N+SFN   G I
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284

Query: 453 PSGGIFNSATKMSFVGNQHLCGTVPGMPIC 482
           P GG        ++  N+ LCG    +P C
Sbjct: 285 PQGGNLQRFDVSAYANNKCLCG--SPLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 88.3 bits (217), Expect = 2e-19
 Identities = 64/272 (23%), Positives = 97/272 (35%), Gaps = 13/272 (4%)

Query: 16  SKLRRLRHLQLDGNNLHG--QIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNV 73
           ++  R+ +L L G NL     IP SLA L  L  + +   N             T L  +
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 74  DLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNL-DVEYNHLSGELP 132
            ++    +G IP+ +     L TL    N L+G LP S+ +         + N +SG +P
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 133 SDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSI 192
               S     T + +S N +      T        +               L G      
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSR---------NMLEGDASVLF 217

Query: 193 GRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSH 252
           G    TQ +             +G   NL  L+L +N + GT+   ++ L  L  L +S 
Sbjct: 218 GSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277

Query: 253 NLFSGEIPAALGKLHHLGLLDLSFNKLSGEIP 284
           N   GEIP   G L    +   + NK     P
Sbjct: 278 NNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 60.5 bits (145), Expect = 2e-10
 Identities = 59/306 (19%), Positives = 101/306 (33%), Gaps = 33/306 (10%)

Query: 72  NVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGEL 131
             D     + G + +       +  L L    L    P                     +
Sbjct: 30  TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP---------------------I 68

Query: 132 PSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAG-MDLGGTLPD 190
           PS + + LP L +L++   N +         P   ++   T L  L +      G     
Sbjct: 69  PSSL-ANLPYLNFLYIGGINNLVG-------PIPPAIAKLTQLHYLYITHTNVSGAIPDF 120

Query: 191 SIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFL 250
                 L  L    N ++G++PP I +L NL+ +    N +SG I       S+L     
Sbjct: 121 LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMT 180

Query: 251 SHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPT 310
                            +L  +DLS N         L    +                  
Sbjct: 181 ISRNRLTGKIPPTFANLNLAFVDLSRNM-LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239

Query: 311 LGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEID 370
           +G   +L  LDL  NR+ G++P  ++ ++ +   LN+S N L G +P +   L+      
Sbjct: 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH-SLNVSFNNLCGEIP-QGGNLQRFDVSA 297

Query: 371 LSSNKF 376
            ++NK 
Sbjct: 298 YANNKC 303

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 55.1 bits (131), Expect = 1e-08
 Identities = 18/68 (26%), Positives = 31/68 (45%), Gaps = 4/68 (5%)

Query: 1   MLVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLP 60
            L +N ++G +P   ++L+ L  L +  NNL G+IP+    L    +    +N      P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

Query: 61  ISFFHNCT 68
           +     CT
Sbjct: 309 LP---ACT 313

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 91.3 bits (225), Expect = 1e-20
 Identities = 58/285 (20%), Positives = 108/285 (37%), Gaps = 13/285 (4%)

Query: 187 TLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLE 246
            +P  +   +   L LQ NKIT        NL NL +L L +N +S       + L +LE
Sbjct: 24  KVPKDLPP-DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82

Query: 247 QLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRS 306
           +L+LS N            L  L + +    K+   +   L  ++ +  L  N  + S  
Sbjct: 83  RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGI 141

Query: 307 IPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENV 366
                     L  + ++   +T         + E    L+L  N++       L  L N+
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTE----LHLDGNKITKVDAASLKGLNNL 197

Query: 367 QEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSG 426
            ++ LS N  +      ++N   +R +++++N L    P  L D K ++ + +  N++S 
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISA 256

Query: 427 I------IPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMS 465
           I       P    K  + + ++L  N  +        F      +
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRA 301

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 84.7 bits (208), Expect = 2e-18
 Identities = 69/314 (21%), Positives = 109/314 (34%), Gaps = 46/314 (14%)

Query: 21  LRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFF 80
           LR +Q     L  ++P+ L    +  L+ L +N +T  +    F N  +L  + L  N  
Sbjct: 12  LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKI 67

Query: 81  TGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLP 140
           +   P        L  L L  NQL                         ELP  +   L 
Sbjct: 68  SKISPGAFAPLVKLERLYLSKNQLK------------------------ELPEKMPKTLQ 103

Query: 141 SLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQL 200
            L         +            FN L     +E         G       G   L+ +
Sbjct: 104 ELRVHENEITKVRKS--------VFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYI 155

Query: 201 LLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIP 260
            + +  IT +IP   G   +L  L+L  N ++   +A +  L+ L +L LS N  S    
Sbjct: 156 RIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDN 212

Query: 261 AALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSR------SIPPTLGRC 314
            +L    HL  L L+ NKL  ++P  L +   I  ++L+NN +S         P    + 
Sbjct: 213 GSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKK 271

Query: 315 TDLYKLDLSYNRLT 328
                + L  N + 
Sbjct: 272 ASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 77.8 bits (190), Expect = 4e-16
 Identities = 48/281 (17%), Positives = 91/281 (32%), Gaps = 21/281 (7%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           L +N +      +F  L+ L  L L  N +    P + A L  L  + L  N L   LP 
Sbjct: 38  LQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPE 96

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLD 121
                   LR  +         +   +     +   +        +  A      +  + 
Sbjct: 97  KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 156

Query: 122 VEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAG 181
           +   +++  +P  +    PSLT LHL  N +   D          SL    +L +L L+ 
Sbjct: 157 IADTNIT-TIPQGL---PPSLTELHLDGNKITKVDA--------ASLKGLNNLAKLGLSF 204

Query: 182 MDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSG------TI 235
             +      S+      + L   N     +P  + +   +  + L +N +S         
Sbjct: 205 NSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264

Query: 236 SAEISWLSQLEQLFLSHN-LFSGEI-PAALGKLHHLGLLDL 274
               +  +    + L  N +   EI P+    ++    + L
Sbjct: 265 PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 76.6 bits (187), Expect = 9e-16
 Identities = 41/228 (17%), Positives = 82/228 (35%), Gaps = 5/228 (2%)

Query: 243 SQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQ 302
                L L +N  +         L +L  L L  NK+S   P +   LV++  L+L+ NQ
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 303 LSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSK 362
           L            +L   +    ++  S+   ++  + I + L  +  +  G        
Sbjct: 91  LKELPEKMPKTLQELRVHENEITKVRKSVFNGLN--QMIVVELGTNPLKSSGIENGAFQG 148

Query: 363 LENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGN 422
           ++ +  I ++    T    I      ++  +++  N +      SL  L NL  + +S N
Sbjct: 149 MKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 205

Query: 423 HLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQ 470
            +S +   SL     L  ++L+ N+   +            +    N 
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 253

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 83.3 bits (205), Expect = 8e-19
 Identities = 33/206 (16%), Positives = 63/206 (30%), Gaps = 20/206 (9%)

Query: 563 RLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITAC 622
           +L+G G    V+    +      VK  ++   +F K   +E +    +    L       
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKV--KEKRDYGDLHFSVLAIRSARN 63

Query: 623 SLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS 682
                + L    +             E         + +     +   I E +A  +H  
Sbjct: 64  EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR- 122

Query: 683 PVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGY 742
              ++H DL   NVL+  +    + DF  +     V VG +G   +       +      
Sbjct: 123 --GIVHGDLSQYNVLV-SEEGIWIIDFPQS-----VEVGEEGWREILERDVRNIITY--- 171

Query: 743 MAPEYGFGSNTSTKGDVYSFGILVLE 768
                 F     T+ D+ S    +L+
Sbjct: 172 ------FSRTYRTEKDINSAIDRILQ 191

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.2 bits (188), Expect = 5e-16
 Identities = 61/284 (21%), Positives = 92/284 (32%), Gaps = 16/284 (5%)

Query: 96  TLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSH 155
           T S     L   +P   I  +   + +  N +S  +P+       +LT L L  N +   
Sbjct: 15  TTSCPQQGLQ-AVPVG-IPAASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARI 71

Query: 156 DDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLN-LTQLLLQENKITGSIPPH 214
           D             + +D          L    P +   L  L  L L    +    P  
Sbjct: 72  DAAAFTGLALLEQLDLSD-------NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGL 124

Query: 215 IGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDL 274
              L+ L  L L  N L          L  L  LFL  N  S     A   LH L  L L
Sbjct: 125 FRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184

Query: 275 SFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAE 334
             N+++   P +  +L ++ +L+L  N LS      L     L  L L+ N         
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-- 242

Query: 335 ISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTG 378
              +         S +++   LP    +L       L++N   G
Sbjct: 243 ARPLWAWLQKFRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.2 bits (175), Expect = 2e-14
 Identities = 45/265 (16%), Positives = 76/265 (28%), Gaps = 47/265 (17%)

Query: 10  AIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNN--------------- 54
           A+P         + + L GN +      S     NLT++ LH N                
Sbjct: 25  AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 55  ---------LTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLT 105
                        +  + FH    L  + L +       P        L  L L +N L 
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 106 GQLPASLINT-SMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNM------------ 152
                +  +  ++ +L +  N +S  +P      L SL  L L  N +            
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201

Query: 153 ----VSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKIT 208
               +    N        +L     L+ L L                 L +     +++ 
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVP 261

Query: 209 GSIPPHIGNLSNLISLNLSSNLLSG 233
            S+P     L+      L++N L G
Sbjct: 262 CSLPQ---RLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.1 bits (167), Expect = 3e-13
 Identities = 47/265 (17%), Positives = 78/265 (29%), Gaps = 31/265 (11%)

Query: 187 TLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNL------------------------- 221
            +P  I      ++ L  N+I+           NL                         
Sbjct: 25  AVPVGIPA-ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 222 ISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSG 281
                 +  L     A    L +L  L L         P     L  L  L L  N L  
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143

Query: 282 EIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREI 341
               +  +L  +  LFL+ N++S            L +L L  NR+    P     +  +
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203

Query: 342 RIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQ 401
                L  N L       L+ L  +Q + L+ N +  +          ++    S + + 
Sbjct: 204 MTL-YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVP 261

Query: 402 GNLPDSLGDLKNLEAIDVSGNHLSG 426
            +LP     L   +   ++ N L G
Sbjct: 262 CSLPQR---LAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.0 bits (159), Expect = 3e-12
 Identities = 33/152 (21%), Positives = 52/152 (34%), Gaps = 5/152 (3%)

Query: 1   MLVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLP 60
            L DN L       F  L  L HL L GN +      +   L +L  + LH N +  + P
Sbjct: 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194

Query: 61  ISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNL 120
              F +   L  + L  N  +    E +     L  L L +N       A  +   +   
Sbjct: 195 -HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKF 253

Query: 121 DVEYNHLSGELPSDIMSKLPSLTYLHLSYNNM 152
               + +   LP     +L       L+ N++
Sbjct: 254 RGSSSEVPCSLP----QRLAGRDLKRLAANDL 281

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.3 bits (139), Expect = 9e-10
 Identities = 39/183 (21%), Positives = 67/183 (36%), Gaps = 3/183 (1%)

Query: 272 LDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSI 331
                  L   +PV +    Q   +FL+ N++S     +   C +L  L L  N L    
Sbjct: 16  TSCPQQGLQ-AVPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72

Query: 332 PAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVR 391
            A  +G+  +       + QL    P     L  +  + L                 A++
Sbjct: 73  AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132

Query: 392 LINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGM 451
            + +  NALQ    D+  DL NL  + + GN +S +   +   +H+L  + L  N    +
Sbjct: 133 YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192

Query: 452 IPS 454
            P 
Sbjct: 193 HPH 195

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.3 bits (126), Expect = 4e-08
 Identities = 35/241 (14%), Positives = 72/241 (29%), Gaps = 28/241 (11%)

Query: 258 EIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQI------------------------ 293
            +P  +        + L  N++S     S      +                        
Sbjct: 25  AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 294 -YSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQL 352
                 +N QL    P T      L+ L L        +   +        +L L  N L
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG-LQELGPGLFRGLAALQYLYLQDNAL 141

Query: 353 EGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLK 412
           +         L N+  + L  N+ +           ++  + +  N +    P +  DL 
Sbjct: 142 QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201

Query: 413 NLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHL 472
            L  + +  N+LS +   +L  +  L ++ L+ N +     +  ++    K     ++  
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVP 261

Query: 473 C 473
           C
Sbjct: 262 C 262

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.0 bits (115), Expect = 1e-06
 Identities = 23/205 (11%), Positives = 54/205 (26%), Gaps = 3/205 (1%)

Query: 295 SLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEG 354
           +       L  ++P  +       ++ L  NR++    A     R + I    S+     
Sbjct: 15  TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71

Query: 355 PLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNL 414
                       Q     + +              +  +++    LQ   P     L  L
Sbjct: 72  DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131

Query: 415 EAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCG 474
           + + +  N L  +   +   +  LT + L  N    +         +     +    +  
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191

Query: 475 TVPGMPICPPKQHWLHTRMYFIIFV 499
             P       +   L+     +  +
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSAL 216

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.3 bits (147), Expect = 1e-10
 Identities = 34/268 (12%), Positives = 81/268 (30%), Gaps = 12/268 (4%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           L   +L   +       + +   +   + +   + E  +    +  + L ++ +      
Sbjct: 7   LTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVSTLH 64

Query: 62  SFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPAS-----LINTS 116
                C+ L+N+ L     +  I   +    NL  L+L       +              
Sbjct: 65  GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 124

Query: 117 MYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEE 176
             NL   ++     +   +     ++T L+LS         + + +          DL +
Sbjct: 125 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSD 184

Query: 177 LELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTIS 236
             +   D            +L+  L +   I       +G +  L +L +   +  GT+ 
Sbjct: 185 SVMLKNDCFQEFFQLNYLQHLS--LSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242

Query: 237 AEISWLSQLEQLFLSHNLFSGEIPAALG 264
                   L  L ++ + F+      +G
Sbjct: 243 L---LKEALPHLQINCSHFTTIARPTIG 267

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.7 bits (130), Expect = 1e-08
 Identities = 28/209 (13%), Positives = 62/209 (29%), Gaps = 4/209 (1%)

Query: 319 KLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTG 378
            LDL+   L   +   +  + +  I      + ++ PL    S    VQ +DLS++    
Sbjct: 4   TLDLTGKNLHPDVTGRL--LSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEV 60

Query: 379 NIFIQI-SNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHT 437
           +    I S C  ++ +++    L   + ++L    NL  +++SG        +       
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120

Query: 438 LTFINLSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPGMPICPPKQHWLHTRMYFII 497
                L+ +              A     +   +L G    +                 +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180

Query: 498 FVLVISISAFLSTICLVTGIHRIKLIISS 526
            +    +             +   L +S 
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSR 209

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.8 bits (125), Expect = 7e-08
 Identities = 43/220 (19%), Positives = 78/220 (35%), Gaps = 17/220 (7%)

Query: 10  AIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLT-LVTLHDNNLTGMLPISFFHNCT 68
            +    S+  +L++L L+G  L   I  +LA  SNL  L     +  +     +   +C+
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121

Query: 69  SLRNVDLSQNFFTGKIPEEIG-------NCPNLWTLSLYNNQLTGQLPASLINTSMYNLD 121
            L  ++LS  F   +   ++              +    N Q +          ++ +LD
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181

Query: 122 VEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAG 181
           +  + +          +L  L +L LS    +  +           LG    L+ L++ G
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPE-------TLLELGEIPTLKTLQVFG 234

Query: 182 MDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNL 221
           +   GTL        L  L +  +  T    P IGN  N 
Sbjct: 235 IVPDGTLQLLKE--ALPHLQINCSHFTTIARPTIGNKKNQ 272

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.5 bits (119), Expect = 3e-07
 Identities = 39/259 (15%), Positives = 90/259 (34%), Gaps = 12/259 (4%)

Query: 198 TQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSG 257
             L L    +   +   + +   +I+     + +   ++   S   +++ + LS+++   
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEV 60

Query: 258 E-IPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSL--FLNNNQLSRSIPPTLGRC 314
             +   L +   L  L L   +LS  I  +L     +  L     +     ++   L  C
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120

Query: 315 TDLYKLDLSYNRLTGSIP-----AEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEI 369
           + L +L+LS+             A +S             N  +  L   + +  N+  +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180

Query: 370 DLSSN-KFTGNIFIQISNCIAVRLINISH-NALQGNLPDSLGDLKNLEAIDVSGNHLSGI 427
           DLS +     + F +      ++ +++S    +       LG++  L+ + V G    G 
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240

Query: 428 IPISLNKIHTLTFINLSFN 446
           + +    +  L      F 
Sbjct: 241 LQLLKEALPHLQINCSHFT 259

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.3 bits (142), Expect = 4e-10
 Identities = 52/210 (24%), Positives = 78/210 (37%), Gaps = 7/210 (3%)

Query: 167 SLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNL 226
            +       E+     +L   LP  + + + T L L EN +       +   + L  LNL
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPK-DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 227 SSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVS 286
                  T       L  L  L LSHN            L  L +LD+SFN+L+     +
Sbjct: 63  DRA--ELTKLQVDGTLPVLGTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLGA 119

Query: 287 LGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLN 346
           L  L ++  L+L  N+L    P  L     L KL L+ N LT      ++G+  +   L 
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT-LL 178

Query: 347 LSHNQLEGPLPIELSKLENVQEIDLSSNKF 376
           L  N L   +P        +    L  N +
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.3 bits (129), Expect = 1e-08
 Identities = 44/217 (20%), Positives = 69/217 (31%), Gaps = 21/217 (9%)

Query: 42  LSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYN 101
           +++   V     NLT  LP     + T L    LS+N         +     L  L+L  
Sbjct: 9   VASHLEVNCDKRNLTA-LPPDLPKDTTIL---HLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 102 NQLTG-------------QLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLS 148
            +LT               L  + + +              ++  + ++ LP      L 
Sbjct: 65  AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124

Query: 149 YNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQLLLQENKI 207
               +    N         L     LE+L LA  +L       +  L NL  LLLQEN +
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184

Query: 208 TGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQ 244
             +IP        L    L  N      + EI +  +
Sbjct: 185 Y-TIPKGFFGSHLLPFAFLHGNPWL--CNCEILYFRR 218

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.8 bits (112), Expect = 2e-06
 Identities = 37/192 (19%), Positives = 56/192 (29%), Gaps = 31/192 (16%)

Query: 10  AIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTS 69
           A+PP+  K      L L  N L+     +L   + LT + L    LT +          +
Sbjct: 24  ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT 81

Query: 70  LRNVDLSQ--------------------NFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLP 109
           L                           N  T      +     L  L L  N+L    P
Sbjct: 82  LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP 141

Query: 110 ASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLG 169
             L  T         N+   ELP+ +++ L +L  L L  N++ +               
Sbjct: 142 GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPK---------GFF 192

Query: 170 NCTDLEELELAG 181
               L    L G
Sbjct: 193 GSHLLPFAFLHG 204

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.0 bits (110), Expect = 4e-06
 Identities = 38/202 (18%), Positives = 67/202 (33%), Gaps = 7/202 (3%)

Query: 272 LDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSI 331
           ++     L+  +P  L     I  L L+ N L      TL   T L +L+L    LT   
Sbjct: 15  VNCDKRNLT-ALPPDLPKDTTI--LHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ 71

Query: 332 PAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVR 391
                 +       +     L             +  +D+S N+ T      +     ++
Sbjct: 72  VDGTLPVLGTLDLSHNQLQSLPLLGQTL----PALTVLDVSFNRLTSLPLGALRGLGELQ 127

Query: 392 LINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGM 451
            + +  N L+   P  L     LE + ++ N+L+ +    LN +  L  + L  N    +
Sbjct: 128 ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTI 187

Query: 452 IPSGGIFNSATKMSFVGNQHLC 473
                  +        GN  LC
Sbjct: 188 PKGFFGSHLLPFAFLHGNPWLC 209

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.5 bits (93), Expect = 6e-04
 Identities = 19/116 (16%), Positives = 33/116 (28%), Gaps = 3/116 (2%)

Query: 383 QISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFIN 442
           ++S   +   +N     L   LP  L   K+   + +S N L      +L     LT +N
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 443 LSFNEFKGMIPSGGIFNSATKMSFVGNQHLCGTVPGMPICPPKQHWLHTRMYFIIF 498
           L   E   +   G +    T             +               R+  +  
Sbjct: 62  LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPL 117

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 56.0 bits (133), Expect = 9e-09
 Identities = 64/323 (19%), Positives = 104/323 (32%), Gaps = 23/323 (7%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGM--- 58
           L +  L  ++P        L  L    N+L  ++PE   L  +L  + + +NNL  +   
Sbjct: 45  LNNLGL-SSLPEL---PPHLESLVASCNSLT-ELPE---LPQSLKSLLVDNNNLKALSDL 96

Query: 59  ---LPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINT 115
              L      N    +  +L  + F   I  +  +   L  L      +           
Sbjct: 97  PPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELP 156

Query: 116 SMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLE 175
            + NL       +       +  LP      ++ NN++        +PF  ++    +L 
Sbjct: 157 ELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLL 216

Query: 176 ELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTI 235
           +           L      L     L Q              LS L       N  S  I
Sbjct: 217 KTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEI 276

Query: 236 SAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYS 295
            +       LE+L +S+N    E+PA   +L     L  SFN L+ E+P    NL Q++ 
Sbjct: 277 RSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVPELPQNLKQLH- 330

Query: 296 LFLNNNQLSRSIPPTLGRCTDLY 318
             +  N L    P       DL 
Sbjct: 331 --VEYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 55.6 bits (132), Expect = 1e-08
 Identities = 63/337 (18%), Positives = 112/337 (33%), Gaps = 35/337 (10%)

Query: 19  RRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQN 78
           R+   L+L+   L   +PE   L  +L  +    N+LT            SL+++ +  N
Sbjct: 38  RQAHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-----ELPELPQSLKSLLVDNN 88

Query: 79  FFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSK 138
                    + + P L      +N    +LP    ++ +  +DV+ N L          +
Sbjct: 89  NLKA-----LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLE 143

Query: 139 LPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLT 198
             +     L     + +      +   N+         L L  +  G  + + +  L   
Sbjct: 144 FIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNL 203

Query: 199 QLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTIS------------AEISWLSQLE 246
             L         +        +L +LN+  N L+                   S LS+L 
Sbjct: 204 PFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELP 263

Query: 247 QLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRS 306
                 N  S EI +       L  L++S NKL  E+P     L     L  + N L+  
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-E 318

Query: 307 IPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRI 343
           +P        L +L + YN L    P     + ++R+
Sbjct: 319 VPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 54.8 bits (130), Expect = 2e-08
 Identities = 48/335 (14%), Positives = 93/335 (27%), Gaps = 26/335 (7%)

Query: 40  ALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSL 99
            L      + L++  L+     S       L ++  S N  T ++PE   +   L +L +
Sbjct: 35  CLDRQAHELELNNLGLS-----SLPELPPHLESLVASCNSLT-ELPELPQS---LKSLLV 85

Query: 100 YNNQLTG--QLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDD 157
            NN L     LP  L    + N  +E            +  + + +   L          
Sbjct: 86  DNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFI 145

Query: 158 NTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGN 217
                                +   +        +     + +             ++  
Sbjct: 146 AAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPF 205

Query: 218 LSNLISL-----NLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLL 272
           L+ + +       L     S                      F          L  L   
Sbjct: 206 LTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPN 265

Query: 273 DLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIP 332
               N  S EI         +  L ++NN+L   +P    R   L +L  S+N L   +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVP 320

Query: 333 AEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQ 367
                +++    L++ +N L    P     +E+++
Sbjct: 321 ELPQNLKQ----LHVEYNPLRE-FPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.1 bits (115), Expect = 1e-06
 Identities = 43/316 (13%), Positives = 80/316 (25%), Gaps = 18/316 (5%)

Query: 67  CTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSM----YNLDV 122
                 ++L+    +  +PE     P+L +L    N LT +LP    +        N   
Sbjct: 37  DRQAHELELNNLGLS-SLPELP---PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLK 91

Query: 123 EYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGM 182
             + L   L    +S         L  ++ +   D  N           +          
Sbjct: 92  ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQ 151

Query: 183 DLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWL 242
                   ++  L          K    +P  + ++    ++      L         + 
Sbjct: 152 LEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYA 211

Query: 243 SQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQ 302
                  L     S E                               L ++       N 
Sbjct: 212 DNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNA 271

Query: 303 LSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSK 362
            S  I         L +L++S N+L   +PA    +      L  S N L   +P     
Sbjct: 272 SSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER----LIASFNHLAE-VPELPQN 325

Query: 363 LENVQEIDLSSNKFTG 378
           L   +++ +  N    
Sbjct: 326 L---KQLHVEYNPLRE 338

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.3 bits (87), Expect = 0.004
 Identities = 17/93 (18%), Positives = 32/93 (34%), Gaps = 9/93 (9%)

Query: 346 NLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLP 405
               N     +        +++E+++S+NK    +         +  +  S N L   +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVP 320

Query: 406 DSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTL 438
           +   +LK L    V  N L    P     +  L
Sbjct: 321 ELPQNLKQL---HVEYNPLRE-FPDIPESVEDL 349

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.9 bits (128), Expect = 2e-08
 Identities = 37/235 (15%), Positives = 74/235 (31%), Gaps = 26/235 (11%)

Query: 18  LRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQ 77
           L     +    +N+   +  + A L  +T ++     +T    I       +L  ++L  
Sbjct: 18  LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT---IEGVQYLNNLIGLELKD 72

Query: 78  NFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMS 137
           N  T     ++    NL  ++            S I        ++         + +  
Sbjct: 73  NQIT-----DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG 127

Query: 138 KLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNL 197
                                      + S+GN    +   LA +              L
Sbjct: 128 LSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLS------------KL 175

Query: 198 TQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSH 252
           T L   +NKI+   P  + +L NLI ++L +N +S      ++  S L  + L++
Sbjct: 176 TTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.2 bits (121), Expect = 1e-07
 Identities = 37/234 (15%), Positives = 73/234 (31%), Gaps = 26/234 (11%)

Query: 42  LSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYN 101
           L+N   +    +N+T  +  +   +   +  +       T    E +    NL  L L +
Sbjct: 18  LANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72

Query: 102 NQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNL 161
           NQ+T   P   +              +                      ++ + D  +  
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKN--------------VSAIAGLQSIKTLDLTSTQ 118

Query: 162 VPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNL 221
           +     L   ++L+ L L    +    P +                  S    + NLS L
Sbjct: 119 ITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYL---SIGNAQVSDLTPLANLSKL 175

Query: 222 ISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLS 275
            +L    N +S      ++ L  L ++ L +N  S   P  L    +L ++ L+
Sbjct: 176 TTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.3 bits (116), Expect = 5e-07
 Identities = 33/228 (14%), Positives = 80/228 (35%), Gaps = 19/228 (8%)

Query: 217 NLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSF 276
            L+N I +    + ++ T++   + L  +  L       +  I   +  L++L  L+L  
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72

Query: 277 NKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEIS 336
           N++           +          +L  S  P            +    LT +   +++
Sbjct: 73  NQI---------TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVT 123

Query: 337 GIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINIS 396
            +  +     L  +  +      L+ L N+Q + + + + +      ++N   +  +   
Sbjct: 124 PLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVS--DLTPLANLSKLTTLKAD 181

Query: 397 HNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLS 444
            N +       L  L NL  + +  N +S + P++      L  + L+
Sbjct: 182 DNKISD--ISPLASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.3 bits (103), Expect = 3e-05
 Identities = 33/213 (15%), Positives = 72/213 (33%), Gaps = 24/213 (11%)

Query: 15  FSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVD 74
            + L  +  L   G  +     E +  L+NL  + L DN       I+      +L  + 
Sbjct: 37  QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ------ITDLAPLKNLTKIT 88

Query: 75  LSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSD 134
             +                        +     +      +++  L ++ N ++   P  
Sbjct: 89  ELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLA 148

Query: 135 IMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGR 194
            ++ L  L+  +   +++    + + L          +D+  L         +LP     
Sbjct: 149 GLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPL--------ASLP----- 195

Query: 195 LNLTQLLLQENKITGSIPPHIGNLSNLISLNLS 227
            NL ++ L+ N+I+   P  + N SNL  + L+
Sbjct: 196 -NLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.3 bits (103), Expect = 3e-05
 Identities = 35/218 (16%), Positives = 69/218 (31%), Gaps = 15/218 (6%)

Query: 90  NCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSY 149
              N   ++   + +T  +  + ++  +  L      ++     + +  L +L  L L  
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQADLD-GITTLSAFGTGVTT---IEGVQYLNNLIGLELKD 72

Query: 150 NNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITG 209
           N +       NL        +   L+ +            D           L       
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 210 SIPPHIGNLSNLISL-------NLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAA 262
            +   +  ++N+  L        LS      +    ++ LS+L  L    N  S   P  
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190

Query: 263 LGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNN 300
           L  L +L  + L  N++S   P  L N   ++ + L N
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.3 bits (98), Expect = 1e-04
 Identities = 29/215 (13%), Positives = 72/215 (33%), Gaps = 21/215 (9%)

Query: 196 NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLF 255
           N  ++   ++ +T ++     +L  + +L+     ++ TI   + +L+ L  L L  N  
Sbjct: 20  NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQI 75

Query: 256 SGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLG--------NLVQIYSLFLNNNQLSRSI 307
           +   P           L  +  K    I               +   +     + L    
Sbjct: 76  TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLY 135

Query: 308 PPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNL-----SHNQLEGPLPIELSK 362
                         L+  +      A++S +  +     L       N++    P  L+ 
Sbjct: 136 LDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LAS 193

Query: 363 LENVQEIDLSSNKFTGNIFIQISNCIAVRLINISH 397
           L N+ E+ L +N+ +      ++N   + ++ +++
Sbjct: 194 LPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 0.001
 Identities = 28/201 (13%), Positives = 64/201 (31%), Gaps = 19/201 (9%)

Query: 266 LHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYN 325
           L +   +    + ++    V+  +L  I +L      ++ +I   +    +L  L+L  N
Sbjct: 18  LANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73

Query: 326 RLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSS------------ 373
           ++T   P +                 +     ++  K  ++    ++             
Sbjct: 74  QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133

Query: 374 -NKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISL 432
                  I           L  +S    Q +    L +L  L  +    N +S I P++ 
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA- 192

Query: 433 NKIHTLTFINLSFNEFKGMIP 453
             +  L  ++L  N+   + P
Sbjct: 193 -SLPNLIEVHLKNNQISDVSP 212

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 51.3 bits (122), Expect = 2e-08
 Identities = 19/108 (17%), Positives = 34/108 (31%), Gaps = 5/108 (4%)

Query: 50  LHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLP 109
           L   +LT    +        + ++DLS N      P  +     L  L   +N     + 
Sbjct: 5   LAHKDLTV---LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNA-LENVD 59

Query: 110 ASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDD 157
                  +  L +  N L        +   P L  L+L  N++   + 
Sbjct: 60  GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 107

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 50.9 bits (121), Expect = 3e-08
 Identities = 25/145 (17%), Positives = 46/145 (31%), Gaps = 28/145 (19%)

Query: 2   LVDNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI 61
           L    L   +     +L  + HL L  N L    P     L+ L  + +   +   +  +
Sbjct: 5   LAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNALENV 58

Query: 62  SFFHNCTSLRNVDLSQNFFTG-KIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNL 120
               N   L+ + L  N        + + +CP L  L+L  N L  +             
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE------------- 105

Query: 121 DVEYNHLSGELPSDIMSKLPSLTYL 145
                     +   +   LPS++ +
Sbjct: 106 --------EGIQERLAEMLPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 50.1 bits (119), Expect = 5e-08
 Identities = 34/119 (28%), Positives = 49/119 (41%), Gaps = 7/119 (5%)

Query: 224 LNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEI 283
           L+L+   L  T+   +  L  +  L LSHN      PA L  L  L +L  S N    E 
Sbjct: 3   LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNA--LEN 57

Query: 284 PVSLGNLVQIYSLFLNNNQLSR-SIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREI 341
              + NL ++  L L NN+L + +    L  C  L  L+L  N L          + E+
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 46.2 bits (109), Expect = 1e-06
 Identities = 26/134 (19%), Positives = 49/134 (36%), Gaps = 17/134 (12%)

Query: 120 LDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELEL 179
           L + +  L+  L    + +L  +T+L LS+N + +            +L     LE L+ 
Sbjct: 3   LHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRLRALPP---------ALAALRCLEVLQA 50

Query: 180 AGMDLGGTLPDSIGRLNLTQLLLQENKITG-SIPPHIGNLSNLISLNLSSNLLS---GTI 235
           +       +        L +LLL  N++   +    + +   L+ LNL  N L    G  
Sbjct: 51  SDNA-LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 109

Query: 236 SAEISWLSQLEQLF 249
                 L  +  + 
Sbjct: 110 ERLAEMLPSVSSIL 123

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 46.2 bits (109), Expect = 1e-06
 Identities = 28/107 (26%), Positives = 41/107 (38%), Gaps = 6/107 (5%)

Query: 200 LLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEI 259
           L L    +T  +  H+  L  +  L+LS N L       ++ L  LE L  S N    E 
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNAL--EN 57

Query: 260 PAALGKLHHLGLLDLSFNKL-SGEIPVSLGNLVQIYSLFLNNNQLSR 305
              +  L  L  L L  N+L        L +  ++  L L  N L +
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.1 bits (106), Expect = 3e-06
 Identities = 24/120 (20%), Positives = 48/120 (40%), Gaps = 7/120 (5%)

Query: 320 LDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGN 379
           L L++  LT  +   +  +  +   L+LSHN+L    P  L+ L  ++ +   ++     
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVT-HLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNALE 56

Query: 380 IFIQISNCIAVRLINISHNALQG-NLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTL 438
               ++N   ++ + + +N LQ       L     L  +++ GN L     I       L
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.3 bits (119), Expect = 1e-07
 Identities = 26/137 (18%), Positives = 45/137 (32%), Gaps = 8/137 (5%)

Query: 13  PEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRN 72
            +++   R R L L G  +   I    A L     +   DN +     +  F     L+ 
Sbjct: 12  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR---KLDGFPLLRRLKT 67

Query: 73  VDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTG----QLPASLINTSMYNLDVEYNHLS 128
           + ++ N             P+L  L L NN L         ASL + +   +        
Sbjct: 68  LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127

Query: 129 GELPSDIMSKLPSLTYL 145
                 ++ K+P +  L
Sbjct: 128 KHYRLYVIYKVPQVRVL 144

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.2 bits (85), Expect = 0.002
 Identities = 23/140 (16%), Positives = 42/140 (30%), Gaps = 7/140 (5%)

Query: 188 LPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQ 247
                  +   +L L+  KI   I      L    +++ S N +          L +L+ 
Sbjct: 11  AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG--FPLLRRLKT 67

Query: 248 LFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSG-EIPVSLGNLVQIYSLFLNN---NQL 303
           L +++N            L  L  L L+ N L        L +L  +  L +        
Sbjct: 68  LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127

Query: 304 SRSIPPTLGRCTDLYKLDLS 323
                  + +   +  LD  
Sbjct: 128 KHYRLYVIYKVPQVRVLDFQ 147

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 48.6 bits (114), Expect = 5e-07
 Identities = 44/181 (24%), Positives = 70/181 (38%), Gaps = 9/181 (4%)

Query: 198 TQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEI-SWLSQLEQLFLSHNLFS 256
           T +      +   IP  I    +   L L+ N L    S  +   L  L +L L  N  +
Sbjct: 11  TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67

Query: 257 GEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTD 316
           G  P A     H+  L L  NK+          L Q+ +L L +NQ+S  +P +      
Sbjct: 68  GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127

Query: 317 LYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKF 376
           L  L+L+ N    +    ++   E     +L+        P   SK+ +VQ  DL  ++F
Sbjct: 128 LTSLNLASNPFNCNCH--LAWFAEWLRKKSLNGGAARCGAP---SKVRDVQIKDLPHSEF 182

Query: 377 T 377
            
Sbjct: 183 K 183

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 43.3 bits (100), Expect = 4e-05
 Identities = 15/107 (14%), Positives = 35/107 (32%), Gaps = 4/107 (3%)

Query: 53  NNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASL 112
            N    +    F     L+ ++L  N  +  +P    +  +L +L+L +N        + 
Sbjct: 87  ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW 146

Query: 113 INTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNT 159
               +    +         P    SK+  +    L ++      +N+
Sbjct: 147 FAEWLRKKSLNGGAARCGAP----SKVRDVQIKDLPHSEFKCSSENS 189

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 39.8 bits (91), Expect = 5e-04
 Identities = 31/210 (14%), Positives = 57/210 (27%), Gaps = 38/210 (18%)

Query: 22  RHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFT 81
             +   G  L  +IP  +    + T + L+DN L  +     F     L  ++L +N  T
Sbjct: 11  TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67

Query: 82  GKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPS 141
           G  P       ++                               +   E+ + +   L  
Sbjct: 68  GIEPNAFEGASHIQE------------------------LQLGENKIKEISNKMFLGLHQ 103

Query: 142 LTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLL 201
           L  L+L  N +              S  +   L  L LA          +     L +  
Sbjct: 104 LKTLNLYDNQISCVMP--------GSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKS 155

Query: 202 LQENKITGSIPPHIGNLSNLISLNLSSNLL 231
           L         P     + ++   +L  +  
Sbjct: 156 LNGGAARCGAPSK---VRDVQIKDLPHSEF 182

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.7 bits (119), Expect = 5e-07
 Identities = 33/160 (20%), Positives = 49/160 (30%), Gaps = 9/160 (5%)

Query: 21  LRHLQLDGNNL-HGQIPESLALLSNLTLVTLHDNNLT--GMLPI-SFFHNCTSLRNVDLS 76
           ++ L +    L   +  E L LL    +V L D  LT      I S      +L  ++L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 77  QNFFTGKIPEEIG-----NCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGEL 131
            N         +          +  LSL N  LTG     L +T      ++  HLS  L
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 123

Query: 132 PSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNC 171
             D   +L     L           +  +L          
Sbjct: 124 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLAS 163

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.4 bits (118), Expect = 7e-07
 Identities = 20/90 (22%), Positives = 34/90 (37%), Gaps = 5/90 (5%)

Query: 220 NLISLNLSSNLLSGTISAEI-SWLSQLEQLFLSHNLFSGE----IPAALGKLHHLGLLDL 274
           ++ SL++    LS    AE+   L Q + + L     +      I +AL     L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 275 SFNKLSGEIPVSLGNLVQIYSLFLNNNQLS 304
             N+L       +   +Q  S  +    L 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.4 bits (113), Expect = 2e-06
 Identities = 16/97 (16%), Positives = 31/97 (31%), Gaps = 13/97 (13%)

Query: 62  SFFHNCTSLRNVDLSQNFFTGK----IPEEIGNCPNLWTLSLYNNQLTGQLPASLI---- 113
                 + LR + L+    +      +   +    +L  L L NN L       L+    
Sbjct: 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR 422

Query: 114 --NTSMYNLDVEYNHLSGELPSDIMS---KLPSLTYL 145
                +  L +   + S E+   + +     PSL  +
Sbjct: 423 QPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 7e-06
 Identities = 13/92 (14%), Positives = 29/92 (31%), Gaps = 5/92 (5%)

Query: 195 LNLTQLLLQENKITGSIPPHI-GNLSNLISLNLSSNLLSG----TISAEISWLSQLEQLF 249
           L++  L +Q  +++ +    +   L     + L    L+      IS+ +     L +L 
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 250 LSHNLFSGEIPAALGKLHHLGLLDLSFNKLSG 281
           L  N         + +        +    L  
Sbjct: 62  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 8e-06
 Identities = 16/90 (17%), Positives = 34/90 (37%), Gaps = 12/90 (13%)

Query: 21  LRHLQLDGNNLHGQ----IPESLALLSNLTLVTLHDNNLTG----MLPISFFHNCTSLRN 72
           LR L L   ++       +  +L    +L  + L +N L       L  S       L  
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 73  VDLSQNFFTGKIPEEIG----NCPNLWTLS 98
           + L   +++ ++ + +     + P+L  +S
Sbjct: 431 LVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (107), Expect = 2e-05
 Identities = 21/85 (24%), Positives = 29/85 (34%), Gaps = 9/85 (10%)

Query: 236 SAEISWLSQLEQLFLSHNLFSGE----IPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLV 291
                  S L  L+L+    S      + A L   H L  LDLS N L     + L   V
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 292 Q-----IYSLFLNNNQLSRSIPPTL 311
           +     +  L L +   S  +   L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (106), Expect = 2e-05
 Identities = 16/70 (22%), Positives = 26/70 (37%), Gaps = 5/70 (7%)

Query: 272 LDLSFNKLSGEIPVSL-GNLVQIYSLFLNNNQLS----RSIPPTLGRCTDLYKLDLSYNR 326
           LD+   +LS      L   L Q   + L++  L+    + I   L     L +L+L  N 
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 327 LTGSIPAEIS 336
           L       + 
Sbjct: 67  LGDVGVHCVL 76

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 3e-05
 Identities = 16/93 (17%), Positives = 35/93 (37%), Gaps = 6/93 (6%)

Query: 316 DLYKLDLSYNRLTGSIPAEI-SGIREIRIFLNLSHNQLEG----PLPIELSKLENVQEID 370
           D+  LD+    L+ +  AE+   +++ ++ + L    L       +   L     + E++
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQV-VRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 371 LSSNKFTGNIFIQISNCIAVRLINISHNALQGN 403
           L SN+        +   +      I   +LQ  
Sbjct: 62  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 4e-05
 Identities = 19/80 (23%), Positives = 31/80 (38%), Gaps = 9/80 (11%)

Query: 196 NLTQLLLQENKITG----SIPPHIGNLSNLISLNLSSNLLSGTISAEIS-----WLSQLE 246
            L  L L +  ++     S+   +    +L  L+LS+N L      ++          LE
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 247 QLFLSHNLFSGEIPAALGKL 266
           QL L    +S E+   L  L
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 5e-05
 Identities = 13/76 (17%), Positives = 26/76 (34%), Gaps = 4/76 (5%)

Query: 120 LDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELEL 179
           LD++   LS    ++++  L     + L    +             ++L     L EL L
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGL----TEARCKDISSALRVNPALAELNL 62

Query: 180 AGMDLGGTLPDSIGRL 195
              +LG      + + 
Sbjct: 63  RSNELGDVGVHCVLQG 78

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 5e-05
 Identities = 9/100 (9%), Positives = 34/100 (34%), Gaps = 10/100 (10%)

Query: 365 NVQEIDLSSNKFTGNIFIQISNCIA-VRLINISHNALQG----NLPDSLGDLKNLEAIDV 419
           ++Q +D+   + +   + ++   +   +++ +    L      ++  +L     L  +++
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 420 SGNHLSGIIPISL-----NKIHTLTFINLSFNEFKGMIPS 454
             N L  +    +          +  ++L      G    
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG 102

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (101), Expect = 7e-05
 Identities = 11/75 (14%), Positives = 23/75 (30%), Gaps = 4/75 (5%)

Query: 44  NLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGK----IPEEIGNCPNLWTLSL 99
           ++  + +    L+              + V L     T      I   +   P L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 100 YNNQLTGQLPASLIN 114
            +N+L       ++ 
Sbjct: 63  RSNELGDVGVHCVLQ 77

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (95), Expect = 3e-04
 Identities = 16/92 (17%), Positives = 34/92 (36%), Gaps = 11/92 (11%)

Query: 173 DLEELELAGMDLGGT-LPDSIGRL-NLTQLLLQENKITG----SIPPHIGNLSNLISLNL 226
           D++ L++   +L      + +  L     + L +  +T      I   +     L  LNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 227 SSNLLSGTISAEI-----SWLSQLEQLFLSHN 253
            SN L       +     +   ++++L L + 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 7e-04
 Identities = 19/78 (24%), Positives = 30/78 (38%), Gaps = 8/78 (10%)

Query: 295 SLFLNNNQLS----RSIPPTLGRCTDLYKLDLSYNRLTGSIPAEIS-GIREIR---IFLN 346
            L+L +  +S     S+  TL     L +LDLS N L  +   ++   +R+       L 
Sbjct: 373 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 432

Query: 347 LSHNQLEGPLPIELSKLE 364
           L        +   L  LE
Sbjct: 433 LYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 0.001
 Identities = 13/77 (16%), Positives = 28/77 (36%), Gaps = 9/77 (11%)

Query: 345 LNLSHNQLEG----PLPIELSKLENVQEIDLSSNKFTGNIFIQISNCI-----AVRLINI 395
           L L+   +       L   L    +++E+DLS+N       +Q+   +      +  + +
Sbjct: 374 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 433

Query: 396 SHNALQGNLPDSLGDLK 412
                   + D L  L+
Sbjct: 434 YDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 0.002
 Identities = 22/141 (15%), Positives = 41/141 (29%), Gaps = 10/141 (7%)

Query: 114 NTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTD 173
              + +L V+    +    S   S L    +L     +    +D              + 
Sbjct: 311 GCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSV 370

Query: 174 LEELELAGMDLGGTLPDSIGRL-----NLTQLLLQENKITGSIPPHIG-----NLSNLIS 223
           L  L LA  D+  +   S+        +L +L L  N +  +    +          L  
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 224 LNLSSNLLSGTISAEISWLSQ 244
           L L     S  +   +  L +
Sbjct: 431 LVLYDIYWSEEMEDRLQALEK 451

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.3 bits (114), Expect = 5e-07
 Identities = 26/117 (22%), Positives = 54/117 (46%), Gaps = 5/117 (4%)

Query: 194 RLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHN 253
           R + +Q  L    +     P +   +  + LN  S++ + T+      + +L  L LS+N
Sbjct: 19  RYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNN 75

Query: 254 LFSG--EIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIP 308
                 ++ + + K  +L +L+LS N+L  E  +     +++  L+L+ N LS +  
Sbjct: 76  RLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.4 bits (91), Expect = 5e-04
 Identities = 22/143 (15%), Positives = 50/143 (34%), Gaps = 6/143 (4%)

Query: 202 LQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPA 261
           L+  ++   +   +    +     L    L      ++   +    L    ++ +  +  
Sbjct: 4   LKPEQVE-QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA-TLRI 59

Query: 262 ALGKLHHLGLLDLSFNKLSG--EIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYK 319
               +  L  L+LS N+L    ++   +     +  L L+ N+L         +   L +
Sbjct: 60  IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119

Query: 320 LDLSYNRLTGSIPAEISGIREIR 342
           L L  N L+ +   + + I  IR
Sbjct: 120 LWLDGNSLSDTFRDQSTYISAIR 142

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.6 bits (89), Expect = 0.001
 Identities = 23/125 (18%), Positives = 47/125 (37%), Gaps = 6/125 (4%)

Query: 258 EIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDL 317
           ++   + K +      L    L       L        L   ++  + ++        +L
Sbjct: 11  QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67

Query: 318 YKLDLSYNRLTG--SIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNK 375
             L+LS NRL     + + +     ++I LNLS N+L+    ++  K   ++E+ L  N 
Sbjct: 68  LSLNLSNNRLYRLDDMSSIVQKAPNLKI-LNLSGNELKSERELDKIKGLKLEELWLDGNS 126

Query: 376 FTGNI 380
            +   
Sbjct: 127 LSDTF 131

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (86), Expect = 0.002
 Identities = 23/144 (15%), Positives = 52/144 (36%), Gaps = 9/144 (6%)

Query: 298 LNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSH-NQLEGPL 356
           L   Q+ + +   + +  D  +  L    L          +    I + L+  + +   L
Sbjct: 4   LKPEQVEQ-LKLIMSKRYDGSQQALDLKGLR-----SDPDLVAQNIDVVLNRRSSMAATL 57

Query: 357 PIELSKLENVQEIDLSSNKFTG--NIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNL 414
            I    +  +  ++LS+N+     ++   +     ++++N+S N L+            L
Sbjct: 58  RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKL 117

Query: 415 EAIDVSGNHLSGIIPISLNKIHTL 438
           E + + GN LS         I  +
Sbjct: 118 EELWLDGNSLSDTFRDQSTYISAI 141

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.3 bits (108), Expect = 2e-06
 Identities = 20/133 (15%), Positives = 40/133 (30%), Gaps = 1/133 (0%)

Query: 21  LRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFF 80
              L+   +         L    NLT + + +      L +        LRN+ + ++  
Sbjct: 10  SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68

Query: 81  TGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLP 140
               P+     P L  L+L  N L      ++   S+  L +  N L        + +  
Sbjct: 69  RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWE 128

Query: 141 SLTYLHLSYNNMV 153
                 +    + 
Sbjct: 129 EEGLGGVPEQKLQ 141

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.3 bits (95), Expect = 1e-04
 Identities = 22/144 (15%), Positives = 41/144 (28%), Gaps = 2/144 (1%)

Query: 196 NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEI-SWLSQLEQLFLSHNL 254
             + L    +        H+    NL  L + +      +       L +L  L +  + 
Sbjct: 9   GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67

Query: 255 FSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRC 314
                P A      L  L+LSFN L      ++  L     +   N          L R 
Sbjct: 68  LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRW 127

Query: 315 TDLYKLDLSYNRLTGSIPAEISGI 338
            +     +   +L       ++ +
Sbjct: 128 EEEGLGGVPEQKLQCHGQGPLAHM 151

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.7 bits (83), Expect = 0.004
 Identities = 24/157 (15%), Positives = 43/157 (27%), Gaps = 11/157 (7%)

Query: 67  CTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLIN--TSMYNLDVEY 124
                 +  +++         +    NL  L + N Q    L    +     + NL +  
Sbjct: 7   PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65

Query: 125 NHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDL 184
           + L    P       P L+ L+LS+N + S    T              L    L     
Sbjct: 66  SGLRFVAPDAFHFT-PRLSRLNLSFNALESLSWKT----VQGLSLQELVLSGNPL---HC 117

Query: 185 GGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNL 221
              L             + E K+       + ++ N 
Sbjct: 118 SCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNA 154

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 48.3 bits (113), Expect = 2e-06
 Identities = 43/296 (14%), Positives = 76/296 (25%), Gaps = 47/296 (15%)

Query: 10  AIPPEFSKLRRLRHLQLDGNNLHGQ----IPESLALLSNLTLVTLHDNNLTGMLPI---- 61
           ++     +   ++ + L GN +  +    + E++A   +L +    D     +       
Sbjct: 22  SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81

Query: 62  -----SFFHNCTSLRNVDLSQNFFTGKIPE------------------EIGNCPNLWTLS 98
                     C  L  V LS N F     E                    G  P      
Sbjct: 82  LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141

Query: 99  LYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDN 158
               Q       +     + ++    N L      +      S   LH            
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201

Query: 159 TNLVPFFNSLGNCTDLEELELAGMDL-----GGTLPDSIGRLNLTQLLLQENKITGSIPP 213
                    L  C +L+ L+L                     NL +L L +  ++     
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261

Query: 214 HIGN------LSNLISLNLSSNLLSGTISAEI-----SWLSQLEQLFLSHNLFSGE 258
            + +         L +L L  N +       +       +  L  L L+ N FS E
Sbjct: 262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 43.7 bits (101), Expect = 7e-05
 Identities = 38/322 (11%), Positives = 90/322 (27%), Gaps = 23/322 (7%)

Query: 141 SLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL----- 195
           S+    L  + + + D        F  L     ++E+ L+G  +G      +        
Sbjct: 4   SIEGKSLKLDAITTED----EKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 59

Query: 196 NLTQLLLQEN---KITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSH 252
           +L      +    ++   IP  +  L   +      + +  + +A      +    FLS 
Sbjct: 60  DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 119

Query: 253 NLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLG 312
           +     +      L       ++       +     N   + S+    N+L         
Sbjct: 120 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 179

Query: 313 RCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLS 372
           +    ++L  +   +   I  E      +         ++        + L +       
Sbjct: 180 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 239

Query: 373 SNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISL 432
            +             ++ R      +A       S  +   L+ + +  N +      +L
Sbjct: 240 KSWPNLRELGLNDCLLSARGAAAVVDAF------SKLENIGLQTLRLQYNEIELDAVRTL 293

Query: 433 -----NKIHTLTFINLSFNEFK 449
                 K+  L F+ L+ N F 
Sbjct: 294 KTVIDEKMPDLLFLELNGNRFS 315

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.6 bits (93), Expect = 6e-04
 Identities = 25/103 (24%), Positives = 45/103 (43%), Gaps = 14/103 (13%)

Query: 90  NCPNLWTLSLYNNQLTG-------QLPASLINTSMYNLDVEYNHLSGE----LPSDIMSK 138
           + PNL  L L +  L+           + L N  +  L ++YN +  +    L + I  K
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300

Query: 139 LPSLTYLHLSYNNMVSHDDN-TNLVPFFNS--LGNCTDLEELE 178
           +P L +L L+ N     DD    +   F++   G   +L+++E
Sbjct: 301 MPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDME 343

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.9 bits (110), Expect = 3e-06
 Identities = 27/213 (12%), Positives = 59/213 (27%), Gaps = 24/213 (11%)

Query: 16  SKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDL 75
                     L   ++   + ++   L+++  +  +++++  +  I       ++  + L
Sbjct: 21  DAFAETIKDNLKKKSVTDAVTQNE--LNSIDQIIANNSDIKSVQGIQ---YLPNVTKLFL 75

Query: 76  SQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDI 135
           + N  T   P           L     +    L       S+       + ++G +    
Sbjct: 76  NGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQ 135

Query: 136 MSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL 195
           +  L            +        L    N + +   L  L                  
Sbjct: 136 LESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLT----------------- 178

Query: 196 NLTQLLLQENKITGSIPPHIGNLSNLISLNLSS 228
            L  L L +N I+      +  L NL  L L S
Sbjct: 179 KLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.4 bits (106), Expect = 8e-06
 Identities = 37/210 (17%), Positives = 67/210 (31%), Gaps = 24/210 (11%)

Query: 42  LSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYN 101
            +      L   ++T  +  +      S+  +  + +         I   PN+  L L  
Sbjct: 23  FAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 102 NQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNL 161
           N+LT   P +  N           +   +L S    K      L  +  + ++   +   
Sbjct: 78  NKLTDIKPLA--NLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQ 135

Query: 162 VPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNL 221
           +       N                T    + RL     L  E+     I P +  L+ L
Sbjct: 136 LESLYLGNNKI--------------TDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKL 180

Query: 222 ISLNLSSNLLSGTISAEISWLSQLEQLFLS 251
            +L LS N +S  + A ++ L  L+ L L 
Sbjct: 181 QNLYLSKNHIS-DLRA-LAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.1 bits (95), Expect = 2e-04
 Identities = 27/188 (14%), Positives = 66/188 (35%), Gaps = 19/188 (10%)

Query: 271 LLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGS 330
            +  +  K S    V+   L  I  +  NN+ +       +    ++ KL L+ N+LT  
Sbjct: 26  TIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDI 83

Query: 331 I--------------PAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKF 376
                            ++  +  ++    L    LE     +++ L ++ +++      
Sbjct: 84  KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGN 143

Query: 377 TGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIH 436
                I + + +         +    ++   L  L  L+ + +S NH+S +  ++   + 
Sbjct: 144 NKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDLRALA--GLK 200

Query: 437 TLTFINLS 444
            L  + L 
Sbjct: 201 NLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 3e-04
 Identities = 29/208 (13%), Positives = 71/208 (34%), Gaps = 29/208 (13%)

Query: 210 SIPPHIG------NLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAAL 263
           ++P  I         +  I  NL    ++  ++   + L+ ++Q+  +++         +
Sbjct: 9   TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--I 64

Query: 264 GKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLS 323
             L ++  L L+ NKL+   P  L NL  +  LFL+ N++         +      L+ +
Sbjct: 65  QYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHN 122

Query: 324 YNRLTGSIPAEISGIREIRIFLNLSHNQLEGPL---------------PIELSKLENVQE 368
                  +               ++   +   L                + L+ L  +Q 
Sbjct: 123 GISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQN 182

Query: 369 IDLSSNKFTGNIFIQISNCIAVRLINIS 396
           + LS N  +      ++    + ++ + 
Sbjct: 183 LYLSKNHISD--LRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 6e-04
 Identities = 38/209 (18%), Positives = 76/209 (36%), Gaps = 30/209 (14%)

Query: 187 TLPDSIGRL-------NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEI 239
           T+P  I ++          +  L++  +T ++      L+++  +  +++ +       I
Sbjct: 9   TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--I 64

Query: 240 SWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSL--- 296
            +L  + +LFL+ N  +   P  L  L +LG L L  NK+     +     ++  SL   
Sbjct: 65  QYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHN 122

Query: 297 -------FLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIR-----IF 344
                   ++  QL                  L+          +IS I  +        
Sbjct: 123 GISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQN 182

Query: 345 LNLSHNQLEGPLPIELSKLENVQEIDLSS 373
           L LS N +       L+ L+N+  ++L S
Sbjct: 183 LYLSKNHISDLRA--LAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.8 bits (89), Expect = 0.001
 Identities = 32/205 (15%), Positives = 72/205 (35%), Gaps = 19/205 (9%)

Query: 84  IPEEIG------NCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMS 137
           +P  I               +L    +T  +  + +N S+  +    + +        + 
Sbjct: 10  VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELN-SIDQIIANNSDIKSVQG---IQ 65

Query: 138 KLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNL 197
            LP++T L L+ N +       NL        +   +++L                    
Sbjct: 66  YLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS 125

Query: 198 TQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTIS-------AEISWLSQLEQLFL 250
               L       S+      ++++  L+  + L + ++          ++ L++L+ L+L
Sbjct: 126 DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYL 185

Query: 251 SHNLFSGEIPAALGKLHHLGLLDLS 275
           S N  S ++  AL  L +L +L+L 
Sbjct: 186 SKNHIS-DLR-ALAGLKNLDVLELF 208

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.8 bits (109), Expect = 4e-06
 Identities = 33/244 (13%), Positives = 67/244 (27%), Gaps = 10/244 (4%)

Query: 67  CT-SLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYN 125
           C  S R     ++  T +IP ++    N   L     +L      +           +  
Sbjct: 6   CHCSNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDL---EKIE 59

Query: 126 HLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLG 185
               ++   I + + S            +++        F +L N   L         L 
Sbjct: 60  ISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLP 119

Query: 186 GTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQL 245
                   +  L  +    N  T      +G     + L L+ N +    +   +     
Sbjct: 120 DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLD 179

Query: 246 EQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSR 305
           E     +N                 +LD+S  ++       L NL ++ +    N +   
Sbjct: 180 ELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK--- 236

Query: 306 SIPP 309
            +P 
Sbjct: 237 KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.7 bits (101), Expect = 4e-05
 Identities = 14/53 (26%), Positives = 20/53 (37%)

Query: 51  HDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQ 103
            DNN    LP   FH  +    +D+S+          + N   L   S YN +
Sbjct: 184 SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 6e-05
 Identities = 28/233 (12%), Positives = 64/233 (27%), Gaps = 9/233 (3%)

Query: 22  RHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFT 81
           R      + +  +IP  L    N   +      L   +    F     L  +++SQN   
Sbjct: 11  RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVL 66

Query: 82  GKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPS 141
             I  ++ +            +    L  +                +  +          
Sbjct: 67  EVIEADVFSNLPKLHEI-RIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD---VH 122

Query: 142 LTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLL 201
             +        +  + N + +   + +G   +   L L    +      +     L +L 
Sbjct: 123 KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELN 182

Query: 202 LQENKITGSIPPHI-GNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHN 253
           L +N     +P  +    S  + L++S   +    S  +  L +L      + 
Sbjct: 183 LSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 4e-04
 Identities = 25/222 (11%), Positives = 57/222 (25%), Gaps = 10/222 (4%)

Query: 10  AIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTS 69
            IP +    R    L+     L      + +   +L  + +  N++  ++    F N   
Sbjct: 22  EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79

Query: 70  LRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYN-NQLTGQLPASLINTSMYNLDVEYNHLS 128
           L  + + +      I  E           L +   +        I++    L    ++++
Sbjct: 80  LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 139

Query: 129 GELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTL 188
                       S   + L  N     + +                        +L    
Sbjct: 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLS------DNNNLEELP 193

Query: 189 PDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSN 229
            D          L +   +I       + NL  L + +  + 
Sbjct: 194 NDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (88), Expect = 0.002
 Identities = 36/256 (14%), Positives = 68/256 (26%), Gaps = 24/256 (9%)

Query: 189 PDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQL 248
              I   +    L QE+K+T  IP  +    N I L      L        S    LE++
Sbjct: 2   HHRICHCSNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKI 58

Query: 249 FLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIP 308
            +S N     I A +                           +    +   NN L  +  
Sbjct: 59  EISQNDVLEVIEADVFSNLPK---------------------LHEIRIEKANNLLYINPE 97

Query: 309 PTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQE 368
                    Y L  +          +I  ++++ + +  + N         +        
Sbjct: 98  AFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVI 157

Query: 369 IDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGII 428
           + L+ N          +      L    +N L+    D          +D+S   +  + 
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217

Query: 429 PISLNKIHTLTFINLS 444
              L  +  L   +  
Sbjct: 218 SYGLENLKKLRARSTY 233

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 43.9 bits (102), Expect = 2e-05
 Identities = 31/172 (18%), Positives = 59/172 (34%), Gaps = 13/172 (7%)

Query: 14  EFSKLRRLRHLQLDGNNLHGQIP------ESLALLSNLTLVTLHDNNLTGMLPISFFHNC 67
            F + + +   + +   LHG IP       +L+ L     + L  NN+     IS     
Sbjct: 13  IFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK---ISSLSGM 69

Query: 68  TSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHL 127
            +LR   LS      K  E +    +       +      L       ++  L +  N +
Sbjct: 70  ENLRI--LSLGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKI 127

Query: 128 SGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNS--LGNCTDLEEL 177
           +     D ++ L  L  L L+ N + +     N    +    +    +L++L
Sbjct: 128 TNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKL 179

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 5e-04
 Identities = 36/208 (17%), Positives = 64/208 (30%), Gaps = 26/208 (12%)

Query: 18  LRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQ 77
           L       L   N+   +  S   L  +T +      +     I       +L  ++ S 
Sbjct: 17  LAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS---IDGVEYLNNLTQINFSN 71

Query: 78  NFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMS 137
           N  T   P  + N   L            Q+       ++ NL       +     D + 
Sbjct: 72  NQLTDITP--LKNLTKLV----DILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 125

Query: 138 KLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-N 196
            L +L  L LS N +      + L        +   + +L+             +  L  
Sbjct: 126 NLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLK------------PLANLTT 173

Query: 197 LTQLLLQENKITGSIPPHIGNLSNLISL 224
           L +L +  NK++      +  L+NL SL
Sbjct: 174 LERLDISSNKVSD--ISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.3 bits (90), Expect = 0.001
 Identities = 32/207 (15%), Positives = 61/207 (29%), Gaps = 24/207 (11%)

Query: 42  LSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYN 101
           L+      L   N+T  +  +     T+L      +        + +    NL  ++  N
Sbjct: 17  LAEKMKTVLGKTNVTDTVSQTDLDQVTTL---QADRLGIKS--IDGVEYLNNLTQINFSN 71

Query: 102 NQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNL 161
           NQLT                     L        +    +         N+ +    T  
Sbjct: 72  NQLTD-----------------ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLF 114

Query: 162 VPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNL 221
                 +    +L  L    +        S      +   L  +    +    + NL+ L
Sbjct: 115 NNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTL 174

Query: 222 ISLNLSSNLLSGTISAEISWLSQLEQL 248
             L++SSN +S    + ++ L+ LE L
Sbjct: 175 ERLDISSNKVSDI--SVLAKLTNLESL 199

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	885
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	100.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	100.0
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	100.0
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	100.0
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	100.0
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.97
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.97
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.97
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.96
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.95
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.95
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.95
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.94
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.93
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.93
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.92
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.9
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.9
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.89
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.89
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.89
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.89
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.83
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.82
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.81
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.8
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.78
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.76
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.68
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.67
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.66
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.65
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.6
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.6
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	99.17
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.91
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.89
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.56
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	98.25
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	98.21
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	98.1
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	98.05
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.84

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=371.57  Aligned_cols=264  Identities=28%  Similarity=0.454  Sum_probs=207.2

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEECCCCEEEEEEEEEC--CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
Q ss_conf             5178646432012762499999699979999994304--78303669999999830589664234433106995139996
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  633 (885)
                      .++|.+.+.||+|+||.||+|+++  ..||||+++..  .....+.|.+|++++++++||||+++++++.. ...++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             CCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf             451899889830788589999999--989999997346998999999999999984799878645679715-58999996


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCCCE
Q ss_conf             44588532255668754558898878899999999999999999631699965844789996676699977981444310
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      |+++|+|.+++.....        .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+
T Consensus        84 y~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~  152 (276)
T d1uwha_          84 WCEGSSLYHHLHIIET--------KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLAT  152 (276)
T ss_dssp             CCCEEEHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred             CCCCCCHHHHHHHCCC--------CCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCHHHEEECCCCCEEECCCCCEE
T ss_conf             5899888999852357--------8999999999999999988875099---9516147899798189978875002213


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
Q ss_conf             01002678999877788754443456542378656898---888533503067999998729999994345885278999
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS---NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~  790 (885)
                      ......         .........||+.|+|||++.+.   .++.++|||||||++|||+||+.||...... ......+
T Consensus       153 ~~~~~~---------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-~~~~~~~  222 (276)
T d1uwha_         153 VKSRWS---------GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIFMV  222 (276)
T ss_dssp             C---------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-HHHHHHH
T ss_pred             ECCCCC---------CCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHH
T ss_conf             335567---------763125665574317999995056899995315163599999999788998998969-9999999


Q ss_pred             HHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHC
Q ss_conf             98511014555324321014789278998799999999999853037899999998999999999998836
Q 002746          791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLG  861 (885)
Q Consensus       791 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~~  861 (885)
                      .....       .+..           ......+++++.+++.+||+.||++||||+|+++.|+.+.+.+.
T Consensus       223 ~~~~~-------~p~~-----------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         223 GRGYL-------SPDL-----------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             HHTSC-------CCCG-----------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             HCCCC-------CCCC-----------HHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf             65888-------9860-----------00365554999999999758897689299999999999997098

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=370.55  Aligned_cols=261  Identities=26%  Similarity=0.406  Sum_probs=206.5

Q ss_pred             HCCCCCCEECCCCCCEEEEEEEC-CC---CEEEEEEEEECC-CCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEE
Q ss_conf             17864643201276249999969-99---799999943047-83036699999998305896642344331069951399
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DG---TAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  631 (885)
                      ++|.+.+.||+|+||.||+|.++ ++   ..||||.+.... ....+.|.+|++++++++|||||++++++..++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf             04278569802788299999995799788999999978445989999999999999857998886189999628877999


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf             96445885322556687545588988788999999999999999996316999658447899966766999779814443
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       632 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~  711 (885)
                      ||||++|+|..++.....        .+++..+..++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       106 ~Ey~~~g~L~~~~~~~~~--------~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGl  174 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL  174 (299)
T ss_dssp             EECCTTEEHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred             EEECCCCCCEEEECCCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCC
T ss_conf             972279853002104567--------9999999999999999889885279---83576150448988999199888443


Q ss_pred             CEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCCCCCCHHHHH
Q ss_conf             100100267899987778875444345654237865689888853350306799999872-9999994345885278999
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~  790 (885)
                      |+.+.......      .........||+.|+|||++.+..++.++|||||||++|||+| |+.||.....     .+..
T Consensus       175 a~~~~~~~~~~------~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-----~~~~  243 (299)
T d1jpaa_         175 SRFLEDDTSDP------TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-----QDVI  243 (299)
T ss_dssp             ---------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHH
T ss_pred             CEECCCCCCCC------EEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH-----HHHH
T ss_conf             15756777765------365025666883003878883699786121445357899998679999999999-----9999


Q ss_pred             HHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             98511014555324321014789278998799999999999853037899999998999999999998
Q 002746          791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR  858 (885)
Q Consensus       791 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~  858 (885)
                      ...         .    ...+...+      ..++.++.+++.+||+.||++||||+|+++.|+++.+
T Consensus       244 ~~i---------~----~~~~~~~~------~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         244 NAI---------E----QDYRLPPP------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             HHH---------H----TTCCCCCC------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHH---------H----CCCCCCCC------CCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf             999---------7----37889997------4226999999999758797689299999999999841

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=368.00  Aligned_cols=250  Identities=21%  Similarity=0.327  Sum_probs=205.8

Q ss_pred             HCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEECC
Q ss_conf             17864643201276249999969-99799999943047830366999999983058966423443310699513999644
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  635 (885)
                      ++|++.+.||+|+||.||+|... +|+.||+|+++.......+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf             05388789812858299999998999899999984301727999999999998679998805857798899989999703


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCCCEEE
Q ss_conf             58853225566875455889887889999999999999999963169996584478999667669997798144431001
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++|+|..++...          .+++..+..++.|++.||.|||++|   |+||||||+|||++.++.+||+|||+|+.+
T Consensus       100 ~gg~L~~~~~~~----------~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~  166 (293)
T d1yhwa1         100 AGGSLTDVVTET----------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (293)
T ss_dssp             TTCBHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCCCHHHHHHCC----------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEE
T ss_conf             798089886415----------9999999999999999999999879---722677688868878996864251564132


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHC
Q ss_conf             00267899987778875444345654237865689888853350306799999872999999434588527899998511
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  795 (885)
                      ...           ........||+.|+|||++.+..++.++||||+||++|+|++|+.||.....     .........
T Consensus       167 ~~~-----------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~~~~  230 (293)
T d1yhwa1         167 TPE-----------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----LRALYLIAT  230 (293)
T ss_dssp             CST-----------TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHH
T ss_pred             CCC-----------CCCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHH
T ss_conf             136-----------6644444447773682664479988012031372999998048899899799-----999999985


Q ss_pred             CHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             014555324321014789278998799999999999853037899999998999999
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       796 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..           ......+      ..++.++.+++.+||+.||++|||++|++++
T Consensus       231 ~~-----------~~~~~~~------~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         231 NG-----------TPELQNP------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             HC-----------SCCCSSG------GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CC-----------CCCCCCC------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             79-----------9988885------5379999999999866996689099999649

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=368.08  Aligned_cols=254  Identities=24%  Similarity=0.404  Sum_probs=205.6

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECC-CCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
Q ss_conf             517864643201276249999969-99799999943047-8303669999999830589664234433106995139996
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  633 (885)
                      .++|++.+.||+|+||.||+|++. +++.||+|+++... ....+.+.+|++++++++||||+++++++.++...++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf             74608998972174809999999999979999998456641279999999999985799888469654046743679886


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCCCE
Q ss_conf             44588532255668754558898878899999999999999999631699965844789996676699977981444310
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      |+++|+|.+++....         .+++..+..++.|++.||.|||++|   |+||||||+|||++.++.+||+|||+|+
T Consensus        84 y~~gg~L~~~l~~~~---------~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~  151 (271)
T d1nvra_          84 YCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT  151 (271)
T ss_dssp             CCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CCCCCCHHHHHHCCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHE
T ss_conf             458980899975379---------9999999999999999999999759---8357546899788789987983231422


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf             0100267899987778875444345654237865689888-853350306799999872999999434588527899998
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  792 (885)
                      .+....         .........||+.|+|||++.+..+ +.++||||+||++|||++|+.||.........+..+.. 
T Consensus       152 ~~~~~~---------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~-  221 (271)
T d1nvra_         152 VFRYNN---------RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-  221 (271)
T ss_dssp             ECEETT---------EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHT-
T ss_pred             EECCCC---------CCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC-
T ss_conf             404688---------6531113255747428728618999997101617379999998299788889859999999863-


Q ss_pred             HHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             511014555324321014789278998799999999999853037899999998999999
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       793 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                                 ..   .....       +...++++.+++.+||+.||++|||++|++++
T Consensus       222 -----------~~---~~~~~-------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         222 -----------KK---TYLNP-------WKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             -----------TC---TTSTT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -----------CC---CCCCC-------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             -----------88---87886-------44699999999999767996689099999619

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=367.96  Aligned_cols=257  Identities=25%  Similarity=0.403  Sum_probs=209.1

Q ss_pred             HCCCCCCEECCCCCCEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEECCC
Q ss_conf             17864643201276249999969997999999430478303669999999830589664234433106995139996445
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMA  636 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  636 (885)
                      ++|++.+.||+|+||.||+|.+.++..||||+++.. ....+.+.+|++++++++||||+++++++..++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf             995888898208882999999889999999998788-6768999999999996689975653524315993379998369


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCCCEEEE
Q ss_conf             88532255668754558898878899999999999999999631699965844789996676699977981444310010
Q 002746          637 NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM  716 (885)
Q Consensus       637 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~  716 (885)
                      +|+|.+++.....        .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+...
T Consensus        84 ~g~L~~~l~~~~~--------~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  152 (263)
T d1sm2a_          84 HGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL  152 (263)
T ss_dssp             TCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------
T ss_pred             CCCHHHHHHCCCC--------CCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCHHHEEECCCCCEEECCCCHHEECC
T ss_conf             9918997520134--------7889999999999999877653164---3104431532666688776865532100236


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCC-CCCCCCCCCCCCCHHHHHHHHHC
Q ss_conf             02678999877788754443456542378656898888533503067999998729-99999434588527899998511
Q 002746          717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-RRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg-~~Pf~~~~~~~~~~~~~~~~~~~  795 (885)
                      ...          ........||+.|+|||++.+..++.++|||||||++|||+|+ ++||...     ...+...... 
T Consensus       153 ~~~----------~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-----~~~~~~~~i~-  216 (263)
T d1sm2a_         153 DDQ----------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNSEVVEDIS-  216 (263)
T ss_dssp             ----------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-----CHHHHHHHHH-
T ss_pred             CCC----------CEEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCC-----CHHHHHHHHH-
T ss_conf             887----------335043001766678578607999840332105999999987898887789-----9999999998-


Q ss_pred             CHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf             0145553243210147892789987999999999998530378999999989999999999988
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRY  859 (885)
Q Consensus       796 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~  859 (885)
                                  .......|.      .+++++.+++.+||+.||++||||+|++++|+++...
T Consensus       217 ------------~~~~~~~p~------~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         217 ------------TGFRLYKPR------LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             ------------HTCCCCCCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------HCCCCCCCC------CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             ------------068889954------3679999999997657976891999999999999857

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=371.09  Aligned_cols=273  Identities=23%  Similarity=0.317  Sum_probs=206.6

Q ss_pred             HHHCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEEC-CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEE
Q ss_conf             8517864643201276249999969-9979999994304-7830366999999983058966423443310699513999
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  632 (885)
                      ..++|++.+.||+|+||+||+|... ++..||+|+++.. .......+.+|+.++++++||||+++++++.++...++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf             75688897897127780999999989996999999875409789999999999998679999994999999899999999


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC-CCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf             6445885322556687545588988788999999999999999996316-999658447899966766999779814443
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHH-SPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       633 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~~ivH~dikp~NILl~~~~~~kl~Dfg~  711 (885)
                      ||+++|+|..++....         .+++..+..++.|++.||.|||++ +   |+||||||+|||++.++.+||+|||+
T Consensus        84 Ey~~gg~L~~~l~~~~---------~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGl  151 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGV  151 (322)
T ss_dssp             ECCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred             ECCCCCCHHHHHHHCC---------CCCHHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEEEECCC
T ss_conf             7679986899874249---------99999999999999999999998599---97144577994687899899954877


Q ss_pred             CEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH-
Q ss_conf             1001002678999877788754443456542378656898888533503067999998729999994345885278999-
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV-  790 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~-  790 (885)
                      |+.+..             ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.............. 
T Consensus       152 a~~~~~-------------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~  218 (322)
T d1s9ja_         152 SGQLID-------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ  218 (322)
T ss_dssp             CHHHHH-------------HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---
T ss_pred             CCCCCC-------------CCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
T ss_conf             625678-------------8621113771411946875899894888998999999999888998998878999999887


Q ss_pred             -HHHHCCHHHH------HHHHHHHH-CCCCCHHH-HHHHH---------HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             -9851101455------53243210-14789278-99879---------9999999999853037899999998999999
Q 002746          791 -KNHYHGRLEK------VIDSSLLR-ASRDQSPE-VKRMW---------DVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       791 -~~~~~~~~~~------~~~~~l~~-~~~~~~~~-~~~~~---------~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                       ..........      ........ ........ .....         ...+.++.+++.+|+..||++|||++|+++|
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         219 VEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ---------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf             51775457742123332211112223541347788766502687667644489999999999868994679089999609

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=365.70  Aligned_cols=246  Identities=26%  Similarity=0.417  Sum_probs=204.6

Q ss_pred             HCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEEC---CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEE
Q ss_conf             17864643201276249999969-9979999994304---7830366999999983058966423443310699513999
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  632 (885)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|++...   .....+.+.+|+++++.++||||+++++++.++...++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf             37699889851778589999998999499999981688567689999999999998568888885999999899989998


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCCC
Q ss_conf             64458853225566875455889887889999999999999999963169996584478999667669997798144431
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++|+|.+++....         .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus        86 Ey~~~g~L~~~l~~~~---------~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a  153 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS---------KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS  153 (263)
T ss_dssp             ECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSC
T ss_pred             EECCCCCHHHHHHHCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCCEECCCCCEEECCCCEE
T ss_conf             5047985898875048---------9999999999999999999999889---465220234414668998711555633


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf             00100267899987778875444345654237865689888853350306799999872999999434588527899998
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  792 (885)
                      .....             .......||+.|+|||++.+..++.++||||+||++|||++|+.||...     ...+....
T Consensus       154 ~~~~~-------------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~~~~~  215 (263)
T d2j4za1         154 VHAPS-------------SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-----TYQETYKR  215 (263)
T ss_dssp             SCCCC-------------CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHH
T ss_pred             EECCC-------------CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHH
T ss_conf             54488-------------8523557887634999975899893144046759999983299998889-----99999999


Q ss_pred             HHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             511014555324321014789278998799999999999853037899999998999999
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       793 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..             ...... |      +.+++++.+++.+||+.||++|||++|++++
T Consensus       216 i~-------------~~~~~~-p------~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         216 IS-------------RVEFTF-P------DFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             HH-------------TTCCCC-C------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             HH-------------CCCCCC-C------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             97-------------189999-8------6689999999999764797689099999719

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=0  Score=361.53  Aligned_cols=252  Identities=18%  Similarity=0.268  Sum_probs=205.5

Q ss_pred             HCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEECC
Q ss_conf             17864643201276249999969-99799999943047830366999999983058966423443310699513999644
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  635 (885)
                      ++|++.+.||+|+||.||+|... +|+.||+|+++.......+.+.+|++++++++||||+++++++.++...++|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECC
T ss_conf             03599899931778299999998999799999988726467999999999998679979891999999899999999828


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC--CCCCEEECCCCCCE
Q ss_conf             5885322556687545588988788999999999999999996316999658447899966766--99977981444310
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN--DDMTALVSDFGIAK  713 (885)
Q Consensus       636 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~--~~~~~kl~Dfg~a~  713 (885)
                      ++|+|.+.+....        ..+++..+..++.|++.||.|||++|   |+||||||+|||++  .++.+||+|||+|+
T Consensus       109 ~gg~L~~~~~~~~--------~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~  177 (352)
T d1koba_         109 SGGELFDRIAAED--------YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLAT  177 (352)
T ss_dssp             CCCBHHHHTTCTT--------CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred             CCCHHHHHHHHCC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCCCCCCCEEEEEECCCCE
T ss_conf             9980888898638--------99899999999999999999999779---265131445531134678848995256303


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf             01002678999877788754443456542378656898888533503067999998729999994345885278999985
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  793 (885)
                      .+..            ........||+.|+|||++.+..++.++||||+||++|||+||+.||....     ........
T Consensus       178 ~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~~~~~~i  240 (352)
T d1koba_         178 KLNP------------DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-----DLETLQNV  240 (352)
T ss_dssp             ECCT------------TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-----HHHHHHHH
T ss_pred             ECCC------------CCCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHH
T ss_conf             4378------------872010047645348999747998976333898999999996889989979-----99999999


Q ss_pred             HCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             11014555324321014789278998799999999999853037899999998999999
Q 002746          794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       794 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .            ........+    .+..+++++.+++.+||+.||++|||++|++++
T Consensus       241 ~------------~~~~~~~~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         241 K------------RCDWEFDED----AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             H------------HCCCCCCSS----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             H------------HCCCCCCCC----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             8------------478898930----024799999999999756996689189999609

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=363.25  Aligned_cols=259  Identities=30%  Similarity=0.437  Sum_probs=206.3

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEECC
Q ss_conf             51786464320127624999996999799999943047830366999999983058966423443310699513999644
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  635 (885)
                      .++|++.+.||+|+||.||+|.++++..||||+++.. ....+.+.+|++++++++||||+++++++.. +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEEC
T ss_conf             8993886798107982899999999999999998647-6888999999999986799988578731045-9769999957


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCCCEEE
Q ss_conf             58853225566875455889887889999999999999999963169996584478999667669997798144431001
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++|+|.+++.....       ..+++..+..++.|++.|+.|||+++   |+||||||+|||++.++.+||+|||+|+.+
T Consensus        90 ~~g~L~~~~~~~~~-------~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~  159 (272)
T d1qpca_          90 ENGSLVDFLKTPSG-------IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI  159 (272)
T ss_dssp             TTCBHHHHTTSHHH-------HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCCCHHHHHHHCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCEEECCCCCEEEC
T ss_conf             89828888751478-------98878899999999999999997489---546756422515620244042341014773


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHC
Q ss_conf             00267899987778875444345654237865689888853350306799999872999999434588527899998511
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  795 (885)
                      ....          ........|++.|+|||++.+..++.++|||||||++|||+||+.|+....    ...+....   
T Consensus       160 ~~~~----------~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~----~~~~~~~~---  222 (272)
T d1qpca_         160 EDNE----------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM----TNPEVIQN---  222 (272)
T ss_dssp             SSSC----------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHHHHH---
T ss_pred             CCCC----------CCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC----CHHHHHHH---
T ss_conf             5886----------442035677444458289837999824564525799999996898888888----99999999---


Q ss_pred             CHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf             0145553243210147892789987999999999998530378999999989999999999988
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRY  859 (885)
Q Consensus       796 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~  859 (885)
                                +....+...|      +.+++++.+++.+||+.+|++||||+||++.|+.+...
T Consensus       223 ----------i~~~~~~~~p------~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         223 ----------LERGYRMVRP------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             ----------HHTTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------HHHCCCCCCC------CCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             ----------9706888896------55719999999997588976893999999986113213

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=369.54  Aligned_cols=259  Identities=25%  Similarity=0.400  Sum_probs=208.1

Q ss_pred             HHHCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
Q ss_conf             8517864643201276249999969-997999999430478303669999999830589664234433106995139996
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  633 (885)
                      ..++|++.+.||+|+||.||+|.+. ++..||||+++.. ....+++.+|++++++++||||+++++++.+++..++|||
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEE
T ss_conf             579939865982088808999999999969999997776-1039999999999986799988267752745785478763


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCCCE
Q ss_conf             44588532255668754558898878899999999999999999631699965844789996676699977981444310
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      |+++|++..++.....       ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+
T Consensus        94 ~~~~g~l~~~l~~~~~-------~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~  163 (287)
T d1opja_          94 FMTYGNLLDYLRECNR-------QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR  163 (287)
T ss_dssp             CCTTCBHHHHHHHSCT-------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred             CCCCCCHHHHHHHCCC-------CCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEE
T ss_conf             1467606777530355-------41579999999999999788898789---3057604576899899928983244546


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf             01002678999877788754443456542378656898888533503067999998729999994345885278999985
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  793 (885)
                      .....          .........|++.|+|||++.+..++.++|||||||++|||++|+.|+...    .+..+.    
T Consensus       164 ~~~~~----------~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~----~~~~~~----  225 (287)
T d1opja_         164 LMTGD----------TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----IDLSQV----  225 (287)
T ss_dssp             TCCSS----------SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT----CCHHHH----
T ss_pred             ECCCC----------CCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC----CHHHHH----
T ss_conf             53788----------722103556654666927872799981043021789999998679988774----259999----


Q ss_pred             HCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf             1101455532432101478927899879999999999985303789999999899999999999
Q 002746          794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLK  857 (885)
Q Consensus       794 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~  857 (885)
                           .+.+...    .....+      ..+++++.+++.+||+.||++|||++|+++.|+.+.
T Consensus       226 -----~~~i~~~----~~~~~~------~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         226 -----YELLEKD----YRMERP------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             -----HHHHHTT----CCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             -----HHHHHCC----CCCCCC------CCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             -----9998558----888887------433099999999975779768939999999999998

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=0  Score=363.38  Aligned_cols=253  Identities=19%  Similarity=0.293  Sum_probs=205.9

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEC
Q ss_conf             517864643201276249999969-9979999994304783036699999998305896642344331069951399964
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  634 (885)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++||||+++++++.++...++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf             65758988984076819999998899989999998452431699999999999867997999299999989999999985


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC--CCCEEECCCCCC
Q ss_conf             458853225566875455889887889999999999999999963169996584478999667669--997798144431
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND--DMTALVSDFGIA  712 (885)
Q Consensus       635 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~--~~~~kl~Dfg~a  712 (885)
                      |++|+|.+++....        ..+++..+..++.||+.||.|||++|   |+||||||+|||++.  ++.+||+|||+|
T Consensus       105 ~~gg~L~~~l~~~~--------~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a  173 (350)
T d1koaa2         105 MSGGELFEKVADEH--------NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT  173 (350)
T ss_dssp             CCSCBHHHHHTCTT--------SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTC
T ss_pred             CCCCCHHHHHHHHC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---CEEEEECHHHEEECCCCCCEEEEEECCHH
T ss_conf             79988999997623--------78999999999999999999997569---76000154673641688986999545210


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf             00100267899987778875444345654237865689888853350306799999872999999434588527899998
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  792 (885)
                      +.+..            ........||+.|+|||++.+..++.++||||+||++|||++|+.||...     ...+....
T Consensus       174 ~~~~~------------~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~~~~~~~  236 (350)
T d1koaa2         174 AHLDP------------KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-----NDDETLRN  236 (350)
T ss_dssp             EECCT------------TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHH
T ss_pred             EECCC------------CCCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC-----CHHHHHHH
T ss_conf             44256------------54320006862421889975899872676554659999998598998997-----99999999


Q ss_pred             HHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             511014555324321014789278998799999999999853037899999998999999
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       793 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ...            ........    .+..+++++.+++.+||..||++|||++|++++
T Consensus       237 i~~------------~~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         237 VKS------------CDWNMDDS----AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             HHH------------TCCCSCCG----GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             HHH------------CCCCCCCC----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             984------------78898942----235899999999999756896679089998629

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=364.11  Aligned_cols=252  Identities=23%  Similarity=0.341  Sum_probs=204.3

Q ss_pred             HCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEECC
Q ss_conf             17864643201276249999969-99799999943047830366999999983058966423443310699513999644
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  635 (885)
                      +.|++.+.||+|+||.||+|.+. ++..||+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf             37598479930778199999999999399999987289999999999999998679999884988980099589999627


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCCCEEE
Q ss_conf             58853225566875455889887889999999999999999963169996584478999667669997798144431001
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++|+|..++....        ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+..
T Consensus        92 ~~g~L~~~~~~~~--------~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~  160 (288)
T d2jfla1          92 AGGAVDAVMLELE--------RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKN  160 (288)
T ss_dssp             TTEEHHHHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCCCHHHHHHHCC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEECCHHHEEECCCCCEEEEECHHHHCC
T ss_conf             9981889998628--------99999999999999999999999889---887140700314878999899716123035


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-----CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
Q ss_conf             0026789998777887544434565423786568-----98888533503067999998729999994345885278999
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGF-----GSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~  790 (885)
                      ...           ........||+.|+|||++.     +..++.++||||+||++|||++|+.||...... ..+....
T Consensus       161 ~~~-----------~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~-~~~~~i~  228 (288)
T d2jfla1         161 TRT-----------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM-RVLLKIA  228 (288)
T ss_dssp             HHH-----------HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG-GHHHHHH
T ss_pred             CCC-----------CCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHH
T ss_conf             778-----------6410010256264799998320257888880665787899999982088999998999-9999997


Q ss_pred             HHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             98511014555324321014789278998799999999999853037899999998999999
Q 002746          791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       791 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .    ...           .....+      ..+++++.+++.+||+.||++|||++|++++
T Consensus       229 ~----~~~-----------~~~~~~------~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         229 K----SEP-----------PTLAQP------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             H----SCC-----------CCCSSG------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             C----CCC-----------CCCCCC------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             0----799-----------877765------6699999999999766996689199999629

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=362.94  Aligned_cols=265  Identities=23%  Similarity=0.368  Sum_probs=207.9

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEECC-C-----CEEEEEEEEEC-CCCCHHHHHHHHHHHHHC-CCCCCCEEEEEEECCCC
Q ss_conf             5178646432012762499999699-9-----79999994304-783036699999998305-89664234433106995
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQD-G-----TAIAVKVLQLQ-SGNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDF  627 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  627 (885)
                      .++|++.+.||+|+||.||+|++.. +     ..||+|.+... .......+.+|+.++.++ +|||||++++++..++.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
T ss_conf             89939701983078819999998578855420499999966335878999999999999971589968687788862995


Q ss_pred             CEEEEECCCCCCCCCCCCCCCCCC--------------CCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCC
Q ss_conf             139996445885322556687545--------------588988788999999999999999996316999658447899
Q 002746          628 KALVLPYMANGSLDSHLYPHSETE--------------FGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKP  693 (885)
Q Consensus       628 ~~lv~e~~~~g~L~~~l~~~~~~~--------------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp  693 (885)
                      .++||||+++|+|.+++.......              .......+++..++.++.|++.||.|||+++   |+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCH
T ss_conf             899997279995999998625777510221000012220012577899999999999999999997399---05052703


Q ss_pred             CCEEECCCCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-C
Q ss_conf             966766999779814443100100267899987778875444345654237865689888853350306799999872-9
Q 002746          694 SNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-R  772 (885)
Q Consensus       694 ~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~ellt-g  772 (885)
                      +|||++.++.+||+|||+|+......         .........||+.|+|||++.+..++.++|||||||++|||+| |
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~---------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g  263 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDS---------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG  263 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCT---------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred             HCCCCCCCCEEEEEECCCCCCCCCCC---------CEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCC
T ss_conf             21443459828985142222045778---------615623435787657838872799996330300039999998389


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             99999434588527899998511014555324321014789278998799999999999853037899999998999999
Q 002746          773 RRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       773 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                      +.||...... ..+.+.+..                ..+...|      ..+++++.+++.+||+.||++|||++||+++
T Consensus       264 ~~Pf~~~~~~-~~~~~~~~~----------------~~~~~~p------~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         264 VNPYPGIPVD-ANFYKLIQN----------------GFKMDQP------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CCSSTTCCCS-HHHHHHHHT----------------TCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCHH-HHHHHHHHC----------------CCCCCCC------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             9999998989-999999856----------------9989988------7678999999999758896689399999999


Q ss_pred             HHH
Q ss_conf             999
Q 002746          853 LDR  855 (885)
Q Consensus       853 L~~  855 (885)
                      |..
T Consensus       321 L~~  323 (325)
T d1rjba_         321 LGC  323 (325)
T ss_dssp             HHH
T ss_pred             HHC
T ss_conf             748

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=359.69  Aligned_cols=266  Identities=23%  Similarity=0.358  Sum_probs=208.7

Q ss_pred             HCCCCCCE-ECCCCCCEEEEEEEC---CCCEEEEEEEEECC-CCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEE
Q ss_conf             17864643-201276249999969---99799999943047-83036699999998305896642344331069951399
Q 002746          557 AEFDEQRL-LGTGSYGRVYKGILQ---DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       557 ~~~~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  631 (885)
                      ++|.+.+. ||+|+||.||+|.++   ++..||||+++... ....+.|.+|++++++++||||+++++++.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEE
T ss_conf             4718878487306080999999960897689999998820397899999999999986799888068656036-807999


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf             96445885322556687545588988788999999999999999996316999658447899966766999779814443
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       632 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~  711 (885)
                      |||+++|+|.+++.....        .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        87 mE~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGl  155 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGL  155 (285)
T ss_dssp             EECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTT
T ss_pred             EEECCCCCHHHHHHCCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEECCCHH
T ss_conf             980789968997521256--------9999999999999999878998688---10576764660454688542033134


Q ss_pred             CEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCCCCCCHHHHH
Q ss_conf             100100267899987778875444345654237865689888853350306799999872-9999994345885278999
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~  790 (885)
                      |+.+.....        .........||+.|+|||++.+..++.++|||||||++|||+| |+.||.....  ......+
T Consensus       156 a~~~~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~~i  225 (285)
T d1u59a_         156 SKALGADDS--------YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFI  225 (285)
T ss_dssp             CEECTTCSC--------EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHH
T ss_pred             HHCCCCCCC--------CCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCH--HHHHHHH
T ss_conf             211554343--------211356211374335868872799995412322017899999389999999799--9999999


Q ss_pred             HHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCC
Q ss_conf             9851101455532432101478927899879999999999985303789999999899999999999883678999
Q 002746          791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGEKHMP  866 (885)
Q Consensus       791 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~~~~~  866 (885)
                      .                .+.+...|      ..+++++.+++.+||+.+|++||||.++.+.|+.+...+.+....
T Consensus       226 ~----------------~~~~~~~p------~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~~  279 (285)
T d1u59a_         226 E----------------QGKRMECP------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG  279 (285)
T ss_dssp             H----------------TTCCCCCC------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred             H----------------CCCCCCCC------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHHCCCH
T ss_conf             8----------------18999999------767899999999975779768909999999999999985411103

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=362.28  Aligned_cols=252  Identities=23%  Similarity=0.346  Sum_probs=204.1

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECC-CCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
Q ss_conf             517864643201276249999969-99799999943047-8303669999999830589664234433106995139996
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  633 (885)
                      .+.|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.++...++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf             66669988994065839999999999989999998157731289999999999986799899919899998998889885


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC---CCCCEEECCCC
Q ss_conf             445885322556687545588988788999999999999999996316999658447899966766---99977981444
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFG  710 (885)
Q Consensus       634 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~---~~~~~kl~Dfg  710 (885)
                      |+++|+|.+++....         .+++..+..++.|++.||.|||+++   |+||||||+||++.   +++.+||+|||
T Consensus        88 ~~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG  155 (307)
T d1a06a_          88 LVSGGELFDRIVEKG---------FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFG  155 (307)
T ss_dssp             CCCSCBHHHHHHTCS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-
T ss_pred             CCCCCCHHHHHHCCC---------CCCHHHHHHHHHHHHHHHHHHHHCE---EEEEEECCCCEEECCCCCCCEEEEECCC
T ss_conf             268984888653036---------7887899999999999987524130---5568704630011046888249983154


Q ss_pred             CCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
Q ss_conf             31001002678999877788754443456542378656898888533503067999998729999994345885278999
Q 002746          711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~  790 (885)
                      +|+....            ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....     .+..
T Consensus       156 ~a~~~~~------------~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~  218 (307)
T d1a06a_         156 LSKMEDP------------GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-----AKLF  218 (307)
T ss_dssp             -----------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHH
T ss_pred             EEEECCC------------CCEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH-----HHHH
T ss_conf             3587258------------9704400328422591887379998078734515999999859799999899-----9999


Q ss_pred             HHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             98511014555324321014789278998799999999999853037899999998999999
Q 002746          791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       791 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..            ..........+    .+..+++++.+++.+||..||++|||++|++++
T Consensus       219 ~~------------i~~~~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         219 EQ------------ILKAEYEFDSP----YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             HH------------HHTTCCCCCTT----TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HH------------HHCCCCCCCCC----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             99------------86168777876----666789999999999760897579189998629

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=358.86  Aligned_cols=253  Identities=25%  Similarity=0.391  Sum_probs=208.5

Q ss_pred             HCCCCCCEECCCCCCEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEECCC
Q ss_conf             17864643201276249999969997999999430478303669999999830589664234433106995139996445
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMA  636 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  636 (885)
                      ++|++.+.||+|+||+||+|+++++..||||.++... ...+.+.+|++++++++||||+++++++.++...++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf             9979968982078839999998899899999987475-778999999999996689860158899850781699997048


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCCCEEEE
Q ss_conf             88532255668754558898878899999999999999999631699965844789996676699977981444310010
Q 002746          637 NGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVM  716 (885)
Q Consensus       637 ~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~  716 (885)
                      +|++..++.....        .+++..+.+++.|+++|+.|||+.+   |+||||||+||+++.++.+||+|||+|+.+.
T Consensus        83 ~g~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~  151 (258)
T d1k2pa_          83 NGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  151 (258)
T ss_dssp             TEEHHHHHHSGGG--------CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred             CCCHHHHHHCCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCEEEEECCCCCEEECCCHHHEECC
T ss_conf             9938886410246--------7768999999999999999875468---4346654135887699847988614420235


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCCCCCCHHHHHHHHHC
Q ss_conf             0267899987778875444345654237865689888853350306799999872-999999434588527899998511
Q 002746          717 TVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       717 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~  795 (885)
                      ...          ........||+.|+|||++.+..++.++||||||+++|||+| |+.||.....     .+....   
T Consensus       152 ~~~----------~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-----~~~~~~---  213 (258)
T d1k2pa_         152 DDE----------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----SETAEH---  213 (258)
T ss_dssp             SSS----------CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----HHHHHH---
T ss_pred             CCC----------CEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCH-----HHHHHH---
T ss_conf             787----------22524657887757807863799885210336432467397559999889999-----999999---


Q ss_pred             CHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf             014555324321014789278998799999999999853037899999998999999999
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDR  855 (885)
Q Consensus       796 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~  855 (885)
                                +....+...|.      .+++++.+++.+||+.||++|||+++++++|.+
T Consensus       214 ----------i~~~~~~~~p~------~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         214 ----------IAQGLRLYRPH------LASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             ----------HHTTCCCCCCT------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ----------HHHCCCCCCCC------CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf             ----------98079789965------465999999999766897689399999987418

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=361.24  Aligned_cols=262  Identities=21%  Similarity=0.282  Sum_probs=209.7

Q ss_pred             HCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEEC---CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEE
Q ss_conf             17864643201276249999969-9979999994304---7830366999999983058966423443310699513999
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  632 (885)
                      ++|++.+.||+|+||.||+|... +++.||||++...   .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             87789889850879099999998999799999986577557778999999999998768888617999999899889999


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCCC
Q ss_conf             64458853225566875455889887889999999999999999963169996584478999667669997798144431
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++|+|.+++....         .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus        88 Ey~~gg~L~~~~~~~~---------~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a  155 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG---------SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTA  155 (288)
T ss_dssp             CCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ECCCCCCHHHHHHCCC---------CCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCCCCCCCCCCCEEEECCCCCC
T ss_conf             7048987777653159---------9999999999999999997621650---884767741236688853886032102


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf             00100267899987778875444345654237865689888853350306799999872999999434588527899998
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  792 (885)
                      +.+....         .........||+.|+|||++.+..++.++||||+||++|||++|+.||...     ........
T Consensus       156 ~~~~~~~---------~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~~~~~~~  221 (288)
T d1uu3a_         156 KVLSPES---------KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-----NEYLIFQK  221 (288)
T ss_dssp             EECC-------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHH
T ss_pred             EECCCCC---------CCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCC-----CHHHHHHH
T ss_conf             4225677---------643335556775525844002689896662304569999980388998995-----99999999


Q ss_pred             HHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH-HHHCCCC
Q ss_conf             51101455532432101478927899879999999999985303789999999899999999999-8836789
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLK-RYLGEKH  864 (885)
Q Consensus       793 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~-~~~~~~~  864 (885)
                      ..             .......       ..+++++.+++.+||+.||++|||++|+..+-.-.. .++..-.
T Consensus       222 i~-------------~~~~~~p-------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~  274 (288)
T d1uu3a_         222 II-------------KLEYDFP-------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  274 (288)
T ss_dssp             HH-------------TTCCCCC-------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             HH-------------CCCCCCC-------CCCCHHHHHHHHHHCCCCHHHCCCHHHHCCCHHHHCCCCCCCCC
T ss_conf             97-------------1899998-------54799999999998557976891978973778987697647899

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=363.86  Aligned_cols=257  Identities=23%  Similarity=0.316  Sum_probs=203.5

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEEC--CCCCEE
Q ss_conf             517864643201276249999969-997999999430478--303669999999830589664234433106--995139
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG--NFTKSFNRECQVLKRIRHRNLMRIITACSL--PDFKAL  630 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l  630 (885)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|.++....  ...+.+.+|++++++++||||+++++++.+  +...++
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf             33379967983088919999999999979999998746579799999999999999778999824899999178998999


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCC--CCEEECCCCCCCEEECCCCCEEECC
Q ss_conf             99644588532255668754558898878899999999999999999631699--9658447899966766999779814
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSP--VRVIHCDLKPSNVLLNDDMTALVSD  708 (885)
Q Consensus       631 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~--~~ivH~dikp~NILl~~~~~~kl~D  708 (885)
                      ||||+++|+|.+++.....     ....+++..++.++.|++.||.|||+++.  .+|+||||||+|||++.++.+||+|
T Consensus        83 vmEy~~~g~L~~~i~~~~~-----~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D  157 (269)
T d2java1          83 VMEYCEGGDLASVITKGTK-----ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD  157 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHH-----HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred             EEECCCCCCHHHHHHHCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEE
T ss_conf             9956899938999985154-----57899999999999999999999997167788788586765425747888579800


Q ss_pred             CCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHH
Q ss_conf             44310010026789998777887544434565423786568988885335030679999987299999943458852789
Q 002746          709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~  788 (885)
                      ||+|+.+...           ........||+.|+|||++.+..++.++|||||||++|||+||+.||....     ..+
T Consensus       158 FG~a~~~~~~-----------~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~-----~~~  221 (269)
T d2java1         158 FGLARILNHD-----------TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-----QKE  221 (269)
T ss_dssp             HHHHHHC----------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHH
T ss_pred             CCCEEECCCC-----------CCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCC-----HHH
T ss_conf             1000322457-----------775566778823279999839999938988752789999801889989989-----999


Q ss_pred             HHHHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             9998511014555324321014789278998799999999999853037899999998999999
Q 002746          789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       789 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ......        ..    ... ..+      ..+++++.+++.+||+.||++|||++|++++
T Consensus       222 ~~~~i~--------~~----~~~-~~~------~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         222 LAGKIR--------EG----KFR-RIP------YRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             HHHHHH--------HT----CCC-CCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHH--------CC----CCC-CCC------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf             999997--------18----998-897------4359999999999767995579189999729

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=356.10  Aligned_cols=261  Identities=28%  Similarity=0.425  Sum_probs=205.6

Q ss_pred             HCCCCCCEECCCCCCEEEEEEECCC-----CEEEEEEEEECCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEE
Q ss_conf             1786464320127624999996999-----7999999430478-303669999999830589664234433106995139
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQDG-----TAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKAL  630 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  630 (885)
                      ..|+..+.||+|+||.||+|.++..     ..||||.++.... .....|.+|++++++++|||||++++++......++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf             99686159811779099999996899878799999998844596899999999999985689878323677833880389


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCC
Q ss_conf             99644588532255668754558898878899999999999999999631699965844789996676699977981444
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG  710 (885)
Q Consensus       631 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg  710 (885)
                      |+||+.+|++...+.....        .+++..+..++.|++.|+.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        87 v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG  155 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFG  155 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             EEEECCCCCCHHHHHCCCC--------CCCHHHHHHHHHHHHHHHHHCCCCC---CCCCCCCCCEEEECCCCEEEECCCC
T ss_conf             9972135740222102345--------4208999999999998541212123---4257656442788899849984551


Q ss_pred             CCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
Q ss_conf             31001002678999877788754443456542378656898888533503067999998729999994345885278999
Q 002746          711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~  790 (885)
                      +|+.+.....        .........||+.|+|||++.+..++.++|||||||++|||++|+.|+....    ...+..
T Consensus       156 la~~~~~~~~--------~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~----~~~~~~  223 (283)
T d1mqba_         156 LSRVLEDDPE--------ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----SNHEVM  223 (283)
T ss_dssp             C-------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHH
T ss_pred             HHHCCCCCCC--------CCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC----CHHHHH
T ss_conf             0300357876--------5267426777734348888704999973556344898999996798865568----999999


Q ss_pred             HHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf             985110145553243210147892789987999999999998530378999999989999999999988
Q 002746          791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRY  859 (885)
Q Consensus       791 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~  859 (885)
                      .         .+...    .+...+      ..++.++.+++.+||+.+|++||||+||++.|+.+.+.
T Consensus       224 ~---------~i~~~----~~~~~~------~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         224 K---------AINDG----FRLPTP------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             H---------HHHTT----CCCCCC------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             H---------HHHCC----CCCCCC------HHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             9---------98635----789985------04579999999997767976893999999999998669

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=359.71  Aligned_cols=246  Identities=25%  Similarity=0.337  Sum_probs=198.1

Q ss_pred             HCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECCC---CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEE
Q ss_conf             17864643201276249999969-997999999430478---30366999999983058966423443310699513999
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG---NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  632 (885)
                      ..|+..+.||+|+||.||+|+.. +++.||||+++....   ...+.+.+|++++++++||||+++++++.++...++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             85676279701888099999998999399999984444358899999999999999778999823899999899889999


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCCC
Q ss_conf             64458853225566875455889887889999999999999999963169996584478999667669997798144431
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a  712 (885)
                      |||++|++..+.....         .+++..+..++.|++.||.|||++|   |+||||||+|||++.++.+||+|||+|
T Consensus        95 E~~~~g~l~~~~~~~~---------~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a  162 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK---------PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA  162 (309)
T ss_dssp             ECCSEEHHHHHHHHTS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred             EECCCCCHHHHHHHCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCCCEEEECCCCCEEEEECCCC
T ss_conf             8069994578997379---------9999999999999999999998689---766678842179879997898443653


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHH
Q ss_conf             00100267899987778875444345654237865689---888853350306799999872999999434588527899
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG---SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKW  789 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~  789 (885)
                      .....               .....||+.|+|||++.+   ..++.++|||||||++|||++|+.||.....     .+.
T Consensus       163 ~~~~~---------------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-----~~~  222 (309)
T d1u5ra_         163 SIMAP---------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSA  222 (309)
T ss_dssp             BSSSS---------------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHH
T ss_pred             CCCCC---------------CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH-----HHH
T ss_conf             34677---------------8731347663688998346788867214545589999999878899999799-----999


Q ss_pred             HHHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             998511014555324321014789278998799999999999853037899999998999999
Q 002746          790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       790 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .....            ........+      ..+++++.+++.+||+.||++|||++|++++
T Consensus       223 ~~~i~------------~~~~~~~~~------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         223 LYHIA------------QNESPALQS------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             HHHHH------------HSCCCCCSC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             HHHHH------------HCCCCCCCC------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf             99998------------289998887------8889999999999773796579189999719

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=357.13  Aligned_cols=248  Identities=26%  Similarity=0.369  Sum_probs=195.1

Q ss_pred             CCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECC--CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEC----CCCCEEE
Q ss_conf             864643201276249999969-99799999943047--8303669999999830589664234433106----9951399
Q 002746          559 FDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSL----PDFKALV  631 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv  631 (885)
                      |...+.||+|+||+||+|.+. ++..||+|.+....  ....+.+.+|++++++++||||+++++++..    ....++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEE
T ss_conf             88516970082849999999999959999998512279899999999999998579998506999984033458889999


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC-CCCCEEECCCC
Q ss_conf             96445885322556687545588988788999999999999999996316999658447899966766-99977981444
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN-DDMTALVSDFG  710 (885)
Q Consensus       632 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~-~~~~~kl~Dfg  710 (885)
                      |||+++|+|.+++....         .+++..+..++.|++.||+|||+++ .+|+||||||+|||++ +++.+||+|||
T Consensus        91 mE~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFG  160 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLG  160 (270)
T ss_dssp             EECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             EECCCCCCHHHHHHCCC---------CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECC
T ss_conf             95789894899975135---------5469999999999999999999789-9799687674351166799988980057


Q ss_pred             CCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
Q ss_conf             31001002678999877788754443456542378656898888533503067999998729999994345885278999
Q 002746          711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~  790 (885)
                      +|+...             ........||+.|+|||++.+ .++.++||||+||++|||++|+.||.....    .....
T Consensus       161 la~~~~-------------~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~----~~~~~  222 (270)
T d1t4ha_         161 LATLKR-------------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIY  222 (270)
T ss_dssp             GGGGCC-------------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHH
T ss_pred             CCEECC-------------CCCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCC----HHHHH
T ss_conf             654236-------------876677553813008988478-999867110079999999878899987655----99999


Q ss_pred             HHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             98511014555324321014789278998799999999999853037899999998999999
Q 002746          791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       791 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ............                  ....++++.+++.+||++||++|||++|++++
T Consensus       223 ~~i~~~~~~~~~------------------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         223 RRVTSGVKPASF------------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             HHHTTTCCCGGG------------------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHCCCCCCCC------------------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             999738998656------------------75578999999999763797589299999677

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=353.51  Aligned_cols=249  Identities=24%  Similarity=0.315  Sum_probs=205.2

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEEC---CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEE
Q ss_conf             517864643201276249999969-9979999994304---783036699999998305896642344331069951399
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  631 (885)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++..   .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf             47428988983176849999999899989999998156544979999999999999867999887787640356421110


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf             96445885322556687545588988788999999999999999996316999658447899966766999779814443
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       632 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~  711 (885)
                      |||+++|+|..++....         .+++..+..++.|++.||.|||++|   |+||||||+|||++.++.+||+|||+
T Consensus        84 ~ey~~gg~L~~~~~~~~---------~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~  151 (337)
T d1o6la_          84 MEYANGGELFFHLSRER---------VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL  151 (337)
T ss_dssp             EECCTTCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EECCCCCCHHHHHHCCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEEEECCC
T ss_conf             00357986055553256---------7759999999999965211343159---62246477784765899888820565


Q ss_pred             CEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHH
Q ss_conf             10010026789998777887544434565423786568988885335030679999987299999943458852789999
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  791 (885)
                      |+.....           .......+||+.|+|||++.+..++.++||||+||++|||++|+.||....     ..+...
T Consensus       152 a~~~~~~-----------~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~-----~~~~~~  215 (337)
T d1o6la_         152 CKEGISD-----------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HERLFE  215 (337)
T ss_dssp             CBCSCCT-----------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH
T ss_pred             CCCCCCC-----------CCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCC-----HHHHHH
T ss_conf             2003567-----------862055100889966665048988833310223067889987899999969-----999999


Q ss_pred             HHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHH
Q ss_conf             851101455532432101478927899879999999999985303789999999-----8999999
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT-----MLDAADD  852 (885)
Q Consensus       792 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ev~~~  852 (885)
                      ...             ...... |      ..+++++.+++.+|+++||++||+     ++|+++|
T Consensus       216 ~i~-------------~~~~~~-p------~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         216 LIL-------------MEEIRF-P------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             HHH-------------HCCCCC-C------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             HHH-------------CCCCCC-C------CCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCC
T ss_conf             985-------------289989-8------668999999998666389344225652349999729

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=351.30  Aligned_cols=252  Identities=22%  Similarity=0.296  Sum_probs=204.2

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECC------CCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCC
Q ss_conf             517864643201276249999969-99799999943047------83036699999998305896642344331069951
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS------GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFK  628 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  628 (885)
                      .++|++.+.||+|+||+||+|+.. +|+.||||++....      ....+.+.+|++++++++||||+++++++.++...
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf             56779827981178959999999999989999998756632134068999999999999867998999388999979989


Q ss_pred             EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCC----CE
Q ss_conf             39996445885322556687545588988788999999999999999996316999658447899966766999----77
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDM----TA  704 (885)
Q Consensus       629 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~----~~  704 (885)
                      ++|||||++|+|.+++....         .+++..+..++.|++.||.|||+++   |+||||||+||+++.++    .+
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~---------~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~v  156 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE---------SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRI  156 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCE
T ss_pred             EEEEECCCCCCCCCHHCCCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEEECCCCCCCCE
T ss_conf             99998677864310010356---------4215578999999999987666254---22113330127982589866646


Q ss_pred             EECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             98144431001002678999877788754443456542378656898888533503067999998729999994345885
Q 002746          705 LVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGL  784 (885)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~  784 (885)
                      |++|||+|..+..            ........||+.|+|||++.+..++.++||||+||++|||++|+.||....    
T Consensus       157 kl~DfG~a~~~~~------------~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----  220 (293)
T d1jksa_         157 KIIDFGLAHKIDF------------GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT----  220 (293)
T ss_dssp             EECCCTTCEECTT------------SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----
T ss_pred             EECCHHHHHHCCC------------CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC----
T ss_conf             9643344210577------------763122477774309999818999976652214099999970889988999----


Q ss_pred             CHHHHHHHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             27899998511014555324321014789278998799999999999853037899999998999999
Q 002746          785 SLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                       ..+......             .......+   .....++.++.+++.+||+.||++|||++|++++
T Consensus       221 -~~~~~~~i~-------------~~~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         221 -KQETLANVS-------------AVNYEFED---EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             -HHHHHHHHH-------------TTCCCCCH---HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -HHHHHHHHH-------------HCCCCCCC---HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             -999999998-------------16888870---1047889999999999863896689199999619

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=351.89  Aligned_cols=245  Identities=27%  Similarity=0.348  Sum_probs=203.2

Q ss_pred             HCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEEC---CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEE
Q ss_conf             17864643201276249999969-9979999994304---7830366999999983058966423443310699513999
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  632 (885)
                      ++|++.+.||+|+||.||+|+.+ +|+.||+|+++..   .....+.+.+|+.+++.++||||+++++++.++...++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf             47088889720768089999998999799999984577548899999999999998636967533035685288005676


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCCC
Q ss_conf             64458853225566875455889887889999999999999999963169996584478999667669997798144431
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+++|++..++.....         +++.....++.|++.|+.|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus        84 E~~~gg~l~~~~~~~~~---------~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a  151 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR---------FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFA  151 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS---------CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             EECCCCCCCCCCCCCCC---------CCCCHHHHHHHHHHHHHHHHCCCC---EECCCCCCHHEEECCCCCEEEECCCCC
T ss_conf             50378632234322221---------110079999999987655412476---770556810503868998898317521


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf             00100267899987778875444345654237865689888853350306799999872999999434588527899998
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  792 (885)
                      +....              ......||+.|+|||++.+..++.++||||+||++|||++|+.||...     ...+....
T Consensus       152 ~~~~~--------------~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~-----~~~~~~~~  212 (316)
T d1fota_         152 KYVPD--------------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-----NTMKTYEK  212 (316)
T ss_dssp             EECSS--------------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-----SHHHHHHH
T ss_pred             EEECC--------------CCCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCC-----CHHHHHHH
T ss_conf             67124--------------564345763435999983899980430465333689997598999996-----99999999


Q ss_pred             HHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHH
Q ss_conf             5110145553243210147892789987999999999998530378999999-----98999999
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP-----TMLDAADD  852 (885)
Q Consensus       793 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~~  852 (885)
                      .             ........+       .+++++.+++.+|+..||.+|+     |+++++++
T Consensus       213 i-------------~~~~~~~p~-------~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         213 I-------------LNAELRFPP-------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             H-------------HHCCCCCCT-------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             H-------------HCCCCCCCC-------CCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf             9-------------708988997-------78999999999995449976664310219999819

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=0  Score=353.38  Aligned_cols=249  Identities=22%  Similarity=0.281  Sum_probs=197.0

Q ss_pred             HCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECC---CCCHHHHHH---HHHHHHHCCCCCCCEEEEEEECCCCCE
Q ss_conf             17864643201276249999969-99799999943047---830366999---999983058966423443310699513
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS---GNFTKSFNR---ECQVLKRIRHRNLMRIITACSLPDFKA  629 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~  629 (885)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++....   ......+.+   ++++++.++||||+++++++..++..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf             76851018842889099999999999799999984587542667999999999999985089985889999999899889


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCC
Q ss_conf             99964458853225566875455889887889999999999999999963169996584478999667669997798144
Q 002746          630 LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDF  709 (885)
Q Consensus       630 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Df  709 (885)
                      +||||+++|+|..++....         .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+||
T Consensus        84 ivmE~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DF  151 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG---------VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL  151 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCC
T ss_pred             EEEEECCCCCHHHHHHHCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCEEECCCEEEECCCCCEEEEEE
T ss_conf             9999148983899987325---------5327899999999999999999779---622044422167858896798220


Q ss_pred             CCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHH
Q ss_conf             43100100267899987778875444345654237865689-88885335030679999987299999943458852789
Q 002746          710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~  788 (885)
                      |+|+.+..             .......||+.|+|||++.. ..++.++||||+||++|||+||+.||......  ....
T Consensus       152 Gla~~~~~-------------~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~  216 (364)
T d1omwa3         152 GLACDFSK-------------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHE  216 (364)
T ss_dssp             TTCEECSS-------------SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS--CHHH
T ss_pred             CEEEECCC-------------CCCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHH--HHHH
T ss_conf             10233378-------------86433113455421687603899984410467789999998599988889989--9999


Q ss_pred             HHHHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHH
Q ss_conf             999851101455532432101478927899879999999999985303789999999-----8999999
Q 002746          789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPT-----MLDAADD  852 (885)
Q Consensus       789 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ev~~~  852 (885)
                      ......             .......       ..+++++.+++.+||..||++|||     ++|++++
T Consensus       217 ~~~~~~-------------~~~~~~~-------~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         217 IDRMTL-------------TMAVELP-------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             HHHHSS-------------SCCCCCC-------SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             HHHHCC-------------CCCCCCC-------CCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCC
T ss_conf             998604-------------6888788-------778999999999985669888088743579999749

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=353.35  Aligned_cols=251  Identities=25%  Similarity=0.359  Sum_probs=199.8

Q ss_pred             CEECCCCCCEEEEEEEC---CCCEEEEEEEEEC--CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEECCCC
Q ss_conf             43201276249999969---9979999994304--783036699999998305896642344331069951399964458
Q 002746          563 RLLGTGSYGRVYKGILQ---DGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYMAN  637 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  637 (885)
                      +.||+|+||.||+|.++   .++.||||+++..  .....+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf             7834587829999998169738599999988010898999999999999986799898527777505-977999974788


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCCCEEEEC
Q ss_conf             85322556687545588988788999999999999999996316999658447899966766999779814443100100
Q 002746          638 GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLVMT  717 (885)
Q Consensus       638 g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~~~  717 (885)
                      |+|.+++....         .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+|++|||+|+.+..
T Consensus        92 g~L~~~l~~~~---------~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~  159 (277)
T d1xbba_          92 GPLNKYLQQNR---------HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA  159 (277)
T ss_dssp             EEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             CCHHHHHHHCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCC
T ss_conf             96899975225---------7899999999999999976687479---55677761131023567512341345331343


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCCCCCCHHHHHHHHHCC
Q ss_conf             267899987778875444345654237865689888853350306799999872-9999994345885278999985110
Q 002746          718 VGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNHYHG  796 (885)
Q Consensus       718 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~~~~  796 (885)
                      ...        .........||+.|+|||++.+..++.++|||||||++|||+| |+.||.....     .+...     
T Consensus       160 ~~~--------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-----~~~~~-----  221 (277)
T d1xbba_         160 DEN--------YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEVTA-----  221 (277)
T ss_dssp             TCS--------EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHH-----
T ss_pred             CCC--------CCCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCH-----HHHHH-----
T ss_conf             234--------432244567784203916653799984344303403132896589999999899-----99999-----


Q ss_pred             HHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             14555324321014789278998799999999999853037899999998999999999998
Q 002746          797 RLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR  858 (885)
Q Consensus       797 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~  858 (885)
                          .+.    .+.+...|      ..++.++.+++.+||+.||++|||+++|.+.|+....
T Consensus       222 ----~i~----~~~~~~~p------~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         222 ----MLE----KGERMGCP------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             ----HHH----TTCCCCCC------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----HHH----CCCCCCCC------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHH
T ss_conf             ----998----28999998------6567999999999758897689098999998528875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=351.26  Aligned_cols=245  Identities=24%  Similarity=0.283  Sum_probs=203.5

Q ss_pred             HCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEEC---CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEE
Q ss_conf             17864643201276249999969-9979999994304---7830366999999983058966423443310699513999
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  632 (885)
                      ++|++.+.||+|+||.||+|+.+ +|+.||+|++...   .....+.+.+|+++++.++||||+++++++......++|+
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf             37089889611768089999998999899999982677458899999999999999748772740344443222223222


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCCC
Q ss_conf             64458853225566875455889887889999999999999999963169996584478999667669997798144431
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIA  712 (885)
Q Consensus       633 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a  712 (885)
                      ||+.+|++..++....         .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus       121 e~~~~g~l~~~l~~~~---------~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a  188 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG---------RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFA  188 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCCCCCCHHHHHHHCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHCCCCCCCCEEEEECEEE
T ss_conf             2334662266675158---------9899999999999999899998599---861767999936077897886101033


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf             00100267899987778875444345654237865689888853350306799999872999999434588527899998
Q 002746          713 KLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       713 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  792 (885)
                      +.+..              ......||+.|+|||++.+..++.++||||+||++|||+||+.||...     ........
T Consensus       189 ~~~~~--------------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-----~~~~~~~~  249 (350)
T d1rdqe_         189 KRVKG--------------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-----QPIQIYEK  249 (350)
T ss_dssp             EECSS--------------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHH
T ss_pred             EECCC--------------CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC-----CHHHHHHH
T ss_conf             32256--------------664336763567889971799885331145007899997588998995-----99999999


Q ss_pred             HHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHH
Q ss_conf             5110145553243210147892789987999999999998530378999999-----98999999
Q 002746          793 HYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP-----TMLDAADD  852 (885)
Q Consensus       793 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~~  852 (885)
                      ..             .......+       .+++++.+++.+||..||.+|+     |++|+++|
T Consensus       250 i~-------------~~~~~~p~-------~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         250 IV-------------SGKVRFPS-------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             HH-------------HCCCCCCT-------TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HH-------------CCCCCCCC-------CCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCC
T ss_conf             86-------------17988976-------68999999999983409986065534549999719

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=353.01  Aligned_cols=258  Identities=28%  Similarity=0.411  Sum_probs=205.8

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEECC
Q ss_conf             51786464320127624999996999799999943047830366999999983058966423443310699513999644
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  635 (885)
                      .++|++.+.||+|+||.||+|.++++..||||+++.. ....+.|.+|+.++++++|+|||++++++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEEC
T ss_conf             7997984699307980999999999999999998804-4888999999999986666788689999823-9759999944


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCCCEEE
Q ss_conf             58853225566875455889887889999999999999999963169996584478999667669997798144431001
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++|++..++.....       ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+
T Consensus        94 ~~g~l~~~~~~~~~-------~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~  163 (285)
T d1fmka3          94 SKGSLLDFLKGETG-------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI  163 (285)
T ss_dssp             TTCBHHHHHSHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             CCCCHHHHHHHCCC-------CCCHHHHHHHHHHHHHHHHHHHHHHH---EECCCCCCEEEEECCCCCEEECCCCHHHHC
T ss_conf             79943542000035-------53059999999999999999875411---433531230799989992998442555425


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHC
Q ss_conf             00267899987778875444345654237865689888853350306799999872999999434588527899998511
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  795 (885)
                      ....          ........||+.|+|||++....++.++||||||+++|||++|+.|+....    ...+...... 
T Consensus       164 ~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~----~~~~~~~~i~-  228 (285)
T d1fmka3         164 EDNE----------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM----VNREVLDQVE-  228 (285)
T ss_dssp             ----------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC----CHHHHHHHHH-
T ss_pred             CCCC----------CEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCC----CHHHHHHHHH-
T ss_conf             6887----------335245455665458089837998917741323589999986899999888----8999999998-


Q ss_pred             CHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             014555324321014789278998799999999999853037899999998999999999998
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR  858 (885)
Q Consensus       796 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~  858 (885)
                                  .......+      ..+++++.+++.+||+.||++||+|++|++.|+....
T Consensus       229 ------------~~~~~~~~------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         229 ------------RGYRMPCP------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             ------------TTCCCCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             ------------HCCCCCCC------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf             ------------26899998------3237999999999756697589199999998766623

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=350.51  Aligned_cols=257  Identities=26%  Similarity=0.431  Sum_probs=204.7

Q ss_pred             HCCCCCCEECCCCCCEEEEEEEC-CCC----EEEEEEEEEC-CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEE
Q ss_conf             17864643201276249999969-997----9999994304-78303669999999830589664234433106995139
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGT----AIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKAL  630 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  630 (885)
                      .+|++.+.||+|+||.||+|.+. +|+    +||+|.++.. .....+.+.+|++++++++||||++++++|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf             999783198208992999999958998898999999965134979999999999999867998881589999619-8369


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCC
Q ss_conf             99644588532255668754558898878899999999999999999631699965844789996676699977981444
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG  710 (885)
Q Consensus       631 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg  710 (885)
                      +++|+.+|+|.+++.....        .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        88 v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFG  156 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFG  156 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSS--------SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCS
T ss_pred             EEEECCCCCCCCCCCCCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCHHHCCEECCCCCEEEECCC
T ss_conf             9984268740101113345--------7999999999999999999998769---5047621203116799875860255


Q ss_pred             CCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCCCCCCHHHH
Q ss_conf             3100100267899987778875444345654237865689888853350306799999872-999999434588527899
Q 002746          711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKW  789 (885)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~ellt-g~~Pf~~~~~~~~~~~~~  789 (885)
                      +|+.+....         .........||+.|+|||++.+..++.++|||||||++|||+| |..||.....  ..+...
T Consensus       157 la~~~~~~~---------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--~~~~~~  225 (317)
T d1xkka_         157 LAKLLGAEE---------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSI  225 (317)
T ss_dssp             HHHHTTTTC---------C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--GGHHHH
T ss_pred             CCEECCCCC---------CCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHH
T ss_conf             222335444---------532236510586446708874699983565440799999999779999999998--999999


Q ss_pred             HHHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             998511014555324321014789278998799999999999853037899999998999999999998
Q 002746          790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR  858 (885)
Q Consensus       790 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~  858 (885)
                      +.                .+.+...+      ..+++++.+++.+||+.||++|||++|++++|..+.+
T Consensus       226 i~----------------~~~~~~~p------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         226 LE----------------KGERLPQP------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             HH----------------HTCCCCCC------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH----------------CCCCCCCC------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             97----------------59989998------5568999999998478993469199999999999875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=354.40  Aligned_cols=271  Identities=24%  Similarity=0.424  Sum_probs=211.5

Q ss_pred             HHHHHHHCCCCCCEECCCCCCEEEEEEEC------CCCEEEEEEEEECCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEE
Q ss_conf             99998517864643201276249999969------997999999430478-30366999999983058966423443310
Q 002746          551 ELLEATAEFDEQRLLGTGSYGRVYKGILQ------DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACS  623 (885)
Q Consensus       551 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~  623 (885)
                      +++...++|++.+.||+|+||.||+|+++      ++..||||+++.... ...+++.+|++++++++|||++++++++.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             HCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEEC
T ss_conf             11389889388679820788399999988876577882999999882108579999999999999668997655246660


Q ss_pred             CCCCCEEEEECCCCCCCCCCCCCCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEE
Q ss_conf             69951399964458853225566875455---------------889887889999999999999999963169996584
Q 002746          624 LPDFKALVLPYMANGSLDSHLYPHSETEF---------------GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIH  688 (885)
Q Consensus       624 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---------------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  688 (885)
                      .....++|+||+++|+|.+++........               ......+++..+..++.|++.|++|||+++   |+|
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             CCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC---EEE
T ss_conf             59803899981589929999985275542100001110012103467889899999999999999855413578---685


Q ss_pred             CCCCCCCEEECCCCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf             47899966766999779814443100100267899987778875444345654237865689888853350306799999
Q 002746          689 CDLKPSNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLE  768 (885)
Q Consensus       689 ~dikp~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~e  768 (885)
                      |||||+|||++.++.+||+|||+|+.+....         .........|++.|+|||++.+..++.++|||||||++||
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~e  234 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE  234 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGG---------CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             EEECCCCEEECCCCCEEECCCHHHEECCCCC---------CCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHH
T ss_conf             4884011689899928983314421136776---------4111577776767679899726889805630252362999


Q ss_pred             HHCCC-CCCCCCCCCCCCHHHHHHHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Q ss_conf             87299-99994345885278999985110145553243210147892789987999999999998530378999999989
Q 002746          769 MVTRR-RPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTML  847 (885)
Q Consensus       769 lltg~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  847 (885)
                      |++|. +||...     ...+......             .......+      ..+++++.+++.+||+.+|++||||.
T Consensus       235 ll~~~~~p~~~~-----~~~e~~~~v~-------------~~~~~~~p------~~~~~~~~~li~~cl~~~P~~RPt~~  290 (301)
T d1lufa_         235 IFSYGLQPYYGM-----AHEEVIYYVR-------------DGNILACP------ENCPLELYNLMRLCWSKLPADRPSFC  290 (301)
T ss_dssp             HHTTTCCTTTTS-----CHHHHHHHHH-------------TTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHCCCCCCCCCC-----CHHHHHHHHH-------------CCCCCCCC------CCCHHHHHHHHHHHCCCCHHHCCCHH
T ss_conf             980689999998-----9999999997-------------39978887------32529999999997488965793999


Q ss_pred             HHHHHHHHHH
Q ss_conf             9999999999
Q 002746          848 DAADDLDRLK  857 (885)
Q Consensus       848 ev~~~L~~l~  857 (885)
                      ||++.|++++
T Consensus       291 ev~~~L~~i~  300 (301)
T d1lufa_         291 SIHRILQRMC  300 (301)
T ss_dssp             HHHHHHHHTT
T ss_pred             HHHHHHHHHC
T ss_conf             9999999842

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.60  Aligned_cols=251  Identities=18%  Similarity=0.273  Sum_probs=204.3

Q ss_pred             HCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEECC
Q ss_conf             17864643201276249999969-99799999943047830366999999983058966423443310699513999644
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPYM  635 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  635 (885)
                      ++|.+.+.||+|+||+||+|... +++.||+|+++.. ......+.+|+++++.++||||+++++++.++...++|||||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf             1058878983177839999999899969999997578-665999999999998579979890989998899889999538


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC--CCCEEECCCCCCE
Q ss_conf             58853225566875455889887889999999999999999963169996584478999667669--9977981444310
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND--DMTALVSDFGIAK  713 (885)
Q Consensus       636 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~--~~~~kl~Dfg~a~  713 (885)
                      ++|+|.+++....        ..+++..+..++.|++.|+.|||++|   |+||||||+|||++.  ...+||+|||.+.
T Consensus        84 ~gg~L~~~i~~~~--------~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~  152 (321)
T d1tkia_          84 SGLDIFERINTSA--------FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             CCCBHHHHHTSSS--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             CCCCHHHHHHHCC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEEECCCCHHH
T ss_conf             9980889987538--------99999999999999999999998769---975135544434437885189976441110


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf             01002678999877788754443456542378656898888533503067999998729999994345885278999985
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  793 (885)
                      ....            ........|++.|+|||...+..++.++||||+||++|+|++|+.||....     ..+.... 
T Consensus       153 ~~~~------------~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~-----~~~~~~~-  214 (321)
T d1tkia_         153 QLKP------------GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-----NQQIIEN-  214 (321)
T ss_dssp             ECCT------------TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-----HHHHHHH-
T ss_pred             CCCC------------CCCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCC-----HHHHHHH-
T ss_conf             0346------------775321223322234021048777840113027999999982899999989-----9999999-


Q ss_pred             HCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             11014555324321014789278998799999999999853037899999998999999
Q 002746          794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       794 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                                 ..........    ..+..+++++.+++.+|+..||++|||++|++++
T Consensus       215 -----------i~~~~~~~~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         215 -----------IMNAEYTFDE----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             -----------HHHTCCCCCH----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----------HHHCCCCCCH----HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             -----------9838999880----2236789999999999866996689099999639

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=346.75  Aligned_cols=252  Identities=21%  Similarity=0.301  Sum_probs=197.7

Q ss_pred             HHCCCCC-CEECCCCCCEEEEEEEC-CCCEEEEEEEEECCCCCHHHHHHHHHHHHHC-CCCCCCEEEEEEEC----CCCC
Q ss_conf             5178646-43201276249999969-9979999994304783036699999998305-89664234433106----9951
Q 002746          556 TAEFDEQ-RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRI-RHRNLMRIITACSL----PDFK  628 (885)
Q Consensus       556 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~  628 (885)
                      .++|.+. +.||+|+||.||+|... +++.||||+++.     ...+.+|++++.++ +||||+++++++.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf             14879810796545486999999889998999999897-----4779999999998669999782989995034689789


Q ss_pred             EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC---CCCEE
Q ss_conf             399964458853225566875455889887889999999999999999963169996584478999667669---99779
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND---DMTAL  705 (885)
Q Consensus       629 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~---~~~~k  705 (885)
                      ++|||||++|+|.+++.....       ..+++..+..++.|++.|+.|||++|   |+||||||+|||++.   ++.+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~-------~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~K  154 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGD-------QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILK  154 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSC-------CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEE
T ss_pred             EEEEECCCCCCHHHHHHHCCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             999977899849999986278-------77579999999999999999999769---86444100220113555566311


Q ss_pred             ECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             81444310010026789998777887544434565423786568988885335030679999987299999943458852
Q 002746          706 VSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLS  785 (885)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~  785 (885)
                      |+|||+|+.....            .......||+.|+|||++.+..++.++||||+||++|+|+||+.||......  .
T Consensus       155 l~DFG~a~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~--~  220 (335)
T d2ozaa1         155 LTDFGFAKETTSH------------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--A  220 (335)
T ss_dssp             ECCCTTCEECCCC------------CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---
T ss_pred             CCCCCEEEECCCC------------CCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHH--H
T ss_conf             3545512333688------------8643226775637927774898888888876451677886588998898877--8


Q ss_pred             HHHHHHHHHCCHHHHHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             789999851101455532432101-4789278998799999999999853037899999998999999
Q 002746          786 LHKWVKNHYHGRLEKVIDSSLLRA-SRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       786 ~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ....+            ...+... .....+    .+..+++++.+++.+|+..||++|||++|++++
T Consensus       221 ~~~~~------------~~~i~~~~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         221 ISPGM------------KTRIRMGQYEFPNP----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             -------------------CCCSCSSSCCTT----HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHH------------HHHHHCCCCCCCCC----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             89999------------99985388888985----434699999999999756996579099999709

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=344.64  Aligned_cols=263  Identities=25%  Similarity=0.392  Sum_probs=205.4

Q ss_pred             CCEECCCCCCEEEEEEECCC----CEEEEEEEEEC-CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEC-CCCCEEEEECC
Q ss_conf             64320127624999996999----79999994304-78303669999999830589664234433106-99513999644
Q 002746          562 QRLLGTGSYGRVYKGILQDG----TAIAVKVLQLQ-SGNFTKSFNRECQVLKRIRHRNLMRIITACSL-PDFKALVLPYM  635 (885)
Q Consensus       562 ~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~  635 (885)
                      .++||+|+||+||+|.+..+    ..||||.++.. .....++|.+|++++++++||||+++++++.. +...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf             66981368809999999779987999999998843697899999999999986789998678678980699438999874


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCCCEEE
Q ss_conf             58853225566875455889887889999999999999999963169996584478999667669997798144431001
Q 002746          636 ANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKLV  715 (885)
Q Consensus       636 ~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~~  715 (885)
                      ++|+|.+++.....        ..++..+.+++.|++.|+.|+|+.+   |+||||||+|||+++++.+||+|||+++.+
T Consensus       112 ~~g~l~~~~~~~~~--------~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~  180 (311)
T d1r0pa_         112 KHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  180 (311)
T ss_dssp             TTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred             ECCCHHHHHCCCCC--------CCHHHHHHHHHHHHHHHHHHHCCCC---CCCCCCCHHHEEECCCCCEEEECCCCHHHC
T ss_conf             06741442101345--------4048999999999887652003367---625776687576779998899106523225


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHC
Q ss_conf             00267899987778875444345654237865689888853350306799999872999999434588527899998511
Q 002746          716 MTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNHYH  795 (885)
Q Consensus       716 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~  795 (885)
                      .....       ..........||+.|+|||++.+..++.++||||||+++|||+||+.||...... .+...++..   
T Consensus       181 ~~~~~-------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~i~~---  249 (311)
T d1r0pa_         181 YDKEF-------DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQ---  249 (311)
T ss_dssp             TTTTC-------CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHT---
T ss_pred             CCCCC-------CCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCH-HHHHHHHHC---
T ss_conf             56655-------5310025655564556768874379997457466199999999789999888999-999999980---


Q ss_pred             CHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCC
Q ss_conf             0145553243210147892789987999999999998530378999999989999999999988367899
Q 002746          796 GRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGEKHM  865 (885)
Q Consensus       796 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~~~~  865 (885)
                                   +.+...|.      .+++++.+++.+||..||++||+|+||+++|+.+......+.+
T Consensus       250 -------------g~~~~~p~------~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~~  300 (311)
T d1r0pa_         250 -------------GRRLLQPE------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY  300 (311)
T ss_dssp             -------------TCCCCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCB
T ss_pred             -------------CCCCCCCC------CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHHHHC
T ss_conf             -------------89889964------4759999999997688976893999999999999975201212

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=348.74  Aligned_cols=252  Identities=28%  Similarity=0.399  Sum_probs=204.7

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEC-CCCCEEEEEC
Q ss_conf             517864643201276249999969997999999430478303669999999830589664234433106-9951399964
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSL-PDFKALVLPY  634 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~  634 (885)
                      .++|++.+.||+|+||.||+|.++ |..||||+++..  ...+.+.+|++++++++||||+++++++.+ ....++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEC
T ss_conf             899488579820798089999999-909999998857--77999999999998678989854987887238928999963


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCCCEE
Q ss_conf             45885322556687545588988788999999999999999996316999658447899966766999779814443100
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +++|+|.+++......       .+++..+.+++.|++.|+.|||+.+   |+||||||+|||++.++.+|++|||.++.
T Consensus        83 ~~~g~L~~~l~~~~~~-------~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~  152 (262)
T d1byga_          83 MAKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE  152 (262)
T ss_dssp             CTTEEHHHHHHHHHHH-------HCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             CCCCCHHHHHHHCCCC-------CCCHHHHHHHHHHHHHHCCCCCCCC---EECCCCCHHHHEECCCCCEEECCCCCCEE
T ss_conf             6999899998745788-------8899999999999985232113376---55366656760146899776324560034


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCCCCCCHHHHHHHH
Q ss_conf             100267899987778875444345654237865689888853350306799999872-9999994345885278999985
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~ellt-g~~Pf~~~~~~~~~~~~~~~~~  793 (885)
                      ...              ......++..|+|||++.+..++.++||||||+++|||+| |++||.....  .+...++.. 
T Consensus       153 ~~~--------------~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~~~~~~i~~-  215 (262)
T d1byga_         153 ASS--------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEK-  215 (262)
T ss_dssp             -----------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHHTT-
T ss_pred             CCC--------------CCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHC-
T ss_conf             478--------------776556664677817872798885887775799999999789999999999--999999980-


Q ss_pred             HCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             11014555324321014789278998799999999999853037899999998999999999998
Q 002746          794 YHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR  858 (885)
Q Consensus       794 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~  858 (885)
                                     ..+...+.      .+++++.+++.+||+.||++||||++++++|+.++.
T Consensus       216 ---------------~~~~~~~~------~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         216 ---------------GYKMDAPD------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             ---------------TCCCCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------------CCCCCCCC------CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             ---------------89999976------579999999999756697689399999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=346.75  Aligned_cols=258  Identities=21%  Similarity=0.318  Sum_probs=205.0

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEECC----CCEEEEEEEEECCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEE
Q ss_conf             5178646432012762499999699----97999999430478-303669999999830589664234433106995139
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQD----GTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKAL  630 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  630 (885)
                      .++|++.+.||+|+||.||+|.+..    +..||+|.++.... ...+.+.+|++++++++||||+++++++. +...++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEE
T ss_conf             8996987799307882999999936996449999999365668799999999999998689999856988995-374799


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCC
Q ss_conf             99644588532255668754558898878899999999999999999631699965844789996676699977981444
Q 002746          631 VLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFG  710 (885)
Q Consensus       631 v~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg  710 (885)
                      ||||+++|++..++.....        .+++..+..++.|+++||.|||+++   |+||||||+||+++.++.+||+|||
T Consensus        85 v~E~~~~g~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG  153 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG  153 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--
T ss_pred             EEEECCCCCHHHHHHCCCC--------CCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCHHHEEECCCCCEEECCCH
T ss_conf             9984069807765422478--------9999999999999987752302267---4414102655320678967876503


Q ss_pred             CCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCCCCCCHHHH
Q ss_conf             3100100267899987778875444345654237865689888853350306799999872-999999434588527899
Q 002746          711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLHKW  789 (885)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~ellt-g~~Pf~~~~~~~~~~~~~  789 (885)
                      +|+.+....          ........||+.|+|||++.+..++.++|||||||++|||++ |.+||.....  ......
T Consensus       154 ~a~~~~~~~----------~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--~~~~~~  221 (273)
T d1mp8a_         154 LSRYMEDST----------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGR  221 (273)
T ss_dssp             ---------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHH
T ss_pred             HHEECCCCC----------CEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH--HHHHHH
T ss_conf             421336776----------23305400583103266751699887452444247899998269999888999--999999


Q ss_pred             HHHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf             9985110145553243210147892789987999999999998530378999999989999999999988
Q 002746          790 VKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRY  859 (885)
Q Consensus       790 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~  859 (885)
                      +.                .......+      ..+++++.+++.+||+.||++|||++|++++|+.+...
T Consensus       222 i~----------------~~~~~~~~------~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         222 IE----------------NGERLPMP------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             HH----------------TTCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HH----------------CCCCCCCC------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf             98----------------18999898------77799999999997687976892999999999999778

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=0  Score=345.60  Aligned_cols=261  Identities=22%  Similarity=0.350  Sum_probs=206.6

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECCC---CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCC----C
Q ss_conf             517864643201276249999969-997999999430478---30366999999983058966423443310699----5
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG---NFTKSFNRECQVLKRIRHRNLMRIITACSLPD----F  627 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~  627 (885)
                      .++|++.+.||+|+||.||+|... +++.||+|+++....   ...+.+.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf             62069868996089929999999999989999998556646989999999999999856999887311435432688766


Q ss_pred             CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEC
Q ss_conf             13999644588532255668754558898878899999999999999999631699965844789996676699977981
Q 002746          628 KALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVS  707 (885)
Q Consensus       628 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~  707 (885)
                      .++||||+++|+|..++....         .+++..+..++.|++.||.|||++|   |+||||||+|||++.++..+++
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~---------~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~  153 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVM  153 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEEC
T ss_pred             EEEEEECCCCCEEHHHHCCCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCEEE
T ss_conf             999997788987101120358---------9999999999999999999998579---5276346755665754320100


Q ss_pred             CCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHH
Q ss_conf             44431001002678999877788754443456542378656898888533503067999998729999994345885278
Q 002746          708 DFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH  787 (885)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~  787 (885)
                      |||.+.......        ..........||+.|+|||++.+..++.++||||+||++|||+||+.||...     ...
T Consensus       154 d~~~~~~~~~~~--------~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-----~~~  220 (277)
T d1o6ya_         154 DFGIARAIADSG--------NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-----SPV  220 (277)
T ss_dssp             CCTTCEECC------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----SHH
T ss_pred             HHHHHHHHCCCC--------CCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCC-----CHH
T ss_conf             344432212354--------4333346425762436999983999996632026528999997697998996-----999


Q ss_pred             HHHHHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHHHH
Q ss_conf             999985110145553243210147892789987999999999998530378999999-9899999999999
Q 002746          788 KWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP-TMLDAADDLDRLK  857 (885)
Q Consensus       788 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~ev~~~L~~l~  857 (885)
                      +......            ........    .....+++++.+++.+|+++||++|| +++++.+.|.++.
T Consensus       221 ~~~~~~~------------~~~~~~~~----~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         221 SVAYQHV------------REDPIPPS----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             HHHHHHH------------HCCCCCGG----GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHHHHHH------------HCCCCCCC----HHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf             9999998------------46999971----0034789999999999866797677739999999999975

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=343.14  Aligned_cols=275  Identities=23%  Similarity=0.356  Sum_probs=207.3

Q ss_pred             HHHHHHHHCCCCCCEECCCCCCEEEEEEEC------CCCEEEEEEEEECC-CCCHHHHHHHHHHHHHC-CCCCCCEEEEE
Q ss_conf             999998517864643201276249999969------99799999943047-83036699999998305-89664234433
Q 002746          550 RELLEATAEFDEQRLLGTGSYGRVYKGILQ------DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRI-RHRNLMRIITA  621 (885)
Q Consensus       550 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~  621 (885)
                      .+++..-++|++.+.||+|+||.||+|.+.      +++.||||+++... ....+.+.+|...+.++ +|++|+.++++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEE
T ss_conf             25261679979844984167839999998677755578399999986001717899999999998861499849974115


Q ss_pred             EECC-CCCEEEEECCCCCCCCCCCCCCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCC
Q ss_conf             1069-951399964458853225566875455-------88988788999999999999999996316999658447899
Q 002746          622 CSLP-DFKALVLPYMANGSLDSHLYPHSETEF-------GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKP  693 (885)
Q Consensus       622 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp  693 (885)
                      +..+ ...++|||||++|+|.+++........       ......+++..+..++.|++.||.|||+++   |+||||||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp  162 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA  162 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred             ECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCC
T ss_conf             404797579999845899299999853666665322202332146899999999999999999887379---71786773


Q ss_pred             CCEEECCCCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCC-
Q ss_conf             9667669997798144431001002678999877788754443456542378656898888533503067999998729-
Q 002746          694 SNVLLNDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTR-  772 (885)
Q Consensus       694 ~NILl~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg-  772 (885)
                      +|||++.++.+||+|||+|+......         .........||+.|+|||++.+..++.++|||||||++|||+|| 
T Consensus       163 ~NILl~~~~~~Kl~DFGla~~~~~~~---------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~  233 (299)
T d1ywna1         163 RNILLSEKNVVKICDFGLARDIYKDP---------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG  233 (299)
T ss_dssp             GGEEECGGGCEEECC------CCSCT---------TSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             CCEEECCCCCEEECCCCCHHHCCCCC---------CCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCC
T ss_conf             10657799828984575200113566---------522247516672102036864688996632213678999998688


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             99999434588527899998511014555324321014789278998799999999999853037899999998999999
Q 002746          773 RRPTDDMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       773 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .+||..... ...+...+..                ......+      +.+++++.+++.+||+.||++|||++|++++
T Consensus       234 ~~p~~~~~~-~~~~~~~~~~----------------~~~~~~~------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         234 ASPYPGVKI-DEEFCRRLKE----------------GTRMRAP------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             CCSSTTCCC-SHHHHHHHHH----------------TCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCH-HHHHHHHHHC----------------CCCCCCC------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf             999989998-9999999963----------------8988888------6578999999999767796679199999999


Q ss_pred             HHHHHHH
Q ss_conf             9999988
Q 002746          853 LDRLKRY  859 (885)
Q Consensus       853 L~~l~~~  859 (885)
                      |+.+.+.
T Consensus       291 L~~ilq~  297 (299)
T d1ywna1         291 LGNLLQA  297 (299)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHC
T ss_conf             9799867

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=346.31  Aligned_cols=248  Identities=24%  Similarity=0.361  Sum_probs=199.9

Q ss_pred             HCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEEC---CCCCHHHHHHHHHHHH-HCCCCCCCEEEEEEECCCCCEEE
Q ss_conf             17864643201276249999969-9979999994304---7830366999999983-05896642344331069951399
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ---SGNFTKSFNRECQVLK-RIRHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv  631 (885)
                      ++|++.+.||+|+||+||+|... +++.||||+++..   .....+.+..|..++. .++||||+++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf             97188658940878289999999999899999980555338489999999999999847999687898897049831677


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf             96445885322556687545588988788999999999999999996316999658447899966766999779814443
Q 002746          632 LPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGI  711 (885)
Q Consensus       632 ~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~  711 (885)
                      |||+++|+|..++....         .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||.
T Consensus        82 mEy~~~g~L~~~i~~~~---------~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~  149 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH---------KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGM  149 (320)
T ss_dssp             EECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEECCCCCHHHHHHCCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCEEECCCCCEECCCCCH
T ss_conf             75037980899864047---------8999999999999999999998689---34034765404444899630155530


Q ss_pred             CEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHH
Q ss_conf             10010026789998777887544434565423786568988885335030679999987299999943458852789999
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVK  791 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~~  791 (885)
                      |+.....           ........||+.|+|||++.+..++.++||||+||++|||++|+.||....     ..+...
T Consensus       150 a~~~~~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~  213 (320)
T d1xjda_         150 CKENMLG-----------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-----EEELFH  213 (320)
T ss_dssp             CBCCCCT-----------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHH
T ss_pred             HHHCCCC-----------CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHH
T ss_conf             2323566-----------533454578777689999827998832320112278989873889999989-----999999


Q ss_pred             HHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHH
Q ss_conf             85110145553243210147892789987999999999998530378999999989-99999
Q 002746          792 NHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTML-DAADD  852 (885)
Q Consensus       792 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-ev~~~  852 (885)
                      ..             ....... |      ..+++++.+++.+||..||++||+++ |+.++
T Consensus       214 ~i-------------~~~~~~~-p------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         214 SI-------------RMDNPFY-P------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             HH-------------HHCCCCC-C------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             HH-------------HCCCCCC-C------CCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHC
T ss_conf             99-------------7189989-7------56799999999996544898783889999809

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=343.16  Aligned_cols=264  Identities=27%  Similarity=0.406  Sum_probs=207.4

Q ss_pred             HCCCCCCEECCCCCCEEEEEEEC-CCC--EEEEEEEEEC-CCCCHHHHHHHHHHHHHC-CCCCCCEEEEEEECCCCCEEE
Q ss_conf             17864643201276249999969-997--9999994304-783036699999998305-896642344331069951399
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGT--AIAVKVLQLQ-SGNFTKSFNRECQVLKRI-RHRNLMRIITACSLPDFKALV  631 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  631 (885)
                      ++|++.+.||+|+||.||+|.++ ++.  .||||.++.. .....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf             99688779820788289999998999699999999782338579999999999998622899883678888418736999


Q ss_pred             EECCCCCCCCCCCCCCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf             96445885322556687545-------58898878899999999999999999631699965844789996676699977
Q 002746          632 LPYMANGSLDSHLYPHSETE-------FGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA  704 (885)
Q Consensus       632 ~e~~~~g~L~~~l~~~~~~~-------~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~  704 (885)
                      |||+++|+|.++++......       .......+++..+..++.|++.|+.|+|+++   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCEEEECCCCCE
T ss_conf             9802898699998640355555123101234578999999999999999987663089---5455505204898688763


Q ss_pred             EECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCC-CCCCCCCCC
Q ss_conf             9814443100100267899987778875444345654237865689888853350306799999872999-999434588
Q 002746          705 LVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRR-PTDDMFAGG  783 (885)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~-Pf~~~~~~~  783 (885)
                      ||+|||+|+.....            .......||..|+|||.+.+..++.++||||||+++|||++|.. ||...    
T Consensus       167 kl~DfG~a~~~~~~------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~----  230 (309)
T d1fvra_         167 KIADFGLSRGQEVY------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM----  230 (309)
T ss_dssp             EECCTTCEESSCEE------------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC----
T ss_pred             EECCCCCCCCCCCC------------CCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCC----
T ss_conf             87434432244422------------34553013775555387526999962215313889999983689999999----


Q ss_pred             CCHHHHHHHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf             5278999985110145553243210147892789987999999999998530378999999989999999999988
Q 002746          784 LSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRY  859 (885)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~  859 (885)
                       ...+.....             ....+...+      ..+++++.+++.+||+.||++||||+||+++|+++.+.
T Consensus       231 -~~~~~~~~i-------------~~~~~~~~~------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         231 -TCAELYEKL-------------PQGYRLEKP------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             -CHHHHHHHG-------------GGTCCCCCC------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -CHHHHHHHH-------------HHCCCCCCC------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             -999999999-------------826888887------66789999999997678966894999999999999861

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=339.29  Aligned_cols=282  Identities=24%  Similarity=0.289  Sum_probs=201.4

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHH--HHHHHCCCCCCCEEEEEEECCC----CCE
Q ss_conf             5178646432012762499999699979999994304783036699999--9983058966423443310699----513
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNREC--QVLKRIRHRNLMRIITACSLPD----FKA  629 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~--~~l~~l~h~niv~~~~~~~~~~----~~~  629 (885)
                      .++|...+.||+|+||.||+|++. |..||||+++...   .+.+..|.  ..+..++||||+++++++.+..    ..+
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             CCEEEEEEEEEECCCEEEEEEEEC-CEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEE
T ss_conf             868999889820788199999999-9899999987200---467999999999962799868326889983798604899


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC-----CCCEEECCCCCCCEEECCCCCE
Q ss_conf             99964458853225566875455889887889999999999999999963169-----9965844789996676699977
Q 002746          630 LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS-----PVRVIHCDLKPSNVLLNDDMTA  704 (885)
Q Consensus       630 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~dikp~NILl~~~~~~  704 (885)
                      +||||+++|+|..+++...          ++|..++.++.|++.|+.|+|+.+     ..+|+||||||+|||++.++.+
T Consensus        78 lv~Ey~~~g~L~~~l~~~~----------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~  147 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  147 (303)
T ss_dssp             EEEECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred             EEEECCCCCCHHHHHHCCC----------CCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCE
T ss_conf             9996466989899986589----------998999999999999999988766520468986615317313578688776


Q ss_pred             EECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCHHHHHHHHHHHCCCCCCCC
Q ss_conf             981444310010026789998777887544434565423786568988------88533503067999998729999994
Q 002746          705 LVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN------TSTKGDVYSFGILVLEMVTRRRPTDD  778 (885)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDVwslG~il~elltg~~Pf~~  778 (885)
                      ||+|||+++........       .........||+.|+|||++.+..      ++.++|||||||++|||+||..||..
T Consensus       148 Kl~DFGl~~~~~~~~~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~  220 (303)
T d1vjya_         148 CIADLGLAVRHDSATDT-------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             EECCCTTCEEEETTTTE-------ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred             EEEECCCCCCCCCCCCC-------EECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCC
T ss_conf             88763866234677762-------00135525035476782210565454677767501220159999999628998876


Q ss_pred             CCCCCCCHHHHHHHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             34588527899998511014555324321014789278998799999999999853037899999998999999999998
Q 002746          779 MFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR  858 (885)
Q Consensus       779 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~  858 (885)
                      .............  .........+.......+...+. .......+.++.+++.+||+.||++|||+.||++.|+++..
T Consensus       221 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         221 HEDYQLPYYDLVP--SDPSVEEMRKVVCEQKLRPNIPN-RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             CCCCCCTTTTTSC--SSCCHHHHHHHHTTSCCCCCCCG-GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHCCC--CCCHHHHHHHHHHCCCCCCCCCC-CCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             6311241012255--64309999998750246888776-55776899999999999760698589599999999998888


Q ss_pred             HHC
Q ss_conf             836
Q 002746          859 YLG  861 (885)
Q Consensus       859 ~~~  861 (885)
                      .-+
T Consensus       298 ~~~  300 (303)
T d1vjya_         298 QEG  300 (303)
T ss_dssp             HHC
T ss_pred             HCC
T ss_conf             659

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=340.39  Aligned_cols=270  Identities=22%  Similarity=0.351  Sum_probs=210.3

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEEC------CCCEEEEEEEEECCC-CCHHHHHHHHHHHHHC-CCCCCCEEEEEEECCCC
Q ss_conf             517864643201276249999969------997999999430478-3036699999998305-89664234433106995
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ------DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRI-RHRNLMRIITACSLPDF  627 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  627 (885)
                      .++|++.+.||+|+||.||+|.+.      ++..||||+++.... .....+.+|+.++.++ +||||+++++++..+..
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE
T ss_conf             89969854982068829999998066447788699999987424877999999999998762699988789989831997


Q ss_pred             CEEEEECCCCCCCCCCCCCCCCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEE
Q ss_conf             1399964458853225566875455---------8898878899999999999999999631699965844789996676
Q 002746          628 KALVLPYMANGSLDSHLYPHSETEF---------GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL  698 (885)
Q Consensus       628 ~~lv~e~~~~g~L~~~l~~~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl  698 (885)
                      .++||||+++|+|..+++.......         ......+++..+..++.|++.|+.|||+++   ++||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             EEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCC
T ss_conf             8999973799879999985356654444453322233458899999999999999999887579---2666241021000


Q ss_pred             CCCCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC
Q ss_conf             69997798144431001002678999877788754443456542378656898888533503067999998729999994
Q 002746          699 NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDD  778 (885)
Q Consensus       699 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~  778 (885)
                      +.++.++++|||.++......         .........||+.|+|||++.+..++.++||||||+++|||+|++.|+..
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~  249 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDS---------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP  249 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCT---------TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             CCCCCCCCCCCCHHEECCCCC---------CCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC
T ss_conf             025752102340102336788---------61586201359687677886179999740010258999999858998877


Q ss_pred             CCCCCCCHHHHHHHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             34588527899998511014555324321014789278998799999999999853037899999998999999999998
Q 002746          779 MFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKR  858 (885)
Q Consensus       779 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~  858 (885)
                      .......+.+.+...            ....    .+      ..++.++.+++.+||+.||++||||+|+++.|+++..
T Consensus       250 ~~~~~~~~~~~i~~~------------~~~~----~~------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         250 GMPVDSKFYKMIKEG------------FRML----SP------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             TCCSSHHHHHHHHHT------------CCCC----CC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHCC------------CCCC----CC------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf             899899999998668------------9889----85------4365999999999757796579299999999987653


Q ss_pred             H
Q ss_conf             8
Q 002746          859 Y  859 (885)
Q Consensus       859 ~  859 (885)
                      .
T Consensus       308 ~  308 (311)
T d1t46a_         308 E  308 (311)
T ss_dssp             H
T ss_pred             C
T ss_conf             4

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=339.84  Aligned_cols=281  Identities=21%  Similarity=0.245  Sum_probs=204.9

Q ss_pred             CCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECCC-----CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEC
Q ss_conf             4643201276249999969-997999999430478-----3036699999998305896642344331069951399964
Q 002746          561 EQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG-----NFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       561 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  634 (885)
                      ..+.||+|+||+||+|... +++.||||+++....     ...+.+.+|+.++++++||||+++++++..++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf             56385127282999999999996999999842021245679999999999999867999986898542258740220455


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCCCEE
Q ss_conf             45885322556687545588988788999999999999999996316999658447899966766999779814443100
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +.++++........         .+++..+..++.|++.||.|||++|   |+||||||+|||++.++.+||+|||.|+.
T Consensus        82 ~~~~~~~~~~~~~~---------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~  149 (299)
T d1ua2a_          82 METDLEVIIKDNSL---------VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS  149 (299)
T ss_dssp             CSEEHHHHHTTCCS---------SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             HCCHHHHHHHHCCC---------CCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCCEEEECCCCCCCCCCCCCCCC
T ss_conf             34507765541266---------7789999999999999998863163---55035776258853778411465761000


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf             100267899987778875444345654237865689-8888533503067999998729999994345885278999985
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  793 (885)
                      ....           ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+.......
T Consensus       150 ~~~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~l~~i~~~~  217 (299)
T d1ua2a_         150 FGSP-----------NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETL  217 (299)
T ss_dssp             TTSC-----------CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHH
T ss_pred             CCCC-----------CCCCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHH-HHHHHHHHHC
T ss_conf             5787-----------554330204733363999726778880564363042899998596999999999-9999999851


Q ss_pred             HCCHH---HHHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf             11014---55532432101-478927899879999999999985303789999999899999999999883678999855
Q 002746          794 YHGRL---EKVIDSSLLRA-SRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGEKHMPSKM  869 (885)
Q Consensus       794 ~~~~~---~~~~~~~l~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~~~~~~~~  869 (885)
                      .....   ........... ...............++++.+++.+|+..||++|||++|++++     .|+.+.+.+...
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H-----p~f~~~p~p~~~  292 (299)
T d1ua2a_         218 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM-----KYFSNRPGPTPG  292 (299)
T ss_dssp             CCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS-----GGGTSSSCCCCS
T ss_pred             CCCCHHHCCCHHCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC-----HHHCCCCCCCCC
T ss_conf             899725452100021344303478988678565689999999999763894569089999679-----965789999898


Q ss_pred             C
Q ss_conf             5
Q 002746          870 N  870 (885)
Q Consensus       870 ~  870 (885)
                      .
T Consensus       293 ~  293 (299)
T d1ua2a_         293 C  293 (299)
T ss_dssp             S
T ss_pred             C
T ss_conf             8

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=0  Score=340.03  Aligned_cols=251  Identities=24%  Similarity=0.360  Sum_probs=201.3

Q ss_pred             HCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECCCC---------CHHHHHHHHHHHHHCC-CCCCCEEEEEEECC
Q ss_conf             17864643201276249999969-9979999994304783---------0366999999983058-96642344331069
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGN---------FTKSFNRECQVLKRIR-HRNLMRIITACSLP  625 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~  625 (885)
                      ++|++.+.||+|+||+||+|+.. +++.||||+++.....         ..+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC
T ss_conf             63888528841768499999999999899999996244641147888999999999999999850799747997621467


Q ss_pred             CCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEE
Q ss_conf             95139996445885322556687545588988788999999999999999996316999658447899966766999779
Q 002746          626 DFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTAL  705 (885)
Q Consensus       626 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~k  705 (885)
                      +..++||||+++|+|.+++....         .+++..+..++.|++.||.|||++|   |+||||||+|||++.++.+|
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~k  150 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV---------TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIK  150 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred             CCEEEEEECCCCCHHHHHHHHCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEE
T ss_conf             60599997689866899998659---------9999999999999999999998759---94323462548986899838


Q ss_pred             ECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCCHHHHHHHHHHHCCCCCCCCC
Q ss_conf             814443100100267899987778875444345654237865689------88885335030679999987299999943
Q 002746          706 VSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG------SNTSTKGDVYSFGILVLEMVTRRRPTDDM  779 (885)
Q Consensus       706 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDVwslG~il~elltg~~Pf~~~  779 (885)
                      |+|||.|+.+...            .......||+.|+|||++.+      ..++.++||||+||++|||++|+.||...
T Consensus       151 l~DFG~a~~~~~~------------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~  218 (277)
T d1phka_         151 LTDFGFSCQLDPG------------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR  218 (277)
T ss_dssp             ECCCTTCEECCTT------------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ECCCHHEEECCCC------------CCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCC
T ss_conf             7124031672688------------7213452467888988860534456788992331856560231032288898899


Q ss_pred             CCCCCCHHHHHHHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             4588527899998511014555324321014789278998799999999999853037899999998999999
Q 002746          780 FAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       780 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..     .......            .........+.    +..+++++.+++.+||++||++|||++|++++
T Consensus       219 ~~-----~~~~~~i------------~~~~~~~~~~~----~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         219 KQ-----MLMLRMI------------MSGNYQFGSPE----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             SH-----HHHHHHH------------HHTCCCCCTTT----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             CH-----HHHHHHH------------HHCCCCCCCCC----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             99-----9999999------------81898889854----34689999999999765896689199999739

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=339.12  Aligned_cols=268  Identities=26%  Similarity=0.397  Sum_probs=210.2

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEECC--------CCEEEEEEEEECCC-CCHHHHHHHHHHHHHC-CCCCCCEEEEEEECC
Q ss_conf             5178646432012762499999699--------97999999430478-3036699999998305-896642344331069
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQD--------GTAIAVKVLQLQSG-NFTKSFNRECQVLKRI-RHRNLMRIITACSLP  625 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  625 (885)
                      .++|++.+.||+|+||.||+|+...        +..||||+++.... .....+.+|...+.++ +||||+++++++..+
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCC
T ss_conf             89969700985167828999998578755566754999999881128688999999999999813999697346522018


Q ss_pred             CCCEEEEECCCCCCCCCCCCCCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEE
Q ss_conf             951399964458853225566875455-------8898878899999999999999999631699965844789996676
Q 002746          626 DFKALVLPYMANGSLDSHLYPHSETEF-------GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLL  698 (885)
Q Consensus       626 ~~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl  698 (885)
                      ...++||||+++|+|.+++........       ......+++..++.++.|++.|++|||+.+   |+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCEEE
T ss_conf             8689999736999099999860677643222334574346799999999999999998766379---7863022102245


Q ss_pred             CCCCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCC
Q ss_conf             6999779814443100100267899987778875444345654237865689888853350306799999872-999999
Q 002746          699 NDDMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTD  777 (885)
Q Consensus       699 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~ellt-g~~Pf~  777 (885)
                      +.++.+||+|||.++......         .........|++.|+|||.+.+..++.++||||||+++|||++ |.+||.
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~  239 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHID---------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP  239 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCC---------TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CCCCCEEECCCHHHCCCCCCC---------CCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             478976762211101135555---------54314667888466326675179888255547758888874017989899


Q ss_pred             CCCCCCCCHHHHHHHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf             43458852789999851101455532432101478927899879999999999985303789999999899999999999
Q 002746          778 DMFAGGLSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLK  857 (885)
Q Consensus       778 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~  857 (885)
                      ....  ......            +...    .....+.      .+++++.+++.+||+.||++|||+.||++.|+++.
T Consensus       240 ~~~~--~~~~~~------------i~~~----~~~~~p~------~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         240 GVPV--EELFKL------------LKEG----HRMDKPS------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             TCCH--HHHHHH------------HHTT----CCCCCCS------SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCH--HHHHHH------------HHCC----CCCCCCC------CCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             9999--999999------------9728----8889874------35299999999976679767939999999998886


Q ss_pred             HH
Q ss_conf             88
Q 002746          858 RY  859 (885)
Q Consensus       858 ~~  859 (885)
                      ..
T Consensus       296 a~  297 (299)
T d1fgka_         296 AL  297 (299)
T ss_dssp             HH
T ss_pred             HC
T ss_conf             04

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=343.14  Aligned_cols=258  Identities=24%  Similarity=0.328  Sum_probs=202.7

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEEC--CC--CEEEEEEEEEC---CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCC
Q ss_conf             517864643201276249999969--99--79999994304---783036699999998305896642344331069951
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ--DG--TAIAVKVLQLQ---SGNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFK  628 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  628 (885)
                      .++|++.+.||+|+||.||+|...  ++  ..||||++...   .....+.|.+|++++++++||||+++++++.+ ...
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             HHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCH
T ss_conf             4891997898038883999999988999079999999983555798999999999999986899998789877740-100


Q ss_pred             EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECC
Q ss_conf             39996445885322556687545588988788999999999999999996316999658447899966766999779814
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSD  708 (885)
Q Consensus       629 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~D  708 (885)
                      ++|+||+++|++.+.+.....        .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~D  154 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGD  154 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECC
T ss_pred             HEEEEEECCCCHHHHHHCCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECHHHHCCCCCCCEEECC
T ss_conf             114654238612544421268--------9999999999999999998752178---75205668881565565433256


Q ss_pred             CCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHC-CCCCCCCCCCCCCCHH
Q ss_conf             443100100267899987778875444345654237865689888853350306799999872-9999994345885278
Q 002746          709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVT-RRRPTDDMFAGGLSLH  787 (885)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~ellt-g~~Pf~~~~~~~~~~~  787 (885)
                      ||+++.+.....        .........|+..|+|||++.+..++.++||||||+++|||+| |+.||...     ...
T Consensus       155 fGl~~~~~~~~~--------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~-----~~~  221 (273)
T d1u46a_         155 FGLMRALPQNDD--------HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-----NGS  221 (273)
T ss_dssp             CTTCEECCC-CC--------EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHH
T ss_pred             CHHHHHCCCCCC--------CCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC-----CHH
T ss_conf             115553035887--------5265476325731079999837999942156614899999996899999996-----999


Q ss_pred             HHHHHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             999985110145553243210147892789987999999999998530378999999989999999999
Q 002746          788 KWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       788 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                      +......            ....+...+      ..++.++.+++.+||..||++||||+|+.+.|.+.
T Consensus       222 ~~~~~i~------------~~~~~~~~~------~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         222 QILHKID------------KEGERLPRP------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHHHHH------------TSCCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHH------------HCCCCCCCC------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf             9999998------------479999985------44539999999997688966792999999999964

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=342.34  Aligned_cols=266  Identities=24%  Similarity=0.391  Sum_probs=207.3

Q ss_pred             HHHCCCCCCEECCCCCCEEEEEEEC------CCCEEEEEEEEECCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCC
Q ss_conf             8517864643201276249999969------997999999430478-303669999999830589664234433106995
Q 002746          555 ATAEFDEQRLLGTGSYGRVYKGILQ------DGTAIAVKVLQLQSG-NFTKSFNRECQVLKRIRHRNLMRIITACSLPDF  627 (885)
Q Consensus       555 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  627 (885)
                      ..++|.+.+.||+|+||.||+|.+.      ++..||||+++.... .....+.+|++++++++||||+++++++..+..
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~   97 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   97 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
T ss_conf             68991883598207881899999878644778968999998701286899999999999997699988412547842881


Q ss_pred             CEEEEECCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf             1399964458853225566875455-889887889999999999999999963169996584478999667669997798
Q 002746          628 KALVLPYMANGSLDSHLYPHSETEF-GSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALV  706 (885)
Q Consensus       628 ~~lv~e~~~~g~L~~~l~~~~~~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl  706 (885)
                      .++||||+++|+|..++........ ......+++..+..++.|+++||.|||+++   |+||||||+|||++.++.+||
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred             EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECEECCCCEEECCCCEEEE
T ss_conf             06777604899889998750332113444688799999999999999999876479---654328677540359964999


Q ss_pred             CCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCC-CCCCCCCCCCCC
Q ss_conf             1444310010026789998777887544434565423786568988885335030679999987299-999943458852
Q 002746          707 SDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRR-RPTDDMFAGGLS  785 (885)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~-~Pf~~~~~~~~~  785 (885)
                      +|||+|+.+....         .........|++.|+|||.+.+..++.++||||||+++|||+||+ .||...     .
T Consensus       175 ~DFGla~~~~~~~---------~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-----~  240 (308)
T d1p4oa_         175 GDFGMTRDIYETD---------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----S  240 (308)
T ss_dssp             CCTTCCCGGGGGG---------CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----C
T ss_pred             EECCCCEECCCCC---------CEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC-----C
T ss_conf             4245420235776---------3031340231632378888736998833344437899999996899999998-----9


Q ss_pred             HHHHHHHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf             78999985110145553243210147892789987999999999998530378999999989999999999
Q 002746          786 LHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRL  856 (885)
Q Consensus       786 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l  856 (885)
                      ..++.....        +     ......+      +.++.++.+++.+||+.+|++||||++|++.|++.
T Consensus       241 ~~~~~~~i~--------~-----~~~~~~p------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         241 NEQVLRFVM--------E-----GGLLDKP------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             HHHHHHHHH--------T-----TCCCCCC------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HHHHHHHHH--------H-----CCCCCCC------CCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf             999999998--------0-----8888886------33539999999997577965893999999997876

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=337.45  Aligned_cols=280  Identities=22%  Similarity=0.285  Sum_probs=205.1

Q ss_pred             HCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECC--CCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
Q ss_conf             17864643201276249999969-99799999943047--8303669999999830589664234433106995139996
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  633 (885)
                      ++|++.+.||+|+||.||+|... +++.||+|+++...  ....+.+.+|++++++++||||+++++++.++...++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf             99776517723768099999999999799999980222575899999999999986799838874453322432037886


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCCCE
Q ss_conf             44588532255668754558898878899999999999999999631699965844789996676699977981444310
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      |+.++.+........        ..+++..+..++.|++.||.|||++|   |+||||||+|||++.++.+||+|||.|+
T Consensus        82 ~~~~~~~~~~~~~~~--------~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~  150 (298)
T d1gz8a_          82 FLHQDLKKFMDASAL--------TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR  150 (298)
T ss_dssp             CCSEEHHHHHHHTTT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHH
T ss_pred             ECCCCHHHHHHHHCC--------CCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCHHEEECCCCCCEECCCCCCE
T ss_conf             237744555442025--------68888999999999999999865288---9921357114011346762103578613


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf             010026789998777887544434565423786568988-8853350306799999872999999434588527899998
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  792 (885)
                      ....           .........||+.|+|||+..... ++.++||||+||++|+|++|+.||...... ..+......
T Consensus       151 ~~~~-----------~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-~~~~~i~~~  218 (298)
T d1gz8a_         151 AFGV-----------PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRT  218 (298)
T ss_dssp             HHCC-----------CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHH
T ss_pred             ECCC-----------CCCCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHH-HHHHHHHHH
T ss_conf             4368-----------8641001036521541122136657774221033331342796687998988999-999999983


Q ss_pred             HHC-CH-H-HHHHH-HHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCCC
Q ss_conf             511-01-4-55532-43210-14789278998799999999999853037899999998999999999998836789
Q 002746          793 HYH-GR-L-EKVID-SSLLR-ASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGEKH  864 (885)
Q Consensus       793 ~~~-~~-~-~~~~~-~~l~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~~~  864 (885)
                      ... .. . ..... +.... ...............++.++.+++.+|+..||++|||++|++++     .|+.+.+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H-----~ff~~~~  290 (298)
T d1gz8a_         219 LGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH-----PFFQDVT  290 (298)
T ss_dssp             HCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS-----GGGTTCC
T ss_pred             CCCCCHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC-----HHHCCCC
T ss_conf             28983331444222421243454322220444166789999999999763995579189999678-----7014699

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=337.47  Aligned_cols=249  Identities=22%  Similarity=0.301  Sum_probs=197.1

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECCC------CCHHHHHHHHHHHHHCC--CCCCCEEEEEEECCC
Q ss_conf             517864643201276249999969-997999999430478------30366999999983058--966423443310699
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG------NFTKSFNRECQVLKRIR--HRNLMRIITACSLPD  626 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~  626 (885)
                      .++|++.+.||+|+||.||+|+.. +++.||||+++....      .....+.+|+.++++++  ||||+++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf             88379967984087839999999999979999998568844334556799999999999974358988127999983099


Q ss_pred             CCEEEEECCCC-CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC-CCCE
Q ss_conf             51399964458-853225566875455889887889999999999999999963169996584478999667669-9977
Q 002746          627 FKALVLPYMAN-GSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND-DMTA  704 (885)
Q Consensus       627 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~-~~~~  704 (885)
                      ..++||||+.+ +++..++....         .+++..+..++.|++.||.|||+++   |+||||||+|||++. ++.+
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~---------~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~v  150 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG---------ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL  150 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEE
T ss_pred             EEEEEEEECCCCCHHHHHHHCCC---------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCEE
T ss_conf             68999983368622899986158---------9999999999999999999998779---75566761114774478848


Q ss_pred             EECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             9814443100100267899987778875444345654237865689888-853350306799999872999999434588
Q 002746          705 LVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNT-STKGDVYSFGILVLEMVTRRRPTDDMFAGG  783 (885)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwslG~il~elltg~~Pf~~~~~~~  783 (885)
                      ||+|||.|+....             .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....   
T Consensus       151 kl~DFG~a~~~~~-------------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---  214 (273)
T d1xwsa_         151 KLIDFGSGALLKD-------------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---  214 (273)
T ss_dssp             EECCCTTCEECCS-------------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---
T ss_pred             EECCCCCCEECCC-------------CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH---
T ss_conf             9775465353244-------------455665658774799998489978865332554034536756889988736---


Q ss_pred             CCHHHHHHHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHCCC
Q ss_conf             52789999851101455532432101478927899879999999999985303789999999899999999999883678
Q 002746          784 LSLHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLGEK  863 (885)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~~  863 (885)
                          ..                 ........+       .+++++.+++.+||..||++|||++|++++     .|+...
T Consensus       215 ----~i-----------------~~~~~~~~~-------~~s~~~~~li~~~L~~dp~~R~s~~eil~h-----p~~~~~  261 (273)
T d1xwsa_         215 ----EI-----------------IRGQVFFRQ-------RVSSECQHLIRWCLALRPSDRPTFEEIQNH-----PWMQDV  261 (273)
T ss_dssp             ----HH-----------------HHCCCCCSS-------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS-----GGGSSC
T ss_pred             ----HH-----------------HHCCCCCCC-------CCCHHHHHHHHHHCCCCHHHCCCHHHHHCC-----HHHCCC
T ss_conf             ----77-----------------615447787-------799999999999760897589399998539-----866788


Q ss_pred             CC
Q ss_conf             99
Q 002746          864 HM  865 (885)
Q Consensus       864 ~~  865 (885)
                      ..
T Consensus       262 ~~  263 (273)
T d1xwsa_         262 LL  263 (273)
T ss_dssp             CC
T ss_pred             CC
T ss_conf             78

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=335.24  Aligned_cols=273  Identities=22%  Similarity=0.302  Sum_probs=197.3

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEEC-C-CCEEEEEEEEECC--CCCHHHHHHHHHHHHHC---CCCCCCEEEEEEEC----
Q ss_conf             517864643201276249999969-9-9799999943047--83036699999998305---89664234433106----
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-D-GTAIAVKVLQLQS--GNFTKSFNRECQVLKRI---RHRNLMRIITACSL----  624 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~----  624 (885)
                      .++|++.+.||+|+||+||+|++. + ++.||||+++...  ......+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf             58979888992155869999999888998999999802324516799999999999987425898802366322146666


Q ss_pred             -CCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCC
Q ss_conf             -9951399964458853225566875455889887889999999999999999963169996584478999667669997
Q 002746          625 -PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMT  703 (885)
Q Consensus       625 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~  703 (885)
                       ....++++||++++.+........        ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~  154 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPE--------PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ  154 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCT--------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCC
T ss_pred             CCCEEEEEEEECCCCCHHHHHHCCC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEECCCCC
T ss_conf             6746999997405871444443037--------89998999999999999999997588---983579862789858997


Q ss_pred             EEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             79814443100100267899987778875444345654237865689888853350306799999872999999434588
Q 002746          704 ALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGG  783 (885)
Q Consensus       704 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~  783 (885)
                      +||+|||.+.....            ........||+.|+|||++.+..++.++||||+||++|||++|+.||..... .
T Consensus       155 ~kl~dfg~~~~~~~------------~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~-~  221 (305)
T d1blxa_         155 IKLADFGLARIYSF------------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-V  221 (305)
T ss_dssp             EEECSCCSCCCCCG------------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-H
T ss_pred             EEECCHHHHHHHCC------------CCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCH-H
T ss_conf             54210001011002------------3457776548511483100179888111000328999999878799899898-9


Q ss_pred             CCHHHHHHHHHCCHHHHHH-HHHHHH-C-CCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             5278999985110145553-243210-1-4789278998799999999999853037899999998999999
Q 002746          784 LSLHKWVKNHYHGRLEKVI-DSSLLR-A-SRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~-~~~l~~-~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..+................ +..... . ...............++++.+++.+|++.||++|||++|++++
T Consensus       222 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         222 DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHHCCCCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             999999984079961105321111033302234564544044589999999999874896679189999669

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=328.99  Aligned_cols=275  Identities=21%  Similarity=0.269  Sum_probs=200.8

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECC-CCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCC----CCE
Q ss_conf             517864643201276249999969-99799999943047-830366999999983058966423443310699----513
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-GNFTKSFNRECQVLKRIRHRNLMRIITACSLPD----FKA  629 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~  629 (885)
                      +.+|.+.+.||+|+||+||+|... +++.||||+++... ....+.+.+|++++++++|||++++++++..+.    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf             89859978994064809999999999949999998031095899999999999997689898858889950564554149


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCC
Q ss_conf             99964458853225566875455889887889999999999999999963169996584478999667669997798144
Q 002746          630 LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDF  709 (885)
Q Consensus       630 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Df  709 (885)
                      ++++|+.+|+|.+++...          .+++..+..++.|++.||.|||++|   |+||||||+|||++.++.+||+||
T Consensus        87 ~l~~~~~~g~L~~~l~~~----------~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~Df  153 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ----------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDF  153 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEECCCCHHHHHHCC----------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCC
T ss_conf             999962598656644058----------9999999999999999999999789---867778764378879997787545


Q ss_pred             CCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHH
Q ss_conf             43100100267899987778875444345654237865689-88885335030679999987299999943458852789
Q 002746          710 GIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       710 g~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~  788 (885)
                      |+|........        .........|++.|+|||++.. ..++.++||||+||++|||++|+.||......+ ....
T Consensus       154 G~a~~~~~~~~--------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~-~~~~  224 (345)
T d1pmea_         154 GLARVADPDHD--------HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNH  224 (345)
T ss_dssp             TTCEECCGGGC--------BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHH
T ss_pred             CCEEECCCCCC--------CCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHH-HHHH
T ss_conf             70565047776--------41010110265200038786047888741010046701337766979978888899-9998


Q ss_pred             HHHHHHCCHHH---HH----HHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             99985110145---55----324321014789278998799999999999853037899999998999999
Q 002746          789 WVKNHYHGRLE---KV----IDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       789 ~~~~~~~~~~~---~~----~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ...........   ..    ...................+...+.++.+++.+|+..||++|||++|++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         225 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             76520699756642343322220244677557787778378999999999999764895679089998619

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=0  Score=332.25  Aligned_cols=272  Identities=21%  Similarity=0.249  Sum_probs=204.0

Q ss_pred             HCCCCCCEECCCCCCEEEEEEECCCCEEEEEEEEECC--CCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEC
Q ss_conf             1786464320127624999996999799999943047--83036699999998305896642344331069951399964
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLPY  634 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  634 (885)
                      ++|++.+.||+|+||+||+|.+++++.||||+++...  ....+.+.+|+.++++++||||+++++++..+...++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf             99634318722778189999968999999999812326858999999999999867998687660120467731589974


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCCCEE
Q ss_conf             45885322556687545588988788999999999999999996316999658447899966766999779814443100
Q 002746          635 MANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       635 ~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      +.++.+........         .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+|++|||.|..
T Consensus        82 ~~~~~~~~~~~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~  149 (286)
T d1ob3a_          82 LDQDLKKLLDVCEG---------GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA  149 (286)
T ss_dssp             CSEEHHHHHHTSTT---------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred             EHHHHHHHHHHHCC---------CCCHHHHHHHHHHHHHHHHHHCCCC---EEECCCCCCEEEECCCCCEEECCCCCCEE
T ss_conf             00456789986047---------7514456899999999999860574---88267877505686899787323664301


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHH
Q ss_conf             1002678999877788754443456542378656898-888533503067999998729999994345885278999985
Q 002746          715 VMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKNH  793 (885)
Q Consensus       715 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  793 (885)
                      ....           ........|++.|+|||.+.+. .++.++||||+||++|||++|+.||...... ..+.......
T Consensus       150 ~~~~-----------~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~-~~~~~i~~~~  217 (286)
T d1ob3a_         150 FGIP-----------VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRIL  217 (286)
T ss_dssp             HCC--------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHH
T ss_pred             CCCC-----------CCCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHH-HHHHHHHHHH
T ss_conf             1467-----------654101024311013788717888884100211175899997797998988989-9999999863


Q ss_pred             HCCHHHHH---HH-HHHHHCCC-CCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             11014555---32-43210147-89278998799999999999853037899999998999999
Q 002746          794 YHGRLEKV---ID-SSLLRASR-DQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       794 ~~~~~~~~---~~-~~l~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ........   .. ........ .............++++.+++.+|+..||++|||++|++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         218 GTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             CCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCCHHHCCCHHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             8997110421233322143333356764666512589999999999866896689099998569

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=321.43  Aligned_cols=287  Identities=20%  Similarity=0.287  Sum_probs=206.8

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEEC--CCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEC--------
Q ss_conf             517864643201276249999969-9979999994304--78303669999999830589664234433106--------
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQ--SGNFTKSFNRECQVLKRIRHRNLMRIITACSL--------  624 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------  624 (885)
                      .++|++.+.||+|+||+||+|++. +|+.||||++...  ......++.+|++++++++|+|++++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf             27988999972274829999999899979999998422246378999999999999835999660676540246544445


Q ss_pred             CCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf             99513999644588532255668754558898878899999999999999999631699965844789996676699977
Q 002746          625 PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTA  704 (885)
Q Consensus       625 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~  704 (885)
                      ....++|+||+.++.+........         .++......++.|++.|+.|||++|   |+||||||+|||++.++.+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~---------~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~  156 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLV---------KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVL  156 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTC---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred             CCEEEEEEECCCCCCCCHHHHCCC---------CCCCHHHHHHHHHHHHHHHHHCCCC---EEECCCCCHHEEECCCCCE
T ss_conf             763899985357874101222034---------4330899999999999998852299---8856767222036689968


Q ss_pred             EECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             98144431001002678999877788754443456542378656898-88853350306799999872999999434588
Q 002746          705 LVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGG  783 (885)
Q Consensus       705 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwslG~il~elltg~~Pf~~~~~~~  783 (885)
                      |++|||++..+......       .........||+.|+|||++.+. .++.++||||+||++|||++|+.||.....  
T Consensus       157 kl~dfg~~~~~~~~~~~-------~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~--  227 (318)
T d3blha1         157 KLADFGLARAFSLAKNS-------QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE--  227 (318)
T ss_dssp             EECCCTTCEECCC------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--
T ss_pred             EEEECCEEEECCCCCCC-------CCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCH--
T ss_conf             76313500223554443-------211356602497874289970799989178700678646617448799899899--


Q ss_pred             CCHHHHHHHHHCC---HHH-HHHHHHHH---HCCCCCHHHHHHHH--HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf             5278999985110---145-55324321---01478927899879--999999999985303789999999899999999
Q 002746          784 LSLHKWVKNHYHG---RLE-KVIDSSLL---RASRDQSPEVKRMW--DVAIGELIELGILCTQESPSTRPTMLDAADDLD  854 (885)
Q Consensus       784 ~~~~~~~~~~~~~---~~~-~~~~~~l~---~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~  854 (885)
                      ......+......   ... ........   ..............  ....+++.+++.+|+..||++|||++|+++   
T Consensus       228 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~---  304 (318)
T d3blha1         228 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN---  304 (318)
T ss_dssp             HHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH---
T ss_pred             HHHHHHHHHHCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC---
T ss_conf             99999999841899825534432034443320133445550334044459989999999987389658909999974---


Q ss_pred             HHHHHHCCCCCCCC
Q ss_conf             99988367899985
Q 002746          855 RLKRYLGEKHMPSK  868 (885)
Q Consensus       855 ~l~~~~~~~~~~~~  868 (885)
                        +.|+.+.++|..
T Consensus       305 --Hpff~~~p~p~~  316 (318)
T d3blha1         305 --HDFFWSDPMPSD  316 (318)
T ss_dssp             --SGGGSSSSCCCC
T ss_pred             --CHHHCCCCCCCC
T ss_conf             --950156999978

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=326.45  Aligned_cols=265  Identities=22%  Similarity=0.275  Sum_probs=196.9

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECC--CCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCC------
Q ss_conf             517864643201276249999969-99799999943047--830366999999983058966423443310699------
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPD------  626 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  626 (885)
                      .++|.+.+.||+|+||+||+|... +++.||||+++...  ....+.+.+|+++++.++|||++++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf             77189988980177819999999999989999998522259699999999999998668987547999863576555541


Q ss_pred             CCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf             51399964458853225566875455889887889999999999999999963169996584478999667669997798
Q 002746          627 FKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALV  706 (885)
Q Consensus       627 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl  706 (885)
                      ..++||||+ ++++.......          .+++..+..++.|++.||.|||++|   |+||||||+|||++.++.+|+
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl  162 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE----------KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKI  162 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred             EEEEEEECC-CCCHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHCCCCCCCCC
T ss_conf             599998405-52189998740----------2269999999999999999987378---764566851111210012211


Q ss_pred             CCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             144431001002678999877788754443456542378656898-8885335030679999987299999943458852
Q 002746          707 SDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLS  785 (885)
Q Consensus       707 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~  785 (885)
                      +|||.|+....              ......||+.|+|||++.+. .++.++||||+||++|+|++|+.||...... ..
T Consensus       163 ~Dfg~a~~~~~--------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~  227 (346)
T d1cm8a_         163 LDFGLARQADS--------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQ  227 (346)
T ss_dssp             CCCTTCEECCS--------------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HH
T ss_pred             CCCCCEECCCC--------------CCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHH-HH
T ss_conf             34310220687--------------6310245533358899817878996501030038999999786998889768-99


Q ss_pred             HHHHHHHHHC--CHHHHH--------HHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             7899998511--014555--------324321014789278998799999999999853037899999998999999
Q 002746          786 LHKWVKNHYH--GRLEKV--------IDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       786 ~~~~~~~~~~--~~~~~~--------~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                      +.........  ......        ....+........   .......++++.+++.+|+..||++|||++|++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         228 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF---ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG---GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHCCCCCCHHHHHHHCCHHHHHHHCCCCCCCCCCH---HHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             999985037884888865300034433115786665566---77556899999999999772995579299999639

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=321.75  Aligned_cols=269  Identities=23%  Similarity=0.303  Sum_probs=191.1

Q ss_pred             HCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECC------CCCE
Q ss_conf             17864643201276249999969-9979999994304783036699999998305896642344331069------9513
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRIITACSLP------DFKA  629 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~  629 (885)
                      .+|...++||+|+||+||+|++. +++.||||++....    ....+|++++++++|+||+++++++...      .+.+
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCC----HHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEE
T ss_conf             77675169821768399999999999799999988160----68999999998668989873878997447657731899


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCC-CEEECC
Q ss_conf             9996445885322556687545588988788999999999999999996316999658447899966766999-779814
Q 002746          630 LVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDM-TALVSD  708 (885)
Q Consensus       630 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~-~~kl~D  708 (885)
                      +||||++++.+........      ....+++..+..++.|++.||.|||++|   |+||||||+|||++.++ .+||+|
T Consensus        96 lv~Ey~~~~~~~~l~~~~~------~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~D  166 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYSR------AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD  166 (350)
T ss_dssp             EEEECCSEEHHHHHHHHHH------TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECC
T ss_pred             EEEECCCCCCHHHHHHHHH------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEECCCCCEEEEC
T ss_conf             9984168860788886310------3689999999999999999999998668---764578860378735897116733


Q ss_pred             CCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHH
Q ss_conf             443100100267899987778875444345654237865689-8888533503067999998729999994345885278
Q 002746          709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFG-SNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH  787 (885)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~  787 (885)
                      ||+|..+..            ........|++.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...+.
T Consensus       167 FG~a~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~-~~~l~  233 (350)
T d1q5ka_         167 FGSAKQLVR------------GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLV  233 (350)
T ss_dssp             CTTCEECCT------------TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-HHHHH
T ss_pred             CCCHHHCCC------------CCCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCH-HHHHH
T ss_conf             660544047------------76532002555556827764046888210002465277855028799898799-99999


Q ss_pred             HHHHHHHCCHHHHHHHH---HHHHC-CCC--CHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             99998511014555324---32101-478--9278998799999999999853037899999998999999
Q 002746          788 KWVKNHYHGRLEKVIDS---SLLRA-SRD--QSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       788 ~~~~~~~~~~~~~~~~~---~l~~~-~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ........ ...+.+..   ..... ...  ..+.........++++.+++.+|+..||++|||++|++++
T Consensus       234 ~i~~~~g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         234 EIIKVLGT-PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             HHHHHHCC-CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHCC-CHHHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             99997489-81776543062101103554456744443156899999999999765895579299999669

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=320.73  Aligned_cols=270  Identities=17%  Similarity=0.259  Sum_probs=200.9

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECCCCCHHHHHHHHHHHHHCCCCCCCEE-EEEEECCCCCEEEEE
Q ss_conf             517864643201276249999969-997999999430478303669999999830589664234-433106995139996
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNLMRI-ITACSLPDFKALVLP  633 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~-~~~~~~~~~~~lv~e  633 (885)
                      .++|++.+.||+|+||.||+|.+. +++.||||++....  ....+..|+++++.++|++++.. .++....+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEE
T ss_conf             888999689850788099999998899899999972100--588899999999970389960179999951987789998


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC---CCCCEEECCCC
Q ss_conf             445885322556687545588988788999999999999999996316999658447899966766---99977981444
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLN---DDMTALVSDFG  710 (885)
Q Consensus       634 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~---~~~~~kl~Dfg  710 (885)
                      |+ ++++...+....        ..+++..+..++.|++.||+|||++|   |+||||||+|||++   .+..++++|||
T Consensus        84 ~~-~~~l~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG  151 (299)
T d1ckia_          84 LL-GPSLEDLFNFCS--------RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFG  151 (299)
T ss_dssp             CC-CCBHHHHHHHTT--------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred             EC-CCCHHHHHHHCC--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHCCCCCCCCCCEEEEECCC
T ss_conf             73-871333244306--------88768999999999999999999799---4426678766064335777615650467


Q ss_pred             CCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
Q ss_conf             31001002678999877788754443456542378656898888533503067999998729999994345885278999
Q 002746          711 IAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       711 ~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~  790 (885)
                      +|+.+.......    ...........||+.|+|||+..+..++.++|||||||++|||++|+.||.......... . .
T Consensus       152 ~a~~~~~~~~~~----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~-~-~  225 (299)
T d1ckia_         152 LAKKYRDARTHQ----HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-K-Y  225 (299)
T ss_dssp             SCEECBCTTTCC----BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---------H
T ss_pred             CCEECCCCCCCC----CEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHH-H-H
T ss_conf             513425544554----100013577678735329999918998983218861778999984987665530577999-9-9


Q ss_pred             HHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf             9851101455532432101478927899879999999999985303789999999899999999999883
Q 002746          791 KNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYL  860 (885)
Q Consensus       791 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~  860 (885)
                      .........            .   ..+...+.+++++.+++.+||+.+|++||+++++.+.|+.+....
T Consensus       226 ~~~~~~~~~------------~---~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         226 ERISEKKMS------------T---PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             HHHHHHHHH------------S---CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHCCCCC------------C---CHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf             985235678------------9---835753478899999999984399557919999999999999976

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=0  Score=320.80  Aligned_cols=266  Identities=21%  Similarity=0.259  Sum_probs=195.8

Q ss_pred             HCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECCCCCHHHHHHHHHHHHHCC-CCCCCEEEEEEEC--CCCCEEEE
Q ss_conf             17864643201276249999969-99799999943047830366999999983058-9664234433106--99513999
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIR-HRNLMRIITACSL--PDFKALVL  632 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~  632 (885)
                      ++|++.+.||+|+||+||+|+.. +++.||+|+++.   ...+.+.+|++++..++ ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf             671897898317481999999889997999999888---99999999999998515799876799999816877126888


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCC-CEEECCCCC
Q ss_conf             6445885322556687545588988788999999999999999996316999658447899966766999-779814443
Q 002746          633 PYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDM-TALVSDFGI  711 (885)
Q Consensus       633 e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~-~~kl~Dfg~  711 (885)
                      ||+++++|.....            .+++..+..++.|++.||.|||++|   |+||||||+|||++.++ .+||+|||.
T Consensus       112 e~~~~~~L~~~~~------------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~  176 (328)
T d3bqca1         112 EHVNNTDFKQLYQ------------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGL  176 (328)
T ss_dssp             ECCCSCBGGGTTT------------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred             EECCCCCHHHHHC------------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEECCCCC
T ss_conf             6317985899746------------8999999999999999998876433---443456441237748998366415654


Q ss_pred             CEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
Q ss_conf             1001002678999877788754443456542378656898-888533503067999998729999994345885278999
Q 002746          712 AKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWV  790 (885)
Q Consensus       712 a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~  790 (885)
                      |+.....            .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||..............
T Consensus       177 a~~~~~~------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~  244 (328)
T d3bqca1         177 AEFYHPG------------QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA  244 (328)
T ss_dssp             CEECCTT------------CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHH
T ss_pred             CEECCCC------------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
T ss_conf             2664688------------7444322486424761026888888452323354555876048899988760189999999


Q ss_pred             HHHHCCHHHHHHH-----------HHHHHCCCCCHHH--HHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             9851101455532-----------4321014789278--998799999999999853037899999998999999
Q 002746          791 KNHYHGRLEKVID-----------SSLLRASRDQSPE--VKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       791 ~~~~~~~~~~~~~-----------~~l~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .............           .............  .......+++++.+++.+|+..||++|||++|++++
T Consensus       245 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         245 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             HHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHCCCHHHHHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             987884155555422544474300000333433112115521124489999999999866995689089999649

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=0  Score=317.97  Aligned_cols=271  Identities=15%  Similarity=0.205  Sum_probs=209.0

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECCCCCHHHHHHHHHHHHHCCC-CCCCEEEEEEECCCCCEEEEE
Q ss_conf             517864643201276249999969-997999999430478303669999999830589-664234433106995139996
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRH-RNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  633 (885)
                      .++|.+.+.||+|+||.||+|++. +++.||+|++....  ....+.+|++.+..++| ++++.+++++......++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf             980699799841788299999998899799999975025--829999999999996489998779999601881179999


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC-----CCCEEECC
Q ss_conf             4458853225566875455889887889999999999999999963169996584478999667669-----99779814
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND-----DMTALVSD  708 (885)
Q Consensus       634 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~-----~~~~kl~D  708 (885)
                      |+ +++|..++.....        .+++..+..++.|++.|+.|||++|   |+||||||+|||++.     ++.+||+|
T Consensus        82 ~~-~~~l~~~~~~~~~--------~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~D  149 (293)
T d1csna_          82 LL-GPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVD  149 (293)
T ss_dssp             CC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred             EC-CCCHHHHHHHHCC--------CHHHHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEECCCCCCCCCCEEECC
T ss_conf             64-8887999975203--------1106899999999999999999779---6626677131523475434479568723


Q ss_pred             CCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHH
Q ss_conf             44310010026789998777887544434565423786568988885335030679999987299999943458852789
Q 002746          709 FGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHK  788 (885)
Q Consensus       709 fg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~  788 (885)
                      ||+|+.......    .............||+.|+|||++.+..++.++||||||+++|||+||+.||.......  ...
T Consensus       150 FG~a~~~~~~~~----~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~--~~~  223 (293)
T d1csna_         150 FGMVKFYRDPVT----KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT--NKQ  223 (293)
T ss_dssp             CTTCEESBCTTT----CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC--HHH
T ss_pred             CCEEEECCCCCC----CCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHH
T ss_conf             660577146766----54111024676277510267989648888869998983199999986987678853021--999


Q ss_pred             HHHHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHC
Q ss_conf             9998511014555324321014789278998799999999999853037899999998999999999998836
Q 002746          789 WVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADDLDRLKRYLG  861 (885)
Q Consensus       789 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~L~~l~~~~~  861 (885)
                      ...........            .   ..+.....+|+++.+++..|+..+|++||+++.+.+.++++.+..+
T Consensus       224 ~~~~i~~~~~~------------~---~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~  281 (293)
T d1csna_         224 KYERIGEKKQS------------T---PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  281 (293)
T ss_dssp             HHHHHHHHHHH------------S---CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHCCCC------------C---CHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCC
T ss_conf             99999705679------------9---9589657998999999999843993008599999999999999759

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=317.20  Aligned_cols=267  Identities=20%  Similarity=0.205  Sum_probs=198.8

Q ss_pred             HCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECC--CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEC------CCC
Q ss_conf             17864643201276249999969-99799999943047--8303669999999830589664234433106------995
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSL------PDF  627 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~  627 (885)
                      ++|++.+.||+|+||+||+|++. +|+.||||++....  ......+.+|+.++++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf             77599889621758599999999999899999988233697999999999999986489876489989702564345762


Q ss_pred             CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEC
Q ss_conf             13999644588532255668754558898878899999999999999999631699965844789996676699977981
Q 002746          628 KALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVS  707 (885)
Q Consensus       628 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~  707 (885)
                      .++||||+.++.+... ..           .+++..+..++.|++.|+.|||++|   |+||||||+|||++.++.++++
T Consensus        97 ~~iv~Ey~~~~l~~~~-~~-----------~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~  161 (355)
T d2b1pa1          97 VYLVMELMDANLCQVI-QM-----------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL  161 (355)
T ss_dssp             EEEEEECCSEEHHHHH-TS-----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEEC
T ss_pred             EEEEEECCCHHHHHHH-HC-----------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCEEEE
T ss_conf             6999841446778765-03-----------8999999999999999998865221---1245677632113654431320


Q ss_pred             CCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHH
Q ss_conf             44431001002678999877788754443456542378656898888533503067999998729999994345885278
Q 002746          708 DFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLH  787 (885)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~  787 (885)
                      |||.++....            ........||+.|+|||++.+..++.++||||+||++|+|++|+.||..... .....
T Consensus       162 df~~~~~~~~------------~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~-~~~~~  228 (355)
T d2b1pa1         162 DFGLARTAGT------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWN  228 (355)
T ss_dssp             CCCC---------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHH
T ss_pred             CHHHHHCCCC------------CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCH-HHHHH
T ss_conf             1023211466------------6553322146555581331477778774333566257898659899888977-88999


Q ss_pred             HHHHHHHCC----------HHHHHHHHHHHHCCCCCHH---------HHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf             999985110----------1455532432101478927---------899879999999999985303789999999899
Q 002746          788 KWVKNHYHG----------RLEKVIDSSLLRASRDQSP---------EVKRMWDVAIGELIELGILCTQESPSTRPTMLD  848 (885)
Q Consensus       788 ~~~~~~~~~----------~~~~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e  848 (885)
                      .........          ......+...... ....+         .........+.++.+++.+|+..||++|||++|
T Consensus       229 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~e  307 (355)
T d2b1pa1         229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYA-GLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD  307 (355)
T ss_dssp             HHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCC-CCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             HHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf             99972058987999876566777764175435-66642126433354321013337999999999987699457908999


Q ss_pred             HHHH
Q ss_conf             9999
Q 002746          849 AADD  852 (885)
Q Consensus       849 v~~~  852 (885)
                      ++++
T Consensus       308 lL~H  311 (355)
T d2b1pa1         308 ALQH  311 (355)
T ss_dssp             HHTS
T ss_pred             HHCC
T ss_conf             9669

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=318.81  Aligned_cols=272  Identities=20%  Similarity=0.233  Sum_probs=202.2

Q ss_pred             HCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECC--CCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
Q ss_conf             17864643201276249999969-99799999943047--8303669999999830589664234433106995139996
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS--GNFTKSFNRECQVLKRIRHRNLMRIITACSLPDFKALVLP  633 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  633 (885)
                      ++|++.+.||+|+||+||+|++. +++.||||+++...  ....+.+.+|+.+++.++||||+++++++......++|++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf             99786269712868199999999999699999980321786899999999999985675788821354444431158863


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEECCCCCCE
Q ss_conf             44588532255668754558898878899999999999999999631699965844789996676699977981444310
Q 002746          634 YMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAK  713 (885)
Q Consensus       634 ~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~  713 (885)
                      ++.++++..+.....         .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+|++|||.|+
T Consensus        82 ~~~~~~l~~~~~~~~---------~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~  149 (292)
T d1unla_          82 FCDQDLKKYFDSCNG---------DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR  149 (292)
T ss_dssp             CCSEEHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             ECCCCCCCCCCCCCC---------CCCHHHHHHHHHHHHHHHHHHHCCC---EEEECCCCCCCCCCCCCCEEEEECCHHH
T ss_conf             023322211212356---------5403678999999999987743399---8600146761211337826652046011


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf             010026789998777887544434565423786568988-8853350306799999872999999434588527899998
Q 002746          714 LVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSN-TSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSLHKWVKN  792 (885)
Q Consensus       714 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~  792 (885)
                      .....           ........+++.|+|||++.+.. ++.++||||+||++|||++|+.||............ +..
T Consensus       150 ~~~~~-----------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~-~~~  217 (292)
T d1unla_         150 AFGIP-----------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR-IFR  217 (292)
T ss_dssp             ECCSC-----------CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHH-HHH
T ss_pred             CCCCC-----------CCCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHH-HHH
T ss_conf             04688-----------751001034431014667506988880444026541889985189999889999999999-986


Q ss_pred             HHCCHHHHHHHHHH--HHC----CCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             51101455532432--101----4789278998799999999999853037899999998999999
Q 002746          793 HYHGRLEKVIDSSL--LRA----SRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       793 ~~~~~~~~~~~~~l--~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ..............  ...    ...............++++.+++.+|++.||.+|||++|++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         218 LLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             HHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             118997355134432221133444544310433065689999999999864996689099999649

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=319.00  Aligned_cols=268  Identities=21%  Similarity=0.246  Sum_probs=199.3

Q ss_pred             HHCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEECC-----CC
Q ss_conf             517864643201276249999969-997999999430478--3036699999998305896642344331069-----95
Q 002746          556 TAEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSG--NFTKSFNRECQVLKRIRHRNLMRIITACSLP-----DF  627 (885)
Q Consensus       556 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~  627 (885)
                      .++|++.+.||+|+||+||+|+.. +++.||||+++....  ...+.+.+|++++++++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf             98718888983178839999999999979999998820028689999999999998668987425999996346456686


Q ss_pred             CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEC
Q ss_conf             13999644588532255668754558898878899999999999999999631699965844789996676699977981
Q 002746          628 KALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVS  707 (885)
Q Consensus       628 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~  707 (885)
                      .+++++|+.+|+|.+++...          .+++..+..++.|++.||.|||++|   |+||||||+|||++.++.+|++
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~----------~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~  163 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL  163 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC----------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEEEEECCCCHHHHCCCC----------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCC
T ss_conf             49999962588623200224----------5309999999999999999997388---7651667763345543220013


Q ss_pred             CCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCH
Q ss_conf             44431001002678999877788754443456542378656898-88853350306799999872999999434588527
Q 002746          708 DFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS-NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLSL  786 (885)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~~  786 (885)
                      |||.|....              .......|++.|+|||...+. .++.++||||+||++|+|++|+.||.....  ...
T Consensus       164 dfg~a~~~~--------------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~--~~~  227 (348)
T d2gfsa1         164 DFGLARHTD--------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQ  227 (348)
T ss_dssp             CC----CCT--------------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHH
T ss_pred             CCCHHCCCC--------------CCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCH--HHH
T ss_conf             210001257--------------5444434543555835533775678551243205899999768899788988--999


Q ss_pred             HHHHHHHHCCH---HHHH-----HHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf             89999851101---4555-----324321014789278998799999999999853037899999998999999
Q 002746          787 HKWVKNHYHGR---LEKV-----IDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       787 ~~~~~~~~~~~---~~~~-----~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev~~~  852 (885)
                      ...+.......   ....     ...................+...++++.+++.+|+..||++|||++|++++
T Consensus       228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         228 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             HHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             99999730799757732001024454443035578755566267899999999999775883459389998559

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=319.95  Aligned_cols=253  Identities=25%  Similarity=0.329  Sum_probs=200.0

Q ss_pred             HCCCCCCEECCCCCCEEEEEEEC----CCCEEEEEEEEEC----CCCCHHHHHHHHHHHHHCCC-CCCCEEEEEEECCCC
Q ss_conf             17864643201276249999969----9979999994304----78303669999999830589-664234433106995
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ----DGTAIAVKVLQLQ----SGNFTKSFNRECQVLKRIRH-RNLMRIITACSLPDF  627 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~  627 (885)
                      ++|++.+.||+|+||+||+|...    +|+.||+|+++..    .....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf             02599989832878399999987658879489999983677210168999999999999864679839996200024873


Q ss_pred             CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEC
Q ss_conf             13999644588532255668754558898878899999999999999999631699965844789996676699977981
Q 002746          628 KALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLNDDMTALVS  707 (885)
Q Consensus       628 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~~~~~kl~  707 (885)
                      .++|+||+.+|+|..++.....         ++......++.|++.|+.|+|+++   |+||||||+|||++.++.+||+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~---------~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~  171 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER---------FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLT  171 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEES
T ss_pred             EEEEEECCCCCHHHHHHHHCCC---------CCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCCCCEEECCCCCEEEE
T ss_conf             0012312341179999873045---------437888888999999998851499---8965477320124699988874


Q ss_pred             CCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             44431001002678999877788754443456542378656898--8885335030679999987299999943458852
Q 002746          708 DFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGS--NTSTKGDVYSFGILVLEMVTRRRPTDDMFAGGLS  785 (885)
Q Consensus       708 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwslG~il~elltg~~Pf~~~~~~~~~  785 (885)
                      |||+|..+...          .........|++.|+|||.+.+.  .++.++||||+||++|||++|+.||...... ..
T Consensus       172 DFG~a~~~~~~----------~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~-~~  240 (322)
T d1vzoa_         172 DFGLSKEFVAD----------ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-NS  240 (322)
T ss_dssp             CSSEEEECCGG----------GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC-CC
T ss_pred             ECCCHHHHCCC----------CCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH-HH
T ss_conf             13202220344----------44322122233333106876057768871325177779999997689998888777-79


Q ss_pred             HHHHHHHHHCCHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHH
Q ss_conf             78999985110145553243210147892789987999999999998530378999999-----98999999
Q 002746          786 LHKWVKNHYHGRLEKVIDSSLLRASRDQSPEVKRMWDVAIGELIELGILCTQESPSTRP-----TMLDAADD  852 (885)
Q Consensus       786 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~ev~~~  852 (885)
                      .........             .......       ..++.++.+++.+||.++|++||     |++|++++
T Consensus       241 ~~~i~~~~~-------------~~~~~~~-------~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         241 QAEISRRIL-------------KSEPPYP-------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             HHHHHHHHH-------------HCCCCCC-------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             HHHHHHHCC-------------CCCCCCC-------CCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCC
T ss_conf             999998335-------------6899886-------547999999999974458988199974509999749

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=284.92  Aligned_cols=272  Identities=18%  Similarity=0.229  Sum_probs=188.7

Q ss_pred             HCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEEEEECCCCCHHHHHHHHHHHHHCC-----------CCCCCEEEEEEEC
Q ss_conf             17864643201276249999969-99799999943047830366999999983058-----------9664234433106
Q 002746          557 AEFDEQRLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQSGNFTKSFNRECQVLKRIR-----------HRNLMRIITACSL  624 (885)
Q Consensus       557 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~  624 (885)
                      ++|.+.+.||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++++.++           |+|++++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf             85799899750778189999999999799999983431-33689999999999840145555542276764789987631


Q ss_pred             --CCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCCCEEECCCCCCCEEECCC
Q ss_conf             --99513999644588532255668754558898878899999999999999999631-699965844789996676699
Q 002746          625 --PDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHH-HSPVRVIHCDLKPSNVLLNDD  701 (885)
Q Consensus       625 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~dikp~NILl~~~  701 (885)
                        ....+++++++..+..........      ....+++..+..++.|++.|+.|||+ .|   |+||||||+|||++.+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~  162 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKY------EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIV  162 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHT------TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEE
T ss_pred             CCCCCEEEEEEECCCCCCCCCCCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECC
T ss_conf             25652023432000354200000122------34678689999999999999888764058---6465677057056305


Q ss_pred             C------CEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf             9------7798144431001002678999877788754443456542378656898888533503067999998729999
Q 002746          702 M------TALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAPEYGFGSNTSTKGDVYSFGILVLEMVTRRRP  775 (885)
Q Consensus       702 ~------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwslG~il~elltg~~P  775 (885)
                      +      .++++|||.|....              .......||+.|+|||+..+..++.++||||+||++++|++|+.|
T Consensus       163 ~~~~~~~~~kl~dfg~s~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~p  228 (362)
T d1q8ya_         163 DSPENLIQIKIADLGNACWYD--------------EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL  228 (362)
T ss_dssp             ETTTTEEEEEECCCTTCEETT--------------BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCC
T ss_pred             CCCCCCCEEEEEECCCCCCCC--------------CCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf             765644305675314421234--------------454223665210571321466777643201237899999878899


Q ss_pred             CCCCCCCC-C----CHHHHHHHHHC--CHHH-------HHHHH-----HHHHCCCCCHHHH----HHHHHHHHHHHHHHH
Q ss_conf             99434588-5----27899998511--0145-------55324-----3210147892789----987999999999998
Q 002746          776 TDDMFAGG-L----SLHKWVKNHYH--GRLE-------KVIDS-----SLLRASRDQSPEV----KRMWDVAIGELIELG  832 (885)
Q Consensus       776 f~~~~~~~-~----~~~~~~~~~~~--~~~~-------~~~~~-----~l~~~~~~~~~~~----~~~~~~~~~~l~~li  832 (885)
                      |....... .    .+...+.....  ....       ...+.     .+...........    .......++++.+++
T Consensus       229 F~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll  308 (362)
T d1q8ya_         229 FEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL  308 (362)
T ss_dssp             C---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHH
T ss_conf             89875543210268999999983799878862453220001320122024323577644421000156743589999999


Q ss_pred             HHHCCCCCCCCCCHHHHHHH
Q ss_conf             53037899999998999999
Q 002746          833 ILCTQESPSTRPTMLDAADD  852 (885)
Q Consensus       833 ~~cl~~dP~~RPt~~ev~~~  852 (885)
                      .+|+..||.+|||++|++++
T Consensus       309 ~~mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         309 SPMLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             GGGGCSSTTTCBCHHHHHTC
T ss_pred             HHHCCCCHHHCCCHHHHHCC
T ss_conf             99877994579089999669

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=100.00  E-value=3.5e-41  Score=234.66  Aligned_cols=357  Identities=25%  Similarity=0.316  Sum_probs=197.3

Q ss_pred             EECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf             85899965433722220799996997358625567852433089888789857873344579567899999599842652
Q 002746           24 LQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQ  103 (885)
Q Consensus        24 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~  103 (885)
                      ..+..+.+.+.+.  .+.+.+|++|++++|.|+ .++ + +..+++|++|++++|+|+++.  .++++++|++|++++|+
T Consensus        27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~-~l~-g-l~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~   99 (384)
T d2omza2          27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-G-VEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQ   99 (384)
T ss_dssp             HHTTCSSTTSEEC--HHHHTTCCEEECCSSCCC-CCT-T-GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred             HHHCCCCCCCCCC--HHHHCCCCEEECCCCCCC-CCC-C-CCCCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCC
T ss_conf             9867777788639--889578789989998987-762-4-245899998968188179886--33477110103013433


Q ss_pred             CCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCC
Q ss_conf             76668712224765258413653468898465407999868877787566888888865444567888989689802730
Q 002746          104 LTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMD  183 (885)
Q Consensus       104 l~~~~~~~~~~~~L~~L~l~~n~l~~~i~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~  183 (885)
                      +.                        .+++  ++++++|+.|++++|.+.....          ......+.......+.
T Consensus       100 i~------------------------~i~~--l~~l~~L~~L~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~  143 (384)
T d2omza2         100 IA------------------------DITP--LANLTNLTGLTLFNNQITDIDP----------LKNLTNLNRLELSSNT  143 (384)
T ss_dssp             CC------------------------CCGG--GTTCTTCCEEECCSSCCCCCGG----------GTTCTTCSEEEEEEEE
T ss_pred             CC------------------------CCCC--CCCCCCCCCCCCCCCCCCCCCC----------CCCCCCCCCCCCCCCC
T ss_conf             32------------------------2221--1123343334433222222222----------2222222112134663


Q ss_pred             CCCCCCCCCCCC-CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCC
Q ss_conf             574478844665-3148982587334568836538888884662265566542021038899985766665253347600
Q 002746          184 LGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAA  262 (885)
Q Consensus       184 l~~~~~~~~~~~-~L~~L~l~~n~i~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~  262 (885)
                      +........... ...........     ...+...+.........|...  ....+..++++..+++++|.++...+  
T Consensus       144 l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--  214 (384)
T d2omza2         144 ISDISALSGLTSLQQLSFGNQVTD-----LKPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--  214 (384)
T ss_dssp             ECCCGGGTTCTTCSEEEEEESCCC-----CGGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCH-----HHHHCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCEEECCCCCCCCCCC--
T ss_conf             131002322221122222123220-----111124542110112224333--21100223532333035774478786--


Q ss_pred             CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCEE
Q ss_conf             00889877032124325566773223777542998357744788994668999987897768847556896656863301
Q 002746          263 LGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIR  342 (885)
Q Consensus       263 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~  342 (885)
                      +..+++|+.|++++|.++..  ..+..+++|+.+++++|++.+..  .+..+++|+.|++++|++++..  .+..+..+ 
T Consensus       215 ~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l-  287 (384)
T d2omza2         215 LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTAL-  287 (384)
T ss_dssp             GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTC-
T ss_pred             CCCCCCCCEEECCCCCCCCC--CHHHCCCCCCHHCCCCCCCCCCC--CCCCCCCCCEEECCCCCCCCCC--CCCCCCCC-
T ss_conf             44457787888877777896--13432565341004467447877--5355466877545674457877--32356522-


Q ss_pred             EEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             34422678677985010027777646504787334435323566764528994378557988884355344330113574
Q 002746          343 IFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGN  422 (885)
Q Consensus       343 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N  422 (885)
                      ..+.+..|.+.+  ...+..+++++.|++++|++++..  .+..+++|+.|++++|++++ ++ .+..+++|+.|++++|
T Consensus       288 ~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N  361 (384)
T d2omza2         288 TNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHN  361 (384)
T ss_dssp             SEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSS
T ss_pred             CCCCCCCCCCCC--CCCCCHHCCCCEEECCCCCCCCCC--CCCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEEECCCC
T ss_conf             223323233333--221000024676777788778984--53668988989898998999-74-6708999998989799


Q ss_pred             CCCCCCCCCCCCCCEECEEECCCCC
Q ss_conf             2032258323787602299733662
Q 002746          423 HLSGIIPISLNKIHTLTFINLSFNE  447 (885)
Q Consensus       423 ~l~~~~~~~~~~l~~l~~l~l~~N~  447 (885)
                      +|++..|  +.++++|+.|++++|.
T Consensus       362 ~l~~l~~--l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         362 QISDLTP--LANLTRITQLGLNDQA  384 (384)
T ss_dssp             CCCBCGG--GTTCTTCSEEECCCEE
T ss_pred             CCCCCHH--HCCCCCCCEEECCCCC
T ss_conf             5899800--0039999996397895

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=100.00  E-value=1.1e-40  Score=231.92  Aligned_cols=353  Identities=24%  Similarity=0.348  Sum_probs=244.7

Q ss_pred             CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCC
Q ss_conf             78544448812348877868858999654337222207999969973586255678524330898887898578733445
Q 002746            4 DNHLFGAIPPEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGK   83 (885)
Q Consensus         4 ~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~l~~n~i~~~   83 (885)
                      ..++++.+.  ..++.+|+.|++++++|+.+  +.++.+++|++|++++|+|+ .++.  |.++++|++|++++|++.++
T Consensus        31 ~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~-~l~~--l~~L~~L~~L~L~~n~i~~i  103 (384)
T d2omza2          31 KTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLT-DITP--LKNLTKLVDILMNNNQIADI  103 (384)
T ss_dssp             CSSTTSEEC--HHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCCC
T ss_pred             CCCCCCCCC--HHHHCCCCEEECCCCCCCCC--CCCCCCCCCCEEECCCCCCC-CCCC--CCCCCCCCCCCCCCCCCCCC
T ss_conf             777788639--88957878998999898776--24245899998968188179-8863--34771101030134333222


Q ss_pred             CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf             79567899999599842652766687122247652584136534688984654079998688777875668888888654
Q 002746           84 IPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVP  163 (885)
Q Consensus        84 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~L~~L~l~~n~l~~~i~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~  163 (885)
                      .  .+.++++|+.|++.+|.++.... ......+..+....|.+. .+....................+           
T Consensus       104 ~--~l~~l~~L~~L~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~-----------  168 (384)
T d2omza2         104 T--PLANLTNLTGLTLFNNQITDIDP-LKNLTNLNRLELSSNTIS-DISALSGLTSLQQLSFGNQVTDL-----------  168 (384)
T ss_dssp             G--GGTTCTTCCEEECCSSCCCCCGG-GTTCTTCSEEEEEEEEEC-CCGGGTTCTTCSEEEEEESCCCC-----------
T ss_pred             C--CCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCHH-----------
T ss_conf             2--11123343334433222222222-222222211213466313-10023222211222221232201-----------


Q ss_pred             CCCCCCCCCCCCEEEECCCCCCCCCCCCCCCC-CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCC
Q ss_conf             44567888989689802730574478844665-31489825873345688365388888846622655665420210388
Q 002746          164 FFNSLGNCTDLEELELAGMDLGGTLPDSIGRL-NLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWL  242 (885)
Q Consensus       164 ~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~-~L~~L~l~~n~i~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l  242 (885)
                                                ..+... .........+...  ....+..++++..+++++|.++...+  +...
T Consensus       169 --------------------------~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~  218 (384)
T d2omza2         169 --------------------------KPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGIL  218 (384)
T ss_dssp             --------------------------GGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGC
T ss_pred             --------------------------HHHCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCEEECCCCCCCCCCC--CCCC
T ss_conf             --------------------------11124542110112224333--21100223532333035774478786--4445


Q ss_pred             CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf             99985766665253347600008898770321243255667732237775429983577447889946689999878977
Q 002746          243 SQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDL  322 (885)
Q Consensus       243 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  322 (885)
                      ++|++|++++|.++. . ..+..+++|+.+++++|.+.+..  .+..+++|+.|++++|++... + .+..++.++.+.+
T Consensus       219 ~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~-~-~~~~~~~l~~l~~  292 (384)
T d2omza2         219 TNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNI-S-PLAGLTALTNLEL  292 (384)
T ss_dssp             TTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCSEEEC
T ss_pred             CCCCEEECCCCCCCC-C-CHHHCCCCCCHHCCCCCCCCCCC--CCCCCCCCCEEECCCCCCCCC-C-CCCCCCCCCCCCC
T ss_conf             778788887777789-6-13432565341004467447877--535546687754567445787-7-3235652222332


Q ss_pred             CCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC
Q ss_conf             68847556896656863301344226786779850100277776465047873344353235667645289943785579
Q 002746          323 SYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQG  402 (885)
Q Consensus       323 ~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~  402 (885)
                      +.|.+++ + ..+..++.+ ..|++++|++++..  .+..+++|+.|++++|++++.  ..+.++++|+.|++++|++++
T Consensus       293 ~~n~l~~-~-~~~~~~~~l-~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l--~~l~~l~~L~~L~l~~N~l~~  365 (384)
T d2omza2         293 NENQLED-I-SPISNLKNL-TYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISD  365 (384)
T ss_dssp             CSSCCSC-C-GGGGGCTTC-SEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCB
T ss_pred             CCCCCCC-C-CCCCHHCCC-CEEECCCCCCCCCC--CCCCCCCCCEEECCCCCCCCC--HHHCCCCCCCEEECCCCCCCC
T ss_conf             3233333-2-210000246-76777788778984--536689889898989989997--467089999989897995899


Q ss_pred             CCCCCCCCCCCCCCCCCCCCC
Q ss_conf             888843553443301135742
Q 002746          403 NLPDSLGDLKNLEAIDVSGNH  423 (885)
Q Consensus       403 ~~~~~~~~l~~L~~L~l~~N~  423 (885)
                      ..|  +..+++|+.|++++|-
T Consensus       366 l~~--l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         366 LTP--LANLTRITQLGLNDQA  384 (384)
T ss_dssp             CGG--GTTCTTCSEEECCCEE
T ss_pred             CHH--HCCCCCCCEEECCCCC
T ss_conf             800--0039999996397895

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=5.8e-41  Score=233.51  Aligned_cols=260  Identities=28%  Similarity=0.498  Sum_probs=205.5

Q ss_pred             CCCCEEECCCCCCCC--CCCHHHCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCE
Q ss_conf             888846622655665--4202103889998576666-5253347600008898770321243255667732237775429
Q 002746          219 SNLISLNLSSNLLSG--TISAEISWLSQLEQLFLSH-NLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYS  295 (885)
Q Consensus       219 ~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  295 (885)
                      .+++.|++++|.+.+  .+|..+..+++|++|+|++ |.+.+.+|..+.++++|++|+|++|++.+..+..+..+..|+.
T Consensus        50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~  129 (313)
T d1ogqa_          50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             EEEEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCC
T ss_conf             79889989899888888798478467533520202654333002431145420011020356434433222220111001


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCHHHHCCCCCCCEEECCCCC
Q ss_conf             98357744788994668999987897768847556896656863301344226786779850100277776465047873
Q 002746          296 LFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNK  375 (885)
Q Consensus       296 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  375 (885)
                      +++++|.+....|..+..++.++.+++++|.+.+.+|..+..+..+...++++.|++++..|..+..+..+ .+++++|.
T Consensus       130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~  208 (313)
T d1ogqa_         130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNM  208 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSE
T ss_pred             CCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCC
T ss_conf             11122455556851220674000000235533562031214431123231022464353324332222222-33333343


Q ss_pred             CCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEECEEECCCCCCCCCCCCC
Q ss_conf             34435323566764528994378557988884355344330113574203225832378760229973366261028999
Q 002746          376 FTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFINLSFNEFKGMIPSG  455 (885)
Q Consensus       376 l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~l~l~~N~l~~~~~~~  455 (885)
                      ..+..+..+..++.++.+++++|.+.+.+ ..+..+++|+.|++++|++++.+|..+.++++|+.|+|++|.+++.+|..
T Consensus       209 ~~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~  287 (313)
T d1ogqa_         209 LEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG  287 (313)
T ss_dssp             EEECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCCC
T ss_conf             32222222222222111222222222222-22224554444447657066608768847999998979588351668986


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             866888754423676543679999998
Q 002746          456 GIFNSATKMSFVGNQHLCGTVPGMPIC  482 (885)
Q Consensus       456 ~~~~~~~~~~~~~n~~~c~~~~~~~~~  482 (885)
                      +.+.++....+.+|+.+||.|.  |.|
T Consensus       288 ~~L~~L~~l~l~~N~~l~g~pl--p~c  312 (313)
T d1ogqa_         288 GNLQRFDVSAYANNKCLCGSPL--PAC  312 (313)
T ss_dssp             TTGGGSCGGGTCSSSEEESTTS--SCC
T ss_pred             CCCCCCCHHHHCCCCCCCCCCC--CCC
T ss_conf             6679989788688950019898--898

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.6e-38  Score=220.47  Aligned_cols=252  Identities=31%  Similarity=0.488  Sum_probs=220.1

Q ss_pred             CCCEEECCCCCCCC--CCCCCCCCCCCCCEEECCC-CCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf             31489825873345--6883653888888466226-55665420210388999857666652533476000088987703
Q 002746          196 NLTQLLLQENKITG--SIPPHIGNLSNLISLNLSS-NLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLL  272 (885)
Q Consensus       196 ~L~~L~l~~n~i~~--~~p~~l~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L  272 (885)
                      .++.|++.++.+.+  .+|..+..+++|++|++++ |.+.+..|..|..+++|++|+|++|.+.+..+..+..+.+|+.+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCC
T ss_conf             98899898998888887984784675335202026543330024311454200110203564344332222201110011


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC-CEEECCCCCCCCCCCCCCCCCCCEEEEEECCCCC
Q ss_conf             212432556677322377754299835774478899466899998-7897768847556896656863301344226786
Q 002746          273 DLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDL-YKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQ  351 (885)
Q Consensus       273 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~  351 (885)
                      ++++|.+....|..+..++.++.+++++|.+.+..|..+..+..+ +.+++++|++++..+..+..+..+  .++++++.
T Consensus       131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~--~l~l~~~~  208 (313)
T d1ogqa_         131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA--FVDLSRNM  208 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS--EEECCSSE
T ss_pred             CCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCC
T ss_conf             1122455556851220674000000235533562031214431123231022464353324332222222--33333343


Q ss_pred             CCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             77985010027777646504787334435323566764528994378557988884355344330113574203225832
Q 002746          352 LEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPIS  431 (885)
Q Consensus       352 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  431 (885)
                      ..+..|..+..+++++.+++++|.+.+. +..+..+++|+.|++++|++++.+|..+..+++|+.|++++|+|+|.+| .
T Consensus       209 ~~~~~~~~~~~~~~l~~l~~~~~~l~~~-~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP-~  286 (313)
T d1ogqa_         209 LEGDASVLFGSDKNTQKIHLAKNSLAFD-LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-Q  286 (313)
T ss_dssp             EEECCGGGCCTTSCCSEEECCSSEECCB-GGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC-C
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCC-C
T ss_conf             3222222222222211122222222222-2222245544444476570666087688479999989795883516689-8


Q ss_pred             CCCCCEECEEECCCCCC-CCC
Q ss_conf             37876022997336626-102
Q 002746          432 LNKIHTLTFINLSFNEF-KGM  451 (885)
Q Consensus       432 ~~~l~~l~~l~l~~N~l-~~~  451 (885)
                      +.++.+|+.+++++|++ ++.
T Consensus       287 ~~~L~~L~~l~l~~N~~l~g~  307 (313)
T d1ogqa_         287 GGNLQRFDVSAYANNKCLCGS  307 (313)
T ss_dssp             STTGGGSCGGGTCSSSEEEST
T ss_pred             CCCCCCCCHHHHCCCCCCCCC
T ss_conf             666799897886889500198

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.9e-36  Score=207.58  Aligned_cols=245  Identities=23%  Similarity=0.285  Sum_probs=140.6

Q ss_pred             CCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf             78688589996543372222079999699735862556785243308988878985787334457956789999959984
Q 002746           20 RLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSL   99 (885)
Q Consensus        20 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L   99 (885)
                      ..+.++-++++++ .+|..+.  +++++|+|++|+|+ .+|...|.++++|++|++++|.+..+.+.+|.++++|+.|++
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l   86 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL   86 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CCCEEEECCCCCC-CCCCCCC--CCCCEEECCCCCCC-CCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECC
T ss_conf             5999985599988-5198889--99798978499189-869657604656523112344344523566527985578315


Q ss_pred             CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEE
Q ss_conf             26527666871222476525841365346889846540799986887778756688888886544456788898968980
Q 002746          100 YNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELEL  179 (885)
Q Consensus       100 ~~n~l~~~~~~~~~~~~L~~L~l~~n~l~~~i~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~~l~~L~~L~l  179 (885)
                      ++|+++..+...  ...+..|++..|.+. .++...+.....+..++...|......                       
T Consensus        87 ~~n~l~~l~~~~--~~~l~~L~~~~n~l~-~l~~~~~~~~~~~~~l~~~~n~~~~~~-----------------------  140 (305)
T d1xkua_          87 SKNQLKELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSG-----------------------  140 (305)
T ss_dssp             CSSCCSBCCSSC--CTTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCSSCCCGGG-----------------------
T ss_pred             CCCCCCCCCCCH--HHHHHHHHCCCCCHH-HHHHHHHHCCCCCCCCCCCCCCCCCCC-----------------------
T ss_conf             687567676400--111323210246102-344445401331100001233333467-----------------------


Q ss_pred             CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCC
Q ss_conf             27305744788446653148982587334568836538888884662265566542021038899985766665253347
Q 002746          180 AGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEI  259 (885)
Q Consensus       180 ~~~~l~~~~~~~~~~~~L~~L~l~~n~i~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~  259 (885)
                                                    ..+..+..+++|+.+++++|.+... +..  ..++|+.|++++|.+....
T Consensus       141 ------------------------------~~~~~~~~l~~L~~l~l~~n~l~~l-~~~--~~~~L~~L~l~~n~~~~~~  187 (305)
T d1xkua_         141 ------------------------------IENGAFQGMKKLSYIRIADTNITTI-PQG--LPPSLTELHLDGNKITKVD  187 (305)
T ss_dssp             ------------------------------BCTTGGGGCTTCCEEECCSSCCCSC-CSS--CCTTCSEEECTTSCCCEEC
T ss_pred             ------------------------------CCCCCCCCCCCCCCCCCCCCCCCCC-CCC--CCCCCCEEECCCCCCCCCC
T ss_conf             ------------------------------7764223456567120346774516-710--1776678989788677888


Q ss_pred             CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             600008898770321243255667732237775429983577447889946689999878977688475
Q 002746          260 PAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLT  328 (885)
Q Consensus       260 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~  328 (885)
                      +..|.+++.++.|++++|.+....+..+.++++|++|++++|++. .+|..|..+++|+.|++++|+|+
T Consensus       188 ~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~  255 (305)
T d1xkua_         188 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS  255 (305)
T ss_dssp             TGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred             HHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCC
T ss_conf             267641341330154455332223454334433224302554002-46311033467898989898657

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.1e-35  Score=202.11  Aligned_cols=245  Identities=22%  Similarity=0.277  Sum_probs=118.8

Q ss_pred             CCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf             99699735862556785243308988878985787334457956789999959984265276668712224765258413
Q 002746           44 NLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVE  123 (885)
Q Consensus        44 ~L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~L~~L~l~  123 (885)
                      ..+.++-+++.++ ++|...   .+++++|+|++|+|+.+.+.+|.++++|++|++++|++.                  
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l---~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~------------------   68 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDL---PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS------------------   68 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSC---CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCC------------------
T ss_pred             CCCEEEECCCCCC-CCCCCC---CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC------------------
T ss_conf             5999985599988-519888---999798978499189869657604656523112344344------------------


Q ss_pred             CCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf             65346889846540799986887778756688888886544456788898968980273057447884466531489825
Q 002746          124 YNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLLQ  203 (885)
Q Consensus       124 ~n~l~~~i~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~~L~~L~l~  203 (885)
                            .+++..|..+++|++|++++|+++.++..                                             
T Consensus        69 ------~i~~~~f~~l~~L~~L~l~~n~l~~l~~~---------------------------------------------   97 (305)
T d1xkua_          69 ------KISPGAFAPLVKLERLYLSKNQLKELPEK---------------------------------------------   97 (305)
T ss_dssp             ------CBCTTTTTTCTTCCEEECCSSCCSBCCSS---------------------------------------------
T ss_pred             ------CCCHHHHHCCCCCCEECCCCCCCCCCCCC---------------------------------------------
T ss_conf             ------52356652798557831568756767640---------------------------------------------


Q ss_pred             CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCC--CCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf             87334568836538888884662265566542021038899985766665253--3476000088987703212432556
Q 002746          204 ENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFS--GEIPAALGKLHHLGLLDLSFNKLSG  281 (885)
Q Consensus       204 ~n~i~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~--~~~~~~~~~l~~L~~L~Ls~N~l~~  281 (885)
                                 +  ...+..|++.+|.+..+.+..+.....+..++...|...  ...+..+..+++|+.+++++|.+..
T Consensus        98 -----------~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~  164 (305)
T d1xkua_          98 -----------M--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT  164 (305)
T ss_dssp             -----------C--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred             -----------H--HHHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             -----------0--111323210246102344445401331100001233333467776422345656712034677451


Q ss_pred             CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCHHHHC
Q ss_conf             67732237775429983577447889946689999878977688475568966568633013442267867798501002
Q 002746          282 EIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELS  361 (885)
Q Consensus       282 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~~~~~~  361 (885)
                      . +..  ..++|+.|++++|.+....+..|..++.++.|++++|.+.+..+..+..+++| +.|+|++|+++ .+|.++.
T Consensus       165 l-~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L-~~L~L~~N~L~-~lp~~l~  239 (305)
T d1xkua_         165 I-PQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL-RELHLNNNKLV-KVPGGLA  239 (305)
T ss_dssp             C-CSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTC-CEEECCSSCCS-SCCTTTT
T ss_pred             C-CCC--CCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-EEEECCCCCCC-CCCCCCC
T ss_conf             6-710--17766789897886778882676413413301544553322234543344332-24302554002-4631103


Q ss_pred             CCCCCCEEECCCCCCCCC
Q ss_conf             777764650478733443
Q 002746          362 KLENVQEIDLSSNKFTGN  379 (885)
Q Consensus       362 ~l~~L~~L~l~~N~l~~~  379 (885)
                      .+++|+.|++++|+|+.+
T Consensus       240 ~l~~L~~L~Ls~N~i~~i  257 (305)
T d1xkua_         240 DHKYIQVVYLHNNNISAI  257 (305)
T ss_dssp             TCSSCCEEECCSSCCCCC
T ss_pred             CCCCCCEEECCCCCCCCC
T ss_conf             346789898989865763

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-33  Score=193.63  Aligned_cols=114  Identities=28%  Similarity=0.281  Sum_probs=52.9

Q ss_pred             CCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf             53888888466226556654202103889998576666525334760000889877032124325566773223777542
Q 002746          215 IGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIY  294 (885)
Q Consensus       215 l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  294 (885)
                      +...++|+.+++++|.++.+.+..|..+++|+.|++++|.+....+.+|.++++|+.+++++|++.++.+..|..+++|+
T Consensus       125 ~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~  204 (284)
T d1ozna_         125 FRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM  204 (284)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred             CCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCC
T ss_conf             32000121102001431445805740434050223141765662566654656341314211434662816766532000


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             9983577447889946689999878977688475
Q 002746          295 SLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLT  328 (885)
Q Consensus       295 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~  328 (885)
                      +|++++|++....+..|..+++|+.|++++|++.
T Consensus       205 ~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~  238 (284)
T d1ozna_         205 TLYLFANNLSALPTEALAPLRALQYLRLNDNPWV  238 (284)
T ss_dssp             EEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
T ss_conf             2333335221000002355465688981199887

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-34  Score=196.75  Aligned_cols=12  Identities=42%  Similarity=0.415  Sum_probs=3.7

Q ss_pred             CCCCCEEECCCC
Q ss_conf             999868877787
Q 002746          139 LPSLTYLHLSYN  150 (885)
Q Consensus       139 l~~L~~L~L~~N  150 (885)
                      +++|++|++++|
T Consensus       104 l~~L~~L~l~~n  115 (284)
T d1ozna_         104 LGRLHTLHLDRC  115 (284)
T ss_dssp             CTTCCEEECTTS
T ss_pred             CCCCCEEECCCC
T ss_conf             102778756885

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.4e-30  Score=177.74  Aligned_cols=37  Identities=30%  Similarity=0.249  Sum_probs=13.9

Q ss_pred             CCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCC
Q ss_conf             8884662265566542021038899985766665253
Q 002746          220 NLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFS  256 (885)
Q Consensus       220 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~  256 (885)
                      ++++|++++|.++.+.+..|..+++|++|+|++|.|+
T Consensus        32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~   68 (266)
T d1p9ag_          32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT   68 (266)
T ss_dssp             TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC
T ss_pred             CCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC
T ss_conf             8898988499289859778634565522135665444

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.2e-30  Score=175.20  Aligned_cols=12  Identities=25%  Similarity=-0.239  Sum_probs=3.9

Q ss_pred             CCCCCEEECCCC
Q ss_conf             999878977688
Q 002746          314 CTDLYKLDLSYN  325 (885)
Q Consensus       314 l~~L~~L~l~~N  325 (885)
                      +++|+.|+|++|
T Consensus       194 ~~~L~~L~L~~N  205 (266)
T d1p9ag_         194 SHLLPFAFLHGN  205 (266)
T ss_dssp             TCCCSEEECCSC
T ss_pred             CCCCCEEEECCC
T ss_conf             888999983699

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.97  E-value=3.2e-27  Score=159.72  Aligned_cols=302  Identities=25%  Similarity=0.313  Sum_probs=141.5

Q ss_pred             CCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCC-CCCCEEE
Q ss_conf             786885899965433722220799996997358625567852433089888789857873344579567899-9995998
Q 002746           20 RLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNC-PNLWTLS   98 (885)
Q Consensus        20 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l-~~L~~L~   98 (885)
                      ++++|++++++++ .+|+   ..++|++|++++|+|+ .+|..    +.+|+.|++++|+++.+ +    .+ +.|++|+
T Consensus        39 ~l~~LdLs~~~L~-~lp~---~~~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~~l-~----~lp~~L~~L~  104 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLKAL-S----DLPPLLEYLG  104 (353)
T ss_dssp             TCSEEECTTSCCS-CCCS---CCTTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCSCC-C----SCCTTCCEEE
T ss_pred             CCCEEEECCCCCC-CCCC---CCCCCCEEECCCCCCC-CCCCC----HHHHHHHHHHHCCCCHH-H----HHCCCCCCCC
T ss_conf             9989993799988-7889---8789888989999796-33620----33203326655143203-2----1022111113


Q ss_pred             CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf             42652766687122247652584136534688984654079998688777875668888888654445678889896898
Q 002746           99 LYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELE  178 (885)
Q Consensus        99 L~~n~l~~~~~~~~~~~~L~~L~l~~n~l~~~i~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~~l~~L~~L~  178 (885)
                      +++|+++                        .+|.  +..+++|++|++++|.+......            ..      
T Consensus       105 L~~n~l~------------------------~lp~--~~~l~~L~~L~l~~~~~~~~~~~------------~~------  140 (353)
T d1jl5a_         105 VSNNQLE------------------------KLPE--LQNSSFLKIIDVDNNSLKKLPDL------------PP------  140 (353)
T ss_dssp             CCSSCCS------------------------SCCC--CTTCTTCCEEECCSSCCSCCCCC------------CT------
T ss_pred             CCCCCCC------------------------CCCC--HHHHCCCEEECCCCCCCCCCCCC------------CC------
T ss_conf             3455432------------------------2210--01101312311356510013223------------33------


Q ss_pred             ECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCC
Q ss_conf             02730574478844665314898258733456883653888888466226556654202103889998576666525334
Q 002746          179 LAGMDLGGTLPDSIGRLNLTQLLLQENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGE  258 (885)
Q Consensus       179 l~~~~l~~~~~~~~~~~~L~~L~l~~n~i~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~  258 (885)
                                       .+..+.+..+...  ....+..++.++.|.+++|..... +   ........+...++.+. .
T Consensus       141 -----------------~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~-~---~~~~~~~~l~~~~~~~~-~  196 (353)
T d1jl5a_         141 -----------------SLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKL-P---DLPLSLESIVAGNNILE-E  196 (353)
T ss_dssp             -----------------TCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSC-C---CCCTTCCEEECCSSCCS-S
T ss_pred             -----------------CCCCHHHCCCCCC--CCCCCCCCCCCEECCCCCCCCCCC-C---CCCCCCCCCCCCCCCCC-C
T ss_conf             -----------------3210000122222--333200012220011123344322-2---21222222334443222-2


Q ss_pred             CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf             76000088987703212432556677322377754299835774478899466899998789776884755689665686
Q 002746          259 IPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGI  338 (885)
Q Consensus       259 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l  338 (885)
                      .+ .+..++.|+.+++++|.... .+   .....+..+.+.++++.. .+.   ....+...++..+.+.+ +..    +
T Consensus       197 ~~-~~~~l~~L~~l~l~~n~~~~-~~---~~~~~l~~~~~~~~~~~~-~~~---~~~~l~~~~~~~~~~~~-l~~----l  262 (353)
T d1jl5a_         197 LP-ELQNLPFLTTIYADNNLLKT-LP---DLPPSLEALNVRDNYLTD-LPE---LPQSLTFLDVSENIFSG-LSE----L  262 (353)
T ss_dssp             CC-CCTTCTTCCEEECCSSCCSS-CC---SCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSE-ESC----C
T ss_pred             CC-CCCCCCCCCCCCCCCCCCCC-CC---CCCCCCCCCCCCCCCCCC-CCC---CCCCCCCCCCCCCCCCC-CCC----C
T ss_conf             12-23455533312225422234-55---323343332223333344-433---34432222222233322-234----5


Q ss_pred             CCEEEEEECCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             33013442267867798501002777764650478733443532356676452899437855798888435534433011
Q 002746          339 REIRIFLNLSHNQLEGPLPIELSKLENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAID  418 (885)
Q Consensus       339 ~~l~~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  418 (885)
                      .......++..+.+.+ .   ...+++|+.|++++|+++. .|.   .+++|+.|++++|+|+. +|..   +++|+.|+
T Consensus       263 ~~~~~~~~~~~~~~~~-~---~~~~~~L~~L~Ls~N~l~~-lp~---~~~~L~~L~L~~N~L~~-l~~~---~~~L~~L~  330 (353)
T d1jl5a_         263 PPNLYYLNASSNEIRS-L---CDLPPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLAE-VPEL---PQNLKQLH  330 (353)
T ss_dssp             CTTCCEEECCSSCCSE-E---CCCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEE
T ss_pred             CCHHCCCCCCCCCCCC-C---CCCCCCCCEEECCCCCCCC-CCC---CCCCCCEEECCCCCCCC-CCCC---CCCCCEEE
T ss_conf             3000123333575323-4---5668988989797991683-566---54879989899996875-4532---28889898


Q ss_pred             CCCCCCCCCCCC
Q ss_conf             357420322583
Q 002746          419 VSGNHLSGIIPI  430 (885)
Q Consensus       419 l~~N~l~~~~~~  430 (885)
                      +++|+|+ .+|.
T Consensus       331 L~~N~L~-~lp~  341 (353)
T d1jl5a_         331 VEYNPLR-EFPD  341 (353)
T ss_dssp             CCSSCCS-SCCC
T ss_pred             CCCCCCC-CCCC
T ss_conf             7699189-7776

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.96  E-value=4.1e-26  Score=153.76  Aligned_cols=304  Identities=26%  Similarity=0.320  Sum_probs=199.2

Q ss_pred             CCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf             99969973586255678524330898887898578733445795678999995998426527666871222476525841
Q 002746           43 SNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLTGQLPASLINTSMYNLDV  122 (885)
Q Consensus        43 ~~L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~L~~L~l  122 (885)
                      .++++|+|++|.++ .+|.    ..++|++|++++|+|+ ..|..   +.+|+.|++.+|+++                 
T Consensus        38 ~~l~~LdLs~~~L~-~lp~----~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-----------------   91 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPE----LPPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-----------------   91 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCS----CCTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-----------------
T ss_pred             CCCCEEEECCCCCC-CCCC----CCCCCCEEECCCCCCC-CCCCC---HHHHHHHHHHHCCCC-----------------
T ss_conf             69989993799988-7889----8789888989999796-33620---332033266551432-----------------


Q ss_pred             CCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf             36534688984654079998688777875668888888654445678889896898027305744788446653148982
Q 002746          123 EYNHLSGELPSDIMSKLPSLTYLHLSYNNMVSHDDNTNLVPFFNSLGNCTDLEELELAGMDLGGTLPDSIGRLNLTQLLL  202 (885)
Q Consensus       123 ~~n~l~~~i~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~~L~~L~l  202 (885)
                             .++.    -.+.|++|++++|.+..++.          +..+++|+.+++.+                     
T Consensus        92 -------~l~~----lp~~L~~L~L~~n~l~~lp~----------~~~l~~L~~L~l~~---------------------  129 (353)
T d1jl5a_          92 -------ALSD----LPPLLEYLGVSNNQLEKLPE----------LQNSSFLKIIDVDN---------------------  129 (353)
T ss_dssp             -------CCCS----CCTTCCEEECCSSCCSSCCC----------CTTCTTCCEEECCS---------------------
T ss_pred             -------HHHH----HCCCCCCCCCCCCCCCCCCC----------HHHHCCCEEECCCC---------------------
T ss_conf             -------0321----02211111334554322210----------01101312311356---------------------


Q ss_pred             CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf             58733456883653888888466226556654202103889998576666525334760000889877032124325566
Q 002746          203 QENKITGSIPPHIGNLSNLISLNLSSNLLSGTISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGE  282 (885)
Q Consensus       203 ~~n~i~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~  282 (885)
                        +.+.. .+.   ....+..+.+..+...  ....+..++.++.+++.+|.+.. .+..   ......+...++.+. .
T Consensus       130 --~~~~~-~~~---~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~-~~~~---~~~~~~l~~~~~~~~-~  196 (353)
T d1jl5a_         130 --NSLKK-LPD---LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKK-LPDL---PLSLESIVAGNNILE-E  196 (353)
T ss_dssp             --SCCSC-CCC---CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-S
T ss_pred             --CCCCC-CCC---CCCCCCCHHHCCCCCC--CCCCCCCCCCCEECCCCCCCCCC-CCCC---CCCCCCCCCCCCCCC-C
T ss_conf             --51001-322---3333210000122222--33320001222001112334432-2221---222222334443222-2


Q ss_pred             CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCHHHHCC
Q ss_conf             77322377754299835774478899466899998789776884755689665686330134422678677985010027
Q 002746          283 IPVSLGNLVQIYSLFLNNNQLSRSIPPTLGRCTDLYKLDLSYNRLTGSIPAEISGIREIRIFLNLSHNQLEGPLPIELSK  362 (885)
Q Consensus       283 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~~L~L~~N~l~~~~~~~~~~  362 (885)
                      . ..+..++.++.+++++|... ..+.   ...++..+.+.+|.+. ..+.....+    ...++..+.+.+     +..
T Consensus       197 ~-~~~~~l~~L~~l~l~~n~~~-~~~~---~~~~l~~~~~~~~~~~-~~~~~~~~l----~~~~~~~~~~~~-----l~~  261 (353)
T d1jl5a_         197 L-PELQNLPFLTTIYADNNLLK-TLPD---LPPSLEALNVRDNYLT-DLPELPQSL----TFLDVSENIFSG-----LSE  261 (353)
T ss_dssp             C-CCCTTCTTCCEEECCSSCCS-SCCS---CCTTCCEEECCSSCCS-CCCCCCTTC----CEEECCSSCCSE-----ESC
T ss_pred             C-CCCCCCCCCCCCCCCCCCCC-CCCC---CCCCCCCCCCCCCCCC-CCCCCCCCC----CCCCCCCCCCCC-----CCC
T ss_conf             1-22345553331222542223-4553---2334333222333334-443334432----222222233322-----234


Q ss_pred             C-CCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEECEE
Q ss_conf             7-776465047873344353235667645289943785579888843553443301135742032258323787602299
Q 002746          363 L-ENVQEIDLSSNKFTGNIFIQISNCIAVRLINISHNALQGNLPDSLGDLKNLEAIDVSGNHLSGIIPISLNKIHTLTFI  441 (885)
Q Consensus       363 l-~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~l~~l  441 (885)
                      + ......++..|.+...    ...+++|+.|++++|.+.. +|.   .+++|+.|++++|+|+ .+|..   +++|+.|
T Consensus       262 l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~~-lp~---~~~~L~~L~L~~N~L~-~l~~~---~~~L~~L  329 (353)
T d1jl5a_         262 LPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLA-EVPEL---PQNLKQL  329 (353)
T ss_dssp             CCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEE
T ss_pred             CCCHHCCCCCCCCCCCCC----CCCCCCCCEEECCCCCCCC-CCC---CCCCCCEEECCCCCCC-CCCCC---CCCCCEE
T ss_conf             530001233335753234----5668988989797991683-566---5487998989999687-54532---2888989


Q ss_pred             ECCCCCCCCCCCC
Q ss_conf             7336626102899
Q 002746          442 NLSFNEFKGMIPS  454 (885)
Q Consensus       442 ~l~~N~l~~~~~~  454 (885)
                      ++++|+++..|+.
T Consensus       330 ~L~~N~L~~lp~~  342 (353)
T d1jl5a_         330 HVEYNPLREFPDI  342 (353)
T ss_dssp             ECCSSCCSSCCCC
T ss_pred             ECCCCCCCCCCCC
T ss_conf             8769918977765

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.3e-32  Score=187.32  Aligned_cols=116  Identities=28%  Similarity=0.262  Sum_probs=69.2

Q ss_pred             CCCCEEECCCCCCCCCC-CHHHHCCCCCCEEECCCCCCCCCCC---HHHHCCCCCCCEEECCCCCCCCCCC----CCCC-
Q ss_conf             77868858999654337-2222079999699735862556785---2433089888789857873344579----5678-
Q 002746           19 RRLRHLQLDGNNLHGQI-PESLALLSNLTLVTLHDNNLTGMLP---ISFFHNCTSLRNVDLSQNFFTGKIP----EEIG-   89 (885)
Q Consensus        19 ~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~N~i~~~~~---~~~~~~l~~L~~L~l~~n~i~~~~~----~~~~-   89 (885)
                      .+|+.|++++++|.... .+-+..++++++|+|++|.|+..--   ..++..+++|++|||++|.|.+.+.    ..+. 
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~   81 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   81 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             CCCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHC
T ss_conf             98777982089588689999997677999998289999889999999998539998889795985972899999999843


Q ss_pred             CCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCC
Q ss_conf             99999599842652766687122247652584136534688984654079998688777875668
Q 002746           90 NCPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMVS  154 (885)
Q Consensus        90 ~l~~L~~L~L~~n~l~~~~~~~~~~~~L~~L~l~~n~l~~~i~~~~~~~l~~L~~L~L~~N~i~~  154 (885)
                      ...+|++|+|++|++++.....+                    ...+..+++|++|++++|.|..
T Consensus        82 ~~~~L~~L~L~~n~it~~~~~~l--------------------~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1          82 PSCKIQKLSLQNCCLTGAGCGVL--------------------SSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHH--------------------HHHTTSCTTCCEEECCSSBCHH
T ss_pred             CCCCCCEEECCCCCCCCCCCCCC--------------------CCHHHCCCCCCCCCCCCCCCHH
T ss_conf             78877887788877543221012--------------------1100003432002444332023

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.95  E-value=3.8e-28  Score=164.71  Aligned_cols=165  Identities=18%  Similarity=0.185  Sum_probs=118.1

Q ss_pred             CCCCCEECCCCCCEEEEEEECCCCEEEEEEEEECCC------------------CCHHHHHHHHHHHHHCCCCCCCEEEE
Q ss_conf             864643201276249999969997999999430478------------------30366999999983058966423443
Q 002746          559 FDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSG------------------NFTKSFNRECQVLKRIRHRNLMRIIT  620 (885)
Q Consensus       559 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~~~~  620 (885)
                      +.+++.||+|+||.||+|...+|+.||||+++....                  ........|...+.++.|.+++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             CHHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf             02277802485659999997999999999986044346665565630008889999997789999999816999144998


Q ss_pred             EEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC
Q ss_conf             31069951399964458853225566875455889887889999999999999999963169996584478999667669
Q 002746          621 ACSLPDFKALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHSPVRVIHCDLKPSNVLLND  700 (885)
Q Consensus       621 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~dikp~NILl~~  700 (885)
                      +.    ..+++|||++++.+...                +......++.|++.++.|||++|   |+||||||+|||+++
T Consensus        82 ~~----~~~lvme~~~~~~~~~l----------------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~  138 (191)
T d1zara2          82 WE----GNAVLMELIDAKELYRV----------------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSE  138 (191)
T ss_dssp             EE----TTEEEEECCCCEEGGGC----------------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEET
T ss_pred             EC----CCEEEEEEECCCCCCCH----------------HHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHEEEEC
T ss_conf             62----88899995045654200----------------15789999999999999982688---898368903611428


Q ss_pred             CCCEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCCCCCCCHHHHHHHH
Q ss_conf             997798144431001002678999877788754443456542378------6568988885335030679999
Q 002746          701 DMTALVSDFGIAKLVMTVGVGNDGAENMGNSTANMLCGSIGYMAP------EYGFGSNTSTKGDVYSFGILVL  767 (885)
Q Consensus       701 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~sDVwslG~il~  767 (885)
                      + .++++|||.|......           .        ...|...      +. ....|..++|+||..--+.
T Consensus       139 ~-~~~liDFG~a~~~~~~-----------~--------~~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         139 E-GIWIIDFPQSVEVGEE-----------G--------WREILERDVRNIITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             T-EEEECCCTTCEETTST-----------T--------HHHHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             C-CEEEEECCCCCCCCCC-----------C--------CHHHHHHHHHHHHHH-HCCCCCCCCCHHHHHHHHH
T ss_conf             9-8999877884308998-----------7--------099998779999999-7578998446899999874

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.2e-31  Score=183.50  Aligned_cols=92  Identities=21%  Similarity=0.286  Sum_probs=42.7

Q ss_pred             CCCCCCCCEEECCCCCCCC----CCCHHHHCCCCCCEEECCCCCCCCCCCHHH---H-CCCCCCCEEECCCCCCCCCC--
Q ss_conf             3488778688589996543----372222079999699735862556785243---3-08988878985787334457--
Q 002746           15 FSKLRRLRHLQLDGNNLHG----QIPESLALLSNLTLVTLHDNNLTGMLPISF---F-HNCTSLRNVDLSQNFFTGKI--   84 (885)
Q Consensus        15 ~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~---~-~~l~~L~~L~l~~n~i~~~~--   84 (885)
                      +..++++++|+|++|.|+.    .+..++..+++|+.|+|++|.|.+.--...   | ....+|++|++++|.+.+..  
T Consensus        23 ~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~  102 (460)
T d1z7xw1          23 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG  102 (460)
T ss_dssp             HHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHH
T ss_pred             HHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCCCCCC
T ss_conf             97677999998289999889999999998539998889795985972899999999843788778877888775432210


Q ss_pred             --CCCCCCCCCCCEEECCCCCCCC
Q ss_conf             --9567899999599842652766
Q 002746           85 --PEEIGNCPNLWTLSLYNNQLTG  106 (885)
Q Consensus        85 --~~~~~~l~~L~~L~L~~n~l~~  106 (885)
                        +.++..+++|++|++++|.+..
T Consensus       103 ~l~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1         103 VLSSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             HHHHHTTSCTTCCEEECCSSBCHH
T ss_pred             CCCCHHHCCCCCCCCCCCCCCCHH
T ss_conf             121100003432002444332023

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=4.8e-26  Score=153.40  Aligned_cols=34  Identities=24%  Similarity=0.195  Sum_probs=11.1

Q ss_pred             CCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCC
Q ss_conf             8846622655665420210388999857666652
Q 002746          221 LISLNLSSNLLSGTISAEISWLSQLEQLFLSHNL  254 (885)
Q Consensus       221 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~  254 (885)
                      +++|++++|.++.+.+.+|.++++|++|++++|.
T Consensus        31 l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~   64 (242)
T d1xwdc1          31 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND   64 (242)
T ss_dssp             CSEEEEESCCCCEECTTTTTTCTTCCEEEEESCT
T ss_pred             CCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCC
T ss_conf             8999876991896496686146432321102211

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=3.3e-25  Score=148.92  Aligned_cols=55  Identities=18%  Similarity=0.249  Sum_probs=21.1

Q ss_pred             CCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCC-CCCCCCCCCCCCCEEEC
Q ss_conf             996997358625567852433089888789857873344-57956789999959984
Q 002746           44 NLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTG-KIPEEIGNCPNLWTLSL   99 (885)
Q Consensus        44 ~L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L   99 (885)
                      ++++|++++|.|+ .+|..+|.++++|++|++++|.+.. +.+.+|.++++++.+.+
T Consensus        30 ~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~   85 (242)
T d1xwdc1          30 NAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI   85 (242)
T ss_dssp             CCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEE
T ss_pred             CCCEEECCCCCCC-CCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCC
T ss_conf             8899987699189-6496686146432321102211242010011222222222111

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.93  E-value=2.6e-25  Score=149.43  Aligned_cols=78  Identities=18%  Similarity=0.214  Sum_probs=37.1

Q ss_pred             CCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf             86885899965433722220799996997358625567852433089888789857873344579567899999599842
Q 002746           21 LRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLY  100 (885)
Q Consensus        21 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~  100 (885)
                      +.++++..+++.+.  ..++.+.+|+.|++.+|.|+ .++ + +..+++|++|++++|++.+..  .+.++++|+.++++
T Consensus        21 ~~~~~l~~~~~~d~--~~~~~l~~L~~L~l~~~~i~-~l~-~-l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~   93 (227)
T d1h6ua2          21 AIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVT-TIE-G-VQYLNNLIGLELKDNQITDLA--PLKNLTKITELELS   93 (227)
T ss_dssp             HHHHHTTCSSTTSE--ECHHHHHTCCEEECTTSCCC-CCT-T-GGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECC
T ss_pred             HHHHHHCCCCCCCC--CCHHHCCCCCEEECCCCCCC-CCH-H-HHCCCCCCEEECCCCEEECCC--CCCCCCCCCCCCCC
T ss_conf             99998488876775--79878488689977799997-664-5-744888837635785320254--31123343201211


Q ss_pred             CCCCC
Q ss_conf             65276
Q 002746          101 NNQLT  105 (885)
Q Consensus       101 ~n~l~  105 (885)
                      +|.++
T Consensus        94 ~n~~~   98 (227)
T d1h6ua2          94 GNPLK   98 (227)
T ss_dssp             SCCCS
T ss_pred             CCCCC
T ss_conf             12222

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.92  E-value=2.4e-24  Score=144.26  Aligned_cols=56  Identities=20%  Similarity=0.163  Sum_probs=28.7

Q ss_pred             CCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             9699735862556785243308988878985787334457956789999959984265276
Q 002746           45 LTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLT  105 (885)
Q Consensus        45 L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~  105 (885)
                      +..++++.+.+.+.+.   +..+.+|++|++++|.|+++  ..+.++++|+.|++++|+++
T Consensus        21 ~~~~~l~~~~~~d~~~---~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~   76 (227)
T d1h6ua2          21 AIKIAAGKSNVTDTVT---QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQIT   76 (227)
T ss_dssp             HHHHHTTCSSTTSEEC---HHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCC
T ss_pred             HHHHHHCCCCCCCCCC---HHHCCCCCEEECCCCCCCCC--HHHHCCCCCCEEECCCCEEE
T ss_conf             9999848887677579---87848868997779999766--45744888837635785320

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.90  E-value=4.7e-23  Score=137.35  Aligned_cols=17  Identities=18%  Similarity=0.157  Sum_probs=6.0

Q ss_pred             CCCCCCCEEECCCCCCC
Q ss_conf             08988878985787334
Q 002746           65 HNCTSLRNVDLSQNFFT   81 (885)
Q Consensus        65 ~~l~~L~~L~l~~n~i~   81 (885)
                      ..+++|++|++++|++.
T Consensus        65 ~~l~~L~~L~L~~n~i~   81 (210)
T d1h6ta2          65 QYLPNVTKLFLNGNKLT   81 (210)
T ss_dssp             GGCTTCCEEECCSSCCC
T ss_pred             HHCCCCCEEECCCCCCC
T ss_conf             64899898769896025

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.90  E-value=1.4e-22  Score=134.76  Aligned_cols=35  Identities=26%  Similarity=0.235  Sum_probs=13.1

Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             8878985787334457956789999959984265276
Q 002746           69 SLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLT  105 (885)
Q Consensus        69 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~  105 (885)
                      +|++|++++|.+....  .+..+++|++|++++|+++
T Consensus        47 ~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~   81 (210)
T d1h6ta2          47 SIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLT   81 (210)
T ss_dssp             TCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCC
T ss_pred             CCCEEECCCCCCCCCH--HHHHCCCCCEEECCCCCCC
T ss_conf             8458978279888744--4764899898769896025

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.89  E-value=7.8e-23  Score=136.16  Aligned_cols=59  Identities=19%  Similarity=0.249  Sum_probs=23.0

Q ss_pred             CCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             9999699735862556785243308988878985787334457956789999959984265276
Q 002746           42 LSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLT  105 (885)
Q Consensus        42 l~~L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~  105 (885)
                      +.+++.|++++|.|. .++.  +..+++|++|++++|++.+..  .+.++++|+.|++++|.+.
T Consensus        39 l~~l~~L~l~~~~i~-~l~~--l~~l~nL~~L~Ls~N~l~~~~--~l~~l~~L~~L~l~~n~~~   97 (199)
T d2omxa2          39 LDQVTTLQADRLGIK-SIDG--VEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIA   97 (199)
T ss_dssp             HTTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred             HCCCCEEECCCCCCC-CCCC--CCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCC
T ss_conf             468789989999997-7520--213788675754565566764--0167752231111222222

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.89  E-value=1.7e-23  Score=139.74  Aligned_cols=110  Identities=26%  Similarity=0.285  Sum_probs=43.8

Q ss_pred             CCCCEEECCCCCCCC-CCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf             888846622655665-4202103889998576666525334760000889877032124325566773223777542998
Q 002746          219 SNLISLNLSSNLLSG-TISAEISWLSQLEQLFLSHNLFSGEIPAALGKLHHLGLLDLSFNKLSGEIPVSLGNLVQIYSLF  297 (885)
Q Consensus       219 ~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  297 (885)
                      +++++|++++|.|+. .....|.++++|+.|+|++|.+....+..|..+++|+.|+|++|++..+.+.+|.++++|++|+
T Consensus        29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~  108 (192)
T d1w8aa_          29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN  108 (192)
T ss_dssp             TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred             CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCC
T ss_conf             78788984898775530200257876272130136322121212221122221010035534434979980797465524


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             3577447889946689999878977688475
Q 002746          298 LNNNQLSRSIPPTLGRCTDLYKLDLSYNRLT  328 (885)
Q Consensus       298 l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~  328 (885)
                      |++|+|+...+++|..+++|++|+|++|.+.
T Consensus       109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~  139 (192)
T d1w8aa_         109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFN  139 (192)
T ss_dssp             CCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred             CCCCCCCCCCHHHHCCCCCCCCCCCCCCCCC
T ss_conf             5774535359778568753342000364434

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.89  E-value=1e-21  Score=130.12  Aligned_cols=37  Identities=19%  Similarity=0.189  Sum_probs=17.0

Q ss_pred             CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             988878985787334457956789999959984265276
Q 002746           67 CTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLT  105 (885)
Q Consensus        67 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~  105 (885)
                      +.++++|++++|.+.++  ..++.+++|++|++++|+++
T Consensus        39 l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~   75 (199)
T d2omxa2          39 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLT   75 (199)
T ss_dssp             HTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCC
T ss_pred             HCCCCEEECCCCCCCCC--CCCCCCCCCCCCCCCCCCCC
T ss_conf             46878998999999775--20213788675754565566

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.89  E-value=6.4e-23  Score=136.62  Aligned_cols=62  Identities=24%  Similarity=0.352  Sum_probs=20.2

Q ss_pred             CCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             99699735862556785243308988878985787334457956789999959984265276
Q 002746           44 NLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLT  105 (885)
Q Consensus        44 ~L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~  105 (885)
                      ++++|+|++|.|+..++...|.++++|++|+|++|.+..+.+..|..+++|+.|+|++|+|+
T Consensus        30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~   91 (192)
T d1w8aa_          30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK   91 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCC
T ss_pred             CCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
T ss_conf             87889848987755302002578762721301363221212122211222210100355344

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.83  E-value=5.2e-22  Score=131.75  Aligned_cols=40  Identities=18%  Similarity=0.135  Sum_probs=15.6

Q ss_pred             CCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCC
Q ss_conf             0898887898578733445----795678999995998426527
Q 002746           65 HNCTSLRNVDLSQNFFTGK----IPEEIGNCPNLWTLSLYNNQL  104 (885)
Q Consensus        65 ~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L~~n~l  104 (885)
                      .....|++|+|++|.+...    ....+...++|+.|+++++..
T Consensus        28 ~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~   71 (344)
T d2ca6a1          28 LEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT   71 (344)
T ss_dssp             HHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCT
T ss_pred             HHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCC
T ss_conf             63899788978498377899999999998589988888877754

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=7.8e-21  Score=125.44  Aligned_cols=16  Identities=38%  Similarity=0.542  Sum_probs=5.6

Q ss_pred             CCCCCCCEEECCCCCC
Q ss_conf             8999995998426527
Q 002746           89 GNCPNLWTLSLYNNQL  104 (885)
Q Consensus        89 ~~l~~L~~L~L~~n~l  104 (885)
                      .++++|++|+|.+|.+
T Consensus        68 ~~c~~L~~L~L~~~~l   83 (284)
T d2astb2          68 SQCSKLQNLSLEGLRL   83 (284)
T ss_dssp             TTBCCCSEEECTTCBC
T ss_pred             HHCCCCCCCCCCCCCC
T ss_conf             7487765145234679

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.81  E-value=3.5e-21  Score=127.33  Aligned_cols=71  Identities=17%  Similarity=0.201  Sum_probs=38.4

Q ss_pred             CCHHHHCCCCCCEEECCCCCCCCCCCH---HHHCCCCCCCEEECCCCCCCCC----------CCCCCCCCCCCCEEECCC
Q ss_conf             722220799996997358625567852---4330898887898578733445----------795678999995998426
Q 002746           35 IPESLALLSNLTLVTLHDNNLTGMLPI---SFFHNCTSLRNVDLSQNFFTGK----------IPEEIGNCPNLWTLSLYN  101 (885)
Q Consensus        35 ~~~~~~~l~~L~~L~l~~N~i~~~~~~---~~~~~l~~L~~L~l~~n~i~~~----------~~~~~~~l~~L~~L~L~~  101 (885)
                      +...+.....++.|+|++|.|......   ..+...++|+.|+++++.....          ...++...++|+.|+|++
T Consensus        23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~  102 (344)
T d2ca6a1          23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD  102 (344)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred             HHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
T ss_conf             99999638997889784983778999999999985899888888777543345421067879998875477756330000


Q ss_pred             CCCC
Q ss_conf             5276
Q 002746          102 NQLT  105 (885)
Q Consensus       102 n~l~  105 (885)
                      |.++
T Consensus       103 n~i~  106 (344)
T d2ca6a1         103 NAFG  106 (344)
T ss_dssp             CCCC
T ss_pred             CCCC
T ss_conf             1345

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=8e-21  Score=125.38  Aligned_cols=13  Identities=23%  Similarity=0.107  Sum_probs=4.2

Q ss_pred             CCCCCCEEECCCC
Q ss_conf             7999868877787
Q 002746          138 KLPSLTYLHLSYN  150 (885)
Q Consensus       138 ~l~~L~~L~L~~N  150 (885)
                      .+++|++|++.+|
T Consensus        69 ~c~~L~~L~L~~~   81 (284)
T d2astb2          69 QCSKLQNLSLEGL   81 (284)
T ss_dssp             TBCCCSEEECTTC
T ss_pred             HCCCCCCCCCCCC
T ss_conf             4877651452346

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=4.4e-19  Score=116.03  Aligned_cols=63  Identities=14%  Similarity=0.100  Sum_probs=27.0

Q ss_pred             HHCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             2079999699735862556785243308988878985787334457956789999959984265276
Q 002746           39 LALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLT  105 (885)
Q Consensus        39 ~~~l~~L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~  105 (885)
                      |.+..++++|+|++|.|+ .++. .+..+++|+.|++++|+|.++  ..|..+++|+.|++++|+++
T Consensus        14 ~~n~~~lr~L~L~~n~I~-~i~~-~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~   76 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC   76 (162)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC
T ss_pred             CCCCCCCCEEECCCCCCC-CCCC-CCCCCCCCCEEECCCCCCCCC--CCCCCCCCHHHHHCCCCCCC
T ss_conf             168574848978899788-6576-200414599898979978764--77445761306431021345

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=1.3e-18  Score=113.54  Aligned_cols=115  Identities=27%  Similarity=0.300  Sum_probs=70.7

Q ss_pred             CCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf             12348877868858999654337222207999969973586255678524330898887898578733445795678999
Q 002746           13 PEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCP   92 (885)
Q Consensus        13 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~   92 (885)
                      ..|.+...++.|+|++|+|.. ++..+..+++|+.|++++|.|+ .++.  |..+++|++|++++|++..+.+..+..++
T Consensus        12 ~~~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~~--~~~l~~L~~L~ls~N~i~~l~~~~~~~l~   87 (162)
T d1a9na_          12 AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLDG--FPLLRRLKTLLVNNNRICRIGEGLDQALP   87 (162)
T ss_dssp             CEEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EECC--CCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred             HHCCCCCCCCEEECCCCCCCC-CCCCCCCCCCCCEEECCCCCCC-CCCC--CCCCCCHHHHHCCCCCCCCCCCCCCCCCC
T ss_conf             751685748489788997886-5762004145998989799787-6477--44576130643102134577763223345


Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCH-HHHCCCCCCCEEECCCCCCCCC
Q ss_conf             99599842652766687122247652584136534688984-6540799986887778756688
Q 002746           93 NLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPS-DIMSKLPSLTYLHLSYNNMVSH  155 (885)
Q Consensus        93 ~L~~L~L~~n~l~~~~~~~~~~~~L~~L~l~~n~l~~~i~~-~~~~~l~~L~~L~L~~N~i~~~  155 (885)
                      +|+.|++++|+|+                        .++. ..++.+++|++|++++|+++..
T Consensus        88 ~L~~L~L~~N~i~------------------------~~~~l~~l~~l~~L~~L~l~~N~i~~~  127 (162)
T d1a9na_          88 DLTELILTNNSLV------------------------ELGDLDPLASLKSLTYLCILRNPVTNK  127 (162)
T ss_dssp             TCCEEECCSCCCC------------------------CGGGGGGGGGCTTCCEEECCSSGGGGS
T ss_pred             CCCCCEECCCCCC------------------------CCCCCCCCCCCCCCCHHHCCCCCCCCC
T ss_conf             3443420300016------------------------654211001365320664079963456

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.68  E-value=2.3e-16  Score=101.45  Aligned_cols=105  Identities=27%  Similarity=0.354  Sum_probs=67.5

Q ss_pred             CEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf             68858999654337222207999969973586255678524330898887898578733445795678999995998426
Q 002746           22 RHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYN  101 (885)
Q Consensus        22 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~  101 (885)
                      +.|++++|+|+. .+ .++.+++|++|++++|.|+ .+|.. |..+++|+.|++++|.|.++  ..+..+++|+.|++++
T Consensus         1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~-~~~l~~L~~L~l~~N~i~~l--~~~~~l~~L~~L~l~~   74 (124)
T d1dcea3           1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPA-LAALRCLEVLQASDNALENV--DGVANLPRLQELLLCN   74 (124)
T ss_dssp             SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGG-GGGCTTCCEEECCSSCCCCC--GGGTTCSSCCEEECCS
T ss_pred             CEEECCCCCCCC-CC-CCCCCCCCCEEECCCCCCC-CCHHH-HHHHHCCCCCCCCCCCCCCC--CCCCCCCCCCEEECCC
T ss_conf             989868998988-71-0105898898979787168-65215-65543135453243211235--7412335557688889


Q ss_pred             CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCH-HHHCCCCCCCEEECCCCCCCCCC
Q ss_conf             52766687122247652584136534688984-65407999868877787566888
Q 002746          102 NQLTGQLPASLINTSMYNLDVEYNHLSGELPS-DIMSKLPSLTYLHLSYNNMVSHD  156 (885)
Q Consensus       102 n~l~~~~~~~~~~~~L~~L~l~~n~l~~~i~~-~~~~~l~~L~~L~L~~N~i~~~~  156 (885)
                      |+|+                        .++. ..+..+++|+.|++++|+++..+
T Consensus        75 N~i~------------------------~~~~~~~l~~~~~L~~L~l~~N~i~~~~  106 (124)
T d1dcea3          75 NRLQ------------------------QSAAIQPLVSCPRLVLLNLQGNSLCQEE  106 (124)
T ss_dssp             SCCC------------------------SSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred             CCCC------------------------CCCCCHHHCCCCCCCEEECCCCCCCCCC
T ss_conf             8658------------------------8888256537999999989799688682

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.67  E-value=4e-16  Score=100.13  Aligned_cols=40  Identities=23%  Similarity=0.286  Sum_probs=13.5

Q ss_pred             CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             08988878985787334457956789999959984265276
Q 002746           65 HNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSLYNNQLT  105 (885)
Q Consensus        65 ~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~  105 (885)
                      ..+++|++|++++|+|+ ..|..|..+++|+.|++++|+|+
T Consensus        17 ~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~   56 (124)
T d1dcea3          17 EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE   56 (124)
T ss_dssp             GGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC
T ss_pred             CCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC
T ss_conf             05898898979787168-65215655431354532432112

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.66  E-value=9e-19  Score=114.36  Aligned_cols=19  Identities=26%  Similarity=0.392  Sum_probs=6.3

Q ss_pred             HHHCCCCCCEEECCCCCCC
Q ss_conf             2207999969973586255
Q 002746           38 SLALLSNLTLVTLHDNNLT   56 (885)
Q Consensus        38 ~~~~l~~L~~L~l~~N~i~   56 (885)
                      ++..+++|++|+|++|.|+
T Consensus        43 sl~~L~~L~~L~Ls~n~I~   61 (198)
T d1m9la_          43 TLSTLKACKHLALSTNNIE   61 (198)
T ss_dssp             HHHHTTTCCEEECSEEEES
T ss_pred             HHHCCCCCCEEECCCCCCC
T ss_conf             7762604615199446899

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.65  E-value=4.3e-16  Score=99.95  Aligned_cols=106  Identities=24%  Similarity=0.205  Sum_probs=63.9

Q ss_pred             CCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCC-CCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf             8688589996543372222079999699735862-556785243308988878985787334457956789999959984
Q 002746           21 LRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNN-LTGMLPISFFHNCTSLRNVDLSQNFFTGKIPEEIGNCPNLWTLSL   99 (885)
Q Consensus        21 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~-i~~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L   99 (885)
                      .+.++..++++. ..|..+..+++|++|++++|+ |+ .++...|.++++|+.|+|++|+|..+.+.+|.++++|+.|+|
T Consensus        10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L   87 (156)
T d2ifga3          10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL   87 (156)
T ss_dssp             SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred             CCEEEECCCCCC-CCCCCCCCCCCCCEEECCCCCCCC-CCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEC
T ss_conf             996985289976-586002576565743168986644-369212256666672162021247742011124554333322


Q ss_pred             CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCC
Q ss_conf             265276668712224765258413653468898465407999868877787566
Q 002746          100 YNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLHLSYNNMV  153 (885)
Q Consensus       100 ~~n~l~~~~~~~~~~~~L~~L~l~~n~l~~~i~~~~~~~l~~L~~L~L~~N~i~  153 (885)
                      ++|+|+                        .++..+|+.+ +|+.|+|++|++.
T Consensus        88 s~N~l~------------------------~l~~~~~~~~-~l~~L~L~~Np~~  116 (156)
T d2ifga3          88 SFNALE------------------------SLSWKTVQGL-SLQELVLSGNPLH  116 (156)
T ss_dssp             CSSCCS------------------------CCCSTTTCSC-CCCEEECCSSCCC
T ss_pred             CCCCCC------------------------CCCHHHHCCC-CCCCCCCCCCCCC
T ss_conf             678785------------------------1574563353-2124335798633

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.60  E-value=6.3e-18  Score=109.81  Aligned_cols=14  Identities=21%  Similarity=0.275  Sum_probs=4.4

Q ss_pred             CCCCCEEECCCCCC
Q ss_conf             98887898578733
Q 002746           67 CTSLRNVDLSQNFF   80 (885)
Q Consensus        67 l~~L~~L~l~~n~i   80 (885)
                      +++|++|+|++|+|
T Consensus        47 L~~L~~L~Ls~n~I   60 (198)
T d1m9la_          47 LKACKHLALSTNNI   60 (198)
T ss_dssp             TTTCCEEECSEEEE
T ss_pred             CCCCCEEECCCCCC
T ss_conf             60461519944689

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.60  E-value=4.2e-15  Score=94.68  Aligned_cols=11  Identities=55%  Similarity=0.416  Sum_probs=3.8

Q ss_pred             CCEEECCCCCC
Q ss_conf             87897768847
Q 002746          317 LYKLDLSYNRL  327 (885)
Q Consensus       317 L~~L~l~~N~l  327 (885)
                      |+.|+|++|++
T Consensus       105 l~~L~L~~Np~  115 (156)
T d2ifga3         105 LQELVLSGNPL  115 (156)
T ss_dssp             CCEEECCSSCC
T ss_pred             CCCCCCCCCCC
T ss_conf             12433579863

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=99.17  E-value=3.2e-10  Score=68.45  Aligned_cols=150  Identities=15%  Similarity=0.137  Sum_probs=99.2

Q ss_pred             HHHHHHHHCCCCCCEECCCCCCEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHCC-CCCCCEEEEEEECCCCC
Q ss_conf             99999851786464320127624999996999799999943047830366999999983058-96642344331069951
Q 002746          550 RELLEATAEFDEQRLLGTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIR-HRNLMRIITACSLPDFK  628 (885)
Q Consensus       550 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  628 (885)
                      .++......|...+..+.++.+.||+.... ++.+++|............+.+|...+..+. +--+.+++.+...++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHHHHCEEEEECCCCCCCCCEEEEEEC-CCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCE
T ss_conf             999975135279976789987718999908-9869999848876532556999999999876069987289997508964


Q ss_pred             EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC--------------------------
Q ss_conf             399964458853225566875455889887889999999999999999963169--------------------------
Q 002746          629 ALVLPYMANGSLDSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS--------------------------  682 (885)
Q Consensus       629 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------  682 (885)
                      ++||+++++..+........           .   ...++.+++..+..||+..                          
T Consensus        86 ~lv~~~l~G~~~~~~~~~~~-----------~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDEQ-----------S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA  151 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTCS-----------C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred             EEEEEECCCCCCCCCCCCCC-----------C---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
T ss_conf             99998604334354334402-----------6---999999899999998556842143576446565557789987765


Q ss_pred             ------------------------------CCCEEECCCCCCCEEECCCCCEEECCCCCCEE
Q ss_conf             ------------------------------99658447899966766999779814443100
Q 002746          683 ------------------------------PVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       683 ------------------------------~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                                                    +..++|+|+.|.||+++++..+-+.||+.+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHCCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf             55543033232005799999999844986781789860047642364996599960231441

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.91  E-value=1.3e-11  Score=75.96  Aligned_cols=115  Identities=19%  Similarity=0.141  Sum_probs=0.0

Q ss_pred             CCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCH--HHHCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf             1234887786885899965433722220799996997358625567852--43308988878985787334457956789
Q 002746           13 PEFSKLRRLRHLQLDGNNLHGQIPESLALLSNLTLVTLHDNNLTGMLPI--SFFHNCTSLRNVDLSQNFFTGKIPEEIGN   90 (885)
Q Consensus        13 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~--~~~~~l~~L~~L~l~~n~i~~~~~~~~~~   90 (885)
                      ..+..+..+..+....+.+. .++..+..+++|++|+|++|+|+ .++.  ..+..+++|+.|++++|.|.++..-.+-+
T Consensus        36 ~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~-~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~  113 (162)
T d1koha1          36 PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLY-RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIK  113 (162)
T ss_dssp             TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCC-CCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHT
T ss_pred             CHHHHCCCHHHCCHHHHHHH-HHHHHHHHCCCCCEEECCCCCCC-CCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHH
T ss_conf             21554664011225556766-60788974878788637776666-77315889865885610004357213423442220


Q ss_pred             CCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEE
Q ss_conf             99995998426527666871222476525841365346889846540799986887
Q 002746           91 CPNLWTLSLYNNQLTGQLPASLINTSMYNLDVEYNHLSGELPSDIMSKLPSLTYLH  146 (885)
Q Consensus        91 l~~L~~L~L~~n~l~~~~~~~~~~~~L~~L~l~~n~l~~~i~~~~~~~l~~L~~L~  146 (885)
                      ..+|+.|++++|.+.....+..                 .--..+++.+|+|+.||
T Consensus       114 ~~~L~~L~L~~Npl~~~~~~~~-----------------~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1         114 GLKLEELWLDGNSLSDTFRDQS-----------------TYISAIRERFPKLLRLD  152 (162)
T ss_dssp             TCCCSSCCCTTSTTSSSSSSHH-----------------HHHHHHHTTSTTCCEET
T ss_pred             CCCCCEEECCCCCCCCCCCCCH-----------------HHHHHHHHHCCCCCEEC
T ss_conf             3310426648997676766615-----------------69999999889978799

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.89  E-value=1.1e-08  Score=60.29  Aligned_cols=131  Identities=17%  Similarity=0.118  Sum_probs=86.4

Q ss_pred             EECCCCC-CEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHCCCCC--CCEEEEEEECCCCCEEEEECCCCCCC
Q ss_conf             3201276-24999996999799999943047830366999999983058966--42344331069951399964458853
Q 002746          564 LLGTGSY-GRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRN--LMRIITACSLPDFKALVLPYMANGSL  640 (885)
Q Consensus       564 ~lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~L  640 (885)
                      .+..|.. +.||+....++..+++|.....   ....+..|+..++.+....  +.+++.+...++..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             ECCCCCCCCEEEEEEECCCCEEEEEECCCC---CHHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf             767865477589999389878999958966---77689999999999986599988613222456615999874413554


Q ss_pred             CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC--------------------------------------
Q ss_conf             225566875455889887889999999999999999963169--------------------------------------
Q 002746          641 DSHLYPHSETEFGSGSSDLTLLQRVNICSDIAEGMAYLHHHS--------------------------------------  682 (885)
Q Consensus       641 ~~~l~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------  682 (885)
                      .....              ..   ...+.+++..+.-||+..                                      
T Consensus        94 ~~~~~--------------~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (255)
T d1nd4a_          94 LSSHL--------------AP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  156 (255)
T ss_dssp             TTSCC--------------CH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             CCCCC--------------CH---HHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHH
T ss_conf             32212--------------68---99999999999987368854488755412468899999987541101134011213


Q ss_pred             -----------------CCCEEECCCCCCCEEECCCCCEEECCCCCCEE
Q ss_conf             -----------------99658447899966766999779814443100
Q 002746          683 -----------------PVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       683 -----------------~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                                       +..++|+|+.|.||+++++..+-++||+.+..
T Consensus       157 ~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         157 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf             7999999998718765795678678887635773796589998533265

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.56  E-value=6.5e-07  Score=50.71  Aligned_cols=76  Identities=14%  Similarity=0.124  Sum_probs=49.3

Q ss_pred             CEECCCCCCEEEEEEEC-CCCEEEEEEEEECC-------CCCHHHHHHHHHHHHHCC--CCC-CCEEEEEEECCCCCEEE
Q ss_conf             43201276249999969-99799999943047-------830366999999983058--966-42344331069951399
Q 002746          563 RLLGTGSYGRVYKGILQ-DGTAIAVKVLQLQS-------GNFTKSFNRECQVLKRIR--HRN-LMRIITACSLPDFKALV  631 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~--h~n-iv~~~~~~~~~~~~~lv  631 (885)
                      +.+|.|....||++... +++.+++|.-....       .....+...|.+.+..+.  -|. +.+++.+  +++..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEEE
T ss_conf             9807985276899995799848999617713034677788877899999999998650579885528998--59887798


Q ss_pred             EECCCCCCC
Q ss_conf             964458853
Q 002746          632 LPYMANGSL  640 (885)
Q Consensus       632 ~e~~~~g~L  640 (885)
                      ||++++..+
T Consensus       110 mE~L~~~~~  118 (392)
T d2pula1         110 MEDLSHLKI  118 (392)
T ss_dssp             ECCCTTSEE
T ss_pred             EECCCCCCC
T ss_conf             713577653

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=98.25  E-value=1.1e-05  Score=44.16  Aligned_cols=73  Identities=12%  Similarity=0.174  Sum_probs=48.3

Q ss_pred             CEECCCCCCEEEEEEECC--------CCEEEEEEEEECCCCCHHHHHHHHHHHHHCCCCCC-CEEEEEEECCCCCEEEEE
Q ss_conf             432012762499999699--------97999999430478303669999999830589664-234433106995139996
Q 002746          563 RLLGTGSYGRVYKGILQD--------GTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNL-MRIITACSLPDFKALVLP  633 (885)
Q Consensus       563 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e  633 (885)
                      +.|+.|-.-.+|++....        ...|.+++.. . ........+|..+++.+.-.++ .++++++..    ..|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-C-CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEEE
T ss_conf             991785334348999688775445789817999659-9-61165899999999999757999808998189----56999


Q ss_pred             CCCCCCCC
Q ss_conf             44588532
Q 002746          634 YMANGSLD  641 (885)
Q Consensus       634 ~~~~g~L~  641 (885)
                      |+++..+.
T Consensus       122 fi~g~~l~  129 (395)
T d1nw1a_         122 YIPSRPLS  129 (395)
T ss_dssp             CCCEEECC
T ss_pred             EECCCCCC
T ss_conf             73455488

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=98.21  E-value=3.2e-07  Score=52.36  Aligned_cols=111  Identities=15%  Similarity=0.167  Sum_probs=0.0

Q ss_pred             CCCCCCCEEECCC-CCCCCC----CCHHHCCCCCCCEEECCCCCCCC----CCCCCCCCCCCCCEEECCCCCCCCC----
Q ss_conf             3888888466226-556654----20210388999857666652533----4760000889877032124325566----
Q 002746          216 GNLSNLISLNLSS-NLLSGT----ISAEISWLSQLEQLFLSHNLFSG----EIPAALGKLHHLGLLDLSFNKLSGE----  282 (885)
Q Consensus       216 ~~l~~L~~L~l~~-n~l~~~----~~~~~~~l~~L~~L~L~~n~i~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----  282 (885)
                      .+.++|++|++++ +.+...    ....+...++|++|+|++|.+..    .+...+...+.|+.|+|++|.+...    
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~   91 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR   91 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             HCCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHH
T ss_conf             28999819782799998989999999997637764540120156215679887531000234330033010214599999


Q ss_pred             CCCCCCCCCCCCEEECCCCCCCCC-------CCCCCCCCCCCCEEECCCCC
Q ss_conf             773223777542998357744788-------99466899998789776884
Q 002746          283 IPVSLGNLVQIYSLFLNNNQLSRS-------IPPTLGRCTDLYKLDLSYNR  326 (885)
Q Consensus       283 ~~~~~~~l~~L~~L~l~~n~l~~~-------~~~~~~~l~~L~~L~l~~N~  326 (885)
                      ...++...+.|++|++++|++...       +...+...+.|+.|+++.+.
T Consensus        92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~  142 (167)
T d1pgva_          92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  142 (167)
T ss_dssp             HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             HHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf             999998489389877887768886579999999999729985386486888

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=98.10  E-value=6.4e-05  Score=40.00  Aligned_cols=166  Identities=16%  Similarity=0.124  Sum_probs=84.6

Q ss_pred             CCCHHHHHHHHHCCCCCCEE-----CCCCCCEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHCCCCCC--CEE
Q ss_conf             76989999985178646432-----01276249999969997999999430478303669999999830589664--234
Q 002746          546 RITYRELLEATAEFDEQRLL-----GTGSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNL--MRI  618 (885)
Q Consensus       546 ~~~~~~~~~~~~~~~~~~~l-----g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~  618 (885)
                      .++.+++.....+|.+++..     ..|.--+.|+....+| .+++|++....  ..+....|.+++..+....+  ...
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~p   78 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP   78 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCC-CEEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf             88999999999867999856852378885267389997897-28999807899--9889999999987543025554556


Q ss_pred             EEE------EECCCCCEEEEECCCCCCCCCCCCCCCC-------------CCCC-CCCCCCCHH----------------
Q ss_conf             433------1069951399964458853225566875-------------4558-898878899----------------
Q 002746          619 ITA------CSLPDFKALVLPYMANGSLDSHLYPHSE-------------TEFG-SGSSDLTLL----------------  662 (885)
Q Consensus       619 ~~~------~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~-~~~~~l~~~----------------  662 (885)
                      +..      .........++.+..+......-.....             ..+. .........                
T Consensus        79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (316)
T d2ppqa1          79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  158 (316)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             CEECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHC
T ss_conf             41048976213412550245311465533320467888889987645444320245310111012002456777765311


Q ss_pred             --HHHHHHHHHHHHHHHHHC-CCCCCEEECCCCCCCEEECCCCCEEECCCCCCEE
Q ss_conf             --999999999999999631-6999658447899966766999779814443100
Q 002746          663 --QRVNICSDIAEGMAYLHH-HSPVRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       663 --~~~~i~~~i~~~L~~LH~-~~~~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                        .....+......+...+. .-+.+++|+|+.++||+++.+...-+.||+.+..
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf             4127999999987642048554545033378636564020454126742221236

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=98.05  E-value=4.5e-05  Score=40.81  Aligned_cols=144  Identities=14%  Similarity=0.132  Sum_probs=77.1

Q ss_pred             CCCCEEEEEEECCCCEEEEEEEEECCCCCHHHHHHHHHHHHHCCCCCC--CEEE-----EEEECCCCCEEEEECCCCCCC
Q ss_conf             276249999969997999999430478303669999999830589664--2344-----331069951399964458853
Q 002746          568 GSYGRVYKGILQDGTAIAVKVLQLQSGNFTKSFNRECQVLKRIRHRNL--MRII-----TACSLPDFKALVLPYMANGSL  640 (885)
Q Consensus       568 G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~-----~~~~~~~~~~lv~e~~~~g~L  640 (885)
                      +.--.||++...+|..|++|+.+.. ....+++..|...+..+....+  +...     .........+.++++++|..+
T Consensus        33 s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          33 SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             CCCCEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCC
T ss_conf             6120269998389997999984787-788999999999999998559987875206898056653479999865277688


Q ss_pred             CCCC--------------CCCCCCCCCCCCCCCC----------------------HHHHHHHHHHHHHHHHHHH-CCCC
Q ss_conf             2255--------------6687545588988788----------------------9999999999999999963-1699
Q 002746          641 DSHL--------------YPHSETEFGSGSSDLT----------------------LLQRVNICSDIAEGMAYLH-HHSP  683 (885)
Q Consensus       641 ~~~l--------------~~~~~~~~~~~~~~l~----------------------~~~~~~i~~~i~~~L~~LH-~~~~  683 (885)
                      ...-              +......-.......+                      .......+..+...+.-.- ...+
T Consensus       112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p  191 (325)
T d1zyla1         112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT  191 (325)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf             99999999998999999886303578655677897887665689998747699889899999999999999984545687


Q ss_pred             CCEEECCCCCCCEEECCCCCEEECCCCCCEE
Q ss_conf             9658447899966766999779814443100
Q 002746          684 VRVIHCDLKPSNVLLNDDMTALVSDFGIAKL  714 (885)
Q Consensus       684 ~~ivH~dikp~NILl~~~~~~kl~Dfg~a~~  714 (885)
                      ..++|+|+.+.|||++++  ..+.||+-+..
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             CEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf             120247888042878389--35886520146

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.84  E-value=8.5e-07  Score=50.07  Aligned_cols=124  Identities=15%  Similarity=0.156  Sum_probs=0.0

Q ss_pred             CCCCCCCCCCCCCCCCCCCCEEECCC-CCCCCCCCHHHC----CCCCCCEEECCCCCCCC----CCCCCCCCCCCCCEEE
Q ss_conf             58733456883653888888466226-556654202103----88999857666652533----4760000889877032
Q 002746          203 QENKITGSIPPHIGNLSNLISLNLSS-NLLSGTISAEIS----WLSQLEQLFLSHNLFSG----EIPAALGKLHHLGLLD  273 (885)
Q Consensus       203 ~~n~i~~~~p~~l~~l~~L~~L~l~~-n~l~~~~~~~~~----~l~~L~~L~L~~n~i~~----~~~~~~~~l~~L~~L~  273 (885)
                      ....+...+.....+.++|++|++++ +.++......+.    ..++|++|++++|.+..    .+...+...++++.++
T Consensus         1 ~~~~i~~~l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~   80 (166)
T d1io0a_           1 NSTDVEETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLN   80 (166)
T ss_dssp             CCCCHHHHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEE
T ss_pred             CCCCHHHHHHHHHHCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHH
T ss_conf             97639999999995599986887689999898999999988841982574301589611778999998775212210121


Q ss_pred             CCCCCCCCCCC----CCCCCCCCCCEEECC--CCCCCC----CCCCCCCCCCCCCEEECCCCC
Q ss_conf             12432556677----322377754299835--774478----899466899998789776884
Q 002746          274 LSFNKLSGEIP----VSLGNLVQIYSLFLN--NNQLSR----SIPPTLGRCTDLYKLDLSYNR  326 (885)
Q Consensus       274 Ls~N~l~~~~~----~~~~~l~~L~~L~l~--~n~l~~----~~~~~~~~l~~L~~L~l~~N~  326 (885)
                      +++|.+.....    ..+...+.|+.++|+  +|.+..    .+...+...+.|+.|+++.+.
T Consensus        81 l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_          81 VESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             CCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred             HCCCCCCCHHHHHHHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf             025432201478899999848652477321677867679999999999849984788581898